Entry,Protein names,Sequence,Length,Mass,Features,Disulfide bond,Signal peptide
Q6ZRP7,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),MAAAGAAVARSPGIGAGPALRARRSPPPRAARLPRLLVLLAAAAVGPGAGGAARLYRAGEDAVWVLDSGSVRGATANSSAAWLVQFYSSWCGHCIGYAPTWRALAGDVRDWASAIRVAALDCMEEKNQAVCHDYDIHFYPTFRYFKAFTKEFTTGENFKGPDRELRTVRQTMIDFLQNHTEGSRPPACPRLDPIQPSDVLSLLDNRGSHYVAIVFESNSSYLGREVILDLIPYESIVVTRALDGDKAFLEKLGVSSVPSCYLIYPNGSHGLINVVKPLRAFFSSYLKSLPDVRKKSLPLPEKPHKEENSEIVVWREFDKSKLYTVDLESGLHYLLRVELAAHKSLAGAELKTLKDFVTVLAKLFPGRPPVKKLLEMLQEWLASLPLDRIPYNAVLDLVNNKMRISGIFLTNHIKWVGCQGSRSELRGYPCSLWKLFHTLTVEASTHPDALVGTGFEDDPQAVLQTMRRYVHTFFGCKECGEHFEEMAKESMDSVKTPDQAILWLWKKHNMVNGRLAGHLSEDPRFPKLQWPTPDLCPACHEEIKGLASWDEGHVLTFLKQHYGRDNLLDTYSADQGDSSEGGTLARGEEEEKRLTPPEVSHGDRDTQSVRPPGALGPRPALPESLHHSLDGKLQSLDGPGAHKEVGGAAPFLGVDFSSLDMSLCVVLYVASSLFLMVMYFFFRVRSRRWKVKHHHPAV,698,"77,529",Active site (2); Binding site (7); Chain (1); Compositional bias (2); Disulfide bond (5); Domain (2); Erroneous initiation (1); Frameshift (1); Glycosylation (4); Modified residue (1); Natural variant (1); Nucleotide binding (1); Sequence conflict (3); Signal peptide (1); Transmembrane (1),"DISULFID 91..94;  /note=""Redox-active"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00654, ECO:0000255|PROSITE-ProRule:PRU00691""; DISULFID 122..131;  /evidence=""ECO:0000250|UniProtKB:O00391""; DISULFID 418..430;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00654""; DISULFID 476..479;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00654""; DISULFID 536..539;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00654""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P07949,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAASTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS,1114,"124,319",Active site (1); Alternative sequence (1); Beta strand (27); Binding site (2); Chain (3); Disulfide bond (1); Domain (2); Erroneous initiation (4); Glycosylation (12); Helix (21); Modified residue (10); Mutagenesis (4); Natural variant (137); Nucleotide binding (1); Region (1); Sequence conflict (4); Signal peptide (1); Site (4); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 137..142;  /evidence=""ECO:0000269|PubMed:20473317""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9HCK4,Roundabout homolog 2,MSLLMFTQLLLCGFLYVRVDGSRLRQEDFPPRIVEHPSDVIVSKGEPTTLNCKAEGRPTPTIEWYKDGERVETDKDDPRSHRMLLPSGSLFFLRIVHGRRSKPDEGSYVCVARNYLGEAVSRNASLEVALLRDDFRQNPTDVVVAAGEPAILECQPPRGHPEPTIYWKKDKVRIDDKEERISIRGGKLMISNTRKSDAGMYTCVGTNMVGERDSDPAELTVFERPTFLRRPINQVVLEEEAVEFRCQVQGDPQPTVRWKKDDADLPRGRYDIKDDYTLRIKKTMSTDEGTYMCIAENRVGKMEASATLTVRAPPQFVVRPRDQIVAQGRTVTFPCETKGNPQPAVFWQKEGSQNLLFPNQPQQPNSRCSVSPTGDLTITNIQRSDAGYYICQALTVAGSILAKAQLEVTDVLTDRPPPIILQGPANQTLAVDGTALLKCKATGDPLPVISWLKEGFTFPGRDPRATIQEQGTLQIKNLRISDTGTYTCVATSSSGETSWSAVLDVTESGATISKNYDLSDLPGPPSKPQVTDVTKNSVTLSWQPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVRTQDISPPAQGVDHRQVQKELGDVLVRLHNPVVLTPTTVQVTWTVDRQPQFIQGYRVMYRQTSGLQATSSWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEEAPSAPPQSVTVLTVGSYNSTSISVSWDPPPPDHQNGIIQEYKIWCLGNETRFHINKTVDAAIRSVIIGGLFPGIQYRVEVAASTSAGVGVKSEPQPIIIGRRNEVVITENNNSITEQITDVVKQPAFIAGIGGACWVILMGFSIWLYWRRKKRKGLSNYAVTFQRGDGGLMSNGSRPGLLNAGDPSYPWLADSWPATSLPVNNSNSGPNEIGNFGRGDVLPPVPGQGDKTATMLSDGAIYSSIDFTTKTSYNSSSQITQATPYATTQILHSNSIHELAVDLPDPQWKSSIQQKTDLMGFGYSLPDQNKGNNGGKGGKKKKNKNSSKPQKNNGSTWANVPLPPPPVQPLPGTELEHYAVEQQENGYDSDSWCPPLPVQTYLHQGLEDELEEDDDRVPTPPVRGVASSPAISFGQQSTATLTPSPREEMQPMLQAHLDELTRAYQFDIAKQTWHIQSNNQPPQPPVPPLGYVSGALISDLETDVADDDADDEEEALEIPRPLRALDQTPGSSMDNLDSSVTGKAFTSSQRPRPTSPFSTDSNTSAALSQSQRPRPTKKHKGGRMDQQPALPHRREGMTDEEALVPYSKPSFPSPGGHSSSGTASSKGSTGPRKTEVLRAGHQRNASDLLDIGYMGSNSQGQFTGEL,1378,"151,200",Alternative sequence (2); Beta strand (52); Chain (1); Disulfide bond (5); Domain (8); Erroneous initiation (1); Frameshift (1); Glycosylation (6); Helix (5); Modified residue (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 52..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 154..203;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 246..293;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 335..391;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 439..488;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q96QU1,Protocadherin-15,MFRQFYLWTCLASGIILGSLFEICLGQYDDDCKLARGGPPATIVAIDEESRNGTILVDNMLIKGTAGGPDPTIELSLKDNVDYWVLMDPVKQMLFLNSTGRVLDRDPPMNIHSIVVQVQCINKKVGTIIYHEVRIVVRDRNDNSPTFKHESYYATVNELTPVGTTIFTGFSGDNGATDIDDGPNGQIEYVIQYNPDDPTSNDTFEIPLMLTGNIVLRKRLNYEDKTRYFVIIQANDRAQNLNERRTTTTTLTVDVLDGDDLGPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNQSPYFTMPSYQGYILESAPVGATISDSLNLTSPLRIVALDKDIEDTKDPELHLFLNDYTSVFTVTQTGITRYLTLLQPVDREEQQTYTFSITAFDGVQESEPVIVNIQVMDANDNTPTFPEISYDVYVYTDMRPGDSVIQLTAVDADEGSNGEITYEILVGAQGDFIINKTTGLITIAPGVEMIVGRTYALTVQAADNAPPAERRNSICTVYIEVLPPNNQSPPRFPQLMYSLEISEAMRVGAVLLNLQATDREGDSITYAIENGDPQRVFNLSETTGILTLGKALDRESTDRYILIITASDGRPDGTSTATVNIVVTDVNDNAPVFDPYLPRNLSVVEEEANAFVGQVKATDPDAGINGQVHYSLGNFNNLFRITSNGSIYTAVKLNREVRDYYELVVVATDGAVHPRHSTLTLAIKVLDIDDNSPVFTNSTYTVLVEENLPAGTTILQIEAKDVDLGANVSYRIRSPEVKHFFALHPFTGELSLLRSLDYEAFPDQEASITFLVEAFDIYGTMPPGIATVTVIVKDMNDYPPVFSKRIYKGMVAPDAVKGTPITTVYAEDADPPGLPASRVRYRVDDVQFPYPASIFEVEEDSGRVITRVNLNEEPTTIFKLVVVAFDDGEPVMSSSATVKILVLHPGEIPRFTQEEYRPPPVSELATKGTMVGVISAAAINQSIVYSIVSGNEEDTFGINNITGVIYVNGPLDYETRTSYVLRVQADSLEVVLANLRVPSKSNTAKVYIEIQDENNHPPVFQKKFYIGGVSEDARMFTSVLRVKATDKDTGNYSVMAYRLIIPPIKEGKEGFVVETYTGLIKTAMLFHNMRRSYFKFQVIATDDYGKGLSGKADVLVSVVNQLDMQVIVSNVPPTLVEKKIEDLTEILDRYVQEQIPGAKVVVESIGARRHGDAFSLEDYTKCDLTVYAIDPQTNRAIDRNELFKFLDGKLLDINKDFQPYYGEGGRILEIRTPEAVTSIKKRGESLGYTEGALLALAFIIILCCIPAILVVLVSYRQFKVRQAECTKTARIQAALPAAKPAVPAPAPVAAPPPPPPPPPGAHLYEELGDSSILFLLYHFQQSRGNNSVSEDRKHQQVVMPFSSNTIEAHKSAHVDGSLKSNKLKSARKFTFLSDEDDLSAHNPLYKENISQVSTNSDISQRTDFVDPFSPKIQAKSKSLRGPREKIQRLWSQSVSLPRRLMRKVPNRPEIIDLQQWQGTRQKAENENTGICTNKRGSSNPLLTTEEANLTEKEEIRQGETLMIEGTEQLKSLSSDSSFCFPRPHFSFSTLPTVSRTVELKSEPNVISSPAECSLELSPSRPCVLHSSLSRRETPICMLPIETERNIFENFAHPPNISPSACPLPPPPPISPPSPPPAPAPLAPPPDISPFSLFCPPPSPPSIPLPLPPPTFFPLSVSTSGPPTPPLLPPFPTPLPPPPPSIPCPPPPSASFLSTECVCITGVKCTTNLMPAEKIKSSMTQLSTTTVCKTDPQREPKGILRHVKNLAELEKSVANMYSQIEKNYLRTNVSELQTMCPSEVTNMEITSEQNKGSLNNIVEGTEKQSHSQSTSL,1955,"216,069",Alternative sequence (9); Beta strand (71); Chain (1); Compositional bias (4); Disulfide bond (1); Domain (11); Erroneous termination (1); Glycosylation (13); Helix (13); Natural variant (14); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (20),"DISULFID 32..120;  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9Y6N7,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),MKWKHVPFLVMISLLSLSPNHLFLAQLIPDPEDVERGNDHGTPIPTSDNDDNSLGYTGSRLRQEDFPPRIVEHPSDLIVSKGEPATLNCKAEGRPTPTIEWYKGGERVETDKDDPRSHRMLLPSGSLFFLRIVHGRKSRPDEGVYVCVARNYLGEAVSHNASLEVAILRDDFRQNPSDVMVAVGEPAVMECQPPRGHPEPTISWKKDGSPLDDKDERITIRGGKLMITYTRKSDAGKYVCVGTNMVGERESEVAELTVLERPSFVKRPSNLAVTVDDSAEFKCEARGDPVPTVRWRKDDGELPKSRYEIRDDHTLKIRKVTAGDMGSYTCVAENMVGKAEASATLTVQEPPHFVVKPRDQVVALGRTVTFQCEATGNPQPAIFWRREGSQNLLFSYQPPQSSSRFSVSQTGDLTITNVQRSDVGYYICQTLNVAGSIITKAYLEVTDVIADRPPPVIRQGPVNQTVAVDGTFVLSCVATGSPVPTILWRKDGVLVSTQDSRIKQLENGVLQIRYAKLGDTGRYTCIASTPSGEATWSAYIEVQEFGVPVQPPRPTDPNLIPSAPSKPEVTDVSRNTVTLSWQPNLNSGATPTSYIIEAFSHASGSSWQTVAENVKTETSAIKGLKPNAIYLFLVRAANAYGISDPSQISDPVKTQDVLPTSQGVDHKQVQRELGNAVLHLHNPTVLSSSSIEVHWTVDQQSQYIQGYKILYRPSGANHGESDWLVFEVRTPAKNSVVIPDLRKGVNYEIKARPFFNEFQGADSEIKFAKTLEEAPSAPPQGVTVSKNDGNGTAILVSWQPPPEDTQNGMVQEYKVWCLGNETRYHINKTVDGSTFSVVIPFLVPGIRYSVEVAASTGAGSGVKSEPQFIQLDAHGNPVSPEDQVSLAQQISDVVKQPAFIAGIGAACWIILMVFSIWLYRHRKKRNGLTSTYAGIRKVPSFTFTPTVTYQRGGEAVSSGGRPGLLNISEPAAQPWLADTWPNTGNNHNDCSISCCTAGNGNSDSNLTTYSRPADCIANYNNQLDNKQTNLMLPESTVYGDVDLSNKINEMKTFNSPNLKDGRFVNPSGQPTPYATTQLIQSNLSNNMNNGSGDSGEKHWKPLGQQKQEVAPVQYNIVEQNKLNKDYRANDTVPPTIPYNQSYDQNTGGSYNSSDRGSSTSGSQGHKKGARTPKVPKQGGMNWADLLPPPPAHPPPHSNSEEYNISVDESYDQEMPCPVPPARMYLQQDELEEEEDERGPTPPVRGAASSPAAVSYSHQSTATLTPSPQEELQPMLQDCPEETGHMQHQPDRRRQPVSPPPPPRPISPPHTYGYISGPLVSDMDTDAPEEEEDEADMEVAKMQTRRLLLRGLEQTPASSVGDLESSVTGSMINGWGSASEEDNISSGRSSVSSSDGSFFTDADFAQAVAAAAEYAGLKVARRQMQDAAGRRHFHASQCPRPTSPVSTDSNMSAAVMQKTRPAKKLKHQPGHLRRETYTDDLPPPPVPPPAIKSPTAQSKTQLEVRPVVVPKLPSMDARTDRSSDRKGSSYKGREVLDGRQVVDMRTNPGDPREAQEQQNDGKGRGNKAAKRDLPPAKTHLIQEDILPYCRPTFPTSNNPRDPSSSSSMSSRGSGSRQREQANVGRRNIAEMQVLGGYERGEDNNEELEETES,1651,"180,930",Alternative sequence (7); Beta strand (64); Chain (1); Disulfide bond (5); Domain (8); Glycosylation (5); Helix (9); Modified residue (8); Natural variant (4); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 89..147;  /evidence=""ECO:0000244|PDB:2V9Q, ECO:0000244|PDB:2V9R, ECO:0000244|PDB:2V9T, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17848514""; DISULFID 191..240;  /evidence=""ECO:0000244|PDB:2V9Q, ECO:0000244|PDB:2V9R, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17848514""; DISULFID 283..330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 372..428;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 476..525;  /evidence=""ECO:0000244|PDB:2EO9, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|Ref.21""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P43629,Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (MHC class I NK cell receptor) (Natural killer-associated transcript 3) (NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11) (p70 NK receptor CL-2/CL-11) (CD antigen CD158e),MSLMVVSMACVGLFLVQRAGPHMGGQDKPFLSAWPSAVVPRGGHVTLRCHYRHRFNNFMLYKEDRIHIPIFHGRIFQESFNMSPVTTAHAGNYTCRGSHPHSPTGWSAPSNPVVIMVTGNHRKPSLLAHPGPLVKSGERVILQCWSDIMFEHFFLHKEGISKDPSRLVGQIHDGVSKANFSIGPMMLALAGTYRCYGSVTHTPYQLSAPSDPLDIVVTGPYEKPSLSAQPGPKVQAGESVTLSCSSRSSYDMYHLSREGGAHERRLPAVRKVNRTFQADFPLGPATHGGTYRCFGSFRHSPYEWSDPSDPLLVSVTGNPSSSWPSPTEPSSKSGNPRHLHILIGTSVVIILFILLLFFLLHLWCSNKKNAAVMDQEPAGNRTANSEDSDEQDPEEVTYAQLDHCVFTQRKITRPSQRPKTPPTDTILYTELPNAKPRSKVVSCP,444,"49,098",Alternative sequence (1); Beta strand (27); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Helix (3); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..95;  /evidence=""ECO:0000269|PubMed:22020283""; DISULFID 144..195;  /evidence=""ECO:0000269|PubMed:22020283""; DISULFID 244..293;  /evidence=""ECO:0000269|PubMed:22020283""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q68D85,Natural cytotoxicity triggering receptor 3 ligand 1 (B7 homolog 6) (B7-H6),MTWRAAASTCAALLILLWALTTEGDLKVEMMAGGTQITPLNDNVTIFCNIFYSQPLNITSMGITWFWKSLTFDKEVKVFEFFGDHQEAFRPGAIVSPWRLKSGDASLRLPGIQLEEAGEYRCEVVVTPLKAQGTVQLEVVASPASRLLLDQVGMKENEDKYMCESSGFYPEAINITWEKQTQKFPHPIEISEDVITGPTIKNMDGTFNVTSCLKLNSSQEDPGTVYQCVVRHASLHTPLRSNFTLTAARHSLSETEKTDNFSIHWWPISFIGVGLVLLIVLIPWKKICNKSSSAYTPLKCILKHWNSFDTQTLKKEHLIFFCTRAWPSYQLQDGEAWPPEGSVNINTIQQLDVFCRQEGKWSEVPYVQAFFALRDNPDLCQCCRIDPALLTVTSGKSIDDNSTKSEKQTPREHSDAVPDAPILPVSPIWEPPPATTSTTPVLSSQPPTLLLPLQ,454,"50,827",Beta strand (20); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (7); Helix (4); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 48..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21422170""; DISULFID 163..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21422170""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q96PC5,Melanoma inhibitory activity protein 2 (MIA protein 2) (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11),MAKFGVHRILLLAISLTKCLESTKLLADLKKCGDLECEALINRVSAMRDYRGPDCRYLNFTKGEEISVYVKLAGEREDLWAGSKGKEFGYFPRDAVQIEEVFISEEIQMSTKESDFLCLLGVSYTFDNEDSELNGDYGENIYPYEEDKDEKSSIYESDFQIEPGFYATYESTLFEDQVPALEAPEDIGSTSESKDWEEVVVESMEQDRIPEVHVPPSSAVSGVKEWFGLGGEQAEEKAFESVIEPVQESSFRSRKIAVEDENDLEELNNGEPQTEHQQESESEIDSVPKTQSELASESEHIPKPQSTGWFGGGFTSYLGFGDEDTGLELIAEESNPPLQDFPNSISSDKEATVPCTEILTEKKDTITNDSLSLKPSWFDFGFAILGFAYAKEDKIMLDDRKNEEDGGADEHEHPLTSELDPEKEQEIETIKIIETEDQIDKKPVSEKTDESDTIPYLKKFLYNFDNPWNFQNIPKETELPFPKQILDQNNVIENEETGEFSIDNYPTDNTKVMIFKSSYSLSDMVSNIELPTRIHEEVYFEPSSSKDSDENSKPSVDTEGPALVEIDRSVENTLLNSQMVSTDNSLSSQNYISQKEDASEFQILKYLFQIDVYDFMNSAFSPIVILTERVVAALPEGMRPDSNLYGFPWELVICAAVVGFFAVLFFLWRSFRSVRSRLYVGREKKLALMLSGLIEEKSKLLEKFSLVQKEYEGYEVESSLKDASFEKEATEAQSLEATCEKLNRSNSELEDEILCLEKELKEEKSKHSEQDELMADISKRIQSLEDESKSLKSQVAEAKMTFKIFQMNEERLKIAIKDALNENSQLQESQKQLLQEAEVWKEQVSELNKQKVTFEDSKVHAEQVLNDKESHIKTLTERLLKMKDWAAMLGEDITDDDNLELEMNSESENGAYLDNPPKGALKKLIHAAKLNASLKTLEGERNQIYIQLSEVDKTKEELTEHIKNLQTEQASLQSENTHFENENQKLQQKLKVMTELYQENEMKLHRKLTVEENYRLEKEEKLSKVDEKISHATEELETYRKRAKDLEEELERTIHSYQGQIISHEKKAHDNWLAARNAERNLNDLRKENAHNRQKLTETELKFELLEKDPYALDVPNTAFGREHSPYGPSPLGWPSSETRAFLSPPTLLEGPLRLSPLLPGGGGRGSRGPGNPLDHQITNERGESSCDRLTDPHRAPSDTGSLSPPWDQDRRMMFPPPGQSYPDSALPPQRQDRFCSNSGRLSGPAELRSFNMPSLDKMDGSMPSEMESSRNDTKDDLGNLNVPDSSLPAENEATGPGFVPPPLAPIRGPLFPVDARGPFLRRGPPFPPPPPGAMFGASRDYFPPGDFPGPPPAPFAMRNVYPPRGFPPYLPPRPGFFPPPPHSEGRSEFPSGLIPPSNEPATEHPEPQQET,1412,"159,836",Alternative sequence (15); Chain (1); Coiled coil (2); Compositional bias (1); Domain (1); Erroneous initiation (2); Glycosylation (2); Intramembrane (1); Mutagenesis (4); Natural variant (12); Region (2); Sequence caution (1); Sequence conflict (11); Signal peptide (1); Topological domain (3); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P23469,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),MEPLCPLLLVGFSLPLARALRGNETTADSNETTTTSGPPDPGASQPLLAWLLLPLLLLLLVLLLAAYFFRFRKQRKAVVSTSDKKMPNGILEEQEQQRVMLLSRSPSGPKKYFPIPVEHLEEEIRIRSADDCKQFREEFNSLPSGHIQGTFELANKEENREKNRYPNILPNDHSRVILSQLDGIPCSDYINASYIDGYKEKNKFIAAQGPKQETVNDFWRMVWEQKSATIVMLTNLKERKEEKCHQYWPDQGCWTYGNIRVCVEDCVVLVDYTIRKFCIQPQLPDGCKAPRLVSQLHFTSWPDFGVPFTPIGMLKFLKKVKTLNPVHAGPIVVHCSAGVGRTGTFIVIDAMMAMMHAEQKVDVFEFVSRIRNQRPQMVQTDMQYTFIYQALLEYYLYGDTELDVSSLEKHLQTMHGTTTHFDKIGLEEEFRKLTNVRIMKENMRTGNLPANMKKARVIQIIPYDFNRVILSMKRGQEYTDYINASFIDGYRQKDYFIATQGPLAHTVEDFWRMIWEWKSHTIVMLTEVQEREQDKCYQYWPTEGSVTHGEITIEIKNDTLSEAISIRDFLVTLNQPQARQEEQVRVVRQFHFHGWPEIGIPAEGKGMIDLIAAVQKQQQQTGNHPITVHCSAGAGRTGTFIALSNILERVKAEGLLDVFQAVKSLRLQRPHMVQTLEQYEFCYKVVQDFIDIFSDYANFK,700,"80,642",Active site (2); Alternative sequence (2); Beta strand (28); Binding site (2); Chain (1); Domain (2); Glycosylation (2); Helix (21); Modified residue (1); Region (1); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q13332,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma),MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSETFESTPIRGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRELREVRRVAPRFSILPMSHEIMPGGNVNITCVAVGSPMPYVKWMQGAEDLTPEDDMPVGRNVLELTDVKDSANYTCVAMSSLGVIEAVAQITVKSLPKAPGTPMVTENTATSITITWDSGNPDPVSYYVIEYKSKSQDGPYQIKEDITTTRYSIGGLSPNSEYEIWVSAVNSIGQGPPSESVVTRTGEQAPASAPRNVQARMLSATTMIVQWEEPVEPNGLIRGYRVYYTMEPEHPVGNWQKHNVDDSLLTTVGSLLEDETYTVRVLAFTSVGDGPLSDPIQVKTQQGVPGQPMNLRAEARSETSITLSWSPPRQESIIKYELLFREGDHGREVGRTFDPTTSYVVEDLKPNTEYAFRLAARSPQGLGAFTPVVRQRTLQSKPSAPPQDVKCVSVRSTAILVSWRPPPPETHNGALVGYSVRYRPLGSEDPEPKEVNGIPPTTTQILLEALEKWTQYRITTVAHTEVGPGPESSPVVVRTDEDVPSAPPRKVEAEALNATAIRVLWRSPAPGRQHGQIRGYQVHYVRMEGAEARGPPRIKDVMLADAQWETDDTAEYEMVITNLQPETAYSITVAAYTMKGDGARSKPKVVVTKGAVLGRPTLSVQQTPEGSLLARWEPPAGTAEDQVLGYRLQFGREDSTPLATLEFPPSEDRYTASGVHKGATYVFRLAARSRGGLGEEAAEVLSIPEDTPRGHPQILEAAGNASAGTVLLRWLPPVPAERNGAIVKYTVAVREAGALGPARETELPAAAEPGAENALTLQGLKPDTAYDLQVRAHTRRGPGPFSPPVRYRTFLRDQVSPKNFKVKMIMKTSVLLSWEFPDNYNSPTPYKIQYNGLTLDVDGRTTKKLITHLKPHTFYNFVLTNRGSSLGGLQQTVTAWTAFNLLNGKPSVAPKPDADGFIMVYLPDGQSPVPVQSYFIVMVPLRKSRGGQFLTPLGSPEDMDLEELIQDISRLQRRSLRHSRQLEVPRPYIAARFSVLPPTFHPGDQKQYGGFDNRGLEPGHRYVLFVLAVLQKSEPTFAASPFSDPFQLDNPDPQPIVDGEEGLIWVIGPVLAVVFIICIVIAILLYKNKPDSKRKDSEPRTKCLLNNADLAPHHPKDPVEMRRINFQTPDSGLRSPLREPGFHFESMLSHPPIPIADMAEHTERLKANDSLKLSQEYESIDPGQQFTWEHSNLEVNKPKNRYANVIAYDHSRVILQPIEGIMGSDYINANYVDGYRCQNAYIATQGPLPETFGDFWRMVWEQRSATIVMMTRLEEKSRIKCDQYWPNRGTETYGFIQVTLLDTIELATFCVRTFSLHKNGSSEKREVRQFQFTAWPDHGVPEYPTPFLAFLRRVKTCNPPDAGPIVVHCSAGVGRTGCFIVIDAMLERIKPEKTVDVYGHVTLMRSQRNYMVQTEDQYSFIHEALLEAVGCGNTEVPARSLYAYIQKLAQVEPGEHVTGMELEFKRLANSKAHTSRFISANLPCNKFKNRLVNIMPYESTRVCLQPIRGVEGSDYINASFIDGYRQQKAYIATQGPLAETTEDFWRMLWENNSTIVVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTVRQFQFTDWPEQGVPKSGEGFIDFIGQVHKTKEQFGQDGPISVHCSAGVGRTGVFITLSIVLERMRYEGVVDIFQTVKMLRTQRPAMVQTEDEYQFCYQAALEYLGSFDHYAT,1948,"217,041",Active site (2); Alternative sequence (7); Beta strand (75); Binding site (2); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (13); Frameshift (1); Glycosylation (4); Helix (27); Mutagenesis (4); Natural variant (2); Region (2); Sequence conflict (13); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (12),"DISULFID 54..107;  /evidence=""ECO:0000244|PDB:2YD2, ECO:0000244|PDB:2YD3, ECO:0000244|PDB:2YD9, ECO:0000244|PDB:4PBX, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21454754, ECO:0000269|PubMed:25385546""; DISULFID 156..216;  /evidence=""ECO:0000244|PDB:2YD2, ECO:0000244|PDB:2YD3, ECO:0000244|PDB:2YD9, ECO:0000244|PDB:4PBX, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 266..311;  /evidence=""ECO:0000244|PDB:2YD2, ECO:0000244|PDB:2YD3, ECO:0000244|PDB:2YD9, ECO:0000244|PDB:4PBX, ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q68DV7,E3 ubiquitin-protein ligase RNF43 (EC 2.3.2.27) (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43),MSGGHQLQLAALWPWLLMATLQAGFGRTGLVLAAAVESERSAEQKAIIRVIPLKMDPTGKLNLTLEGVFAGVAEITPAEGKLMQSHPLYLCNASDDDNLEPGFISIVKLESPRRAPRPCLSLASKARMAGERGASAVLFDITEDRAAAEQLQQPLGLTWPVVLIWGNDAEKLMEFVYKNQKAHVRIELKEPPAWPDYDVWILMTVVGTIFVIILASVLRIRCRPRHSRPDPLQQRTAWAISQLATRRYQASCRQARGEWPDSGSSCSSAPVCAICLEEFSEGQELRVISCLHEFHRNCVDPWLHQHRTCPLCMFNITEGDSFSQSLGPSRSYQEPGRRLHLIRQHPGHAHYHLPAAYLLGPSRSAVARPPRPGPFLPSQEPGMGPRHHRFPRAAHPRAPGEQQRLAGAQHPYAQGWGLSHLQSTSQHPAACPVPLRRARPPDSSGSGESYCTERSGYLADGPASDSSSGPCHGSSSDSVVNCTDISLQGVHGSSSTFCSSLSSDFDPLVYCSPKGDPQRVDMQPSVTSRPRSLDSVVPTGETQVSSHVHYHRHRHHHYKKRFQWHGRKPGPETGVPQSRPPIPRTQPQPEPPSPDQQVTRSNSAAPSGRLSNPQCPRALPEPAPGPVDASSICPSTSSLFNLQKSSLSARHPQRKRRGGPSEPTPGSRPQDATVHPACQIFPHYTPSVAYPWSPEAHPLICGPPGLDKRLLPETPGPCYSNSQPVWLCLTPRQPLEPHPPGEGPSEWSSDTAEGRPCPYPHCQVLSAQPGSEEELEELCEQAV,783,"85,722",Alternative sequence (3); Beta strand (11); Chain (1); Compositional bias (3); Disulfide bond (1); Erroneous initiation (1); Glycosylation (2); Helix (4); Mutagenesis (4); Natural variant (7); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2); Zinc finger (1),"DISULFID 91..119;  /evidence=""ECO:0000244|PDB:4KNG, ECO:0000269|PubMed:23756651""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9NPG4,"Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2) (VE-cad-2) (VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form]",MMQLLQLLLGLLGPGGYLFLLGDCQEVTTLTVKYQVSEEVPSGTVIGKLSQELGREERRRQAGAAFQVLQLPQALPIQVDSEEGLLSTGRRLDREQLCRQWDPCLVSFDVLATGDLALIHVEIQVLDINDHQPRFPKGEQELEISESASLRTRIPLDRALDPDTGPNTLHTYTLSPSEHFALDVIVGPDETKHAELIVVKELDREIHSFFDLVLTAYDNGNPPKSGTSLVKVNVLDSNDNSPAFAESSLALEIQEDAAPGTLLIKLTATDPDQGPNGEVEFFLSKHMPPEVLDTFSIDAKTGQVILRRPLDYEKNPAYEVDVQARDLGPNPIPAHCKVLIKVLDVNDNIPSIHVTWASQPSLVSEALPKDSFIALVMADDLDSGHNGLVHCWLSQELGHFRLKRTNGNTYMLLTNATLDREQWPKYTLTLLAQDQGLQPLSAKKQLSIQISDINDNAPVFEKSRYEVSTRENNLPSLHLITIKAHDADLGINGKVSYRIQDSPVAHLVAIDSNTGEVTAQRSLNYEEMAGFEFQVIAEDSGQPMLASSVSVWVSLLDANDNAPEVVQPVLSDGKASLSVLVNASTGHLLVPIETPNGLGPAGTDTPPLATHSSRPFLLTTIVARDADSGANGEPLYSIRSGNEAHLFILNPHTGQLFVNVTNASSLIGSEWELEIVVEDQGSPPLQTRALLRVMFVTSVDHLRDSARKPGALSMSMLTVICLAVLLGIFGLILALFMSICRTEKKDNRAYNCREAESTYRQQPKRPQKHIQKADIHLVPVLRGQAGEPCEVGQSHKDVDKEAMMEAGWDPCLQAPFHLTPTLYRTLRNQGNQGAPAESREVLQDTVNLLFNHPRQRNASRENLNLPEPQPATGQPRSRPLKVAGSPTGRLAGDQGSEEAPQRPPASSATLRRQRHLNGKVSPEKESGPRQILRSLVRLSVAAFAERNPVEELTVDSPPVQQISQLLSLLHQGQFQPKPNHRGNKYLAKPGGSRSAIPDTDGPSARAGGQTDPEQEEGPLDPEEDLSVKQLLEEELSSLLDPSTGLALDRLSAPDPAWMARLSLPLTTNYRDNVISPDAAATEEPRTFQTFGKAEAPELSPTGTRLASTFVSEMSSLLEMLLEQRSSMPVEAASEALRRLSVCGRTLSLDLATSAASGMKVQGDPGGKTGTEGKSRGSSSSSRCL,1184,"128,995",Chain (2); Compositional bias (1); Domain (6); Glycosylation (4); Modified residue (2); Natural variant (7); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P40967,Melanocyte protein PMEL (ME20-M) (ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen) (ME20-S) (ME20S); M-beta],MDLVLKRCLLHLAVIGALLAVGATKVPRNQDWLGVSRQLRTKAWNRQLYPEWTEAQRLDCWRGGQVSLKVSNDGPTLIGANASFSIALNFPGSQKVLPDGQVIWVNNTIINGSQVWGGQPVYPQETDDACIFPDGGPCPSGSWSQKRSFVYVWKTWGQYWQVLGGPVSGLSIGTGRAMLGTHTMEVTVYHRRGSRSYVPLAHSSSAFTITDQVPFSVSVSQLRALDGGNKHFLRNQPLTFALQLHDPSGYLAEADLSYTWDFGDSSGTLISRALVVTHTYLEPGPVTAQVVLQAAIPLTSCGSSPVPGTTDGHRPTAEAPNTTAGQVPTTEVVGTTPGQAPTAEPSGTTSVQVPTTEVISTAPVQMPTAESTGMTPEKVPVSEVMGTTLAEMSTPEATGMTPAEVSIVVLSGTTAAQVTTTEWVETTARELPIPEPEGPDASSIMSTESITGSLGPLLDGTATLRLVKRQVPLDCVLYRYGSFSVTLDIVQGIESAEILQAVPSGEGDAFELTVSCQGGLPKEACMEISSPGCQPPAQRLCQPVLPSPACQLVLHQILKGGSGTYCLNVSLADTNSLAVVSTQLIMPGQEAGLGQVPLIVGILLVLMAVVLASLIYRRRLMKQDFSVPQLPHSSSHWLRLPRIFCSCPIGENSPLLSGQQV,661,"70,255",Alternative sequence (3); Chain (3); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (5); Mutagenesis (1); Natural variant (2); Region (1); Repeat (10); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:8179825"""
Q15262,Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),MDTTAAAALPAFVALLLLSPWPLLGSAQGQFSAGGCTFDDGPGACDYHQDLYDDFEWVHVSAQEPHYLPPEMPQGSYMIVDSSDHDPGEKARLQLPTMKENDTHCIDFSYLLYSQKGLNPGTLNILVRVNKGPLANPIWNVTGFTGRDWLRAELAVSTFWPNEYQVIFEAEVSGGRSGYIAIDDIQVLSYPCDKSPHFLRLGDVEVNAGQNATFQCIATGRDAVHNKLWLQRRNGEDIPVAQTKNINHRRFAASFRLQEVTKTDQDLYRCVTQSERGSGVSNFAQLIVREPPRPIAPPQLLGVGPTYLLIQLNANSIIGDGPIILKEVEYRMTSGSWTETHAVNAPTYKLWHLDPDTEYEIRVLLTRPGEGGTGLPGPPLITRTKCAEPMRTPKTLKIAEIQARRIAVDWESLGYNITRCHTFNVTICYHYFRGHNESKADCLDMDPKAPQHVVNHLPPYTNVSLKMILTNPEGRKESEETIIQTDEDVPGPVPVKSLQGTSFENKIFLNWKEPLDPNGIITQYEISYSSIRSFDPAVPVAGPPQTVSNLWNSTHHVFMHLHPGTTYQFFIRASTVKGFGPATAINVTTNISAPTLPDYEGVDASLNETATTITVLLRPAQAKGAPISAYQIVVEELHPHRTKREAGAMECYQVPVTYQNAMSGGAPYYFAAELPPGNLPEPAPFTVGDNRTYQGFWNPPLAPRKGYNIYFQAMSSVEKETKTQCVRIATKAATEEPEVIPDPAKQTDRVVKIAGISAGILVFILLLLVVILIVKKSKLAKKRKDAMGNTRQEMTHMVNAMDRSYADQSTLHAEDPLSITFMDQHNFSPRYENHSATAESSRLLDVPRYLCEGTESPYQTGQLHPAIRVADLLQHINLMKTSDSYGFKEEYESFFEGQSASWDVAKKDQNRAKNRYGNIIAYDHSRVILQPVEDDPSSDYINANYIDGYQRPSHYIATQGPVHETVYDFWRMIWQEQSACIVMVTNLVEVGRVKCYKYWPDDTEVYGDFKVTCVEMEPLAEYVVRTFTLERRGYNEIREVKQFHFTGWPDHGVPYHATGLLSFIRRVKLSNPPSAGPIVVHCSAGAGRTGCYIVIDIMLDMAEREGVVDIYNCVKALRSRRINMVQTEEQYIFIHDAILEACLCGETAIPVCEFKAAYFDMIRIDSQTNSSHLKDEFQTLNSVTPRLQAEDCSIACLPRNHDKNRFMDMLPPDRCLPFLITIDGESSNYINAALMDSYRQPAAFIVTQYPLPNTVKDFWRLVYDYGCTSIVMLNEVDLSQGCPQYWPEEGMLRYGPIQVECMSCSMDCDVINRIFRICNLTRPQEGYLMVQQFQYLGWASHREVPGSKRSFLKLILQVEKWQEECEEGEGRTIIHCLNGGGRSGMFCAIGIVVEMVKRQNVVDVFHAVKTLRNSKPNMVEAPEQYRFCYDVALEYLESS,1439,"162,102",Active site (2); Alternative sequence (3); Beta strand (13); Binding site (2); Chain (1); Disulfide bond (1); Domain (8); Glycosylation (12); Helix (13); Modified residue (1); Region (1); Sequence conflict (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 216..270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8N271,Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2),MKHTLALLAPLLGLGLGLALSQLAAGATDCKFLGPAEHLTFTPAARARWLAPRVRAPGLLDSLYGTVRRFLSVVQLNPFPSELVKALLNELASVKVNEVVRYEAGYVVCAVIAGLYLLLVPTAGLCFCCCRCHRRCGGRVKTEHKALACERAALMVFLLLTTLLLLIGVVCAFVTNQRTHEQMGPSIEAMPETLLSLWGLVSDVPQELQAVAQQFSLPQEQVSEELDGVGVSIGSAIHTQLRSSVYPLLAAVGSLGQVLQVSVHHLQTLNATVVELQAGQQDLEPAIREHRDRLLELLQEARCQGDCAGALSWARTLELGADFSQVPSVDHVLHQLKGVPEANFSSMVQEENSTFNALPALAAMQTSSVVQELKKAVAQQPEGVRTLAEGFPGLEAASRWAQALQEVEESSRPYLQEVQRYETYRWIVGCVLCSVVLFVVLCNLLGLNLGIWGLSARDDPSHPEAKGEAGARFLMAGVGLSFLFAAPLILLVFATFLVGGNVQTLVCQSWENGELFEFADTPGNLPPSMNLSQLLGLRKNISIHQAYQQCKEGAALWTVLQLNDSYDLEEHLDINQYTNKLRQELQSLKVDTQSLDLLSSAARRDLEALQSSGLQRIHYPDFLVQIQRPVVKTSMEQLAQELQGLAQAQDNSVLGQRLQEEAQGLRNLHQEKVVPQQSLVAKLNLSVRALESSAPNLQLETSDVLANVTYLKGELPAWAARILRNVSECFLAREMGYFSQYVAWVREEVTQRIATCQPLSGALDNSRVILCDMMADPWNAFWFCLAWCTFFLIPSIIFAVKTSKYFRPIRKRLSSTSSEETQLFHIPRVTSLKL,834,"91,883",Alternative sequence (2); Chain (1); Erroneous initiation (1); Glycosylation (1); Modified residue (2); Natural variant (1); Sequence conflict (4); Signal peptide (1); Topological domain (6); Transmembrane (5),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
O60486,Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232),MEVSRRKAPPRPPRPAAPLPLLAYLLALAAPGRGADEPVWRSEQAIGAIAASQEDGVFVASGSCLDQLDYSLEHSLSRLYRDQAGNCTEPVSLAPPARPRPGSSFSKLLLPYREGAAGLGGLLLTGWTFDRGACEVRPLGNLSRNSLRNGTEVVSCHPQGSTAGVVYRAGRNNRWYLAVAATYVLPEPETASRCNPAASDHDTAIALKDTEGRSLATQELGRLKLCEGAGSLHFVDAFLWNGSIYFPYYPYNYTSGAATGWPSMARIAQSTEVLFQGQASLDCGHGHPDGRRLLLSSSLVEALDVWAGVFSAAAGEGQERRSPTTTALCLFRMSEIQARAKRVSWDFKTAESHCKEGDQPERVQPIASSTLIHSDLTSVYGTVVMNRTVLFLGTGDGQLLKVILGENLTSNCPEVIYEIKEETPVFYKLVPDPVKNIYIYLTAGKEVRRIRVANCNKHKSCSECLTATDPHCGWCHSLQRCTFQGDCVHSENLENWLDISSGAKKCPKIQIIRSSKEKTTVTMVGSFSPRHSKCMVKNVDSSRELCQNKSQPNRTCTCSIPTRATYKDVSVVNVMFSFGSWNLSDRFNFTNCSSLKECPACVETGCAWCKSARRCIHPFTACDPSDYERNQEQCPVAVEKTSGGGRPKENKGNRTNQALQVFYIKSIEPQKVSTLGKSNVIVTGANFTRASNITMILKGTSTCDKDVIQVSHVLNDTHMKFSLPSSRKEMKDVCIQFDGGNCSSVGSLSYIALPHCSLIFPATTWISGGQNITMMGRNFDVIDNLIISHELKGNINVSEYCVATYCGFLAPSLKSSKVRTNVTVKLRVQDTYLDCGTLQYREDPRFTGYRVESEVDTELEVKIQKENDNFNISKKDIEITLFHGENGQLNCSFENITRNQDLTTILCKIKGIKTASTIANSSKKVRVKLGNLELYVEQESVPSTWYFLIVLPVLLVIVIFAAVGVTRHKSKELSRKQSQQLELLESELRKEIRDGFAELQMDKLDVVDSFGTVPFLDYKHFALRTFFPESGGFTHIFTEDMHNRDANDKNESLTALDALICNKSFLVTVIHTLEKQKNFSVKDRCLFASFLTIALQTKLVYLTSILEVLTRDLMEQCSNMQPKLMLRRTESVVEKLLTNWMSVCLSGFLRETVGEPFYLLVTTLNQKINKGPVDVITCKALYTLNEDWLLWQVPEFSTVALNVVFEKIPENESADVCRNISVNVLDCDTIGQAKEKIFQAFLSKNGSPYGLQLNEIGLELQMGTRQKELLDIDSSSVILEDGITKLNTIGHYEISNGSTIKVFKKIANFTSDVEYSDDHCHLILPDSEAFQDVQGKRHRGKHKFKVKEMYLTKLLSTKVAIHSVLEKLFRSIWSLPNSRAPFAIKYFFDFLDAQAENKKITDPDVVHIWKTNSLPLRFWVNILKNPQFVFDIKKTPHIDGCLSVIAQAFMDAFSLTEQQLGKEAPTNKLLYAKDIPTYKEEVKSYYKAIRDLPPLSSSEMEEFLTQESKKHENEFNEEVALTEIYKYIVKYFDEILNKLERERGLEEAQKQLLHVKVLFDEKKKCKWM,1568,"175,742",Beta strand (76); Chain (1); Disulfide bond (8); Domain (1); Glycosylation (16); Helix (12); Modified residue (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 64..87;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 156..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 226..354;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 283..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 455..472;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 461..506;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 464..481;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""; DISULFID 475..487;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:20727575""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
O15031,Plexin-B2 (MM1),MALQLWALTLLGLLGAGASLRPRKLDFFRSEKELNHLAVDEASGVVYLGAVNALYQLDAKLQLEQQVATGPALDNKKCTPPIEASQCHEAEMTDNVNQLLLLDPPRKRLVECGSLFKGICALRALSNISLRLFYEDGSGEKSFVASNDEGVATVGLVSSTGPGGDRVLFVGKGNGPHDNGIIVSTRLLDRTDSREAFEAYTDHATYKAGYLSTNTQQFVAAFEDGPYVFFVFNQQDKHPARNRTLLARMCREDPNYYSYLEMDLQCRDPDIHAAAFGTCLAASVAAPGSGRVLYAVFSRDSRSSGGPGAGLCLFPLDKVHAKMEANRNACYTGTREARDIFYKPFHGDIQCGGHAPGSSKSFPCGSEHLPYPLGSRDGLRGTAVLQRGGLNLTAVTVAAENNHTVAFLGTSDGRILKVYLTPDGTSSEYDSILVEINKRVKRDLVLSGDLGSLYAMTQDKVFRLPVQECLSYPTCTQCRDSQDPYCGWCVVEGRCTRKAECPRAEEASHWLWSRSKSCVAVTSAQPQNMSRRAQGEVQLTVSPLPALSEEDELLCLFGESPPHPARVEGEAVICNSPSSIPVTPPGQDHVAVTIQLLLRRGNIFLTSYQYPFYDCRQAMSLEENLPCISCVSNRWTCQWDLRYHECREASPNPEDGIVRAHMEDSCPQFLGPSPLVIPMNHETDVNFQGKNLDTVKGSSLHVGSDLLKFMEPVTMQESGTFAFRTPKLSHDANETLPLHLYVKSYGKNIDSKLHVTLYNCSFGRSDCSLCRAANPDYRCAWCGGQSRCVYEALCNTTSECPPPVITRIQPETGPLGGGIRITILGSNLGVQAGDIQRISVAGRNCSFQPERYSVSTRIVCVIEAAETPFTGGVEVDVFGKLGRSPPNVQFTFQQPKPLSVEPQQGPQAGGTTLTIHGTHLDTGSQEDVRVTLNGVPCKVTKFGAQLQCVTGPQATRGQMLLEVSYGGSPVPNPGIFFTYRENPVLRAFEPLRSFASGGRSINVTGQGFSLIQRFAMVVIAEPLQSWQPPREAESLQPMTVVGTDYVFHNDTKVVFLSPAVPEEPEAYNLTVLIEMDGHRALLRTEAGAFEYVPDPTFENFTGGVKKQVNKLIHARGTNLNKAMTLQEAEAFVGAERCTMKTLTETDLYCEPPEVQPPPKRRQKRDTTHNLPEFIVKFGSREWVLGRVEYDTRVSDVPLSLILPLVIVPMVVVIAVSVYCYWRKSQQAEREYEKIKSQLEGLEESVRDRCKKEFTDLMIEMEDQTNDVHEAGIPVLDYKTYTDRVFFLPSKDGDKDVMITGKLDIPEPRRPVVEQALYQFSNLLNSKSFLINFIHTLENQREFSARAKVYFASLLTVALHGKLEYYTDIMHTLFLELLEQYVVAKNPKLMLRRSETVVERMLSNWMSICLYQYLKDSAGEPLYKLFKAIKHQVEKGPVDAVQKKAKYTLNDTGLLGDDVEYAPLTVSVIVQDEGVDAIPVKVLNCDTISQVKEKIIDQVYRGQPCSCWPRPDSVVLEWRPGSTAQILSDLDLTSQREGRWKRVNTLMHYNVRDGATLILSKVGVSQQPEDSQQDLPGERHALLEEENRVWHLVRPTDEVDEGKSKRGSVKEKERTKAITEIYLTRLLSVKGTLQQFVDNFFQSVLAPGHAVPPAVKYFFDFLDEQAEKHNIQDEDTIHIWKTNSLPLRFWVNILKNPHFIFDVHVHEVVDASLSVIAQTFMDACTRTEHKLSRDSPSNKLLYAKEISTYKKMVEDYYKGIRQMVQVSDQDMNTHLAEISRAHTDSLNTLVALHQLYQYTQKYYDEIINALEEDPAAQKMQLAFRLQQIAAALENKVTDL,1838,"205,127",Beta strand (4); Chain (1); Disulfide bond (10); Domain (4); Erroneous initiation (1); Glycosylation (13); Helix (2); Modified residue (3); Mutagenesis (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 78..87;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 112..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 250..364;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 266..312;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 330..351;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 469..486;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 475..518;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 478..495;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 489..501;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 555..574;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q16849,Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)],MRRPRRPGGLGGSGGLRLLLCLLLLSSRPGGCSAVSAHGCLFDRRLCSHLEVCIQDGLFGQCQVGVGQARPLLQVTSPVLQRLQGVLRQLMSQGLSWHDDLTQYVISQEMERIPRLRPPEPRPRDRSGLAPKRPGPAGELLLQDIPTGSAPAAQHRLPQPPVGKGGAGASSSLSPLQAELLPPLLEHLLLPPQPPHPSLSYEPALLQPYLFHQFGSRDGSRVSEGSPGMVSVGPLPKAEAPALFSRTASKGIFGDHPGHSYGDLPGPSPAQLFQDSGLLYLAQELPAPSRARVPRLPEQGSSSRAEDSPEGYEKEGLGDRGEKPASPAVQPDAALQRLAAVLAGYGVELRQLTPEQLSTLLTLLQLLPKGAGRNPGGVVNVGADIKKTMEGPVEGRDTAELPARTSPMPGHPTASPTSSEVQQVPSPVSSEPPKAARPPVTPVLLEKKSPLGQSQPTVAGQPSARPAAEEYGYIVTDQKPLSLAAGVKLLEILAEHVHMSSGSFINISVVGPALTFRIRHNEQNLSLADVTQQAGLVKSELEAQTGLQILQTGVGQREEAAAVLPQTAHSTSPMRSVLLTLVALAGVAGLLVALAVALCVRQHARQQDKERLAALGPEGAHGDTTFEYQDLCRQHMATKSLFNRAEGPPEPSRVSSVSSQFSDAAQASPSSHSSTPSWCEEPAQANMDISTGHMILAYMEDHLRNRDRLAKEWQALCAYQAEPNTCATAQGEGNIKKNRHPDFLPYDHARIKLKVESSPSRSDYINASPIIEHDPRMPAYIATQGPLSHTIADFWQMVWESGCTVIVMLTPLVEDGVKQCDRYWPDEGASLYHVYEVNLVSEHIWCEDFLVRSFYLKNVQTQETRTLTQFHFLSWPAEGTPASTRPLLDFRRKVNKCYRGRSCPIIVHCSDGAGRTGTYILIDMVLNRMAKGVKEIDIAATLEHVRDQRPGLVRSKDQFEFALTAVAEEVNAILKALPQ,979,"105,848",Alternative sequence (2); Beta strand (15); Chain (4); Cross-link (1); Disulfide bond (3); Domain (1); Glycosylation (3); Helix (15); Modified residue (1); Mutagenesis (3); Natural variant (1); Region (3); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 40;  /note=""Interchain (with C-40 or C-47); in multimeric form"";  /evidence=""ECO:0000305|PubMed:26836020""; DISULFID 47;  /note=""Interchain (with C-40 or C-47); in multimeric form"";  /evidence=""ECO:0000305|PubMed:26836020""; DISULFID 53..62;  /evidence=""ECO:0000305|PubMed:26836020""","SIGNAL 1..34;  /evidence=""ECO:0000250"""
P10586,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),MAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEVIEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFKDFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPMPYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKALPKPPIDLVVTETTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQAPSSPPRRVQARMLSASTMLVQWEPPEEPNGLVRGYRVYYTPDSRRPPNAWHKHNTDAGLLTTVGSLLPGITYSLRVLAFTAVGDGPPSPTIQVKTQQGVPAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDEDVPSGPPRKVEVEPLNSTAVHVYWKLPVPSKQHGQIRGYQVTYVRLENGEPRGLPIIQDVMLAEAQWRPEESEDYETTISGLTPETTYSVTVAAYTTKGDGARSKPKIVTTTGAVPGRPTMMISTTAMNTALLQWHPPKELPGELLGYRLQYCRADEARPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFEKEIRTPEDLPSGFPQNLHVTGLTTSTTELAWDPPVLAERNGRIISYTVVFRDINSQQELQNITTDTRFTLTGLKPDTTYDIKVRAWTSKGSGPLSPSIQSRTMPVEQVFAKNFRVAAAMKTSVLLSWEVPDSYKSAVPFKILYNGQSVEVDGHSMRKLIADLQPNTEYSFVLMNRGSSAGGLQHLVSIRTAPDLLPHKPLPASAYIEDGRFDLSMPHVQDPSLVRWFYIVVVPIDRVGGSMLTPRWSTPEELELDELLEAIEQGGEEQRRRRRQAERLKPYVAAQLDVLPETFTLGDKKNYRGFYNRPLSPDLSYQCFVLASLKEPMDQKRYASSPYSDEIVVQVTPAQQQEEPEMLWVTGPVLAVILIILIVIAILLFKRKRTHSPSSKDEQSIGLKDSLLAHSSDPVEMRRLNYQTPGMRDHPPIPITDLADNIERLKANDGLKFSQEYESIDPGQQFTWENSNLEVNKPKNRYANVIAYDHSRVILTSIDGVPGSDYINANYIDGYRKQNAYIATQGPLPETMGDFWRMVWEQRTATVVMMTRLEEKSRVKCDQYWPARGTETCGLIQVTLLDTVELATYTVRTFALHKSGSSEKRELRQFQFMAWPDHGVPEYPTPILAFLRRVKACNPLDAGPMVVHCSAGVGRTGCFIVIDAMLERMKHEKTVDIYGHVTCMRSQRNYMVQTEDQYVFIHEALLEAATCGHTEVPARNLYAHIQKLGQVPPGESVTAMELEFKLLASSKAHTSRFISANLPCNKFKNRLVNIMPYELTRVCLQPIRGVEGSDYINASFLDGYRQQKAYIATQGPLAESTEDFWRMLWEHNSTIIVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTIRQFQFTDWPEQGVPKTGEGFIDFIGQVHKTKEQFGQDGPITVHCSAGVGRTGVFITLSIVLERMRYEGVVDMFQTVKTLRTQRPAMVQTEDQYQLCYRAALEYLGSFDHYAT,1907,"212,879",Active site (2); Alternative sequence (1); Beta strand (87); Binding site (2); Chain (1); Disulfide bond (3); Domain (13); Erroneous initiation (2); Glycosylation (5); Helix (27); Modified residue (1); Mutagenesis (1); Natural variant (3); Region (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (12),"DISULFID 54..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 156..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 253..298;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UMZ3,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48),MKKVPIKPEQPEKLRAFNISTHSFSLHWSLPSGHVERYQVDLVPDSGFVTIRDLGGGEYQVDVSNVVPGTRYDITISSISTTYTSPVTRIVTTNVTKPGPPVFLAGERVGSAGILLSWNTPPNPNGRIISYIVKYKEVCPWMQTVYTQVRSKPDSLEVLLTNLNPGTTYEIKVAAENSAGIGVFSDPFLFQTAESAPGKVVNLTVEAYNASAVKLIWYLPRQPNGKITSFKISVKHARSGIVVKDVSIRVEDILTGKLPECNENSESFLWSTASPSPTLGRVTPPSRTTHSSSTLTQNEISSVWKEPISFVVTHLRPYTTYLFEVSAVTTEAGYIDSTIVRTPESVPEGPPQNCVTGNITGKSFSILWDPPTIVTGKFSYRVELYGPSGRILDNSTKDLKFAFTNLTPFTMYDVYIAAETSAGTGPKSNISVFTPPDVPGAVFDLQLAEVESTQVRITWKKPRQPNGIINQYRVKVLVPETGIILENTLLTGNNEYINDPMAPEIVNIVEPMVGLYEGSAEMSSDLHSLATFIYNSHPDKNFPARNRAEDQTSPVVTTRNQYITDIAAEQLSYVIRRLVPFTEHMISVSAFTIMGEGPPTVLSVRTRQQVPSSIKIINYKNISSSSILLYWDPPEYPNGKITHYTIYAMELDTNRAFQITTIDNSFLITGLKKYTKYKMRVAASTHVGESSLSEENDIFVRTSEDEPESSPQDVEVIDVTADEIRLKWSPPEKPNGIIIAYEVLYKNIDTLYMKNTSTTDIILRNLRPHTLYNISVRSYTRFGHGNQVSSLLSVRTSETVPDSAPENITYKNISSGEIELSFLPPSSPNGIIKKYTIYLKRSNGNEERTINTTSLTQNIKVLKKYTQYIIEVSASTLKGEGVRSAPISILTEEDAPDSPPQDFSVKQLSGVTVKLSWQPPLEPNGIILYYTVYVWNRSSLKTINVTETSLELSDLDYNVEYSAYVTASTRFGDGKTRSNIISFQTPEGAPSDPPKDVYYANLSSSSIILFWTPPSKPNGIIQYYSVYYRNTSGTFMQNFTLHEVTNDFDNMTVSTIIDKLTIFSYYTFWLTASTSVGNGNKSSDIIEVYTDQDIPEGFVGNLTYESISSTAINVSWVPPAQPNGLVFYYVSLILQQTPRHVRPPLVTYERSIYFDNLEKYTDYILKITPSTEKGFSDTYTAQLYIKTEEDVPETSPIINTFKNLSSTSVLLSWDPPVKPNGAIISYDLTLQGPNENYSFITSDNYIILEELSPFTLYSFFAAARTRKGLGPSSILFFYTDESVPLAPPQNLTLINCTSDFVWLKWSPSPLPGGIVKVYSFKIHEHETDTIYYKNISGFKTEAKLVGLEPVSTYSIRVSAFTKVGNGNQFSNVVKFTTQESVPDVVQNMQCMATSWQSVLVKWDPPKKANGIITQYMVTVERNSTKVSPQDHMYTFIKLLANTSYVFKVRASTSAGEGDESTCHVSTLPETVPSVPTNIAFSDVQSTSATLTWIRPDTILGYFQNYKITTQLRAQKCKEWESEECVEYQKIQYLYEAHLTEETVYGLKKFRWYRFQVAASTNAGYGNASNWISTKTLPGPPDGPPENVHVVATSPFSISISWSEPAVITGPTCYLIDVKSVDNDEFNISFIKSNEENKTIEIKDLEIFTRYSVVITAFTGNISAAYVEGKSSAEMIVTTLESAPKDPPNNMTFQKIPDEVTKFQLTFLPPSQPNGNIQVYQALVYREDDPTAVQIHNLSIIQKTNTFVIAMLEGLKGGHTYNISVYAVNSAGAGPKVPMRITMDIKAPARPKTKPTPIYDATGKLLVTSTTITIRMPICYYSDDHGPIKNVQVLVTETGAQHDGNVTKWYDAYFNKARPYFTNEGFPNPPCTEGKTKFSGNEEIYIIGADNACMIPGNEDKICNGPLKPKKQYLFKFRATNIMGQFTDSDYSDPVKTLGEGLSERTVEIILSVTLCILSIILLGTAIFAFARIRQKQKEGGTYSPQDAEIIDTKLKLDQLITVADLELKDERLTRPISKKSFLQHVEELCTNNNLKFQEEFSELPKFLQDLSSTDADLPWNRAKNRFPNIKPYNNNRVKLIADASVPGSDYINASYISGYLCPNEFIATQGPLPGTVGDFWRMVWETRAKTLVMLTQCFEKGRIRCHQYWPEDNKPVTVFGDIVITKLMEDVQIDWTIRDLKIERHGDCMTVRQCNFTAWPEHGVPENSAPLIHFVKLVRASRAHDTTPMIVHCSAGVGRTGVFIALDHLTQHINDHDFVDIYGLVAELRSERMCMVQNLAQYIFLHQCILDLLSNKGSNQPICFVNYSALQKMDSLDAMEGDVELEWEETTM,2332,"260,924",Active site (1); Beta strand (12); Chain (1); Domain (19); Glycosylation (10); Helix (9); Natural variant (9); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
O00168,Phospholemman (FXYD domain-containing ion transport regulator 1) (Sodium/potassium-transporting ATPase subunit FXYD1),MASLGHILVFCVGLLTMAKAESPKEHDPFTYDYQSLQIGGLVIAGILFILGILIVLSRRCRCKFNQQQRTGEPDEEEGTFRSSIRRLSTRRR,92,"10,441",Beta strand (1); Chain (1); Helix (4); Lipidation (2); Modified residue (6); Mutagenesis (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..20;  /evidence=""ECO:0000250|UniProtKB:P56513"""
Q99943,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15),MDLWPGAWMLLLLLFLLLLFLLPTLWFCSPSAKYFFKMAFYNGWILFLAVLAIPVCAVRGRNVENMKILRLMLLHIKYLYGIRVEVRGAHHFPPSQPYVVVSNHQSSLDLLGMMEVLPGRCVPIAKRELLWAGSAGLACWLAGVIFIDRKRTGDAISVMSEVAQTLLTQDVRVWVFPEGTRNHNGSMLPFKRGAFHLAVQAQVPIVPIVMSSYQDFYCKKERRFTSGQCQVRVLPPVPTEGLTPDDVPALADRVRHSMLTVFREISTDGRGGGDYLKKPGGGG,283,"31,717",Chain (1); Erroneous initiation (1); Motif (2); Natural variant (1); Signal peptide (1); Topological domain (3); Transmembrane (2),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8TEB7,E3 ubiquitin-protein ligase RNF128 (EC 2.3.2.27) (Gene related to anergy in lymphocytes protein) (GRAIL) (RING finger protein 128) (RING-type E3 ubiquitin transferase RNF128),MGPPPGAGVSCRGGCGFSRLLAWCFLLALSPQAPGSRGAEAVWTAYLNVSWRVPHTGVNRTVWELSEEGVYGQDSPLEPVAGVLVPPDGPGALNACNPHTNFTVPTVWGSTVQVSWLALIQRGGGCTFADKIHLAYERGASGAVIFNFPGTRNEVIPMSHPGAVDIVAIMIGNLKGTKILQSIQRGIQVTMVIEVGKKHGPWVNHYSIFFVSVSFFIITAATVGYFIFYSARRLRNARAQSRKQRQLKADAKKAIGRLQLRTLKQGDKEIGPDGDSCAVCIELYKPNDLVRILTCNHIFHKTCVDPWLLEHRTCPMCKCDILKALGIEVDVEDGSVSLQVPVSNEISNSASSHEEDNRSETASSGYASVQGTDEPPLEEHVQSTNESLQLVNHEANSVAVDVIPHVDNPTFEEDETPNQETAVREIKS,428,"46,521",Alternative sequence (1); Beta strand (7); Chain (1); Domain (1); Frameshift (1); Glycosylation (3); Helix (2); Sequence conflict (7); Signal peptide (1); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q07001,Acetylcholine receptor subunit delta,MEGPVLTLGLLAALAVCGSWGLNEEERLIRHLFQEKGYNKELRPVAHKEESVDVALALTLSNLISLKEVEETLTTNVWIEHGWTDNRLKWNAEEFGNISVLRLPPDMVWLPEIVLENNNDGSFQISYSCNVLVYHYGFVYWLPPAIFRSSCPISVTYFPFDWQNCSLKFSSLKYTAKEITLSLKQDAKENRTYPVEWIIIDPEGFTENGEWEIVHRPARVNVDPRAPLDSPSRQDITFYLIIRRKPLFYIINILVPCVLISFMVNLVFYLPADSGEKTSVAISVLLAQSVFLLLISKRLPATSMAIPLIGKFLLFGMVLVTMVVVICVIVLNIHFRTPSTHVLSEGVKKLFLETLPELLHMSRPAEDGPSPGALVRRSSSLGYISKAEEYFLLKSRSDLMFEKQSERHGLARRLTTARRPPASSEQAQQELFNELKPAVDGANFIVNHMRDQNNYNEEKDSWNRVARTVDRLCLFVVTPVMVVGTAWIFLQGVYNQPPPQPFPGDPYSYNVQDKRFI,517,"58,895",Alternative sequence (1); Chain (1); Disulfide bond (1); Glycosylation (2); Modified residue (1); Mutagenesis (1); Natural variant (10); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 151..165;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q9BZ11,Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-),MGWRPRRARGTPLLLLLLLLLLWPVPGAGVLQGHIPGQPVTPHWVLDGQPWRTVSLEEPVSKPDMGLVALEAEGQELLLELEKNHRLLAPGYIETHYGPDGQPVVLAPNHTDHCHYQGRVRGFPDSWVVLCTCSGMSGLITLSRNASYYLRPWPPRGSKDFSTHEIFRMEQLLTWKGTCGHRDPGNKAGMTSLPGGPQSRGRREARRTRKYLELYIVADHTLFLTRHRNLNHTKQRLLEVANYVDQLLRTLDIQVALTGLEVWTERDRSRVTQDANATLWAFLQWRRGLWAQRPHDSAQLLTGRAFQGATVGLAPVEGMCRAESSGGVSTDHSELPIGAAATMAHEIGHSLGLSHDPDGCCVEAAAESGGCVMAAATGHPFPRVFSACSRRQLRAFFRKGGGACLSNAPDPGLPVPPALCGNGFVEAGEECDCGPGQECRDLCCFAHNCSLRPGAQCAHGDCCVRCLLKPAGALCRQAMGDCDLPEFCTGTSSHCPPDVYLLDGSPCARGSGYCWDGACPTLEQQCQQLWGPGSHPAPEACFQVVNSAGDAHGNCGQDSEGHFLPCAGRDALCGKLQCQGGKPSLLAPHMVPVDSTVHLDGQEVTCRGALALPSAQLDLLGLGLVEPGTQCGPRMVCQSRRCRKNAFQELQRCLTACHSHGVCNSNHNCHCAPGWAPPFCDKPGFGGSMDSGPVQAENHDTFLLAMLLSVLLPLLPGAGLAWCCYRLPGAHLQRCSWGCRRDPACSGPKDGPHRDHPLGGVHPMELGPTATGQPWPLDPENSHEPSSHPEKPLPAVSPDPQADQVQMPRSCLW,813,"87,739",Active site (1); Alternative sequence (2); Beta strand (6); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Helix (9); Metal binding (4); Motif (1); Natural variant (15); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 320..404;  /evidence=""ECO:0000269|PubMed:14659745""; DISULFID 360..388;  /evidence=""ECO:0000269|PubMed:14659745""; DISULFID 361..371;  /evidence=""ECO:0000269|PubMed:14659745""; DISULFID 475..495;  /evidence=""ECO:0000250""; DISULFID 653..663;  /evidence=""ECO:0000250""; DISULFID 657..669;  /evidence=""ECO:0000250""; DISULFID 671..680;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6UXG8,Butyrophilin-like protein 9,MVDLSVSPDSLKPVSLTSSLVFLMHLLLLQPGEPSSEVKVLGPEYPILALVGEEVEFPCHLWPQLDAQQMEIRWFRSQTFNVVHLYQEQQELPGRQMPAFRNRTKLVKDDIAYGSVVLQLHSIIPSDKGTYGCRFHSDNFSGEALWELEVAGLGSDPHLSLEGFKEGGIQLRLRSSGWYPKPKVQWRDHQGQCLPPEFEAIVWDAQDLFSLETSVVVRAGALSNVSVSIQNLLLSQKKELVVQIADVFVPGASAWKSAFVATLPLLLVLAALALGVLRKQRRSREKLRKQAEKRQEKLTAELEKLQTELDWRRAEGQAEWRAAQKYAVDVTLDPASAHPSLEVSEDGKSVSSRGAPPGPAPGHPQRFSEQTCALSLERFSAGRHYWEVHVGRRSRWFLGACLAAVPRAGPARLSPAAGYWVLGLWNGCEYFVLAPHRVALTLRVPPRRLGVFLDYEAGELSFFNVSDGSHIFTFHDTFSGALCAYFRPRAHDGGEHPDPLTICPLPVRGTGVPEENDSDTWLQPYEPADPALDWW,535,"59,716",Alternative sequence (4); Chain (1); Coiled coil (1); Disulfide bond (1); Domain (2); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 59..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q8IYJ0,PILR alpha-associated neural protein (PILR-associating neural protein) (Paired immunoglobin-like type 2 receptor-associating neural protein),MESRMWPALLLSHLLPLWPLLLLPLPPPAQGSSSSPRTPPAPARPPCARGGPSAPRHVCVWERAPPPSRSPRVPRSRRQVLPGTAPPATPSGFEEGPPSSQYPWAIVWGPTVSREDGGDPNSANPGFLDYGFAAPHGLATPHPNSDSMRGDGDGLILGEAPATLRPFLFGGRGEGVDPQLYVTITISIIIVLVATGIIFKFCWDRSQKRRRPSGQQGALRQEESQQPLTDLSPAGVTVLGAFGDSPTPTPDHEEPRGGPRPGMPHPKGAPAFQLNRIPLVNL,282,"30,076",Alternative sequence (1); Chain (1); Glycosylation (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9Y5G2,Protocadherin gamma-B2 (PCDH-gamma-B2),MKASSGRCGLVRWLQVLLPFLLSLFPGALPVQIRYSIPEELAKNSVVGNLAKDLGLSVRDLPARKLRVSAEKEYFTVNPESGDLLVSDRIDREQICGKQPLCVLDFDTVAENPLNIFYIAVIVQDINDNTPLFKQTKINLKIGESTKPGTTFPLDPALDSDVGPNSLQRYHLNDNEYFDLAEKQTPDGRKYPELILKHSLDREEHSLHQLVLTAVDGGDPPQSGTTQIRIKVTDANDNPPVFSQDVYRVTLREDVPPGFFVLQVTATDRDEGINAEITYSFHNVDEQVKHFFNLNEKTGEITTKDDLDFEIASSYTLSIEAKDPGDLAAHCSIQVEILDDNDCAPEVIVTSVSTPLPEDSPPGTVIALIKTRDRDSGENGEVYCQVLGNAKFILKSSSKNYYKLVTDGALDREEIPEYNLTITATDGGKPPLSSSIIVTLHISDVNDNAPVFQQTSYMVHVAENNPPGASIAQISASDPDLGPSGQVSYSIVASDLKPREILSYVSVSAQSGVVFAQRAFDHEQLRAFELTLQARDQGSPALSANVSLRVLVGDLNDNAPRVLYPALGPDGSALFDMVPRAAEPGYLVTKVVAVDADSGHNAWLSYHVLQASEPGLFSLGLRTGEVRTARALGDRDAARQRLLVAVRDGGQPPLSATATLHLIFADSLQEVLPDLSDRREPSDPQAKLQFYLVVALALISVLFFLAVILAISLRLRLSSRSDAWDCFQPGLSSKPGPGVLPNYSEGTLPYSYNLCVASQSAKTEFNFLNITPELVPAQDLVCDNASWEQNTNHGAAGVPFASDTILKQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,931,"100,875",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9Y5E2,Protocadherin beta-7 (PCDH-beta-7),MEARVERAVQKRQVLFLCVFLGMSWAGAEPLRYFVAEETERGTFLTNLAKDLGLGVGELRARGTRIVSDQNMQILLLSSLTGDLLLNEKLDREELCGPREPCVLPFQLLLEKPFQIFRAELWVRDINDHAPVFLDREISLKILESTTPGAAFLLESAQDSDVGTNSLSNYTISPNAYFHINVHDSGEGNIYPELVLNQVLDREEIPEFSLTLTALDGGSPPRSGTALVRILVLDVNDNAPDFVRSLYKVQVPENSPVGSMVVSVSARDLDTGSNGEIAYAFSYATERILKTFQINPTSGSLHLKAQLDYEAIQTYTLTIQAKDGGGLSGKCTVVVDVTDINDNRPELLLSSLTSPIAENSPETVVAVFRIRDRDSGNNGKTVCSIQDDVPFILKPSVENFYTLVTEKPLDRERNTEYNITITVTDLGTPRLKTEHNITVLVSDVNDNAPAFTQTSYTLFVRENNSPALPIGSVSATDRDSGTNAQVIYSLLPSQDPHLPLASLVSINADNGHLFALRSLDYEALQAFEFRVGATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNSSAPCTEPLPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKQRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLRLPEAAPDQANSLTVYLVVALASVSSLFLLSVLLFVAVRLCRRSRAAPVGRCSVPEGPFPRHLVDLSGTGTLSQSYQYEVCLTGGSGTNEFKFLKPIIPNLLPQSTGREVEENRPFQNNLGF,793,"86,707",Chain (1); Domain (6); Glycosylation (4); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
A0A1B0GV85,Reelin domain-containing protein 1,MRMQAALVGWACTTLCLASCSSAFSHGASTVACDDMQPKHIQAQPQHQDSHHITIHTHRTSYAPGDKIPVTVRSSRDFMGFLLQARRVSDHQIAGTFVLIPPHSKLMTCFQEADAVTHSDKSLKRNLSFVWKAPAQPVGDIKFLLSVVQSYFVYWARIESSVVSQQTHSSAHSDDRMEPRLLMPNLHQRLGDVEGAAPAPRTPITLPQQHTHVFAVALPGAAEEDNLDPVPASIWVTKFPGDAETLSQPSSHTATEGSINQQPSGDSNPTLEPSLEVHRLERLVALKRVSSESFASSLSTHHRTQDDPSFDSLETCLSSDGGEQDKTKASNRTVTQPPLSTVQLTYPQCLWSSETFTGNGVRASNPIPVLQTSGTSGLPAAGDQSEASRASASFLPQSKHKELRAGKGNGEGGVGYPRQTNPRPDIGLEGAQAPLGIQLRTPQLGILLCLSATLGMALAAGLRYLHTQYCHQQTEVSFSEPASDAVARSNSGETVHVRKIGENSFVLVQAEYNWITPSVGSKKTVL,526,"56,837",Chain (1); Domain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q86XR5,Proline-rich membrane anchor 1 (PRiMA),MLLRDLVLRRGCCWSSLLLHCALHPLWGFVQVTHGEPQKSCSKVTDSCRHVCQCRPPPPLPPPPPPPPPPRLLSAPAPNSTSCPTEESWWSGLVIIIAVCCASLVFLTVLVIICYKAIKRKPLRKDENGTSVAEYPMSASQSNKGVDVNNAVV,153,"16,689",Alternative sequence (2); Chain (1); Domain (1); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000250"""
Q6ISU1,Pre T-cell antigen receptor alpha (pT-alpha) (pTa) (pT-alpha-TCR),MAGTWLLLLLALGCPALPTGVGGTPFPSLAPPIMLLVDGKQQMVVVCLVLDVAPPGLDSPIWFSAGNGSALDAFTYGPSPATDGTWTNLAHLSLPSEELASWEPLVCHTGPGAEGHSRSTQPMHLSGEASTARTCPQEPLRGTPGGALWLGVLRLLLFKLLLFDLLLTCSCLCDPAGPLPSPATTTRLRALGSHRLHPATETGGREATSSPRPQPRDRRWGDTPPGRKPGSPVWGEGSYLSSYPTCPAQAWCSRSALRAPSSSLGAFFAGDLPPPLQAGAA,281,"29,266",Alternative sequence (2); Beta strand (6); Chain (1); Disulfide bond (2); Glycosylation (1); Helix (1); Natural variant (2); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 47..107;  /evidence=""ECO:0000269|PubMed:20944746""; DISULFID 135;  /note=""Interchain (with TCRB)"";  /evidence=""ECO:0000305|PubMed:20944746""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O43570,Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3),MPRRSLHAAAVLLLVILKEQPSSPAPVNGSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQVQVCTAAGLSLGIILSLALAGILGICIVVVVSIWLFRRKSIKKGDNKGVIYKPATKMETEAHA,354,"39,451",Active site (1); Alternative sequence (1); Beta strand (16); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (3); Helix (9); Metal binding (3); Natural variant (2); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 50..230;  /evidence=""ECO:0000269|PubMed:11493685""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q96NU0,Contactin-associated protein-like 3B (Cell recognition molecule Caspr3b),MASVAWAVLKVLLLLPTQTWSPVGAGNPPDCDSPLASALPRSSFSSSSELSSSHGPGFSRLNRRDGAGGWTPLVSNKYQWLQIDLGERMEVTAVATQGGYGSSDWVTSYLLMFSDGGRNWKQYRREESIWGFPGNTNADSVVHYRLQPPFEARFLRFLPLAWNPRGRIGMRIEVYGCAYKSEVVYFDGQSALLYTLDKKPLKPIRDVISLKFKAMQSNGILLHREGQHGNHITLELIKGKLVFFLNSGNAKLPSTIAPVTLTLGSLLDDQHWHSVLIELLDTQVNFTVDKHTHHFQAKGDSSNLDLNFEISFGGILSPGRSRAFTRKSFHGCLENLYYNGVDVTELAKKHKPQILMMGNVSFSCPQPQTVPVTFLSSRSYLALPGNSGEDKVSVTFQFRTWNRAGHLLFGELQRGSGSFVLFLKDGKLKLSLFQAGQSPRNVTAGAGLNDGQWHSVSFSAKWSHMNVVVDDDTAVQPLVAVLIDSGDTYYFGGCLGNSSGSGCKSPLGGFQGCLRLITIGDKAVDPILVQQGALGSFRDLQIDSCGITDRCLPSYCEHGGECSQSWDTFSCDCLGTGYTGETCHSSLYEQSCEAHKHRGNPSGLYYIDADGSGPLGPFLVYCNMTADSAWTVVRHGGPDAVTLRGAPSGHPLSAVSFAYAAGAGQLRAAVNLAERCEQRLALRCGTARRPDSRDGTPLSWWVGRTNETHTSWGGSLPDAQKCTCGLEGNCIDSQYYCNCDAGQNEWTSDTIVLSQKEHLPVTQIVMTDTGQPHSEADYTLGPLLCRGDKSFWNSASFNTETSYLHFPAFHGELTADVCFFFKTTVSSGVFMENLGITDFIRIELRAPTEVTFSFDVGNGPCEVTVQSPTPFNDNQWHHVRAERNVKGASLQVDQLPQKMQPAPADGHVRLQLNSQLFIGGTATRQRGFLGCIRSLQLNGVALDLEERATVTPGVEPGCAGHCSTYGHLCRNGGRCREKRRGVTCDCAFSAYDGPFCSNEISAYFATGSSMTYHFQEHYTLSENSSSLVSSLHRDVTLTREMITLSFRTTRTPSLLLYVSSFYEEYLSVILANNGSLQIRYKLDRHQNPDAFTFDFKNMADGQLHQVKINREEAVVMVEVNQSAKKQVILSSGTEFNAVKSLILGKVLEAAGADPDTRRAATSGFTGCLSAVRFGCAAPLKAALRPSGPSRVTVRGHVAPMARCAAGAASGSPARELAPRLAGGAGRSGPVDEGEPLVNADRRDSAVIGGVIAVEIFILLCITAIAIRIYQQRKLRKENESKVSKKEEC,1288,"140,415",Alternative sequence (4); Chain (1); Disulfide bond (11); Domain (8); Erroneous gene model prediction (3); Glycosylation (2); Sequence conflict (13); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 31..177;  /evidence=""ECO:0000250""; DISULFID 332..364;  /evidence=""ECO:0000250""; DISULFID 513..545;  /evidence=""ECO:0000250""; DISULFID 551..562;  /evidence=""ECO:0000250""; DISULFID 556..571;  /evidence=""ECO:0000250""; DISULFID 573..583;  /evidence=""ECO:0000250""; DISULFID 931..958;  /evidence=""ECO:0000250""; DISULFID 962..975;  /evidence=""ECO:0000250""; DISULFID 969..984;  /evidence=""ECO:0000250""; DISULFID 986..996;  /evidence=""ECO:0000250""; DISULFID 1167..1203;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8TDQ1,CMRF35-like molecule 1 (CLM-1) (CD300 antigen-like family member F) (Immune receptor expressed on myeloid cells 1) (IREM-1) (Immunoglobulin superfamily member 13) (IgSF13) (NK inhibitory receptor) (CD antigen CD300f),MPLLTLYLLLFWLSGYSIVTQITGPTTVNGLERGSLTVQCVYRSGWETYLKWWCRGAIWRDCKILVKTSGSEQEVKRDRVSIKDNQKNRTFTVTMEDLMKTDADTYWCGIEKTGNDLGVTVQVTIDPAPVTQEETSSSPTLTGHHLDNRHKLLKLSVLLPLIFTILLLLLVAASLLAWRMMKYQQKAAGMSPEQVLQPLEGDLCYADLTLQLAGTSPQKATTKLSSAQVDQVEVEYVTMASLPKEDISYASLTLGAEDQEPTYCNMGHLSSHLPGRGPEEPTEYSTISRP,290,"32,335",Alternative sequence (10); Beta strand (11); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (1); Mutagenesis (3); Natural variant (2); Sequence conflict (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 40..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17275839""; DISULFID 54..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17275839""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9NRD9,Dual oxidase 1 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1),MGFCLALAWTLLVGAWTPLGAQNPISWEVQRFDGWYNNLMEHRWGSKGSRLQRLVPASYADGVYQPLGEPHLPNPRDLSNTISRGPAGLASLRNRTVLGVFFGYHVLSDLVSVETPGCPAEFLNIRIPPGDPMFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDPANQVTGWLDGSAIYGSSHSWSDALRSFSRGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYEWLPSFLQKTLPEYTGYRPFLDPSISSEFVAASEQFLSTMVPPGVYMRNASCHFQGVINRNSSVSRALRVCNSYWSREHPSLQSAEDVDALLLGMASQIAEREDHVLVEDVRDFWPGPLKFSRTDHLASCLQRGRDLGLPSYTKARAALGLSPITRWQDINPALSRSNDTVLEATAALYNQDLSWLELLPGGLLESHRDPGPLFSTIVLEQFVRLRDGDRYWFENTRNGLFSKKEIEEIRNTTLQDVLVAVINIDPSALQPNVFVWHKGDPCPQPRQLSTEGLPACAPSVVRDYFEGSGFGFGVTIGTLCCFPLVSLLSAWIVARLRMRNFKRLQGQDRQSIVSEKLVGGMEALEWQGHKEPCRPVLVYLQPGQIRVVDGRLTVLRTIQLQPPQKVNFVLSSNRGRRTLLLKIPKEYDLVLLFNLEEERQALVENLRGALKESGLSIQEWELREQELMRAAVTREQRRHLLETFFRHLFSQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEEKSRLMFRMYDFDGNGLISKDEFIRMLRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHNSELRFTQLCVKGVEVPEVIKDLCRRASYISQDMICPSPRVSARCSRSDIETELTPQRLQCPMDTDPPQEIRRRFGKKVTSFQPLLFTEAHREKFQRSCLHQTVQQFKRFIENYRRHIGCVAVFYAIAGGLFLERAYYYAFAAHHTGITDTTRVGIILSRGTAASISFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRLIASTAIVLTVLHSVGHVVNVYLFSISPLSVLSCLFPGLFHDDGSELPQKYYWWFFQTVPGLTGVVLLLILAIMYVFASHHFRRRSFRGFWLTHHLYILLYVLLIIHGSFALIQLPRFHIFFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTHLRFQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAAGPWTTRLREIYSAPTGDRCARYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSVSCQVFCKKIYFIWVTRTQRQFEWLADIIREVEENDHQDLVSVHIYITQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLINRQDRTHFSHHYENF,1551,"177,235",Alternative sequence (2); Calcium binding (2); Chain (1); Domain (5); Erroneous initiation (1); Erroneous termination (1); Glycosylation (5); Natural variant (3); Region (2); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q92637,High affinity immunoglobulin gamma Fc receptor IB (IgG Fc receptor IB) (Fc-gamma RIB) (FcRIB) (hFcgammaRIB),MWFLTTLLLWVPVDGQVDTTKAVITLQPPWVSVFQEETVTLHCEVLHLPGSSSTQWFLNGTATQTSTPSYRITSASVNDSGEYRCQRGLSGRSDPIQLEIHRGWLLLQVSSRVFMEGEPLALRCHAWKDKLVYNVLYYRNGKAFKFFHWNSNLTILKTNISHNGTYHCSGMGKHRYTSAGISQYTVKGLQLPTPVWFHVLFYLAVGIMFLVNTVLWVTIRKELKRKKKWNLEISLDSGHEKKVISSLQEDRHLEEELKCQEQKEEQLQEGVHRKEPQGAT,280,"32,232",Alternative sequence (3); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 124..168;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
P11362,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331),MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR,822,"91,868",Active site (1); Alternative sequence (17); Beta strand (41); Binding site (4); Chain (1); Disulfide bond (3); Domain (4); Erroneous initiation (1); Glycosylation (8); Helix (19); Modified residue (7); Mutagenesis (8); Natural variant (91); Nucleotide binding (2); Region (1); Sequence conflict (13); Signal peptide (1); Site (4); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 55..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 178..230; DISULFID 277..341",SIGNAL 1..21
O14764,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta),MDAPARLLAPLLLLCAQQLRGTRAMNDIGDYVGSNLEISWLPNLDGLIAGYARNFRPGIGGPPVNVALALEVASIDHISEANMEYTMTVFLHQSWRDSRLSYNHTNETLGLDSRFVDKLWLPDTFIVNAKSAWFHDVTVENKLIRLQPDGVILYSIRITSTVACDMDLAKYPMDEQECMLDLESYGYSSEDIVYYWSESQEHIHGLDKLQLAQFTITSYRFTTELMNFKSAGQFPRLSLHFHLRRNRGVYIIQSYMPSVLLVAMSWVSFWISQAAVPARVSLGITTVLTMTTLMVSARSSLPRASAIKALDVYFWICYVFVFAALVEYAFAHFNADYRKKQKAKVKVSRPRAEMDVRNAIVLFSLSAAGVTQELAISRRQRRVPGNLMGSYRSVGVETGETKKEGAARSGGQGGIRARLRPIDADTIDIYARAVFPAAFAAVNVIYWAAYAM,452,"50,708",Chain (1); Disulfide bond (1); Glycosylation (2); Modified residue (1); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 164..178;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
P07359,Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin],MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDTEGDKVRATRTVVKFPTKAHTTPWGLFYSWSTASLDSQMPSSLHPTQESTKEQTTFPPRWTPNFTLHMESITFSKTPKSTTEPTPSPTTSEPVPEPAPNMTTLEPTPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTPIPTIATSPTILVSATSLITPKSTFLTTTKPVSLLESTKKTIPELDQPPKLRGVLQGHLESSRNDPFLHPDFCCLLPLGFYVLGLFWLLFASVVLILLLSWVGHVKPQALDSGQGAALTTATQTTHLELQRGRQVTVPRAWLLFLRGSLPTFRSSLFLWVRPNGRVGPLVAGRRPSALSQGRGQDLLSTVSIRYSGHSL,652,"71,540",Beta strand (17); Chain (2); Compositional bias (1); Disulfide bond (5); Domain (2); Glycosylation (3); Helix (8); Modified residue (5); Mutagenesis (3); Natural variant (13); Repeat (7); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 20..33;  /evidence=""ECO:0000269|PubMed:2070794""; DISULFID 225..264;  /evidence=""ECO:0000269|PubMed:2070794""; DISULFID 227..280;  /evidence=""ECO:0000269|PubMed:2070794""; DISULFID 526;  /note=""Interchain (with C-147 in GP1BB)"";  /evidence=""ECO:0000269|PubMed:2070794""; DISULFID 527;  /note=""Interchain (with C-147 in GP1BB)"";  /evidence=""ECO:0000269|PubMed:2070794""","SIGNAL 1..16;  /evidence=""ECO:0000269|PubMed:3497398"""
Q5T6X5,G-protein coupled receptor family C group 6 member A (hGPRC6A) (G-protein coupled receptor GPCR33) (hGPCR33),MAFLIILITCFVIILATSQPCQTPDDFVAATSPGHIIIGGLFAIHEKMLSSEDSPRRPQIQECVGFEISVFLQTLAMIHSIEMINNSTLLPGVKLGYEIYDTCTEVTVAMAATLRFLSKFNCSRETVEFKCDYSSYMPRVKAVIGSGYSEITMAVSRMLNLQLMPQVGYESTAEILSDKIRFPSFLRTVPSDFHQIKAMAHLIQKSGWNWIGIITTDDDYGRLALNTFIIQAEANNVCIAFKEVLPAFLSDNTIEVRINRTLKKIILEAQVNVIVVFLRQFHVFDLFNKAIEMNINKMWIASDNWSTATKITTIPNVKKIGKVVGFAFRRGNISSFHSFLQNLHLLPSDSHKLLHEYAMHLSACAYVKDTDLSQCIFNHSQRTLAYKANKAIERNFVMRNDFLWDYAEPGLIHSIQLAVFALGYAIRDLCQARDCQNPNAFQPWELLGVLKNVTFTDGWNSFHFDAHGDLNTGYDVVLWKEINGHMTVTKMAEYDLQNDVFIIPDQETKNEFRNLKQIQSKCSKECSPGQMKKTTRSQHICCYECQNCPENHYTNQTDMPHCLLCNNKTHWAPVRSTMCFEKEVEYLNWNDSLAILLLILSLLGIIFVLVVGIIFTRNLNTPVVKSSGGLRVCYVILLCHFLNFASTSFFIGEPQDFTCKTRQTMFGVSFTLCISCILTKSLKILLAFSFDPKLQKFLKCLYRPILIIFTCTGIQVVICTLWLIFAAPTVEVNVSLPRVIILECEEGSILAFGTMLGYIAILAFICFIFAFKGKYENYNEAKFITFGMLIYFIAWITFIPIYATTFGKYVPAVEIIVILISNYGILYCTFIPKCYVIICKQEINTKSAFLKMIYSYSSHSVSSIALSPASLDSMSGNVTMTNPSSSGKSATWQKSKDLQAQAFAHICRENATSVSKTLPRKRMSSI,926,"104,753",Alternative sequence (2); Chain (1); Disulfide bond (1); Erroneous gene model prediction (1); Glycosylation (9); Mutagenesis (2); Natural variant (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 131;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:25617829""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
O15389,Sialic acid-binding Ig-like lectin 5 (Siglec-5) (CD33 antigen-like 2) (Obesity-binding protein 2) (OB-BP2) (OB-binding protein 2) (CD antigen CD170),MLPLLLLPLLWGGSLQEKPVYELQVQKSVTVQEGLCVLVPCSFSYPWRSWYSSPPLYVYWFRDGEIPYYAEVVATNNPDRRVKPETQGRFRLLGDVQKKNCSLSIGDARMEDTGSYFFRVERGRDVKYSYQQNKLNLEVTALIEKPDIHFLEPLESGRPTRLSCSLPGSCEAGPPLTFSWTGNALSPLDPETTRSSELTLTPRPEDHGTNLTCQMKRQGAQVTTERTVQLNVSYAPQTITIFRNGIALEILQNTSYLPVLEGQALRLLCDAPSNPPAHLSWFQGSPALNATPISNTGILELRRVRSAEEGGFTCRAQHPLGFLQIFLNLSVYSLPQLLGPSCSWEAEGLHCRCSFRARPAPSLCWRLEEKPLEGNSSQGSFKVNSSSAGPWANSSLILHGGLSSDLKVSCKAWNIYGSQSGSVLLLQGRSNLGTGVVPAALGGAGVMALLCICLCLIFFLIVKARRKQAAGRPEKMDDEDPIMGTITSGSRKKPWPDSPGDQASPPGDAPPLEEQKELHYASLSFSEMKSREPKDQEAPSTTEYSEIKTSK,551,"60,715",Beta strand (20); Binding site (3); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (8); Helix (3); Motif (2); Natural variant (5); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 36..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18022638""; DISULFID 41..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18022638""; DISULFID 164..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18022638""; DISULFID 269..314;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q9P246,Stromal interaction molecule 2,MLVLGLLVAGAADGCELVPRHLRGRRATGSAATAASSPAAAAGDSPALMTDPCMSLSPPCFTEEDRFSLEALQTIHKQMDDDKDGGIEVEESDEFIREDMKYKDATNKHSHLHREDKHITIEDLWKRWKTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDRSHRQKLQLKALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAYTQNKTSKEHVAKMMKDLESLQTAEQSLMDLQERLEKAQEENRNVAVEKQNLERKMMDEINYAKEEACRLRELREGAECELSRRQYAEQELEQVRMALKKAEKEFELRSSWSVPDALQKWLQLTHEVEVQYYNIKRQNAEMQLAIAKDEAEKIKKKRSTVFGTLHVAHSSSLDEVDHKILEAKKALSELTTCLRERLFRWQQIEKICGFQIAHNSGLPSLTSSLYSDHSWVVMPRVSIPPYPIAGGVDDLDEDTPPIVSQFPGTMAKPPGSLARSSSLCRSRRSIVPSSPQPQRAQLAPHAPHPSHPRHPHHPQHTPHSLPSPDPDILSVSSCPALYRNEEEEEAIYFSAEKQWEVPDTASECDSLNSSIGRKQSPPLSLEIYQTLSPRKISRDEVSLEDSSRGDSPVTVDVSWGSPDCVGLTETKSMIFSPASKVYNGILEKSCSMNQLSSGIPVPKPRHTSCSSAGNDSKPVQEAPSVARISSIPHDLCHNGEKSKKPSKIKSLFKKKSK,746,"83,971",Alternative sequence (4); Beta strand (3); Calcium binding (1); Chain (1); Coiled coil (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Glycosylation (1); Helix (8); Modified residue (9); Mutagenesis (2); Sequence caution (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),,"SIGNAL 1..14;  /evidence=""ECO:0000269|PubMed:11463338"""
Q15399,Toll-like receptor 1 (EC 3.2.2.6) (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281),MTSIFHFAIIFMLILQIRIQLSEESEFLVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELGEFVKNIDQVSSEVLEGWPDSYKCDYPESYRGTLLKDFHMSELSCNITLLIVTIVATMLVLAVTVTSLCSYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSGHDSFWVKNELLPNLEKEGMQICLHERNFVPGKSIVENIITCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNSLILILLEPIPQYSIPSSYHKLKSLMARRTYLEWPKEKSKRGLFWANLRAAINIKLTEQAKK,786,"90,291",Active site (1); Beta strand (28); Chain (1); Disulfide bond (4); Domain (2); Erroneous initiation (1); Glycosylation (6); Helix (25); Natural variant (18); Region (1); Repeat (19); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 110..132;  /evidence=""ECO:0000269|PubMed:17889651""; DISULFID 223..230;  /evidence=""ECO:0000269|PubMed:17889651""; DISULFID 343..368;  /evidence=""ECO:0000269|PubMed:17889651""; DISULFID 419..442;  /evidence=""ECO:0000269|PubMed:17889651""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
A2RRL7,Transmembrane protein 213,MQRLPAATRATLILSLAFASLHSACSAEASSSNSSSLTAHHPDPGTLEQCLNVDFCPQAARCCRTGVDEYGWIAAAVGWSLWFLTLILLCVDKLMKLTPDEPKDLQA,107,"11,520",Alternative sequence (3); Chain (1); Erroneous initiation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P0DTF9,PTTG1IP family member 2,MCWLRAWGQILLPVFLSLFLIQLLISFSENGFIHSPRNNQKPRDGNEEECAVKKSCQLCTEDKKCVWCSEEKACKKYCFPYFGCRFSSIYWLNCKVDMFGIMMLLLIAVLITGFVWYCCAYHFYLQDLNRNRVYFYGRRETVPIHDRSATVYDE,154,"18,282",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8NC42,E3 ubiquitin-protein ligase RNF149 (EC 2.3.2.27) (DNA polymerase-transactivated protein 2) (RING finger protein 149) (RING-type E3 ubiquitin transferase RNF149),MAWRRREASVGARGVLALALLALALCVPGARGRALEWFSAVVNIEYVDPQTNLTVWSVSESGRFGDSSPKEGAHGLVGVPWAPGGDLEGCAPDTRFFVPEPGGRGAAPWVALVARGGCTFKDKVLVAARRNASAVVLYNEERYGNITLPMSHAGTGNIVVIMISYPKGREILELVQKGIPVTMTIGVGTRHVQEFISGQSVVFVAIAFITMMIISLAWLIFYYIQRFLYTGSQIGSQSHRKETKKVIGQLLLHTVKHGEKGIDVDAENCAVCIENFKVKDIIRILPCKHIFHRICIDPWLLDHRTCPMCKLDVIKALGYWGEPGDVQEMPAPESPPGRDPAANLSLALPDDDGSDDSSPPSASPAESEPQCDPSFKGDAGENTALLEAGRSDSRHGGPIS,400,"43,165",Chain (1); Domain (1); Glycosylation (2); Modified residue (1); Natural variant (4); Signal peptide (1); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9H6Y7,E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167) (RING-type E3 ubiquitin transferase RNF167) (RING105),MHPAAFPLPVVVAAVLWGAAPTRGLIRATSDHNASMDFADLPALFGATLSQEGLQGFLVEAHPDNACSPIAPPPPAPVNGSVFIALLRRFDCNFDLKVLNAQKAGYGAAVVHNVNSNELLNMVWNSEEIQQQIWIPSVFIGERSSEYLRALFVYEKGARVLLVPDNTFPLGYYLIPFTGIVGLLVLAMGAVMIARCIQHRKRLQRNRLTKEQLKQIPTHDYQKGDQYDVCAICLDEYEDGDKLRVLPCAHAYHSRCVDPWLTQTRKTCPICKQPVHRGPGDEDQEEETQGQEEGDEGEPRDHPASERTPLLGSSPTLPTSFGSLAPAPLVFPGPSTDPPLSPPSSPVILV,350,"38,299",Chain (1); Domain (1); Frameshift (1); Glycosylation (1); Mutagenesis (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
A4D0T7,Small integral membrane protein 30,MTSVSTQLSLVLMSLLLVLPVVEAVEAGDAIALLLGVVLSITGICACLGVYARKRNGQM,59,"6,102",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q6ZMC9,Sialic acid-binding Ig-like lectin 15 (Siglec-15) (CD33 antigen-like 3),MEKSIWLLACLAWVLPTGSFVRTKIDTTENLLNTEVHSSPAQRWSMQVPPEVSAEAGDAAVLPCTFTHPHRHYDGPLTAIWRAGEPYAGPQVFRCAAARGSELCQTALSLHGRFRLLGNPRRNDLSLRVERLALADDRRYFCRVEFAGDVHDRYESRHGVRLHVTAAPRIVNISVLPSPAHAFRALCTAEGEPPPALAWSGPALGNSLAAVRSPREGHGHLVTAELPALTHDGRYTCTAANSLGRSEASVYLFRFHGASGASTVALLLGALGFKALLLLGVLAARAARRRPEHLDTPDTPPRSQAQESNYENLSQMNPRSPPATMCSP,328,"35,653",Alternative sequence (2); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (2); Glycosylation (1); Mutagenesis (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 64..142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 95..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 187..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q6UWW9,Transmembrane protein 207,MSRSRLFSVTSAISTIGILCLPLFQLVLSDLPCEEDEMCVNYNDQHPNGWYIWILLLLVLVAALLCGAVVLCLQCWLRRPRIDSHRRTMAVFAVGDLDSIYGTEAAVSPTVGIHLQTQTPDLYPVPAPCFGPLGSPPPYEEIVKTT,146,"16,116",Chain (1); Mutagenesis (1); Natural variant (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q96HV5,Transmembrane protein 41A,MRPLLGLLLVFAGCTFALYLLSTRLPRGRRLGSTEEAGGRSLWFPSDLAELRELSEVLREYRKEHQAYVFLLFCGAYLYKQGFAIPGSSFLNVLAGALFGPWLGLLLCCVLTSVGATCCYLLSSIFGKQLVVSYFPDKVALLQRKVEENRNSLFFFLLFLRLFPMTPNWFLNLSAPILNIPIVQFFFSVLIGLIPYNFICVQTGSILSTLTSLDALFSWDTVFKLLAIAMVALIPGTLIKKFSQKHLQLNETSTANHIHSRKDT,264,"29,665",Chain (1); Glycosylation (1); Region (1); Sequence caution (1); Signal peptide (1); Transmembrane (5),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q8NBN3,Transmembrane protein 87A,MAAAAWLQVLPVILLLLGAHPSPLSFFSAGPATVAAADRSKWHIPIPSGKNYFSFGKILFRNTTIFLKFDGEPCDLSLNITWYLKSADCYNEIYNFKAEEVELYLEKLKEKRGLSGKYQTSSKLFQNCSELFKTQTFSGDFMHRLPLLGEKQEAKENGTNLTFIGDKTAMHEPLQTWQDAPYIFIVHIGISSSKESSKENSLSNLFTMTVEVKGPYEYLTLEDYPLMIFFMVMCIVYVLFGVLWLAWSACYWRDLLRIQFWIGAVIFLGMLEKAVFYAEFQNIRYKGESVQGALILAELLSAVKRSLARTLVIIVSLGYGIVKPRLGVTLHKVVVAGALYLLFSGMEGVLRVTGAQTDLASLAFIPLAFLDTALCWWIFISLTQTMKLLKLRRNIVKLSLYRHFTNTLILAVAASIVFIIWTTMKFRIVTCQSDWRELWVDDAIWRLLFSMILFVIMVLWRPSANNQRFAFSPLSEEEEEDEQKEPMLKESFEGMKMRSTKQEPNGNSKVNKAQEDDLKWVEENVPSSVTDVALPALLDSDEERMITHFERSKME,555,"63,430",Alternative sequence (3); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (4); Modified residue (1); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9Y5U5,Tumor necrosis factor receptor superfamily member 18 (Activation-inducible TNFR family receptor) (Glucocorticoid-induced TNFR-related protein) (CD antigen CD357),MAQHGAMGAFRALCGLALLCALSLGQRPTGGPGCGPGRLLLGTGTDARCCRVHTTRCCRDYPGEECCSEWDCMCVQPEFHCGDPCCTTCRHHPCPPGQGVQSQGKFSFGFQCIDCASGTFSGGHEGHCKPWTDCTQFGFLTVFPGNKTHNAVCVPGSPPAEPLGWLTVVLLAVAACVLLLTSAQLGLHIWQLRSQCMWPRETQLLLEVPPSTEDARSCQFPEEERGERSAEEKGRLGDLWV,241,"26,000",Alternative sequence (2); Chain (1); Disulfide bond (5); Glycosylation (1); Natural variant (4); Repeat (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..49;  /evidence=""ECO:0000250""; DISULFID 74..86;  /evidence=""ECO:0000250""; DISULFID 81..94;  /evidence=""ECO:0000250""; DISULFID 115..134;  /evidence=""ECO:0000250""; DISULFID 128..153;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15340161"""
Q6ZMH5,Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5),MMGSPVSHLLAGFCVWVVLGWVGGSVPNLGPAEQEQNHYLAQLFGLYGENGTLTAGGLARLLHSLGLGRVQGLRLGQHGPLTGRAASPAADNSTHRPQNPELSVDVWAGMPLGPSGWGDLEESKAPHLPRGPAPSGLDLLHRLLLLDHSLADHLNEDCLNGSQLLVNFGLSPAAPLTPRQFALLCPALLYQIDSRVCIGAPAPAPPGDLLSALLQSALAVLLLSLPSPLSLLLLRLLGPRLLRPLLGFLGALAVGTLCGDALLHLLPHAQEGRHAGPGGLPEKDLGPGLSVLGGLFLLFVLENMLGLLRHRGLRPRCCRRKRRNLETRNLDPENGSGMALQPLQAAPEPGAQGQREKNSQHPPALAPPGHQGHSHGHQGGTDITWMVLLGDGLHNLTDGLAIGAAFSDGFSSGLSTTLAVFCHELPHELGDFAMLLQSGLSFRRLLLLSLVSGALGLGGAVLGVGLSLGPVPLTPWVFGVTAGVFLYVALVDMLPALLRPPEPLPTPHVLLQGLGLLLGGGLMLAITLLEERLLPVTTEG,540,"56,461",Chain (1); Erroneous initiation (2); Glycosylation (2); Modified residue (1); Natural variant (2); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
O43699,Sialic acid-binding Ig-like lectin 6 (Siglec-6) (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1) (OB-BP1) (CD antigen CD327),MQGAQEASASEMLPLLLPLLWAGALAQERRFQLEGPESLTVQEGLCVLVPCRLPTTLPASYYGYGYWFLEGADVPVATNDPDEEVQEETRGRFHLLWDPRRKNCSLSIRDARRRDNAAYFFRLKSKWMKYGYTSSKLSVRVMALTHRPNISIPGTLESGHPSNLTCSVPWVCEQGTPPIFSWMSAAPTSLGPRTTQSSVLTITPRPQDHSTNLTCQVTFPGAGVTMERTIQLNVSYAPQKVAISIFQGNSAAFKILQNTSSLPVLEGQALRLLCDADGNPPAHLSWFQGFPALNATPISNTGVLELPQVGSAEEGDFTCRAQHPLGSLQISLSLFVHWKPEGRAGGVLGAVWGASITTLVFLCVCFIFRVKTRRKKAAQPVQNTDDVNPVMVSGSRGHQHQFQTGIVSDHPAEAGPISEDEQELHYAVLHFHKVQPQEPKVTDTEYSEIKIHK,453,"49,913",Alternative sequence (7); Binding site (1); Chain (1); Disulfide bond (4); Domain (3); Erroneous initiation (5); Glycosylation (4); Motif (2); Natural variant (2); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 46..172;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 51..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 166..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 274..319;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8NBJ9,SID1 transmembrane family member 2,MFALGLPFLVLLVASVESHLGVLGPKNVSQKDAEFERTYVDEVNSELVNIYTFNHTVTRNRTEGVRVSVNVLNKQKGAPLLFVVRQKEAVVSFQVPLILRGMFQRKYLYQKVERTLCQPPTKNESEIQFFYVDVSTLSPVNTTYQLRVSRMDDFVLRTGEQFSFNTTAAQPQYFKYEFPEGVDSVIVKVTSNKAFPCSVISIQDVLCPVYDLDNNVAFIGMYQTMTKKAAITVQRKDFPSNSFYVVVVVKTEDQACGGSLPFYPFAEDEPVDQGHRQKTLSVLVSQAVTSEAYVSGMLFCLGIFLSFYLLTVLLACWENWRQKKKTLLVAIDRACPESGHPRVLADSFPGSSPYEGYNYGSFENVSGSTDGLVDSAGTGDLSYGYQGRSFEPVGTRPRVDSMSSVEEDDYDTLTDIDSDKNVIRTKQYLYVADLARKDKRVLRKKYQIYFWNIATIAVFYALPVVQLVITYQTVVNVTGNQDICYYNFLCAHPLGNLSAFNNILSNLGYILLGLLFLLIILQREINHNRALLRNDLCALECGIPKHFGLFYAMGTALMMEGLLSACYHVCPNYTNFQFDTSFMYMIAGLCMLKLYQKRHPDINASAYSAYACLAIVIFFSVLGVVFGKGNTAFWIVFSIIHIIATLLLSTQLYYMGRWKLDSGIFRRILHVLYTDCIRQCSGPLYVDRMVLLVMGNVINWSLAAYGLIMRPNDFASYLLAIGICNLLLYFAFYIIMKLRSGERIKLIPLLCIVCTSVVWGFALFFFFQGLSTWQKTPAESREHNRDCILLDFFDDHDIWHFLSSIAMFGSFLVLLTLDDDLDTVQRDKIYVF,832,"94,454",Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (2); Glycosylation (10); Modified residue (3); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (11); Transmembrane (10),,"SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:15340161"""
Q96RL6,Sialic acid-binding Ig-like lectin 11 (Sialic acid-binding lectin 11) (Siglec-11),MVPGQAQPQSPEMLLLPLLLPVLGAGSLNKDPSYSLQVQRQVPVPEGLCVIVSCNLSYPRDGWDESTAAYGYWFKGRTSPKTGAPVATNNQSREVEMSTRDRFQLTGDPGKGSCSLVIRDAQREDEAWYFFRVERGSRVRHSFLSNAFFLKVTALTKKPDVYIPETLEPGQPVTVICVFNWAFKKCPAPSFSWTGAALSPRRTRPSTSHFSVLSFTPSPQDHDTDLTCHVDFSRKGVSAQRTVRLRVAYAPKDLIISISHDNTSALELQGNVIYLEVQKGQFLRLLCAADSQPPATLSWVLQDRVLSSSHPWGPRTLGLELRGVRAGDSGRYTCRAENRLGSQQQALDLSVQYPPENLRVMVSQANRTVLENLGNGTSLPVLEGQSLRLVCVTHSSPPARLSWTRWGQTVGPSQPSDPGVLELPPIQMEHEGEFTCHAQHPLGSQHVSLSLSVHYPPQLLGPSCSWEAEGLHCSCSSQASPAPSLRWWLGEELLEGNSSQGSFEVTPSSAGPWANSSLSLHGGLSSGLRLRCKAWNVHGAQSGSVFQLLPGKLEHGGGLGLGAALGAGVAALLAFCSCLVVFRVKICRKEARKRAAAEQDVPSTLGPISQGHQHECSAGSSQDHPPPGAATYTPGKGEEQELHYASLSFQGLRLWEPADQEAPSTTEYSEIKIHTGQPLRGPGFGLQLEREMSGMVPK,698,"75,795",Alternative sequence (1); Binding site (1); Chain (1); Disulfide bond (5); Domain (4); Erroneous initiation (2); Glycosylation (7); Modified residue (1); Motif (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..186;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 54..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 177..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 287..334;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 391..436;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
B8ZZ34,Protein shisa-8 (Shisa family member 8),MARAGARGLLGGRRPPGLRLALALRLALLLARPPSGRAGAPEAQGPAAPGTTAPEGGDRCRGYYDVMGQWDPPFNCSSGAYSFCCGTCGYRFCCHDGPRRLDQSRCSNYDTPAWVQTGRPPARARDTAAPRDPGRERSHTAVYAVCGVAALLVLAGIGARLGLERAHSPRARRTVTRALTELLKQPGPQEPLPPTLGPPLGGCVQVQMGDGLPRGSPHNSADKKRLNNAPRGSAAPGPPRGPRLQGGGSLTLQPDYAKYATFKAAALKAAEAAPRDFCQRFPALEPSPRQPPARAPRPSPDLPAPLDACPWAPPVYAPPAAPGPYAAWTSSRPARPAPLSHPTARAFQVPRRPGHAARRQFSVKMPETFNPQLPGLYGSAGRGSRYLRTNSKTEVTV,397,"41,995",Alternative sequence (1); Chain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q92537,Sushi domain-containing protein 6 (Drug-activated gene overexpressed protein),MCHGRIAPKSTSVFAVASVGHGVFLPLVILCTLLGDGLASVCPLPPEPENGGYICHPRPCRDPLTAGSVIEYLCAEGYMLKGDYKYLTCKNGEWKPAMEISCRLNEDKDTHTSLGVPTLSIVASTASSVALILLLVVLFVLLQPKLKSFHHSRRDQGVSGDQVSIMVDGVQVALPSYEEAVYGSSGHCVPPADPRVQIVLSEGSGPSGRSVPREQQLPDQGACSSAGGEDEAPGQSGLCEAWGSRASETVMVHQATTSSWVAGSGNRQLAHKETADSENSDIQSLLSLTSEEYTDDIPLLKEA,303,"32,090",Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..89;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 74..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
B0FP48,Uroplakin-3b-like protein 1,MDNSWRLGPAIGLSAGQSQLLVSLLLLLTRVQPGTDVAAPEHISYVPQLSNDTLAGRLTLSTFTLEQPLGQFSSHNISDLDTIWLVVALSNATQSFTAPRTNQDIPAPANFSQRGYYLTLRANRVLYQTRGQLHVLRVGNDTHCQPTKIGCNHPLPGPGPYRVKFLVMNDEGPVAETKWSSDTRLQQAQALRAVPGPQSPGTVVIIAILSILLAVLLTVLLAVLIYTCFNSCRSTSLSGPEEAGSVRRYTTHLAFSTPAEGAS,263,"28,385",Chain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
P05106,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61),MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGTFECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFGKITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDRGALHDENTCNRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT,788,"87,058",Alternative sequence (2); Beta strand (52); Chain (1); Disulfide bond (28); Domain (1); Glycosylation (6); Helix (27); Modified residue (4); Natural variant (39); Region (3); Repeat (4); Sequence conflict (10); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (17),"DISULFID 31..461;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 39..49;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 42..75;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 52..64;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 203..210;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 258..299;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 400..412;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 432..681;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 459..463;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 474..486;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 483..521;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 488..497;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 499..512;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 527..532;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 529..562;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 534..547;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 549..554;  /evidence=""ECO:0000269|PubMed:2001252""; DISULFID 568..573;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 570..601;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 575..584;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 586..593;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 607..612;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 609..657;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 614..624;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 627..630;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 634..643;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 640..713;  /evidence=""ECO:0000305|PubMed:2001252""; DISULFID 661..689;  /evidence=""ECO:0000269|PubMed:2001252""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8NHK3,Killer cell immunoglobulin-like receptor 2DL5B (CD158 antigen-like family member F2) (Killer cell immunoglobulin-like receptor 2DLX) (CD antigen CD158f2),MSLMVVSMACVGFFLLQGAWTHEGGQDKPLLSAWPSAVVPRGGHVTLLCRSRLGFTIFSLYKEDGVPVPELYNKIFWKSILMGPVTPAHAGTYRCRGSHPRSPIEWSAPSNPLVIVVTGLFGKPSLSAQPGPTVRTGENVTLSCSSRSSFDMYHLSREGRAHEPRLPAVPSVDGTFQADFPLGPATHGGTYTCFSSLHDSPYEWSDPSDPLLVSVTGNSSSSSSSPTEPSSKTGIRRHLHILIGTSVAIILFIILFFFLLHCCCSNKKNAAVMDQEPAGDRTVNREDSDDQDPQEVTYAQLDHCVFTQTKITSPSQRPKTPPTDTTMYMELPNAKPRSLSPAHKHHSQALRGSSRETTALSQNRVASSHVPAAGI,375,"40,695",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..95;  /evidence=""ECO:0000250""; DISULFID 144..193;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q6UWI4,Protein shisa-2 homolog (Transmembrane protein 46),MWGARRSSVSSSWNAASLLQLLLAALLAAGARASGEYCHGWLDAQGVWRIGFQCPERFDGGDATICCGSCALRYCCSSAEARLDQGGCDNDRQQGAGEPGRADKDGPDGSAVPIYVPFLIVGSVFVAFIILGSLVAACCCRCLRPKQDPQQSRAPGGNRLMETIPMIPSASTSRGSSSRQSSTAASSSSSANSGARAPPTRSQTNCCLPEGTMNNVYVNMPTNFSVLNCQQATQIVPHQGQYLHPPYVGYTVQHDSVPMTAVPPFMDGLQPGYRQIQSPFPHTNSEQKMYPAVTV,295,"31,375",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9NY15,"Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)",MAGPRGLLPLCLLAFCLAGFSFVRGQVLFKGCDVKTTFVTHVPCTSCAAIKKQTCPSGWLRELPDQITQDCRYEVQLGGSMVSMSGCRRKCRKQVVQKACCPGYWGSRCHECPGGAETPCNGHGTCLDGMDRNGTCVCQENFRGSACQECQDPNRFGPDCQSVCSCVHGVCNHGPRGDGSCLCFAGYTGPHCDQELPVCQELRCPQNTQCSAEAPSCRCLPGYTQQGSECRAPNPCWPSPCSLLAQCSVSPKGQAQCHCPENYHGDGMVCLPKDPCTDNLGGCPSNSTLCVYQKPGQAFCTCRPGLVSINSNASAGCFAFCSPFSCDRSATCQVTADGKTSCVCRESEVGDGRACYGHLLHEVQKATQTGRVFLQLRVAVAMMDQGCREILTTAGPFTVLVPSVSSFSSRTMNASLAQQLCRQHIIAGQHILEDTRTQQTRRWWTLAGQEITVTFNQFTKYSYKYKDQPQQTFNIYKANNIAANGVFHVVTGLRWQAPSGTPGDPKRTIGQILASTEAFSRFETILENCGLPSILDGPGPFTVFAPSNEAVDSLRDGRLIYLFTAGLSKLQELVRYHIYNHGQLTVEKLISKGRILTMANQVLAVNISEEGRILLGPEGVPLQRVDVMAANGVIHMLDGILLPPTILPILPKHCSEEQHKIVAGSCVDCQALNTSTCPPNSVKLDIFPKECVYIHDPTGLNVLKKGCASYCNQTIMEQGCCKGFFGPDCTQCPGGFSNPCYGKGNCSDGIQGNGACLCFPDYKGIACHICSNPNKHGEQCQEDCGCVHGLCDNRPGSGGVCQQGTCAPGFSGRFCNESMGDCGPTGLAQHCHLHARCVSQEGVARCRCLDGFEGDGFSCTPSNPCSHPDRGGCSENAECVPGSLGTHHCTCHKGWSGDGRVCVAIDECELDMRGGCHTDALCSYVGPGQSRCTCKLGFAGDGYQCSPIDPCRAGNGGCHGLATCRAVGGGQRVCTCPPGFGGDGFSCYGDIFRELEANAHFSIFYQWLKSAGITLPADRRVTALVPSEAAVRQLSPEDRAFWLQPRTLPNLVRAHFLQGALFEEELARLGGQEVATLNPTTRWEIRNISGRVWVQNASVDVADLLATNGVLHILSQVLLPPRGDVPGGQGLLQQLDLVPAFSLFRELLQHHGLVPQIEAATAYTIFVPTNRSLEAQGNSSHLDADTVRHHVVLGEALSMETLRKGGHRNSLLGPAHWIVFYNHSGQPEVNHVPLEGPMLEAPGRSLIGLSGVLTVGSSRCLHSHAEALREKCVNCTRRFRCTQGFQLQDTPRKSCVYRSGFSFSRGCSYTCAKKIQVPDCCPGFFGTLCEPCPGGLGGVCSGHGQCQDRFLGSGECHCHEGFHGTACEVCELGRYGPNCTGVCDCAHGLCQEGLQGDGSCVCNVGWQGLRCDQKITSPQCPRKCDPNANCVQDSAGASTCACAAGYSGNGIFCSEVDPCAHGHGGCSPHANCTKVAPGQRTCTCQDGYMGDGELCQEINSCLIHHGGCHIHAECIPTGPQQVSCSCREGYSGDGIRTCELLDPCSKNNGGCSPYATCKSTGDGQRTCTCDTAHTVGDGLTCRARVGLELLRDKHASFFSLRLLEYKELKGDGPFTIFVPHADLMSNLSQDELARIRAHRQLVFRYHVVGCRRLRSEDLLEQGYATALSGHPLRFSEREGSIYLNDFARVVSSDHEAVNGILHFIDRVLLPPEALHWEPDDAPIPRRNVTAAAQGFGYKIFSGLLKVAGLLPLLREASHRPFTMLWPTDAAFRALPPDRQAWLYHEDHRDKLAAILRGHMIRNVEALASDLPNLGPLRTMHGTPISFSCSRTRAGELMVGEDDARIVQRHLPFEGGLAYGIDQLLEPPGLGARCDHFETRPLRLNTCSICGLEPPCPEGSQEQGSPEACWRFYPKFWTSPPLHSLGLRSVWVHPSLWGRPQGLGRGCHRNCVTTTWKPSCCPGHYGSECQACPGGPSSPCSDRGVCMDGMSGSGQCLCRSGFAGTACELCAPGAFGPHCQACRCTVHGRCDEGLGGSGSCFCDEGWTGPRCEVQLELQPVCTPPCAPEAVCRAGNSCECSLGYEGDGRVCTVADLCQDGHGGCSEHANCSQVGTMVTCTCLPDYEGDGWSCRARNPCTDGHRGGCSEHANCLSTGLNTRRCECHAGYVGDGLQCLEESEPPVDRCLGQPPPCHSDAMCTDLHFQEKRAGVFHLQATSGPYGLNFSEAEAACEAQGAVLASFPQLSAAQQLGFHLCLMGWLANGSTAHPVVFPVADCGNGRVGIVSLGARKNLSERWDAYCFRVQDVACRCRNGFVGDGISTCNGKLLDVLAATANFSTFYGMLLGYANATQRGLDFLDFLDDELTYKTLFVPVNEGFVDNMTLSGPDLELHASNATLLSANASQGKLLPAHSGLSLIISDAGPDNSSWAPVAPGTVVVSRIIVWDIMAFNGIIHALASPLLAPPQPQAVLAPEAPPVAAGVGAVLAAGALLGLVAGALYLRARGKPMGFGFSAFQAEDDADDDFSPWQEGTNPTLVSVPNPVFGSDTFCEPFDDSLLEEDFPDTQRILTVK,2570,"275,482",Alternative sequence (2); Chain (1); Disulfide bond (59); Domain (26); Erroneous initiation (1); Glycosylation (29); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 112..126;  /evidence=""ECO:0000250""; DISULFID 120..136;  /evidence=""ECO:0000250""; DISULFID 138..147;  /evidence=""ECO:0000250""; DISULFID 160..171;  /evidence=""ECO:0000250""; DISULFID 164..181;  /evidence=""ECO:0000250""; DISULFID 183..192;  /evidence=""ECO:0000250""; DISULFID 199..210;  /evidence=""ECO:0000250""; DISULFID 204..217;  /evidence=""ECO:0000250""; DISULFID 236..247;  /evidence=""ECO:0000250""; DISULFID 241..257;  /evidence=""ECO:0000250""; DISULFID 259..270;  /evidence=""ECO:0000250""; DISULFID 732..746;  /evidence=""ECO:0000250""; DISULFID 740..756;  /evidence=""ECO:0000250""; DISULFID 758..767;  /evidence=""ECO:0000250""; DISULFID 822..837;  /evidence=""ECO:0000250""; DISULFID 831..846;  /evidence=""ECO:0000250""; DISULFID 865..879;  /evidence=""ECO:0000250""; DISULFID 873..889;  /evidence=""ECO:0000250""; DISULFID 891..902;  /evidence=""ECO:0000250""; DISULFID 908..922;  /evidence=""ECO:0000250""; DISULFID 916..932;  /evidence=""ECO:0000250""; DISULFID 934..945;  /evidence=""ECO:0000250""; DISULFID 951..964;  /evidence=""ECO:0000250""; DISULFID 958..974;  /evidence=""ECO:0000250""; DISULFID 1332..1346;  /evidence=""ECO:0000250""; DISULFID 1340..1356;  /evidence=""ECO:0000250""; DISULFID 1358..1367;  /evidence=""ECO:0000250""; DISULFID 1379..1390;  /evidence=""ECO:0000250""; DISULFID 1383..1400;  /evidence=""ECO:0000250""; DISULFID 1402..1411;  /evidence=""ECO:0000250""; DISULFID 1420..1430;  /evidence=""ECO:0000250""; DISULFID 1424..1440;  /evidence=""ECO:0000250""; DISULFID 1442..1453;  /evidence=""ECO:0000250""; DISULFID 1459..1472;  /evidence=""ECO:0000250""; DISULFID 1466..1482;  /evidence=""ECO:0000250""; DISULFID 1484..1495;  /evidence=""ECO:0000250""; DISULFID 1501..1514;  /evidence=""ECO:0000250""; DISULFID 1508..1524;  /evidence=""ECO:0000250""; DISULFID 1526..1538;  /evidence=""ECO:0000250""; DISULFID 1544..1557;  /evidence=""ECO:0000250""; DISULFID 1551..1567;  /evidence=""ECO:0000250""; DISULFID 1569..1581;  /evidence=""ECO:0000250""; DISULFID 1971..1985;  /evidence=""ECO:0000250""; DISULFID 1979..1995;  /evidence=""ECO:0000250""; DISULFID 1997..2006;  /evidence=""ECO:0000250""; DISULFID 2018..2029;  /evidence=""ECO:0000250""; DISULFID 2023..2039;  /evidence=""ECO:0000250""; DISULFID 2041..2050;  /evidence=""ECO:0000250""; DISULFID 2060..2070;  /evidence=""ECO:0000250""; DISULFID 2064..2076;  /evidence=""ECO:0000250""; DISULFID 2078..2089;  /evidence=""ECO:0000250""; DISULFID 2095..2108;  /evidence=""ECO:0000250""; DISULFID 2102..2117;  /evidence=""ECO:0000250""; DISULFID 2119..2130;  /evidence=""ECO:0000250""; DISULFID 2136..2150;  /evidence=""ECO:0000250""; DISULFID 2144..2160;  /evidence=""ECO:0000250""; DISULFID 2162..2173;  /evidence=""ECO:0000250""; DISULFID 2230..2299;  /evidence=""ECO:0000250""; DISULFID 2254..2275;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O43157,Plexin-B1 (Semaphorin receptor SEP),MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSAAPPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLPRGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGLWELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYRRKSKQALRDYKKVQIQLENLESSVRDRCKKEFTDLMTEMTDLTSDLLGSGIPFLDYKVYAERIFFPGHRESPLHRDLGVPESRRPTVEQGLGQLSNLLNSKLFLTKFIHTLESQRTFSARDRAYVASLLTVALHGKLEYFTDILRTLLSDLVAQYVAKNPKLMLRRTETVVEKLLTNWMSICLYTFVRDSVGEPLYMLFRGIKHQVDKGPVDSVTGKAKYTLNDNRLLREDVEYRPLTLNALLAVGPGAGEAQGVPVKVLDCDTISQAKEKMLDQLYKGVPLTQRPDPRTLDVEWRSGVAGHLILSDEDVTSEVQGLWRRLNTLQHYKVPDGATVALVPCLTKHVLRENQDYVPGERTPMLEDVDEGGIRPWHLVKPSDEPEPPRPRRGSLRGGERERAKAIPEIYLTRLLSMKGTLQKFVDDLFQVILSTSRPVPLAVKYFFDLLDEQAQQHGISDQDTIHIWKTNSLPLRFWINIIKNPQFVFDVQTSDNMDAVLLVIAQTFMDACTLADHKLGRDSPINKLLYARDIPRYKRMVERYYADIRQTVPASDQEMNSVLAELSWNYSGDLGARVALHELYKYINKYYDQIITALEEDGTAQKMQLGYRLQQIAAAVENKVTDL,2135,"232,298",Alternative sequence (3); Beta strand (58); Chain (1); Coiled coil (1); Compositional bias (2); Disulfide bond (10); Domain (4); Erroneous initiation (1); Glycosylation (6); Helix (36); Mutagenesis (4); Natural variant (3); Sequence conflict (2); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 79..88;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 111..119;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 252..377;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 268..322;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 340..364;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 482..499;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 488..533;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 491..508;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 502..514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 570..588;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q16586,Alpha-sarcoglycan (Alpha-SG) (50 kDa dystrophin-associated glycoprotein) (50DAG) (Adhalin) (Dystroglycan-2),MAETLFWTPLLVVLLAGLGDTEAQQTTLHPLVGRVFVHTLDHETFLSLPEHVAVPPAVHITYHAHLQGHPDLPRWLRYTQRSPHHPGFLYGSATPEDRGLQVIEVTAYNRDSFDTTRQRLVLEIGDPEGPLLPYQAEFLVRSHDAEEVLPSTPASRFLSALGGLWEPGELQLLNVTSALDRGGRVPLPIEGRKEGVYIKVGSASPFSTCLKMVASPDSHARCAQGQPPLLSCYDTLAPHFRVDWCNVTLVDKSVPEPADEVPTPGDGILEHDPFFCPPTEAPDRDFLVDALVTLLVPLLVALLLTLLLAYVMCCRREGRLKRDLATSDIQMVHHCTIHGNTEELRQMAASREVPRPLSTLPMFNVHTGERLPPRVDSAQVPLILDQH,387,"42,875",Alternative sequence (1); Chain (1); Glycosylation (2); Modified residue (1); Natural variant (30); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9H156,SLIT and NTRK-like protein 2,MLSGVWFLSVLTVAGILQTESRKTAKDICKIRCLCEEKENVLNINCENKGFTTVSLLQPPQYRIYQLFLNGNLLTRLYPNEFVNYSNAVTLHLGNNGLQEIRTGAFSGLKTLKRLHLNNNKLEILREDTFLGLESLEYLQADYNYISAIEAGAFSKLNKLKVLILNDNLLLSLPSNVFRFVLLTHLDLRGNRLKVMPFAGVLEHIGGIMEIQLEENPWNCTCDLLPLKAWLDTITVFVGEIVCETPFRLHGKDVTQLTRQDLCPRKSASDSSQRGSHADTHVQRLSPTMNPALNPTRAPKASRPPKMRNRPTPRVTVSKDRQSFGPIMVYQTKSPVPLTCPSSCVCTSQSSDNGLNVNCQERKFTNISDLQPKPTSPKKLYLTGNYLQTVYKNDLLEYSSLDLLHLGNNRIAVIQEGAFTNLTSLRRLYLNGNYLEVLYPSMFDGLQSLQYLYLEYNVIKEIKPLTFDALINLQLLFLNNNLLRSLPDNIFGGTALTRLNLRNNHFSHLPVKGVLDQLPAFIQIDLQENPWDCTCDIMGLKDWTEHANSPVIINEVTCESPAKHAGEILKFLGREAICPDSPNLSDGTVLSMNHNTDTPRSLSVSPSSYPELHTEVPLSVLILGLLVVFILSVCFGAGLFVFVLKRRKGVPSVPRNTNNLDVSSFQLQYGSYNTETHDKTDGHVYNYIPPPVGQMCQNPIYMQKEGDPVAYYRNLQEFSYSNLEEKKEEPATPAYTISATELLEKQATPREPELLYQNIAERVKELPSAGLVHYNFCTLPKRQFAPSYESRRQNQDRINKTVLYGTPRKCFVGQSKPNHPLLQAKPQSEPDYLEVLEKQTAISQL,845,"95,404",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (3); Erroneous initiation (1); Glycosylation (2); Modified residue (1); Natural variant (3); Region (1); Repeat (12); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 29..35;  /evidence=""ECO:0000250|UniProtKB:Q810C0""; DISULFID 33..46;  /evidence=""ECO:0000250|UniProtKB:Q810C0""; DISULFID 220..243;  /evidence=""ECO:0000250|UniProtKB:Q810C0""; DISULFID 222..263;  /evidence=""ECO:0000250|UniProtKB:Q810C0""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9C0K1,Metal cation symporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6) (LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8) (ZIP-8),MAPGRAVAGLLLLAAAGLGGVAEGPGLAFSEDVLSVFGANLSLSAAQLQHLLEQMGAASRVGVPEPGQLHFNQCLTAEEIFSLHGFSNATQITSSKFSVICPAVLQQLNFHPCEDRPKHKTRPSHSEVWGYGFLSVTIINLASLLGLILTPLIKKSYFPKILTFFVGLAIGTLFSNAIFQLIPEAFGFDPKVDSYVEKAVAVFGGFYLLFFFERMLKMLLKTYGQNGHTHFGNDNFGPQEKTHQPKALPAINGVTCYANPAVTEANGHIHFDNVSVVSLQDGKKEPSSCTCLKGPKLSEIGTIAWMITLCDALHNFIDGLAIGASCTLSLLQGLSTSIAILCEEFPHELGDFVILLNAGMSTRQALLFNFLSACSCYVGLAFGILVGNNFAPNIIFALAGGMFLYISLADMFPEMNDMLREKVTGRKTDFTFFMIQNAGMLTGFTAILLITLYAGEIELE,460,"49,631",Alternative sequence (3); Chain (1); Glycosylation (2); Motif (1); Natural variant (7); Sequence conflict (1); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q96BY9,Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66),MAAACGPGAAGYCLLLGLHLFLLTAGPALGWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYKWSSADSCNMSGLITIVVLLGIAFVVYKLFLSDGQYSPPPYSEYPPFSHRYQRFTNSAGPPPPGFKSEFTGPQNTGHGATSGFGSAFTGQQGYENSGPGFWTGLGTGGILGYLFGSNRAATPFSDSWYYPSYPPSYPGTWNRAYSPLHGGSGSYSVCSNSDTKTRTASGYGGTRRR,339,"36,975",Alternative sequence (1); Beta strand (12); Chain (1); Frameshift (1); Helix (2); Mutagenesis (1); Natural variant (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..30;  /evidence=""ECO:0000269|PubMed:15340161"""
Q58EX2,Protein sidekick-2,MWGLLIWTLLALHQIRAARAQDDVSPYFKTEPVRTQVHLEGNRLVLTCMAEGSWPLEFKWLHNNRELTKFSLEYRYMITSLDRTHAGFYRCIVRNRMGALLQRQTEVQVAYMGSFEEGEKHQSVSHGEAAVIRAPRIASFPQPQVTWFRDGRKIPPSSRIAITLENTLVILSTVAPDAGRYYVQAVNDKNGDNKTSQPITLTVENVGGPADPIAPTIIIPPKNTSVVAGTSEVTLECVANARPLIKLHIIWKKDGVLLSGGISDHNRRLTIPNPTGSDAGYYECEAVLRSSSVPSVVRGAYLSVLEPPQFVKEPERHITAEMEKVVDIPCQAKGVPPPSITWYKDAAVVEVEKLTRFRQRNDGGLQISGLVPDDTGMFQCFARNAAGEVQTSTYLAVTSIAPNITRGPLDSTVIDGMSVVLACETSGAPRPAITWQKGERILASGSVQLPRFTPLESGSLLISPTHISDAGTYTCLATNSRGVDEASADLVVWARTRITKPPQDQSVIKGTQASMVCGVTHDPRVTIRYIWEKDGATLGTESHPRIRLDRNGSLHISQTWSGDIGTYTCRVISAGGNDSRSAHLRVRQLPHAPEHPVATLSTVERRAINLTWTKPFDGNSPLIRYILEMSENNAPWTVLLASVDPKATSVTVKGLVPARSYQFRLCAVNDVGKGQFSKDTERVSLPEEPPTAPPQNVIASGRTNQSIMIQWQPPPESHQNGILKGYIIRYCLAGLPVGYQFKNITDADVNNLLLEDLIIWTNYEIEVAAYNSAGLGVYSSKVTEWTLQGVPTVPPGNVHAEATNSTTIRFTWNAPSPQFINGINQGYKLIAWEPEQEEEVTMVTARPNFQDSIHVGFVSGLKKFTEYFTSVLCFTTPGDGPRSTPQLVRTHEDVPGPVGHLSFSEILDTSLKVSWQEPGEKNGILTGYRISWEEYNRTNTRVTHYLPNVTLEYRVTGLTALTTYTIEVAAMTSKGQGQVSASTISSGVPPELPGPPTNLGISNIGPRSVTLQFRPGYDGKTSISRWLVEAQVGVVGEGEEWLLIHQLSNEPDARSMEVPDLNPFTCYSFRMRQVNIVGTSPPSQPSRKIQTLQAPPDMAPANVSLRTASETSLWLRWMPLPEMEYNGNPESVGYKIKYSRSDGHGKTLSHVVQDRVERDYTIEDLEEWTEYRVQVQAFNAIGSGPWSQTVVGRTRESVPSSGPTNVSALATTSSSMLVRWSEVPEADRNGLVLGYKVMYKEKDSDTQPRFWLVEGNSSRSAQLTGLGKYVLYEVQVLAFTRIGDGSPSHPPILERTLDDVPGPPMGILFPEVRTTSVRLIWQPPAAPNGIILAYQITHRLNTTTANTATVEVLAPSARQYTATGLKPESVYLFRITAQTRKGWGEAAEALVVTTEKRDRPQPPSRPMVQQEDVRARSVLLSWEPGSDGLSPVRYYTIQTRELPSGRWALHSASVSHNASSFIVDRLKPFTSYKFRVKATNDIGDSEFSEESESLTTLQAAPDEAPTILSVTPHTTTSVLIRWQPPAEDKINGILLGFRIRYRELLYEGLRGFTLRGINNPGATWAELTSMYSMRNLSRPSLTQYELDNLNKHRRYEIRMSVYNAVGEGPSSPPQEVFVGEAVPTAAPRNVVVHGATATQLDVTWEPPPLDSQNGDIQGYKIYFWEAQRGNLTERVKTLFLAENSVKLKNLTGYTAYMVSVAAFNAAGDGPRSTPTQGQTQQAAPSAPSSVKFSELTTTSVNVSWEAPQFPNGILEGYRLVYEPCSPVDGVSKIVTVDVKGNSPLWLKVKDLAEGVTYRFRIRAKTFTYGPEIEANVTTGPGEGAPGPPGVPIIVRYSSAIAIHWSSGDPGKGPITRYVIEARPSDEGLWDILIKDIPKEVSSYTFSMDILKPGVSYDFRVIAVNDYGFGTPSSPSQSVPAQKANPFYEEWWFLVVIALVGLIFILLLVFVLIIRGQSKKYAKKTDSGNSAKSGALGHSEMMSLDESSFPALELNNRRLSVKNSFCRKNGLYTRSPPRPSPGSLHYSDEDVTKYNDLIPAESSSLTEKPSEISDSQGSDSEYEVDSNHQKAHSFVNHYISDPTYYNSWRRQQKGISRAQAYSYTESDSGEPDHTTVTNSTSTQQGSLFRPKASRTPTPQNPPNPPSQQSTLYRPPSSLAPGSRAPIAGFSSFV,2172,"239,396",Alternative sequence (4); Beta strand (29); Chain (1); Disulfide bond (5); Domain (19); Erroneous initiation (1); Glycosylation (7); Helix (1); Motif (1); Natural variant (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 48..91;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 237..284;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 330..380;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 423..475;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 517..569;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q96PQ0,VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain],MAHRGPSRASKGPGPTARAPSPGAPPPPRSPRSRPLLLLLLLLGACGAAGRSPEPGRLGPHAQLTRVPRSPPAGRAEPGGGEDRQARGTEPGAPGPSPGPAPGPGEDGAPAAGYRRWERAAPLAGVASRAQVSLISTSFVLKGDATHNQAMVHWTGENSSVILILTKYYHADMGKVLESSLWRSSDFGTSYTKLTLQPGVTTVIDNFYICPTNKRKVILVSSSLSDRDQSLFLSADEGATFQKQPIPFFVETLIFHPKEEDKVLAYTKESKLYVSSDLGKKWTLLQERVTKDHVFWSVSGVDADPDLVHVEAQDLGGDFRYVTCAIHNCSEKMLTAPFAGPIDHGSLTVQDDYIFFKATSANQTKYYVSYRRNEFVLMKLPKYALPKDLQIISTDESQVFVAVQEWYQMDTYNLYQSDPRGVRYALVLQDVRSSRQAEESVLIDILEVRGVKGVFLANQKIDGKVMTLITYNKGRDWDYLRPPSMDMNGKPTNCKPPDCHLHLHLRWADNPYVSGTVHTKDTAPGLIMGAGNLGSQLVEYKEEMYITSDCGHTWRQVFEEEHHILYLDHGGVIVAIKDTSIPLKILKFSVDEGLTWSTHNFTSTSVFVDGLLSEPGDETLVMTVFGHISFRSDWELVKVDFRPSFSRQCGEEDYSSWELSNLQGDRCIMGQQRSFRKRKSTSWCIKGRSFTSALTSRVCECRDSDFLCDYGFERSSSSESSTNKCSANFWFNPLSPPDDCALGQTYTSSLGYRKVVSNVCEGGVDMQQSQVQLQCPLTPPRGLQVSIQGEAVAVRPGEDVLFVVRQEQGDVLTTKYQVDLGDGFKAMYVNLTLTGEPIRHRYESPGIYRVSVRAENTAGHDEAVLFVQVNSPLQALYLEVVPVIGLNQEVNLTAVLLPLNPNLTVFYWWIGHSLQPLLSLDNSVTTRFSDTGDVRVTVQAACGNSVLQDSRVLRVLDQFQVMPLQFSKELDAYNPNTPEWREDVGLVVTRLLSKETSVPQELLVTVVKPGLPTLADLYVLLPPPRPTRKRSLSSDKRLAAIQQVLNAQKISFLLRGGVRVLVALRDTGTGAEQLGGGGGYWAVVVLFVIGLFAAGAFILYKFKRKRPGRTVYAQMHNEKEQEMTSPVSHSEDVQGAVQGNHSGVVLSINSREMHSYLVS,1159,"128,152",Beta strand (8); Chain (4); Compositional bias (1); Disulfide bond (7); Domain (1); Glycosylation (7); Helix (1); Mutagenesis (4); Natural variant (3); Repeat (6); Sequence conflict (1); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1),"DISULFID 324..329;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 494..499;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 649..684;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 667..699;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 701..760;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 708..725;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""; DISULFID 740..775;  /evidence=""ECO:0000250|UniProtKB:Q9EPR5""","SIGNAL 1..50;  /evidence=""ECO:0000255"""
A0PJX4,Protein shisa-3 homolog,MRALLALCLLLGWLRWGPAGAQQSGEYCHGWVDVQGNYHEGFQCPEDFDTLDATICCGSCALRYCCAAADARLEQGGCTNDRRELEHPGITAQPVYVPFLIVGSIFIAFIILGSVVAIYCCTCLRPKEPSQQPIRFSLRSYQTETLPMILTSTSPRAPSRQSSTATSSSSTGGSIRRFSFARAEPGCLVPSPPPPYTTSHSIHLAQPSGFLVSPQYFAYPLQQEPPLPGKSCPDFSSS,238,"25,832",Chain (1); Compositional bias (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P08842,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),MPLRKMKIPFLLLFFLWEAESHAASRPNIILVMADDLGIGDPGCYGNKTIRTPNIDRLASGGVKLTQHLAASPLCTPSRAAFMTGRYPVRSGMASWSRTGVFLFTASSGGLPTDEITFAKLLKDQGYSTALIGKWHLGMSCHSKTDFCHHPLHHGFNYFYGISLTNLRDCKPGEGSVFTTGFKRLVFLPLQIVGVTLLTLAALNCLGLLHVPLGVFFSLLFLAALILTLFLGFLHYFRPLNCFMMRNYEIIQQPMSYDNLTQRLTVEAAQFIQRNTETPFLLVLSYLHVHTALFSSKDFAGKSQHGVYGDAVEEMDWSVGQILNLLDELRLANDTLIYFTSDQGAHVEEVSSKGEIHGGSNGIYKGGKANNWEGGIRVPGILRWPRVIQAGQKIDEPTSNMDIFPTVAKLAGAPLPEDRIIDGRDLMPLLEGKSQRSDHEFLFHYCNAYLNAVRWHPQNSTSIWKAFFFTPNFNPVGSNGCFATHVCFCFGSYVTHHDPPLLFDISKDPRERNPLTPASEPRFYEILKVMQEAADRHTQTLPEVPDQFSWNNFLWKPWLQLCCPSTGLSCQCDREKQDKRLSR,583,"65,492",Active site (2); Beta strand (23); Chain (1); Disulfide bond (6); Glycosylation (2); Helix (20); Metal binding (5); Modified residue (1); Natural variant (8); Sequence conflict (1); Signal peptide (1); Site (2); Topological domain (3); Transmembrane (2); Turn (8),DISULFID 141..148; DISULFID 170..242; DISULFID 446..489; DISULFID 481..487; DISULFID 562..570; DISULFID 563..572,"SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:2765556"""
P16144,Integrin beta-4 (GP150) (CD antigen CD104),MAGPRPSPWARLLLAALISVSLSGTLANRCKKAPVKSCTECVRVDKDCAYCTDEMFRDRRCNTQAELLAAGCQRESIVVMESSFQITEETQIDTTLRRSQMSPQGLRVRLRPGEERHFELEVFEPLESPVDLYILMDFSNSMSDDLDNLKKMGQNLARVLSQLTSDYTIGFGKFVDKVSVPQTDMRPEKLKEPWPNSDPPFSFKNVISLTEDVDEFRNKLQGERISGNLDAPEGGFDAILQTAVCTRDIGWRPDSTHLLVFSTESAFHYEADGANVLAGIMSRNDERCHLDTTGTYTQYRTQDYPSVPTLVRLLAKHNIIPIFAVTNYSYSYYEKLHTYFPVSSLGVLQEDSSNIVELLEEAFNRIRSNLDIRALDSPRGLRTEVTSKMFQKTRTGSFHIRRGEVGIYQVQLRALEHVDGTHVCQLPEDQKGNIHLKPSFSDGLKMDAGIICDVCTCELQKEVRSARCSFNGDFVCGQCVCSEGWSGQTCNCSTGSLSDIQPCLREGEDKPCSGRGECQCGHCVCYGEGRYEGQFCEYDNFQCPRTSGFLCNDRGRCSMGQCVCEPGWTGPSCDCPLSNATCIDSNGGICNGRGHCECGRCHCHQQSLYTDTICEINYSAIHPGLCEDLRSCVQCQAWGTGEKKGRTCEECNFKVKMVDELKRAEEVVVRCSFRDEDDDCTYSYTMEGDGAPGPNSTVLVHKKKDCPPGSFWWLIPLLLLLLPLLALLLLLCWKYCACCKACLALLPCCNRGHMVGFKEDHYMLRENLMASDHLDTPMLRSGNLKGRDVVRWKVTNNMQRPGFATHAASINPTELVPYGLSLRLARLCTENLLKPDTRECAQLRQEVEENLNEVYRQISGVHKLQQTKFRQQPNAGKKQDHTIVDTVLMAPRSAKPALLKLTEKQVEQRAFHDLKVAPGYYTLTADQDARGMVEFQEGVELVDVRVPLFIRPEDDDEKQLLVEAIDVPAGTATLGRRLVNITIIKEQARDVVSFEQPEFSVSRGDQVARIPVIRRVLDGGKSQVSYRTQDGTAQGNRDYIPVEGELLFQPGEAWKELQVKLLELQEVDSLLRGRQVRRFHVQLSNPKFGAHLGQPHSTTIIIRDPDELDRSFTSQMLSSQPPPHGDLGAPQNPNAKAAGSRKIHFNWLPPSGKPMGYRVKYWIQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTHQEVPSEPGRLAFNVVSSTVTQLSWAEPAETNGEITAYEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQPKRPMSIPIIPDIPIVDAQSGEDYDSFLMYSDDVLRSPSGSQRPSVSDDTGCGWKFEPLLGEELDLRRVTWRLPPELIPRLSASSGRSSDAEAPHGPPDDGGAGGKGGSLPRSATPGPPGEHLVNGRMDFAFPGSTNSLHRMTTTSAAAYGTHLSPHVPHRVLSTSSTLTRDYNSLTRSEHSHSTTLPRDYSTLTSVSSHDSRLTAGVPDTPTRLVFSALGPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQVHPQSPLCPLPGSAFTLSTPSAPGPLVFTALSPDSLQLSWERPRRPNGDIVGYLVTCEMAQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQARTTEGFGPEREGIITIESQDGGPFPQLGSRAGLFQHPLQSEYSSITTTHTSATEPFLVDGLTLGAQHLEAGGSLTRHVTQEFVSRTLTTSGTLSTHMDQQFFQT,1822,"202,167",Alternative sequence (5); Beta strand (45); Chain (1); Disulfide bond (23); Domain (7); Frameshift (1); Glycosylation (5); Helix (3); Modified residue (10); Natural variant (20); Region (3); Repeat (4); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 30..455;  /evidence=""ECO:0000250""; DISULFID 38..48;  /evidence=""ECO:0000250""; DISULFID 41..72;  /evidence=""ECO:0000250""; DISULFID 51..61;  /evidence=""ECO:0000250""; DISULFID 245..288;  /evidence=""ECO:0000250""; DISULFID 424..671;  /evidence=""ECO:0000250""; DISULFID 452..457;  /evidence=""ECO:0000250""; DISULFID 468..479;  /evidence=""ECO:0000250""; DISULFID 476..512;  /evidence=""ECO:0000250""; DISULFID 481..490;  /evidence=""ECO:0000250""; DISULFID 492..503;  /evidence=""ECO:0000250""; DISULFID 518..523;  /evidence=""ECO:0000250""; DISULFID 520..551;  /evidence=""ECO:0000250""; DISULFID 525..536;  /evidence=""ECO:0000250""; DISULFID 557..562;  /evidence=""ECO:0000250""; DISULFID 564..573;  /evidence=""ECO:0000250""; DISULFID 575..582;  /evidence=""ECO:0000250""; DISULFID 596..601;  /evidence=""ECO:0000250""; DISULFID 598..648;  /evidence=""ECO:0000250""; DISULFID 603..614;  /evidence=""ECO:0000250""; DISULFID 626..635;  /evidence=""ECO:0000250""; DISULFID 632..706;  /evidence=""ECO:0000250""; DISULFID 651..680;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:2542022"""
A6NI73,Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11) (ILT-11) (Leukocyte immunoglobulin-like receptor 9) (LIR-9) (CD antigen CD85f),MAPWSHPSAQLQPVGGDAVSPALMVLLCLGLSLGPRTHVQAGNLSKATLWAEPGSVISRGNSVTIRCQGTLEAQEYRLVKEGSPEPWDTQNPLEPKNKARFSIPSMTEHHAGRYRCYYYSPAGWSEPSDPLELVVTGFYNKPTLSALPSPVVTSGENVTLQCGSRLRFDRFILTEEGDHKLSWTLDSQLTPSGQFQALFPVGPVTPSHRWMLRCYGSRRHILQVWSEPSDLLEIPVSGAADNLSPSQNKSDSGTASHLQDYAVENLIRMGMAGLILVVLGILIFQDWHSQRSPQAAAGR,299,"32,755",Alternative sequence (2); Beta strand (16); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Helix (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 67..116;  /evidence=""ECO:0000244|PDB:2D3V, ECO:0000269|PubMed:16675463""; DISULFID 162..214;  /evidence=""ECO:0000244|PDB:2D3V, ECO:0000269|PubMed:16675463""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q9H9K5,"Endogenous retroviral envelope protein HEMO (Endogenous retrovirus group MER34 member 1 Env polyprotein) (HERV-MER_4q12 provirus ancestral Env polyprotein) (Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame) (Human endogenous MER34 ORF) (HEMO) [Cleaved into: Endogenous retroviral envelope protein HEMO, secreted form (Endogenous retroviral envelope protein HEMO, 48 kDa form)]",MGSLSNYALLQLTLTAFLTILVQPQHLLAPVFRTLSILTNQSNCWLCEHLDNAEQPELVFVPASASTWWTYSGQWMYERVWYPQAEVQNHSTSSYRKVTWHWEASMEAQGLSFAQVRLLEGNFSLCVENKNGSGPFLGNIPKQYCNQILWFDSTDGTFMPSIDVTNESRNDDDDTSVCLGTRQCSWFAGCTNRTWNSSAVPLIGLPNTQDYKWVDRNSGLTWSGNDTCLYSCQNQTKGLLYQLFRNLFCSYGLTEAHGKWRCADASITNDKGHDGHRTPTWWLTGSNLTLSVNNSGLFFLCGNGVYKGFPPKWSGRCGLGYLVPSLTRYLTLNASQITNLRSFIHKVTPHRCTQGDTDNPPLYCNPKDNSTIRALFPSLGTYDLEKAILNISKAMEQEFSATKQTLEAHQSKVSSLASASRKDHVLDIPTTQRQTACGTVGKQCCLYINYSEEIKSNIQRLHEASENLKNVPLLDWQGIFAKVGDWFRSWGYVLLIVLFCLFIFVLIYVRVFRKSRRSLNSQPLNLALSPQQSAQLLVSETSCQVSNRAMKGLTTHQYDTSLL,563,"63,547",Chain (2); Compositional bias (1); Frameshift (1); Glycosylation (2); Mutagenesis (4); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:28739914"""
Q969N2,GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein),MAAAMPLALLVLLLLGPGGWCLAEPPRDSLREELVITPLPSGDVAATFQFRTRWDSELQREGVSHYRLFPKALGQLISKYSLRELHLSFTQGFWRTRYWGPPFLQAPSGAELWVWFQDTVTDVDKSWKELSNVLSGIFCASLNFIDSTNTVTPTASFKPLGLANDTDHYFLRYAVLPREVVCTENLTPWKKLLPCSSKAGLSVLLKADRLFHTSYHSQAVHIRPVCRNARCTSISWELRQTLSVVFDAFITGQGKKDWSLFRMFSRTLTEPCPLASESRVYVDITTYNQDNETLEVHPPPTTTYQDVILGTRKTYAIYDLLDTAMINNSRNLNIQLKWKRPPENEAPPVPFLHAQRYVSGYGLQKGELSTLLYNTHPYRAFPVLLLDTVPWYLRLYVHTLTITSKGKENKPSYIHYQPAQDRLQPHLLEMLIQLPANSVTKVSIQFERALLKWTEYTPDPNHGFYVSPSVLSALVPSMVAAKPVDWEESPLFNSLFPVSDGSNYFVRLYTEPLLVNLPTPDFSMPYNVICLTCTVVAVCYGSFYNLLTRTFHIEEPRTGGLAKRLANLIRRARGVPPL,578,"65,700",Alternative sequence (6); Chain (1); Disulfide bond (1); Erroneous initiation (2); Frameshift (1); Glycosylation (3); Mutagenesis (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 182;  /note=""Interchain (with C-92 in PIGK/GPI8)"";  /evidence=""ECO:0000269|PubMed:12582175""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:11483512"""
O60603,Toll-like receptor 2 (EC 3.2.2.6) (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282),MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS,784,"89,838",Active site (1); Beta strand (33); Chain (1); Cross-link (1); Disulfide bond (3); Domain (2); Glycosylation (4); Helix (24); Motif (1); Mutagenesis (10); Natural variant (9); Repeat (19); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (10),"DISULFID 30..36;  /evidence=""ECO:0000269|PubMed:17889651""; DISULFID 353..382;  /evidence=""ECO:0000269|PubMed:17889651""; DISULFID 432..454;  /evidence=""ECO:0000269|PubMed:17889651""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q5T292,Transmembrane protein 273,MNLGVSMLRILFLLDVGGAQVLATGKTPGAEIDFKYALIGTAVGVAISAGFLALKICMIRRHLFDDDSSDLKSTPGGLSDTIPLKKRAPRRNHNFSKRDAQVIEL,105,"11,325",Alternative sequence (3); Chain (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P36897,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM,503,"55,960",Active site (1); Alternative sequence (2); Beta strand (24); Binding site (1); Chain (1); Cross-link (1); Disulfide bond (5); Domain (2); Glycosylation (1); Helix (18); Modified residue (6); Motif (1); Mutagenesis (10); Natural variant (21); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 36..54;  /evidence=""ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 38..41;  /evidence=""ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 48..71;  /evidence=""ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 86..100;  /evidence=""ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 101..106;  /evidence=""ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""","SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:9661882"""
P39656,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),MGYFRCARAGSFGRRRKMEPSTAARAWALFWLLLPLLGAVCASGPRTLVLLDNLNVRETHSLFFRSLKDRGFELTFKTADDPSLSLIKYGEFLYDNLIIFSPSVEDFGGNINVETISAFIDGGGSVLVAASSDIGDPLRELGSECGIEFDEEKTAVIDHHNYDISDLGQHTLIVADTENLLKAPTIVGKSSLNPILFRGVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGKNTLLIAGLQARNNARVIFSGSLDFFSDSFFNSAVQKAAPGSQRYSQTGNYELAVALSRWVFKEEGVLRVGPVSHHRVGETAPPNAYTVTDLVEYSIVIQQLSNGKWVPFDGDDIQLEFVRIDPFVRTFLKKKGGKYSVQFKLPDVYGVFQFKVDYNRLGYTHLYSSTQVSVRPLQHTQYERFIPSAYPYYASAFSMMLGLFIFSIVFLHMKEKEKSD,456,"50,801",Alternative sequence (2); Beta strand (34); Chain (1); Erroneous initiation (1); Helix (9); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..42;  /evidence=""ECO:0000250"""
Q9Y336,Sialic acid-binding Ig-like lectin 9 (Siglec-9) (CDw329) (Protein FOAP-9) (CD antigen CD329),MLLLLLPLLWGRERAEGQTSKLLTMQSSVTVQEGLCVHVPCSFSYPSHGWIYPGPVVHGYWFREGANTDQDAPVATNNPARAVWEETRDRFHLLGDPHTKNCTLSIRDARRSDAGRYFFRMEKGSIKWNYKHHRLSVNVTALTHRPNILIPGTLESGCPQNLTCSVPWACEQGTPPMISWIGTSVSPLDPSTTRSSVLTLIPQPQDHGTSLTCQVTFPGASVTTNKTVHLNVSYPPQNLTMTVFQGDGTVSTVLGNGSSLSLPEGQSLRLVCAVDAVDSNPPARLSLSWRGLTLCPSQPSNPGVLELPWVHLRDAAEFTCRAQNPLGSQQVYLNVSLQSKATSGVTQGVVGGAGATALVFLSFCVIFVVVRSCRKKSARPAAGVGDTGIEDANAVRGSASQGPLTEPWAEDSPPDQPPPASARSSVGEGELQYASLSFQMVKPWDSRGQEATDTEYSEIKIHR,463,"50,082",Alternative sequence (1); Binding site (1); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (8); Motif (2); Mutagenesis (1); Natural variant (7); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 41..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 164..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 272..320;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q8IUH8,Signal peptide peptidase-like 2C (SPP-like 2C) (SPPL2c) (EC 3.4.23.-) (Intramembrane protease 5) (IMP-5),MACLGFLLPVGFLLLISTVAGGKYGVAHVVSENWSKDYCILFSSDYITLPRDLHHAPLLPLYDGTKAPWCPGEDSPHQAQLRSPSQRPLRQTTAMVMRGNCSFHTKGWLAQGQGAHGLLIVSRVSDQQCSDTTLAPQDPRQPLADLTIPVAMLHYADMLDILSHTRGEAVVRVAMYAPPEPIIDYNMLVIFILAVGTVAAGGYWAGLTEANRLQRRRARRGGGSGGHHQLQEAAAAEGAQKEDNEDIPVDFTPAMTGVVVTLSCSLMLLLYFFYDHFVYVTIGIFGLGAGIGLYSCLSPLVCRLSLRQYQRPPHSLWASLPLPLLLLASLCATVIIFWVAYRNEDRWAWLLQDTLGISYCLFVLHRVRLPTLKNCSSFLLALLAFDVFFVFVTPFFTKTGESIMAQVALGPAESSSHERLPMVLKVPRLRVSALTLCSQPFSILGFGDIVVPGFLVAYCCRFDVQVCSRQIYFVACTVAYAVGLLVTFMAMVLMQMGQPALLYLVSSTLLTSLAVAACRQELSLFWTGQGRAKMCGLGCAPSAGSRQKQEGAADAHTASTLERGTSRGAGDLDSNPGEDTTEIVTISENEATNPEDRSDSSEGWSDAHLDPNELPFIPPGASEELMPLMPMAMLIPLMPLMPPPSELGHVHAQAQAHETGLPWAGLHKRKGLKVRKSMSTQAPL,684,"74,503",Active site (2); Chain (1); Domain (1); Glycosylation (1); Motif (1); Natural variant (9); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15385547"""
P40200,T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96),MEKKWKYCAVYYIIQIHFVKGVWEKTVNTEENVYATLGSDVNLTCQTQTVGFFVQMQWSKVTNKIDLIAVYHPQYGFYCAYGRPCESLVTFTETPENGSKWTLHLRNMSCSVSGRYECMLVLYPEGIQTKIYNLLIQTHVTADEWNSNHTIEIEINQTLEIPCFQNSSSKISSEFTYAWSVENSSTDSWVLLSKGIKEDNGTQETLISQNHLISNSTLLKDRVKLGTDYRLHLSPVQIFDDGRKFSCHIRVGPNKILRSSTTVKVFAKPEIPVIVENNSTDVLVERRFTCLLKNVFPKANITWFIDGSFLHDEKEGIYITNEERKGKDGFLELKSVLTRVHSNKPAQSDNLTIWCMALSPVPGNKVWNISSEKITFLLGSEISSTDPPLSVTESTLDTQPSPASSVSPARYPATSSVTLVDVSALRPNTTPQPSNSSMTTRGFNYPWTSSGTDTKKSVSRIPSETYSSSPSGAGSTLHDNVFTSTARAFSEVPTTANGSTKTNHVHITGIVVNKPKDGMSWPVIVAALLFCCMILFGLGVRKWCQYQKEIMERPPPFKPPPPPIKYTCIQEPNESDLPYHEMETL,585,"65,634",Alternative sequence (1); Beta strand (8); Chain (1); Compositional bias (2); Disulfide bond (3); Domain (3); Glycosylation (15); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 45..118;  /evidence=""ECO:0000305""; DISULFID 163..247;  /evidence=""ECO:0000305""; DISULFID 290..355;  /evidence=""ECO:0000305""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P17948,Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor),MVSYWDTGVLLCALLSCLLLTGSSSGSKLKDPELSLKGTQHIMQAGQTLHLQCRGEAAHKWSLPEMVSKESERLSITKSACGRNGKQFCSTLTLNTAQANHTGFYSCKYLAVPTSKKKETESAIYIFISDTGRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQTNTIIDVQISTPRPVKLLRGHTLVLNCTATTPLNTRVQMTWSYPDEKNKRASVRRRIDQSNSHANIFYSVLTIDKMQNKDKGLYTCRVRSGPSFKSVNTSVHIYDKAFITVKHRKQQVLETVAGKRSYRLSMKVKAFPSPEVVWLKDGLPATEKSARYLTRGYSLIIKDVTEEDAGNYTILLSIKQSNVFKNLTATLIVNVKPQIYEKAVSSFPDPALYPLGSRQILTCTAYGIPQPTIKWFWHPCNHNHSEARCDFCSNNEESFILDADSNMGNRIESITQRMAIIEGKNKMASTLVVADSRISGIYICIASNKVGTVGRNISFYITDVPNGFHVNLEKMPTEGEDLKLSCTVNKFLYRDVTWILLRTVNNRTMHYSISKQKMAITKEHSITLNLTIMNVSLQDSGTYACRARNVYTGEEILQKKEITIRDQEAPYLLRNLSDHTVAISSSTTLDCHANGVPEPQITWFKNNHKIQQEPGIILGPGSSTLFIERVTEEDEGVYHCKATNQKGSVESSAYLTVQGTSDKSNLELITLTCTCVAATLFWLLLTLFIRKMKRSSSEIKTDYLSIIMDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLLQANVQQDGKDYIPINAILTGNSGFTYSTPAFSEDFFKESISAPKFNSGSSDDVRYVNAFKFMSLERIKTFEELLPNATSMFDDYQGDSSTLLASPMLKRFTWTDSKPKASLKIDLRVTSKSKESGLSDVSRPSFCHSSCGHVSEGKRRFTYDHAELERKIACCSPPPDYNSVVLYSTPPI,1338,"150,769",Active site (1); Alternative sequence (11); Beta strand (20); Binding site (1); Chain (1); Disulfide bond (6); Domain (8); Glycosylation (13); Helix (19); Modified residue (8); Mutagenesis (9); Natural variant (9); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 53..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 158..207; DISULFID 252..311;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 454..535;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 577..636;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 682..731;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:8248162"""
Q6UX71,Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein),MARFPKADLAAAGVMLLCHFFTDQFQFADGKPGDQILDWQYGVTQAFPHTEEEVEVDSHAYSHRWKRNLDFLKAVDTNRASVGQDSPEPRSFTDLLLDDGQDNNTQIEEDTDHNYYISRIYGPSDSASRDLWVNIDQMEKDKVKIHGILSNTHRQAARVNLSFDFPFYGHFLREITVATGGFIYTGEVVHRMLTATQYIAPLMANFDPSVSRNSTVRYFDNGTALVVQWDHVHLQDNYNLGSFTFQATLLMDGRIIFGYKEIPVLVTQISSTNHPVKVGLSDAFVVVHRIQQIPNVRRRTIYEYHRVELQMSKITNISAVEMTPLPTCLQFNRCGPCVSSQIGFNCSWCSKLQRCSSGFDRHRQDWVDSGCPEESKEKMCENTEPVETSSRTTTTVGATTTQFRVLTTTRRAVTSQFPTSLPTEDDTKIALHLKDNGASTDDSAAEKKGGTLHAGLIIGILILVLIVATAILVTVYMYHHPTSAASIFFIERRPSRWPAMKFRRGSGHPAYAEVEPVGEKEGFIVSEQC,529,"59,583",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (1); Glycosylation (2); Modified residue (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q15109,Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products),MAAGTAVGAWVLVLSLWGAVVGAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQLVVEPEGGAVAPGGTVTLTCEVPAQPSPQIHWMKDGVPLPLPPSPVLILPEIGPQDQGTYSCVATHSSHGPQESRAVSISIIEPGEEGPTAGSVGGSGLGTLALALGILGGLGTAALLIGVILWQRRQRRGEERKAPENQEEEEERAELNQSEEPEAGESSTGGP,404,"42,803",Alternative sequence (11); Beta strand (32); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (3); Glycosylation (2); Helix (3); Modified residue (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 38..99;  /evidence=""ECO:0000269|PubMed:20943659, ECO:0000269|PubMed:20947022, ECO:0000269|PubMed:21565706, ECO:0000269|Ref.18""; DISULFID 144..208;  /evidence=""ECO:0000269|PubMed:20943659, ECO:0000269|PubMed:20947022, ECO:0000269|PubMed:21565706, ECO:0000269|Ref.18""; DISULFID 259;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:23284645""; DISULFID 301;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:23284645""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P04843,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),MEAPAAGLFLLLLLGTWAPAPGSASSEAPPLINEDVKRTVDLSSHLAKVTAEVVLAHLGGGSTSRATSFLLALEPELEARLAHLGVQVKGEDEEENNLEVRETKIKGKSGRFFTVKLPVALDPGAKISVIVETVYTHVLHPYPTQITQSEKQFVVFEGNHYFYSPYPTKTQTMRVKLASRNVESYTKLGNPTRSEDLLDYGPFRDVPAYSQDTFKVHYENNSPFLTITSMTRVIEVSHWGNIAVEENVDLKHTGAVLKGPFSRYDYQRQPDSGISSIRSFKTILPAAAQDVYYRDEIGNVSTSHLLILDDSVEMEIRPRFPLFGGWKTHYIVGYNLPSYEYLYNLGDQYALKMRFVDHVFDEQVIDSLTVKIILPEGAKNIEIDSPYEISRAPDELHYTYLDTFGRPVIVAYKKNLVEQHIQDIVVHYTFNKVLMLQEPLLVVAAFYILFFTVIIYVRLDFSITKDPAAEARMKVACITEQVLTLVNKRIGLYRHFDETVNRYKQSRDISTLNSGKKSLETEHKALTSEIALLQSRLKTEGSDLCDRVSEMQKLDAQVKELVLKSAVEAERLVAGKLKKDTYIENEKLISGKRQELVTKIDHILDAL,607,"68,569",Beta strand (38); Chain (1); Cross-link (1); Glycosylation (1); Helix (9); Modified residue (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,SIGNAL 1..23
O75264,Small integral membrane protein 24,METLGALLVLEFLLLSPVEAQQATEHRLKPWLVGLAAVVGFLFIVYLVLLANRLWCSKARAEDEEETTFRMESNLYQDQSEDKREKKEAKEKEEKRKKEKKTAKEGESNLGLDLEEKEPGDHERAKSTVM,130,"14,964",Chain (1); Erroneous gene model prediction (2); Frameshift (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9BX74,TM2 domain-containing protein 1 (Amyloid-beta-binding protein) (hBBP),MAAAWPSGPSAPEAVTARLVGVLWFVSVTTGPWGAVATSAGGEESLKCEDLKVGQYICKDPKINDATQEPVNCTNYTAHVSCFPAPNITCKDSSGNETHFTGNEVGFFKPISCRNVNGYSYKVAVALSLFLGWLGADRFYLGYPALGLLKFCTVGFCGIGSLIDFILISMQIVGPSDGSSYIIDYYGTRLTRLSITNETFRKTQLYP,207,"22,327",Chain (1); Glycosylation (4); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..37;  /evidence=""ECO:0000269|PubMed:11278849"""
Q8TBF5,Phosphatidylinositol-glycan biosynthesis class X protein (PIG-X),MAARVAAVRAAAWLLLGAATGLTRGPAAAFTAARSDAGIRAMCSEIILRQEVLKDGFHRDLLIKVKFGESIEDLHTCRLLIKQDIPAGLYVDPYELASLRERNITEAVMVSENFDIEAPNYLSKESEVLIYARRDSQCIDCFQAFLPVHCRYHRPHSEDGEASIVVNNPDLLMFCDQEFPILKCWAHSEVAAPCALENEDICQWNKMKYKSVYKNVILQVPVGLTVHTSLVCSVTLLITILCSTLILVAVFKYGHFSL,258,"28,788",Alternative sequence (1); Chain (1); Erroneous initiation (2); Glycosylation (1); Natural variant (2); Sequence caution (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UIW2,Plexin-A1 (Semaphorin receptor NOV),MPLPPRSLQVLLLLLLLLLLLPGMWAEAGLPRAGGGSQPPFRTFSASDWGLTHLVVHEQTGEVYVGAVNRIYKLSGNLTLLRAHVTGPVEDNEKCYPPPSVQSCPHGLGSTDNVNKLLLLDYAANRLLACGSASQGICQFLRLDDLFKLGEPHHRKEHYLSSVQEAGSMAGVLIAGPPGQGQAKLFVGTPIDGKSEYFPTLSSRRLMANEEDADMFGFVYQDEFVSSQLKIPSDTLSKFPAFDIYYVYSFRSEQFVYYLTLQLDTQLTSPDAAGEHFFTSKIVRLCVDDPKFYSYVEFPIGCEQAGVEYRLVQDAYLSRPGRALAHQLGLAEDEDVLFTVFAQGQKNRVKPPKESALCLFTLRAIKEKIKERIQSCYRGEGKLSLPWLLNKELGCINSPLQIDDDFCGQDFNQPLGGTVTIEGTPLFVDKDDGLTAVAAYDYRGRTVVFAGTRSGRIRKILVDLSNPGGRPALAYESVVAQEGSPILRDLVLSPNHQYLYAMTEKQVTRVPVESCVQYTSCELCLGSRDPHCGWCVLHSICSRRDACERADEPQRFAADLLQCVQLTVQPRNVSVTMSQVPLVLQAWNVPDLSAGVNCSFEDFTESESVLEDGRIHCRSPSAREVAPITRGQGDQRVVKLYLKSKETGKKFASVDFVFYNCSVHQSCLSCVNGSFPCHWCKYRHVCTHNVADCAFLEGRVNVSEDCPQILPSTQIYVPVGVVKPITLAARNLPQPQSGQRGYECLFHIPGSPARVTALRFNSSSLQCQNSSYSYEGNDVSDLPVNLSVVWNGNFVIDNPQNIQAHLYKCPALRESCGLCLKADPRFECGWCVAERRCSLRHHCAADTPASWMHARHGSSRCTDPKILKLSPETGPRQGGTRLTITGENLGLRFEDVRLGVRVGKVLCSPVESEYISAEQIVCEIGDASSVRAHDALVEVCVRDCSPHYRALSPKRFTFVTPTFYRVSPSRGPLSGGTWIGIEGSHLNAGSDVAVSVGGRPCSFSWRNSREIRCLTPPGQSPGSAPIIININRAQLTNPEVKYNYTEDPTILRIDPEWSINSGGTLLTVTGTNLATVREPRIRAKYGGIERENGCLVYNDTTMVCRAPSVANPVRSPPELGERPDELGFVMDNVRSLLVLNSTSFLYYPDPVLEPLSPTGLLELKPSSPLILKGRNLLPPAPGNSRLNYTVLIGSTPCTLTVSETQLLCEAPNLTGQHKVTVRAGGFEFSPGTLQVYSDSLLTLPAIVGIGGGGGLLLLVIVAVLIAYKRKSRDADRTLKRLQLQMDNLESRVALECKEAFAELQTDIHELTNDLDGAGIPFLDYRTYAMRVLFPGIEDHPVLKEMEVQANVEKSLTLFGQLLTKKHFLLTFIRTLEAQRSFSMRDRGNVASLIMTALQGEMEYATGVLKQLLSDLIEKNLESKNHPKLLLRRTESVAEKMLTNWFTFLLYKFLKECAGEPLFMLYCAIKQQMEKGPIDAITGEARYSLSEDKLIRQQIDYKTLTLNCVNPENENAPEVPVKGLDCDTVTQAKEKLLDAAYKGVPYSQRPKAADMDLEWRQGRMARIILQDEDVTTKIDNDWKRLNTLAHYQVTDGSSVALVPKQTSAYNISNSSTFTKSLSRYESMLRTASSPDSLRSRTPMITPDLESGTKLWHLVKNHDHLDQREGDRGSKMVSEIYLTRLLATKGTLQKFVDDLFETIFSTAHRGSALPLAIKYMFDFLDEQADKHQIHDADVRHTWKSNCLPLRFWVNVIKNPQFVFDIHKNSITDACLSVVAQTFMDSCSTSEHKLGKDSPSNKLLYAKDIPNYKSWVERYYADIAKMPAISDQDMSAYLAEQSRLHLSQFNSMSALHEIYSYITKYKDEILAALEKDEQARRQRLRSKLEQVVDTMALSS,1896,"211,067",Chain (1); Coiled coil (1); Disulfide bond (10); Domain (5); Glycosylation (7); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 95..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 130..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 286..407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 302..358;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 376..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 515..532;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 521..563;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 524..541;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 535..547;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 598..617;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8N131,Porimin (Keratinocytes-associated transmembrane protein 3) (KCT-3) (Pro-oncosis receptor inducing membrane injury) (Transmembrane protein 123),MGLGARGAWAALLLGTLQVLALLGAAHESAAMAASANIENSGLPHNSSANSTETLQHVPSDHTNETSNSTVKPPTSVASDSSNTTVTTMKPTAASNTTTPGMVSTNMTSTTLKSTPKTTSVSQNTSQISTSTMTVTHNSSVTSAASSVTITTTMHSEAKKGSKFDTGSFVGGIVLTLGVLSILYIGCKMYYSRRGIRYRTIDEHDAII,208,"21,531",Alternative sequence (1); Chain (1); Compositional bias (1); Glycosylation (9); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,SIGNAL 1..26
Q6P1J6,"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",MGLRPGIFLLELLLLLGQGTPQIHTSPRKSTLEGQLWPETLKNSPFPCNPNKLGVNMPSKSVHSLKPSDIKFVAAIGNLEIPPDPGTGDLEKQDWTERPQQVCMGVMTVLSDIIRYFSPSVPMPVCHTGKRVIPHDGAEDLWIQAQELVRNMKENLQLDFQFDWKLINVFFSNASQCYLCPSAQQNGLAAGGVDELMGVLDYLQQEVPRAFVNLVDLSEVAEVSRQYHGTWLSPAPEPCNCSEETTRLAKVVMQWSYQEAWNSLLASSRYSEQESFTVVFQPFFYETTPSLHSEDPRLQDSTTLAWHLWNRMMEPAGEKDEPLSVKHGRPMKCPSQESPYLFSYRNSNYLTRLQKPQDKLEVREGAEIRCPDKDPSDTVPTSVHRLKPADINVIGALGDSLTAGNGAGSTPGNVLDVLTQYRGLSWSVGGDENIGTVTTLANILREFNPSLKGFSVGTGKETSPNAFLNQAVAGGRAEDLPVQARRLVDLMKNDTRIHFQEDWKIITLFIGGNDLCDFCNDLVHYSPQNFTDNIGKALDILHAEVPRAFVNLVTVLEIVNLRELYQEKKVYCPRMILRSLCPCVLKFDDNSTELATLIEFNKKFQEKTHQLIESGRYDTREDFTVVVQPFFENVDMPKTSEGLPDNSFFAPDCFHFSSKSHSRAASALWNNMLEPVGQKTTRHKFENKINITCPNQVQPFLRTYKNSMQGHGTWLPCRDRAPSALHPTSVHALRPADIQVVAALGDSLTAGNGIGSKPDDLPDVTTQYRGLSYSAGGDGSLENVTTLPNILREFNRNLTGYAVGTGDANDTNAFLNQAVPGAKAEDLMSQVQTLMQKMKDDHRVNFHEDWKVITVLIGGSDLCDYCTDSNLYSAANFVHHLRNALDVLHREVPRVLVNLVDFLNPTIMRQVFLGNPDKCPVQQASVLCNCVLTLRENSQELARLEAFSRAYRSSMRELVGSGRYDTQEDFSVVLQPFFQNIQLPVLADGLPDTSFFAPDCIHPNQKFHSQLARALWTNMLEPLGSKTETLDLRAEMPITCPTQNEPFLRTPRNSNYTYPIKPAIENWGSDFLCTEWKASNSVPTSVHQLRPADIKVVAALGDSLTTAVGARPNNSSDLPTSWRGLSWSIGGDGNLETHTTLPNILKKFNPYLLGFSTSTWEGTAGLNVAAEGARARDMPAQAWDLVERMKNSPDINLEKDWKLVTLFIGVNDLCHYCENPEAHLATEYVQHIQQALDILSEELPRAFVNVVEVMELASLYQGQGGKCAMLAAQNNCTCLRHSQSSLEKQELKKVNWNLQHGISSFSYWHQYTQREDFAVVVQPFFQNTLTPLNERGDTDLTFFSEDCFHFSDRGHAEMAIALWNNMLEPVGRKTTSNNFTHSRAKLKCPSPESPYLYTLRNSRLLPDQAEEAPEVLYWAVPVAAGVGLVVGIIGTVVWRCRRGGRREDPPMSLRTVAL,1458,"163,081",Active site (3); Alternative sequence (8); Chain (1); Erroneous initiation (1); Glycosylation (13); Natural variant (6); Region (2); Repeat (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
O14522,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),MASLAALALSLLLRLQLPPLPGARAQSAAGGCSFDEHYSNCGYSVALGTNGFTWEQINTWEKPMLDQAVPTGSFMMVNSSGRASGQKAHLLLPTLKENDTHCIDFHYYFSSRDRSSPGALNVYVKVNGGPQGNPVWNVSGVVTEGWVKAELAISTFWPHFYQVIFESVSLKGHPGYIAVDEVRVLAHPCRKAPHFLRLQNVEVNVGQNATFQCIAGGKWSQHDKLWLQQWNGRDTALMVTRVVNHRRFSATVSVADTAQRSVSKYRCVIRSDGGSGVSNYAELIVKEPPTPIAPPELLAVGATYLWIKPNANSIIGDGPIILKEVEYRTTTGTWAETHIVDSPNYKLWHLDPDVEYEIRVLLTRPGEGGTGPPGPPLTTRTKCADPVHGPQNVEIVDIRARQLTLQWEPFGYAVTRCHSYNLTVQYQYVFNQQQYEAEEVIQTSSHYTLRGLRPFMTIRLRLLLSNPEGRMESEELVVQTEEDVPGAVPLESIQGGPFEEKIYIQWKPPNETNGVITLYEINYKAVGSLDPSADLSSQRGKVFKLRNETHHLFVGLYPGTTYSFTIKASTAKGFGPPVTTRIATKISAPSMPEYDTDTPLNETDTTITVMLKPAQSRGAPVSVYQLVVKEERLQKSRRAADIIECFSVPVSYRNASSLDSLHYFAAELKPANLPVTQPFTVGDNKTYNGYWNPPLSPLKSYSIYFQALSKANGETKINCVRLATKGASTQNSNTVEPEKQVDNTVKMAGVIAGLLMFIIILLGVMLTIKRRRNAYSYSYYLKLAKKQKETQSGAQREMGPVASADKPTTKLSASRNDEGFSSSSQDVNGFTDGSRGELSQPTLTIQTHPYRTCDPVEMSYPRDQFQPAIRVADLLQHITQMKRGQGYGFKEEYEALPEGQTASWDTAKEDENRNKNRYGNIISYDHSRVRLLVLDGDPHSDYINANYIDGYHRPRHYIATQGPMQETVKDFWRMIWQENSASIVMVTNLVEVGRVKCVRYWPDDTEVYGDIKVTLIETEPLAEYVIRTFTVQKKGYHEIRELRLFHFTSWPDHGVPCYATGLLGFVRQVKFLNPPEAGPIVVHCSAGAGRTGCFIAIDTMLDMAENEGVVDIFNCVRELRAQRVNLVQTEEQYVFVHDAILEACLCGNTAIPVCEFRSLYYNISRLDPQTNSSQIKDEFQTLNIVTPRVRPEDCSIGLLPRNHDKNRSMDVLPLDRCLPFLISVDGESSNYINAALMDSHKQPAAFVVTQHPLPNTVADFWRLVFDYNCSSVVMLNEMDTAQFCMQYWPEKTSGCYGPIQVEFVSADIDEDIIHRIFRICNMARPQDGYRIVQHLQYIGWPAYRDTPPSKRSLLKVVRRLEKWQEQYDGREGRTVVHCLNGGGRSGTFCAICSVCEMIQQQNIIDVFHIVKTLRNNKSNMVETLEQYKFVYEVALEYLSSF,1441,"162,134",Active site (2); Alternative sequence (2); Beta strand (12); Binding site (2); Chain (1); Disulfide bond (1); Domain (8); Erroneous initiation (1); Glycosylation (10); Helix (11); Modified residue (1); Natural variant (28); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 213..267;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q5FWE3,Proline-rich transmembrane protein 3,MASSPWGCVCGLLLLLLPLLGTGPALGRGFPRPLENSEIPMIPGAHPKGSVGSEPQAFDVFPENPRADSHRNSDVRHAPAEEMPEKPVASPLGPALYGPKAAQGAQRERLPVTDDLQMAQGPSSHGWTGPLDSQELLQQEAVAPHPVGHPHLTFIPTTPRRQLRVATVPPSLQHEGQEGQWPPRDEGLKAKTKSRVPPTSPSDHQGPPHTLVSHSGTVKRPVLEGQGGFEEHLQEAAQGPHFTQQDPAAPDVGSVPPVEVVYSQEPGAQPDLALARSLPPAEELPVETPKRAGAEVSWEVSSPGPPPKQADLPDAKDSPGPQPTDPPASEAPDRPSKPERAAMNGADPISPQRVRGAVEAPGTPKSLIPGPSDPGPAVNRTESPMGALQPDEAEEWPGRPQSHPPAPPVQAPSTSRRGLIRVTTQRALGQPPPPEPTASSMASAPASSPPANATAPPLRWGPLRRVLSFSWELHVYGVGVLFLLPALLALAALAAAPAGPRLALVAAVLVLVASALRSAYMLTDPYGSQARLGVRGGLVLYNLPFPLLLTALAALTLLGLGAGLPPPLQNPLLLGAVALVHGVGLLATDLLSTWSVLNLLTQGLSCAWGAAVALGTLCLCRRRLLDGPRGWDASPGPRLLAVAGALGLLASGLQLAAALWLYPGPGRVGRFSWAWWGVHFWLRLLELTWALALALAAVAAARPRPPTEHACWAKLMRLACPAPSGKSEVPERPNNCYAGPSNVGAGSLDISKSLIRNPAESGQLATPSSGAWGSAASLGRGPQGGPGLSRNGVGPAPSLSELDLRPPSPINLSRSIDAALFREHLVRDSVFQRCGLRGLASPPPGGALRPRRGSHPKAELDDAGSSLLRGRCRSLSDVRVRGPVPQHVVEAPDGAAAAASGSSLDSFSRGSLKISWNPWRHGLSSVDSLPLDELPSTVQLLPAPTPAPDSTAARQGDGQGEVQPRGKPGESRSASSDTIEL,981,"102,197",Alternative sequence (3); Chain (1); Compositional bias (1); Glycosylation (3); Modified residue (11); Natural variant (5); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:15340161"""
Q92932,Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60],MGPPLPLLLLLLLLLPPRVLPAAPSSVPRGRQLPGRLGCLLEEGLCGASEACVNDGVFGRCQKVPAMDFYRYEVSPVALQRLRVALQKLSGTGFTWQDDYTQYVMDQELADLPKTYLRRPEASSPARPSKHSVGSERRYSREGGAALANALRRHLPFLEALSQAPASDVLARTHTAQDRPPAEGDDRFSESILTYVAHTSALTYPPGSRTQLREDLLPRTLGQLQPDELSPKVDSGVDRHHLMAALSAYAAQRPPAPPGEGSLEPQYLLRAPSRMPRPLLAPAAPQKWPSPLGDSEDPSSTGDGARIHTLLKDLQRQPAEVRGLSGLELDGMAELMAGLMQGVDHGVARGSPGRAALGESGEQADGPKATLRGDSFPDDGVQDDDDRLYQEVHRLSATLGGLLQDHGSRLLPGALPFARPLDMERKKSEHPESSLSSEEETAGVENVKSQTYSKDLLGQQPHSEPGAAAFGELQNQMPGPSKEEQSLPAGAQEALSDGLQLEVQPSEEEARGYIVTDRDPLRPEEGRRLVEDVARLLQVPSSAFADVEVLGPAVTFKVSANVQNVTTEDVEKATVDNKDKLEETSGLKILQTGVGSKSKLKFLPPQAEQEDSTKFIALTLVSLACILGVLLASGLIYCLRHSSQHRLKEKLSGLGGDPGADATAAYQELCRQRMATRPPDRPEGPHTSRISSVSSQFSDGPIPSPSARSSASSWSEEPVQSNMDISTGHMILSYMEDHLKNKNRLEKEWEALCAYQAEPNSSFVAQREENVPKNRSLAVLTYDHSRVLLKAENSHSHSDYINASPIMDHDPRNPAYIATQGPLPATVADFWQMVWESGCVVIVMLTPLAENGVRQCYHYWPDEGSNLYHIYEVNLVSEHIWCEDFLVRSFYLKNLQTNETRTVTQFHFLSWYDRGVPSSSRSLLDFRRKVNKCYRGRSCPIIVHCSDGAGRSGTYVLIDMVLNKMAKGAKEIDIAATLEHLRDQRPGMVQTKEQFEFALTAVAEEVNAILKALPQ,1015,"111,271",Active site (1); Alternative sequence (3); Beta strand (16); Binding site (2); Chain (2); Domain (1); Erroneous initiation (1); Glycosylation (1); Helix (14); Modified residue (5); Motif (2); Mutagenesis (2); Natural variant (7); Region (2); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (4),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P18827,Syndecan-1 (SYND1) (CD antigen CD138),MRRAALWLWLCALALSLQPALPQIVATNLPPEDQDGSGDDSDNFSGSGAGALQDITLSQQTPSTWKDTQLLTAIPTSPEPTGLEATAASTSTLPAGEGPKEGEAVVLPEVEPGLTAREQEATPRPRETTQLPTTHLASTTTATTAQEPATSHPHRDMQPGHHETSTPAGPSQADLHTPHTEDGGPSATERAAEDGASSQLPAAEGSGEQDFTFETSGENTAVVAVEPDRRNQSPVDQGATGASQGLLDRKEVLGGVIAGGLVGLIFAVCLVGFMLYRMKKKDEGSYSLEEPKQANGGAYQKPTKQEEFYA,310,"32,462",Beta strand (1); Chain (1); Glycosylation (6); Modified residue (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P31431,Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein),MAPARLFALLLFFVGGVAESIRETEVIDPQDLLEGRYFSGALPDDEDVVGPGQESDDFELSGSGDLDDLEDSMIGPEVVHPLVPLDNHIPERAGSGSQVPTEPKKLEENEVIPKRISPVEESEDVSNKVSMSSTVQGSNIFERTEVLAALIVGGIVGILFAVFLILLLMYRMKKKDEGSYDLGKKPIYKKAPTNEFYA,198,"21,642",Alternative sequence (1); Beta strand (2); Chain (1); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8NFY4,Semaphorin-6D,MRVFLLCAYILLLMVSQLRAVSFPEDDEPLNTVDYHYSRQYPVFRGRPSGNESQHRLDFQLMLKIRDTLYIAGRDQVYTVNLNEMPKTEVIPNKKLTWRSRQQDRENCAMKGKHKDECHNFIKVFVPRNDEMVFVCGTNAFNPMCRYYRLSTLEYDGEEISGLARCPFDARQTNVALFADGKLYSATVADFLASDAVIYRSMGDGSALRTIKYDSKWIKEPHFLHAIEYGNYVYFFFREIAVEHNNLGKAVYSRVARICKNDMGGSQRVLEKHWTSFLKARLNCSVPGDSFFYFDVLQSITDIIQINGIPTVVGVFTTQLNSIPGSAVCAFSMDDIEKVFKGRFKEQKTPDSVWTAVPEDKVPKPRPGCCAKHGLAEAYKTSIDFPDETLSFIKSHPLMDSAVPPIADEPWFTKTRVRYRLTAISVDHSAGPYQNYTVIFVGSEAGMVLKVLAKTSPFSLNDSVLLEEIEAYNHAKCSAENEEDKKVISLQLDKDHHALYVAFSSCIIRIPLSRCERYGSCKKSCIASRDPYCGWLSQGSCGRVTPGMLAEGYEQDTEFGNTAHLGDCHEILPTSTTPDYKIFGGPTSDMEVSSSSVTTMASIPEITPKVIDTWRPKLTSSRKFVVQDDPNTSDFTDPLSGIPKGVRWEVQSGESNQMVHMNVLITCVFAAFVLGAFIAGVAVYCYRDMFVRKNRKIHKDAESAQSCTDSSGSFAKLNGLFDSPVKEYQQNIDSPKLYSNLLTSRKELPPNGDTKSMVMDHRGQPPELAALPTPESTPVLHQKTLQAMKSHSEKAHGHGASRKETPQFFPSSPPPHSPLSHGHIPSAIVLPNATHDYNTSFSNSNAHKAEKKLQNIDHPLTKSSSKRDHRRSVDSRNTLNDLLKHLNDPNSNPKAIMGDIQMAHQNLMLDPMGSMSEVPPKVPNREASLYSPPSTLPRNSPTKRVDVPTTPGVPMTSLERQRGYHKNSSQRHSISAMPKNLNSPNGVLLSRQPSMNRGGYMPTPTGAKVDYIQGTPVSVHLQPSLSRQSSYTSNGTLPRTGLKRTPSLKPDVPPKPSFVPQTPSVRPLNKYTY,1073,"119,872",Alternative sequence (6); Chain (1); Disulfide bond (8); Domain (2); Erroneous initiation (1); Glycosylation (5); Modified residue (7); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 108..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 136..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 259..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 284..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 477..506;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 515..533;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 521..568;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 525..541;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9H3T3,Semaphorin-6B (Semaphorin-Z) (Sema Z),MQTPRASPPRPALLLLLLLLGGAHGLFPEEPPPLSVAPRDYLNHYPVFVGSGPGRLTPAEGADDLNIQRVLRVNRTLFIGDRDNLYRVELEPPTSTELRYQRKLTWRSNPSDINVCRMKGKQEGECRNFVKVLLLRDESTLFVCGSNAFNPVCANYSIDTLQPVGDNISGMARCPYDPKHANVALFSDGMLFTATVTDFLAIDAVIYRSLGDRPTLRTVKHDSKWFKEPYFVHAVEWGSHVYFFFREIAMEFNYLEKVVVSRVARVCKNDVGGSPRVLEKQWTSFLKARLNCSVPGDSHFYFNVLQAVTGVVSLGGRPVVLAVFSTPSNSIPGSAVCAFDLTQVAAVFEGRFREQKSPESIWTPVPEDQVPRPRPGCCAAPGMQYNASSALPDDILNFVKTHPLMDEAVPSLGHAPWILRTLMRHQLTRVAVDVGAGPWGNQTVVFLGSEAGTVLKFLVRPNASTSGTSGLSVFLEEFETYRPDRCGRPGGGETGQRLLSLELDAASGGLLAAFPRCVVRVPVARCQQYSGCMKNCIGSQDPYCGWAPDGSCIFLSPGTRAAFEQDVSGASTSGLGDCTGLLRASLSEDRAGLVSVNLLVTSSVAAFVVGAVVSGFSVGWFVGLRERRELARRKDKEAILAHGAGEAVLSVSRLGERRAQGPGGRGGGGGGGAGVPPEALLAPLMQNGWAKATLLQGGPHDLDSGLLPTPEQTPLPQKRLPTPHPHPHALGPRAWDHGHPLLPASASSSLLLLAPARAPEQPPAPGEPTPDGRLYAARPGRASHGDFPLTPHASPDRRRVVSAPTGPLDPASAADGLPRPWSPPPTGSLRRPLGPHAPPAATLRRTHTFNSGEARPGDRHRGCHARPGTDLAHLLPYGGADRTAPPVP,888,"95,285",Alternative sequence (2); Chain (1); Compositional bias (2); Disulfide bond (8); Domain (1); Glycosylation (7); Modified residue (1); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 116..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 144..153;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 267..378;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 292..337;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 486..517;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 526..544;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 532..578;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 536..552;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15340161"""
Q92673,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),MATRSSRRESRLPFLFTLVALLPPGALCEVWTQRLHGGSAPLPQDRGFLVVQGDPRELRLWARGDARGASRADEKPLRRKRSAALQPEPIKVYGQVSLNDSHNQMVVHWAGEKSNVIVALARDSLALARPKSSDVYVSYDYGKSFKKISDKLNFGLGNRSEAVIAQFYHSPADNKRYIFADAYAQYLWITFDFCNTLQGFSIPFRAADLLLHSKASNLLLGFDRSHPNKQLWKSDDFGQTWIMIQEHVKSFSWGIDPYDKPNTIYIERHEPSGYSTVFRSTDFFQSRENQEVILEEVRDFQLRDKYMFATKVVHLLGSEQQSSVQLWVSFGRKPMRAAQFVTRHPINEYYIADASEDQVFVCVSHSNNRTNLYISEAEGLKFSLSLENVLYYSPGGAGSDTLVRYFANEPFADFHRVEGLQGVYIATLINGSMNEENMRSVITFDKGGTWEFLQAPAFTGYGEKINCELSQGCSLHLAQRLSQLLNLQLRRMPILSKESAPGLIIATGSVGKNLASKTNVYISSSAGARWREALPGPHYYTWGDHGGIITAIAQGMETNELKYSTNEGETWKTFIFSEKPVFVYGLLTEPGEKSTVFTIFGSNKENVHSWLILQVNATDALGVPCTENDYKLWSPSDERGNECLLGHKTVFKRRTPHATCFNGEDFDRPVVVSNCSCTREDYECDFGFKMSEDLSLEVCVPDPEFSGKSYSPPVPCPVGSTYRRTRGYRKISGDTCSGGDVEARLEGELVPCPLAEENEFILYAVRKSIYRYDLASGATEQLPLTGLRAAVALDFDYEHNCLYWSDLALDVIQRLCLNGSTGQEVIINSGLETVEALAFEPLSQLLYWVDAGFKKIEVANPDGDFRLTIVNSSVLDRPRALVLVPQEGVMFWTDWGDLKPGIYRSNMDGSAAYHLVSEDVKWPNGISVDDQWIYWTDAYLECIERITFSGQQRSVILDNLPHPYAIAVFKNEIYWDDWSQLSIFRASKYSGSQMEILANQLTGLMDMKIFYKGKNTGSNACVPRPCSLLCLPKANNSRSCRCPEDVSSSVLPSGDLMCDCPQGYQLKNNTCVKQENTCLRNQYRCSNGNCINSIWWCDFDNDCGDMSDERNCPTTICDLDTQFRCQESGTCIPLSYKCDLEDDCGDNSDESHCEMHQCRSDEYNCSSGMCIRSSWVCDGDNDCRDWSDEANCTAIYHTCEASNFQCRNGHCIPQRWACDGDTDCQDGSDEDPVNCEKKCNGFRCPNGTCIPSSKHCDGLRDCSDGSDEQHCEPLCTHFMDFVCKNRQQCLFHSMVCDGIIQCRDGSDEDAAFAGCSQDPEFHKVCDEFGFQCQNGVCISLIWKCDGMDDCGDYSDEANCENPTEAPNCSRYFQFRCENGHCIPNRWKCDRENDCGDWSDEKDCGDSHILPFSTPGPSTCLPNYYRCSSGTCVMDTWVCDGYRDCADGSDEEACPLLANVTAASTPTQLGRCDRFEFECHQPKTCIPNWKRCDGHQDCQDGRDEANCPTHSTLTCMSREFQCEDGEACIVLSERCDGFLDCSDESDEKACSDELTVYKVQNLQWTADFSGDVTLTWMRPKKMPSASCVYNVYYRVVGESIWKTLETHSNKTNTVLKVLKPDTTYQVKVQVQCLSKAHNTNDFVTLRTPEGLPDAPRNLQLSLPREAEGVIVGHWAPPIHTHGLIREYIVEYSRSGSKMWASQRAASNFTEIKNLLVNTLYTVRVAAVTSRGIGNWSDSKSITTIKGKVIPPPDIHIDSYGENYLSFTLTMESDIKVNGYVVNLFWAFDTHKQERRTLNFRGSILSHKVGNLTAHTSYEISAWAKTDLGDSPLAFEHVMTRGVRPPAPSLKAKAINQTAVECTWTGPRNVVYGIFYATSFLDLYRNPKSLTTSLHNKTVIVSKDEQYLFLVRVVVPYQGPSSDYVVVKMIPDSRLPPRHLHVVHTGKTSVVIKWESPYDSPDQDLLYAVAVKDLIRKTDRSYKVKSRNSTVEYTLNKLEPGGKYHIIVQLGNMSKDSSIKITTVSLSAPDALKIITENDHVLLFWKSLALKEKHFNESRGYEIHMFDSAMNITAYLGNTTDNFFKISNLKMGHNYTFTVQARCLFGNQICGEPAILLYDELGSGADASATQAARSTDVAAVVVPILFLILLSLGVGFAILYTKHRRLQSSFTAFANSHYSSRLGSAIFSSGDDLGEDDEDAPMITGFSDDVPMVIA,2214,"248,426",Beta strand (65); Chain (1); Disulfide bond (33); Domain (18); Glycosylation (27); Helix (14); Modified residue (2); Motif (4); Mutagenesis (14); Natural variant (11); Propeptide (1); Region (2); Repeat (10); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 1078..1090;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1085..1103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1097..1112;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1117..1131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1125..1144;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1138..1153;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1158..1170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1165..1183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1177..1192;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1199..1211;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1206..1224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1218..1235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1239..1249;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1244..1262;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1256..1271;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1275..1289;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1283..1302;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1296..1315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1325..1337;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1332..1350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1344..1359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1368..1381;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1376..1394;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1388..1403;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1419..1431;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1426..1444;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1438..1453;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1471..1484;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1478..1497;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1491..1506;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1514..1527;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1521..1540;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1534..1549;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9NXL6,SID1 transmembrane family member 1,MRGCLRLALLCALPWLLLAASPGHPAKSPRQPPAPRRDPFDAARGADFDHVYSGVVNLSTENIYSFNYTSQPDQVTAVRVYVNSSSENLNYPVLVVVRQQKEVLSWQVPLLFQGLYQRSYNYQEVSRTLCPSEATNETGPLQQLIFVDVASMAPLGAQYKLLVTKLKHFQLRTNVAFHFTASPSQPQYFLYKFPKDVDSVIIKVVSEMAYPCSVVSVQNIMCPVYDLDHNVEFNGVYQSMTKKAAITLQKKDFPGEQFFVVFVIKPEDYACGGSFFIQEKENQTWNLQRKKNLEVTIVPSIKESVYVKSSLFSVFIFLSFYLGCLLVGFVHYLRFQRKSIDGSFGSNDGSGNMVASHPIAASTPEGSNYGTIDESSSSPGRQMSSSDGGPPGQSDTDSSVEESDFDTMPDIESDKNIIRTKMFLYLSDLSRKDRRIVSKKYKIYFWNIITIAVFYALPVIQLVITYQTVVNVTGNQDICYYNFLCAHPLGVLSAFNNILSNLGHVLLGFLFLLIVLRRDILHRRALEAKDIFAVEYGIPKHFGLFYAMGIALMMEGVLSACYHVCPNYSNFQFDTSFMYMIAGLCMLKLYQTRHPDINASAYSAYASFAVVIMVTVLGVVFGKNDVWFWVIFSAIHVLASLALSTQIYYMGRFKIDLGIFRRAAMVFYTDCIQQCSRPLYMDRMVLLVVGNLVNWSFALFGLIYRPRDFASYMLGIFICNLLLYLAFYIIMKLRSSEKVLPVPLFCIVATAVMWAAALYFFFQNLSSWEGTPAESREKNRECILLDFFDDHDIWHFLSATALFFSFLVLLTLDDDLDVVRRDQIPVF,827,"93,839",Alternative sequence (1); Chain (1); Glycosylation (8); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
A2RUT3,Transmembrane protein 89,MLHVLASLPLLLLLVTSASTHAWSRPLWYQVGLDLQPWGCQPKSVEGCRGGLSCPGYWLGPGASRIYPVAAVMITTTMLMICRKILQGRRRSQATKGEHPQVTTEPCGPWKRRAPISDHTLLRGVLHMLDALLVHIEGHLRHLATQRQIQIKGTSTQSG,159,"17,572",Chain (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9H1E5,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),MAGGRCGPQLTALLAAWIAAVAATAGPEEAALPPEQSRVQPMTASNWTLVMEGEWMLKFYAPWCPSCQQTDSEWEAFAKNGEILQISVGKVDVIQEPGLSGRFFVTTLPAFFHAKDGIFRRYRGPGIFEDLQNYILEKKWQSVEPLTGWKSPASLTMSGMAGLFSISGKIWHLHNYFTVTLGIPAWCSYVFFVIATLVFGLFMGLVLVVISECFYVPLPRHLSERSEQNRRSEEAHRAEQLQDAEEEKDDSNEEENKDSLVDDEEEKEDLGDEDEAEEEEEEDNLAAGVDEERSEANDQGPPGEDGVTREEVEPEEAEEGISEQPCPADTEVVEDSLRQRKSQHADKGL,349,"38,952",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Modified residue (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Transmembrane (1),"DISULFID 64..67;  /note=""Redox-active"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00691""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O00220,Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261),MAPPPARVHLGAFLAVTPNPGSAASGTEAAAATPSKVWGSSAGRIEPRGGGRGALPTSMGQHGPSARARAGRAPGPRPAREASPRLRVHKTFKFVVVGVLLQVVPSSAATIKLHDQSIGTQQWEHSPLGELCPPGSHRSEHPGACNRCTEGVGYTNASNNLFACLPCTACKSDEEERSPCTTTRNTACQCKPGTFRNDNSAEMCRKCSRGCPRGMVKVKDCTPWSDIECVHKESGNGHNIWVILVVTLVVPLLLVAVLIVCCCIGSGCGGDPKCMDRVCFWRLGLLRGPGAEDNAHNEILSNADSLSTFVSEQQMESQEPADLTGVTVQSPGEAQCLLGPAEAEGSQRRRLLVPANGADPTETLMLFFDKFANIVPFDSWDQLMRQLDLTKNEIDVVRAGTAGPGDALYAMLMKWVNKTGRNASIHTLLDALERMEERHAREKIQDLLVDSGKFIYLEDGTGSAVSLE,468,"50,089",Beta strand (7); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (1); Glycosylation (1); Modified residue (4); Mutagenesis (6); Natural variant (8); Repeat (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 132..145;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 148..164;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 167..180;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 170..188;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 190..204;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 207..221;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""; DISULFID 211..229;  /evidence=""ECO:0000244|PDB:5CIR, ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:26457518""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9H158,Protocadherin alpha-C1 (PCDH-alpha-C1),MVGCGVAVLCLWVSCGAAAGQLEYSVPEETERGVAVGNLSADLRLPAAAMSSRNFRFLSSHRELYFGVDLPSGNLVVREPADREQLCRAKAACVLTYDLVLEDPLELHKIRIHVLDTNDNSPLFPAGDVQLHIPEFLTPGARFTLPNAQDDDEGSNGILSYSLSPSQHFRLDMGSRVDGSEYPELVLEKALDREQRATHLLVLTARDGGLPARSGDAQVTIIVVDTNDNAPVFERSVYRTKVPETAPNGTVLFRVQALDPDEGSNGEVQYSLSNSTQAELRHRFHVHPKSGEVQVAASLGPPETLLEAYIEARDEGVFGLASTAKLLVEVTDVNDHAPELDFLTLSNPVPEDAAPGTVIALFSVKDEDLDSNGRVICGMSSAGPFQLTASFDNYYSLLIDGPLDREQISEYQVLITASDSGSPPLSTRRTITVSVADVNDNTPNFPQPQQELFVAENNGPGASLGRVFAQDPDLGKNGLVSYELLDVISEGPSASSLLAVESSSGAITAKTSFDFEQLRGFHFQVEGRDGGIPPRSATVTINLFVVDRNDNYPVILFPLPRNGSVPVEIVPRSARTGHLVTKVVAEDADSGSNAWLSYHISRASDSSLFRISANIGELRTARLVLPTDAVKQRVVVVVRDHGDPPLSSSVTLGVLLSNSVPQLLPDFEDVWEPGGQLSAQNLYLVIALACISFLFLGCLLFFVCTKLHQSPGCCAQSCCRSTEDLRYGSKMVSNPCMTSATIDVTTVERLSQTYLYRASLGLGSDNNSLLLRGEYNAADLRNLATGVGLNLPISCIQIRNRKGDHANVNAMPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,963,"103,942",Alternative sequence (2); Chain (1); Compositional bias (2); Domain (6); Glycosylation (4); Natural variant (1); Region (1); Repeat (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9Y3P8,Signaling threshold-regulating transmembrane adapter 1 (SHP2-interacting transmembrane adapter protein) (Suppression-inducing transmembrane adapter 1) (gp30/40),MNQADPRLRAVCLWTLTSAAMSRGDNCTDLLALGIPSITQAWGLWVLLGAVTLLFLISLAAHLSQWTRGRSRSHPGQGRSGESVEEVPLYGNLHYLQTGRLSQDPEPDQQDPTLGGPARAAEEVMCYTSLQLRPPQGRIPGPGTPVKYSEVVLDSEPKSQASGPEPELYASVCAQTRRARASFPDQAYANSQPAAS,196,"21,126",Chain (1); Disulfide bond (1); Glycosylation (1); Modified residue (10); Mutagenesis (6); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 27;  /note=""Interchain"";  /evidence=""ECO:0000305""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9NQ25,SLAM family member 7 (CD2 subset 1) (CD2-like receptor-activating cytotoxic cells) (CRACC) (Membrane protein FOAP-12) (Novel Ly9) (Protein 19A) (CD antigen CD319),MAGSPTCLTLIYILWQLTGSAASGPVKELVGSVGGAVTFPLKSKVKQVDSIVWTFNTTPLVTIQPEGGTIIVTQNRNRERVDFPDGGYSLKLSKLKKNDSGIYYVGIYSSSLQQPSTQEYVLHVYEHLSKPKVTMGLQSNKNGTCVTNLTCCMEHGEEDVIYTWKALGQAANESHNGSILPISWRWGESDMTFICVARNPVSRNFSSPILARKLCEGAADDPDSSMVLLCLLLVPLLLSLFVLGLFLWFLKRERQEEYIEEKKRVDICRETPNICPHSGENTEYDTIPHTNRTILKEDPANTVYSTVEIPKKMENPHSLLTMPDTPRLFAYENVI,335,"37,421",Alternative sequence (7); Chain (1); Disulfide bond (2); Domain (2); Frameshift (1); Glycosylation (6); Motif (1); Natural variant (2); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 145..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 151..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BVK6,Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25),MAVELGVLLVRPRPGTGLGRVMRTLLLVLWLATRGSALYFHIGETEKKCFIEEIPDETMVIGNYRTQLYDKQREEYQPATPGLGMFVEVKDPEDKVILARQYGSEGRFTFTSHTPGEHQICLHSNSTKFSLFAGGMLRVHLDIQVGEHANDYAEIAAKDKLSELQLRVRQLVEQVEQIQKEQNYQRWREERFRQTSESTNQRVLWWSILQTLILVAIGVWQMRHLKSFFEAKKLV,235,"27,277",Chain (1); Coiled coil (1); Domain (1); Erroneous initiation (2); Glycosylation (1); Modified residue (1); Motif (2); Mutagenesis (1); Natural variant (1); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..37;  /evidence=""ECO:0000250"""
P0DTU4,T cell receptor beta chain MC.7.G5 (TR beta chain TRBV25-1*01J2S3*01C2*01) (MC.7.G5 TRB),MTIRLLCYMGFYFLGAGLMEADIYQTPRYLVIGTGKKITLECSQTMGHDKMYWYQQDPGMELHLIHYSYGVNSTEKGDLSSESTVSRIRTEHFPLTLESARPSHTSQYLCASSEARGLAEFTDTQYFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPALNDSRYCLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRADCGFTSESYQQGVLSATILYEILLGKATLYAVLVSALVLMAMVKRKDSRG,315,"35,490",Chain (1); Disulfide bond (3); Domain (2); Glycosylation (2); Region (7); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 42..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 167..232;  /evidence=""ECO:0000250|UniProtKB:A0A5B9, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 267;  /note=""Interchain (with C-94 in TRAC)"";  /evidence=""ECO:0000250|UniProtKB:P01850""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UBN6,Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2) (DcR2) (TNF-related apoptosis-inducing ligand receptor 4) (TRAIL receptor 4) (TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264),MGLWGQSVPTASSARAGRYPGARTASGTRPWLLDPKILKFVVFIVAVLLPVRVDSATIPRQDEVPQQTVAPQQQRRSLKEEECPAGSHRSEYTGACNPCTEGVDYTIASNNLPSCLLCTVCKSGQTNKSSCTTTRDTVCQCEKGSFQDKNSPEMCRTCRTGCPRGMVKVSNCTPRSDIKCKNESAASSTGKTPAAEETVTTILGMLASPYHYLIIIVVLVIILAVVVVGFSCRKKFISYLKGICSGGGGGPERVHRVLFRRRSCPSRVPGAEDNARNETLSNRYLQPTQVSEQEIQGQELAELTGVTVESPEEPQRLLEQAEAEGCQRRRLLVPVNDADSADISTLLDASATLEEGHAKETIQDQLVGSEKLFYEEDEAGSATSCL,386,"41,823",Chain (1); Compositional bias (2); Disulfide bond (7); Domain (1); Glycosylation (2); Natural variant (4); Repeat (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 83..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 99..115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 118..131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 121..139;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 141..155;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 158..172;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 162..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..55;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:9382840"""
Q9P2J2,Protein turtle homolog A (Immunoglobulin superfamily member 9A) (IgSF9A),MVWCLGLAVLSLVISQGADGRGKPEVVSVVGRAGESVVLGCDLLPPAGRPPLHVIEWLRFGFLLPIFIQFGLYSPRIDPDYVGRVRLQKGASLQIEGLRVEDQGWYECRVFFLDQHIPEDDFANGSWVHLTVNSPPQFQETPPAVLEVQELEPVTLRCVARGSPLPHVTWKLRGKDLGQGQGQVQVQNGTLRIRRVERGSSGVYTCQASSTEGSATHATQLLVLGPPVIVVPPKNSTVNASQDVSLACHAEAYPANLTYSWFQDNINVFHISRLQPRVRILVDGSLRLLATQPDDAGCYTCVPSNGLLHPPSASAYLTVLYPAQVTAMPPETPLPIGMPGVIRCPVRANPPLLFVSWTKDGKALQLDKFPGWSQGTEGSLIIALGNEDALGEYSCTPYNSLGTAGPSPVTRVLLKAPPAFIERPKEEYFQEVGRELLIPCSAQGDPPPVVSWTKVGRGLQGQAQVDSNSSLILRPLTKEAHGHWECSASNAVARVATSTNVYVLGTSPHVVTNVSVVALPKGANVSWEPGFDGGYLQRFSVWYTPLAKRPDRMHHDWVSLAVPVGAAHLLVPGLQPHTQYQFSVLAQNKLGSGPFSEIVLSAPEGLPTTPAAPGLPPTEIPPPLSPPRGLVAVRTPRGVLLHWDPPELVPKRLDGYVLEGRQGSQGWEVLDPAVAGTETELLVPGLIKDVLYEFRLVAFAGSFVSDPSNTANVSTSGLEVYPSRTQLPGLLPQPVLAGVVGGVCFLGVAVLVSILAGCLLNRRRAARRRRKRLRQDPPLIFSPTGKSAAPSALGSGSPDSVAKLKLQGSPVPSLRQSLLWGDPAGTPSPHPDPPSSRGPLPLEPICRGPDGRFVMGPTVAAPQERSGREQAEPRTPAQRLARSFDCSSSSPSGAPQPLCIEDISPVAPPPAAPPSPLPGPGPLLQYLSLPFFREMNVDGDWPPLEEPSPAAPPDYMDTRRCPTSSFLRSPETPPVSPRESLPGAVVGAGATAEPPYTALADWTLRERLLPGLLPAAPRGSLTSQSSGRGSASFLRPPSTAPSAGGSYLSPAPGDTSSWASGPERWPRREHVVTVSKRRNTSVDENYEWDSEFPGDMELLETLHLGLASSRLRPEAEPELGVKTPEEGCLLNTAHVTGPEARCAALREEFLAFRRRRDATRARLPAYRQPVPHPEQATLL,1179,"126,580",Alternative sequence (1); Beta strand (7); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (7); Erroneous initiation (1); Glycosylation (4); Modified residue (2); Motif (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 158..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 248..301;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 440..486;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q5TFQ8,Signal-regulatory protein beta-1 isoform 3 (SIRP-beta-1 isoform 3),MPVPASWPHLPSPFLLMTLLLGRLTGVAGEEELQVIQPDKSISVAAGESATLHCTVTSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRISNITPADAGTYYCVKFRKGSPDHVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPAGDSVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTLTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAPGPALASAAPLLIAFLLGPKVLLVVGVSVIYVYWKQKA,398,"43,359",Beta strand (12); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Helix (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18657508""; DISULFID 169..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 272..330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UBS9,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),MKKHRRALALVSCLFLCSLVWLPSWRVCCKESSSASASSYYSQDDNCALENEDVQFQKKDEREGPINAESLGKSGSNLPISPKEHKLKDDSIVDVQNTESKKLSPPVVETLPTVDLHEESSNAVVDSETVENISSSSTSEITPISKLDEIEKSGTIPIAKPSETEQSETDCDVGEALDASAPIEQPSFVSPPDSLVGQHIENVSSSHGKGKITKSEFESKVSASEQGGGDPKSALNASDNLKNESSDYTKPGDIDPTSVASPKDPEDIPTFDEWKKKVMEVEKEKSQSMHASSNGGSHATKKVQKNRNNYASVECGAKILAANPEAKSTSAILIENMDLYMLNPCSTKIWFVIELCEPIQVKQLDIANYELFSSTPKDFLVSISDRYPTNKWIKLGTFHGRDERNVQSFPLDEQMYAKYVKMFIKYIKVELLSHFGSEHFCPLSLIRVFGTSMVEEYEEIADSQYHSERQELFDEDYDYPLDYNTGEDKSSKNLLGSATNAILNMVNIAANILGAKTEDLTEGNKSISENATATAAPKMPESTPVSTPVPSPEYVTTEVHTHDMEPSTPDTPKESPIVQLVQEEEEEASPSTVTLLGSGEQEDESSPWFESETQIFCSELTTICCISSFSEYIYKWCSVRVALYRQRSRTALSKGKDYLVLAQPPLLLPAESVDVSVLQPLSGELENTNIEREAETVVLGDLSSSMHQDDLVNHTVDAVELEPSHSQTLSQSLLLDITPEINPLPKIEVSESVEYEAGHIPSPVIPQESSVEIDNETEQKSESFSSIEKPSITYETNKVNELMDNIIKEDVNSMQIFTKLSETIVPPINTATVPDNEDGEAKMNIADTAKQTLISVVDSSSLPEVKEEEQSPEDALLRGLQRTATDFYAELQNSTDLGYANGNLVHGSNQKESVFMRLNNRIKALEVNMSLSGRYLEELSQRYRKQMEEMQKAFNKTIVKLQNTSRIAEEQDQRQTEAIQLLQAQLTNMTQLVSNLSATVAELKREVSDRQSYLVISLVLCVVLGLMLCMQRCRNTSQFDGDYISKLPKSNQYPSPKRCFSSYDDMNLKRRTSFPLMRSKSLQLTGKEVDPNDLYIVEPLKFSPEKKKKRCKYKIEKIETIKPEEPLHPIANGDIKGRKPFTNQRDFSNMGEVYHSSYKGPPSEGSSETSSQSEESYFCGISACTSLCNGQSQKTKTEKRALKRRRSKVQDQGKLIKTLIQTKSGSLPSLHDIIKGNKEITVGTFGVTAVSGHI,1254,"139,430",Alternative sequence (3); Chain (1); Coiled coil (1); Domain (1); Glycosylation (5); Modified residue (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6UWL2,Sushi domain-containing protein 1,MGRGPWDAGPSRRLLPLLLLLGLARGAAGAPGPDGLDVCATCHEHATCQQREGKKICICNYGFVGNGRTQCVDKNECQFGATLVCGNHTSCHNTPGGFYCICLEGYRATNNNKTFIPNDGTFCTDIDECEVSGLCRHGGRCVNTHGSFECYCMDGYLPRNGPEPFHPTTDATSCTEIDCGTPPEVPDGYIIGNYTSSLGSQVRYACREGFFSVPEDTVSSCTGLGTWESPKLHCQEINCGNPPEMRHAILVGNHSSRLGGVARYVCQEGFESPGGKITSVCTEKGTWRESTLTCTEILTKINDVSLFNDTCVRWQINSRRINPKISYVISIKGQRLDPMESVREETVNLTTDSRTPEVCLALYPGTNYTVNISTAPPRRSMPAVIGFQTAEVDLLEDDGSFNISIFNETCLKLNRRSRKVGSEHMYQFTVLGQRWYLANFSHATSFNFTTREQVPVVCLDLYPTTDYTVNVTLLRSPKRHSVQITIATPPAVKQTISNISGFNETCLRWRSIKTADMEEMYLFHIWGQRWYQKEFAQEMTFNISSSSRDPEVCLDLRPGTNYNVSLRALSSELPVVISLTTQITEPPLPEVEFFTVHRGPLPRLRLRKAKEKNGPISSYQVLVLPLALQSTFSCDSEGASSFFSNASDADGYVAAELLAKDVPDDAMEIPIGDRLYYGEYYNAPLKRGSDYCIILRITSEWNKVRRHSCAVWAQVKDSSLMLLQMAGVGLGSLAVVIILTFLSFSAV,747,"82,710",Alternative sequence (2); Chain (1); Disulfide bond (11); Domain (5); Erroneous initiation (2); Glycosylation (7); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 39..48;  /evidence=""ECO:0000250""; DISULFID 42..57;  /evidence=""ECO:0000250""; DISULFID 59..71;  /evidence=""ECO:0000250""; DISULFID 77..91;  /evidence=""ECO:0000250""; DISULFID 85..100;  /evidence=""ECO:0000250""; DISULFID 129..141;  /evidence=""ECO:0000250""; DISULFID 135..150;  /evidence=""ECO:0000250""; DISULFID 179..221;  /evidence=""ECO:0000250""; DISULFID 206..234;  /evidence=""ECO:0000250""; DISULFID 239..281;  /evidence=""ECO:0000250""; DISULFID 266..294;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UGT4,Sushi domain-containing protein 2,MKPALLPWALLLLATALGPGPGPTADAQESCSMRCGALDGPCSCHPTCSGLGTCCLDFRDFCLEILPYSGSMMGGKDFVVRHFKMSSPTDASVICRFKDSIQTLGHVDSSGQVHCVSPLLYESGRIPFTVSLDNGHSFPRAGTWLAVHPNKVSMMEKSELVNETRWQYYGTANTSGNLSLTWHVKSLPTQTITIELWGYEETGMPYSQEWTAKWSYLYPLATHIPNSGSFTFTPKPAPPSYQRWRVGALRIIDSKNYAGQKDVQALWTNDHALAWHLSDDFREDPVAWARTQCQAWEELEDQLPNFLEELPDCPCTLTQARADSGRFFTDYGCDMEQGSVCTYHPGAVHCVRSVQASLRYGSGQQCCYTADGTQLLTADSSGGSTPDRGHDWGAPPFRTPPRVPSMSHWLYDVLSFYYCCLWAPDCPRYMQRRPSNDCRNYRPPRLASAFGDPHFVTFDGTNFTFNGRGEYVLLEAALTDLRVQARAQPGTMSNGTETRGTGLTAVAVQEGNSDVVEVRLANRTGGLEVLLNQEVLSFTEQSWMDLKGMFLSVAAGDRVSIMLASGAGLEVSVQGPFLSVSVLLPEKFLTHTHGLLGTLNNDPTDDFTLHSGRVLPPGTSPQELFLFGANWTVHNASSLLTYDSWFLVHNFLYQPKHDPTFEPLFPSETTLNPSLAQEAAKLCGDDHFCNFDVAATGSLSTGTATRVAHQLHQRRMQSLQPVVSCGWLAPPPNGQKEGNRYLAGSTIYFHCDNGYSLAGAETSTCQADGTWSSPTPKCQPGRSYAVLLGIIFGGLAVVAAVALVYVLLRRRKGNTHVWGAQP,822,"90,208",Chain (1); Disulfide bond (9); Domain (4); Frameshift (1); Glycosylation (3); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 31..44;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 31..35;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 35..62;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 42..55;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 42..44;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 48..54;  /evidence=""ECO:0000250|UniProtKB:Q9DBX3""; DISULFID 55..62;  /note=""Alternate"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00350""; DISULFID 725..765;  /evidence=""ECO:0000250""; DISULFID 751..778;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q92854,Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100),MRMCTPIRGLLMALAVMFGTAMAFAPIPRITWEHREVHLVQFHEPDIYNYSALLLSEDKDTLYIGAREAVFAVNALNISEKQHEVYWKVSEDKKAKCAEKGKSKQTECLNYIRVLQPLSATSLYVCGTNAFQPACDHLNLTSFKFLGKNEDGKGRCPFDPAHSYTSVMVDGELYSGTSYNFLGSEPIISRNSSHSPLRTEYAIPWLNEPSFVFADVIRKSPDSPDGEDDRVYFFFTEVSVEYEFVFRVLIPRIARVCKGDQGGLRTLQKKWTSFLKARLICSRPDSGLVFNVLRDVFVLRSPGLKVPVFYALFTPQLNNVGLSAVCAYNLSTAEEVFSHGKYMQSTTVEQSHTKWVRYNGPVPKPRPGACIDSEARAANYTSSLNLPDKTLQFVKDHPLMDDSVTPIDNRPRLIKKDVNYTQIVVDRTQALDGTVYDVMFVSTDRGALHKAISLEHAVHIIEETQLFQDFEPVQTLLLSSKKGNRFVYAGSNSGVVQAPLAFCGKHGTCEDCVLARDPYCAWSPPTATCVALHQTESPSRGLIQEMSGDASVCPDKSKGSYRQHFFKHGGTAELKCSQKSNLARVFWKFQNGVLKAESPKYGLMGRKNLLIFNLSEGDSGVYQCLSEERVKNKTVFQVVAKHVLEVKVVPKPVVAPTLSVVQTEGSRIATKVLVASTQGSSPPTPAVQATSSGAITLPPKPAPTGTSCEPKIVINTVPQLHSEKTMYLKSSDNRLLMSLFLFFFVLFLCLFFYNCYKGYLPRQCLKFRSALLIGKKKPKSDFCDREQSLKETLVEPGSFSQQNGEHPKPALDTGYETEQDTITSKVPTDREDSQRIDDLSARDKPFDVKCELKFADSDADGD,862,"96,150",Alternative sequence (2); Beta strand (45); Chain (1); Disulfide bond (8); Domain (3); Glycosylation (9); Helix (12); Modified residue (1); Mutagenesis (5); Natural variant (2); Sequence caution (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),DISULFID 97..108; DISULFID 126..135; DISULFID 257..370; DISULFID 281..326; DISULFID 503..520; DISULFID 509..553; DISULFID 512..529; DISULFID 576..624,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q5TF21,Protein SOGA3,MSQPPIGGAAPATAAASPAAAATEARLHPEGSSRKQQRAQSPARPRDSSLRQTIAATRSPVGAGTKLNSVRQQQLQQQQQQGNKTGSRTGPPASIRGGGGGAEKATPLAPKGAAPGAVQPVAGAEAAPAATLAALGGRRPGPPEEPPRELESVPSKLGEPPPLGEGGGGGGEGGGAGGGSGEREGGAPQPPPPRGWRGKGVRAQQRGGSGGEGASPSPSSSSAGKTPGTGSRNSGSGVAGGGSGGGGSYWKEGCLQSELIQFHLKKERAAAAAAAAQMHAKNGGGSSSRSSPVSGPPAVCETLAVASASPMAAAAEGPQQSAEGSASGGGMQAAAPPSSQPHPQQLQEQEEMQEEMEKLREENETLKNEIDELRTEMDEMRDTFFEEDACQLQEMRHELERANKNCRILQYRLRKAERKRLRYAQTGEIDGELLRSLEQDLKVAKDVSVRLHHELENVEEKRTTTEDENEKLRQQLIEVEIAKQALQNELEKMKELSLKRRGSKDLPKSEKKAQQTPTEEDNEDLKCQLQFVKEEAALMRKKMAKIDKEKDRFEHELQKYRSFYGDLDSPLPKGEAGGPPSTREAELKLRLRLVEEEANILGRKIVELEVENRGLKAELDDLRGDDFNGSANPLMREQSESLSELRQHLQLVEDETELLRRNVADLEEQNKRITAELNKYKYKSGGHDSARHHDNAKTEALQEELKAARLQINELSGKVMQLQYENRVLMSNMQRYDLASHLGIRGSPRDSDAESDAGKKESDDDSRPPHRKREGPIGGESDSEEVRNIRCLTPTRSFYPAPGPWPKSFSDRQQMKDIRSEAERLGKTIDRLIADTSTIITEARIYVANGDLFGLMDEEDDGSRIREHELLYRINAQMKAFRKELQTFIDRLEVPKSADDRGAEEPISVSQMFQPIILLILILVLFSSLSYTTIFKLVFLFTLFFVL,947,"103,199",Chain (1); Coiled coil (2); Compositional bias (3); Modified residue (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UPU3,VPS10 domain-containing receptor SorCS3,MEAARTERPAGRPGAPLVRTGLLLLSTWVLAGAEITWDATGGPGRPAAPASRPPALSPLSPRAVASQWPEELASARRAAVLGRRAGPELLPQQGGGRGGEMQVEAGGTSPAGERRGRGIPAPAKLGGARRSRRAQPPITQERGDAWATAPADGSRGSRPLAKGSREEVKAPRAGGSAAEDLRLPSTSFALTGDSAHNQAMVHWSGHNSSVILILTKLYDFNLGSVTESSLWRSTDYGTTYEKLNDKVGLKTVLSYLYVNPTNKRKIMLLSDPEMESSILISSDEGATYQKYRLTFYIQSLLFHPKQEDWVLAYSLDQKLYSSMDFGRRWQLMHERITPNRFYWSVAGLDKEADLVHMEVRTTDGYAHYLTCRIQECAETTRSGPFARSIDISSLVVQDEYIFIQVTTSGRASYYVSYRREAFAQIKLPKYSLPKDMHIISTDENQVFAAVQEWNQNDTYNLYISDTRGIYFTLAMENIKSSRGLMGNIIIELYEVAGIKGIFLANKKVDDQVKTYITYNKGRDWRLLQAPDVDLRGSPVHCLLPFCSLHLHLQLSENPYSSGRISSKETAPGLVVATGNIGPELSYTDIGVFISSDGGNTWRQIFDEEYNVWFLDWGGALVAMKHTPLPVRHLWVSFDEGHSWDKYGFTSVPLFVDGALVEAGMETHIMTVFGHFSLRSEWQLVKVDYKSIFSRHCTKEDYQTWHLLNQGEPCVMGERKIFKKRKPGAQCALGRDHSGSVVSEPCVCANWDFECDYGYERHGESQCVPAFWYNPASPSKDCSLGQSYLNSTGYRRIVSNNCTDGLREKYTAKAQMCPGKAPRGLHVVTTDGRLVAEQGHNATFIILMEEGDLQRTNIQLDFGDGIAVSYANFSPIEDGIKHVYKSAGIFQVTAYAENNLGSDTAVLFLHVVCPVEHVHLRVPFVAIRNKEVNISAVVWPSQLGTLTYFWWFGNSTKPLITLDSSISFTFLAEGTDTITVQVAAGNALIQDTKEIAVHEYFQSQLLSFSPNLDYHNPDIPEWRKDIGNVIKRALVKVTSVPEDQILIAVFPGLPTSAELFILPPKNLTERRKGNEGDLEQIVETLFNALNQNLVQFELKPGVQVIVYVTQLTLAPLVDSSAGHSSSAMLMLLSVVFVGLAVFLIYKFKRKIPWINIYAQVQHDKEQEMIGSVSQSENAPKITLSDFTEPEELLDKELDTRVIGGIATIANSESTKEIPNCTSV,1222,"135,755",Chain (1); Domain (1); Glycosylation (8); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9BT76,Uroplakin-3b (UP3b) (Uroplakin IIIb) (UPIIIb) (p35),MGLPWGQPHLGLQMLLLALNCLRPSLSLGEWGSWMDASSQTQGAGGPAGVIGPWAPAPLRLGEAAPGTPTPVSVAHLLSPVATELVPYTPQITAWDLEGKVTATTFSLEQPRCVFDGLASASDTVWLVVAFSNASRGFQNPETLADIPASPQLLTDGHYMTLPLSPDQLPCGDPMAGSGGAPVLRVGHDHGCHQQPFCNAPLPGPGPYREDPRIHRHLARAAKWQHDRHYLHPLFSGRPPTLGLLGSLYHALLQPVVAGGGPGAAADRLLHGQALHDPPHPTQRGRHTAGGLQAWPGPPPQPQPLAWPLCMGLGEMGRWE,320,"33,882",Alternative sequence (2); Chain (1); Erroneous gene model prediction (1); Frameshift (1); Glycosylation (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
P0DTU3,T cell receptor alpha chain MC.7.G5 (MC.7.G5 TRA) (TR alpha chain TRAV38-2DV8*01J31*01C*01),MACPGFLWALVISTCLEFSMAQTVTQSQPEMSVQEAETVTLSCTYDTSESDYYLFWYKQPPSRQMILVIRQEAYKQQNATENRFSVNFQKAAKSFSLKISDSQLGDAAMYFCAYRSAVNARLMFGDGTQLVVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESSCDVKLVEKSFETDTNLNFQNLSVIGFRILLLKVAGFNLLMTLRLWSS,275,"30,989",Chain (1); Disulfide bond (3); Domain (2); Glycosylation (5); Region (7); Sequence caution (1); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 43..112;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 157..207;  /evidence=""ECO:0000250|UniProtKB:P01848""; DISULFID 229;  /note=""Interchain (with C-130 in TRBC1 or TRBC2)"";  /evidence=""ECO:0000250|UniProtKB:P01848""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P30530,Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene),MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQVQGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVFLGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPLATAPGHGPQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTELEVAWTPGLSGIYPLTHCTLQAVLSDDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLHPHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPLQGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLPVPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYALMSRCWELNPQDRPSFTELREDLENTLKALPPAQEPDEILYVNMDEGGGYPEPPGAAGGADPPTQPDPKDSCSCLTAAEVHPAGRYVLCPSTTPSPAQPADRGSPAAPGQEDGA,894,"98,337",Active site (1); Alternative sequence (1); Beta strand (31); Binding site (1); Chain (1); Disulfide bond (2); Domain (5); Glycosylation (6); Helix (14); Modified residue (5); Mutagenesis (3); Natural variant (5); Nucleotide binding (1); Region (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 56..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..205;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P16234,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a),MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYPMSEEESSDVEIRNEENNSGLFVTVLEVSSASAAHTGLYTCYYNHTQTEENELEGRHIYIYVPDPDVAFVPLGMTDYLVIVEDDDSAIIPCRTTDPETPVTLHNSEGVVPASYDSRQGFNGTFTVGPYICEATVKGKKFQTIPFNVYALKATSELDLEMEALKTVYKSGETIVVTCAVFNNEVVDLQWTYPGEVKGKGITMLEEIKVPSIKLVYTLTVPEATVKDSGDYECAARQATREVKEMKKVTISVHEKGFIEIKPTFSQLEAVNLHEVKHFVVEVRAYPPPRISWLKNNLTLIENLTEITTDVEKIQEIRYRSKLKLIRAKEEDSGHYTIVAQNEDAVKSYTFELLTQVPSSILDLVDDHHGSTGGQTVRCTAEGTPLPDIEWMICKDIKKCNNETSWTILANNVSNIITEIHSRDRSTVEGRVTFAKVEETIAVRCLAKNLLGAENRELKLVAPTLRSELTVAAAVLVLLVIVIISLIVLVVIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHHPEKPKKELDIFGLNPADESTRSYVILSFENNGDYMDMKQADTTQYVPMLERKEVSKYSDIQRSLYDRPASYKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSDHPAVARMRVDSDNAYIGVTYKNEEDKLKDWEGGLDEQRLSADSGYIIPLPDIDPVPEEEDLGKRNRHSSQTSEESAIETGSSSSTFIKREDETIEDIDMMDDIGIDSSDLVEDSFL,1089,"122,670",Active site (1); Alternative sequence (4); Beta strand (15); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (6); Erroneous initiation (1); Glycosylation (8); Helix (20); Modified residue (11); Mutagenesis (6); Natural variant (26); Nucleotide binding (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 150..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 235..290;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 435..501;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..23
Q9NYZ4,Sialic acid-binding Ig-like lectin 8 (Siglec-8) (Sialoadhesin family member 2) (SAF-2),MLLLLLLLPLLWGTKGMEGDRQYGDGYLLQVQELVTVQEGLCVHVPCSFSYPQDGWTDSDPVHGYWFRAGDRPYQDAPVATNNPDREVQAETQGRFQLLGDIWSNDCSLSIRDARKRDKGSYFFRLERGSMKWSYKSQLNYKTKQLSVFVTALTHRPDILILGTLESGHSRNLTCSVPWACKQGTPPMISWIGASVSSPGPTTARSSVLTLTPKPQDHGTSLTCQVTLPGTGVTTTSTVRLDVSYPPWNLTMTVFQGDATASTALGNGSSLSVLEGQSLRLVCAVNSNPPARLSWTRGSLTLCPSRSSNPGLLELPRVHVRDEGEFTCRAQNAQGSQHISLSLSLQNEGTGTSRPVSQVTLAAVGGAGATALAFLSFCIIFIIVRSCRKKSARPAAGVGDTGMEDAKAIRGSASQGPLTESWKDGNPLKKPPPAVAPSSGEEGELHYATLSFHKVKPQDPQGQEATDSEYSEIKIHKRETAETQACLRNHNPSSKEVRG,499,"54,042",Alternative sequence (2); Beta strand (12); Binding site (2); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (3); Helix (3); Motif (2); Mutagenesis (7); Natural variant (3); Region (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 42..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 47..107;  /evidence=""ECO:0000244|PDB:2N7A, ECO:0000244|PDB:2N7B, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:27357658""; DISULFID 175..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 283..328;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
O00241,Signal-regulatory protein beta-1 (SIRP-beta-1) (CD172 antigen-like family member B) (CD antigen CD172b),MPVPASWPHLPSPFLLMTLLLGRLTGVAGEDELQVIQPEKSVSVAAGESATLRCAMTSLIPVGPIMWFRGAGAGRELIYNQKEGHFPRVTTVSELTKRNNLDFSISISNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSAPVVSGPAVRATPEHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPAGDSVSYSIHSTARVVLTRGDVHSQVICEIAHITLQGDPLRGTANLSEAIRVPPTLEVTQQPMRAENQANVTCQVSNFYPRGLQLTWLENGNVSRTETASTLIENKDGTYNWMSWLLVNTCAHRDDVVLTCQVEHDGQQAVSKSYALEISAHQKEHGSDITHEAALAPTAPLLVALLLGPKLLLVVGVSAIYICWKQKA,398,"43,211",Alternative sequence (1); Beta strand (12); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Helix (1); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18657508""; DISULFID 169..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 320;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18657508""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6ZSJ9,Protein shisa-6,MALRRLLLLLLLSLESLDLLPSVHGARGRAANRTLSAGGAAVGGRRAGGALARGGRELNGTARAPGIPEAGSRRGQPAAAVAAAASAAVTYETCWGYYDVSGQYDKEFECNNSESGYLYCCGTCYYRFCCKKRHEKLDQRQCTNYQSPVWVQTPSTKVVSPGPENKYDPEKDKTNFTVYITCGVIAFVIVAGVFAKVSYDKAHRPPREMNIHRALADILRQQGPIPIAHCERETISAIDTSPKENTPVRSSSKNHYTPVRTAKQTPEKPRMNNILTSATEPYDLSFSRSFQNLAHLPPSYESAVKTNPSKYSSLKRLTDKEADEYYMRRRHLPDLAARGTLPLNVIQMSQQKPLPRERPRRPIRAMSQDRVLSPDRGLPDEFSMPYDRILSDEQLLSTERLHSQDPLLSPERTAFPEQSLSRAISHTDVFVSTPVLDRYRMSKMHSHPSASNNSYATLGQSQTAAKRHAFASRRHNTVEQLHYIPGHHTCYTASKTEVTV,500,"55,764",Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (2); Glycosylation (2); Modified residue (5); Motif (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8NBM4,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),MFTSTGSSGLYKAPLSKSLLLVPSALSLLLALLLPHCQKLFVYDLHAVKNDFQIWRLICGRIICLDLKDTFCSSLLIYNFRIFERRYGSRKFASFLLGSWVLSALFDFLLIEAMQYFFGITAASNLPSGFLAPVFALFVPFYCSIPRVQVAQILGPLSITNKTLIYILGLQLFTSGSYIWIVAISGLMSGLCYDSKMFQVHQVLCIPSWMAKFFSWTLEPIFSSSEPTSEARIGMGATLDIQRQQRMELLDRQLMFSQFAQGRRQRQQQGGMINWNRLFPPLRQRQNVNYQGGRQSEPAAPPLEVSEEQVARLMEMGFSRGDALEALRASNNDLNVATNFLLQH,344,"38,964",Alternative sequence (6); Chain (1); Domain (1); Erroneous initiation (2); Glycosylation (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q9HAW8,UDP-glucuronosyltransferase 1A10 (UGT1A10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-10) (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J),MARAGWTSPVPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLERSLNCTVKTYSTSYTLEDQNREFMVFAHAQWKAQAQSIFSLLMSSSSGFLDLFFSHCRSLFNDRKLVEYLKESSFDAVFLDPFDTCGLIVAKYFSLPSVVFTRGIFCHHLEEGAQCPAPLSYVPNDLLGFSDAMTFKERVWNHIVHLEDHLFCQYLFRNALEIASEILQTPVTAYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,530,"59,810",Alternative sequence (1); Chain (1); Glycosylation (3); Mutagenesis (4); Natural variant (4); Sequence conflict (4); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q01974,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",MARGSALPRRPLLCIPAVWAAAALLLSVSRTSGEVEVLDPNDPLGPLDGQDGPIPTLKGYFLNFLEPVNNITIVQGQTAILHCKVAGNPPPNVRWLKNDAPVVQEPRRIIIRKTEYGSRLRIQDLDTTDTGYYQCVATNGMKTITATGVLFVRLGPTHSPNHNFQDDYHEDGFCQPYRGIACARFIGNRTIYVDSLQMQGEIENRITAAFTMIGTSTHLSDQCSQFAIPSFCHFVFPLCDARSRTPKPRELCRDECEVLESDLCRQEYTIARSNPLILMRLQLPKCEALPMPESPDAANCMRIGIPAERLGRYHQCYNGSGMDYRGTASTTKSGHQCQPWALQHPHSHHLSSTDFPELGGGHAYCRNPGGQMEGPWCFTQNKNVRMELCDVPSCSPRDSSKMGILYILVPSIAIPLVIACLFFLVCMCRNKQKASASTPQRRQLMASPSQDMEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLSNYNSSAQTSGASNTTQTSSLSTSPVSNVSNARYVGPKQKAPPFPQPQFIPMKGQIRPMVPPPQLYVPVNGYQPVPAYGAYLPNFYPVQIPMQMAPQQVPPQMVPKPSSHHSGSGSTSTGYVTTAPSNTSMADRAALLSEGADDTQNAPEDGAQSTVQEAEEEEEGSVPETELLGDCDTLQVDEAQVQLEA,943,"104,757",Active site (1); Beta strand (12); Binding site (1); Chain (1); Compositional bias (3); Disulfide bond (9); Domain (4); Erroneous initiation (1); Glycosylation (3); Helix (16); Modified residue (4); Mutagenesis (1); Natural variant (20); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 83..135;  /evidence=""ECO:0000250""; DISULFID 174..239;  /evidence=""ECO:0000250""; DISULFID 182..232;  /evidence=""ECO:0000250""; DISULFID 223..264;  /evidence=""ECO:0000250""; DISULFID 252..300;  /evidence=""ECO:0000250""; DISULFID 256..286;  /evidence=""ECO:0000250""; DISULFID 316..394;  /evidence=""ECO:0000250""; DISULFID 337..377;  /evidence=""ECO:0000250""; DISULFID 365..389;  /evidence=""ECO:0000250""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9Y286,Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328),MLLLLLLPLLWGRERVEGQKSNRKDYSLTMQSSVTVQEGMCVHVRCSFSYPVDSQTDSDPVHGYWFRAGNDISWKAPVATNNPAWAVQEETRDRFHLLGDPQTKNCTLSIRDARMSDAGRYFFRMEKGNIKWNYKYDQLSVNVTALTHRPNILIPGTLESGCFQNLTCSVPWACEQGTPPMISWMGTSVSPLHPSTTRSSVLTLIPQPQHHGTSLTCQVTLPGAGVTTNRTIQLNVSYPPQNLTVTVFQGEGTASTALGNSSSLSVLEGQSLRLVCAVDSNPPARLSWTWRSLTLYPSQPSNPLVLELQVHLGDEGEFTCRAQNSLGSQHVSLNLSLQQEYTGKMRPVSGVLLGAVGGAGATALVFLSFCVIFIVVRSCRKKSARPAADVGDIGMKDANTIRGSASQGNLTESWADDNPRHHGLAAHSSGEEREIQYAPLSFHKGEPQDLSGQEATNNEYSEIKIPK,467,"51,143",Alternative sequence (4); Beta strand (12); Binding site (1); Chain (1); Disulfide bond (3); Domain (3); Frameshift (1); Glycosylation (8); Helix (6); Modified residue (1); Motif (1); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 46..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12438315, ECO:0000269|PubMed:14747738, ECO:0000269|PubMed:16623661, ECO:0000269|PubMed:16895906""; DISULFID 168..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 276..320;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q13291,Signaling lymphocytic activation molecule (CDw150) (IPO-3) (SLAM family member 1) (CD antigen CD150),MDPKGLLSLTFVLFLSLAFGASYGTGGRMMNCPKILRQLGSKVLLPLTYERINKSMNKSIHIVVTMAKSLENSVENKIVSLDPSEAGPPRYLGDRYKFYLENLTLGIRESRKEDEGWYLMTLEKNVSVQRFCLQLRLYEQVSTPEIKVLNKTQENGTCTLILGCTVEKGDHVAYSWSEKAGTHPLNPANSSHLLSLTLGPQHADNIYICTVSNPISNNSQTFSPWPGCRTDPSETKPWAVYAGLLGGVIMILIMVVILQLRRRGKTNHYQTTVEKKSLTIYAQVQKPGPLQKKLDSFPAQDPCTTIYVAATEPVPESVQETNSITVYASVTLPES,335,"37,231",Alternative sequence (4); Beta strand (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (8); Modified residue (3); Motif (3); Mutagenesis (8); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 158..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 164..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P11117,Lysosomal acid phosphatase (LAP) (EC 3.1.3.2),MAGKRSGWSRAALLQLLLGVNLVVMPPTRARSLRFVTLLYRHGDRSPVKTYPKDPYQEEEWPQGFGQLTKEGMLQHWELGQALRQRYHGFLNTSYHRQEVYVRSTDFDRTLMSAEANLAGLFPPNGMQRFNPNISWQPIPVHTVPITEDRLLKFPLGPCPRYEQLQNETRQTPEYQNESSRNAQFLDMVANETGLTDLTLETVWNVYDTLFCEQTHGLRLPPWASPQTMQRLSRLKDFSFRFLFGIYQQAEKARLQGGVLLAQIRKNLTLMATTSQLPKLLVYSAHDTTLVALQMALDVYNGEQAPYASCHIFELYQEDSGNFSVEMYFRNESDKAPWPLSLPGCPHRCPLQDFLRLTEPVVPKDWQQECQLASGPADTEVIVALAVCGSILFLLIVLLLTVLFRMQAQPPGYRHVADGEDHA,423,"48,344",Active site (2); Alternative sequence (2); Chain (1); Disulfide bond (3); Glycosylation (8); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 159..370;  /evidence=""ECO:0000250""; DISULFID 212..310;  /evidence=""ECO:0000250""; DISULFID 345..349;  /evidence=""ECO:0000250""",SIGNAL 1..30
P51805,Plexin-A3 (Plexin-4) (Semaphorin receptor SEX),MPSVCLLLLLFLAVGGALGNRPFRAFVVTDTTLTHLAVHRVTGEVFVGAVNRVFKLAPNLTELRAHVTGPVEDNARCYPPPSMRVCAHRLAPVDNINKLLLIDYAARRLVACGSIWQGICQFLRLDDLFKLGEPHHRKEHYLSGAQEPDSMAGVIVEQGQGPSKLFVGTAVDGKSEYFPTLSSRKLISDEDSADMFSLVYQDEFVSSQIKIPSDTLSLYPAFDIYYIYGFVSASFVYFLTLQLDTQQTLLDTAGEKFFTSKIVRMCAGDSEFYSYVEFPIGCSWRGVEYRLVQSAHLAKPGLLLAQALGVPADEDVLFTIFSQGQKNRASPPRQTILCLFTLSNINAHIRRRIQSCYRGEGTLALPWLLNKELPCINTPMQINGNFCGLVLNQPLGGLHVIEGLPLLADSTDGMASVAAYTYRQHSVVFIGTRSGSLKKVRVDGFQDAHLYETVPVVDGSPILRDLLFSPDHRHIYLLSEKQVSQLPVETCEQYQSCAACLGSGDPHCGWCVLRHRCCREGACLGASAPHGFAEELSKCVQVRVRPNNVSVTSPGVQLTVTLHNVPDLSAGVSCAFEAAAENEAVLLPSGELLCPSPSLQELRALTRGHGATRTVRLQLLSKETGVRFAGADFVFYNCSVLQSCMSCVGSPYPCHWCKYRHTCTSRPHECSFQEGRVHSPEGCPEILPSGDLLIPVGVMQPLTLRAKNLPQPQSGQKNYECVVRVQGRQQRVPAVRFNSSSVQCQNASYSYEGDEHGDTELDFSVVWDGDFPIDKPPSFRALLYKCWAQRPSCGLCLKADPRFNCGWCISEHRCQLRTHCPAPKTNWMHLSQKGTRCSHPRITQIHPLVGPKEGGTRVTIVGDNLGLLSREVGLRVAGVRCNSIPAEYISAERIVCEMEESLVPSPPPGPVELCVGDCSADFRTQSEQVYSFVTPTFDQVSPSRGPASGGTRLTISGSSLDAGSRVTVTVRDSECQFVRRDAKAIVCISPLSTLGPSQAPITLAIDRANISSPGLIYTYTQDPTVTRLEPTWSIINGSTAITVSGTHLLTVQEPRVRAKYRGIETTNTCQVINDTAMLCKAPGIFLGRPQPRAQGEHPDEFGFLLDHVQTARSLNRSSFTYYPDPSFEPLGPSGVLDVKPGSHVVLKGKNLIPAAAGSSRLNYTVLIGGQPCSLTVSDTQLLCDSPSQTGRQPVMVLVGGLEFWLGTLHISAERALTLPAMMGLAAGGGLLLLAITAVLVAYKRKTQDADRTLKRLQLQMDNLESRVALECKEAFAELQTDINELTNHMDEVQIPFLDYRTYAVRVLFPGIEAHPVLKELDTPPNVEKALRLFGQLLHSRAFVLTFIHTLEAQSSFSMRDRGTVASLTMVALQSRLDYATGLLKQLLADLIEKNLESKNHPKLLLRRTESVAEKMLTNWFTFLLHKFLKECAGEPLFLLYCAIKQQMEKGPIDAITGEARYSLSEDKLIRQQIDYKTLTLHCVCPENEGSAQVPVKVLNCDSITQAKDKLLDTVYKGIPYSQRPKAEDMDLEWRQGRMTRIILQDEDVTTKIECDWKRLNSLAHYQVTDGSLVALVPKQVSAYNMANSFTFTRSLSRYESLLRTASSPDSLRSRAPMITPDQETGTKLWHLVKNHDHADHREGDRGSKMVSEIYLTRLLATKGTLQKFVDDLFETVFSTAHRGSALPLAIKYMFDFLDEQADQRQISDPDVRHTWKSNCLPLRFWVNVIKNPQFVFDIHKNSITDACLSVVAQTFMDSCSTSEHRLGKDSPSNKLLYAKDIPNYKSWVERYYRDIAKMASISDQDMDAYLVEQSRLHASDFSVLSALNELYFYVTKYRQEILTALDRDASCRKHKLRQKLEQIISLVSSDS,1871,"207,703",Chain (1); Disulfide bond (10); Domain (5); Glycosylation (10); Modified residue (1); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 77..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 112..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 266..387;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 282..338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 356..375;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 491..508;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 497..539;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 500..517;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 511..523;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 574..594;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NQ34,Transmembrane protein 9B,MATLWGGLLRLGSLLSLSCLALSVLLLAQLSDAAKNFEDVRCKCICPPYKENSGHIYNKNISQKDCDCLHVVEPMPVRGPDVEAYCLRCECKYEERSSVTIKVTIIIYLSILGLLLLYMVYLTLVEPILKRRLFGHAQLIQSDDDIGDHQPFANAHDVLARSRSRANVLNKVEYAQQRWKLQVQEQRKSVFDRHVVLS,198,"22,531",Alternative sequence (1); Chain (1); Glycosylation (1); Modified residue (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:15340161"""
Q13445,Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1),MMAAGAALALALWLLMPPVEVGGAGPPPIQDGEFTFLLPAGRKQCFYQSAPANASLETEYQVIGGAGLDVDFTLESPQGVLLVSESRKADGVHTVEPTEAGDYKLCFDNSFSTISEKLVFFELIFDSLQDDEEVEGWAEAVEPEEMLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVNFWSAVNVAVLLLVAVLQVCTLKRFFQDKRPVPT,227,"25,206",Chain (1); Coiled coil (1); Domain (1); Motif (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:19892738"""
Q9BXS4,Transmembrane protein 59 (Liver membrane-bound protein),MAAPKGSLWVRTQLGLPPLLLLTMALAGGSGTASAEAFDSVLGDTASCHRACQLTYPLHTYPKEEELYACQRGCRLFSICQFVDDGIDLNRTKLECESACTEAYSQSDEQYACHLGCQNQLPFAELRQEQLMSLMPKMHLLFPLTLVRSFWSDMMDSAQSFITSSWTFYLQADDGKIVIFQSKPEIQYAPHLEQEPTNLRESSLSKMSYLQMRNSQAHRNFLEDGESDGFLRCLSLNSGWILTTTLVLSVMVLLWICCATVATAVEQYVPSEKLSIYGDLEFMNEQKLNRYPASSLVVVRSKTEDHEEAGPLPTKVNLAHSEI,323,"36,223",Chain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (1); Modified residue (1); Motif (1); Mutagenesis (9); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P08138,Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271),MGAGATGRAMDGPRLLLLLLLGVSLGGAKEACPTGLYTHSGECCKACNLGEGVAQPCGANQTVCEPCLDSVTFSDVVSATEPCKPCTECVGLQSMSAPCVEADDAVCRCAYGYYQDETTGRCEACRVCEAGSGLVFSCQDKQNTVCEECPDGTYSDEANHVDPCLPCTVCEDTERQLRECTRWADAECEEIPGRWITRSTPPEGSDSTAPSTQEPEAPPEQDLIASTVAGVVTTVMGSSQPVVTRGTTDNLIPVYCSILAAVVVGLVAYIAFKRWNSCKQNKQGANSRPVNQTPPPEGEKLHSDSGISVDSQSLHDQQPHTQTASGQALKGDGGLYSSLPPAKREEVEKLLNGSAGDTWRHLAGELGYQPEHIDSFTHEACPVRALLASWATQDSATLDALLAALRRIQRADLVESLCSESTATSPV,427,"45,183",Alternative sequence (1); Beta strand (2); Chain (1); Compositional bias (1); Disulfide bond (12); Domain (1); Glycosylation (1); Helix (8); Modified residue (1); Mutagenesis (3); Natural variant (1); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 32..43;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 44..57;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 47..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 67..83;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 86..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 89..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 109..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 125..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 128..146;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 149..164;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 167..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 170..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""",SIGNAL 1..28
Q9NRR2,Tryptase gamma (EC 3.4.21.-) (Serine protease 31) (Transmembrane tryptase) [Cleaved into: Tryptase gamma light chain; Tryptase gamma heavy chain],MALGACGLLLLLAVPGVSLRTLQPGCGRPQVSDAGGRIVGGHAAPAGAWPWQASLRLRRMHVCGGSLLSPQWVLTAAHCFSGSLNSSDYQVHLGELEITLSPHFSTVRQIILHSSPSGQPGTSGDIALVELSVPVTLSSRILPVCLPEASDDFCPGIRCWVTGWGYTREGEPLPPPYSLREVKVSVVDTETCRRDYPGPGGSILQPDMLCARGPGDACQDDSGGPLVCQVNGAWVQAGTVSWGEGCGRPNRPGVYTRVPAYVNWIRRHITASGGSESGYPRLPLLAGLFLPGLFLLLVSCVLLAKCLLHPSADGTPFPAPD,321,"33,815",Active site (3); Chain (3); Disulfide bond (5); Domain (1); Glycosylation (1); Natural variant (7); Signal peptide (1); Transmembrane (1),"DISULFID 26..145;  /note=""Interchain (between light and heavy chains)"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 63..79;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 159..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 192..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 218..246;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P49190,Parathyroid hormone 2 receptor (PTH2 receptor),MAGLGASLHVWGWLMLGSCLLARAQLDSDGTITIEEQIVLVLKAKVQCELNITAQLQEGEGNCFPEWDGLICWPRGTVGKISAVPCPPYIYDFNHKGVAFRHCNPNGTWDFMHSLNKTWANYSDCLRFLQPDISIGKQEFFERLYVMYTVGYSISFGSLAVAILIIGYFRRLHCTRNYIHMHLFVSFMLRATSIFVKDRVVHAHIGVKELESLIMQDDPQNSIEATSVDKSQYIGCKIAVVMFIYFLATNYYWILVEGLYLHNLIFVAFFSDTKYLWGFILIGWGFPAAFVAAWAVARATLADARCWELSAGDIKWIYQAPILAAIGLNFILFLNTVRVLATKIWETNAVGHDTRKQYRKLAKSTLVLVLVFGVHYIVFVCLPHSFTGLGWEIRMHCELFFNSFQGFFVSIIYCYCNGEVQAEVKKMWSRWNLSVDWKRTPPCGSRRCGSVLTTVTHSTSSQSQVAASTRMVLISGKAAKIASRQPDSHITLPGYVWSNSEQDCLPHSFHEETKEDSGRQGDDILMEKPSRPMESNPDTEGCQGETEDVL,550,"62,236",Chain (1); Glycosylation (4); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
O75310,UDP-glucuronosyltransferase 2B11 (UDPGT 2B11) (EC 2.4.1.17),MTLKWTSVLLLIHLSCYFSSGSCGKVLVWAAEYSHWMNMKTILKELVQRGHEVTVLASSASILFDPNDASTLKFEVYPTSLTKTEFENIIMQQVKRWSDIRKDSFWLYFSQEQEILWELYDIFRNFCKDVVSNKKVMKKLQESRFDIVFADAVFPCGELLAALLNIRFVYSLRFTPGYTIERHSGGLIFPPSYIPIVMSKLSDQMTFMERVKNMIYVLYFDFWFQMSDMKKWDQFYSEVLGRPTTLFETMGKADIWLMRNSWSFQFPHPFLPNVDFVGGFHCKPAKPLPKEMEEFVQSSGENGVVVFSLGSVISNMTAERANVIATALAKIPQKVLWRFDGNKPDALGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFFDQPDNIAHMKAKGAAVRLDFNTMSSTDLLNALKTVINDPLYKENIMKLSRIQHDQPVKPLDRAVFWIEFVMPHKGAKHLRVAAHDLTWFQYHSLDVIGFLLACVATVIFIITKFCLFCFWKFARKGKKGKRD,529,"61,038",Chain (1); Glycosylation (1); Modified residue (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9Y5H8,Protocadherin alpha-3 (PCDH-alpha-3),MLFSWREDPGAQCLLLSLLLLAASEVGSGQLHYSVSEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKRHGDLLEVNLQNGILFVNSRIDREELCGRSAECSIHLEVIVDRPLQVFHVEVEVKDINDNAPVFPMAVKNLFISESRQPGSRFSLEGASDADIGTNSLLTYSLDSTEYFTLDVKRNDEEIKSLGLVLKKNLNREDTPKHYLLITAIDGGKPELTGTTQLKITVLDVNDNAPAFERTIYKVRLLENAPNGTLVVTVNATDLDEGVNKDIAYSFNTDMSADILSKFHLDPVNGQISVKGNIDFEESKSYEIQVEATDKGNPPMSDHCTVLLEIVDINDNVPELVIQSLSLPVLEDSPLSTVIALISVSDRDSGVNGQVTCSLTPHVPFKLVSTFKNYYSLVLDSPLDRESVSAYELVVTARDGGSPSLWATASVSVEVADVNDNAPAFSQSEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRVGERALSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLMPRVGGIGGAVSELVPRSVGAGHVVAKVRAVDADSGYNAWLSYELQPGTGGARIPFRVGLYTGEISTTRALDEVDAPRHRLLVLVKDHGEPSLTATATVLVSLVESGQAPKASSQASAGATGPEAALVDVNVYLIVAICAVSSLLVLTLLLYTALRCSAPPTEGDCGPGKPTLVCSSAVGSWSYSQQRQQRVCSGEGLPKTDLMAFSPSLPPCPISRDREEKQDVDVDLSAKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"102,428",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (5); Region (1); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UN72,Protocadherin alpha-7 (PCDH-alpha-7),MVCPNGYDPGGRHLLLFIIILAAWEAGRGQLHYSVPEEAKHGNFVGRIAQDLGLELAELVPRLFRAVCKFRGDLLEVNLQNGILFVNSRIDREELCGRSAECSIHLEVIVERPLQVFHVDVEVKDINDNPPVFPATQRNLFIAESRPLDSRFPLEGASDADIGENALLTYRLSPNEYFFLDVPTSNQQVKPLGLVLRKLLDREETPELHLLLTATDGGKPELTGTVQLLITVLDNNDNAPVFDRTLYTVKLPENVSIGTLVIHPNASDLDEGLNGDIIYSFSSDVSPDIKSKFHMDPLSGAITVIGHMDFEESRAHKIPVEAVDKGFPPLAGHCTVLVEVVDVNDNAPQLTLTSLSLPIPEDAQPGTVITLISVFDRDFGVNGQVTCSLTPRVPFKLVSTFKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATASVSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSAGDADAQKNALVSYSLVELRVGERALSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLAPRVGGTGGAVRELVPRSVGAGHVVAKVRAVDADSGYNAWLSYELQPVAAGASIPFRVGLYTGEISTTRALDETDAPRHRLLVLVKDHGEPSLTATATVLVSLVESGQAPKASSRASLGIAGPETELVDVNVYLIIAICAVSSLLVLTLLLYTALRCSAPSSEGACSLVKPTLVCSSAVGSWSFSQQRRQRVCSGEGPPKTDLMAFSPSLPQGPSSTDNPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,937,"100,865",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (6); Glycosylation (3); Natural variant (2); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 96..102;  /evidence=""ECO:0000250|UniProtKB:Q91Y13""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
O14917,Protocadherin-17 (Protocadherin-68),MYLSICCCFLLWAPALTLKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYRVLENSAPHLLDVDADSGLLYTKQRIDRESLCRHNAKCQLSLEVFANDKEICMIKVEIQDINDNAPSFSSDQIEMDISENAAPGTRFPLTSAHDPDAGENGLRTYLLTRDDHGLFGLDVKSRGDGTKFPELVIQKALDREQQNHHTLVLTALDGGEPPRSATVQINVKVIDSNDNSPVFEAPSYLVELPENAPLGTVVIDLNATDADEGPNGEVLYSFSSYVPDRVRELFSIDPKTGLIRVKGNLDYEENGMLEIDVQARDLGPNPIPAHCKVTVKLIDRNDNAPSIGFVSVRQGALSEAAPPGTVIALVRVTDRDSGKNGQLQCRVLGGGGTGGGGGLGGPGGSVPFKLEENYDNFYTVVTDRPLDRETQDEYNVTIVARDGGSPPLNSTKSFAIKILDENDNPPRFTKGLYVLQVHENNIPGEYLGSVLAQDPDLGQNGTVSYSILPSHIGDVSIYTYVSVNPTNGAIYALRSFNFEQTKAFEFKVLAKDSGAPAHLESNATVRVTVLDVNDNAPVIVLPTLQNDTAELQVPRNAGLGYLVSTVRALDSDFGESGRLTYEIVDGNDDHLFEIDPSSGEIRTLHPFWEDVTPVVELVVKVTDHGKPTLSAVAKLIIRSVSGSLPEGVPRVNGEQHHWDMSLPLIVTLSTISIILLAAMITIAVKCKRENKEIRTYNCRIAEYSHPQLGGGKGKKKKINKNDIMLVQSEVEERNAMNVMNVVSSPSLATSPMYFDYQTRLPLSSPRSEVMYLKPASNNLTVPQGHAGCHTSFTGQGTNASETPATRMSIIQTDNFPAEPNYMGSRQQFVQSSSTFKDPERASLRDSGHGDSDQADSDQDTNKGSCCDMSVREALKMKTTSTKSQPLEQEPEECVNCTDECRVLGHSDRCWMPQFPAANQAENADYRTNLFVPTVEANVETETYETVNPTGKKTFCTFGKDKREHTILIANVKPYLKAKRALSPLLQEVPSASSSPTKACIEPCTSTKGSLDGCEAKPGALAEASSQYLPTDSQYLSPSKQPRDPPFMASDQMARVFADVHSRASRDSSEMGAVLEQLDHPNRDLGRESVDAEEVVREIDKLLQDCRGNDPVAVRK,1159,"126,229",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (7); Motif (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9UN66,Protocadherin beta-8 (PCDH-beta-8) (Protocadherin-3I),MEASGKLICRQRQVLFSFLLLGLSLAGAAEPRSYSVVEETEGSSFVTNLAKDLGLEQREFSRRGVRVVSRGNKLHLQLNQETADLLLNEKLDREDLCGHTEPCVLRFQVLLESPFEFFQAELQVIDINDHSPVFLDKQMLVKVSESSPPGTAFPLKNAEDLDIGQNNIENYIISPNSYFRVLTRKRSDGRKYPELVLDKALDREEEAELRLTLTALDGGSPPRSGTAQVYIEVVDVNDNAPEFEQPFYRVQISEDSPISFLVVKVSATDVDTGVNGEISYSLFQASDEISKTFKVDFLTGEIRLKKQLDFEKFQSYEVNIEARDAGGFSGKCTVLIQVIDVNDHAPEVTMSAFTSPIPENAPETVVALFSVSDLDSGENGKISCSIQEDLPFLLKSSVGNFYTLLTETPLDRESRAEYNVTITVTDLGTPRLTTHLNMTVLVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINTDNGHLFALRSLDYEALQAFEFRVGASDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKQRLVVLVKDNGEPPCSATATLHVLLVDGFSQPYLPLPEAAPAQGQADSLTVYLVVALASVSSLFLFSVLLFVAVLLCRRSRAASVGRCSVPEGPFPGHLVDVRGTGSLSQNYQYEVCLAGGSGTNEFQLLKPVLPNIQGHSFGPEMEQNSNFRNGFGFSLQLK,801,"87,591",Chain (1); Disulfide bond (1); Domain (6); Glycosylation (3); Natural variant (11); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 97..103;  /evidence=""ECO:0000250|UniProtKB:Q91XZ2""","SIGNAL 1..29;  /evidence=""ECO:0000250|UniProtKB:Q91XZ2"""
P05187,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",MLGPCMLLLLLLLGLRLQLSLGIIPVEEENPDFWNREAAEALGAAKKLQPAQTAAKNLIIFLGDGMGVSTVTAARILKGQKKDKLGPEIPLAMDRFPYVALSKTYNVDKHVPDSGATATAYLCGVKGNFQTIGLSAAARFNQCNTTRGNEVISVMNRAKKAGKSVGVVTTTRVQHASPAGTYAHTVNRNWYSDADVPASARQEGCQDIATQLISNMDIDVILGGGRKYMFRMGTPDPEYPDDYSQGGTRLDGKNLVQEWLAKRQGARYVWNRTELMQASLDPSVTHLMGLFEPGDMKYEIHRDSTLDPSLMEMTEAALRLLSRNPRGFFLFVEGGRIDHGHHESRAYRALTETIMFDDAIERAGQLTSEEDTLSLVTADHSHVFSFGGYPLRGSSIFGLAPGKARDRKAYTVLLYGNGPGYVLKDGARPDVTESESGSPEYRQQSAVPLDEETHAGEDVAVFARGPQAHLVHGVQEQTFIAHVMAFAACLEPYTACDLAPPAGTTDAAHPGRSVVPALLPLLAGTLLLLETATAP,535,"57,954",Active site (1); Beta strand (16); Chain (1); Disulfide bond (2); Erroneous initiation (1); Glycosylation (2); Helix (23); Lipidation (1); Metal binding (10); Natural variant (5); Propeptide (1); Sequence conflict (10); Signal peptide (1); Transmembrane (1); Turn (3),"DISULFID 143..205;  /evidence=""ECO:0000269|PubMed:11124260, ECO:0000269|PubMed:11937510, ECO:0000269|PubMed:15946677, ECO:0000269|PubMed:16815919, ECO:0000269|PubMed:20693656""; DISULFID 489..496;  /evidence=""ECO:0000269|PubMed:11124260, ECO:0000269|PubMed:11937510, ECO:0000269|PubMed:15946677, ECO:0000269|PubMed:16815919, ECO:0000269|PubMed:20693656""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:6651840"""
Q8N3G9,Transmembrane protein 130,MAQAVWSRLGRILWLACLLPWAPAGVAAGLYELNLTTDSPATTGAVVTISASLVAKDNGSLALPADAHLYRFHWIHTPLVLTGKMEKGLSSTIRVVGHVPGEFPVSVWVTAADCWMCQPVARGFVVLPITEFLVGDLVVTQNTSLPWPSSYLTKTVLKVSFLLHDPSNFLKTALFLYSWDFGDGTQMVTEDSVVYYNYSIIGTFTVKLKVVAEWEEVEPDATRAVKQKTGDFSASLKLQETLRGIQVLGPTLIQTFQKMTVTLNFLGSPPLTVCWRLKPECLPLEEGECHPVSVASTAYNLTHTFRDPGDYCFSIRAENIISKTHQYHKIQVWPSRIQPAVFAFPCATLITVMLAFIMYMTLRNATQQKDMVEVADFDFSPMSDKNPEPPSGVRCCCQMCCGPFLLETPSEYLEIVRENHGLLPPLYKSVKTYTV,435,"48,329",Alternative sequence (2); Chain (1); Domain (1); Glycosylation (3); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P49755,Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (S31I125) (S31III125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta),MSGLSGPPARRGPFPLALLLLFLLGPRLVLAISFHLPINSRKCLREEIHKDLLVTGAYEISDQSGGAGGLRSHLKITDSAGHILYSKEDATKGKFAFTTEDYDMFEVCFESKGTGRIPDQLVILDMKHGVEAKNYEEIAKVEKLKPLEVELRRLEDLSESIVNDFAYMKKREEEMRDTNESTNTRVLYFSIFSMFCLIGLATWQVFYLRRFFKAKKLIE,219,"24,976",Chain (1); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (1); Modified residue (2); Motif (2); Mutagenesis (4); Natural variant (2); Region (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:19892738"""
P16662,"UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (UGT2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)",MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSASILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFGDITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTFEKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVLGRPTTLSETMGKADVWLIRNSWNFQFPYPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSGENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTMSSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND,529,"60,721",Beta strand (6); Binding site (1); Chain (1); Glycosylation (3); Helix (7); Mutagenesis (11); Natural variant (3); Nucleotide binding (1); Signal peptide (1); Transmembrane (1); Turn (4),,"SIGNAL 1..23;  /evidence=""ECO:0000250"""
O60656,UDP-glucuronosyltransferase 1A9 (UGT1A9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-9) (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (lugP4),MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLILRGHEVVVVMPEVSWQLGRSLNCTVKTYSTSYTLEDLDREFKAFAHAQWKAQVRSIYSLLMGSYNDIFDLFFSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIVAKYFSLPSVVFARGILCHYLEEGAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLLCHRFFKNALEIASEILQTPVTEYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,530,"59,941",Alternative sequence (1); Chain (1); Frameshift (1); Glycosylation (3); Modified residue (1); Natural variant (2); Sequence conflict (3); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q99650,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),MALFAVFQTTFFLTLLSLRTYQSEVLAERLPLTPVSLKVSTNSTRQSLHLQWTVHNLPYHQELKMVFQIQISRIETSNVIWVGNYSTTVKWNQVLHWSWESELPLECATHFVRIKSLVDDAKFPEPNFWSNWSSWEEVSVQDSTGQDILFVFPKDKLVEEGTNVTICYVSRNIQNNVSCYLEGKQIHGEQLDPHVTAFNLNSVPFIRNKGTNIYCEASQGNVSEGMKGIVLFVSKVLEEPKDFSCETEDFKTLHCTWDPGTDTALGWSKQPSQSYTLFESFSGEKKLCTHKNWCNWQITQDSQETYNFTLIAENYLRKRSVNILFNLTHRVYLMNPFSVNFENVNATNAIMTWKVHSIRNNFTYLCQIELHGEGKMMQYNVSIKVNGEYFLSELEPATEYMARVRCADASHFWKWSEWSGQNFTTLEAAPSEAPDVWRIVSLEPGNHTVTLFWKPLSKLHANGKILFYNVVVENLDKPSSSELHSIPAPANSTKLILDRCSYQICVIANNSVGASPASVIVISADPENKEVEEERIAGTEGGFSLSWKPQPGDVIGYVVDWCDHTQDVLGDFQWKNVGPNTTSTVISTDAFRPGVRYDFRIYGLSTKRIACLLEKKTGYSQELAPSDNPHVLVDTLTSHSFTLSWKDYSTESQPGFIQGYHVYLKSKARQCHPRFEKAVLSDGSECCKYKIDNPEEKALIVDNLKPESFYEFFITPFTSAGEGPSATFTKVTTPDEHSSMLIHILLPMVFCVLLIMVMCYLKSQWIKETCYPDIPDPYKSSILSLIKFKENPHLIIMNVSDCIPDAIEVVSKPEGTKIQFLGTRKSLTETELTKPNYLYLLPTEKNHSGPGPCICFENLTYNQAASDSGSCGHVPVSPKAPSMLGLMTSPENVLKALEKNYMNSLGEIPAGETSLNYVSQLASPMFGDKDSLPTNPVEAPHCSEYKMQMAVSLRLALPPPTENSSLSSITLLDPGEHYC,979,"110,509",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (4); Erroneous termination (1); Frameshift (1); Glycosylation (5); Modified residue (2); Motif (2); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 245..255;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9BZZ2,Sialoadhesin (Sialic acid-binding Ig-like lectin 1) (Siglec-1) (CD antigen CD169),MGFLPKLLLLASFFPAGQASWGVSSPQDVQGVKGSCLLIPCIFSFPADVEVPDGITAIWYYDYSGQRQVVSHSADPKLVEARFRGRTEFMGNPEHRVCNLLLKDLQPEDSGSYNFRFEISEVNRWSDVKGTLVTVTEEPRVPTIASPVELLEGTEVDFNCSTPYVCLQEQVRLQWQGQDPARSVTFNSQKFEPTGVGHLETLHMAMSWQDHGRILRCQLSVANHRAQSEIHLQVKYAPKGVKILLSPSGRNILPGELVTLTCQVNSSYPAVSSIKWLKDGVRLQTKTGVLHLPQAAWSDAGVYTCQAENGVGSLVSPPISLHIFMAEVQVSPAGPILENQTVTLVCNTPNEAPSDLRYSWYKNHVLLEDAHSHTLRLHLATRADTGFYFCEVQNVHGSERSGPVSVVVNHPPLTPVLTAFLETQAGLVGILHCSVVSEPLATLVLSHGGHILASTSGDSDHSPRFSGTSGPNSLRLEIRDLEETDSGEYKCSATNSLGNATSTLDFHANAARLLISPAAEVVEGQAVTLSCRSGLSPTPDARFSWYLNGALLHEGPGSSLLLPAASSTDAGSYHCRARDGHSASGPSSPAVLTVLYPPRQPTFTTRLDLDAAGAGAGRRGLLLCRVDSDPPARLQLLHKDRVVATSLPSGGGCSTCGGCSPRMKVTKAPNLLRVEIHNPLLEEEGLYLCEASNALGNASTSATFNGQATVLAIAPSHTLQEGTEANLTCNVSREAAGSPANFSWFRNGVLWAQGPLETVTLLPVARTDAALYACRILTEAGAQLSTPVLLSVLYPPDRPKLSALLDMGQGHMALFICTVDSRPLALLALFHGEHLLATSLGPQVPSHGRFQAKAEANSLKLEVRELGLGDSGSYRCEATNVLGSSNTSLFFQVRGAWVQVSPSPELQEGQAVVLSCQVHTGVPEGTSYRWYRDGQPLQESTSATLRFAAITLTQAGAYHCQAQAPGSATTSLAAPISLHVSYAPRHVTLTTLMDTGPGRLGLLLCRVDSDPPAQLRLLHGDRLVASTLQGVGGPEGSSPRLHVAVAPNTLRLEIHGAMLEDEGVYICEASNTLGQASASADFDAQAVNVQVWPGATVREGQLVNLTCLVWTTHPAQLTYTWYQDGQQRLDAHSIPLPNVTVRDATSYRCGVGPPGRAPRLSRPITLDVLYAPRNLRLTYLLESHGGQLALVLCTVDSRPPAQLALSHAGRLLASSTAASVPNTLRLELRGPQPRDEGFYSCSARSPLGQANTSLELRLEGVRVILAPEAAVPEGAPITVTCADPAAHAPTLYTWYHNGRWLQEGPAASLSFLVATRAHAGAYSCQAQDAQGTRSSRPAALQVLYAPQDAVLSSFRDSRARSMAVIQCTVDSEPPAELALSHDGKVLATSSGVHSLASGTGHVQVARNALRLQVQDVPAGDDTYVCTAQNLLGSISTIGRLQVEGARVVAEPGLDVPEGAALNLSCRLLGGPGPVGNSTFAWFWNDRRLHAEPVPTLAFTHVARAQAGMYHCLAELPTGAAASAPVMLRVLYPPKTPTMMVFVEPEGGLRGILDCRVDSEPLASLTLHLGSRLVASSQPQGAPAEPHIHVLASPNALRVDIEALRPSDQGEYICSASNVLGSASTSTYFGVRALHRLHQFQQLLWVLGLLVGLLLLLLGLGACYTWRRRRVCKQSMGENSVEMAFQKETTQLIDPDAATCETSTCAPPLG,1709,"182,624",Alternative sequence (2); Binding site (2); Chain (1); Disulfide bond (18); Domain (17); Glycosylation (14); Natural variant (9); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..166;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 41..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 262..305;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 346..390;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 433..491;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 531..575;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 624..689;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 729..774;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 817..876;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 916..960;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1005..1067;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1107..1149;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1193..1241;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1281..1324;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1367..1425;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1465..1511;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1554..1613;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000250"""
Q9BY64,UDP-glucuronosyltransferase 2B28 (UDPGT 2B28) (UGT2B28) (EC 2.4.1.17),MALKWTSVLLLIHLGCYFSSGSCGKVLVWTGEYSHWMNMKTILKELVQRGHEVTVLASSASILFDPNDAFTLKLEVYPTSLTKTEFENIIMQQVKRWSDIQKDSFWLYFSQEQEILWEFHDIFRNFCKDVVSNKKVMKKLQESRFDIIFADAFFPCGELLAALLNIPFVYSLCFTPGYTIERHSGGLIFPPSYIPVVMSKLSDQMTFMERVKNMIYVLYFDFWFQMCDMKKWDQFYSEVLGRPTTLFETMGKADIWLMRNSWSFQFPHPFLPNIDFVGGLHCKPAKPLPKEMEEFVQSSGENGVVVFSLGSVISNMTAERANVIATALAKIPQKVLWRFDGNKPDALGLNTRLYKWIPQNDLLGLPKTRAFITHGGANGIYEAIYHGIPMVGIPLFWDQPDNIAHMKAKGAAVRLDFHTMSSTDLLNALKTVINDPSYKENVMKLSIIQHDQPVKPLHRAVFWIEFVMCHKGAKHLRVAARDLTWFQYHSLDVIGFLLACVATVIFVVTKFCLFCFWKFARKGKKGKRD,529,"60,906",Alternative sequence (2); Chain (1); Glycosylation (1); Modified residue (1); Natural variant (3); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
A6NLU5,V-set and transmembrane domain-containing protein 2B,MEQRNRLGALGYLPPLLLHALLLFVADAAFTEVPKDVTVREGDDIEMPCAFRASGATSYSLEIQWWYLKEPPRELLHELALSVPGARSKVTNKDATKISTVRVQGNDISHRLRLSAVRLQDEGVYECRVSDYSDDDTQEHKAQAMLRVLSRFAPPNMQAAEAVSHIQSSGPRRHGPASAANANNAGAASRTTSEPGRGDKSPPPGSPPAAIDPAVPEAAAASAAHTPTTTVAAAAAASSASPPSGQAVLLRQRHGSGTGRSYTTDPLLSLLLLALHKFLRLLLGH,285,"30,297",Chain (1); Disulfide bond (1); Domain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q7Z5B4,Protein RIC-3 (Resistant to inhibitor of cholinesterase 3),MAYSTVQRVALASGLVLALSLLLPKAFLSRGKRQEPPPTPEGKLGRFPPMMHHHQAPSDGQTPGARFQRSHLAEAFAKAKGSGGGAGGGGSGRGLMGQIIPIYGFGIFLYILYILFKLSKGKTTAEDGKCYTAMPGNTHRKITSFELAQLQEKLKETEAAMEKLINRVGPNGESRAQTVTSDQEKRLLHQLREITRVMKEGKFIDRFSPEKEAEEAPYMEDWEGYPEETYPIYDLSDCIKRRQETILVDYPDPKELSAEEIAERMGMIEEEESDHLGWESLPTDPRAQEDNSVTSCDPKPETCSCCFHEDEDPAVLAENAGFSADSYPEQEETTKEEWSQDFKDEGLGISTDKAYTGSMLRKRNPQGLE,369,"41,092",Alternative sequence (5); Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Modified residue (1); Natural variant (3); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000250"""
Q8N7C7,RING finger protein 148,MSFLRITPSTHSSVSSGLLRLSIFLLLSFPDSNGKAIWTAHLNITFQVGNEITSELGESGVFGNHSPLERVSGVVALPEGWNQNACHPLTNFSRPKQADSWLALIERGGCTFTHKINVAAEKGANGVIIYNYQGTGSKVFPMSHQGTENIVAVMISNLKGMEILHSIQKGVYVTVIIEVGRMHMQWVSHYIMYLFTFLAATIAYFYLDCVWRLTPRVPNSFTRRRSQIKTDVKKAIDQLQLRVLKEGDEELDLNEDNCVVCFDTYKPQDVVRILTCKHFFHKACIDPWLLAHRTCPMCKCDILKT,305,"34,397",Chain (1); Domain (1); Glycosylation (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q96MS0,Roundabout homolog 3 (Roundabout-like protein 3),MLRYLLKTLLQMNLFADSLAGDISNSSELLLGFNSSLAALNHTLLPPGDPSLNGSRVGPEDAMPRIVEQPPDLLVSRGEPATLPCRAEGRPRPNIEWYKNGARVATVREDPRAHRLLLPSGALFFPRIVHGRRARPDEGVYTCVARNYLGAAASRNASLEVAVLRDDFRQSPGNVVVAVGEPAVLECVPPRGHPEPSVSWRKDGARLKEEEGRITIRGGKLMMSHTLKSDAGMYVCVASNMAGERESAAAEVMVLERPSFLRRPVNQVVLADAPVTFLCEVKGDPPPRLRWRKEDGELPTGRYEIRSDHSLWIGHVSAEDEGTYTCVAENSVGRAEASGSLSVHVPPQLVTQPQDQMAAPGESVAFQCETKGNPPPAIFWQKEGSQVLLFPSQSLQPTGRFSVSPRGQLNITAVQRGDAGYYVCQAVSVAGSILAKALLEIKGASLDGLPPVILQGPANQTLVLGSSVWLPCRVTGNPQPSVRWKKDGQWLQGDDLQFKTMANGTLYIANVQEMDMGFYSCVAKSSTGEATWSGWLKMREDWGVSPDPPTEPSSPPGAPSQPVVTEITKNSITLTWKPNPQTGAAVTSYVIEAFSPAAGNTWRTVADGVQLETHTVSGLQPNTIYLFLVRAVGAWGLSEPSPVSEPVRTQDSSPSRPVEDPWRGQQGLAEVAVRLQEPIVLGPRTLQVSWTVDGPVQLVQGFRVSWRVAGPEGGSWTMLDLQSPSQQSTVLRGLPPGTQIQIKVQAQGQEGLGAESLSVTRSIPEEAPSGPPQGVAVALGGDGNSSITVSWEPPLPSQQNGVITEYQIWCLGNESRFHLNRSAAGWARSAMLRGLVPGLLYRTLVAAATSAGVGVPSAPVLVQLPSPPDLEPGLEVGAGLAVRLARVLREPAFLAGSGAACGALLLGLCAALYWRRKQRKELSHYTASFAYTPAVSFPHSEGLSGASSRPPMGLGPAPYSWLADSWPHPSRSPSAQEPRGSCCPSNPDPDDRYYNEAGISLYLAQTARGTAAPGEGPVYSTIDPAGEELQTFHGGFPQHPSGDLGPWSQYAPPEWSQGDSGAKGGKVKLLGKPVQMPSLNWPEALPPPPPSCELSCLEGPEEELEGSSEPEEWCPPMPERSHLTEPSSSGGCLVTPSRRETPSPTPSYGQQSTATLTPSPPDPPQPPTDMPHLHQMPRRVPLGPSSPLSVSQPMLGIREARPAGLGAGPAASPHLSPSPAPSTASSAPGRTWQGNGEMTPPLQGPRARFRKKPKALPYRRENSPGDLPPPPLPPPEEEASWALELRAAGSMSSLERERSGERKAVQAVPLAAQRVLHPDEEAWLPYSRPSFLSRGQGTSTCSTAGSNSSRGSSSSRGSRGPGRSRSRSQSRSQSQRPGQKRREEPR,1386,"148,209",Alternative sequence (2); Beta strand (22); Chain (1); Disulfide bond (5); Domain (8); Glycosylation (11); Helix (3); Modified residue (1); Natural variant (10); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 85..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 187..236;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 279..326;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 368..424;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 472..521;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P09758,Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1),MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGSGMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCNQTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLFRERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRGGLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVITNRRKSGKYKKVEIKELGELRKEPSL,323,"35,709",Chain (1); Disulfide bond (3); Domain (1); Glycosylation (4); Helix (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 73..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500""; DISULFID 119..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500""; DISULFID 127..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q06418,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF),MALRRSMGRPGLPPLPLPPPPRLGLLLAALASLLLPESAAAGLKLMGAPVKLTVSQGQPVKLNCSVEGMEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTMFSCEAHNLKGLASSRTATVHLQALPAAPFNITVTKLSSSNASVAWMPGADGRALLQSCTVQVTQAPGGWEVLAVVVPVPPFTCLLRDLVPATNYSLRVRCANALGPSPYADWVPFQTKGLAPASAPQNLHAIRTDSGLILEWEEVIPEAPLEGPLGPYKLSWVQDNGTQDELTVEGTRANLTGWDPQKDLIVRVCVSNAVGCGPWSQPLVVSSHDRAGQQGPPHSRTSWVPVVLGVLTALVTAAALALILLRKRRKETRFGQAFDSVMARGEPAVHFRAARSFNRERPERIEATLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLIRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVQSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEDVYDLMYQCWSADPKQRPSFTCLRMELENILGQLSVLSASQDPLYINIERAEEPTAGGSLELPGRDQPYSGAGDGSGMGAVGGTPSDCRYILTPGGLAEQPGQAEHQPESPLNETQRLLLLQQGLLPHSSC,890,"96,905",Active site (1); Beta strand (16); Binding site (1); Chain (1); Disulfide bond (2); Domain (5); Erroneous initiation (1); Glycosylation (7); Helix (1); Modified residue (7); Mutagenesis (1); Natural variant (7); Nucleotide binding (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 64..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:14623883""; DISULFID 160..203;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:14623883""","SIGNAL 1..40;  /evidence=""ECO:0000255"""
Q6UWM9,UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17),MRSDKSALVFLLLQLFCVGCGFCGKVLVWPCDMSHWLNVKVILEELIVRGHEVTVLTHSKPSLIDYRKPSALKFEVVHMPQDRTEENEIFVDLALNVLPGLSTWQSVIKLNDFFVEIRGTLKMMCESFIYNQTLMKKLQETNYDVMLIDPVIPCGDLMAELLAVPFVLTLRISVGGNMERSCGKLPAPLSYVPVPMTGLTDRMTFLERVKNSMLSVLFHFWIQDYDYHFWEEFYSKALGRPTTLCETVGKAEIWLIRTYWDFEFPQPYQPNFEFVGGLHCKPAKALPKEMENFVQSSGEDGIVVFSLGSLFQNVTEEKANIIASALAQIPQKVLWRYKGKKPSTLGANTRLYDWIPQNDLLGHPKTKAFITHGGMNGIYEAIYHGVPMVGVPIFGDQLDNIAHMKAKGAAVEINFKTMTSEDLLRALRTVITDSSYKENAMRLSRIHHDQPVKPLDRAVFWIEFVMRHKGAKHLRSAAHDLTWFQHYSIDVIGFLLACVATAIFLFTKCFLFSCQKFNKTRKIEKRE,527,"60,254",Chain (1); Erroneous initiation (1); Glycosylation (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P98164,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),MDRGPAAVACTLLLALVACLAPASGQECDSAHFRCGSGHCIPADWRCDGTKDCSDDADEIGCAVVTCQQGYFKCQSEGQCIPNSWVCDQDQDCDDGSDERQDCSQSTCSSHQITCSNGQCIPSEYRCDHVRDCPDGADENDCQYPTCEQLTCDNGACYNTSQKCDWKVDCRDSSDEINCTEICLHNEFSCGNGECIPRAYVCDHDNDCQDGSDEHACNYPTCGGYQFTCPSGRCIYQNWVCDGEDDCKDNGDEDGCESGPHDVHKCSPREWSCPESGRCISIYKVCDGILDCPGREDENNTSTGKYCSMTLCSALNCQYQCHETPYGGACFCPPGYIINHNDSRTCVEFDDCQIWGICDQKCESRPGRHLCHCEEGYILERGQYCKANDSFGEASIIFSNGRDLLIGDIHGRSFRILVESQNRGVAVGVAFHYHLQRVFWTDTVQNKVFSVDINGLNIQEVLNVSVETPENLAVDWVNNKIYLVETKVNRIDMVNLDGSYRVTLITENLGHPRGIAVDPTVGYLFFSDWESLSGEPKLERAFMDGSNRKDLVKTKLGWPAGVTLDMISKRVYWVDSRFDYIETVTYDGIQRKTVVHGGSLIPHPFGVSLFEGQVFFTDWTKMAVLKANKFTETNPQVYYQASLRPYGVTVYHSLRQPYATNPCKDNNGGCEQVCVLSHRTDNDGLGFRCKCTFGFQLDTDERHCIAVQNFLIFSSQVAIRGIPFTLSTQEDVMVPVSGNPSFFVGIDFDAQDSTIFFSDMSKHMIFKQKIDGTGREILAANRVENVESLAFDWISKNLYWTDSHYKSISVMRLADKTRRTVVQYLNNPRSVVVHPFAGYLFFTDWFRPAKIMRAWSDGSHLLPVINTTLGWPNGLAIDWAASRLYWVDAYFDKIEHSTFDGLDRRRLGHIEQMTHPFGLAIFGEHLFFTDWRLGAIIRVRKADGGEMTVIRSGIAYILHLKSYDVNIQTGSNACNQPTHPNGDCSHFCFPVPNFQRVCGCPYGMRLASNHLTCEGDPTNEPPTEQCGLFSFPCKNGRCVPNYYLCDGVDDCHDNSDEQLCGTLNNTCSSSAFTCGHGECIPAHWRCDKRNDCVDGSDEHNCPTHAPASCLDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNCNSTETCQPSQFNCPNHRCIDLSFVCDGDKDCVDGSDEVGCVLNCTASQFKCASGDKCIGVTNRCDGVFDCSDNSDEAGCPTRPPGMCHSDEFQCQEDGICIPNFWECDGHPDCLYGSDEHNACVPKTCPSSYFHCDNGNCIHRAWLCDRDNDCGDMSDEKDCPTQPFRCPSWQWQCLGHNICVNLSVVCDGIFDCPNGTDESPLCNGNSCSDFNGGCTHECVQEPFGAKCLCPLGFLLANDSKTCEDIDECDILGSCSQHCYNMRGSFRCSCDTGYMLESDGRTCKVTASESLLLLVASQNKIIADSVTSQVHNIYSLVENGSYIVAVDFDSISGRIFWSDATQGKTWSAFQNGTDRRVVFDSSIILTETIAIDWVGRNLYWTDYALETIEVSKIDGSHRTVLISKNLTNPRGLALDPRMNEHLLFWSDWGHHPRIERASMDGSMRTVIVQDKIFWPCGLTIDYPNRLLYFMDSYLDYMDFCDYNGHHRRQVIASDLIIRHPYALTLFEDSVYWTDRATRRVMRANKWHGGNQSVVMYNIQWPLGIVAVHPSKQPNSVNPCAFSRCSHLCLLSSQGPHFYSCVCPSGWSLSPDLLNCLRDDQPFLITVRQHIIFGISLNPEVKSNDAMVPIAGIQNGLDVEFDDAEQYIYWVENPGEIHRVKTDGTNRTVFASISMVGPSMNLALDWISRNLYSTNPRTQSIEVLTLHGDIRYRKTLIANDGTALGVGFPIGITVDPARGKLYWSDQGTDSGVPAKIASANMDGTSVKTLFTGNLEHLECVTLDIEEQKLYWAVTGRGVIERGNVDGTDRMILVHQLSHPWGIAVHDSFLYYTDEQYEVIERVDKATGANKIVLRDNVPNLRGLQVYHRRNAAESSNGCSNNMNACQQICLPVPGGLFSCACATGFKLNPDNRSCSPYNSFIVVSMLSAIRGFSLELSDHSETMVPVAGQGRNALHVDVDVSSGFIYWCDFSSSVASDNAIRRIKPDGSSLMNIVTHGIGENGVRGIAVDWVAGNLYFTNAFVSETLIEVLRINTTYRRVLLKVTVDMPRHIVVDPKNRYLFWADYGQRPKIERSFLDCTNRTVLVSEGIVTPRGLAVDRSDGYVYWVDDSLDIIARIRINGENSEVIRYGSRYPTPYGITVFENSIIWVDRNLKKIFQASKEPENTEPPTVIRDNINWLRDVTIFDKQVQPRSPAEVNNNPCLENNGGCSHLCFALPGLHTPKCDCAFGTLQSDGKNCAISTENFLIFALSNSLRSLHLDPENHSPPFQTINVERTVMSLDYDSVSDRIYFTQNLASGVGQISYATLSSGIHTPTVIASGIGTADGIAFDWITRRIYYSDYLNQMINSMAEDGSNRTVIARVPKPRAIVLDPCQGYLYWADWDTHAKIERATLGGNFRVPIVNSSLVMPSGLTLDYEEDLLYWVDASLQRIERSTLTGVDREVIVNAAVHAFGLTLYGQYIYWTDLYTQRIYRANKYDGSGQIAMTTNLLSQPRGINTVVKNQKQQCNNPCEQFNGGCSHICAPGPNGAECQCPHEGNWYLANNRKHCIVDNGERCGASSFTCSNGRCISEEWKCDNDNDCGDGSDEMESVCALHTCSPTAFTCANGRCVQYSYRCDYYNDCGDGSDEAGCLFRDCNATTEFMCNNRRCIPREFICNGVDNCHDNNTSDEKNCPDRTCQSGYTKCHNSNICIPRVYLCDGDNDCGDNSDENPTYCTTHTCSSSEFQCASGRCIPQHWYCDQETDCFDASDEPASCGHSERTCLADEFKCDGGRCIPSEWICDGDNDCGDMSDEDKRHQCQNQNCSDSEFLCVNDRPPDRRCIPQSWVCDGDVDCTDGYDENQNCTRRTCSENEFTCGYGLCIPKIFRCDRHNDCGDYSDERGCLYQTCQQNQFTCQNGRCISKTFVCDEDNDCGDGSDELMHLCHTPEPTCPPHEFKCDNGRCIEMMKLCNHLDDCLDNSDEKGCGINECHDPSISGCDHNCTDTLTSFYCSCRPGYKLMSDKRTCVDIDECTEMPFVCSQKCENVIGSYICKCAPGYLREPDGKTCRQNSNIEPYLIFSNRYYLRNLTIDGYFYSLILEGLDNVVALDFDRVEKRLYWIDTQRQVIERMFLNKTNKETIINHRLPAAESLAVDWVSRKLYWLDARLDGLFVSDLNGGHRRMLAQHCVDANNTFCFDNPRGLALHPQYGYLYWADWGHRAYIGRVGMDGTNKSVIISTKLEWPNGITIDYTNDLLYWADAHLGYIEYSDLEGHHRHTVYDGALPHPFAITIFEDTIYWTDWNTRTVEKGNKYDGSNRQTLVNTTHRPFDIHVYHPYRQPIVSNPCGTNNGGCSHLCLIKPGGKGFTCECPDDFRTLQLSGSTYCMPMCSSTQFLCANNEKCIPIWWKCDGQKDCSDGSDELALCPQRFCRLGQFQCSDGNCTSPQTLCNAHQNCPDGSDEDRLLCENHHCDSNEWQCANKRCIPESWQCDTFNDCEDNSDEDSSHCASRTCRPGQFRCANGRCIPQAWKCDVDNDCGDHSDEPIEECMSSAHLCDNFTEFSCKTNYRCIPKWAVCNGVDDCRDNSDEQGCEERTCHPVGDFRCKNHHCIPLRWQCDGQNDCGDNSDEENCAPRECTESEFRCVNQQCIPSRWICDHYNDCGDNSDERDCEMRTCHPEYFQCTSGHCVHSELKCDGSADCLDASDEADCPTRFPDGAYCQATMFECKNHVCIPPYWKCDGDDDCGDGSDEELHLCLDVPCNSPNRFRCDNNRCIYSHEVCNGVDDCGDGTDETEEHCRKPTPKPCTEYEYKCGNGHCIPHDNVCDDADDCGDWSDELGCNKGKERTCAENICEQNCTQLNEGGFICSCTAGFETNVFDRTSCLDINECEQFGTCPQHCRNTKGSYECVCADGFTSMSDRPGKRCAAEGSSPLLLLPDNVRIRKYNLSSERFSEYLQDEEYIQAVDYDWDPKDIGLSVVYYTVRGEGSRFGAIKRAYIPNFESGRNNLVQEVDLKLKYVMQPDGIAVDWVGRHIYWSDVKNKRIEVAKLDGRYRKWLISTDLDQPAAIAVNPKLGLMFWTDWGKEPKIESAWMNGEDRNILVFEDLGWPTGLSIDYLNNDRIYWSDFKEDVIETIKYDGTDRRVIAKEAMNPYSLDIFEDQLYWISKEKGEVWKQNKFGQGKKEKTLVVNPWLTQVRIFHQLRYNKSVPNLCKQICSHLCLLRPGGYSCACPQGSSFIEGSTTECDAAIELPINLPPPCRCMHGGNCYFDETDLPKCKCPSGYTGKYCEMAFSKGISPGTTAVAVLLTILLIVVIGALAIAGFFHYRRTGSLLPALPKLPSLSSLVKPSENGNGVTFRSGADLNMDIGVSGFGPETAIDRSMAMSEDFVMEMGKQPIIFENPMYSARDSAVKVVQPIQVTVSENVDNKNYGSPINPSEIVPETNPTSPAADGTQVTKWNLFKRKSKQTTNFENPIYAQMENEQKESVAATPPPSPSLPAKPKPPSRRDPTPTYSATEDTFKDTANLVKEDSEV,4655,"521,958",Beta strand (4); Chain (1); Disulfide bond (126); Domain (42); Glycosylation (40); Helix (1); Metal binding (11); Modified residue (6); Motif (7); Natural variant (20); Region (1); Repeat (35); Sequence conflict (16); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 28..40;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 35..53;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 47..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 67..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 74..93;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 87..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 108..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 115..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 127..142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 147..157;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 152..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 164..179;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 183..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 190..208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 202..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 222..234;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 229..247;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 241..256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 266..279;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 273..292;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 286..307;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1026..1038;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1033..1051;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1045..1060;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1067..1079;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1074..1092;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1086..1101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1109..1121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:23275343""; DISULFID 1116..1134;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:23275343""; DISULFID 1128..1143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:23275343""; DISULFID 1149..1161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1156..1174;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1168..1183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1187..1200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1194..1213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1207..1222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1230..1243;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1237..1256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1250..1266;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1271..1283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1278..1296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1290..1305;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1305..1325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1312..1338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1332..1348;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1394..1404;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1400..1413;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1415..1428;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1704..1713;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1709..1725;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1727..1740;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 2700..2712;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2707..2725;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2719..2736;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2741..2753;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2748..2766;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2760..2775;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2780..2793;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2788..2806;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2800..2817;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2822..2835;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2829..2848;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2842..2859;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2864..2876;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2871..2889;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2883..2899;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2906..2918;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2913..2931;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2925..2943;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2948..2965;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2955..2978;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2972..2988;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2993..3005;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3000..3018;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3012..3027;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3032..3044;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3039..3057;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3051..3068;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3075..3087;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3082..3100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3094..3109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3114..3126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3122..3135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3137..3150;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3156..3167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3163..3176;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3178..3191;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 3512..3525;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3519..3538;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3532..3548;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3553..3565;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3560..3578;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3572..3589;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3594..3606;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3601..3619;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3613..3630;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3635..3647;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3642..3660;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3654..3671;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3678..3692;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3686..3705;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3699..3714;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3719..3732;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3727..3745;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3739..3754;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3759..3771;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3766..3784;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3778..3793;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3798..3810;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3805..3823;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3817..3832;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3842..3854;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3849..3867;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3861..3878;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3883..3896;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3891..3909;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3903..3920;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3928..3940;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3935..3953;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 3947..3962;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 4011..4021;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4017..4030;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4032..4047;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4381..4389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4383..4399;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4401..4410;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9BY71,Leucine-rich repeat-containing protein 3,MGTVRPPRPSLLLVSTRESCLFLLFCLHLGAACPQPCRCPDHAGAVAVFCSLRGLQEVPEDIPANTVLLKLDANKISHLPDGAFQHLHRLRELDLSHNAIEAIGSATFAGLAGGLRLLDLSYNRIQRIPKDALGKLSAKIRLSHNPLHCECALQEALWELKLDPDSVDEIACHTSVQEEFVGKPLVQALDAGASLCSVPHRTTDVAMLVTMFGWFAMVIAYVVYYVRHNQEDARRHLEYLKSLPSAPASKDPIGPGP,257,"28,108",Chain (1); Domain (1); Repeat (4); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q7Z2Q7,Leucine-rich repeat-containing protein 70 (Synleurin),MCGLQFSLPCLRLFLVVTCYLLLLLHKEILGCSSVCQLCTGRQINCRNLGLSSIPKNFPESTVFLYLTGNNISYINESELTGLHSLVALYLDNSNILYVYPKAFVQLRHLYFLFLNNNFIKRLDPGIFKGLLNLRNLYLQYNQVSFVPRGVFNDLVSVQYLNLQRNRLTVLGSGTFVGMVALRILDLSNNNILRISESGFQHLENLACLYLGSNNLTKVPSNAFEVLKSLRRLSLSHNPIEAIQPFAFKGLANLEYLLLKNSRIRNVTRDGFSGINNLKHLILSHNDLENLNSDTFSLLKNLIYLKLDRNRIISIDNDTFENMGASLKILNLSFNNLTALHPRVLKPLSSLIHLQANSNPWECNCKLLGLRDWLASSAITLNIYCQNPPSMRGRALRYINITNCVTSSINVSRAWAVVKSPHIHHKTTALMMAWHKVTTNGSPLENTETENITFWERIPTSPAGRFFQENAFGNPLETTAVLPVQIQLTTSVTLNLEKNSALPNDAASMSGKTSLICTQEVEKLNEAFDILLAFFILACVLIIFLIYKVVQFKQKLKASENSRENRLEYYSFYQSARYNVTASICNTSPNSLESPGLEQIRLHKQIVPENEAQVILFEHSAL,622,"70,301",Chain (1); Domain (2); Glycosylation (4); Repeat (12); Sequence conflict (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q96JA1,Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1),MARPVRGGLGAPRRSPCLLLLWLLLLRLEPVTAAAGPRAPCAAACTCAGDSLDCGGRGLAALPGDLPSWTRSLNLSYNKLSEIDPAGFEDLPNLQEVYLNNNELTAVPSLGAASSHVVSLFLQHNKIRSVEGSQLKAYLSLEVLDLSLNNITEVRNTCFPHGPPIKELNLAGNRIGTLELGAFDGLSRSLLTLRLSKNRITQLPVRAFKLPRLTQLDLNRNRIRLIEGLTFQGLNSLEVLKLQRNNISKLTDGAFWGLSKMHVLHLEYNSLVEVNSGSLYGLTALHQLHLSNNSIARIHRKGWSFCQKLHELVLSFNNLTRLDEESLAELSSLSVLRLSHNSISHIAEGAFKGLRSLRVLDLDHNEISGTIEDTSGAFSGLDSLSKLTLFGNKIKSVAKRAFSGLEGLEHLNLGGNAIRSVQFDAFVKMKNLKELHISSDSFLCDCQLKWLPPWLIGRMLQAFVTATCAHPESLKGQSIFSVPPESFVCDDFLKPQIITQPETTMAMVGKDIRFTCSAASSSSSPMTFAWKKDNEVLTNADMENFVHVHAQDGEVMEYTTILHLRQVTFGHEGRYQCVITNHFGSTYSHKARLTVNVLPSFTKTPHDITIRTTTMARLECAATGHPNPQIAWQKDGGTDFPAARERRMHVMPDDDVFFITDVKIDDAGVYSCTAQNSAGSISANATLTVLETPSLVVPLEDRVVSVGETVALQCKATGNPPPRITWFKGDRPLSLTERHHLTPDNQLLVVQNVVAEDAGRYTCEMSNTLGTERAHSQLSVLPAAGCRKDGTTVGIFTIAVVSSIVLTSLVWVCIIYQTRKKSEEYSVTNTDETVVPPDVPSYLSSQGTLSDRQETVVRTEGGPQANGHIESNGVCPRDASHFPEPDTHSVACRQPKLCAGSAYHKEPWKAMEKAEGTPGPHKMEHGGRVVCSDCNTEVDCYSRGQAFHPQPVSRDSAQPSAPNGPEPGGSDQEHSPHHQCSRTAAGSCPECQGSLYPSNHDRMLTAVKKKPMASLDGKGDSSWTLARLYHPDSTELQPASSLTSGSPERAEAQYLLVSNGHLPKACDASPESTPLTGQLPGKQRVPLLLAPKS,1093,"119,113",Alternative sequence (2); Beta strand (45); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (5); Glycosylation (6); Helix (15); Natural variant (7); Repeat (15); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 45..54;  /evidence=""ECO:0000244|PDB:4U7L, ECO:0000269|PubMed:25765764""; DISULFID 444..468;  /evidence=""ECO:0000244|PDB:4U7L, ECO:0000269|PubMed:25765764""; DISULFID 446..489;  /evidence=""ECO:0000244|PDB:4U7L, ECO:0000269|PubMed:25765764""; DISULFID 516..577;  /evidence=""ECO:0000244|PDB:4U7M, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25765764""; DISULFID 620..672;  /evidence=""ECO:0000244|PDB:4U7M, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25765764""; DISULFID 714..763;  /evidence=""ECO:0000244|PDB:4U7M, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25765764""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q9H3W5,Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3) (NLRR-3),MKDMPLRIHVLLGLAITTLVQAVDKKVDCPRLCTCEIRPWFTPRSIYMEASTVDCNDLGLLTFPARLPANTQILLLQTNNIAKIEYSTDFPVNLTGLDLSQNNLSSVTNINVKKMPQLLSVYLEENKLTELPEKCLSELSNLQELYINHNLLSTISPGAFIGLHNLLRLHLNSNRLQMINSKWFDALPNLEILMIGENPIIRIKDMNFKPLINLRSLVIAGINLTEIPDNALVGLENLESISFYDNRLIKVPHVALQKVVNLKFLDLNKNPINRIRRGDFSNMLHLKELGINNMPELISIDSLAVDNLPDLRKIEATNNPRLSYIHPNAFFRLPKLESLMLNSNALSALYHGTIESLPNLKEISIHSNPIRCDCVIRWMNMNKTNIRFMEPDSLFCVDPPEFQGQNVRQVHFRDMMEICLPLIAPESFPSNLNVEAGSYVSFHCRATAEPQPEIYWITPSGQKLLPNTLTDKFYVHSEGTLDINGVTPKEGGLYTCIATNLVGADLKSVMIKVDGSFPQDNNGSLNIKIRDIQANSVLVSWKASSKILKSSVKWTAFVKTENSHAAQSARIPSDVKVYNLTHLNPSTEYKICIDIPTIYQKNRKKCVNVTTKGLHPDQKEYEKNNTTTLMACLGGLLGIIGVICLISCLSPEMNCDGGHSYVRNYLQKPTFALGELYPPLINLWEAGKEKSTSLKVKATVIGLPTNMS,708,"79,424",Chain (1); Disulfide bond (1); Domain (4); Glycosylation (9); Natural variant (1); Repeat (12); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 444..496;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N6Y1,Protocadherin-20 (Protocadherin-13),MRGRGNARSSQALGVSWCPATWHPRLDMGRLHRPRSSTSYRNLPHLFLFFLFVGPFSCLGSYSRATELLYSLNEGLPAGVLIGSLAEDLRLLPRSAGRPDPQSQLPERTGAEWNPPLSFSLASRGLSGQYVTLDNRSGELHTSAQEIDREALCVEGGGGTAWSGSVSISSSPSDSCLLLLDVLVLPQEYFRFVKVKIAIRDINDNAPQFPVSQISVWVPENAPVNTRLAIEHPAVDPDVGINGVQTYRLLDYHGMFTLDVEENENGERTPYLIVMGALDRETQDQYVSIIIAEDGGSPPLLGSATLTIGISDINDNCPLFTDSQINVTVYGNATVGTPIAAVQAVDKDLGTNAQITYSYSQKVPQASKDLFHLDENTGVIKLFSKIGGSVLESHKLTILANGPGCIPAVITALVSIIKVIFRPPEIVPRYIANEIDGVVYLKELEPVNTPIAFFTIRDPEGKYKVNCYLDGEGPFRLSPYKPYNNEYLLETTKPMDYELQQFYEVAVVAWNSEGFHVKRVIKVQLLDDNDNAPIFLQPLIELTIEENNSPNAFLTKLYATDADSEERGQVSYFLGPDAPSYFSLDSVTGILTVSTQLDREEKEKYRYTVRAVDCGKPPRESVATVALTVLDKNDNSPRFINKDFSFFVPENFPGYGEIGVISVTDADAGRNGWVALSVVNQSDIFVIDTGKGMLRAKVSLDREQQSSYTLWVEAVDGGEPALSSTAKITILLLDINDNPPLVLFPQSNMSYLLVLPSTLPGSPVTEVYAVDKDTGMNAVIAYSIIGRRGPRPESFRIDPKTGNITLEEALLQTDYGLHRLLVKVSDHGYPEPLHSTVMVNLFVNDTVSNESYIESLLRKEPEINIEEKEPQISIEPTHRKVESVSCMPTLVALSVISLGSITLVTGMGIYICLRKGEKHPREDENLEVQIPLKGKIDLHMRERKPMDISNI,951,"104,919",Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (8); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..60;  /evidence=""ECO:0000255"""
Q9Y5E6,Protocadherin beta-3 (PCDH-beta-3),MEAGGERFLRQRQVLLLFVFLGGSLAGSESRRYSVAEEKEKGFLIANLAKDLGLRVEELAARGAQVVSKGNKQHFQLSHQTGDLLLNEKLDREELCGPTEPCILHFQILLQNPLQFVTNELRIIDVNDHSPVFFENEMHLKILESTLPGTVIPLGNAEDLDVGRNSLQNYTITPNSHFHVLTRSRRDGRKYPELVLDKALDPEEQPELSLTLTALDGGSPPRSGTAQINIQVLDINDNAPEFAQPLYEVAVLENTPVNSVIVTVSASDLDTGSFGTISYAFFHASEEIRKTFQLNPITGDMQLVKYLNFEAINSYEVDIEAKDGGGLSGKSTVIVQVVDVNDNPPELTLSSVNSPIPENSGETVLAVFSVSDLDSGDNGRVMCSIENNLPFFLKPSVENFYTLVSEGALDRETRSEYNITITITDLGTPRLKTKYNITVLVSDVNDNAPAFTQISYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLSSLVSINADNGHLFALRSLDYEALQAFEFRVGATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADLLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGQMVDVSGTGTLSQSYQYEVCLTGGSGTNEFKFLKPIIPNFVAQGAERVSEANPSFRKSFEFS,796,"86,714",Chain (1); Domain (6); Glycosylation (4); Natural variant (3); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q86WS5,Transmembrane protease serine 12 (EC 3.4.21.-),MRLGLLSVALLFVGSSHLYSDHYSPSGRHRLGPSPEPAASSQQAEAVRKRLRRRREGGAHAEDCGTAPLKDVLQGSRIIGGTEAQAGAWPWVVSLQIKYGRVLVHVCGGTLVRERWVLTAAHCTKDASDPLMWTAVIGTNNIHGRYPHTKKIKIKAIIIHPNFILESYVNDIALFHLKKAVRYNDYIQPICLPFDVFQILDGNTKCFISGWGRTKEEGNATNILQDAEVHYISREMCNSERSYGGIIPNTSFCAGDEDGAFDTCRGDSGGPLMCYLPEYKRFFVMGITSYGHGCGRRGFPGVYIGPSFYQKWLTEHFFHASTQGILTINILRGQILIALCFVILLATT,348,"38,605",Active site (3); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (1); Glycosylation (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 107..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 206..274;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 237..253;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 264..294;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9Y320,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),MAVLAPLIALVYSVPRLSRWLAQPYYLLSALLSAAFLLVRKLPPLCHGLPTQREDGNPCDFDWREVEILMFLSAIVMMKNRRSITVEQHIGNIFMFSKVANTILFFRLDIRMGLLYITLCIVFLMTCKPPLYMGPEYIKYFNDKTIDEELERDKRVTWIVEFFANWSNDCQSFAPIYADLSLKYNCTGLNFGKVDVGRYTDVSTRYKVSTSPLTKQLPTLILFQGGKEAMRRPQIDKKGRAVSWTFSEENVIREFNLNELYQRAKKLSKAGDNIPEEQPVASTPTTVSDGENKKDK,296,"34,038",Alternative sequence (1); Beta strand (6); Chain (1); Domain (1); Frameshift (2); Helix (5); Modified residue (3); Motif (1); Mutagenesis (1); Natural variant (10); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..48;  /evidence=""ECO:0000255"""
Q7RTX1,Taste receptor type 1 member 1 (G-protein coupled receptor 70),MLLCTARLVGLQLLISCCWAFACHSTESSPDFTLPGDYLLAGLFPLHSGCLQVRHRPEVTLCDRSCSFNEHGYHLFQAMRLGVEEINNSTALLPNITLGYQLYDVCSDSANVYATLRVLSLPGQHHIELQGDLLHYSPTVLAVIGPDSTNRAATTAALLSPFLVPMISYAASSETLSVKRQYPSFLRTIPNDKYQVETMVLLLQKFGWTWISLVGSSDDYGQLGVQALENQATGQGICIAFKDIMPFSAQVGDERMQCLMRHLAQAGATVVVVFSSRQLARVFFESVVLTNLTGKVWVASEAWALSRHITGVPGIQRIGMVLGVAIQKRAVPGLKAFEEAYARADKKAPRPCHKGSWCSSNQLCRECQAFMAHTMPKLKAFSMSSAYNAYRAVYAVAHGLHQLLGCASGACSRGRVYPWQLLEQIHKVHFLLHKDTVAFNDNRDPLSSYNIIAWDWNGPKWTFTVLGSSTWSPVQLNINETKIQWHGKDNQVPKSVCSSDCLEGHQRVVTGFHHCCFECVPCGAGTFLNKSDLYRCQPCGKEEWAPEGSQTCFPRTVVFLALREHTSWVLLAANTLLLLLLLGTAGLFAWHLDTPVVRSAGGRLCFLMLGSLAAGSGSLYGFFGEPTRPACLLRQALFALGFTIFLSCLTVRSFQLIIIFKFSTKVPTFYHAWVQNHGAGLFVMISSAAQLLICLTWLVVWTPLPAREYQRFPHLVMLECTETNSLGFILAFLYNGLLSISAFACSYLGKDLPENYNEAKCVTFSLLFNFVSWIAFFTTASVYDGKYLPAANMMAGLSSLSSGFGGYFLPKCYVILCRPDLNSTEHFQASIQDYTRRCGST,841,"93,074",Alternative sequence (4); Chain (1); Erroneous gene model prediction (1); Erroneous initiation (3); Frameshift (1); Glycosylation (6); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q96PX8,SLIT and NTRK-like protein 1 (Leucine-rich repeat-containing protein 12),MLLWILLLETSLCFAAGNVTGDVCKEKICSCNEIEGDLHVDCEKKGFTSLQRFTAPTSQFYHLFLHGNSLTRLFPNEFANFYNAVSLHMENNGLHEIVPGAFLGLQLVKRLHINNNKIKSFRKQTFLGLDDLEYLQADFNLLRDIDPGAFQDLNKLEVLILNDNLISTLPANVFQYVPITHLDLRGNRLKTLPYEEVLEQIPGIAEILLEDNPWDCTCDLLSLKEWLENIPKNALIGRVVCEAPTRLQGKDLNETTEQDLCPLKNRVDSSLPAPPAQEETFAPGPLPTPFKTNGQEDHATPGSAPNGGTKIPGNWQIKIRPTAAIATGSSRNKPLANSLPCPGGCSCDHIPGSGLKMNCNNRNVSSLADLKPKLSNVQELFLRDNKIHSIRKSHFVDYKNLILLDLGNNNIATVENNTFKNLLDLRWLYMDSNYLDTLSREKFAGLQNLEYLNVEYNAIQLILPGTFNAMPKLRILILNNNLLRSLPVDVFAGVSLSKLSLHNNYFMYLPVAGVLDQLTSIIQIDLHGNPWECSCTIVPFKQWAERLGSEVLMSDLKCETPVNFFRKDFMLLSNDEICPQLYARISPTLTSHSKNSTGLAETGTHSNSYLDTSRVSISVLVPGLLLVFVTSAFTVVGMLVFILRNRKRSKRRDANSSASEINSLQTVCDSSYWHNGPYNADGAHRVYDCGSHSLSD,696,"77,735",Beta strand (23); Chain (1); Domain (4); Erroneous initiation (1); Helix (13); Modified residue (1); Mutagenesis (3); Natural variant (5); Repeat (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (10),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q96DU3,SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen) (NTB-A) (CD antigen CD352),MLWLFQSLLFVFCFGPGNVVSQSSLTPLMVNGILGESVTLPLEFPAGEKVNFITWLFNETSLAFIVPHETKSPEIHVTNPKQGKRLNFTQSYSLQLSNLKMEDTGSYRAQISTKTSAKLSSYTLRILRQLRNIQVTNHSQLFQNMTCELHLTCSVEDADDNVSFRWEALGNTLSSQPNLTVSWDPRISSEQDYTCIAENAVSNLSFSVSAQKLCEDVKIQYTDTKMILFMVSGICIVFGFIILLLLVLRKRRDSLSLSTQRTQGPAESARNLEYVSVSPTNNTVYASVTHSNRETEIWTPRENDTITIYSTINHSKESKPTFSRATALDNVV,332,"37,345",Alternative sequence (2); Beta strand (16); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (7); Helix (3); Modified residue (3); Motif (2); Mutagenesis (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 147..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17045824""; DISULFID 153..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17045824""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q08ET2,Sialic acid-binding Ig-like lectin 14 (Siglec-14),MLPLLLLPLLWGGSLQEKPVYELQVQKSVTVQEGLCVLVPCSFSYPWRSWYSSPPLYVYWFRDGEIPYYAEVVATNNPDRRVKPETQGRFRLLGDVQKKNCSLSIGDARMEDTGSYFFRVERGRDVKYSYQQNKLNLEVTALIEKPDIHFLEPLESGRPTRLSCSLPGSCEAGPPLTFSWTGNALSPLDPETTRSSELTLTPRPEDHGTNLTCQVKRQGAQVTTERTVQLNVSYAPQNLAISIFFRNGTGTALRILSNGMSVPIQEGQSLFLACTVDSNPPASLSWFREGKALNPSQTSMSGTLELPNIGAREGGEFTCRVQHPLGSQHLSFILSVQRSSSSCICVTEKQQGSWPLVLTLIRGALMGAGFLLTYGLTWIYYTRCGGPQQSRAERPG,396,"43,970",Binding site (1); Chain (1); Disulfide bond (2); Domain (3); Glycosylation (1); Mutagenesis (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 164..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 274..319;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
B6A8C7,"T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein) (OLT-2)",MIPKLLSLLCFRLCVGQGDTRGDGSLPKPSLSAWPSSVVPANSNVTLRCWTPARGVSFVLRKGGIILESPKPLDSTEGAAEFHLNNLKVRNAGEYTCEYYRKASPHILSQRSDVLLLLVTGHLSKPFLRTYQRGTVTAGGRVTLQCQKRDQLFVPIMFALLKAGTPSPIQLQSPAGKEIDFSLVDVTAGDAGNYSCMYYQTKSPFWASEPSDQLEILVTVPPGTTSSNYSLGNFVRLGLAAVIVVIMGAFLVEAWYSRNVSPGESEAFKPE,271,"29,474",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..196;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q9BXR5,Toll-like receptor 10 (EC 3.2.2.6) (CD antigen CD290),MRLIRNIYIFCSIVMTAEGDAPELPEERELMTNCSNMSLRKVPADLTPATTTLDLSYNLLFQLQSSDFHSVSKLRVLILCHNRIQQLDLKTFEFNKELRYLDLSNNRLKSVTWYLLAGLRYLDLSFNDFDTMPICEEAGNMSHLEILGLSGAKIQKSDFQKIAHLHLNTVFLGFRTLPHYEEGSLPILNTTKLHIVLPMDTNFWVLLRDGIKTSKILEMTNIDGKSQFVSYEMQRNLSLENAKTSVLLLNKVDLLWDDLFLILQFVWHTSVEHFQIRNVTFGGKAYLDHNSFDYSNTVMRTIKLEHVHFRVFYIQQDKIYLLLTKMDIENLTISNAQMPHMLFPNYPTKFQYLNFANNILTDELFKRTIQLPHLKTLILNGNKLETLSLVSCFANNTPLEHLDLSQNLLQHKNDENCSWPETVVNMNLSYNKLSDSVFRCLPKSIQILDLNNNQIQTVPKETIHLMALRELNIAFNFLTDLPGCSHFSRLSVLNIEMNFILSPSLDFVQSCQEVKTLNAGRNPFRCTCELKNFIQLETYSEVMMVGWSDSYTCEYPLNLRGTRLKDVHLHELSCNTALLIVTIVVIMLVLGLAVAFCCLHFDLPWYLRMLGQCTQTWHRVRKTTQEQLKRNVRFHAFISYSEHDSLWVKNELIPNLEKEDGSILICLYESYFDPGKSISENIVSFIEKSYKSIFVLSPNFVQNEWCHYEFYFAHHNLFHENSDHIILILLEPIPFYCIPTRYHKLKALLEKKAYLEWPKDRRKCGLFWANLRAAINVNVLATREMYELQTFTELNEESRGSTISLMRTDCL,811,"94,564",Active site (1); Beta strand (4); Chain (1); Domain (2); Glycosylation (9); Helix (12); Natural variant (17); Repeat (15); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NR97,Toll-like receptor 8 (CD antigen CD288),MENMFLQSSMLTCIFLLISGSCELCAEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTAVILFFFTFFITTMVMLAALAHHLFYWDVWFIYNVCLAKVKGYRSLSTSQTFYDAYISYDTKDASVTDWVINELRYHLEESRDKNVLLCLEERDWDPGLAIIDNLMQSINQSKKTVFVLTKKYAKSWNFKTAFYLALQRLMDENMDVIIFILLEPVLQHSQYLRLRQRICKSSILQWPDNPKAEGLFWQTLRNVVLTENDSRYNNMYVDSIKQY,1041,"119,828",Alternative sequence (1); Beta strand (45); Chain (1); Disulfide bond (6); Domain (2); Glycosylation (21); Helix (21); Mutagenesis (11); Natural variant (2); Repeat (23); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (13),"DISULFID 36..49;  /evidence=""ECO:0000269|PubMed:23520111""; DISULFID 181..187;  /evidence=""ECO:0000269|PubMed:23520111""; DISULFID 257..270;  /evidence=""ECO:0000269|PubMed:23520111""; DISULFID 260..267;  /evidence=""ECO:0000269|PubMed:23520111""; DISULFID 479..509;  /evidence=""ECO:0000269|PubMed:23520111""; DISULFID 776..803;  /evidence=""ECO:0000269|PubMed:23520111""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q08174,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),MDSGAGGRRCPEAALLILGPPRMEHLRHSPGPGGQRLLLPSMLLALLLLLAPSPGHATRVVYKVPEEQPPNTLIGSLAADYGFPDVGHLYKLEVGAPYLRVDGKTGDIFTTETSIDREGLRECQNQLPGDPCILEFEVSITDLVQNGSPRLLEGQIEVQDINDNTPNFASPVITLAIPENTNIGSLFPIPLASDRDAGPNGVASYELQAGPEAQELFGLQVAEDQEEKQPQLIVMGNLDRERWDSYDLTIKVQDGGSPPRASSALLRVTVLDTNDNAPKFERPSYEAELSENSPIGHSVIQVKANDSDQGANAEIEYTFHQAPEVVRRLLRLDRNTGLITVQGPVDREDLSTLRFSVLAKDRGTNPKSARAQVVVTVKDMNDNAPTIEIRGIGLVTHQDGMANISEDVAEETAVALVQVSDRDEGENAAVTCVVAGDVPFQLRQASETGSDSKKKYFLQTTTPLDYEKVKDYTIEIVAVDSGNPPLSSTNSLKVQVVDVNDNAPVFTQSVTEVAFPENNKPGEVIAEITASDADSGSNAELVYSLEPEPAAKGLFTISPETGEIQVKTSLDREQRESYELKVVAADRGSPSLQGTATVLVNVLDCNDNDPKFMLSGYNFSVMENMPALSPVGMVTVIDGDKGENAQVQLSVEQDNGDFVIQNGTGTILSSLSFDREQQSTYTFQLKAVDGGVPPRSAYVGVTINVLDENDNAPYITAPSNTSHKLLTPQTRLGETVSQVAAEDFDSGVNAELIYSIAGGNPYGLFQIGSHSGAITLEKEIERRHHGLHRLVVKVSDRGKPPRYGTALVHLYVNETLANRTLLETLLGHSLDTPLDIDIAGDPEYERSKQRGNILFGVVAGVVAVALLIALAVLVRYCRQREAKSGYQAGKKETKDLYAPKPSGKASKGNKSKGKKSKSPKPVKPVEDEDEAGLQKSLKFNLMSDAPGDSPRIHLPLNYPPGSPDLGRHYRSNSPLPSIQLQPQSPSASKKHQVVQDLPPANTFVGTGDTTSTGSEQYSDYSYRTNPPKYPSKQVGQPFQLSTPQPLPHPYHGAIWTEVWE,1060,"114,743",Alternative sequence (1); Beta strand (33); Chain (1); Domain (7); Glycosylation (6); Helix (7); Modified residue (5); Natural variant (3); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),,"SIGNAL 1..57;  /evidence=""ECO:0000255"""
Q4G0T1,Scavenger receptor cysteine-rich domain-containing protein SCART1,MRAALWTLGLGPLLLNLWAVPIGGPGALRLAYRHSTCDGVVLVRHHGAWGYVCNQEWTLAEASVVCRQLGCGPAVGAPKYVPLPGEMAQPWLHNVSCRGNESSLWECSLGSWCQSPCPHAWVVVALCSNGTFRELRLVKGRSPCAGLPEIRNVNGVDRLCVLHVEEAMVFCRELGCGPVLQAPRRDVGVVRKYLACRGTEPTIRSCRLDNNFRSGCDLRLDAEVVCSGHTEARLVGGEHPCAGRLEVTWGTVCDAALDLATAHVVCRELQCGAVVSTPEGARFGRGSGPVWTEAFRCAGNESLLFHCPRGRGSQCGHGHDAGLRCSEFRMVNGSSSCEGRVEFQVQGSWAPLCATHWDIADATVLCHQLNCGNAVAAPGGGHFGDGDAAIWPDAFHCEGTESYLWNCPVSTLGAPACAPGNTASAVCSGLAHALRLREGQSRCDGRVEVSLDGVWGRVLDDAWDLRGAGVVCRQLGCRGAQQAYDAPAPSRGSVQVALSRVRCLGTETRLTQCNVSATLQEPAGTSRDAGVVCSGEVGTASPMARRHGIPGALTLSLHREPQGAAGRGAGALHGGAWGTVCDDAWDLRDAHVVCRQLGCGRALSALGAAHFGAGAGRIWLDELGCQGHESALWQCPSAGWGRHDWRHKEDAGVFCSESVALRLRGGTCCCAGWLDVFYNGTWGAMCSNALKDLSLSIICKQLGCGVWGVGLAGEQALPLCGHRDRLGGQHRVPQAAQLHSVAMPFPPMAPALLRPSRAGLSEDRPQAAGEPLNCSSWLGCPEEGALRVRGGEDRCSGRVELWHAGSWGTVCDDGWDLADAEVVCRQLGCGRAVAALGAAAFGPGSGPVWLDEVGCRGSEASLWGCPAERWGRGDRAHEEDAGVRCWEPGPGPPLPAAPFRTFWVVSVVLGSLLGLLLLGLMAFLILPRVTQAMQRGLGRSEVSPGEAIYDVIGEMPPAGLYEEIMEAEAVLQDEEDGSVVKVDTEAAVSGEVSNLLEGQSIRAEGGHSRPVSQGYDEAAFPLEEMTL,1027,"108,611",Alternative sequence (4); Chain (1); Disulfide bond (18); Domain (8); Glycosylation (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 66..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 97..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 160..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 171..226;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 196..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 253..315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 266..325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 297..307;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 353..417;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 366..427;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 397..407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 472..533;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 503..513;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 594..655;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 625..635;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 824..885;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 855..865;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q02763,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b),MDSLASLVLCGVSLLLSGTVEGAMDLILINSLPLVSDAETSLTCIASGWRPHEPITIGRDFEALMNQHQDPLEVTQDVTREWAKKVVWKREKASKINGAYFCEGRVRGEAIRIRTMKMRQQASFLPATLTMTVDKGDNVNISFKKVLIKEEDAVIYKNGSFIHSVPRHEVPDILEVHLPHAQPQDAGVYSARYIGGNLFTSAFTRLIVRRCEAQKWGPECNHLCTACMNNGVCHEDTGECICPPGFMGRTCEKACELHTFGRTCKERCSGQEGCKSYVFCLPDPYGCSCATGWKGLQCNEACHPGFYGPDCKLRCSCNNGEMCDRFQGCLCSPGWQGLQCEREGIQRMTPKIVDLPDHIEVNSGKFNPICKASGWPLPTNEEMTLVKPDGTVLHPKDFNHTDHFSVAIFTIHRILPPDSGVWVCSVNTVAGMVEKPFNISVKVLPKPLNAPNVIDTGHNFAVINISSEPYFGDGPIKSKKLLYKPVNHYEAWQHIQVTNEIVTLNYLEPRTEYELCVQLVRRGEGGEGHPGPVRRFTTASIGLPPPRGLNLLPKSQTTLNLTWQPIFPSSEDDFYVEVERRSVQKSDQQNIKVPGNLTSVLLNNLHPREQYVVRARVNTKAQGEWSEDLTAWTLSDILPPQPENIKISNITHSSAVISWTILDGYSISSITIRYKVQGKNEDQHVDVKIKNATITQYQLKGLEPETAYQVDIFAENNIGSSNPAFSHELVTLPESQAPADLGGGKMLLIAILGSAGMTCLTVLLAFLIILQLKRANVQRRMAQAFQNVREEPAVQFNSGTLALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA,1124,"125,830",Active site (1); Alternative sequence (3); Beta strand (66); Binding site (1); Chain (1); Disulfide bond (14); Domain (9); Glycosylation (9); Helix (25); Modified residue (4); Mutagenesis (3); Natural variant (30); Nucleotide binding (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 44..102;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 211..220;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 224..233;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 227..240;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 242..251;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 255..264;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 268..274;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 280..287;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 289..298;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 302..311;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 315..323;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 317..329;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 331..340;  /evidence=""ECO:0000269|PubMed:16732286""; DISULFID 370..424;  /evidence=""ECO:0000269|PubMed:16732286""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q96H15,T-cell immunoglobulin and mucin domain-containing protein 4 (TIMD-4) (T-cell immunoglobulin mucin receptor 4) (TIM-4) (T-cell membrane protein 4),MSKEPLILWLMIEFWWLYLTPVTSETVVTEVLGHRVTLPCLYSSWSHNSNSMCWGKDQCPYSGCKEALIRTDGMRVTSRKSAKYRLQGTIPRGDVSLTILNPSESDSGVYCCRIEVPGWFNDVKINVRLNLQRASTTTHRTATTTTRRTTTTSPTTTRQMTTTPAALPTTVVTTPDLTTGTPLQMTTIAVFTTANTCLSLTPSTLPEEATGLLTPEPSKEGPILTAESETVLPSDSWSSVESTSADTVLLTSKESKVWDLPSTSHVSMWKTSDSVSSPQPGASDTAVPEQNKTTKTGQMDGIPMSMKNEMPISQLLMIIAPSLGFVLFALFVAFLLRGKLMETYCSQKHTRLDYIGDSKNVLNDVQHGREDEDGLFTL,378,"41,578",Alternative sequence (1); Beta strand (10); Chain (1); Compositional bias (2); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (2); Modified residue (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 40..112;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 53..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 59..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
E5RIL1,Uroplakin-3b-like protein 2,MDNSWRLGPAIGLSAGQSQLLVSLLLLLTRVQPGTDVAAPEHISYVPQLSNDTLAGRLTLSTFTLEQPLGQFSSHNISDLDTIWLVVALSNATQSFTAPRTNQDIPAPANFSQRGYYLTLRANRVLYQTRGQLHVLRVGNDTHCQPTKIGCNHPLPGPGPYRVKFLVMNDEGPVAETKWSSDTRLQQAQALRAVPGPQSPGTVVIIAILSILLAVLLTVLLAVLIYTCFNSCRSTSLSGPEEAGSVRRYTTHLAFSTPAEGAS,263,"28,385",Chain (1); Glycosylation (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q6EMK4,Vasorin (Protein slit-like 2),MCSRVPLLLPLLLLLALGPGVQGCPSGCQCSQPQTVFCTARQGTTVPRDVPPDTVGLYVFENGITMLDAGSFAGLPGLQLLDLSQNQIASLPSGVFQPLANLSNLDLTANRLHEITNETFRGLRRLERLYLGKNRIRHIQPGAFDTLDRLLELKLQDNELRALPPLRLPRLLLLDLSHNSLLALEPGILDTANVEALRLAGLGLQQLDEGLFSRLRNLHDLDVSDNQLERVPPVIRGLRGLTRLRLAGNTRIAQLRPEDLAGLAALQELDVSNLSLQALPGDLSGLFPRLRLLAAARNPFNCVCPLSWFGPWVRESHVTLASPEETRCHFPPKNAGRLLLELDYADFGCPATTTTATVPTTRPVVREPTALSSSLAPTWLSPTEPATEAPSPPSTAPPTVGPVPQPQDCPPSTCLNGGTCHLGTRHHLACLCPEGFTGLYCESQMGQGTRPSPTPVTPRPPRSLTLGIEPVSPTSLRVGLQRYLQGSSVQLRSLRLTYRNLSGPDKRLVTLRLPASLAEYTVTQLRPNATYSVCVMPLGPGRVPEGEEACGEAHTPPAVHSNHAPVTQAREGNLPLLIAPALAAVLLAALAAVGAAYCVRRGRAMAAAAQDKGQVGPGAGPLELEGVKVPLEPGPKATEGGGEALPSGSECEVPLMGFPGPGLQSPLHAKPYI,673,"71,713",Chain (1); Disulfide bond (3); Domain (4); Glycosylation (5); Natural variant (1); Repeat (10); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 409..420;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 414..430;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 432..441;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P15151,Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155),MARAMAAAWPLLLVALLVLSWPPPGTGDVVVQAPTQVPGFLGDSVTLPCYLQVPNMEVTHVSQLTWARHGESGSMAVFHQTQGPSYSESKRLEFVAARLGAELRNASLRMFGLRVEDEGNYTCLFVTFPQGSRSVDIWLRVLAKPQNTAEVQKVQLTGEPVPMARCVSTGGRPPAQITWHSDLGGMPNTSQVPGFLSGTVTVTSLWILVPSSQVDGKNVTCKVEHESFEKPQLLTVNLTVYYPPEVSISGYDNNWYLGQNEATLTCDARSNPEPTGYNWSTTMGPLPPFAVAQGAQLLIRPVDKPINTTLICNVTNALGARQAELTVQVKEGPPSEHSGISRNAIIFLVLGILVFLILLGIGIYFYWSKCSREVLWHCHLCPSSTEHASASANGHVSYSAVSRENSSSQDPQTEGTR,417,"45,303",Alternative sequence (5); Beta strand (28); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (10); Helix (1); Modified residue (1); Motif (1); Mutagenesis (1); Natural variant (3); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 49..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22421438""; DISULFID 166..221;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 266..312;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q99835,Smoothened homolog (SMO) (Protein Gx),MAAARPARGPELPLLGLLLLLLLGDPGRGAASSGNATGPGPRSAGGSARRSAAVTGPPPPLSHCGRAAPCEPLRYNVCLGSVLPYGATSTLLAGDSDSQEEAHGKLVLWSGLRNAPRCWAVIQPLLCAVYMPKCENDRVELPSRTLCQATRGPCAIVERERGWPDFLRCTPDRFPEGCTNEVQNIKFNSSGQCEVPLVRTDNPKSWYEDVEGCGIQCQNPLFTEAEHQDMHSYIAAFGAVTGLCTLFTLATFVADWRNSNRYPAVILFYVNACFFVGSIGWLAQFMDGARREIVCRADGTMRLGEPTSNETLSCVIIFVIVYYALMAGVVWFVVLTYAWHTSFKALGTTYQPLSGKTSYFHLLTWSLPFVLTVAILAVAQVDGDSVSGICFVGYKNYRYRAGFVLAPIGLVLIVGGYFLIRGVMTLFSIKSNHPGLLSEKAASKINETMLRLGIFGFLAFGFVLITFSCHFYDFFNQAEWERSFRDYVLCQANVTIGLPTKQPIPDCEIKNRPSLLVEKINLFAMFGTGIAMSTWVWTKATLLIWRRTWCRLTGQSDDEPKRIKKSKMIAKAFSKRHELLQNPGQELSFSMHTVSHDGPVAGLAFDLNEPSADVSSAWAQHVTKMVARRGAILPQDISVTPVATPVPPEEQANLWLVEAEISPELQKRLGRKKKRRKRKKEVCPLAPPPELHPPAPAPSTIPRLPQLPRQKCLVAAGAWGAGDSCRQGAWTLVSNPFCPEPSPPQDPFLPSAPAPVAWAHGRRQGLGPIHSRTNLMDTELMDADSDF,787,"86,397",Beta strand (16); Chain (1); Disulfide bond (8); Domain (1); Glycosylation (3); Helix (19); Natural variant (4); Region (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (7),"DISULFID 70..134;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 78..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 118..154;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 147..169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 193..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:23636324""; DISULFID 217..295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:23636324""; DISULFID 314..390;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:23636324""; DISULFID 490..507;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:23636324""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8N114,Protein shisa-5 (Putative NF-kappa-B-activating protein 120) (Scotin),MTAPVPAPRILLPLLLLLLLTPPPGARGEVCMASRGLSLFPESCPDFCCGTCDDQYCCSDVLKKFVWSEERCAVPEASVPASVEPVEQLGSALRFRPGYNDPMSGFGATLAVGLTIFVLSVVTIIICFTCSCCCLYKTCRRPRPVVTTTTSTTVVHAPYPQPPSVPPSYPGPSYQGYHTMPPQPGMPAAPYPMQYPPPYPAQPMGPPAYHETLAGGAAAPYPASQPPYNPAYMDAPKAAL,240,"25,582",Alternative sequence (5); Chain (1); Compositional bias (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
O43291,Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2) (HAI-2) (Placental bikunin),MAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHDFCLVSKVVGRCRASMPRWWYNVTDGSCQLFVYGGCDGNSNNYLTKEECLKKCATVTENATGDLATSRNAADSSVPSAPRRQDSEDHSSDMFNYEEYCTANAVTGPCRASFPRWYFDVERNSCNNFIYGGCRGNKNSYRSEEACMLRCFRQQENPPLPLGSKVVVLAGLFVMVLILFLGASMVYLIRVARRNQERALRTVWSSGDDKEQLVKNTYVL,252,"28,228",Alternative sequence (1); Beta strand (4); Chain (1); Disulfide bond (6); Domain (2); Glycosylation (2); Helix (1); Natural variant (2); Sequence conflict (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 38..88;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 47..71;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 63..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 133..183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 142..166;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 158..179;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:9115294"""
A6NL88,Protein shisa-7 (Cystine-knot AMPAR modulating protein of 59 kDa) (CKAMP59) (GABA(A) receptor auxiliary subunit Shisa7) (Protein shisa-6-like),MPALLLLVLLASSAGQARARPSNATSAEPAGPLPALLAHLRRLTGALTGGGGAASPGANGTRTGPAGGAGAAARAPPPAELCHGYYDVMGQYDATFNCSTGSYRFCCGTCHYRFCCEHRHMRLAQASCSNYDTPRWATTPPPLAGGAGGAGGAGGGPGPGQAGWLEGGRTGGAGGRGGEGPGGSTAYVVCGVISFALAVGVGAKVAFSKASRAPRAHRDINVPRALVDILRHQAGPGTRPDRARSSSLTPGIGGPDSMPPRTPKNLYNTVKTPNLDWRALPPPSPSLHYSTLSCSRSFHNLSHLPPSYEAAVKSELNRYSSLKRLAEKDLDEAYLKRRPLELPRGTLPLHALRRPGTGGGYRMEAWGGPEELGLAPAPNPRRVMSQEHLLGDGGRSRYEFTLPRARLVSQEHLLLSSPEALRQSREHLLSPPRSPALPPDPTARASLAASHSNLLLGPGGPPTPLRGLPPPSSLHAHHHHALHGSPQPAWMSDAGGGGGTLARRPPFQRQGTLEQLQFIPGHHLPQHLRTASKNEVTV,538,"56,214",Chain (1); Compositional bias (1); Glycosylation (2); Modified residue (2); Motif (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P43308,Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta),MRLLSFVVLALFAVTQAEEGARLLASKSLLNRYAVEGRDLTLQYNIYNVGSSAALDVELSDDSFPPEDFGIVSGMLNVKWDRIAPASNVSHTVVLRPLKAGYFNFTSATITYLAQEDGPVVIGSTSAPGQGGILAQREFDRRFSPHFLDWAAFGVMTLPSIGIPLLLWYSSKRKYDTPKTKKN,183,"20,135",Chain (1); Glycosylation (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000250"""
Q6IEE7,Transmembrane protein 132E,MAPGMSGRGGAALLCLSALLAHASGRSHPASPSPPGPQASPVLPVSYRLSHTRLAFFLREARPPSPAVANSSLQRSEPFVVFQTKELPVLNVSLGPFSTSQVVARELLQPSSTLDIPERLTVNWKVRAFIVRSHVPASQPVVQVLFYVAGRDWDDFGVTERLPCVRLHAFRDAREVKSSCRLSGGLATCLVRAELPLAWFGPPAPAAPPTARRKSPDGLEPEATGESQQAELYYTLHAPDASGGCGGSRRGAGPGVGARAESPTQHPLLRIGSISLFRPPPRRTLQEHRLDSNLMIRLPDRPLKPGEVLSILLYLAPNSSSPSSPSVEHFTLRVKAKKGVTLLGTKSRSGQWHVTSELLTGAKHSTATVDVAWAQSTPLPPREGQGPLEILQLDFEMENFTSQSVKRRIMWHIDYRGHGALPDLERAVTELTVIQRDVQAILPLAMDTEIINTAILTGRTVAIPVKVIAIEVNGLVLDISALVECESDNEDIIKVSSSCDYVFVSGKESRGSMNARVTFRYDVLNAPLEMTVWVPKLPLHIELSDARLSQVKGWRVPILPDRRSVRESEDEDEEEEERRQSASRGCTLQYQHATLQVFTQFHTTSSEGTDQVVTMLGPDWLVEVTDLVSDFMRVGDPRVAHMVDSSTLAGLEPGTTPFKVVSPLTEAVLGETLLTVTEEKVSITQLQAQVVASLALSLRPSPGSSHTILATTAAQQTLSFLKQEALLSLWLSYSDGTTAPLSLYSPRDYGLLVSSLDEHVATVTQDRAFPLVVAEAEGSGELLRAELTIAESCQKTKRKSVLATTPVGLRVHFGRDEEDPTYDYPGPSQPGPGGGEDEARGAGPPGSALPAPEAPGPGTASPVVPPTEDFLPLPTGFLQVPRGLTDLEIGMYALLGVFCLAILVFLINCIVFVLRYRHKRIPPEGQTSMDHSHHWVFLGNGQPLRVQGELSPPAGNPLETVPAFCHGDHHSSGSSQTSVQSQVHGRGDGSSGGSARDQAEDPASSPTSKRKRVKFTTFTTLPSEELAYDSVPAGEEDEEEEEDLGWGCPDVAGPTRPTAPPDLHNYMRRIKEIA,1074,"116,150",Chain (1); Glycosylation (4); Natural variant (1); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
P13726,Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142),METPAWPRVPRPETAVARTLLLGWVFAQVAGASGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECMGQEKGEFREIFYIIGAVVFVVIILVIILAISLHKCRKAGVGQSWKENSPLNVS,295,"33,068",Alternative sequence (2); Beta strand (21); Chain (1); Disulfide bond (2); Glycosylation (2); Helix (6); Lipidation (1); Motif (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 81..89;  /evidence=""ECO:0000269|PubMed:3166978""; DISULFID 218..241;  /evidence=""ECO:0000269|PubMed:3166978""",SIGNAL 1..32
Q9NT99,Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand) (NGL-3),MARARGSPCPPLPPGRMSWPHGALLFLWLFSPPLGAGGGGVAVTSAAGGGSPPATSCPVACSCSNQASRVICTRRDLAEVPASIPVNTRYLNLQENGIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCCARCHAPAGLKGRYIGELDQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWLTPNGTLMTHGSYRVRISVLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVDPVAAGGTGSGGGGPGGSGGVGGGSGGYTYFTTVTVETLETQPGEEALQPRGTEKEPPGPTTDGVWGGGRPGDAAGPASSSTTAPAPRSSRPTEKAFTVPITDVTENALKDLDDVMKTTKIIIGCFVAITFMAAVMLVAFYKLRKQHQLHKHHGPTRTVEIINVEDELPAASAVSVAAAAAVASGGGVGGDSHLALPALERDHLNHHHYVAAAFKAHYSSNPSGGGCGGKGPPGLNSIHEPLLFKSGSKENVQETQI,713,"76,434",Chain (1); Compositional bias (2); Disulfide bond (1); Domain (3); Erroneous initiation (1); Glycosylation (9); Modified residue (1); Repeat (9); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 385..436;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q14392,Transforming growth factor beta activator LRRC32 (Garpin) (Glycoprotein A repetitions predominant) (GARP) (Leucine-rich repeat-containing protein 32),MRPQILLLLALLTLGLAAQHQDKVPCKMVDKKVSCQVLGLLQVPSVLPPDTETLDLSGNQLRSILASPLGFYTALRHLDLSTNEISFLQPGAFQALTHLEHLSLAHNRLAMATALSAGGLGPLPRVTSLDLSGNSLYSGLLERLLGEAPSLHTLSLAENSLTRLTRHTFRDMPALEQLDLHSNVLMDIEDGAFEGLPRLTHLNLSRNSLTCISDFSLQQLRVLDLSCNSIEAFQTASQPQAEFQLTWLDLRENKLLHFPDLAALPRLIYLNLSNNLIRLPTGPPQDSKGIHAPSEGWSALPLSAPSGNASGRPLSQLLNLDLSYNEIELIPDSFLEHLTSLCFLNLSRNCLRTFEARRLGSLPCLMLLDLSHNALETLELGARALGSLRTLLLQGNALRDLPPYTFANLASLQRLNLQGNRVSPCGGPDEPGPSGCVAFSGITSLRSLSLVDNEIELLRAGAFLHTPLTELDLSSNPGLEVATGALGGLEASLEVLALQGNGLMVLQVDLPCFICLKRLNLAENRLSHLPAWTQAVSLEVLDLRNNSFSLLPGSAMGGLETSLRRLYLQGNPLSCCGNGWLAAQLHQGRVDVDATQDLICRFSSQEEVSLSHVRPEDCEKGGLKNINLIIILTFILVSAILLTTLAACCCVRRQKFNQQYKA,662,"71,979",Beta strand (30); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (5); Helix (9); Mutagenesis (3); Natural variant (2); Repeat (20); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 211;  /note=""Interchain (with C-33 in TGFB1); in linked form"";  /evidence=""ECO:0000269|PubMed:22278742""; DISULFID 350;  /note=""Interchain (with C-33 in TGFB1); in linked form"";  /evidence=""ECO:0000269|PubMed:22278742""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:21615933"""
O75581,Low-density lipoprotein receptor-related protein 6 (LRP-6),MGAVLRSLLACSFCVLLRAAPLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAVVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSCGEPPTCSPQQFTCFTGEIDCIPVAWRCDGFTECEDHSDELNCPVCSESQFQCASGQCIDGALRCNGDANCQDKSDEKNCEVLCLIDQFRCANGQCIGKHKKCDHNVDCSDKSDELDCYPTEEPAPQATNTVGSVIGVIVTIFVSGTVYFICQRMLCPRMKGDGETMTNDYVVHGPASVPLGYVPHPSSLSGSLPGMSRGKSMISSLSIMGGSSGPPYDRAHVTGASSSSSSSTKGTYFPAILNPPPSPATERSHYTMEFGYSSNSPSTHRSYSYRPYSYRHFAPPTTPCSTDVCDSDYAPSRRMTSVATAKGYTSDLNYDSEPVPPPPTPRSQYLSAEENYESCPPSPYTERSYSHHLYPPPPSPCTDSS,1613,"180,429",Beta strand (109); Chain (1); Cross-link (1); Disulfide bond (21); Domain (7); Glycosylation (10); Helix (11); Lipidation (2); Modified residue (5); Motif (5); Mutagenesis (24); Natural variant (10); Region (4); Repeat (20); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (36),"DISULFID 286..297;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 293..308;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 310..323;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 592..603;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 599..612;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 614..627;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 893..904;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 900..914;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 916..929;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 1207..1218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 1214..1228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 1230..1243;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:22000856""; DISULFID 1249..1263;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1256..1276;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1270..1285;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1288..1300;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1295..1313;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1307..1322;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1326..1338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1333..1351;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1345..1360;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
A6NDA9,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 (Leucine-rich repeat-containing protein 22)",MASVFHYFLLVLVFLDTHAAQPFCLPGCTCSEESFGRTLQCTSVSLGKIPGNLSEEFKQVRIENSPLFEMPQGSFINMSTLEYLWLNFNNISVIHLGALEHLPELRELRLEGNKLCSVPWTAFRATPLLRVLDLKRNKIDALPELALQFLVSLTYLDLSSNRLTVVSKSVFLNWPAYQKCRQPDCGAEILSSLVVALHDNPWVCDCRLRGLVQFVKSITLPVILVNSYLICQGPLSKAGQLFHETELSACMKPQISTPSANITIRAGQNVTLRCLAQASPSPSIAWTYPLSMWREFDVLTSSTGEDTALSELAIPAAHLVDSGNYTCMASNSIGKSNLVISLHVQPAQALHAPDSLSIPSEGNAYIDLRVVKQTVHGILLEWLAVADTSKEEWFTLYIASDEAFRKEVVHIGPGINTYAVDDLLPGTKYEACLSLEGQPPHQGQCVAFVTGRDAGGLEAREHLLHVTVVLCVVLLAVPVGAYAWAAQGPCSCSKWVLRGCLHRRKAPSCTPAAPQSKDGSFREHPAVCDDGEGHIDTEGDKEKGGTEDNS,550,"60,168",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (4); Glycosylation (1); Natural variant (5); Repeat (4); Signal peptide (1); Transmembrane (1),"DISULFID 274..327;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q86VH5,Leucine-rich repeat transmembrane neuronal protein 3,MGFNVIRLLSGSAVALVIAPTVLLTMLSSAERGCPKGCRCEGKMVYCESQKLQEIPSSISAGCLGLSLRYNSLQKLKYNQFKGLNQLTWLYLDHNHISNIDENAFNGIRRLKELILSSNRISYFLNNTFRPVTNLRNLDLSYNQLHSLGSEQFRGLRKLLSLHLRSNSLRTIPVRIFQDCRNLELLDLGYNRIRSLARNVFAGMIRLKELHLEHNQFSKLNLALFPRLVSLQNLYLQWNKISVIGQTMSWTWSSLQRLDLSGNEIEAFSGPSVFQCVPNLQRLNLDSNKLTFIGQEILDSWISLNDISLAGNIWECSRNICSLVNWLKSFKGLRENTIICASPKELQGVNVIDAVKNYSICGKSTTERFDLARALPKPTFKPKLPRPKHESKPPLPPTVGATEPGPETDADAEHISFHKIIAGSVALFLSVLVILLVIYVSWKRYPASMKQLQQRSLMRRHRKKKRQSLKQMTPSTQEFYVDYKPTNTETSEMLLNGTGPCTYNKSGSRECEIPLSMNVSTFLAYDQPTISYCGVHHELLSHKSFETNAQEDTMETHLETELDLSTITTAGRISDHKQQLA,581,"65,896",Alternative sequence (2); Chain (1); Domain (2); Glycosylation (2); Repeat (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9H0U3,Magnesium transporter protein 1 (MagT1) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1) (Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein) (IAP),MAARWRFWCVSVTMVVALLIVCDVPSASAQRKKEMVLSEKVSQLMEWTNKRPVIRMNGDKFRRLVKAPPRNYSVIVMFTALQLHRQCVVCKQADEEFQILANSWRYSSAFTNRIFFAMVDFDEGSDVFQMLNMNSAPTFINFPAKGKPKRGDTYELQVRGFSAEQIARWIADRTDVNIRVIRPPNYAGPLMLGLLLAVIGGLVYLRRSNMEFLFNKTGWAFAALCFVLAMTSGQMWNHIRGPPYAHKNPHTGHVNYIHGSSQAQFVAETHIVLLFNGGVTLGMVLLCEAATSDMDIGKRKIMCVAGIGLVVLFFSWMLSIFRSKYHGYPYSFLMS,335,"38,037",Alternative sequence (2); Beta strand (1); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Helix (4); Mutagenesis (2); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 87..90;  /note=""Redox-active"";  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q13477,Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) (hMAdCAM-1),MDFGLALLLAGLLGLLLGQSLQVKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQWRGLDTSLGAVQSDTGRSVLTVRNASLSAAGTRVCVGSCGGRTFQHTVQLLVYAFPDQLTVSPAALVPGDPEVACTAHKVTPVDPNALSFSLLVGGQELEGAQALGPEVQEEEEEPQGDEDVLFRVTERWRLPPLGTPVPPALYCQATMRLPGLELSHRQAIPVLHSPTSPEPPDTTSPESPDTTSPESPDTTSQEPPDTTSPEPPDKTSPEPAPQQGSTHTPRSPGSTRTRRPEISQAGPTQGEVIPTGSSKPAGDQLPAALWTSSAVLGLLLLALPTYHLWKRCRHLAEDDTHPPASLRLLPQVSAWAGLRGTGQVGISPS,382,"40,155",Alternative sequence (3); Beta strand (16); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (1); Helix (1); Natural variant (2); Region (2); Repeat (6); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 47..94;  /evidence=""ECO:0000244|PDB:1BQS, ECO:0000244|PDB:1GSM, ECO:0000244|PDB:4HBQ, ECO:0000244|PDB:4HC1, ECO:0000244|PDB:4HCR, ECO:0000244|PDB:4HD9, ECO:0000269|PubMed:11807247, ECO:0000269|PubMed:23297416, ECO:0000269|PubMed:9655832""; DISULFID 51..98;  /evidence=""ECO:0000244|PDB:1BQS, ECO:0000244|PDB:1GSM, ECO:0000244|PDB:4HBQ, ECO:0000244|PDB:4HC1, ECO:0000244|PDB:4HCR, ECO:0000244|PDB:4HD9, ECO:0000269|PubMed:11807247, ECO:0000269|PubMed:23297416, ECO:0000269|PubMed:9655832""; DISULFID 134..204;  /evidence=""ECO:0000244|PDB:1BQS, ECO:0000244|PDB:1GSM, ECO:0000244|PDB:4HBQ, ECO:0000244|PDB:4HC1, ECO:0000244|PDB:4HCR, ECO:0000244|PDB:4HD9, ECO:0000269|PubMed:11807247, ECO:0000269|PubMed:23297416, ECO:0000269|PubMed:9655832""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9Y4D7,Plexin-D1,MAPRAAGGAPLSARAAAASPPPFQTPPRCPVPLLLLLLLGAARAGALEIQRRFPSPTPTNNFALDGAAGTVYLAAVNRLYQLSGANLSLEAEAAVGPVPDSPLCHAPQLPQASCEHPRRLTDNYNKILQLDPGQGLVVVCGSIYQGFCQLRRRGNISAVAVRFPPAAPPAEPVTVFPSMLNVAANHPNASTVGLVLPPAAGAGGSRLLVGATYTGYGSSFFPRNRSLEDHRFENTPEIAIRSLDTRGDLAKLFTFDLNPSDDNILKIKQGAKEQHKLGFVSAFLHPSDPPPGAQSYAYLALNSEARAGDKESQARSLLARICLPHGAGGDAKKLTESYIQLGLQCAGGAGRGDLYSRLVSVFPARERLFAVFERPQGSPAARAAPAALCAFRFADVRAAIRAARTACFVEPAPDVVAVLDSVVQGTGPACERKLNIQLQPEQLDCGAAHLQHPLSILQPLKATPVFRAPGLTSVAVASVNNYTAVFLGTVNGRLLKINLNESMQVVSRRVVTVAYGEPVHHVMQFDPADSGYLYLMTSHQMARVKVAACNVHSTCGDCVGAADAYCGWCALETRCTLQQDCTNSSQQHFWTSASEGPSRCPAMTVLPSEIDVRQEYPGMILQISGSLPSLSGMEMACDYGNNIRTVARVPGPAFGHQIAYCNLLPRDQFPPFPPNQDHVTVEMSVRVNGRNIVKANFTIYDCSRTAQVYPHTACTSCLSAQWPCFWCSQQHSCVSNQSRCEASPNPTSPQDCPRTLLSPLAPVPTGGSQNILVPLANTAFFQGAALECSFGLEEIFEAVWVNESVVRCDQVVLHTTRKSQVFPLSLQLKGRPARFLDSPEPMTVMVYNCAMGSPDCSQCLGREDLGHLCMWSDGCRLRGPLQPMAGTCPAPEIHAIEPLSGPLDGGTLLTIRGRNLGRRLSDVAHGVWIGGVACEPLPDRYTVSEEIVCVTGPAPGPLSGVVTVNASKEGKSRDRFSYVLPLVHSLEPTMGPKAGGTRITIHGNDLHVGSELQVLVNDTDPCTELMRTDTSIACTMPEGALPAPVPVCVRFERRGCVHGNLTFWYMQNPVITAISPRRSPVSGGRTITVAGERFHMVQNVSMAVHHIGREPTLCKVLNSTLITCPSPGALSNASAPVDFFINGRAYADEVAVAEELLDPEEAQRGSRFRLDYLPNPQFSTAKREKWIKHHPGEPLTLVIHKEQDSLGLQSHEYRVKIGQVSCDIQIVSDRIIHCSVNESLGAAVGQLPITIQVGNFNQTIATLQLGGSETAIIVSIVICSVLLLLSVVALFVFCTKSRRAERYWQKTLLQMEEMESQIREEIRKGFAELQTDMTDLTKELNRSQGIPFLEYKHFVTRTFFPKCSSLYEERYVLPSQTLNSQGSSQAQETHPLLGEWKIPESCRPNMEEGISLFSSLLNNKHFLIVFVHALEQQKDFAVRDRCSLASLLTIALHGKLEYYTSIMKELLVDLIDASAAKNPKLMLRRTESVVEKMLTNWMSICMYSCLRETVGEPFFLLLCAIKQQINKGSIDAITGKARYTLSEEWLLRENIEAKPRNLNVSFQGCGMDSLSVRAMDTDTLTQVKEKILEAFCKNVPYSQWPRAEDVDLEWFASSTQSYILRDLDDTSVVEDGRKKLNTLAHYKIPEGASLAMSLIDKKDNTLGRVKDLDTEKYFHLVLPTDELAEPKKSHRQSHRKKVLPEIYLTRLLSTKGTLQKFLDDLFKAILSIREDKPPLAVKYFFDFLEEQAEKRGISDPDTLHIWKTNSLPLRFWVNILKNPQFVFDIDKTDHIDACLSVIAQAFIDACSISDLQLGKDSPTNKLLYAKEIPEYRKIVQRYYKQIQDMTPLSEQEMNAHLAEESRKYQNEFNTNVAMAEIYKYAKRYRPQIMAALEANPTARRTQLQHKFEQVVALMEDNIYECYSEA,1925,"212,007",Alternative sequence (1); Beta strand (7); Chain (1); Disulfide bond (9); Domain (4); Erroneous initiation (1); Glycosylation (18); Helix (3); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 104..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 140..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 322..445;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 345..389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 549..566;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 555..600;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 558..575;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 569..581;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 637..661;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..46;  /evidence=""ECO:0000255"""
Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor),MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPASIMESDKGWTSASTSGKPRKDKASGKLYPESEEDKEAPTGSRYRGRPCLPEWDHILCWPLGAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETREREVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCWDLSSGNKKWIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHPQLPGHAKPGTPALETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEWETVM,593,"66,361",Beta strand (7); Chain (1); Disulfide bond (3); Glycosylation (4); Helix (14); Modified residue (1); Motif (1); Mutagenesis (2); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (4),"DISULFID 48..117;  /evidence=""ECO:0000244|PDB:3C4M, ECO:0000244|PDB:3H3G, ECO:0000244|PDB:3L2J, ECO:0000269|PubMed:10913300, ECO:0000269|PubMed:18375760, ECO:0000269|PubMed:19674967""; DISULFID 108..148;  /evidence=""ECO:0000244|PDB:3C4M, ECO:0000244|PDB:3H3G, ECO:0000244|PDB:3L2J, ECO:0000269|PubMed:10913300, ECO:0000269|PubMed:18375760, ECO:0000269|PubMed:19674967""; DISULFID 131..170;  /evidence=""ECO:0000244|PDB:3C4M, ECO:0000244|PDB:3H3G, ECO:0000244|PDB:3L2J, ECO:0000269|PubMed:10913300, ECO:0000269|PubMed:18375760, ECO:0000269|PubMed:19674967""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9HD43,Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H),MAGAGGGLGVWGNLVLLGLCSWTGARAPAPNPGRNLTVETQTTSSISLSWEVPDGLDSQNSNYWVQCTGDGGTTETRNTTATNVTVDGLGPGSLYTCSVWVEKDGVNSSVGTVTTATAPNPVRNLRVEAQTNSSIALTWEVPDGPDPQNSTYGVEYTGDGGRAGTRSTAHTNITVDGLEPGCLYAFSMWVGKNGINSSRETRNATTAHNPVRNLRVEAQTTSSISLSWEVPDGTDPQNSTYCVQCTGDGGRTETRNTTDTRVTVDGLGPGSLYTCSVWVEKDGVNSSVEIVTSATAPNPVRNLTVEAQTNSSIALTWEVPDGPDPQNSTYGVEYTGDGGRAGTRSTAHTNITVDRLEPGCLYVFSVWVGKNGINSSRETRNATTAPNPVRNLHMETQTNSSIALCWEVPDGPYPQDYTYWVEYTGDGGGTETRNTTNTSVTAERLEPGTLYTFSVWAEKNGARGSRQNVSISTVPNAVTSLSKQDWTNSTIALRWTAPQGPGQSSYSYWVSWVREGMTDPRTQSTSGTDITLKELEAGSLYHLTVWAERNEVRGYNSTLTAATAPNEVTDLQNETQTKNSVMLWWKAPGDPHSQLYVYWVQWASKGHPRRGQDPQANWVNQTSRTNETWYKVEALEPGTLYNFTVWAERNDVASSTQSLCASTYPDTVTITSCVSTSAGYGVNLIWSCPQGGYEAFELEVGGQRGSQDRSSCGEAVSVLGLGPARSYPATITTIWDGMKVVSHSVVCHTESAGVIAGAFVGILLFLILVGLLIFFLKRRNKKKQQKPELRDLVFSSPGDIPAEDFADHVRKNERDSNCGFADEYQQLSLVGHSQSQMVASASENNAKNRYRNVLPYDWSRVPLKPIHEEPGSDYINASFMPGLWSPQEFIATQGPLPQTVGDFWRLVWEQQSHTLVMLTNCMEAGRVKCEHYWPLDSQPCTHGHLRVTLVGEEVMENWTVRELLLLQVEEQKTLSVRQFHYQAWPDHGVPSSPDTLLAFWRMLRQWLDQTMEGGPPIVHCSAGVGRTGTLIALDVLLRQLQSEGLLGPFSFVRKMRESRPLMVQTEAQYVFLHQCILRFLQQSAQAPAEKEVPYEDVENLIYENVAAIQAHKLEV,1115,"122,353",Active site (1); Alternative sequence (2); Chain (1); Domain (9); Frameshift (1); Glycosylation (10); Modified residue (2); Mutagenesis (2); Natural variant (8); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
O60896,Receptor activity-modifying protein 3 (Calcitonin-receptor-like receptor activity-modifying protein 3) (CRLR activity-modifying protein 3),METGALRRPQLLPLLLLLCGGCPRAGGCNETGMLERLPLCGKAFADMMGKVDVWKWCNLSEFIVYYESFTNCTEMEANVVGCYWPNPLAQGFITGIHRQFFSNCTVDRVHLEDPPDEVLIPLIVIPVVLTVAMAGLVVWRSKRTDTLL,148,"16,518",Beta strand (2); Chain (1); Disulfide bond (2); Glycosylation (4); Helix (5); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 40..72;  /evidence=""ECO:0000250""; DISULFID 57..104;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q2VWP7,Protogenin (Protein Shen-Dan),MAPPLRPLARLRPPGMLLRALLLLLLLSPLPGVWCFSELSFVKEPQDVTVTRKDPVVLDCQAHGEVPIKVTWLKNGAKMSENKRIEVLSNGSLYISEVEGRRGEQSDEGFYQCLAMNKYGAILSQKAHLALSTISAFEVQPISTEVHEGGVARFACKISSHPPAVITWEFNRTTLPMTMDRITALPTGVLQIYDVSQRDSGNYRCIAATVAHRRKSMEASLTVIPAKESKSFHTPTIIAGPQNITTSLHQTVVLECMATGNPKPIISWSRLDHKSIDVFNTRVLGNGNLMISDVRLQHAGVYVCRATTPGTRNFTVAMATLTVLAPPSFVEWPESLTRPRAGTARFVCQAEGIPSPKMSWLKNGRKIHSNGRIKMYNSKLVINQIIPEDDAIYQCMAENSQGSILSRARLTVVMSEDRPSAPYNVHAETMSSSAILLAWERPLYNSDKVIAYSVHYMKAEGLNNEEYQVVIGNDTTHYIIDDLEPASNYTFYIVAYMPMGASQMSDHVTQNTLEDVPLRPPEISLTSRSPTDILISWLPIPAKYRRGQVVLYRLSFRLSTENSIQVLELPGTTHEYLLEGLKPDSVYLVRITAATRVGLGESSVWTSHRTPKATSVKAPKSPELHLEPLNCTTISVRWQQDVEDTAAIQGYKLYYKEEGQQENGPIFLDTKDLLYTLSGLDPRRKYHVRLLAYNNIDDGYQADQTVSTPGCVSVRDRMVPPPPPPHHLYAKANTSSSIFLHWRRPAFTAAQIINYTIRCNPVGLQNASLVLYLQTSETHMLVQGLEPNTKYEFAVRLHVDQLSSPWSPVVYHSTLPEAPAGPPVGVKVTLIEDDTALVSWKPPDGPETVVTRYTILYASRKAWIAGEWQVLHREGAITMALLENLVAGNVYIVKISASNEVGEGPFSNSVELAVLPKETSESNQRPKRLDSADAKVYSGYYHLDQKSMTGIAVGVGIALTCILICVLILIYRSKARKSSASKTAQNGTQQLPRTSASLASGNEVGKNLEGAVGNEESLMPMIMPNSFIDAKGGTDLIINSYGPIIKNNSKKKWFFFQDSKKIQVEQPQRRFTPAVCFYQPGTTVLISDEDSPSSPGQTTSFSRPFGVAADTEHSANSEGSHETGDSGRFSHESNDEIHLSSVISTTPPNL,1150,"127,076",Chain (1); Disulfide bond (4); Domain (9); Erroneous initiation (1); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 60..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 156..205;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 256..304;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 348..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q15256,Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1),MRRAVCFPALCLLLNLHAAGCFSGNNDHFLAINQKKSGKPVFIYKHSQDIEKSLDIAPQKIYRHSYHSSSEAQVSKRHQIVNSAFPRPAYDPSLNLLAMDGQDLEVENLPIPAANVIVVTLQMDVNKLNITLLRIFRQGVAAALGLLPQQVHINRLIGKKNSIELFVSPINRKTGISDALPSEEVLRSLNINVLHQSLSQFGITEVSPEKNVLQGQHEADKIWSKEGFYAVVIFLSIFVIIVTCLMILYRLKERFQLSLRQDKEKNQEIHLSPITLQPALSEAKTVHSMVQPEQAPKVLNVVVDPQGRGAPEIKATTATSVCPSPFKMKPIGLQERRGSNVSLTLDMSSLGNIEPFVSIPTPREKVAMEYLQSASRILTRSQLRDVVASSHLLQSEFMEIPMNFVDPKEIDIPRHGTKNRYKTILPNPLSRVCLRPKNVTDSLSTYINANYIRGYSGKEKAFIATQGPMINTVDDFWQMVWQEDSPVIVMITKLKEKNEKCVLYWPEKRGIYGKVEVLVISVNECDNYTIRNLVLKQGSHTQHVKHYWYTSWPDHKTPDSAQPLLQLMLDVEEDRLASQGRGPVVVHCSAGIGRTGCFIATSIGCQQLKEEGVVDALSIVCQLRMDRGGMVQTSEQYEFVHHALCLYESRLSAETVQ,657,"73,834",Active site (1); Alternative sequence (5); Beta strand (13); Binding site (2); Chain (1); Domain (1); Frameshift (2); Glycosylation (1); Helix (13); Modified residue (2); Natural variant (4); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q5TEA6,Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2) (Sel-1L2),MKPLSLLIEILIILGVTIKTIKAEEHNKRQKERNVTTQVSVNEIKQYLSHILEQRTSSNVINKRENLLEKKKNQRKIRIKGIQNKDILKRNKNHLQKQAEKNFTDEGDQLFKMGIKVLQQSKSQKQKEEAYLLFAKAADMGNLKAMEKMADALLFGNFGVQNITAAIQLYESLAKEGSCKAQNALGFLSSYGIGMEYDQAKALIYYTFGSAGGNMMSQMILGYRYLSGINVLQNCEVALSYYKKVADYIADTFEKSEGVPVEKVRLTERPENLSSNSEILDWDIYQYYKFLAERGDVQIQVSLGQLHLIGRKGLDQDYYKALHYFLKAAKAGSANAMAFIGKMYLEGNAAVPQNNATAFKYFSMAASKGNAIGLHGLGLLYFHGKGVPLNYAEALKYFQKAAEKGWPDAQFQLGFMYYSGSGIWKDYKLAFKYFYLASQSGQPLAIYYLAKMYATGTGVVRSCRTAVELYKGVCELGHWAEKFLTAYFAYKDGDIDSSLVQYALLAEMGYEVAQSNSAFILESKKANILEKEKMYPMALLLWNRAAIQGNAFARVKIGDYHYYGYGTKKDYQTAATHYSIAANKYHNAQAMFNLAYMYEHGLGITKDIHLARRLYDMAAQTSPDAHIPVLFAVMKLETTHLLRDILFFNFTTRWNWLKLDNTIGPHWDLFVIGLIVPGLILLLRNHHG,688,"77,964",Alternative sequence (1); Chain (1); Glycosylation (1); Natural variant (2); Repeat (11); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P34741,Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362),MRRAWILLTLGLVACVSAESRAELTSDKDMYLDNSSIEEASGVYPIDDDDYASASGSGADEDVESPELTTSRPLPKILLTSAAPKVETTTLNIQNKIPAQTKSPEETDKEKVHLSDSERKMDPAEEDTNVYTEKHSDSLFKRTEVLAAVIAGGVIGFLFAIFLILLLVYRMRKKDEGSYDLGERKPSSAAYQKAPTKEFYA,201,"22,160",Chain (1); Erroneous initiation (1); Glycosylation (4); Helix (1); Modified residue (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
A6NGZ8,Small integral membrane protein 9,MEPQKLLIIGFLLCSLTCLLLETVASSPLPLSALGIQEKTGSKPRSGGNHRSWLNNFRDYLWQLIKSALPPAAIVAFLLTSALMGILCCFTILVVDPVH,99,"10,777",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9P0V8,SLAM family member 8 (B-lymphocyte activator macrophage expressed) (BCM-like membrane protein) (CD antigen CD353),MVMRPLWSLLLWEALLPITVTGAQVLSKVGGSVLLVAARPPGFQVREAIWRSLWPSEELLATFFRGSLETLYHSRFLGRAQLHSNLSLELGPLESGDSGNFSVLMVDTRGQPWTQTLQLKVYDAVPRPVVQVFIAVERDAQPSKTCQVFLSCWAPNISEITYSWRRETTMDFGMEPHSLFTDGQVLSISLGPGDRDVAYSCIVSNPVSWDLATVTPWDSCHHEAAPGKASYKDVLLVVVPVSLLLMLVTLFSAWHWCPCSGKKKKDVHADRVGPETENPLVQDLP,285,"31,670",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 152..201;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q99523,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),MERPWGAADGLSRWPHGLGLLLLLQLLPPSTLSQDRLDAPPPPAAPLPRWSGPIGVSWGLRAAAAGGAFPRGGRWRRSAPGEDEECGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSVCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPEKQNSKSNSVPIILAIVGLMLVTVVAGVLIVKKYVCGGRFLVHRYSVLQQHAEANGVDGVDALDTASHTNKSGYHDDSDEDLLE,831,"92,068",Alternative sequence (2); Beta strand (57); Chain (1); Disulfide bond (8); Glycosylation (6); Helix (15); Lipidation (1); Modified residue (3); Motif (2); Mutagenesis (10); Natural variant (1); Propeptide (1); Region (3); Repeat (9); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),DISULFID 86..556; DISULFID 257..277; DISULFID 448..458; DISULFID 612..651; DISULFID 634..666; DISULFID 668..723; DISULFID 675..688; DISULFID 702..740,"SIGNAL 1..33;  /evidence=""ECO:0000250|UniProtKB:O54861"""
P51571,Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta),MAAMASLGALALLLLSSLSRCSAEACLEPQITPSYYTTSDAVISTETVFIVEISLTCKNRVQNMALYADVGGKQFPVTRGQDVGRYQVSWSLDHKSAHAGTYEVRFFDEESYSLLRKAQRNNEDISIIPPLFTVSVDHRGTWNGPWVSTEVLAAAIGLVIYYLAFSAKSHIQA,173,"18,999",Chain (1); Cross-link (1); Disulfide bond (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 26..57;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8N743,Killer cell immunoglobulin-like receptor 3DL3 (CD158 antigen-like family member Z) (Killer cell inhibitory receptor 1) (CD antigen CD158z),MSLMVVSMACVGFFLLEGPWPHVGGQDKPFLSAWPGTVVSEGQHVTLQCRSRLGFNEFSLSKEDGMPVPELYNRIFRNSFLMGPVTPAHAGTYRCCSSHPHSPTGWSAPSNPVVIMVTGVHRKPSLLAHPGPLVKSGETVILQCWSDVRFERFLLHREGITEDPLRLVGQLHDAGSQVNYSMGPMTPALAGTYRCFGSVTHLPYELSAPSDPLDIVVVGLYGKPSLSAQPGPTVQAGENVTLSCSSRSLFDIYHLSREAEAGELRLTAVLRVNGTFQANFPLGPVTHGGNYRCFGSFRALPHAWSDPSDPLPVSVTGNSRHLHVLIGTSVVIIPFAILLFFLLHRWCANKKNAVVMDQEPAGNRTVNREDSDEQDPQEVTYAQLNHCVFTQRKITRPSQRPKTPPTDTSV,410,"44,928",Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Natural variant (14); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..95;  /evidence=""ECO:0000305""; DISULFID 144..195;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""; DISULFID 244..293;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q16288,NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase),MDVSLCPAKCSFWRIFLLGSVWLDYVGSVLACPANCVCSKTEINCRRPDDGNLFPLLEGQDSGNSNGNASINITDISRNITSIHIENWRSLHTLNAVDMELYTGLQKLTIKNSGLRSIQPRAFAKNPHLRYINLSSNRLTTLSWQLFQTLSLRELQLEQNFFNCSCDIRWMQLWQEQGEAKLNSQNLYCINADGSQLPLFRMNISQCDLPEISVSHVNLTVREGDNAVITCNGSGSPLPDVDWIVTGLQSINTHQTNLNWTNVHAINLTLVNVTSEDNGFTLTCIAENVVGMSNASVALTVYYPPRVVSLEEPELRLEHCIEFVVRGNPPPTLHWLHNGQPLRESKIIHVEYYQEGEISEGCLLFNKPTHYNNGNYTLIAKNPLGTANQTINGHFLKEPFPESTDNFILFDEVSPTPPITVTHKPEEDTFGVSIAVGLAAFACVLLVVLFVMINKYGRRSKFGMKGPVAVISGEEDSASPLHHINHGITTPSSLDAGPDTVVIGMTRIPVIENPQYFRQGHNCHKPDTYVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRLFNPSGNDFCIWCEVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATPIYLDILG,839,"94,428",Active site (1); Alternative sequence (4); Beta strand (14); Binding site (1); Chain (1); Disulfide bond (6); Domain (4); Glycosylation (13); Helix (15); Modified residue (5); Mutagenesis (1); Natural variant (19); Nucleotide binding (1); Repeat (2); Sequence conflict (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 32..38;  /evidence=""ECO:0000250|UniProtKB:Q91044""; DISULFID 36..45;  /evidence=""ECO:0000250|UniProtKB:Q91044""; DISULFID 164..189;  /evidence=""ECO:0000250|UniProtKB:Q91044""; DISULFID 166..207;  /evidence=""ECO:0000250|UniProtKB:Q91044""; DISULFID 231..284;  /evidence=""ECO:0000250|UniProtKB:Q91044""; DISULFID 320..362;  /evidence=""ECO:0000244|PDB:1WWC, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10388563""",SIGNAL 1..31
Q13591,Semaphorin-5A (Semaphorin-F) (Sema F),MKGTCVIAWLFSSLGLWRLAHPEAQGTTQCQRTEHPVISYKEIGPWLREFRAKNAVDFSQLTFDPGQKELVVGARNYLFRLQLEDLSLIQAVEWECDEATKKACYSKGKSKEECQNYIRVLLVGGDRLFTCGTNAFTPVCTNRSLSNLTEIHDQISGMARCPYSPQHNSTALLTAGGELYAATAMDFPGRDPAIYRSLGILPPLRTAQYNSKWLNEPNFVSSYDIGNFTYFFFRENAVEHDCGKTVFSRAARVCKNDIGGRFLLEDTWTTFMKARLNCSRPGEVPFYYNELQSTFFLPELDLIYGIFTTNVNSIAASAVCVFNLSAIAQAFSGPFKYQENSRSAWLPYPNPNPHFQCGTVDQGLYVNLTERNLQDAQKFILMHEVVQPVTTVPSFMEDNSRFSHVAVDVVQGREALVHIIYLATDYGTIKKVRVPLNQTSSSCLLEEIELFPERRREPIRSLQILHSQSVLFVGLREHVVKIPLKRCQFYRTRSTCIGAQDPYCGWDVVMKKCTSLEESLSMTQWEQSISACPTRNLTVDGHFGVWSPWTPCTHTDGSAVGSCLCRTRSCDSPAPQCGGWQCEGPGMEIANCSRNGGWTPWTSWSPCSTTCGIGFQVRQRSCSNPTPRHGGRVCVGQNREERYCNEHLLCPPHMFWTGWGPWERCTAQCGGGIQARRRICENGPDCAGCNVEYQSCNTNPCPELKKTTPWTPWTPVNISDNGGHYEQRFRYTCKARLADPNLLEVGRQRIEMRYCSSDGTSGCSTDGLSGDFLRAGRYSAHTVNGAWSAWTSWSQCSRDCSRGIRNRKRVCNNPEPKYGGMPCLGPSLEYQECNILPCPVDGVWSCWSPWTKCSATCGGGHYMRTRSCSNPAPAYGGDICLGLHTEEALCNTQPCPESWSEWSDWSECEASGVQVRARQCILLFPMGSQCSGNTTESRPCVFDSNFIPEVSVARSSSVEEKRCGEFNMFHMIAVGLSSSILGCLLTLLVYTYCQRYQQQSHDATVIHPVSPAPLNTSITNHINKLDKYDSVEAIKAFNKNNLILEERNKYFNPHLTGKTYSNAYFTDLNNYDEY,1074,"120,615",Chain (1); Disulfide bond (18); Domain (8); Glycosylation (11); Natural variant (3); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 104..114;  /evidence=""ECO:0000250""; DISULFID 131..140;  /evidence=""ECO:0000250""; DISULFID 254..357;  /evidence=""ECO:0000250""; DISULFID 278..320;  /evidence=""ECO:0000250""; DISULFID 487..504;  /evidence=""ECO:0000250""; DISULFID 496..513;  /evidence=""ECO:0000250""; DISULFID 607..644;  /evidence=""ECO:0000250""; DISULFID 611..650;  /evidence=""ECO:0000250""; DISULFID 622..634;  /evidence=""ECO:0000250""; DISULFID 665..696;  /evidence=""ECO:0000250""; DISULFID 669..701;  /evidence=""ECO:0000250""; DISULFID 680..686;  /evidence=""ECO:0000250""; DISULFID 796..833;  /evidence=""ECO:0000250""; DISULFID 800..838;  /evidence=""ECO:0000250""; DISULFID 811..823;  /evidence=""ECO:0000250""; DISULFID 853..890;  /evidence=""ECO:0000250""; DISULFID 857..895;  /evidence=""ECO:0000250""; DISULFID 868..880;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
O94933,SLIT and NTRK-like protein 3,MKPSIAEMLHRGRMLWIILLSTIALGWTTPIPLIEDSEEIDEPCFDPCYCEVKESLFHIHCDSKGFTNISQITEFWSRPFKLYLQRNSMRKLYTNSFLHLNNAVSINLGNNALQDIQTGAFNGLKILKRLYLHENKLDVFRNDTFLGLESLEYLQADYNVIKRIESGAFRNLSKLRVLILNDNLIPMLPTNLFKAVSLTHLDLRGNRLKVLFYRGMLDHIGRSLMELQLEENPWNCTCEIVQLKSWLERIPYTALVGDITCETPFHFHGKDLREIRKTELCPLLSDSEVEASLGIPHSSSSKENAWPTKPSSMLSSVHFTASSVEYKSSNKQPKPTKQPRTPRPPSTSQALYPGPNQPPIAPYQTRPPIPIICPTGCTCNLHINDLGLTVNCKERGFNNISELLPRPLNAKKLYLSSNLIQKIYRSDFWNFSSLDLLHLGNNRISYVQDGAFINLPNLKSLFLNGNDIEKLTPGMFRGLQSLHYLYFEFNVIREIQPAAFSLMPNLKLLFLNNNLLRTLPTDAFAGTSLARLNLRKNYFLYLPVAGVLEHLNAIVQIDLNENPWDCTCDLVPFKQWIETISSVSVVGDVLCRSPENLTHRDVRTIELEVLCPEMLHVAPAGESPAQPGDSHLIGAPTSASPYEFSPPGGPVPLSVLILSLLVLFFSAVFVAAGLFAYVLRRRRKKLPFRSKRQEGVDLTGIQMQCHRLFEDGGGGGGGSGGGGRPTLSSPEKAPPVGHVYEYIPHPVTQMCNNPIYKPREEEEVAVSSAQEAGSAERGGPGTQPPGMGEALLGSEQFAETPKENHSNYRTLLEKEKEWALAVSSSQLNTIVTVNHHHPHHPAVGGVSGVVGGTGGDLAGFRHHEKNGGVVLFPPGGGCGSGSMLLDRERPQPAPCTVGFVDCLYGTVPKLKELHVHPPGMQYPDLQQDARLKETLLFSAGKGFTDHQTQKSDYLELRAKLQTKPDYLEVLEKTTYRF,977,"108,934",Chain (1); Compositional bias (1); Domain (3); Erroneous initiation (1); Glycosylation (2); Natural variant (1); Repeat (12); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q96A28,SLAM family member 9 (CD2 family member 10) (CD2F-10) (CD84 homolog 1) (CD84-H1),MCAFPWLLLLLLLQEGSQRRLWRWCGSEEVVAVLQESISLPLEIPPDEEVENIIWSSHKSLATVVPGKEGHPATIMVTNPHYQGQVSFLDPSYSLHISNLSWEDSGLYQAQVNLRTSQISTMQQYNICVYRWLSEPQITVNFESSGEGACSMSLVCSVEKAGMDMTYSWLSRGDSTYTFHEGPVLSTSWRPGDSALSYTCRANNPISNVSSCPIPDGPFYADPNYASEKPSTAFCLLAKGLLIFLLLVILAMGLWVIRVQKRHKMPRMKKLMRNRMKLRKEAKPGSSPA,289,"32,436",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 156..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q96PQ1,Sialic acid-binding Ig-like lectin 12 (Siglec-12) (Sialic acid-binding Ig-like lectin-like 1) (Siglec-L1),MLLLLLLLPPLLCGRVGAKEQKDYLLTMQKSVTVQEGLCVSVLCSFSYPQNGWTASDPVHGYWFRAGDHVSRNIPVATNNPARAVQEETRDRFHLLGDPQNKDCTLSIRDTRESDAGTYVFCVERGNMKWNYKYDQLSVNVTASQDLLSRYRLEVPESVTVQEGLCVSVPCSVLYPHYNWTASSPVYGSWFKEGADIPWDIPVATNTPSGKVQEDTHGRFLLLGDPQTNNCSLSIRDARKGDSGKYYFQVERGSRKWNYIYDKLSVHVTALTHMPTFSIPGTLESGHPRNLTCSVPWACEQGTPPTITWMGASVSSLDPTITRSSMLSLIPQPQDHGTSLTCQVTLPGAGVTMTRAVRLNISYPPQNLTMTVFQGDGTASTTLRNGSALSVLEGQSLHLVCAVDSNPPARLSWTWGSLTLSPSQSSNLGVLELPRVHVKDEGEFTCRAQNPLGSQHISLSLSLQNEYTGKMRPISGVTLGAFGGAGATALVFLYFCIIFVVVRSCRKKSARPAVGVGDTGMEDANAVRGSASQGPLIESPADDSPPHHAPPALATPSPEEGEIQYASLSFHKARPQYPQEQEAIGYEYSEINIPK,595,"64,984",Alternative sequence (1); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (7); Modified residue (2); Motif (2); Natural variant (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 166..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 171..231;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 293..342;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 401..446;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P43121,Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146),MGLPRLVCAFLLAACCCCPRVAGVPGEAEQPAPELVEVEVGSTALLKCGLSQSQGNLSHVDWFSVHKEKRTLIFRVRQGQGQSEPGEYEQRLSLQDRGATLALTQVTPQDERIFLCQGKRPRSQEYRIQLRVYKAPEEPNIQVNPLGIPVNSKEPEEVATCVGRNGYPIPQVIWYKNGRPLKEEKNRVHIQSSQTVESSGLYTLQSILKAQLVKEDKDAQFYCELNYRLPSGNHMKESREVTVPVFYPTEKVWLEVEPVGMLKEGDRVEIRCLADGNPPPHFSISKQNPSTREAEEETTNDNGVLVLEPARKEHSGRYECQGLDLDTMISLLSEPQELLVNYVSDVRVSPAAPERQEGSSLTLTCEAESSQDLEFQWLREETGQVLERGPVLQLHDLKREAGGGYRCVASVPSIPGLNRTQLVNVAIFGPPWMAFKERKVWVKENMVLNLSCEASGHPRPTISWNVNGTASEQDQDPQRVLSTLNVLVTPELLETGVECTASNDLGKNTSILFLELVNLTTLTPDSNTTTGLSTSTASPHTRANSTSTERKLPEPESRGVVIVAVIVCILVLAVLGAVLYFLYKKGKLPCRRSGKQEITLPPSRKSELVVEVKSDKLPEEMGLLQGSSGDKRAPGDQGEKYIDLRH,646,"71,607",Alternative sequence (2); Chain (1); Disulfide bond (5); Domain (5); Erroneous initiation (1); Glycosylation (8); Modified residue (3); Natural variant (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 48..116;  /evidence=""ECO:0000305""; DISULFID 161..223;  /evidence=""ECO:0000305""; DISULFID 272..320;  /evidence=""ECO:0000305""; DISULFID 365..407;  /evidence=""ECO:0000305""; DISULFID 452..499;  /evidence=""ECO:0000305""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:8162602"""
Q9HDB5,"Neurexin-3-beta (Neurexin III-beta) [Cleaved into: Neurexin-3-beta, soluble form; Neurexin-3-beta, C-terminal fragment (NRXN3-CTF)]",MHLRIHARRSPPRRPAWTLGIWFLFWGCIVSSVWSSSNVASSSSTSSSPGSHSQHEHHFHGSKHHSVPISIYRSPVSLRGGHAGATYIFGKSGGLILYTWPANDRPSTRSDRLAVGFSTTVKDGILVRIDSAPGLGDFLQLHIEQGKIGVVFNIGTVDISIKEERTPVNDGKYHVVRFTRNGGNATLQVDNWPVNEHYPTGRQLTIFNTQAQIAIGGKDKGRLFQGQLSGLYYDGLKVLNMAAENNPNIKINGSVRLVGEVPSILGTTQTTSMPPEMSTTVMETTTTMATTTTRKNRSTASIQPTSDDLVSSAECSSDDEDFVECEPSTGGELVIPLLVEDPLATPPIATRAPSITLPPTFRPLLTIIETTKDSLSMTSEAGLPCLSDQGSDGCDDDGLVISGYGSGETFDSNLPPTDDEDFYTTFSLVTDKSLSTSIFEGGYKAHAPKWESKDFRPNKVSETSRTTTTSLSPELIRFTASSSSGMVPKLPAGKMNNRDLKPQPDIVLLPLPTAYELDSTKLKSPLITSPMFRNVPTANPTEPGIRRVPGASEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDETRNYISNSAQSNGTLMKEKQQSSKSGHKKQKNKDREYYV,637,"69,305",Alternative sequence (6); Chain (3); Domain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000250"""
Q9Y5H4,Protocadherin gamma-A1 (PCDH-gamma-A1),MKIQKKLTGCSRLMLLCLSLELLLEAGAGNIHYSVPEETDKGSFVGNIAKDLGLQPQELADGGVRIVSRGRMPLFALNPRSGSLITARRIDREELCAQSMPCLVSFNILVEDKMKLFPVEVEIIDINDNTPQFQLEELEFKMNEITTPGTRVSLPFGQDLDVGMNSLQSYQLSSNPHFSLDVQQGADGPQHPEMVLQSPLDREEEAVHHLILTASDGGEPVRSGTLRIYIQVVDANDNPPAFTQAQYHINVPENVPLGTQLLMVNATDPDEGANGEVTYSFHNVDHRVAQIFRLDSYTGEISNKEPLDFEEYKMYSMEVQAQDGAGLMAKVKVLIKVLDVNDNAPEVTITSVTTAVPENFPPGTIIALISVHDQDSGDNGYTTCFIPGNLPFKLEKLVDNYYRLVTERTLDRELISGYNITITAIDQGTPALSTETHISLLVTDINDNSPVFHQDSYSAYIPENNPRGASIFSVRAHDLDSNENAQITYSLIEDTIQGAPLSAYLSINSDTGVLYALRSFDYEQFRDMQLKVMARDSGDPPLSSNVSLSLFLLDQNDNAPEILYPALPTDGSTGVELAPLSAEPGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADRISDILADLGSLEPSAKPNDSDLTLYLVVAAAAVSCVFLAFVIVLLAHRLRRWHKSRLLQASGGGLASMPGSHFVGVDGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLISQESCEKKGFLSAPQSLLEDKKEPFSQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,931,"101,226",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (4); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5G7,Protocadherin gamma-A6 (PCDH-gamma-A6),MAPPQRHPQRSEQVLLLTLLGTLWGAAAAQIRYSIPEELEKGSFVGNIVKDLGLEPQELAEHGVRIVSRGRMQLFSLNPRNGSLVTAGRIDREELCAQSPRCLVSFNILVEDKLNLYPVEVEIVDINDNTPRFLKEELEVKILENAAPSSRFPLMEVYDPDVGMNSLQGFKLSGNSHFSVDVQSEAHGPKYPELVLEGTLDREGEAVYRLVLTAMDGGDPVRSSVAQILVTVLDVNDNTPMFTQPVYRVSVPENLPVGTPVLAVTATDQDEGVHGEVTYSFVKITEKISQIFCLNVLTGEISTSANLDYEDSSFYELGVEARDGPGLRDRAKVLITILDVNDNVPEVVVTSGSRTIAESAPPGTVIALFQVFDRDSGLNGLVTCSIPRSLPFELEKSVGNYYRLVTNAALDREEVFLYNITVTATDKGTPPLSTETIISLNVADTNDNPPTFPHSSYSVYVLENNPRGASIFSVNALDPDVDQNAQVSYSLAEDTLQGAPLSSYVSINSDTGILYALRSFDYEQLRDLQLWVTASDSGDPPLSSNVSLSLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADRIPDILADLGSLEPSAKPNDSDLTLYLVVAVAAVSCVFLAFVIVLLALRLQRWHKSRLLQASGGGLASMPGSHFVGVEGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLINQESYEKSEPLLITQDLLETKGEPRQLQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"100,871",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (4); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q53EL9,Seizure protein 6 homolog (SEZ-6) (hSEZ-6),MRPVALLLLPSLLALLAHGLSLEAPTVGKGQAPGIEETDGELTAAPTPEQPERGVHFVTTAPTLKLLNHHPLLEEFLQEGLEKGDEELRPALPFQPDPPAPFTPSPLPRLANQDSRPVFTSPTPAMAAVPTQPQSKEGPWSPESESPMLRITAPLPPGPSMAVPTLGPGEIASTTPPSRAWTPTQEGPGDMGRPWVAEVVSQGAGIGIQGTITSSTASGDDEETTTTTTIITTTITTVQTPGPCSWNFSGPEGSLDSPTDLSSPTDVGLDCFFYISVYPGYGVEIKVQNISLREGETVTVEGLGGPDPLPLANQSFLLRGQVIRSPTHQAALRFQSLPPPAGPGTFHFHYQAYLLSCHFPRRPAYGDVTVTSLHPGGSARFHCATGYQLKGARHLTCLNATQPFWDSKEPVCIAACGGVIRNATTGRIVSPGFPGNYSNNLTCHWLLEAPEGQRLHLHFEKVSLAEDDDRLIIRNGDNVEAPPVYDSYEVEYLPIEGLLSSGKHFFVELSTDSSGAAAGMALRYEAFQQGHCYEPFVKYGNFSSSTPTYPVGTTVEFSCDPGYTLEQGSIIIECVDPHDPQWNETEPACRAVCSGEITDSAGVVLSPNWPEPYGRGQDCIWGVHVEEDKRIMLDIRVLRIGPGDVLTFYDGDDLTARVLGQYSGPRSHFKLFTSMADVTIQFQSDPGTSVLGYQQGFVIHFFEVPRNDTCPELPEIPNGWKSPSQPELVHGTVVTYQCYPGYQVVGSSVLMCQWDLTWSEDLPSCQRVTSCHDPGDVEHSRRLISSPKFPVGATVQYICDQGFVLMGSSILTCHDRQAGSPKWSDRAPKCLLEQLKPCHGLSAPENGARSPEKQLHPAGATIHFSCAPGYVLKGQASIKCVPGHPSHWSDPPPICRAASLDGFYNSRSLDVAKAPAASSTLDAAHIAAAIFLPLVAMVLLVGGVYFYFSRLQGKSSLQLPRPRPRPYNRITIESAFDNPTYETGSLSFAGDERI,994,"107,425",Alternative sequence (4); Chain (1); Compositional bias (2); Disulfide bond (12); Domain (7); Erroneous initiation (2); Frameshift (2); Glycosylation (4); Natural variant (7); Region (2); Sequence conflict (17); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 357..397;  /evidence=""ECO:0000250""; DISULFID 383..412;  /evidence=""ECO:0000250""; DISULFID 416..443;  /evidence=""ECO:0000250""; DISULFID 532..574;  /evidence=""ECO:0000250""; DISULFID 559..589;  /evidence=""ECO:0000250""; DISULFID 593..619;  /evidence=""ECO:0000250""; DISULFID 710..752;  /evidence=""ECO:0000250""; DISULFID 738..765;  /evidence=""ECO:0000250""; DISULFID 771..813;  /evidence=""ECO:0000250""; DISULFID 799..830;  /evidence=""ECO:0000250""; DISULFID 838..880;  /evidence=""ECO:0000250""; DISULFID 866..895;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q6ZPB5,Stress-responsive DNAJB4-interacting membrane protein 1,MWPAPCSVGRLLIFFMCSSSGYVVQGCGPSPGARTTLGSPLSLWSIKTPSHIFCTRRAINLGFPSPPLVQLIFWSLNAGLDLYLCLISSCGFSQVFWPVEAFCSFSLSFFALALSHKFVICRLDQHIFSGFTKSLKNLPPCHRTDI,146,"16,112",Chain (1); Sequence conflict (2); Signal peptide (1); Topological domain (3); Transmembrane (2),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q5VU65,Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like),MTGCPASSRRRGFGLFFFLRLHRLLLLFLVLRGTLANKLNVPQVLLPFGREPGRVPFLLEAQRGCYTWHSTHHDAVTVEPLYENGTLCSQKAVLIAESTQPIRLSSIILAREIVTDHELRCDVKVDVINSIEIVSRARELYVDDSPLELMVRALDAEGNTFSSLAGMMFEWSIAQDNESAREELSSKIRILKYSEAEYAPPIYIAEMEKEEKQGDVILVSGIRTGAAVVKVRIHEPFYKKVAAALIRLLVLENIFLIPSHDIYLLVGTYIKYQVAKMVQGRVTEVKFPLEHYILELQDHRVALNGSHSEKVAILDDKTAMVTASQLGQTNLVFVHKNVHMRSVSGLPNCTIYVVEPGFLGFTVQPGNRWSLEVGQVYVITVDVFDKSSTKVYISDNLRITYDFPKEYFEEQLTTVNGSYHIVKALKDGVVVINASLTSIIYQNKDIQPIKFLIKHQQEVKIYFPIMLTPKFLAFPHHPMGMLYRYKVQVEGGSGNFTWTSSNETVVIVTTKGVVTAGQVRGNSTVLARDVQNPFRYGEIKIHVLKLNKMELLPFHADVEIGQIIEIPIAMYHINKETKEAMAFTDCSHLSLDLNMDKQGVFTLLKEGIQRPGPMHCSSTHIAAKSLGHTLVTVSVNECDKYLESSATFAAYEPLKALNPVEVALVTWQSVKEMVFEGGPRPWILEPSRFFLELNAEKTEKIGIAQVWLPSKRKQNQYIYRIQCLDLGEQVLTFRIGNHPGVLNPSPAVEVLQVRFICAHPASMSVTPVYKVPAGAQPCPLPQHNKWLIPVSRLRDTVLELAVFDQHRRKFDNFSSLMLEWKSSNETLAHFEDYKSVEMVAKDDGSGQTRLHGHQILKVHQIKGTVLIGVNFVGYSEKKSPKEISNLPRSVDVELLLVDDVTVVPENATIYNHPDVKETFSLVEGSGYFLVNSSEQGVVTITYMEAESSVELVPLHPGFFTLEVYDLCLAFLGPATAHLRVSDIQELELDLIDKVEIDKTVLVTVRVLGSSKRPFQNKYFRNMELKLQLASAIVTLTPMEQQDEYSENYILRATTIGQTTLVAIAKDKMGRKYTSTPRHIEVFPPFRLLPEKMTLIPMNMMQVMSEGGPQPQSIVHFSISNQTVAVVNRRGQVTGKIVGTAVVHGTIQTVNEDTGKVIVFSQDEVQIEVVQLRAVRILAAATRLITATKMPVYVMGVTSTQTPFSFSNANPGLTFHWSMSKRDVLDLVPRHSEVFLQLPVEHNFAMVVHTKAAGRTSIKVTVHCMNSSSGQFEGNLLELSDEVQILVFEKLQLFYPECQPEQILMPINSQLKLHTNREGAAFVSSRVLKCFPNSSVIEEDGEGLLKAGSIAGTAVLEVTSIEPFGVNQTTITGVQVAPVTYLRVSSQPKLYTAQGRTLSAFPLGMSLTFTVQFYNSIGEKFHTHNTQLYLALNRDDLLHIGPGNKNYTYMAQAVNRGLTLVGLWDRRHPGMADYIPVAVEHAIEPDTKLTFVGDIICFSTHLVSQHGEPGIWMISANNILQTDIVTGVGVARSPGTAMIFHDIPGVVKTYREVVVNASSRLMLSYDLKTYLTNTLNSTVFKLFITTGRNGVNLKGFCTPNQALAITKVLLPATLMLCHVQFSNTLLDIPASKVFQVHSDFSMEKGVYVCIIKVRPQSEELLQALSVADTSVYGWATLVSERSKNGMQRILIPFIPAFYINQSELVLSHKQDIGEIRVLGVDRVLRKLEVISSSPVLVVAGHSHSPLTPGLAIYSVRVVNFTSFQQMASPVFINISCVLTSQSEAVVVRAMKDKLGADHCEDSAILKRFTGSYQILLLTLFAVLASTASIFLAYNAFLNKIQTVPVVYVPTLGTPQPGFFNSTSSPPHFMSLQPPLAQSRLQHWLWSIRH,1888,"210,605",Alternative sequence (1); Chain (1); Domain (1); Erroneous initiation (3); Glycosylation (9); Natural variant (1); Sequence conflict (8); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q13433,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),MARKLSVILILTFALSVTNPLHELKAAAFPQTTEKISPNWESGINVDLAISTRQYHLQQLFYRYGENNSLSVEGFRKLLQNIGIDKIKRIHIHHDHDHHSDHEHHSDHERHSDHEHHSEHEHHSDHDHHSHHNHAASGKNKRKALCPDHDSDSSGKDPRNSQGKGAHRPEHASGRRNVKDSVSASEVTSTVYNTVSEGTHFLETIETPRPGKLFPKDVSSSTPPSVTSKSRVSRLAGRKTNESVSEPRKGFMYSRNTNENPQECFNASKLLTSHGMGIQVPLNATEFNYLCPAIINQIDARSCLIHTSEKKAEIPPKTYSLQIAWVGGFIAISIISFLSLLGVILVPLMNRVFFKFLLSFLVALAVGTLSGDAFLHLLPHSHASHHHSHSHEEPAMEMKRGPLFSHLSSQNIEESAYFDSTWKGLTALGGLYFMFLVEHVLTLIKQFKDKKKKNQKKPENDDDVEIKKQLSKYESQLSTNEEKVDTDDRTEGYLRADSQEPSHFDSQQPAVLEEEEVMIAHAHPQEVYNEYVPRGCKNKCHSHFHDTLGQSDDLIHHHHDYHHILHHHHHQNHHPHSHSQRYSREELKDAGVATLAWMVIMGDGLHNFSDGLAIGAAFTEGLSSGLSTSVAVFCHELPHELGDFAVLLKAGMTVKQAVLYNALSAMLAYLGMATGIFIGHYAENVSMWIFALTAGLFMYVALVDMVPEMLHNDASDHGCSRWGYFFLQNAGMLLGFGIMLLISIFEHKIVFRINF,755,"85,047",Alternative sequence (3); Chain (1); Coiled coil (1); Compositional bias (5); Erroneous initiation (1); Glycosylation (5); Modified residue (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:15340161"""
Q6UX34,Protein SNORC (Secondary ossification center-associated regulator of chondrocyte maturation protein),MASCLALRMALLLVSGVLAPAVLTDDVPQEPVPTLWNEPAELPSGEGPVESTSPGREPVDTGPPAPTVAPGPEDSTAQERLDQGGGSLGPGAIAAIVIAALLATCVVLALVVVALRKFSAS,121,"12,073",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q3SXP7,Protein shisa-like-1,MTSCGQQSLNVLAVLFSLLFSAVLSAHFRVCEPYTDHKGRYHFGFHCPRLSDNKTFILCCHHNNTVFKYCCNETEFQAVMQANLTASSEGYMHNNYTALLGVWIYGFFVLMLLVLDLLYYSAMNYDICKVYLARWGIQGRWMKQDPRRWGNPARAPRPGQRAPQPQPPPGPLPQAPQAVHTLRGDAHSPPLMTFQSSSA,199,"22,573",Chain (1); Glycosylation (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9UKJ1,Paired immunoglobulin-like type 2 receptor alpha (Cell surface receptor FDF03) (Inhibitory receptor PILR-alpha),MGRPLLLPLLPLLLPPAFLQPSGSTGSGPSYLYGVTQPKHLSASMGGSVEIPFSFYYPWELATAPDVRISWRRGHFHRQSFYSTRPPSIHKDYVNRLFLNWTEGQKSGFLRISNLQKQDQSVYFCRVELDTRSSGRQQWQSIEGTKLSITQAVTTTTQRPSSMTTTWRLSSTTTTTGLRVTQGKRRSDSWHISLETAVGVAVAVTVLGIMILGLICLLRWRRRKGQQRTKATTPAREPFQNTEEPYENIRNEGQNTDPKLNPKDDGIVYASLALSSSTSPRAPPSHRPLKSPQNETLYSVLKA,303,"34,005",Alternative sequence (3); Beta strand (10); Chain (1); Domain (1); Glycosylation (1); Helix (2); Motif (2); Mutagenesis (1); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q5JXA9,Signal-regulatory protein beta-2 (SIRP-beta-2) (Protein tyrosine phosphatase non-receptor type substrate 1-like 3) (Protein tyrosine phosphatase non-receptor type substrate protein),MCSTMSAPTCLAHLPPCFLLLALVLVPSDASGQSSRNDWQVLQPEGPMLVAEGETLLLRCMVVGSCTDGMIKWVKVSTQDQQEIYNFKRGSFPGVMPMIQRTSEPLNCDYSIYIHNVTREHTGTYHCVRFDGLSEHSEMKSDEGTSVLVKGAGDPEPDLWIIQPQELVLGTTGDTVFLNCTVLGDGPPGPIRWFQGAGLSREAIYNFGGISHPKETAVQASNNDFSILLQNVSSEDAGTYYCVKFQRKPNRQYLSGQGTSLKVKAKSTSSKEAEFTSEPATEMSPTGLLVVFAPVVLGLKAITLAALLLALATSRRSPGQEDVKTTGPAGAMNTLAWSKGQE,342,"36,968",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 60..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 180..242;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9H5Y7,SLIT and NTRK-like protein 6,MKLWIHLFYSSLLACISLHSQTPVLSSRGSCDSLCNCEEKDGTMLINCEAKGIKMVSEISVPPSRPFQLSLLNNGLTMLHTNDFSGLTNAISIHLGFNNIADIEIGAFNGLGLLKQLHINHNSLEILKEDTFHGLENLEFLQADNNFITVIEPSAFSKLNRLKVLILNDNAIESLPPNIFRFVPLTHLDLRGNQLQTLPYVGFLEHIGRILDLQLEDNKWACNCDLLQLKTWLENMPPQSIIGDVVCNSPPFFKGSILSRLKKESICPTPPVYEEHEDPSGSLHLAATSSINDSRMSTKTTSILKLPTKAPGLIPYITKPSTQLPGPYCPIPCNCKVLSPSGLLIHCQERNIESLSDLRPPPQNPRKLILAGNIIHSLMKSDLVEYFTLEMLHLGNNRIEVLEEGSFMNLTRLQKLYLNGNHLTKLSKGMFLGLHNLEYLYLEYNAIKEILPGTFNPMPKLKVLYLNNNLLQVLPPHIFSGVPLTKVNLKTNQFTHLPVSNILDDLDLLTQIDLEDNPWDCSCDLVGLQQWIQKLSKNTVTDDILCTSPGHLDKKELKALNSEILCPGLVNNPSMPTQTSYLMVTTPATTTNTADTILRSLTDAVPLSVLILGLLIMFITIVFCAAGIVVLVLHRRRRYKKKQVDEQMRDNSPVHLQYSMYGHKTTHHTTERPSASLYEQHMVSPMVHVYRSPSFGPKHLEEEEERNEKEGSDAKHLQRSLLEQENHSPLTGSNMKYKTTNQSTEFLSFQDASSLYRNILEKERELQQLGITEYLRKNIAQLQPDMEAHYPGAHEELKLMETLMYSRPRKVLVEQTKNEYFELKANLHAEPDYLEVLEQQT,841,"95,110",Chain (1); Domain (4); Erroneous initiation (2); Frameshift (1); Natural variant (3); Repeat (11); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
A6NMB1,Sialic acid-binding Ig-like lectin 16 (Siglec-16) (Siglec-P16),MLLLPLLLPVLGAGSLNKDPSYSLQVQRQVPVPEGLCVIVSCNLSYPRDGWDESTAAYGYWFKGRTSPKTGAPVATNNQSREVAMSTRDRFQLTGDPGKGSCSLVIRDAQREDEAWYFFRVERGSRVRHSFLSNAFFLKVTALTQKPDVYIPETLEPGQPVTVICVFNWAFKKCPAPSFSWTGAALSPRRTRPSTSHFSVLSFTPSPQDHDTDLTCHVDFSRKGVSAQRTVRLRVASLELQGNVIYLEVQKGQFLRLLCAADSQPPATLSWVLQDRVLSSSHPWGPRTLGLELPGVKAGDSGRYTCRAENRLGSQQRALDLSVQYPPENLRVMVSQANRTVLENLRNGTSLRVLEGQSLRLVCVTHSSPPARLSWTWGEQTVGPSQPSDPGVLQLPRVQMEHEGEFTCHARHPLGSQRVSLSFSVHCKSGPMTGVVLVAVGEVAMKILLLCLCLILLRVRSCRRKAARAALGMEAADAVTD,481,"52,992",Binding site (1); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..174;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 42..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 165..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 259..306;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 363..408;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
P78324,Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a),MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLVALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK,504,"54,967",Alternative sequence (2); Beta strand (26); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (4); Helix (3); Modified residue (4); Motif (5); Natural variant (46); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 55..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17369261, ECO:0000269|PubMed:18657508""; DISULFID 170..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 273..331;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q96GP6,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),MEGAGPRGAGPARRRGAGGPPSPLLPSLLLLLLLWMLPDTVAPQELNPRGRNVCRAPGSQVPTCCAGWRQQGDECGIAVCEGNSTCSENEVCVRPGECRCRHGYFGANCDTKCPRQFWGPDCKELCSCHPHGQCEDVTGQCTCHARRWGARCEHACQCQHGTCHPRSGACRCEPGWWGAQCASACYCSATSRCDPQTGACLCHAGWWGRSCNNQCACNSSPCEQQSGRCQCRERTFGARCDRYCQCFRGRCHPVDGTCACEPGYRGKYCREPCPAGFYGLGCRRRCGQCKGQQPCTVAEGRCLTCEPGWNGTKCDQPCATGFYGEGCSHRCPPCRDGHACNHVTGKCTRCNAGWIGDRCETKCSNGTYGEDCAFVCADCGSGHCDFQSGRCLCSPGVHGPHCNVTCPPGLHGADCAQACSCHEDTCDPVTGACHLETNQRKGVMGAGALLVLLVCLLLSLLGCCCACRGKDPTRRPRPRRELSLGRKKAPHRLCGRFSRISMKLPRIPLRRQKLPKVVVAHHDLDNTLNCSFLEPPSGLEQPSPSWSSRASFSSFDTTDEGPVYCVPHEEAPAESRDPEVPTVPAEAPAPSPVPLTTPASAEEAIPLPASSDSERSASSVEGPGGALYARVARREARPARARGEIGGLSLSPSPERRKPPPPDPATKPKVSWIHGKHSAAAAGRAPSPPPPGSEAAPSPSKRKRTPSDKSAHTVEHGSPRTRDPTPRPPGLPEEATALAAPSPPRARARGRGPGLLEPTDAGGPPRSAPEAASMLAAELRGKTRSLGRAEVALGAQGPREKPAPPQKAKRSVPPASPARAPPATETPGPEKAATDLPAPETPRKKTPIQKPPRKKSREAAGELGRAGAPTL,871,"92,384",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (21); Domain (7); Frameshift (1); Glycosylation (4); Modified residue (8); Natural variant (9); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 75..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 80..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 100..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 126..134;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 128..141;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 143..152;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 156..163;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 158..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 172..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 185..193;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 187..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 202..211;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 215..222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 217..229;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 231..240;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 244..251;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 246..258;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 260..269;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 376..384;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 379..391;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 393..402;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..43;  /evidence=""ECO:0000255"""
O75631,Uroplakin-3a (UP3a) (Uroplakin III) (UPIII),MPPLWALLALGCLRFGSAVNLQPQLASVTFATNNPTLTTVALEKPLCMFDSKEALTGTHEVYLYVLVDSAISRNASVQDSTNTPLGSTFLQTEGGRTGPYKAVAFDLIPCSDLPSLDAIGDVSKASQILNAYLVRVGANGTCLWDPNFQGLCNAPLSAATEYRFKYVLVNMSTGLVEDQTLWSDPIRTNQLTPYSTIDTWPGRRSGGMIVITSILGSLPFFLLVGFAGAIALSLVDMGSSDGETTHDSQITQEAVPKSLGASESSYTSVNRGPPLDRAEVYSSKLQD,287,"30,670",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000250"""
Q04912,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],MELLPPLPQSFLLLLLLPAKPAAGEDWQCPRTPYAASRDFDVKYVVPSFSAGGLVQAMVTYEGDRNESAVFVAIRNRLHVLGPDLKSVQSLATGPAGDPGCQTCAACGPGPHGPPGDTDTKVLVLDPALPALVSCGSSLQGRCFLHDLEPQGTAVHLAAPACLFSAHHNRPDDCPDCVASPLGTRVTVVEQGQASYFYVASSLDAAVAASFSPRSVSIRRLKADASGFAPGFVALSVLPKHLVSYSIEYVHSFHTGAFVYFLTVQPASVTDDPSALHTRLARLSATEPELGDYRELVLDCRFAPKRRRRGAPEGGQPYPVLRVAHSAPVGAQLATELSIAEGQEVLFGVFVTGKDGGPGVGPNSVVCAFPIDLLDTLIDEGVERCCESPVHPGLRRGLDFFQSPSFCPNPPGLEALSPNTSCRHFPLLVSSSFSRVDLFNGLLGPVQVTALYVTRLDNVTVAHMGTMDGRILQVELVRSLNYLLYVSNFSLGDSGQPVQRDVSRLGDHLLFASGDQVFQVPIQGPGCRHFLTCGRCLRAWHFMGCGWCGNMCGQQKECPGSWQQDHCPPKLTEFHPHSGPLRGSTRLTLCGSNFYLHPSGLVPEGTHQVTVGQSPCRPLPKDSSKLRPVPRKDFVEEFECELEPLGTQAVGPTNVSLTVTNMPPGKHFRVDGTSVLRGFSFMEPVLIAVQPLFGPRAGGTCLTLEGQSLSVGTSRAVLVNGTECLLARVSEGQLLCATPPGATVASVPLSLQVGGAQVPGSWTFQYREDPVVLSISPNCGYINSHITICGQHLTSAWHLVLSFHDGLRAVESRCERQLPEQQLCRLPEYVVRDPQGWVAGNLSARGDGAAGFTLPGFRFLPPPHPPSANLVPLKPEEHAIKFEYIGLGAVADCVGINVTVGGESCQHEFRGDMVVCPLPPSLQLGQDGAPLQVCVDGECHILGRVVRPGPDGVPQSTLLGILLPLLLLVAALATALVFSYWWRRKQLVLPPNLNDLASLDQTAGATPLPILYSGSDYRSGLALPAIDGLDSTTCVHGASFSDSEDESCVPLLRKESIQLRDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWMALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLPATYMNLGPSTSHEMNVRPEQPQFSPMPGNVRRPRPLSEPPRPT,1400,"152,241",Active site (1); Alternative sequence (8); Beta strand (57); Binding site (2); Chain (3); Compositional bias (2); Disulfide bond (11); Domain (5); Glycosylation (8); Helix (28); Modified residue (4); Natural variant (20); Nucleotide binding (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 101..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 107..162;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 135..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 174..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 300..367;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 385..407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 386..422;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 527..545;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 533..567;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 536..552;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""; DISULFID 548..558;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:22848655""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9H3S1,Semaphorin-4A (Semaphorin-B) (Sema B),MALPALGLDPWSLLGLFLFQLLQLLLPTTTAGGGGQGPMPRVRYYAGDERRALSFFHQKGLQDFDTLLLSGDGNTLYVGAREAILALDIQDPGVPRLKNMIPWPASDRKKSECAFKKKSNETQCFNFIRVLVSYNVTHLYTCGTFAFSPACTFIELQDSYLLPISEDKVMEGKGQSPFDPAHKHTAVLVDGMLYSGTMNNFLGSEPILMRTLGSQPVLKTDNFLRWLHHDASFVAAIPSTQVVYFFFEETASEFDFFERLHTSRVARVCKNDVGGEKLLQKKWTTFLKAQLLCTQPGQLPFNVIRHAVLLPADSPTAPHIYAVFTSQWQVGGTRSSAVCAFSLLDIERVFKGKYKELNKETSRWTTYRGPETNPRPGSCSVGPSSDKALTFMKDHFLMDEQVVGTPLLVKSGVEYTRLAVETAQGLDGHSHLVMYLGTTTGSLHKAVVSGDSSAHLVEEIQLFPDPEPVRNLQLAPTQGAVFVGFSGGVWRVPRANCSVYESCVDCVLARDPHCAWDPESRTCCLLSAPNLNSWKQDMERGNPEWACASGPMSRSLRPQSRPQIIKEVLAVPNSILELPCPHLSALASYYWSHGPAAVPEASSTVYNGSLLLIVQDGVGGLYQCWATENGFSYPVISYWVDSQDQTLALDPELAGIPREHVKVPLTRVSGGAALAAQQSYWPHFVTVTVLFALVLSGALIILVASPLRALRARGKVQGCETLRPGEKAPLSREQHLQSPKECRTSASDVDADNNCLGTEVA,761,"83,574",Alternative sequence (2); Chain (1); Disulfide bond (7); Domain (3); Glycosylation (4); Natural variant (4); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 113..124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 142..151;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 269..379;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 293..339;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 497..514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 506..523;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 580..624;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
B4DS77,Protein shisa-9,MRRVLRLLLGCFLTELCARVCRAQERAGHGQLAQLGGVLLLAGGNRSGAASGEASEGAEASDAPPTRAPTPDFCRGYFDVMGQWDPPFNCSSGDFIFCCGTCGFRFCCTFKKRRLNQSTCTNYDTPLWLNTGKPPARKDDPLHDPTKDKTNLIVYIICGVVAVMVLVGIFTKLGLEKAHRPQREHMSRALADVMRPQGHCNTDHMERDLNIVVHVQHYENMDTRTPINNLHATQMNNAVPTSPLLQQMGHPHSYPNLGQISNPYEQQPPGKELNKYASLKAVGSSDGDWAVSTLKSPKADKVNDDFYTKRRHLAELAAKGNLPLHPVRVEDEPRAFSPEHGPAKQNGQKSRTNKMPPHPLAYTSTTNFKGWDPNEQSLRRQAYSNKGKLGTAETGSSDPLGTRPQHYPPPQPYFITNSKTEVTV,424,"46,925",Alternative sequence (3); Chain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P53801,Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor),MAPGVARGPTPYWRLRLGGAALLLLLIPVAAAQEPPGAACSQNTNKTCEECLKNVSCLWCNTNKACLDYPVTSVLPPASLCKLSSARWGVCWVNFEALIITMSVVGGTLLLGIAICCCCCCRRKRSRKPDRSEEKAMREREERRIRQEERRAEMKTRHDEIRKKYGLFKEENPYARFENN,180,"20,324",Chain (1); Coiled coil (1); Compositional bias (1); Domain (1); Glycosylation (2); Modified residue (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
P08922,Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase),MKNIYCLIPKLVNFATLGCLWISVVQCTVLNSCLKSCVTNLGQQLDLGTPHNLSEPCIQGCHFWNSVDQKNCALKCRESCEVGCSSAEGAYEEEVLENADLPTAPFASSIGSHNMTLRWKSANFSGVKYIIQWKYAQLLGSWTYTKTVSRPSYVVKPLHPFTEYIFRVVWIFTAQLQLYSPPSPSYRTHPHGVPETAPLIRNIESSSPDTVEVSWDPPQFPGGPILGYNLRLISKNQKLDAGTQRTSFQFYSTLPNTIYRFSIAAVNEVGEGPEAESSITTSSSAVQQEEQWLFLSRKTSLRKRSLKHLVDEAHCLRLDAIYHNITGISVDVHQQIVYFSEGTLIWAKKAANMSDVSDLRIFYRGSGLISSISIDWLYQRMYFIMDELVCVCDLENCSNIEEITPPSISAPQKIVADSYNGYVFYLLRDGIYRADLPVPSGRCAEAVRIVESCTLKDFAIKPQAKRIIYFNDTAQVFMSTFLDGSASHLILPRIPFADVKSFACENNDFLVTDGKVIFQQDALSFNEFIVGCDLSHIEEFGFGNLVIFGSSSQLHPLPGRPQELSVLFGSHQALVQWKPPALAIGANVILISDIIELFELGPSAWQNWTYEVKVSTQDPPEVTHIFLNISGTMLNVPELQSAMKYKVSVRASSPKRPGPWSEPSVGTTLVPASEPPFIMAVKEDGLWSKPLNSFGPGEFLSSDIGNVSDMDWYNNSLYYSDTKGDVFVWLLNGTDISENYHLPSIAGAGALAFEWLGHFLYWAGKTYVIQRQSVLTGHTDIVTHVKLLVNDMVVDSVGGYLYWTTLYSVESTRLNGESSLVLQTQPWFSGKKVIALTLDLSDGLLYWLVQDSQCIHLYTAVLRGQSTGDTTITEFAAWSTSEISQNALMYYSGRLFWINGFRIITTQEIGQKTSVSVLEPARFNQFTIIQTSLKPLPGNFSFTPKVIPDSVQESSFRIEGNASSFQILWNGPPAVDWGVVFYSVEFSAHSKFLASEQHSLPVFTVEGLEPYALFNLSVTPYTYWGKGPKTSLSLRAPETVPSAPENPRIFILPSGKCCNKNEVVVEFRWNKPKHENGVLTKFEIFYNISNQSITNKTCEDWIAVNVTPSVMSFQLEGMSPRCFIAFQVRAFTSKGPGPYADVVKSTTSEINPFPHLITLLGNKIVFLDMDQNQVVWTFSAERVISAVCYTADNEMGYYAEGDSLFLLHLHNRSSSELFQDSLVFDITVITIDWISRHLYFALKESQNGMQVFDVDLEHKVKYPREVKIHNRNSTIISFSVYPLLSRLYWTEVSNFGYQMFYYSIISHTLHRILQPTATNQQNKRNQCSCNVTEFELSGAMAIDTSNLEKPLIYFAKAQEIWAMDLEGCQCWRVITVPAMLAGKTLVSLTVDGDLIYWIITAKDSTQIYQAKKGNGAIVSQVKALRSRHILAYSSVMQPFPDKAFLSLASDTVEPTILNATNTSLTIRLPLAKTNLTWYGITSPTPTYLVYYAEVNDRKNSSDLKYRILEFQDSIALIEDLQPFSTYMIQIAVKNYYSDPLEHLPPGKEIWGKTKNGVPEAVQLINTTVRSDTSLIISWRESHKPNGPKESVRYQLAISHLALIPETPLRQSEFPNGRLTLLVTRLSGGNIYVLKVLACHSEEMWCTESHPVTVEMFNTPEKPYSLVPENTSLQFNWKAPLNVNLIRFWVELQKWKYNEFYHVKTSCSQGPAYVCNITNLQPYTSYNVRVVVVYKTGENSTSLPESFKTKAGVPNKPGIPKLLEGSKNSIQWEKAEDNGCRITYYILEIRKSTSNNLQNQNLRWKMTFNGSCSSVCTWKSKNLKGIFQFRVVAANNLGFGEYSGISENIILVGDDFWIPETSFILTIIVGIFLVVTIPLTFVWHRRLKNQKSAKEGVTVLINEDKELAELRGLAAGVGLANACYAIHTLPTQEEIENLPAFPREKLTLRLLLGSGAFGEVYEGTAVDILGVGSGEIKVAVKTLKKGSTDQEKIEFLKEAHLMSKFNHPNILKQLGVCLLNEPQYIILELMEGGDLLTYLRKARMATFYGPLLTLVDLVDLCVDISKGCVYLERMHFIHRDLAARNCLVSVKDYTSPRIVKIGDFGLARDIYKNDYYRKRGEGLLPVRWMAPESLMDGIFTTQSDVWSFGILIWEILTLGHQPYPAHSNLDVLNYVQTGGRLEPPRNCPDDLWNLMTQCWAQEPDQRPTFHRIQDQLQLFRNFFLNSIYKSRDEANNSGVINESFEGEDGDVICLNSDDIMPVALMETKNREGLNYMVLATECGQGEEKSEGPLGSQESESCGLRKEEKEPHADKDFCQEKQVAYCPSGKPEGLNYACLTHSGYGDGSD,2347,"263,915",Active site (1); Beta strand (9); Binding site (1); Chain (1); Domain (10); Glycosylation (30); Helix (12); Modified residue (2); Mutagenesis (3); Natural variant (31); Nucleotide binding (1); Sequence conflict (2); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q7Z3Q1,Solute carrier family 46 member 3,MKILFVEPAIFLSAFAMTLTGPLTTQYVYRRIWEETGNYTFSSDSNISECEKNKSSPIFAFQEEVQKKVSRFNLQMDISGLIPGLVSTFILLSISDHYGRKFPMILSSVGALATSVWLCLLCYFAFPFQLLIASTFIGAFCGNYTTFWGACFAYIVDQCKEHKQKTIRIAIIDFLLGLVTGLTGLSSGYFIRELGFEWSFLIIAVSLAVNLIYILFFLGDPVKECSSQNVTMSCSEGFKNLFYRTYMLFKNASGKRRFLLCLLLFTVITYFFVVIGIAPIFILYELDSPLCWNEVFIGYGSALGSASFLTSFLGIWLFSYCMEDIHMAFIGIFTTMTGMAMTAFASTTLMMFLARVPFLFTIVPFSVLRSMLSKVVRSTEQGTLFACIAFLETLGGVTAVSTFNGIYSATVAWYPGFTFLLSAGLLLLPAISLCVVKCTSWNEGSYELLIQEESSEDASDR,461,"51,519",Alternative sequence (2); Chain (1); Frameshift (1); Glycosylation (3); Sequence conflict (4); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8N755,Solute carrier family 66 member 3 (PQ-loop repeat-containing protein 3),MEAALLGLCNWSTLGVCAALKLPQISAVLAARSARGLSLPSLLLELAGFLVFLRYQCYYGYPPLTYLEYPILIAQDVILLLCIFHFNGNVKQATPYIAVLVSSWFILALQKWIIDLAMNLCTFISAASKFAQLQCLWKTRDSGTVSALTWSLSSYTCATRIITTLMTTNDFTILLRFVIMLALNIWVTVTVLRYRKTAIKAE,202,"22,575",Alternative sequence (1); Chain (1); Signal peptide (1); Transmembrane (4),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8WVN6,Secreted and transmembrane protein 1 (Protein K-12),MQTCPLAFPGHVSQALGTLLFLAASLSAQNEGWDSPICTEGVVSVSWGENTVMSCNISNAFSHVNIKLRAHGQESAIFNEVAPGYFSRDGWQLQVQGGVAQLVIKGARDSHAGLYMWHLVGHQRNNRQVTLEVSGAEPQSAPDTGFWPVPAVVTAVFILLVALVMFAWYRCRCSQQRREKKFFLLEPQMKVAALRAGAQQGLSRASAELWTPDSEPTPRPLALVFKPSPLGALELLSPQPLFPYAADP,248,"27,039",Chain (1); Disulfide bond (1); Glycosylation (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..55;  /evidence=""ECO:0000255""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
O94991,SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11),MHTCCPPVTLEQDLHRKMHSWMLQTLAFAVTSLVLSCAETIDYYGEICDNACPCEEKDGILTVSCENRGIISLSEISPPRFPIYHLLLSGNLLNRLYPNEFVNYTGASILHLGSNVIQDIETGAFHGLRGLRRLHLNNNKLELLRDDTFLGLENLEYLQVDYNYISVIEPNAFGKLHLLQVLILNDNLLSSLPNNLFRFVPLTHLDLRGNRLKLLPYVGLLQHMDKVVELQLEENPWNCSCELISLKDWLDSISYSALVGDVVCETPFRLHGRDLDEVSKQELCPRRLISDYEMRPQTPLSTTGYLHTTPASVNSVATSSSAVYKPPLKPPKGTRQPNKPRVRPTSRQPSKDLGYSNYGPSIAYQTKSPVPLECPTACSCNLQISDLGLNVNCQERKIESIAELQPKPYNPKKMYLTENYIAVVRRTDFLEATGLDLLHLGNNRISMIQDRAFGDLTNLRRLYLNGNRIERLSPELFYGLQSLQYLFLQYNLIREIQSGTFDPVPNLQLLFLNNNLLQAMPSGVFSGLTLLRLNLRSNHFTSLPVSGVLDQLKSLIQIDLHDNPWDCTCDIVGMKLWVEQLKVGVLVDEVICKAPKKFAETDMRSIKSELLCPDYSDVVVSTPTPSSIQVPARTSAVTPAVRLNSTGAPASLGAGGGASSVPLSVLILSLLLVFIMSVFVAAGLFVLVMKRRKKNQSDHTSTNNSDVSSFNMQYSVYGGGGGTGGHPHAHVHHRGPALPKVKTPAGHVYEYIPHPLGHMCKNPIYRSREGNSVEDYKDLHELKVTYSSNHHLQQQQQPPPPPQQPQQQPPPQLQLQPGEEERRESHHLRSPAYSVSTIEPREDLLSPVQDADRFYRGILEPDKHCSTTPAGNSLPEYPKFPCSPAAYTFSPNYDLRRPHQYLHPGAGDSRLREPVLYSPPSAVFVEPNRNEYLELKAKLNVEPDYLEVLEKQTTFSQF,958,"107,486",Alternative sequence (2); Chain (1); Domain (3); Erroneous initiation (1); Glycosylation (2); Repeat (12); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..40;  /evidence=""ECO:0000255"""
O15120,1-acyl-sn-glycerol-3-phosphate acyltransferase beta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 2) (1-AGP acyltransferase 2) (1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta) (LPAAT-beta),MELWPCLAAALLLLLLLVQLSRAAEFYAKVALYCALCFTVSAVASLVCLLRHGGRTVENMSIIGWFVRSFKYFYGLRFEVRDPRRLQEARPCVIVSNHQSILDMMGLMEVLPERCVQIAKRELLFLGPVGLIMYLGGVFFINRQRSSTAMTVMADLGERMVRENLKVWIYPEGTRNDNGDLLPFKKGAFYLAVQAQVPIVPVVYSSFSSFYNTKKKFFTSGTVTVQVLEAIPTSGLTAADVPALVDTCHRAMRTTFLHISKTPQENGATAGSGVQPAQ,278,"30,914",Alternative sequence (1); Chain (1); Motif (2); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (3); Transmembrane (2),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P34925,Tyrosine-protein kinase RYK (EC 2.7.10.1),MRGAARLGRPGRSCLPGARGLRAPPPPPLLLLLALLPLLPAPGAAAAPAPRPPELQSASAGPSVSLYLSEDEVRRLIGLDAELYYVRNDLISHYALSFSLLVPSETNFLHFTWHAKSKVEYKLGFQVDNVLAMDMPQVNISVQGEVPRTLSVFRVELSCTGKVDSEVMILMQLNLTVNSSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAAPTTSTRVFYISVGVCCAVIFLVAIILAVLHLHSMKRIELDDSISASSSSQGLSQPSTQTTQYLRADTPNNATPITSYPTLRIEKNDLRSVTLLEAKGKVKDIAISRERITLKDVLQEGTFGRIFHGILIDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLLPITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSYLARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLVNNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVMACCWALDPEERPKFQQLVQCLTEFHAALGAYV,607,"67,815",Active site (1); Alternative sequence (1); Beta strand (7); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (2); Erroneous initiation (1); Frameshift (1); Glycosylation (5); Helix (18); Modified residue (1); Mutagenesis (3); Natural variant (3); Nucleotide binding (1); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 159..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00222""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9NTN9,Semaphorin-4G,MWGRLWPLLLSILTATAVPGPSLRRPSRELDATPRMTIPYEELSGTRHFKGQAQNYSTLLLEEASARLLVGARGALFSLSANDIGDGAHKEIHWEASPEMQSKCHQKGKNNQTECFNHVRFLQRLNSTHLYACGTHAFQPLCAAIDAEAFTLPTSFEEGKEKCPYDPARGFTGLIIDGGLYTATRYEFRSIPDIRRSRHPHSLRTEETPMHWLNDAEFVFSVLVRESKASAVGDDDKVYYFFTERATEEGSGSFTQSRSSHRVARVARVCKGDLGGKKILQKKWTSFLKARLICHIPLYETLRGVCSLDAETSSRTHFYAAFTLSTQWKTLEASAICRYDLAEIQAVFAGPYMEYQDGSRRWGRYEGGVPEPRPGSCITDSLRSQGYNSSQDLPSLVLDFVKLHPLMARPVVPTRGRPLLLKRNIRYTHLTGTPVTTPAGPTYDLLFLGTADGWIHKAVVLGSGMHIIEETQVFRESQSVENLVISLLQHSLYVGAPSGVIQLPLSSCSRYRSCYDCILARDPYCGWDPGTHACAAATTIANRTALIQDIERGNRGCESSRDTGPPPPLKTRSVLRGDDVLLPCDQPSNLARALWLLNGSMGLSDGQGGYRVGVDGLLVTDAQPEHSGNYGCYAEENGLRTLLASYSLTVRPATPAPAPKAPATPGAQLAPDVRLLYVLAIAALGGLCLILASSLLYVACLREGRRGRRRKYSLGRASRAGGSAVQLQTVSGQCPGEEDEGDDEGAGGLEGSCLQIIPGEGAPAPPPPPPPPPPAELTNGLVALPSRLRRMNGNSYVLLRQSNNGVPAGPCSFAEELSRILEKRKHTQLVEQLDESSV,838,"91,497",Alternative sequence (2); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (3); Erroneous initiation (1); Glycosylation (6); Modified residue (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 104..115;  /evidence=""ECO:0000250""; DISULFID 133..142;  /evidence=""ECO:0000250""; DISULFID 270..377;  /evidence=""ECO:0000250""; DISULFID 294..337;  /evidence=""ECO:0000250""; DISULFID 508..525;  /evidence=""ECO:0000250""; DISULFID 517..534;  /evidence=""ECO:0000250""; DISULFID 584..632;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9NPR2,Semaphorin-4B (Semaphorin-C),MLRTAMGLRSWLAAPWGALPPRPPLLLLLLLLLLLQPPPPTWALSPRISLPLGSEERPFLRFEAEHISNYTALLLSRDGRTLYVGAREALFALSSNLSFLPGGEYQELLWGADAEKKQQCSFKGKDPQRDCQNYIKILLPLSGSHLFTCGTAAFSPMCTYINMENFTLARDEKGNVLLEDGKGRCPFDPNFKSTALVVDGELYTGTVSSFQGNDPAISRSQSLRPTKTESSLNWLQDPAFVASAYIPESLGSLQGDDDKIYFFFSETGQEFEFFENTIVSRIARICKGDEGGERVLQQRWTSFLKAQLLCSRPDDGFPFNVLQDVFTLSPSPQDWRDTLFYGVFTSQWHRGTTEGSAVCVFTMKDVQRVFSGLYKEVNRETQQWYTVTHPVPTPRPGACITNSARERKINSSLQLPDRVLNFLKDHFLMDGQVRSRMLLLQPQARYQRVAVHRVPGLHHTYDVLFLGTGDGRLHKAVSVGPRVHIIEELQIFSSGQPVQNLLLDTHRGLLYAASHSGVVQVPMANCSLYRSCGDCLLARDPYCAWSGSSCKHVSLYQPQLATRPWIQDIEGASAKDLCSASSVVSPSFVPTGEKPCEQVQFQPNTVNTLACPLLSNLATRLWLRNGAPVNASASCHVLPTGDLLLVGTQQLGEFQCWSLEEGFQQLVASYCPEVVEDGVADQTDEGGSVPVIISTSRVSAPAGGKASWGADRSYWKEFLVMCTLFVLAVLLPVLFLLYRHRNSMKVFLKQGECASVHPKTCPVVLPPETRPLNGLGPPSTPLDHRGYQSLSDSPPGSRVFTESEKRPLSIQDSFVEVSPVCPRPRVRLGSEIRDSVV,837,"92,766",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (3); Erroneous initiation (2); Glycosylation (6); Modified residue (3); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 120..131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 149..158;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 286..399;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 310..359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 526..543;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 611..656;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..43;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BQ49,Small integral membrane protein 7,MIGDILLFGTLLMNAGAVLNFKLKKKDTQGFGEESREPSTGDNIREFLLSLRYFRIFIALWNIFMMFCMIVLFGS,75,"8,631",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q13308,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),MGAARGSPARPRRLPLLSVLLLPLLGGTQTAIVFIKQPSSQDALQGRRALLRCEVEAPGPVHVYWLLDGAPVQDTERRFAQGSSLSFAAVDRLQDSGTFQCVARDDVTGEEARSANASFNIKWIEAGPVVLKHPASEAEIQPQTQVTLRCHIDGHPRPTYQWFRDGTPLSDGQSNHTVSSKERNLTLRPAGPEHSGLYSCCAHSAFGQACSSQNFTLSIADESFARVVLAPQDVVVARYEEAMFHCQFSAQPPPSLQWLFEDETPITNRSRPPHLRRATVFANGSLLLTQVRPRNAGIYRCIGQGQRGPPIILEATLHLAEIEDMPLFEPRVFTAGSEERVTCLPPKGLPEPSVWWEHAGVRLPTHGRVYQKGHELVLANIAESDAGVYTCHAANLAGQRRQDVNITVATVPSWLKKPQDSQLEEGKPGYLDCLTQATPKPTVVWYRNQMLISEDSRFEVFKNGTLRINSVEVYDGTWYRCMSSTPAGSIEAQARVQVLEKLKFTPPPQPQQCMEFDKEATVPCSATGREKPTIKWERADGSSLPEWVTDNAGTLHFARVTRDDAGNYTCIASNGPQGQIRAHVQLTVAVFITFKVEPERTTVYQGHTALLQCEAQGDPKPLIQWKGKDRILDPTKLGPRMHIFQNGSLVIHDVAPEDSGRYTCIAGNSCNIKHTEAPLYVVDKPVPEESEGPGSPPPYKMIQTIGLSVGAAVAYIIAVLGLMFYCKKRCKAKRLQKQPEGEEPEMECLNGGPLQNGQPSAEIQEEVALTSLGSGPAATNKRHSTSDKMHFPRSSLQPITTLGKSEFGEVFLAKAQGLEEGVAETLVLVKSLQSKDEQQQLDFRRELEMFGKLNHANVVRLLGLCREAEPHYMVLEYVDLGDLKQFLRISKSKDEKLKSQPLSTKQKVALCTQVALGMEHLSNNRFVHKDLAARNCLVSAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAILEGDFSTKSDVWAFGVLMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWALSPKDRPSFSEIASALGDSTVDSKP,1070,"118,392",Alternative sequence (6); Beta strand (10); Chain (1); Disulfide bond (7); Domain (8); Glycosylation (10); Helix (13); Modified residue (1); Mutagenesis (3); Natural variant (9); Region (1); Sequence conflict (12); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 53..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 150..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 246..301;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 343..391;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 433..481;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 524..570;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 613..664;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q5VX71,Sushi domain-containing protein 4,MYHGMNPSNGDGFLEQQQQQQQPQSPQRLLAVILWFQLALCFGPAQLTGGFDDLQVCADPGIPENGFRTPSGGVFFEGSVARFHCQDGFKLKGATKRLCLKHFNGTLGWIPSDNSICVQEDCRIPQIEDAEIHNKTYRHGEKLIITCHEGFKIRYPDLHNMVSLCRDDGTWNNLPICQGCLRPLASSNGYVNISELQTSFPVGTVISYRCFPGFKLDGSAYLECLQNLIWSSSPPRCLALEVCPLPPMVSHGDFVCHPRPCERYNHGTVVEFYCDPGYSLTSDYKYITCQYGEWFPSYQVYCIKSEQTWPSTHETLLTTWKIVAFTATSVLLVLLLVILARMFQTKFKAHFPPRGPPRSSSSDPDFVVVDGVPVMLPSYDEAVSGGLSALGPGYMASVGQGCPLPVDDQSPPAYPGSGDTDTGPGESETCDSVSGSSELLQSLYSPPRCQESTHPASDNPDIIASTAEEVASTSPGIDIADEIPLMEEDP,490,"53,778",Alternative sequence (6); Chain (1); Disulfide bond (8); Domain (4); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 57..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 85..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 122..165;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 147..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 180..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 210..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 243..289;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 274..302;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
O60279,Sushi domain-containing protein 5,MTAEGPSPPARWHRRLPGLWAAALLLLGLPRLSVRADGKFFVLESQNGSQGLQLEAARLSCKSRGAHLASADELRRVVQDCSFAVCTTGWLADGTLGTTVCSKGSGEQQIMRAVDVRIESNPVPGGTYSALCIKDEEKPCGDPPSFPHTILQGRTGLEMGDELLYVCAPGHIMGHRETAFTLLCNSCGEWYGLVQACGKDEAEAHIDYEDNFPDDRSVSFRELMEDSRTEADEDRGQGDSSEEAPKQDRLVSISVGRENIARDKVFVPTTGLPGAGSSVPADSPGSRLLQKHLFWFPAEAFHKPGLEKEVDDDTKKQFSAGDNHSGVKLVPGEPETKVIYGNTDGPSGPFVGKNDSKAGDPVVSSSDESWLDGYPVTEGAWRKTEAEEEEDGDRGDGSVGLDENVLVTPDQPILVEVKKPKSSTLTPSEGMTHSSVLPSQMLDVEALALRPVNASETEGIGDGDLTKYQSTLPWRFITEESPMATLSYELTSSTLEILTVNTVKQTPNHIPSTIMATTQPPVETTVPEIQDSFPYLLSEDFFGQEGPGPGASEELHPTLESCVGDGCPGLSRGPVIATIVTVLCLLLLLAGVGMVWGYRKCQHKSSVYKLNVGQRQARHYHQQIEMEKV,629,"68,021",Chain (1); Disulfide bond (3); Domain (2); Erroneous initiation (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 61..132;  /evidence=""ECO:0000250""; DISULFID 140..184;  /evidence=""ECO:0000250""; DISULFID 167..197;  /evidence=""ECO:0000250""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
P43307,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),MRLLPRLLLLLLLVFPATVLFRGGPRGLLAVAQDLTEDEETVEDSIIEDEDDEAEVEEDEPTDLVEDKEEEDVSGEPEASPSADTTILFVKGEDFPANNIVKFLVGFTNKGTEDFIVESLDASFRYPQDYQFYIQNFTALPLNTVVPPQRQATFEYSFIPAEPMGGRPFGLVINLNYKDLNGNVFQDAVFNQTVTVIEREDGLDGETIFMYMFLAGLGLLVIVGLHQLLESRKRKRPIQKVEMGTSSQNDVDMSWIPQETLNQINKASPRRLPRKRAQKRSVGSDE,286,"32,235",Alternative sequence (1); Chain (1); Glycosylation (2); Modified residue (3); Natural variant (1); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:1557127"""
Q9UQF0,Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein (SU) (gp50); Transmembrane protein (TM) (gp24)],MALPYHIFLFTVLLPSFTLTAPPPCRCMTSSSPYQEFLWRMQRPGNIDAPSYRSLSKGTPTFTAHTHMPRNCYHSATLCMHANTHYWTGKMINPSCPGGLGVTVCWTYFTQTGMSDGGGVQDQAREKHVKEVISQLTRVHGTSSPYKGLDLSKLHETLRTHTRLVSLFNTTLTGLHEVSAQNPTNCWICLPLNFRPYVSIPVPEQWNNFSTEINTTSVLVGPLVSNLEITHTSNLTCVKFSNTTYTTNSQCIRWVTPPTQIVCLPSGIFFVCGTSAYRCLNGSSESMCFLSFLVPPMTIYTEQDLYSYVISKPRNKRVPILPFVIGAGVLGALGTGIGGITTSTQFYYKLSQELNGDMERVADSLVTLQDQLNSLAAVVLQNRRALDLLTAERGGTCLFLGEECCYYVNQSGIVTEKVKEIRDRIQRRAEELRNTGPWGLLSQWMPWILPFLGPLAAIILLLLFGPCIFNLLVNFVSSRIEAVKLQMEPKMQSKTKIYRRPLDRPASPRSDVNDIKGTPPEEISAAQPLLRPNSAGSS,538,"59,866",Chain (3); Disulfide bond (3); Glycosylation (7); Helix (4); Motif (2); Mutagenesis (3); Natural variant (4); Region (3); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 186..405;  /note=""Interchain (between SU and TM chains, or C-189 with C-405); in linked form"";  /evidence=""ECO:0000305|PubMed:15827173""; DISULFID 186..189;  /evidence=""ECO:0000250|UniProtKB:P23064""; DISULFID 397..404;  /evidence=""ECO:0000250|UniProtKB:P60508""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q4V9L6,Transmembrane protein 119 (Osteoblast induction factor) (OBIF),MVSAAAPSLLILLLLLLGSVPATDARSVPLKATFLEDVAGSGEAEGSSASSPSLPPPWTPALSPTSMGPQPITLGGPSPPTNFLDGIVDFFRQYVMLIAVVGSLAFLLMFIVCAAVITRQKQKASAYYPSSFPKKKYVDQSDRAGGPRAFSEVPDRAPDSRPEEALDSSRQLQADILAATQNLKSPTRAALGGGDGARMVEGRGAEEEEKGSQEGDQEVQGHGVPVETPEAQEEPCSGVLEGAVVAGEGQGELEGSLLLAQEAQGPVGPPESPCACSSVHPSV,283,"29,203",Chain (1); Glycosylation (1); Modified residue (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q92544,Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1),MATAMDWLPWSLLLFSLMCETSAFYVPGVAPINFHQNDPVEIKAVKLTSSRTQLPYEYYSLPFCQPSKITYKAENLGEVLRGDRIVNTPFQVLMNSEKKCEVLCSQSNKPVTLTVEQSRLVAERITEDYYVHLIADNLPVATRLELYSNRDSDDKKKEKDVQFEHGYRLGFTDVNKIYLHNHLSFILYYHREDMEEDQEHTYRVVRFEVIPQSIRLEDLKADEKSSCTLPEGTNSSPQEIDPTKENQLYFTYSVHWEESDIKWASRWDTYLTMSDVQIHWFSIINSVVVVFFLSGILSMIIIRTLRKDIANYNKEDDIEDTMEESGWKLVHGDVFRPPQYPMILSSLLGSGIQLFCMILIVIFVAMLGMLSPSSRGALMTTACFLFMFMGVFGGFSAGRLYRTLKGHRWKKGAFCTATLYPGVVFGICFVLNCFIWGKHSSGAVPFPTMVALLCMWFGISLPLVYLGYYFGFRKQPYDNPVRTNQIPRQIPEQRWYMNRFVGILMAGILPFGAMFIELFFIFSAIWENQFYYLFGFLFLVFIILVVSCSQISIVMVYFQLCAEDYRWWWRNFLVSGGSAFYVLVYAIFYFVNKLDIVEFIPSLLYFGYTALMVLSFWLLTGTIGFYAAYMFVRKIYAAVKID,642,"74,519",Chain (1); Erroneous initiation (2); Modified residue (1); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9Y3Q3,Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26),MGSTVPRSASVLLLLLLLRRAEQPCGAELTFELPDNAKQCFHEEVEQGVKFSLDYQVITGGHYDVDCYVEDPQGNTIYRETKKQYDSFTYRAEVKGVYQFCFSNEFSTFSHKTVYFDFQVGDEPPILPDMGNRVTALTQMESACVTIHEALKTVIDSQTHYRLREAQDRARAEDLNSRVSYWSVGETIALFVVSFSQVLLLKSFFTEKRPISRAVHS,217,"24,777",Alternative sequence (1); Chain (1); Domain (1); Motif (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9BYH1,Seizure 6-like protein,MPAARPPAAGLRGISLFLALLLGSPAAALERDALPEGDASPLGPYLLPSGAPERGSPGKEHPEERVVTAPPSSSQSAEVLGELVLDGTAPSAHHDIPALSPLLPEEARPKHALPPKKKLPSLKQVNSARKQLRPKATSAATVQRAGSQPASQGLDLLSSSTEKPGPPGDPDPIVASEEASEVPLWLDRKESAVPTTPAPLQISPFTSQPYVAHTLPQRPEPGEPGPDMAQEAPQEDTSPMALMDKGENELTGSASEESQETTTSTIITTTVITTEQAPALCSVSFSNPEGYIDSSDYPLLPLNNFLECTYNVTVYTGYGVELQVKSVNLSDGELLSIRGVDGPTLTVLANQTLLVEGQVIRSPTNTISVYFRTFQDDGLGTFQLHYQAFMLSCNFPRRPDSGDVTVMDLHSGGVAHFHCHLGYELQGAKMLTCINASKPHWSSQEPICSAPCGGAVHNATIGRVLSPSYPENTNGSQFCIWTIEAPEGQKLHLHFERLLLHDKDRMTVHSGQTNKSALLYDSLQTESVPFEGLLSEGNTIRIEFTSDQARAASTFNIRFEAFEKGHCYEPYIQNGNFTTSDPTYNIGTIVEFTCDPGHSLEQGPAIIECINVRDPYWNDTEPLCRAMCGGELSAVAGVVLSPNWPEPYVEGEDCIWKIHVGEEKRIFLDIQFLNLSNSDILTIYDGDEVMPHILGQYLGNSGPQKLYSSTPDLTIQFHSDPAGLIFGKGQGFIMNYIEVSRNDSCSDLPEIQNGWKTTSHTELVRGARITYQCDPGYDIVGSDTLTCQWDLSWSSDPPFCEKIMYCTDPGEVDHSTRLISDPVLLVGTTIQYTCNPGFVLEGSSLLTCYSRETGTPIWTSRLPHCVSEESLACDNPGLPENGYQILYKRLYLPGESLTFMCYEGFELMGEVTIRCILGQPSHWNGPLPVCKVNQDSFEHALEVAEAAAETSLEGGNMALAIFIPVLIISLLLGGAYIYITRCRYYSNLRLPLMYSHPYSQITVETEFDNPIYETGETREYEVSI,1024,"111,782",Alternative sequence (7); Beta strand (7); Chain (1); Disulfide bond (11); Domain (8); Erroneous initiation (1); Glycosylation (12); Natural variant (4); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 281..308;  /evidence=""ECO:0000250""; DISULFID 393..433;  /evidence=""ECO:0000250""; DISULFID 419..448;  /evidence=""ECO:0000250""; DISULFID 567..609;  /evidence=""ECO:0000250""; DISULFID 594..624;  /evidence=""ECO:0000250""; DISULFID 745..787;  /evidence=""ECO:0000269|Ref.10""; DISULFID 773..800;  /evidence=""ECO:0000269|Ref.10""; DISULFID 806..848;  /evidence=""ECO:0000250""; DISULFID 834..865;  /evidence=""ECO:0000250""; DISULFID 873..915;  /evidence=""ECO:0000250""; DISULFID 901..930;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q07699,Sodium channel subunit beta-1,MGRLLALVVGAALVSSACGGCVEVDSETEAVYGMTFKILCISCKRRSETNAETFTEWTFRQKGTEEFVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIFITNVTYNHSGDYECHVYRLLFFENYEHNTSVVKKIHIEVVDKANRDMASIVSEIMMYVLIVVLTIWLVAEMIYCYKKIAAATETAAQENASEYLAITSESKENCTGVQVAE,218,"24,707",Alternative sequence (1); Beta strand (14); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (2); Natural variant (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 21..43;  /evidence=""ECO:0000244|PDB:6AGF, ECO:0000244|PDB:6J8G, ECO:0000244|PDB:6J8H, ECO:0000244|PDB:6J8I, ECO:0000244|PDB:6J8J, ECO:0000269|PubMed:30190309, ECO:0000269|PubMed:30765606""; DISULFID 40..121;  /evidence=""ECO:0000244|PDB:6AGF, ECO:0000244|PDB:6J8G, ECO:0000244|PDB:6J8H, ECO:0000244|PDB:6J8I, ECO:0000244|PDB:6J8J, ECO:0000269|PubMed:30190309, ECO:0000269|PubMed:30765606""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9UIB8,SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84),MAQHHLWILLLCLQTWPEAAGKDSEIFTVNGILGESVTFPVNIQEPRQVKIIAWTSKTSVAYVTPGDSETAPVVTVTHRNYYERIHALGPNYNLVISDLRMEDAGDYKADINTQADPYTTTKRYNLQIYRRLGKPKITQSLMASVNSTCNVTLTCSVEKEEKNVTYNWSPLGEEGNVLQIFQTPEDQELTYTCTAQNPVSNNSDSISARQLCADIAMGFRTHHTGLLSVLAMFFLLVLILSSVFLFRLFKRRQGRIFPEGSCLNTFTKNPYAASKKTIYTYIMASRNTQPAESRIYDEILQSKVLPSKEEPVNTVYSEVQFADKMGKASTQDSKPPGTSSYEIVI,345,"38,782",Alternative sequence (9); Beta strand (9); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (1); Helix (2); Modified residue (4); Motif (2); Mutagenesis (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 155..193;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:10698700"""
Q96DD7,Protein shisa-4 (Transmembrane protein 58),MPPAGLRRAAPLTAIALLVLGAPLVLAGEDCLWYLDRNGSWHPGFNCEFFTFCCGTCYHRYCCRDLTLLITERQQKHCLAFSPKTIAGIASAVILFVAVVATTICCFLCSCCYLYRRRQQLQSPFEGQEIPMTGIPVQPVYPYPQDPKAGPAPPQPGFIYPPSGPAPQYPLYPAGPPVYNPAAPPPYMPPQPSYPGA,197,"21,522",Chain (1); Compositional bias (1); Erroneous initiation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8IV31,Transmembrane protein 139,MVPMHLLGRLEKPLLLLCCASFLLGLALLGIKTDITPVAYFFLTLGGFFLFAYLLVRFLEWGLRSQLQSMQTESPGPSGNARDNEAFEVPVYEEAVVGLESQCRPQELDQPPPYSTVVIPPAPEEEQPSHPEGSRRAKLEQRRMASEGSMAQEGSPGRAPINLRLRGPRAVSTAPDLQSLAAVPTLEPLTPPPAYDVCFGHPDDDSVFYEDNWAPP,216,"23,729",Chain (1); Erroneous initiation (1); Modified residue (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q4KMG9,Transmembrane protein 52B,MGVRVHVVAASALLYFILLSGTRCEENCGNPEHCLTTDWVHLWYIWLLVVIGALLLLCGLTSLCFRCCCLSRQQNGEDGGPPPCEVTVIAFDHDSTLQSTITSLQSVFGPAARRILAVAHSHSSLGQLPSSLDTLPGYEEALHMSRFTVAMCGQKAPDLPPVPEEKQLPPTEKESTRIVDSWN,183,"20,002",Alternative sequence (1); Chain (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P23467,Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP),MLSHGAGLALWITLSLLQTGLAEPERCNFTLAESKASSHSVSIQWRILGSPCNFSLIYSSDTLGAALCPTFRIDNTTYGCNLQDLQAGTIYNFRIISLDEERTVVLQTDPLPPARFGVSKEKTTSTSLHVWWTPSSGKVTSYEVQLFDENNQKIQGVQIQESTSWNEYTFFNLTAGSKYNIAITAVSGGKRSFSVYTNGSTVPSPVKDIGISTKANSLLISWSHGSGNVERYRLMLMDKGILVHGGVVDKHATSYAFHGLTPGYLYNLTVMTEAAGLQNYRWKLVRTAPMEVSNLKVTNDGSLTSLKVKWQRPPGNVDSYNITLSHKGTIKESRVLAPWITETHFKELVPGRLYQVTVSCVSGELSAQKMAVGRTFPDKVANLEANNNGRMRSLVVSWSPPAGDWEQYRILLFNDSVVLLNITVGKEETQYVMDDTGLVPGRQYEVEVIVESGNLKNSERCQGRTVPLAVLQLRVKHANETSLSIMWQTPVAEWEKYIISLADRDLLLIHKSLSKDAKEFTFTDLVPGRKYMATVTSISGDLKNSSSVKGRTVPAQVTDLHVANQGMTSSLFTNWTQAQGDVEFYQVLLIHENVVIKNESISSETSRYSFHSLKSGSLYSVVVTTVSGGISSRQVVVEGRTVPSSVSGVTVNNSGRNDYLSVSWLLAPGDVDNYEVTLSHDGKVVQSLVIAKSVRECSFSSLTPGRLYTVTITTRSGKYENHSFSQERTVPDKVQGVSVSNSARSDYLRVSWVHATGDFDHYEVTIKNKNNFIQTKSIPKSENECVFVQLVPGRLYSVTVTTKSGQYEANEQGNGRTIPEPVKDLTLRNRSTEDLHVTWSGANGDVDQYEIQLLFNDMKVFPPFHLVNTATEYRFTSLTPGRQYKILVLTISGDVQQSAFIEGFTVPSAVKNIHISPNGATDSLTVNWTPGGGDVDSYTVSAFRHSQKVDSQTIPKHVFEHTFHRLEAGEQYQIMIASVSGSLKNQINVVGRTVPASVQGVIADNAYSSYSLIVSWQKAAGVAERYDILLLTENGILLRNTSEPATTKQHKFEDLTPGKKYKIQILTVSGGLFSKEAQTEGRTVPAAVTDLRITENSTRHLSFRWTASEGELSWYNIFLYNPDGNLQERAQVDPLVQSFSFQNLLQGRMYKMVIVTHSGELSNESFIFGRTVPASVSHLRGSNRNTTDSLWFNWSPASGDFDFYELILYNPNGTKKENWKDKDLTEWRFQGLVPGRKYVLWVVTHSGDLSNKVTAESRTAPSPPSLMSFADIANTSLAITWKGPPDWTDYNDFELQWLPRDALTVFNPYNNRKSEGRIVYGLRPGRSYQFNVKTVSGDSWKTYSKPIFGSVRTKPDKIQNLHCRPQNSTAIACSWIPPDSDFDGYSIECRKMDTQEVEFSRKLEKEKSLLNIMMLVPHKRYLVSIKVQSAGMTSEVVEDSTITMIDRPPPPPPHIRVNEKDVLISKSSINFTVNCSWFSDTNGAVKYFTVVVREADGSDELKPEQQHPLPSYLEYRHNASIRVYQTNYFASKCAENPNSNSKSFNIKLGAEMESLGGKCDPTQQKFCDGPLKPHTAYRISIRAFTQLFDEDLKEFTKPLYSDTFFSLPITTESEPLFGAIEGVSAGLFLIGMLVAVVALLICRQKVSHGRERPSARLSIRRDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQENPLFPIYENVNPEYHRDPVYSRH,1997,"224,301",Active site (1); Alternative sequence (3); Beta strand (16); Binding site (2); Chain (1); Domain (18); Glycosylation (26); Helix (10); Modified residue (1); Natural variant (7); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P23471,Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2),MRILKRFLACIQLLCVCRLDWANGYYRQQRKLVEEIGWSYTGALNQKNWGKKYPTCNSPKQSPINIDEDLTQVNVNLKKLKFQGWDKTSLENTFIHNTGKTVEINLTNDYRVSGGVSEMVFKASKITFHWGKCNMSSDGSEHSLEGQKFPLEMQIYCFDADRFSSFEEAVKGKGKLRALSILFEVGTEENLDFKAIIDGVESVSRFGKQAALDPFILLNLLPNSTDKYYIYNGSLTSPPCTDTVDWIVFKDTVSISESQLAVFCEVLTMQQSGYVMLMDYLQNNFREQQYKFSRQVFSSYTGKEEIHEAVCSSEPENVQADPENYTSLLVTWERPRVVYDTMIEKFAVLYQQLDGEDQTKHEFLTDGYQDLGAILNNLLPNMSYVLQIVAICTNGLYGKYSDQLIVDMPTDNPELDLFPELIGTEEIIKEEEEGKDIEEGAIVNPGRDSATNQIRKKEPQISTTTHYNRIGTKYNEAKTNRSPTRGSEFSGKGDVPNTSLNSTSQPVTKLATEKDISLTSQTVTELPPHTVEGTSASLNDGSKTVLRSPHMNLSGTAESLNTVSITEYEEESLLTSFKLDTGAEDSSGSSPATSAIPFISENISQGYIFSSENPETITYDVLIPESARNASEDSTSSGSEESLKDPSMEGNVWFPSSTDITAQPDVGSGRESFLQTNYTEIRVDESEKTTKSFSAGPVMSQGPSVTDLEMPHYSTFAYFPTEVTPHAFTPSSRQQDLVSTVNVVYSQTTQPVYNGETPLQPSYSSEVFPLVTPLLLDNQILNTTPAASSSDSALHATPVFPSVDVSFESILSSYDGAPLLPFSSASFSSELFRHLHTVSQILPQVTSATESDKVPLHASLPVAGGDLLLEPSLAQYSDVLSTTHAASETLEFGSESGVLYKTLMFSQVEPPSSDAMMHARSSGPEPSYALSDNEGSQHIFTVSYSSAIPVHDSVGVTYQGSLFSGPSHIPIPKSSLITPTASLLQPTHALSGDGEWSGASSDSEFLLPDTDGLTALNISSPVSVAEFTYTTSVFGDDNKALSKSEIIYGNETELQIPSFNEMVYPSESTVMPNMYDNVNKLNASLQETSVSISSTKGMFPGSLAHTTTKVFDHEISQVPENNFSVQPTHTVSQASGDTSLKPVLSANSEPASSDPASSEMLSPSTQLLFYETSASFSTEVLLQPSFQASDVDTLLKTVLPAVPSDPILVETPKVDKISSTMLHLIVSNSASSENMLHSTSVPVFDVSPTSHMHSASLQGLTISYASEKYEPVLLKSESSHQVVPSLYSNDELFQTANLEINQAHPPKGRHVFATPVLSIDEPLNTLINKLIHSDEILTSTKSSVTGKVFAGIPTVASDTFVSTDHSVPIGNGHVAITAVSPHRDGSVTSTKLLFPSKATSELSHSAKSDAGLVGGGEDGDTDDDGDDDDDDRGSDGLSIHKCMSCSSYRESQEKVMNDSDTHENSLMDQNNPISYSLSENSEEDNRVTSVSSDSQTGMDRSPGKSPSANGLSQKHNDGKEENDIQTGSALLPLSPESKAWAVLTSDEESGSGQGTSDSLNENETSTDFSFADTNEKDADGILAAGDSEITPGFPQSPTSSVTSENSEVFHVSEAEASNSSHESRIGLAEGLESEKKAVIPLVIVSALTFICLVVLVGILIYWRKCFQTAHFYLEDSTSPRVISTPPTPIFPISDDVGAIPIKHFPKHVADLHASSGFTEEFETLKEFYQEVQSCTVDLGITADSSNHPDNKHKNRYINIVAYDHSRVKLAQLAEKDGKLTDYINANYVDGYNRPKAYIAAQGPLKSTAEDFWRMIWEHNVEVIVMITNLVEKGRRKCDQYWPADGSEEYGNFLVTQKSVQVLAYYTVRNFTLRNTKIKKGSQKGRPSGRVVTQYHYTQWPDMGVPEYSLPVLTFVRKAAYAKRHAVGPVVVHCSAGVGRTGTYIVLDSMLQQIQHEGTVNIFGFLKHIRSQRNYLVQTEEQYVFIHDTLVEAILSKETEVLDSHIHAYVNALLIPGPAGKTKLEKQFQLLSQSNIQQSDYSAALKQCNREKNRTSSIIPVERSRVGISSLSGEGTDYINASYIMGYYQSNEFIITQHPLLHTIKDFWRMIWDHNAQLVVMIPDGQNMAEDEFVYWPNKDEPINCESFKVTLMAEEHKCLSNEEKLIIQDFILEATQDDYVLEVRHFQCPKWPNPDSPISKTFELISVIKEEAANRDGPMIVHDEHGGVTAGTFCALTTLMHQLEKENSVDVYQVAKMINLMRPGVFADIEQYQFLYKVILSLVSTRQEENPSTSLDSNGAALPDGNIAESLESLV,2315,"254,587",Active site (1); Alternative sequence (2); Beta strand (30); Binding site (2); Chain (1); Disulfide bond (2); Domain (4); Glycosylation (24); Helix (21); Modified residue (5); Natural variant (3); Region (1); Sequence caution (1); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 56..240;  /evidence=""ECO:0000269|PubMed:20133774""; DISULFID 133..264;  /evidence=""ECO:0000269|PubMed:20133774""","SIGNAL 1..24;  /evidence=""ECO:0000250"""
Q8TCT8,Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2),MGPQRRLSPAGAALLWGFLLQLTAAQEAILHASGNGTTKDYCMLYNPYWTALPSTLENATSISLMNLTSTPLCNLSDIPPVGIKSKAVVVPWGSCHFLEKARIAQKGGAEAMLVVNNSVLFPPSGNRSEFPDVKILIAFISYKDFRDMNQTLGDNITVKMYSPSWPNFDYTMVVIFVIAVFTVALGGYWSGLVELENLKAVTTEDREMRKKKEEYLTFSPLTVVIFVVICCVMMVLLYFFYKWLVYVMIAIFCIASAMSLYNCLAALIHKIPYGQCTIACRGKNMEVRLIFLSGLCIAVAVVWAVFRNEDRWAWILQDILGIAFCLNLIKTLKLPNFKSCVILLGLLLLYDVFFVFITPFITKNGESIMVELAAGPFGNNEKLPVVIRVPKLIYFSVMSVCLMPVSILGFGDIIVPGLLIAYCRRFDVQTGSSYIYYVSSTVAYAIGMILTFVVLVLMKKGQPALLYLVPCTLITASVVAWRRKEMKKFWKGNSYQMMDHLDCATNEENPVISGEQIVQQ,520,"58,143",Active site (2); Chain (1); Domain (1); Erroneous initiation (2); Glycosylation (7); Motif (2); Mutagenesis (1); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15385547"""
Q6UXZ0,Transmembrane and immunoglobulin domain-containing protein 1,MAWKSSVIMQMGRFLLLVILFLPREMTSSVLTVNGKTENYILDTTPGSQASLICAVQNHTREEELLWYREEGRVDLKSGNKINSSSVCVSSISENDNGISFTCRLGRDQSVSVSVVLNVTFPPLLSGNDFQTVEEGSNVKLVCNVKANPQAQMMWYKNSSLLDLEKSRHQIQQTSESFQLSITKVEKPDNGTYSCIAKSSLKTESLDFHLIVKDKTVGVPIEPIIAACVVIFLTLCFGLIARRKKIMKLCMKDKDPHSETAL,262,"29,185",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
P14679,Tyrosinase (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB),MLLAVLYCLLWSFQTSAGHFPRACVSSKNLMEKECCPPWSGDRSPCGQLSGRGSCQNILLSNAPLGPQFPFTGVDDRESWPSVFYNRTCQCSGNFMGFNCGNCKFGFWGPNCTERRLLVRRNIFDLSAPEKDKFFAYLTLAKHTISSDYVIPIGTYGQMKNGSTPMFNDINIYDLFVWMHYYVSMDALLGGSEIWRDIDFAHEAPAFLPWHRLFLLRWEQEIQKLTGDENFTIPYWDWRDAEKCDICTDEYMGGQHPTNPNLLSPASFFSSWQIVCSRLEEYNSHQSLCNGTPEGPLRRNPGNHDKSRTPRLPSSADVEFCLSLTQYESGSMDKAANFSFRNTLEGFASPLTGIADASQSSMHNALHIYMNGTMSQVQGSANDPIFLLHHAFVDSIFEQWLRRHRPLQEVYPEANAPIGHNRESYMVPFIPLYRNGDFFISSKDLGYDYSYLQDSDPDSFQDYIKSYLEQASRIWSWLLGAAMVGAVLTALLAGLVSLLCRHKRKQLPEEKQPLLMEKEDYHSLYQSHL,529,"60,393",Alternative sequence (2); Chain (1); Erroneous initiation (2); Glycosylation (6); Metal binding (6); Natural variant (119); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
P16473,Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R),MRPADLLQLVLLLDLPRDLGGMGCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTLKKLPLSLSFLHLTRADLSYPSHCCAFKNQKKIRGILESLMCNESSMQSLRQRKSVNALNSPLHQEYEENLGDSIVGYKEKSKFQDTHNNAHYYVFFEEQEDEIIGFGQELKNPQEETLQAFDSHYDYTICGDSEDMVCTPKSDEFNPCEDIMGYKFLRIVVWFVSLLALLGNVFVLLILLTSHYKLNVPRFLMCNLAFADFCMGMYLLLIASVDLYTHSEYYNHAIDWQTGPGCNTAGFFTVFASELSVYTLTVITLERWYAITFAMRLDRKIRLRHACAIMVGGWVCCFLLALLPLVGISSYAKVSICLPMDTETPLALAYIVFVLTLNIVAFVIVCCCYVKIYITVRNPQYNPGDKDTKIAKRMAVLIFTDFICMAPISFYALSAILNKPLITVSNSKILLVLFYPLNSCANPFLYAIFTKAFQRDVFILLSKFGICKRQAQAYRGQRVPPKNSTDIQVQKVTHDMRQGLHNMEDVYELIENSHLTPKKQGQISEEYMQTVL,764,"86,830",Alternative sequence (4); Beta strand (16); Chain (1); Disulfide bond (2); Frameshift (1); Glycosylation (6); Modified residue (1); Motif (1); Mutagenesis (7); Natural variant (70); Repeat (7); Sequence conflict (17); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (6),"DISULFID 31..41; DISULFID 494..569;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""",SIGNAL 1..20
Q96LC7,Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2),MLLPLLLSSLLGGSQAMDGRFWIRVQESVMVPEGLCISVPCSFSYPRQDWTGSTPAYGYWFKAVTETTKGAPVATNHQSREVEMSTRGRFQLTGDPAKGNCSLVIRDAQMQDESQYFFRVERGSYVRYNFMNDGFFLKVTALTQKPDVYIPETLEPGQPVTVICVFNWAFEECPPPSFSWTGAALSSQGTKPTTSHFSVLSFTPRPQDHNTDLTCHVDFSRKGVSAQRTVRLRVAYAPRDLVISISRDNTPALEPQPQGNVPYLEAQKGQFLRLLCAADSQPPATLSWVLQNRVLSSSHPWGPRPLGLELPGVKAGDSGRYTCRAENRLGSQQRALDLSVQYPPENLRVMVSQANRTVLENLGNGTSLPVLEGQSLCLVCVTHSSPPARLSWTQRGQVLSPSQPSDPGVLELPRVQVEHEGEFTCHARHPLGSQHVSLSLSVHYSPKLLGPSCSWEAEGLHCSCSSQASPAPSLRWWLGEELLEGNSSQDSFEVTPSSAGPWANSSLSLHGGLSSGLRLRCEAWNVHGAQSGSILQLPDKKGLISTAFSNGAFLGIGITALLFLCLALIIMKILPKRRTQTETPRPRFSRHSTILDYINVVPTAGPLAQKRNQKATPNSPRTPLPPGAPSPESKKNQKKQYQLPSFPEPKSSTQAPESQESQEELHYATLNFPGVRPRPEARMPKGTQADYAEVKFQ,697,"76,592",Alternative sequence (9); Binding site (1); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (5); Modified residue (1); Motif (2); Mutagenesis (2); Natural variant (2); Sequence conflict (10); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..173;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 41..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 164..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 276..323;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 380..425;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q8WWQ8,"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]",MMLQHLVIFCLGLVVQNFCSPAETTGQARRCDRKSLLTIRTECRSCALNLGVKCPDGYTMITSGSVGVRDCRYTFEVRTYSLSLPGCRHICRKDYLQPRCCPGRWGPDCIECPGGAGSPCNGRGSCAEGMEGNGTCSCQEGFGGTACETCADDNLFGPSCSSVCNCVHGVCNSGLDGDGTCECYSAYTGPKCDKPIPECAALLCPENSRCSPSTEDENKLECKCLPNYRGDGKYCDPINPCLRKICHPHAHCTYLGPNRHSCTCQEGYRGDGQVCLPVDPCQINFGNCPTKSTVCKYDGPGQSHCECKEHYQNFVPGVGCSMTDICKSDNPCHRNANCTTVAPGRTECICQKGYVGDGLTCYGNIMERLRELNTEPRGKWQGRLTSFISLLDKAYAWPLSKLGPFTVLLPTDKGLKGFNVNELLVDNKAAQYFVKLHIIAGQMNIEYMNNTDMFYTLTGKSGEIFNSDKDNQIKLKLHGGKKKVKIIQGDIIASNGLLHILDRAMDKLEPTFESNNEQTIMTMLQPRYSKFRSLLEETNLGHALDEDGVGGPYTIFVPNNEALNNMKDGTLDYLLSPEGSRKLLELVRYHIVPFTQLEVATLISTPHIRSMANQLIQFNTTDNGQILANDVAMEEIEITAKNGRIYTLTGVLIPPSIVPILPHRCDETKREMKLGTCVSCSLVYWSRCPANSEPTALFTHRCVYSGRFGSLKSGCARYCNATVKIPKCCKGFYGPDCNQCPGGFSNPCSGNGQCADSLGGNGTCICEEGFQGSQCQFCSDPNKYGPRCNKKCLCVHGTCNNRIDSDGACLTGTCRDGSAGRLCDKQTSACGPYVQFCHIHATCEYSNGTASCICKAGYEGDGTLCSEMDPCTGLTPGGCSRNAECIKTGTGTHTCVCQQGWTGNGRDCSEINNCLLPSAGGCHDNASCLYVGPGQNECECKKGFRGNGIDCEPITSCLEQTGKCHPLASCQSTSSGVWSCVCQEGYEGDGFLCYGNAAVELSFLSEAAIFNRWINNASLQPTLSATSNLTVLVPSQQATEDMDQDEKSFWLSQSNIPALIKYHMLLGTYRVADLQTLSSSDMLATSLQGNFLHLAKVDGNITIEGASIVDGDNAATNGVIHIINKVLVPQRRLTGSLPNLLMRLEQMPDYSIFRGYIIQYNLANAIEAADAYTVFAPNNNAIENYIREKKVLSLEEDVLRYHVVLEEKLLKNDLHNGMHRETMLGFSYFLSFFLHNDQLYVNEAPINYTNVATDKGVIHGLGKVLEIQKNRCDNNDTTIIRGRCRTCSSELTCPFGTKSLGNEKRRCIYTSYFMGRRTLFIGCQPKCVRTVITRECCAGFFGPQCQPCPGNAQNVCFGNGICLDGVNGTGVCECGEGFSGTACETCTEGKYGIHCDQACSCVHGRCNQGPLGDGSCDCDVGWRGVHCDNATTEDNCNGTCHTSANCLTNSDGTASCKCAAGFQGNGTICTAINACEISNGGCSAKADCKRTTPGRRVCTCKAGYTGDGIVCLEINPCLENHGGCDKNAECTQTGPNQAACNCLPAYTGDGKVCTLINVCLTKNGGCSEFAICNHTGQVERTCTCKPNYIGDGFTCRGSIYQELPKNPKTSQYFFQLQEHFVKDLVGPGPFTVFAPLSAAFDEEARVKDWDKYGLMPQVLRYHVVACHQLLLENLKLISNATSLQGEPIVISVSQSTVYINNKAKIISSDIISTNGIVHIIDKLLSPKNLLITPKDNSGRILQNLTTLATNNGYIKFSNLIQDSGLLSVITDPIHTPVTLFWPTDQALHALPAEQQDFLFNQDNKDKLKEYLKFHVIRDAKVLAVDLPTSTAWKTLQGSELSVKCGAGRDIGDLFLNGQTCRIVQRELLFDLGVAYGIDCLLIDPTLGGRCDTFTTFDASGECGSCVNTPSCPRWSKPKGVKQKCLYNLPFKRNLEGCRERCSLVIQIPRCCKGYFGRDCQACPGGPDAPCNNRGVCLDQYSATGECKCNTGFNGTACEMCWPGRFGPDCLPCGCSDHGQCDDGITGSGQCLCETGWTGPSCDTQAVLPAVCTPPCSAHATCKENNTCECNLDYEGDGITCTVVDFCKQDNGGCAKVARCSQKGTKVSCSCQKGYKGDGHSCTEIDPCADGLNGGCHEHATCKMTGPGKHKCECKSHYVGDGLNCEPEQLPIDRCLQDNGQCHADAKCVDLHFQDTTVGVFHLRSPLGQYKLTFDKAREACANEAATMATYNQLSYAQKAKYHLCSAGWLETGRVAYPTAFASQNCGSGVVGIVDYGPRPNKSEMWDVFCYRMKDVNCTCKVGYVGDGFSCSGNLLQVLMSFPSLTNFLTEVLAYSNSSARGRAFLEHLTDLSIRGTLFVPQNSGLGENETLSGRDIEHHLANVSMFFYNDLVNGTTLQTRLGSKLLITASQDPLQPTETRFVDGRAILQWDIFASNGIIHVISRPLKAPPAPVTLTHTGLGAGIFFAIILVTGAVALAAYSYFRINRRTIGFQHFESEEDINVAALGKQQPENISNPLYESTTSAPPEPSYDPFTDSEERQLEGNDPLRTL,2551,"276,988",Beta strand (7); Chain (2); Disulfide bond (63); Domain (27); Erroneous initiation (1); Frameshift (1); Glycosylation (28); Helix (6); Modified residue (1); Natural variant (9); Region (1); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 112..126;  /evidence=""ECO:0000250""; DISULFID 120..136;  /evidence=""ECO:0000250""; DISULFID 138..147;  /evidence=""ECO:0000250""; DISULFID 160..171;  /evidence=""ECO:0000250""; DISULFID 164..181;  /evidence=""ECO:0000250""; DISULFID 183..192;  /evidence=""ECO:0000250""; DISULFID 199..210;  /evidence=""ECO:0000250""; DISULFID 204..222;  /evidence=""ECO:0000250""; DISULFID 224..235;  /evidence=""ECO:0000250""; DISULFID 241..252;  /evidence=""ECO:0000250""; DISULFID 246..262;  /evidence=""ECO:0000250""; DISULFID 264..275;  /evidence=""ECO:0000250""; DISULFID 326..338;  /evidence=""ECO:0000250""; DISULFID 332..348;  /evidence=""ECO:0000250""; DISULFID 350..361;  /evidence=""ECO:0000250""; DISULFID 740..754;  /evidence=""ECO:0000250""; DISULFID 748..764;  /evidence=""ECO:0000250""; DISULFID 766..775;  /evidence=""ECO:0000250""; DISULFID 830..843;  /evidence=""ECO:0000250""; DISULFID 837..852;  /evidence=""ECO:0000250""; DISULFID 854..865;  /evidence=""ECO:0000250""; DISULFID 871..885;  /evidence=""ECO:0000250""; DISULFID 879..895;  /evidence=""ECO:0000250""; DISULFID 897..908;  /evidence=""ECO:0000250""; DISULFID 914..928;  /evidence=""ECO:0000250""; DISULFID 922..938;  /evidence=""ECO:0000250""; DISULFID 940..951;  /evidence=""ECO:0000250""; DISULFID 957..970;  /evidence=""ECO:0000250""; DISULFID 964..980;  /evidence=""ECO:0000250""; DISULFID 1348..1362;  /evidence=""ECO:0000250""; DISULFID 1356..1372;  /evidence=""ECO:0000250""; DISULFID 1374..1383;  /evidence=""ECO:0000250""; DISULFID 1395..1406;  /evidence=""ECO:0000250""; DISULFID 1399..1416;  /evidence=""ECO:0000250""; DISULFID 1418..1427;  /evidence=""ECO:0000250""; DISULFID 1436..1446;  /evidence=""ECO:0000250""; DISULFID 1440..1456;  /evidence=""ECO:0000250""; DISULFID 1458..1469;  /evidence=""ECO:0000250""; DISULFID 1475..1488;  /evidence=""ECO:0000250""; DISULFID 1482..1498;  /evidence=""ECO:0000250""; DISULFID 1500..1511;  /evidence=""ECO:0000250""; DISULFID 1517..1530;  /evidence=""ECO:0000250""; DISULFID 1524..1540;  /evidence=""ECO:0000250""; DISULFID 1542..1553;  /evidence=""ECO:0000250""; DISULFID 1559..1572;  /evidence=""ECO:0000250""; DISULFID 1566..1582;  /evidence=""ECO:0000250""; DISULFID 1962..1976;  /evidence=""ECO:0000250""; DISULFID 1970..1986;  /evidence=""ECO:0000250""; DISULFID 1988..1997;  /evidence=""ECO:0000250""; DISULFID 2009..2020;  /evidence=""ECO:0000250""; DISULFID 2014..2030;  /evidence=""ECO:0000250""; DISULFID 2032..2041;  /evidence=""ECO:0000250""; DISULFID 2051..2061;  /evidence=""ECO:0000250""; DISULFID 2055..2067;  /evidence=""ECO:0000250""; DISULFID 2069..2080;  /evidence=""ECO:0000250""; DISULFID 2086..2099;  /evidence=""ECO:0000250""; DISULFID 2093..2108;  /evidence=""ECO:0000250""; DISULFID 2110..2121;  /evidence=""ECO:0000250""; DISULFID 2127..2141;  /evidence=""ECO:0000250""; DISULFID 2135..2151;  /evidence=""ECO:0000250""; DISULFID 2153..2164;  /evidence=""ECO:0000250""; DISULFID 2220..2289;  /evidence=""ECO:0000250""; DISULFID 2244..2265;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q24JP5,Transmembrane protein 132A (HSPA5-binding protein 1),MCARMAGRTTAAPRGPYGPWLCLLVALALDVVRVDCGQAPLDPVYLPAALELLDAPEHFRVQQVGHYPPANSSLSSRSETFLLLQPWPRAQPLLRASYPPFATQQVVPPRVTEPHQRPVPWDVRAVSVEAAVTPAEPYARVLFHLKGQDWPPGSGSLPCARLHATHPAGTAHQACRFQPSLGACVVELELPSHWFSQASTTRAELAYTLEPAAEGPGGCGSGEENDPGEQALPVGGVELRPADPPQYQEVPLDEAVTLRVPDMPVRPGQLFSATLLLRHNFTASLLTLRIKVKKGLHVTAARPAQPTLWTAKLDRFKGSRHHTTLITCHRAGLTEPDSSPLELSEFLWVDFVVENSTGGGVAVTRPVTWQLEYPGQAPEAEKDKMVWEILVSERDIRALIPLAKAEELVNTAPLTGVPQHVPVRLVTVDGGGALVEVTEHVGCESANTQVLQVSEACDAVFVAGKESRGARGVRVDFWWRRLRASLRLTVWAPLLPLRIELTDTTLEQVRGWRVPGPAEGPAEPAAEASDEAERRARGCHLQYQRAGVRFLAPFAAHPLDGGRRLTHLLGPDWLLDVSHLVAPHARVLDSRVASLEGGRVVVGREPGVTSIEVRSPLSDSILGEQALAVTDDKVSVLELRVQPVMGISLTLSRGTAHPGEVTATCWAQSALPAPKQEVALSLWLSFSDHTVAPAELYDRRDLGLSVSAEEPGAILPAEEQGAQLGVVVSGAGAEGLPLHVALHPPEPCRRGRHRVPLASGTAWLGLPPASTPAPALPSSPAWSPPATEATMGGKRQVAGSVGGNTGVRGKFERAEEEARKEETEAREEEEEEEEEMVPAPQHVTELELGMYALLGVFCVAIFIFLVNGVVFVLRYQRKEPPDSATDPTSPQPHNWVWLGTDQEELSRQLDRQSPGPPKGEGSCPCESGGGGEAPTLAPGPPGGTTSSSSTLARKEAGGRRKRVEFVTFAPAPPAQSPEEPVGAPAVQSILVAGEEDIRWVCEDMGLKDPEELRNYMERIRGSS,1023,"110,110",Alternative sequence (5); Chain (1); Compositional bias (1); Erroneous initiation (2); Glycosylation (1); Modified residue (1); Natural variant (2); Region (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q96JJ7,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),MAAWKSWTALRLCATVVVLDMVVCKGFVEDLDESFKENRNDDIWLVDFYAPWCGHCKKLEPIWNEVGLEMKSIGSPVKVGKMDATSYSSIASEFGVRGYPTIKLLKGDLAYNYRGPRTKDDIIEFAHRVSGALIRPLPSQQMFEHMQKRHRVFFVYVGGESPLKEKYIDAASELIVYTYFFSASEEVVPEYVTLKEMPAVLVFKDETYFVYDEYEDGDLSSWINRERFQNYLAMDGFLLYELGDTGKLVALAVIDEKNTSVEHTRLKSIIQEVARDYRDLFHRDFQFGHMDGNDYINTLLMDELTVPTVVVLNTSNQQYFLLDRQIKNVEDMVQFINNILDGTVEAQGGDSILQRLKRIVFDAKSTIVSIFKSSPLMGCFLFGLPLGVISIMCYGIYTADTDGGYIEERYEVSKSENENQEQIEESKEQQEPSSGGSVVPTVQEPKDVLEKKKD,454,"51,872",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (2); Glycosylation (2); Motif (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..56;  /note=""Redox-active"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00691""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q96FM1,Post-GPI attachment to proteins factor 3 (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1),MAGLAARLVLLAGAAALASGSQGDREPVYRDCVLQCEEQNCSGGALNHFRSRQPIYMSLAGWTCRDDCKYECMWVTVGLYLQEGHKVPQFHGKWPFSRFLFFQEPASAVASFLNGLASLVMLCRYRTFVPASSPMYHTCVAFAWVSLNAWFWSTVFHTRDTDLTEKMDYFCASTVILHSIYLCCVRTVGLQHPAVVSAFRALLLLMLTVHVSYLSLIRFDYGYNLVANVAIGLVNVVWWLAWCLWNQRRLPHVRKCVVVVLLLQGLSLLELLDFPPLFWVLDAHAIWHISTIPVHVLFFSFLEDDSLYLLKESEDKFKLD,320,"36,475",Alternative sequence (2); Chain (1); Frameshift (1); Glycosylation (1); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q86YD3,Transmembrane protein 25,MALPPGPAALRHTLLLLPALLSSGWGELEPQIDGQTWAERALRENERHAFTCRVAGGPGTPRLAWYLDGQLQEASTSRLLSVGGEAFSGGTSTFTVTAHRAQHELNCSLQDPRSGRSANASVILNVQFKPEIAQVGAKYQEAQGPGLLVVLFALVRANPPANVTWIDQDGPVTVNTSDFLVLDAQNYPWLTNHTVQLQLRSLAHNLSVVATNDVGVTSASLPAPGLLATRVEVPLLGIVVAAGLALGTLVGFSTLVACLVCRKEKKTKGPSRHPSLISSDSNNLKLNNVRLPRENMSLPSNLQLNDLTPDSRAVKPADRQMAQNNSRPELLDPEPGGLLTSQGFIRLPVLGYIYRVSSVSSDEIWL,366,"39,285",Alternative sequence (4); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (5); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 52..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8WY21,VPS10 domain-containing receptor SorCS1 (hSorCS),MGKVGAGGGSQARLSALLAGAGLLILCAPGVCGGGSCCPSPHPSSAPRSASTPRGFSHQGRPGRAPATPLPLVVRPLFSVAPGDRALSLERARGTGASMAVAARSGRRRRSGADQEKAERGEGASRSPRGVLRDGGQQEPGTRERDPDKATRFRMEELRLTSTTFALTGDSAHNQAMVHWSGHNSSVILILTKLYDYNLGSITESSLWRSTDYGTTYEKLNDKVGLKTILSYLYVCPTNKRKIMLLTDPEIESSLLISSDEGATYQKYRLNFYIQSLLFHPKQEDWILAYSQDQKLYSSAEFGRRWQLIQEGVVPNRFYWSVMGSNKEPDLVHLEARTVDGHSHYLTCRMQNCTEANRNQPFPGYIDPDSLIVQDHYVFVQLTSGGRPHYYVSYRRNAFAQMKLPKYALPKDMHVISTDENQVFAAVQEWNQNDTYNLYISDTRGVYFTLALENVQSSRGPEGNIMIDLYEVAGIKGMFLANKKIDNQVKTFITYNKGRDWRLLQAPDTDLRGDPVHCLLPYCSLHLHLKVSENPYTSGIIASKDTAPSIIVASGNIGSELSDTDISMFVSSDAGNTWRQIFEEEHSVLYLDQGGVLVAMKHTSLPIRHLWLSFDEGRSWSKYSFTSIPLFVDGVLGEPGEETLIMTVFGHFSHRSEWQLVKVDYKSIFDRRCAEEDYRPWQLHSQGEACIMGAKRIYKKRKSERKCMQGKYAGAMESEPCVCTEADFDCDYGYERHSNGQCLPAFWFNPSSLSKDCSLGQSYLNSTGYRKVVSNNCTDGVREQYTAKPQKCPGKAPRGLRIVTADGKLTAEQGHNVTLMVQLEEGDVQRTLIQVDFGDGIAVSYVNLSSMEDGIKHVYQNVGIFRVTVQVDNSLGSDSAVLYLHVTCPLEHVHLSLPFVTTKNKEVNATAVLWPSQVGTLTYVWWYGNNTEPLITLEGSISFRFTSEGMNTITVQVSAGNAILQDTKTIAVYEEFRSLRLSFSPNLDDYNPDIPEWRRDIGRVIKKSLVEATGVPGQHILVAVLPGLPTTAELFVLPYQDPAGENKRSTDDLEQISELLIHTLNQNSVHFELKPGVRVLVHAAHLTAAPLVDLTPTHSGSAMLMLLSVVFVGLAVFVIYKFKRRVALPSPPSPSTQPGDSSLRLQRARHATPPSTPKRGSAGAQYAI,1168,"129,635",Alternative sequence (3); Chain (1); Domain (1); Erroneous initiation (1); Glycosylation (10); Natural variant (1); Repeat (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q13586,Stromal interaction molecule 1,MDVCVRLALWLLWGLLLHQGQSLSHSHSEKATGTSSGANSEESTAAEFCRIDKPLCHSEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWYAPEALQKWLQLTHEVEVQYYNIKKQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHSSSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAALNIDPSWMGSTRPNPAHFIMTDDVDDMDEEIVSPLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHMSDRQRVAPKPPQMSRAADEALNAMTSNGSHRLIEGVHPGSLVEKLPDSPALAKKALLALNHGLDKAHSLMELSPSAPPGGSPHLDSSRSHSPSSPDPDTPSPVGDSRALQASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK,685,"77,423",Alternative sequence (2); Beta strand (2); Calcium binding (1); Chain (1); Coiled coil (1); Compositional bias (3); Domain (2); Glycosylation (2); Helix (17); Modified residue (18); Motif (1); Mutagenesis (16); Natural variant (14); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9UKJ0,Paired immunoglobulin-like type 2 receptor beta (Activating receptor PILR-beta) (Cell surface receptor FDFACT),MGRPLLLPLLLLLQPPAFLQPGGSTGSGPSYLYGVTQPKHLSASMGGSVEIPFSFYYPWELAIVPNVRISWRRGHFHGQSFYSTRPPSIHKDYVNRLFLNWTEGQESGFLRISNLRKEDQSVYFCRVELDTRRSGRQQLQSIKGTKLTITQAVTTTTTWRPSSTTTIAGLRVTESKGHSESWHLSLDTAIRVALAVAVLKTVILGLLCLLLLWWRRRKGSRAPSSDF,227,"25,542",Alternative sequence (2); Beta strand (10); Chain (1); Domain (1); Glycosylation (1); Helix (2); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P16471,Prolactin receptor (PRL-R),MKENVASATVFTLLLFLNTCLLNGQLPPGKPEIFKCRSPNKETFTCWWRPGTDGGLPTNYSLTYHREGETLMHECPDYITGGPNSCHFGKQYTSMWRTYIMMVNATNQMGSSFSDELYVDVTYIVQPDPPLELAVEVKQPEDRKPYLWIKWSPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQKYLVQVRCKPDHGYWSAWSPATFIQIPSDFTMNDTTVWISVAVLSAVICLIIVWAVALKGYSMVTCIFPPVPGPKIKGFDAHLLEKGKSEELLSALGCQDFPPTSDYEDLLVEYLEVDDSEDQHLMSVHSKEHPSQGMKPTYLDPDTDSGRGSCDSPSLLSEKCEEPQANPSTFYDPEVIEKPENPETTHTWDPQCISMEGKIPYFHAGGSKCSTWPLPQPSQHNPRSSYHNITDVCELAVGPAGAPATLLNEAGKDALKSSQTIKSREEGKATQQREVESFHSETDQDTPWLLPQEKTPFGSAKPLDYVEIHKVNKDGALSLLPKQRENSGKPKKPGTPENNKEYAKVSGVMDNNILVLVPDPHAKNVACFEESAKEAPPSLEQNQAEKALANFTATSSKCRLQLGGLDYLDPACFTHSFH,622,"69,506",Alternative sequence (14); Beta strand (20); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Helix (4); Metal binding (2); Motif (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 36..46;  /evidence=""ECO:0000269|PubMed:18467331""; DISULFID 75..86;  /evidence=""ECO:0000269|PubMed:18467331""",SIGNAL 1..24
Q8NBL3,Transmembrane protein 178A,MEPRALVTALSLGLSLCSLGLLVTAIFTDHWYETDPRRHKESCERSRAGADPPDQKNRLMPLSHLPLRDSPPLGRRLLPGGPGRADPESWRSLLGLGGLDAECGRPLFATYSGLWRKCYFLGIDRDIDTLILKGIAQRCTAIKYHFSQPIRLRNIPFNLTKTIQQDEWHLLHLRRITAGFLGMAVAVLLCGCIVATVSFFWEESLTQHVAGLLFLMTGIFCTISLCTYAASISYDLNRLPKLIYSLPADVEHGYSWSIFCAWCSLGFIVAAGGLCIAYPFISRTKIAQLKSGRDSTV,297,"33,019",Alternative sequence (2); Chain (1); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8WW62,Transmembrane emp24 domain-containing protein 6 (p24 family protein gamma-5) (p24gamma5),MSPLLFGAGLVVLNLVTSARSQKTEPLSGSGDQPLFRGADRYDFAIMIPPGGTECFWQFAHQTGYFYFSYEVQRTVGMSHDRHVAATAHNPQGFLIDTSQGVRGQINFSTQETGFYQLCLSNQHNHFGSVQVYLNFGVFYEGPETDHKQKERKQLNDTLDAIEDGTQKVQNNIFHMWRYYNFARMRKMADFFLIQSNYNYVNWWSTAQSLVIILSGILQLYFLKRLFNVPTTTDTKKPRC,240,"27,631",Chain (1); Domain (1); Glycosylation (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P60508,Syncytin-2 (Endogenous retrovirus group FRD member 1) (Envelope polyprotein) (HERV-FRD) (HERV-FRD_6p24.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MGLLLLVLILTPSLAAYRHPDFPLLEKAQQLLQSTGSPYSTNCWLCTSSSTETPGTAYPASPREWTSIEAELHISYRWDPNLKGLMRPANSLLSTVKQDFPDIRQKPPIFGPIFTNINLMGIAPICVMAKRKNGTNVGTLPSTVCNVTFTVDSNQQTYQTYTHNQFRHQPRFPKPPNITFPQGTLLDKSSRFCQGRPSSCSTRNFWFRPADYNQCLQISNLSSTAEWVLLDQTRNSLFWENKTKGANQSQTPCVQVLAGMTIATSYLGISAVSEFFGTSLTPLFHFHISTCLKTQGAFYICGQSIHQCLPSNWTGTCTIGYVTPDIFIAPGNLSLPIPIYGNSPLPRVRRAIHFIPLLAGLGILAGTGTGIAGITKASLTYSQLSKEIANNIDTMAKALTTMQEQIDSLAAVVLQNRRGLDMLTAAQGGICLALDEKCCFWVNQSGKVQDNIRQLLNQASSLRERATQGWLNWEGTWKWFSWVLPLTGPLVSLLLLLLFGPCLLNLITQFVSSRLQAIKLQTNLSAGRHPRNIQESPF,538,"59,523",Chain (3); Disulfide bond (3); Glycosylation (9); Helix (5); Motif (3); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 43..439;  /note=""Interchain (between SU and TM chains, or C-46 with C-439); in linked form"";  /evidence=""ECO:0000250|UniProtKB:Q9UQF0""; DISULFID 43..46;  /evidence=""ECO:0000250|UniProtKB:P23064""; DISULFID 431..438;  /evidence=""ECO:0000269|PubMed:16140326""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
O60602,Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3),MGDHLDLLLGVVLMAGPVFGIPSCSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYDAYLCFSSKDFTWVQNALLKHLDTQYSDQNRFNLCFEERDFVPGENRIANIQDAIWNSRKIVCLVSRHFLRDGWCLEAFSYAQGRCLSDLNSALIMVVVGSLSQYQLMKHQSIRGFVQKQQYLRWPEDFQDVGWFLHKLSQQILKKEKEKKKDNNIPLQTVATIS,858,"97,834",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (7); Modified residue (2); Natural variant (10); Repeat (20); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 583..610;  /evidence=""ECO:0000269|PubMed:22173220""; DISULFID 585..629;  /evidence=""ECO:0000269|PubMed:22173220""","SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9ULT6,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),MRPRSGGRPGATGRRRRRLRRRPRGLRCSRLPPPPPLPLLLGLLLAAAGPGAARAKETAFVEVVLFESSPSGDYTTYTTGLTGRFSRAGATLSAEGEIVQMHPLGLCNNNDEEDLYEYGWVGVVKLEQPELDPKPCLTVLGKAKRAVQRGATAVIFDVSENPEAIDQLNQGSEDPLKRPVVYVKGADAIKLMNIVNKQKVARARIQHRPPRQPTEYFDMGIFLAFFVVVSLVCLILLVKIKLKQRRSQNSMNRLAVQALEKMETRKFNSKSKGRREGSCGALDTLSSSSTSDCAICLEKYIDGEELRVIPCTHRFHRKCVDPWLLQHHTCPHCRHNIIEQKGNPSAVCVETSNLSRGRQQRVTLPVHYPGRVHRTNAIPAYPTRTSMDSHGNPVTLLTMDRHGEQSLYSPQTPAYIRSYPPLHLDHSLAAHRCGLEHRAYSPAHPFRRPKLSGRSFSKAACFSQYETMYQHYYFQGLSYPEQEGQSPPSLAPRGPARAFPPSGSGSLLFPTVVHVAPPSHLESGSTSSFSCYHGHRSVCSGYLADCPGSDSSSSSSSGQCHCSSSDSVVDCTEVSNQGVYGSCSTFRSSLSSDYDPFIYRSRSPCRASEAGGSGSSGRGPALCFEGSPPPEELPAVHSHGAGRGEPWPGPASPSGDQVSTCSLEMNYSSNSSLEHRGPNSSTSEVGLEASPGAAPDLRRTWKGGHELPSCACCCEPQPSPAGPSAGAAGSSTLFLGPHLYEGSGPAGGEPQSGSSQGLYGLHPDHLPRTDGVKYEGLPCCFYEEKQVARGGGGGSGCYTEDYSVSVQYTLTEEPPPGCYPGARDLSQRIPIIPEDVDCDLGLPSDCQGTHSLGSWGGTRGPDTPRPHRGLGATREEERALCCQARALLRPGCPPEEAGAVRANFPSALQDTQESSTTATEAAGPRSHSADSSSPGA,936,"100,574",Alternative sequence (1); Chain (1); Erroneous initiation (1); Mutagenesis (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..55;  /evidence=""ECO:0000255"""
Q9BRK3,Matrix remodeling-associated protein 8 (Limitrin),MALPSRILLWKLVLLQSSAVLLHSGSSVPAAAGSSVVSESAVSWEAGARAVLRCQSPRMVWTQDRLHDRQRVLHWDLRGPGGGPARRLLDLYSAGEQRVYEARDRGRLELSASAFDDGNFSLLIRAVEETDAGLYTCNLHHHYCHLYESLAVRLEVTDGPPATPAYWDGEKEVLAVARGAPALLTCVNRGHVWTDRHVEEAQQVVHWDRQPPGVPHDRADRLLDLYASGERRAYGPLFLRDRVAVGADAFERGDFSLRIEPLEVADEGTYSCHLHHHYCGLHERRVFHLTVAEPHAEPPPRGSPGNGSSHSGAPGPDPTLARGHNVINVIVPESRAHFFQQLGYVLATLLLFILLLVTVLLAARRRRGGYEYSDQKSGKSKGKDVNLAEFAVAAGDQMLYRSEDIQLDYKNNILKERAELAHSPLPAKYIDLDKGFRKENCK,442,"49,132",Alternative sequence (4); Beta strand (18); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (2); Helix (4); Modified residue (1); Motif (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 54..137;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 186..272;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q6P9G4,Transmembrane protein 154,MQAPRAALVFALVIALVPVGRGNYEELENSGDTTVESERPNKVTIPSTFAAVTIKETLNANINSTNFAPDENQLEFILMVLIPLILLVLLLLSVVFLATYYKRKRTKQEPSSQGSQSALQTYELGSENVKVPIFEEDTPSVMEIEMEELDKWMNSMNRNADFECLPTLKEEKESNHNPSDSES,183,"20,498",Chain (1); Modified residue (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N3T6,Transmembrane protein 132C,MRSEGAAPGPAAPLCGALSLLLGALLGKVIEGHGVTDNIQRFSSLPPYLPVSYHILRAETSFFLKEANQDLLRNSSLQARVESFFTYKTRQPPVLNASYGPFSVEKVVPLDLMLTSNFLGPTNKFSFDWKLKAHILRDKVYLSRPKVQVLFHIMGRDWDDHGAGEKLPCLRVFAFRETREVRGSCRLKGDLGLCVAELELLSSWFSAPTVGAGRKKSMDQPEGTPVELYYTVHPGNERGDCAGGDFRKGNAIRPGKDGLEETTSHLQRIGTVGLYRAQDSAQLSELRLDGNVVIWLPSRPVKQGEVVTAYVTISSNSSVDLFILRAKVKKGVNILSAQTREPRQWGVKQEVGSGGKHVTATVACQRLGPSPRNRSSSLFNEVVQMNFEIASFSSLSGTQPITWQVEYPRKGTTDIAVSEIFVSQKDLVGIVPLAMDTEILNTAVLTGKTVAMPIKVVSVEENSAVMDISESVECKSTDEDVIKVSERCDYIFVNGKEIKGKMDAVVNFTYQYLSAPLCVTVWVPRLPLQIEVSDTELSQIKGWRVPIVTNKRPTRESEDEDEEERRGRGCALQYQHATVRVLTQFVSEGAGPWGQPNYLLSPNWQFDITHLVADFMKLEEPHVATLQDSRVLVGREVGMTTIQVLSPLSDSILAEKTITVLDDKVSVTDLAIQLVAGLSVALYPNAENSKAVTAVVTAEEVLRTPKQEAVFSTWLQFSDGSVTPLDIYDTKDFSLAATSQDEAVVSVPQPRSPRWPVVVAEGEGQGPLIRVDMTIAEACQKSKRKSILAVGVGNVRVKFGQNDADSSPGGDYEEDEIKNHASDRRQKGQHHERTGQDGHLYGSSPVEREEGALRRATTTARSLLDNKVVKNSRADGGRLAGEGQLQNIPIDFTNFPAHVDLPKAGSGLEENDLVQTPRGLSDLEIGMYALLGVFCLAILVFLINCATFALKYRHKQVPLEGQASMTHSHDWVWLGNEAELLESMGDAPPPQDEHTTIIDRGPGACEESNHLLLNGGSHKHVQSQIHRSADSGGRQGREQKQDPLHSPTSKRKKVKFTTFTTIPPDDSCPTVNSIVSSNDEDIKWVCQDVAVGAPKELRNYLEKLKDKA,1108,"121,787",Chain (1); Glycosylation (2); Natural variant (7); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
O14763,Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262),MEQRGQNAPAASGARKRHGPGPREARGARPGPRVPKTLVLVVAAVLLLVSAESALITQQDLAPQQRAAPQQKRSSPSEGLCPPGHHISEDGRDCISCKYGQDYSTHWNDLLFCLRCTRCDSGEVELSPCTTTRNTVCQCEEGTFREEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECVHKESGTKHSGEVPAVEETVTSSPGTPASPCSLSGIIIGVTVAAVVLIVAVFVCKSLLWKKVLPYLKGICSGGGGDPERVDRSSQRPGAEDNVLNEIVSILQPTQVPEQEMEVQEPAEPTGVNMLSPGESEHLLEPAEAERSQRRRLLVPANEGDPTETLRQCFDDFADLVPFDSWEPLMRKLGLMDNEIKVAKAEAAGHRDTLYTMLIKWVNKTGRDASVHTLLDALETLGERLAKQKIEDHLLSSGKFMYLEGNADSAMS,440,"47,878",Alternative sequence (2); Beta strand (15); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (1); Helix (2); Natural variant (3); Repeat (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 81..94;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 97..113;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 116..129;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 119..137;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 139..153;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000244|PDB:4N90, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 156..170;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""; DISULFID 160..178;  /evidence=""ECO:0000244|PDB:1D0G, ECO:0000244|PDB:1D4V, ECO:0000244|PDB:4I9X, ECO:0000269|PubMed:10542098, ECO:0000269|PubMed:10549288, ECO:0000269|PubMed:23555243""","SIGNAL 1..55;  /evidence=""ECO:0000269|PubMed:9311998"""
P20333,"Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]",MAPVAVWAALAVGLELWAAAHALPAQVAFTPYAPEPGSTCRLREYYDQTAQMCCSKCSPGQHAKVFCTKTSDTVCDSCEDSTYTQLWNWVPECLSCGSRCSSDQVETQACTREQNRICTCRPGWYCALSKQEGCRLCAPLRKCRPGFGVARPGTETSDVVCKPCAPGTFSNTTSSTDICRPHQICNVVAIPGNASMDAVCTSTSPTRSMAPGAVHLPQPVSTRSQHTQPTPEPSTAPSTSFLLPMGPSPPAEGSTGDFALPVGLIVGVTALGLLIIGVVNCVIMTQVKKKPLCLQREAKVPHLPADKARGTQGPEQQHLLITAPSSSSSSLESSASALDRRAPTRNQPQAPGVEASGAGEARASTGSSDSSPGGHGTQVNVTCIVNVCSSSDHSSQCSSQASSTMGDTDSSPSESPKDEQVPFSKEECAFRSQLETPETLLGSTEEKPLPLGVPDAGMKPS,461,"48,291",Alternative sequence (2); Beta strand (14); Chain (2); Disulfide bond (10); Glycosylation (6); Modified residue (1); Natural variant (8); Repeat (4); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 40..53;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 54..67;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 57..75;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 78..93;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 96..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 100..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 120..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 134..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 137..161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 164..179;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:2173696"""
Q6H3X3,UL-16 binding protein 5 (Retinoic acid early transcript 1G protein),MAAAASPAFLLRLPLLLLLSSWCRTGLADPHSLCYDITVIPKFRPGPRWCAVQGQVDEKTFLHYDCGSKTVTPVSPLGKKLNVTTAWKAQNPVLREVVDILTEQLLDIQLENYIPKEPLTLQARMSCEQKAEGHGSGSWQLSFDGQIFLLFDSENRMWTTVHPGARKMKEKWENDKDMTMSFHYISMGDCTGWLEDFLMGMDSTLEPSAGAPPTMSSGTAQPRATATTLILCCLLIMCLLICSRHSLTQSHGHHPQSLQPPPHPPLLHPTWLLRRVLWSDSYQIAKRPLSGGHVTRVTLPIIGDDSHSLPCPLALYTINNGAARYSEPLQVSIS,334,"37,106",Alternative sequence (3); Chain (1); Disulfide bond (2); Glycosylation (1); Lipidation (1); Mutagenesis (1); Natural variant (1); Propeptide (1); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..66;  /evidence=""ECO:0000250|UniProtKB:Q9BZM4""; DISULFID 127..190;  /evidence=""ECO:0000250|UniProtKB:Q9BZM4""","SIGNAL 1..25;  /evidence=""ECO:0000250|UniProtKB:Q9BZM5"""
P35503,UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3),MATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVVLTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNMSLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDLDFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQREVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,534,"60,338",Alternative sequence (1); Chain (1); Glycosylation (4); Natural variant (10); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
P19320,Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106),MPGKMVVILGASNILWIMFAASQAFKIETTPESRYLAQIGDSVSLTCSTTGCESPFFSWRTQIDSPLNGKVTNEGTTSTLTMNPVSFGNEHSYLCTATCESRKLEKGIQVEIYSFPKDPEIHLSGPLEAGKPITVKCSVADVYPFDRLEIDLLKGDHLMKSQEFLEDADRKSLETKSLEVTFTPVIEDIGKVLVCRAKLHIDEMDSVPTVRQAVKELQVYISPKNTVISVNPSTKLQEGGSVTMTCSSEGLPAPEIFWSKKLDNGNLQHLSGNATLTLIAMRMEDSGIYVCEGVNLIGKNRKEVELIVQEKPFTVEISPGPRIAAQIGDSVMLTCSVMGCESPSFSWRTQIDSPLSGKVRSEGTNSTLTLSPVSFENEHSYLCTVTCGHKKLEKGIQVELYSFPRDPEIEMSGGLVNGSSVTVSCKVPSVYPLDRLEIELLKGETILENIEFLEDTDMKSLENKSLEMTFIPTIEDTGKALVCQAKLHIDDMEFEPKQRQSTQTLYVNVAPRDTTVLVSPSSILEEGSSVNMTCLSQGFPAPKILWSRQLPNGELQPLSENATLTLISTKMEDSGVYLCEGINQAGRSRKEVELIIQVTPKDIKLTAFPSESVKEGDTVIISCTCGNVPETWIILKKKAETGDTVLKSIDGAYTIRKAQLKDAGVYECESKNKVGSQLRSLTLDVQGRENNKDYFSPELLVLYFASSLIIPAIGMIIYFARKANMKGSYSLVEAQKSKV,739,"81,276",Alternative sequence (2); Beta strand (15); Chain (1); Disulfide bond (6); Domain (7); Glycosylation (6); Helix (3); Natural variant (7); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..95;  /evidence=""ECO:0000269|PubMed:7539925""; DISULFID 52..99;  /evidence=""ECO:0000269|PubMed:7539925""; DISULFID 137..195;  /evidence=""ECO:0000269|PubMed:7539925""; DISULFID 246..291;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 335..383;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 534..579;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
Q92823,Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),MQLKIMPKKKRLSAGRVPLILFLCQMISALEVPLDPKLLEDLVQPPTITQQSPKDYIIDPRENIVIQCEAKGKPPPSFSWTRNGTHFDIDKDPLVTMKPGTGTLIINIMSEGKAETYEGVYQCTARNERGAAVSNNIVVRPSRSPLWTKEKLEPITLQSGQSLVLPCRPPIGLPPPIIFWMDNSFQRLPQSERVSQGLNGDLYFSNVLPEDTREDYICYARFNHTQTIQQKQPISVKVISVDELNDTIAANLSDTEFYGAKSSRERPPTFLTPEGNASNKEELRGNVLSLECIAEGLPTPIIYWAKEDGMLPKNRTVYKNFEKTLQIIHVSEADSGNYQCIAKNALGAIHHTISVRVKAAPYWITAPQNLVLSPGEDGTLICRANGNPKPRISWLTNGVPIEIAPDDPSRKIDGDTIIFSNVQERSSAVYQCNASNEYGYLLANAFVNVLAEPPRILTPANTLYQVIANRPALLDCAFFGSPLPTIEWFKGAKGSALHEDIYVLHENGTLEIPVAQKDSTGTYTCVARNKLGMAKNEVHLEIKDPTWIVKQPEYAVVQRGSMVSFECKVKHDHTLSLTVLWLKDNRELPSDERFTVDKDHLVVADVSDDDSGTYTCVANTTLDSVSASAVLSVVAPTPTPAPVYDVPNPPFDLELTDQLDKSVQLSWTPGDDNNSPITKFIIEYEDAMHKPGLWHHQTEVSGTQTTAQLKLSPYVNYSFRVMAVNSIGKSLPSEASEQYLTKASEPDKNPTAVEGLGSEPDNLVITWKPLNGFESNGPGLQYKVSWRQKDGDDEWTSVVVANVSKYIVSGTPTFVPYLIKVQALNDMGFAPEPAVVMGHSGEDLPMVAPGNVRVNVVNSTLAEVHWDPVPLKSIRGHLQGYRIYYWKTQSSSKRNRRHIEKKILTFQGSKTHGMLPGLEPFSHYTLNVRVVNGKGEGPASPDRVFNTPEGVPSAPSSLKIVNPTLDSLTLEWDPPSHPNGILTEYTLKYQPINSTHELGPLVDLKIPANKTRWTLKNLNFSTRYKFYFYAQTSAGSGSQITEEAVTTVDEAGILPPDVGAGKVQAVNPRISNLTAAAAETYANISWEYEGPEHVNFYVEYGVAGSKEEWRKEIVNGSRSFFGLKGLMPGTAYKVRVGAVGDSGFVSSEDVFETGPAMASRQVDIATQGWFIGLMCAVALLILILLIVCFIRRNKGGKYPVKEKEDAHADPEIQPMKEDDGTFGEYSDAEDHKPLKKGSRTPSDRTVKKEDSDDSLVDYGEGVNGQFNEDGSFIGQYSGKKEKEPAEGNESSEAPSPVNAMNSFV,1304,"143,890",Alternative sequence (8); Beta strand (15); Chain (1); Disulfide bond (6); Domain (11); Erroneous initiation (2); Glycosylation (18); Helix (1); Modified residue (9); Natural variant (3); Sequence conflict (20); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 68..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 167..218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 292..340;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 382..432;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 476..525;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 567..616;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q86V40,Metalloprotease TIKI1 (EC 3.4.-.-) (TRAB domain-containing protein 2A),MSPWSWFLLQTLCLLPTGAASRRGAPGTANCELKPQQSELNSFLWTIKRDPPSYFFGTIHVPYTRVWDFIPDNSKEAFLQSSIVYFELDLTDPYTISALTSCQMLPQGENLQDVLPRDIYCRLKRHLEYVKLMMPLWMTPDQRGKGLYADYLFNAIAGNWERKRPVWVMLMVNSLTEVDIKSRGVPVLDLFLAQEAERLRKQTGAVEKVEEQCHPLNGLNFSQVIFALNQTLLQQESLRAGSLQIPYTTEDLIKHYNCGDLSSVILSHDSSQVPNFINATLPPQERITAQEIDSYLRRELIYKRNERIGKRVKALLEEFPDKGFFFAFGAGHFMGNNTVLDVLRREGYEVEHAPAGRPIHKGKSKKTSTRPTLSTIFAPKVPTLEVPAPEAVSSGHSTLPPLVSRPGSADTPSEAEQRFRKKRRRSQRRPRLRQFSDLWVRLEESDIVPQLQVPVLDRHISTELRLPRRGHSHHSQMVASSACLSLWTPVFWVLVLAFQTETPLL,505,"57,676",Alternative sequence (1); Chain (1); Erroneous initiation (1); Glycosylation (4); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q07011,Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137),MGNSCYNIVATLLLVLNFERTRSLQDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQRTCDICRQCKGVFRTRKECSSTSNAECDCTPGFHCLGAGCSMCEQDCKQGQELTKKGCKDCCFGTFNDQKRGICRPWTNCSLDGKSVLVNGTKERDVVCGPSPADLSPGASSVTPPAPAREPGHSPQIISFFLALTSTALLFLLFFLTLRFSVVKRGRKKLLYIFKQPFMRPVQTTQEEDGCSCRFPEEEEGGCEL,255,"27,899",Beta strand (15); Chain (1); Disulfide bond (10); Glycosylation (2); Helix (3); Natural variant (4); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 28..37;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 31..45;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 48..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 65..78;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 68..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 88..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 99..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 102..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 121..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 139..158;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9NR96,Toll-like receptor 9 (CD antigen CD289),MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE,1032,"115,860",Alternative sequence (4); Binding site (2); Chain (1); Disulfide bond (8); Domain (1); Glycosylation (13); Natural variant (6); Region (4); Repeat (26); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..45;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 98..110;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 178..184;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 255..268;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 258..265;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 470..500;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 764..790;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""; DISULFID 766..809;  /evidence=""ECO:0000250|UniProtKB:Q2EEY0""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9NZC2,Triggering receptor expressed on myeloid cells 2 (TREM-2) (Triggering receptor expressed on monocytes 2),MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT,230,"25,447",Alternative sequence (2); Beta strand (9); Binding site (4); Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (1); Glycosylation (2); Helix (2); Mutagenesis (7); Natural variant (29); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 36..110;  /evidence=""ECO:0000244|PDB:5ELI, ECO:0000244|PDB:5UD7, ECO:0000244|PDB:5UD8, ECO:0000244|PDB:6B8O, ECO:0000269|PubMed:27995897, ECO:0000269|PubMed:29794134""; DISULFID 51..60;  /evidence=""ECO:0000244|PDB:5ELI, ECO:0000244|PDB:5UD8, ECO:0000244|PDB:6B8O, ECO:0000269|PubMed:27995897, ECO:0000269|PubMed:29794134""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q15363,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),MVTLAELLVLLAALLATVSGYFVSIDAHAEECFFERVTSGTKMGLIFEVAEGGFLDIDVEITGPDNKGIYKGDRESSGKYTFAAHMDGTYKFCFSNRMSTMTPKIVMFTIDIGEAPKGQDMETEAHQNKLEEMINELAVAMTAVKHEQEYMEVRERIHRAINDNTNSRVVLWSFFEALVLVAMTLGQIYYLKRFFEVRRVV,201,"22,761",Beta strand (8); Chain (1); Coiled coil (1); Domain (1); Motif (2); Mutagenesis (4); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P40238,Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110),MPSWALFMVTSCLLLAPQNLAQVSSQDVSLLASDSEPLKCFSRTFEDLTCFWDEEEAAPSGTYQLLYAYPREKPRACPLSSQSMPHFGTRYVCQFPDQEEVRLFFPLHLWVKNVFLNQTRTQRVLFVDSVGLPAPPSIIKAMGGSQPGELQISWEEPAPEISDFLRYELRYGPRDPKNSTGPTVIQLIATETCCPALQRPHSASALDQSPCAQPTMPWQDGPKQTSPSREASALTAEGGSCLISGLQPGNSYWLQLRSEPDGISLGGSWGSWSLPVTVDLPGDAVALGLQCFTLDLKNVTCQWQQQDHASSQGFFYHSRARCCPRDRYPIWENCEEEEKTNPGLQTPQFSRCHFKSRNDSIIHILVEVTTAPGTVHSYLGSPFWIHQAVRLPTPNLHWREISSGHLELEWQHPSSWAAQETCYQLRYTGEGHQDWKVLEPPLGARGGTLELRPRSRYRLQLRARLNGPTYQGPWSSWSDPTRVETATETAWISLVTALHLVLGLSAVLGLLLLRWQFPAHYRRLRHALWPSLPDLHRVLGQYLRDTAALSPPKATVSDTCEEVEPSLLEILPKSSERTPLPLCSSQAQMDYRRLQPSCLGTMPLSVCPPMAESGSCCTTHIANHSYLPLSYWQQP,635,"71,245",Alternative sequence (2); Chain (1); Compositional bias (2); Cross-link (2); Disulfide bond (4); Domain (2); Glycosylation (4); Motif (2); Natural variant (17); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 40..50;  /evidence=""ECO:0000250""; DISULFID 77..93;  /evidence=""ECO:0000250""; DISULFID 291..301;  /evidence=""ECO:0000250""; DISULFID 323..334;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P17643,"5,6-dihydroxyindole-2-carboxylic acid oxidase (DHICA oxidase) (EC 1.14.18.-) (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1) (TRP) (TRP-1) (TRP1)",MSAPKLLSLGCIFFPLLLFQQARAQFPRQCATVEALRSGMCCPDLSPVSGPGTDRCGSSSGRGRCEAVTADSRPHSPQYPHDGRDDREVWPLRFFNRTCHCNGNFSGHNCGTCRPGWRGAACDQRVLIVRRNLLDLSKEEKNHFVRALDMAKRTTHPLFVIATRRSEEILGPDGNTPQFENISIYNYFVWTHYYSVKKTFLGVGQESFGEVDFSHEGPAFLTWHRYHLLRLEKDMQEMLQEPSFSLPYWNFATGKNVCDICTDDLMGSRSNFDSTLISPNSVFSQWRVVCDSLEDYDTLGTLCNSTEDGPIRRNPAGNVARPMVQRLPEPQDVAQCLEVGLFDTPPFYSNSTNSFRNTVEGYSDPTGKYDPAVRSLHNLAHLFLNGTGGQTHLSPNDPIFVLLHTFTDAVFDEWLRRYNADISTFPLENAPIGHNRQYNMVPFWPPVTNTEMFVTAPDNLGYTYEIQWPSREFSVPEIIAIAVVGALLLVALIFGTASYLIRARRSMDEANQPLLTDQYQCYAEEYEKLQNPNQSVV,537,"60,724",Beta strand (15); Chain (1); Disulfide bond (7); Glycosylation (6); Helix (18); Metal binding (6); Mutagenesis (3); Natural variant (4); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 30..41;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 42..65;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 56..99;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 101..110;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 113..122;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 258..261;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""; DISULFID 290..303;  /evidence=""ECO:0000244|PDB:5M8L, ECO:0000244|PDB:5M8M, ECO:0000244|PDB:5M8N, ECO:0000244|PDB:5M8O, ECO:0000244|PDB:5M8P, ECO:0000244|PDB:5M8Q, ECO:0000244|PDB:5M8R, ECO:0000244|PDB:5M8T, ECO:0000269|PubMed:28661582""",SIGNAL 1..24
Q9HC07,Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL),MAAAAPGNGRASAPRLLLLFLVPLLWAPAAVRAGPDEDLSHRNKEPPAPAQQLQPQPVAVQGPEPARVEKIFTPAAPVHTNKEDPATQTNLGFIHAFVAAISVIIVSELGDKTFFIAAIMAMRYNRLTVLAGAMLALGLMTCLSVLFGYATTVIPRVYTYYVSTVLFAIFGIRMLREGLKMSPDEGQEELEEVQAELKKKDEEFQRTKLLNGPGDVETGTSITVPQKKWLHFISPIFVQALTLTFLAEWGDRSQLTTIVLAAREDPYGVAVGGTVGHCLCTGLAVIGGRMIAQKISVRTVTIIGGIVFLAFAFSALFISPDSGF,324,"34,906",Alternative sequence (1); Chain (1); Coiled coil (1); Frameshift (1); Mutagenesis (3); Natural variant (3); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9Y3B3,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),MPRPGSAQRWAAVAGRWGCRLLALLLLVPGPGGASEITFELPDNAKQCFYEDIAQGTKCTLEFQVITGGHYDVDCRLEDPDGKVLYKEMKKQYDSFTFTASKNGTYKFCFSNEFSTFTHKTVYFDFQVGEDPPLFPSENRVSALTQMESACVSIHEALKSVIDYQTHFRLREAQGRSRAEDLNTRVAYWSVGEALILLVVSIGQVFLLKSFFSDKRTTTTRVGS,224,"25,172",Alternative sequence (1); Chain (1); Domain (1); Glycosylation (1); Motif (2); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
O75509,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),MGTSPSSSTALASCSRIARRATATMIAGSLLLLGFLSTTTAQPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHLPWMIVLFLLLVLVVIVVCSIRKSSRTLKKGPRQDPSAIVEKAGLKKSMTPTQNREKWIYYCNGHGIDILKLVAAQVGSQWKDIYQFLCNASEREVAAFSNGYTADHERAYAALQHWTIRGPEASLAQLISALRQHRRNDVVEKIRGLMEDTTQLETDKLALPMSPSPLSPSPIPSPNAKLENSALLTVEPSPQDKNKGFFVDESEPLLRCDSTSSGSSALSRNGSFITKEKKDTVLRQVRLDPCDLQPIFDDMLHFLNPEELRVIEEIPQAEDKLDRLFEIIGVKSQEASQTLLDSVYSHLPDLL,655,"71,845",Beta strand (18); Chain (1); Disulfide bond (9); Domain (1); Erroneous initiation (1); Glycosylation (6); Helix (7); Lipidation (1); Mutagenesis (7); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 67..80; DISULFID 70..88; DISULFID 91..106; DISULFID 109..123; DISULFID 113..131; DISULFID 133..144; DISULFID 150..168; DISULFID 171..186; DISULFID 192..211,"SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q14C87,Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein) (Mature OL transmembrane protein),MCPSEMGTLWHHWSPVLISLAALFSKVTEGRGILESIQRFSLLPTYLPVTYHINNADVSFFLKEANQDIMRNSSLQSRVESFLIYKSRRLPVLNASYGPFSIEQVVPQDLMLPSNPFGFTNKFSLNWKLKAHILRDKVYLSRPKVQVLFHIMGRDWDDRSAGEKLPCLRVFAFRETREVRGSCRLQGDLGLCVAELELLSSWFSPPTVVAGRRKSVDQPEGTPVELYYTVHPGGERGDCVREDARRSNGIRTGHSDIDESGPPLQRIGSIFLYQTHRKPSLRELRLDNSVAIHYIPKTVRKGDVLTFPVSISRNSTEDRFTLRAKVKKGVNIIGVRASSPSIWDVKERTDYTGKYAPAVIVCQKKAAGSENSADGASYEVMQIDVEVEEPGDLPATQLVTWQVEYPGEITSDLGVSKIYVSPKDLIGVVPLAMEAEILNTAILTGKTVAVPVKVVSVEDDGTVTELLESVECRSSDEDVIKVSDRCDYVFVNGKEMKGKVNVVVNFTYQHLSSPLEMTVWVPRLPLQIEVSDTELNQIKGWRVPIVSSRRPAGDSEEEEDDERRGRGCTLQYQHAMVRVLTQFVAEAAGPGGHLAHLLGSDWQVDITELINDFMQVEEPRIAKLQGGQILMGQELGMTTIQILSPLSDTILAEKTITVLDEKVTITDLGVQLVTGLSLSLQLSPGSNRAIFATAVAQELLQRPKQEAAISCWVQFSDGSVTPLDIYDGKDFSLMATSLDEKVVSIHQDPKFKWPIIAAETEGQGTLVKVEMVISESCQKSKRKSVLAVGTANIKVKFGQNDANPNTSDSRHTGAGVHMENNVSDRRPKKPSQEWGSQEGQYYGSSSMGLMEGRGTTTDRSILQKKKGQESLLDDNSHLQTIPSDLTSFPAQVDLPRSNGEMDGNDLMQASKGLSDLEIGMYALLGVFCLAILVFLINCVTFALKYRHKQVPFEEQEGMSHSHDWVGLSNRTELLENHINFASSQDEQITAIDRGMDFEESKYLLSTNSQKSINGQLFKPLGPIIIDGKDQKSEPPTSPTSKRKRVKFTTFTAVSSDDEYPTRNSIVMSSEDDIKWVCQDLDPGDCKELHNYMERLHENV,1099,"122,309",Alternative sequence (2); Chain (1); Erroneous initiation (1); Glycosylation (1); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q8N2U0,Transmembrane protein 256,MAGPAAAFRRLGALSGAAALGFASYGAHGAQFPDAYGKELFDKANKHHFLHSLALLGVPHCRKPLWAGLLLASGTTLFCTSFYYQALSGDPSIQTLAPAGGTLLLLGWLALAL,113,"11,742",Chain (1); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (2),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q96GX1,Tectonic-2,MGFQPPAALLLRLFLLQGILRLLWGDLAFIPPFIRMSGPAVSASLVGDTEGVTVSLAVLQDEAGILPIPTCGVLNNETEDWSVTVIPGAKVLEVTVRWKRGLDWCSSNETDSFSESPCILQTLLVSASHNSSCSAHLLIQVEIYANSSLTHNASENVTVIPNQVYQPLGPCPCNLTAGACDVRCCCDQECSSNLTTLFRRSCFTGVFGGDVNPPFDQLCSAGTTTRGVPDWFPFLCVQSPLANTPFLGYFYHGAVSPKQDSSFEVYVDTDAKDFADFGYKQGDPIMTVKKAYFTIPQVSLAGQCMQNAPVAFLHNFDVKCVTNLELYQERDGIINAKIKNVALGGIVTPKVIYEEATDLDKFITNTETPLNNGSTPRIVNVEEHYIFKWNNNTISEINVKIFRAEINAHQKGIMTQRFVVKFLSYNSGNEEELSGNPGYQLGKPVRALNINRMNNVTTLHLWQSAGRGLCTSATFKPILFGENVLSGCLLEVGINENCTQLRENAVERLDSLIQATHVAMRGNSDYADLSDGWLEIIRVDAPDPGADPLASSVNGMCLDIPAHLSIRILISDAGAVEGITQQEILGVETRFSSVNWQYQCGLTCEHKADLLPISASVQFIKIPAQLPHPLTRFQINYTEYDCNRNEVCWPQLLYPWTQYYQGELHSQCVAKGLLLLLFLTLALFLSNPWTRICKAYS,697,"76,871",Alternative sequence (1); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q92956,Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270),MEPPGDWGPPPWRSTPKTDVLRLVLYLTFLGAPCYAPALPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYATSSPGQRVQKGGTESQDTLCQNCPPGTFSPNGTLEECQHQTKCSWLVTKAGAGTSSSHWVWWFLSGSLVIVIVCSTVGLIICVKRRKPRGDVVKVIVSVQRKRQEAEGEATVIEALQAPPDVTTVAVEETIPSFTGRSPNH,283,"30,392",Alternative sequence (1); Beta strand (11); Chain (1); Disulfide bond (8); Glycosylation (2); Helix (1); Modified residue (1); Mutagenesis (2); Natural variant (4); Repeat (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..53;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 54..67;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 57..75;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 78..93;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 96..111;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 99..119;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 121..138;  /evidence=""ECO:0000269|PubMed:16169851""; DISULFID 127..135;  /evidence=""ECO:0000269|PubMed:16169851""","SIGNAL 1..38;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9Y493,Zonadhesin,MVPPVWTLLLLVGAALFRKEKPPDQKLVVRSSRDNYVLTQCDFEDDAKPLCDWSQVSADDEDWVRASGPSPTGSTGAPGGYPNGEGSYLHMESNSFHRGGVARLLSPDLWEQGPLCVHFAHHMFGLSWGAQLRLLLLSGEEGRRPDVLWKHWNTQRPSWMLTTVTVPAGFTLPTRLMFEGTRGSTAYLDIALDALSIRRGSCNRVCMMQTCSFDIPNDLCDWTWIPTASGAKWTQKKGSSGKPGVGPDGDFSSPGSGCYMLLDPKNARPGQKAVLLSPVSLSSGCLSFSFHYILRGQSPGAALHIYASVLGSIRKHTLFSGQPGPNWQAVSVNYTAVGRIQFAVVGVFGKTPEPAVAVDATSIAPCGEGFPQCDFEDNAHPFCDWVQTSGDGGHWALGHKNGPVHGMGPAGGFPNAGGHYIYLEADEFSQAGQSVRLVSRPFCAPGDICVEFAYHMYGLGEGTMLELLLGSPAGSPPIPLWKRVGSQRPYWQNTSVTVPSGHQQPMQLIFKGIQGSNTASVVAMGFILINPGTCPVKVLPELPPVSPVSSTGPSETTGLTENPTISTKKPTVSIEKPSVTTEKPTVPKEKPTIPTEKPTISTEKPTIPSEKPNMPSEKPTIPSEKPTILTEKPTIPSEKPTIPSEKPTISTEKPTVPTEEPTTPTEETTTSMEEPVIPTEKPSIPTEKPSIPTEKPTISMEETIISTEKPTISPEKPTIPTEKPTIPTEKSTISPEKPTTPTEKPTIPTEKPTISPEKPTTPTEKPTISPEKLTIPTEKPTIPTEKPTIPTEKPTISTEEPTTPTEETTISTEKPSIPMEKPTLPTEETTTSVEETTISTEKLTIPMEKPTISTEKPTIPTEKPTISPEKLTIPTEKLTIPTEKPTIPIEETTISTEKLTIPTEKPTISPEKPTISTEKPTIPTEKPTIPTEETTISTEKLTIPTEKPTISPEKLTIPTEKPTISTEKPTIPTEKLTIPTEKPTIPTEKPTIPTEKLTALRPPHPSPTATGLAALVMSPHAPSTPMTSVILGTTTTSRSSTERCPPNARYESCACPASCKSPRPSCGPLCREGCVCNPGFLFSDNHCIQASSCNCFYNNDYYEPGAEWFSPNCTEHCRCWPGSRVECQISQCGTHTVCQLKNGQYGCHPYAGTATCLVYGDPHYVTFDGRHFGFMGKCTYILAQPCGNSTDPFFRVTAKNEEQGQEGVSCLSKVYVTLPESTVTLLKGRRTLVGGQQVTLPAIPSKGVFLGASGRFVELQTEFGLRVRWDGDQQLYVTVSSTYSGKLCGLCGNYDGNSDNDHLKLDGSPAGDKEELGNSWQTDQDEDQECQKYQVVNSPSCDSSLQSSMSGPGFCGRLVDTHGPFETCLLHVKAASFFDSCMLDMCGFQGLQHLLCTHMSTMTTTCQDAGHAVKPWREPHFCPMACPPNSKYSLCAKPCPDTCHSGFSGMFCSDRCVEACECNPGFVLSGLECIPRSQCGCLHPAGSYFKVGERWYKPGCKELCVCESNNRIRCQPWRCRAQEFCGQQDGIYGCHAQGAATCTASGDPHYLTFDGALHHFMGTCTYVLTRPCWSRSQDSYFVVSATNENRGGILEVSYIKAVHVTVFDLSISLLRGCKVMLNGHRVALPVWLAQGRVTIRLSSNLVLLYTNFGLQVRYDGSHLVEVTVPSSYGGQLCGLCGNYNNNSLDDNLRPDRKLAGDSMQLGAAWKLPESSEPGCFLVGGKPSSCQENSMADAWNKNCAILINPQGPFSQCHQVVPPQSSFASCVHGQCGTKGDTTALCRSLQAYASLCAQAGQAPAWRNRTFCPMRCPPGSSYSPCSSPCPDTCSSINNPRDCPKALPCAESCECQKGHILSGTSCVPLGQCGCTDPAGSYHPVGERWYTENTCTRLCTCSVHNNITCFQSTCKPNQICWALDGLLHCRASGVGVCQLPGESHYVSFDGSNHSIPDACTLVLVKVCHPAMALPFFKISAKHEKEEGGTEAFRLHEVYIDIYDAQVTLQKGHRVLINSKQVTLPAISQIPGVSVKSSSIYSIVNIKIGVQVKFDGNHLLEIEIPTTYYGKVCGMCGNFNDEEEDELMMPSDEVANSDSEFVNSWKDKDIDPSCQSLLVDEQQIPAEQQENPSGNCRAADLRRAREKCEAALRAPVWAQCASRIDLTPFLVDCANTLCEFGGLYQALCQALQAFGATCQSQGLKPPLWRNSSFCPLECPAYSSYTNCLPSCSPSCWDLDGRCEGAKVPSACAEGCICQPGYVLSEDKCVPRSQCGCKDAHGGSIPLGKSWVSSGCTEKCVCTGGAIQCGDFRCPSGSHCQLTSDNSNSNCVSDKSEQCSVYGDPRYLTFDGFSYRLQGRMTYVLIKTVDVLPEGVEPLLVEGRNKMDPPRSSIFLQEVITTVYGYKVQLQAGLELVVNNQKMAVPYRPNEHLRVTLWGQRLYLVTDFELVVSFGGRKNAVISLPSMYEGLVSGLCGNYDKNRKNDMMLPSGALTQNLNTFGNSWEVKTEDALLRFPRAIPAEEEGQGAELGLRTGLQVSECSPEQLASNSTQACRVLADPQGPFAACHQTVAPEPFQEHCVLDLCSAQDPREQEELRCQVLSGHGVSSRYHISELYDTLPSILCQPGRPRGLRGPLRGRLRQHPRLCLQWHPEPPLADCGCTSNGIYYQLGSSFLTEDCSQRCTCASSRILLCEPFSCRAGEVCTLGNHTQGCFPESPCLQNPCQNDGQCREQGATFTCECEVGYGGGLCMEPRDAPPPRKPASNLVGVLLGLLVPVVVVLLAVTRECIYRTRRKREKTQEGDRLARLVDTDTVLDCAC,2812,"305,630",Alternative sequence (12); Chain (1); Disulfide bond (3); Domain (17); Erroneous gene model prediction (7); Glycosylation (11); Natural variant (23); Region (1); Sequence conflict (24); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 2712..2723;  /evidence=""ECO:0000250""; DISULFID 2717..2732;  /evidence=""ECO:0000250""; DISULFID 2734..2743;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9C0I4,Thrombospondin type-1 domain-containing protein 7B,MFPKSNLTVTCWVWRSMRKLFLLLSLLLSHAAHLEGKKDNQFIWKPGPWGRCTGDCGPGGVQSRAVWCFHVDGWTSHLSNCGESNRPPKERSCFRVCDWHSDLFQWEVSDWHHCVLVPYARGEVKPRTAECVTAQHGLQHRMVRCIQKLNRTVVANEICEHFALQPPTEQACLIPCPRDCVVSEFLPWSNCSKGCGKKLQHRTRAVIAPPLFGGLQCPNLTESRACDAPISCPLGEEEYTFSLKVGPWSKCRLPHLKEINPSGRTVLDFNSDSNERVTFKHQSYKAHHHSKSWAIEIGYQTRQVSCTRSDGQNAMLSLCLQDSFPLTVQSCIMPKDCETSQWSSWSPCSKTCRSGSLLPGFRSRSRNVKHMAIGGGKECPELLEKEACIVEGELLQQCPRYSWRTSEWKECQVSLLLEQQDPHWHVTGPVCGGGIQTREVYCAQSVPAAAALRAKEVSRPVEKALCVGPAPLPSQLCNIPCSTDCIVSSWSAWGLCIHENCHDPQGKKGFRTRQRHVLMESTGPAGHCPHLVESVPCEDPMCYRWLASEGICFPDHGKCGLGHRILKAVCQNDRGEDVSGSLCPVPPPPERKSCEIPCRMDCVLSEWTEWSSCSQSCSNKNSDGKQTRSRTILALAGEGGKPCPPSQALQEHRLCNDHSCMQLHWETSPWGPCSEDTLVTALNATIGWNGEATCGVGIQTRRVFCVKSHVGQVMTKRCPDSTRPETVRPCFLPCKKDCIVTAFSEWTPCPRMCQAGNATVKQSRYRIIIQEAANGGQECPDTLYEERECEDVSLCPVYRWKPQKWSPCILVPESVWQGITGSSEACGKGLQTRAVSCISDDNRSAEMMECLKQTNGMPLLVQECTVPCREDCTFTAWSKFTPCSTNCEATKSRRRQLTGKSRKKEKCQDSDLYPLVETELCPCDEFISQPYGNWSDCILPEGRREPHRGLRVQADSKECGEGLRFRAVACSDKNGRPVDPSFCSSSGYIQEKCVIPCPFDCKLSDWSSWGSCSSSCGIGVRIRSKWLKEKPYNGGRPCPKLDLKNQVHEAVPCYSECNQYSWVVEHWSSCKINNELRSLRCGGGTQSRKIRCVNTADGEGGAVDSNLCNQDEIPPETQSCSLMCPNECVMSEWGLWSKCPQSCDPHTMQRRTRHLLRPSLNSRTCAEDSQVQPCLLNENCFQFQYNLTEWSTCQLSENAPCGQGVRTRLLSCVCSDGKPVSMDQCEQHNLEKPQRMSIPCLVECVVNCQLSGWTAWTECSQTCGHGGRMSRTRFIIMPTQGEGRPCPTELTQEKTCPVTPCYSWVLGNWSACKLEGGDCGEGVQIRSLSCMVHSGSISHAAGRVEDALCGEMPFQDSILKQLCSVPCPGDCHLTEWSEWSTCELTCIDGRSFETVGRQSRSRTFIIQSFENQDSCPQQVLETRPCTGGKCYHYTWKASLWNNNERTVWCQRSDGVNVTGGCSPQARPAAIRQCIPACRKPFSYCTQGGVCGCEKGYTEIMKSNGFLDYCMKVPGSEDKKADVKNLSGKNRPVNSKIHDIFKGWSLQPLDPDGRVKIWVYGVSGGAFLIMIFLIFTSYLVCKKPKPHQSTPPQQKPLTLAYDGDLDM,1606,"179,199",Chain (1); Compositional bias (1); Disulfide bond (24); Domain (18); Glycosylation (11); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 411..477;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 431..481;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 442..466;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 602..643;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 613..617;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 655..660;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 738..779;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 749..753;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 789..795;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 872..907;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 883..887;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 921..923;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 937..993;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 959..997;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 970..983;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1001..1038;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1012..1016;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1120..1124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1248..1286;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1259..1263;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1296..1301;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1371..1415;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1382..1386;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1425..1430;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9NP99,Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354),MRKTRLWGLLWMLFVSELRAATKLTEEKYELKEGQTLDVKCDYTLEKFASSQKAWQIIRDGEMPKTLACTERPSKNSHPVQVGRIILEDYHDHGLLRVRMVNLQVEDSGLYQCVIYQPPKEPHMLFDRIRLVVTKGFSGTPGSNENSTQNVYKIPPTTTKALCPLYTSPRTVTQAPPKSTADVSTPDSEINLTNVTDIIRVPVFNIVILLAGGFLSKSLVFSVLFAVTLRSFVP,234,"26,387",Alternative sequence (3); Beta strand (10); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (3); Helix (2); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 41..113;  /evidence=""ECO:0000244|PDB:1Q8M, ECO:0000244|PDB:1SMO, ECO:0000269|PubMed:14656437, ECO:0000269|PubMed:15351648""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8WZ59,Transmembrane protein 190,MLGCGIPALGLLLLLQGSADGNGIQGFFYPWSCEGDIWDRESCGGQAAIDSPNLCLRLRCCYRNGVCYHQRPDENVRRKHMWALVWTCSGLLLLSCSICLFWWAKRRDVLHMPGFLAGPCDMSKSVSLLSKHRGTKKTPSTGSVPVALSKESRDVEGGTEGEGTEEGEETEGEEEED,177,"19,457",Chain (1); Compositional bias (1); Disulfide bond (3); Domain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 33..61;  /evidence=""ECO:0000250""; DISULFID 43..60;  /evidence=""ECO:0000250""; DISULFID 55..67;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q8IYR6,Tomoregulin-1 (TR-1) (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain),MGAAAAEAPLRLPAAPPLAFCCYTSVLLLFAFSLPGSRASNQPPGGGGGSGGDCPGGKGKSINCSELNVRESDVRVCDESSCKYGGVCKEDGDGLKCACQFQCHTNYIPVCGSNGDTYQNECFLRRAACKHQKEITVIARGPCYSDNGSGSGEGEEEGSGAEVHRKHSKCGPCKYKAECDEDAENVGCVCNIDCSGYSFNPVCASDGSSYNNPCFVREASCIKQEQIDIRHLGHCTDTDDTSLLGKKDDGLQYRPDVKDASDQREDVYIGNHMPCPENLNGYCIHGKCEFIYSTQKASCRCESGYTGQHCEKTDFSILYVVPSRQKLTHVLIAAIIGAVQIAIIVAIVMCITRKCPKNNRGRRQKQNLGHFTSDTSSRMV,380,"40,934",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (9); Domain (3); Frameshift (2); Natural variant (1); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 99..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 103..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 111..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 190..221;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 194..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 203..235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 275..288;  /evidence=""ECO:0000250""; DISULFID 283..299;  /evidence=""ECO:0000250""; DISULFID 301..310;  /evidence=""ECO:0000250""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
P78423,Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine],MAPISLSWLLRLATFCHLTVLLAGQHHGVTKCNITCSKMTSKIPVALLIHYQQNQASCGKRAIILETRQHRLFCADPKEQWVKDAMQHLDRQAAALTRNGGTFEKQIGEVKPRTTPAAGGMDESVVLEPEATGESSSLEPTPSSQEAQRALGTSPELPTGVTGSSGTRLPPTPKAQDGGPVGTELFRVPPVSTAATWQSSAPHQPGPSLWAEAKTSEAPSTQDPSTQASTASSPAPEENAPSEGQRVWGQGQSPRPENSLEREEMGPVPAHTDAFQDWGPGSMAHVSVVPVSSEGTPSREPVASGSWTPKAEEPIHATMDPQRLGVLITPVPDAQAATRRQAVGLLAFLGLLFCLGVAMFTYQSLQGCPRKMAGEMAEGLRYIPRSCGSNSYVLVPV,397,"42,203",Beta strand (5); Chain (2); Disulfide bond (2); Glycosylation (4); Helix (4); Mutagenesis (8); Natural variant (1); Region (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 32..58;  /evidence=""ECO:0000269|PubMed:10770945""; DISULFID 36..74;  /evidence=""ECO:0000269|PubMed:10770945""",SIGNAL 1..24
Q14162,Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I),MGLGLLLPLLLLWTRGTQGSELDPKGQHVCVASSPSAELQCCAGWRQKDQECTIPICEGPDACQKDEVCVKPGLCRCKPGFFGAHCSSRCPGQYWGPDCRESCPCHPHGQCEPATGACQCQADRWGARCEFPCACGPHGRCDPATGVCHCEPGWWSSTCRRPCQCNTAAARCEQATGACVCKPGWWGRRCSFRCNCHGSPCEQDSGRCACRPGWWGPECQQQCECVRGRCSAASGECTCPPGFRGARCELPCPAGSHGVQCAHSCGRCKHNEPCSPDTGSCESCEPGWNGTQCQQPCLPGTFGESCEQQCPHCRHGEACEPDTGHCQRCDPGWLGPRCEDPCPTGTFGEDCGSTCPTCVQGSCDTVTGDCVCSAGYWGPSCNASCPAGFHGNNCSVPCECPEGLCHPVSGSCQPGSGSRDTALIAGSLVPLLLLFLGLACCACCCWAPRSDLKDRPARDGATVSRMKLQVWGTLTSLGSTLPCRSLSSHKLPWVTVSHHDPEVPFNHSFIEPPSAGWATDDSFSSDPESGEADEVPAYCVPPQEGMVPVAQAGSSEASLAAGAFPPPEDASTPFAIPRTSSLARAKRPSVSFAEGTKFAPQSRRSSGELSSPLRKPKRLSRGAQSGPEGREAEESTGPEEAEAPESFPAAASPGDSATGHRRPPLGGRTVAEHVEAIEGSVQESSGPVTTIYMLAGKPRGSEGPVRSVFRHFGSFQKGQAEAKVKRAIPKPPRQALNRKKGSPGLASGSVGQSPNSAPKAGLPGATGPMAVRPEEAVRGLGAGTESSRRAQEPVSGCGSPEQDPQKQAEEERQEEPEYENVVPISRPPEP,830,"87,387",Alternative sequence (6); Chain (1); Compositional bias (3); Disulfide bond (18); Domain (6); Glycosylation (3); Modified residue (2); Natural variant (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 57..69;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 63..75;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 77..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 99..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 105..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 120..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 159..172;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 165..179;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 181..190;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 219..230;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 225..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 239..248;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 306..319;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 313..326;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 329..338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 355..363;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 358..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 372..381;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
O14669,Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2) (Proline-rich Gla protein 2),MRGHPSLLLLYMALTTCLDTSPSEETDQEVFLGPPEAQSFLSSHTRIPRANHWDLELLTPGNLERECLEERCSWEEAREYFEDNTLTERFWESYIYNGKGGRGRVDVASLAVGLTGGILLIVLAGLGAFWYLRWRQHRGQQPCPQEAGLISPLSPLNPLGPPTPLPPPPPPPPGLPTYEQALAASGVHDAPPPPYTSLRRPH,202,"22,393",Chain (1); Compositional bias (2); Disulfide bond (1); Domain (1); Modified residue (1); Motif (2); Mutagenesis (11); Natural variant (2); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 67..72;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00463""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q96BF3,Transmembrane and immunoglobulin domain-containing protein 2 (CD28 homolog) (Immunoglobulin and proline-rich receptor 1) (IGPR-1),MGSPGMVLGLLVQIWALQEASSLSVQQGPNLLQVRQGSQATLVCQVDQATAWERLRVKWTKDGAILCQPYITNGSLSLGVCGPQGRLSWQAPSHLTLQLDPVSLNHSGAYVCWAAVEIPELEEAEGNITRLFVDPDDPTQNRNRIASFPGFLFVLLGVGSMGVAAIVWGAWFWGRRSCQQRDSGNSPGNAFYSNVLYRPRGAPKKSEDCSGEGKDQRGQSIYSTSFPQPAPRQPHLASRPCPSPRPCPSPRPGHPVSMVRVSPRPSPTQQPRPKGFPKVGEE,282,"30,675",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Glycosylation (3); Modified residue (3); Mutagenesis (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..112;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8TCW7,"Zona pellucida-like domain-containing protein 1 (ZP domain-containing protein 1) (Cupulin) [Cleaved into: Zona pellucida-like domain-containing protein 1, secreted form]",MEQIWLLLLLTIRVLPGSAQFNGYNCDANLHSRFPAERDISVYCGVQAITMKINFCTVLFSGYSETDLALNGRHGDSHCRGFINNNTFPAVVIFIINLSTLEGCGNNLVVSTIPGVSAYGNATSVQVGNISGYIDTPDPPTIISYLPGLLYKFSCSYPLEYLVNNTQLASSSAAISVRENNGTFVSTLNLLLYNDSTYNQQLIIPSIGLPLKTKVFAAVQATNLDGRWNVLMDYCYTTPSGNPNDDIRYDLFLSCDKDPQTTVIENGRSQRGRFSFEVFRFVKHKNQKMSTVFLHCVTKLCRADDCPFLMPICSHRERRDAGRRTTWSPQSSSGSAVLSAGPIITRSDETPTNNSQLGSPSMPPFQLNAITSALISGMVILGVTSFSLLLCSLALLHRKGPTSLVLNGIRNPVFD,415,"45,530",Alternative sequence (1); Chain (2); Disulfide bond (4); Domain (1); Erroneous gene model prediction (1); Glycosylation (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 44..155;  /evidence=""ECO:0000250|UniProtKB:P10761""; DISULFID 79..104;  /evidence=""ECO:0000250|UniProtKB:P10761""; DISULFID 235..296;  /evidence=""ECO:0000250|UniProtKB:P10761""; DISULFID 255..313;  /evidence=""ECO:0000250|UniProtKB:P10761""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NP84,Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14) (FGF-inducible 14) (Tweak-receptor) (TweakR) (CD antigen CD266),MARGSLRRLLRLLVLGLWLALLRSVAGEQAPGTAPCSRGSSWSADLDKCMDCASCRARPHSDFCLGCAAAPPAPFRLLWPILGGALSLTFVLGLLSGFLVWRRCRRREKFTTPIEETGGEGCPAVALIQ,129,"13,911",Alternative sequence (1); Beta strand (2); Chain (1); Disulfide bond (3); Helix (3); Repeat (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 36..49;  /evidence=""ECO:0000269|PubMed:19241374""; DISULFID 52..67;  /evidence=""ECO:0000269|PubMed:19241374""; DISULFID 55..64;  /evidence=""ECO:0000269|PubMed:19241374""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
O00526,Uroplakin-2 (UP2) (Uroplakin II) (UPII),MAPLLPIRTLPLILILLALLSPGAADFNISSLSGLLSPALTESLLVALPPCHLTGGNATLMVRRANDSKVVTSSFVVPPCRGRRELVSVVDSGAGFTVTRLSAYQVTNLVPGTKFYISYLVKKGTATESSREIPMSTLPRRNMESIGLGMARTGGMVVITVLLSVAMFLLVLGFIIALALGSRK,184,"19,438",Chain (1); Glycosylation (3); Natural variant (2); Propeptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8TAB3,Protocadherin-19,MESLLLPVLLLLAILWTQAAALINLKYSVEEEQRAGTVIANVAKDAREAGFALDPRQASAFRVVSNSAPHLVDINPSSGLLVTKQKIDRDLLCRQSPKCIISLEVMSSSMEICVIKVEIKDLNDNAPSFPAAQIELEISEAASPGTRIPLDSAYDPDSGSFGVQTYELTPNELFGLEIKTRGDGSRFAELVVEKSLDRETQSHYSFRITALDGGDPPRLGTVGLSIKVTDSNDNNPVFSESTYAVSVPENSPPNTPVIRLNASDPDEGTNGQVVYSFYGYVNDRTRELFQIDPHSGLVTVTGALDYEEGHVYELDVQAKDLGPNSIPAHCKVTVSVLDTNDNPPVINLLSVNSELVEVSESAPPGYVIALVRVSDRDSGLNGRVQCRLLGNVPFRLQEYESFSTILVDGRLDREQHDQYNLTIQARDGGVPMLQSAKSFTVLITDENDNHPHFSKPYYQVIVQENNTPGAYLLSVSARDPDLGLNGSVSYQIVPSQVRDMPVFTYVSINPNSGDIYALRSFNHEQTKAFEFKVLAKDGGLPSLQSNATVRVIILDVNDNTPVITAPPLINGTAEVYIPRNSGIGYLVTVVKAEDYDEGENGRVTYDMTEGDRGFFEIDQVNGEVRTTRTFGESSKSSYELIVVAHDHGKTSLSASALVLIYLSPALDAQESMGSVNLSLIFIIALGSIAGILFVTMIFVAIKCKRDNKEIRTYNCSNCLTITCLLGCFIKGQNSKCLHCISVSPISEEQDKKTEEKVSLRGKRIAEYSYGHQKKSSKKKKISKNDIRLVPRDVEETDKMNVVSCSSLTSSLNYFDYHQQTLPLGCRRSESTFLNVENQNTRNTSANHIYHHSFNSQGPQQPDLIINGVPLPETENYSFDSNYVNSRAHLIKSSSTFKDLEGNSLKDSGHEESDQTDSEHDVQRSLYCDTAVNDVLNTSVTSMGSQMPDHDQNEGFHCREECRILGHSDRCWMPRNPMPIRSKSPEHVRNIIALSIEATAADVEAYDDCGPTKRTFATFGKDVSDHPAEERPTLKGKRTVDVTICSPKVNSVIREAGNGCEAISPVTSPLHLKSSLPTKPSVSYTIALAPPARDLEQYVNNVNNGPTRPSEAEPRGADSEKVMHEVSPILKEGRNKESPGVKRLKDIVL,1148,"126,253",Alternative sequence (2); Beta strand (30); Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (6); Helix (6); Natural variant (45); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9Y5E8,Protocadherin beta-15 (PCDH-beta-15),MEPAGERFPEQRQVLILLLLLEVTLAGWEPRRYSVMEETERGSFVANLANDLGLGVGELAERGARVVSEDNEQGLQLDLQTGQLILNEKLDREKLCGPTEPCIMHFQVLLKKPLEVFRAELLVTDINDHSPEFPEREMTLKIPETSSLGTVFPLKKARDLDVGSNNVQNYNISPNSHFHVSTRTRGDGRKYPELVLDTELDREEQAELRLTLTAVDGGSPPRSGTVQILILVLDANDNAPEFVQALYEVQVPENSPVGSLVVKVSARDLDTGTNGEISYSLYYSSQEIDKPFELSSLSGEIRLIKKLDFETMSSYDLDIEASDGGGLSGKCSVSVKVLDVNDNFPELSISSLTSPIPENSPETEVALFRIRDRDSGENGKMICSIQDDVPFKLKPSVENFYRLVTEGALDRETRAEYNITITITDLGTPRLKTEQSITVLVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPRDPHLPLTSLVSINTDNGHLFALQSLDYEALQAFEFRVGATDRGFPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDVAKHRLVVLVKDNGEPPRSATATLQVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVFLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVSGTGTLSQSYQYEVCLTGGSESNDFKFLKPIFPNIVSQDSRRKSEFLE,787,"86,329",Chain (1); Domain (6); Glycosylation (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9Y5E9,Protocadherin beta-14 (PCDH-beta-14),MEIRGALDLRKRQVLIFLVLLGLSRAGTESAHYSVAEETEIGSFVANLARDLGLGVEELSSREARVVSDDNKKYLHLDLLTGNLLLNEKLDRDELCGSTEPCVLHFQVVLENPLQFFRFELCVKDINDHSPTFLDKEILIKISEGTTVGATFLMESAQDLDVGSNSLQNYTISPNSHFYIKIPDSSDRKIYPELVLDRALDYEQEAELRLTLTAVDGGSPPKSGTTLVLIKVLDINDNAPEFPQSLYEVQVPEDRPLGSWIATISAKDLDAGNYGKISYTFFHASEDIRKTFEINPISGEVNLRSPLDFEVIQSYTINIQATDGGGLSGKCTLLVKVMDINDNPPEVTISSITKRIPENASETLVALFSILDQDSGDNGRMICSIQDNLPFFLKPTFKNFFTLVSEKALDRESQAEYNITITVTDLGTPRLKTEYNITVLLSDVNDNAPTFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVNYSLLPPQDRHLPLASLVSINADNGHLFALRSLDYEALQEFEFRVGATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVSGTGTLSQSYQYEVCLTGGSGTNEFKFLKPIIPNFQVHDTGRNMGEIENFRNSFGLNIQ,798,"87,548",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (6); Glycosylation (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 96..102;  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9UQV4,Lysosome-associated membrane glycoprotein 3 (LAMP-3) (Lysosomal-associated membrane protein 3) (DC-lysosome-associated membrane glycoprotein) (DC LAMP) (Protein TSC403) (CD antigen CD208),MPRQLSAAAALFASLAVILHDGSQMRAKAFPETRDYSQPTAAATVQDIKKPVQQPAKQAPHQTLAARFMDGHITFQTAATVKIPTTTPATTKNTATTSPITYTLVTTQATPNNSHTAPPVTEVTVGPSLAPYSLPPTITPPAHTTGTSSSTVSHTTGNTTQPSNQTTLPATLSIALHKSTTGQKPVQPTHAPGTTAAAHNTTRTAAPASTVPGPTLAPQPSSVKTGIYQVLNGSRLCIKAEMGIQLIVQDKESVFSPRRYFNIDPNATQASGNCGTRKSNLLLNFQGGFVNLTFTKDEESYYISEVGAYLTVSDPETIYQGIKHAVVMFQTAVGHSFKCVSEQSLQLSAHLQVKTTDVQLQAFDFEDDHFGNVDECSSDYTIVLPVIGAIVVGLCLMGMGVYKIRLRCQSSGYQRI,416,"44,346",Beta strand (14); Chain (1); Compositional bias (1); Disulfide bond (2); Glycosylation (7); Helix (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 237..274;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:22809326""; DISULFID 339..376;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:22809326""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9Y5H0,Protocadherin gamma-A3 (PCDH-gamma-A3),MTNCLSFRNGRGLALLCALLGTLCETGSGQIRYSVSEELDKGSFVGNIANDLGLEPRELAERGVRIVSRGRTQLFSLNPQSGSLVTAERIDREELCAQIPLCLVKINILVEDKLKIFEVEIEIKDINDNAPNFPTEELEIKIGELTVPGTRFPIKTAFDPDVGINSLQNYKLSPNDYFSLAVNSVSEGAKYPELVLERALDREKKEIHQLVLVASDGGDPVHSGNLHIQVIVLDANDNPPMFTQPEYRVSVWENVPVGTRLLTVNATDPDEGFNAQVSYILDKMPGKIAEIFHLNSVSGEVSILKSLDYEDAMFYEIKIEAQDGPGLLSRAKILVTVLDVNDNAPEITITSLTSSVPEEGTVGREIALIDVHDRDSGQNGQVEVFVLGNLPFKLEKSIDQYYRLVTATSLDREQISEYNISLRASDGGSPPLSTETHITLHVIDINDNPPTFPHLSYSAYIPENNPRGASIFSVTAQDPDSNNNARITYALTEDTLQGAPLSSFVSINSNTGVLYALRSFDYEQFRDLKLLVTASDSGNPPLSSNVSLNLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADRIPDILADLGSLEPSAKPNDSDLTLYLVVAVAAVSCVFLAFVIVLLALRLRRWHKSRLLQASGGGLASTPGSHFVGADGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLISQESCEKSEPLLITQDLLEMKGDSNLLQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"100,971",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (4); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9HC56,Protocadherin-9,MDLRDFYLLAALIACLRLDSAIAQELIYTIREELPENVPIGNIPKDLNISHINAATGTSASLVYRLVSKAGDAPLVKVSSSTGEIFTTSNRIDREKLCAGASYAEENECFFELEVVILPNDFFRLIKIKIIVKDTNDNAPMFPSPVINISIPENTLINSRFPIPSATDPDTGFNGVQHYELLNGQSVFGLDIVETPEGEKWPQLIVQQNLDREQKDTYVMKIKVEDGGTPQKSSTAILQVTVSDVNDNRPVFKEGQVEVHIPENAPVGTSVIQLHATDADIGSNAEIRYIFGAQVAPATKRLFALNNTTGLITVQRSLDREETAIHKVTVLASDGSSTPARATVTINVTDVNDNPPNIDLRYIISPINGTVYLSEKDPVNTKIALITVSDKDTDVNGKVICFIEREVPFHLKAVYDNQYLLETSSLLDYEGTKEFSFKIVASDSGKPSLNQTALVRVKLEDENDNPPIFNQPVIELSVSENNRRGLYLTTISATDEDSGKNADIVYQLGPNASFFDLDRKTGVLTASRVFDREEQERFIFTVTARDNGTPPLQSQAAVIVTVLDENDNSPKFTHNHFQFFVSENLPKYSTVGVITVTDADAGENKAVTLSILNDNDNFVLDPYSGVIKSNVSFDREQQSSYTFDVKATDGGQPPRSSTAKVTINVMDVNDNSPVVISPPSNTSFKLVPLSAIPGSVVAEVFAVDVDTGMNAELKYTIVSGNNKGLFRIDPVTGNITLEEKPAPTDVGLHRLVVNISDLGYPKSLHTLVLVFLYVNDTAGNASYIYDLIRRTMETPLDRNIGDSSQPYQNEDYLTIMIAIIAGAMVVIVVIFVTVLVRCRHASRFKAAQRSKQGAEWMSPNQENKQNKKKKRKKRKSPKSSLLNFVTIEESKPDDAVHEPINGTISLPAELEEQSIGRFDWGPAPPTTFKPNSPDLAKHYKSASPQPAFHLKPDTPVSVKKHHVIQELPLDNTFVGGCDTLSKRSSTSSDHFSASECSSQGGFKTKGPLHTRQCNSHSKSDNIPVTPQKCPSSTGFHIQENEESHYESQRRVTFHLPDGSQESCSDSGLGDHEPVGSGTLISHPLPLVQPQDEFYDQASPDKRTEADGNSDPNSDGPLGPRGLAEATEMCTQECLVLGHSDNCWMPPGLGPYQHPKSPLSTFAPQKEWVKKDKLVNGHTLTRAWKEDSNRNQFNDRKQYGSNEGHFNNGSHMTDIPLANLKSYKQAGGATESPKEHQL,1237,"136,064",Alternative sequence (1); Beta strand (7); Chain (1); Domain (7); Glycosylation (14); Helix (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P62341,Thioredoxin reductase-like selenoprotein T (SelT) (EC 1.8.1.9),MRLLLLLLVAASAMVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMRVISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQWGQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNEMKLNVHMDSIPHHRS,195,"22,324",Chain (1); Cross-link (1); Erroneous termination (3); Frameshift (1); Mutagenesis (1); Non-standard residue (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q14242,P-selectin glycoprotein ligand 1 (PSGL-1) (Selectin P ligand) (CD antigen CD162),MPLQLLLLLILLGPGNSLQLWDTWADEAEKALGPLLARDRRQATEYEYLDYDFLPETEPPEMLRNSTDTTPLTGPGTPESTTVEPAARRSTGLDAGGAVTELTTELANMGNLSTDSAAMEIQTTQPAATEAQTTQPVPTEAQTTPLAATEAQTTRLTATEAQTTPLAATEAQTTPPAATEAQTTQPTGLEAQTTAPAAMEAQTTAPAAMEAQTTPPAAMEAQTTQTTAMEAQTTAPEATEAQTTQPTATEAQTTPLAAMEALSTEPSATEALSMEPTTKRGLFIPFSVSSVTHKGIPMAASNLSVNYPVGAPDHISVKQCLLAILILALVATIFFVCTVVLAVRLSRKGHMYPVRNYSPTEMVCISSLLPDGGEGPSATANGGLSKAKSPGLTPEPREDREGDDLTLHSFLP,412,"43,201",Alternative sequence (1); Chain (1); Disulfide bond (1); Glycosylation (4); Modified residue (6); Mutagenesis (8); Natural variant (4); Propeptide (1); Region (1); Repeat (12); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 320;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:10713099""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q6UXD5,Seizure 6-like protein 2,MGTPRAQHPPPPQLLFLILLSCPWIQGLPLKEEEILPEPGSETPTVASEALAELLHGALLRRGPEMGYLPGSDRDPTLATPPAGQTLAVPSLPRATEPGTGPLTTAVTPNGVRGAGPTAPELLTPPPGTTAPPPPSPASPGPPLGPEGGEEETTTTIITTTTVTTTVTSPVLCNNNISEGEGYVESPDLGSPVSRTLGLLDCTYSIHVYPGYGIEIQVQTLNLSQEEELLVLAGGGSPGLAPRLLANSSMLGEGQVLRSPTNRLLLHFQSPRVPRGGGFRIHYQAYLLSCGFPPRPAHGDVSVTDLHPGGTATFHCDSGYQLQGEETLICLNGTRPSWNGETPSCMASCGGTIHNATLGRIVSPEPGGAVGPNLTCRWVIEAAEGRRLHLHFERVSLDEDNDRLMVRSGGSPLSPVIYDSDMDDVPERGLISDAQSLYVELLSETPANPLLLSLRFEAFEEDRCFAPFLAHGNVTTTDPEYRPGALATFSCLPGYALEPPGPPNAIECVDPTEPHWNDTEPACKAMCGGELSEPAGVVLSPDWPQSYSPGQDCVWGVHVQEEKRILLQVEILNVREGDMLTLFDGDGPSARVLAQLRGPQPRRRLLSSGPDLTLQFQAPPGPPNPGLGQGFVLHFKEVPRNDTCPELPPPEWGWRTASHGDLIRGTVLTYQCEPGYELLGSDILTCQWDLSWSAAPPACQKIMTCADPGEIANGHRTASDAGFPVGSHVQYRCLPGYSLEGAAMLTCYSRDTGTPKWSDRVPKCALKYEPCLNPGVPENGYQTLYKHHYQAGESLRFFCYEGFELIGEVTITCVPGHPSQWTSQPPLCKVTQTTDPSRQLEGGNLALAILLPLGLVIVLGSGVYIYYTKLQGKSLFGFSGSHSYSPITVESDFSNPLYEAGDTREYEVSI,910,"97,560",Alternative sequence (6); Chain (1); Compositional bias (2); Disulfide bond (13); Domain (8); Glycosylation (9); Natural variant (1); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 173..202;  /evidence=""ECO:0000250""; DISULFID 290..330;  /evidence=""ECO:0000250""; DISULFID 316..345;  /evidence=""ECO:0000250""; DISULFID 349..376;  /evidence=""ECO:0000250""; DISULFID 464..508;  /evidence=""ECO:0000250""; DISULFID 491..523;  /evidence=""ECO:0000250""; DISULFID 527..553;  /evidence=""ECO:0000250""; DISULFID 644..686;  /evidence=""ECO:0000250""; DISULFID 672..699;  /evidence=""ECO:0000250""; DISULFID 705..747;  /evidence=""ECO:0000250""; DISULFID 733..764;  /evidence=""ECO:0000250""; DISULFID 771..813;  /evidence=""ECO:0000250""; DISULFID 799..828;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:19838169"""
Q9NS62,Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module),MKPMLKDFSNLLLVVLCDYVLGEAEYLLLREPGHVALSNDTVYVDFQYFDGANGTLRNVSVLLLEANTNQTVTTKYLLTNQSQGTLKFECFYFKEAGDYWFTMTPEATDNSTPFPWWEKSAFLKVEWPVFHVDLNRSAKAAEGTFQVGLFTSQPLCPFPVDKPNIVVDVIFTNSLPEARRNSRQPLEIRTSKRTELAQGQWVEFGCAPLGPEAYVTVVLKLLGRDSVITSTGPIDLAQKFGYKLVMVPELTCESGVEVTVLPPPCTFVQGVVTVFKEAPRYPGKRTIHLAENSLPLGERRTIFNCTLFDMGKNKYCFDFGISSRSHFSAKEECMLIQRNTETWGLWQPWSQCSATCGDGVRERRRVCLTSFPSSPVCPGMSLEASLCSLEECAAFQPSSPSPLQPQGPVKSNNIVTVTGISLCLFIIIATVLITLWRRFGRPAKCSTPARHNSIHSPSFRKNSDEENICELSEQRGSFSDGGDGPTGSPGDTGIPLTYRRSGPVPPEDDASGSESFQSNAQKIIPPLFSYRLAQQQLKEMKKKGLTETTKVYHVSQSPLTDTAIDAAPSAPLDLESPEEAAANKFRIKSPFPEQPAVSAGERPPSRLDLNVTQASCAISPSQTLIRKSQARHVGSRGGPSERSHARNAHFRRTASFHEARQARPFRERSMSTLTPRQAPAYSSRTRTCEQAEDRFRPQSRGAHLFPEKLEHFQEASGTRGPLNPLPKSYTLGQPLRKPDLGDHQAGLVAGIERTEPHRARRGPSPSHKSVSRKQSSPISPKDNYQRVSSLSPSQCRKDKCQSFPTHPEFAFYDNTSFGLTEAEQRMLDLPGYFGSNEEDETTSTLSVEKLVI,852,"94,584",Alternative sequence (3); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (7); Modified residue (1); Natural variant (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 352..387;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 356..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 367..377;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q8IW52,SLIT and NTRK-like protein 4,MFLWLFLILSALISSTNADSDISVEICNVCSCVSVENVLYVNCEKVSVYRPNQLKPPWSNFYHLNFQNNFLNILYPNTFLNFSHAVSLHLGNNKLQNIEGGAFLGLSALKQLHLNNNELKILRADTFLGIENLEYLQADYNLIKYIERGAFNKLHKLKVLILNDNLISFLPDNIFRFASLTHLDIRGNRIQKLPYIGVLEHIGRVVELQLEDNPWNCSCDLLPLKAWLENMPYNIYIGEAICETPSDLYGRLLKETNKQELCPMGTGSDFDVRILPPSQLENGYTTPNGHTTQTSLHRLVTKPPKTTNPSKISGIVAGKALSNRNLSQIVSYQTRVPPLTPCPAPCFCKTHPSDLGLSVNCQEKNIQSMSELIPKPLNAKKLHVNGNSIKDVDVSDFTDFEGLDLLHLGSNQITVIKGDVFHNLTNLRRLYLNGNQIERLYPEIFSGLHNLQYLYLEYNLIKEISAGTFDSMPNLQLLYLNNNLLKSLPVYIFSGAPLARLNLRNNKFMYLPVSGVLDQLQSLTQIDLEGNPWDCTCDLVALKLWVEKLSDGIVVKELKCETPVQFANIELKSLKNEILCPKLLNKPSAPFTSPAPAITFTTPLGPIRSPPGGPVPLSILILSILVVLILTVFVAFCLLVFVLRRNKKPTVKHEGLGNPDCGSMQLQLRKHDHKTNKKDGLSTEAFIPQTIEQMSKSHTCGLKESETGFMFSDPPGQKVVMRNVADKEKDLLHVDTRKRLSTIDELDELFPSRDSNVFIQNFLESKKEYNSIGVSGFEIRYPEKQPDKKSKKSLIGGNHSKIVVEQRKSEYFELKAKLQSSPDYLQVLEEQTALNKI,837,"94,331",Chain (1); Domain (3); Erroneous initiation (1); Glycosylation (2); Natural variant (2); Repeat (12); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9P1W8,Signal-regulatory protein gamma (SIRP-gamma) (CD172 antigen-like family member B) (Signal-regulatory protein beta-2) (SIRP-b2) (SIRP-beta-2) (CD antigen CD172g),MPVPASWPHPPGPFLLLTLLLGLTEVAGEEELQMIQPEKLLLVTVGKTATLHCTVTSLLPVGPVLWFRGVGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRISSITPADVGTYYCVKFRKGSPENVEFKSGPGTEMALGAKPSAPVVLGPAARTTPEHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPTGQSVAYSIRSTARVVLDPWDVRSQVICEVAHVTLQGDPLRGTANLSEAIRVPPTLEVTQQPMRVGNQVNVTCQVRKFYPQSLQLTWSENGNVCQRETASTLTENKDGTYNWTSWFLVNISDQRDDVVLTCQVKHDGQLAVSKRLALEVTVHQKDQSSDATPGPASSLTALLLIAVLLGPIYVPWKQKT,387,"42,498",Alternative sequence (3); Beta strand (25); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (4); Helix (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 53..119;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18657508""; DISULFID 168..226;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 271..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5G9,Protocadherin gamma-A4 (PCDH-gamma-A4),MHFILDPEDPGAPQASTEGKPKHRRLRGGVVMAAPPARPDHTRLLQICLLLGVLVEIRAEQILYSVFEEQEEGSVVGNIAKDLGLAPRELAERGVRIVSRGRTQLFALNPRSGTLVTAGRIDREELCDRSPNCVTNLEILLEDTVKILRVEVEIIDVNDNPPSFGTEQREIKVAENENPGARFPLPEAFDPDVGVNSLQGYQLNSNGYFSLDVQSGADGIKYPELVLERALDREEEAVHHLVLTAFDGGDPVRSGTARILIILVDTNDNAPVFTQPEYHVSVRENVPVGTRLLTVKATDPDEGANGDVTYSFRKVRDKISQLFQLNSLSGDITILGGLDYEDSGFYDIDVEAHDGPGLRARSKVLVTVLDENDNAPEVTVTSLTSSVQESSSPGTVIALFNVHDSDSGGNGLVTCSIPDNLPFTLEKTYGNYYRLLTHRTLDREEVSEYNITVTATDQGTPPLSTETHISLQVMDINDNPPTFPHASYSAYIPENNPRGASILSMTAQDPDSGDNARITYSLAEDTFQGAPLSSYVSINSNTGILYALCSFDYEQFRDLQLLMTASDSGDPPLSSNVSLSLFVLDQNDNVPEILYPTFPTDGSTGVELAPRSADSGYLVTKVVAVDRDSGQNAWLSYSLLKSSEPGLFAVGLHTGEVRTARALLDRDALKQRLVVVVQDHGQPPLSATVTLTVAVADSIPDVLADLGSLKPSADPDDSGLTLYLVVAVAAVSCVFLAFVTVLLALKLRRWHKSRLLHAEGSRLAGVPASHFVGVDGVRAFLQTYSHEVSLTADSRKSHLIFSQPSYADTLISRESCEKSEPLLITQDLLETKGDPNLQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,962,"103,968",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..59;  /evidence=""ECO:0000305"""
Q92824,Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5),MGWGSRCCCPGRLDLLCVLALLGGCLLPVCRTRVYTNHWAVKIAGGFPEANRIASKYGFINIGQIGALKDYYHFYHSRTIKRSVISSRGTHSFISMEPKVEWIQQQVVKKRTKRDYDFSRAQSTYFNDPKWPSMWYMHCSDNTHPCQSDMNIEGAWKRGYTGKNIVVTILDDGIERTHPDLMQNYDALASCDVNGNDLDPMPRYDASNENKHGTRCAGEVAAAANNSHCTVGIAFNAKIGGVRMLDGDVTDMVEAKSVSFNPQHVHIYSASWGPDDDGKTVDGPAPLTRQAFENGVRMGRRGLGSVFVWASGNGGRSKDHCSCDGYTNSIYTISISSTAESGKKPWYLEECSSTLATTYSSGESYDKKIITTDLRQRCTDNHTGTSASAPMAAGIIALALEANPFLTWRDVQHVIVRTSRAGHLNANDWKTNAAGFKVSHLYGFGLMDAEAMVMEAEKWTTVPRQHVCVESTDRQIKTIRPNSAVRSIYKASGCSDNPNRHVNYLEHVVVRITITHPRRGDLAIYLTSPSGTRSQLLANRLFDHSMEGFKNWEFMTIHCWGERAAGDWVLEVYDTPSQLRNFKTPGKLKEWSLVLYGTSVQPYSPTNEFPKVERFRYSRVEDPTDDYGTEDYAGPCDPECSEVGCDGPGPDHCNDCLHYYYKLKNNTRICVSSCPPGHYHADKKRCRKCAPNCESCFGSHGDQCMSCKYGYFLNEETNSCVTHCPDGSYQDTKKNLCRKCSENCKTCTEFHNCTECRDGLSLQGSRCSVSCEDGRYFNGQDCQPCHRFCATCAGAGADGCINCTEGYFMEDGRCVQSCSISYYFDHSSENGYKSCKKCDISCLTCNGPGFKNCTSCPSGYLLDLGMCQMGAICKDGEYVDEHGHCQTCEASCAKCQGPTQEDCTTCPMTRIFDDGRCVSNCPSWKFEFENQCHPCHHTCQRCQGSGPTHCTSCGADNYGREHFLYQGECGDSCPEGHYATEGNTCLPCPDNCELCHSVHVCTRCMKGYFIAPTNHTCQKLECGQGEVQDPDYEECVPCEEGCLGCSLDDPGTCTSCAMGYYRFDHHCYKTCPEKTYSEEVECKACDSNCGSCDQNGCYWCEEGFFLLGGSCVRKCGPGFYGDQEMGECESCHRACETCTGPGHDECSSCQEGLQLLRGMCVHATKTQEEGKFWNDILRKLQPCHSSCKTCNGSATLCTSCPKGAYLLAQACVSSCPQGTWPSVRSGSCENCTEACAICSGADLCKKCQMQPGHPLFLHEGRCYSKCPEGSYAEDGICERCSSPCRTCEGNATNCHSCEGGHVLHHGVCQENCPERHVAVKGVCKHCPEMCQDCIHEKTCKECTPEFFLHDDMCHQSCPRGFYADSRHCVPCHKDCLECSGPKADDCELCLESSWVLYDGLCLEECPAGTYYEKETKECRDCHKSCLTCSSSGTCTTCQKGLIMNPRGSCMANEKCSPSEYWDEDAPGCKPCHVKCFHCMGPAEDQCQTCPMNSLLLNTTCVKDCPEGYYADEDSNRCAHCHSSCRTCEGRHSRQCHSCRPGWFQLGKECLLQCREGYYADNSTGRCERCNRSCKGCQGPRPTDCLSCDRFFFLLRSKGECHRSCPDHYYVEQSTQTCERCHPTCDQCKGKGALNCLSCVWSYHLMGGICTSDCLVGEYRVGEGEKFNCEKCHESCMECKGPGAKNCTLCPANLVLHMDDSHCLHCCNTSDPPSAQECCDCQDTTDECILRTSKVRPATEHFKTALFITSSMMLVLLLGAAVVVWKKSRGRVQPAAKAGYEKLADPNKSYSSYKSSYRESTSFEEDQVIEYRDRDYDEDDDDDIVYMGQDGTVYRKFKYGLLDDDDIDELEYDDESYSYYQ,1860,"206,942",Active site (3); Alternative sequence (2); Chain (1); Compositional bias (1); Domain (3); Glycosylation (12); Motif (1); Propeptide (1); Region (3); Repeat (22); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000250"""
Q01973,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",MHRPRRRGTRPPLLALLAALLLAARGAAAQETELSVSAELVPTSSWNISSELNKDSYLTLDEPMNNITTSLGQTAELHCKVSGNPPPTIRWFKNDAPVVQEPRRLSFRSTIYGSRLRIRNLDTTDTGYFQCVATNGKEVVSSTGVLFVKFGPPPTASPGYSDEYEEDGFCQPYRGIACARFIGNRTVYMESLHMQGEIENQITAAFTMIGTSSHLSDKCSQFAIPSLCHYAFPYCDETSSVPKPRDLCRDECEILENVLCQTEYIFARSNPMILMRLKLPNCEDLPQPESPEAANCIRIGIPMADPINKNHKCYNSTGVDYRGTVSVTKSGRQCQPWNSQYPHTHTFTALRFPELNGGHSYCRNPGNQKEAPWCFTLDENFKSDLCDIPACDSKDSKEKNKMEILYILVPSVAIPLAIALLFFFICVCRNNQKSSSAPVQRQPKHVRGQNVEMSMLNAYKPKSKAKELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHPNIVCLLGAVTQEQPVCMLFEYINQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWNEIPSRRPRFKDIHVRLRSWEGLSSHTSSTTPSGGNATTQTTSLSASPVSNLSNPRYPNYMFPSQGITPQGQIAGFIGPPIPQNQRFIPINGYPIPPGYAAFPAAHYQPTGPPRVIQHCPPPKSRSPSSASGSTSTGHVTSLPSSGSNQEANIPLLPHMSIPNHPGGMGITVFGNKSQKPYKIDSKQASLLGDANIHGHTESMISAEL,937,"104,283",Alternative sequence (3); Beta strand (12); Binding site (1); Chain (1); Compositional bias (3); Disulfide bond (9); Domain (4); Glycosylation (4); Helix (17); Modified residue (1); Mutagenesis (1); Natural variant (10); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 79..131;  /evidence=""ECO:0000250""; DISULFID 170..235;  /evidence=""ECO:0000250""; DISULFID 178..228;  /evidence=""ECO:0000250""; DISULFID 219..260;  /evidence=""ECO:0000250""; DISULFID 248..296;  /evidence=""ECO:0000250""; DISULFID 252..282;  /evidence=""ECO:0000250""; DISULFID 313..391;  /evidence=""ECO:0000250""; DISULFID 334..374;  /evidence=""ECO:0000250""; DISULFID 362..386;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9ULK6,RING finger protein 150,MAMSLIQACCSLALSTWLLSFCFVHLLCLDFTVAEKEEWYTAFVNITYAEPAPDPGAGAAGGGGAELHTEKTECGRYGEHSPKQDARGEVVMASSAHDRLACDPNTKFAAPTRGKNWIALIPKGNCTYRDKIRNAFLQNASAVVIFNVGSNTNETITMPHAGVEDIVAIMIPEPKGKEIVSLLERNITVTMYITIGTRNLQKYVSRTSVVFVSISFIVLMIISLAWLVFYYIQRFRYANARDRNQRRLGDAAKKAISKLQIRTIKKGDKETESDFDNCAVCIEGYKPNDVVRILPCRHLFHKSCVDPWLLDHRTCPMCKMNILKALGIPPNADCMDDLPTDFEGSLGGPPTNQITGASDTTVNESSVTLDPAVRTVGALQVVQDTDPIPQEGDVIFTTNSEQEPAVSSDSDISLIMAMEVGLSDVELSTDQDCEEVKS,438,"48,072",Alternative sequence (5); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (1); Glycosylation (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q9UBV2,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),MRVRIGLTLLLCAVLLSLASASSDEEGSQDESLDSKTTLTSDESVKDHTTAGRVVAGQIFLDSEESELESSIQEEEDSLKSQEGESVTEDISFLESPNPENKDYEEPKKVRKPALTAIEGTAHGEPCHFPFLFLDKEYDECTSDGREDGRLWCATTYDYKADEKWGFCETEEEAAKRRQMQEAEMMYQTGMKILNGSNKKSQKREAYRYLQKAASMNHTKALERVSYALLFGDYLPQNIQAAREMFEKLTEEGSPKGQTALGFLYASGLGVNSSQAKALVYYTFGALGGNLIAHMVLGYRYWAGIGVLQSCESALTHYRLVANHVASDISLTGGSVVQRIRLPDEVENPGMNSGMLEEDLIQYYQFLAEKGDVQAQVGLGQLHLHGGRGVEQNHQRAFDYFNLAANAGNSHAMAFLGKMYSEGSDIVPQSNETALHYFKKAADMGNPVGQSGLGMAYLYGRGVQVNYDLALKYFQKAAEQGWVDGQLQLGSMYYNGIGVKRDYKQALKYFNLASQGGHILAFYNLAQMHASGTGVMRSCHTAVELFKNVCERGRWSERLMTAYNSYKDGDYNAAVIQYLLLAEQGYEVAQSNAAFILDQREASIVGENETYPRALLHWNRAASQGYTVARIKLGDYHFYGFGTDVDYETAFIHYRLASEQQHSAQAMFNLGYMHEKGLGIKQDIHLAKRFYDMAAEASPDAQVPVFLALCKLGVVYFLQYIRETNIRDMFTQLDMDQLLGPEWDLYLMTIIALLLGTVIAYRQRQHQDMPAPRPPGPRPAPPQQEGPPEQQPPQ,794,"88,755",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (1); Glycosylation (5); Modified residue (1); Natural variant (2); Region (4); Repeat (11); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 127..153;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479""; DISULFID 141..168;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
O60939,Sodium channel subunit beta-2,MHRDAWLPRPAFSLTGLSLFFSLVPPGRSMEVTVPATLNVLNGSDARLPCTFNSCYTVNHKQFSLNWTYQECNNCSEEMFLQFRMKIINLKLERFQDRVEFSGNPSKYDVSVMLRNVQPEDEGIYNCYIMNPPDRHRGHGKIHLQVLMEEPPERDSTVAVIVGASVGGFLAVVILVLMVVKCVRRKKEQKLSTDDLKTEEEGKTDGEGNPDDGAK,215,"24,326",Beta strand (10); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (3); Helix (3); Modified residue (2); Mutagenesis (1); Natural variant (4); Sequence conflict (7); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 50..127;  /evidence=""ECO:0000244|PDB:5FDY, ECO:0000244|PDB:5FEB, ECO:0000244|PDB:6J8E, ECO:0000244|PDB:6J8G, ECO:0000244|PDB:6J8H, ECO:0000244|PDB:6J8I, ECO:0000244|PDB:6J8J, ECO:0000269|PubMed:22992729, ECO:0000269|PubMed:26894959, ECO:0000269|PubMed:30765605, ECO:0000269|PubMed:30765606""; DISULFID 55;  /note=""Interchain; with alpha subunit"";  /evidence=""ECO:0000244|PDB:6J8E, ECO:0000244|PDB:6J8G, ECO:0000244|PDB:6J8H, ECO:0000244|PDB:6J8I, ECO:0000244|PDB:6J8J, ECO:0000269|PubMed:22992729, ECO:0000269|PubMed:26894959, ECO:0000269|PubMed:30765605, ECO:0000269|PubMed:30765606""; DISULFID 72..75;  /evidence=""ECO:0000244|PDB:5FDY, ECO:0000244|PDB:5FEB, ECO:0000244|PDB:6J8E, ECO:0000244|PDB:6J8G, ECO:0000244|PDB:6J8H, ECO:0000244|PDB:6J8I, ECO:0000244|PDB:6J8J, ECO:0000269|PubMed:26894959, ECO:0000269|PubMed:30765605, ECO:0000269|PubMed:30765606""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q8TCT7,Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1),MAAAVAAALARLLAAFLLLAAQVACEYGMVHVVSQAGGPEGKDYCILYNPQWAHLPHDLSKASFLQLRNWTASLLCSAADLPARGFSNQIPLVARGNCTFYEKVRLAQGSGARGLLIVSRERLVPPGGNKTQYDEIGIPVALLSYKDMLDIFTRFGRTVRAALYAPKEPVLDYNMVIIFIMAVGTVAIGGYWAGSRDVKKRYMKHKRDDGPEKQEDEAVDVTPVMTCVFVVMCCSMLVLLYYFYDLLVYVVIGIFCLASATGLYSCLAPCVRRLPFGKCRIPNNSLPYFHKRPQARMLLLALFCVAVSVVWGVFRNEDQWAWVLQDALGIAFCLYMLKTIRLPTFKACTLLLLVLFLYDIFFVFITPFLTKSGSSIMVEVATGPSDSATREKLPMVLKVPRLNSSPLALCDRPFSLLGFGDILVPGLLVAYCHRFDIQVQSSRVYFVACTIAYGVGLLVTFVALALMQRGQPALLYLVPCTLVTSCAVALWRRELGVFWTGSGFAKVLPPSPWAPAPADGPQPPKDSATPLSPQPPSEEPATSPWPAEQSPKSRTSEEMGAGAPMREPGSPAESEGRDQAQPSPVTQPGASA,592,"64,644",Active site (2); Alternative sequence (3); Chain (1); Compositional bias (2); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (2); Erroneous translation (1); Glycosylation (2); Motif (1); Mutagenesis (1); Natural variant (1); Sequence caution (1); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15385547"""
P23468,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),MVHVARLLLLLLTFFLRTDAETPPRFTRTPVDQTGVSGGVASFICQATGDPRPKIVWNKKGKKVSNQRFEVIEFDDGSGSVLRIQPLRTPRDEAIYECVASNNVGEISVSTRLTVLREDQIPRGFPTIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDTSNNNGRIKQLRSESIGGTPIRGALQIEQSEESDQGKYECVATNSAGTRYSAPANLYVRELREVRRVPPRFSIPPTNHEIMPGGSVNITCVAVGSPMPYVKWMLGAEDLTPEDDMPIGRNVLELNDVRQSANYTCVAMSTLGVIEAIAQITVKALPKPPGTPVVTESTATSITLTWDSGNPEPVSYYIIQHKPKNSEELYKEIDGVATTRYSVAGLSPYSDYEFRVVAVNNIGRGPPSEPVLTQTSEQAPSSAPRDVQARMLSSTTILVQWKEPEEPNGQIQGYRVYYTMDPTQHVNNWMKHNVADSQITTIGNLVPQKTYSVKVLAFTSIGDGPLSSDIQVITQTGVPGQPLNFKAEPESETSILLSWTPPRSDTIANYELVYKDGEHGEEQRITIEPGTSYRLQGLKPNSLYYFRLAARSPQGLGASTAEISARTMQSKPSAPPQDISCTSPSSTSILVSWQPPPVEKQNGIITEYSIKYTAVDGEDDKPHEILGIPSDTTKYLLEQLEKWTEYRITVTAHTDVGPGPESLSVLIRTNEDVPSGPPRKVEVEAVNSTSVKVSWRSPVPNKQHGQIRGYQVHYVRMENGEPKGQPMLKDVMLADAQWEFDDTTEHDMIISGLQPETSYSLTVTAYTTKGDGARSKPKLVSTTGAVPGKPRLVINHTQMNTALIQWHPPVDTFGPLQGYRLKFGRKDMEPLTTLEFSEKEDHFTATDIHKGASYVFRLSARNKVGFGEEMVKEISIPEEVPTGFPQNLHSEGTTSTSVQLSWQPPVLAERNGIITKYTLLYRDINIPLLPMEQLIVPADTTMTLTGLKPDTTYDVKVRAHTSKGPGPYSPSVQFRTLPVDQVFAKNFHVKAVMKTSVLLSWEIPENYNSAMPFKILYDDGKMVEEVDGRATQKLIVNLKPEKSYSFVLTNRGNSAGGLQHRVTAKTAPDVLRTKPAFIGKTNLDGMITVQLPEVPANENIKGYYIIIVPLKKSRGKFIKPWESPDEMELDELLKEISRKRRSIRYGREVELKPYIAAHFDVLPTEFTLGDDKHYGGFTNKQLQSGQEYVFFVLAVMEHAESKMYATSPYSDPVVSMDLDPQPITDEEEGLIWVVGPVLAVVFIICIVIAILLYKRKRAESDSRKSSIPNNKEIPSHHPTDPVELRRLNFQTPGMASHPPIPILELADHIERLKANDNLKFSQEYESIDPGQQFTWEHSNLEVNKPKNRYANVIAYDHSRVLLSAIEGIPGSDYVNANYIDGYRKQNAYIATQGSLPETFGDFWRMIWEQRSATVVMMTKLEERSRVKCDQYWPSRGTETHGLVQVTLLDTVELATYCVRTFALYKNGSSEKREVRQFQFTAWPDHGVPEHPTPFLAFLRRVKTCNPPDAGPMVVHCSAGVGRTGCFIVIDAMLERIKHEKTVDIYGHVTLMRAQRNYMVQTEDQYIFIHDALLEAVTCGNTEVPARNLYAYIQKLTQIETGENVTGMELEFKRLASSKAHTSRFISANLPCNKFKNRLVNIMPYESTRVCLQPIRGVEGSDYINASFIDGYRQQKAYIATQGPLAETTEDFWRMLWEHNSTIVVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTVRQFQFTDWPEQGVPKSGEGFIDFIGQVHKTKEQFGQDGPISVHCSAGVGRTGVFITLSIVLERMRYEGVVDIFQTVKMLRTQRPAMVQTEDQYQFSYRAALEYLGSFDHYAT,1912,"214,760",Active site (2); Alternative sequence (13); Beta strand (42); Binding site (2); Chain (1); Disulfide bond (3); Domain (13); Glycosylation (4); Helix (4); Mutagenesis (2); Natural variant (6); Region (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 45..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 147..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 257..302;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P47872,Secretin receptor (SCT-R),MRPHLSPPLQQLLLPVLLACAAHSTGALPRLCDVLQVLWEEQDQCLQELSREQTGDLGTEQPVPGCEGMWDNISCWPSSVPGRMVEVECPRFLRMLTSRNGSLFRNCTQDGWSETFPRPNLACGVNVNDSSNEKRHSYLLKLKVMYTVGYSSSLVMLLVALGILCAFRRLHCTRNYIHMHLFVSFILRALSNFIKDAVLFSSDDVTYCDAHRAGCKLVMVLFQYCIMANYSWLLVEGLYLHTLLAISFFSERKYLQGFVAFGWGSPAIFVALWAIARHFLEDVGCWDINANASIWWIIRGPVILSILINFILFINILRILMRKLRTQETRGNEVSHYKRLARSTLLLIPLFGIHYIVFAFSPEDAMEIQLFFELALGSFQGLVVAVLYCFLNGEVQLEVQKKWQQWHLREFPLHPVASFSNSTKASHLEQSQGTCRTSII,440,"50,207",Chain (1); Glycosylation (5); Natural variant (2); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P21583,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],MKKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGALYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV,273,"30,899",Alternative sequence (3); Beta strand (5); Chain (2); Disulfide bond (2); Glycosylation (7); Helix (6); Natural variant (6); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),DISULFID 29..114; DISULFID 68..163,SIGNAL 1..25
Q9Y5G6,Protocadherin gamma-A7 (PCDH-gamma-A7),MAAQPRGGDYRGFFLLSILLGTPWEAWAGRILYSVSEETDKGSFVGDIAKDLGLEPRELAERGVRIISRGRTQLFALNQRSGSLVTAGRIDREEICAQSARCLVNFNILMEDKMNLYPIDVEIIDINDNVPRFLTEEINVKIMENTAPGVRFPLSEAGDPDVGTNSLQSYQLSPNRHFSLAVQSGDDETKYPELVLERVLDREEERVHHLVLTASDGGDPPRSSTAHIQVTVVDVNDHTPVFSLPQYQVTVPENVPVGTRLLTVHAIDLDEGVNGEVTYSFRKITPKLPKMFHLNSLTGEISTLEGLDYEETAFYEMEVQAQDGPGSLTKAKVLITVLDVNDNAPEVTMTSLSSSIPEDTPLGTVIALFYLQDRDSGKNGEVTCTIPENLPFKLEKSIDNYYRLVTTKNLDRETLSLYNITLKATDGGTPPLSRETHIFMQVADTNDNPPTFPHSSYSVYIAENNPRGASIFLVTAQDHDSEDNAQITYSLAEDTIQGAPVSSYVSINSDTGVLYALQSFDYEQLRELQLRVTAHDSGDPPLSSNMSLSLFVLDQNDNPPEILYPALPTDGSTGMELAPRSAEPGYLVTKVVAVDKDSGQNAWLSYLLLKASEPGLFAVGLYTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADSIPEVLADLGSLEPSDGPYNYDLTLYLVVAVATVSCVFLAFVLVLLALRLRRWHKSRLLQASEGGLANVPTSHFVGMDGVQAFLQTYSHEVSLTADSRKSHLIFPQPNYVDMLISQESCEKNDSLLTSVDFQECKENLPSIQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"101,722",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9BZA7,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S),MDLLSGTYIFAVLLACVVFHSGAQEKNYTIREEMPENVLIGDLLKDLNLSLIPNKSLTTAMQFKLVYKTGDVPLIRIEEDTGEIFTTGARIDREKLCAGIPRDEHCFYEVEVAILPDEIFRLVKIRFLIEDINDNAPLFPATVINISIPENSAINSKYTLPAAVDPDVGINGVQNYELIKSQNIFGLDVIETPEGDKMPQLIVQKELDREEKDTYVMKVKVEDGGFPQRSSTAILQVSVTDTNDNHPVFKETEIEVSIPENAPVGTSVTQLHATDADIGENAKIHFSFSNLVSNIARRLFHLNATTGLITIKEPLDREETPNHKLLVLASDGGLMPARAMVLVNVTDVNDNVPSIDIRYIVNPVNDTVVLSENIPLNTKIALITVTDKDADHNGRVTCFTDHEIPFRLRPVFSNQFLLETAAYLDYESTKEYAIKLLAADAGKPPLNQSAMLFIKVKDENDNAPVFTQSFVTVSIPENNSPGIQLTKVSAMDADSGPNAKINYLLGPDAPPEFSLDCRTGMLTVVKKLDREKEDKYLFTILAKDNGVPPLTSNVTVFVSIIDQNDNSPVFTHNEYNFYVPENLPRHGTVGLITVTDPDYGDNSAVTLSILDENDDFTIDSQTGVIRPNISFDREKQESYTFYVKAEDGGRVSRSSSAKVTINVVDVNDNKPVFIVPPSNCSYELVLPSTNPGTVVFQVIAVDNDTGMNAEVRYSIVGGNTRDLFAIDQETGNITLMEKCDVTDLGLHRVLVKANDLGQPDSLFSVVIVNLFVNESVTNATLINELVRKSTEAPVTPNTEIADVSSPTSDYVKILVAAVAGTITVVVVIFITAVVRCRQAPHLKAAQKNKQNSEWATPNPENRQMIMMKKKKKKKKHSPKNLLLNFVTIEETKADDVDSDGNRVTLDLPIDLEEQTMGKYNWVTTPTTFKPDSPDLARHYKSASPQPAFQIQPETPLNSKHHIIQELPLDNTFVACDSISKCSSSSSDPYSVSDCGYPVTTFEVPVSVHTRPPMKEVVRSCTPMKESTTMEIWIHPQPQRKSEGKVAGKSQRRVTFHLPEGSQESSSDGGLGDHDAGSLTSTSHGLPLGYPQEEYFDRATPSNRTEGDGNSDPESTFIPGLKKAAEITVQPTVEEASDNCTQECLIYGHSDACWMPASLDHSSSSQAQASALCHSPPLSQASTQHHSPRVTQTIALCHSPPVTQTIALCHSPPPIQVSALHHSPPLVQATALHHSPPSAQASALCYSPPLAQAAAISHSSPLPQVIALHRSQAQSSVSLQQGWVQGADGLCSVDQGVQGSATSQFYTMSERLHPSDDSIKVIPLTTFTPRQQARPSRGDSPIMEEHPL,1347,"147,558",Alternative sequence (9); Chain (1); Compositional bias (1); Domain (7); Glycosylation (6); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8N357,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),MAWTKYQLFLAGLMLVTGSINTLSAKWADNFMAEGCGGSKEHSFQHPFLQAVGMFLGEFSCLAAFYLLRCRAAGQSDSSVDPQQPFNPLLFLPPALCDMTGTSLMYVALNMTSASSFQMLRGAVIIFTGLFSVAFLGRRLVLSQWLGILATIAGLVVVGLADLLSKHDSQHKLSEVITGDLLIIMAQIIVAIQMVLEEKFVYKHNVHPLRAVGTEGLFGFVILSLLLVPMYYIPAGSFSGNPRGTLEDALDAFCQVGQQPLIAVALLGNISSIAFFNFAGISVTKELSATTRMVLDSLRTVVIWALSLALGWEAFHALQILGFLILLIGTALYNGLHRPLLGRLSRGRPLAEESEQERLLGGTRTPINDAS,371,"40,214",Chain (1); Domain (1); Glycosylation (1); Modified residue (1); Sequence conflict (5); Signal peptide (1); Transmembrane (9),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9ULF5,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),MKVHMHTKFCLICLLTFIFHHCNHCHEEHDHGPEALHRQHRGMTELEPSKFSKQAAENEKKYYIEKLFERYGENGRLSFFGLEKLLTNLGLGERKVVEINHEDLGHDHVSHLDILAVQEGKHFHSHNHQHSHNHLNSENQTVTSVSTKRNHKCDPEKETVEVSVKSDDKHMHDHNHRLRHHHRLHHHLDHNNTHHFHNDSITPSERGEPSNEPSTETNKTQEQSDVKLPKGKRKKKGRKSNENSEVITPGFPPNHDQGEQYEHNRVHKPDRVHNPGHSHVHLPERNGHDPGRGHQDLDPDNEGELRHTRKREAPHVKNNAIISLRKDLNEDDHHHECLNVTQLLKYYGHGANSPISTDLFTYLCPALLYQIDSRLCIEHFDKLLVEDINKDKNLVPEDEANIGASAWICGIISITVISLLSLLGVILVPIINQGCFKFLLTFLVALAVGTMSGDALLHLLPHSQGGHDHSHQHAHGHGHSHGHESNKFLEEYDAVLKGLVALGGIYLLFIIEHCIRMFKHYKQQRGKQKWFMKQNTEESTIGRKLSDHKLNNTPDSDWLQLKPLAGTDDSVVSEDRLNETELTDLEGQQESPPKNYLCIEEEKIIDHSHSDGLHTIHEHDLHAAAHNHHGENKTVLRKHNHQWHHKHSHHSHGPCHSGSDLKETGIANIAWMVIMGDGIHNFSDGLAIGAAFSAGLTGGISTSIAVFCHELPHELGDFAVLLKAGMTVKQAIVYNLLSAMMAYIGMLIGTAVGQYANNITLWIFAVTAGMFLYVALVDMLPEMLHGDGDNEEHGFCPVGQFILQNLGLLFGFAIMLVIALYEDKIVFDIQF,831,"94,132",Alternative sequence (1); Chain (1); Compositional bias (4); Erroneous initiation (1); Glycosylation (4); Modified residue (3); Natural variant (1); Sequence caution (1); Sequence conflict (2); Signal peptide (1); Transmembrane (7),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9NY72,Sodium channel subunit beta-3,MPAFNRLFPLASLVLIYWVSVCFPVCVEVPSETEAVQGNPMKLRCISCMKREEVEATTVVEWFYRPEGGKDFLIYEYRNGHQEVESPFQGRLQWNGSKDLQDVSITVLNVTLNDSGLYTCNVSREFEFEAHRPFVKTTRLIPLRVTEEAGEDFTSVVSEIMMYILLVFLTLWLLIEMIYCYRKVSKAEEAAQENASDYLAIPSENKENSAVPVEE,215,"24,702",Beta strand (9); Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (1); Glycosylation (4); Helix (1); Natural variant (8); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 26..48;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 45..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000250"""
Q9H2E6,Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1),MRSEALLLYFTLLHFAGAGFPEDSEPISISHGNYTKQYPVFVGHKPGRNTTQRHRLDIQMIMIMNGTLYIAARDHIYTVDIDTSHTEEIYCSKKLTWKSRQADVDTCRMKGKHKDECHNFIKVLLKKNDDALFVCGTNAFNPSCRNYKMDTLEPFGDEFSGMARCPYDAKHANVALFADGKLYSATVTDFLAIDAVIYRSLGESPTLRTVKHDSKWLKEPYFVQAVDYGDYIYFFFREIAVEYNTMGKVVFPRVAQVCKNDMGGSQRVLEKQWTSFLKARLNCSVPGDSHFYFNILQAVTDVIRINGRDVVLATFSTPYNSIPGSAVCAYDMLDIASVFTGRFKEQKSPDSTWTPVPDERVPKPRPGCCAGSSSLERYATSNEFPDDTLNFIKTHPLMDEAVPSIFNRPWFLRTMVRYRLTKIAVDTAAGPYQNHTVVFLGSEKGIILKFLARIGNSGFLNDSLFLEEMSVYNSEKCSYDGVEDKRIMGMQLDRASSSLYVAFSTCVIKVPLGRCERYGKCKKTCIASRDPYCGWIKEGGACSHLSPNSRLTFEQDIERGNTDGLGDCHNSFVALNGHSSSLLPSTTTSDSTAQEGYESRGGMLDWKHLLDSPDSTDPLGAVSSHNHQDKKGVIRESYLKGHDQLVPVTLLAIAVILAFVMGAVFSGITVYCVCDHRRKDVAVVQRKEKELTHSRRGSMSSVTKLSGLFGDTQSKDPKPEAILTPLMHNGKLATPGNTAKMLIKADQHHLDLTALPTPESTPTLQQKRKPSRGSREWERNQNLINACTKDMPPMGSPVIPTDLPLRASPSHIPSVVVLPITQQGYQHEYVDQPKMSEVAQMALEDQAATLEYKTIKEHLSSKSPNHGVNLVENLDSLPPKVPQREASLGPPGASLSQTGLSKRLEMHHSSSYGVDYKRSYPTNSLTRSHQATTLKRNNTNSSNSSHLSRNQSFGRGDNPPPAPQRVDSIQVHSSQPSGQAVTVSRQPSLNAYNSLTRSGLKRTPSLKPDVPPKPSFAPLSTSMKPNDACT,1030,"114,395",Alternative sequence (1); Beta strand (34); Chain (1); Compositional bias (1); Disulfide bond (8); Domain (1); Erroneous initiation (1); Glycosylation (6); Helix (11); Modified residue (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 107..117;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 135..144;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 258..369;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 283..328;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 477..506;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 515..533;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""; DISULFID 521..568;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 525..542;  /evidence=""ECO:0000244|PDB:6WTS, ECO:0000255|PROSITE-ProRule:PRU00352, ECO:0000269|PubMed:32589945""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q7Z6M3,Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32) (MCA-32) (Mast cell immunoglobulin-like receptor 1),MWSHLNRLLFWSIFSSVTCRKAVLDCEAMKTNEFPSPCLDSKTKVVMKGQNVSMFCSHKNKSLQITYSLFRRKTHLGTQDGKGEPAIFNLSITEAHESGPYKCKAQVTSCSKYSRDFSFTIVDPVTSPVLNIMVIQTETDRHITLHCLSVNGSLPINYTFFENHVAISPAISKYDREPAEFNLTKKNPGEEEEYRCEAKNRLPNYATYSHPVTMPSTGGDSCPFCLKLLLPGLLLLLVVIILILAFWVLPKYKTRKAMRNNVPRDRGDTAMEVGIYANILEKQAKEESVPEVGSRPCVSTAQDEAKHSQELQYATPVFQEVAPREQEACDSYKSGYVYSELNF,343,"38,735",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (2); Glycosylation (6); Modified residue (2); Motif (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 56..103;  /evidence=""ECO:0000250""; DISULFID 147..196;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9Y4C0,Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha),MSSTLHSVFFTLKVSILLGSLLGLCLGLEFMGLPNQWARYLRWDASTRSDLSFQFKTNVSTGLLLYLDDGGVCDFLCLSLVDGRVQLRFSMDCAETAVLSNKQVNDSSWHFLMVSRDRLRTVLMLDGEGQSGELQPQRPYMDVVSDLFLGGVPTDIRPSALTLDGVQAMPGFKGLILDLKYGNSEPRLLGSRGVQMDAEGPCGERPCENGGICFLLDGHPTCDCSTTGYGGKLCSEDVSQDPGLSHLMMSEQAREENVATFRGSEYLCYDLSQNPIQSSSDEITLSFKTWQRNGLILHTGKSADYVNLALKDGAVSLVINLGSGAFEAIVEPVNGKFNDNAWHDVKVTRNLRQVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLPGSPVSNNFMGCLKEVVYKNNDIRLELSRLARIADTKMKIYGEVVFKCENVATLDPINFETPEAYISLPKWNTKRMGSISFDFRTTEPNGLILFTHGKPQERKDARSQKNTKVDFFAVELLDGNLYLLLDMGSGTIKVKATQKKANDGEWYHVDIQRDGRSGTISVNSRRTPFTASGESEILDLEGDMYLGGLPENRAGLILPTELWTAMLNYGYVGCIRDLFIDGRSKNIRQLAEMQNAAGVKSSCSRMSAKQCDSYPCKNNAVCKDGWNRFICDCTGTGYWGRTCEREASILSYDGSMYMKIIMPMVMHTEAEDVSFRFMSQRAYGLLVATTSRDSADTLRLELDGGRVKLMVNLDCIRINCNSSKGPETLYAGQKLNDNEWHTVRVVRRGKSLKLTVDDDVAEGTMVGDHTRLEFHNIETGIMTEKRYISVVPSSFIGHLQSLMFNGLLYIDLCKNGDIDYCELKARFGLRNIIADPVTFKTKSSYLSLATLQAYTSMHLFFQFKTTSPDGFILFNSGDGNDFIAVELVKGYIHYVFDLGNGPNVIKGNSDRPLNDNQWHNVVITRDNSNTHSLKVDTKVVTQVINGAKNLDLKGDLYMAGLAQGMYSNLPKLVASRDGFQGCLASVDLNGRLPDLINDALHRSGQIERGCEGPSTTCQEDSCANQGVCMQQWEGFTCDCSMTSYSGNQCNDPGATYIFGKSGGLILYTWPANDRPSTRSDRLAVGFSTTVKDGILVRIDSAPGLGDFLQLHIEQGKIGVVFNIGTVDISIKEERTPVNDGKYHVVRFTRNGGNATLQVDNWPVNEHYPTGRQLTIFNTQAQIAIGGKDKGRLFQGQLSGLYYDGLKVLNMAAENNPNIKINGSVRLVGEVPSILGTTQTTSMPPEMSTTVMETTTTMATTTTRKNRSTASIQPTSDDLVSSAECSSDDEDFVECEPSTTGGELVIPLLVEDPLATPPIATRAPSITLPPTFRPLLTIIETTKDSLSMTSEAGLPCLSDQGSDGCDDDGLVISGYGSGETFDSNLPPTDDEDFYTTFSLVTDKSLSTSIFEGGYKAHAPKWESKDFRPNKVSETSRTTTTSLSPELIRFTASSSSGMVPKLPAGKMNNRDLKPQPDIVLLPLPTAYELDSTKLKSPLITSPMFRNVPTANPTEPGIRRVPGASEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDETRNYISNSAQSNGTLMKEKQQSSKSGHKKQKNKDREYYV,1643,"180,599",Alternative sequence (8); Chain (1); Disulfide bond (12); Domain (9); Erroneous initiation (1); Glycosylation (6); Metal binding (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 202..213;  /evidence=""ECO:0000250""; DISULFID 207..222;  /evidence=""ECO:0000250""; DISULFID 224..234;  /evidence=""ECO:0000250""; DISULFID 404..440;  /evidence=""ECO:0000250""; DISULFID 610..639;  /evidence=""ECO:0000250""; DISULFID 647..658;  /evidence=""ECO:0000250""; DISULFID 652..667;  /evidence=""ECO:0000250""; DISULFID 669..679;  /evidence=""ECO:0000250""; DISULFID 1018..1046;  /evidence=""ECO:0000250""; DISULFID 1053..1064;  /evidence=""ECO:0000250""; DISULFID 1058..1073;  /evidence=""ECO:0000250""; DISULFID 1075..1085;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000250"""
O95754,Semaphorin-4F (Semaphorin-M) (Sema M) (Semaphorin-W) (Sema W),MPASAARPRPGPGQPTASPFPLLLLAVLSGPVSGRVPRSVPRTSLPISEADSCLTRFAVPHTYNYSVLLVDPASHTLYVGARDTIFALSLPFSGERPRRIDWMVPEAHRQNCRKKGKKEDECHNFVQILAIANASHLLTCGTFAFDPKCGVIDVSRFQQVERLESGRGKCPFEPAQRSAAVMAGGVLYAATVKNYLGTEPIITRAVGRAEDWIRTDTLPSWLNAPAFVAAVALSPAEWGDEDGDDEIYFFFTETSRAFDSYERIKVPRVARVCAGDLGGRKTLQQRWTTFLKADLLCPGPEHGRASSVLQDVAVLRPELGAGTPIFYGIFSSQWEGATISAVCAFRPQDIRTVLNGPFRELKHDCNRGLPVVDNDVPQPRPGECITNNMKLRHFGSSLSLPDRVLTFIRDHPLMDRPVFPADGHPLLVTTDTAYLRVVAHRVTSLSGKEYDVLYLGTEDGHLHRAVRIGAQLSVLEDLALFPEPQPVENMKLYHSWLLVGSRTEVTQVNTTNCGRLQSCSECILAQDPVCAWSFRLDECVAHAGEHRGLVQDIESADVSSLCPKEPGERPVVFEVPVATAAHVVLPCSPSSAWASCVWHQPSGVTALTPRRDGLEVVVTPGAMGAYACECQEGGAAHVVAAYSLVWGSQRDAPSRAHTVGAGLAGFFLGILAASLTLILIGRRQQRRRQRELLARDKVGLDLGAPPSGTTSYSQDPPSPSPEDERLPLALAKRGSGFGGFSPPFLLDPCPSPAHIRLTGAPLATCDETSI,770,"83,511",Alternative sequence (1); Chain (1); Disulfide bond (7); Domain (3); Glycosylation (3); Modified residue (2); Motif (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 112..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 140..149;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 273..384;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 297..343;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 513..530;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 522..539;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 587..628;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q8IWT1,Sodium channel subunit beta-4,MPGAGDGGKAPARWLGTGLLGLFLLPVTLSLEVSVGKATDIYAVNGTEILLPCTFSSCFGFEDLHFRWTYNSSDAFKILIEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTCHVKNPKENNLQHHATIFLQVVDRLEEVDNTVTLIILAVVGGVIGLLILILLIKKLIIFILKKTREKKKECLVSSSGNDNTENGLPGSKAEEKPPSKV,228,"24,969",Alternative sequence (2); Beta strand (11); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (3); Helix (2); Mutagenesis (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 53..131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:24297919""; DISULFID 58;  /note=""Interchain; with alpha subunit"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:24297919""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9H3T2,Semaphorin-6C (Semaphorin-Y) (Sema Y),MPRAPHFMPLLLLLLLLSLPHTQAAFPQDPLPLLISDLQGTSPLSWFRGLEDDAVAAELGLDFQRFLTLNRTLLVAARDHVFSFDLQAEEEGEGLVPNKYLTWRSQDVENCAVRGKLTDECYNYIRVLVPWDSQTLLACGTNSFSPVCRSYGITSLQQEGEELSGQARCPFDATQSNVAIFAEGSLYSATAADFQASDAVVYRSLGPQPPLRSAKYDSKWLREPHFVQALEHGDHVYFFFREVSVEDARLGRVQFSRVARVCKRDMGGSPRALDRHWTSFLKLRLNCSVPGDSTFYFDVLQALTGPVNLHGRSALFGVFTTQTNSIPGSAVCAFYLDEIERGFEGKFKEQRSLDGAWTPVSEDRVPSPRPGSCAGVGGAALFSSSRDLPDDVLTFIKAHPLLDPAVPPVTHQPLLTLTSRALLTQVAVDGMAGPHSNITVMFLGSNDGTVLKVLTPGGRSGGPEPILLEEIDAYSPARCSGKRTAQTARRIIGLELDTEGHRLFVAFSGCIVYLPLSRCARHGACQRSCLASQDPYCGWHSSRGCVDIRGSGGTDVDQAGNQESMEHGDCQDGATGSQSGPGDSAYGVRRDLPPASASRSVPIPLLLASVAAAFALGASVSGLLVSCACRRAHRRRGKDIETPGLPRPLSLRSLARLHGGGPEPPPPSKDGDAVQTPQLYTTFLPPPEGVPPPELACLPTPESTPELPVKHLRAAGDPWEWNQNRNNAKEGPGRSRGGHAAGGPAPRVLVRPPPPGCPGQAVEVTTLEELLRYLHGPQPPRKGAEPPAPLTSRALPPEPAPALLGGPSPRPHECASPLRLDVPPEGRCASAPARPALSAPAPRLGVGGGRRLPFSGHRAPPALLTRVPSGGPSRYSGGPGKHLLYLGRPEGYRGRALKRVDVEKPQLSLKPPLVGPSSRQAVPNGGRFNF,930,"99,686",Alternative sequence (2); Chain (1); Compositional bias (2); Disulfide bond (8); Domain (1); Erroneous initiation (1); Glycosylation (3); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 111..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 139..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 262..373;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 287..332;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 479..510;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 519..537;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 525..570;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 529..545;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9HBV2,Sperm acrosome membrane-associated protein 1 (Sperm acrosomal membrane-associated protein 32),MSPRGTGCSAGLLMTVGWLLLAGLQSARGTNVTAAVQDAGLAHEGEGEEETENNDSETAENYAPPETEDVSNRNVVKEVEFGMCTVTCGIGVREVILTNGCPGGESKCVVRVEECRGPTDCGWGKPISESLESVRLACIHTSPLNRFKYMWKLLRQDQQSIILVNDSAILEVRKESHPLAFECDTLDNNEIVATIKFTVYTSSELQMRRSSLPATDAALIFVLTIGVIICVFIIFLLIFIIINWAAVKAFWGAKASTPEVQSEQSSVRYKDSTSLDQLPTEMPGEDDALSEWNE,294,"32,143",Chain (1); Glycosylation (1); Modified residue (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6P5W5,Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4),MASLVSLELGLLLAVLVVTATASPPAGLLSLLTSGQGALDQEALGGLLNTLADRVHCANGPCGKCLSVEDALGLGEPEGSGLPPGPVLEARYVARLSAAAVLYLSNPEGTCEDARAGLWASHADHLLALLESPKALTPGLSWLLQRMQARAAGQTPKMACVDIPQLLEEAVGAGAPGSAGGVLAALLDHVRSGSCFHALPSPQYFVDFVFQQHSSEVPMTLAELSALMQRLGVGREAHSDHSHRHRGASSRDPVPLISSSNSSSVWDTVCLSARDVMAAYGLSEQAGVTPEAWAQLSPALLQQQLSGACTSQSRPPVQDQLSQSERYLYGSLATLLICLCAVFGLLLLTCTGCRGVTHYILQTFLSLAVGAVTGDAVLHLTPKVLGLHTHSEEGLSPQPTWRLLAMLAGLYAFFLFENLFNLLLPRDPEDLEDGPCGHSSHSHGGHSHGVSLQLAPSELRQPKPPHEGSRADLVAEESPELLNPEPRRLSPELRLLPYMITLGDAVHNFADGLAVGAAFASSWKTGLATSLAVFCHELPHELGDFAALLHAGLSVRQALLLNLASALTAFAGLYVALAVGVSEESEAWILAVATGLFLYVALCDMLPAMLKVRDPRPWLLFLLHNVGLLGGWTVLLLLSLYEDDITF,647,"68,408",Alternative sequence (2); Chain (1); Frameshift (1); Glycosylation (1); Natural variant (20); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q15043,Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),MKLLLLHPAFQSCLLLTLLGLWRTTPEAHASSLGAPAISAASFLQDLIHRYGEGDSLTLQQLKALLNHLDVGVGRGNVTQHVQGHRNLSTCFSSGDLFTAHNFSEQSRIGSSELQEFCPTILQQLDSRACTSENQENEENEQTEEGRPSAVEVWGYGLLCVTVISLCSLLGASVVPFMKKTFYKRLLLYFIALAIGTLYSNALFQLIPEAFGFNPLEDYYVSKSAVVFGGFYLFFFTEKILKILLKQKNEHHHGHSHYASESLPSKKDQEEGVMEKLQNGDLDHMIPQHCSSELDGKAPMVDEKVIVGSLSVQDLQASQSACYWLKGVRYSDIGTLAWMITLSDGLHNFIDGLAIGASFTVSVFQGISTSVAILCEEFPHELGDFVILLNAGMSIQQALFFNFLSACCCYLGLAFGILAGSHFSANWIFALAGGMFLYISLADMFPEMNEVCQEDERKGSILIPFIIQNLGLLTGFTIMVVLTMYSGQIQIG,492,"54,212",Alternative sequence (2); Chain (1); Erroneous initiation (1); Glycosylation (3); Motif (2); Mutagenesis (3); Natural variant (5); Sequence conflict (3); Signal peptide (1); Topological domain (7); Transmembrane (6),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9C0C4,Semaphorin-4C,MAPHWAVWLLAARLWGLGIGAEVWWNLVPRKTVSSGELATVVRRFSQTGIQDFLTLTLTEPTGLLYVGAREALFAFSMEALELQGAISWEAPVEKKTECIQKGKNNQTECFNFIRFLQPYNASHLYVCGTYAFQPKCTYVNMLTFTLEHGEFEDGKGKCPYDPAKGHAGLLVDGELYSATLNNFLGTEPIILRNMGPHHSMKTEYLAFWLNEPHFVGSAYVPESVGSFTGDDDKVYFFFRERAVESDCYAEQVVARVARVCKGDMGGARTLQRKWTTFLKARLACSAPNWQLYFNQLQAMHTLQDTSWHNTTFFGVFQAQWGDMYLSAICEYQLEEIQRVFEGPYKEYHEEAQKWDRYTDPVPSPRPGSCINNWHRRHGYTSSLELPDNILNFVKKHPLMEEQVGPRWSRPLLVKKGTNFTHLVADRVTGLDGATYTVLFIGTGDGWLLKAVSLGPWVHLIEELQLFDQEPMRSLVLSQSKKLLFAGSRSQLVQLPVADCMKYRSCADCVLARDPYCAWSVNTSRCVAVGGHSGSLLIQHVMTSDTSGICNLRGSKKVRPTPKNITVVAGTDLVLPCHLSSNLAHARWTFGGRDLPAEQPGSFLYDARLQALVVMAAQPRHAGAYHCFSEEQGARLAAEGYLVAVVAGPSVTLEARAPLENLGLVWLAVVALGAVCLVLLLLVLSLRRRLREELEKGAKATERTLVYPLELPKEPTSPPFRPCPEPDEKLWDPVGYYYSDGSLKIVPGHARCQPGGGPPSPPPGIPGQPLPSPTRLHLGGGRNSNANGYVRLQLGGEDRGGLGHPLPELADELRRKLQQRQPLPDSNPEESSV,833,"92,623",Beta strand (2); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (3); Glycosylation (6); Modified residue (1); Motif (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 99..110;  /evidence=""ECO:0000250""; DISULFID 128..137;  /evidence=""ECO:0000250""; DISULFID 261..370;  /evidence=""ECO:0000250""; DISULFID 285..330;  /evidence=""ECO:0000250""; DISULFID 500..517;  /evidence=""ECO:0000250""; DISULFID 509..526;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q86WI0,LHFPL tetraspan subfamily member 1 protein (Lipoma HMGIC fusion partner-like 1 protein),MRSSLTMVGTLWAFLSLVTAVTSSTSYFLPYWLFGSQMGKPVSFSTFRRCNYPVRGEGHSLIMVEECGRYASFNAIPSLAWQMCTVVTGAGCALLLLVALAAVLGCCMEELISRMMGRCMGAAQFVGGLLISSGCALYPLGWNSPEIMQTCGNVSNQFQLGTCRLGWAYYCAGGGAAAAMLICTWLSCFAGRNPKPVILVESIMRNTNSYAMELDHCLKP,220,"23,777",Alternative sequence (2); Chain (1); Erroneous initiation (1); Glycosylation (1); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
O60487,Myelin protein zero-like protein 2 (Epithelial V-like antigen 1),MYGKSSTRAVLLLLGIQLTALWPIAAVEIYTSRVLEAVNGTDARLKCTFSSFAPVGDALTVTWNFRPLDGGPEQFVFYYHIDPFQPMSGRFKDRVSWDGNPERYDASILLWKLQFDDNGTYTCQVKNPPDVDGVIGEIRLSVVHTVRFSEIHFLALAIGSACALMIIIVIVVVLFQHYRKKRWAERAHKVVEIKSKEEERLNQEKKVSVYLEDTD,215,"24,484",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
O15146,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)",MRELVNIPLVHILTLVAFSGTEKLPKAPVITTPLETVDALVEEVATFMCAVESYPQPEISWTRNKILIKLFDTRYSIRENGQLLTILSVEDSDDGIYCCTANNGVGGAVESCGALQVKMKPKITRPPINVKIIEGLKAVLPCTTMGNPKPSVSWIKGDSPLRENSRIAVLESGSLRIHNVQKEDAGQYRCVAKNSLGTAYSKVVKLEVEVFARILRAPESHNVTFGSFVTLHCTATGIPVPTITWIENGNAVSSGSIQESVKDRVIDSRLQLFITKPGLYTCIATNKHGEKFSTAKAAATISIAEWSKPQKDNKGYCAQYRGEVCNAVLAKDALVFLNTSYADPEEAQELLVHTAWNELKVVSPVCRPAAEALLCNHIFQECSPGVVPTPIPICREYCLAVKELFCAKEWLVMEEKTHRGLYRSEMHLLSVPECSKLPSMHWDPTACARLPHLDYNKENLKTFPPMTSSKPSVDIPNLPSSSSSSFSVSPTYSMTVIISIMSSFAIFVLLTITTLYCCRRRKQWKNKKRESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSMRAQVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKANENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILSCPENCPVELYNLMRLCWSKLPADRPSFTSIHRILERMCERAEGTVSV,869,"97,056",Active site (1); Alternative sequence (3); Binding site (1); Chain (1); Disulfide bond (9); Domain (5); Glycosylation (2); Modified residue (4); Mutagenesis (3); Natural variant (21); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..99;  /evidence=""ECO:0000250""; DISULFID 98..112;  /evidence=""ECO:0000250""; DISULFID 142..190;  /evidence=""ECO:0000250""; DISULFID 233..282;  /evidence=""ECO:0000250""; DISULFID 317..382;  /evidence=""ECO:0000250""; DISULFID 325..375;  /evidence=""ECO:0000250""; DISULFID 366..406;  /evidence=""ECO:0000250""; DISULFID 394..447;  /evidence=""ECO:0000250""; DISULFID 398..434;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P55085,"Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]",MRSPSAAWLLGAAILLAASLSCSGTIQGTNRSSKGRSLIGKVDGTSHVTGKGVTVETVFSVDEFSASVLTGKLTTVFLPIVYTIVFVVGLPSNGMALWVFLFRTKKKHPAVIYMANLALADLLSVIWFPLKIAYHIHGNNWIYGEALCNVLIGFFYGNMYCSILFMTCLSVQRYWVIVNPMGHSRKKANIAIGISLAIWLLILLVTIPLYVVKQTIFIPALNITTCHDVLPEQLLVGDMFNYFLSLAIGVFLFPAFLTASAYVLMIRMLRSSAMDENSEKKRKRAIKLIVTVLAMYLICFTPSNLLLVVHYFLIKSQGQSHVYALYIVALCLSTLNSCIDPFVYYFVSHDFRDHAKNALLCRSVRTVKQMQVSLTSKKHSRKSSSYSSSSTTVKTSY,397,"44,126",Beta strand (2); Chain (3); Compositional bias (1); Disulfide bond (1); Glycosylation (2); Helix (17); Lipidation (1); Mutagenesis (16); Natural variant (4); Propeptide (1); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 148..226;  /evidence=""ECO:0000244|PDB:5NDD, ECO:0000244|PDB:5NDZ, ECO:0000244|PDB:5NJ6, ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:28445455""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9UN73,Protocadherin alpha-6 (PCDH-alpha-6),MVFTPEDRLGKQCLLLPLLLLAAWKVGSGQLHYSVPEEAKHGTFVGRIAQDLGLELAELVPRLFRMASKDREDLLEVNLQNGILFVNSRIDREELCGRSAECSIHLEVIVDRPLQVFHVDVEVRDINDNPPLFPVEEQRVLIYESRLPDSVFPLEGASDADVGSNSILTYKLSSSEYFGLDVKINSDDNKQIGLLLKKSLDREEAPAHNLFLTATDGGKPELTGTVQLLVTVLDVNDNAPTFEQSEYEVRIFENADNGTTVIRLNASDRDEGANGAISYSFNSLVAAMVIDHFSIDRNTGEIVIRGNLDFEQENLYKILIDATDKGHPPMAGHCTVLVRILDKNDNVPEIALTSLSLPVREDAQFGTVIALISVNDLDSGANGQVNCSLTPHVPFKLVSTFKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATASLSVEVADMNDNAPAFAQPEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRVGERALSSYISVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLAPRVGGTGGAVSELVPRSLGAGQVVAKVRAVDADSGYNAWLSYELQPPASSARFPFRVGLYTGEISTTRVLDEADSPRHRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRASVGAAGPEAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSAPPTEGACTADKPTLVCSSAVGSWSYSQQRRQRVCSGEGPPKMDLMAFSPSLSPCPIMMGKAENQDLNEDHDAKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"102,716",Alternative sequence (3); Chain (1); Compositional bias (1); Domain (6); Erroneous initiation (1); Glycosylation (4); Natural variant (1); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6UWI2,Prostate androgen-regulated mucin-like protein 1 (PARM-1),MVYKTLFALCILTAGWRVQSLPTSAPLSVSLPTNIVPPTTIWTSSPQNTDADTASPSNGTHNNSVLPVTASAPTSLLPKNISIESREEEITSPGSNWEGTNTDPSPSGFSSTSGGVHLTTTLEEHSSGTPEAGVAATLSQSAAEPPTLISPQAPASSPSSLSTSPPEVFSASVTTNHSSTVTSTQPTGAPTAPESPTEESSSDHTPTSHATAEPVPQEKTPPTTVSGKVMCELIDMETTTTFPRVIMQEVEHALSSGSIAAITVTVIAVVLLVFGVAAYLKIRHSSYGRLLDDHDYGSWGNYNNPLYDDS,310,"32,289",Chain (1); Frameshift (1); Glycosylation (4); Modified residue (1); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
Q12913,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),MKPAAREARLPPRSPGLRWALPLLLLLLRLGQILCAGGTPSPIPDPSVATVATGENGITQISSTAESFHKQNGTGTPQVETNTSEDGESSGANDSLRTPEQGSNGTDGASQKTPSSTGPSPVFDIKAVSISPTNVILTWKSNDTAASEYKYVVKHKMENEKTITVVHQPWCNITGLRPATSYVFSITPGIGNETWGDPRVIKVITEPIPVSDLRVALTGVRKAALSWSNGNGTASCRVLLESIGSHEELTQDSRLQVNISGLKPGVQYNINPYLLQSNKTKGDPLGTEGGLDASNTERSRAGSPTAPVHDESLVGPVDPSSGQQSRDTEVLLVGLEPGTRYNATVYSQAANGTEGQPQAIEFRTNAIQVFDVTAVNISATSLTLIWKVSDNESSSNYTYKIHVAGETDSSNLNVSEPRAVIPGLRSSTFYNITVCPVLGDIEGTPGFLQVHTPPVPVSDFRVTVVSTTEIGLAWSSHDAESFQMHITQEGAGNSRVEITTNQSIIIGGLFPGTKYCFEIVPKGPNGTEGASRTVCNRTVPSAVFDIHVVYVTTTEMWLDWKSPDGASEYVYHLVIESKHGSNHTSTYDKAITLQGLIPGTLYNITISPEVDHVWGDPNSTAQYTRPSNVSNIDVSTNTTAATLSWQNFDDASPTYSYCLLIEKAGNSSNATQVVTDIGITDATVTELIPGSSYTVEIFAQVGDGIKSLEPGRKSFCTDPASMASFDCEVVPKEPALVLKWTCPPGANAGFELEVSSGAWNNATHLESCSSENGTEYRTEVTYLNFSTSYNISITTVSCGKMAAPTRNTCTTGITDPPPPDGSPNITSVSHNSVKVKFSGFEASHGPIKAYAVILTTGEAGHPSADVLKYTYEDFKKGASDTYVTYLIRTEEKGRSQSLSEVLKYEIDVGNESTTLGYYNGKLEPLGSYRACVAGFTNITFHPQNKGLIDGAESYVSFSRYSDAVSLPQDPGVICGAVFGCIFGALVIVTVGGFIFWRKKRKDAKNNEVSFSQIKPKKSKLIRVENFEAYFKKQQADSNCGFAEEYEDLKLVGISQPKYAAELAENRGKNRYNNVLPYDISRVKLSVQTHSTDDYINANYMPGYHSKKDFIATQGPLPNTLKDFWRMVWEKNVYAIIMLTKCVEQGRTKCEEYWPSKQAQDYGDITVAMTSEIVLPEWTIRDFTVKNIQTSESHPLRQFHFTSWPDHGVPDTTDLLINFRYLVRDYMKQSPPESPILVHCSAGVGRTGTFIAIDRLIYQIENENTVDVYGIVYDLRMHRPLMVQTEDQYVFLNQCVLDIVRSQKDSKVDLIYQNTTAMTIYENLAPVTTFGKTNGYIA,1337,"145,941",Active site (1); Alternative sequence (2); Beta strand (17); Binding site (2); Chain (1); Domain (10); Glycosylation (34); Helix (8); Modified residue (1); Mutagenesis (3); Natural variant (7); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P28827,Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48),MRGLGTCLATLAGLLLTAAGETFSGGCLFDEPYSTCGYSQSEGDDFNWEQVNTLTKPTSDPWMPSGSFMLVNASGRPEGQRAHLLLPQLKENDTHCIDFHYFVSSKSNSPPGLLNVYVKVNNGPLGNPIWNISGDPTRTWNRAELAISTFWPNFYQVIFEVITSGHQGYLAIDEVKVLGHPCTRTPHFLRIQNVEVNAGQFATFQCSAIGRTVAGDRLWLQGIDVRDAPLKEIKVTSSRRFIASFNVVNTTKRDAGKYRCMIRTEGGVGISNYAELVVKEPPVPIAPPQLASVGATYLWIQLNANSINGDGPIVAREVEYCTASGSWNDRQPVDSTSYKIGHLDPDTEYEISVLLTRPGEGGTGSPGPALRTRTKCADPMRGPRKLEVVEVKSRQITIRWEPFGYNVTRCHSYNLTVHYCYQVGGQEQVREEVSWDTENSHPQHTITNLSPYTNVSVKLILMNPEGRKESQELIVQTDEDLPGAVPTESIQGSTFEEKIFLQWREPTQTYGVITLYEITYKAVSSFDPEIDLSNQSGRVSKLGNETHFLFFGLYPGTTYSFTIRASTAKGFGPPATNQFTTKISAPSMPAYELETPLNQTDNTVTVMLKPAHSRGAPVSVYQIVVEEERPRRTKKTTEILKCYPVPIHFQNASLLNSQYYFAAEFPADSLQAAQPFTIGDNKTYNGYWNTPLLPYKSYRIYFQAASRANGETKIDCVQVATKGAATPKPVPEPEKQTDHTVKIAGVIAGILLFVIIFLGVVLVMKKRKLAKKRKETMSSTRQEMTVMVNSMDKSYAEQGTNCDEAFSFMDTHNLNGRSVSSPSSFTMKTNTLSTSVPNSYYPDETHTMASDTSSLVQSHTYKKREPADVPYQTGQLHPAIRVADLLQHITQMKCAEGYGFKEEYESFFEGQSAPWDSAKKDENRMKNRYGNIIAYDHSRVRLQTIEGDTNSDYINGNYIDGYHRPNHYIATQGPMQETIYDFWRMVWHENTASIIMVTNLVEVGRVKCCKYWPDDTEIYKDIKVTLIETELLAEYVIRTFAVEKRGVHEIREIRQFHFTGWPDHGVPYHATGLLGFVRQVKSKSPPSAGPLVVHCSAGAGRTGCFIVIDIMLDMAEREGVVDIYNCVRELRSRRVNMVQTEEQYVFIHDAILEACLCGDTSVPASQVRSLYYDMNKLDPQTNSSQIKEEFRTLNMVTPTLRVEDCSIALLPRNHEKNRCMDILPPDRCLPFLITIDGESSNYINAALMDSYKQPSAFIVTQHPLPNTVKDFWRLVLDYHCTSVVMLNDVDPAQLCPQYWPENGVHRHGPIQVEFVSADLEEDIISRIFRIYNAARPQDGYRMVQQFQFLGWPMYRDTPVSKRSFLKLIRQVDKWQEEYNGGEGRTVVHCLNGGGRSGTFCAISIVCEMLRHQRTVDVFHAVKTLRNNKPNMVDLLDQYKFCYEVALEYLNSG,1452,"163,682",Active site (2); Alternative sequence (1); Beta strand (57); Binding site (2); Chain (1); Disulfide bond (3); Domain (8); Glycosylation (12); Helix (12); Modified residue (1); Natural variant (1); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 27..36;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16456543""; DISULFID 96..182;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16456543""; DISULFID 206..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16456543""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
W5XKT8,Sperm acrosome membrane-associated protein 6 (BACHELOR-like protein),MALLALASAVPSALLALAVFRVPAWACLLCFTTYSERLRICQMFVGMRSPKLEECEEAFTAAFQGLSDTEINYDERSHLHDTFTQMTHALQELAAAQGSFEVAFPDAAEKMKKVITQLKEAQACIPPCGLQEFARRFLCSGCYSRVCDLPLDCPVQDVTVTRGDQAMFSCIVNFQLPKEEITYSWKFAGGGLRTQDLSYFRDMPRAEGYLARIRPAQLTHRGTFSCVIKQDQRPLARLYFFLNVTGPPPRAETELQASFREVLRWAPRDAELIEPWRPSLGELLARPEALTPSNLFLLAVLGALASASATVLAWMFFRWYCSGN,324,"36,333",Alternative sequence (4); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 170..226;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q7Z5N4,Protein sidekick-1,MARGARPSAAGGGGGGAEPPERAGPGRPRGSPPGRARPSLAPRPGPEPSRPRAAPETSGGDTAGAGRCGGRRAAKLGPGRRGWWALLALQLHLLRALAQDDVAPYFKTEPGLPQIHLEGNRLVLTCLAEGSWPLEFKWMRDDSELTTYSSEYKYIIPSLQKLDAGFYRCVVRNRMGALLQRKSEVQVAYMGSFMDTDQRKTVSQGRAAILNLLPITSYPRPQVTWFREGHKIIPSNRIAITLENQLVILATTTSDAGAYYVQAVNEKNGENKTSPFIHLSIARDVGTPETMAPTIVVPPGNRSVVAGSSETTLECIASARPVEDLSVTWKRNGVRITSGLHSFGRRLTISNPTSADTGPYVCEAALPGSAFEPARATAFLFIIEPPYFTAEPESRISAEVEETVDIGCQAMGVPLPTLQWYKDAISISRLQNPRYKVLASGGLRIQKLRPEDSGIFQCFASNEGGEIQTHTYLDVTNIAPVFTQRPVDTTVTDGMTAILRCEVSGAPKPAITWKRENHILASGSVRIPRFMLLESGGLQIAPVFIQDAGNYTCYAANTEGSLNASATLTVWNRTSIVHPPEDHVVIKGTTATLHCGATHDPRVSLRYVWKKDNVALTPSSTSRIVVEKDGSLLISQTWSGDIGDYSCEIVSEGGNDSRMARLEVIELPHSPQNLLVSPNSSHSHAVVLSWVRPFDGNSPILYYIVELSENNSPWKVHLSNVGPEMTGVTVSGLTPARTYQFRVCAVNEVGRGQYSAETSRLMLPEEPPSAPPKNIVASGRTNQSIMVQWQPPPETEHNGVLRGYILRYRLAGLPGEYQQRNITSPEVNYCLVTDLIIWTQYEIQVAAYNGAGLGVFSRAVTEYTLQGVPTAPPQNVQTEAVNSTTIQFLWNPPPQQFINGINQGYKLLAWPADAPEAVTVVTIAPDFHGVHHGHITNLKKFTAYFTSVLCFTTPGDGPPSTPQLVWTQEDKPGAVGHLSFTEILDTSLKVSWQEPLEKNGIITGYQISWEVYGRNDSRLTHTLNSTTHEYKIQGLSSLTTYTIDVAAVTAVGTGLVTSSTISSGVPPDLPGAPSNLVISNISPRSATLQFRPGYDGKTSISRWIVEGQVGAIGDEEEWVTLYEEENEPDAQMLEIPNLTPYTHYRFRMKQVNIVGPSPYSPSSRVIQTLQAPPDVAPTSVTVRTASETSLRLRWVPLPDSQYNGNPESVGYRIKYWRSDLQSSAVAQVVSDRLEREFTIEELEEWMEYELQMQAFNAVGAGPWSEVVRGRTRESVPSAAPENVSAEAVSSTQILLTWTSVPEQDQNGLILGYKILFRAKDLDPEPRSHIVRGNHTQSALLAGLRKFVLYELQVLAFTRIGNGVPSTPLILERTKDDAPGPPVRLVFPEVRLTSVRIVWQPPEEPNGIILGYQIAYRLASSSPHTFTTVEVGATVRQFTATDLAPESAYIFRLSAKTRQGWGEPLEATVITTEKRERPAPPRELLVPQAEVTARSLRLQWVPGSDGASPIRYFTMQVRELPRGEWQTYSSSISHEATACVVDRLRPFTSYKLRLKATNDIGDSDFSSETEAVTTLQDVPGEPPGSVSATPHTTSSVLIQWQPPRDESLNGLLQGYRIYYRELEYEAGSGTEAKTLKNPIALHAELTAQSSFKTVNSSSTSTMCELTHLKKYRRYEVIMTAYNIIGESPASAPVEVFVGEAAPAMAPQNVQVTPLTASQLEVTWDPPPPESQNGNIQGYKIYYWEADSQNETEKMKVLFLPEPVVRLKNLTSHTKYLVSISAFNAAGDGPKSDPQQGRTHQAAPGAPSFLAFSEITSTTLNVSWGEPAAANGILQGYRVVYEPLAPVQGVSKVVTVEVRGNWQRWLKVRDLTKGVTYFFRVQARTITYGPELQANITAGPAEGSPGSPRDVLVTKSASELTLQWTEGHSGDTPTTGYVIEARPSDEGLWDMFVKDIPRSATSYTLSLDKLRQGVTYEFRVVAVNEAGYGEPSNPSTAVSAQVEAPFYEEWWFLLVMALSSLIVILLVVFALVLHGQNKKYKNCSTGKGISTMEESVTLDNGGFAALELSSRHLNVKSTFSKKNGTRSPPRPSPGGLHYSDEDICNKYNGAVLTESVSLKEKSADASESEATDSDYEDALPKHSFVNHYMSDPTYYNSWKRRAQGRAPAPHRYEAVAGSEAGAQLHPVITTQSAGGVYTPAGPGARTPLTGFSSFV,2213,"242,112",Alternative sequence (3); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (19); Glycosylation (19); Motif (1); Natural variant (2); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 126..169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 315..362;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 408..458;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 501..553;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 595..647;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..?;  /evidence=""ECO:0000255"""
Q9Y5F7,Protocadherin gamma-C4 (PCDH-gamma-C4),MLRKVRSWTEIWRWATLLFLFYHLGYVCGQIRYPVPEESQEGTFVGNVAQDFLLDTDSLSARRLQVAGEVNQRHFRVDLDSGALLIKNPIDREALCGLSASCIVPLEFVTEGPLEMYRAEVEIVDVNDHAPRFPRQQLDLEIGEAAPPGQRFPLEKAQDADVGSNSISSYRLSSNEHFALDVKKRSDGSLVPELLLEKPLDREKQSDYRLVLTAVDGGNPPRSGTAELRVSVLDVNDNAPAFQQSSYRISVLESAPAGMVLIQLNASDPDLGPSGNVTFYFSGHTPDRVRNLFSLHPTTGKLTLLGPLDFESENYYEFDVRARDGGSPAMEQHCSLRVDLLDVNDNAPYITVTSELGTLPESAEPGTVVALISVQDPDSGSNGDVSLRIPDHLPFALKSAFRNQFSLVTAGPLDREAKSSYDIMVTASDAGNPPLSTHRTIFLNISDVNDNPPSFFQRSHEVFVPENNRPGDLLCSLAASDPDSGLNALISYSLLEPRNRDVSASSFISLNPQTGAVHATRSFDYEQTQTLQFEVQARDRGNPPLSSTVTVRLFVLDLNDNAPAVLRPRARPGSLCPQALPPSVGAGHLITKVTAVDLDSGYNAWVSYQLLEAPDPSLFAVSRYAGEVRTAVPIPADLPPQKLVIVVKDSGSPPLSTSVTLLVSLEEDTHPVVPDLRESSAPREGESRLTLYLAVSLVAICFVSFGSFVALLSKCLRGAACGVTCFPAGTCACLTRSRRREGLPPSNGILRIQLGSDDPIKFVDVGGHSHGCTPLASAPTRSDSFMMVKSPSAPMAGEPVRPSCPPSDLLYGLEQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,938,"101,214",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5I4,Protocadherin alpha-C2 (PCDH-alpha-C2),MEQAGTRPAATEHPRLRRPMPWLLLLPLLLLLLLLLPGPAASQLRYSVPEEQAPGALVGNVARALGLELRRLGPGCLRINHLGAPSPRYLELDLTSGALFVNERIDREALCEQRPRCLLSLEVLAHNPVAVSAVEVEILDINDNSPRFPRPNYQLQVSESVAPGARFHIESAQDPDVGANSVQTYELSPSEHFELDLKPLQENSKVLELVLRKGLDREQAALHHLVLTAVDGGIPARSGTAQISVRVLDTNDNSPAFDQSTYRVQLREDSPPGTLVVKLNASDPDEGSNGELRYSLSSYTSDRERQLFSIDASTGEVRVIGGLDYEEASSYQIYVQATDRGPVPMAGHCKVLVDIVDVNDNAPEVVLTDLYSPVPENATPNTIVAVLSVNDQDSGPNRKVSLGLEATLPFRLNGFGNSYTLVVSGPLDRERVAVYNITVTATDGGIPQLTSLRTLKVEISDINDNPPSFLEDSYSIYIQENNLPGVLLCTVQATDPDEKENAEVTYSLLEREIQGLPVTSYVSINSASGSLYAVNSFDYEKFREFFVTVEAQDKGSPPLSSTVTANVYVVDMNDHAPHILYPTSTNSSAAFEMVPRTAPAGYLVTKVIAMDSDSGQNAWLFYHLAQTSDLDLFKVELHTGEIRTTRKMGDESGSTFNLTVVVRDNGEPSLSASVAITVAVVDRVSKILPDTQRHVKSPRTYSEITLYLIIALSTVSFIFLLTIIILSIIKCYRYTAYGTACCGGFCGVRERSPAELYKQANNNIDARIPHGLKVQPHFIEVRGNGSLTKTYCYKACLTAGSGSDTFMFYNTGAQTGPGPSGAQAAVTDSRNLTGQSGQNAGNLIILKNEAVSQNEPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,1007,"109,450",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (4); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q9HCL0,Protocadherin-18,MHQMNAKMHFRFVFALLIVSFNHDVLGKNLKYRIYEEQRVGSVIARLSEDVADVLLKLPNPSTVRFRAMQRGNSPLLVVNEDNGEISIGATIDREQLCQKNLNCSIEFDVITLPTEHLQLFHIEVEVLDINDNSPQFSRSLIPIEISESAAVGTRIPLDSAFDPDVGENSLHTYSLSANDFFNIEVRTRTDGAKYAELIVVRELDRELKSSYELQLTASDMGVPQRSGSSILKISISDSNDNSPAFEQQSYIIQLLENSPVGTLLLDLNATDPDEGANGKIVYSFSSHVSPKIMETFKIDSERGHLTLFKQVDYEITKSYEIDVQAQDLGPNSIPAHCKIIIKVVDVNDNKPEININLMSPGKEEISYIFEGDPIDTFVALVRVQDKDSGLNGEIVCKLHGHGHFKLQKTYENNYLILTNATLDREKRSEYSLTVIAEDRGTPSLSTVKHFTVQINDINDNPPHFQRSRYEFVISENNSPGAYITTVTATDPDLGENGQVTYTILESFILGSSITTYVTIDPSNGAIYALRIFDHEEVSQITFVVEARDGGSPKQLVSNTTVVLTIIDENDNVPVVIGPALRNNTAEITIPKGAESGFHVTRIRAIDRDSGVNAELSCAIVAGNEENIFIIDPRSCDIHTNVSMDSVPYTEWELSVIIQDKGNPQLHTKVLLKCMIFEYAESVTSTAMTSVSQASLDVSMIIIISLGAICAVLLVIMVLFATRCNREKKDTRSYNCRVAESTYQHHPKRPSRQIHKGDITLVPTINGTLPIRSHHRSSPSSSPTLERGQMGSRQSHNSHQSLNSLVTISSNHVPENFSLELTHATPAVEQVSQLLSMLHQGQYQPRPSFRGNKYSRSYRYALQDMDKFSLKDSGRGDSEAGDSDYDLGRDSPIDRLLGEGFSDLFLTDGRIPAAMRLCTEECRVLGHSDQCWMPPLPSPSSDYRSNMFIPGEEFPTQPQQQHPHQSLEDDAQPADSGEKKKSFSTFGKDSPNDEDTGDTSTSSLLSEMSSVFQRLLPPSLDTYSECSEVDRSNSLERRKGPLPAKTVGYPQGVAAWAASTHFQNPTTNCGPPLGTHSSVQPSSKWLPAMEEIPENYEEDDFDNVLNHLNDGKHELMDASELVAEINKLLQDVRQS,1135,"126,149",Alternative sequence (1); Beta strand (30); Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (6); Helix (8); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8TD07,Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4) (N2DL-4) (NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4),MRRISLTSSPVRLLLFLLLLLIALEIMVGGHSLCFNFTIKSLSRPGQPWCEAQVFLNKNLFLQYNSDNNMVKPLGLLGKKVYATSTWGELTQTLGEVGRDLRMLLCDIKPQIKTSDPSTLQVEMFCQREAERCTGASWQFATNGEKSLLFDAMNMTWTVINHEASKIKETWKKDRGLEKYFRKLSKGDCDHWLREFLGHWEAMPEPTVSPVNASDIHWSSSSLPDRWIILGAFILLVLMGIVLICVWWQNGEWQAGLWPLRTS,263,"30,122",Alternative sequence (6); Chain (1); Compositional bias (1); Disulfide bond (1); Glycosylation (3); Natural variant (7); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 126..189;  /evidence=""ECO:0000250""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P04844,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2),MAPPGSSTVFLLALTIIASTWALTPTHYLTKHDVERLKASLDRPFTNLESAFYSIVGLSSLGAQVPDAKKACTYIRSNLDPSNVDSLFYAAQASQALSGCEISISNETKDLLLAAVSEDSSVTQIYHAVAALSGFGLPLASQEALSALTARLSKEETVLATVQALQTASHLSQQADLRSIVEEIEDLVARLDELGGVYLQFEEGLETTALFVAATYKLMDHVGTEPSIKEDQVIQLMNAIFSKKNFESLSEAFSVASAAAVLSHNRYHVPVVVVPEGSASDTHEQAILRLQVTNVLSQPLTQATVKLEHAKSVASRATVLQKTSFTPVGDVFELNFMNVKFSSGYYDFLVEVEGDNRYIANTVELRVKISTEVGITNVDLSTVDKDQSIAPKTTRVTYPAKAKGTFIADSHQNFALFFQLVDVNTGAELTPHQTFVRLHNQKTGQEVVFVAEPDNKNVYKFELDTSERKIEFDSASGTYTLYLIIGDATLKNPILWNVADVVIKFPEEEAPSTVLSQNLFTPKQEIQHLFREPEKRPPTVVSNTFTALILSPLLLLFALWIRIGANVSNFTFAPSTIIFHLGHAAMLGLMYVYWTQLNMFQTLKYLAILGSVTFLAGNRMLAQQAVKRTAH,631,"69,284",Alternative sequence (2); Beta strand (15); Chain (1); Cross-link (1); Glycosylation (1); Helix (3); Natural variant (1); Sequence conflict (7); Signal peptide (1); Topological domain (4); Transmembrane (3); Turn (2),,"SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:12665801"""
Q9NPH3,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),MTLLWCVVSLYFYGILQSDASERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKFNYSTAHSAGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMKLPVHKLYIEYGIQRITCPNVDGYFPSSVKPTITWYMGCYKIQNFNNVIPEGMNLSFLIALISNNGNYTCVVTYPENGRTFHLTRTLTVKVVGSPKNAVPPVIHSPNDHVVYEKEPGEELLIPCTVYFSFLMDSRNEVWWTIDGKKPDDITIDVTINESISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAAKVKQKVPAPRYTVELACGFGATVLLVVILIVVYHVYWLEMVLFYRAHFGTDETILDGKEYDIYVSYARNAEEEEFVLLTLRGVLENEFGYKLCIFDRDSLPGGIVTDETLSFIQKSRRLLVVLSPNYVLQGTQALLELKAGLENMASRGNINVILVQYKAVKETKVKELKRAKTVLTVIKWKGEKSKYPQGRFWKQLQVAMPVKKSPRRSSSDEQGLSYSSLKNV,570,"65,418",Active site (1); Alternative sequence (4); Beta strand (26); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (7); Helix (6); Modified residue (1); Natural variant (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 24..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 47..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 137..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 160..212;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 266..332;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8NFM7,Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (IL17Rhom) (Interleukin-17 receptor-like protein) (Sef homolog) (hSef),MAPWLQLCSVFFTVNACLNGSQLAVAAGGSGRARGADTCGWRGVGPASRNSGLYNITFKYDNCTTYLNPVGKHVIADAQNITISQYACHDQVAVTILWSPGALGIEFLKGFRVILEELKSEGRQCQQLILKDPKQLNSSFKRTGMESQPFLNMKFETDYFVKVVPFPSIKNESNYHPFFFRTRACDLLLQPDNLACKPFWKPRNLNISQHGSDMQVSFDHAPHNFGFRFFYLHYKLKHEGPFKRKTCKQEQTTETTSCLLQNVSPGDYIIELVDDTNTTRKVMHYALKPVHSPWAGPIRAVAITVPLVVISAFATLFTVMCRKKQQENIYSHLDEESSESSTYTAALPRERLRPRPKVFLCYSSKDGQNHMNVVQCFAYFLQDFCGCEVALDLWEDFSLCREGQREWVIQKIHESQFIIVVCSKGMKYFVDKKNYKHKGGGRGSGKGELFLVAVSAIAEKLRQAKQSSSAALSKFIAVYFDYSCEGDVPGILDLSTKYRLMDNLPQLCSHLHSRDHGLQEPGQHTRQGSRRNYFRSKSGRSLYVAICNMHQFIDEEPDWFEKQFVPFHPPPLRYREPVLEKFDSGLVLNDVMCKPGPESDFCLKVEAAVLGATGPADSQHESQHGGLDQDGEARPALDGSAALQPLLHTVKAGSPSDMPRDSGIYDSSVPSSELSLPLMEGLSTDQTETSSLTESVSSSSGLGEEEPPALPSKLLSSGSCKADLGCRSYTDELHAVAPL,739,"82,411",Alternative sequence (3); Chain (1); Compositional bias (1); Domain (1); Glycosylation (8); Natural variant (9); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
P98153,Integral membrane protein DGCR2/IDD,MVPKADSGAFLLLFLLVLTVTEPLRPELRCNPGQFACRSGTIQCIPLPWQCDGWATCEDESDEANCPEVTGEVRPHHGKEAVDPRQGRARGGDPSHFHAVNVAQPVRFSSFLGKCPTGWHHYEGTASCYRVYLSGENYWDAAQTCQRLNGSLATFSTDQELRFVLAQEWDQPERSFGWKDQRKLWVGYQYVITGRNRSLEGRWEVAFKGSSEVFLPPDPIFASAMSENDNVFCAQLQCFHFPTLRHHDLHSWHAESCYEKSSFLCKRSQTCVDIKDNVVDEGFYFTPKGDDPCLSCTCHGGEPEMCVAALCERPQGCQQYRKDPKECCKFMCLDPDGNSLFDSMASGMRLVVSCISSFLILSLLLFMVHRLRQRRRERIESLIGANLHHFNLGRRIPGFDYGPDGFGTGLTPLHLSDDGEGGTFHFHDPPPPYTAYKYPDIGQPDDPPPPYEASIHPDSVFYDPADDDAFEPVEVSLPAPGDGGSEGALLRRLEQPLPTAGASLADLEDSADSSSALLVPPDPAQSGSTPAAEALPGGGRHSRSSLNTVV,550,"60,811",Alternative sequence (3); Chain (1); Disulfide bond (5); Domain (3); Glycosylation (2); Modified residue (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 30..44;  /evidence=""ECO:0000250""; DISULFID 37..57;  /evidence=""ECO:0000250""; DISULFID 51..66;  /evidence=""ECO:0000250""; DISULFID 145..265;  /evidence=""ECO:0000250""; DISULFID 233..257;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q16819,Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha) (PABA peptide hydrolase) (PPH alpha),MAWIRSTCILFFTLLFAHIAAVPIKYLPEENVHDADFGEQKDISEINLAAGLDLFQGDILLQKSRNGLRDPNTRWTFPIPYILADNLGLNAKGAILYAFEMFRLKSCVDFKPYEGESSYIIFQQFDGCWSEVGDQHVGQNISIGQGCAYKAIIEHEILHALGFYHEQSRTDRDDYVNIWWDQILSGYQHNFDTYDDSLITDLNTPYDYESLMHYQPFSFNKNASVPTITAKIPEFNSIIGQRLDFSAIDLERLNRMYNCTTTHTLLDHCTFEKANICGMIQGTRDDTDWAHQDSAQAGEVDHTLLGQCTGAGYFMQFSTSSGSAEEAALLESRILYPKRKQQCLQFFYKMTGSPSDRLVVWVRRDDSTGNVRKLVKVQTFQGDDDHNWKIAHVVLKEEQKFRYLFQGTKGDPQNSTGGIYLDDITLTETPCPTGVWTVRNFSQVLENTSKGDKLQSPRFYNSEGYGFGVTLYPNSRESSGYLRLAFHVCSGENDAILEWPVENRQVIITILDQEPDVRNRMSSSMVFTTSKSHTSPAINDTVIWDRPSRVGTYHTDCNCFRSIDLGWSGFISHQMLKRRSFLKNDDLIIFVDFEDITHLSQTEVPTKGKRLSPQGLILQGQEQQVSEEGSGKAMLEEALPVSLSQGQPSRQKRSVENTGPLEDHNWPQYFRDPCDPNPCQNDGICVNVKGMASCRCISGHAFFYTGERCQAVQVHGSVLGMVIGGTAGVIFLTFSIIAILSQRPRK,746,"84,419",Active site (1); Chain (1); Disulfide bond (8); Domain (4); Glycosylation (7); Metal binding (3); Natural variant (5); Propeptide (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 107..259;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01211""; DISULFID 128..147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01211""; DISULFID 269..431;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 277;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 308;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 674..685;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 679..694;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 696..709;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q16820,Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta),MDLWNLSWFLFLDALLVISGLATPENFDVDGGMDQDIFDINEGLGLDLFEGDIRLDRAQIRNSIIGEKYRWPHTIPYVLEDSLEMNAKGVILNAFERYRLKTCIDFKPWAGETNYISVFKGSGCWSSVGNRRVGKQELSIGANCDRIATVQHEFLHALGFWHEQSRSDRDDYVRIMWDRILSGREHNFNTYSDDISDSLNVPYDYTSVMHYSKTAFQNGTEPTIVTRISDFEDVIGQRMDFSDSDLLKLNQLYNCSSSLSFMDSCSFELENVCGMIQSSGDNADWQRVSQVPRGPESDHSNMGQCQGSGFFMHFDSSSVNVGATAVLESRTLYPKRGFQCLQFYLYNSGSESDQLNIYIREYSADNVDGNLTLVEEIKEIPTGSWQLYHVTLKVTKKFRVVFEGRKGSGASLGGLSIDDINLSETRCPHHIWHIRNFTQFIGSPNGTLYSPPFYSSKGYAFQIYLNLAHVTNAGIYFHLISGANDDQLQWPCPWQQATMTLLDQNPDIRQRMSNQRSITTDPFMTTDNGNYFWDRPSKVGTVALFSNGTQFRRGGGYGTSAFITHERLKSRDFIKGDDVYILLTVEDISHLNSTQIQLTPAPSVQDLCSKTTCKNDGVCTVRDGKAECRCQSGEDWWYMGERCEKRGSTRDTIVIAVSSTVAVFALMLIITLVSVYCTRKKYRERMSSNRPNLTPQNQHAF,701,"79,571",Active site (1); Beta strand (37); Chain (1); Disulfide bond (9); Domain (4); Glycosylation (12); Helix (17); Metal binding (3); Mutagenesis (2); Natural variant (3); Propeptide (1); Region (1); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 103..255;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01211, ECO:0000269|PubMed:22988105""; DISULFID 124..144;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01211, ECO:0000269|PubMed:22988105""; DISULFID 265..427;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:22988105""; DISULFID 273;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 305;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:22988105""; DISULFID 492;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 608..619;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 613..628;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 630..643;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
O75578,Integrin alpha-10,MELPFVTHLFLPLVFLTGLCSPFNLDEHHPRLFPGPPEAEFGYSVLQHVGGGQRWMLVGAPWDGPSGDRRGDVYRCPVGGAHNAPCAKGHLGDYQLGNSSHPAVNMHLGMSLLETDGDGGFMACAPLWSRACGSSVFSSGICARVDASFQPQGSLAPTAQRCPTYMDVVIVLDGSNSIYPWSEVQTFLRRLVGKLFIDPEQIQVGLVQYGESPVHEWSLGDFRTKEEVVRAAKNLSRREGRETKTAQAIMVACTEGFSQSHGGRPEAARLLVVVTDGESHDGEELPAALKACEAGRVTRYGIAVLGHYLRRQRDPSSFLREIRTIASDPDERFFFNVTDEAALTDIVDALGDRIFGLEGSHAENESSFGLEMSQIGFSTHRLKDGILFGMVGAYDWGGSVLWLEGGHRLFPPRMALEDEFPPALQNHAAYLGYSVSSMLLRGGRRLFLSGAPRFRHRGKVIAFQLKKDGAVRVAQSLQGEQIGSYFGSELCPLDTDRDGTTDVLLVAAPMFLGPQNKETGRVYVYLVGQQSLLTLQGTLQPEPPQDARFGFAMGALPDLNQDGFADVAVGAPLEDGHQGALYLYHGTQSGVRPHPAQRIAAASMPHALSYFGRSVDGRLDLDGDDLVDVAVGAQGAAILLSSRPIVHLTPSLEVTPQAISVVQRDCRRRGQEAVCLTAALCFQVTSRTPGRWDHQFYMRFTASLDEWTAGARAAFDGSGQRLSPRRLRLSVGNVTCEQLHFHVLDTSDYLRPVALTVTFALDNTTKPGPVLNEGSPTSIQKLVPFSKDCGPDNECVTDLVLQVNMDIRGSRKAPFVVRGGRRKVLVSTTLENRKENAYNTSLSLIFSRNLHLASLTPQRESPIKVECAAPSAHARLCSVGHPVFQTGAKVTFLLEFEFSCSSLLSQVFVKLTASSDSLERNGTLQDNTAQTSAYIQYEPHLLFSSESTLHRYEVHPYGTLPVGPGPEFKTTLRVQNLGCYVVSGLIISALLPAVAHGGNYFLSLSQVITNNASCIVQNLTEPPGPPVHPEELQHTNRLNGSNTQCQVVRCHLGQLAKGTEVSVGLLRLVHNEFFRRAKFKSLTVVSTFELGTEEGSVLQLTEASRWSESLLEVVQTRPILISLWILIGSVLGGLLLLALLVFCLWKLGFFAHKKIPEEEKREEKLEQ,1167,"127,602",Alternative sequence (3); Calcium binding (3); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (1); Glycosylation (11); Natural variant (5); Repeat (7); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 76..86;  /evidence=""ECO:0000250""; DISULFID 666..675;  /evidence=""ECO:0000250""; DISULFID 681..736;  /evidence=""ECO:0000250""; DISULFID 789..795;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P43630,Killer cell immunoglobulin-like receptor 3DL2 (CD158 antigen-like family member K) (MHC class I NK cell receptor) (Natural killer-associated transcript 4) (NKAT-4) (p70 natural killer cell receptor clone CL-5) (p70 NK receptor CL-5) (CD antigen CD158k),MSLTVVSMACVGFFLLQGAWPLMGGQDKPFLSARPSTVVPRGGHVALQCHYRRGFNNFMLYKEDRSHVPIFHGRIFQESFIMGPVTPAHAGTYRCRGSRPHSLTGWSAPSNPLVIMVTGNHRKPSLLAHPGPLLKSGETVILQCWSDVMFEHFFLHREGISEDPSRLVGQIHDGVSKANFSIGPLMPVLAGTYRCYGSVPHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVQAGENVTLSCSSWSSYDIYHLSREGEAHERRLRAVPKVNRTFQADFPLGPATHGGTYRCFGSFRALPCVWSNSSDPLLVSVTGNPSSSWPSPTEPSSKSGICRHLHVLIGTSVVIFLFILLLFFLLYRWCSNKKNAAVMDQEPAGDRTVNRQDSDEQDPQEVTYAQLDHCVFIQRKISRPSQRPKTPLTDTSVYTELPNAEPRSKVVSCPRAPQSGLEGVF,455,"50,230",Alternative sequence (1); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (4); Natural variant (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..95;  /evidence=""ECO:0000305""; DISULFID 144..195;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""; DISULFID 244..293;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
P11279,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),MAAPGSARRPLLLLLLLLLLGLMHCASAAMFMVKNGNGTACIMANFSAAFSVNYDTKSGPKNMTFDLPSDATVVLNRSSCGKENTSDPSLVIAFGRGHTLTLNFTRNATRYSVQLMSFVYNLSDTHLFPNASSKEIKTVESITDIRADIDKKYRCVSGTQVHMNNVTVTLHDATIQAYLSNSSFSRGETRCEQDRPSPTTAPPAPPSPSPSPVPKSPSVDKYNVSGTNGTCLLASMGLQLNLTYERKDNTTVTRLLNINPNKTSASGSCGAHLVTLELHSEGTTVLLFQFGMNASSSRFFLQGIQLNTILPDARDPAFKAANGSLRALQATVGNSYKCNAEEHVRVTKAFSVNIFKVWVQAFKVEGGQFGSVEECLLDENSMLIPIAVGGALAGLVLIVLIAYLVGRKRSHAGYQTI,417,"44,882",Alternative sequence (1); Chain (1); Disulfide bond (4); Glycosylation (24); Mutagenesis (1); Natural variant (1); Region (3); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:2584229""; DISULFID 155..191;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:2584229""; DISULFID 231..269;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:2584229""; DISULFID 338..375;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740, ECO:0000269|PubMed:2584229""","SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:2912382, ECO:0000269|PubMed:3198605"""
Q9NZ94,Neuroligin-3 (Gliotactin homolog),MWLRLGPPSLSLSPKPTVGRSLCLTLWFLSLALRASTQAPAPTVNTHFGKLRGARVPLPSEILGPVDQYLGVPYAAPPIGEKRFLPPEPPPSWSGIRNATHFPPVCPQNIHTAVPEVMLPVWFTANLDIVATYIQEPNEDCLYLNVYVPTEDVKRISKECARKPNKKICRKGGSGAKKQGEDLADNDGDEDEDIRDSGAKPVMVYIHGGSYMEGTGNMIDGSILASYGNVIVITLNYRVGVLGFLSTGDQAAKGNYGLLDQIQALRWVSENIAFFGGDPRRITVFGSGIGASCVSLLTLSHHSEGLFQRAIIQSGSALSSWAVNYQPVKYTSLLADKVGCNVLDTVDMVDCLRQKSAKELVEQDIQPARYHVAFGPVIDGDVIPDDPEILMEQGEFLNYDIMLGVNQGEGLKFVEGVVDPEDGVSGTDFDYSVSNFVDNLYGYPEGKDTLRETIKFMYTDWADRDNPETRRKTLVALFTDHQWVEPSVVTADLHARYGSPTYFYAFYHHCQSLMKPAWSDAAHGDEVPYVFGVPMVGPTDLFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNKPVPQDTKFIHTKANRFEEVAWSKYNPRDQLYLHIGLKPRVRDHYRATKVAFWKHLVPHLYNLHDMFHYTSTTTKVPPPDTTHSSHITRRPNGKTWSTKRPAISPAYSNENAQGSWNGDQDAGPLLVENPRDYSTELSVTIAVGASLLFLNVLAFAALYYRKDKRRQEPLRQPSPQRGAGAPELGAAPEEELAALQLGPTHHECEAGPPHDTLRLTALPDYTLTLRRSPDDIPLMTPNTITMIPNSLVGLQTLHPYNTFAAGFNSTGLPHSHSTTRV,848,"93,895",Alternative sequence (2); Chain (1); Disulfide bond (3); Erroneous initiation (2); Glycosylation (2); Modified residue (2); Natural variant (5); Sequence caution (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 106..141;  /evidence=""ECO:0000250""; DISULFID 340..351;  /evidence=""ECO:0000250""; DISULFID 510..544;  /evidence=""ECO:0000250""","SIGNAL 1..37;  /evidence=""ECO:0000255"""
O14786,Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304),MERGLPLLCAVLALVLAPAGAFRNDKCGDTIKIESPGYLTSPGYPHSYHPSEKCEWLIQAPDPYQRIMINFNPHFDLEDRDCKYDYVEVFDGENENGHFRGKFCGKIAPPPVVSSGPFLFIKFVSDYETHGAGFSIRYEIFKRGPECSQNYTTPSGVIKSPGFPEKYPNSLECTYIVFVPKMSEIILEFESFDLEPDSNPPGGMFCRYDRLEIWDGFPDVGPHIGRYCGQKTPGRIRSSSGILSMVFYTDSAIAKEGFSANYSVLQSSVSEDFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSYINEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSFEGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVEAPTAGPTTPNGNLVDECDDDQANCHSGTGDDFQLTGGTTVLATEKPTVIDSTIQSEFPTYGFNCEFGWGSHKTFCHWEHDNHVQLKWSVLTSKTGPIQDHTGDGNFIYSQADENQKGKVARLVSPVVYSQNSAHCMTFWYHMSGSHVGTLRVKLRYQKPEEYDQLVWMAIGHQGDHWKEGRVLLHKSLKLYQVIFEGEIGKGNLGGIAVDDISINNHISQEDCAKPADLDKKNPEIKIDETGSTPGYEGEGEGDKNISRKPGNVLKTLDPILITIIAMSALGVLLGAVCGVVLYCACWHNGMSERNLSALENYNFELVDGVKLKKDKLNTQSTYSEA,923,"103,134",Alternative sequence (3); Beta strand (41); Chain (1); Disulfide bond (6); Domain (5); Glycosylation (7); Helix (9); Metal binding (3); Modified residue (1); Natural variant (3); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (12),"DISULFID 27..54;  /evidence=""ECO:0000305|PubMed:17989695""; DISULFID 82..104;  /evidence=""ECO:0000305|PubMed:17989695""; DISULFID 147..173;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 206..228;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 275..424;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 431..583;  /evidence=""ECO:0000269|PubMed:17989695""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:10688880, ECO:0000269|PubMed:9529250"""
Q9UM47,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],MGPGARGRRRRRRPMSPPPPPPPVRALPLLLLLAGPGAAAPPCLDGSPCANGGRCTQLPSREAACLCPPGWVGERCQLEDPCHSGPCAGRGVCQSSVVAGTARFSCRCPRGFRGPDCSLPDPCLSSPCAHGARCSVGPDGRFLCSCPPGYQGRSCRSDVDECRVGEPCRHGGTCLNTPGSFRCQCPAGYTGPLCENPAVPCAPSPCRNGGTCRQSGDLTYDCACLPGFEGQNCEVNVDDCPGHRCLNGGTCVDGVNTYNCQCPPEWTGQFCTEDVDECQLQPNACHNGGTCFNTLGGHSCVCVNGWTGESCSQNIDDCATAVCFHGATCHDRVASFYCACPMGKTGLLCHLDDACVSNPCHEDAICDTNPVNGRAICTCPPGFTGGACDQDVDECSIGANPCEHLGRCVNTQGSFLCQCGRGYTGPRCETDVNECLSGPCRNQATCLDRIGQFTCICMAGFTGTYCEVDIDECQSSPCVNGGVCKDRVNGFSCTCPSGFSGSTCQLDVDECASTPCRNGAKCVDQPDGYECRCAEGFEGTLCDRNVDDCSPDPCHHGRCVDGIASFSCACAPGYTGTRCESQVDECRSQPCRHGGKCLDLVDKYLCRCPSGTTGVNCEVNIDDCASNPCTFGVCRDGINRYDCVCQPGFTGPLCNVEINECASSPCGEGGSCVDGENGFRCLCPPGSLPPLCLPPSHPCAHEPCSHGICYDAPGGFRCVCEPGWSGPRCSQSLARDACESQPCRAGGTCSSDGMGFHCTCPPGVQGRQCELLSPCTPNPCEHGGRCESAPGQLPVCSCPQGWQGPRCQQDVDECAGPAPCGPHGICTNLAGSFSCTCHGGYTGPSCDQDINDCDPNPCLNGGSCQDGVGSFSCSCLPGFAGPRCARDVDECLSNPCGPGTCTDHVASFTCTCPPGYGGFHCEQDLPDCSPSSCFNGGTCVDGVNSFSCLCRPGYTGAHCQHEADPCLSRPCLHGGVCSAAHPGFRCTCLESFTGPQCQTLVDWCSRQPCQNGGRCVQTGAYCLCPPGWSGRLCDIRSLPCREAAAQIGVRLEQLCQAGGQCVDEDSSHYCVCPEGRTGSHCEQEVDPCLAQPCQHGGTCRGYMGGYMCECLPGYNGDNCEDDVDECASQPCQHGGSCIDLVARYLCSCPPGTLGVLCEINEDDCGPGPPLDSGPRCLHNGTCVDLVGGFRCTCPPGYTGLRCEADINECRSGACHAAHTRDCLQDPGGGFRCLCHAGFSGPRCQTVLSPCESQPCQHGGQCRPSPGPGGGLTFTCHCAQPFWGPRCERVARSCRELQCPVGVPCQQTPRGPRCACPPGLSGPSCRSFPGSPPGASNASCAAAPCLHGGSCRPAPLAPFFRCACAQGWTGPRCEAPAAAPEVSEEPRCPRAACQAKRGDQRCDRECNSPGCGWDGGDCSLSVGDPWRQCEALQCWRLFNNSRCDPACSSPACLYDNFDCHAGGRERTCNPVYEKYCADHFADGRCDQGCNTEECGWDGLDCASEVPALLARGVLVLTVLLPPEELLRSSADFLQRLSAILRTSLRFRLDAHGQAMVFPYHRPSPGSEPRARRELAPEVIGSVVMLEIDNRLCLQSPENDHCFPDAQSAADYLGALSAVERLDFPYPLRDVRGEPLEPPEPSVPLLPLLVAGAVLLLVILVLGVMVARRKREHSTLWFPEGFSLHKDVASGHKGRREPVGQDALGMKNMAKGESLMGEVATDWMDTECPEAKRLKVEEPGMGAEEAVDCRQWTQHHLVAADIRVAPAMALTPPQGDADADGMDVNVRGPDGFTPLMLASFCGGALEPMPTEEDEADDTSASIISDLICQGAQLGARTDRTGETALHLAARYARADAAKRLLDAGADTNAQDHSGRTPLHTAVTADAQGVFQILIRNRSTDLDARMADGSTALILAARLAVEGMVEELIASHADVNAVDELGKSALHWAAAVNNVEATLALLKNGANKDMQDSKEETPLFLAAREGSYEAAKLLLDHFANREITDHLDRLPRDVAQERLHQDIVRLLDQPSGPRSPPGPHGLGPLLCPPGAFLPGLKAAQSGSKKSRRPPGKAGLGPQGPRGRGKKLTLACPGPLADSSVTLSPVDSLDSPRPFGGPPASPGGFPLEGPYAAATATAVSLAQLGGPGRAGLGRQPPGGCVLSLGLLNPVAVPLDWARLPPPAPPGPSFLLPLAPGPQLLNPGTPVSPQERPPPYLAVPGHGEEYPAAGAHSSPPKARFLRVPSEHPYLTPSPESPEHWASPSPPSLSDWSESTPSPATATGAMATTTGALPAQPLPLSVPSSLAQAQTQLGPQPEVTPKRQVLA,2321,"243,631",Beta strand (10); Chain (3); Disulfide bond (111); Domain (34); Glycosylation (3); Helix (15); Modified residue (1); Natural variant (122); Repeat (8); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 43..55;  /evidence=""ECO:0000250""; DISULFID 49..65;  /evidence=""ECO:0000250""; DISULFID 67..76;  /evidence=""ECO:0000250""; DISULFID 82..93;  /evidence=""ECO:0000250""; DISULFID 87..106;  /evidence=""ECO:0000250""; DISULFID 108..117;  /evidence=""ECO:0000250""; DISULFID 123..134;  /evidence=""ECO:0000250""; DISULFID 128..144;  /evidence=""ECO:0000250""; DISULFID 146..155;  /evidence=""ECO:0000250""; DISULFID 162..174;  /evidence=""ECO:0000250""; DISULFID 168..183;  /evidence=""ECO:0000250""; DISULFID 185..194;  /evidence=""ECO:0000250""; DISULFID 201..212;  /evidence=""ECO:0000250""; DISULFID 206..222;  /evidence=""ECO:0000250""; DISULFID 224..233;  /evidence=""ECO:0000250""; DISULFID 240..251;  /evidence=""ECO:0000250""; DISULFID 245..260;  /evidence=""ECO:0000250""; DISULFID 262..271;  /evidence=""ECO:0000250""; DISULFID 278..291;  /evidence=""ECO:0000250""; DISULFID 285..300;  /evidence=""ECO:0000250""; DISULFID 302..311;  /evidence=""ECO:0000250""; DISULFID 318..329;  /evidence=""ECO:0000250""; DISULFID 323..338;  /evidence=""ECO:0000250""; DISULFID 340..349;  /evidence=""ECO:0000250""; DISULFID 355..366;  /evidence=""ECO:0000250""; DISULFID 360..377;  /evidence=""ECO:0000250""; DISULFID 379..388;  /evidence=""ECO:0000250""; DISULFID 395..408;  /evidence=""ECO:0000250""; DISULFID 402..417;  /evidence=""ECO:0000250""; DISULFID 419..428;  /evidence=""ECO:0000250""; DISULFID 435..446;  /evidence=""ECO:0000250""; DISULFID 440..455;  /evidence=""ECO:0000250""; DISULFID 457..466;  /evidence=""ECO:0000250""; DISULFID 473..484;  /evidence=""ECO:0000250""; DISULFID 478..493;  /evidence=""ECO:0000250""; DISULFID 495..504;  /evidence=""ECO:0000250""; DISULFID 511..522;  /evidence=""ECO:0000250""; DISULFID 516..531;  /evidence=""ECO:0000250""; DISULFID 533..542;  /evidence=""ECO:0000250""; DISULFID 549..559;  /evidence=""ECO:0000250""; DISULFID 554..568;  /evidence=""ECO:0000250""; DISULFID 570..579;  /evidence=""ECO:0000250""; DISULFID 586..597;  /evidence=""ECO:0000250""; DISULFID 591..606;  /evidence=""ECO:0000250""; DISULFID 608..617;  /evidence=""ECO:0000250""; DISULFID 624..634;  /evidence=""ECO:0000250""; DISULFID 629..643;  /evidence=""ECO:0000250""; DISULFID 645..654;  /evidence=""ECO:0000250""; DISULFID 661..672;  /evidence=""ECO:0000250""; DISULFID 666..681;  /evidence=""ECO:0000250""; DISULFID 683..692;  /evidence=""ECO:0000250""; DISULFID 699..709;  /evidence=""ECO:0000250""; DISULFID 704..718;  /evidence=""ECO:0000250""; DISULFID 720..729;  /evidence=""ECO:0000250""; DISULFID 738..749;  /evidence=""ECO:0000250""; DISULFID 743..758;  /evidence=""ECO:0000250""; DISULFID 760..769;  /evidence=""ECO:0000250""; DISULFID 775..786;  /evidence=""ECO:0000250""; DISULFID 780..796;  /evidence=""ECO:0000250""; DISULFID 798..807;  /evidence=""ECO:0000250""; DISULFID 814..826;  /evidence=""ECO:0000250""; DISULFID 820..835;  /evidence=""ECO:0000250""; DISULFID 837..846;  /evidence=""ECO:0000250""; DISULFID 853..864;  /evidence=""ECO:0000250""; DISULFID 858..873;  /evidence=""ECO:0000250""; DISULFID 875..884;  /evidence=""ECO:0000250""; DISULFID 891..901;  /evidence=""ECO:0000250""; DISULFID 896..910;  /evidence=""ECO:0000250""; DISULFID 912..921;  /evidence=""ECO:0000250""; DISULFID 928..939;  /evidence=""ECO:0000250""; DISULFID 933..948;  /evidence=""ECO:0000250""; DISULFID 950..959;  /evidence=""ECO:0000250""; DISULFID 966..977;  /evidence=""ECO:0000250""; DISULFID 971..986;  /evidence=""ECO:0000250""; DISULFID 988..997;  /evidence=""ECO:0000250""; DISULFID 1004..1015;  /evidence=""ECO:0000250""; DISULFID 1009..1022;  /evidence=""ECO:0000250""; DISULFID 1024..1033;  /evidence=""ECO:0000250""; DISULFID 1040..1061;  /evidence=""ECO:0000305""; DISULFID 1055..1070;  /evidence=""ECO:0000250""; DISULFID 1072..1081;  /evidence=""ECO:0000250""; DISULFID 1088..1099;  /evidence=""ECO:0000250""; DISULFID 1093..1108;  /evidence=""ECO:0000250""; DISULFID 1110..1119;  /evidence=""ECO:0000250""; DISULFID 1126..1137;  /evidence=""ECO:0000250""; DISULFID 1131..1146;  /evidence=""ECO:0000250""; DISULFID 1148..1157;  /evidence=""ECO:0000250""; DISULFID 1164..1182;  /evidence=""ECO:0000250""; DISULFID 1176..1191;  /evidence=""ECO:0000250""; DISULFID 1193..1202;  /evidence=""ECO:0000250""; DISULFID 1209..1222;  /evidence=""ECO:0000250""; DISULFID 1214..1232;  /evidence=""ECO:0000250""; DISULFID 1234..1243;  /evidence=""ECO:0000250""; DISULFID 1250..1261;  /evidence=""ECO:0000250""; DISULFID 1255..1275;  /evidence=""ECO:0000250""; DISULFID 1277..1286;  /evidence=""ECO:0000250""; DISULFID 1293..1304;  /evidence=""ECO:0000250""; DISULFID 1298..1313;  /evidence=""ECO:0000250""; DISULFID 1315..1324;  /evidence=""ECO:0000250""; DISULFID 1339..1350;  /evidence=""ECO:0000250""; DISULFID 1344..1361;  /evidence=""ECO:0000250""; DISULFID 1363..1372;  /evidence=""ECO:0000250""; DISULFID 1387..1410;  /evidence=""ECO:0000250""; DISULFID 1392..1405;  /evidence=""ECO:0000250""; DISULFID 1401..1417;  /evidence=""ECO:0000250""; DISULFID 1428..1451;  /evidence=""ECO:0000250""; DISULFID 1433..1446;  /evidence=""ECO:0000250""; DISULFID 1442..1458;  /evidence=""ECO:0000250""; DISULFID 1467..1493;  /evidence=""ECO:0000250""; DISULFID 1475..1488;  /evidence=""ECO:0000250""; DISULFID 1484..1500;  /evidence=""ECO:0000250""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
Q9Y624,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),MGTKAQVERKLLCLFILAILLCSLALGSVTVHSSEPEVRIPENNPVKLSCAYSGFSSPRVEWKFDQGDTTRLVCYNNKITASYEDRVTFLPTGITFKSVTREDTGTYTCMVSEEGGNSYGEVKVKLIVLVPPSKPTVNIPSSATIGNRAVLTCSEQDGSPPSEYTWFKDGIVMPTNPKSTRAFSNSSYVLNPTTGELVFDPLSASDTGEYSCEARNGYGTPMTSNAVRMEAVERNVGVIVAAVLVTLILLGILVFGIWFAYSRGHFDRTKKGTSSKKVIYSQPSARSEGEFKQTSSFLV,299,"32,583",Alternative sequence (1); Beta strand (20); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Helix (2); Modified residue (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 50..109;  /evidence=""ECO:0000269|PubMed:12697893""; DISULFID 153..212;  /evidence=""ECO:0000269|PubMed:12697893""","SIGNAL 1..27;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801, ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:7646439"""
O14931,Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein) (NK-p30) (NKp30) (CD antigen CD337),MAWMLLLILIMVHPGSCALWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGKEVRNGTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTGNGTRLVVEKEHPQLGAGTVLLLRAGFYAVSFLSVAVGSTVYYQGKCLTWKGPRRQLPAVVPAPLPPPCGSSAHLLPPVPGG,201,"21,593",Alternative sequence (3); Beta strand (7); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Helix (4); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 39..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21422170, ECO:0000269|PubMed:21444796""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q14957,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",MGGALGPALLLTSLFGAWAGLGPGQGEQGMTVAVVFSSSGPPQAQFRARLTPQSFLDLPLEIQPLTVGVNTTNPSSLLTQICGLLGAAHVHGIVFEDNVDTEAVAQILDFISSQTHVPILSISGGSAVVLTPKEPGSAFLQLGVSLEQQLQVLFKVLEEYDWSAFAVITSLHPGHALFLEGVRAVADASHVSWRLLDVVTLELGPGGPRARTQRLLRQLDAPVFVAYCSREEAEVLFAEAAQAGLVGPGHVWLVPNLALGSTDAPPATFPVGLISVVTESWRLSLRQKVRDGVAILALGAHSYWRQHGTLPAPAGDCRVHPGPVSPAREAFYRHLLNVTWEGRDFSFSPGGYLVQPTMVVIALNRHRLWEMVGRWEHGVLYMKYPVWPRYSASLQPVVDSRHLTVATLEERPFVIVESPDPGTGGCVPNTVPCRRQSNHTFSSGDVAPYTKLCCKGFCIDILKKLARVVKFSYDLYLVTNGKHGKRVRGVWNGMIGEVYYKRADMAIGSLTINEERSEIVDFSVPFVETGISVMVARSNGTVSPSAFLEPYSPAVWVMMFVMCLTVVAITVFMFEYFSPVSYNQNLTRGKKSGGPAFTIGKSVWLLWALVFNNSVPIENPRGTTSKIMVLVWAFFAVIFLASYTANLAAFMIQEQYIDTVSGLSDKKFQRPQDQYPPFRFGTVPNGSTERNIRSNYRDMHTHMVKFNQRSVEDALTSLKMGKLDAFIYDAAVLNYMAGKDEGCKLVTIGSGKVFATTGYGIAMQKDSHWKRAIDLALLQFLGDGETQKLETVWLSGICQNEKNEVMSSKLDIDNMAGVFYMLLVAMGLALLVFAWEHLVYWKLRHSVPNSSQLDFLLAFSRGIYSCFSGVQSLASPPRQASPDLTASSAQASVLKMLQAARDMVTTAGVSSSLDRATRTIENWGGGRRAPPPSPCPTPRSGPSPCLPTPDPPPEPSPTGWGPPDGGRAALVRRAPQPPGRPPTPGPPLSDVSRVSRRPAWEARWPVRTGHCGRHLSASERPLSPARCHYSSFPRADRSGRPFLPLFPELEDLPLLGPEQLARREALLHAAWARGSRPRHASLPSSVAEAFARPSSLPAGCTGPACARPDGHSACRRLAQAQSMCLPIYREACQEGEQAGAPAWQHRQHVCLHAHAHLPFCWGAVCPHLPPCASHGSWLSGAWGPLGHRGRTLGLGTGYRDSGGLDEISRVARGTQGFPGPCTWRRISSLESEV,1233,"134,209",Binding site (3); Chain (1); Disulfide bond (4); Glycosylation (6); Intramembrane (1); Modified residue (3); Motif (1); Mutagenesis (1); Natural variant (18); Region (3); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (3),"DISULFID 82..317;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 426..453;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 433..454;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 743..798;  /evidence=""ECO:0000250|UniProtKB:Q00959""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P22897,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),MRLPLLLVFASVIPGAVLLLDTRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSRSQGPEIVEVEKGCRKGWKKHHFYCYMIGHTLSTFAEANQTCNNENAYLTTIEDRYEQAFLTSFVGLRPEKYFWTGLSDIQTKGTFQWTIEEEVRFTHWNSDMPGRKPGCVAMRTGIAGGLWDVLKCDEKAKFVCKHWAEGVTHPPKPTTTPEPKCPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLTYGSPSEGFTWSDGSPVSYENWAYGEPNNYQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQKGQTPKPEPTPAPQDNPPVTEDGWVIYKDYQYYFSKEKETMDNARAFCKRNFGDLVSIQSESEKKFLWKYVNRNDAQSAYFIGLLISLDKKFAWMDGSKVDYVSWATGEPNFANEDENCVTMYSNSGFWNDINCGYPNAFICQRHNSSINATTVMPTMPSVPSGCKEGWNFYSNKCFKIFGFMEEERKNWQEARKACIGFGGNLVSIQNEKEQAFLTYHMKDSTFSAWTGLNDVNSEHTFLWTDGRGVHYTNWGKGYPGGRRSSLSYEDADCVVIIGGASNEAGKWMDDTCDSKRGYICQTRSDPSLTNPPATIQTDGFVKYGKSSYSLMRQKFQWHEAETYCKLHNSLIASILDPYSNAFAWLQMETSNERVWIALNSNLTDNQYTWTDKWRVRYTNWAADEPKLKSACVYLDLDGYWKTAHCNESFYFLCKRSDEIPATEPPQLPGRCPESDHTAWIPFHGHCYYIESSYTRNWGQASLECLRMGSSLVSIESAAESSFLSYRVEPLKSKTNFWIGLFRNVEGTWLWINNSPVSFVNWNTGDPSGERNDCVALHASSGFWSNIHCSSYKGYICKRPKIIDAKPTHELLTTKADTRKMDPSKPSSNVAGVVIIVILLILTGAGLAAYFFYKKRRVHLPQEGAFENTLYFNSQSSPGTSDMKDLVGNIEQNEHSVI,1456,"166,012",Alternative sequence (2); Beta strand (52); Chain (1); Disulfide bond (21); Domain (10); Erroneous gene model prediction (3); Glycosylation (7); Helix (18); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 35..49;  /evidence=""ECO:0000250""; DISULFID 74..91;  /evidence=""ECO:0000250""; DISULFID 168..194;  /evidence=""ECO:0000250""; DISULFID 182..209;  /evidence=""ECO:0000250""; DISULFID 247..340;  /evidence=""ECO:0000250""; DISULFID 316..332;  /evidence=""ECO:0000250""; DISULFID 391..486;  /evidence=""ECO:0000250""; DISULFID 463..478;  /evidence=""ECO:0000250""; DISULFID 532..625;  /evidence=""ECO:0000250""; DISULFID 600..617;  /evidence=""ECO:0000250""; DISULFID 646..659; DISULFID 680..777; DISULFID 753..769; DISULFID 828..922;  /evidence=""ECO:0000250""; DISULFID 899..914;  /evidence=""ECO:0000250""; DISULFID 977..1079;  /evidence=""ECO:0000250""; DISULFID 1052..1071;  /evidence=""ECO:0000250""; DISULFID 1123..1212;  /evidence=""ECO:0000250""; DISULFID 1190..1204;  /evidence=""ECO:0000250""; DISULFID 1263..1355;  /evidence=""ECO:0000250""; DISULFID 1332..1347;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P57103,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),MAWLRLQPLTSAFLHFGLVTFVLFLNGLRAEAGGSGDVPSTGQNNESCSGSSDCKEGVILPIWYPENPSLGDKIARVIVYFVALIYMFLGVSIIADRFMASIEVITSQEREVTIKKPNGETSTTTIRVWNETVSNLTLMALGSSAPEILLSLIEVCGHGFIAGDLGPSTIVGSAAFNMFIIIGICVYVIPDGETRKIKHLRVFFITAAWSIFAYIWLYMILAVFSPGVVQVWEGLLTLFFFPVCVLLAWVADKRLLFYKYMHKKYRTDKHRGIIIETEGDHPKGIEMDGKMMNSHFLDGNLVPLEGKEVDESRREMIRILKDLKQKHPEKDLDQLVEMANYYALSHQQKSRAFYRIQATRMMTGAGNILKKHAAEQAKKASSMSEVHTDEPEDFISKVFFDPCSYQCLENCGAVLLTVVRKGGDMSKTMYVDYKTEDGSANAGADYEFTEGTVVLKPGETQKEFSVGIIDDDIFEEDEHFFVRLSNVRIEEEQPEEGMPPAIFNSLPLPRAVLASPCVATVTILDDDHAGIFTFECDTIHVSESIGVMEVKVLRTSGARGTVIVPFRTVEGTAKGGGEDFEDTYGELEFKNDETVKTIRVKIVDEEEYERQENFFIALGEPKWMERGISALLLSPDVTDRKLTMEEEEAKRIAEMGKPVLGEHPKLEVIIEESYEFKTTVDKLIKKTNLALVVGTHSWRDQFMEAITVSAAGDEDEDESGEERLPSCFDYVMHFLTVFWKVLFACVPPTEYCHGWACFAVSILIIGMLTAIIGDLASHFGCTIGLKDSVTAVVFVAFGTSVPDTFASKAAALQDVYADASIGNVTGSNAVNVFLGIGLAWSVAAIYWALQGQEFHVSAGTLAFSVTLFTIFAFVCISVLLYRRRPHLGGELGGPRGCKLATTWLFVSLWLLYILFATLEAYCYIKGF,927,"103,010",Alternative sequence (7); Chain (1); Domain (2); Glycosylation (2); Metal binding (25); Natural variant (1); Region (1); Repeat (2); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9Y5F8,Protocadherin gamma-B7 (PCDH-gamma-B7),MGGSCAQRRRAGPRQVLFPLLLPLFYPTLCEPIRYSIPEELAKGSVVGNLAKDLGLSVLDVSARELRVSAEKLHFSVDAQSGDLLVKDRIDREQICKERRRCELQLEAVVENPLNIFHVIVVIEDVNDHAPQFRKDEINLEISESVSLGMGTILESAEDPDISMNSLSKYQLSPNEYFSLVEKDNPDGGKYPELVLQKTLDRETQSAHHLVLTALDGGDPPRSGTAQIRILVIDANDNPPVFSQDVYRVSLREDVPPGTSILRVKATDQDEGINSEITYSFFGVADKAQHVFSLDYTTGNILTQQPLDFEEVERYTINIEAKDRGSLSTRCKVIVEVVDENDNSPEIIITSLSDQIMEDSPPGVVVALFKTRDQDSGENGEVRCSLSRGVPFKIHSSSNNYYKLVTDEALDREQTPEYNVTIAATDRGKPPLSSSKTITLHITDVNDNAPVFGQSAYLVHVPENNQPGASIAQVSASDPDFGLNGRVSYSLIASDLESRTLSSYVSVSAQSGVVFAQRAFDHEQLRTFELTLQARDQGSPALSANVSLRVLVGDRNDNAPRVLYPALGPDGSALFDTVPRAAQPGYLVTKVVAVDADSGHNAWLSYHVVQASEPGLFSLGLRTGEVRMVRALGDKDSVRQRLLVAVRDGGQPPLSATATLHLVFADSLQEVLPDFSDHPTPSDSQAEMQFYLVVALALISVLFLLAVILAIALRLRQSFSPTAGDCFESVLCSKSGPVGPPNYSEGTLPYAYNFCVPGDQMNPEFNFFTSVDHCPATQDNLNKDSMLLASILTPSVEADKKILKQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,929,"100,974",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q86YL7,Podoplanin (Aggrus) (Glycoprotein 36) (Gp36) (PA2.26 antigen) (T1-alpha) (T1A) [Cleaved into: 29kDa cytosolic podoplanin intracellular domain (PICD)],MWKVSALLFVLGSASLWVLAEGASTGQPEDDTETTGLEGGVAMPGAEDDVVTPGTSEDRYKSGLTTLVATSVNSVTGIRIEDLPTSESTVHAQEQSPSATASNVATSHSTEKVDGDTQTTVEKDGLSTVTLVGIIVGVLLAIGFIGAIIVVVMRKMSGRYSP,162,"16,698",Alternative sequence (7); Chain (1); Erroneous initiation (5); Glycosylation (24); Mutagenesis (5); Natural variant (2); Peptide (1); Region (2); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:17222411"""
O00592,Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1),MRCALALSALLLLLSTPPLLPSSPSPSPSPSQNATQTTTDSSNKTAPTPASSVTIMATDTAQQSTVPTSKANEILASVKATTLGVSSDSPGTTTLAQQVSGPVNTTVARGGGSGNPTTTIESPKSTKSADTTTVATSTATAKPNTTSSQNGAEDTTNSGGKSSHSVTTDLTSTKAEHLTTPHPTSPLSPRQPTSTHPVATPTSSGHDHLMKISSSSSTVAIPGYTFTSPGMTTTLLETVFHHVSQAGLELLTSGDLPTLASQSAGITASSVISQRTQQTSSQMPASSTAPSSQETVQPTSPATALRTPTLPETMSSSPTAASTTHRYPKTPSPTVAHESNWAKCEDLETQTQSEKQLVLNLTGNTLCAGGASDEKLISLICRAVKATFNPAQDKCGIRLASVPGSQTVVVKEITIHTKLPAKDVYERLKDKWDELKEAGVSDMKLGDQGPPEEAEDRFSMPLIITIVCMASFLLLVAALYGCCHQRLSQRKDQQRLTEELQTVENGYHDNPTLEVMETSSEMQEKKVVSLNGELGDSWIVPLDNLTKDDLDEEEDTHL,558,"58,635",Alternative sequence (1); Chain (1); Compositional bias (1); Glycosylation (5); Modified residue (4); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q92729,Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi),MARAQALVLALTFQLCAPETETPAAGCTFEEASDPAVPCEYSQAQYDDFQWEQVRIHPGTRAPADLPHGSYLMVNTSQHAPGQRAHVIFQSLSENDTHCVQFSYFLYSRDGHSPGTLGVYVRVNGGPLGSAVWNMTGSHGRQWHQAELAVSTFWPNEYQVLFEALISPDRRGYMGLDDILLLSYPCAKAPHFSRLGDVEVNAGQNASFQCMAAGRAAEAERFLLQRQSGALVPAAGVRHISHRRFLATFPLAAVSRAEQDLYRCVSQAPRGAGVSNFAELIVKEPPTPIAPPQLLRAGPTYLIIQLNTNSIIGDGPIVRKEIEYRMARGPWAEVHAVSLQTYKLWHLDPDTEYEISVLLTRPGDGGTGRPGPPLISRTKCAEPMRAPKGLAFAEIQARQLTLQWEPLGYNVTRCHTYTVSLCYHYTLGSSHNQTIRECVKTEQGVSRYTIKNLLPYRNVHVRLVLTNPEGRKEGKEVTFQTDEDVPSGIAAESLTFTPLEDMIFLKWEEPQEPNGLITQYEISYQSIESSDPAVNVPGPRRTISKLRNETYHVFSNLHPGTTYLFSVRARTGKGFGQAALTEITTNISAPSFDYADMPSPLGESENTITVLLRPAQGRGAPISVYQVIVEEERARRLRREPGGQDCFPVPLTFEAALARGLVHYFGAELAASSLPEAMPFTVGDNQTYRGFWNPPLEPRKAYLIYFQAASHLKGETRLNCIRIARKAACKESKRPLEVSQRSEEMGLILGICAGGLAVLILLLGAIIVIIRKGRDHYAYSYYPKPVNMTKATVNYRQEKTHMMSAVDRSFTDQSTLQEDERLGLSFMDTHGYSTRGDQRSGGVTEASSLLGGSPRRPCGRKGSPYHTGQLHPAVRVADLLQHINQMKTAEGYGFKQEYESFFEGWDATKKKDKVKGSRQEPMPAYDRHRVKLHPMLGDPNADYINANYIDGYHRSNHFIATQGPKPEMVYDFWRMVWQEHCSSIVMITKLVEVGRVKCSRYWPEDSDTYGDIKIMLVKTETLAEYVVRTFALERRGYSARHEVRQFHFTAWPEHGVPYHATGLLAFIRRVKASTPPDAGPIVIHCSAGTGRTGCYIVLDVMLDMAECEGVVDIYNCVKTLCSRRVNMIQTEEQYIFIHDAILEACLCGETTIPVSEFKATYKEMIRIDPQSNSSQLREEFQTLNSVTPPLDVEECSIALLPRNRDKNRSMDVLPPDRCLPFLISTDGDSNNYINAALTDSYTRSAAFIVTLHPLQSTTPDFWRLVYDYGCTSIVMLNQLNQSNSAWPCLQYWPEPGRQQYGLMEVEFMSGTADEDLVARVFRVQNISRLQEGHLLVRHFQFLRWSAYRDTPDSKKAFLHLLAEVDKWQAESGDGRTIVHCLNGGGRSGTFCACATVLEMIRCHNLVDVFFAAKTLRNYKPNMVETMDQYHFCYDVALEYLEGLESR,1446,"162,423",Active site (2); Alternative sequence (4); Beta strand (12); Binding site (2); Chain (1); Disulfide bond (1); Domain (8); Glycosylation (3); Helix (8); Modified residue (4); Mutagenesis (2); Natural variant (6); Region (2); Sequence caution (2); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 210..264;  /evidence=""ECO:0000255""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P18084,Integrin beta-5,MPRAPAPLYACLLGLCALLPRLAGLNICTSGSATSCEECLLIHPKCAWCSKEDFGSPRSITSRCDLRANLVKNGCGGEIESPASSFHVLRSLPLSSKGSGSAGWDVIQMTPQEIAVNLRPGDKTTFQLQVRQVEDYPVDLYYLMDLSLSMKDDLDNIRSLGTKLAEEMRKLTSNFRLGFGSFVDKDISPFSYTAPRYQTNPCIGYKLFPNCVPSFGFRHLLPLTDRVDSFNEEVRKQRVSRNRDAPEGGFDAVLQAAVCKEKIGWRKDALHLLVFTTDDVPHIALDGKLGGLVQPHDGQCHLNEANEYTASNQMDYPSLALLGEKLAENNINLIFAVTKNHYMLYKNFTALIPGTTVEILDGDSKNIIQLIINAYNSIRSKVELSVWDQPEDLNLFFTATCQDGVSYPGQRKCEGLKIGDTASFEVSLEARSCPSRHTEHVFALRPVGFRDSLEVGVTYNCTCGCSVGLEPNSARCNGSGTYVCGLCECSPGYLGTRCECQDGENQSVYQNLCREAEGKPLCSGRGDCSCNQCSCFESEFGKIYGPFCECDNFSCARNKGVLCSGHGECHCGECKCHAGYIGDNCNCSTDISTCRGRDGQICSERGHCLCGQCQCTEPGAFGEMCEKCPTCPDACSTKRDCVECLLLHSGKPDNQTCHSLCRDEVITWVDTIVKDDQEAVLCFYKTAKDCVMMFTYVELPSGKSNLTVLREPECGNTPNAMTILLAVVGSILLVGLALLAIWKLLVTIHDRREFAKFQSERSRARYEMASNPLYRKPISTHTVDFTFNKFNKSYNGTVD,799,"88,054",Chain (1); Disulfide bond (28); Domain (2); Glycosylation (8); Modified residue (1); Natural variant (3); Region (1); Repeat (4); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 28..463;  /evidence=""ECO:0000250""; DISULFID 36..46;  /evidence=""ECO:0000250""; DISULFID 39..75;  /evidence=""ECO:0000250""; DISULFID 49..64;  /evidence=""ECO:0000250""; DISULFID 202..211;  /evidence=""ECO:0000250""; DISULFID 259..300;  /evidence=""ECO:0000250""; DISULFID 401..413;  /evidence=""ECO:0000250""; DISULFID 433..682;  /evidence=""ECO:0000250""; DISULFID 461..465;  /evidence=""ECO:0000250""; DISULFID 476..487;  /evidence=""ECO:0000250""; DISULFID 484..522;  /evidence=""ECO:0000250""; DISULFID 489..498;  /evidence=""ECO:0000250""; DISULFID 500..513;  /evidence=""ECO:0000250""; DISULFID 528..533;  /evidence=""ECO:0000250""; DISULFID 530..563;  /evidence=""ECO:0000250""; DISULFID 535..548;  /evidence=""ECO:0000250""; DISULFID 550..555;  /evidence=""ECO:0000250""; DISULFID 569..574;  /evidence=""ECO:0000250""; DISULFID 571..602;  /evidence=""ECO:0000250""; DISULFID 576..585;  /evidence=""ECO:0000250""; DISULFID 587..594;  /evidence=""ECO:0000250""; DISULFID 608..613;  /evidence=""ECO:0000250""; DISULFID 610..657;  /evidence=""ECO:0000250""; DISULFID 615..625;  /evidence=""ECO:0000250""; DISULFID 628..631;  /evidence=""ECO:0000250""; DISULFID 635..644;  /evidence=""ECO:0000250""; DISULFID 641..714;  /evidence=""ECO:0000250""; DISULFID 661..690;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9Y5H2,Protocadherin gamma-A11 (PCDH-gamma-A11),MANRLQRGDRSRLLLLLCIFLGTLRGFRARQIRYSVPEETEKGSFVGNISKDLGLEPRELAKRGVRIVSRGKTQLFAVNPRSGSLITAGRIDREELCETVSSCFLNMELLVEDTLKIYGVEVEIIDINDNAPSFQEDEVEIKVSEHAIPGARFALPNARDPDVGVNSLQSYQLSPNNYFSLQLRGRTDGAKNPELVLEGSLDREKEAAHLLLLTALDGGDPIRKGAVPIRVVVLDVNDHIPMFTQSVYRVSVPENISSGTRVLMVNATDPDEGINGEVMYSFRNMESKASEIFQLDSQTGEVQVRGSLDFEKYRFYEMEIQGQDGGGLFTTTTMLITVVDVNDNAPEITITSSINSILENSPPGTVIALLNVQDQDSGENGQVSCFIPNHLPFKLEKTYGNYYKLITSRVLDRELVQSYNITLTATDQGSPPLSAETHVWLNVADDNDNPPVFPHSSYSAYIPENNPRGASIFSVTALDPDSKQNALVTYSLTDDTVQGVPLSSYVSINSNTGVLYALQSFDYEQFRDLELRVIARDSGDPPLSSNVSLSLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDKDSGQNAWLSYRLLKASEPGLFAVGEHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADSIPEVLADLGSLESLANSETSDLSLYLVVAVAAVSCIFLVFVIVLLALRLWRWHKSRLLQASEGGLAGMPTSHFVGVDGVQAFLQTYSHEVSLIADSQKSHLIFPQPNYGDTLISQESCEKSEPLLIAEDSAIILGKCDPTSNQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,935,"101,543",Alternative sequence (3); Chain (1); Domain (6); Glycosylation (5); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q16620,BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B),MSSWIRWHGPAMARLWGFCWLVVGFWRAAFACPTSCKCSASRIWCSDPSPGIVAFPRLEPNSVDPENITEIFIANQKRLEIINEDDVEAYVGLRNLTIVDSGLKFVAHKAFLKNSNLQHINFTRNKLTSLSRKHFRHLDLSELILVGNPFTCSCDIMWIKTLQEAKSSPDTQDLYCLNESSKNIPLANLQIPNCGLPSANLAAPNLTVEEGKSITLSCSVAGDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNPKPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYGTAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTPSSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG,822,"91,999",Active site (1); Alternative sequence (8); Beta strand (21); Binding site (1); Chain (1); Disulfide bond (6); Domain (5); Glycosylation (11); Helix (17); Modified residue (5); Natural variant (11); Nucleotide binding (1); Region (1); Repeat (2); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 32..38;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:7574684""; DISULFID 36..45;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:7574684""; DISULFID 152..176;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:7574684""; DISULFID 154..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:7574684""; DISULFID 218..266;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:7574684""; DISULFID 302..345;  /evidence=""ECO:0000244|PDB:1HCF, ECO:0000244|PDB:1WWB, ECO:0000244|PDB:5MO9, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10388563, ECO:0000269|PubMed:11738045, ECO:0000269|PubMed:7574684""",SIGNAL 1..31
P48357,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295),MICQKFCVVLLHWEFIYVITAFNLSYPITPWRFKLSCMPPNSTYDYFLLPAGLSKNTSNSNGHYETAVEPKFNSSGTHFSNLSKTTFHCCFRSEQDRNCSLCADNIEGKTFVSTVNSLVFQQIDANWNIQCWLKGDLKLFICYVESLFKNLFRNYNYKVHLLYVLPEVLEDSPLVPQKGSFQMVHCNCSVHECCECLVPVPTAKLNDTLLMCLKITSGGVIFQSPLMSVQPINMVKPDPPLGLHMEITDDGNLKISWSSPPLVPFPLQYQVKYSENSTTVIREADKIVSATSLLVDSILPGSSYEVQVRGKRLDGPGIWSDWSTPRVFTTQDVIYFPPKILTSVGSNVSFHCIYKKENKIVPSKEIVWWMNLAEKIPQSQYDVVSDHVSKVTFFNLNETKPRGKFTYDAVYCCNEHECHHRYAELYVIDVNINISCETDGYLTKMTCRWSTSTIQSLAESTLQLRYHRSSLYCSDIPSIHPISEPKDCYLQSDGFYECIFQPIFLLSGYTMWIRINHSLGSLDSPPTCVLPDSVVKPLPPSSVKAEITINIGLLKISWEKPVFPENNLQFQIRYGLSGKEVQWKMYEVYDAKSKSVSLPVPDLCAVYAVQVRCKRLDGLGYWSNWSNPAYTVVMDIKVPMRGPEFWRIINGDTMKKEKNVTLLWKPLMKNDSLCSVQRYVINHHTSCNGTWSEDVGNHTKFTFLWTEQAHTVTVLAINSIGASVANFNLTFSWPMSKVNIVQSLSAYPLNSSCVIVSWILSPSDYKLMYFIIEWKNLNEDGEIKWLRISSSVKKYYIHDHFIPIEKYQFSLYPIFMEGVGKPKIINSFTQDDIEKHQSDAGLYVIVPVIISSSILLLGTLLISHQRMKKLFWEDVPNPKNCSWAQGLNFQKPETFEHLFIKHTASVTCGPLLLEPETISEDISVDTSWKNKDEMMPTTVVSLLSTTDLEKGSVCISDQFNSVNFSEAEGTEVTYEDESQRQPFVKYATLISNSKPSETGEEQGLINSSVTKCFSSKNSPLKDSFSNSSWEIEAQAFFILSDQHPNIISPHLTFSEGLDELLKLEGNFPEENNDKKSIYYLGVTSIKKRESGVLLTDKSRVSCPFPAPCLFTDIRVLQDSCSHFVENNINLGTSSKKTFASYMPQFQTCSTQTHKIMENKMCDLTV,1165,"132,494",Alternative sequence (7); Beta strand (15); Chain (1); Disulfide bond (10); Domain (5); Glycosylation (18); Helix (2); Modified residue (4); Motif (2); Mutagenesis (3); Natural variant (11); Region (3); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 37..90;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 89..99;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 131..142;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 186..196;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 188..193;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 352..412;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 413..418;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 436..447;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 473..528;  /evidence=""ECO:0000269|PubMed:22405007""; DISULFID 488..498;  /evidence=""ECO:0000269|PubMed:22405007""",SIGNAL 1..21
Q2M385,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2),MNNFRATILFWAAAAWAKSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLLVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSGGAAAGVTVGVTTILAVVITLAIYGTRKFKKKAYQAIEERQSLVPGTAATGDTTYQEQGQSPA,716,"78,587",Beta strand (35); Chain (1); Domain (1); Erroneous initiation (1); Glycosylation (4); Helix (13); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9H195,Mucin-3B (MUC-3B) (Intestinal mucin-3B) (Fragments),MQLLGLLSILWMLKSSPGATGTLSTATSTSHVTFPRAEATRTALSNSPHSRYLAEWPQGVPQLASPAPGHRENAPMTLTTSPHDTLISETLLSSLVSSNTSTTPTSKFAFKVETTPPTVLVYSATTECVYPTSFIITISHSTSICVTTTQVTFTSSYTPTPVTQKPVTTVTRTYPMTTTEKGTSAMISSPSTTTARETPIVTVTPSSSVSATDTTFHTTISSTTRTTERTPLPTGSIHTTMSPTPVFTTLKTAVTSTSPITSTITSTNTVTSMTTTTSRPTATNTLSSLTSSILSSTPAPNTEVITSHTTTTTPPSTLVTTLPTAIARSTPTSETTPSFMSSIITTETTSHSTPSFSSSTIHSTVSSSTTAITSPFTTAETGVTSTPSSPSSLSTDIPTTSLRTLTPLSLSTSTSLTTTTDLPSIPTDISSLPTPIHIISSSPSIQSTETSSLVGTTSPTMSTVRATLRSTENTPISSFSTSIVVTPETPTTQAPPVLMSATGTQTSPVPTTVTFGSMDSSTSTLHTLTPSTALSKIMSTSQFPIPSTHSSTLQTTPSIPSLQTSLTSTSEFTTESFTRGSTSTNAILTSFSTIIWSSTPTIIMSSSPSSASITPVFATTIHSVPSSPYIFSTENVGSASITAFPSLSSSSTTSTSPTSSSLTTALTEITPFSYISLPSTTPCPGTITITIVPASPTDPCVEMDPSTEATSPPTTPLTVFPFTTEMVTCPSSISMQTTLATHMDTSSMTPESESSIIPNASSSTGTGTVPTNTVFTSTRLPTSETWLSNNSVIPTPLPGVSTIPLTMKPSSSLPTILRTSSKSTHPSPPTARTSQTSVATTQTPTTLTTCRTTPITSWMTTQSTLTTTAGTCDNGGTWEQGQCACLPGFSGDRCQLQTRCQNGGQWDGLKCQCPSTFYGSSCEFAVEQVDLDVVETEVGMEVSVDQQFSPDLNDNTSQAYRDFNKTFWNQMQKIFADMQGFTFKGVEILSLRNGSIVVDYLVLLEMPFSPQLESEYEQVKTTLKEGLQNASQDANSCQDSQALCFKPDSIKVNNNSKTELTPEAICRRAAPTGYEEFYFPLVEATRLRCVTKCTSGLDNAIDCHQGQCVLETSGPACRCYSTDTHWFSGPRCEVTVHWRALVGGLTAGAALLVLLLLALGVRAVRSEWWGRQRRGRSWDQDRKWFETWDEEVVGTFSNWGFEDDGTDKDTNFHVALENVDTTMKVHIKRPEMTSSSV,1237,"131,402",Chain (1); Compositional bias (4); Disulfide bond (2); Domain (2); Natural variant (2); Non-adjacent residues (1); Sequence conflict (23); Signal peptide (1); Transmembrane (1),"DISULFID 894..900;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 913..922;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
O00533,Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein],MEPLLLGRGLIVYLMFLLLKFSKAIEIPSSVQQVPTIIKQSKVQVAFPFDEYFQIECEAKGNPEPTFSWTKDGNPFYFTDHRIIPSNNSGTFRIPNEGHISHFQGKYRCFASNKLGIAMSEEIEFIVPSVPKFPKEKIDPLEVEEGDPIVLPCNPPKGLPPLHIYWMNIELEHIEQDERVYMSQKGDLYFANVEEKDSRNDYCCFAAFPRLRTIVQKMPMKLTVNSSNSIKQRKPKLLLPPTESGSESSITILKGEILLLECFAEGLPTPQVDWNKIGGDLPKGRETKENYGKTLKIENVSYQDKGNYRCTASNFLGTATHDFHVIVEEPPRWTKKPQSAVYSTGSNGILLCEAEGEPQPTIKWRVNGSPVDNHPFAGDVVFPREISFTNLQPNHTAVYQCEASNVHGTILANANIDVVDVRPLIQTKDGENYATVVGYSAFLHCEFFASPEAVVSWQKVEEVKPLEGRRYHIYENGTLQINRTTEEDAGSYSCWVENAIGKTAVTANLDIRNATKLRVSPKNPRIPKLHMLELHCESKCDSHLKHSLKLSWSKDGEAFEINGTEDGRIIIDGANLTISNVTLEDQGIYCCSAHTALDSAADITQVTVLDVPDPPENLHLSERQNRSVRLTWEAGADHNSNISEYIVEFEGNKEEPGRWEELTRVQGKKTTVILPLAPFVRYQFRVIAVNEVGRSQPSQPSDHHETPPAAPDRNPQNIRVQASQPKEMIIKWEPLKSMEQNGPGLEYRVTWKPQGAPVEWEEETVTNHTLRVMTPAVYAPYDVKVQAINQLGSGPDPQSVTLYSGEDYPDTAPVIHGVDVINSTLVKVTWSTVPKDRVHGRLKGYQINWWKTKSLLDGRTHPKEVNILRFSGQRNSGMVPSLDAFSEFHLTVLAYNSKGAGPESEPYIFQTPEGVPEQPTFLKVIKVDKDTATLSWGLPKKLNGNLTGYLLQYQIINDTYEIGELNDINITTPSKPSWHLSNLNATTKYKFYLRACTSQGCGKPITEESSTLGEGSKGIGKISGVNLTQKTHPIEVFEPGAEHIVRLMTKNWGDNDSIFQDVIETRGREYAGLYDDISTQGWFIGLMCAIALLTLLLLTVCFVKRNRGGKYSVKEKEDLHPDPEIQSVKDETFGEYSDSDEKPLKGSLRSLNRDMQPTESADSLVEYGEGDHGLFSEDGSFIGAYAGSKEKGSVESNGSSTATFPLRA,1208,"135,071",Alternative sequence (1); Chain (2); Disulfide bond (6); Domain (10); Erroneous initiation (1); Glycosylation (10); Modified residue (3); Motif (2); Natural variant (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),"DISULFID 57..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 153..204;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 262..310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 352..401;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 445..494;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 536..591;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q16549,Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7),MPKGRQKVPHLDAPLGLPTCLWLELAGLFLLVPWVMGLAGTGGPDGQGTGGPSWAVHLESLEGDGEEETLEQQADALAQAAGLVNAGRIGELQGHYLFVQPAGHRPALEVEAIRQQVEAVLAGHEAVRWHSEQRLLRRAKRSVHFNDPKYPQQWHLNNRRSPGRDINVTGVWERNVTGRGVTVVVVDDGVEHTIQDIAPNYSPEGSYDLNSNDPDPMPHPDVENGNHHGTRCAGEIAAVPNNSFCAVGVAYGSRIAGIRVLDGPLTDSMEAVAFNKHYQINDIYSCSWGPDDDGKTVDGPHQLGKAALQHGVIAGRQGFGSIFVVASGNGGQHNDNCNYDGYANSIYTVTIGAVDEEGRMPFYAEECASMLAVTFSGGDKMLRSIVTTDWDLQKGTGCTEGHTGTSAAAPLAAGMIALMLQVRPCLTWRDVQHIIVFTATRYEDRRAEWVTNEAGFSHSHQHGFGLLNAWRLVNAAKIWTSVPYLASYVSPVLKENKAIPQSPRSLEVLWNVSRMDLEMSGLKTLEHVAVTVSITHPRRGSLELKLFCPSGMMSLIGAPRSMDSDPNGFNDWTFSTVRCWGERARGTYRLVIRDVGDESFQVGILRQWQLTLYGSVWSAVDIRDRQRLLESAMSGKYLHDDFALPCPPGLKIPEEDGYTITPNTLKTLVLVGCFTVFWTVYYMLEVYLSQRNVASNQVCRSGPCHWPHRSRKAKEEGTELESVPLCSSKDPDEVETESRGPPTTSDLLAPDLLEQGDWSLSQNKSALDCPHQHLDVPHGKEEQIC,785,"86,247",Active site (3); Chain (1); Domain (2); Glycosylation (4); Natural variant (5); Propeptide (1); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..37;  /evidence=""ECO:0000250"""
A6NMS7,Leucine-rich repeat-containing protein 37A,MSSAQCPALVCVMSRLRFWGPWPLLMWQLLWLLVKEAQPLEWVKDPLQLTSNPLGPPESWSSHSSHFPRESPHAPTLPADPWDFDHLGPSASSEMPAPPQESTENLVPFLDTWDSAGEQPLEPEQFLASQQDLKDKLSPQERLPVSPKKLKKDPAQRWSLAEIIGITRQLSTPQSQKQTLQNEYSSTDTPYPGSLPPELRVKSDEPPGPSEQVGPSQFHLEPETQNPETLEDIQSSSLQQEAPAQLPQLLEEEPSSMQQEAPALPPESSMESLTLPNHEVSVQPPGEDQAYYHLPNITVKPADVEVTITSEPTNETESSQAQQETPIQFPEEVEPSATQQEAPIEPPVPPMEHELSISEQQQPVQPSESPREVESSPTQQETPGQPPEHHEVTVSPPGHHQTHHLASPSVSVKPPDVQLTIAAEPSAEVGTSLVHQEATTRLSGSGNDVEPPAIQHGGPPLLPESSEEAGPLAVQQETSFQSPEPINNENPSPTQQEAAAEHPQTAEEGESSLTHQEAPAQTPEFPNVVVAQPPEHSHLTQATVQPLDLGFTITPESKTEVELSPTMKETPTQPPKKVVPQLRVYQGVTNPTPGQDQAQHPVSPSVTVQLLDLGLTITPEPTTEVGHSTPPKRTIVSPKHPEVTLPHPDQVQTQHSHLTRATVQPLDLGFTITPKSMTEVEPSTALMTTAPPPGHPEVTLPPSDKGQAQHSHLTQATVQPLDLELTITTKPTTEVKPSPTTEETSTQPPDLGLAIIPEPTTETGHSTALEKTTAPRPDRVQTLHRSLTEVTGPPTELEPAQDSLVQSESYTQNKALTAPEEHKASTSTNICELCTCGDEMLSCIDLNPEQRLRQVPVPEPNTHNGTFTILNFQGNYISYIDGNVWKAYSWTEKLILRENNLTELHKDSFEGLLSLQYLDLSCNKIQSIERHTFEPLPFLKFINLSCNVITELSFGTFQAWHGMQFLHKLILNHNPLTTVEDPYLFKLPALKYLDMGTTLVPLTTLKNILMMTVELEKLILPSHMACCLCQFKNSIEAVCKTVKLHCNSACLTNTTHCPEEASVGNPEGAFMKVLQARKNYTSTELIVEPEEPSDSSGINLSGFGSEQLDTNDESDFISTLSYILPYFSAVNLDVKSLLLPFIKLPTTGNSLAKIQTVGQNRQRVKRVLMGPRSIQKRHFKEVGRQSIRREQGAQASVENAAEEKRLTSPAPREVEQPHTQQGPEKLAGNAVYTKPSFTQEHKAAVSVLKPFSKGTPSTSSPAKALPQVRDRSKDLTHAISILESAKARVTNTKTSKPIVHARKKYRFHKTRSHVTHRTTKVKKSPKVRKKSYLSRLMLANRLPFSAAKSLINSPSQGAFSSLGDLSPQENPFLEVSALSEHFIEKNNTKHTTARNAFEENDFMENTNMPEGTISENTNYNHPPEADSAGTAFNLGPTVKQTETKWEYNNVGTDLSPEPKSFNYPLLSSPGDQFEIQLTQQLQSLIPNNNVRRLIAHVIRTLKMDCSGAHVQVTCAKLISRTGHLMKLLSGQQEVKASKIEWDTDQWKIENYINESTEAQSEQKEKSLELKKEVPGYGYTDKLILALIVTGILTILIILFCLIVICCHRRSLQEDEEGFSRGIFRFLPWRGCSSRRESQDGLSSFGQPLWFKDLYKPLSATRINNHAWKLHKKSSNEDKILNRDPGDSEAPTEEEESEALP,1700,"188,258",Chain (1); Frameshift (1); Glycosylation (2); Repeat (5); Sequence conflict (26); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q8N967,Leucine-rich repeat and transmembrane domain-containing protein 2,MLAPGSSPGQRGRLALQWRQVSWITCWIALYAVEALPTCPFSCKCDSRSLEVDCSGLGLTTVPPDVPAATRTLLLLNNKLSALPSWAFANLSSLQRLDLSNNFLDRLPRSIFGDLTNLTELQLRNNSIRTLDRDLLRHSPLLRHLDLSINGLAQLPPGLFDGLLALRSLSLRSNRLQNLDRLTFEPLANLQLLQVGDNPWECDCNLREFKHWMEWFSYRGGRLDQLACTLPKELRGKDMRMVPMEMFNYCSQLEDENSSAGLDIPGPPCTKASPEPAKPKPGAEPEPEPSTACPQKQRHRPASVRRAMGTVIIAGVVCGVVCIMMVVAAAYGCIYASLMAKYHRELKKRQPLMGDPEGEHEDQKQISSVA,370,"41,158",Chain (1); Domain (2); Glycosylation (4); Natural variant (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q14703,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),MKLVNIWLLLLVVLLCGKKHLGDRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTAKARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSSRPLRRASLSLGSGFWHATGRHSSRRLLRAIPRQVAQTLQADVLWQMGYTGANVRVAVFDTGLSEKHPHFKNVKERTNWTNERTLDDGLGHGTFVAGVIASMRECQGFAPDAELHIFRVFTNNQVSYTSWFLDAFNYAILKKIDVLNLSIGGPDFMDHPFVDKVWELTANNVIMVSAIGNDGPLYGTLNNPADQMDVIGVGGIDFEDNIARFSSRGMTTWELPGGYGRMKPDIVTYGAGVRGSGVKGGCRALSGTSVASPVVAGAVTLLVSTVQKRELVNPASMKQALIASARRLPGVNMFEQGHGKLDLLRAYQILNSYKPQASLSPSYIDLTECPYMWPYCSQPIYYGGMPTVVNVTILNGMGVTGRIVDKPDWQPYLPQNGDNIEVAFSYSSVLWPWSGYLAISISVTKKAASWEGIAQGHVMITVASPAETESKNGAEQTSTVKLPIKVKIIPTPPRSKRVLWDQYHNLRYPPGYFPRDNLRMKNDPLDWNGDHIHTNFRDMYQHLRSMGYFVEVLGAPFTCFDASQYGTLLMVDSEEEYFPEEIAKLRRDVDNGLSLVIFSDWYNTSVMRKVKFYDENTRQWWMPDTGGANIPALNELLSVWNMGFSDGLYEGEFTLANHDMYYASGCSIAKFPEDGVVITQTFKDQGLEVLKQETAVVENVPILGLYQIPAEGGGRIVLYGDSNCLDDSHRQKDCFWLLDALLQYTSYGVTPPSLSHSGNRQRPPSGAGSVTPERMEGNHLHRYSKVLEAHLGDPKPRPLPACPRLSWAKPQPLNETAPSNLWKHQKLLSIDLDKVVLPNFRSNRPQVRPLSPGESGAWDIPGGIMPGRYNQEVGQTIPVFAFLGAMVVLAFFVVQINKAKSRPKRRKPRVKRPQLMQQVHPPKTPSV,1052,"117,749",Active site (3); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (1); Glycosylation (5); Modified residue (1); Mutagenesis (2); Natural variant (3); Propeptide (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,SIGNAL 1..17
Q29980,MHC class I polypeptide-related sequence B (MIC-B),MGLGRVLLFLAVAFPFAPPAAAAEPHSLRYNLMVLSQDGSVQSGFLAEGHLDGQPFLRYDRQKRRAKPQGQWAENVLGAKTWDTETEDLTENGQDLRRTLTHIKDQKGGLHSLQEIRVCEIHEDSSTRGSRHFYYDGELFLSQNLETQESTVPQSSRAQTLAMNVTNFWKEDAMKTKTHYRAMQADCLQKLQRYLKSGVAIRRTVPPMVNVTCSEVSEGNITVTCRASSFYPRNITLTWRQDGVSLSHNTQQWGDVLPDGNGTYQTWVATRIRQGEEQRFTCYMEHSGNHGTHPVPSGKALVLQSQRTDFPYVSAAMPCFVIIIILCVPCCKKKTSAAEGPELVSLQVLDQHPVGTGDHRDAAQLGFQPLMSATGSTGSTEGT,383,"42,575",Alternative sequence (3); Beta strand (16); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (6); Natural variant (15); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 119..187;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12133964""; DISULFID 225..282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12133964""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q5VY43,Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12),MSPPLCPLLLLAVGLRLAGTLNPSDPNTCSFWESFTTTTKESHSRPFSLLPSEPCERPWEGPHTCPQPTVVYRTVYRQVVKTDHRQRLQCCHGFYESRGFCVPLCAQECVHGRCVAPNQCQCVPGWRGDDCSSECAPGMWGPQCDKPCSCGNNSSCDPKSGVCSCPSGLQPPNCLQPCTPGYYGPACQFRCQCHGAPCDPQTGACFCPAERTGPSCDVSCSQGTSGFFCPSTHSCQNGGVFQTPQGSCSCPPGWMGTICSLPCPEGFHGPNCSQECRCHNGGLCDRFTGQCRCAPGYTGDRCREECPVGRFGQDCAETCDCAPDARCFPANGACLCEHGFTGDRCTDRLCPDGFYGLSCQAPCTCDREHSLSCHPMNGECSCLPGWAGLHCNESCPQDTHGPGCQEHCLCLHGGVCQATSGLCQCAPGYTGPHCASLCPPDTYGVNCSARCSCENAIACSPIDGECVCKEGWQRGNCSVPCPPGTWGFSCNASCQCAHEAVCSPQTGACTCTPGWHGAHCQLPCPKGQFGEGCASRCDCDHSDGCDPVHGRCQCQAGWMGARCHLSCPEGLWGVNCSNTCTCKNGGTCLPENGNCVCAPGFRGPSCQRSCQPGRYGKRCVPCKCANHSFCHPSNGTCYCLAGWTGPDCSQPCPPGHWGENCAQTCQCHHGGTCHPQDGSCICPLGWTGHHCLEGCPLGTFGANCSQPCQCGPGEKCHPETGACVCPPGHSGAPCRIGIQEPFTVMPTTPVAYNSLGAVIGIAVLGSLVVALVALFIGYRHWQKGKEHHHLAVAYSSGRLDGSEYVMPDVPPSYSHYYSNPSYHTLSQCSPNPPPPNKVPGPLFASLQNPERPGGAQGHDNHTTLPADWKHRREPPPGPLDRGSSRLDRSYSYSYSNGPGPFYNKGLISEEELGASVASLSSENPYATIRDLPSLPGGPRESSYMEMKGPPSGSPPRQPPQFWDSQRRRQPQPQRDSGTYEQPSPLIHDRDSVGSQPPLPPGLPPGHYDSPKNSHIPGHYDLPPVRHPPSPPLRRQDR,1037,"110,666",Chain (1); Compositional bias (1); Disulfide bond (29); Domain (10); Frameshift (1); Glycosylation (5); Modified residue (3); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 29..91;  /evidence=""ECO:0000255""; DISULFID 55..65;  /evidence=""ECO:0000255""; DISULFID 90..101;  /evidence=""ECO:0000255""; DISULFID 105..114;  /evidence=""ECO:0000250""; DISULFID 109..120;  /evidence=""ECO:0000250""; DISULFID 122..131;  /evidence=""ECO:0000250""; DISULFID 235..248;  /evidence=""ECO:0000250""; DISULFID 250..259;  /evidence=""ECO:0000250""; DISULFID 272..284;  /evidence=""ECO:0000250""; DISULFID 278..291;  /evidence=""ECO:0000250""; DISULFID 293..302;  /evidence=""ECO:0000250""; DISULFID 315..327;  /evidence=""ECO:0000250""; DISULFID 321..334;  /evidence=""ECO:0000250""; DISULFID 336..345;  /evidence=""ECO:0000250""; DISULFID 404..416;  /evidence=""ECO:0000250""; DISULFID 410..423;  /evidence=""ECO:0000250""; DISULFID 425..434;  /evidence=""ECO:0000250""; DISULFID 490..502;  /evidence=""ECO:0000250""; DISULFID 496..509;  /evidence=""ECO:0000250""; DISULFID 511..520;  /evidence=""ECO:0000250""; DISULFID 580..588;  /evidence=""ECO:0000250""; DISULFID 582..595;  /evidence=""ECO:0000250""; DISULFID 597..606;  /evidence=""ECO:0000250""; DISULFID 619..630;  /evidence=""ECO:0000250""; DISULFID 624..637;  /evidence=""ECO:0000250""; DISULFID 639..648;  /evidence=""ECO:0000250""; DISULFID 661..673;  /evidence=""ECO:0000250""; DISULFID 667..680;  /evidence=""ECO:0000250""; DISULFID 682..691;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8TEM1,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),MAARGRGLLLLTLSVLLAAGPSAAAAKLNIPKVLLPFTRATRVNFTLEASEGCYRWLSTRPEVASIEPLGLDEQQCSQKAVVQARLTQPARLTSIIFAEDITTGQVLRCDAIVDLIHDIQIVSTTRELYLEDSPLELKIQALDSEGNTFSTLAGLVFEWTIVKDSEADRFSDSHNALRILTFLESTYIPPSYISEMEKAAKQGDTILVSGMKTGSSKLKARIQEAVYKNVRPAEVRLLILENILLNPAYDVYLMVGTSIHYKVQKIRQGKITELSMPSDQYELQLQNSIPGPEGDPARPVAVLAQDTSMVTALQLGQSSLVLGHRSIRMQGASRLPNSTIYVVEPGYLGFTVHPGDRWVLETGRLYEITIEVFDKFSNKVYVSDNIRIETVLPAEFFEVLSSSQNGSYHRIRALKRGQTAIDAALTSVVDQDGGVHILQVPVWNQQEVEIHIPITLYPSILTFPWQPKTGAYQYTIRAHGGSGNFSWSSSSHLVATVTVKGVMTTGSDIGFSVIQAHDVQNPLHFGEMKVYVIEPHSMEFAPCQVEARVGQALELPLRISGLMPGGASEVVTLSDCSHFDLAVEVENQGVFQPLPGRLPPGSEHCSGIRVKAEAQGSTTLLVSYRHGHVHLSAKITIAAYLPLKAVDPSSVALVTLGSSKEMLFEGGPRPWILEPSKFFQNVTAEDTDSIGLALFAPHSSRNYQQHWILVTCQALGEQVIALSVGNKPSLTNPFPAVEPAVVKFVCAPPSRLTLAPVYTSPQLDMSCPLLQQNKQVVPVSSHRNPRLDLAAYDQEGRRFDNFSSLSIQWESTRPVLASIEPELPMQLVSQDDESGQKKLHGLQAILVHEASGTTAITATATGYQESHLSSARTKQPHDPLVPLSASIELILVEDVRVSPEEVTIYNHPGIQAELRIREGSGYFFLNTSTADVVKVAYQEARGVAMVHPLLPGSSTIMIHDLCLVFPAPAKAVVYVSDIQELYIRVVDKVEIGKTVKAYVRVLDLHKKPFLAKYFPFMDLKLRAASPIITLVALDEALDNYTITFLIRGVAIGQTSLTASVTNKAGQRINSAPQQIEVFPPFRLMPRKVTLLIGATMQVTSEGGPQPQSNILFSISNESVALVSAAGLVQGLAIGNGTVSGLVQAVDAETGKVVIISQDLVQVEVLLLRAVRIRAPIMRMRTGTQMPIYVTGITNHQNPFSFGNAVPGLTFHWSVTKRDVLDLRGRHHEASIRLPSQYNFAMNVLGRVKGRTGLRVVVKAVDPTSGQLYGLARELSDEIQVQVFEKLQLLNPEIEAEQILMSPNSYIKLQTNRDGAASLSYRVLDGPEKVPVVHVDEKGFLASGSMIGTSTIEVIAQEPFGANQTIIVAVKVSPVSYLRVSMSPVLHTQNKEALVAVPLGMTVTFTVHFHDNSGDVFHAHSSVLNFATNRDDFVQIGKGPTNNTCVVRTVSVGLTLLRVWDAEHPGLSDFMPLPVLQAISPELSGAMVVGDVLCLATVLTSLEGLSGTWSSSANSILHIDPKTGVAVARAVGSVTVYYEVAGHLRTYKEVVVSVPQRIMARHLHPIQTSFQEATASKVIVAVGDRSSNLRGECTPTQREVIQALHPETLISCQSQFKPAVFDFPSQDVFTVEPQFDTALGQYFCSITMHRLTDKQRKHLSMKKTALVVSASLSSSHFSTEQVGAEVPFSPGLFADQAEILLSNHYTSSEIRVFGAPEVLENLEVKSGSPAVLAFAKEKSFGWPSFITYTVGVLDPAAGSQGPLSTTLTFSSPVTNQAIAIPVTVAFVVDRRGPGPYGASLFQHFLDSYQVMFFTLFALLAGTAVMIIAYHTVCTPRDLAVPAALTPRASPGHSPHYFAASSPTSPNALPPARKASPPSGLWSPAYASH,1887,"205,111",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (2); Glycosylation (12); Modified residue (5); Natural variant (10); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000250"""
Q13797,Integrin alpha-9 (Integrin alpha-RLC),MGGPAAPRGAGRLRALLLALVVAGIPAGAYNLDPQRPVHFQGPADSFFGYAVLEHFHDNTRWVLVGAPKADSKYSPSVKSPGAVFKCRVHTNPDRRCTELDMARGKNRGTSCGKTCREDRDDEWMGVSLARQPKADGRVLACAHRWKNIYYEADHILPHGFCYIIPSNLQAKGRTLIPCYEEYKKKYGEEHGSCQAGIAGFFTEELVVMGAPGSFYWAGTIKVLNLTDNTYLKLNDEVIMNRRYTYLGYAVTAGHFSHPSTIDVVGGAPQDKGIGKVYIFRADRRSGTLIKIFQASGKKMGSYFGSSLCAVDLNGDGLSDLLVGAPMFSEIRDEGQVTVYINRGNGALEEQLALTGDGAYNAHFGESIASLDDLDNDGFPDVAIGAPKEDDFAGAVYIYHGDAGGIVPQYSMKLSGQKINPVLRMFGQSISGGIDMDGNGYPDVTVGAFMSDSVVLLRARPVITVDVSIFLPGSINITAPQCHDGQQPVNCLNVTTCFSFHGKHVPGEIGLNYVLMADVAKKEKGQMPRVYFVLLGETMGQVTEKLQLTYMEETCRHYVAHVKRRVQDVISPIVFEAAYSLSEHVTGEEERELPPLTPVLRWKKGQKIAQKNQTVFERNCRSEDCAADLQLQGKLLLSSMDEKTLYLALGAVKNISLNISISNLGDDAYDANVSFNVSRELFFINMWQKEEMGISCELLESDFLKCSVGFPFMRSKSKYEFSVIFDTSHLSGEEEVLSFIVTAQSGNTERSESLHDNTLVLMVPLMHEVDTSITGIMSPTSFVYGESVDAANFIQLDDLECHFQPINITLQVYNTGPSTLPGSSVSISFPNRLSSGGAEMFHVQEMVVGQEKGNCSFQKNPTPCIIPQEQENIFHTIFAFFTKSGRKVLDCEKPGISCLTAHCNFSALAKEESRTIDIYMLLNTEILKKDSSSVIQFMSRAKVKVDPALRVVEIAHGNPEEVTVVFEALHNLEPRGYVVGWIIAISLLVGILIFLLLAVLLWKMGFFRRRYKEIIEAEKNRKENEDSWDWVQKNQ,1035,"114,489",Calcium binding (3); Chain (1); Disulfide bond (9); Glycosylation (11); Motif (1); Natural variant (2); Repeat (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 87..97;  /evidence=""ECO:0000250""; DISULFID 142..162;  /evidence=""ECO:0000250""; DISULFID 179..194;  /evidence=""ECO:0000250""; DISULFID 482..491;  /evidence=""ECO:0000250""; DISULFID 497..555;  /evidence=""ECO:0000250""; DISULFID 620..625;  /evidence=""ECO:0000250""; DISULFID 696..706;  /evidence=""ECO:0000250""; DISULFID 855..891;  /evidence=""ECO:0000250""; DISULFID 898..903;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9NRX6,Protein kish-B (Transmembrane protein 167B),MTNVYSLDGILVFGLLFVCTCAYFKKVPRLKTWLLSEKKGVWGVFYKAAVIGTRLHAAVAIACVVMAFYVLFIK,74,"8,294",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q7Z4F1,Low-density lipoprotein receptor-related protein 10 (LRP-10),MLLATLLLLLLGGALAHPDRIIFPNHACEDPPAVLLEVQGTLQRPLVRDSRTSPANCTWLILGSKEQTVTIRFQKLHLACGSERLTLRSPLQPLISLCEAPPSPLQLPGGNVTITYSYAGARAPMGQGFLLSYSQDWLMCLQEEFQCLNHRCVSAVQRCDGVDACGDGSDEAGCSSDPFPGLTPRPVPSLPCNVTLEDFYGVFSSPGYTHLASVSHPQSCHWLLDPHDGRRLAVRFTALDLGFGDAVHVYDGPGPPESSRLLRSLTHFSNGKAVTVETLSGQAVVSYHTVAWSNGRGFNATYHVRGYCLPWDRPCGLGSGLGAGEGLGERCYSEAQRCDGSWDCADGTDEEDCPGCPPGHFPCGAAGTSGATACYLPADRCNYQTFCADGADERRCRHCQPGNFRCRDEKCVYETWVCDGQPDCADGSDEWDCSYVLPRKVITAAVIGSLVCGLLLVIALGCTCKLYAIRTQEYSIFAPLSRMEAEIVQQQAPPSYGQLIAQGAIPPVEDFPTENPNDNSVLGNLRSLLQILRQDMTPGGGPGARRRQRGRLMRRLVRRLRRWGLLPRTNTPARASEARSQVTPSAAPLEALDGGTGPAREGGAVGGQDGEQAPPLPIKAPLPSASTSPAPTTVPEAPGPLPSLPLEPSLLSGVVQALRGRLLPSLGPPGPTRSPPGPHTAVLALEDEDDVLLVPLAEPGVWVAEAEDEPLLT,713,"76,193",Alternative sequence (1); Chain (1); Compositional bias (2); Disulfide bond (15); Domain (6); Erroneous initiation (1); Frameshift (2); Glycosylation (4); Modified residue (1); Natural variant (2); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 28..57;  /evidence=""ECO:0000250""; DISULFID 80..98;  /evidence=""ECO:0000250""; DISULFID 140..152;  /evidence=""ECO:0000250""; DISULFID 147..165;  /evidence=""ECO:0000250""; DISULFID 159..174;  /evidence=""ECO:0000250""; DISULFID 192..220;  /evidence=""ECO:0000250""; DISULFID 308..331;  /evidence=""ECO:0000250""; DISULFID 315..344;  /evidence=""ECO:0000250""; DISULFID 338..353;  /evidence=""ECO:0000250""; DISULFID 356..374;  /evidence=""ECO:0000250""; DISULFID 363..387;  /evidence=""ECO:0000250""; DISULFID 381..396;  /evidence=""ECO:0000250""; DISULFID 399..411;  /evidence=""ECO:0000250""; DISULFID 406..424;  /evidence=""ECO:0000250""; DISULFID 418..433;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q8TF66,Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib),MPLKHYLLLLVGCQAWGAGLAYHGCPSECTCSRASQVECTGARIVAVPTPLPWNAMSLQILNTHITELNESPFLNISALIALRIEKNELSRITPGAFRNLGSLRYLSLANNKLQVLPIGLFQGLDSLESLLLSSNQLLQIQPAHFSQCSNLKELQLHGNHLEYIPDGAFDHLVGLTKLNLGKNSLTHISPRVFQHLGNLQVLRLYENRLTDIPMGTFDGLVNLQELALQQNQIGLLSPGLFHNNHNLQRLYLSNNHISQLPPSVFMQLPQLNRLTLFGNSLKELSPGIFGPMPNLRELWLYDNHISSLPDNVFSNLRQLQVLILSRNQISFISPGAFNGLTELRELSLHTNALQDLDGNVFRMLANLQNISLQNNRLRQLPGNIFANVNGLMAIQLQNNQLENLPLGIFDHLGKLCELRLYDNPWRCDSDILPLRNWLLLNQPRLGTDTVPVCFSPANVRGQSLIIINVNVAVPSVHVPEVPSYPETPWYPDTPSYPDTTSVSSTTELTSPVEDYTDLTTIQVTDDRSVWGMTQAQSGLAIAAIVIGIVALACSLAACVGCCCCKKRSQAVLMQMKAPNEC,581,"64,366",Alternative sequence (1); Chain (1); Domain (2); Erroneous initiation (2); Glycosylation (2); Natural variant (2); Repeat (15); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P14151,L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L),MIFPWKCQSTQRDLWNIFKLWGWTMLCCDFLAHHGTDCWTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPNNKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINNYTCNCDVGYYGPQCQFVIQCEPLEAPELGTMDCTHPLGNFSFSSQCAFSCSEGTNLTGIEETTCGPFGNWSSPEPTCQVIQCEPLSAPDLGIMNCSHPLASFSFTSACTFICSEGTELIGKKKTICESSGIWSNPSPICQKLDKSFSMIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKRSMNDPY,372,"42,187",Alternative sequence (1); Beta strand (11); Chain (1); Disulfide bond (9); Domain (4); Glycosylation (6); Helix (4); Metal binding (5); Mutagenesis (4); Natural variant (4); Propeptide (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 57..155;  /evidence=""ECO:0000244|PDB:3CFW, ECO:0000244|PDB:5VC1, ECO:0000269|PubMed:28011641, ECO:0000269|PubMed:28489325""; DISULFID 128..147;  /evidence=""ECO:0000244|PDB:3CFW, ECO:0000244|PDB:5VC1, ECO:0000269|PubMed:28011641, ECO:0000269|PubMed:28489325""; DISULFID 160..171;  /evidence=""ECO:0000244|PDB:3CFW, ECO:0000244|PDB:5VC1, ECO:0000269|PubMed:28011641, ECO:0000269|PubMed:28489325""; DISULFID 165..180;  /evidence=""ECO:0000244|PDB:3CFW, ECO:0000269|PubMed:28011641, ECO:0000269|PubMed:28489325""; DISULFID 182..191;  /evidence=""ECO:0000244|PDB:3CFW, ECO:0000244|PDB:5VC1, ECO:0000269|PubMed:28011641, ECO:0000269|PubMed:28489325""; DISULFID 197..241;  /evidence=""ECO:0000250""; DISULFID 227..254;  /evidence=""ECO:0000250""; DISULFID 259..303;  /evidence=""ECO:0000250""; DISULFID 289..316;  /evidence=""ECO:0000250""",SIGNAL 1..28
Q5VYJ5,MAM and LDL-receptor class A domain-containing protein 1,MLFFLDRMLAFPMNETFCCLWIACVFNSTLAQQGTESFQCDNGVSLPPDSICDFTDQCGDSSDERHCLNYERCDFEDGLCHMTQDQSLQPSWTKRSGMIGLSPPFYDHNGDVSAHFLSLVSRVDSISSSLRSRVFLPTNDQHDCQITFYYFSCQVSGKLMVGLQTACGGPIQHLWQNTAALPNQWERNVIKIQSSQRFQVVFEGQMASTYEQDEVIAIDDISFSSGCLPANDGILLCQEALNAERELCHPDTDLCRFDATDEELRLCQACGFEFDMCEWTSEASAGQISWMRTKAREIPAFESTPQQDQGGDDEGYYVWVGAKHGFTLNHLDSRAYLNSSVCHCLGKSCHLQFYYAMESSVLRVRLYNNKEEEIFWTYNISTHSQWVKADVLIPEDLKTFKIIFEGTLLSQRSFIALDHLWVYACGQTQSRKLCSADEFPCTSGQCIAKESVCDSRQDCSDESDEDPATCSKHLTCDFESGFCGWEPFLTEDSHWKLMKGLNNGEHHFPAADHTANINHGSFIYLEAQRSPGVAKLGSPVLTKLLTASTPCQVQFWYHLSQHSNLSVFTRTSLDGNLQKQGKIIRFSESQWSHAKIDLIAEAGESTLPFQLILEATVLSSNATVALDDISVSQECEISYKSLPRTSTQSKFSKCDFEANSCDWFEAISGDHFDWIRSSQSELSADFEHQAPPRDHSLNASQGHFMFILKKSSSLWQVAKLQSPTFSQTGPGCILSFWFYNYGLSVGAAELQLHMENSHDSTVIWRVLYNQGKQWLEATIQLGRLSQPFHLSLDKVSLGIYDGVSAIDDIRFENCTLPLPAESCEGLDHFWCRHTRACIEKLRLCDLVDDCGDRTDEVNCAPELQCNFETGICNWEQDAKDDFDWTRSQGPTPTLNTGPMKDNTLGTAKGHYLYIESSEPQAFQDSAALLSPILNATDTKGCTFRFYYHMFGKRIYRLAIYQRIWSDSRGQLLWQIFGNQGNRWIRKHLNISSRQPFQILVEASVGDGFTGDIAIDDLSFMDCTLYPGNLPADLPTPPETSVPVTLPPHNCTDNEFICRSDGHCIEKMQKCDFKYDCPDKSDEASCVMEVCSFEKRSLCKWYQPIPVHLLQDSNTFRWGLGNGISIHHGEENHRPSVDHTQNTTDGWYLYADSSNGKFGDTADILTPIISLTGPKCTLVFWTHMNGATVGSLQVLIKKDNVTSKLWAQTGQQGAQWKRAEVFLGIRSHTQIVFRAKRGISYIGDVAVDDISFQDCSPLLSPERKCTDHEFMCANKHCIAKDKLCDFVNDCADNSDETTFICRTSSGRCDFEFDLCSWKQEKDEDFDWNLKASSIPAAGTEPAADHTLGNSSGHYIFIKSLFPQQPMRAARISSPVISKRSKNCKIIFHYHMYGNGIGALTLMQVSVTNQTKVLLNLTVEQGNFWRREELSLFGDEDFQLKFEGRVGKGQRGDIALDDIVLTENCLSLHDSVQEELAVPLPTGFCPLGYRECHNGKCYRLEQSCNFVDNCGDNTDENECGSSCTFEKGWCGWQNSQADNFDWVLGVGSHQSLRPPKDHTLGNENGHFMYLEATAVGLRGDKAHFRSTMWRESSAACTMSFWYFVSAKATGSIQILIKTEKGLSKVWQESKQNPGNHWQKADILLGKLRNFEVIFQGIRTRDLGGGAAIDDIEFKNCTTVGEISELCPEITDFLCRDKKCIASHLLCDYKPDCSDRSDEAHCAHYTSTTGSCNFETSSGNWTTACSLTQDSEDDLDWAIGSRIPAKALIPDSDHTPGSGQHFLYVNSSGSKEGSVARITTSKSFPASLGMCTVRFWFYMIDPRSMGILKVYTIEESGLNILVWSVIGNKRTGWTYGSVPLSSNSPFKVAFEADLDGNEDIFIALDDISFTPECVTGGPVPVQPSPCEADQFSCIYTLQCVPLSGKCDGHEDCIDGSDEMDCPLSPTPPLCSNMEFPCSTDECIPSLLLCDGVPDCHFNEDELICSNKSCSNGALVCASSNSCIPAHQRCDGFADCMDFQLDESSCSECPLNYCRNGGTCVVEKNGPMCRCRQGWKGNRCHIKFNPPATDFTYAQNNTWTLLGIGLAFLMTHITVAVLCFLANRKVPIRKTEGSGNCAFVNPVYGNWSNPEKTESSVYSFSNPLYGTTSGSLETLSHHLK,2156,"241,008",Chain (1); Disulfide bond (32); Domain (20); Glycosylation (4); Natural variant (16); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 40..58;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 52..67;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 434..446;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 441..459;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 453..470;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 823..837;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 831..850;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 844..859;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1050..1063;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1057..1076;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1070..1085;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1264..1276;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1271..1289;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1283..1300;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1483..1495;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1490..1508;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1502..1517;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1684..1697;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1692..1710;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1704..1719;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1903..1916;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1910..1929;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1923..1938;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1947..1959;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1954..1972;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1966..1981;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1986..1999;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1993..2012;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2006..2022;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 2025..2036;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 2030..2045;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 2047..2056;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P23470,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),MRRLLEPCWWILFLKITSSVLHYVVCFPALTEGYVGALHENRHGSAVQIRRRKASGDPYWAYSGAYGPEHWVTSSVSCGGRHQSPIDILDQYARVGEEYQELQLDGFDNESSNKTWMKNTGKTVAILLKDDYFVSGAGLPGRFKAEKVEFHWGHSNGSAGSEHSINGRRFPVEMQIFFYNPDDFDSFQTAISENRIIGAMAIFFQVSPRDNSALDPIIHGLKGVVHHEKETFLDPFVLRDLLPASLGSYYRYTGSLTTPPCSEIVEWIVFRRPVPISYHQLEAFYSIFTTEQQDHVKSVEYLRNNFRPQQRLHDRVVSKSAVRDSWNHDMTDFLENPLGTEASKVCSSPPIHMKVQPLNQTALQVSWSQPETIYHPPIMNYMISYSWTKNEDEKEKTFTKDSDKDLKATISHVSPDSLYLFRVQAVCRNDMRSDFSQTMLFQANTTRIFQGTRIVKTGVPTASPASSADMAPISSGSSTWTSSGIPFSFVSMATGMGPSSSGSQATVASVVTSTLLAGLGFGGGGISSFPSTVWPTRLPTAASASKQAARPVLATTEALASPGPDGDSSPTKDGEGTEEGEKDEKSESEDGEREHEEDGEKDSEKKEKSGVTHAAEERNQTEPSPTPSSPNRTAEGGHQTIPGHEQDHTAVPTDQTGGRRDAGPGLDPDMVTSTQVPPTATEEQYAGSDPKRPEMPSKKPMSRGDRFSEDSRFITVNPAEKNTSGMISRPAPGRMEWIIPLIVVSALTFVCLILLIAVLVYWRGCNKIKSKGFPRRFREVPSSGERGEKGSRKCFQTAHFYVEDSSSPRVVPNESIPIIPIPDDMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVSSNQLHSYVNSILIPGVGGKTRLEKQFKLVTQCNAKYVECFSAQKECNKEKNRNSSVVPSERARVGLAPLPGMKGTDYINASYIMGYYRSNEFIITQHPLPHTTKDFWRMIWDHNAQIIVMLPDNQSLAEDEFVYWPSREESMNCEAFTVTLISKDRLCLSNEEQIIIHDFILEATQDDYVLEVRHFQCPKWPNPDAPISSTFELINVIKEEALTRDGPTIVHDEYGAVSAGMLCALTTLSQQLENENAVDVFQVAKMINLMRPGVFTDIEQYQFIYKAMLSLVSTKENGNGPMTVDKNGAVLIADESDPAESMESLV,1445,"162,003",Active site (1); Alternative sequence (1); Beta strand (40); Binding site (2); Chain (1); Disulfide bond (1); Domain (4); Erroneous initiation (1); Glycosylation (8); Helix (30); Modified residue (1); Mutagenesis (4); Natural variant (3); Region (1); Sequence conflict (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 78..261;  /evidence=""ECO:0000269|PubMed:20133774""",SIGNAL 1..19
P53708,Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain],MSPGASRGPRGSQAPLIAPLCCAAAALGMLLWSPACQAFNLDVEKLTVYSGPKGSYFGYAVDFHIPDARTASVLVGAPKANTSQPDIVEGGAVYYCPWPAEGSAQCRQIPFDTTNNRKIRVNGTKEPIEFKSNQWFGATVKAHKGKVVACAPLYHWRTLKPTPEKDPVGTCYVAIQNFSAYAEFSPCRNSNADPEGQGYCQAGFSLDFYKNGDLIVGGPGSFYWQGQVITASVADIIANYSFKDILRKLAGEKQTEVAPASYDDSYLGYSVAAGEFTGDSQQELVAGIPRGAQNFGYVSIINSTDMTFIQNFTGEQMASYFGYTVVVSDVNSDGLDDVLVGAPLFMEREFESNPREVGQIYLYLQVSSLLFRDPQILTGTETFGRFGSAMAHLGDLNQDGYNDIAIGVPFAGKDQRGKVLIYNGNKDGLNTKPSQVLQGVWASHAVPSGFGFTLRGDSDIDKNDYPDLIVGAFGTGKVAVYRARPVVTVDAQLLLHPMIINLENKTCQVPDSMTSAACFSLRVCASVTGQSIANTIVLMAEVQLDSLKQKGAIKRTLFLDNHQAHRVFPLVIKRQKSHQCQDFIVYLRDETEFRDKLSPINISLNYSLDESTFKEGLEVKPILNYYRENIVSEQAHILVDCGEDNLCVPDLKLSARPDKHQVIIGDENHLMLIINARNEGEGAYEAELFVMIPEEADYVGIERNNKGFRPLSCEYKMENVTRMVVCDLGNPMVSGTNYSLGLRFAVPRLEKTNMSINFDLQIRSSNKDNPDSNFVSLQINITAVAQVEIRGVSHPPQIVLPIHNWEPEEEPHKEEEVGPLVEHIYELHNIGPSTISDTILEVGWPFSARDEFLLYIFHIQTLGPLQCQPNPNINPQDIKPAASPEDTPELSAFLRNSTIPHLVRKRDVHVVEFHRQSPAKILNCTNIECLQISCAVGRLEGGESAVLKVRSRLWAHTFLQRKNDPYALASLVSFEVKKMPYTDQPAKLPEGSIVIKTSVIWATPNVSFSIPLWVIILAILLGLLVLAILTLALWKCGFFDRARPPQEDMTDREQLTNDKTPEA,1063,"117,474",Calcium binding (3); Chain (3); Disulfide bond (9); Glycosylation (16); Motif (1); Natural variant (9); Repeat (7); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 96..106;  /evidence=""ECO:0000250""; DISULFID 150..171;  /evidence=""ECO:0000250""; DISULFID 187..200;  /evidence=""ECO:0000250""; DISULFID 507..518;  /evidence=""ECO:0000250""; DISULFID 524..580;  /evidence=""ECO:0000250""; DISULFID 641..647;  /evidence=""ECO:0000250""; DISULFID 713..726;  /evidence=""ECO:0000250""; DISULFID 867..924;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000250""; DISULFID 929..934;  /evidence=""ECO:0000250""","SIGNAL 1..38;  /evidence=""ECO:0000255"""
P20701,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a),MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHCLPVTLRGSNYTSKYLGMTLATDPTDGSILACDPGLSRTCDQNTYLSGLCYLFRQNLQGPMLQGRPGFQECIKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSRGHAVVGAVGAKDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYTVTWLPSRQKTSLLASGAPRYQHMGRVLLFQEPQGGGHWSQVQTIHGTQIGSYFGGELCGVDVDQDGETELLLIGAPLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYPLGRFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFNGRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLEGDGLADVAVGAESQMIVLSSRPVVDMVTLMSFSPAEIPVHEVECSYSTSNKMKEGVNITICFQIKSLIPQFQGRLVANLTYTLQLDGHRTRRRGLFPGGRHELRRNIAVTTSMSCTDFSFHFPVCVQDLISPINVSLNFSLWEEEGTPRDQRAQGKDIPPILRPSLHSETWEIPFEKNCGEDKKCEANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSFRKVEMLKPHSQIPVSCEELPEESRLLSRALSCNVSSPIFKAGHSVALQMMFNTLVNSSWGDSVELHANVTCNNEDSDLLEDNSATTIIPILYPINILIQDQEDSTLYVSFTPKGPKIHQVKHMYQVRIQPSIHDHNIPTLEAVVGVPQPPSEGPITHQWSVQMEPPVPCHYEDLERLPDAAEPCLPGALFRCPVVFRQEILVQVIGTLELVGEIEASSMFSLCSSLSISFNSSKHFHLYGSNASLAQVVMKVDVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLASGQEAGDPGCLKPLHEKDSESGGGKD,1170,"128,770",Alternative sequence (3); Beta strand (40); Calcium binding (3); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (12); Helix (22); Modified residue (1); Motif (1); Mutagenesis (1); Natural variant (4); Repeat (7); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 73..80;  /evidence=""ECO:0000250""; DISULFID 111..129;  /evidence=""ECO:0000250""; DISULFID 653..707;  /evidence=""ECO:0000250""; DISULFID 771..777;  /evidence=""ECO:0000250""; DISULFID 845..861;  /evidence=""ECO:0000250""; DISULFID 998..1013;  /evidence=""ECO:0000250""; DISULFID 1021..1052;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P15260,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119),MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS,489,"54,405",Alternative sequence (3); Beta strand (14); Chain (1); Disulfide bond (4); Glycosylation (5); Helix (3); Modified residue (4); Mutagenesis (1); Natural variant (24); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 77..85;  /evidence=""ECO:0000269|PubMed:8443182""; DISULFID 122..167;  /evidence=""ECO:0000269|PubMed:8443182""; DISULFID 195..200;  /evidence=""ECO:0000269|PubMed:8443182""; DISULFID 214..235;  /evidence=""ECO:0000269|PubMed:8443182""",SIGNAL 1..17
O75325,Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5),MRLLVAPLLLAWVAGATAAVPVVPWHVPCPPQCACQIRPWYTPRSSYREATTVDCNDLFLTAVPPALPAGTQTLLLQSNSIVRVDQSELGYLANLTELDLSQNSFSDARDCDFHALPQLLSLHLEENQLTRLEDHSFAGLASLQELYLNHNQLYRIAPRAFSGLSNLLRLHLNSNLLRAIDSRWFEMLPNLEILMIGGNKVDAILDMNFRPLANLRSLVLAGMNLREISDYALEGLQSLESLSFYDNQLARVPRRALEQVPGLKFLDLNKNPLQRVGPGDFANMLHLKELGLNNMEELVSIDKFALVNLPELTKLDITNNPRLSFIHPRAFHHLPQMETLMLNNNALSALHQQTVESLPNLQEVGLHGNPIRCDCVIRWANATGTRVRFIEPQSTLCAEPPDLQRLPVREVPFREMTDHCLPLISPRSFPPSLQVASGESMVLHCRALAEPEPEIYWVTPAGLRLTPAHAGRRYRVYPEGTLELRRVTAEEAGLYTCVAQNLVGADTKTVSVVVGRALLQPGRDEGQGLELRVQETHPYHILLSWVTPPNTVSTNLTWSSASSLRGQGATALARLPRGTHSYNITRLLQATEYWACLQVAFADAHTQLACVWARTKEATSCHRALGDRPGLIAILALAVLLLAAGLAAHLGTGQPRKGVGGRRPLPPAWAFWGWSAPSVRVVSAPLVLPWNPGRKLPRSSEGETLLPPLSQNS,713,"78,859",Chain (1); Disulfide bond (1); Domain (3); Glycosylation (4); Natural variant (5); Repeat (12); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 445..497;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
O75023,Leukocyte immunoglobulin-like receptor subfamily B member 5 (CD85 antigen-like family member C) (Leukocyte immunoglobulin-like receptor 8) (LIR-8) (CD antigen CD85c),MTLTLSVLICLGLSVGPRTCVQAGTLPKPTLWAEPASVIARGKPVTLWCQGPLETEEYRLDKEGLPWARKRQNPLEPGAKAKFHIPSTVYDSAGRYRCYYETPAGWSEPSDPLELVATGFYAEPTLLALPSPVVASGGNVTLQCDTLDGLLTFVLVEEEQKLPRTLYSQKLPKGPSQALFPVGPVTPSCRWRFRCYYYYRKNPQVWSNPSDLLEILVPGVSRKPSLLIPQGSVVARGGSLTLQCRSDVGYDIFVLYKEGEHDLVQGSGQQPQAGLSQANFTLGPVSRSHGGQYRCYGAHNLSPRWSAPSDPLDILIAGLIPDIPALSVQPGPKVASGENVTLLCQSWHQIDTFFLTKEGAAHPPLCLKSKYQSYRHQAEFSMSPVTSAQGGTYRCYSAIRSYPYLLSSPSYPQELVVSGPSGDPSLSPTGSTPTPGPEDQPLTPTGLDPQSGLGRHLGVVTGVSVAFVLLLFLLLFLLLRHRHQSKHRTSAHFYRPAGAAGPEPKDQGLQKRASPVADIQEEILNAAVKDTQPKDGVEMDARAAASEAPQDVTYAQLHSLTLRREATEPPPSQEREPPAEPSIYAPLAIH,590,"64,126",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (3); Modified residue (1); Motif (2); Natural variant (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 144..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 244..295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9P2E7,Protocadherin-10,MIVLLLFALLWMVEGVFSQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYLDLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDREQQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEESPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKSIQVQVSDVNDNAPRFSQPVYDVYVTENNVPGAYIYAVSATDRDEGANAQLAYSILECQIQGMSVFTYVSINSENGYLYALRSFDYEQLKDFSFQVEARDAGSPQALAGNATVNILIVDQNDNAPAIVAPLPGRNGTPAREVLPRSAEPGYLLTRVAAVDADDGENARLTYSIVRGNEMNLFRMDWRTGELRTARRVPAKRDPQRPYELVIEVRDHGQPPLSSTATLVVQLVDGAVEPQGGGGSGGGGSGEHQRPSRSGGGETSLDLTLILIIALGSVSFIFLLAMIVLAVRCQKEKKLNIYTCLASDCCLCCCCCGGGGSTCCGRQARARKKKLSKSDIMLVQSSNVPSNPAQVPIEESGGFGSHHHNQNYCYQVCLTPESAKTDLMFLKPCSPSRSTDTEHNPCGAIVTGYTDQQPDIISNGSILSNETKHQRAELSYLVDRPRRVNSSAFQEADIVSSKDSGHGDSEQGDSDHDATNRAQSAGMDLFSNCTEECKALGHSDRCWMPSFVPSDGRQAADYRSNLHVPGMDSVPDTEVFETPEAQPGAERSFSTFGKEKALHSTLERKELDGLLTNTRAPYKPPYLTRKRIC,1040,"112,936",Alternative sequence (2); Beta strand (51); Chain (1); Compositional bias (1); Domain (6); Erroneous initiation (1); Glycosylation (2); Helix (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (10),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9Y5H9,Protocadherin alpha-2 (PCDH-alpha-2),MASSIRRGRGAWTRLLSLLLLAAWEVGSGQLRYSVPEEAKHGTFVGRIAQDLGLELEELVPRLFRVASKRHGDLLEVNLQNGILFVNSRIDREELCGRSAECSIHVEVIVDRPLQVFHVEVEVKDINDNPPIFPMTVKTIRFPESRLLDSRFPLEGASDADIGVNALLSYKLSSSEFFFLDIQANDELSESLSLVLGKSLDREETAEVNLLLVATDGGKPELTGTVQILIKVLDVNDNEPTFAQSVYKVKLLENTANGTLVVKLNASDADEGPNSEIVYSLGSDVSSTIQTKFTIDPISGEIRTKGKLDYEEAKSYEIQVTATDKGTPSMSGHCKISLKLVDINDNTPEVSITSLSLPISENASLGTVIALITVSDRDSGTNGHVTCSLTPHVPFKLVSTFKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATTSVSIEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSAWDADAQENALVSYSLVERRVGERALSSYVSVHAESGKVYALQPLDHEEVELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLAPRAGTAAGAVSELVPWSVGAGHVVAKVRAVDADSGYNAWLSYELQLGTGSARIPFRVGLYTGEISTTRALDEADSPRHRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRAWVGAAGSEATLVDVNVYLIIAICAVSSLLVLTVLLYTALRCSVPPTEGARAPGKPTLVCSSAVGSWSYSQQRRQRVCSGEDPPKTDLMAFSPSLSQGPDSAEEKQLSESEYVGKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,948,"102,063",Alternative sequence (4); Chain (1); Compositional bias (1); Domain (6); Glycosylation (4); Natural variant (3); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:12665801"""
Q96FE7,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),MLLAWVQAFLVSNMLLAEAYGSGGCFWDNGHLYREDQTSPAPGLRCLNWLDAQSGLASAPVSGAGNHSYCRNPDEDPRGPWCYVSGEAGVPEKRPCEDLRCPETTSQALPAFTTEIQEASEGPGADEVQVFAPANALPARSEAAAVQPVIGISQRVRMNSKEKKDLGTLGYVLGITMMVIIIAIGAGIILGYSYKRGKDLKEQHDQKVCEREMQRITLPLSAFTNPTCEIVDEKTVVVHTSQTPVDPQEGTTPLMGQAGTPGA,263,"28,248",Alternative sequence (5); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (2); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 25..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00121""; DISULFID 46..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00121""; DISULFID 70..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00121""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BQS7,Hephaestin (EC 1.-.-.-),MESGHLLWALLFMQSLWPQLTDGATRVYYLGIRDVQWNYAPKGRNVITNQPLDSDIVASSFLKSDKNRIGGTYKKTIYKEYKDDSYTDEVAQPAWLGFLGPVLQAEVGDVILIHLKNFATRPYTIHPHGVFYEKDSEGSLYPDGSSGPLKADDSVPPGGSHIYNWTIPEGHAPTDADPACLTWIYHSHVDAPRDIATGLIGPLITCKRGALDGNSPPQRQDVDHDFFLLFSVVDENLSWHLNENIATYCSDPASVDKEDETFQESNRMHAINGFVFGNLPELNMCAQKRVAWHLFGMGNEIDVHTAFFHGQMLTTRGHHTDVANIFPATFVTAEMVPWEPGTWLISCQVNSHFRDGMQALYKVKSCSMAPPVDLLTGKVRQYFIEAHEIQWDYGPMGHDGSTGKNLREPGSISDKFFQKSSSRIGGTYWKVRYEAFQDETFQEKMHLEEDRHLGILGPVIRAEVGDTIQVVFYNRASQPFSMQPHGVFYEKDYEGTVYNDGSSYPGLVAKPFEKVTYRWTVPPHAGPTAQDPACLTWMYFSAADPIRDTNSGLVGPLLVCRAGALGADGKQKGVDKEFFLLFTVLDENKSWYSNANQAAAMLDFRLLSEDIEGFQDSNRMHAINGFLFSNLPRLDMCKGDTVAWHLLGLGTETDVHGVMFQGNTVQLQGMRKGAAMLFPHTFVMAIMQPDNLGTFEIYCQAGSHREAGMRAIYNVSQCPGHQATPRQRYQAARIYYIMAEEVEWDYCPDRSWEREWHNQSEKDSYGYIFLSNKDGLLGSRYKKAVFREYTDGTFRIPRPRTGPEEHLGILGPLIKGEVGDILTVVFKNNASRPYSVHAHGVLESTTVWPLAAEPGEVVTYQWNIPERSGPGPNDSACVSWIYYSAVDPIKDMYSGLVGPLAICQKGILEPHGGRSDMDREFALLFLIFDENKSWYLEENVATHGSQDPGSINLQDETFLESNKMHAINGKLYANLRGLTMYQGERVAWYMLAMGQDVDLHTIHFHAESFLYRNGENYRADVVDLFPGTFEVVEMVASNPGTWLMHCHVTDHVHAGMETLFTVFSRTEHLSPLTVITKETEKAVPPRDIEEGNVKMLGMQIPIKNVEMLASVLVAISVTLLLVVLALGGVVWYQHRQRKLRRNRRSILDDSFKLLSFKQ,1158,"130,449",Alternative sequence (3); Chain (1); Disulfide bond (5); Domain (6); Erroneous initiation (3); Glycosylation (8); Metal binding (19); Modified residue (3); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 180..206;  /evidence=""ECO:0000255""; DISULFID 285..366;  /evidence=""ECO:0000255""; DISULFID 534..560;  /evidence=""ECO:0000255""; DISULFID 637..718;  /evidence=""ECO:0000255""; DISULFID 877..903;  /evidence=""ECO:0000255""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P42701,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212),MEPLVTWVVPLLFLFLLSRQGAACRTSECCFQDPPYPDADSGSASGPRDLRCYRISSDRYECSWQYEGPTAGVSHFLRCCLSSGRCCYFAAGSATRLQFSDQAGVSVLYTVTLWVESWARNQTEKSPEVTLQLYNSVKYEPPLGDIKVSKLAGQLRMEWETPDNQVGAEVQFRHRTPSSPWKLGDCGPQDDDTESCLCPLEMNVAQEFQLRRRQLGSQGSSWSKWSSPVCVPPENPPQPQVRFSVEQLGQDGRRRLTLKEQPTQLELPEGCQGLAPGTEVTYRLQLHMLSCPCKAKATRTLHLGKMPYLSGAAYNVAVISSNQFGPGLNQTWHIPADTHTEPVALNISVGTNGTTMYWPARAQSMTYCIEWQPVGQDGGLATCSLTAPQDPDPAGMATYSWSRESGAMGQEKCYYITIFASAHPEKLTLWSTVLSTYHFGGNASAAGTPHHVSVKNHSLDSVSVDWAPSLLSTCPGVLKEYVVRCRDEDSKQVSEHPVQPTETQVTLSGLRAGVAYTVQVRADTAWLRGVWSQPQRFSIEVQVSDWLIFFASLGSFLSILLVGVLGYLGLNRAARHLCPPLPTPCASSAIEFPGGKETWQWINPVDFQEEASLQEALVVEMSWDKGERTEPLEKTELPEGAPELALDTELSLEDGDRCKAKM,662,"73,109",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (5); Glycosylation (6); Motif (2); Natural variant (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 52..62;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O95256,Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (EC 3.2.2.6) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b),MLCLGWIFLWLVAGERIKGFNISGCSTKKLLWTYSTRSEEEFVLFCDLPEPQKSHFCHRNRLSPKQVPEHLPFMGSNDLSDVQWYQQPSNGDPLEDIRKSYPHIIQDKCTLHFLTPGVNNSGSYICRPKMIKSPYDVACCVKMILEVKPQTNASCEYSASHKQDLLLGSTGSISCPSLSCQSDAQSPAVTWYKNGKLLSVERSNRIVVDEVYDYHQGTYVCDYTQSDTVSSWTVRAVVQVRTIVGDTKLKPDILDPVEDTLEVELGKPLTISCKARFGFERVFNPVIKWYIKDSDLEWEVSVPEAKSIKSTLKDEIIERNIILEKVTQRDLRRKFVCFVQNSIGNTTQSVQLKEKRGVVLLYILLGTIGTLVAVLAASALLYRHWIEIVLLYRTYQSKDQTLGDKKDFDAFVSYAKWSSFPSEATSSLSEEHLALSLFPDVLENKYGYSLCLLERDVAPGGVYAEDIVSIIKRSRRGIFILSPNYVNGPSIFELQAAVNLALDDQTLKLILIKFCYFQEPESLPHLVKKALRVLPTVTWRGLKSVPPNSRFWAKMRYHMPVKNSQGFTWNQLRITSRIFQWKGLSRTETTGRSSQPKEW,599,"68,310",Active site (1); Alternative sequence (5); Beta strand (23); Chain (1); Disulfide bond (5); Domain (3); Glycosylation (4); Helix (3); Mutagenesis (6); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 46..126;  /evidence=""ECO:0000244|PDB:3WO4, ECO:0000269|PubMed:25500532""; DISULFID 155..180;  /evidence=""ECO:0000244|PDB:3WO4, ECO:0000269|PubMed:25500532""; DISULFID 175..221;  /evidence=""ECO:0000244|PDB:3WO4, ECO:0000269|PubMed:25500532""; DISULFID 180..221;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 273..337;  /evidence=""ECO:0000244|PDB:3WO4, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25500532""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P78504,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),MRSPRTRGRSGRPLSLLLALLCALRAKVCGASGQFELEILSMQNVNGELQNGNCCGGARNPGDRKCTRDECDTYFKVCLKEYQSRVTAGGPCSFGSGSTPVIGGNTFNLKASRGNDRNRIVLPFSFAWPRSYTLLVEAWDSSNDTVQPDSIIEKASHSGMINPSRQWQTLKQNTGVAHFEYQIRVTCDDYYYGFGCNKFCRPRDDFFGHYACDQNGNKTCMEGWMGPECNRAICRQGCSPKHGSCKLPGDCRCQYGWQGLYCDKCIPHPGCVHGICNEPWQCLCETNWGGQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEIAEHACLSDPCHNRGSCKETSLGFECECSPGWTGPTCSTNIDDCSPNNCSHGGTCQDLVNGFKCVCPPQWTGKTCQLDANECEAKPCVNAKSCKNLIASYYCDCLPGWMGQNCDININDCLGQCQNDASCRDLVNGYRCICPPGYAGDHCERDIDECASNPCLNGGHCQNEINRFQCLCPTGFSGNLCQLDIDYCEPNPCQNGAQCYNRASDYFCKCPEDYEGKNCSHLKDHCRTTPCEVIDSCTVAMASNDTPEGVRYISSNVCGPHGKCKSQSGGKFTCDCNKGFTGTYCHENINDCESNPCRNGGTCIDGVNSYKCICSDGWEGAYCETNINDCSQNPCHNGGTCRDLVNDFYCDCKNGWKGKTCHSRDSQCDEATCNNGGTCYDEGDAFKCMCPGGWEGTTCNIARNSSCLPNPCHNGGTCVVNGESFTCVCKEGWEGPICAQNTNDCSPHPCYNSGTCVDGDNWYRCECAPGFAGPDCRININECQSSPCAFGATCVDEINGYRCVCPPGHSGAKCQEVSGRPCITMGSVIPDGAKWDDDCNTCQCLNGRIACSKVWCGPRPCLLHKGHSECPSGQSCIPILDDQCFVHPCTGVGECRSSSLQPVKTKCTSDSYYQDNCANITFTFNKEMMSPGLTTEHICSELRNLNILKNVSAEYSIYIACEPSPSANNEIHVAISAEDIRDDGNPIKEITDKIIDLVSKRDGNSSLIAAVAEVRVQRRPLKNRTDFLVPLLSSVLTVAWICCLVTAFYWCLRKRRKPGSHTHSASEDNTTNNVREQLNQIKNPIEKHGANTVPIKDYENKNSKMSKIRTHNSEVEEDDMDKHQQKARFAKQPAYTLVDREEKPPNGTPTKHPNWTNKQDNRDLESAQSLNRMEYIV,1218,"133,799",Alternative sequence (1); Beta strand (23); Chain (1); Disulfide bond (51); Domain (17); Frameshift (1); Glycosylation (9); Helix (1); Mutagenesis (1); Natural variant (69); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 187..196; DISULFID 200..212; DISULFID 220..229; DISULFID 234..245; DISULFID 238..251; DISULFID 253..262; DISULFID 265..276; DISULFID 271..282; DISULFID 284..293; DISULFID 300..312; DISULFID 306..322; DISULFID 324..333; DISULFID 340..351;  /evidence=""ECO:0000250""; DISULFID 345..360;  /evidence=""ECO:0000250""; DISULFID 362..371;  /evidence=""ECO:0000250""; DISULFID 378..389;  /evidence=""ECO:0000250""; DISULFID 383..398;  /evidence=""ECO:0000250""; DISULFID 400..409;  /evidence=""ECO:0000250""; DISULFID 416..427;  /evidence=""ECO:0000250""; DISULFID 421..436;  /evidence=""ECO:0000250""; DISULFID 438..447;  /evidence=""ECO:0000250""; DISULFID 454..464;  /evidence=""ECO:0000250""; DISULFID 458..473;  /evidence=""ECO:0000250""; DISULFID 475..484;  /evidence=""ECO:0000250""; DISULFID 491..502;  /evidence=""ECO:0000250""; DISULFID 496..511;  /evidence=""ECO:0000250""; DISULFID 513..522;  /evidence=""ECO:0000250""; DISULFID 529..540;  /evidence=""ECO:0000250""; DISULFID 534..549;  /evidence=""ECO:0000250""; DISULFID 551..560;  /evidence=""ECO:0000250""; DISULFID 578..605;  /evidence=""ECO:0000250""; DISULFID 599..615;  /evidence=""ECO:0000250""; DISULFID 617..626;  /evidence=""ECO:0000250""; DISULFID 633..644;  /evidence=""ECO:0000250""; DISULFID 638..653;  /evidence=""ECO:0000250""; DISULFID 655..664;  /evidence=""ECO:0000250""; DISULFID 671..682;  /evidence=""ECO:0000250""; DISULFID 676..691;  /evidence=""ECO:0000250""; DISULFID 693..702;  /evidence=""ECO:0000250""; DISULFID 709..720;  /evidence=""ECO:0000250""; DISULFID 714..729;  /evidence=""ECO:0000250""; DISULFID 731..740;  /evidence=""ECO:0000250""; DISULFID 748..759;  /evidence=""ECO:0000250""; DISULFID 753..768;  /evidence=""ECO:0000250""; DISULFID 770..779;  /evidence=""ECO:0000250""; DISULFID 786..797;  /evidence=""ECO:0000250""; DISULFID 791..806;  /evidence=""ECO:0000250""; DISULFID 808..817;  /evidence=""ECO:0000250""; DISULFID 824..835;  /evidence=""ECO:0000250""; DISULFID 829..844;  /evidence=""ECO:0000250""; DISULFID 846..855;  /evidence=""ECO:0000250""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q13349,Integrin alpha-D (ADB2) (CD11 antigen-like family member D) (Leukointegrin alpha D) (CD antigen CD11d),MTFGTVLLLSVLASYHGFNLDVEEPTIFQEDAGGFGQSVVQFGGSRLVVGAPLEVVAANQTGRLYDCAAATGMCQPIPLHIRPEAVNMSLGLTLAASTNGSRLLACGPTLHRVCGENSYSKGSCLLLGSRWEIIQTVPDATPECPHQEMDIVFLIDGSGSIDQNDFNQMKGFVQAVMGQFEGTDTLFALMQYSNLLKIHFTFTQFRTSPSQQSLVDPIVQLKGLTFTATGILTVVTQLFHHKNGARKSAKKILIVITDGQKYKDPLEYSDVIPQAEKAGIIRYAIGVGHAFQGPTARQELNTISSAPPQDHVFKVDNFAALGSIQKQLQEKIYAVEGTQSRASSSFQHEMSQEGFSTALTMDGLFLGAVGSFSWSGGAFLYPPNMSPTFINMSQENVDMRDSYLGYSTELALWKGVQNLVLGAPRYQHTGKAVIFTQVSRQWRKKAEVTGTQIGSYFGASLCSVDVDSDGSTDLILIGAPHYYEQTRGGQVSVCPLPRGRVQWQCDAVLRGEQGHPWGRFGAALTVLGDVNEDKLIDVAIGAPGEQENRGAVYLFHGASESGISPSHSQRIASSQLSPRLQYFGQALSGGQDLTQDGLMDLAVGARGQVLLLRSLPVLKVGVAMRFSPVEVAKAVYRCWEEKPSALEAGDATVCLTIQKSSLDQLGDIQSSVRFDLALDPGRLTSRAIFNETKNPTLTRRKTLGLGIHCETLKLLLPDCVEDVVSPIILHLNFSLVREPIPSPQNLRPVLAVGSQDLFTASLPFEKNCGQDGLCEGDLGVTLSFSGLQTLTVGSSLELNVIVTVWNAGEDSYGTVVSLYYPAGLSHRRVSGAQKQPHQSALRLACETVPTEDEGLRSSRCSVNHPIFHEGSNGTFIVTFDVSYKATLGDRMLMRASASSENNKASSSKATFQLELPVKYAVYTMISRQEESTKYFNFATSDEKKMKEAEHRYRVNNLSQRDLAISINFWVPVLLNGVAVWDVVMEAPSQSLPCVSERKPPQHSDFLTQISRSPMLDCSIADCLQFRCDVPSFSVQEELDFTLKGNLSFGWVRETLQKKVLVVSVAEITFDTSVYSQLPGQEAFMRAQMEMVLEEDEVYNAIPIIMGSSVGALLLLALITATLYKLGFFKRHYKEMLEDKPEDTATFSGDDFSCVAPNVPLS,1161,"126,758",Calcium binding (3); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (9); Motif (1); Repeat (7); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 67..74;  /evidence=""ECO:0000250""; DISULFID 106..124;  /evidence=""ECO:0000250""; DISULFID 654..709;  /evidence=""ECO:0000250""; DISULFID 768..774;  /evidence=""ECO:0000250""; DISULFID 845..860;  /evidence=""ECO:0000250""; DISULFID 993..1017;  /evidence=""ECO:0000250""; DISULFID 1022..1027;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q6GTX8,Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) (hLAIR1) (CD antigen CD305),MSPHPTALLGLVLCLAQTIHTQEEDLPRPSISAEPGTVIPLGSHVTFVCRGPVGVQTFRLERESRSTYNDTEDVSQASPSESEARFRIDSVSEGNAGPYRCIYYKPPKWSEQSDYLELLVKETSGGPDSPDTEPGSSAGPTQRPSDNSHNEHAPASQGLKAEHLYILIGVSVVFLFCLLLLVLFCLHRQNQIKQGPPRSKDEEQKPQQRPDLAVDVLERTADKATVNGLPEKDRETDTSALAAGSSQEVTYAQLDHWALTQRTARAVSPQSTKPMAESITYAAVARH,287,"31,412",Alternative sequence (3); Beta strand (9); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Helix (2); Modified residue (2); Motif (2); Mutagenesis (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..101;  /evidence=""ECO:0000269|PubMed:20007810""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P19256,Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58),MVAGSDAGRALGVLSVVCLLHCFGFISCFSQQIYGVVYGNVTFHVPSNVPLKEVLWKKQKDKVAELENSEFRAFSSFKNRVYLDTVSGSLTIYNLTSSDEDEYEMESPNITDTMKFFLYVLESLPSPTLTCALTNGSIEVQCMIPEHYNSHRGLIMYSWDCPMEQCKRNSTSIYFKMENDLPQKIQCTLSNPLFNTTSSIILTTCIPSSGHSRHRYALIPIPLAVITTCIVLYMNGILKCDRKPDRTNSN,250,"28,147",Alternative sequence (3); Beta strand (9); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (6); Helix (2); Mutagenesis (6); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 142..187;  /evidence=""ECO:0000250""",SIGNAL 1..28
Q86YC3,Transforming growth factor beta activator LRRC33 (Leucine-rich repeat-containing protein 33) (Negative regulator of reactive oxygen species),MELLPLWLCLGFHFLTVGWRNRSGTATAASQGVCKLVGGAADCRGQSLASVPSSLPPHARMLTLDANPLKTLWNHSLQPYPLLESLSLHSCHLERISRGAFQEQGHLRSLVLGDNCLSENYEETAAALHALPGLRRLDLSGNALTEDMAALMLQNLSSLRSVSLAGNTIMRLDDSVFEGLERLRELDLQRNYIFEIEGGAFDGLAELRHLNLAFNNLPCIVDFGLTRLRVLNVSYNVLEWFLATGGEAAFELETLDLSHNQLLFFPLLPQYSKLRTLLLRDNNMGFYRDLYNTSSPREMVAQFLLVDGNVTNITTVSLWEEFSSSDLADLRFLDMSQNQFQYLPDGFLRKMPSLSHLNLHQNCLMTLHIREHEPPGALTELDLSHNQLSELHLAPGLASCLGSLRLFNLSSNQLLGVPPGLFANARNITTLDMSHNQISLCPLPAASDRVGPPSCVDFRNMASLRSLSLEGCGLGALPDCPFQGTSLTYLDLSSNWGVLNGSLAPLQDVAPMLQVLSLRNMGLHSSFMALDFSGFGNLRDLDLSGNCLTTFPRFGGSLALETLDLRRNSLTALPQKAVSEQLSRGLRTIYLSQNPYDCCGVDGWGALQHGQTVADWAMVTCNLSSKIIRVTELPGGVPRDCKWERLDLGLLYLVLILPSCLTLLVACTVIVLTFKKPLLQVIKSRCHWSSVY,692,"76,366",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (11); Natural variant (2); Repeat (21); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 219;  /note=""Interchain (with C-? in TGFB1); in linked form"";  /evidence=""ECO:0000250|UniProtKB:Q8BMT4""; DISULFID 363;  /note=""Interchain (with C-? in TGFB1); in linked form"";  /evidence=""ECO:0000250|UniProtKB:Q8BMT4""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q6ZSA7,Leucine-rich repeat-containing protein 55 (BK channel auxiliary gamma subunit LRRC55),MGDTWAQLPWPGPPHPAMLLISLLLAAGLMHSDAGTSCPVLCTCRNQVVDCSSQRLFSVPPDLPMDTRNLSLAHNRITAVPPGYLTCYMELQVLDLHNNSLMELPRGLFLHAKRLAHLDLSYNNFSHVPADMFQEAHGLVHIDLSHNPWLRRVHPQAFQGLMQLRDLDLSYGGLAFLSLEALEGLPGLVTLQIGGNPWVCGCTMEPLLKWLRNRIQRCTADSQLAECRGPPEVEGAPLFSLTEESFKACHLTLTLDDYLFIAFVGFVVSIASVATNFLLGITANCCHRWSKASEEEEI,298,"33,009",Chain (1); Compositional bias (1); Disulfide bond (4); Domain (2); Erroneous initiation (4); Repeat (5); Signal peptide (1); Transmembrane (1),"DISULFID 38..44;  /evidence=""ECO:0000255""; DISULFID 42..51;  /evidence=""ECO:0000255""; DISULFID 200..227;  /evidence=""ECO:0000255""; DISULFID 202..249;  /evidence=""ECO:0000255""","SIGNAL 1..34;  /evidence=""ECO:0000269|PubMed:15340161"""
P51512,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),MILLTFSTGRRLDFVHHSGVFFLQTLLWILCATVCGTEQYFNVEVWLQKYGYLPPTDPRMSVLRSAETMQSALAAMQQFYGINMTGKVDRNTIDWMKKPRCGVPDQTRGSSKFHIRRKRYALTGQKWQHKHITYSIKNVTPKVGDPETRKAIRRAFDVWQNVTPLTFEEVPYSELENGKRDVDITIIFASGFHGDSSPFDGEGGFLAHAYFPGPGIGGDTHFDSDEPWTLGNPNHDGNDLFLVAVHELGHALGLEHSNDPTAIMAPFYQYMETDNFKLPNDDLQGIQKIYGPPDKIPPPTRPLPTVPPHRSIPPADPRKNDRPKPPRPPTGRPSYPGAKPNICDGNFNTLAILRREMFVFKDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYENSDGNFVFFKGNKYWVFKDTTLQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESPQGAFVHKENGFTYFYKGKEYWKFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCLLVLVYTVFQFKRKGTPRHILYCKRSMQEWV,607,"69,521",Active site (1); Alternative sequence (2); Beta strand (11); Chain (1); Disulfide bond (1); Glycosylation (1); Helix (3); Metal binding (16); Motif (1); Propeptide (1); Repeat (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 343..532;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q29983,MHC class I polypeptide-related sequence A (MIC-A),MGLGPVFLLLAGIFPFAPPGAAAEPHSLRYNLTVLSWDGSVQSGFLTEVHLDGQPFLRCDRQKCRAKPQGQWAEDVLGNKTWDRETRDLTGNGKDLRMTLAHIKDQKEGLHSLQEIRVCEIHEDNSTRSSQHFYYDGELFLSQNLETKEWTMPQSSRAQTLAMNVRNFLKEDAMKTKTHYHAMHADCLQELRRYLKSGVVLRRTVPPMVNVTRSEASEGNITVTCRASGFYPWNITLSWRQDGVSLSHDTQQWGDVLPDGNGTYQTWVATRICQGEEQRFTCYMEHSGNHSTHPVPSGKVLVLQSHWQTFHVSAVAAAAIFVIIIFYVRCCKKKTSAAEGPELVSLQVLDQHPVGTSDHRDATQLGFQPLMSDLGSTGSTEGA,383,"42,915",Alternative sequence (1); Beta strand (17); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (5); Helix (5); Natural variant (44); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 59..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10367903""; DISULFID 119..187;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10367903""; DISULFID 225..282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10367903""",SIGNAL 1..23
Q5SSG8,Mucin-21 (MUC-21) (Epiglycanin),MKMQKGNVLLMFGLLLHLEAATNSNETSTSANTGSSVISSGASTATNSGSSVTSSGVSTATISGSSVTSNGVSIVTNSEFHTTSSGISTATNSEFSTVSSGISIATNSESSTTSSGASTATNSESSTPSSGASTATNSDSSTTSSGASTATNSDSSTTSSEASTATNSESSTTSSGASTATNSESSTVSSRASTATNSESSTTSSGASTATNSESRTTSNGAGTATNSESSTTSSGASTATNSESSTPSSGAGTATNSESSTTSSGAGTATNSESSTVSSGISTVTNSESSTPSSGANTATNSESSTTSSGANTATNSDSSTTSSGASTATNSESSTTSSGASTATNSESSTTSSGASTATNSGSSTTSSGTSTATNSESSTVSSGASTATTSESSTTSSGASTATNSESSTVSSGASTATNSESSTTSSGANTATNSGSSVTSAGSGTAALTGMHTTSHSASTAVSEAKPGGSLVPWEIFLITLVSVVAAVGLFAGLFFCVRNSLSLRNTFNTAVYHPHGLNHGLGPGPGGNHGAPHRPRWSPNWFWRRPVSSIAMEMSGRNSGP,566,"54,228",Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (1); Natural variant (14); Region (2); Repeat (28); Sequence conflict (39); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q04900,Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v) (CD antigen CD164),MSRLSRSLLWAATCLGVLCVLSADKNTTQHPNVTTLAPISNVTSAPVTSLPLVTTPAPETCEGRNSCVSCFNVSVVNTTCFWIECKDESYCSHNSTVSDCQVGNTTDFCSVSTATPVPTANSTAKPTVQPSPSTTSKTVTTSGTTNNTVTPTSQPVRKSTFDAASFIGGIVLVLGVQAVIFFLYKFCKSKERNYHTL,197,"20,917",Alternative sequence (5); Chain (1); Compositional bias (1); Glycosylation (10); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9Y5H6,Protocadherin alpha-8 (PCDH-alpha-8),MDYHWRGELGSWRLLLLLLLLAAWKVGSGQLHYSVPEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKRHRDLLEVSLQNGILFVNSRIDREELCGRSAECSIHLEVIVDRPLQVFHVDVEVKDVNDNPPVFRVKDQKLFVSESRMPDSRFPLEGASDADVGANSVLTYRLSSHDYFMLDVNSKNDENKLVELVLRKSLDREDAPAHHLFLTATDGGKPELTGTVQLLVTVLDVNDNAPTFEQSEYEVRIFENADNGTTVIKLNASDPDEGANGAISYSFNSLVETMVIDHFSIDRNTGEIVIRGNLDFEQENLYKILIDATDKGHPPMAGHCTVLVRILDKNDNVPEIALTSLSLPVREDAQFGTVIALISVNDLDSGANGQVTCSLMPHVPFKLVSTFKNYYSLVLDSALDRERVSAYELVVTARDGGSPSLWATASLSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRVGERSLSSYISVHTESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLEPRVGGTGGAASKLVPRSVGAGHVVAKVRAVDADSGYNAWLSYELQPAASSPRIPFRVGLYTGEISTTRVLDEADSPRHRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRQSAGVLGPEAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSALPTEGGCRAGKPTLVCSSAVGSWSYSQQQPQRVCSGEGPPKTDLMAFSPCLPPDLGSVDVGEEQDLNVDHGLKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"103,051",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (3); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
P01833,Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component],MLLFVLTCLLAVFPAISTKSPIFGPEEVNSVEGNSVSITCYYPPTSVNRHTRKYWCRQGARGGCITLISSEGYVSSKYAGRANLTNFPENGTFVVNIAQLSQDDSGRYKCGLGINSRGLSFDVSLEVSQGPGLLNDTKVYTVDLGRTVTINCPFKTENAQKRKSLYKQIGLYPVLVIDSSGYVNPNYTGRIRLDIQGTGQLLFSVVINQLRLSDAGQYLCQAGDDSNSNKKNADLQVLKPEPELVYEDLRGSVTFHCALGPEVANVAKFLCRQSSGENCDVVVNTLGKRAPAFEGRILLNPQDKDGSFSVVITGLRKEDAGRYLCGAHSDGQLQEGSPIQAWQLFVNEESTIPRSPTVVKGVAGGSVAVLCPYNRKESKSIKYWCLWEGAQNGRCPLLVDSEGWVKAQYEGRLSLLEEPGNGTFTVILNQLTSRDAGFYWCLTNGDTLWRTTVEIKIIEGEPNLKVPGNVTAVLGETLKVPCHFPCKFSSYEKYWCKWNNTGCQALPSQDEGPSKAFVNCDENSRLVSLTLNLVTRADEGWYWCGVKQGHFYGETAAVYVAVEERKAAGSRDVSLAKADAAPDEKVLDSGFREIENKAIQDPRLFAEEKAVADTRDQADGSRASVDSGSSEEQGGSSRALVSTLVPLGLVLAVGAVAVGVARARHRKNVDRVSIRSYRTDISMSDFENSREFGANDNMGASSITQETSLGGKEEFVATTESTTETKEPKKAKRSSKEEAEMAYKDFLLQSSTVAAEAQDGPQEA,764,"83,284",Beta strand (51); Chain (2); Disulfide bond (11); Domain (5); Glycosylation (7); Helix (11); Modified residue (4); Natural variant (3); Sequence conflict (20); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 40..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 56..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 152..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 257..325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 271..279;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 371..441;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 385..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 482..544;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 486..520;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 496..503;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:6526384""; DISULFID 503;  /note=""Interchain (with C-179 of IGHA2/constant region of IgA2 heavy chain)"";  /evidence=""ECO:0000269|PubMed:32029686, ECO:0000269|PubMed:8292260""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:1859628, ECO:0000269|PubMed:6526384"""
Q8N7C0,Leucine-rich repeat-containing protein 52 (BK channel auxiliary gamma subunit LRRC52),MSLASGPGPGWLLFSFGMGLVSGSKCPNNCLCQAQEVICTGKQLTEYPLDIPLNTRRLFLNENRITSLPAMHLGLLSDLVYLDCQNNRIREVMDYTFIGVFKLIYLDLSSNNLTSISPFTFSVLSNLVQLNIANNPHLLSLHKFTFANTTSLRYLDLRNTGLQTLDSAALYHLTTLETLFLSGNPWKCNCSFLDFAIFLIVFHMDPSDDLNATCVEPTELTGWPITRVGNPLRYMCITHLDHKDYIFLLLIGFCIFAAGTVAAWLTGVCAVLYQNTRHKSSEEDEDEAGTRVEVSRRIFQTQTSSVQEFPQLI,313,"35,126",Chain (1); Disulfide bond (4); Domain (2); Glycosylation (4); Natural variant (1); Repeat (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 26..32;  /evidence=""ECO:0000255""; DISULFID 30..39;  /evidence=""ECO:0000255""; DISULFID 188..214;  /evidence=""ECO:0000255""; DISULFID 190..236;  /evidence=""ECO:0000255""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O75074,Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105),MEKRAAAGLEGAPGARAQLAVVCLVNIFLTGRLSSAVPALAACSGKLEQHTERRGVIYSPAWPLNYPPGTNCSWYIQGDRGDMITISFRNFDVEESHQCSLDWLLLGPAAPPRQEAFRLCGSAIPPAFISARDHVWIFFHSDASSSGQAQGFRLSYIRGKLGQASCQADEFRCDNGKCLPGPWQCNTVDECGDGSDEGNCSAPASEPPGSLCPGGTFPCSGARSTRCLPVERRCDGLQDCGDGSDEAGCPDLACGRRLGSFYGSFASPDLFGAARGPSDLHCTWLVDTQDSRRVLLQLELRLGYDDYVQVYEGLGERGDRLLQTLSYRSNHRPVSLEAAQGRLTVAYHARARSAGHGFNATYQVKGYCLPWEQPCGSSSDSDGGSLGDQGCFSEPQRCDGWWHCASGRDEQGCPACPPDQYPCEGGSGLCYTPADRCNNQKSCPDGADEKNCFSCQPGTFHCGTNLCIFETWRCDGQEDCQDGSDEHGCLAAVPRKVITAALIGSLVCGLLLVIALGCAFKLYSLRTQEYRAFETQMTRLEAEFVRREAPPSYGQLIAQGLIPPVEDFPVYSASQASVLQNLRTAMRRQMRRHASRRGPSRRRLGRLWNRLFHRPRAPRGQIPLLTAARPSQTVLGDGFLQPAPGAAPDPPAPLMDTGSTRAAGDRPPSAPGRAPEVGPSGPPLPSGLRDPECRPVDKDRKVCREPLVDGPAPADAPREPCSAQDPHPQVSTASSTLGPHSPEPLGVCRNPPPPCSPMLEASDDEALLVC,770,"82,884",Chain (1); Compositional bias (1); Disulfide bond (15); Domain (6); Erroneous initiation (2); Glycosylation (3); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..72;  /evidence=""ECO:0000250""; DISULFID 99..120;  /evidence=""ECO:0000250""; DISULFID 166..178;  /evidence=""ECO:0000250""; DISULFID 173..191;  /evidence=""ECO:0000250""; DISULFID 185..200;  /evidence=""ECO:0000250""; DISULFID 212..227;  /evidence=""ECO:0000250""; DISULFID 219..240;  /evidence=""ECO:0000250""; DISULFID 234..249;  /evidence=""ECO:0000250""; DISULFID 254..282;  /evidence=""ECO:0000250""; DISULFID 416..430;  /evidence=""ECO:0000250""; DISULFID 423..443;  /evidence=""ECO:0000250""; DISULFID 437..452;  /evidence=""ECO:0000250""; DISULFID 455..467;  /evidence=""ECO:0000250""; DISULFID 462..480;  /evidence=""ECO:0000250""; DISULFID 474..489;  /evidence=""ECO:0000250""","SIGNAL 1..36;  /evidence=""ECO:0000255"""
Q5VT99,Leucine-rich repeat-containing protein 38 (BK channel auxiliary gamma subunit LRRC38),MRPRAPACAAAALGLCSLLLLLAPGHACPAGCACTDPHTVDCRDRGLPSVPDPFPLDVRKLLVAGNRIQRIPEDFFIFYGDLVYLDFRNNSLRSLEEGTFSGSAKLVFLDLSYNNLTQLGAGAFRSAGRLVKLSLANNNLVGVHEDAFETLESLQVLELNDNNLRSLSVAALAALPALRSLRLDGNPWLCDCDFAHLFSWIQENASKLPKGLDEIQCSLPMESRRISLRELSEASFSECRFSLSLTDLCIIIFSGVAVSIAAIISSFFLATVVQCLQRCAPNKDAEDEDEDKDD,294,"32,082",Chain (1); Disulfide bond (4); Domain (2); Frameshift (1); Natural variant (2); Repeat (5); Signal peptide (1); Transmembrane (1),"DISULFID 28..34;  /evidence=""ECO:0000255""; DISULFID 32..42;  /evidence=""ECO:0000255""; DISULFID 190..217;  /evidence=""ECO:0000255""; DISULFID 192..239;  /evidence=""ECO:0000255""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
O75197,Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7),MEAAPPGPPWPLLLLLLLLLALCGCPAPAAASPLLLFANRRDVRLVDAGGVKLESTIVVSGLEDAAAVDFQFSKGAVYWTDVSEEAIKQTYLNQTGAAVQNVVISGLVSPDGLACDWVGKKLYWTDSETNRIEVANLNGTSRKVLFWQDLDQPRAIALDPAHGYMYWTDWGETPRIERAGMDGSTRKIIVDSDIYWPNGLTIDLEEQKLYWADAKLSFIHRANLDGSFRQKVVEGSLTHPFALTLSGDTLYWTDWQTRSIHACNKRTGGKRKEILSALYSPMDIQVLSQERQPFFHTRCEEDNGGCSHLCLLSPSEPFYTCACPTGVQLQDNGRTCKAGAEEVLLLARRTDLRRISLDTPDFTDIVLQVDDIRHAIAIDYDPLEGYVYWTDDEVRAIRRAYLDGSGAQTLVNTEINDPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTSRKILVSEDLDEPRAIALHPVMGLMYWTDWGENPKIECANLDGQERRVLVNASLGWPNGLALDLQEGKLYWGDAKTDKIEVINVDGTKRRTLLEDKLPHIFGFTLLGDFIYWTDWQRRSIERVHKVKASRDVIIDQLPDLMGLKAVNVAKVVGTNPCADRNGGCSHLCFFTPHATRCGCPIGLELLSDMKTCIVPEAFLVFTSRAAIHRISLETNNNDVAIPLTGVKEASALDFDVSNNHIYWTDVSLKTISRAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFGLTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQDGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCSPPTTFLLFSQKSAISRMIPDDQHSPDLILPLHGLRNVKAIDYDPLDKFIYWVDGRQNIKRAKDDGTQPFVLTSLSQGQNPDRQPHDLSIDIYSRTLFWTCEATNTINVHRLSGEAMGVVLRGDRDKPRAIVVNAERGYLYFTNMQDRAAKIERAALDGTEREVLFTTGLIRPVALVVDNTLGKLFWVDADLKRIESCDLSGANRLTLEDANIVQPLGLTILGKHLYWIDRQQQMIERVEKTTGDKRTRIQGRVAHLTGIHAVEEVSLEEFSAHPCARDNGGCSHICIAKGDGTPRCSCPVHLVLLQNLLTCGEPPTCSPDQFACATGEIDCIPGAWRCDGFPECDDQSDEEGCPVCSAAQFPCARGQCVDLRLRCDGEADCQDRSDEADCDAICLPNQFRCASGQCVLIKQQCDSFPDCIDGSDELMCEITKPPSDDSPAHSSAIGPVIGIILSLFVMGGVYFVCQRVVCQRYAGANGPFPHEYVSGTPHVPLNFIAPGGSQHGPFTGIACGKSMMSSVSLMGGRGGVPLYDRNHVTGASSSSSSSTKATLYPPILNPPPSPATDPSLYNMDMFYSSNIPATARPYRPYIIRGMAPPTTPCSTDVCDSDYSASRWKASKYYLDLNSDSDPYPPPPTPHSQYLSAEDSCPPSPATERSYFHLFPPPPSPCTDSS,1615,"179,145",Chain (1); Compositional bias (1); Disulfide bond (21); Domain (7); Glycosylation (6); Motif (5); Natural variant (83); Region (4); Repeat (31); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 299..310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 306..321;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 323..336;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 605..616;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 612..625;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 627..640;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 906..917;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 913..926;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 928..941;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1217..1228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1224..1238;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1240..1253;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1259..1273;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1266..1286;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1280..1295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1298..1310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1305..1323;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1317..1332;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1336..1348;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1343..1361;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 1355..1370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
O60449,Lymphocyte antigen 75 (Ly-75) (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205),MRTGWATPRRPAGLLMLLFWFFDLAEPSGRAANDPFTIVHGNTGKCIKPVYGWIVADDCDETEDKLWKWVSQHRLFHLHSQKCLGLDITKSVNELRMFSCDSSAMLWWKCEHHSLYGAARYRLALKDGHGTAISNASDVWKKGGSEESLCDQPYHEIYTRDGNSYGRPCEFPFLIDGTWHHDCILDEDHSGPWCATTLNYEYDRKWGICLKPENGCEDNWEKNEQFGSCYQFNTQTALSWKEAYVSCQNQGADLLSINSAAELTYLKEKEGIAKIFWIGLNQLYSARGWEWSDHKPLNFLNWDPDRPSAPTIGGSSCARMDAESGLWQSFSCEAQLPYVCRKPLNNTVELTDVWTYSDTRCDAGWLPNNGFCYLLVNESNSWDKAHAKCKAFSSDLISIHSLADVEVVVTKLHNEDIKEEVWIGLKNINIPTLFQWSDGTEVTLTYWDENEPNVPYNKTPNCVSYLGELGQWKVQSCEEKLKYVCKRKGEKLNDASSDKMCPPDEGWKRHGETCYKIYEDEVPFGTNCNLTITSRFEQEYLNDLMKKYDKSLRKYFWTGLRDVDSCGEYNWATVGGRRRAVTFSNWNFLEPASPGGCVAMSTGKSVGKWEVKDCRSFKALSICKKMSGPLGPEEASPKPDDPCPEGWQSFPASLSCYKVFHAERIVRKRNWEEAERFCQALGAHLSSFSHVDEIKEFLHFLTDQFSGQHWLWIGLNKRSPDLQGSWQWSDRTPVSTIIMPNEFQQDYDIRDCAAVKVFHRPWRRGWHFYDDREFIYLRPFACDTKLEWVCQIPKGRTPKTPDWYNPDRAGIHGPPLIIEGSEYWFVADLHLNYEEAVLYCASNHSFLATITSFVGLKAIKNKIANISGDGQKWWIRISEWPIDDHFTYSRYPWHRFPVTFGEECLYMSAKTWLIDLGKPTDCSTKLPFICEKYNVSSLEKYSPDSAAKVQCSEQWIPFQNKCFLKIKPVSLTFSQASDTCHSYGGTLPSVLSQIEQDFITSLLPDMEATLWIGLRWTAYEKINKWTDNRELTYSNFHPLLVSGRLRIPENFFEEESRYHCALILNLQKSPFTGTWNFTSCSERHFVSLCQKYSEVKSRQTLQNASETVKYLNNLYKIIPKTLTWHSAKRECLKSNMQLVSITDPYQQAFLSVQALLHNSSLWIGLFSQDDELNFGWSDGKRLHFSRWAETNGQLEDCVVLDTDGFWKTVDCNDNQPGAICYYSGNETEKEVKPVDSVKCPSPVLNTPWIPFQNCCYNFIITKNRHMATTQDEVHTKCQKLNPKSHILSIRDEKENNFVLEQLLYFNYMASWVMLGITYRNKSLMWFDKTPLSYTHWRAGRPTIKNEKFLAGLSTDGFWDIQTFKVIEEAVYFHQHSILACKIEMVDYKEEYNTTLPQFMPYEDGIYSVIQKKVTWYEALNMCSQSGGHLASVHNQNGQLFLEDIVKRDGFPLWVGLSSHDGSESSFEWSDGSTFDYIPWKGQTSPGNCVLLDPKGTWKHEKCNSVKDGAICYKPTKSKKLSRLTYSSRCPAAKENGSRWIQYKGHCYKSDQALHSFSEAKKLCSKHDHSATIVSIKDEDENKFVSRLMRENNNITMRVWLGLSQHSVDQSWSWLDGSEVTFVKWENKSKSGVGRCSMLIASNETWKKVECEHGFGRVVCKVPLGPDYTAIAIIVATLSILVLMGGLIWFLFQRHRLHLAGFSSVRYAQGVNEDEIMLPSFHD,1722,"198,311",Alternative sequence (2); Chain (1); Disulfide bond (13); Domain (12); Glycosylation (14); Modified residue (3); Natural variant (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 169..194;  /evidence=""ECO:0000250""; DISULFID 183..209;  /evidence=""ECO:0000250""; DISULFID 247..340;  /evidence=""ECO:0000250""; DISULFID 317..332;  /evidence=""ECO:0000250""; DISULFID 389..485;  /evidence=""ECO:0000250""; DISULFID 462..477;  /evidence=""ECO:0000250""; DISULFID 597..614;  /evidence=""ECO:0000250""; DISULFID 840..930;  /evidence=""ECO:0000250""; DISULFID 904..922;  /evidence=""ECO:0000250""; DISULFID 1060..1080;  /evidence=""ECO:0000250""; DISULFID 1197..1211;  /evidence=""ECO:0000250""; DISULFID 1488..1502;  /evidence=""ECO:0000250""; DISULFID 1635..1650;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:9862343"""
P59901,Leukocyte immunoglobulin-like receptor subfamily A member 4 (CD85 antigen-like family member G) (Immunoglobulin-like transcript 7) (ILT-7) (CD antigen CD85g),MTLILTSLLFFGLSLGPRTRVQAENLPKPILWAEPGPVITWHNPVTIWCQGTLEAQGYRLDKEGNSMSRHILKTLESENKVKLSIPSMMWEHAGRYHCYYQSPAGWSEPSDPLELVVTAYSRPTLSALPSPVVTSGVNVTLRCASRLGLGRFTLIEEGDHRLSWTLNSHQHNHGKFQALFPMGPLTFSNRGTFRCYGYENNTPYVWSEPSDPLQLLVSGVSRKPSLLTLQGPVVTPGENLTLQCGSDVGYIRYTLYKEGADGLPQRPGRQPQAGLSQANFTLSPVSRSYGGQYRCYGAHNVSSEWSAPSDPLDILIAGQISDRPSLSVQPGPTVTSGEKVTLLCQSWDPMFTFLLTKEGAAHPPLRLRSMYGAHKYQAEFPMSPVTSAHAGTYRCYGSRSSNPYLLSHPSEPLELVVSGATETLNPAQKKSDSKTAPHLQDYTVENLIRMGVAGLVLLFLGILLFEAQHSQRSPPRCSQEANSRKDNAPFRVVEPWEQI,499,"55,165",Alternative sequence (1); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (4); Modified residue (1); Natural variant (2); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 244..295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9H8J5,MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein),MFFGGEGSLTYTLVIICFLTLRLSASQNCLKKSLEDVVIDIQSSLSKGIRGNEPVYTSTQEDCINSCCSTKNISGDKACNLMIFDTRKTARQPNCYLFFCPNEEACPLKPAKGLMSYRIITDFPSLTRNLPSQELPQEDSLLHGQFSQAVTPLAHHHTDYSKPTDISWRDTLSQKFGSSDHLEKLFKMDEASAQLLAYKEKGHSQSSQFSSDQEIAHLLPENVSALPATVAVASPHTTSATPKPATLLPTNASVTPSGTSQPQLATTAPPVTTVTSQPPTTLISTVFTRAAATLQAMATTAVLTTTFQAPTDSKGSLETIPFTEISNLTLNTGNVYNPTALSMSNVESSTMNKTASWEGREASPGSSSQGSVPENQYGLPFEKWLLIGSLLFGVLFLVIGLVLLGRILSESLRRKRYSRLDYLINGIYVDI,431,"46,810",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Glycosylation (5); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q99102,Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)],MKGARWRRVPWVSLSCLCLCLLPHVVPGTTEDTLITGSKTAAPVTSTGSTTATLEGQSTAASSRTSNQDISASSQNHQTKSTETTSKAQTDTLTQMMTSTLFSSPSVHNVMETVTQETAPPDEMTTSFPSSVTNTLMMTSKTITMTTSTDSTLGNTEETSTAGTESSTPVTSAVSITAGQEGQSRTTSWRTSIQDTSASSQNHWTRSTQTTRESQTSTLTHRTTSTPSFSPSVHNVTGTVSQKTSPSGETATSSLCSVTNTSMMTSEKITVTTSTGSTLGNPGETSSVPVTGSLMPVTSAALVTVDPEGQSPATFSRTSTQDTTAFSKNHQTQSVETTRVSQINTLNTLTPVTTSTVLSSPSGFNPSGTVSQETFPSGETTISSPSSVSNTFLVTSKVFRMPISRDSTLGNTEETSLSVSGTISAITSKVSTIWWSDTLSTALSPSSLPPKISTAFHTQQSEGAETTGRPHERSSFSPGVSQEIFTLHETTTWPSSFSSKGHTTWSQTELPSTSTGAATRLVTGNPSTRAAGTIPRVPSKVSAIGEPGEPTTYSSHSTTLPKTTGAGAQTQWTQETGTTGEALLSSPSYSVIQMIKTATSPSSSPMLDRHTSQQITTAPSTNHSTIHSTSTSPQESPAVSQRGHTRAPQTTQESQTTRSVSPMTDTKTVTTPGSSFTASGHSPSEIVPQDAPTISAATTFAPAPTGNGHTTQAPTTALQAAPSSHDATLGPSGGTSLSKTGALTLANSVVSTPGGPEGQWTSASASTSPDTAAAMTHTHQAESTEASGQTQTSEPASSGSRTTSAGTATPSSSGASGTTPSGSEGISTSGETTRFSSNPSRDSHTTQSTTELLSASASHGAIPVSTGMASSIVPGTFHPTLSEASTAGRPTGQSSPTSPSASPQETAAISRMAQTQRTGTSRGSDTISLASQATDTFSTVPPTPPSITSSGLTSPQTQTHTLSPSGSGKTFTTALISNATPLPVTSTSSASTGHATPLAVSSATSASTVSSDSPLKMETSGMTTPSLKTDGGRRTATSPPPTTSQTIISTIPSTAMHTRSTAAPIPILPERGVSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPLGSSLRDSLYFTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWDDADFSTGRGTTFYQEYETFYGEHSLLVQQAESWIRKMTNNGGYKARWALKVTWVNAHAYPAQWTLGSNTYQAILSTDGSRSYALFLYQSGGMQWDVAQRSGNPVLMGFSSGDGYFENSPLMSQPVWERYRPDRFLNSNSGLQGLQFYRLHREERPNYRLECLQWLKSQPRWPSWGWNQVSCPCSWQQGRRDLRFQPVSIGRWGLGSRQLCSFTSWRGGVCCSYGPWGEFREGWHVQRPWQLAQELEPQSWCCRWNDKPYLCALYQQRRPHVGCATYRPPQPAWMFGDPHITTLDGVSYTFNGLGDFLLVGAQDGNSSFLLQGRTAQTGSAQATNFIAFAAQYRSSSLGPVTVQWLLEPHDAIRVLLDNQTVTFQPDHEDGGGQETFNATGVLLSRNGSEVSASFDGWATVSVIALSNILHASASLPPEYQNRTEGLLGVWNNNPEDDFRMPNGSTIPPGSPEEMLFHFGMTWQINGTGLLGKRNDQLPSNFTPVFYSQLQKNSSWAEHLISNCDGDSSCIYDTLALRNASIGLHTREVSKNYEQANATLNQYPPSINGGRVIEAYKGQTTLIQYTSNAEDANFTLRDSCTDLELFENGTLLWTPKSLEPFTLEILARSAKIGLASALQPRTVVCHCNAESQCLYNQTSRVGNSSLEVAGCKCDGGTFGRYCEGSEDACEEPCFPSVHCVPGKGCEACPPNLTGDGRHCAALGSSFLCQNQSCPVNYCYNQGHCYISQTLGCQPMCTCPPAFTDSRCFLAGNNFSPTVNLELPLRVIQLLLSEEENASMAEVNASVAYRLGTLDMRAFLRNSQVERIDSAAPASGSPIQHWMVISEFQYRPRGPVIDFLNNQLLAAVVEAFLYHVPRRSEEPRNDVVFQPISGEDVRDVTALNVSTLKAYFRCDGYKGYDLVYSPQSGFTCVSPCSRGYCDHGGQCQHLPSGPRCSCVSFSIYTAWGEHCEHLSMKLDAFFGIFFGALGGLLLLGVGTFVVLRFWGCSGARFSYFLNSAEALP,2169,"231,518",Alternative sequence (22); Chain (3); Compositional bias (1); Disulfide bond (6); Domain (5); Frameshift (2); Glycosylation (23); Natural variant (8); Region (1); Sequence caution (1); Sequence conflict (34); Signal peptide (1); Site (1); Transmembrane (1),"DISULFID 1879..1890;  /evidence=""ECO:0000250""; DISULFID 1884..1902;  /evidence=""ECO:0000250""; DISULFID 1904..1913;  /evidence=""ECO:0000250""; DISULFID 2081..2092;  /evidence=""ECO:0000250""; DISULFID 2086..2101;  /evidence=""ECO:0000250""; DISULFID 2103..2116;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
O95944,Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein) (NK-p44) (NKp44) (CD antigen CD336),MAWRALHPLLLLLLLFPGSQAQSKAQVLQSVAGQTLTVRCQYPPTGSLYEKKGWCKEASALVCIRLVTSSKPRTMAWTSRFTIWDDPDAGFFTVTMTDLREEDSGHYWCRIYRPSDNSVSKSVRFYLVVSPASASTQTSWTPRDLVSSQTQTQSCVPPTAGARQAPESPSTIPVPSQPQNSTLRPGPAAPIALVPVFCGLLVAKSLVLSALLVWWGDIWWKTMMELRSLDTQKATCHLQQVTDLPWTSVSSPVEREILYHTVARTKISDDDDEHTL,276,"30,677",Alternative sequence (2); Beta strand (8); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (1); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 40..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 55..63;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q04721,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],MPALRPALLWALLALWLCCAAPAHALQCRDGYEPCVNEGMCVTYHNGTGYCKCPEGFLGEYCQHRDPCEKNRCQNGGTCVAQAMLGKATCRCASGFTGEDCQYSTSHPCFVSRPCLNGGTCHMLSRDTYECTCQVGFTGKECQWTDACLSHPCANGSTCTTVANQFSCKCLTGFTGQKCETDVNECDIPGHCQHGGTCLNLPGSYQCQCPQGFTGQYCDSLYVPCAPSPCVNGGTCRQTGDFTFECNCLPGFEGSTCERNIDDCPNHRCQNGGVCVDGVNTYNCRCPPQWTGQFCTEDVDECLLQPNACQNGGTCANRNGGYGCVCVNGWSGDDCSENIDDCAFASCTPGSTCIDRVASFSCMCPEGKAGLLCHLDDACISNPCHKGALCDTNPLNGQYICTCPQGYKGADCTEDVDECAMANSNPCEHAGKCVNTDGAFHCECLKGYAGPRCEMDINECHSDPCQNDATCLDKIGGFTCLCMPGFKGVHCELEINECQSNPCVNNGQCVDKVNRFQCLCPPGFTGPVCQIDIDDCSSTPCLNGAKCIDHPNGYECQCATGFTGVLCEENIDNCDPDPCHHGQCQDGIDSYTCICNPGYMGAICSDQIDECYSSPCLNDGRCIDLVNGYQCNCQPGTSGVNCEINFDDCASNPCIHGICMDGINRYSCVCSPGFTGQRCNIDIDECASNPCRKGATCINGVNGFRCICPEGPHHPSCYSQVNECLSNPCIHGNCTGGLSGYKCLCDAGWVGINCEVDKNECLSNPCQNGGTCDNLVNGYRCTCKKGFKGYNCQVNIDECASNPCLNQGTCFDDISGYTCHCVLPYTGKNCQTVLAPCSPNPCENAAVCKESPNFESYTCLCAPGWQGQRCTIDIDECISKPCMNHGLCHNTQGSYMCECPPGFSGMDCEEDIDDCLANPCQNGGSCMDGVNTFSCLCLPGFTGDKCQTDMNECLSEPCKNGGTCSDYVNSYTCKCQAGFDGVHCENNINECTESSCFNGGTCVDGINSFSCLCPVGFTGSFCLHEINECSSHPCLNEGTCVDGLGTYRCSCPLGYTGKNCQTLVNLCSRSPCKNKGTCVQKKAESQCLCPSGWAGAYCDVPNVSCDIAASRRGVLVEHLCQHSGVCINAGNTHYCQCPLGYTGSYCEEQLDECASNPCQHGATCSDFIGGYRCECVPGYQGVNCEYEVDECQNQPCQNGGTCIDLVNHFKCSCPPGTRGLLCEENIDDCARGPHCLNGGQCMDRIGGYSCRCLPGFAGERCEGDINECLSNPCSSEGSLDCIQLTNDYLCVCRSAFTGRHCETFVDVCPQMPCLNGGTCAVASNMPDGFICRCPPGFSGARCQSSCGQVKCRKGEQCVHTASGPRCFCPSPRDCESGCASSPCQHGGSCHPQRQPPYYSCQCAPPFSGSRCELYTAPPSTPPATCLSQYCADKARDGVCDEACNSHACQWDGGDCSLTMENPWANCSSPLPCWDYINNQCDELCNTVECLFDNFECQGNSKTCKYDKYCADHFKDNHCDQGCNSEECGWDGLDCAADQPENLAEGTLVIVVLMPPEQLLQDARSFLRALGTLLHTNLRIKRDSQGELMVYPYYGEKSAAMKKQRMTRRSLPGEQEQEVAGSKVFLEIDNRQCVQDSDHCFKNTDAAAALLASHAIQGTLSYPLVSVVSESLTPERTQLLYLLAVAVVIILFIILLGVIMAKRKRKHGSLWLPEGFTLRRDASNHKRREPVGQDAVGLKNLSVQVSEANLIGTGTSEHWVDDEGPQPKKVKAEDEALLSEEDDPIDRRPWTQQHLEAADIRRTPSLALTPPQAEQEVDVLDVNVRGPDGCTPLMLASLRGGSSDLSDEDEDAEDSSANIITDLVYQGASLQAQTDRTGEMALHLAARYSRADAAKRLLDAGADANAQDNMGRCPLHAAVAADAQGVFQILIRNRVTDLDARMNDGTTPLILAARLAVEGMVAELINCQADVNAVDDHGKSALHWAAAVNNVEATLLLLKNGANRDMQDNKEETPLFLAAREGSYEAAKILLDHFANRDITDHMDRLPRDVARDRMHHDIVRLLDEYNVTPSPPGTVLTSALSPVICGPNRSFLSLKHTPMGKKSRRPSAKSTMPTSLPNLAKEAKDAKGSRRKKSLSEKVQLSESSVTLSPVDSLESPHTYVSDTTSSPMITSPGILQASPNPMLATAAPPAPVHAQHALSFSNLHEMQPLAHGASTVLPSVSQLLSHHHIVSPGSGSAGSLSRLHPVPVPADWMNRMEVNETQYNEMFGMVLAPAEGTHPGIAPQSRPPEGKHITTPREPLPPIVTFQLIPKGSIAQPAGAPQPQSTCPPAVAGPLPTMYQIPEMARLPSVAFPTAMMPQQDGQVAQTILPAYHPFPASVGKYPTPPSQHSYASSNAAERTPSHSGHLQGEHPYLTPSPESPDQWSSSSPHSASDWSDVTTSPTPGGAGGGQRGPGTHMSEPPHNNMQVYA,2471,"265,405",Beta strand (17); Chain (3); Compositional bias (3); Disulfide bond (115); Domain (35); Glycosylation (7); Helix (15); Modified residue (11); Mutagenesis (1); Natural variant (14); Region (1); Repeat (9); Sequence conflict (8); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 28..41;  /evidence=""ECO:0000250""; DISULFID 35..51;  /evidence=""ECO:0000250""; DISULFID 53..62;  /evidence=""ECO:0000250""; DISULFID 68..79;  /evidence=""ECO:0000250""; DISULFID 73..90;  /evidence=""ECO:0000250""; DISULFID 92..101;  /evidence=""ECO:0000250""; DISULFID 109..121;  /evidence=""ECO:0000250""; DISULFID 115..131;  /evidence=""ECO:0000250""; DISULFID 133..142;  /evidence=""ECO:0000250""; DISULFID 148..159;  /evidence=""ECO:0000250""; DISULFID 153..168;  /evidence=""ECO:0000250""; DISULFID 170..179;  /evidence=""ECO:0000250""; DISULFID 186..198;  /evidence=""ECO:0000250""; DISULFID 192..207;  /evidence=""ECO:0000250""; DISULFID 209..218;  /evidence=""ECO:0000250""; DISULFID 225..236;  /evidence=""ECO:0000250""; DISULFID 230..246;  /evidence=""ECO:0000250""; DISULFID 248..257;  /evidence=""ECO:0000250""; DISULFID 264..275;  /evidence=""ECO:0000250""; DISULFID 269..284;  /evidence=""ECO:0000250""; DISULFID 286..295;  /evidence=""ECO:0000250""; DISULFID 302..315;  /evidence=""ECO:0000250""; DISULFID 309..324;  /evidence=""ECO:0000250""; DISULFID 326..335;  /evidence=""ECO:0000250""; DISULFID 342..353;  /evidence=""ECO:0000250""; DISULFID 347..362;  /evidence=""ECO:0000250""; DISULFID 364..373;  /evidence=""ECO:0000250""; DISULFID 379..390;  /evidence=""ECO:0000250""; DISULFID 384..401;  /evidence=""ECO:0000250""; DISULFID 403..412;  /evidence=""ECO:0000250""; DISULFID 419..433;  /evidence=""ECO:0000250""; DISULFID 427..442;  /evidence=""ECO:0000250""; DISULFID 444..453;  /evidence=""ECO:0000250""; DISULFID 460..471;  /evidence=""ECO:0000250""; DISULFID 465..480;  /evidence=""ECO:0000250""; DISULFID 482..491;  /evidence=""ECO:0000250""; DISULFID 498..509;  /evidence=""ECO:0000250""; DISULFID 503..518;  /evidence=""ECO:0000250""; DISULFID 520..529;  /evidence=""ECO:0000250""; DISULFID 536..547;  /evidence=""ECO:0000250""; DISULFID 541..556;  /evidence=""ECO:0000250""; DISULFID 558..567;  /evidence=""ECO:0000250""; DISULFID 574..584;  /evidence=""ECO:0000250""; DISULFID 579..593;  /evidence=""ECO:0000250""; DISULFID 595..604;  /evidence=""ECO:0000250""; DISULFID 611..622;  /evidence=""ECO:0000250""; DISULFID 616..631;  /evidence=""ECO:0000250""; DISULFID 633..642;  /evidence=""ECO:0000250""; DISULFID 649..659;  /evidence=""ECO:0000250""; DISULFID 654..668;  /evidence=""ECO:0000250""; DISULFID 670..679;  /evidence=""ECO:0000250""; DISULFID 686..697;  /evidence=""ECO:0000250""; DISULFID 691..706;  /evidence=""ECO:0000250""; DISULFID 708..717;  /evidence=""ECO:0000250""; DISULFID 724..734;  /evidence=""ECO:0000250""; DISULFID 729..743;  /evidence=""ECO:0000250""; DISULFID 745..754;  /evidence=""ECO:0000250""; DISULFID 761..772;  /evidence=""ECO:0000250""; DISULFID 766..781;  /evidence=""ECO:0000250""; DISULFID 783..792;  /evidence=""ECO:0000250""; DISULFID 799..810;  /evidence=""ECO:0000250""; DISULFID 804..819;  /evidence=""ECO:0000250""; DISULFID 821..830;  /evidence=""ECO:0000250""; DISULFID 837..848;  /evidence=""ECO:0000250""; DISULFID 842..859;  /evidence=""ECO:0000250""; DISULFID 861..870;  /evidence=""ECO:0000250""; DISULFID 877..888;  /evidence=""ECO:0000250""; DISULFID 882..897;  /evidence=""ECO:0000250""; DISULFID 899..908;  /evidence=""ECO:0000250""; DISULFID 915..926;  /evidence=""ECO:0000250""; DISULFID 920..935;  /evidence=""ECO:0000250""; DISULFID 937..946;  /evidence=""ECO:0000250""; DISULFID 953..964;  /evidence=""ECO:0000250""; DISULFID 958..973;  /evidence=""ECO:0000250""; DISULFID 975..984;  /evidence=""ECO:0000250""; DISULFID 991..1002;  /evidence=""ECO:0000250""; DISULFID 996..1011;  /evidence=""ECO:0000250""; DISULFID 1013..1022;  /evidence=""ECO:0000250""; DISULFID 1029..1040;  /evidence=""ECO:0000250""; DISULFID 1034..1049;  /evidence=""ECO:0000250""; DISULFID 1051..1060;  /evidence=""ECO:0000250""; DISULFID 1067..1078;  /evidence=""ECO:0000250""; DISULFID 1072..1087;  /evidence=""ECO:0000250""; DISULFID 1089..1098;  /evidence=""ECO:0000250""; DISULFID 1105..1126;  /evidence=""ECO:0000305""; DISULFID 1120..1135;  /evidence=""ECO:0000250""; DISULFID 1137..1146;  /evidence=""ECO:0000250""; DISULFID 1153..1164;  /evidence=""ECO:0000250""; DISULFID 1158..1173;  /evidence=""ECO:0000250""; DISULFID 1175..1184;  /evidence=""ECO:0000250""; DISULFID 1191..1202;  /evidence=""ECO:0000250""; DISULFID 1196..1211;  /evidence=""ECO:0000250""; DISULFID 1213..1222;  /evidence=""ECO:0000250""; DISULFID 1229..1241;  /evidence=""ECO:0000250""; DISULFID 1235..1250;  /evidence=""ECO:0000250""; DISULFID 1252..1261;  /evidence=""ECO:0000250""; DISULFID 1268..1281;  /evidence=""ECO:0000250""; DISULFID 1273..1290;  /evidence=""ECO:0000250""; DISULFID 1292..1301;  /evidence=""ECO:0000250""; DISULFID 1308..1319;  /evidence=""ECO:0000250""; DISULFID 1313..1331;  /evidence=""ECO:0000250""; DISULFID 1333..1342;  /evidence=""ECO:0000250""; DISULFID 1378..1389;  /evidence=""ECO:0000250""; DISULFID 1383..1400;  /evidence=""ECO:0000250""; DISULFID 1402..1411;  /evidence=""ECO:0000250""; DISULFID 1425..1448;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1430..1443;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1439..1455;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1466..1489;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1472..1484;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1480..1496;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1503..1527;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1509..1522;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1518..1534;  /evidence=""ECO:0000269|PubMed:17401372""; DISULFID 1632..1639;  /evidence=""ECO:0000269|PubMed:17401372""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9UEF7,Klotho (EC 3.2.1.31) [Cleaved into: Klotho peptide],MPASAPPRRPRPPPPSLSLLLVLLGLGGRRLRAEPGDGAQTWARFSRPPAPEAAGLFQGTFPDGFLWAVGSAAYQTEGGWQQHGKGASIWDTFTHHPLAPPGDSRNASLPLGAPSPLQPATGDVASDSYNNVFRDTEALRELGVTHYRFSISWARVLPNGSAGVPNREGLRYYRRLLERLRELGVQPVVTLYHWDLPQRLQDAYGGWANRALADHFRDYAELCFRHFGGQVKYWITIDNPYVVAWHGYATGRLAPGIRGSPRLGYLVAHNLLLAHAKVWHLYNTSFRPTQGGQVSIALSSHWINPRRMTDHSIKECQKSLDFVLGWFAKPVFIDGDYPESMKNNLSSILPDFTESEKKFIKGTADFFALCFGPTLSFQLLDPHMKFRQLESPNLRQLLSWIDLEFNHPQIFIVENGWFVSGTTKRDDAKYMYYLKKFIMETLKAIKLDGVDVIGYTAWSLMDGFEWHRGYSIRRGLFYVDFLSQDKMLLPKSSALFYQKLIEKNGFPPLPENQPLEGTFPCDFAWGVVDNYIQVDTTLSQFTDLNVYLWDVHHSKRLIKVDGVVTKKRKSYCVDFAAIQPQIALLQEMHVTHFRFSLDWALILPLGNQSQVNHTILQYYRCMASELVRVNITPVVALWQPMAPNQGLPRLLARQGAWENPYTALAFAEYARLCFQELGHHVKLWITMNEPYTRNMTYSAGHNLLKAHALAWHVYNEKFRHAQNGKISIALQADWIEPACPFSQKDKEVAERVLEFDIGWLAEPIFGSGDYPWVMRDWLNQRNNFLLPYFTEDEKKLIQGTFDFLALSHYTTILVDSEKEDPIKYNDYLEVQEMTDITWLNSPSQVAVVPWGLRKVLNWLKFKYGDLPMYIISNGIDDGLHAEDDQLRVYYMQNYINEALKAHILDGINLCGYFAYSFNDRTAPRFGLYRYAADQFEPKASMKHYRKIIDSNGFPGPETLERFCPEEFTVCTECSFFHTRKSLLAFIAFLFFASIISLSLIFYYSKKGRRSYK,1012,"116,181",Alternative sequence (2); Beta strand (36); Chain (2); Glycosylation (7); Helix (40); Natural variant (7); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
P16109,P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P),MANCQIAILYQRFQRVVFGISQLLCFSALISELTNQKEVAAWTYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTWTWVGTKKALTNEAENWADNEPNNKRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTASCQDMSCSKQGECLETIGNYTCSCYPGFYGPECEYVRECGELELPQHVLMNCSHPLGNFSFNSQCSFHCTDGYQVNGPSKLECLASGIWTNKPPQCLAAQCPPLKIPERGNMTCLHSAKAFQHQSSCSFSCEEGFALVGPEVVQCTASGVWTAPAPVCKAVQCQHLEAPSEGTMDCVHPLTAFAYGSSCKFECQPGYRVRGLDMLRCIDSGHWSAPLPTCEAISCEPLESPVHGSMDCSPSLRAFQYDTNCSFRCAEGFMLRGADIVRCDNLGQWTAPAPVCQALQCQDLPVPNEARVNCSHPFGAFRYQSVCSFTCNEGLLLVGASVLQCLATGNWNSVPPECQAIPCTPLLSPQNGTMTCVQPLGSSSYKSTCQFICDEGYSLSGPERLDCTRSGRWTDSPPMCEAIKCPELFAPEQGSLDCSDTRGEFNVGSTCHFSCDNGFKLEGPNNVECTTSGRWSATPPTCKGIASLPTPGLQCPALTTPGQGTMYCRHHPGTFGFNTTCYFGCNAGFTLIGDSTLSCRPSGQWTAVTPACRAVKCSELHVNKPIAMNCSNLWGNFSYGSICSFHCLEGQLLNGSAQTACQENGHWSTTVPTCQAGPLTIQEALTYFGGAVASTIGLIMGGTLLALLRKRFRQKDDGKCPLNPHSHLGTYGVFTNAAFDPSP,830,"90,834",Beta strand (11); Binding site (3); Chain (1); Disulfide bond (23); Domain (11); Glycosylation (12); Helix (3); Lipidation (2); Metal binding (5); Motif (1); Mutagenesis (1); Natural variant (17); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 60..158;  /evidence=""ECO:0000244|PDB:1G1Q, ECO:0000244|PDB:1G1R, ECO:0000244|PDB:1G1S, ECO:0000269|PubMed:11081633""; DISULFID 131..150;  /evidence=""ECO:0000244|PDB:1G1Q, ECO:0000244|PDB:1G1R, ECO:0000244|PDB:1G1S, ECO:0000269|PubMed:11081633""; DISULFID 163..174;  /evidence=""ECO:0000244|PDB:1G1Q, ECO:0000244|PDB:1G1R, ECO:0000244|PDB:1G1S, ECO:0000269|PubMed:11081633""; DISULFID 168..183;  /evidence=""ECO:0000244|PDB:1G1Q, ECO:0000244|PDB:1G1R, ECO:0000244|PDB:1G1S, ECO:0000269|PubMed:11081633""; DISULFID 185..194;  /evidence=""ECO:0000244|PDB:1G1Q, ECO:0000244|PDB:1G1R, ECO:0000244|PDB:1G1S, ECO:0000269|PubMed:11081633""; DISULFID 200..244;  /evidence=""ECO:0000250""; DISULFID 230..257;  /evidence=""ECO:0000250""; DISULFID 262..306;  /evidence=""ECO:0000250""; DISULFID 292..319;  /evidence=""ECO:0000250""; DISULFID 324..368;  /evidence=""ECO:0000250""; DISULFID 354..381;  /evidence=""ECO:0000250""; DISULFID 386..430;  /evidence=""ECO:0000250""; DISULFID 416..443;  /evidence=""ECO:0000250""; DISULFID 448..492;  /evidence=""ECO:0000250""; DISULFID 478..505;  /evidence=""ECO:0000250""; DISULFID 510..554;  /evidence=""ECO:0000250""; DISULFID 540..567;  /evidence=""ECO:0000250""; DISULFID 572..616;  /evidence=""ECO:0000250""; DISULFID 602..629;  /evidence=""ECO:0000250""; DISULFID 642..686;  /evidence=""ECO:0000250""; DISULFID 672..699;  /evidence=""ECO:0000250""; DISULFID 704..748;  /evidence=""ECO:0000250""; DISULFID 734..761;  /evidence=""ECO:0000250""",SIGNAL 1..41
Q9H0V9,VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein),MAATLGPLGSWQQWRRCLSARDGSRMLLLLLLLGSGQGPQQVGAGQTFEYLKREHSLSKPYQGVGTGSSSLWNLMGNAMVMTQYIRLTPDMQSKQGALWNRVPCFLRDWELQVHFKIHGQGKKNLHGDGLAIWYTKDRMQPGPVFGNMDKFVGLGVFVDTYPNEEKQQERVFPYISAMVNNGSLSYDHERDGRPTELGGCTAIVRNLHYDTFLVIRYVKRHLTIMMDIDGKHEWRDCIEVPGVRLPRGYYFGTSSITGDLSDNHDVISLKLFELTVERTPEEEKLHRDVFLPSVDNMKLPEMTAPLPPLSGLALFLIVFFSLVFSVFAIVIGIILYNKWQEQSRKRFY,348,"39,711",Alternative sequence (3); Binding site (3); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Metal binding (4); Motif (1); Mutagenesis (1); Natural variant (1); Region (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 200..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00658""","SIGNAL 1..44;  /evidence=""ECO:0000255"""
P69849,Nodal modulator 3 (pM5 protein 3),MLVGQGAGPLGPAVVTAAVVLLLSGVGPAHGSEDIVVGCGGFVKSDVEINYSLIEIKLYTKHGTLKYQTDCAPNNGYFMIPLYDKGDFILKIEPPLGWSFEPTTVELHVDGVSDICTKGGDINFVFTGFSVNGKVLSKGQPLGPAGVQVSLRNTGTEAKIQSTVTQPGGKFAFFKVLPGDYEILATHPTWALKEASTTVRVTNSNANAASPLIVAGYNVSGSVRSDGEPMKGVKFLLFSSLVTKEDVLGCNVSPVPGFQPQDESLVYLCYTVSREDGSFSFYSLPSGGYTVIPFYRGERITFDVAPSRLDFTVEHDSLKIEPVFHVMGFSVTGRVLNGPEGDGVPEAVVTLNNQIKVKTKADGSFRLENITTGTYTIHAQKEHLYFETVTIKIAPNTPQLADIVATGFSVCGQISIIRFPDTVKQMNKYKVVLSSQDKDKSLVTVETDAHGSFCFKANPGTYKVQVMVPEAETRAGLTLKPQTFPLTVTDRPVMDVAFVQFLASVSGKVSCLDTCGDLLVTLQSLSRQGEKRSLQLSGKVNAMTFTFDNVLPGKYKISIMHEDWCWKNKSLEVEVLEDDVSAVEFRQTGYMLRCSLSHAITLEFYQDGNGRENVGIYNLSKGVNRFCLSKPGVYKVTPRSCHRFEQAFYTYDTSSPSILTLTAIRHHVLGTITTDKMMDVTVTIKSSIDSEPALVLGPLKSVQELRREQQLAEIEARRQEREKNGNEEGEERMTKPPVQEMVDELQGPFSYDFSYWARSGEKITVTPSSKELLFYPPSMEAVVSGESCPGKLIEIHGKAGLFLEGQIHPELEGVEIVISEKGASSPLITVFTDDKGAYSVGPLHSDLEYTVTSQKEGYVLTAVEGTIGDFKAYALAGVSFEIKAEDDQPLPGVLLSLSGGLFRSNLLTQDNGILTFSNLSPGQYYFKPMMKEFRFEPSSQMIEVQEGQNLKITITGYRTAYSCYGTVSSLNGEPEQGVAMEAVGQNDCSIYGEDTVTDEEGKFRLRGLLPGCVYHVQLKAEGNDHIERALPHHRVIEVGNNDIDDVNIIVFRQINQFDLSGNVITSSEYLPTLWVKLYKSENLDNPIQTVSLGQSLFFHFPPLLRDGENYVVLLDSTLPRSQYDYILPQVSFTAVGYHKHITLIFNPTRKLPEQDIAQGSYIALPLTLLVLLAGYNHDKLIPLLLQLTSRLQGVGALGQAASDNSGPEDAKRQAKKQKTRRT,1222,"134,134",Chain (1); Glycosylation (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
O00254,Proteinase-activated receptor 3 (PAR-3) (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2),MKALIFAAAGLLLLLPTFCQSGMENDTNNLAKPTLPIKTFRGAPPNSFEEFPFSALEGWTGATITVKIKCPEESASHLHVKNATMGYLTSSLSTKLIPAIYLLVFVVGVPANAVTLWMLFFRTRSICTTVFYTNLAIADFLFCVTLPFKIAYHLNGNNWVFGEVLCRATTVIFYGNMYCSILLLACISINRYLAIVHPFTYRGLPKHTYALVTCGLVWATVFLYMLPFFILKQEYYLVQPDITTCHDVHNTCESSSPFQLYYFISLAFFGFLIPFVLIIYCYAAIIRTLNAYDHRWLWYVKASLLILVIFTICFAPSNIILIIHHANYYYNNTDGLYFIYLIALCLGSLNSCLDPFLYFLMSKTRNHSTAYLTK,374,"42,508",Alternative sequence (1); Chain (1); Disulfide bond (1); Frameshift (1); Glycosylation (3); Mutagenesis (2); Natural variant (3); Propeptide (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 166..245;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UN67,Protocadherin beta-10 (PCDH-beta-10),MAVRELCFPRQRQVLFLFLFWGVSLAGSGFGRYSVTEETEKGSFVVNLAKDLGLAEGELAARGTRVVSDDNKQYLLLDSHTGNLLTNEKLDREKLCGPKEPCMLYFQILMDDPFQIYRAELRVRDINDHAPVFQDKETVLKISENTAEGTAFRLERAQDPDGGLNGIQNYTISPNSFFHINISGGDEGMIYPELVLDKALDREEQGELSLTLTALDGGSPSRSGTSTVRIVVLDVNDNAPQFAQALYETQAPENSPIGFLIVKVWAEDVDSGVNAEVSYSFFDASENIRTTFQINPFSGEIFLRELLDYELVNSYKINIQAMDGGGLSARCRVLVEVLDTNDNPPELIVSSFSNSVAENSPETPLAVFKINDRDSGENGKMVCYIQENLPFLLKPSVENFYILITEGALDREIRAEYNITITVTDLGTPRLKTEHNITVLVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINADNGHLFALRSLDYEALQAFEFRVGATDRGSPALSREALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHLLLVDGFSQPYLPLPEAAPAQAQAEADLLTVYLVVALASVSSLFLLSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVRGAETLSQSYQYEVCLTGGPGTSEFKFLKPVISDIQAQGPGRKGEENSTFRNSFGFNIQ,800,"87,621",Chain (1); Domain (6); Glycosylation (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:15340161"""
Q50LG9,Leucine-rich repeat-containing protein 24,MALRAPALLPLLLLLLPLRAAGCPAACRCYSATVECGALRLRVVPLGIPPGTQTLFLQDNNIARLEPGALAPLAALRRLYLHNNSLRALEAGAFRAQPRLLELALTSNRLRGLRSGAFVGLAQLRVLYLAGNQLARLLDFTFLHLPRLQELHLQENSIELLEDQALAGLSSLALLDLSRNQLGTISREALQPLASLQVLRLTENPWRCDCALHWLGAWIKEGGQRLLTSRDRKIMCAEPPRLALQSLLDVSHSSLICIPPSVHVQPLELTANLGEDLRVACQASGYPQPLVTWRKVPQPREGRPRAQAQLEGGLLGLGGHSASDTGSGMLFLSNITLAHAGKYECEASNAGGAARVPFRLLVNASRQQPQQPAQPPPPAARPAGSEPRPEAGSMAFRALGVATQTAIAAAIALLALTALLLVAMICRRRRRRKKARGPPGEGALFVNDYLDGPCTFAQLEELRDERGHEMFVINRSKPLFAEGPAEAPADCGPEQGAGPGLRVPPPVAYEIHC,513,"55,257",Chain (1); Compositional bias (2); Disulfide bond (1); Domain (3); Glycosylation (2); Repeat (6); Sequence conflict (2); Signal peptide (1); Transmembrane (1),"DISULFID 281..345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q12866,Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK),MGPAPLPLLLGLFLPALWRRAITEAREEAKPYPLFPGPFPGSLQTDHTPLLSLPHASGYQPALMFSPTQPGRPHTGNVAIPQVTSVESKPLPPLAFKHTVGHIILSEHKGVKFNCSISVPNIYQDTTISWWKDGKELLGAHHAITQFYPDDEVTAIIASFSITSVQRSDNGSYICKMKINNEEIVSDPIYIEVQGLPHFTKQPESMNVTRNTAFNLTCQAVGPPEPVNIFWVQNSSRVNEQPEKSPSVLTVPGLTEMAVFSCEAHNDKGLTVSKGVQINIKAIPSPPTEVSIRNSTAHSILISWVPGFDGYSPFRNCSIQVKEADPLSNGSVMIFNTSALPHLYQIKQLQALANYSIGVSCMNEIGWSAVSPWILASTTEGAPSVAPLNVTVFLNESSDNVDIRWMKPPTKQQDGELVGYRISHVWQSAGISKELLEEVGQNGSRARISVQVHNATCTVRIAAVTRGGVGPFSDPVKIFIPAHGWVDYAPSSTPAPGNADPVLIIFGCFCGFILIGLILYISLAIRKRVQETKFGNAFTEEDSELVVNYIAKKSFCRRAIELTLHSLGVSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDVRNQADVIYVNTQLLESSEGLAQGSTLAPLDLNIDPDSIIASCTPRAAISVVTAEVHDSKPHEGRYILNGGSEEWEDLTSAPSAAVTAEKNSVLPGERLVRNGVSWSHSSMLPLGSSLPDELLFADDSSEGSEVLM,999,"110,249",Active site (1); Beta strand (18); Binding site (1); Chain (1); Disulfide bond (2); Domain (5); Glycosylation (14); Helix (13); Modified residue (6); Natural variant (23); Nucleotide binding (1); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 115..175;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 218..262;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P04629,High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA),MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG,796,"87,497",Active site (1); Alternative sequence (3); Beta strand (37); Binding site (1); Chain (1); Disulfide bond (5); Domain (4); Erroneous termination (1); Frameshift (1); Glycosylation (13); Helix (25); Modified residue (5); Motif (2); Mutagenesis (6); Natural variant (45); Nucleotide binding (1); Region (1); Repeat (2); Sequence caution (4); Sequence conflict (3); Signal peptide (1); Site (4); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 36..41;  /evidence=""ECO:0000244|PDB:2IFG""; DISULFID 40..50;  /evidence=""ECO:0000244|PDB:2IFG""; DISULFID 154..191;  /evidence=""ECO:0000244|PDB:2IFG, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17196528""; DISULFID 215..265;  /evidence=""ECO:0000244|PDB:2IFG, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17196528""; DISULFID 300..345;  /evidence=""ECO:0000244|PDB:1HE7, ECO:0000244|PDB:1WWA, ECO:0000244|PDB:1WWW, ECO:0000244|PDB:2IFG, ECO:0000244|PDB:4CRP""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9Y5G3,Protocadherin gamma-B1 (PCDH-gamma-B1),MQRAREAEMMKSQVLFPFLLSLFCGAISQQIRYTIPEELANGSRVGKLAKDLGLSVRELPTRKLRVSAEDYFNVSLESGDLLVNGRIDREKICGRKLECALEFETVAENPMNVFHVVVVIQDINDNAPRFVAKGIDLEICESALPGVKFSLDSAQDADVEGNSLKLYTINPNQYFSLSTKESPDGSKYPVLLLEKPLDREHQSSHRLILTAMDGGDPPLSGTTHIWIRVTDANDNAPVFSQEVYRVSLQENVPWGTSVLRVMATDQDEGINAEITYAFLNSPISTSLFNLNPNTGDITTNGTLDFEETSRYVLSVEAKDGGVHTAHCNVQIEIVDENDNAPEVTFMSFSNQIPEDSDLGTVIALIKVRDKDSGQNGMVTCYTQEEVPFKLESTSKNYYKLVIAGALNREQTADYNVTIIATDKGKPALSSRTSITLHISDINDNAPVFHQASYVVHVSENNPPGASIAQVSASDPDLGPNGRVSYSILASDLEPRELLSYVSVSPQSGVVFAQRAFDHEQLRAFELTLQARDQGSPALSANVSLRVLVGDLNDNAPRVLYPALGPDGSALFDMVPRAAEPGYLVTKVVAVDADSGHNAWLSYHVLQASEPGLFSLGLRTGEVRTARALGDRDAARQRLLVAVRDGGQPPLSATATLHLIFADSLQEVLPDLSDRPEPSDPQTELQFYLVVALALISVLFLLAVILAIALRLRRSSSLDTEGCFQTGLCSKSGPGVPPNHSEGTLPYSYNLCIASHSAKTEFNSLNLTPEMAPPQDLLCDDPSMVVCASNEDHKIAYDPSLSSHQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,927,"100,360",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5G5,Protocadherin gamma-A8 (PCDH-gamma-A8),MAAPQSRPRRGELILLCALLGTLWEIGRGQIRYSVPEETDKGSFVGNISKDLGLDPRKLAKHGVRIVSRGRTQLFALNPRSGSLITAGRIDREELCAQSPRCLININTLVEDKGKLFGVEIEIIDINDNNPKFQVEDLEVKINEIAVPGARYPLPEAVDPDVGVNSLQSYQLSPNHHFSLDVQTGDNGAINPELVLERALDREEEAAHHLVLTASDGGKPPRSSTVRIHVTVLDTNDNAPVFPHPIYRVKVLENMPPGTRLLTVTASDPDEGINGKVAYKFRKINEKQTPLFQLNENTGEISIAKSLDYEECSFYEMEIQAEDVGALLGRTKLLISVEDVNDNRPEVIITSLFSPVLENSLPGTVIAFLSVHDQDSGKNGQVVCYTRDNLPFKLEKSIGNYYRLVTRKYLDRENVSIYNITVMASDLGTPPLSTETQIALHVADINDNPPTFPHASYSAYILENNLRGASIFSLTAHDPDSQENAQVTYSVTEDTLQGAPLSSYISINSDTGVLYALQSFDYEQIRDLQLLVTASDSGDPPLSSNMSLSLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAERGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADSIPEVLTELGSLKPSVDPNDSSLTLYLVVAVAAISCVFLAFVAVLLGLRLRRWHKSRLLQDSGGRLVGVPASHFVGVEEVQAFLQTYSQEVSLTADSRKSHLIFPQPNYADMLISQEGCEKNDSLLTSVDFHEYKNEADHGQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"101,480",Alternative sequence (2); Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (5); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5G0,Protocadherin gamma-B5 (PCDH-gamma-B5),MGSGAGELGRAERLPVLFLFLLSLFCPALCEQIRYRIPEEMPKGSVVGNLATDLGFSVQELPTRKLRVSSEKPYFTVSAESGELLVSSRLDREEICGKKPACALEFEAVAENPLNFYHVNVEIEDINDHTPKFTQNSFELQISESAQPGTRFILEVAEDADIGLNSLQKYKLSLNPSFSLIIKEKQDGSKYPELALEKTLDREQQSYHRLVLTALDGGHPPLSGTTELRIQVTDANDNPPVFNRDVYRVSLRENVPPGTTVLQVSATDQDEGINSEITYSFYRTGQIFSLNSKSGEITTQKKLDFEETKEYSMVVEGRDGGGLVAQCTVEINIQDENDNSPEVTFHSLLEMILENAVPGTLIALIKIHDQDSGENGEVNCQLQGEVPFKIISSSKNSYKLVTDGTLDREQTPEYNVTITATDRGKPPLSSSISVILHIRDVNDNAPVFHQASYLVSVPENNPPGASIAQVCASDLDLGLNGQVSYSIMASDLEPLALASYVSMSAQSGVVFAQRAFDYEQLRTFELTLQARDQGSPALSANVSLRVLVGDRNDNAPRVLYPALGPDGSALFDMVPRAAEPGYLVTKVVAVDADSGHNAWLSYHVLQASEPGLFSLGLRTGEVRTARALGDRDAARQRLLVAVRDGGQPPLSATATLHLVFADSLQEVLPDITDRPVPSDPQAELQFYLVVALALISVLFLLAVILAVALRLRRSSSPAAWSCFQPGLCVKSGPVVPPNYSQGTLPYSYNLCVAHTGKTEFNFLKCSEQLSSGQDILCGDSSGALFPLCNSSESTSHPELQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,923,"99,875",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q96RI0,Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3),MWGRLLLWPLVLGFSLSGGTQTPSVYDESGSTGGGDDSTPSILPAPRGYPGQVCANDSDTLELPDSSRALLLGWVPTRLVPALYGLVLVVGLPANGLALWVLATQAPRLPSTMLLMNLAAADLLLALALPPRIAYHLRGQRWPFGEAACRLATAALYGHMYGSVLLLAAVSLDRYLALVHPLRARALRGRRLALGLCMAAWLMAAALALPLTLQRQTFRLARSDRVLCHDALPLDAQASHWQPAFTCLALLGCFLPLLAMLLCYGATLHTLAASGRRYGHALRLTAVVLASAVAFFVPSNLLLLLHYSDPSPSAWGNLYGAYVPSLALSTLNSCVDPFIYYYVSAEFRDKVRAGLFQRSPGDTVASKASAEGGSRGMGTHSSLLQ,385,"41,133",Beta strand (1); Chain (1); Compositional bias (1); Disulfide bond (1); Glycosylation (1); Mutagenesis (2); Natural variant (4); Propeptide (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 149..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9Y5E3,Protocadherin beta-6 (PCDH-beta-6),MMQTKVQNKKRQVAFFILLMLWGEVGSESIQYSVLEETESGTFVANLTKDLGLRVGELASRGARVVFKGNRQHLQFDPQTHDLLLNEKLDREELCGSTEPCVLPFQVLLENPLQFFQASLRVRDINDHAPEFPAREMLLKISEITMPGKIFPLKMAHDLDTGSNGLQRYTISSNPHFHVLTRNRSEGRKFPELVLDKPLDREEQPQLRLTLIALDGGSPPRSGTSEIQIQVLDINDNVPEFAQELYEAQVPENNPLGSLVITVSARDLDAGSFGKVSYALFQVDDVNQPFEINAITGEIRLRKALDFEEIQSYDVDVEATDGGGLSGKCSLVVRVLDVNDNAPELTMSFFISLIPENLPEITVAVFSVSDADSGHNQQVICSIENNLPFLLRPSVENFYTLVTEGALDRESRAEYNITITVTDLGTPRLKTQQSITVQVSDVNDNVPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGINAQVTYSLLPPQDPHLPLSSLVSINADNGHLFALRSLDYEALQSFEFRVGATDRGSPALSSEALVRLLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATELGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRYSVPEGPFPGHLVDVSGTGTLSQSYQYKVCLTGGSETNEFKFLKPIMPNFPPQGTEREMEETPTSRNSFPFS,794,"87,350",Chain (1); Disulfide bond (1); Domain (6); Glycosylation (4); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 95..101;  /evidence=""ECO:0000250|UniProtKB:Q91XZ4""","SIGNAL 1..27;  /evidence=""ECO:0000250|UniProtKB:Q91XZ4"""
P51511,Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2),MGSDPSAPGRPGWTGSLLGDREEAARPRLLPLLLVLLGCLGLGVAAEDAEVHAENWLRLYGYLPQPSRHMSTMRSAQILASALAEMQRFYGIPVTGVLDEETKEWMKRPRCGVPDQFGVRVKANLRRRRKRYALTGRKWNNHHLTFSIQNYTEKLGWYHSMEAVRRAFRVWEQATPLVFQEVPYEDIRLRRQKEADIMVLFASGFHGDSSPFDGTGGFLAHAYFPGPGLGGDTHFDADEPWTFSSTDLHGNNLFLVAVHELGHALGLEHSSNPNAIMAPFYQWKDVDNFKLPEDDLRGIQQLYGTPDGQPQPTQPLPTVTPRRPGRPDHRPPRPPQPPPPGGKPERPPKPGPPVQPRATERPDQYGPNICDGDFDTVAMLRGEMFVFKGRWFWRVRHNRVLDNYPMPIGHFWRGLPGDISAAYERQDGRFVFFKGDRYWLFREANLEPGYPQPLTSYGLGIPYDRIDTAIWWEPTGHTFFFQEDRYWRFNEETQRGDPGYPKPISVWQGIPASPKGAFLSNDAAYTYFYKGTKYWKFDNERLRMEPGYPKSILRDFMGCQEHVEPGPRWPDVARPPFNPHGGAEPGADSAEGDVGDGDGDFGAGVNKDGGSRVVVQMEEVARTVNVVMVLVPLLLLLCVLGLTYALVQMQRKGAPRVLLYCKRSLQEWV,669,"75,807",Active site (1); Chain (1); Compositional bias (1); Disulfide bond (1); Erroneous initiation (1); Glycosylation (1); Metal binding (4); Modified residue (1); Motif (1); Natural variant (5); Propeptide (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 370..559;  /evidence=""ECO:0000250""","SIGNAL 1..41;  /note=""Or 45"";  /evidence=""ECO:0000255"""
Q9HC58,Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3),MRPSGDEDRARRRRRRRRRRDLLLSQLCFLASVALLLWSLSSLREQKELDLMDLVGEDRKWMMARKLMQVNDTLTSEDAGLRNSKNCTEPALHEFPNDIFTNEDRRQGAVVLHVLCAIYMFYALAIVCDDFFVPSLEKICERLHLSEDVAGATFMAAGSSAPELFTSVIGVFITKGDVGVGTIVGSAVFNILCIIGVCGLFAGQVVALSSWCLLRDSIYYTLSVIALIVFIYDEKVSWWESLVLVLMYLIYIVIMKYNACIHQCFERRTKGAGNMVNGLANNAEIDDSSNCDATVVLLKKANFHRKASVIMVDELLSAYPHQLSFSEAGLRIMITSHFPPKTRLSMASRMLINERQRLINSRAYTNGESEVAIKIPIKHTVENGTGPSSAPDRGVNGTRRDDVVAEAGNETENENEDNENDEEEEEDEDDDEGPYTPFDTPSGKLETVKWAFTWPLSFVLYFTVPNCNKPRWEKWFMVTFASSTLWIAAFSYMMVWMVTIIGYTLGIPDVIMGITFLAAGTSVPDCMASLIVARQGMGDMAVSNSIGSNVFDILIGLGLPWALQTLAVDYGSYIRLNSRGLIYSVGLLLASVFVTVFGVHLNKWQLDKKLGCGCLLLYGVFLCFSIMTEFNVFTFVNLPMCGDH,644,"71,992",Chain (1); Compositional bias (1); Glycosylation (2); Modified residue (1); Natural variant (4); Repeat (2); Signal peptide (1); Topological domain (11); Transmembrane (10),,"SIGNAL 1..44;  /evidence=""ECO:0000255"""
Q8NFF2,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),MALRGTLRPLKVRRRREMLPQQVGFVCAVLALVCCASGLFGSLGHKTASASKRVLPDTWRNRKLMAPVNGTQTAKNCTDPAIHEFPTDLFSNKERQHGAVLLHILGALYMFYALAIVCDDFFVPSLEKICERLHLSEDVAGATFMAAGSSTPELFASVIGVFITHGDVGVGTIVGSAVFNILCIIGVCGLFAGQVVRLTWWAVCRDSVYYTISVIVLIVFIYDEQIVWWEGLVLIILYVFYILIMKYNVKMQAFFTVKQKSIANGNPVNSELEAGNDFYDGSYDDPSVPLLGQVKEKPQYGKNPVVMVDEIMSSSPPKFTFPEAGLRIMITNKFGPRTRLRMASRIIINERQRLINSANGVSSKPLQNGRHENIENGNVPVENPEDPQQNQEQQPPPQPPPPEPEPVEADFLSPFSVPEARGDKVKWVFTWPLIFLLCVTIPNCSKPRWEKFFMVTFITATLWIAVFSYIMVWLVTIIGYTLGIPDVIMGITFLAAGTSVPDCMASLIVARQGLGDMAVSNTIGSNVFDILVGLGVPWGLQTMVVNYGSTVKINSRGLVYSVVLLLGSVALTVLGIHLNKWRLDRKLGVYVLVLYAIFLCFSIMIEFNVFTFVNLPMCREDD,622,"69,042",Alternative sequence (4); Chain (1); Compositional bias (1); Erroneous initiation (4); Glycosylation (2); Natural variant (3); Repeat (2); Sequence caution (1); Sequence conflict (2); Signal peptide (1); Topological domain (11); Transmembrane (10),,"SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q9HCN3,Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A),MGRAGTGTGGEAVAAVVAGPLLLLLLARPPPASAGYSGKSEVGLVSEHFSQAPQRLSFYSWYGSARLFRFRVPPDAVLLRWLLQVSRESGAACTDAEITVHFRSGAPPVINPLGTSFPDDTAVQPSFQVGVPLSTTPRSNASVNVSHPAPGDWFVAAHLPPSSQKIELKGLAPTCAYVFQPELLVTRVVEISIMEPDVPLPQTLLSHPSYLKVFVPDYTRELLLELRDCVSNGSLGCPVRLTVGPVTLPSNFQKVLTCTGAPWPCRLLLPSPPWDRWLQVTAESLVGPLGTVAFSAVAALTACRPRSVTIQPLLQSSQNQSFNASSGLLSPSPDHQDLGRSGRVDRSPFCLTNYPVTREDMDVVSVHFQPLDRVSVRVCSDTPSVMRLRLNTGMDSGGSLTISLRANKTEMRNETVVVACVNAASPFLGFNTSLNCTTAFFQGYPLSLSAWSRRANLIIPYPETDNWYLSLQLMCPENAEDCEQAVVHVETTLYLVPCLNDCGPYGQCLLLRRHSYLYASCSCKAGWRGWSCTDNSTAQTVAQQRAATLLLTLSNLMFLAPIAVSVRRFFLVEASVYAYTMFFSTFYHACDQPGEAVLCILSYDTLQYCDFLGSGAAIWVTILCMARLKTVLKYVLFLLGTLVIAMSLQLDRRGMWNMLGPCLFAFVIMASMWAYRCGHRRQCYPTSWQRWAFYLLPGVSMASVGIAIYTSMMTSDNYYYTHSIWHILLAGSAALLLPPPDQPAEPWACSQKFPCHYQICKNDREELYAVT,771,"84,761",Chain (1); Disulfide bond (3); Domain (1); Erroneous termination (1); Glycosylation (3); Mutagenesis (5); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 498..508;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 502..521;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 523..532;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
P01889,"HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B) (HLA-B)",MLVMAPRTVLLLLSAALALTETWAGSHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHDQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGECVEWLRRYLENGKDKLERADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACSDSAQGSDVSLTA,362,"40,460",Beta strand (22); Binding site (7); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (8); Motif (1); Natural variant (97); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 125..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17057332, ECO:0000269|PubMed:25808313, ECO:0000269|PubMed:29531227""; DISULFID 227..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17057332, ECO:0000269|PubMed:25808313, ECO:0000269|PubMed:29531227""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:518865"""
Q8TDY8,Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36),MARGDAGRGRGLLALTFCLLAARGELLLPQETTVELSCGVGPLQVILGPEQAAVLNCSLGAAAAGPPTRVTWSKDGDTLLEHDHLHLLPNGSLWLSQPLAPNGSDESVPEAVGVIEGNYSCLAHGPLGVLASQTAVVKLATLADFSLHPESQTVEENGTARFECHIEGLPAPIITWEKDQVTLPEEPRLIVLPNGVLQILDVQESDAGPYRCVATNSARQHFSQEALLSVAHRGSLASTRGQDVVIVAAPENTTVVSGQSVVMECVASADPTPFVSWVRQDGKPISTDVIVLGRTNLLIANAQPWHSGVYVCRANKPRTRDFATAAAELRVLAAPAITQAPEALSRTRASTARFVCRASGEPRPALRWLHNGAPLRPNGRVKVQGGGGSLVITQIGLQDAGYYQCVAENSAGMACAAASLAVVVREGLPSAPTRVTATPLSSSAVLVAWERPEMHSEQIIGFSLHYQKARGMDNVEYQFAVNNDTTELQVRDLEPNTDYEFYVVAYSQLGASRTSTPALVHTLDDVPSAAPQLSLSSPNPSDIRVAWLPLPPSLSNGQVVKYKIEYGLGKEDQIFSTEVRGNETQLMLNSLQPNKVYRVRISAGTAAGFGAPSQWMHHRTPSMHNQSHVPFAPAELKVQAKMESLVVSWQPPPHPTQISGYKLYWREVGAEEEANGDRLPGGRGDQAWDVGPVRLKKKVKQYELTQLVPGRLYEVKLVAFNKHEDGYAAVWKGKTEKAPAPDMPIQRGPPLPPAHVHAESNSSTSIWLRWKKPDFTTVKIVNYTVRFSPWGLRNASLVTYYTSSGEDILIGGLKPFTKYEFAVQSHGVDMDGPFGSVVERSTLPDRPSTPPSDLRLSPLTPSTVRLHWCPPTEPNGEIVEYLILYSSNHTQPEHQWTLLTTQGNIFSAEVHGLESDTRYFFKMGARTEVGPGPFSRLQDVITLQEKLSDSLDMHSVTGIIVGVCLGLLCLLACMCAGLRRSPHRESLPGLSSTATPGNPALYSRARLGPPSPPAAHELESLVHPHPQDWSPPPSDVEDRAEVHSLMGGGVSEGRSHSKRKISWAQPSGLSWAGSWAGCELPQAGPRPALTRALLPPAGTGQTLLLQALVYDAIKGNGRKKSPPACRNQVEAEVIVHSDFSASNGNPDLHLQDLEPEDPLPPEAPDLISGVGDPGQGAAWLDRELGGCELAAPGPDRLTCLPEAASASCSYPDLQPGEVLEETPGDSCQLKSPCPLGASPGLPRSPVSSSA,1250,"134,210",Alternative sequence (1); Chain (1); Compositional bias (2); Disulfide bond (4); Domain (9); Glycosylation (5); Modified residue (1); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 57..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 164..212;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 265..312;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 356..405;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P38570,Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain],MWLFHTLLCIASLALLAAFNVDVARPWLTPKGGAPFVLSSLLHQDPSTNQTWLLVTSPRTKRTPGPLHRCSLVQDEILCHPVEHVPIPKGRHRGVTVVRSHHGVLICIQVLVRRPHSLSSELTGTCSLLGPDLRPQAQANFFDLENLLDPDARVDTGDCYSNKEGGGEDDVNTARQRRALEKEEEEDKEEEEDEEEEEAGTEIAIILDGSGSIDPPDFQRAKDFISNMMRNFYEKCFECNFALVQYGGVIQTEFDLRDSQDVMASLARVQNITQVGSVTKTASAMQHVLDSIFTSSHGSRRKASKVMVVLTDGGIFEDPLNLTTVINSPKMQGVERFAIGVGEEFKSARTARELNLIASDPDETHAFKVTNYMALDGLLSKLRYNIISMEGTVGDALHYQLAQIGFSAQILDERQVLLGAVGAFDWSGGALLYDTRSRRGRFLNQTAAAAADAEAAQYSYLGYAVAVLHKTCSLSYIAGAPRYKHHGAVFELQKEGREASFLPVLEGEQMGSYFGSELCPVDIDMDGSTDFLLVAAPFYHVHGEEGRVYVYRLSEQDGSFSLARILSGHPGFTNARFGFAMAAMGDLSQDKLTDVAIGAPLEGFGADDGASFGSVYIYNGHWDGLSASPSQRIRASTVAPGLQYFGMSMAGGFDISGDGLADITVGTLGQAVVFRSRPVVRLKVSMAFTPSALPIGFNGVVNVRLCFEISSVTTASESGLREALLNFTLDVDVGKQRRRLQCSDVRSCLGCLREWSSGSQLCEDLLLMPTEGELCEEDCFSNASVKVSYQLQTPEGQTDHPQPILDRYTEPFAIFQLPYEKACKNKLFCVAELQLATTVSQQELVVGLTKELTLNINLTNSGEDSYMTSMALNYPRNLQLKRMQKPPSPNIQCDDPQPVASVLIMNCRIGHPVLKRSSAHVSVVWQLEENAFPNRTADITVTVTNSNERRSLANETHTLQFRHGFVAVLSKPSIMYVNTGQGLSHHKEFLFHVHGENLFGAEYQLQICVPTKLRGLQVVAVKKLTRTQASTVCTWSQERACAYSSVQHVEEWHSVSCVIASDKENVTVAAEISWDHSEELLKDVTELQILGEISFNKSLYEGLNAENHRTKITVVFLKDEKYHSLPIIIKGSVGGLLVLIVILVILFKCGFFKRKYQQLNLESIRKAQLKSENLLEEEN,1179,"130,159",Calcium binding (3); Chain (3); Compositional bias (1); Disulfide bond (7); Domain (1); Glycosylation (11); Motif (1); Mutagenesis (2); Natural variant (7); Region (1); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 70..79;  /evidence=""ECO:0000250""; DISULFID 126..159;  /evidence=""ECO:0000250""; DISULFID 706..762;  /evidence=""ECO:0000250""; DISULFID 823..829;  /evidence=""ECO:0000250""; DISULFID 893..907;  /evidence=""ECO:0000250""; DISULFID 1008..1033;  /evidence=""ECO:0000250""; DISULFID 1041..1057;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:8119947"""
Q8IWB1,"Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)",MAMGLFRVCLVVVTAIINHPLLFPRENATVPENEEEIIRKMQAHQEKLQLEQLRLEEEVARLAAEKEALEQVAEEGRQQNETRVAWDLWSTLCMILFLMIEVWRQDHQEGPSPECLGGEEDELPGLGGAPLQGLTLPNKATLGHFYERCIRGATADAARTREFLEGFVDDLLEALRSLCNRDTDMEVEDFIGVDSMYENWQVDRPLLCHLFVPFTPPEPYRFHPELWCSGRSVPLDRQGYGQIKVVRADGDTLSCICGKTKLGEDMLCLLHGRNSMAPPCGDMENLLCATDSLYLDTMQVMKWFQTALTRAWKGIAHKYEFDLAFGQLDSPGSLKIKFRSGKFMPFNLIPVIQCDDSDLYFVSHLPREPSEGTPASSTDWLLSFAVYERHFLRTTLKALPEGACHLSCLQIASFLLSKQSRLTGPSGLSSYHLKTALLHLLLLRQAADWKAGQLDARLHELLCFLEKSLLQKKLHHFFIGNRKVPEAMGLPEAVLRAEPLNLFRPFVLQRSLYRKTLDSFYEMLKNAPALISEYSLHVPSDQPTPKS,547,"62,060",Chain (1); Coiled coil (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (2); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q8IU57,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2),MAGPERWGPLLLCLLQAAPGRPRLAPPQNVTLLSQNFSVYLTWLPGLGNPQDVTYFVAYQSSPTRRRWREVEECAGTKELLCSMMCLKKQDLYNKFKGRVRTVSPSSKSPWVESEYLDYLFEVEPAPPVLVLTQTEEILSANATYQLPPCMPPLDLKYEVAFWKEGAGNKTLFPVTPHGQPVQITLQPAASEHHCLSARTIYTFSVPKYSKFSKPTCFLLEVPEANWAFLVLPSLLILLLVIAAGGVIWKTLMGNPWFQRAKMPRALDFSGHTHPVATFQPSRPESVNDLFLCPQKELTRGVRPTPRVRAPATQQTRWKKDLAEDEEEEDEEDTEDGVSFQPYIEPPSFLGQEHQAPGHSEAGGVDSGRPRAPLVPSEGSSAWDSSDRSWASTVDSSWDRAGSSGYLAEKGPGQGPGGDGHQESLPPPEFSKDSGFLEELPEDNLSSWATWGTLPPEPNLVPGGPPVSLQTLTFCWESSPEEEEEARESEIEDSDAGSWGAESTQRTEDRGRTLGHYMAR,520,"57,653",Alternative sequence (5); Beta strand (16); Chain (1); Disulfide bond (3); Domain (1); Erroneous initiation (1); Glycosylation (4); Helix (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 74..82;  /evidence=""ECO:0000269|PubMed:20934432""; DISULFID 86..150;  /evidence=""ECO:0000269|PubMed:20934432""; DISULFID 195..217;  /evidence=""ECO:0000269|PubMed:20934432""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q96FE5,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A),MQVSKRMLAGGVRSMPSPLLACWQPILLLVLGSVLSGSATGCPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLPNYFTCRRARIRDRKAQQVFVDEGHTVQFVCRADGDPPPAILWLSPRKHLVSAKSNGRLTVFPDGTLEVRYAQVQDNGTYLCIAANAGGNDSMPAHLHVRSYSPDWPHQPNKTFAFISNQPGEGEANSTRATVPFPFDIKTLIIATTMGFISFLGVVLFCLVLLFLWSRGKGNTKHNIEIEYVPRKSDAGISSADAPRKFNMKMI,620,"69,876",Alternative sequence (1); Beta strand (26); Chain (1); Disulfide bond (5); Domain (3); Glycosylation (10); Helix (9); Modified residue (1); Natural variant (3); Repeat (11); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 42..48;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17005555""; DISULFID 46..57;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17005555""; DISULFID 373..396;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17005555""; DISULFID 375..421;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17005555""; DISULFID 446..497;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17005555""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q15116,Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279),MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL,288,"31,647",Beta strand (14); Chain (1); Cross-link (1); Disulfide bond (1); Domain (1); Glycosylation (4); Helix (2); Modified residue (2); Motif (2); Mutagenesis (6); Natural variant (1); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..123;  /evidence=""ECO:0000244|PDB:2M2D, ECO:0000244|PDB:4ZQK, ECO:0000244|PDB:5B8C, ECO:0000244|PDB:5JXE, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23417675, ECO:0000269|PubMed:26602187, ECO:0000269|PubMed:27325296, ECO:0000269|PubMed:27734966""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q14943,Killer cell immunoglobulin-like receptor 3DS1 (MHC class I NK cell receptor) (Natural killer-associated transcript 10) (NKAT-10),MLLMVVSMACVGLFLVQRAGPHMGGQDKPFLSAWPSAVVPRGGHVTLRCHYRHRFNNFMLYKEDRIHVPIFHGRIFQEGFNMSPVTTAHAGNYTCRGSHPHSPTGWSAPSNPMVIMVTGNHRKPSLLAHPGPLVKSGERVILQCWSDIMFEHFFLHREWISKDPSRLVGQIHDGVSKANFSIGSMMRALAGTYRCYGSVTHTPYQLSAPSDPLDIVVTGLYEKPSLSAQPGPKVQAGESVTLSCSSRSSYDMYHLSREGGAHERRLPAVRKVNRTFQADFPLGPATHGGTYRCFGSFRHSPYEWSDPSDPLLVSVTGNPSSSWPSPTEPSSKSGNLRHLHILIGTSVVKIPFTILLFFLLHRWCSNKKKCCCNGPRACREQK,382,"42,475",Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Natural variant (10); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..95;  /evidence=""ECO:0000250""; DISULFID 144..195;  /evidence=""ECO:0000250""; DISULFID 244..293;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
A6NJW4,Leucine-rich repeat-containing protein 3C,MRMTSSSFVSYCTPGLCQFMAMLPTAGHLLPLLLVIGTGGTVPSPQVPPRGCYVAKEAGERTFRCSQAGLSAVPSGIPNDTRKLYLDANQLASVPAGAFQHLPVLEELDLSHNALAHLSGAAFQGLEGTLRHLDLSANQLASVPVEAFVGLQIQVNLSANPWHCDCALQEVLRQVRLVPGTGTGIVCGSGARPDLVGQEFLLLAGEEELCGSGWGGARRSTDVALLVTMGGWLTLMVAYLVHYVWQNRDETRRSLKRAPVLPVRSEDSSILSTVV,275,"29,314",Chain (1); Domain (2); Erroneous gene model prediction (1); Glycosylation (1); Repeat (3); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..41;  /evidence=""ECO:0000255"""
O75022,Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a),MTPALTALLCLGLSLGPRTRVQAGPFPKPTLWAEPGSVISWGSPVTIWCQGSQEAQEYRLHKEGSPEPLDRNNPLEPKNKARFSIPSMTEHHAGRYRCHYYSSAGWSEPSDPLEMVMTGAYSKPTLSALPSPVVASGGNMTLRCGSQKGYHHFVLMKEGEHQLPRTLDSQQLHSRGFQALFPVGPVTPSHRWRFTCYYYYTNTPWVWSHPSDPLEILPSGVSRKPSLLTLQGPVLAPGQSLTLQCGSDVGYNRFVLYKEGERDFLQRPGQQPQAGLSQANFTLGPVSPSNGGQYRCYGAHNLSSEWSAPSDPLNILMAGQIYDTVSLSAQPGPTVASGENVTLLCQSWWQFDTFLLTKEGAAHPPLRLRSMYGAHKYQAEFPMSPVTSAHAGTYRCYGSYSSNPHLLSHPSEPLELVVSGHSGGSSLPPTGPPSTPGLGRYLEVLIGVSVAFVLLLFLLLFLLLRRQRHSKHRTSDQRKTDFQRPAGAAETEPKDRGLLRRSSPAADVQEENLYAAVKDTQSEDRVELDSQSPHDEDPQAVTYAPVKHSSPRREMASPPSSLSGEFLDTKDRQVEEDRQMDTEAAASEASQDVTYAQLHSLTLRRKATEPPPSQEGEPPAEPSIYATLAIH,631,"69,386",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (4); Modified residue (2); Motif (3); Natural variant (13); Sequence conflict (25); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 144..196;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 245..296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 345..396;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8N0W4,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",MSRPQGLLWLPLLFTPVCVMLNSNVLLWLTALAIKFTLIDSQAQYPVVNTNYGKIRGLRTPLPNEILGPVEQYLGVPYASPPTGERRFQPPEPPSSWTGIRNTTQFAAVCPQHLDERSLLHDMLPIWFTANLDTLMTYVQDQNEDCLYLNIYVPTEDDIHDQNSKKPVMVYIHGGSYMEGTGNMIDGSILASYGNVIVITINYRLGILGFLSTGDQAAKGNYGLLDQIQALRWIEENVGAFGGDPKRVTIFGSGAGASCVSLLTLSHYSEGLFQKAIIQSGTALSSWAVNYQPAKYTRILADKVGCNMLDTTDMVECLRNKNYKELIQQTITPATYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVDGIVDNEDGVTPNDFDFSVSNFVDNLYGYPEGKDTLRETIKFMYTDWADKENPETRRKTLVALFTDHQWVAPAVATADLHAQYGSPTYFYAFYHHCQSEMKPSWADSAHGDEVPYVFGIPMIGPTELFSCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWSKYNPKDQLYLHIGLKPRVRDHYRATKVAFWLELVPHLHNLNEIFQYVSTTTKVPPPDMTSFPYGTRRSPAKIWPTTKRPAITPANNPKHSKDPHKTGPEDTTVLIETKRDYSTELSVTIAVGASLLFLNILAFAALYYKKDKRRHETHRRPSPQRNTTNDIAHIQNEEIMSLQMKQLEHDHECESLQAHDTLRLTCPPDYTLTLRRSPDDIPLMTPNTITMIPNTLTGMQPLHTFNTFSGGQNSTNLPHGHSTTRV,816,"91,915",Alternative sequence (1); Beta strand (20); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (2); Helix (26); Modified residue (1); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 110..146;  /evidence=""ECO:0000269|PubMed:18093521""; DISULFID 306..317;  /evidence=""ECO:0000269|PubMed:18093521""; DISULFID 476..510;  /evidence=""ECO:0000269|PubMed:18093521""","SIGNAL 1..41;  /evidence=""ECO:0000269|PubMed:15340161"""
Q13224,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)",MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAIKDAHEKDDFHHLSVVPRVELVAMNETDPKSIITRICDLMSDRKIQGVVFADDTDQEAIAQILDFISAQTLTPILGIHGGSSMIMADKDESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTYFPGYQDFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQNQLKKLQSPIILLYCTKEEATYIFEVANSVGLTGYGYTWIVPSLVAGDTDTVPAEFPTGLISVSYDEWDYGLPARVRDGIAIITTAASDMLSEHSFIPEPKSSCYNTHEKRIYQSNMLNRYLINVTFEGRNLSFSEDGYQMHPKLVIILLNKERKWERVGKWKDKSLQMKYYVWPRMCPETEEQEDDHLSIVTLEEAPFVIVESVDPLSGTCMRNTVPCQKRIVTENKTDEEPGYIKKCCKGFCIDILKKISKSVKFTYDLYLVTNGKHGKKINGTWNGMIGEVVMKRAYMAVGSLTINEERSEVVDFSVPFIETGISVMVSRSNGTVSPSAFLEPFSADVWVMMFVMLLIVSAVAVFVFEYFSPVGYNRCLADGREPGGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEYVDQVSGLSDKKFQRPNDFSPPFRFGTVPNGSTERNIRNNYAEMHAYMGKFNQRGVDDALLSLKTGKLDAFIYDAAVLNYMAGRDEGCKLVTIGSGKVFASTGYGIAIQKDSGWKRQVDLAILQLFGDGEMEELEALWLTGICHNEKNEVMSSQLDIDNMAGVFYMLGAAMALSLITFICEHLFYWQFRHCFMGVCSGKPGMVFSISRGIYSCIHGVAIEERQSVMNSPTATMNNTHSNILRLLRTAKNMANLSGVNGSPQSALDFIRRESSVYDISEHRRSFTHSDCKSYNNPPCEENLFSDYISEVERTFGNLQLKDSNVYQDHYHHHHRPHSIGSASSIDGLYDCDNPPFTTQSRSISKKPLDIGLPSSKHSQLSDLYGKFSFKSDRYSGHDDLIRSDVSDISTHTVTYGNIEGNAAKRRKQQYKDSLKKRPASAKSRREFDEIELAYRRRPPRSPDHKRYFRDKEGLRDFYLDQFRTKENSPHWEHVDLTDIYKERSDDFKRDSVSGGGPCTNRSHIKHGTGDKHGVVSGVPAPWEKNLTNVEWEDRSGGNFCRSCPSKLHNYSTTVTGQNSGRQACIRCEACKKAGNLYDISEDNSLQELDQPAAPVAVTSNASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPRSVSLKDKGRFMDGSPYAHMFEMSAGESTFANNKSSVPTAGHHHHNNPGGGYMLSKSLYPDRVTQNPFIPTFGDDQCLLHGSKSYFFRQPTVAGASKARPDFRALVTNKPVVSALHGAVPARFQKDICIGNQSNPCVPNNKNPRAFNGSSNGHVYEKLSSIESDV,1484,"166,367",Beta strand (16); Binding site (3); Chain (1); Compositional bias (2); Disulfide bond (4); Glycosylation (7); Helix (13); Intramembrane (1); Metal binding (2); Modified residue (17); Motif (1); Mutagenesis (2); Natural variant (25); Region (3); Sequence conflict (16); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (3); Turn (1),"DISULFID 86..321;  /evidence=""ECO:0000250|UniProtKB:Q00960""; DISULFID 429..456;  /evidence=""ECO:0000250|UniProtKB:Q00960""; DISULFID 436..457;  /evidence=""ECO:0000250|UniProtKB:Q00960""; DISULFID 746..801;  /evidence=""ECO:0000250|UniProtKB:Q00960""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q92542,Nicastrin,MATAGGGSGADPGSRGLLRLLSFCVLLAGLCRGNSVERKIYIPLNKTAPCVRLLNATHQIGCQSSISGDTGVIHVVEKEEDLQWVLTDGPNPPYMVLLESKHFTRDLMEKLKGRTSRIAGLAVSLTKPSPASGFSPSVQCPNDGFGVYSNSYGPEFAHCREIQWNSLGNGLAYEDFSFPIFLLEDENETKVIKQCYQDHNLSQNGSAPTFPLCAMQLFSHMHAVISTATCMRRSSIQSTFSINPEIVCDPLSDYNVWSMLKPINTTGTLKPDDRVVVAATRLDSRSFFWNVAPGAESAVASFVTQLAAAEALQKAPDVTTLPRNVMFVFFQGETFDYIGSSRMVYDMEKGKFPVQLENVDSFVELGQVALRTSLELWMHTDPVSQKNESVRNQVEDLLATLEKSGAGVPAVILRRPNQSQPLPPSSLQRFLRARNISGVVLADHSGAFHNKYYQSIYDTAENINVSYPEWLSPEEDLNFVTDTAKALADVATVLGRALYELAGGTNFSDTVQADPQTVTRLLYGFLIKANNSWFQSILRQDLRSYLGDGPLQHYIAVSSPTNTTYVVQYALANLTGTVVNLTREQCQDPSKVPSENKDLYEYSWVQGPLHSNETDRLPRCVRSTARLARALSPAFELSQWSSTEYSTWTESRWKDIRARIFLIASKELELITLTVGFGILIFSLIVTYCINAKADVLFIAPREPGAVSY,709,"78,411",Alternative sequence (2); Beta strand (43); Chain (1); Disulfide bond (5); Glycosylation (16); Helix (27); Mutagenesis (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 50..62;  /evidence=""ECO:0000244|PDB:4UIS, ECO:0000244|PDB:5A63, ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5, ECO:0000244|PDB:6IDF, ECO:0000244|PDB:6IYC, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874, ECO:0000305|PubMed:25043039, ECO:0000305|PubMed:25918421""; DISULFID 140..159;  /evidence=""ECO:0000244|PDB:5A63, ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5, ECO:0000244|PDB:6IDF, ECO:0000244|PDB:6IYC, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874""; DISULFID 195..213;  /evidence=""ECO:0000244|PDB:4UIS, ECO:0000244|PDB:5A63, ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517, ECO:0000305|PubMed:25918421""; DISULFID 230..248;  /evidence=""ECO:0000244|PDB:4UIS, ECO:0000244|PDB:5A63, ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5, ECO:0000244|PDB:6IDF, ECO:0000244|PDB:6IYC, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874, ECO:0000305|PubMed:25918421""; DISULFID 586..620;  /evidence=""ECO:0000244|PDB:5A63, ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5, ECO:0000244|PDB:6IDF, ECO:0000244|PDB:6IYC, ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517, ECO:0000269|PubMed:30598546, ECO:0000269|PubMed:30630874""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9UN70,Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43),MVPEAWRSGLVSTGRVVGVLLLLGALNKASTVIHYEIPEEREKGFAVGNVVANLGLDLGSLSARRFRVVSGASRRFFEVNRETGEMFVNDRLDREELCGTLPSCTVTLELVVENPLELFSVEVVIQDINDNNPAFPTQEMKLEISEAVAPGTRFPLESAHDPDVGSNSLQTYELSRNEYFALRVQTREDSTKYAELVLERALDREREPSLQLVLTALDGGTPALSASLPIHIKVLDANDNAPVFNQSLYRARVLEDAPSGTRVVQVLATDLDEGPNGEIIYSFGSHNRAGVRQLFALDLVTGMLTIKGRLDFEDTKLHEIYIQAKDKGANPEGAHCKVLVEVVDVNDNAPEITVTSVYSPVPEDAPLGTVIALLSVTDLDAGENGLVTCEVPPGLPFSLTSSLKNYFTLKTSADLDRETVPEYNLSITARDAGTPSLSALTIVRVQVSDINDNPPQSSQSSYDVYIEENNLPGAPILNLSVWDPDAPQNARLSFFLLEQGAETGLVGRYFTINRDNGIVSSLVPLDYEDRREFELTAHISDGGTPVLATNISVNIFVTDRNDNAPQVLYPRPGGSSVEMLPRGTSAGHLVSRVVGWDADAGHNAWLSYSLLGSPNQSLFAIGLHTGQISTARPVQDTDSPRQTLTVLIKDNGEPSLSTTATLTVSVTEDSPEARAEFPSGSAPREQKKNLTFYLLLSLILVSVGFVVTVFGVIIFKVYKWKQSRDLYRAPVSSLYRTPGPSLHADAVRGGLMSPHLYHQVYLTTDSRRSDPLLKKPGAASPLASRQNTLRSCDPVFYRQVLGAESAPPGQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,934,"101,077",Alternative sequence (2); Chain (1); Domain (6); Frameshift (2); Glycosylation (6); Sequence caution (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9Y5H3,Protocadherin gamma-A10 (PCDH-gamma-A10),MAAQRNRSKESKDCSGLVLLCLFFGIPWEAGARQISYSIPEELEKGSFVGNISKDLGLAPRELAERGVRIVSRGRTQLFSLNPRSGSLITAGRIDREELCAQSARCVVSFNILVEDRVKLFGIEIEVTDINDNAPKFQAENLDVKINENVAAGMRFPLPEAIDPDVGVNSLQSYQLSPNKHFSLRVQSRANGVKYPELVLEHSLDREEEAIHHLVLTASDGGDPLRSGTVLVSVTVFDANDNAPVFTLPEYRVSVPENLPVGTQLLTVTATDRDEGANGEVTYSFRKLPDTQLLKFQLNKYTGEIKISENLDYEETGFYEIEIQAEDGGAYLATAKVLITVEDVNDNSPELTITSLFSPVTEDSPLGTVVALLNVHDLDSEQNGQVTCSILAYLPFKLEKSIDSYYRLVIHRALDREQVSSYNITVTATDGGSPPLSTEAHFMLQVADINDNPPTFSQVSYFTYIPENNARGASIFSVTALDPDSKENAQIIYSLAEDTIQGVPLSSYISINSDTGVLYALRSFDYEQFHELQMQVTASDSGDPPLSSNVSLSLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFAVGEHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADSIPQVLADLGSFESPANSETSDLTLYLVVAVAAVSCVFLAFVIVLLAHRLRRWHKSRLLQASGGGLTGVSGSHFVGVDGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLISQESCEKNDPLSLLDDSKFPIEDTPLVPQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,936,"101,447",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9Y5H1,Protocadherin gamma-A2 (PCDH-gamma-A2),MAALQKLPHCRKLVLLCFLLATLWEARAGQIRYSVREEIDRGSFVGNIAKDLGLEPLALAEQGVRIVSRGRSQLFALNPRSGSLVTANRIDREELCAQSAPCLLNFNILLEDKLTIYSVEVEITDINDNAPRFGVEELELKISETTTPGFRIPLKNAHDADVGENALQKYALNPNDHFSLDVRRGADGNKYPELVLERSLDREEEAVHHLVLVASDGGDPVLSGTSRICVKVLDANDNAPVFTQPEYRISIPENTLVGTRILTVTATDADEGYYAQVVYFLEKSPGETSEVFELKSTSGELTIIKDLDYEDATFHEIDIEAQDGPGLLTRAKVIVTVLDVNDNAPEFYMTSATSSVSEDSLPGTIIGLFNVHDRDSGQNAFTTCSLPEDLPFKLEKSVDNYYRLVTTRALDREQFSFYNITLTAKDGGNPSLSTDAHILLQVADINDNAPAFSRTSYSTYIPENNPRGASVFSVTAHDPDSNDNAHVTYSFAEDTVQGAPLSSYISINSDTGVLYALRSFDYEQLRDLQVWVIARDSGNPPLSSNVSLSLFVLDQNDNAPEILYPAFPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYHLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAIQDHGQPPLSATVTLTVAVADRIPDILADLGSLEPSAIPNDSDLTLYLVVAVAAVSCVFLAFVIVLLAHRLRRWHKSRLLQASGGSLTGMQSSHFVGVDGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLISQESCEKKDFLSAPQSLLEEEREETFSQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"101,484",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q96MU8,Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose),MAPPAARLALLSAAALTLAARPAPSPGLGPECFTANGADYRGTQNWTALQGGKPCLFWNETFQHPYNTLKYPNGEGGLGEHNYCRNPDGDVSPWCYVAEHEDGVYWKYCEIPACQMPGNLGCYKDHGNPPPLTGTSKTSNKLTIQTCISFCRSQRFKFAGMESGYACFCGNNPDYWKYGEAASTECNSVCFGDHTQPCGGDGRIILFDTLVGACGGNYSAMSSVVYSPDFPDTYATGRVCYWTIRVPGASHIHFSFPLFDIRDSADMVELLDGYTHRVLARFHGRSRPPLSFNVSLDFVILYFFSDRINQAQGFAVLYQAVKEELPQERPAVNQTVAEVITEQANLSVSAARSSKVLYVITTSPSHPPQTVPGSNSWAPPMGAGSHRVEGWTVYGLATLLILTVTAIVAKILLHVTFKSHRVPASGDLRDCHQPGTSGEIWSIFYKPSTSISIFKKKLKGQSQQDDRNPLVSD,473,"51,744",Alternative sequence (3); Beta strand (23); Chain (1); Disulfide bond (8); Domain (3); Glycosylation (6); Helix (3); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 32..114;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 55..95;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 84..109;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 122..186;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 147..167;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 151..169;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 190..198;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""; DISULFID 214..240;  /evidence=""ECO:0000244|PDB:5FWS, ECO:0000244|PDB:5FWT, ECO:0000244|PDB:5FWU, ECO:0000244|PDB:5FWV, ECO:0000244|PDB:5FWW, ECO:0000269|PubMed:27524201""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P42702,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118),MMDIYVCLKRPSWMVDNKRMRTASNFQWLLSTFILLYLMNQVNSQKKGAPHDLKCVTNNLQVWNCSWKAPSGTGRGTDYEVCIENRSRSCYQLEKTSIKIPALSHGDYEITINSLHDFGSSTSKFTLNEQNVSLIPDTPEILNLSADFSTSTLYLKWNDRGSVFPHRSNVIWEIKVLRKESMELVKLVTHNTTLNGKDTLHHWSWASDMPLECAIHFVEIRCYIDNLHFSGLEEWSDWSPVKNISWIPDSQTKVFPQDKVILVGSDITFCCVSQEKVLSALIGHTNCPLIHLDGENVAIKIRNISVSASSGTNVVFTTEDNIFGTVIFAGYPPDTPQQLNCETHDLKEIICSWNPGRVTALVGPRATSYTLVESFSGKYVRLKRAEAPTNESYQLLFQMLPNQEIYNFTLNAHNPLGRSQSTILVNITEKVYPHTPTSFKVKDINSTAVKLSWHLPGNFAKINFLCEIEIKKSNSVQEQRNVTIKGVENSSYLVALDKLNPYTLYTFRIRCSTETFWKWSKWSNKKQHLTTEASPSKGPDTWREWSSDGKNLIIYWKPLPINEANGKILSYNVSCSSDEETQSLSEIPDPQHKAEIRLDKNDYIISVVAKNSVGSSPPSKIASMEIPNDDLKIEQVVGMGKGILLTWHYDPNMTCDYVIKWCNSSRSEPCLMDWRKVPSNSTETVIESDEFRPGIRYNFFLYGCRNQGYQLLRSMIGYIEELAPIVAPNFTVEDTSADSILVKWEDIPVEELRGFLRGYLFYFGKGERDTSKMRVLESGRSDIKVKNITDISQKTLRIADLQGKTSYHLVLRAYTDGGVGPEKSMYVVTKENSVGLIIAILIPVAVAVIVGVVTSILCYRKREWIKETFYPDIPNPENCKALQFQKSVCEGSSALKTLEMNPCTPNNVEVLETRSAFPKIEDTEIISPVAERPEDRSDAEPENHVVVSYCPPIIEEEIPNPAADEAGGTAQVIYIDVQSMYQPQAKPEEEQENDPVGGAGYKPQMHLPINSTVEDIAAEEDLDKTAGYRPQANVNTWNLVSPDSPRSIDSNSEIVSFGSPCSINSRQFLIPPKDEDSPKSNGGGWSFTNFFQNKPND,1097,"123,743",Beta strand (40); Chain (1); Disulfide bond (5); Domain (6); Glycosylation (19); Helix (4); Modified residue (2); Motif (2); Natural variant (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 55..65;  /evidence=""ECO:0000269|PubMed:18775332""; DISULFID 82..90;  /evidence=""ECO:0000269|PubMed:18775332""; DISULFID 213..270;  /evidence=""ECO:0000269|PubMed:18775332""; DISULFID 341..351;  /evidence=""ECO:0000269|PubMed:18775332""; DISULFID 466..511;  /evidence=""ECO:0000269|PubMed:18775332""","SIGNAL 1..44;  /evidence=""ECO:0000255"""
A0A1B0GTW7,Leishmanolysin-like peptidase 2 (EC 3.4.24.-),MLLLLLLLLLLPPLVLRVAASRCLHDETQKSVSLLRPPFSQLPSKSRSSSLTLPSSRDPQPLRIQSCYLGDHISDGAWDPEGEGMRGGSRALAAVREATQRIQAVLAVQGPLLLSRDPAQYCHAVWGDPDSPNYHRCSLLNPGYKGESCLGAKIPDTHLRGYALWPEQGPPQLVQPDGPGVQNTDFLLYVRVAHTSKCHQETVSLCCPGWSTAAQSQLTAALTSWAQRRGFVMLPRLCLKLLGSSNLPTLASQSIRITGPSVIAYAACCQLDSEDRPLAGTIVYCAQHLTSPSLSHSDIVMATLHELLHALGFSGQLFKKWRDCPSGFSVRENCSTRQLVTRQDEWGQLLLTTPAVSLSLAKHLGVSGASLGVPLEEEEGLLSSHWEARLLQGSLMTATFDGAQRTRLDPITLAAFKDSGWYQVNHSAAEELLWGQGSGPEFGLVTTCGTGSSDFFCTGSGLGCHYLHLDKGSCSSDPMLEGCRMYKPLANGSECWKKENGFPAGVDNPHGEIYHPQSRCFFANLTSQLLPGDKPRHPSLTPHLKEAELMGRCYLHQCTGRGAYKVQVEGSPWVPCLPGKVIQIPGYYGLLFCPRGRLCQTNEDINAVTSPPVSLSTPDPLFQLSLELAGPPGHSLGKEQQEGLAEAVLEALASKGGTGRCYFHGPSITTSLVFTVHMWKSPGCQGPSVATLHKALTLTLQKKPLEVYHGGANFTTQPSKLLVTSDHNPSMTHLRLSMGLCLMLLILVGVMGTTAYQKRATLPVRPSASYHSPELHSTRVPVRGIREV,788,"85,397",Active site (1); Chain (1); Glycosylation (5); Metal binding (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9NQX5,Neural proliferation differentiation and control protein 1 (NPDC-1),MATPLPPPSPRHLRLLRLLLSGLVLGAALRGAAAGHPDVAACPGSLDCALKRRARCPPGAHACGPCLQPFQEDQQGLCVPRMRRPPGGGRPQPRLEDEIDFLAQELARKESGHSTPPLPKDRQRLPEPATLGFSARGQGLELGLPSTPGTPTPTPHTSLGSPVSSDPVHMSPLEPRGGQGDGLALVLILAFCVAGAAALSVASLCWCRLQREIRLTQKADYATAKAPGSPAAPRISPGDQRLAQSAEMYHYQHQRQQMLCLERHKEPPKELDTASSDEENEDGDFTVYECPGLAPTGEMEVRNPLFDHAALSAPLPAPSSPPALP,325,"34,516",Chain (1); Compositional bias (2); Modified residue (1); Sequence conflict (5); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
P58400,Neurexin-1-beta (Neurexin I-beta),MYQRMLRCGAELGSPGGGGGGGGGGGAGGRLALLWIVPLTLSGLLGVAWGASSLGAHHIHHFHGSSKHHSVPIAIYRSPASLRGGHAGTTYIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGNNDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNVRLVGEVPSSMTTESTATAMQSEMSTSIMETTTTLATSTARRGKPPTKEPISQTTDDILVASAECPSDDEDIDPCEPSSGGLANPTRAGGREPYPGSAEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYHVDESRNYISNSAQSNGAVVKEKQPSSAKSSNKNKKNKDKEYYV,472,"50,424",Alternative sequence (1); Beta strand (13); Chain (1); Compositional bias (3); Domain (1); Frameshift (1); Glycosylation (1); Helix (1); Metal binding (4); Region (1); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..50;  /evidence=""ECO:0000250"""
Q9Y5G1,Protocadherin gamma-B3 (PCDH-gamma-B3),MGNSSGWRGPAGQRRMLFLFLLSLLDQALSEPIRYAIPEELDRGSLVGNLAKDLGFGVGDLPTRNLRVIAEKKFFTVSPENGNLLVSDRIDREEICGKKSTCVLEFEMVAEKPLNFFHVTVLIQDINDNPPTFSQNITELEISELALTGATFALESAQDPDVGVNSLQQYYLSPDPHFSLIQKENLDGSRYPELVLKAPLDREEQPHHHLVLTAVDGGEPSRSCTTQIRVIVADANDNPPVFTQDMYRVNVAENLPAGSSVLKVMAIDMDEGINAEIIYAFINIGKEVRQLFKLDSKTGELTTIGELDFEERDSYTIGVEAKDGGHHTAYCKVQIDISDENDNAPEITLASESQHIQEDAELGTAVALIKTHDLDSGFNGEILCQLKGNFPFKIVQDTKNTYRLVTDGALDREQIPEYNVTITATDKGNPPLSSSKTITLHILDVNDNVPVFHQASYTVHVAENNPPGASIAHVRASDPDLGPNGLVSYYIVASDLEPRELSSYVSVSARSGVVFAQRAFDHEQLRAFELTLQARDQGSPTLSANVSLRVLVDDRNDNAPLVLYPALGPEGSALFDMVPRSAEPGYLVTKVVAVDADSGYNAWLSYHIVQASEPGLFSLGLRTGEVRTARTLGDREAARQRLLVTVRDGGQQPLSATVMLHLIFADSLQEIQPDLSDRPTPSDPQAELQFHLVVALALISVLFLLAVILAISLRLRCSSRPATEGYFQPGVCFKTVPGVLPTYSERTLPYSYNPCAASHSSNTEFKFLNIKAENAAPQDLLCDEASWFESNDNPEMPSNSGNLQKQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,929,"101,204",Alternative sequence (2); Beta strand (32); Chain (1); Domain (6); Glycosylation (3); Helix (8); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9BZG2,Testicular acid phosphatase (EC 3.1.3.2) (Acid phosphatase 4),MAGLGFWGHPAGPLLLLLLLVLPPRALPEGPLVFVALVFRHGDRAPLASYPMDPHKEVASTLWPRGLGQLTTEGVRQQLELGRFLRSRYEAFLSPEYRREEVYIRSTDFDRTLESAQANLAGLFPEAAPGSPEARWRPIPVHTVPVAEDKLLRFPMRSCPRYHELLREATEAAEYQEALEGWTGFLSRLENFTGLSLVGEPLRRAWKVLDTLMCQQAHGLPLPAWASPDVLRTLAQISALDIGAHVGPPRAAEKAQLTGGILLNAILANFSRVQRLGLPLKMVMYSAHDSTLLALQGALGLYDGHTPPYAACLGFEFRKHLGNPAKDGGNVTVSLFYRNDSAHLPLPLSLPGCPAPCPLGRFYQLTAPARPPAHGVSCHGPYEAAIPPAPVVPLLAGAVAVLVALSLGLGLLAWRPGCLRALGGPV,426,"46,090",Active site (2); Alternative sequence (3); Chain (1); Disulfide bond (3); Glycosylation (4); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 159..378;  /evidence=""ECO:0000250|UniProtKB:P15309""; DISULFID 214..312;  /evidence=""ECO:0000250|UniProtKB:P15309""; DISULFID 353..357;  /evidence=""ECO:0000250|UniProtKB:P15309""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
O43567,E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13),MLLSIGMLMLSATQVYTILTVQLFAFLNLLPVEADILAYNFENASQTFDDLPARFGYRLPAEGLKGFLINSKPENACEPIVPPPVKDNSSGTFIVLIRRLDCNFDIKVLNAQRAGYKAAIVHNVDSDDLISMGSNDIEVLKKIDIPSVFIGESSANSLKDEFTYEKGGHLILVPEFSLPLEYYLIPFLIIVGICLILIVIFMITKFVQDRHRARRNRLRKDQLKKLPVHKFKKGDEYDVCAICLDEYEDGDKLRILPCSHAYHCKCVDPWLTKTKKTCPVCKQKVVPSQGDSDSDTDSSQEENEVTEHTPLLRPLASVSAQSFGALSESRSHQNMTESSDYEEDDNEDTDSSDAENEINEHDVVVQLQPNGERDYNIANTV,381,"42,814",Alternative sequence (2); Beta strand (4); Chain (1); Domain (1); Glycosylation (1); Helix (2); Mutagenesis (10); Natural variant (2); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2); Zinc finger (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
P98155,Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R),MGTSALWALWLLLALCWAPRESGATGTGRKAKCEPSQFQCTNGRCITLLWKCDGDEDCVDGSDEKNCVKKTCAESDFVCNNGQCVPSRWKCDGDPDCEDGSDESPEQCHMRTCRIHEISCGAHSTQCIPVSWRCDGENDCDSGEDEENCGNITCSPDEFTCSSGRCISRNFVCNGQDDCSDGSDELDCAPPTCGAHEFQCSTSSCIPISWVCDDDADCSDQSDESLEQCGRQPVIHTKCPASEIQCGSGECIHKKWRCDGDPDCKDGSDEVNCPSRTCRPDQFECEDGSCIHGSRQCNGIRDCVDGSDEVNCKNVNQCLGPGKFKCRSGECIDISKVCNQEQDCRDWSDEPLKECHINECLVNNGGCSHICKDLVIGYECDCAAGFELIDRKTCGDIDECQNPGICSQICINLKGGYKCECSRGYQMDLATGVCKAVGKEPSLIFTNRRDIRKIGLERKEYIQLVEQLRNTVALDADIAAQKLFWADLSQKAIFSASIDDKVGRHVKMIDNVYNPAAIAVDWVYKTIYWTDAASKTISVATLDGTKRKFLFNSDLREPASIAVDPLSGFVYWSDWGEPAKIEKAGMNGFDRRPLVTADIQWPNGITLDLIKSRLYWLDSKLHMLSSVDLNGQDRRIVLKSLEFLAHPLALTIFEDRVYWIDGENEAVYGANKFTGSELATLVNNLNDAQDIIVYHELVQPSGKNWCEEDMENGGCEYLCLPAPQINDHSPKYTCSCPSGYNVEENGRDCQSTATTVTYSETKDTNTTEISATSGLVPGGINVTTAVSEVSVPPKGTSAAWAILPLLLLVMAAVGGYLMWRNWQHKNMKSMNFDNPVYLKTTEEDLSIDIGRHSASVGHTYPAISVVSTDDDLA,873,"96,098",Alternative sequence (1); Beta strand (6); Chain (1); Cross-link (1); Disulfide bond (33); Domain (11); Glycosylation (3); Helix (4); Motif (1); Mutagenesis (3); Natural variant (7); Region (1); Repeat (6); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 33..45;  /evidence=""ECO:0000250""; DISULFID 40..58;  /evidence=""ECO:0000250""; DISULFID 52..67;  /evidence=""ECO:0000250""; DISULFID 72..84;  /evidence=""ECO:0000250""; DISULFID 79..97;  /evidence=""ECO:0000250""; DISULFID 91..108;  /evidence=""ECO:0000250""; DISULFID 113..127; DISULFID 120..140; DISULFID 134..149; DISULFID 154..166;  /evidence=""ECO:0000250""; DISULFID 161..179;  /evidence=""ECO:0000250""; DISULFID 173..188;  /evidence=""ECO:0000250""; DISULFID 193..205;  /evidence=""ECO:0000250""; DISULFID 200..218;  /evidence=""ECO:0000250""; DISULFID 212..229;  /evidence=""ECO:0000250""; DISULFID 239..251;  /evidence=""ECO:0000250""; DISULFID 246..264;  /evidence=""ECO:0000250""; DISULFID 258..273;  /evidence=""ECO:0000250""; DISULFID 278..290;  /evidence=""ECO:0000250""; DISULFID 285..303;  /evidence=""ECO:0000250""; DISULFID 297..312;  /evidence=""ECO:0000250""; DISULFID 318..331;  /evidence=""ECO:0000250""; DISULFID 326..344;  /evidence=""ECO:0000250""; DISULFID 338..355;  /evidence=""ECO:0000250""; DISULFID 360..371;  /evidence=""ECO:0000250""; DISULFID 367..380;  /evidence=""ECO:0000250""; DISULFID 382..394;  /evidence=""ECO:0000250""; DISULFID 400..410;  /evidence=""ECO:0000250""; DISULFID 406..419;  /evidence=""ECO:0000250""; DISULFID 421..434;  /evidence=""ECO:0000250""; DISULFID 706..719;  /evidence=""ECO:0000250""; DISULFID 715..734;  /evidence=""ECO:0000250""; DISULFID 736..749;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8TB96,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),MAAAGRLPSSWALFSPLLAGLALLGVGPVPARALHNVTAELFGAEAWGTLAAFGDLNSDKQTDLFVLRERNDLIVFLADQNAPYFKPKVKVSFKNHSALITSVVPGDYDGDSQMDVLLTYLPKNYAKSELGAVIFWGQNQTLDPNNMTILNRTFQDEPLIMDFNGDLIPDIFGITNESNQPQILLGGNLSWHPALTTTSKMRIPHSHAFIDLTEDFTADLFLTTLNATTSTFQFEIWENLDGNFSVSTILEKPQNMMVVGQSAFADFDGDGHMDHLLPGCEDKNCQKSTIYLVRSGMKQWVPVLQDFSNKGTLWGFVPFVDEQQPTEIPIPITLHIGDYNMDGYPDALVILKNTSGSNQQAFLLENVPCNNASCEEARRMFKVYWELTDLNQIKDAMVATFFDIYEDGILDIVVLSKGYTKNDFAIHTLKNNFEADAYFVKVIVLSGLCSNDCPRKITPFGVNQPGPYIMYTTVDANGYLKNGSAGQLSQSAHLALQLPYNVLGLGRSANFLDHLYVGIPRPSGEKSIRKQEWTAIIPNSQLIVIPYPHNVPRSWSAKLYLTPSNIVLLTAIALIGVCVFILAIIGILHWQEKKADDREKRQEAHRFHFDAM,612,"68,108",Chain (1); Frameshift (1); Glycosylation (12); Repeat (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
A6NFA1,"Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)",MHAALAGPLLAALLATARARPQPPDGGQCRPPGSQRDLNSFLWTIRRDPPAYLFGTIHVPYTRVWDFIPDNSKAAFQASTRVYFELDLTDPYTISALASCQLLPHGENLQDVLPHELYWRLKRHLDYVKLMMPSWMTPAQRGKGLYADYLFNAIAGNWERKRPVWVMLMVNSLTERDVRFRGVPVLDLYLAQQAEKMKKTTGAVEQVEEQCHPLNNGLNFSQVLFALNQTLLQQESVRAGSLQASYTTEDLIKHYNCGDLSAVIFNHDTSQLPNFINTTLPPHEQVTAQEIDSYFRQELIYKRNERMGKRVMALLRENEDKICFFAFGAGHFLGNNTVIDILRQAGLEVDHTPAGQAIHSPAPQSPAPSPEGTSTSPAPVTPAAAVPEAPSVTPTAPPEDEDPALSPHLLLPDSLSQLEEFGRQRKWHKRQSTHQRPRQFNDLWVRIEDSTTASPPPLPLQPTHSSGTAKPPFQLSDQLQQQDPPGPASSSAPTLGLLPAIATTIAVCFLLHSLGPS,517,"57,421",Chain (1); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
O15321,Transmembrane 9 superfamily member 1 (MP70 protein family member) (hMP70),MTVVGNPRSWSCQWLPILILLLGTGHGPGVEGVTHYKAGDPVILYVNKVGPYHNPQETYHYYQLPVCCPEKIRHKSLSLGEVLDGDRMAESLYEIRFRENVEKRILCHMQLSSAQVEQLRQAIEELYYFEFVVDDLPIRGFVGYMEESGFLPHSHKIGLWTHLDFHLEFHGDRIIFANVSVRDVKPHSLDGLRPDEFLGLTHTYSVRWSETSVERRSDRRRGDDGGFFPRTLEIHWLSIINSMVLVFLLVGFVAVILMRVLRNDLARYNLDEETTSAGSGDDFDQGDNGWKIIHTDVFRFPPYRGLLCAVLGVGAQFLALGTGIIVMALLGMFNVHRHGAINSAAILLYALTCCISGYVSSHFYRQIGGERWVWNIILTTSLFSVPFFLTWSVVNSVHWANGSTQALPATTILLLLTVWLLVGFPLTVIGGIFGKNNASPFDAPCRTKNIAREIPPQPWYKSTVIHMTVGGFLPFSAISVELYYIFATVWGREQYTLYGILFFVFAILLSVGACISIALTYFQLSGEDYRWWWRSVLSVGSTGLFIFLYSVFYYARRSNMSGAVQTVEFFGYSLLTGYVFFLMLGTISFFSSLKFIRYIYVNLKMD,606,"68,861",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (2); Sequence conflict (3); Signal peptide (1); Transmembrane (9),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P0DKB5,Trophoblast glycoprotein-like,MAPRAGQPGLQGLLLVAAALSQPAAPCPFQCYCFGGPKLLLRCASGAELRQPPRDVPPDARNLTIVGANLTVLRAAAFAGGDGDGDQAAGVRLPLLSALRLTHNHIEVVEDGAFDGLPSLAALDLSHNPLRALGGGAFRGLPALRSLQLNHALVRGGPALLAALDAALAPLAELRLLGLAGNALSRLPPAALRLARLEQLDVRLNALAGLDPDELRALERDGGLPGPRLLLADNPLRCGCAARPLLAWLRNATERVPDSRRLRCAAPRALLDRPLLDLDGARLRCADSGADARGEEAEAAGPELEASYVFFGLVLALIGLIFLMVLYLNRRGIQRWMRNLREACRDQMEGYHYRYEQDADPRRAPAPAAPAGSRATSPGSGL,382,"40,400",Chain (1); Disulfide bond (4); Glycosylation (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 27..33;  /evidence=""ECO:0000250""; DISULFID 31..43;  /evidence=""ECO:0000250""; DISULFID 238..264;  /evidence=""ECO:0000250""; DISULFID 240..285;  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9HAW7,UDP-glucuronosyltransferase 1A7 (UGT1A7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-7) (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G),MARAGWTGLLPLYVCLLLTCGFAKAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLGRSLNCTVKTYSTSYTLEDQDREFMVFADARWTAPLRSAFSLLTSSSNGIFDLFFSNCRSLFNDRKLVEYLKESCFDAVFLDPFDACGLIVAKYFSLPSVVFARGIFCHYLEEGAQCPAPLSYVPRLLLGFSDAMTFKERVWNHIMHLEEHLFCPYFFKNVLEIASEILQTPVTAYDLYSHTSIWLLRTDFVLEYPKPVMPNMIFIGGINCHQGKPVPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,530,"59,819",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (4); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9HAW9,UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H),MARTGWTSPIPLCVSLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLGKSLNCTVKTYSTSYTLEDLDREFMDFADAQWKAQVRSLFSLFLSSSNGFFNLFFSHCRSLFNDRKLVEYLKESSFDAVFLDPFDACGLIVAKYFSLPSVVFARGIACHYLEEGAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLFCQYFSKNALEIASEILQTPVTAYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,530,"59,742",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (10); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9NX61,Transmembrane protein 161A (Adaptive response to oxidative stress protein 29) (AROS-29),MAVLGVQLVVTLLTATLMHRLAPHCSFARWLLCNGSLFRYKHPSEEELRALAGKPRPRGRKERWANGLSEEKPLSVPRDAPFQLETCPLTTVDALVLRFFLEYQWFVDFAVYSGGVYLFTEAYYYMLGPAKETNIAVFWCLLTVTFSIKMFLTVTRLYFSAEEGGERSVCLTFAFLFLLLAMLVQVVREETLELGLEPGLASMTQNLEPLLKKQGWDWALPVAKLAIRVGLAVVGSVLGAFLTFPGLRLAQTHRDALTMSEDRPMLQFLLHTSFLSPLFILWLWTKPIARDFLHQPPFGETRFSLLSDSAFDSGRLWLLVVLCLLRLAVTRPHLQAYLCLAKARVEQLRREAGRIEAREIQQRVVRVYCYVTVVSLQYLTPLILTLNCTLLLKTLGGYSWGLGPAPLLSPDPSSASAAPIGSGEDEVQQTAARIAGALGGLLTPLFLRGVLAYLIWWTAACQLLASLFGLYFHQHLAGS,479,"53,602",Alternative sequence (1); Chain (1); Glycosylation (1); Modified residue (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (9); Transmembrane (8),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y2C9,Toll-like receptor 6 (EC 3.2.2.6) (CD antigen CD286),MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS,796,"91,880",Active site (1); Alternative sequence (1); Beta strand (4); Chain (1); Disulfide bond (4); Domain (2); Glycosylation (9); Helix (11); Mutagenesis (3); Natural variant (19); Repeat (19); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 117..139;  /evidence=""ECO:0000250""; DISULFID 235..265;  /evidence=""ECO:0000250""; DISULFID 348..373;  /evidence=""ECO:0000250""; DISULFID 424..447;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P36537,UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17),MALKWTTVLLIQLSFYFSSGSCGKVLVWAAEYSLWMNMKTILKELVQRGHEVTVLASSASILFDPNDSSTLKLEVYPTSLTKTEFENIIMQLVKRLSEIQKDTFWLPFSQEQEILWAINDIIRNFCKDVVSNKKLMKKLQESRFDIVFADAYLPCGELLAELFNIPFVYSHSFSPGYSFERHSGGFIFPPSYVPVVMSKLSDQMTFMERVKNMLYVLYFDFWFQIFNMKKWDQFYSEVLGRPTTLSETMRKADIWLMRNSWNFKFPHPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSSGENGVVVFSLGSMVSNMTEERANVIATALAKIPQKVLWRFDGNKPDALGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFFDQPDNIAHMKAKGAAVRVDFNTMSSTDLLNALKTVINDPSYKENIMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHNLTWFQYHSLDVIGFLLACVATVLFIITKCCLFCFWKFARKGKKGKRD,528,"60,774",Alternative sequence (1); Chain (1); Glycosylation (3); Modified residue (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000250"""
Q86XK7,V-set and immunoglobulin domain-containing protein 1 (Cell surface A33 antigen) (Glycoprotein A34),MVFAFWKVFLILSCLAGQVSVVQVTIPDGFVNVTVGSNVTLICIYTTTVASREQLSIQWSFFHKKEMEPISIYFSQGGQAVAIGQFKDRITGSNDPGNASITISHMQPADSGIYICDVNNPPDFLGQNQGILNVSVLVKPSKPLCSVQGRPETGHTISLSCLSALGTPSPVYYWHKLEGRDIVPVKENFNPTTGILVIGNLTNFEQGYYQCTAINRLGNSSCEIDLTSSHPEVGIIVGALIGSLVGAAIIISVVCFARNKAKAKAKERNSKTIAELEPMTKINPRGESEAMPREDATQLEVTLPSSIHETGPDTIQEPDYEPKPTQEPAPEPAPGSEPMAVPDLDIELELEPETQSELEPEPEPEPESEPGVVVEPLSEDEKGVVKA,387,"41,811",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (5); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 161..211;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9Y279,V-set and immunoglobulin domain-containing protein 4 (Protein Z39Ig),MGILLGLLLLGHLTVDTYGRPILEVPESVTGPWKGDVNLPCTYDPLQGYTQVLVKWLVQRGSDPVTIFLRDSSGDHIQQAKYQGRLHVSHKVPGDVSLQLSTLEMDDRSHYTCEVTWQTPDGNQVVRDKITELRVQKLSVSKPTVTTGSGYGFTVPQGMRISLQCQARGSPPISYIWYKQQTNNQEPIKVATLSTLLFKPAVIADSGSYFCTAKGQVGSEQHSDIVKFVVKDSSKLLKTKTEAPTTMTYPLKATSTVKQSWDWTTDMDGYLGETSAGPGKSLPVFAIILIISLCCMVVFTMAYIMLCRKTSQQEHVYEAARAHAREANDSGETMRVAIFASGCSSDEPTSQNLGNNYSDEPCIGQEYQIIAQINGNYARLLDTVPLDYEFLATEGKSVC,399,"43,987",Alternative sequence (2); Beta strand (11); Chain (1); Disulfide bond (2); Domain (2); Helix (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 41..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17051150""; DISULFID 165..211;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8N1Y9,Putative uncharacterized protein FLJ37218,MAKWVPALLLRRVPLFSLRFRPASSTFLPVLAATEPAVSVPSGDLSMPVKTRAEGEDDGFGEAGDPRRLLERPWRFRGCLPGKGNRDVGFEGTEGPTSTRPEWVWSCRCCLGCRASTRERVTSPVRAAGPQPRFTDRETEAAAGTLAHMGFAPPTSFSHFTDQELRDCSSLECLGVVEGDPHVLCSTLSLSRPSPSATLTLLLASSCLLAPAPPSFILLLFTLIAPDLPHS,231,"24,915",Chain (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
A6NLX4,Transmembrane protein 210,MAPGPWPVSCLRGGPLGLTYLSLLLIPAAAGTYCECSLGLSREALIALLVVLAGISASCFCALVIVAIGVLRAKGETCPRQVDNRLVENFGVQEDLMDLHPVYVESQLMDADLEVSLVPPLEDQSLVAIPMEASSEEPPPPPPLPPE,147,"15,516",Chain (1); Compositional bias (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q8NCS4,Transmembrane protein 35B (ZMYM6 neighbor protein),MALLLSVLRVLLGGFFALVGLAKLSEEISAPVSERMNALFVQFAEVFPLKVFGYQPDPLNYQIAVGFLELLAGLLLVMGPPMLQEISNLFLILLMMGAIFTLAALKESLSTCIPAIVCLGFLLLLNVGQLLAQTKKVVRPTRKKTLSTFKESWK,154,"16,885",Chain (1); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
A2VDJ0,Transmembrane protein 131-like,MAGLRRPQPGCYCRTAAAVNLLLGVFQVLLPCCRPGGAQGQAIEPLPNVVELWQAEEGELLLPTQGDSEEGLEEPSQEQSFSDKLFSGKGLHFQPSVLDFGIQFLGHPVAKILHAYNPSRDSEVVVNSVFAAAGHFHVPPVPCRVIPAMGKTSFRIIFLPTEEGSIESSLFINTSSYGVLSYHVSGIGTRRISTEGSAKQLPNAYFLLPKVQSIQLSQMQAETTNTSLLQVQLECSLHNKVCQQLKGCYLESDDVLRLQMSIMVTMENFSKEFEENTQHLLDHLSIVYVATDESETSDDSAVNMYILHSGNSLIWIQDIRHFSQRDALSLQFEPVLLPTSTTNFTKIASFTCKATSCDSGIIEDVKKTTHTPTLKACLFSSVAQGYFRMDSSATQFHIETHENTSGLWSIWYRNHFDRSVVLNDVFLSKETKHMLKILNFTGPLFLPPGCWNIFSLKLAVKDIAINLFTNVFLTTNIGAIFAIPLQIYSAPTKEGSLGFEVIAHCGMHYFMGKSKAGNPNWNGSLSLDQSTWNVDSELANKLYERWKKYKNGDVCKRNVLGTTRFAHLKKSKESESFVFFLPRLIAEPGLMLNFSATALRSRMIKYFVVQNPSSWPVSLQLLPLSLYPKPEALVHLLHRWFGTDMQMINFTTGEFQLTEACPYLGTHSEESRFGILHLHLQPLEMKRVGVVFTPADYGKVTSLILIRNNLTVIDMIGVEGFGARELLKVGGRLPGAGGSLRFKVPESTLMDCRRQLKDSKQILSITKNFKVENIGPLPITVSSLKINGYNCQGYGFEVLDCHQFSLDPNTSRDISIVFTPDFTSSWVIRDLSLVTAADLEFRFTLNVTLPHHLLPLCADVVPGPSWEESFWRLTVFFVSLSLLGVILIAFQQAQYILMEFMKTRQRQNASSSSQQNNGPMDVISPHSYKSNCKNFLDTYGPSDKGRGKNCLPVNTPQSRIQNAAKRSPATYGHSQKKHKCSVYYSKHKTSTAAASSTSTTTEEKQTSPLGSSLPAAKEDICTDAMRENWISLRYASGINVNLQKNLTLPKNLLNKEENTLKNTIVFSNPSSECSMKEGIQTCMFPKETDIKTSENTAEFKERELCPLKTSKKLPENHLPRNSPQYHQPDLPEISRKNNGNNQQVPVKNEVDHCENLKKVDTKPSSEKKIHKTSREDMFSEKQDIPFVEQEDPYRKKKLQEKREGNLQNLNWSKSRTCRKNKKRGVAPVSRPPEQSDLKLVCSDFERSELSSDINVRSWCIQESTREVCKADAEIASSLPAAQREAEGYYQKPEKKCVDKFCSDSSSDCGSSSGSVRASRGSWGSWSSTSSSDGDKKPMVDAQHFLPAGDSVSQNDFPSEAPISLNLSHNICNPMTVNSLPQYAEPSCPSLPAGPTGVEEDKGLYSPGDLWPTPPVCVTSSLNCTLENGVPCVIQESAPVHNSFIDWSATCEGQFSSAYCPLELNDYNAFPEENMNYANGFPCPADVQTDFIDHNSQSTWNTPPNMPAAWGHASFISSPPYLTSTRSLSPMSGLFGSIWAPQSDVYENCCPINPTTEHSTHMENQAVVCKEYYPGFNPFRAYMNLDIWTTTANRNANFPLSRDSSYCGNV,1609,"179,339",Alternative sequence (5); Chain (1); Compositional bias (2); Glycosylation (6); Modified residue (1); Natural variant (5); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..40;  /evidence=""ECO:0000255"""
Q96J42,Thioredoxin domain-containing protein 15,MVPAAGRRPPRVMRLLGWWQVLLWVLGLPVRGVEVAEESGRLWSEEQPAHPLQVGAVYLGEEELLHDPMGQDRAAEEANAVLGLDTQGDHMVMLSVIPGEAEDKVSSEPSGVTCGAGGAEDSRCNVRESLFSLDGAGAHFPDREEEYYTEPEVAESDAAPTEDSNNTESLKSPKVNCEERNITGLENFTLKILNMSQDLMDFLNPNGSDCTLVLFYTPWCRFSASLAPHFNSLPRAFPALHFLALDASQHSSLSTRFGTVAVPNILLFQGAKPMARFNHTDRTLETLKIFIFNQTGIEAKKNVVVTQADQIGPLPSTLIKSVDWLLVFSLFFLISFIMYATIRTESIRWLIPGQEQEHVE,360,"39,885",Alternative sequence (1); Chain (1); Domain (1); Glycosylation (4); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q6UXZ4,Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D),MGRAAATAGGGGGARRWLPWLGLCFWAAGTAAARGTDNGEALPESIPSAPGTLPHFIEEPDDAYIIKSNPIALRCKARPAMQIFFKCNGEWVHQNEHVSEETLDESSGLKVREVFINVTRQQVEDFHGPEDYWCQCVAWSHLGTSKSRKASVRIAYLRKNFEQDPQGREVPIEGMIVLHCRPPEGVPAAEVEWLKNEEPIDSEQDENIDTRADHNLIIRQARLSDSGNYTCMAANIVAKRRSLSATVVVYVNGGWSSWTEWSACNVRCGRGWQKRSRTCTNPAPLNGGAFCEGMSVQKITCTSLCPVDGSWEVWSEWSVCSPECEHLRIRECTAPPPRNGGKFCEGLSQESENCTDGLCILDKKPLHEIKPQSIENASDIALYSGLGAAVVAVAVLVIGVTLYRRSQSDYGVDVIDSSALTGGFQTFNFKTVRQGNSLLLNSAMQPDLTVSRTYSGPICLQDPLDKELMTESSLFNPLSDIKVKVQSSFMVSLGVSERAEYHGKNHSRTFPHGNNHSFSTMHPRNKMPYIQNLSSLPTRTELRTTGVFGHLGGRLVMPNTGVSLLIPHGAIPEENSWEIYMSINQGEPSLQSDGSEVLLSPEVTCGPPDMIVTTPFALTIPHCADVSSEHWNIHLKKRTQQGKWEEVMSVEDESTSCYCLLDPFACHVLLDSFGTYALTGEPITDCAVKQLKVAVFGCMSCNSLDYNLRVYCVDNTPCAFQEVVSDERHQGGQLLEEPKLLHFKGNTFSLQISVLDIPPFLWRIKPFTACQEVPFSRVWCSNRQPLHCAFSLERYTPTTTQLSCKICIRQLKGHEQILQVQTSILESERETITFFAQEDSTFPAQTGPKAFKIPYSIRQRICATFDTPNAKGKDWQMLAQKNSINRNLSYFATQSSPSAVILNLWEARHQHDGDLDSLACALEEIGRTHTKLSNISESQLDEADFNYSRQNGL,953,"105,880",Alternative sequence (1); Chain (1); Disulfide bond (9); Domain (6); Glycosylation (4); Natural variant (1); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 75..136;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 87..134;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 180..231;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 264..301;  /evidence=""ECO:0000250""; DISULFID 268..305;  /evidence=""ECO:0000250""; DISULFID 279..291;  /evidence=""ECO:0000250""; DISULFID 320..354;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 324..359;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 332..344;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
A6NFC5,Transmembrane protein 235,MARLGALLLAAALGALLSFALLAAAVASDYWYILEVADAGNGSAWPGRAELLSSHSGLWRICEGQNGCIPLVDPFASESLDVSTSVQHLILLHRAVIVVLPLSLVLLVCGWICGLLSSLAQSVSLLLFTGCYFLLGSVLTLAGVSIYISYSHLAFAETVQQYGPQHMQGVRVSFGWSMALAWGSCALEAFSGTLLLSAAWTLSLSPPICGHLSPQQVGGRGGD,223,"23,360",Alternative sequence (2); Chain (1); Erroneous gene model prediction (1); Glycosylation (1); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
H3BS89,Transmembrane protein 178B,MAAGRLLLYTGLSLALCALGMLAVAICSDHWYETDARKHRDRCKAFNTRRVDPGFIYNNNNNLPLRASRSRLDRWEGKLLRARNRRQLFAMSPADECSRQYNSTNMGLWRKCHRQGFDPEIAALIRKGEIERCTYIKYHYSSATIPRNLTFNITKTIRQDEWHALHLRRMTAGFMGMAVAIILFGWIIGVLGCCWDRGLMQYVAGLLFLMGGTFCIISLCTCVAGINFELSRYPRYLYGLPDDISHGYGWSMFCAWGGLGLTLISGFFCTLAPSVQPVPRTNYPKSRPENGTVC,294,"33,409",Chain (1); Glycosylation (2); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q96CP7,TLC domain-containing protein 1 (Calfacilitin),MPRLLHPALPLLLGATLTFRALRRALCRLPLPVHVRADPLRTWRWHNLLVSFAHSIVSGIWALLCVWQTPDMLVEIETAWSLSGYLLVCFSAGYFIHDTVDIVASGQTRASWEYLVHHVMAMGAFFSGIFWSSFVGGGVLTLLVEVSNIFLTIRMMMKISNAQDHLLYRVNKYVNLVMYFLFRLAPQAYLTHFFLRYVNQRTLGTFLLGILLMLDVMIIIYFSRLLRSDFCPEHVPKKQHKDKFLTE,247,"28,548",Alternative sequence (1); Chain (1); Domain (1); Intramembrane (1); Signal peptide (1); Topological domain (6); Transmembrane (4),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q9NS93,Transmembrane 7 superfamily member 3 (Seven span transmembrane protein),MGFLQLLVVAVLASEHRVAGAAEVFGNSSEGLIEFSVGKFRYFELNRPFPEEAILHDISSNVTFLIFQIHSQYQNTTVSFSPTLLSNSSETGTASGLVFILRPEQSTCTWYLGTSGIQPVQNMAILLSYSERDPVPGGCNLEFDLDIDPNIYLEYNFFETTIKFAPANLGYARGVDPPPCDAGTDQDSRWRLQYDVYQYFLPENDLTEEMLLKHLQRMVSVPQVKASALKVVTLTANDKTSVSFSSLPGQGVIYNVIVWDPFLNTSAAYIPAHTYACSFEAGEGSCASLGRVSSKVFFTLFALLGFFICFFGHRFWKTELFFIGFIIMGFFFYILITRLTPIKYDVNLILTAVTGSVGGMFLVAVWWRFGILSICMLCVGLVLGFLISSVTFFTPLGNLKIFHDDGVFWVTFSCIAILIPVVFMGCLRILNILTCGVIGSYSVVLAIDSYWSTSLSYITLNVLKRALNKDFHRAFTNVPFQTNDFIILAVWGMLAVSGITLQIRRERGRPFFPPHPYKLWKQERERRVTNILDPSYHIPPLRERLYGRLTQIKGLFQKEQPAGERTPLLL,570,"64,166",Chain (1); Compositional bias (1); Glycosylation (5); Natural variant (2); Sequence conflict (1); Signal peptide (1); Transmembrane (7),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P43489,Tumor necrosis factor receptor superfamily member 4 (ACT35 antigen) (OX40L receptor) (TAX transcriptionally-activated glycoprotein 1 receptor) (CD antigen CD134),MCVGARRLGRGPCAALLLLGLGLSTVTGLHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKPCKPCTWCNLRSGSERKQLCTATQDTVCRCRAGTQPLDSYKPGVDCAPCPPGHFSPGDNQACKPWTNCTLAGKHTLQPASNSSDAICEDRDPPATQPQETQGPPARPITVQPTEAWPRTSQGPSTRPVEVPGGRAVAAILGLGLVLGLLGPLAILLALYLLRRDQRLPPDAHKPPGGGSFRTPIQEEQADAHSTLAKI,277,"29,341",Beta strand (16); Chain (1); Disulfide bond (9); Erroneous initiation (1); Glycosylation (2); Helix (1); Natural variant (2); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 31..42;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 43..56;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 46..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 67..81;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 84..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 87..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 109..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 128..141;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206, ECO:0000269|PubMed:16905106""; DISULFID 147..166;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q3SY77,UDP-glucuronosyltransferase 3A2 (UDPGT 3A2) (EC 2.4.1.17),MAGQRVLLLVGFLLPGVLLSEAAKILTISTVGGSHYLLMDRVSQILQDHGHNVTMLNHKRGPFMPDFKKEEKSYQVISWLAPEDHQREFKKSFDFFLEETLGGRGKFENLLNVLEYLALQCSHFLNRKDIMDSLKNENFDMVIVETFDYCPFLIAEKLGKPFVAILSTSFGSLEFGLPIPLSYVPVFRSLLTDHMDFWGRVKNFLMFFSFCRRQQHMQSTFDNTIKEHFTEGSRPVLSHLLLKAELWFINSDFAFDFARPLLPNTVYVGGLMEKPIKPVPQDLENFIAKFGDSGFVLVTLGSMVNTCQNPEIFKEMNNAFAHLPQGVIWKCQCSHWPKDVHLAANVKIVDWLPQSDLLAHPSIRLFVTHGGQNSIMEAIQHGVPMVGIPLFGDQPENMVRVEAKKFGVSIQLKKLKAETLALKMKQIMEDKRYKSAAVAASVILRSHPLSPTQRLVGWIDHVLQTGGATHLKPYVFQQPWHEQYLLDVFVFLLGLTLGTLWLCGKLLGMAVWWLRGARKVKET,523,"59,547",Alternative sequence (1); Chain (1); Glycosylation (1); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9H7M9,V-type immunoglobulin domain-containing suppressor of T-cell activation (Platelet receptor Gi24) (Stress-induced secreted protein-1) (Sisp-1) (V-set domain-containing immunoregulatory receptor) (V-set immunoregulatory receptor),MGVPTALEAGSWRWGSLLFALFLAASLGPVAAFKVATPYSLYVCPEGQNVTLTCRLLGPVDKGHDVTFYKTWYRSSRGEVQTCSERRPIRNLTFQDLHLHHGGHQAANTSHDLAQRHGLESASDHHGNFSITMRNLTLLDSGLYCCLVVEIRHHHSEHRVHGAMELQVQTGKDAPSNCVVYPSSSQDSENITAAALATGACIVGILCLPLILLLVYKQRQAASNRRAQELVRMDSNIQGIENPGFEASPPAQGIPEAKVRHPLSYVAQRQPSESGRHLLSEPSTPLSPPGPGDVFFPSLDPVPDSPNFEVI,311,"33,908",Beta strand (12); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Erroneous termination (1); Glycosylation (3); Helix (2); Modified residue (2); Natural variant (1); Sequence caution (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 54..146;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8NEW7,Transmembrane inner ear expressed protein,MAGWPGAGPLCVLGGAALGVCLAGVAGQLVEPSTAPPKPKPPPLTKETVVFWDMRLWHVVGIFSLFVLSIIITLCCVFNCRVPRTRKEIEARYLQRKAAKMYTDKLETVPPLNELTEVPGEDKKKKKKKKKDSVDTVAIKVEEDEKNEAKKKKGEK,156,"17,241",Chain (1); Compositional bias (1); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8IZJ1,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1),MGARSGARGALLLALLLCWDPRLSQAGTDSGSEVLPDSFPSAPAEPLPYFLQEPQDAYIVKNKPVELRCRAFPATQIYFKCNGEWVSQNDHVTQEGLDEATGLRVREVQIEVSRQQVEELFGLEDYWCQCVAWSSAGTTKSRRAYVRIAYLRKNFDQEPLGKEVPLDHEVLLQCRPPEGVPVAEVEWLKNEDVIDPTQDTNFLLTIDHNLIIRQARLSDTANYTCVAKNIVAKRRSTTATVIVYVNGGWSSWAEWSPCSNRCGRGWQKRTRTCTNPAPLNGGAFCEGQAFQKTACTTICPVDGAWTEWSKWSACSTECAHWRSRECMAPPPQNGGRDCSGTLLDSKNCTDGLCMQNKKTLSDPNSHLLEASGDAALYAGLVVAIFVVVAILMAVGVVVYRRNCRDFDTDITDSSAALTGGFHPVNFKTARPSNPQLLHPSVPPDLTASAGIYRGPVYALQDSTDKIPMTNSPLLDPLPSLKVKVYSSSTTGSGPGLADGADLLGVLPPGTYPSDFARDTHFLHLRSASLGSQQLLGLPRDPGSSVSGTFGCLGGRLSIPGTGVSLLVPNGAIPQGKFYEMYLLINKAESTLPLSEGTQTVLSPSVTCGPTGLLLCRPVILTMPHCAEVSARDWIFQLKTQAHQGHWEEVVTLDEETLNTPCYCQLEPRACHILLDQLGTYVFTGESYSRSAVKRLQLAVFAPALCTSLEYSLRVYCLEDTPVALKEVLELERTLGGYLVEEPKPLMFKDSYHNLRLSLHDLPHAHWRSKLLAKYQEIPFYHIWSGSQKALHCTFTLERHSLASTELTCKICVRQVEGEGQIFQLHTTLAETPAGSLDTLCSAPGSTVTTQLGPYAFKIPLSIRQKICNSLDAPNSRGNDWRMLAQKLSMDRYLNYFATKASPTGVILDLWEALQQDDGDLNSLASALEEMGKSEMLVAVATDGDC,945,"103,638",Alternative sequence (1); Chain (1); Disulfide bond (9); Domain (6); Erroneous initiation (2); Glycosylation (2); Lipidation (1); Modified residue (1); Mutagenesis (1); Natural variant (2); Region (2); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 69..130;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 81..128;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 174..225;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 258..295;  /evidence=""ECO:0000250""; DISULFID 262..299;  /evidence=""ECO:0000250""; DISULFID 273..285;  /evidence=""ECO:0000250""; DISULFID 314..348;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 318..353;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 326..338;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q6ZN44,Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A),MAVRPGLWPALLGIVLAAWLRGSGAQQSATVANPVPGANPDLLPHFLVEPEDVYIVKNKPVLLVCKAVPATQIFFKCNGEWVRQVDHVIERSTDGSSGLPTMEVRINVSRQQVEKVFGLEEYWCQCVAWSSSGTTKSQKAYIRIAYLRKNFEQEPLAKEVSLEQGIVLPCRPPEGIPPAEVEWLRNEDLVDPSLDPNVYITREHSLVVRQARLADTANYTCVAKNIVARRRSASAAVIVYVDGSWSPWSKWSACGLDCTHWRSRECSDPAPRNGGEECQGTDLDTRNCTSDLCVHTASGPEDVALYVGLIAVAVCLVLLLLVLILVYCRKKEGLDSDVADSSILTSGFQPVSIKPSKADNPHLLTIQPDLSTTTTTYQGSLCPRQDGPSPKFQLTNGHLLSPLGGGRHTLHHSSPTSEAEEFVSRLSTQNYFRSLPRGTSNMTYGTFNFLGGRLMIPNTGISLLIPPDAIPRGKIYEIYLTLHKPEDVRLPLAGCQTLLSPIVSCGPPGVLLTRPVILAMDHCGEPSPDSWSLRLKKQSCEGSWEDVLHLGEEAPSHLYYCQLEASACYVFTEQLGRFALVGEALSVAAAKRLKLLLFAPVACTSLEYNIRVYCLHDTHDALKEVVQLEKQLGGQLIQEPRVLHFKDSYHNLRLSIHDVPSSLWKSKLLVSYQEIPFYHIWNGTQRYLHCTFTLERVSPSTSDLACKLWVWQVEGDGQSFSINFNITKDTRFAELLALESEAGVPALVGPSAFKIPFLIRQKIISSLDPPCRRGADWRTLAQKLHLDSHLSFFASKPSPTAMILNLWEARHFPNGNLSQLAAAVAGLGQPDAGLFTVSEAEC,842,"92,932",Alternative sequence (3); Beta strand (20); Chain (1); Disulfide bond (6); Domain (5); Glycosylation (3); Helix (2); Region (1); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 65..126;  /evidence=""ECO:0000244|PDB:4V2A""; DISULFID 77..124;  /evidence=""ECO:0000244|PDB:4V2A""; DISULFID 170..221;  /evidence=""ECO:0000244|PDB:4V2A""; DISULFID 254..288;  /evidence=""ECO:0000244|PDB:4V2A""; DISULFID 258..293;  /evidence=""ECO:0000244|PDB:4V2A""; DISULFID 266..278;  /evidence=""ECO:0000244|PDB:4V2A""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O75445,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),MNCPVLSLGSGFLFQVIEMLIFAYFASISLTESRGLFPRLENVGAFKKVSIVPTQAVCGLPDRSTFCHSSAAAESIQFCTQRFCIQDCPYRSSHPTYTALFSAGLSSCITPDKNDLHPNAHSNSASFIFGNHKSCFSSPPSPKLMASFTLAVWLKPEQQGVMCVIEKTVDGQIVFKLTISEKETMFYYRTVNGLQPPIKVMTLGRILVKKWIHLSVQVHQTKISFFINGVEKDHTPFNARTLSGSITDFASGTVQIGQSLNGLEQFVGRMQDFRLYQVALTNREILEVFSGDLLRLHAQSHCRCPGSHPRVHPLAQRYCIPNDAGDTADNRVSRLNPEAHPLSFVNDNDVGTSWVSNVFTNITQLNQGVTISVDLENGQYQVFYIIIQFFSPQPTEIRIQRKKENSLDWEDWQYFARNCGAFGMKNNGDLEKPDSVNCLQLSNFTPYSRGNVTFSILTPGPNYRPGYNNFYNTPSLQEFVKATQIRFHFHGQYYTTETAVNLRHRYYAVDEITISGRCQCHGHADNCDTTSQPYRCLCSQESFTEGLHCDRCLPLYNDKPFRQGDQVYAFNCKPCQCNSHSKSCHYNISVDPFPFEHFRGGGGVCDDCEHNTTGRNCELCKDYFFRQVGADPSAIDVCKPCDCDTVGTRNGSILCDQIGGQCNCKRHVSGRQCNQCQNGFYNLQELDPDGCSPCNCNTSGTVDGDITCHQNSGQCKCKANVIGLRCDHCNFGFKFLRSFNDVGCEPCQCNLHGSVNKFCNPHSGQCECKKEAKGLQCDTCRENFYGLDVTNCKACDCDTAGSLPGTVCNAKTGQCICKPNVEGRQCNKCLEGNFYLRQNNSFLCLPCNCDKTGTINGSLLCNKSTGQCPCKLGVTGLRCNQCEPHRYNLTIDNFQHCQMCECDSLGTLPGTICDPISGQCLCVPNRQGRRCNQCQPGFYISPGNATGCLPCSCHTTGAVNHICNSLTGQCVCQDASIAGQRCDQCKDHYFGFDPQTGRCQPCNCHLSGALNETCHLVTGQCFCKQFVTGSKCDACVPSASHLDVNNLLGCSKTPFQQPPPRGQVQSSSAINLSWSPPDSPNAHWLTYSLLRDGFEIYTTEDQYPYSIQYFLDTDLLPYTKYSYYIETTNVHGSTRSVAVTYKTKPGVPEGNLTLSYIIPIGSDSVTLTWTTLSNQSGPIEKYILSCAPLAGGQPCVSYEGHETSATIWNLVPFAKYDFSVQACTSGGCLHSLPITVTTAQAPPQRLSPPKMQKISSTELHVEWSPPAELNGIIIRYELYMRRLRSTKETTSEESRVFQSSGWLSPHSFVESANENALKPPQTMTTITGLEPYTKYEFRVLAVNMAGSVSSAWVSERTGESAPVFMIPPSVFPLSSYSLNISWEKPADNVTRGKVVGYDINMLSEQSPQQSIPMAFSQLLHTAKSQELSYTVEGLKPYRIYEFTITLCNSVGCVTSASGAGQTLAAAPAQLRPPLVKGINSTTIHLRWFPPEELNGPSPIYQLERRESSLPALMTTMMKGIRFIGNGYCKFPSSTHPVNTDFTGIKASFRTKVPEGLIVFAASPGNQEEYFALQLKKGRLYFLFDPQGSPVEVTTTNDHGKQYSDGKWHEIIAIRHQAFGQITLDGIYTGSSAILNGSTVIGDNTGVFLGGLPRSYTILRKDPEIIQKGFVGCLKDVHFMKNYNPSAIWEPLDWQSSEEQINVYNSWEGCPASLNEGAQFLGAGFLELHPYMFHGGMNFEISFKFRTDQLNGLLLFVYNKDGPDFLAMELKSGILTFRLNTSLAFTQVDLLLGLSYCNGKWNKVIIKKEGSFISASVNGLMKHASESGDQPLVVNSPVYVGGIPQELLNSYQHLCLEQGFGGCMKDVKFTRGAVVNLASVSSGAVRVNLDGCLSTDSAVNCRGNDSILVYQGKEQSVYEGGLQPFTEYLYRVIASHEGGSVYSDWSRGRTTGAAPQSVPTPSRVRSLNGYSIEVTWDEPVVRGVIEKYILKAYSEDSTRPPRMPSASAEFVNTSNLTGILTGLLPFKNYAVTLTACTLAGCTESSHALNISTPQEAPQEVQPPVAKSLPSSLLLSWNPPKKANGIITQYCLYMDGRLIYSGSEENYIVTDLAVFTPHQFLLSACTHVGCTNSSWVLLYTAQLPPEHVDSPVLTVLDSRTIHIQWKQPRKISGILERYVLYMSNHTHDFTIWSVIYNSTELFQDHMLQYVLPGNKYLIKLGACTGGGCTVSEASEALTDEDIPEGVPAPKAHSYSPDSFNVSWTEPEYPNGVITSYGLYLDGILIHNSSELSYRAYGFAPWSLHSFRVQACTAKGCALGPLVENRTLEAPPEGTVNVFVKTQGSRKAHVRWEAPFRPNGLLTHSVLFTGIFYVDPVGNNYTLLNVTKVMYSGEETNLWVLIDGLVPFTNYTVQVNISNSQGSLITDPITIAMPPGAPDGVLPPRLSSATPTSLQVVWSTPARNNAPGSPRYQLQMRSGDSTHGFLELFSNPSASLSYEVSDLQPYTEYMFRLVASNGFGSAHSSWIPFMTAEDKPGPVVPPILLDVKSRMMLVTWQHPRKSNGVITHYNIYLHGRLYLRTPGNVTNCTVMHLHPYTAYKFQVEACTSKGCSLSPESQTVWTLPGAPEGIPSPELFSDTPTSVIISWQPPTHPNGLVENFTIERRVKGKEEVTTLVTLPRSHSMRFIDKTSALSPWTKYEYRVLMSTLHGGTNSSAWVEVTTRPSRPAGVQPPVVTVLEPDAVQVTWKPPLIQNGDILSYEIHMPDPHITLTNVTSAVLSQKVTHLIPFTNYSVTIVACSGGNGYLGGCTESLPTYVTTHPTVPQNVGPLSVIPLSESYVVISWQPPSKPNGPNLRYELLRRKIQQPLASNPPEDLNRWHNIYSGTQWLYEDKGLSRFTTYEYMLFVHNSVGFTPSREVTVTTLAGLPERGANLTASVLNHTAIDVRWAKPTVQDLQGEVEYYTLFWSSATSNDSLKILPDVNSHVIGHLKPNTEYWIFISVFNGVHSINSAGLHATTCDGEPQGMLPPEVVIINSTAVRVIWTSPSNPNGVVTEYSIYVNNKLYKTGMNVPGSFILRDLSPFTIYDIQVEVCTIYACVKSNGTQITTVEDTPSDIPTPTIRGITSRSLQIDWVSPRKPNGIILGYDLLWKTWYPCAKTQKLVQDQSDELCKAVRCQKPESICGHICYSSEAKVCCNGVLYNPKPGHRCCEEKYIPFVLNSTGVCCGGRIQEAQPNHQCCSGYYARILPGEVCCPDEQHNRVSVGIGDSCCGRMPYSTSGNQICCAGRLHDGHGQKCCGRQIVSNDLECCGGEEGVVYNRLPGMFCCGQDYVNMSDTICCSASSGESKAHIKKNDPVPVKCCETELIPKSQKCCNGVGYNPLKYVCSDKISTGMMMKETKECRILCPASMEATEHCGRCDFNFTSHICTVIRGSHNSTGKASIEEMCSSAEETIHTGSVNTYSYTDVNLKPYMTYEYRISAWNSYGRGLSKAVRARTKEDVPQGVSPPTWTKIDNLEDTIVLNWRKPIQSNGPIIYYILLRNGIERFRGTSLSFSDKEGIQPFQEYSYQLKACTVAGCATSSKVVAATTQGVPESILPPSITALSAVALHLSWSVPEKSNGVIKEYQIRQVGKGLIHTDTTDRRQHTVTGLQPYTNYSFTLTACTSAGCTSSEPFLGQTLQAAPEGVWVTPRHIIINSTTVELYWSLPEKPNGLVSQYQLSRNGNLLFLGGSEEQNFTDKNLEPNSRYTYKLEVKTGGGSSASDDYIVQTPMSTPEEIYPPYNITVIGPYSIFVAWIPPGILIPEIPVEYNVLLNDGSVTPLAFSVGHHQSTLLENLTPFTQYEIRIQACQNGSCGVSSRMFVKTPEAAPMDLNSPVLKALGSACIEIKWMPPEKPNGIIINYFIYRRPAGIEEESVLFVWSEGALEFMDEGDTLRPFTLYEYRVRACNSKGSVESLWSLTQTLEAPPQDFPAPWAQATSAHSVLLNWTKPESPNGIISHYRVVYQERPDDPTFNSPTVHAFTVKGTSHQAHLYGLEPFTTYRIGVVAANHAGEILSPWTLIQTLESSPSGLRNFIVEQKENGRALLLQWSEPMRTNGVIKTYNIFSDGFLEYSGLNRQFLFRRLDPFTLYTLTLEACTRAGCAHSAPQPLWTDEAPPDSQLAPTVHSVKSTSVELSWSEPVNPNGKIIRYEVIRRCFEGKAWGNQTIQADEKIVFTEYNTERNTFMYNDTGLQPWTQCEYKIYTWNSAGHTCSSWNVVRTLQAPPEGLSPPVISYVSMNPQKLLISWIPPEQSNGIIQSYRLQRNEMLYPFSFDPVTFNYTDEELLPFSTYSYALQACTSGGCSTSKPTSITTLEAAPSEVSPPDLWAVSATQMNVCWSPPTVQNGKITKYLVRYDNKESLAGQGLCLLVSHLQPYSQYNFSLVACTNGGCTASVSKSAWTMEALPENMDSPTLQVTGSESIEITWKPPRNPNGQIRSYELRRDGTIVYTGLETRYRDFTLTPGVEYSYTVTASNSQGGILSPLVKDRTSPSAPSGMEPPKLQARGPQEILVNWDPPVRTNGDIINYTLFIRELFERETKIIHINTTHNSFGMQSYIVNQLKPFHRYEIRIQACTTLGCASSDWTFIQTPEIAPLMQPPPHLEVQMAPGGFQPTVSLLWTGPLQPNGKVLYYELYRRQIATQPRKSNPVLIYNGSSTSFIDSELLPFTEYEYQVWAVNSAGKAPSSWTWCRTGPAPPEGLRAPTFHVISSTQAVVNISAPGKPNGIVSLYRLFSSSAHGAETVLSEGMATQQTLHGLQAFTNYSIGVEACTCFNCCSKGPTAELRTHPAPPSGLSSPQIGTLASRTASFRWSPPMFPNGVIHSYELQFHVACPPDSALPCTPSQIETKYTGLGQKASLGGLQPYTTYKLRVVAHNEVGSTASEWISFTTQKELPQYRAPFSVDSNLSVVCVNWSDTFLLNGQLKEYVLTDGGRRVYSGLDTTLYIPRTADKTFFFQVICTTDEGSVKTPLIQYDTSTGLGLVLTTPGKKKGSRSKSTEFYSELWFIVLMAMLGLILLAIFLSLILQRKIHKEPYIRERPPLVPLQKRMSPLNVYPPGENHMGLADTKIPRSGTPVSIRSNRSACVLRIPSQNQTSLTYSQGSLHRSVSQLMDIQDKKVLMDNSLWEAIMGHNSGLYVDEEDLMNAIKDFSSVTKERTTFTDTHL,5202,"575,600",Alternative sequence (3); Chain (1); Disulfide bond (44); Domain (47); Glycosylation (66); Motif (1); Natural variant (184); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 518..527;  /evidence=""ECO:0000250""; DISULFID 520..536;  /evidence=""ECO:0000250""; DISULFID 538..549;  /evidence=""ECO:0000250""; DISULFID 552..572;  /evidence=""ECO:0000250""; DISULFID 575..584;  /evidence=""ECO:0000250""; DISULFID 577..605;  /evidence=""ECO:0000250""; DISULFID 608..617;  /evidence=""ECO:0000250""; DISULFID 620..638;  /evidence=""ECO:0000250""; DISULFID 641..655;  /evidence=""ECO:0000250""; DISULFID 643..662;  /evidence=""ECO:0000250""; DISULFID 664..673;  /evidence=""ECO:0000250""; DISULFID 676..691;  /evidence=""ECO:0000250""; DISULFID 694..708;  /evidence=""ECO:0000250""; DISULFID 696..715;  /evidence=""ECO:0000250""; DISULFID 717..726;  /evidence=""ECO:0000250""; DISULFID 729..744;  /evidence=""ECO:0000250""; DISULFID 747..759;  /evidence=""ECO:0000250""; DISULFID 749..766;  /evidence=""ECO:0000250""; DISULFID 768..777;  /evidence=""ECO:0000250""; DISULFID 780..792;  /evidence=""ECO:0000250""; DISULFID 795..808;  /evidence=""ECO:0000250""; DISULFID 797..815;  /evidence=""ECO:0000250""; DISULFID 817..826;  /evidence=""ECO:0000250""; DISULFID 829..844;  /evidence=""ECO:0000250""; DISULFID 847..861;  /evidence=""ECO:0000250""; DISULFID 849..868;  /evidence=""ECO:0000250""; DISULFID 870..879;  /evidence=""ECO:0000250""; DISULFID 882..897;  /evidence=""ECO:0000250""; DISULFID 900..913;  /evidence=""ECO:0000250""; DISULFID 902..920;  /evidence=""ECO:0000250""; DISULFID 922..931;  /evidence=""ECO:0000250""; DISULFID 934..948;  /evidence=""ECO:0000250""; DISULFID 951..963;  /evidence=""ECO:0000250""; DISULFID 953..970;  /evidence=""ECO:0000250""; DISULFID 972..982;  /evidence=""ECO:0000250""; DISULFID 985..999;  /evidence=""ECO:0000250""; DISULFID 1002..1014;  /evidence=""ECO:0000250""; DISULFID 1004..1021;  /evidence=""ECO:0000250""; DISULFID 1023..1032;  /evidence=""ECO:0000250""; DISULFID 1035..1050;  /evidence=""ECO:0000250""; DISULFID 1672..1709;  /evidence=""ECO:0000250""; DISULFID 1862..1891;  /evidence=""ECO:0000250""; DISULFID 3371..3444;  /evidence=""ECO:0000250""; DISULFID 3399..3425;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
O15455,Toll-like receptor 3 (CD antigen CD283),MRQTLPCIYFWGGLLPFGMLCASSTTKCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAPFELFFMINTSILLIFIFIVLLIHFEGWRISFYWNVSVHRVLGFKEIDRQTEQFEYAAYIIHAYKDKDWVWEHFSSMEKEDQSLKFCLEERDFEAGVFELEAIVNSIKRSRKIIFVITHHLLKDPLCKRFKVHHAVQQAIEQNLDSIILVFLEEIPDYKLNHALCLRRGMFKSHCILNWPVQKERIGAFRHKLQVALGSKNSVH,904,"103,829",Alternative sequence (1); Beta strand (35); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (15); Helix (14); Modified residue (2); Mutagenesis (9); Natural variant (12); Repeat (22); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (15),DISULFID 28..37; DISULFID 95..122; DISULFID 649..677; DISULFID 651..696,"SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BX73,TM2 domain-containing protein 2 (Beta-amyloid-binding protein-like protein 1) (BBP-like protein 1),MVLGGCPVSYLLLCGQAALLLGNLLLLHCVSRSHSQNATAEPELTSAGAAQPEGPGGAASWEYGDPHSPVILCSYLPDEFIECEDPVDHVGNATASQELGYGCLKFGGQAYSDVEHTSVQCHALDGIECASPRTFLRENKPCIKYTGHYFITTLLYSFFLGCFGVDRFCLGHTGTAVGKLLTLGGLGIWWFVDLILLITGGLMPSDGSNWCTVY,214,"22,871",Alternative sequence (1); Chain (1); Glycosylation (1); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q86YW5,Trem-like transcript 1 protein (TLT-1) (Triggering receptor expressed on myeloid cells-like protein 1),MGLTLLLLLLLGLEGQGIVGSLPEVLQAPVGSSILVQCHYRLQDVKAQKVWCRFLPEGCQPLVSSAVDRRAPAGRRTFLTDLGGGLLQVEMVTLQEEDAGEYGCMVDGARGPQILHRVSLNILPPEEEEETHKIGSLAENAFSDPAGSANPLEPSQDEKSIPLIWGAVLLVGLLVAAVVLFAVMAKRKQGNRLGVCGRFLSSRVSGMNPSSVVHHVSDSGPAAELPLDVPHIRLDSPPSFDNTTYTSLPLDSPSGKPSLPAPSSLPPLPPKVLVCSKPVTYATVIFPGGNKGGGTSCGPAQNPPNNQTPSS,311,"32,679",Alternative sequence (3); Beta strand (9); Chain (1); Compositional bias (2); Disulfide bond (2); Domain (1); Helix (2); Lipidation (1); Motif (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 38..104;  /evidence=""ECO:0000269|PubMed:16505478""; DISULFID 52..59;  /evidence=""ECO:0000269|PubMed:16505478""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q9NS68,Tumor necrosis factor receptor superfamily member 19 (TRADE) (Toxicity and JNK inducer),MALKVLLEQEKTFFTLLVLLGYLSCKVTCESGDCRQQEFRDRSGNCVPCNQCGPGMELSKECGFGYGEDAQCVTCRLHRFKEDWGFQKCKPCLDCAVVNRFQKANCSATSDAICGDCLPGFYRKTKLVGFQDMECVPCGDPPPPYEPHCASKVNLVKIASTASSPRDTALAAVICSALATVLLALLILCVIYCKRQFMEKKPSWSLRSQDIQYNGSELSCFDRPQLHEYAHRACCQCRRDSVQTCGPVRLLPSMCCEEACSPNPATLGCGVHSAASLQARNAGPAGEMVPTFFGSLTQSICGEFSDAWPLMQNPMGGDNISFCDSYPELTGEDIHSLNPELESSTSLDSNSSQDLVGGAVPVQSHSENFTAATDLSRYNNTLVESASTQDALTMRSQLDQESGAVIHPATQTSLQVRQRLGSL,423,"46,015",Alternative sequence (2); Chain (1); Disulfide bond (8); Glycosylation (1); Natural variant (3); Repeat (3); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..46;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 49..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 52..72;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 75..89;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 92..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 95..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 117..135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 138..149;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
Q13454,Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33),MGARGAPSRRRQAGRRLRYLPTGSFPFLLLLLLLCIQLGGGQKKKENLLAEKVEQLMEWSSRRSIFRMNGDKFRKFIKAPPRNYSMIVMFTALQPQRQCSVCRQANEEYQILANSWRYSSAFCNKLFFSMVDYDEGTDVFQQLNMNSAPTFMHFPPKGRPKRADTFDLQRIGFAAEQLAKWIADRTDVHIRVFRPPNYSGTIALALLVSLVGGLLYLRRNNLEFIYNKTGWAMVSLCIVFAMTSGQMWNHIRGPPYAHKNPHNGQVSYIHGSSQAQFVAESHIILVLNAAITMGMVLLNEAATSKGDVGKRRIICLVGLGLVVFFFSFLLSIFRSKYHGYPYSDLDFE,348,"39,676",Alternative sequence (1); Beta strand (5); Chain (1); Disulfide bond (1); Domain (1); Helix (8); Mutagenesis (2); Natural variant (2); Signal peptide (1); Topological domain (5); Transmembrane (4); Turn (1),"DISULFID 99..102;  /note=""Redox-active"";  /evidence=""ECO:0000244|PDB:4M8G, ECO:0000244|PDB:4M90, ECO:0000269|PubMed:24685145""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q12836,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],MWLLRCVLLCVSLSLAVSGQHKPEAPDYSSVLHCGPWSFQFAVNLNQEATSPPVLIAWDNQGLLHELQNDSDCGTWIRKGPGSSVVLEATYSSCYVTEWDSHYIMPVGVEGAGAAEHKVVTERKLLKCPMDLLARDAPDTDWCDSIPARDRLPCAPSPISRGDCEGLGCCYSSEEVNSCYYGNTVTLHCTREGHFSIAVSRNVTSPPLLLDSVRLALRNDSACNPVMATQAFVLFQFPFTSCGTTRQITGDRAVYENELVATRDVKNGSRGSVTRDSIFRLHVSCSYSVSSNSLPINVQVFTLPPPFPETQPGPLTLELQIAKDKNYGSYYGVGDYPVVKLLRDPIYVEVSILHRTDPYLGLLLQQCWATPSTDPLSQPQWPILVKGCPYIGDNYQTQLIPVQKALDLPFPSHHQRFSIFTFSFVNPTVEKQALRGPVHLHCSVSVCQPAETPSCVVTCPDLSRRRNFDNSSQNTTASVSSKGPMILLQATKDPPEKLRVPVDSKVLWVAGLSGTLILGALLVSYLAVKKQKSCPDQMCQ,540,"59,400",Chain (2); Disulfide bond (1); Domain (2); Glycosylation (7); Natural variant (2); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 367..442;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00779""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9ULB1,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),MGTALLQRGGCFLLCLSLLLLGCWAELGSGLEFPGAEGQWTRFPKWNACCESEMSFQLKTRSARGLVLYFDDEGFCDFLELILTRGGRLQLSFSIFCAEPATLLADTPVNDGAWHSVRIRRQFRNTTLFIDQVEAKWVEVKSKRRDMTVFSGLFVGGLPPELRAAALKLTLASVREREPFKGWIRDVRVNSSQVLPVDSGEVKLDDEPPNSGGGSPCEAGEEGEGGVCLNGGVCSVVDDQAVCDCSRTGFRGKDCSQEDNNVEGLAHLMMGDQGKSKGKEEYIATFKGSEYFCYDLSQNPIQSSSDEITLSFKTLQRNGLMLHTGKSADYVNLALKNGAVSLVINLGSGAFEALVEPVNGKFNDNAWHDVKVTRNLRQHSGIGHAMVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLPGSPVSNNFMGCLKEVVYKNNDVRLELSRLAKQGDPKMKIHGVVAFKCENVATLDPITFETPESFISLPKWNAKKTGSISFDFRTTEPNGLILFSHGKPRHQKDAKHPQMIKVDFFAIEMLDGHLYLLLDMGSGTIKIKALLKKVNDGEWYHVDFQRDGRSGTISVNTLRTPYTAPGESEILDLDDELYLGGLPENKAGLVFPTEVWTALLNYGYVGCIRDLFIDGQSKDIRQMAEVQSTAGVKPSCSKETAKPCLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCEREATVLSYDGSMFMKIQLPVVMHTEAEDVSLRFRSQRAYGILMATTSRDSADTLRLELDAGRVKLTVNLDCIRINCNSSKGPETLFAGYNLNDNEWHTVRVVRRGKSLKLTVDDQQAMTGQMAGDHTRLEFHNIETGIITERRYLSSVPSNFIGHLQSLTFNGMAYIDLCKNGDIDYCELNARFGFRNIIADPVTFKTKSSYVALATLQAYTSMHLFFQFKTTSLDGLILYNSGDGNDFIVVELVKGYLHYVFDLGNGANLIKGSSNKPLNDNQWHNVMISRDTSNLHTVKIDTKITTQITAGARNLDLKSDLYIGGVAKETYKSLPKLVHAKEGFQGCLASVDLNGRLPDLISDALFCNGQIERGCEGPSTTCQEDSCSNQGVCLQQWDGFSCDCSMTSFSGPLCNDPGTTYIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNVRLVGEVPSSMTTESTATAMQSEMSTSIMETTTTLATSTARRGKPPTKEPISQTTDDILVASAECPSDDEDIDPCEPSSGGLANPTRAGGREPYPGSAEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYHVDESRNYISNSAQSNGAVVKEKQPSSAKSSNKNKKNKDKEYYV,1477,"161,883",Alternative sequence (7); Beta strand (1); Chain (1); Compositional bias (2); Disulfide bond (11); Domain (9); Erroneous initiation (1); Glycosylation (4); Metal binding (11); Natural variant (2); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 228..243;  /evidence=""ECO:0000250""; DISULFID 245..255;  /evidence=""ECO:0000250""; DISULFID 437..473;  /evidence=""ECO:0000250""; DISULFID 643..672;  /evidence=""ECO:0000250""; DISULFID 680..691;  /evidence=""ECO:0000250""; DISULFID 685..700;  /evidence=""ECO:0000250""; DISULFID 702..712;  /evidence=""ECO:0000250""; DISULFID 1052..1080;  /evidence=""ECO:0000250""; DISULFID 1087..1098;  /evidence=""ECO:0000250""; DISULFID 1092..1107;  /evidence=""ECO:0000250""; DISULFID 1109..1119;  /evidence=""ECO:0000250""","SIGNAL 1..30;  /evidence=""ECO:0000250"""
O75787,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment],MAVFVVLLALVAGVLGNEFSILKSPGSVVFRNGNWPIPGERIPDVAALSMGFSVKEDLSWPGLAVGNLFHRPRATVMVMVKGVNKLALPPGSVISYPLENAVPFSLDSVANSIHSLFSEETPVVLQLAPSEERVYMVGKANSVFEDLSVTLRQLRNRLFQENSVLSSLPLNSLSRNNEVDLLFLSELQVLHDISSLLSRHKHLAKDHSPDLYSLELAGLDEIGKRYGEDSEQFRDASKILVDALQKFADDMYSLYGGNAVVELVTVKSFDTSLIRKTRTILEAKQAKNPASPYNLAYKYNFEYSVVFNMVLWIMIALALAVIITSYNIWNMDPGYDSIIYRMTNQKIRMD,350,"39,008",Alternative sequence (1); Chain (3); Erroneous initiation (2); Frameshift (1); Helix (1); Motif (1); Mutagenesis (2); Natural variant (4); Sequence conflict (6); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q6UWJ8,CD164 sialomucin-like 2 protein,MEAPGPRALRTALCGGCCCLLLCAQLAVAGKGARGFGRGALIRLNIWPAVQGACKQLEVCEHCVEGDGARNLSSCVWEQCRPEEPGHCVAQSEVVKEGCSIYNRSEACPAAHHHPTYEPKTVTTGSPPVPEAHSPGFDGASFIGGVVLVLSLQAVAFFVLHFLKAKDSTYQTLI,174,"18,403",Alternative sequence (1); Chain (1); Glycosylation (2); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
P27824,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),MEGKWLLCMLLVLGTAIVEAHDGHDDDVIDIEDDLDDVIEEVEDSKPDTTAPPSSPKVTYKAPVPTGEVYFADSFDRGTLSGWILSKAKKDDTDDEIAKYDGKWEVEEMKESKLPGDKGLVLMSRAKHHAISAKLNKPFLFDTKPLIVQYEVNFQNGIECGGAYVKLLSKTPELNLDQFHDKTPYTIMFGPDKCGEDYKLHFIFRHKNPKTGIYEEKHAKRPDADLKTYFTDKKTHLYTLILNPDNSFEILVDQSVVNSGNLLNDMTPPVNPSREIEDPEDRKPEDWDERPKIPDPEAVKPDDWDEDAPAKIPDEEATKPEGWLDDEPEYVPDPDAEKPEDWDEDMDGEWEAPQIANPRCESAPGCGVWQRPVIDNPNYKGKWKPPMIDNPSYQGIWKPRKIPNPDFFEDLEPFRMTPFSAIGLELWSMTSDIFFDNFIICADRRIVDDWANDGWGLKKAADGAAEPGVVGQMIEAAEERPWLWVVYILTVALPVFLVILFCCSGKKQTSGMEYKKTDAPQPDVKEEEEEKEEEKDKGDEEEEGEEKLEEKQKSDAEEDGGTVSQEEEDRKPKAEEDEILNRSPRNRKPRRE,592,"67,568",Alternative sequence (2); Binding site (4); Chain (1); Disulfide bond (2); Lipidation (2); Metal binding (3); Modified residue (5); Region (5); Repeat (8); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 160..194;  /evidence=""ECO:0000250""; DISULFID 360..366;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000255"""
Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2],MAVPARTCGASRPGPARTARPWPGCGPHPGPGTRRPTSGPPRPLWLLLPLLPLLAAPGASAYSFPQQHTMQHWARRLEQEVDGVMRIFGGVQQLREIYKDNRNLFEVQENEPQKLVEKVAGDIESLLDRKVQALKRLADAAENFQKAHRWQDNIKEEDIVYYDAKADAELDDPESEDVERGSKASTLRLDFIEDPNFKNKVNYSYAAVQIPTDIYKGSTVILNELNWTEALENVFMENRRQDPTLLWQVFGSATGVTRYYPATPWRAPKKIDLYDVRRRPWYIQGASSPKDMVIIVDVSGSVSGLTLKLMKTSVCEMLDTLSDDDYVNVASFNEKAQPVSCFTHLVQANVRNKKVFKEAVQGMVAKGTTGYKAGFEYAFDQLQNSNITRANCNKMIMMFTDGGEDRVQDVFEKYNWPNRTVRVFTFSVGQHNYDVTPLQWMACANKGYYFEIPSIGAIRINTQEYLDVLGRPMVLAGKEAKQVQWTNVYEDALGLGLVVTGTLPVFNLTQDGPGEKKNQLILGVMGIDVALNDIKRLTPNYTLGANGYVFAIDLNGYVLLHPNLKPQTTNFREPVTLDFLDAELEDENKEEIRRSMIDGNKGHKQIRTLVKSLDERYIDEVTRNYTWVPIRSTNYSLGLVLPPYSTFYLQANLSDQILQVKLPISKLKDFEFLLPSSFESEGHVFIAPREYCKDLNASDNNTEFLKNFIELMEKVTPDSKQCNNFLLHNLILDTGITQQLVERVWRDQDLNTYSLLAVFAATDGGITRVFPNKAAEDWTENPEPFNASFYRRSLDNHGYVFKPPHQDALLRPLELENDTVGILVSTAVELSLGRRTLRPAVVGVKLDLEAWAEKFKVLASNRTHQDQPQKCGPNSHCEMDCEVNNEDLLCVLIDDGGFLVLSNQNHQWDQVGRFFSEVDANLMLALYNNSFYTRKESYDYQAACAPQPPGNLGAAPRGVFVPTVADFLNLAWWTSAAAWSLFQQLLYGLIYHSWFQADPAEAEGSPETRESSCVMKQTQYYFGSVNASYNAIIDCGNCSRLFHAQRLTNTNLLFVVAEKPLCSQCEAGRLLQKETHSDGPEQCELVQRPRYRRGPHICFDYNATEDTSDCGRGASFPPSLGVLVSLQLLLLLGLPPRPQPQVLVHASRRL,1150,"129,817",Alternative sequence (3); Chain (3); Disulfide bond (1); Domain (2); Glycosylation (6); Metal binding (3); Motif (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 443..1098;  /note=""Interchain (between alpha-2-2 and delta-2 chains)"";  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q13324,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2),MDAALLHSLLEANCSLALAEELLLDGWGPPLDPEGPYSYCNTTLDQIGTCWPRSAAGALVERPCPEYFNGVKYNTTRNAYRECLENGTWASKINYSQCEPILDDKQRKYDLHYRIALVVNYLGHCVSVAALVAAFLLFLALRSIRCLRNVIHWNLITTFILRNVMWFLLQLVDHEVHESNEVWCRCITTIFNYFVVTNFFWMFVEGCYLHTAIVMTYSTERLRKCLFLFIGWCIPFPIIVAWAIGKLYYENEQCWFGKEPGDLVDYIYQGPIILVLLINFVFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDDLSQIMFIYFNSFLQSFQGFFVSVFYCFFNGEVRSAVRKRWHRWQDHHSLRVPMARAMSIPTSPTRISFHSIKQTAAV,411,"47,688",Alternative sequence (6); Chain (1); Disulfide bond (5); Glycosylation (5); Helix (14); Natural variant (1); Sequence conflict (6); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (2),"DISULFID 14..50;  /evidence=""ECO:0000269|PubMed:20966082""; DISULFID 40..83;  /evidence=""ECO:0000269|PubMed:20966082""; DISULFID 64..98;  /evidence=""ECO:0000269|PubMed:20966082""; DISULFID 184..254;  /evidence=""ECO:0000250""; DISULFID Q13324-2:51..77;  /evidence=""ECO:0000305""","SIGNAL 1..19;  /note=""Not cleaved"""
P17813,Endoglin (CD antigen CD105),MDRGTLPLAVALLLASCSLSPTSLAETVHCDLQPVGPERGEVTYTTSQVSKGCVAQAPNAILEVHVLFLEFPTGPSQLELTLQASKQNGTWPREVLLVLSVNSSVFLHLQALGIPLHLAYNSSLVTFQEPPGVNTTELPSFPKTQILEWAAERGPITSAAELNDPQSILLRLGQAQGSLSFCMLEASQDMGRTLEWRPRTPALVRGCHLEGVAGHKEAHILRVLPGHSAGPRTVTVKVELSCAPGDLDAVLILQGPPYVSWLIDANHNMQIWTTGEYSFKIFPEKNIRGFKLPDTPQGLLGEARMLNASIVASFVELPLASIVSLHASSCGGRLQTSPAPIQTTPPKDTCSPELLMSLIQTKCADDAMTLVLKKELVAHLKCTITGLTFWDPSCEAEDRGDKFVLRSAYSSCGMQVSASMISNEAVVNILSSSSPQRKKVHCLNMDSLSFQLGLYLSPHFLQASNTIEPGQQSFVQVRVSPSVSEFLLQLDSCHLDLGPEGGTVELIQGRAAKGNCVSLLSPSPEGDPRFSFLLHFYTVPIPKTGTLSCTVALRPKTGSQDQEVHRTVFMRLNIISPDLSGCTSKGLVLPAVLGITFGAFLIGALLTAALWYIYSHTRSPSKREPVVAVAAPASSESSSTNHSIGSTQSTPCSTSSMA,658,"70,578",Alternative sequence (1); Beta strand (36); Chain (1); Compositional bias (1); Disulfide bond (8); Domain (1); Glycosylation (5); Helix (5); Modified residue (2); Motif (1); Mutagenesis (11); Natural variant (49); Region (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 30..207;  /evidence=""ECO:0000244|PDB:5HZW, ECO:0000244|PDB:5I04, ECO:0000269|PubMed:28564608""; DISULFID 53..182;  /evidence=""ECO:0000244|PDB:5HZW, ECO:0000244|PDB:5I04, ECO:0000269|PubMed:28564608""; DISULFID 242..330;  /evidence=""ECO:0000244|PDB:5HZW, ECO:0000269|PubMed:28564608""; DISULFID 350..382;  /evidence=""ECO:0000244|PDB:5HZV, ECO:0000269|PubMed:28564608""; DISULFID 363..442;  /evidence=""ECO:0000244|PDB:5HZV, ECO:0000269|PubMed:28564608""; DISULFID 394..412;  /evidence=""ECO:0000244|PDB:5HZV, ECO:0000269|PubMed:28564608""; DISULFID 493..549;  /evidence=""ECO:0000244|PDB:5HZV, ECO:0000269|PubMed:28564608""; DISULFID 516;  /note=""Interchain"";  /evidence=""ECO:0000305|PubMed:28564608""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:1692830"""
Q9H6D8,Fibronectin type III domain-containing protein 4 (Fibronectin type III repeat-containing protein 1),MPSGCHSSPPSGLRGDMASLVPLSPYLSPTVLLLVSCDLGFVRADRPPSPVNVTVTHLRANSATVSWDVPEGNIVIGYSISQQRQNGPGQRVIREVNTTTRACALWGLAEDSDYTVQVRSIGLRGESPPGPRVHFRTLKGSDRLPSNSSSPGDITVEGLDGERPLQTGEVVIIVVVLLMWAAVIGLFCRQYDIIKDNDSNNNPKEKGKGPEQSPQGRPVGTRQKKSPSINTIDV,234,"25,159",Chain (1); Domain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..44;  /evidence=""ECO:0000255"""
Q6DN72,Fc receptor-like protein 6 (FcR-like protein 6) (FcRL6) (Fc receptor homolog 6) (FcRH6) (IFGP6),MLLWTAVLLFVPCVGKTVWLYLQAWPNPVFEGDALTLRCQGWKNTPLSQVKFYRDGKFLHFSKENQTLSMGAATVQSRGQYSCSGQVMYIPQTFTQTSETAMVQVQELFPPPVLSAIPSPEPREGSLVTLRCQTKLHPLRSALRLLFSFHKDGHTLQDRGPHPELCIPGAKEGDSGLYWCEVAPEGGQVQKQSPQLEVRVQAPVSRPVLTLHHGPADPAVGDMVQLLCEAQRGSPPILYSFYLDEKIVGNHSAPCGGTTSLLFPVKSEQDAGNYSCEAENSVSRERSEPKKLSLKGSQVLFTPASNWLVPWLPASLLGLMVIAAALLVYVRSWRKAGPLPSQIPPTAPGGEQCPLYANVHHQKGKDEGVVYSVVHRTSKRSEARSAEFTVGRKDSSIICAEVRCLQPSEVSSTEVNMRSRTLQEPLSDCEEVLC,434,"47,748",Alternative sequence (6); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (2); Modified residue (1); Motif (1); Mutagenesis (2); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 39..83;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 132..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 228..276;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NZU0,Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3),MISAAWSIFLIGTKIGLFLQVAPLSVMAKSCPSVCRCDAGFIYCNDRFLTSIPTGIPEDATTLYLQNNQINNAGIPSDLKNLLKVERIYLYHNSLDEFPTNLPKYVKELHLQENNIRTITYDSLSKIPYLEELHLDDNSVSAVSIEEGAFRDSNYLRLLFLSRNHLSTIPWGLPRTIEELRLDDNRISTISSPSLQGLTSLKRLVLDGNLLNNHGLGDKVFFNLVNLTELSLVRNSLTAAPVNLPGTNLRKLYLQDNHINRVPPNAFSYLRQLYRLDMSNNNLSNLPQGIFDDLDNITQLILRNNPWYCGCKMKWVRDWLQSLPVKVNVRGLMCQAPEKVRGMAIKDLNAELFDCKDSGIVSTIQITTAIPNTVYPAQGQWPAPVTKQPDIKNPKLTKDHQTTGSPSRKTITITVKSVTSDTIHISWKLALPMTALRLSWLKLGHSPAFGSITETIVTGERSEYLVTALEPDSPYKVCMVPMETSNLYLFDETPVCIETETAPLRMYNPTTTLNREQEKEPYKNPNLPLAAIIGGAVALVTIALLALVCWYVHRNGSLFSRNCAYSKGRRRKDDYAEAGTKKDNSILEIRETSFQMLPISNEPISKEEFVIHTIFPPNGMNLYKNNHSESSSNRSYRDSGIPDSDHSHS,649,"73,004",Beta strand (15); Chain (1); Disulfide bond (3); Domain (3); Erroneous initiation (3); Glycosylation (3); Helix (7); Mutagenesis (11); Natural variant (8); Region (1); Repeat (10); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 31..37;  /evidence=""ECO:0000269|PubMed:26235030""; DISULFID 35..44;  /evidence=""ECO:0000269|PubMed:26235030""; DISULFID 309..334;  /evidence=""ECO:0000269|PubMed:26235030""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P28476,Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor),MPYFTRLILFLFCLMVLVESRKPKRKRWTGQVEMPKPSHLYKKNLDVTKIRKGKPQQLLRVDEHDFSMRPAFGGPAIPVGVDVQVESLDSISEVDMDFTMTLYLRHYWKDERLAFSSASNKSMTFDGRLVKKIWVPDVFFVHSKRSFTHDTTTDNIMLRVFPDGHVLYSMRITVTAMCNMDFSHFPLDSQTCSLELESYAYTDEDLMLYWKNGDESLKTDEKISLSQFLIQKFHTTSRLAFYSSTGWYNRLYINFTLRRHIFFFLLQTYFPATLMVMLSWVSFWIDRRAVPARVSLGITTVLTMTTIITGVNASMPRVSYVKAVDIYLWVSFVFVFLSVLEYAAVNYLTTVQERKERKLREKFPCMCGMLHSKTMMLDGSYSESEANSLAGYPRSHILTEEERQDKIVVHLGLSGEANAARKKGLLKGQTGFRIFQNTHAIDKYSRLIFPASYIFFNLIYWSVFS,465,"54,151",Alternative sequence (1); Chain (1); Disulfide bond (1); Glycosylation (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 178..192;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P28472,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3),MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMDYTLTMYFQQYWRDKRLAYSGIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTGVERIELPQFSIVEHRLVSRNVVFATGAYPRLSLSFRLKRNIGYFILQTYMPSILITILSWVSFWINYDASAARVALGITTVLTMTTINTHLRETLPKIPYVKAIDMYLMGCFVFVFLALLEYAFVNYIFFGRGPQRQKKLAEKTAKAKNDRSKSESNRVDAHGNILLTSLEVHNEMNEVSGGIGDTRNSAISFDNSGIQYRKQSMPREGHGRFLGDRSLPHKKTHLRRRSSQLKIKIPDLTDVNAIDRWSRIVFPFTFSLFNLVYWLYYVN,473,"54,116",Alternative sequence (3); Beta strand (13); Binding site (1); Chain (1); Disulfide bond (1); Glycosylation (3); Helix (11); Natural variant (17); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (4); Transmembrane (4); Turn (5),"DISULFID 161..175;  /evidence=""ECO:0000269|PubMed:24909990""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P23416,Glycine receptor subunit alpha-2,MNRQLVNILTALFAFFLETNHFRTAFCKDHDSRSGKQPSQTLSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSVTETTMDYRVNIFLRQQWNDSRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHDVTTDNKLLRISKNGKVLYSIRLTLTLSCPMDLKNFPMDVQTCTMQLESFGYTMNDLIFEWLSDGPVQVAEGLTLPQFILKEEKELGYCTKHYNTGKFTCIEVKFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFAALLEYAAVNFVSRQHKEFLRLRRRQKRQNKEEDVTRESRFNFSGYGMGHCLQVKDGTAVKATPANPLPQPPKDGDAIKKKFVDRAKRIDTISRAAFPLAFLIFNIFYWITYKIIRHEDVHKK,452,"52,002",Alternative sequence (2); Chain (1); Disulfide bond (2); Glycosylation (2); Metal binding (3); Region (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (4),"DISULFID 172..186;  /evidence=""ECO:0000250|UniProtKB:P23415""; DISULFID 232..243;  /evidence=""ECO:0000250|UniProtKB:P23415""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q99665,Interleukin-12 receptor subunit beta-2 (IL-12 receptor subunit beta-2) (IL-12R subunit beta-2) (IL-12R-beta-2) (IL-12RB2),MAHTFRGCSLAFMFIITWLLIKAKIDACKRGDVTVKPSHVILLGSTVNITCSLKPRQGCFHYSRRNKLILYKFDRRINFHHGHSLNSQVTGLPLGTTLFVCKLACINSDEIQICGAEIFVGVAPEQPQNLSCIQKGEQGTVACTWERGRDTHLYTEYTLQLSGPKNLTWQKQCKDIYCDYLDFGINLTPESPESNFTAKVTAVNSLGSSSSLPSTFTFLDIVRPLPPWDIRIKFQKASVSRCTLYWRDEGLVLLNRLRYRPSNSRLWNMVNVTKAKGRHDLLDLKPFTEYEFQISSKLHLYKGSWSDWSESLRAQTPEEEPTGMLDVWYMKRHIDYSRQQISLFWKNLSVSEARGKILHYQVTLQELTGGKAMTQNITGHTSWTTVIPRTGNWAVAVSAANSKGSSLPTRINIMNLCEAGLLAPRQVSANSEGMDNILVTWQPPRKDPSAVQEYVVEWRELHPGGDTQVPLNWLRSRPYNVSALISENIKSYICYEIRVYALSGDQGGCSSILGNSKHKAPLSGPHINAITEEKGSILISWNSIPVQEQMGCLLHYRIYWKERDSNSQPQLCEIPYRVSQNSHPINSLQPRVTYVLWMTALTAAGESSHGNEREFCLQGKANWMAFVAPSICIAIIMVGIFSTHYFQQKVFVLLAALRPQWCSREIPDPANSTCAKKYPIAEEKTQLPLDRLLIDWPTPEDPEPLVISEVLHQVTPVFRHPPCSNWPQREKGIQGHQASEKDMMHSASSPPPPRALQAESRQLVDLYKVLESRGSDPKPENPACPWTVLPAGDLPTHDGYLPSNIDDLPSHEAPLADSLEELEPQHISLSVFPSSSLHPLTFSCGDKLTLDQLKMRCDSLML,862,"97,135",Alternative sequence (3); Chain (1); Compositional bias (2); Domain (5); Glycosylation (8); Modified residue (1); Motif (2); Mutagenesis (7); Natural variant (12); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
O95976,Immunoglobulin superfamily member 6 (IgSF6) (Protein DORA),MGTASRSNIARHLQTNLILFCVGAVGACTLSVTQPWYLEVDYTHEAVTIKCTFSATGCPSEQPTCLWFRYGAHQPENLCLDGCKSEADKFTVREALKENQVSLTVNRVTSNDSAIYICGIAFPSVPEARAKQTGGGTTLVVREIKLLSKELRSFLTALVSLLSVYVTGVCVAFILLSKSKSNPLRNKEIKEDSQKKKSARRIFQEIAQELYHKRHVETNQQSEKDNNTYENRRVLSNYERP,241,"27,013",Chain (1); Disulfide bond (1); Domain (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q5VV43,Dyslexia-associated protein KIAA0319,MAPPTGVLSSLLLLVTIAGCARKQCSEGRTYSNAVISPNLETTRIMRVSHTFPVVDCTAACCDLSSCDLAWWFEGRCYLVSCPHKENCEPKKMGPIRSYLTFVLRPVQRPAQLLDYGDMMLNRGSPSGIWGDSPEDIRKDLTFLGKDWGLEEMSEYSDDYRELEKDLLQPSGKQEPRGSAEYTDWGLLPGSEGAFNSSVGDSPAVPAETQQDPELHYLNESASTPAPKLPERSVLLPLPTTPSSGEVLEKEKASQLQEQSSNSSGKEVLMPSHSLPPASLELSSVTVEKSPVLTVTPGSTEHSIPTPPTSAAPSESTPSELPISPTTAPRTVKELTVSAGDNLIITLPDNEVELKAFVAPAPPVETTYNYEWNLISHPTDYQGEIKQGHKQTLNLSQLSVGLYVFKVTVSSENAFGEGFVNVTVKPARRVNLPPVAVVSPQLQELTLPLTSALIDGSQSTDDTEIVSYHWEEINGPFIEEKTSVDSPVLRLSNLDPGNYSFRLTVTDSDGATNSTTAALIVNNAVDYPPVANAGPNHTITLPQNSITLNGNQSSDDHQIVLYEWSLGPGSEGKHVVMQGVQTPYLHLSAMQEGDYTFQLKVTDSSRQQSTAVVTVIVQPENNRPPVAVAGPDKELIFPVESATLDGSSSSDDHGIVFYHWEHVRGPSAVEMENIDKAIATVTGLQVGTYHFRLTVKDQQGLSSTSTLTVAVKKENNSPPRARAGGRHVLVLPNNSITLDGSRSTDDQRIVSYLWIRDGQSPAAGDVIDGSDHSVALQLTNLVEGVYTFHLRVTDSQGASDTDTATVEVQPDPRKSGLVELTLQVGVGQLTEQRKDTLVRQLAVLLNVLDSDIKVQKIRAHSDLSTVIVFYVQSRPPFKVLKAAEVARNLHMRLSKEKADFLLFKVLRVDTAGCLLKCSGHGHCDPLTKRCICSHLWMENLIQRYIWDGESNCEWSIFYVTVLAFTLIVLTGGFTWLCICCCKRQKRTKIRKKTKYTILDNMDEQERMELRPKYGIKHRSTEHNSSLMVSESEFDSDQDTIFSREKMERGNPKVSMNGSIRNGASFSYCSKDR,1072,"117,763",Alternative sequence (3); Beta strand (10); Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (10); Motif (1); Mutagenesis (1); Natural variant (7); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
O76036,Natural cytotoxicity triggering receptor 1 (Lymphocyte antigen 94 homolog) (NK cell-activating receptor) (Natural killer cell p46-related protein) (NK-p46) (NKp46) (hNKp46) (CD antigen CD335),MSSTLPALLCVGLCLSQRISAQQQTLPKPFIWAEPHFMVPKEKQVTICCQGNYGAVEYQLHFEGSLFAVDRPKPPERINKVKFYIPDMNSRMAGQYSCIYRVGELWSEPSNLLDLVVTEMYDTPTLSVHPGPEVISGEKVTFYCRLDTATSMFLLLKEGRSSHVQRGYGKVQAEFPLGPVTTAHRGTYRCFGSYNNHAWSFPSEPVKLLVTGDIENTSLAPEDPTFPADTWGTYLLTTETGLQKDHALWDHTAQNLLRMGLAFLVLVALVWFLVEDWLSRKRTRERASRASTWEGRRRLNTQTL,304,"34,481",Alternative sequence (4); Beta strand (19); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Helix (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000244|PDB:1OLL, ECO:0000244|PDB:1P6F, ECO:0000269|PubMed:12960161, ECO:0000269|PubMed:16959974""; DISULFID 144..190;  /evidence=""ECO:0000244|PDB:1OLL, ECO:0000244|PDB:1P6F, ECO:0000269|PubMed:12960161, ECO:0000269|PubMed:16959974""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q8IUK5,Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7),MRGELWLLVLVLREAARALSPQPGAGHDEGPGSGWAAKGTVRGWNRRARESPGHVSEPDRTQLSQDLGGGTLAMDTLPDNRTRVVEDNHSYYVSRLYGPSEPHSRELWVDVAEANRSQVKIHTILSNTHRQASRVVLSFDFPFYGHPLRQITIATGGFIFMGDVIHRMLTATQYVAPLMANFNPGYSDNSTVVYFDNGTVFVVQWDHVYLQGWEDKGSFTFQAALHHDGRIVFAYKEIPMSVPEISSSQHPVKTGLSDAFMILNPSPDVPESRRRSIFEYHRIELDPSKVTSMSAVEFTPLPTCLQHRSCDACMSSDLTFNCSWCHVLQRCSSGFDRYRQEWMDYGCAQEAEGRMCEDFQDEDHDSASPDTSFSPYDGDLTTTSSSLFIDSLTTEDDTKLNPYAGGDGLQNNLSPKTKGTPVHLGTIVGIVLAVLLVAAIILAGIYINGHPTSNAALFFIERRPHHWPAMKFRSHPDHSTYAEVEPSGHEKEGFMEAEQC,500,"55,760",Alternative sequence (5); Chain (1); Glycosylation (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q7Z442,Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2),MSAVGLVLLVLALRLRATTVKPEEGSFCSNSQVAFRDACYEFVPLGRTFRDAQSWCEGQGGHLVFIQDEGTQWFLQKHISQDREWWIGLTWNLARNGTTEGPGTWLDTSNVTYSNWHGGQAAAAPDTCGHIGRGPSSEWVTSDCAQTFAFMCEFRVGQSLACEGLNATVHCGLGQVIQVQDAVYGRQNPHFCTQDAGRPSDLEQGCSWANVKEEVAGQCQELQSCQVAADETYFGNLCPTQGSYLWVQYQCREALQLMVSSESFIFDNVTISLTWLLSPYIGNLSCIISTGDSHTFDPYNPPSVSSNVTHQFTSPGEFTVFAECTTSEWHVTAQRQVTVRDKMETLSVTACSGLSQSGAGPLCQAVFGDPLWIQVELDGGTGVTYTVLLGDITLAESTTQKGSLPYNLILDRETQKLMGPGRHRLEIQATGNTTTSTISRNITVHLVELLSGLQASWASDHLELGQDLLITISLAQGTPEELTFEVAGLNATFSHEQVSFGEPFGICRLAVPVEGTFLVTMLVRNAFSNLSLEIGNITITAPSGLQEPSGMNAEGKSKDKGDMEVYIQPGPYVDPFTTVTLGWPDNDKELRFQWSCGSCWALWSSCVERQLLRTDQRELVVPASCLPPPDSAVTLRLAVLRGQELENRAEQCLYVSAPWELRPRVSCERNCRPVNASKDILLRVTMGEDSPVAMFSWYLDNTPTEQAEPLLDACRLRGFWPRSLTLLQSNTSTLLLNSSFLQSRGEVIRIRATALTRHAYGEDTYVISTVPPREVPACTIAPEEGTVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGPEPALPSVYLPLGEENNDFVLTVVISATNRAGDTQQTQAMAKVALGDTCVEDVAFQAAVSEKIPTALQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLSIDVRQKVREHVLGSLSAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQWEASLALQHASEALLTVSAKARPEDQRRQAATRDLFQAVGSVLEASLSNRPEEPAEASSSQIATVLRLLRVMEHVQTTLLLGKLPGGLPAMLATPSISVYTNRIQPWSWQGSSLRPDAADSATFMLPAASSLSSLEGGQEPVDIKIMSFPKSPFPARSHFDVSGTVGGLRVTSPSGQLIPVKNLSENIEILLPRHSQRHSQPTVLNLTSPEALWVNVTSGEATLGIQLHWRPDIALTLSLGYGYHPNKSSYDAQTHLVPMVAPDELPTWILSPQDLRFGEGVYYLTVVPESDLEPAPGRDLTVGITTFLSHCVFWDEVQETWDDSGCQVGPRTSPYQTHCLCNHLTFFGSTFLVMSNAINIHQTAELFATFEDNPVVVTTVGCLCVVYVLVVIWARRKDAQDQAKVKVTVLEDNDPFAQYHYLVTVYTGHRRGAATSSKVTVTLYGLDGEREPHHLADPDTPVFERGAVDAFLLSTLFPLGELRSLRLWHDNSGDRPSWYVSRVLVYDLVMDRKWYFLCNSWLSINVGDCVLDKVFPVATEQDRKQFSHLFFMKTSAGFQDGHIWYSIFSRCARSSFTRVQRVSCCFSLLLCTMLTSIMFWGVPKDPAEQKMDLGKIEFTWQEVMIGLESSILMFPINLLIVQIFQNTRPRVAKEQNTGKWDRGSPNLTPSPQPMEDGLLTPEAVTKDVSRIVSSLFKALKVPSPALGWDSVNLMDINSLLALVEDVIYPQNTSGQVFWEEAKKREDPVTLTLGSSEMKEKSQCPKPKAARSGPWKDSAYRQCLYLQLEHVEQELRLVGPRGFSQPHSHAQALRQLQTLKGGLGVQPGTWAPAHASALQVSKPPQGLPWWCILVGWLLVAATSGVAAFFTMLYGLHYGRASSLRWLISMAVSFVESMFVTQPLKVLGFAAFFALVLKRVDDEEDTVAPLPGHLLGPDPYALFRARRNSSRDVYQPPLTAAIEKMKTTHLKEQKAFALIREILAYLGFLWMLLLVAYGQRDPSAYHLNRHLQHSFTRGFSGVLGFREFFKWANTTLVSNLYGHPPGFITDGNSKLVGSAQIRQVRVQESSCPLAQQPQAYLNGCRAPYSLDAEDMADYGEGWNATTLSEWQYQSQDQRQGYPIWGKLTVYRGGGYVVPLGTDRQSTSRILRYLFDNTWLDALTRAVFVESTVYNANVNLFCIVTLTLETSALGTFFTHAALQSLRLYPFTDGWHPFVVAAELIYFLFLLYYMVVQGKRMSKETWGYFCSKWNLLELAIILASWSALAVFVKRAVLAERDLQRCRNHREEGISFSETAAADAALGYIIAFLVLLSTVKLWHLLRLNPKMNMITAALRRAWGDISGFMIVILTMLLAYSIASNLIFGWKLRSYKTLFDAAETMVSLQLGIFNYEEVLDYSPVLGSFLIGSCIVFMTFVVLNLFISVILVAFSEEQKYYQLSEEGEIVDLLLMKILSFLGIKSKREEPGSSREQPGSLSQTRHSRPAQALPKD,2459,"272,514",Alternative sequence (6); Chain (1); Disulfide bond (2); Domain (5); Erroneous initiation (1); Erroneous translation (1); Frameshift (1); Glycosylation (8); Natural variant (51); Region (2); Sequence caution (1); Sequence conflict (8); Signal peptide (1); Topological domain (13); Transmembrane (12),"DISULFID 56..152;  /evidence=""ECO:0000250""; DISULFID 128..144;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
O60895,Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2),MASLRVERAGGPRLPRTRVGRPAALRLLLLLGAVLNPHEALAQPLPTTGTPGSEGGTVKNYETAVQFCWNHYKDQMDPIEKDWCDWAMISRPYSTLRDCLEHFAELFDLGFPNPLAERIIFETHQIHFANCSLVQPTFSDPPEDVLLAMIIAPICLIPFLITLVVWRSKDSEAQA,175,"19,608",Alternative sequence (1); Chain (1); Disulfide bond (2); Glycosylation (1); Helix (7); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 68..99; DISULFID 84..131,"SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q6UXK2,Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein),MFPLRALWLVWALLGVAGSCPEPCACVDKYAHQFADCAYKELREVPEGLPANVTTLSLSANKITVLRRGAFADVTQVTSLWLAHNEVRTVEPGALAVLSQLKNLDLSHNFISSFPWSDLRNLSALQLLKMNHNRLGSLPRDALGALPDLRSLRINNNRLRTLAPGTFDALSALSHLQLYHNPFHCGCGLVWLQAWAASTRVSLPEPDSIACASPPALQGVPVYRLPALPCAPPSVHLSAEPPLEAPGTPLRAGLAFVLHCIADGHPTPRLQWQLQIPGGTVVLEPPVLSGEDDGVGAEEGEGEGDGDLLTQTQAQTPTPAPAWPAPPATPRFLALANGSLLVPLLSAKEAGVYTCRAHNELGANSTSIRVAVAATGPPKHAPGAGGEPDGQAPTSERKSTAKGRGNSVLPSKPEGKIKGQGLAKVSILGETETEPEEDTSEGEEAEDQILADPAEEQRCGNGDPSRYVSNHAFNQSAELKPHVFELGVIALDVAEREARVQLTPLAARWGPGPGGAGGAPRPGRRPLRLLYLCPAGGGAAVQWSRVEEGVNAYWFRGLRPGTNYSVCLALAGEACHVQVVFSTKKELPSLLVIVAVSVFLLVLATVPLLGAACCHLLAKHPGKPYRLILRPQAPDPMEKRIAADFDPRASYLESEKSYPAGGEAGGEEPEDVQGEGLDEDAEQGDPSGDLQREESLAACSLVESQSKANQEEFEAGSEYSDRLPLGAEAVNIAQEINGNYRQTAG,745,"78,990",Chain (1); Disulfide bond (1); Domain (3); Erroneous initiation (1); Glycosylation (6); Modified residue (2); Natural variant (1); Repeat (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 260..355;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8N386,Leucine-rich repeat-containing protein 25 (Monocyte and plasmacytoid-activated protein),MGGTLAWTLLLPLLLRESDSLEPSCTVSSADVDWNAEFSATCLNFSGLSLSLPHNQSLRASNVILLDLSGNGLRELPVTFFAHLQKLEVLNVLRNPLSRVDGALAARCDLDLQADCNCALESWHDIRRDNCSGQKPLLCWDTTSSQHNLSAFLEVSCAPGLASATIGAVVVSGCLLLGLAIAGPVLAWRLWRCRVARSRELNKPWAAQDGPKPGLGLQPRYGSRSAPKPQVAVPSCPSTPDYENMFVGQPAAEHQWDEQGAHPSEDNDFYINYKDIDLASQPVYCNLQSLGQAPMDEEEYVIPGH,305,"33,179",Chain (1); Glycosylation (4); Modified residue (1); Natural variant (2); Repeat (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9P244,Leucine-rich repeat and fibronectin type III domain-containing protein 1 (Synaptic adhesion-like molecule 2),MAPGPFSSALLSPPPAALPFLLLLWAGASRGQPCPGRCICQNVAPTLTMLCAKTGLLFVPPAIDRRVVELRLTDNFIAAVRRRDFANMTSLVHLTLSRNTIGQVAAGAFADLRALRALHLDSNRLAEVRGDQLRGLGNLRHLILGNNQIRRVESAAFDAFLSTVEDLDLSYNNLEALPWEAVGQMVNLNTLTLDHNLIDHIAEGTFVQLHKLVRLDMTSNRLHKLPPDGLFLRSQGTGPKPPTPLTVSFGGNPLHCNCELLWLRRLTREDDLETCATPEHLTDRYFWSIPEEEFLCEPPLITRQAGGRALVVEGQAVSLRCRAVGDPEPVVHWVAPDGRLLGNSSRTRVRGDGTLDVTITTLRDSGTFTCIASNAAGEATAPVEVCVVPLPLMAPPPAAPPPLTEPGSSDIATPGRPGANDSAAERRLVAAELTSNSVLIRWPAQRPVPGIRMYQVQYNSSVDDSLVYRMIPSTSQTFLVNDLAAGRAYDLCVLAVYDDGATALPATRVVGCVQFTTAGDPAPCRPLRAHFLGGTMIIAIGGVIVASVLVFIVLLMIRYKVYGDGDSRRVKGSRSLPRVSHVCSQTNGAGTGAAQAPALPAQDHYEALREVESQAAPAVAVEAKAMEAETASAEPEVVLGRSLGGSATSLCLLPSEETSGEESRAAVGPRRSRSGALEPPTSAPPTLALVPGGAAARPRPQQRYSFDGDYGALFQSHSYPRRARRTKRHRSTPHLDGAGGGAAGEDGDLGLGSARACLAFTSTEWMLESTV,771,"82,318",Chain (1); Disulfide bond (1); Domain (4); Glycosylation (2); Modified residue (2); Motif (1); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 321..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q96KJ4,Mesothelin-like protein (Pre-pro-megakaryocyte-potentiating-factor-like),MAAAVTIPGPRIGALQSSGLTLLLSLAAHCSGPQAKVLSPGGLDASGANLWASANCSLLQGFWCQPASQLPRDQLSALIQRLALLQVPLQAWQLSCLANLASRCGLQDDFTLHPPNLLLFYNLSQVREADCRAFIRRAAQGDVELLSHLPDQRVALWRAAVACLVGAGLRLSASDQQLLGALVCDMDASSIGAADPHMLENLRRCPRLTAAQRIALNSLLAGGKTSLGPPGSWTLEGLQALGPLATYISPHLWAQVQEAVGLGFFRSVVASCQVGRLGQREARCFVTSFLESKTKPVSSRPRLSTGNITAATLRDDLFLVHYDCAELESCLDGCILRTNLDTLLQHLLPTECQHVVKAKLAQIYPQGLPEDQLRLITSLVYLYSRTEIGQWSITSQDTVMALLASDVALENQTEAVLQKFLEHNGTVSGALLLAIGGTRLCWMSPHQIQTIHPQELRLAGALDLSSCPQSRKDVLYTKAHETFGSSGTLAAYYRLMRPYLGGSPGGAQPPSPVPPGGAPVEELRHLAHANISMDIDTFTSLNPLELQSLDVGNVTALLGHNVGDLQKARSHPTVRAWLRSLNSSTLGQLGLDASPTSPTGPAHGTRGPPSTTHQVLHLVHTSGLPTNDAQASTSGSLWAPLGYLPLAMALPCSLLCLLHWGTCILVSVDSVASGWLGSQGSGAGKTEVLDSAGRPLGLTGQL,702,"74,540",Chain (1); Erroneous gene model prediction (2); Glycosylation (3); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P41586,Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1),MAGVVHVSLAALLLLPMAPAMHSDCIFKKEQAMCLEKIQRANELMGFNDSSPGCPGMWDNITCWKPAHVGEMVLVSCPELFRIFNPDQVWETETIGESDFGDSNSLDLSDMGVVSRNCTEDGWSEPFPHYFDACGFDEYESETGDQDYYYLSVKALYTVGYSTSLVTLTTAMVILCRFRKLHCTRNFIHMNLFVSFMLRAISVFIKDWILYAEQDSNHCFISTVECKAVMVFFHYCVVSNYFWLFIEGLYLFTLLVETFFPERRYFYWYTIIGWGTPTVCVTVWATLRLYFDDTGCWDMNDSTALWWVIKGPVVGSIMVNFVLFIGIIVILVQKLQSPDMGGNESSIYLRLARSTLLLIPLFGIHYTVFAFSPENVSKRERLVFELGLGSFQGFVVAVLYCFLNGEVQAEIKRKWRSWKVNRYFAVDFKHRHPSLASSGVNGGTQLSILSKSSSQIRMSGLPADNLAT,468,"53,314",Alternative sequence (3); Beta strand (6); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (5); Helix (16); Modified residue (2); Mutagenesis (5); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (5),DISULFID 34..63; DISULFID 54..118; DISULFID 77..134,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9Y5F9,Protocadherin gamma-B6 (PCDH-gamma-B6),MGGSCAQRRRAGPRQVLFPLLLPLFYPTLSEPIRYSIPEELAKGSVVGNLAKDLGLSVLDVSARKLRVSAEKLHFSVDAESGDLLVKNRIDREQICKERRRCELQLEAVVENPLNIFHVIVVIEDVNDHAPQFDKKEIHLEIFESASAGTRLSLDPATDPDININSIKDYKINSNPYFSLMVRVNSDGGKYPELSLEKLLDREEQRSHSLILTALDGGDPPRSATAHIEISVKDTNDNPPVFSRDEYRISLSENLPPGSPVLQVTATDQDEGVNAEINYYFRSTAQSTKHMFSLDEKTGMIKNNQSFDFEDVERYTMEVEAKDGGGLSTQCKVIIEILDENDNSPEIIITSLSDQILENSPPGMVVALFKTRDLDFGGNGEVRCNIETDIPFKIYSSSNNYYKLVTDGALDREQTPEYNVTIVATDRGKPPLSSSRSITLYVADINDNAPVFDQTSYVVHVAENNPPGASIAQVSASDPDLGLNGHISYSIVASDLEPLAVSSYVSVSAQSGVVFAQRAFDHEQLRAFALTLQARDHGSPTLSANVSLRVLVGDRNDNAPRVLYPALGPDGSAFFDMVPRSAEPGYLVTKVVAVDADSGHNAWLSYHVLQASEPGLFSLGLRTGEVRTARALGDRDAARQRLLVAVRDGGQPPLSATATLHLVFADNLQEILPDLSDRPVLSDPQAELQFYLVVALALISVLFLLAVILAIALRLRRSLSPATWDCFHPGLCVKSGPVVPPNYSEGTLPYSYNLCIAHTGTKEFNFLKCSVPLHSNEDMVCSVSPGALIPPHGGEDLTSHPETLTSQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,930,"101,043",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q8IYV9,Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor) (OBF) (Sperm-specific protein izumo),MGPHFTLLCAALAGCLLPAEGCVICDPSVVLALKSLEKDYLPGHLDAKHHKAMMERVENAVKDFQELSLNEDAYMGVVDEATLQKGSWSLLKDLKRITDSDVKGDLFVKELFWMLHLQKETFATYVARFQKEAYCPNKCGVMLQTLIWCKNCKKEVHACRKSYDCGERNVEVPQMEDMILDCELNWHQASEGLTDYSFYRVWGNNTETLVSKGKEATLTKPMVGPEDAGSYRCELGSVNSSPATIINFHVTVLPKMIKEEKPSPNIVTPGEATTESSISLQPLQPEKMLASRLLGLLICGSLALITGLTFAIFRRRKVIDFIKSSLFGLGSGAAEQTQVPKEKATDSRQQ,350,"38,930",Alternative sequence (4); Beta strand (13); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (1); Helix (10); Modified residue (1); Mutagenesis (4); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 22..149;  /evidence=""ECO:0000244|PDB:5F4E, ECO:0000244|PDB:5F4T, ECO:0000244|PDB:5F4V, ECO:0000244|PDB:5JK9, ECO:0000244|PDB:5JKC, ECO:0000244|PDB:5JKD, ECO:0000244|PDB:5JKE, ECO:0000269|PubMed:27309808, ECO:0000269|PubMed:27309818""; DISULFID 25..152;  /evidence=""ECO:0000244|PDB:5F4E, ECO:0000244|PDB:5F4T, ECO:0000244|PDB:5F4V, ECO:0000244|PDB:5JK9, ECO:0000244|PDB:5JKC, ECO:0000244|PDB:5JKD, ECO:0000244|PDB:5JKE, ECO:0000269|PubMed:27309808, ECO:0000269|PubMed:27309818""; DISULFID 135..159;  /evidence=""ECO:0000244|PDB:5F4E, ECO:0000244|PDB:5F4T, ECO:0000244|PDB:5F4V, ECO:0000244|PDB:5JK9, ECO:0000244|PDB:5JKC, ECO:0000244|PDB:5JKD, ECO:0000244|PDB:5JKE, ECO:0000269|PubMed:27309808, ECO:0000269|PubMed:27309818""; DISULFID 139..165;  /evidence=""ECO:0000244|PDB:5F4E, ECO:0000244|PDB:5F4T, ECO:0000244|PDB:5F4V, ECO:0000244|PDB:5JK9, ECO:0000244|PDB:5JKC, ECO:0000244|PDB:5JKD, ECO:0000244|PDB:5JKE, ECO:0000269|PubMed:27309808, ECO:0000269|PubMed:27309818""; DISULFID 182..233;  /evidence=""ECO:0000244|PDB:5F4E, ECO:0000244|PDB:5F4T, ECO:0000244|PDB:5F4V, ECO:0000244|PDB:5JK9, ECO:0000244|PDB:5JKC, ECO:0000244|PDB:5JKD, ECO:0000244|PDB:5JKE, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:27309808, ECO:0000269|PubMed:27309818""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
O75051,Plexin-A2 (Semaphorin receptor OCT),MEQRRPWPRALEVDSRSVVLLSVVWVLLAPPAAGMPQFSTFHSENRDWTFNHLTVHQGTGAVYVGAINRVYKLTGNLTIQVAHKTGPEEDNKSCYPPLIVQPCSEVLTLTNNVNKLLIIDYSENRLLACGSLYQGVCKLLRLDDLFILVEPSHKKEHYLSSVNKTGTMYGVIVRSEGEDGKLFIGTAVDGKQDYFPTLSSRKLPRDPESSAMLDYELHSDFVSSLIKIPSDTLALVSHFDIFYIYGFASGGFVYFLTVQPETPEGVAINSAGDLFYTSRIVRLCKDDPKFHSYVSLPFGCTRAGVEYRLLQAAYLAKPGDSLAQAFNITSQDDVLFAIFSKGQKQYHHPPDDSALCAFPIRAINLQIKERLQSCYQGEGNLELNWLLGKDVQCTKAPVPIDDNFCGLDINQPLGGSTPVEGLTLYTTSRDRMTSVASYVYNGYSVVFVGTKSGKLKKIRADGPPHGGVQYEMVSVLKDGSPILRDMAFSIDQRYLYVMSERQVTRVPVESCEQYTTCGECLSSGDPHCGWCALHNMCSRRDKCQQAWEPNRFAASISQCVSLAVHPSSISVSEHSRLLSLVVSDAPDLSAGIACAFGNLTEVEGQVSGSQVICISPGPKDVPVIPLDQDWFGLELQLRSKETGKIFVSTEFKFYNCSAHQLCLSCVNSAFRCHWCKYRNLCTHDPTTCSFQEGRINISEDCPQLVPTEEILIPVGEVKPITLKARNLPQPQSGQRGYECVLNIQGAIHRVPALRFNSSSVQCQNSSYQYDGMDISNLAVDFAVVWNGNFIIDNPQDLKVHLYKCAAQRESCGLCLKADRKFECGWCSGERRCTLHQHCTSPSSPWLDWSSHNVKCSNPQITEILTVSGPPEGGTRVTIHGVNLGLDFSEIAHHVQVAGVPCTPLPGEYIIAEQIVCEMGHALVGTTSGPVRLCIGECKPEFMTKSHQQYTFVNPSVLSLNPIRGPESGGTMVTITGHYLGAGSSVAVYLGNQTCEFYGRSMSEIVCVSPPSSNGLGPVPVSVSVDRAHVDSNLQFEYIDDPRVQRIEPEWSIASGHTPLTITGFNLDVIQEPRIRVKFNGKESVNVCKVVNTTTLTCLAPSLTTDYRPGLDTVERPDEFGFVFNNVQSLLIYNDTKFIYYPNPTFELLSPTGVLDQKPGSPIILKGKNLCPPASGGAKLNYTVLIGETPCAVTVSETQLLCEPPNLTGQHKVMVHVGGMVFSPGSVSVISDSLLTLPAIVSIAAGGSLLLIIVIIVLIAYKRKSRENDLTLKRLQMQMDNLESRVALECKEAFAELQTDINELTSDLDRSGIPYLDYRTYAMRVLFPGIEDHPVLRELEVQGNGQQHVEKALKLFAQLINNKVFLLTFIRTLELQRSFSMRDRGNVASLIMTGLQGRLEYATDVLKQLLSDLIDKNLENKNHPKLLLRRTESVAEKMLTNWFAFLLHKFLKECAGEPLFMLYCAIKQQMEKGPIDAITGEARYSLSEDKLIRQQIEYKTLILNCVNPDNENSPEIPVKVLNCDTITQVKEKILDAVYKNVPYSQRPRAVDMDLEWRQGRIARVVLQDEDITTKIEGDWKRLNTLMHYQVSDRSVVALVPKQTSSYNIPASASISRTSISRYDSSFRYTGSPDSLRSRAPMITPDLESGVKVWHLVKNHDHGDQKEGDRGSKMVSEIYLTRLLATKGTLQKFVDDLFETLFSTVHRGSALPLAIKYMFDFLDEQADRHSIHDTDVRHTWKSNCLPLRFWVNVIKNPQFVFDIHKGSITDACLSVVAQTFMDSCSTSEHRLGKDSPSNKLLYAKDIPSYKSWVERYYADIAKLPAISDQDMNAYLAEQSRLHAVEFNMLSALNEIYSYVSKYSEELIGALEQDEQARRQRLAYKVEQLINAMSIES,1894,"211,104",Alternative sequence (3); Beta strand (6); Chain (1); Coiled coil (1); Disulfide bond (10); Domain (5); Erroneous initiation (1); Glycosylation (7); Helix (3); Modified residue (1); Natural variant (6); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 94..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 129..137;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 284..405;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 300..356;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 374..393;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 511..528;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 517..559;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 520..537;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 531..543;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 594..613;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
P18433,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),MDSWFILVLLGSGLICVSANNATTVAPSVGITRLINSSTAEPVKEEAKTSNPTSSLTSLSVAPTFSPNITLGPTYLTTVNSSDSDNGTTRTASTNSIGITISPNGTWLPDNQFTDARTEPWEGNSSTAATTPETFPPSGNSDSKDRRDETPIIAVMVALSSLLVIVFIIIVLYMLRFKKYKQAGSHSNSFRLSNGRTEDVEPQSVPLLARSPSTNRKYPPLPVDKLEEEINRRMADDNKLFREEFNALPACPIQATCEAASKEENKEKNRYVNILPYDHSRVHLTPVEGVPDSDYINASFINGYQEKNKFIAAQGPKEETVNDFWRMIWEQNTATIVMVTNLKERKECKCAQYWPDQGCWTYGNIRVSVEDVTVLVDYTVRKFCIQQVGDMTNRKPQRLITQFHFTSWPDFGVPFTPIGMLKFLKKVKACNPQYAGAIVVHCSAGVGRTGTFVVIDAMLDMMHTERKVDVYGFVSRIRAQRCQMVQTDMQYVFIYQALLEHYLYGDTELEVTSLETHLQKIYNKIPGTSNNGLEEEFKKLTSIKIQNDKMRTGNLPANMKKNRVLQIIPYEFNRVIIPVKRGEENTDYVNASFIDGYRQKDSYIASQGPLLHTIEDFWRMIWEWKSCSIVMLTELEERGQEKCAQYWPSDGLVSYGDITVELKKEEECESYTVRDLLVTNTRENKSRQIRQFHFHGWPEVGIPSDGKGMISIIAAVQKQQQQSGNHPITVHCSAGAGRTGTFCALSTVLERVKAEGILDVFQTVKSLRLQRPHMVQTLEQYEFCYKVVQEYIDAFSDYANFK,802,"90,719",Active site (2); Alternative sequence (1); Beta strand (28); Binding site (2); Chain (1); Domain (2); Glycosylation (7); Helix (23); Modified residue (3); Mutagenesis (1); Natural variant (1); Region (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
O00391,Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6),MRRCNSGSGPPPSLLLLLLWLLAVPGANAAPRSALYSPSDPLTLLQADTVRGAVLGSRSAWAVEFFASWCGHCIAFAPTWKALAEDVKAWRPALYLAALDCAEETNSAVCRDFNIPGFPTVRFFKAFTKNGSGAVFPVAGADVQTLRERLIDALESHHDTWPPACPPLEPAKLEEIDGFFARNNEEYLALIFEKGGSYLGREVALDLSQHKGVAVRRVLNTEANVVRKFGVTDFPSCYLLFRNGSVSRVPVLMESRSFYTAYLQRLSGLTREAAQTTVAPTTANKIAPTVWKLADRSKIYMADLESALHYILRIEVGRFPVLEGQRLVALKKFVAVLAKYFPGRPLVQNFLHSVNEWLKRQKRNKIPYSFFKTALDDRKEGAVLAKKVNWIGCQGSEPHFRGFPCSLWVLFHFLTVQAARQNVDHSQEAAKAKEVLPAIRGYVHYFFGCRDCASHFEQMAAASMHRVGSPNAAVLWLWSSHNRVNARLAGAPSEDPQFPKVQWPPRELCSACHNERLDVPVWDVEATLNFLKAHFSPSNIILDFPAAGSAARRDVQNVAAAPELAMGALELESRNSTLDPGKPEMMKSPTNTTPHVPAEGPEASRPPKLHPGLRAAPGQEPPEHMAELQRNEQEQPLGQWHLSKRDTGAALLAESRAEKNRLWGPLEVRRVGRSSKQLVDIPEGQLEARAGRGRGQWLQVLGGGFSYLDISLCVGLYSLSFMGLLAMYTYFQAKIRALKGHAGHPAA,747,"82,578",Active site (2); Alternative sequence (2); Beta strand (17); Binding site (7); Chain (1); Disulfide bond (5); Domain (2); Erroneous initiation (1); Glycosylation (3); Helix (27); Modified residue (1); Mutagenesis (12); Natural variant (7); Nucleotide binding (1); Signal peptide (1); Transmembrane (1); Turn (5),"DISULFID 70..73;  /note=""Redox-active"";  /evidence=""ECO:0000244|PDB:3LLI, ECO:0000244|PDB:3LLK, ECO:0000305|PubMed:18393449, ECO:0000305|PubMed:20211621, ECO:0000305|PubMed:23704371, ECO:0000305|PubMed:30367560""; DISULFID 101..110;  /evidence=""ECO:0000244|PDB:3Q6O, ECO:0000244|PDB:4IJ3, ECO:0000269|PubMed:22801504, ECO:0000269|PubMed:23867277""; DISULFID 393..405;  /evidence=""ECO:0000244|PDB:3LLI, ECO:0000244|PDB:3LLK, ECO:0000255|PROSITE-ProRule:PRU00654, ECO:0000269|PubMed:20211621""; DISULFID 449..452;  /evidence=""ECO:0000244|PDB:3LLI, ECO:0000244|PDB:3LLK, ECO:0000255|PROSITE-ProRule:PRU00654, ECO:0000269|PubMed:20211621""; DISULFID 509..512;  /evidence=""ECO:0000244|PDB:3LLI, ECO:0000244|PDB:3LLK, ECO:0000255|PROSITE-ProRule:PRU00654, ECO:0000269|PubMed:20211621""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
O60462,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),MDMFPLTWVFLALYFSRHQVRGQPDPPCGGRLNSKDAGYITSPGYPQDYPSHQNCEWIVYAPEPNQKIVLNFNPHFEIEKHDCKYDFIEIRDGDSESADLLGKHCGNIAPPTIISSGSMLYIKFTSDYARQGAGFSLRYEIFKTGSEDCSKNFTSPNGTIESPGFPEKYPHNLDCTFTILAKPKMEIILQFLIFDLEHDPLQVGEGDCKYDWLDIWDGIPHVGPLIGKYCGTKTPSELRSSTGILSLTFHTDMAVAKDGFSARYYLVHQEPLENFQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWTPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQEYLWSPSAARLVSSRSGWFPRIPQAQPGEEWLQVDLGTPKTVKGVIIQGARGGDSITAVEARAFVRKFKVSYSLNGKDWEYIQDPRTQQPKLFEGNMHYDTPDIRRFDPIPAQYVRVYPERWSPAGIGMRLEVLGCDWTDSKPTVETLGPTVKSEETTTPYPTEEEATECGENCSFEDDKDLQLPSGFNCNFDFLEEPCGWMYDHAKWLRTTWASSSSPNDRTFPDDRNFLRLQSDSQREGQYARLISPPVHLPRSPVCMEFQYQATGGRGVALQVVREASQESKLLWVIREDQGGEWKHGRIILPSYDMEYQIVFEGVIGKGRSGEIAIDDIRISTDVPLENCMEPISAFAGENFKVDIPEIHEREGYEDEIDDEYEVDWSNSSSATSGSGAPSTDKEKSWLYTLDPILITIIAMSSLGVLLGATCAGLLLYCTCSYSGLSSRSCTTLENYNFELYDGLKHKVKMNHQKCCSEA,931,"104,831",Alternative sequence (5); Beta strand (41); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (5); Glycosylation (4); Helix (6); Metal binding (3); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 28..55;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 83..105;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 149..175;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 208..230;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 277..427;  /evidence=""ECO:0000269|PubMed:17989695""; DISULFID 434..592;  /evidence=""ECO:0000269|PubMed:17989695""","SIGNAL 1..20;  /note=""Or 22"";  /evidence=""ECO:0000255"""
Q6Q8B3,Cell surface glycoprotein CD200 receptor 2 (CD200 cell surface glycoprotein receptor-like 2) (CD200 receptor-like 2) (HuCD200R2) (CD200 cell surface glycoprotein receptor-like a) (CD200RLa) (Cell surface glycoprotein CD200 receptor 1-like) (Cell surface glycoprotein OX2 receptor 2),MSAPRLLISIIIMVSASSSSCMGGKQMTQNYSTIFAEGNISQPVLMDINAVLCCPPIALRNLIIITWEIILRGQPSCTKAYKKETNETKETNCTVERITWVSRPDQNSDLQIRPVDTTHDGYYRGIVVTPDGNFHRGYHLQVLVTPEVNLFQSRNITAVCKAVTGKPAAQISWIPEGSILATKQEYWGNGTVTVKSTCPWEGHKSTVTCHVSHLTGNKSLSVKLNSGLRTSGSPALSLLIILYVKLSLFVVILVTTGFVFFQRINHVRKVL,271,"29,920",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (6); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 160..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P41217,OX-2 membrane glycoprotein (CD antigen CD200),MERLVIRMPFSHLSTYSLVWVMAAVVLCTAQVQVVTQDEREQLYTPASLKCSLQNAQEALIVTWQKKKAVSPENMVTFSENHGVVIQPAYKDKINITQLGLQNSTITFWNITLEDEGCYMCLFNTFGFGKISGTACLTVYVQPIVSLHYKFSEDHLNITCSATARPAPMVFWKVPRSGIENSTVTLSHPNGTTSVTSILHIKDPKNQVGKEVICQVLHLGTVTDFKQTVNKGYWFSVPLLLSIVSLVILLVLISILLYWKRHRNQDRGELSQGVQKMT,278,"31,264",Alternative sequence (2); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (6); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 118..136;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9Y5E7,Protocadherin beta-2 (PCDH-beta-2),MEAGEGKERVPKQRQVLIFFVLLGIAQASCQPRHYSVAEETESGSFVANLLKDLGLEIGELAVRGARVVSKGKKMHLQFDRQTGDLLLNEKLDREELCGPTEPCVLPFQVLLENPLQFFQAELRIRDVNDHSPVFLDKEILLKIPESITPGTTFLIERAQDLDVGTNSLQNYTISPNFHFHLNLQDSLDGIILPQLVLNRALDREEQPEIRLTLTALDGGSPPRSGTALVRIEVVDINDNVPEFAKLLYEVQIPEDSPVGSQVAIVSARDLDIGTNGEISYAFSQASEDIRKTFRLSAKSGELLLRQKLDFESIQTYTVNIQATDGGGLSGTCVVFVQVMDLNDNPPELTMSTLINQIPENLQDTLIAVFSVSDPDSGDNGRMVCSIQDDLPFFLKPSVENFYTLVISTALDRETRSEYNITITVTDFGTPRLKTEHNITVLVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINADNGHLFALQSLDYEALQAFEFRVGAADRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLRERDAAKQRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLLLPEAAPAQAQADLLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGQMVDVSGTGTLSQSYQYEVCLTGGSGTNEFKFLKPIIPNFVAQGAERVSEANPSFRKSFEFT,798,"87,254",Chain (1); Domain (6); Glycosylation (4); Modified residue (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9Y5I3,Protocadherin alpha-1 (PCDH-alpha-1),MVFSRRGGLGARDLLLWLLLLAAWEVGSGQLHYSIPEEAKHGTFVGRVAQDLGLELAELVPRLFRVASKTHRDLLEVNLQNGILFVNSRIDREELCQWSAECSIHLELIADRPLQVFHVEVKVKDINDNPPVFRGREQIIFIPESRLLNSRFPIEGAADADIGANALLTYTLSPSDYFSLDVEASDELSKSLWLELRKYLDREETPELHLLLTATDGGKPELQGTVELLITVLDVNDNAPLFDQAVYRVHLLETTANGTLVTTLNASDADEGVNGEVVFSFDSGISRDIQEKFKVDSSSGEIRLIDKLDYEETKSYEIQVKAVDKGSPPMSNHCKVLVKVLDVNDNAPELAVTSLYLPIREDAPLSTVIALITVSDRDSGANGQVTCSLMPHVPFKLVSTFKNYYSLVLDSALDRESLSVYELVVTARDGGSPSLWATARVSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRVGERALSNYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLAPRVGGTIGAVSELVPRLVGAGHVVAKVRAVDADSGYNAWLSYELQPAAGGARIPFRVGLYTGEISTTRVLDEADLSRYRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRASVGVAGPEAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSVPPTEGAYVPGKPTLVCSSALGSWSNSQQRRQRVCSSEGPPKTDLMAFSPGLSPSLNTSERNEQPEANLDLSGNPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"102,952",Alternative sequence (3); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (4); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q8IUW5,RELT-like protein 1,MAPRALPGSAVLAAAVFVGGAVSSPLVAPDNGSSRTLHSRTETTPSPSNDTGNGHPEYIAYALVPVFFIMGLFGVLICHLLKKKGYRCTTEAEQDIEEEKVEKIELNDSVNENSDTVGQIVHYIMKNEANADVLKAMVADNSLYDPESPVTPSTPGSPPVSPGPLSPGGTPGKHVCGHHLHTVGGVVERDVCHRCRHKRWHFIKPTNKSRESRPRRQGEVTVLSVGRFRVTKVEHKSNQKERRSLMSVSGAETVNGEVPATPVKRERSGTE,271,"29,340",Chain (1); Coiled coil (1); Glycosylation (2); Modified residue (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
O60894,Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1),MARALCRLPRRGLWLLLAHHLFMTTACQEANYGALLRELCLTQFQVDMEAVGETLWCDWGRTIRSYRELADCTWHMAEKLGCFWPNAEVDRFFLAVHGRYFRSCPISGRAVRDPPGSILYPFIVVPITVTLLVTALVVWQSKRTEGIV,148,"16,988",Beta strand (2); Chain (1); Disulfide bond (3); Helix (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 27..82; DISULFID 40..72; DISULFID 57..104,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
O76095,Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein) (PAR protein),MLAGAGRPGLPQGRHLCWLLCAFTLKLCQAEAPVQEEKLSASTSNLPCWLVEEFVVAEECSPCSNFRAKTTPECGPTGYVEKITCSSSKRNEFKSCRSALMEQRLFWKFEGAVVCVALIFACLVIIRQRQLDRKALEKVRKQIESI,146,"16,358",Alternative sequence (1); Beta strand (3); Chain (1); Helix (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
P32004,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),MVVALRYVWPLLLCSPCLLIQIPEEYEGHHVMEPPVITEQSPRRLVVFPTDDISLKCEASGKPEVQFRWTRDGVHFKPKEELGVTVYQSPHSGSFTITGNNSNFAQRFQGIYRCFASNKLGTAMSHEIRLMAEGAPKWPKETVKPVEVEEGESVVLPCNPPPSAEPLRIYWMNSKILHIKQDERVTMGQNGNLYFANVLTSDNHSDYICHAHFPGTRTIIQKEPIDLRVKATNSMIDRKPRLLFPTNSSSHLVALQGQPLVLECIAEGFPTPTIKWLRPSGPMPADRVTYQNHNKTLQLLKVGEEDDGEYRCLAENSLGSARHAYYVTVEAAPYWLHKPQSHLYGPGETARLDCQVQGRPQPEVTWRINGIPVEELAKDQKYRIQRGALILSNVQPSDTMVTQCEARNRHGLLLANAYIYVVQLPAKILTADNQTYMAVQGSTAYLLCKAFGAPVPSVQWLDEDGTTVLQDERFFPYANGTLGIRDLQANDTGRYFCLAANDQNNVTIMANLKVKDATQITQGPRSTIEKKGSRVTFTCQASFDPSLQPSITWRGDGRDLQELGDSDKYFIEDGRLVIHSLDYSDQGNYSCVASTELDVVESRAQLLVVGSPGPVPRLVLSDLHLLTQSQVRVSWSPAEDHNAPIEKYDIEFEDKEMAPEKWYSLGKVPGNQTSTTLKLSPYVHYTFRVTAINKYGPGEPSPVSETVVTPEAAPEKNPVDVKGEGNETTNMVITWKPLRWMDWNAPQVQYRVQWRPQGTRGPWQEQIVSDPFLVVSNTSTFVPYEIKVQAVNSQGKGPEPQVTIGYSGEDYPQAIPELEGIEILNSSAVLVKWRPVDLAQVKGHLRGYNVTYWREGSQRKHSKRHIHKDHVVVPANTTSVILSGLRPYSSYHLEVQAFNGRGSGPASEFTFSTPEGVPGHPEALHLECQSNTSLLLRWQPPLSHNGVLTGYVLSYHPLDEGGKGQLSFNLRDPELRTHNLTDLSPHLRYRFQLQATTKEGPGEAIVREGGTMALSGISDFGNISATAGENYSVVSWVPKEGQCNFRFHILFKALGEEKGGASLSPQYVSYNQSSYTQWDLQPDTDYEIHLFKERMFRHQMAVKTNGTGRVRLPPAGFATEGWFIGFVSAIILLLLVLLILCFIKRSKGGKYSVKDKEDTQVDSEARPMKDETFGEYRSLESDNEEKAFGSSQPSLNGDIKPLGSDDSLADYGGSVDVQFNEDGSFIGQYSGKKEKEAAGGNDSSGATSPINPAVALE,1257,"140,003",Alternative sequence (2); Chain (1); Disulfide bond (6); Domain (11); Glycosylation (20); Modified residue (9); Motif (1); Mutagenesis (1); Natural variant (88); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 57..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 158..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 264..312;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 354..404;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 448..497;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 539..591;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:3136168"""
P50281,Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP),MSPAPRPPRCLLLPLLTLGTALASLGSAQSSSFSPEAWLQQYGYLPPGDLRTHTQRSPQSLSAAIAAMQKFYGLQVTGKADADTMKAMRRPRCGVPDKFGAEIKANVRRKRYAIQGLKWQHNEITFCIQNYTPKVGEYATYEAIRKAFRVWESATPLRFREVPYAYIREGHEKQADIMIFFAEGFHGDSTPFDGEGGFLAHAYFPGPNIGGDTHFDSAEPWTVRNEDLNGNDIFLVAVHELGHALGLEHSSDPSAIMAPFYQWMDTENFVLPDDDRRGIQQLYGGESGFPTKMPPQPRTTSRPSVPDKPKNPTYGPNICDGNFDTVAMLRGEMFVFKERWFWRVRNNQVMDGYPMPIGQFWRGLPASINTAYERKDGKFVFFKGDKHWVFDEASLEPGYPKHIKELGRGLPTDKIDAALFWMPNGKTYFFRGNKYYRFNEELRAVDSEYPKNIKVWEGIPESPRGSFMGSDEVFTYFYKGNKYWKFNNQKLKVEPGYPKSALRDWMGCPSGGRPDEGTEEETEVIIIEVDEEGGGAVSAAAVVLPVLLLLLVLAVGLAVFFFRRHGTPRRLLYCQRSLLDKV,582,"65,894",Active site (1); Beta strand (31); Chain (1); Disulfide bond (1); Helix (9); Metal binding (4); Modified residue (1); Motif (1); Natural variant (9); Propeptide (1); Repeat (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 319..508;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9HCM2,Plexin-A4,MKAMPWNWTCLLSHLLMVGMGSSTLLTRQPAPLSQKQRSFVTFRGEPAEGFNHLVVDERTGHIYLGAVNRIYKLSSDLKVLVTHETGPDEDNPKCYPPRIVQTCNEPLTTTNNVNKMLLIDYKENRLIACGSLYQGICKLLRLEDLFKLGEPYHKKEHYLSGVNESGSVFGVIVSYSNLDDKLFIATAVDGKPEYFPTISSRKLTKNSEADGMFAYVFHDEFVASMIKIPSDTFTIIPDFDIYYVYGFSSGNFVYFLTLQPEMVSPPGSTTKEQVYTSKLVRLCKEDTAFNSYVEVPIGCERSGVEYRLLQAAYLSKAGAVLGRTLGVHPDDDLLFTVFSKGQKRKMKSLDESALCIFILKQINDRIKERLQSCYRGEGTLDLAWLKVKDIPCSSALLTIDDNFCGLDMNAPLGVSDMVRGIPVFTEDRDRMTSVIAYVYKNHSLAFVGTKSGKLKKIRVDGPRGNALQYETVQVVDPGPVLRDMAFSKDHEQLYIMSERQLTRVPVESCGQYQSCGECLGSGDPHCGWCVLHNTCTRKERCERSKEPRRFASEMKQCVRLTVHPNNISVSQYNVLLVLETYNVPELSAGVNCTFEDLSEMDGLVVGNQIQCYSPAAKEVPRIITENGDHHVVQLQLKSKETGMTFASTSFVFYNCSVHNSCLSCVESPYRCHWCKYRHVCTHDPKTCSFQEGRVKLPEDCPQLLRVDKILVPVEVIKPITLKAKNLPQPQSGQRGYECILNIQGSEQRVPALRFNSSSVQCQNTSYSYEGMEINNLPVELTVVWNGHFNIDNPAQNKVHLYKCGAMRESCGLCLKADPDFACGWCQGPGQCTLRQHCPAQESQWLELSGAKSKCTNPRITEIIPVTGPREGGTKVTIRGENLGLEFRDIASHVKVAGVECSPLVDGYIPAEQIVCEMGEAKPSQHAGFVEICVAVCRPEFMARSSQLYYFMTLTLSDLKPSRGPMSGGTQVTITGTNLNAGSNVVVMFGKQPCLFHRRSPSYIVCNTTSSDEVLEMKVSVQVDRAKIHQDLVFQYVEDPTIVRIEPEWSIVSGNTPIAVWGTHLDLIQNPQIRAKHGGKEHINICEVLNATEMTCQAPALALGPDHQSDLTERPEEFGFILDNVQSLLILNKTNFTYYPNPVFEAFGPSGILELKPGTPIILKGKNLIPPVAGGNVKLNYTVLVGEKPCTVTVSDVQLLCESPNLIGRHKVMARVGGMEYSPGMVYIAPDSPLSLPAIVSIAVAGGLLIIFIVAVLIAYKRKSRESDLTLKRLQMQMDNLESRVALECKEAFAELQTDIHELTSDLDGAGIPFLDYRTYTMRVLFPGIEDHPVLRDLEVPGYRQERVEKGLKLFAQLINNKVFLLSFIRTLESQRSFSMRDRGNVASLIMTVLQSKLEYATDVLKQLLADLIDKNLESKNHPKLLLRRTESVAEKMLTNWFTFLLYKFLKECAGEPLFSLFCAIKQQMEKGPIDAITGEARYSLSEDKLIRQQIDYKTLVLSCVSPDNANSPEVPVKILNCDTITQVKEKILDAIFKNVPCSHRPKAADMDLEWRQGSGARMILQDEDITTKIENDWKRLNTLAHYQVPDGSVVALVSKQVTAYNAVNNSTVSRTSASKYENMIRYTGSPDSLRSRTPMITPDLESGVKMWHLVKNHEHGDQKEGDRGSKMVSEIYLTRLLATKGTLQKFVDDLFETIFSTAHRGSALPLAIKYMFDFLDEQADKHGIHDPHVRHTWKSNCLPLRFWVNMIKNPQFVFDIHKNSITDACLSVVAQTFMDSCSTSEHRLGKDSPSNKLLYAKDIPSYKNWVERYYSDIGKMPAISDQDMNAYLAEQSRMHMNEFNTMSALSEIFSYVGKYSEEILGPLDHDDQCGKQKLAYKLEQVITLMSLDS,1894,"212,455",Alternative sequence (5); Beta strand (6); Chain (1); Disulfide bond (10); Domain (8); Erroneous initiation (1); Glycosylation (4); Helix (4); Modified residue (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 95..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 130..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 284..405;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 300..356;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 374..393;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 510..527;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 516..558;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 519..536;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 530..542;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 593..612;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P09619,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b),MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL,1106,"123,968",Active site (1); Alternative sequence (2); Beta strand (23); Binding site (1); Chain (1); Disulfide bond (4); Domain (6); Glycosylation (11); Helix (3); Modified residue (16); Mutagenesis (13); Natural variant (15); Nucleotide binding (1); Sequence conflict (1); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 54..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20534510""; DISULFID 149..190;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20534510""; DISULFID 235..291;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20534510""; DISULFID 436..508;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8TD46,Cell surface glycoprotein CD200 receptor 1 (CD200 cell surface glycoprotein receptor) (Cell surface glycoprotein OX2 receptor 1),MLCPWRTANLGLLLILTIFLVAASSSLCMDEKQITQNYSKVLAEVNTSWPVKMATNAVLCCPPIALRNLIIITWEIILRGQPSCTKAYRKETNETKETNCTDERITWVSRPDQNSDLQIRPVAITHDGYYRCIMVTPDGNFHRGYHLQVLVTPEVTLFQNRNRTAVCKAVAGKPAAQISWIPEGDCATKQEYWSNGTVTVKSTCHWEVHNVSTVTCHVSHLTGNKSLYIELLPVPGAKKSAKLYIPYIILTIIILTIVGFIWLLKVNGCRKYKLNKTESTPVVEEDEMQPYASYTEKNNPLYDTTNKVKASEALQSEVDTDLHTL,325,"36,620",Alternative sequence (3); Chain (1); Disulfide bond (4); Domain (2); Glycosylation (8); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 60..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 84..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 167..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 186..204;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
O15399,"Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D)",MRGAGGPRGPRGPAKMLLLLALACASPFPEEAPGPGGAGGPGGGLGGARPLNVALVFSGPAYAAEAARLGPAVAAAVRSPGLDVRPVALVLNGSDPRSLVLQLCDLLSGLRVHGVVFEDDSRAPAVAPILDFLSAQTSLPIVAVHGGAALVLTPKEKGSTFLQLGSSTEQQLQVIFEVLEEYDWTSFVAVTTRAPGHRAFLSYIEVLTDGSLVGWEHRGALTLDPGAGEAVLSAQLRSVSAQIRLLFCAREEAEPVFRAAEEAGLTGSGYVWFMVGPQLAGGGGSGAPGEPPLLPGGAPLPAGLFAVRSAGWRDDLARRVAAGVAVVARGAQALLRDYGFLPELGHDCRAQNRTHRGESLHRYFMNITWDNRDYSFNEDGFLVNPSLVVISLTRDRTWEVVGSWEQQTLRLKYPLWSRYGRFLQPVDDTQHLTVATLEERPFVIVEPADPISGTCIRDSVPCRSQLNRTHSPPPDAPRPEKRCCKGFCIDILKRLAHTIGFSYDLYLVTNGKHGKKIDGVWNGMIGEVFYQRADMAIGSLTINEERSEIVDFSVPFVETGISVMVARSNGTVSPSAFLEPYSPAVWVMMFVMCLTVVAVTVFIFEYLSPVGYNRSLATGKRPGGSTFTIGKSIWLLWALVFNNSVPVENPRGTTSKIMVLVWAFFAVIFLASYTANLAAFMIQEEYVDTVSGLSDRKFQRPQEQYPPLKFGTVPNGSTEKNIRSNYPDMHSYMVRYNQPRVEEALTQLKAGKLDAFIYDAAVLNYMARKDEGCKLVTIGSGKVFATTGYGIALHKGSRWKRPIDLALLQFLGDDEIEMLERLWLSGICHNDKIEVMSSKLDIDNMAGVFYMLLVAMGLSLLVFAWEHLVYWRLRHCLGPTHRMDFLLAFSRGMYSCCSAEAAPPPAKPPPPPQPLPSPAYPAPRPAPGPAPFVPRERASVDRWRRTKGAGPPGGAGLADGFHRYYGPIEPQGLGLGLGEARAAPRGAAGRPLSPPAAQPPQKPPPSYFAIVRDKEPAEPPAGAFPGFPSPPAPPAAAATAVGPPLCRLAFEDESPPAPARWPRSDPESQPLLGPGAGGAGGTGGAGGGAPAAPPPCRAAPPPCPYLDLEPSPSDSEDSESLGGASLGGLEPWWFADFPYPYAERLGPPPGRYWSVDKLGGWRAGSWDYLPPRSGPAAWHCRHCASLELLPPPRHLSCSHDGLDGGWWAPPPPPWAAGPLPRRRARCGCPRSHPHRPRASHRTPAAAAPHHHRHRRAAGGWDLPPPAPTSRSLEDLSSCPRAAPARRLTGPSRHARRCPHAAHWGPPLPTASHRRHRGGDLGTRRGSAHFSSLESEV,1336,"143,752",Binding site (3); Chain (1); Compositional bias (5); Disulfide bond (4); Glycosylation (7); Intramembrane (1); Modified residue (2); Motif (1); Mutagenesis (2); Natural variant (13); Region (3); Sequence conflict (4); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (3),"DISULFID 104..348;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 455..483;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 462..484;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 773..828;  /evidence=""ECO:0000250|UniProtKB:Q00959""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9BXB1,Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48),MPGPLGLLCFLALGLLGSAGPSGAAPPLCAAPCSCDGDRRVDCSGKGLTAVPEGLSAFTQALDISMNNITQLPEDAFKNFPFLEELQLAGNDLSFIHPKALSGLKELKVLTLQNNQLKTVPSEAIRGLSALQSLRLDANHITSVPEDSFEGLVQLRHLWLDDNSLTEVPVHPLSNLPTLQALTLALNKISSIPDFAFTNLSSLVVLHLHNNKIRSLSQHCFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELGFHSNSISVIPDGAFDGNPLLRTIHLYDNPLSFVGNSAFHNLSDLHSLVIRGASMVQQFPNLTGTVHLESLTLTGTKISSIPNNLCQEQKMLRTLDLSYNNIRDLPSFNGCHALEEISLQRNQIYQIKEGTFQGLISLRILDLSRNLIHEIHSRAFATLGPITNLDVSFNELTSFPTEGLNGLNQLKLVGNFKLKEALAAKDFVNLRSLSVPYAYQCCAFWGCDSYANLNTEDNSLQDHSVAQEKGTADAANVTSTLENEEHSQIIIHCTPSTGAFKPCEYLLGSWMIRLTVWFIFLVALFFNLLVILTTFASCTSLPSSKLFIGLISVSNLFMGIYTGILTFLDAVSWGRFAEFGIWWETGSGCKVAGFLAVFSSESAIFLLMLATVERSLSAKDIMKNGKSNHLKQFRVAALLAFLGATVAGCFPLFHRGEYSASPLCLPFPTGETPSLGFTVTLVLLNSLAFLLMAVIYTKLYCNLEKEDLSENSQSSMIKHVAWLIFTNCIFFCPVAFFSFAPLITAISISPEIMKSVTLIFFPLPACLNPVLYVFFNPKFKEDWKLLKRRVTKKSGSVSVSISSQGGCLEQDFYYDCGMYSHLQGNLTVCDCCESFLLTKPVSCKHLIKSHSCPALAVASCQRPEGYWSDCGTQSAHSDYADEEDSFVSDSSDQVQACGRACFYQSRGFPLVRYAYNLPRVKD,951,"104,475",Alternative sequence (1); Beta strand (20); Chain (1); Disulfide bond (6); Domain (1); Glycosylation (5); Helix (5); Modified residue (1); Natural variant (6); Repeat (15); Sequence conflict (8); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (12),"DISULFID 29..35;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:23756652""; DISULFID 33..43;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:23756652""; DISULFID 339..364;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:23756652""; DISULFID 470..522;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:23756652""; DISULFID 471..476;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:23756652""; DISULFID 618..693;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q96NY8,Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4],MPLSLGAEMWGPEAWLLLLLLLASFTGRCPAGELETSDVVTVVLGQDAKLPCFYRGDSGEQVGQVAWARVDAGEGAQELALLHSKYGLHVSPAYEGRVEQPPPPRNPLDGSVLLRNAVQADEGEYECRVSTFPAGSFQARLRLRVLVPPLPSLNPGPALEEGQGLTLAASCTAEGSPAPSVTWDTEVKGTTSSRSFKHSRSAAVTSEFHLVPSRSMNGQPLTCVVSHPGLLQDQRITHILHVSFLAEASVRGLEDQNLWHIGREGAMLKCLSEGQPPPSYNWTRLDGPLPSGVRVDGDTLGFPPLTTEHSGIYVCHVSNEFSSRDSQVTVDVLDPQEDSGKQVDLVSASVVVVGVIAALLFCLLVVVVVLMSRYHRRKAQQMTQKYEEELTLTRENSIRRLHSHHTDPRSQPEESVGLRAEGHPDSLKDNSSCSVMSEEPEGRSYSTLTTVREIETQTELLSPGSGRAEEEEDQDEGIKQAMNHFVQENGTLRAKPTGNGIYINGRGHLV,510,"55,454",Alternative sequence (2); Beta strand (16); Chain (2); Disulfide bond (3); Domain (3); Glycosylation (1); Helix (3); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 52..127;  /evidence=""ECO:0000244|PDB:4FRW, ECO:0000269|PubMed:22902367, ECO:0000269|PubMed:23202587""; DISULFID 171..223;  /evidence=""ECO:0000244|PDB:4FRW, ECO:0000269|PubMed:22902367""; DISULFID 270..315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L)",MRRLSLWWLLSRVCLLLPPPCALVLAGVPSSSSHPQPCQILKRIGHAVRVGAVHLQPWTTAPRAASRAPDDSRAGAQRDEPEPGTRRSPAPSPGARWLGSTLHGRGPPGSRKPGEGARAEALWPRDALLFAVDNLNRVEGLLPYNLSLEVVMAIEAGLGDLPLLPFSSPSSPWSSDPFSFLQSVCHTVVVQGVSALLAFPQSQGEMMELDLVSLVLHIPVISIVRHEFPRESQNPLHLQLSLENSLSSDADVTVSILTMNNWYNFSLLLCQEDWNITDFLLLTQNNSKFHLGSIINITANLPSTQDLLSFLQIQLESIKNSTPTVVMFGCDMESIRRIFEITTQFGVMPPELRWVLGDSQNVEELRTEGLPLGLIAHGKTTQSVFEHYVQDAMELVARAVATATMIQPELALIPSTMNCMEVETTNLTSGQYLSRFLANTTFRGLSGSIRVKGSTIVSSENNFFIWNLQHDPMGKPMWTRLGSWQGGKIVMDYGIWPEQAQRHKTHFQHPSKLHLRVVTLIEHPFVFTREVDDEGLCPAGQLCLDPMTNDSSTLDSLFSSLHSSNDTVPIKFKKCCYGYCIDLLEKIAEDMNFDFDLYIVGDGKYGAWKNGHWTGLVGDLLRGTAHMAVTSFSINTARSQVIDFTSPFFSTSLGILVRTRDTAAPIGAFMWPLHWTMWLGIFVALHITAVFLTLYEWKSPFGLTPKGRNRSKVFSFSSALNICYALLFGRTVAIKPPKCWTGRFLMNLWAIFCMFCLSTYTANLAAVMVGEKIYEELSGIHDPKLHHPSQGFRFGTVRESSAEDYVRQSFPEMHEYMRRYNVPATPDGVEYLKNDPEKLDAFIMDKALLDYEVSIDADCKLLTVGKPFAIEGYGIGLPPNSPLTANISELISQYKSHGFMDMLHDKWYRVVPCGKRSFAVTETLQMGIKHFSGLFVLLCIGFGLSILTTIGEHIVYRLLLPRIKNKSKLQYWLHTSQRLHRAINTSFIEEKQQHFKTKRVEKRSNVGPRQLTVWNTSNLSHDNRRKYIFSDEEGQNQLGIRIHQDIPLPPRRRELPALRTTNGKADSLNVSRNSVMQELSELEKQIQVIRQELQLAVSRKTELEEYQRTSRTCES,1115,"125,465",Chain (1); Coiled coil (1); Erroneous initiation (1); Glycosylation (10); Natural variant (22); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q6UW60,Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4),MRPAPIALWLRLVLALALVRPRAVGWAPVRAPIYVSSWAVQVSQGNREVERLARKFGFVNLGPIFPDGQYFHLRHRGVVQQSLTPHWGHRLHLKKNPKVQWFQQQTLQRRVKRSVVVPTDPWFSKQWYMNSEAQPDLSILQAWSQGLSGQGIVVSVLDDGIEKDHPDLWANYDPLASYDFNDYDPDPQPRYTPSKENRHGTRCAGEVAAMANNGFCGVGVAFNARIGGVRMLDGTITDVIEAQSLSLQPQHIHIYSASWGPEDDGRTVDGPGILTREAFRRGVTKGRGGLGTLFIWASGNGGLHYDNCNCDGYTNSIHTLSVGSTTQQGRVPWYSEACASTLTTTYSSGVATDPQIVTTDLHHGCTDQHTGTSASAPLAAGMIALALEANPFLTWRDMQHLVVRASKPAHLQAEDWRTNGVGRQVSHHYGYGLLDAGLLVDTARTWLPTQPQRKCAVRVQSRPTPILPLIYIRENVSACAGLHNSIRSLEHVQAQLTLSYSRRGDLEISLTSPMGTRSTLVAIRPLDVSTEGYNNWVFMSTHFWDENPQGVWTLGLENKGYYFNTGTLYRYTLLLYGTAEDMTARPTGPQVTSSACVQRDTEGLCQACDGPAYILGQLCLAYCPPRFFNHTRLVTAGPGHTAAPALRVCSSCHASCYTCRGGSPRDCTSCPPSSTLDQQQGSCMGPTTPDSRPRLRAAACPHHRCPASAMVLSLLAVTLGGPVLCGMSMDLPLYAWLSRARATPTKPQVWLPAGT,755,"82,795",Active site (3); Alternative sequence (1); Chain (1); Domain (2); Glycosylation (2); Mutagenesis (1); Natural variant (1); Propeptide (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
O43490,Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133),MALVLGSLLLLGLCGNSFSGGQPSSTDAPKAWNYELPATNYETQDSHKAGPIGILFELVHIFLYVVQPRDFPEDTLRKFLQKAYESKIDYDKPETVILGLKIVYYEAGIILCCVLGLLFIILMPLVGYFFCMCRCCNKCGGEMHQRQKENGPFLRKCFAISLLVICIIISIGIFYGFVANHQVRTRIKRSRKLADSNFKDLRTLLNETPEQIKYILAQYNTTKDKAFTDLNSINSVLGGGILDRLRPNIIPVLDEIKSMATAIKETKEALENMNSTLKSLHQQSTQLSSSLTSVKTSLRSSLNDPLCLVHPSSETCNSIRLSLSQLNSNPELRQLPPVDAELDNVNNVLRTDLDGLVQQGYQSLNDIPDRVQRQTTTVVAGIKRVLNSIGSDIDNVTQRLPIQDILSAFSVYVNNTESYIHRNLPTLEEYDSYWWLGGLVICSLLTLIVIFYYLGLLCGVCGYDRHATPTTRGCVSNTGGVFLMVGVGLSFLFCWILMIIVVLTFVFGANVEKLICEPYTSKELFRVLDTPYLLNEDWEYYLSGKLFNKSKMKLTFEQVYSDCKKNRGTYGTLHLQNSFNISEHLNINEHTGSISSELESLKVNLNIFLLGAAGRKNLQDFAACGIDRMNYDSYLAQTGKSPAGVNLLSFAYDLEAKANSLPPGNLRNSLKRDAQTIKTIHQQRVLPIEQSLSTLYQSVKILQRTGNGLLERVTRILASLDFAQNFITNNTSSVIIEETKKYGRTIIGYFEHYLQWIEFSISEKVASCKPVATALDTAVDVFLCSYIIDPLNLFWFGIGKATVFLLPALIFAVKLAKYYRRMDSEDVYDDVETIPMKNMENGNNGYHKDHVYGIHNPVMTSPSQH,865,"97,202",Alternative sequence (6); Chain (1); Glycosylation (8); Modified residue (4); Mutagenesis (6); Natural variant (3); Sequence conflict (4); Signal peptide (1); Topological domain (6); Transmembrane (5),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9Y219,Protein jagged-2 (Jagged2) (hJ2),MRAQGRGRLPRRLLLLLALWVQAARPMGYFELQLSALRNVNGELLSGACCDGDGRTTRAGGCGHDECDTYVRVCLKEYQAKVTPTGPCSYGHGATPVLGGNSFYLPPAGAAGDRARARARAGGDQDPGLVVIPFQFAWPRSFTLIVEAWDWDNDTTPNEELLIERVSHAGMINPEDRWKSLHFSGHVAHLELQIRVRCDENYYSATCNKFCRPRNDFFGHYTCDQYGNKACMDGWMGKECKEAVCKQGCNLLHGGCTVPGECRCSYGWQGRFCDECVPYPGCVHGSCVEPWQCNCETNWGGLLCDKDLNYCGSHHPCTNGGTCINAEPDQYRCTCPDGYSGRNCEKAEHACTSNPCANGGSCHEVPSGFECHCPSGWSGPTCALDIDECASNPCAAGGTCVDQVDGFECICPEQWVGATCQLDANECEGKPCLNAFSCKNLIGGYYCDCIPGWKGINCHINVNDCRGQCQHGGTCKDLVNGYQCVCPRGFGGRHCELERDECASSPCHSGGLCEDLADGFHCHCPQGFSGPLCEVDVDLCEPSPCRNGARCYNLEGDYYCACPDDFGGKNCSVPREPCPGGACRVIDGCGSDAGPGMPGTAASGVCGPHGRCVSQPGGNFSCICDSGFTGTYCHENIDDCLGQPCRNGGTCIDEVDAFRCFCPSGWEGELCDTNPNDCLPDPCHSRGRCYDLVNDFYCACDDGWKGKTCHSREFQCDAYTCSNGGTCYDSGDTFRCACPPGWKGSTCAVAKNSSCLPNPCVNGGTCVGSGASFSCICRDGWEGRTCTHNTNDCNPLPCYNGGICVDGVNWFRCECAPGFAGPDCRINIDECQSSPCAYGATCVDEINGYRCSCPPGRAGPRCQEVIGFGRSCWSRGTPFPHGSSWVEDCNSCRCLDGRRDCSKVWCGWKPCLLAGQPEALSAQCPLGQRCLEKAPGQCLRPPCEAWGECGAEEPPSTPCLPRSGHLDNNCARLTLHFNRDHVPQGTTVGAICSGIRSLPATRAVARDRLLVLLCDRASSGASAVEVAVSFSPARDLPDSSLIQGAAHAIVAAITQRGNSSLLLAVTEVKVETVVTGGSSTGLLVPVLCGAFSVLWLACVVLCVWWTRKRRKERERSRLPREESANNQWAPLNPIRNPIERPGGHKDVLYQCKNFTPPPRRADEALPGPAGHAAVREDEEDEDLGRGEEDSLEAEKFLSHKFTKDPGRSPGRPAHWASGPKVDNRAVRSINEARYAGKE,1238,"133,367",Alternative sequence (1); Beta strand (23); Chain (1); Disulfide bond (51); Domain (18); Glycosylation (5); Helix (2); Modified residue (1); Natural variant (2); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 198..207;  /evidence=""ECO:0000250""; DISULFID 211..223;  /evidence=""ECO:0000250""; DISULFID 231..240;  /evidence=""ECO:0000250""; DISULFID 245..256;  /evidence=""ECO:0000250""; DISULFID 249..262;  /evidence=""ECO:0000250""; DISULFID 264..273;  /evidence=""ECO:0000250""; DISULFID 276..287;  /evidence=""ECO:0000250""; DISULFID 282..293;  /evidence=""ECO:0000250""; DISULFID 295..304;  /evidence=""ECO:0000250""; DISULFID 311..323;  /evidence=""ECO:0000250""; DISULFID 317..333;  /evidence=""ECO:0000250""; DISULFID 335..344;  /evidence=""ECO:0000250""; DISULFID 351..362;  /evidence=""ECO:0000250""; DISULFID 356..371;  /evidence=""ECO:0000250""; DISULFID 373..382;  /evidence=""ECO:0000250""; DISULFID 389..400;  /evidence=""ECO:0000250""; DISULFID 394..409;  /evidence=""ECO:0000250""; DISULFID 411..420;  /evidence=""ECO:0000250""; DISULFID 427..438;  /evidence=""ECO:0000250""; DISULFID 432..447;  /evidence=""ECO:0000250""; DISULFID 449..458;  /evidence=""ECO:0000250""; DISULFID 465..475;  /evidence=""ECO:0000250""; DISULFID 469..484;  /evidence=""ECO:0000250""; DISULFID 486..495;  /evidence=""ECO:0000250""; DISULFID 502..513;  /evidence=""ECO:0000250""; DISULFID 507..522;  /evidence=""ECO:0000250""; DISULFID 524..533;  /evidence=""ECO:0000250""; DISULFID 540..551;  /evidence=""ECO:0000250""; DISULFID 545..560;  /evidence=""ECO:0000250""; DISULFID 562..571;  /evidence=""ECO:0000250""; DISULFID 589..612;  /evidence=""ECO:0000255""; DISULFID 606..622;  /evidence=""ECO:0000255""; DISULFID 624..633;  /evidence=""ECO:0000250""; DISULFID 640..651;  /evidence=""ECO:0000250""; DISULFID 645..660;  /evidence=""ECO:0000250""; DISULFID 662..671;  /evidence=""ECO:0000250""; DISULFID 678..689;  /evidence=""ECO:0000250""; DISULFID 683..698;  /evidence=""ECO:0000250""; DISULFID 700..709;  /evidence=""ECO:0000250""; DISULFID 716..727;  /evidence=""ECO:0000250""; DISULFID 721..736;  /evidence=""ECO:0000250""; DISULFID 738..747;  /evidence=""ECO:0000250""; DISULFID 755..766;  /evidence=""ECO:0000250""; DISULFID 760..775;  /evidence=""ECO:0000250""; DISULFID 777..786;  /evidence=""ECO:0000250""; DISULFID 793..804;  /evidence=""ECO:0000250""; DISULFID 798..813;  /evidence=""ECO:0000250""; DISULFID 815..824;  /evidence=""ECO:0000250""; DISULFID 831..842;  /evidence=""ECO:0000250""; DISULFID 836..851;  /evidence=""ECO:0000250""; DISULFID 853..862;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P14616,Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain],MAVPSLWPWGACLPVIFLSLGFGLDTVEVCPSLDIRSEVAELRQLENCSVVEGHLQILLMFTATGEDFRGLSFPRLTQVTDYLLLFRVYGLESLRDLFPNLAVIRGTRLFLGYALVIFEMPHLRDVALPALGAVLRGAVRVEKNQELCHLSTIDWGLLQPAPGANHIVGNKLGEECADVCPGVLGAAGEPCAKTTFSGHTDYRCWTSSHCQRVCPCPHGMACTARGECCHTECLGGCSQPEDPRACVACRHLYFQGACLWACPPGTYQYESWRCVTAERCASLHSVPGRASTFGIHQGSCLAQCPSGFTRNSSSIFCHKCEGLCPKECKVGTKTIDSIQAAQDLVGCTHVEGSLILNLRQGYNLEPQLQHSLGLVETITGFLKIKHSFALVSLGFFKNLKLIRGDAMVDGNYTLYVLDNQNLQQLGSWVAAGLTIPVGKIYFAFNPRLCLEHIYRLEEVTGTRGRQNKAEINPRTNGDRAACQTRTLRFVSNVTEADRILLRWERYEPLEARDLLSFIVYYKESPFQNATEHVGPDACGTQSWNLLDVELPLSRTQEPGVTLASLKPWTQYAVFVRAITLTTEEDSPHQGAQSPIVYLRTLPAAPTVPQDVISTSNSSSHLLVRWKPPTQRNGNLTYYLVLWQRLAEDGDLYLNDYCHRGLRLPTSNNDPRFDGEDGDPEAEMESDCCPCQHPPPGQVLPPLEAQEASFQKKFENFLHNAITIPISPWKVTSINKSPQRDSGRHRRAAGPLRLGGNSSDFEIQEDKVPRERAVLSGLRHFTEYRIDIHACNHAAHTVGCSAATFVFARTMPHREADGIPGKVAWEASSKNSVLLRWLEPPDPNGLILKYEIKYRRLGEEATVLCVSRLRYAKFGGVHLALLPPGNYSARVRATSLAGNGSWTDSVAFYILGPEEEDAGGLHVLLTATPVGLTLLIVLAALGFFYGKKRNRTLYASVNPEYFSASDMYVPDEWEVPREQISIIRELGQGSFGMVYEGLARGLEAGEESTPVALKTVNELASPRECIEFLKEASVMKAFKCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSHLRSLRPEAENNPGLPQPALGEMIQMAGEIADGMAYLAANKFVHRDLAARNCMVSQDFTVKIGDFGMTRDVYETDYYRKGGKGLLPVRWMAPESLKDGIFTTHSDVWSFGVVLWEIVTLAEQPYQGLSNEQVLKFVMDGGVLEELEGCPLQLQELMSRCWQPNPRLRPSFTHILDSIQEELRPSFRLLSFYYSPECRGARGSLPTTDAEPDSSPTPRDCSPQNGGPGH,1297,"143,720",Active site (1); Binding site (1); Chain (3); Disulfide bond (10); Domain (4); Glycosylation (10); Modified residue (2); Mutagenesis (1); Natural variant (8); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 214..222;  /evidence=""ECO:0000250""; DISULFID 216..228;  /evidence=""ECO:0000250""; DISULFID 229..237;  /evidence=""ECO:0000250""; DISULFID 233..246;  /evidence=""ECO:0000250""; DISULFID 249..258;  /evidence=""ECO:0000250""; DISULFID 262..274;  /evidence=""ECO:0000250""; DISULFID 280..300;  /evidence=""ECO:0000250""; DISULFID 304..317;  /evidence=""ECO:0000250""; DISULFID 320..324;  /evidence=""ECO:0000250""; DISULFID 657..864;  /note=""Interchain (between alpha and beta chains)"";  /evidence=""ECO:0000255""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q16651,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],MAQKGVLGPGQLGAVAILLYLGLLRSGTGAEGAEAPCGVAPQARITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPICLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNCLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTELQPRVVPQTQESQPDSNLCGSHLAFSSAPAQGLLRPILFLPLGLALGLLSPWLSEH,343,"36,431",Active site (3); Alternative sequence (1); Beta strand (17); Chain (3); Disulfide bond (5); Domain (1); Glycosylation (1); Helix (6); Propeptide (2); Signal peptide (1); Transmembrane (1); Turn (3),"DISULFID 37..154;  /note=""Interchain (between light and heavy chains)"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""; DISULFID 70..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000269|PubMed:19388054""; DISULFID 168..244;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000269|PubMed:19388054""; DISULFID 201..223;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000269|PubMed:19388054""; DISULFID 234..262;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000269|PubMed:19388054""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q5R3F8,Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62),MLRLGLCAAALLCVCRPGAVRADCWLIEGDKGYVWLAICSQNQPPYETIPQHINSTVHDLRLNENKLKAVLYSSLNRFGNLTDLNLTKNEISYIEDGAFLGQSSLQVLQLGYNKLSNLTEGMLRGMSRLQFLFVQHNLIEVVTPTAFSECPSLISIDLSSNRLSRLDGATFASLASLMVCELAGNPFNCECDLFGFLAWLVVFNNVTKNYDRLQCESPREFAGYPLLVPRPYHSLNAITVLQAKCRNGSLPARPVSHPTPYSTDAQREPDENSGFNPDEILSVEPPASSTTDASAGPAIKLHHVTFTSATLVVIIPHPYSKMYILVQYNNSYFSDVMTLKNKKEIVTLDKLRAHTEYTFCVTSLRNSRRFNHTCLTFTTRDPVPGDLAPSTSTTTHYIMTILGCLFGMVIVLGAVYYCLRKRRMQEEKQKSVNVKKTILEMRYGADVDAGSIVHAAQKLGEPPVLPVSRMASIPSMIGEKLPTAKGLEAGLDTPKVATKGNYIEVRTGAGGDGLARPEDDLPDLENGQGSAAEISTIAKEVDKVNQIINNCIDALKLDSASFLGGGSSSGDPELAFECQSLPAAAAASSATGPGALERPSFLSPPYKESSHHPLQRQLSADAAVTRKTCSVSSSGSIKSAKVFSLDVPDHPAATGLAKGDSKYIEKGSPLNSPLDRLPLVPAGSGGGSGGGGGIHHLEVKPAYHCSEHRHSFPALYYEEGADSLSQRVSFLKPLTRSKRDSTYSQLSPRHYYSGYSSSPEYSSESTHKIWERFRPYKKHHREEVYMAAGHALRKKVQFAKDEDLHDILDYWKGVSAQQKL,820,"89,687",Chain (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Glycosylation (6); Modified residue (3); Repeat (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P43626,Killer cell immunoglobulin-like receptor 2DL1 (CD158 antigen-like family member A) (MHC class I NK cell receptor) (Natural killer-associated transcript 1) (NKAT-1) (p58 natural killer cell receptor clones CL-42/47.11) (p58 NK receptor CL-42/47.11) (p58.1 MHC class-I-specific NK receptor) (CD antigen CD158a),MSLLVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVMFEHFLLHREGMFNDTLRLIGEHHDGVSKANFSISRMTQDLAGTYRCYGSVTHSPYQVSAPSDPLDIVIIGLYEKPSLSAQPGPTVLAGENVTLSCSSRSSYDMYHLSREGEAHERRLPAGPKVNGTFQADFPLGPATHGGTYRCFGSFHDSPYEWSKSSDPLLVSVTGNPSNSWPSPTEPSSKTGNPRHLHILIGTSVVIILFILLFFLLHRWCSNKKNAAVMDQESAGNRTANSEDSDEQDPQEVTYTQLNHCVFTQRKITRPSQRPKTPPTDIIVYTELPNAESRSKVVSCP,348,"38,505",Alternative sequence (1); Beta strand (19); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (4); Helix (1); Mutagenesis (2); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000244|PDB:1NKR, ECO:0000269|PubMed:9288975""; DISULFID 149..198;  /evidence=""ECO:0000244|PDB:1NKR, ECO:0000269|PubMed:9288975""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:7749980"""
Q86WC4,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit),MEPGPTAAQRRCSLPPWLPLGLLLWSGLALGALPFGSSPHRVFHDLLSEQQLLEVEDLSLSLLQGGGLGPLSLPPDLPDLDPECRELLLDFANSSAELTGCLVRSARPVRLCQTCYPLFQQVVSKMDNISRAAGNTSESQSCARSLLMADRMQIVVILSEFFNTTWQEANCANCLTNNSEELSNSTVYFLNLFNHTLTCFEHNLQGNAHSLLQTKNYSEVCKNCREAYKTLSSLYSEMQKMNELENKAEPGTHLCIDVEDAMNITRKLWSRTFNCSVPCSDTVPVIAVSVFILFLPVVFYLSSFLHSEQKKRKLILPKRLKSSTSFANIQENSN,334,"37,257",Chain (1); Frameshift (1); Glycosylation (10); Modified residue (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
P16284,Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31),MQPRWAQGATMWLGVLLTLLLCSSLEGQENSFTINSVDMKSLPDWTVQNGKNLTLQCFADVSTTSHVKPQHQMLFYKDDVLFYNISSMKSTESYFIPEVRIYDSGTYKCTVIVNNKEKTTAEYQVLVEGVPSPRVTLDKKEAIQGGIVRVNCSVPEEKAPIHFTIEKLELNEKMVKLKREKNSRDQNFVILEFPVEEQDRVLSFRCQARIISGIHMQTSESTKSELVTVTESFSTPKFHISPTGMIMEGAQLHIKCTIQVTHLAQEFPEIIIQKDKAIVAHNRHGNKAVYSVMAMVEHSGNYTCKVESSRISKVSSIVVNITELFSKPELESSFTHLDQGERLNLSCSIPGAPPANFTIQKEDTIVSQTQDFTKIASKSDSGTYICTAGIDKVVKKSNTVQIVVCEMLSQPRISYDAQFEVIKGQTIEVRCESISGTLPISYQLLKTSKVLENSTKNSNDPAVFKDNPTEDVEYQCVADNCHSHAKMLSEVLRVKVIAPVDEVQISILSSKVVESGEDIVLQCAVNEGSGPITYKFYREKEGKPFYQMTSNATQAFWTKQKASKEQEGEYYCTAFNRANHASSVPRSKILTVRVILAPWKKGLIAVVIIGVIIALLIIAAKCYFLRKAKAKQMPVEMSRPAVPLLNSNNEKMSDPNMEANSHYGHNDDVRNHAMKPINDNKEPLNSDVQYTEVQVSSAESHKDLGKKDTETVYSEVRKAVPDAVESRYSRTEGSLDGT,738,"82,522",Alternative sequence (6); Beta strand (17); Chain (1); Disulfide bond (6); Domain (6); Glycosylation (9); Helix (2); Lipidation (1); Modified residue (4); Motif (2); Mutagenesis (11); Natural variant (5); Region (2); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 57..109;  /evidence=""ECO:0000244|PDB:5C14, ECO:0000244|PDB:5GNI, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:26702061, ECO:0000269|PubMed:27958302""; DISULFID 152..206;  /evidence=""ECO:0000244|PDB:5C14, ECO:0000244|PDB:5GNI, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:26702061, ECO:0000269|PubMed:27958302""; DISULFID 256..304;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 347..386;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 431..476;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 523..572;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..27
P08F94,Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin),MTAWLISLMSIEVLLLAVRHLSLHIEPEEGSLAGGTWITVIFDGLELGVLYPNNGSQLEIHLVNVNMVVPALRSVPCDVFPVFLDLPVVTCRTRSVLSEAHEGLYFLEAYFGGQLVSSPNPGPRDSCTFKFSKAQTPIVHQVYPPSGVPGKLIHVYGWIITGRLETFDFDAEYIDSPVILEAQGDKWVTPCSLINRQMGSCYPIQEDHGLGTLQCHVEGDYIGSQNVSFSVFNKGKSMVHKKAWLISAKQDLFLYQTHSEILSVFPETGSLGGRTNITITGDFFDNSAQVTIAGIPCDIRHVSPRKIECTTRAPGKDVRLTTPQPGNRGLLFEVGDAVEGLELTEATPGYRWQIVPNASSPFGFWSQEGQPFRARLSGFFVAPETNNYTFWIQADSQASLHFSWSEEPRTKVKVASISVGTADWFDSWEQNRDEGTWQQKTPKLELLGGAMYYLEAEHHGIAPSRGMRIGVQIHNTWLNPDVVTTYLREKHQIRVRAQRLPEVQVLNVSGRGNFFLTWDNVSSQPIPANATAHLIQTTIEELLAVKCKLEPLWSNILLRLGFERGPEVSNSDGDLTSGTEPFCGRFSLRQPRHLVLTPPAAQKGYRLDQYTHLCLAYKGHMNKILKMIVSFTIGFQNMVKNTTCDWSLTRTSPESWQFDCTDLWETCVRCFGDLQPPPANSPVLVHQINLLPLAQETGLFYVDEIIIADTNVTVSQADSGTARPGGNLVESVSVVGSPPVYSVTSWLAGCGTELPLITARSVPTEGTEEGSGLVLVTTQRRQRTSPPLGGHFRIQLPNTVISDVPVQISAHHLHQLLQNNADDFTSRYLNASDFTVKEDLYTCYEHVWTLSWSTQIGDLPNFIRVSDENLTGVNPAAATRVVYDGGVFLGPIFGDMLATANQHTQVVVRVNDVPAHCPGSCSFQYLQGSTPCVHSVWYSIDGDINLMIYITGTGFSGDSQFLQVTVNKTSCKVIFSNQTNVVCQTDLLPVGMHRILMLVRPSGLAISATGEDLFLNVKPRLDMVEPSRAADIGGLWATIRGSSLEGVSLILFGSYSCAINVATSNSSRIQCKVPPRGKDGRIVNVTVIRGDYSAVLPRAFTYVSSLNPVIVTLSRNISNIAGGETLVIGVARLMNYTDLDVEVHVQDALAPVHTQSAWGLEVALPPLPAGLHRISVSINGVSIHSQGVDLHIQYLTEVFSIEPCCGSLLGGTILSISGIGFSRDPALVWVLVGNRSCDIVNLTEASIWCETLPAPQIPDAGAPTVPAAVEVWAGNRFFARGPSPSLVGKGFTFMYEAAATPVVTAMQGEITNSSLSLHVGGSNLSNSVILLGNLNCDVETQSFQGNVSLSGCSIPLHSLEAGIYPLQVRQKQMGFANMSVVLQQFAVMPRIMAIFPSQGSACGGTILTVRGLLLNSRRRSVRVDLSGPFTCVILSLGDHTILCQVSLEGDPLPGASFSLNVTVLVNGLTSECQGNCTLFIREEASPVMDALSTNTSGSLTTVLIRGQRLATTADEPMVFVDDQLPCNVTFFNASHVVCQTRDLAPGPHYLSVFYTRNGYACSGNVSRHFYIMPQVFHYFPKNFSLHGGSLLTIEGTGLRGQNTTSVYIDQQTCLTVNIGAELIRCIVPTGNGSVALEIEVDGLWYHIGVIGYNKAFTPELISISQSDDILTFAVAQISGAANIDIFIGMSPCVGVSGNHTVLQCVVPSLPAGEYHVRGYDCIRGWASSALVFTSRVIITAVTENFGCLGGRLVHVFGAGFSPGNVSAAVCGAPCRVLANATVSAFSCLVLPLDVSLAFLCGLKREEDSCEAARHTYVQCDLTVAMATEQLLESWPYLYICEESSQCLFVPDHWAESMFPSFSGLFISPKLERDEVLIYNSSCNITMETEAEMECETPNQPITVKITEIRKRWGQNTQGNFSLQFCRRWSRTHSWFPERLPQDGDNVTVENGQLLLLDTNTSILNLLHIKGGKLIFMAPGPIELRAHAILVSDGGELRIGSEDKPFQGRAQITLYGSSYSTPFFPYGVKFLAVRNGTLSLHGSLPEVIVTCLRATAHALDTVLALEDAVDWNPGDEVVIISGTGVKGAKPMEEIVTVETVQDTDLYLKSPLRYSHNFTENWVAGEHHILKATVALLSRSITIQGNLTNEREKLLVSCQEANAPEGNLQHCLYSMSEKMLGSRDMGARVIVQSFPEEPSQVQLKGVQFQVLGQAFHKHLSSLTLVGAMRESFIQGCTVRNSFSRGLSMCGTLGLKVDSNVFYNILGHALLVGTCTEMRYISWEAIHGRKDDWSGHGNIIRNNVIIQVSGAEGLSNPEMLTPSGIYICSPTNVIEGNRVCGAGYGYFFHLMTNQTSQAPLLSFTQNIAHSCTRYGLFVYPKFQPPWDNVTGTTLFQSFTVWESAGGAQIFRSSNLRLKNFKVYSCRDFGIDVLESDANTSVTDSLLLGHFAHKGSLCMSSGIKTPKRWELMVSNTTFVNFDLINCVAIRTCSDCSQGQGGFTVKTSQLKFTNSSNLVAFPFPHAAILEDLDGSLSGKNRSHILASMETLSASCLVNSSFGRVVHGSACGGGVLFHRMSIGLANTPEVSYDLTMTDSRNKTTTVNYVRDTLSNPRGWMALLLDQETYSLQSENLWINRSLQYSATFDNFAPGNYLLLVHTDLPPYPDILLRCGSRVGLSFPFLPSPGQNQGCDWFFNSQLRQLTYLVSGEGQVQVILRVKEGMPPTISASTSAPESALKWSLPETWQGVEEGWGGYNNTIPGPGDDVLILPNRTVLVDTDLPFFKGLYVMGTLDFPVDRSNVLSVACMVIAGGELKVGTLENPLEKEQKLLILLRASEGVFCDRMNGIHIDPGTIGVYGKVHLYSAYPKNSWTHLGADIASGNERIIVEDAVDWRPHDKIVLSSSSYEPHEAEVLTVKEVKGHHVRIYERLKHRHIGSVHVTEDGRHIRLAAEVGLLTRNIQIQPDVSCRGRLFVGSFRKSSREEFSGVLQLLNVEIQNFGSPLYSSVEFSNVSAGSWIISSTLHQSCGGGIHAAASHGVLLNDNIVFGTAGHGIDLEGQAYTVTNNLVVLMTQPAWSTIWVAGIKVNQVKDINLHGNVVAGSERLGFHIRGHKCSSCELLWSDNVAHSSLHGLHLYKESGLDNCTRISGFLAFKNFDYGAMLHVENSVEIENITLVDNTIGLLAVVYVFSAPQNSVKKVQIVLRNSVIVATSSSFDCIQDKVKPHSANLTSTDRAPSNPRGGRIGILWPVFTSEPNQWPQEPWHKVRNDHSISGIMKLQDVTFSSFVKSCYSDDLDVCILPNAENSGIMHPITAERTRMLKIKDKNKFYFPSLQPRKDLGKVVCPELDCASPRKYLFKDLDGRALGLPPPVSVFPKTEAEWTASFFNAGTFREEQKCTYQFLMQGFICKQTDQVVLILDSADAIWAIQKLYPVVSVTSGFVDVFSSVNANIPCSTSGSVSTFYSILPIRQITKVCFMDQTPQVLRFFLLGNKSTSKLLLAVFYHELQSPHVFLGESFIPPTLVQSASLLLNESIGANYFNIMDNLLYVVLQGEEPIEIRSGVSIHLALTVMVSVLEKGWEIVILERLTNFLQIGQNQIRFIHEMPGHEETLKAIADSRAKRKRNCPTVTCTSHYRRVGQRRPLMMEMNSHRASPPMTVETISKVIVIEIGDSPTVRSTGMISSLSSNKLQNLAHRVITAQQTGVLENVLNMTIGALLVTQSKGVIGYGNTSSFKTGNLIYIRPYALSILVQPSDGEVGNELPVQPQLVFLDEQNRRVESLGPPSEPWTISASLEGASDSVLKGCTQAETQDGYVSFYNLAVLISGSNWHFIFTVTSPPGVNFTARSKPFAVLPVTRKEKSTIILAASLSSVASWLALSCLVCCWLKRSKSRKTKPEEIPESQTNNQNIHIHISSKRRESQGPKKEDTVVGEDMRMKVMLGKVNQCPHQLMNGVSRRKVSRHIVREEEAAVPAPGTTGITSHGHICAPGAPAQQVYLQETGNWKEGQEQLLRYQLAGQNQLLLLCPDFRQERQQLPGQSRLSKQSGSLGLSQEKKASCGATEAFCLHSVHPETIQEQL,4074,"446,702",Alternative sequence (2); Chain (1); Domain (15); Glycosylation (64); Mutagenesis (1); Natural variant (159); Region (2); Repeat (9); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P28067,"HLA class II histocompatibility antigen, DM alpha chain (MHC class II antigen DMA) (Really interesting new gene 6 protein)",MGHEQNQGAALLQMLPLLWLLPHSWAVPEAPTPMWPDDLQNHTFLHTVYCQDGSPSVGLSEAYDEDQLFFFDFSQNTRVPRLPEFADWAQEQGDAPAILFDKEFCEWMIQQIGPKLDGKIPVSRGFPIAEVFTLKPLEFGKPNTLVCFVSNLFPPMLTVNWHDHSVPVEGFGPTFVSAVDGLSFQAFSYLNFTPEPSDIFSCIVTHEIDRYTAIAYWVPRNALPSDLLENVLCGVAFGLGVLGIIVGIVLIIYFRKPCSGD,261,"29,194",Beta strand (12); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (3); Mutagenesis (5); Natural variant (7); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 50..105;  /evidence=""ECO:0000244|PDB:4GBX, ECO:0000269|PubMed:23260142""; DISULFID 147..202;  /evidence=""ECO:0000244|PDB:4GBX, ECO:0000269|PubMed:23260142""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q6UY11,Protein delta homolog 2 (DLK-2) (Epidermal growth factor-like protein 9) (EGF-like protein 9),MPSGCRCLHLVCLLCILGAPGQPVRADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCERCVRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQSPCQNGGQCMYDGGGEYHCVCLPGFHGRDCERKAGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLVGFVGARCEVNVDDCLMRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRDRVHDFDCLCPSGYGGKTCELVLPVPDPPTTVDTPLGPTSAVVVPATGPAPHSAGAGLLRISVKEVVRRQEAGLGEPSLVALVVFGALTAALVLATVLLTLRAWRRGVCPPGPCCYPAPHYAPACQDQECQVSMLPAGLPLPRDLPPEPGKTTAL,383,"40,548",Alternative sequence (1); Chain (1); Disulfide bond (17); Domain (6); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 29..40;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 33..46;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 48..57;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 66..71;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 79..88;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 95..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 101..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 119..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 135..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 142..160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 162..171;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 178..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 183..198;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 200..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 216..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 221..236;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 238..247;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P06028,Glycophorin-B (PAS-3) (SS-active sialoglycoprotein) (Sialoglycoprotein delta) (CD antigen CD235b),MYGKIIFVLLLSEIVSISALSTTEVAMHTSTSSSVTKSYISSQTNGETGQLVHRFTVPAPVVIILIILCVMAGIIGTILLISYSIRRLIKA,91,"9,782",Alternative sequence (1); Chain (1); Glycosylation (2); Natural variant (5); Sequence conflict (2); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:3571235, ECO:0000269|PubMed:3595615, ECO:0000269|PubMed:7681597"""
Q9NQ84,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),MAIHKALVMCLGLPLFLFPGAWAQGHVPPGCSQGLNPLYYNLCDRSGAWGIVLEAVAGAGIVTTFVLTIILVASLPFVQDTKKRSLLGTQVFFLLGTLGLFCLVFACVVKPDFSTCASRRFLFGVLFAICFSCLAAHVFALNFLARKNHGPRGWVIFTVALLLTLVEVIINTEWLIITLVRGSGEGGPQGNSSAGWAVASPCAIANMDFVMALIYVMLLLLGAFLGAWPALCGRYKRWRKHGVFVLLTTATSVAIWVVWIVMYTYGNKQHNSPTWDDPTLAIALAANAWAFVLFYVIPEVSQVTKSSPEQSYQGDMYPTRGVGYETILKEQKGQSMFVENKAFSMDEPVAAKRPVSPYSGYNGQLLTSVYQPTEMALMHKVPSEGAYDIILPRATANSQVMGSANSTLRAEDMYSAQSHQAATPPKDGKNSQVFRNPYVWD,441,"48,193",Alternative sequence (1); Chain (1); Erroneous initiation (6); Glycosylation (1); Modified residue (6); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9N2J8,HERV-H_2q24.1 provirus ancestral Env polyprotein (Env protein HERV-H/p59) (Envelope polyprotein) (HERV-H/env59) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MILAGRAPSNTSTLMKFYSLLLYSLLFSFPFLYHPLPLPSYLHHTINLTHSLPAASNPSLANNCWLCISLSSSAYIAVPTLQTDRATSPVSLHLRTSFNSPHLYPPEELIYFLDRSSKTSPDISHQPAAALLHIYLKNLSPYINSTPPIFGPLTTQTTIPVAAPLCISRQRPTGIPLGNISPSRCSFTLHLQSPTTHVTETIGVFQLHIIDKPSINTDKLKNVSSNYCLGRHLPYISLHPWLPSPCSSDSPPRPSSCLLTPSPQNNSERLLVDTQRFLIHHENRTSSSMQLAHQSPLQPLTAAALAGSLGVWVQDTPFSTPSHPFSLHLQFCLTQGLFFLCGSSTYMCLPANWTGTCTLVFLTPKIQFANGTKELPVPLMTLTPQKRVIPLIPLMVGLGLSASTIALSTGIAGISTSVTTFRSPSNDFSASITDISQTLSVLQAQVDSLAAVVLQNRRGLGLSILLNEECCFYLNQSGLVYENIKKLKDRAQKLANQASNYAESPWALSNWMSWVLPILSPLIPIFLLLLFGPCIFHLVSQFIQNRIQAITNHSI,555,"60,911",Chain (3); Glycosylation (7); Motif (1); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P12318,Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32),MTMETQMSQNVCPRNLWLLQPLTVLLLLASADSQAAAPPKAVLKLEPPWINVLQEDSVTLTCQGARSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIMLRCHSWKDKPLVKVTFFQNGKSQKFSHLDPTFSIPQANHSHSGDYHCTGNIGYTLFSSKPVTITVQVPSMGSSSPMGIIVAVVIATAVAAIVAAVVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQLEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN,317,"35,001",Alternative sequence (1); Beta strand (19); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (2); Helix (3); Modified residue (2); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 62..104;  /evidence=""ECO:0000244|PDB:1FCG, ECO:0000269|PubMed:10331870, ECO:0000269|PubMed:11397093, ECO:0000269|PubMed:19011614""; DISULFID 143..187;  /evidence=""ECO:0000244|PDB:1FCG, ECO:0000269|PubMed:10331870, ECO:0000269|PubMed:11397093, ECO:0000269|PubMed:19011614""","SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:10397151"""
O60883,G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2) (ETBR-LP-2),MRWLWPLAVSLAVILAVGLSRVSGGAPLHLGRHRAETQEQQSRSKRGTEDEEAKGVQQYVPEEWAEYPRPIHPAGLQPTKPLVATSPNPGKDGGTPDSGQELRGNLTGAPGQRLQIQNPLYPVTESSYSAYAIMLLALVVFAVGIVGNLSVMCIVWHSYYLKSAWNSILASLALWDFLVLFFCLPIVIFNEITKQRLLGDVSCRAVPFMEVSSLGVTTFSLCALGIDRFHVATSTLPKVRPIERCQSILAKLAVIWVGSMTLAVPELLLWQLAQEPAPTMGTLDSCIMKPSASLPESLYSLVMTYQNARMWWYFGCYFCLPILFTVTCQLVTWRVRGPPGRKSECRASKHEQCESQLNSTVVGLTVVYAFCTLPENVCNIVVAYLSTELTRQTLDLLGLINQFSTFFKGAITPVLLLCICRPLGQAFLDCCCCCCCEECGGASEASAANGSDNKLKTEVSSSIYFHKPRESPPLLPLGTPC,481,"52,771",Chain (1); Compositional bias (1); Disulfide bond (1); Glycosylation (6); Modified residue (2); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 203..286;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P04439,"HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)",MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV,365,"40,841",Alternative sequence (2); Beta strand (24); Binding site (8); Chain (1); Disulfide bond (2); Domain (1); Erroneous gene model prediction (1); Glycosylation (1); Helix (8); Modified residue (8); Mutagenesis (3); Natural variant (93); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 125..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806""; DISULFID 227..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847, ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:92029"""
Q6UWB1,Interleukin-27 receptor subunit alpha (IL-27 receptor subunit alpha) (IL-27R subunit alpha) (IL-27R-alpha) (IL-27RA) (Cytokine receptor WSX-1) (Cytokine receptor-like 1) (Type I T-cell cytokine receptor) (TCCR) (ZcytoR1),MRGGRGAPFWLWPLPKLALLPLLWVLFQRTRPQGSAGPLQCYGVGPLGDLNCSWEPLGDLGAPSELHLQSQKYRSNKTQTVAVAAGRSWVAIPREQLTMSDKLLVWGTKAGQPLWPPVFVNLETQMKPNAPRLGPDVDFSEDDPLEATVHWAPPTWPSHKVLICQFHYRRCQEAAWTLLEPELKTIPLTPVEIQDLELATGYKVYGRCRMEKEEDLWGEWSPILSFQTPPSAPKDVWVSGNLCGTPGGEEPLLLWKAPGPCVQVSYKVWFWVGGRELSPEGITCCCSLIPSGAEWARVSAVNATSWEPLTNLSLVCLDSASAPRSVAVSSIAGSTELLVTWQPGPGEPLEHVVDWARDGDPLEKLNWVRLPPGNLSALLPGNFTVGVPYRITVTAVSASGLASASSVWGFREELAPLVGPTLWRLQDAPPGTPAIAWGEVPRHQLRGHLTHYTLCAQSGTSPSVCMNVSGNTQSVTLPDLPWGPCELWVTASTIAGQGPPGPILRLHLPDNTLRWKVLPGILFLWGLFLLGCGLSLATSGRCYHLRHKVLPRWVWEKVPDPANSSSGQPHMEQVPEAQPLGDLPILEVEEMEPPPVMESSQPAQATAPLDSGYEKHFLPTPEELGLLGPPRPQVLA,636,"69,474",Chain (1); Domain (3); Glycosylation (7); Motif (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q13683,Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],MAGARSRDPWGASGICYLFGSLLVELLFSRAVAFNLDVMGALRKEGEPGSLFGFSVALHRQLQPRPQSWLLVGAPQALALPGQQANRTGGLFACPLSLEETDCYRVDIDQGADMQKESKENQWLGVSVRSQGPGGKIVTCAHRYEARQRVDQILETRDMIGRCFVLSQDLAIRDELDGGEWKFCEGRPQGHEQFGFCQQGTAAAFSPDSHYLLFGAPGTYNWKGTARVELCAQGSADLAHLDDGPYEAGGEKEQDPRLIPVPANSYFGLLFVTNIDSSDPDQLVYKTLDPADRLPGPAGDLALNSYLGFSIDSGKGLVRAEELSFVAGAPRANHKGAVVILRKDSASRLVPEVMLSGERLTSGFGYSLAVADLNSDGWPDLIVGAPYFFERQEELGGAVYVYLNQGGHWAGISPLRLCGSPDSMFGISLAVLGDLNQDGFPDIAVGAPFDGDGKVFIYHGSSLGVVAKPSQVLEGEAVGIKSFGYSLSGSLDMDGNQYPDLLVGSLADTAVLFRARPILHVSHEVSIAPRSIDLEQPNCAGGHSVCVDLRVCFSYIAVPSSYSPTVALDYVLDADTDRRLRGQVPRVTFLSRNLEEPKHQASGTVWLKHQHDRVCGDAMFQLQENVKDKLRAIVVTLSYSLQTPRLRRQAPGQGLPPVAPILNAHQPSTQRAEIHFLKQGCGEDKICQSNLQLVRARFCTRVSDTEFQPLPMDVDGTTALFALSGQPVIGLELMVTNLPSDPAQPQADGDDAHEAQLLVMLPDSLHYSGVRALDPAEKPLCLSNENASHVECELGNPMKRGAQVTFYLILSTSGISIETTELEVELLLATISEQELHPVSARARVFIELPLSIAGMAIPQQLFFSGVVRGERAMQSERDVGSKVKYEVTVSNQGQSLRTLGSAFLNIMWPHEIANGKWLLYPMQVELEGGQGPGQKGLCSPRPNILHLDVDSRDRRRRELEPPEQQEPGERQEPSMSWWPVSSAEKKKNITLDCARGTANCVVFSCPLYSFDRAAVLHVWGRLWNSTFLEEYSAVKSLEVIVRANITVKSSIKNLMLRDASTVIPVMVYLDPMAVVAEGVPWWVILLAVLAGLLVLALLVLLLWKMGFFKRAKHPEATVPQYHAVKIPREDRQQFKEEKTGTILRNNWGSPRREGPDAHPILAADGHPELGPDGHPGPGTA,1181,"128,948",Alternative sequence (6); Calcium binding (3); Chain (4); Compositional bias (1); Disulfide bond (9); Glycosylation (5); Motif (1); Natural variant (5); Region (1); Repeat (10); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 94..103;  /evidence=""ECO:0000250""; DISULFID 140..163;  /evidence=""ECO:0000250""; DISULFID 184..197;  /evidence=""ECO:0000250""; DISULFID 539..546;  /evidence=""ECO:0000250""; DISULFID 552..615;  /evidence=""ECO:0000250""; DISULFID 681..687;  /evidence=""ECO:0000250""; DISULFID 781..792;  /evidence=""ECO:0000250""; DISULFID 939..994;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000250""; DISULFID 1001..1006;  /evidence=""ECO:0000250""","SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:1839357"""
O00481,Butyrophilin subfamily 3 member A1 (CD antigen CD277),MKMASFLAFLLLNFRVCLLLLQLLMPHSAQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSDLHVDVKGYKDGGIHLECRSTGWYPQPQIQWSNNKGENIPTVEAPVVADGVGLYAVAASVIMRGSSGEGVSCTIRSSLLGLEKTASISIADPFFRSAQRWIAALAGTLPVLLLLLGGAGYFLWQQQEEKKTQFRKKKREQELREMAWSTMKQEQSTRVKLLEELRWRSIQYASRGERHSAYNEWKKALFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPA,513,"57,677",Alternative sequence (4); Beta strand (30); Chain (1); Disulfide bond (2); Domain (3); Erroneous initiation (1); Glycosylation (1); Helix (8); Natural variant (4); Sequence conflict (10); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 52..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""; DISULFID 166..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
O00478,Butyrophilin subfamily 3 member A3,MKMASSLAFLLLNFHVSLFLVQLLTPCSAQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELRWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSDLHIEVKGYEDGGIHLECRSTGWYPQPQIKWSDTKGENIPAVEAPVVADGVGLYAVAASVIMRGSSGGGVSCIIRNSLLGLEKTASISIADPFFRSAQPWIAALAGTLPISLLLLAGASYFLWRQQKEKIALSRETEREREMKEMGYAATEQEISLREKLQEELKWRKIQYMARGEKSLAYHEWKMALFKPADVILDPDTANAILLVSEDQRSVQRAEEPRDLPDNPERFEWRYCVLGCENFTSGRHYWEVEVGDRKEWHIGVCSKNVERKKGWVKMTPENGYWTMGLTDGNKYRALTEPRTNLKLPEPPRKVGIFLDYETGEISFYNATDGSHIYTFPHASFSEPLYPVFRILTLEPTALTICPIPKEVESSPDPDLVPDHSLETPLTPGLANESGEPQAEVTSLLLPAHPGAEVSPSATTNQNHKLQARTEALY,584,"65,002",Alternative sequence (2); Beta strand (32); Chain (1); Disulfide bond (2); Domain (3); Glycosylation (1); Helix (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 52..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""; DISULFID 166..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9Y5Z0,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),MGALARALLLPLLAQWLLRAAPELAPAPFTLPLRVAAATNRVVAPTPGPGTPAERHADGLALALEPALASPAGAANFLAMVDNLQGDSGRGYYLEMLIGTPPQKLQILVDTGSSNFAVAGTPHSYIDTYFDTERSSTYRSKGFDVTVKYTQGSWTGFVGEDLVTIPKGFNTSFLVNIATIFESENFFLPGIKWNGILGLAYATLAKPSSSLETFFDSLVTQANIPNVFSMQMCGAGLPVAGSGTNGGSLVLGGIEPSLYKGDIWYTPIKEEWYYQIEILKLEIGGQSLNLDCREYNADKAIVDSGTTLLRLPQKVFDAVVEAVARASLIPEFSDGFWTGSQLACWTNSETPWSYFPKISIYLRDENSSRSFRITILPQLYIQPMMGAGLNYECYRFGISPSTNALVIGATVMEGFYVIFDRAQKRVGFAASPCAEIAGAAVSEISGPFSTEDVASNCVPAQSLSEPILWIVSYALMSVCGAILLVLIVLLLLPFRCQRRPRDPEVVNDESSLVRHRWK,518,"56,180",Active site (2); Alternative sequence (5); Beta strand (28); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (2); Helix (14); Mutagenesis (2); Propeptide (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 233..433;  /evidence=""ECO:0000269|PubMed:16305800""; DISULFID 292..457;  /evidence=""ECO:0000269|PubMed:16305800""; DISULFID 344..393;  /evidence=""ECO:0000269|PubMed:16305800""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9HCU4,Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3),MRSPATGVPLPTPPPPLLLLLLLLLPPPLLGDQVGPCRSLGSRGRGSSGACAPMGWLCPSSASNLWLYTSRCRDAGTELTGHLVPHHDGLRVWCPESEAHIPLPPAPEGCPWSCRLLGIGGHLSPQGKLTLPEEHPCLKAPRLRCQSCKLAQAPGLRAGERSPEESLGGRRKRNVNTAPQFQPPSYQATVPENQPAGTPVASLRAIDPDEGEAGRLEYTMDALFDSRSNQFFSLDPVTGAVTTAEELDRETKSTHVFRVTAQDHGMPRRSALATLTILVTDTNDHDPVFEQQEYKESLRENLEVGYEVLTVRATDGDAPPNANILYRLLEGSGGSPSEVFEIDPRSGVIRTRGPVDREEVESYQLTVEASDQGRDPGPRSTTAAVFLSVEDDNDNAPQFSEKRYVVQVREDVTPGAPVLRVTASDRDKGSNAVVHYSIMSGNARGQFYLDAQTGALDVVSPLDYETTKEYTLRVRAQDGGRPPLSNVSGLVTVQVLDINDNAPIFVSTPFQATVLESVPLGYLVLHVQAIDADAGDNARLEYRLAGVGHDFPFTINNGTGWISVAAELDREEVDFYSFGVEARDHGTPALTASASVSVTVLDVNDNNPTFTQPEYTVRLNEDAAVGTSVVTVSAVDRDAHSVITYQITSGNTRNRFSITSQSGGGLVSLALPLDYKLERQYVLAVTASDGTRQDTAQIVVNVTDANTHRPVFQSSHYTVNVNEDRPAGTTVVLISATDEDTGENARITYFMEDSIPQFRIDADTGAVTTQAELDYEDQVSYTLAITARDNGIPQKSDTTYLEILVNDVNDNAPQFLRDSYQGSVYEDVPPFTSVLQISATDRDSGLNGRVFYTFQGGDDGDGDFIVESTSGIVRTLRRLDRENVAQYVLRAYAVDKGMPPARTPMEVTVTVLDVNDNPPVFEQDEFDVFVEENSPIGLAVARVTATDPDEGTNAQIMYQIVEGNIPEVFQLDIFSGELTALVDLDYEDRPEYVLVIQATSAPLVSRATVHVRLLDRNDNPPVLGNFEILFNNYVTNRSSSFPGGAIGRVPAHDPDISDSLTYSFERGNELSLVLLNASTGELKLSRALDNNRPLEAIMSVLVSDGVHSVTAQCALRVTIITDEMLTHSITLRLEDMSPERFLSPLLGLFIQAVAATLATPPDHVVVFNVQRDTDAPGGHILNVSLSVGQPPGPGGGPPFLPSEDLQERLYLNRSLLTAISAQRVLPFDDNICLREPCENYMRCVSVLRFDSSAPFIASSSVLFRPIHPVGGLRCRCPPGFTGDYCETEVDLCYSRPCGPHGRCRSREGGYTCLCRDGYTGEHCEVSARSGRCTPGVCKNGGTCVNLLVGGFKCDCPSGDFEKPYCQVTTRSFPAHSFITFRGLRQRFHFTLALSFATKERDGLLLYNGRFNEKHDFVALEVIQEQVQLTFSAGESTTTVSPFVPGGVSDGQWHTVQLKYYNKPLLGQTGLPQGPSEQKVAVVTVDGCDTGVALRFGSVLGNYSCAAQGTQGGSKKSLDLTGPLLLGGVPDLPESFPVRMRQFVGCMRNLQVDSRHIDMADFIANNGTVPGCPAKKNVCDSNTCHNGGTCVNQWDAFSCECPLGFGGKSCAQEMANPQHFLGSSLVAWHGLSLPISQPWYLSLMFRTRQADGVLLQAITRGRSTITLQLREGHVMLSVEGTGLQASSLRLEPGRANDGDWHHAQLALGASGGPGHAILSFDYGQQRAEGNLGPRLHGLHLSNITVGGIPGPAGGVARGFRGCLQGVRVSDTPEGVNSLDPSHGESINVEQGCSLPDPCDSNPCPANSYCSNDWDSYSCSCDPGYYGDNCTNVCDLNPCEHQSVCTRKPSAPHGYTCECPPNYLGPYCETRIDQPCPRGWWGHPTCGPCNCDVSKGFDPDCNKTSGECHCKENHYRPPGSPTCLLCDCYPTGSLSRVCDPEDGQCPCKPGVIGRQCDRCDNPFAEVTTNGCEVNYDSCPRAIEAGIWWPRTRFGLPAAAPCPKGSFGTAVRHCDEHRGWLPPNLFNCTSITFSELKGFAERLQRNESGLDSGRSQQLALLLRNATQHTAGYFGSDVKVAYQLATRLLAHESTQRGFGLSATQDVHFTENLLRVGSALLDTANKRHWELIQQTEGGTAWLLQHYEAYASALAQNMRHTYLSPFTIVTPNIVISVVRLDKGNFAGAKLPRYEALRGEQPPDLETTVILPESVFRETPPVVRPAGPGEAQEPEELARRQRRHPELSQGEAVASVIIYRTLAGLLPHNYDPDKRSLRVPKRPIINTPVVSISVHDDEELLPRALDKPVTVQFRLLETEERTKPICVFWNHSILVSGTGGWSARGCEVVFRNESHVSCQCNHMTSFAVLMDVSRRENGEILPLKTLTYVALGVTLAALLLTFFFLTLLRILRSNQHGIRRNLTAALGLAQLVFLLGINQADLPFACTVIAILLHFLYLCTFSWALLEALHLYRALTEVRDVNTGPMRFYYMLGWGVPAFITGLAVGLDPEGYGNPDFCWLSIYDTLIWSFAGPVAFAVSMSVFLYILAARASCAAQRQGFEKKGPVSGLQPSFAVLLLLSATWLLALLSVNSDTLLFHYLFATCNCIQGPFIFLSYVVLSKEVRKALKLACSRKPSPDPALTTKSTLTSSYNCPSPYADGRLYQPYGDSAGSLHSTSRSGKSQPSYIPFLLREESALNPGQGPPGLGDPGSLFLEGQDQQHDPDTDSDSDLSLEDDQSGSYASTHSSDSEEEEEEEEEEAAFPGEQGWDSLLGPGAERLPLHSTPKDGGPGPGKAPWPGDFGTTAKESSGNGAPEERLRENGDALSREGSLGPLPGSSAQPHKGILKKKCLPTISEKSSLLRLPLEQCTGSSRGSSASEGSRGGPPPRPPPRQSLQEQLNGVMPIAMSIKAGTVDEDSSGSEFLFFNFLH,2923,"317,453",Chain (1); Compositional bias (1); Disulfide bond (27); Domain (20); Glycosylation (17); Modified residue (2); Natural variant (5); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 1232..1243;  /evidence=""ECO:0000250""; DISULFID 1237..1274;  /evidence=""ECO:0000250""; DISULFID 1276..1285;  /evidence=""ECO:0000250""; DISULFID 1292..1303;  /evidence=""ECO:0000250""; DISULFID 1297..1312;  /evidence=""ECO:0000250""; DISULFID 1314..1323;  /evidence=""ECO:0000250""; DISULFID 1332..1343;  /evidence=""ECO:0000250""; DISULFID 1337..1353;  /evidence=""ECO:0000250""; DISULFID 1355..1365;  /evidence=""ECO:0000250""; DISULFID 1545..1571;  /evidence=""ECO:0000250""; DISULFID 1578..1589;  /evidence=""ECO:0000250""; DISULFID 1583..1598;  /evidence=""ECO:0000250""; DISULFID 1600..1609;  /evidence=""ECO:0000250""; DISULFID 1761..1791;  /evidence=""ECO:0000250""; DISULFID 1797..1808;  /evidence=""ECO:0000250""; DISULFID 1802..1817;  /evidence=""ECO:0000250""; DISULFID 1819..1828;  /evidence=""ECO:0000250""; DISULFID 1832..1843;  /evidence=""ECO:0000250""; DISULFID 1837..1855;  /evidence=""ECO:0000250""; DISULFID 1857..1866;  /evidence=""ECO:0000250""; DISULFID 1887..1899;  /evidence=""ECO:0000250""; DISULFID 1889..1906;  /evidence=""ECO:0000250""; DISULFID 1908..1921;  /evidence=""ECO:0000250""; DISULFID 1924..1936;  /evidence=""ECO:0000250""; DISULFID 1926..1943;  /evidence=""ECO:0000250""; DISULFID 1945..1954;  /evidence=""ECO:0000250""; DISULFID 1957..1969;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P28068,"HLA class II histocompatibility antigen, DM beta chain (MHC class II antigen DMB) (Really interesting new gene 7 protein)",MITFLPLLLGLSLGCTGAGGFVAHVESTCLLDDAGTPKDFTYCISFNKDLLTCWDPEENKMAPCEFGVLNSLANVLSQHLNQKDTLMQRLRNGLQNCATHTQPFWGSLTNRTRPPSVQVAKTTPFNTREPVMLACYVWGFYPAEVTITWRKNGKLVMPHSSAHKTAQPNGDWTYQTLSHLALTPSYGDTYTCVVEHIGAPEPILRDWTPGLSPMQTLKVSVSAVTLGLGLIIFSLGVISWRRAGHSSYTPLPGSNYSEGWHIS,263,"28,943",Beta strand (15); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (4); Motif (1); Mutagenesis (10); Natural variant (7); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 29..97;  /evidence=""ECO:0000244|PDB:4GBX, ECO:0000269|PubMed:23260142""; DISULFID 43..53;  /evidence=""ECO:0000244|PDB:4GBX, ECO:0000269|PubMed:23260142""; DISULFID 135..192;  /evidence=""ECO:0000244|PDB:4GBX, ECO:0000269|PubMed:23260142""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9UF33,Ephrin type-A receptor 6 (EC 2.7.10.1) (EPH homology kinase 2) (EHK-2) (EPH-like kinase 12) (EK12),MGGCEVREFLLQFGFFLPLLTAWPGDCSHVSNNQVVLLDTTTVLGELGWKTYPLNGWDAITEMDEHNRPIHTYQVCNVMEPNQNNWLRTNWISRDAAQKIYVEMKFTLRDCNSIPWVLGTCKETFNLFYMESDESHGIKFKPNQYTKIDTIAADESFTQMDLGDRILKLNTEIREVGPIERKGFYLAFQDIGACIALVSVRVFYKKCPFTVRNLAMFPDTIPRVDSSSLVEVRGSCVKSAEERDTPKLYCGADGDWLVPLGRCICSTGYEEIEGSCHACRPGFYKAFAGNTKCSKCPPHSLTYMEATSVCQCEKGYFRAEKDPPSMACTRPPSAPRNVVFNINETALILEWSPPSDTGGRKDLTYSVICKKCGLDTSQCEDCGGGLRFIPRHTGLINNSVIVLDFVSHVNYTFEIEAMNGVSELSFSPKPFTAITVTTDQDAPSLIGVVRKDWASQNSIALSWQAPAFSNGAILDYEIKYYEKEHEQLTYSSTRSKAPSVIITGLKPATKYVFHIRVRTATGYSGYSQKFEFETGDETSDMAAEQGQILVIATAAVGGFTLLVILTLFFLITGRCQWYIKAKMKSEEKRRNHLQNGHLRFPGIKTYIDPDTYEDPSLAVHEFAKEIDPSRIRIERVIGAGEFGEVCSGRLKTPGKREIPVAIKTLKGGHMDRQRRDFLREASIMGQFDHPNIIRLEGVVTKRSFPAIGVEAFCPSFLRAGFLNSIQAPHPVPGGGSLPPRIPAGRPVMIVVEYMENGSLDSFLRKHDGHFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTTGGKIPIRWTAPEAIAYRKFSSASDAWSYGIVMWEVMSYGERPYWEMSNQDVILSIEEGYRLPAPMGCPASLHQLMLHCWQKERNHRPKFTDIVSFLDKLIRNPSALHTLVEDILVMPESPGEVPEYPLFVTVGDWLDSIKMGQYKNNFVAAGFTTFDLISRMSIDDIRRIGVILIGHQRRIVSSIQTLRLHMMHIQEKGFHV,1036,"116,379",Active site (1); Alternative sequence (6); Binding site (1); Chain (1); Domain (5); Glycosylation (3); Modified residue (4); Motif (1); Natural variant (2); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
O15197,Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6),MATEGAAQLGNRVAGMVCSLWVLLLVSSVLALEEVLLDTTGETSEIGWLTYPPGGWDEVSVLDDQRRLTRTFEACHVAGAPPGTGQDNWLQTHFVERRGAQRAHIRLHFSVRACSSLGVSGGTCRETFTLYYRQAEEPDSPDSVSSWHLKRWTKVDTIAADESFPSSSSSSSSSSSAAWAVGPHGAGQRAGLQLNVKERSFGPLTQRGFYVAFQDTGACLALVAVRLFSYTCPAVLRSFASFPETQASGAGGASLVAAVGTCVAHAEPEEDGVGGQAGGSPPRLHCNGEGKWMVAVGGCRCQPGYQPARGDKACQACPRGLYKSSAGNAPCSPCPARSHAPNPAAPVCPCLEGFYRASSDPPEAPCTGPPSAPQELWFEVQGSALMLHWRLPRELGGRGDLLFNVVCKECEGRQEPASGGGGTCHRCRDEVHFDPRQRGLTESRVLVGGLRAHVPYILEVQAVNGVSELSPDPPQAAAINVSTSHEVPSAVPVVHQVSRASNSITVSWPQPDQTNGNILDYQLRYYDQAEDESHSFTLTSETNTATVTQLSPGHIYGFQVRARTAAGHGPYGGKVYFQTLPQGELSSQLPERLSLVIGSILGALAFLLLAAITVLAVVFQRKRRGTGYTEQLQQYSSPGLGVKYYIDPSTYEDPCQAIRELAREVDPAYIKIEEVIGTGSFGEVRQGRLQPRGRREQTVAIQALWAGGAESLQMTFLGRAAVLGQFQHPNILRLEGVVTKSRPLMVLTEFMELGPLDSFLRQREGQFSSLQLVAMQRGVAAAMQYLSSFAFVHRSLSAHSVLVNSHLVCKVARLGHSPQGPSCLLRWAAPEVIAHGKHTTSSDVWSFGILMWEVMSYGERPYWDMSEQEVLNAIEQEFRLPPPPGCPPGLHLLMLDTWQKDRARRPHFDQLVAAFDKMIRKPDTLQAGGDPGERPSQALLTPVALDFPCLDSPQAWLSAIGLECYQDNFSKFGLCTFSDVAQLSLEDLPALGITLAGHQKKLLHHIQLLQQHLRQQGSVEV,1021,"110,700",Alternative sequence (3); Chain (1); Compositional bias (3); Domain (5); Erroneous gene model prediction (2); Erroneous initiation (4); Glycosylation (1); Motif (1); Natural variant (18); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:15340161"""
P48546,Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor),MTTSPILQLLLRLSLCGLLLQRAETGSKGQTAGELYQRWERYRRECQETLAAAEPPSGLACNGSFDMYVCWDYAAPNATARASCPWYLPWHHHVAAGFVLRQCGSDGQWGLWRDHTQCENPEKNEAFLDQRLILERLQVMYTVGYSLSLATLLLALLILSLFRRLHCTRNYIHINLFTSFMLRAAAILSRDRLLPRPGPYLGDQALALWNQALAACRTAQIVTQYCVGANYTWLLVEGVYLHSLLVLVGGSEEGHFRYYLLLGWGAPALFVIPWVIVRYLYENTQCWERNEVKAIWWIIRTPILMTILINFLIFIRILGILLSKLRTRQMRCRDYRLRLARSTLTLVPLLGVHEVVFAPVTEEQARGALRFAKLGFEIFLSSFQGFLVSVLYCFINKEVQSEIRRGWHHCRLRRSLGEEQRQLPERAFRALPSGSGPGEVPTSRGLSSGTLPGPGNEASRELESYC,466,"53,157",Alternative sequence (3); Beta strand (6); Chain (1); Disulfide bond (3); Frameshift (1); Glycosylation (2); Helix (4); Natural variant (4); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 46..70;  /evidence=""ECO:0000269|PubMed:17715056""; DISULFID 61..103;  /evidence=""ECO:0000269|PubMed:17715056""; DISULFID 84..118;  /evidence=""ECO:0000269|PubMed:17715056""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q16445,Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6),MASSLPWLCIILWLENALGKLEVEGNFYSENVSRILDNLLEGYDNRLRPGFGGAVTEVKTDIYVTSFGPVSDVEMEYTMDVFFRQTWTDERLKFGGPTEILSLNNLMVSKIWTPDTFFRNGKKSIAHNMTTPNKLFRIMQNGTILYTMRLTINADCPMRLVNFPMDGHACPLKFGSYAYPKSEIIYTWKKGPLYSVEVPEESSSLLQYDLIGQTVSSETIKSNTGEYVIMTVYFHLQRKMGYFMIQIYTPCIMTVILSQVSFWINKESVPARTVFGITTVLTMTTLSISARHSLPKVSYATAMDWFIAVCFAFVFSALIEFAAVNYFTNLQTQKAKRKAQFAAPPTVTISKATEPLEAEIVLHPDSKYHLKKRITSLSLPIVSSSEANKVLTRAPILQSTPVTPPPLSPAFGGTSKIDQYSRILFPVAFAGFNLVYWVVYLSKDTMEVSSSVE,453,"51,024",Chain (1); Disulfide bond (1); Glycosylation (3); Modified residue (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 156..170;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q5VW38,Protein GPR107 (Lung seven transmembrane receptor 1),MAALAPVGSPASRGPRLAAGLRLLPMLGLLQLLAEPGLGRVHHLALKDDVRHKVHLNTFGFFKDGYMVVNVSSLSLNEPEDKDVTIGFSLDRTKNDGFSSYLDEDVNYCILKKQSVSVTLLILDISRSEVRVKSPPEAGTQLPKIIFSRDEKVLGQSQEPNVNPASAGNQTQKTQDGGKSKRSTVDSKAMGEKSFSVHNNGGAVSFQFFFNISTDDQEGLYSLYFHKCLGKELPSDKFTFSLDIEITEKNPDSYLSAGEIPLPKLYISMAFFFFLSGTIWIHILRKRRNDVFKIHWLMAALPFTKSLSLVFHAIDYHYISSQGFPIEGWAVVYYITHLLKGALLFITIALIGTGWAFIKHILSDKDKKIFMIVIPLQVLANVAYIIIESTEEGTTEYGLWKDSLFLVDLLCCGAILFPVVWSIRHLQEASATDGKGDSMGPLQQRANLRAGSRIESHHFAQADLELLASSCPPASVSQRAGITAAINLAKLKLFRHYYVLIVCYIYFTRIIAFLLKLAVPFQWKWLYQLLDETATLVFFVLTGYKFRPASDNPYLQLSQEEEDLEMESVVTTSGVMESMKKVKKVTNGSVEPQGEWEGAV,600,"66,990",Alternative sequence (3); Chain (1); Disulfide bond (1); Glycosylation (3); Mutagenesis (1); Natural variant (1); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 109..228;  /evidence=""ECO:0000269|PubMed:25031321""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
P42261,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)",MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLTEPPKLLPQIDIVNISDSFEMTYRFCSQFSKGVYAIFGFYERRTVNMLTSFCGALHVCFITPSFPVDTSNQFVLQLRPELQDALISIIDHYKWQKFVYIYDADRGLSVLQKVLDTAAEKNWQVTAVNILTTTEEGYRMLFQDLEKKKERLVVVDCESERLNAILGQIIKLEKNGIGYHYILANLGFMDIDLNKFKESGANVTGFQLVNYTDTIPAKIMQQWKNSDARDHTRVDWKRPKYTSALTYDGVKVMAEAFQSLRRQRIDISRRGNAGDCLANPAVPWGQGIDIQRALQQVRFEGLTGNVQFNEKGRRTNYTLHVIEMKHDGIRKIGYWNEDDKFVPAATDAQAGGDNSSVQNRTYIVTTILEDPYVMLKKNANQFEGNDRYEGYCVELAAEIAKHVGYSYRLEIVSDGKYGARDPDTKAWNGMVGELVYGRADVAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHSEEFEEGRDQTTSDQSNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIAYGTLEAGSTKEFFRRSKIAVFEKMWTYMKSAEPSVFVRTTEEGMIRVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSALRNPVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKDKTSALSLSNVAGVFYILIGGLGLAMLVALIEFCYKSRSESKRMKGFCLIPQQSINEAIRTSTLPRNSGAGASSGGSGENGRVVSHDFPKSMQSIPCMSHSSGMPLGATGL,906,"101,506",Alternative sequence (4); Binding site (3); Chain (1); Disulfide bond (2); Glycosylation (6); Intramembrane (2); Lipidation (2); Modified residue (4); Motif (1); Natural variant (6); Region (2); Sequence conflict (5); Signal peptide (1); Topological domain (5); Transmembrane (3),"DISULFID 75..323;  /evidence=""ECO:0000250""; DISULFID 732..787;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
O75077,"Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3)",MKPPGSSSRQPPLAGCSLAGASCGPQRGPAGSVPASAPARTPPCRLLLVLLLLPPLAASSRPRAWGAAAPSAPHWNETAEKNLGVLADEDNTLQQNSSSNISYSNAMQKEITLPSRLIYYINQDSESPYHVLDTKARHQQKHNKAVHLAQASFQIEAFGSKFILDLILNNGLLSSDYVEIHYENGKPQYSKGGEHCYYHGSIRGVKDSKVALSTCNGLHGMFEDDTFVYMIEPLELVHDEKSTGRPHIIQKTLAGQYSKQMKNLTMERGDQWPFLSELQWLKRRKRAVNPSRGIFEEMKYLELMIVNDHKTYKKHRSSHAHTNNFAKSVVNLVDSIYKEQLNTRVVLVAVETWTEKDQIDITTNPVQMLHEFSKYRQRIKQHADAVHLISRVTFHYKRSSLSYFGGVCSRTRGVGVNEYGLPMAVAQVLSQSLAQNLGIQWEPSSRKPKCDCTESWGGCIMEETGVSHSRKFSKCSILEYRDFLQRGGGACLFNRPTKLFEPTECGNGYVEAGEECDCGFHVECYGLCCKKCSLSNGAHCSDGPCCNNTSCLFQPRGYECRDAVNECDITEYCTGDSGQCPPNLHKQDGYACNQNQGRCYNGECKTRDNQCQYIWGTKAAGSDKFCYEKLNTEGTEKGNCGKDGDRWIQCSKHDVFCGFLLCTNLTRAPRIGQLQGEIIPTSFYHQGRVIDCSGAHVVLDDDTDVGYVEDGTPCGPSMMCLDRKCLQIQALNMSSCPLDSKGKVCSGHGVCSNEATCICDFTWAGTDCSIRDPVRNLHPPKDEGPKGPSATNLIIGSIAGAILVAAIVLGGTGWGFKNVKKRRFDPTQQGPI,832,"91,926",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (8); Mutagenesis (1); Propeptide (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 408..491;  /evidence=""ECO:0000250""; DISULFID 450..475;  /evidence=""ECO:0000250""; DISULFID 452..459;  /evidence=""ECO:0000250""; DISULFID 560..580;  /evidence=""ECO:0000250""; DISULFID 736..751;  /evidence=""ECO:0000250""; DISULFID 745..757;  /evidence=""ECO:0000250""; DISULFID 759..768;  /evidence=""ECO:0000250""","SIGNAL 1..59;  /evidence=""ECO:0000255"""
Q9BQT9,Calsyntenin-3 (Alcadein-beta) (Alc-beta),MTLLLLPLLLASLLASCSCNKANKHKPWIEAEYQGIVMENDNTVLLNPPLFALDKDAPLRYAGEICGFRLHGSGVPFEAVILDKATGEGLIRAKEPVDCEAQKEHTFTIQAYDCGEGPDGANTKKSHKATVHVRVNDVNEFAPVFVERLYRAAVTEGKLYDRILRVEAIDGDCSPQYSQICYYEILTPNTPFLIDNDGNIENTEKLQYSGERLYKFTVTAYDCGKKRAADDAEVEIQVKPTCKPSWQGWNKRIEYAPGAGSLALFPGIRLETCDEPLWNIQATIELQTSHVAKGCDRDNYSERALRKLCGAATGEVDLLPMPGPNANWTAGLSVHYSQDSSLIYWFNGTQAVQVPLGGPSGLGSGPQDSLSDHFTLSFWMKHGVTPNKGKKEEETIVCNTVQNEDGFSHYSLTVHGCRIAFLYWPLLESARPVKFLWKLEQVCDDEWHHYALNLEFPTVTLYTDGISFDPALIHDNGLIHPPRREPALMIGACWTEEKNKEKEKGDNSTDTTQGDPLSIHHYFHGYLAGFSVRSGRLESREVIECLYACREGLDYRDFESLGKGMKVHVNPSQSLLTLEGDDVETFNHALQHVAYMNTLRFATPGVRPLRLTTAVKCFSEESCVSIPEVEGYVVVLQPDAPQILLSGTAHFARPAVDFEGTNGVPLFPDLQITCSISHQVEAKKDESWQGTVTDTRMSDEIVHNLDGCEISLVGDDLDPERESLLLDTTSLQQRGLELTNTSAYLTIAGVESITVYEEILRQARYRLRHGAALYTRKFRLSCSEMNGRYSSNEFIVEVNVLHSMNRVAHPSHVLSSQQFLHRGHQPPPEMAGHSLASSHRNSMIPSAATLIIVVCVGFLVLMVVLGLVRIHSLHRRVSGAGGPPGASSDPKDPDLFWDDSALTIIVNPMESYQNRQSCVTGAVGGQQEDEDSSDSEVADSPSSDERRIIETPPHRY,956,"106,098",Alternative sequence (1); Chain (1); Domain (2); Erroneous initiation (1); Glycosylation (5); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NYJ7,Delta-like protein 3 (Drosophila Delta homolog 3) (Delta3),MVSPRMSGLLSQTVILALIFLPQTRPAGVFELQIHSFGPGPGPGAPRSPCSARLPCRLFFRVCLKPGLSEEAAESPCALGAALSARGPVYTEQPGAPAPDLPLPDGLLQVPFRDAWPGTFSFIIETWREELGDQIGGPAWSLLARVAGRRRLAAGGPWARDIQRAGAWELRFSYRARCEPPAVGTACTRLCRPRSAPSRCGPGLRPCAPLEDECEAPLVCRAGCSPEHGFCEQPGECRCLEGWTGPLCTVPVSTSSCLSPRGPSSATTGCLVPGPGPCDGNPCANGGSCSETPRSFECTCPRGFYGLRCEVSGVTCADGPCFNGGLCVGGADPDSAYICHCPPGFQGSNCEKRVDRCSLQPCRNGGLCLDLGHALRCRCRAGFAGPRCEHDLDDCAGRACANGGTCVEGGGAHRCSCALGFGGRDCRERADPCAARPCAHGGRCYAHFSGLVCACAPGYMGARCEFPVHPDGASALPAAPPGLRPGDPQRYLLPPALGLLVAAGVAGAALLLVHVRRRGHSQDAGSRLLAGTPEPSVHALPDALNNLRTQEGSGDGPSSSVDWNRPEDVDPQGIYVISAPSIYAREVATPLFPPLHTGRAGQRQHLLFPYPSSILSVK,618,"64,618",Alternative sequence (1); Chain (1); Disulfide bond (18); Domain (7); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 220..231;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 224..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 239..248;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 278..289;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 283..298;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 300..309;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 316..327;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 321..339;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 341..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 357..368;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 362..377;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 379..388;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 395..406;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 400..415;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 417..426;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 433..444;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 438..453;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 455..464;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P21709,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),MERRWPLGLGLVLLLCAPLPPGARAKEVTLMDTSKAQGELGWLLDPPKDGWSEQQQILNGTPLYMYQDCPMQGRRDTDHWLRSNWIYRGEEASRVHVELQFTVRDCKSFPGGAGPLGCKETFNLLYMESDQDVGIQLRRPLFQKVTTVAADQSFTIRDLVSGSVKLNVERCSLGRLTRRGLYLAFHNPGACVALVSVRVFYQRCPETLNGLAQFPDTLPGPAGLVEVAGTCLPHARASPRPSGAPRMHCSPDGEWLVPVGRCHCEPGYEEGGSGEACVACPSGSYRMDMDTPHCLTCPQQSTAESEGATICTCESGHYRAPGEGPQVACTGPPSAPRNLSFSASGTQLSLRWEPPADTGGRQDVRYSVRCSQCQGTAQDGGPCQPCGVGVHFSPGARGLTTPAVHVNGLEPYANYTFNVEAQNGVSGLGSSGHASTSVSISMGHAESLSGLSLRLVKKEPRQLELTWAGSRPRSPGANLTYELHVLNQDEERYQMVLEPRVLLTELQPDTTYIVRVRMLTPLGPGPFSPDHEFRTSPPVSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRRAQRQRQQRQRDRATDVDREDKLWLKPYVDLQAYEDPAQGALDFTRELDPAWLMVDTVIGEGEFGEVYRGTLRLPSQDCKTVAIKTLKDTSPGGQWWNFLREATIMGQFSHPHILHLEGVVTKRKPIMIITEFMENGALDAFLREREDQLVPGQLVAMLQGIASGMNYLSNHNYVHRDLAARNILVNQNLCCKVSDFGLTRLLDDFDGTYETQGGKIPIRWTAPEAIAHRIFTTASDVWSFGIVMWEVLSFGDKPYGEMSNQEVMKSIEDGYRLPPPVDCPAPLYELMKNCWAYDRARRPHFQKLQAHLEQLLANPHSLRTIANFDPRMTLRLPSLSGSDGIPYRTVSEWLESIRMKRYILHFHSAGLDTMECVLELTAEDLTQMGITLPGHQKRILCSIQGFKD,976,"108,127",Active site (1); Alternative sequence (4); Beta strand (1); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Frameshift (1); Glycosylation (1); Helix (7); Modified residue (6); Motif (1); Natural variant (9); Nucleotide binding (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
P01589,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25),MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTTDFQIQTEMAATMETSIFTTEYQVAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI,272,"30,819",Beta strand (15); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (6); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),DISULFID 24..168; DISULFID 49..80; DISULFID 51..82; DISULFID 67..125; DISULFID 152..184,SIGNAL 1..21
Q93033,Immunoglobulin superfamily member 2 (IgSF2) (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101) (EWI-101) (CD antigen CD101),MAGISYVASFFLLLTKLSIGQREVTVQKGPLFRAEGYPVSIGCNVTGHQGPSEQHFQWSVYLPTNPTQEVQIISTKDAAFSYAVYTQRVRSGDVYVERVQGNSVLLHISKLQMKDAGEYECHTPNTDEKYYGSYSAKTNLIVIPDTLSATMSSQTLGKEEGEPLALTCEASKATAQHTHLSVTWYLTQDGGGSQATEIISLSKDFILVPGPLYTERFAASDVQLNKLGPTTFRLSIERLQSSDQGQLFCEATEWIQDPDETWMFITKKQTDQTTLRIQPAVKDFQVNITADSLFAEGKPLELVCLVVSSGRDPQLQGIWFFNGTEIAHIDAGGVLGLKNDYKERASQGELQVSKLGPKAFSLKIFSLGPEDEGAYRCVVAEVMKTRTGSWQVLQRKQSPDSHVHLRKPAARSVVMSTKNKQQVVWEGETLAFLCKAGGAESPLSVSWWHIPRDQTQPEFVAGMGQDGIVQLGASYGVPSYHGNTRLEKMDWATFQLEITFTAITDSGTYECRVSEKSRNQARDLSWTQKISVTVKSLESSLQVSLMSRQPQVMLTNTFDLSCVVRAGYSDLKVPLTVTWQFQPASSHIFHQLIRITHNGTIEWGNFLSRFQKKTKVSQSLFRSQLLVHDATEEETGVYQCEVEVYDRNSLYNNRPPRASAISHPLRIAVTLPESKLKVNSRSQVQELSINSNTDIECSILSRSNGNLQLAIIWYFSPVSTNASWLKILEMDQTNVIKTGDEFHTPQRKQKFHTEKVSQDLFQLHILNVEDSDRGKYHCAVEEWLLSTNGTWHKLGEKKSGLTELKLKPTGSKVRVSKVYWTENVTEHREVAIRCSLESVGSSATLYSVMWYWNRENSGSKLLVHLQHDGLLEYGEEGLRRHLHCYRSSSTDFVLKLHQVEMEDAGMYWCRVAEWQLHGHPSKWINQASDESQRMVLTVLPSEPTLPSRICSSAPLLYFLFICPFVLLLLLLISLLCLYWKARKLSTLRSNTRKEKALWVDLKEAGGVTTNRREDEEEDEGN,1021,"115,109",Chain (1); Disulfide bond (7); Domain (7); Glycosylation (2); Motif (1); Natural variant (11); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 168..249;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 304..377;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 434..511;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 562..640;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 697..778;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 834..909;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P36894,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),MPQLYIYIRLLGAYLFIISRVQGQNLDSMLHGTGMKSDSDQKKSENGVTLAPEDTLPFLKCYCSGHCPDDAINNTCITNGHCFAIIEEDDQGETTLASGCMKYEGSDFQCKDSPKAQLRRTIECCRTNLCNQYLQPTLPPVVIGPFFDGSIRWLVLLISMAVCIIAMIIFSSCFCYKHYCKSISSRRRYNRDLEQDEAFIPVGESLKDLIDQSQSSGSGSGLPLLVQRTIAKQIQMVRQVGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDFLKCATLDTRALLKLAYSAACGLCHLHTEIYGTQGKPAIAHRDLKSKNILIKKNGSCCIADLGLAVKFNSDTNEVDVPLNTRVGTKRYMAPEVLDESLNKNHFQPYIMADIYSFGLIIWEMARRCITGGIVEEYQLPYYNMVPSDPSYEDMREVVCVKRLRPIVSNRWNSDECLRAVLKLMSECWAHNPASRLTALRIKKTLAKMVESQDVKI,532,"60,198",Active site (1); Beta strand (7); Binding site (1); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (1); Helix (2); Mutagenesis (1); Natural variant (13); Nucleotide binding (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 61..82;  /evidence=""ECO:0000269|PubMed:10881198, ECO:0000269|PubMed:18937504""; DISULFID 63..67;  /evidence=""ECO:0000269|PubMed:10881198, ECO:0000269|PubMed:18937504""; DISULFID 76..100;  /evidence=""ECO:0000269|PubMed:10881198, ECO:0000269|PubMed:18937504""; DISULFID 110..124;  /evidence=""ECO:0000269|PubMed:10881198, ECO:0000269|PubMed:18937504""; DISULFID 125..130;  /evidence=""ECO:0000269|PubMed:10881198, ECO:0000269|PubMed:18937504""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q16790,Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1),MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQRLPRMQEDSPLGGGSSGEDDPLGEEDLPSEEDSPREEDPPGEEDLPGEEDLPGEEDLPEVKPKSEEEGSLKLEDLPTVEAPGDPQEPQNNAHRDKEGDDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFCPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVDSSPRAAEPVQLNSCLAAGDILALVFGLLFAVTSVAFLVQMRRQHRRGTKGGVSYRPAEVAETGA,459,"49,698",Active site (1); Beta strand (17); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (2); Helix (7); Metal binding (3); Modified residue (1); Natural variant (2); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 156..336;  /evidence=""ECO:0000269|PubMed:19805286""; DISULFID 174;  /note=""Interchain"";  /evidence=""ECO:0000305|PubMed:19805286""","SIGNAL 1..37;  /evidence=""ECO:0000269|PubMed:15340161"""
P01732,T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a),MALPVTALLLPLALLLHAARPSQFRVSPLDRTWNLGETVELKCQVLLSNPTSGCSWLFQPRGAAASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIYIWAPLAGTCGVLLLSLVITLYCNHRNRRRVCKCPRPVVKSGDKPSLSARYV,235,"25,729",Alternative sequence (2); Beta strand (9); Chain (1); Disulfide bond (1); Domain (1); Helix (1); Lipidation (1); Mutagenesis (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 43..115;  /evidence=""ECO:0000269|PubMed:1547508, ECO:0000269|PubMed:9177355""",SIGNAL 1..21
Q8IX05,CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302),MLRAALPALLLPLLGLAAAAVADCPSSTWIQFQDSCYIFLQEAIKVESIEDVRNQCTDHGADMISIHNEEENAFILDTLKKQWKGPDDILLGMFYDTDDASFKWFDNSNMTFDKWTDQDDDEDLVDTCAFLHIKTGEWKKGNCEVSSVEGTLCKTAIPYKRKYLSDNHILISALVIASTVILTVLGAIIWFLYKKHSDSRFTTVFSTAPQSPYNEDCVLVVGEENEYPVQFD,232,"26,183",Alternative sequence (2); Beta strand (8); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Helix (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 128..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P54756,Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7),MRGSGPRGAGRRRPPSGGGDTPITPASLAGCYSAPRRAPLWTCLLLCAALRTLLASPSNEVNLLDSRTVMGDLGWIAFPKNGWEEIGEVDENYAPIHTYQVCKVMEQNQNNWLLTSWISNEGASRIFIELKFTLRDCNSLPGGLGTCKETFNMYYFESDDQNGRNIKENQYIKIDTIAADESFTELDLGDRVMKLNTEVRDVGPLSKKGFYLAFQDVGACIALVSVRVYYKKCPSVVRHLAVFPDTITGADSSQLLEVSGSCVNHSVTDEPPKMHCSAEGEWLVPIGKCMCKAGYEEKNGTCQVCRPGFFKASPHIQSCGKCPPHSYTHEEASTSCVCEKDYFRRESDPPTMACTRPPSAPRNAISNVNETSVFLEWIPPADTGGRKDVSYYIACKKCNSHAGVCEECGGHVRYLPRQSGLKNTSVMMVDLLAHTNYTFEIEAVNGVSDLSPGARQYVSVNVTTNQAAPSPVTNVKKGKIAKNSISLSWQEPDRPNGIILEYEIKYFEKDQETSYTIIKSKETTITAEGLKPASVYVFQIRARTAAGYGVFSRRFEFETTPVFAASSDQSQIPVIAVSVTVGVILLAVVIGVLLSGSCCECGCGRASSLCAVAHPSLIWRCGYSKAKQDPEEEKMHFHNGHIKLPGVRTYIDPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNPSSLKTLVNASCRVSNLLAEHSPLGSGAYRSVGEWLEAIKMGRYTEIFMENGYSSMDAVAQVTLEDLRRLGVTLVGHQKKIMNSLQEMKVQLVNGMVPL,1037,"114,803",Active site (1); Alternative sequence (3); Beta strand (20); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (6); Helix (15); Modified residue (4); Motif (1); Natural variant (12); Nucleotide binding (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P31994,Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32),MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPNFSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISALPGYPECREMGETLPEKPANPTNPDEADKVGAENTITYSLLMHPDALEEPDDQNRI,310,"34,044",Alternative sequence (3); Beta strand (17); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (3); Helix (3); Modified residue (1); Motif (1); Natural variant (4); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 71..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10064577""; DISULFID 152..196;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10064577""","SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q9NZU1,Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1),MDLRDWLFLCYGLIAFLTEVIDSTTCPSVCRCDNGFIYCNDRGLTSIPADIPDDATTLYLQNNQINNAGIPQDLKTKVNVQVIYLYENDLDEFPINLPRSLRELHLQDNNVRTIARDSLARIPLLEKLHLDDNSVSTVSIEEDAFADSKQLKLLFLSRNHLSSIPSGLPHTLEELRLDDNRISTIPLHAFKGLNSLRRLVLDGNLLANQRIADDTFSRLQNLTELSLVRNSLAAPPLNLPSAHLQKLYLQDNAISHIPYNTLAKMRELERLDLSNNNLTTLPRGLFDDLGNLAQLLLRNNPWFCGCNLMWLRDWVKARAAVVNVRGLMCQGPEKVRGMAIKDITSEMDECFETGPQGGVANAAAKTTASNHASATTPQGSLFTLKAKRPGLRLPDSNIDYPMATGDGAKTLAIHVKALTADSIRITWKATLPASSFRLSWLRLGHSPAVGSITETLVQGDKTEYLLTALEPKSTYIICMVTMETSNAYVADETPVCAKAETADSYGPTTTLNQEQNAGPMASLPLAGIIGGAVALVFLFLVLGAICWYVHQAGELLTRERAYNRGSRKKDDYMESGTKKDNSILEIRGPGLQMLPINPYRAKEEYVVHTIFPSNGSSLCKATHTIGYGTTRGYRDGGIPDIDYSYT,646,"71,358",Chain (1); Disulfide bond (3); Domain (3); Erroneous initiation (5); Glycosylation (2); Repeat (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 26..32;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""; DISULFID 30..39;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""; DISULFID 304..329;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q14332,Frizzled-2 (Fz-2) (hFz2) (FzE2),MRPRSALPRLLLPLLLLPAAGPAQFHGEKGISIPDHGFCQPISIPLCTDIAYNQTIMPNLLGHTNQEDAGLEVHQFYPLVKVQCSPELRFFLCSMYAPVCTVLEQAIPPCRSICERARQGCEALMNKFGFQWPERLRCEHFPRHGAEQICVGQNHSEDGAPALLTTAPPPGLQPGAGGTPGGPGGGGAPPRYATLEHPFHCPRVLKVPSYLSYKFLGERDCAAPCEPARPDGSMFFSQEETRFARLWILTWSVLCCASTFFTVTTYLVDMQRFRYPERPIIFLSGCYTMVSVAYIAGFVLQERVVCNERFSEDGYRTVVQGTKKEGCTILFMMLYFFSMASSIWWVILSLTWFLAAGMKWGHEAIEANSQYFHLAAWAVPAVKTITILAMGQIDGDLLSGVCFVGLNSLDPLRGFVLAPLFVYLFIGTSFLLAGFVSLFRIRTIMKHDGTKTEKLERLMVRIGVFSVLYTVPATIVIACYFYEQAFREHWERSWVSQHCKSLAIPCPAHYTPRMSPDFTVYMIKYLMTLIVGITSGFWIWSGKTLHSWRKFYTRLTNSRHGETTV,565,"63,554",Beta strand (4); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (1); Glycosylation (2); Helix (7); Motif (2); Mutagenesis (2); Natural variant (6); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 39..100;  /evidence=""ECO:0000244|PDB:6C0B, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:29748286""; DISULFID 47..93;  /evidence=""ECO:0000244|PDB:6C0B, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:29748286""; DISULFID 84..121;  /evidence=""ECO:0000244|PDB:6C0B, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:29748286""; DISULFID 110..150;  /evidence=""ECO:0000244|PDB:6C0B, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:29748286""; DISULFID 114..138;  /evidence=""ECO:0000244|PDB:6C0B, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:29748286""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P24046,Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor),MLAVPNMRFGIFLLWWGWVLATESRMHWPGREVHEMSKKGRPQRQRREVHEDAHKQVSPILRRSPDITKSPLTKSEQLLRIDDHDFSMRPGFGGPAIPVGVDVQVESLDSISEVDMDFTMTLYLRHYWKDERLSFPSTNNLSMTFDGRLVKKIWVPDMFFVHSKRSFIHDTTTDNVMLRVQPDGKVLYSLRVTVTAMCNMDFSRFPLDTQTCSLEIESYAYTEDDLMLYWKKGNDSLKTDERISLSQFLIQEFHTTTKLAFYSSTGWYNRLYINFTLRRHIFFFLLQTYFPATLMVMLSWVSFWIDRRAVPARVPLGITTVLTMSTIITGVNASMPRVSYIKAVDIYLWVSFVFVFLSVLEYAAVNYLTTVQERKEQKLREKLPCTSGLPPPRTAMLDGNYSDGEVNDLDNYMPENGEKPDRMMVQLTLASERSSPQRKSQRSSYVSMRIDTHAIDKYSRIIFPAAYILFNLIYWSIFS,479,"55,883",Alternative sequence (2); Chain (1); Disulfide bond (1); Erroneous initiation (2); Glycosylation (3); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 198..212;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor),MVLAFQLVSFTYIWIILKPNVCAASNIKMTHQRCSSSMKQTCKQETRMKKDDSTKARPQKYEQLLHIEDNDFAMRPGFGGSPVPVGIDVHVESIDSISETNMDFTMTFYLRHYWKDERLSFPSTANKSMTFDHRLTRKIWVPDIFFVHSKRSFIHDTTMENIMLRVHPDGNVLLSLRITVSAMCFMDFSRFPLDTQNCSLELESYAYNEDDLMLYWKHGNKSLNTEEHMSLSQFFIEDFSASSGLAFYSSTGWYNRLFINFVLRRHVFFFVLQTYFPAILMVMLSWVSFWIDRRAVPARVSLGITTVLTMSTIITAVSASMPQVSYLKAVDVYLWVSSLFVFLSVIEYAAVNYLTTVEERKQFKKTGKISRMYNIDAVQAMAFDGCYHDSEIDMDQTSLSLNSEDFMRRKSICSPSTDSSRIKRRKSLGGHVGRIILENNHVIDTYSRILFPIVYILFNLFYWGVYV,467,"54,272",Chain (1); Disulfide bond (1); Glycosylation (1); Region (1); Signal peptide (1); Topological domain (4); Transmembrane (4),"DISULFID 184..198;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9UM44,HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2),MKAQTALSFFLILITSLSGSQGIFPLAFFIYVPMNEQIVIGRLDEDIILPSSFERGSEVVIHWKYQDSYKVHSYYKGSDHLESQDPRYANRTSLFYNEIQNGNASLFFRRVSLLDEGIYTCYVGTAIQVITNKVVLKVGVFLTPVMKYEKRNTNSFLICSVLSVYPRPIITWKMDNTPISENNMEETGSLDSFSINSPLNITGSNSSYECTIENSLLKQTWTGRWTMKDGLHKMQSEHVSLSCQPVNDYFSPNQDFKVTWSRMKSGTFSVLAYYLSSSQNTIINESRFSWNKELINQSDFSMNLMDLNLSDSGEYLCNISSDEYTLLTIHTVHVEPSQETASHNKGLWILVPSAILAAFLLIWSVKCCRAQLEARRSRHPADGAQQERCCVPPGERCPSAPDNGEENVPLSGKV,414,"46,850",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (3); Erroneous termination (1); Glycosylation (3); Natural variant (3); Signal peptide (1); Transmembrane (1),"DISULFID 159..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 243..317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P40189,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130),MLTLQTWLVQALFIFLTTESTGELLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIINRTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYEDRPSKAPSFWYKIDPSHTQGYRTVQLVWKTLPPFEANGKILDYEVTLTRWKSHLQNYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLTIPACDFQATHPVMDLKAFPKDNMLWVEWTTPRESVKKYILEWCVLSDKAPCITDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIKAYLKQAPPSKGPTVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFTFTTPKFAQGEIEAIVVPVCLAFLLTTLLGVLFCFNKRDLIKKHIWPNVPDPSKSHIAQWSPHTPPRHNFNSKDQMYSDGNFTDVSVVEIEANDKKPFPEDLKSLDLFKKEKINTEGHSSGIGGSSCMSSSRPSISSSDENESSQNTSSTVQYSTVVHSGYRHQVPSVQVFSRSESTQPLLDSEERPEDLQLVDHVDGGDGILPRQQYFKQNCSQHESSPDISHFERSKQVSSVNEEDFVRLKQQISDHISQSCGSGQMKMFQEVSAADAFGPGTEGQVERFETVGMEAATDEGMPKSYLPQTVRQGGYMPQ,918,"103,537",Alternative sequence (3); Beta strand (46); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (6); Glycosylation (10); Helix (9); Modified residue (6); Motif (2); Mutagenesis (8); Natural variant (9); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 28..54;  /evidence=""ECO:0000269|PubMed:11098061, ECO:0000269|PubMed:20489211""; DISULFID 48..103;  /evidence=""ECO:0000269|PubMed:11098061, ECO:0000269|PubMed:20489211""; DISULFID 134..144;  /evidence=""ECO:0000269|PubMed:11098061, ECO:0000269|PubMed:20489211""; DISULFID 172..182;  /evidence=""ECO:0000269|PubMed:11098061, ECO:0000269|PubMed:20489211""; DISULFID 458..466;  /evidence=""ECO:0000269|PubMed:11098061, ECO:0000269|PubMed:20489211""",SIGNAL 1..22
Q01638,Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2),MGFWILAILTILMYSTAAKFSKQSWGLENEALIVRCPRQGKPSYTVDWYYSQTNKSIPTQERNRVFASGQLLKFLPAAVADSGIYTCIVRSPTFNRTGYANVTIYKKQSDCNVPDYLMYSTVSGSEKNSKIYCPTIDLYNWTAPLEWFKNCQALQGSRYRAHKSFLVIDNVMTEDAGDYTCKFIHNENGANYSVTATRSFTVKDEQGFSLFPVIGAPAQNEIKEVEIGKNANLTCSACFGKGTQFLAAVLWQLNGTKITDFGEPRIQQEEGQNQSFSNGLACLDMVLRIADVKEEDLLLQYDCLALNLHGLRRHTVRLSRKNPIDHHSIYCIIAVCSVFLMLINVLVIILKMFWIEATLLWRDIAKPYKTRNDGKLYDAYVVYPRNYKSSTDGASRVEHFVHQILPDVLENKCGYTLCIYGRDMLPGEDVVTAVETNIRKSRRHIFILTPQITHNKEFAYEQEVALHCALIQNDAKVILIEMEALSELDMLQAEALQDSLQHLMKVQGTIKWREDHIANKRSLNSKFWKHVRYQMPVPSKIPRKASSLTPLAAQKQ,556,"63,358",Active site (1); Alternative sequence (5); Beta strand (23); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (8); Helix (4); Natural variant (6); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 36..87;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23980170""; DISULFID 111..151;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23980170""; DISULFID 133..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23980170""; DISULFID 235..303;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23980170""; DISULFID 238..282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23980170""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:15340161"""
P78552,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1),MEWPARLCGLWALLLCAGGGGGGGGAAPTETQPPVTNLSVSVENLCTVIWTWNPPEGASSNCSLWYFSHFGDKQDKKIAPETRRSIEVPLNERICLQVGSQCSTNESEKPSILVEKCISPPEGDPESAVTELQCIWHNLSYMKCSWLPGRNTSPDTNYTLYYWHRSLEKIHQCENIFREGQYFGCSFDLTKVKDSSFEQHSVQIMVKDNAGKIKPSFNIVPLTSRVKPDPPHIKNLSFHNDDLYVQWENPQNFISRCLFYEVEVNNSQTETHNVFYVQEAKCENPEFERNVENTSCFMVPGVLPDTLNTVRIRVKTNKLCYEDDKLWSNWSQEMSIGKKRNSTLYITMLLIVPVIVAGAIIVLLLYLKRLKIIIFPPIPDPGKIFKEMFGDQNDDTLHWKKYDIYEKQTKEETDSVVLIENLKKASQ,427,"48,760",Alternative sequence (2); Beta strand (25); Chain (1); Disulfide bond (6); Domain (3); Glycosylation (10); Helix (2); Motif (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 62..102;  /evidence=""ECO:0000269|PubMed:18243101""; DISULFID 95..117;  /evidence=""ECO:0000269|PubMed:18243101""; DISULFID 134..144;  /evidence=""ECO:0000269|PubMed:18243101""; DISULFID 173..185;  /evidence=""ECO:0000269|PubMed:18243101""; DISULFID 257..320;  /evidence=""ECO:0000269|PubMed:18243101""; DISULFID 282..296;  /evidence=""ECO:0000269|PubMed:18243101""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P06213,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],MATGGRRGAAAAPLLVAVAALLLGAAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCENELLKFSYIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDGQDACGSNSWTVVDIDPPLRSNDPKSQNHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVFWERQAEDSELFELDYCLKGLKLPSRTWSPPFESEDSQKHNQSEYEDSAGECCSCPKTDSQILKELEESSFRKTFEDYLHNVVFVPRKTSSGTGAEDPRPSRKRRSLGDVGNVTVAVPTVAAFPNTSSTSVPTSPEEHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDTPEERCSVAAYVSARTMPEAKADDIVGPVTHEIFENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCVSRKHFALERGCRLRGLSPGNYSVRIRATSLAGNGSWTEPTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSVVIGSIYLFLRKRQPDGPLGPLYASSNPEYLSASDVFPCSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENKAPESEELEMEFEDMENVPLDRSSHCQREEAGGRDGGSSLGFKRSYEEHIPYTHMNGGKKNGRILTLPRSNPS,1382,"156,333",Active site (1); Alternative sequence (1); Beta strand (76); Binding site (3); Chain (2); Compositional bias (2); Disulfide bond (19); Domain (4); Glycosylation (18); Helix (31); Modified residue (11); Mutagenesis (17); Natural variant (82); Nucleotide binding (2); Region (3); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (3); Transmembrane (1); Turn (14),"DISULFID 35..53; DISULFID 153..182; DISULFID 186..209; DISULFID 196..215; DISULFID 219..228; DISULFID 223..234; DISULFID 235..243; DISULFID 239..252; DISULFID 255..264; DISULFID 268..280; DISULFID 286..311; DISULFID 293..301; DISULFID 315..328; DISULFID 331..335; DISULFID 339..360; DISULFID 462..495;  /evidence=""ECO:0000269|PubMed:1472036""; DISULFID 551;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:1472036""; DISULFID 674..899; DISULFID 825..834","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:2211730, ECO:0000269|PubMed:2983222, ECO:0000269|PubMed:8257688"""
P17787,Neuronal acetylcholine receptor subunit beta-2,MARRCGPVALLLGFGLLRLCSGVWGTDTEERLVEHLLDPSRYNKLIRPATNGSELVTVQLMVSLAQLISVHEREQIMTTNVWLTQEWEDYRLTWKPEEFDNMKKVRLPSKHIWLPDVVLYNNADGMYEVSFYSNAVVSYDGSIFWLPPAIYKSACKIEVKHFPFDQQNCTMKFRSWTYDRTEIDLVLKSEVASLDDFTPSGEWDIVALPGRRNENPDDSTYVDITYDFIIRRKPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSLDVPLVGKYLMFTMVLVTFSIVTSVCVLNVHHRSPTTHTMAPWVKVVFLEKLPALLFMQQPRHHCARQRLRLRRRQREREGAGALFFREAPGADSCTCFVNRASVQGLAGAFGAEPAPVAGPGRSGEPCGCGLREAVDGVRFIADHMRSEDDDQSVSEDWKYVAMVIDRLFLWIFVFVCVFGTIGMFLQPLFQNYTTTTFLHSDHSAPSSK,502,"57,019",Beta strand (13); Chain (1); Disulfide bond (1); Glycosylation (3); Helix (10); Mutagenesis (1); Natural variant (3); Sequence conflict (3); Signal peptide (1); Site (3); Topological domain (4); Transmembrane (4); Turn (9),"DISULFID 155..169;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000250"""
P07510,Acetylcholine receptor subunit gamma,MHGGQGPLLLLLLLAVCLGAQGRNQEERLLADLMQNYDPNLRPAERDSDVVNVSLKLTLTNLISLNEREEALTTNVWIEMQWCDYRLRWDPRDYEGLWVLRVPSTMVWRPDIVLENNVDGVFEVALYCNVLVSPDGCIYWLPPAIFRSACSISVTYFPFDWQNCSLIFQSQTYSTNEIDLQLSQEDGQTIEWIFIDPEAFTENGEWAIQHRPAKMLLDPAAPAQEAGHQKVVFYLLIQRKPLFYVINIIAPCVLISSVAILIHFLPAKAGGQKCTVAINVLLAQTVFLFLVAKKVPETSQAVPLISKYLTFLLVVTILIVVNAVVVLNVSLRSPHTHSMARGVRKVFLRLLPQLLRMHVRPLAPAAVQDTQSRLQNGSSGWSITTGEEVALCLPRSELLFQQWQRQGLVAAALEKLEKGPELGLSQFCGSLKQAAPAIQACVEACNLIACARHQQSHFDNGNEEWFLVGRVLDRVCFLAMLSLFICGTAGIFLMAHYNRVPALPFPGDPRPYLPSPD,517,"57,883",Alternative sequence (1); Chain (1); Disulfide bond (1); Erroneous gene model prediction (2); Glycosylation (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 150..164;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q99062,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114),MARLGNCSLTWAALIILLLPGSLEECGHISVSAPIVHLGDPITASCIIKQNCSHLDPEPQILWRLGAELQPGGRQQRLSDGTQESIITLPHLNHTQAFLSCCLNWGNSLQILDQVELRAGYPPAIPHNLSCLMNLTTSSLICQWEPGPETHLPTSFTLKSFKSRGNCQTQGDSILDCVPKDGQSHCCIPRKHLLLYQNMGIWVQAENALGTSMSPQLCLDPMDVVKLEPPMLRTMDPSPEAAPPQAGCLQLCWEPWQPGLHINQKCELRHKPQRGEASWALVGPLPLEALQYELCGLLPATAYTLQIRCIRWPLPGHWSDWSPSLELRTTERAPTVRLDTWWRQRQLDPRTVQLFWKPVPLEEDSGRIQGYVVSWRPSGQAGAILPLCNTTELSCTFHLPSEAQEVALVAYNSAGTSRPTPVVFSESRGPALTRLHAMARDPHSLWVGWEPPNPWPQGYVIEWGLGPPSASNSNKTWRMEQNGRATGFLLKENIRPFQLYEIIVTPLYQDTMGPSQHVYAYSQEMAPSHAPELHLKHIGKTWAQLEWVPEPPELGKSPLTHYTIFWTNAQNQSFSAILNASSRGFVLHGLEPASLYHIHLMAASQAGATNSTVLTLMTLTPEGSELHIILGLFGLLLLLTCLCGTAWLCCSPNRKNPLWPSVPDPAHSSLGSWVPTIMEEDAFQLPGLGTPPITKLTVLEEDEKKPVPWESHNSSETCGLPTLVQTYVLQGDPRAVSTQPQSQSGTSDQVLYGQLLGSPTSPGPGHYLRCDSTQPLLAGLTPSPKSYENLWFQASPLGTLVTPAPSQEDDCVFGPLLNFPLLQGIRVHGMEALGSF,836,"92,156",Alternative sequence (4); Beta strand (23); Chain (1); Disulfide bond (7); Domain (6); Glycosylation (8); Helix (3); Motif (2); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 26..52;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 46..101;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 131..142;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 167..218;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 177..186;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 248..295;  /evidence=""ECO:0000269|PubMed:16492764""; DISULFID 266..309;  /evidence=""ECO:0000269|PubMed:16492764""",SIGNAL 1..24
Q5IJ48,Protein crumbs homolog 2 (Crumbs-like protein 2),MALARPGTPDPQALASVLLLLLWAPALSLLAGTVPSEPPSACASDPCAPGTECQATESGGYTCGPMEPRGCATQPCHHGALCVPQGPDPTGFRCYCVPGFQGPRCELDIDECASRPCHHGATCRNLADRYECHCPLGYAGVTCEMEVDECASAPCLHGGSCLDGVGSFRCVCAPGYGGTRCQLDLDECQSQPCAHGGTCHDLVNGFRCDCAGTGYEGTHCEREVLECASAPCEHNASCLEGLGSFRCLCWPGYSGELCEVDEDECASSPCQHGGRCLQRSDPALYGGVQAAFPGAFSFRHAAGFLCHCPPGFEGADCGVEVDECASRPCLNGGHCQDLPNGFQCHCPDGYAGPTCEEDVDECLSDPCLHGGTCSDTVAGYICRCPETWGGRDCSVQLTGCQGHTCPLAATCIPIFESGVHSYVCHCPPGTHGPFCGQNTTFSVMAGSPIQASVPAGGPLGLALRFRTTLPAGTLATRNDTKESLELALVAATLQATLWSYSTTVLVLRLPDLALNDGHWHQVEVVLHLATLELRLWHEGCPARLCVASGPVALASTASATPLPAGISSAQLGDATFAGCLQDVRVDGHLLLPEDLGENVLLGCERREQCRPLPCVHGGSCVDLWTHFRCDCARPHRGPTCADEIPAATFGLGGAPSSASFLLQELPGPNLTVSFLLRTRESAGLLLQFANDSAAGLTVFLSEGRIRAEVPGSPAVVLPGRWDDGLRHLVMLSFGPDQLQDLGQHVHVGGRLLAADSQPWGGPFRGCLQDLRLDGCHLPFFPLPLDNSSQPSELGGRQSWNLTAGCVSEDMCSPDPCFNGGTCLVTWNDFHCTCPANFTGPTCAQQLWCPGQPCLPPATCEEVPDGFVCVAEATFREGPPAAFSGHNASSGRLLGGLSLAFRTRDSEAWLLRAAAGALEGVWLAVRNGSLAGGVRGGHGLPGAVLPIPGPRVADGAWHRVRLAMERPAATTSRWLLWLDGAATPVALRGLASDLGFLQGPGAVRILLAENFTGCLGRVALGGLPLPLARPRPGAAPGAREHFASWPGTPAPILGCRGAPVCAPSPCLHDGACRDLFDAFACACGPGWEGPRCEAHVDPCHSAPCARGRCHTHPDGRFECRCPPGFGGPRCRLPVPSKECSLNVTCLDGSPCEGGSPAANCSCLEGLAGQRCQVPTLPCEANPCLNGGTCRAAGGVSECICNARFSGQFCEVAKGLPLPLPFPLLEVAVPAACACLLLLLLGLLSGILAARKRRQSEGTYSPSQQEVAGARLEMDSVLKVPPEERLI,1285,"134,265",Alternative sequence (4); Chain (1); Disulfide bond (48); Domain (18); Glycosylation (14); Mutagenesis (3); Natural variant (33); Region (2); Sequence conflict (5); Signal peptide (1); Transmembrane (1),"DISULFID 71..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 76..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 96..105;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 112..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 117..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 134..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 150..161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 155..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 172..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 188..199;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 193..208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 210..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 227..238;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 232..247;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 249..258;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 265..276;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 270..306;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 308..317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 324..335;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 329..344;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 346..355;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 362..373;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 367..382;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 384..393;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 400..411;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 405..424;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 426..435;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 579..603;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""; DISULFID 609..620;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 614..629;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 631..640;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 766..805;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""; DISULFID 811..822;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 816..831;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 833..842;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1013..1054;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""; DISULFID 1060..1071;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1065..1080;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1082..1091;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1098..1108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1103..1118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1120..1129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1138..1150;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1144..1159;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1161..1170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1177..1188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1182..1197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1199..1208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
O95196,Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C),MGRAGGGGPGRGPPPLLLFLGAALVLASGAVPAREAGSAVEAEELVKGSPAWEPPANDTREEAGPPAAGEDEASWTAPGGELAGPEEVLQESAAVTGTAWLEADSPGLGGVTAEAGSGDAQALPATLQAPHEVLGQSIMPPAIPEATEASGPPSPTPGDKLSPASELPKESPLEVWLNLGGSTPDPQGPELTYPFQGTLEPQPASDIIDIDYFEGLDGEGRGADLGSFPGSPGTSENHPDTEGETPSWSLLDLYDDFTPFDESDFYPTTSFYDDLDEEEEEEEDDKDAVGGGDLEDENELLVPTGKPGLGPGTGQPTSRWHAVPPQHTLGSVPGSSIALRPRPGEPGRDLASSENGTECRSGFVRHNGSCRSVCDLFPSYCHNGGQCYLVENIGAFCRCNTQDYIWHKGMRCESIITDFQVMCVAVGSAALVLLLLFMMTVFFAKKLYLLKTENTKLRRTNKFRTPSELHNDNFSLSTIAEGSHPNVRKLCNTPRTSSPHARALAHYDNVICQDDPSAPHKIQEVLKSCLKEEESFNIQNSMSPKLEGGKGDQADLDVNCLQNNLT,566,"60,016",Alternative sequence (2); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (3); Modified residue (4); Natural variant (2); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 374..387;  /evidence=""ECO:0000250""; DISULFID 381..397;  /evidence=""ECO:0000250""; DISULFID 399..412;  /evidence=""ECO:0000250""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
O94985,Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)],MLRRPAPALAPAARLLLAGLLCGGGVWAARVNKHKPWLEPTYHGIVTENDNTVLLDPPLIALDKDAPLRFAESFEVTVTKEGEICGFKIHGQNVPFDAVVVDKSTGEGVIRSKEKLDCELQKDYSFTIQAYDCGKGPDGTNVKKSHKATVHIQVNDVNEYAPVFKEKSYKATVIEGKQYDSILRVEAVDADCSPQFSQICSYEIITPDVPFTVDKDGYIKNTEKLNYGKEHQYKLTVTAYDCGKKRATEDVLVKISIKPTCTPGWQGWNNRIEYEPGTGALAVFPNIHLETCDEPVASVQATVELETSHIGKGCDRDTYSEKSLHRLCGAAAGTAELLPSPSGSLNWTMGLPTDNGHDSDQVFEFNGTQAVRIPDGVVSVSPKEPFTISVWMRHGPFGRKKETILCSSDKTDMNRHHYSLYVHGCRLIFLFRQDPSEEKKYRPAEFHWKLNQVCDEEWHHYVLNVEFPSVTLYVDGTSHEPFSVTEDYPLHPSKIETQLVVGACWQEFSGVENDNETEPVTVASAGGDLHMTQFFRGNLAGLTLRSGKLADKKVIDCLYTCKEGLDLQVLEDSGRGVQIQAHPSQLVLTLEGEDLGELDKAMQHISYLNSRQFPTPGIRRLKITSTIKCFNEATCISVPPVDGYVMVLQPEEPKISLSGVHHFARAASEFESSEGVFLFPELRIISTITREVEPEGDGAEDPTVQESLVSEEIVHDLDTCEVTVEGEELNHEQESLEVDMARLQQKGIEVSSSELGMTFTGVDTMASYEEVLHLLRYRNWHARSLLDRKFKLICSELNGRYISNEFKVEVNVIHTANPMEHANHMAAQPQFVHPEHRSFVDLSGHNLANPHPFAVVPSTATVVIVVCVSFLVFMIILGVFRIRAAHRRTMRDQDTGKENEMDWDDSALTITVNPMETYEDQHSSEEEEEEEEEEESEDGEEEDDITSAESESSEEEEGEQGDPQNATRQQQLEWDDSTLSY,981,"109,793",Alternative sequence (1); Chain (3); Compositional bias (1); Domain (2); Erroneous initiation (1); Glycosylation (3); Mutagenesis (2); Natural variant (6); Sequence conflict (3); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:15037614"""
Q14126,Desmoglein-2 (Cadherin family member 5) (HDGC),MARSPGRAYALLLLLICFNVGSGLHLQVLSTRNENKLLPKHPHLVRQKRAWITAPVALREGEDLSKKNPIAKIHSDLAEERGLKITYKYTGKGITEPPFGIFVFNKDTGELNVTSILDREETPFFLLTGYALDARGNNVEKPLELRIKVLDINDNEPVFTQDVFVGSVEELSAAHTLVMKINATDADEPNTLNSKISYRIVSLEPAYPPVFYLNKDTGEIYTTSVTLDREEHSSYTLTVEARDGNGEVTDKPVKQAQVQIRILDVNDNIPVVENKVLEGMVEENQVNVEVTRIKVFDADEIGSDNWLANFTFASGNEGGYFHIETDAQTNEGIVTLIKEVDYEEMKNLDFSVIVANKAAFHKSIRSKYKPTPIPIKVKVKNVKEGIHFKSSVISIYVSESMDRSSKGQIIGNFQAFDEDTGLPAHARYVKLEDRDNWISVDSVTSEIKLAKLPDFESRYVQNGTYTVKIVAISEDYPRKTITGTVLINVEDINDNCPTLIEPVQTICHDAEYVNVTAEDLDGHPNSGPFSFSVIDKPPGMAEKWKIARQESTSVLLQQSEKKLGRSEIQFLISDNQGFSCPEKQVLTLTVCECLHGSGCREAQHDSYVGLGPAAIALMILAFLLLLLVPLLLLMCHCGKGAKGFTPIPGTIEMLHPWNNEGAPPEDKVVPSFLPVDQGGSLVGRNGVGGMAKEATMKGSSSASIVKGQHEMSEMDGRWEEHRSLLSGRATQFTGATGAIMTTETTKTARATGASRDMAGAQAAAVALNEEFLRNYFTDKAASYTEEDENHTAKDCLLVYSQEETESLNASIGCCSFIEGELDDRFLDDLGLKFKTLAEVCLGQKIDINKEIEQRQKPATETSMNTASHSLCEQTMVNSENTYSSGSSFPVPKSLQEANAEKVTQEIVTERSVSSRQAQKVATPLPDPMASRNVIATETSYVTGSTMPPTTVILGPSQPQSLIVTERVYAPASTLVDQPYANEGTVVVTERVIQPHGGGSNPLEGTQHLQDVPYVMVRERESFLAPSSGVQPTLAMPNIAVGQNVTVTERVLAPASTLQSSYQIPTENSMTARNTTVSGAGVPGPLPDFGLEESGHSNSTITTSSTRVTKHSTVQHSYS,1118,"122,294",Beta strand (41); Chain (1); Domain (4); Glycosylation (5); Helix (2); Modified residue (11); Natural variant (15); Propeptide (1); Repeat (6); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (14),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q86SJ6,Desmoglein-4 (Cadherin family member 13),MDWLFFRNICLLIILMVVMEVNSEFIVEVKEFDIENGTTKWQTVRRQKREWIKFAAACREGEDNSKRNPIAKIRSDCESNQKITYRISGVGIDRPPYGVFTINPRTGEINITSVVDREITPLFLIYCRALNSRGEDLERPLELRVKVMDINDNAPVFSQSVYTASIEENSDANTLVVKLCATDADEENHLNSKIAYKIVSQEPSGAPMFILNRYTGEVCTMSSFLDREQHSMYNLVVRGSDRDGAADGLSSECDCRIKVLDVNDNFPTLEKTSYSASIEENCLSSELIRLQAIDLDEEGTDNWLAQYLILSGNDGNWFDIQTDPQTNEGILKVVKMLDYEQAPNIQLSIGVKNQADFHYSVASQFQMHPTPVRIQVVDVREGPAFHPSTMAFSVREGIKGSSLLNYVLGTYTAIDLDTGNPATDVRYIIGHDAGSWLKIDSRTGEIQFSREFDKKSKYIINGIYTAEILAIDDGSGKTATGTICIEVPDINDYCPNIFPERRTICIDSPSVLISVNEHSYGSPFTFCVVDEPPGIADMWDVRSTNATSAILTAKQVLSPGFYEIPILVKDSYNRACELAQMVQLYACDCDDNHMCLDSGAAGIYTEDITGDTYGPVTEDQAGVSNVGLGPAGIGMMVLGILLLILAPLLLLLCCCKQRQPEGLGTRFAPVPEGGEGVMQSWRIEGAHPEDRDVSNICAPMTASNTQDRMDSSEIYTNTYAAGGTVEGGVSGVELNTGMGTAVGLMAAGAAGASGAARKRSSTMGTLRDYADADINMAFLDSYFSEKAYAYADEDEGRPANDCLLIYDHEGVGSPVGSIGCCSWIVDDLDESCMETLDPKFRTLAEICLNTEIEPFPSHQACIPISTDLPLLGPNYFVNESSGLTPSEVEFQEEMAASEPVVHGDIIVTETYGNADPCVQPTTIIFDPQLAPNVVVTEAVMAPVYDIQGNICVPAELADYNNVIYAERVLASPGVPDMSNSSTTEGCMGPVMSGNILVGPEIQVMQMMSPDLPIGQTVGSTSPMTSRHRVTRYSNIHYTQQ,1040,"113,824",Alternative sequence (1); Chain (1); Domain (4); Glycosylation (2); Natural variant (4); Propeptide (1); Repeat (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q02487,Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III),MEAARPSGSWNGALCRLLLLTLAILIFASDACKNVTLHVPSKLDAEKLVGRVNLKECFTAANLIHSSDPDFQILEDGSVYTTNTILLSSEKRSFTILLSNTENQEKKKIFVFLEHQTKVLKKRHTKEKVLRRAKRRWAPIPCSMLENSLGPFPLFLQQVQSDTAQNYTIYYSIRGPGVDQEPRNLFYVERDTGNLYCTRPVDREQYESFEIIAFATTPDGYTPELPLPLIIKIEDENDNYPIFTEETYTFTIFENCRVGTTVGQVCATDKDEPDTMHTRLKYSIIGQVPPSPTLFSMHPTTGVITTTSSQLDRELIDKYQLKIKVQDMDGQYFGLQTTSTCIINIDDVNDHLPTFTRTSYVTSVEENTVDVEILRVTVEDKDLVNTANWRANYTILKGNENGNFKIVTDAKTNEGVLCVVKPLNYEEKQQMILQIGVVNEAPFSREASPRSAMSTATVTVNVEDQDEGPECNPPIQTVRMKENAEVGTTSNGYKAYDPETRSSSGIRYKKLTDPTGWVTIDENTGSIKVFRSLDREAETIKNGIYNITVLASDQGGRTCTGTLGIILQDVNDNSPFIPKKTVIICKPTMSSAEIVAVDPDEPIHGPPFDFSLESSTSEVQRMWRLKAINDTAARLSYQNDPPFGSYVVPITVRDRLGMSSVTSLDVTLCDCITENDCTHRVDPRIGGGGVQLGKWAILAILLGIALLFCILFTLVCGASGTSKQPKVIPDDLAQQNLIVSNTEAPGDDKVYSANGFTTQTVGASAQGVCGTVGSGIKNGGQETIEMVKGGHQTSESCRGAGHHHTLDSCRGGHTEVDNCRYTYSEWHSFTQPRLGEKVYLCNQDENHKHAQDYVLTYNYEGRGSVAGSVGCCSERQEEDGLEFLDNLEPKFRTLAEACMKR,901,"99,962",Alternative sequence (2); Beta strand (36); Chain (1); Domain (5); Erroneous initiation (2); Glycosylation (5); Helix (3); Modified residue (3); Natural variant (11); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (13),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P15421,Glycophorin-E,MYGKIIFVLLLSGIVSISASSTTGVAMHTSTSSSVTKSYISSQTNGITLINWWAMARVIFEVMLVVVGMIILISYCIR,78,"8,463",Chain (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,SIGNAL 1..19
Q14832,Metabotropic glutamate receptor 3 (mGluR3),MKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNICIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPYEYLADEFTCMDCGSGQWPTADLTGCYDLPEDYIRWEDAWAIGPVTIACLGFMCTCMVVTVFIKHNNTPLVKASGRELCYILLFGVGLSYCMTFFFIAKPSPVICALRRLGLGSSFAICYSALLTKTNCIARIFDGVKNGAQRPKFISPSSQVFICLGLILVQIVMVSVWLILEAPGTRRYTLAEKRETVILKCNVKDSSMLISLTYDVILVILCTVYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCISVSLSGFVVLGCLFAPKVHIILFQPQKNVVTHRLHLNRFSVSGTGTTYSQSSASTYVPTVCNGREVLDSTTSSL,879,"98,879",Alternative sequence (2); Beta strand (18); Binding site (4); Chain (1); Disulfide bond (8); Erroneous initiation (3); Glycosylation (4); Helix (18); Natural variant (1); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (7),"DISULFID 57..99;  /evidence=""ECO:0000269|Ref.5""; DISULFID 240..527;  /evidence=""ECO:0000250""; DISULFID 361..373;  /evidence=""ECO:0000269|Ref.5""; DISULFID 412..419;  /evidence=""ECO:0000269|Ref.5""; DISULFID 509..528;  /evidence=""ECO:0000250""; DISULFID 513..531;  /evidence=""ECO:0000250""; DISULFID 534..546;  /evidence=""ECO:0000250""; DISULFID 549..562;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P30511,"HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)",MAPRSLLLLLSGALALTDTWAGSHSLRYFSTAVSRPGRGEPRYIAVEYVDDTQFLRFDSDAAIPRMEPREPWVEQEGPQYWEWTTGYAKANAQTDRVALRNLLRRYNQSEAGSHTLQGMNGCDMGPDGRLLRGYHQHAYDGKDYISLNEDLRSWTAADTVAQITQRFYEAEEYAEEFRTYLEGECLELLRRYLENGKETLQRADPPKAHVAHHPISDHEATLRCWALGFYPAEITLTWQRDGEEQTQDTELVETRPAGDGTFQKWAAVVVPPGEEQRYTCHVQHEGLPQPLILRWEQSPQPTIPIVGIVAGLVVLGAVVTGAVVAAVMWRKKSSDRNRGSYSQAAV,346,"39,062",Alternative sequence (2); Beta strand (18); Binding site (5); Chain (1); Disulfide bond (2); Domain (1); Erroneous gene model prediction (4); Erroneous initiation (1); Glycosylation (1); Helix (7); Motif (1); Mutagenesis (5); Natural variant (3); Region (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 122..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:28636952""; DISULFID 224..280;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:28636952""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P16410,Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152),MACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSDFLLWILAAVSSGLFFYSFLLTAVSLSKMLKKRSPLTTGVYVKMPPTEPECEKQFQPYFIPIN,223,"24,656",Alternative sequence (6); Beta strand (14); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (2); Helix (1); Modified residue (1); Mutagenesis (8); Natural variant (2); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 58..129;  /evidence=""ECO:0000244|PDB:3BX7, ECO:0000244|PDB:5TRU, ECO:0000269|PubMed:11279501, ECO:0000269|PubMed:11279502, ECO:0000269|PubMed:21156796, ECO:0000269|PubMed:28484017, ECO:0000269|PubMed:9228944, ECO:0000269|Ref.23""; DISULFID 85..103;  /evidence=""ECO:0000244|PDB:3BX7, ECO:0000244|PDB:5TRU, ECO:0000269|PubMed:11279501, ECO:0000269|PubMed:11279502, ECO:0000269|PubMed:21156796, ECO:0000269|PubMed:28484017, ECO:0000269|PubMed:9228944, ECO:0000269|Ref.23""; DISULFID 157;  /note=""Interchain"";  /evidence=""ECO:0000244|PDB:3BX7, ECO:0000269|PubMed:28484017, ECO:0000269|Ref.23""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
P0C7U0,Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28),MAGRGWGALWVCVAAATLLHAGGLARADCWLIEGDKGFVWLAICSQNQPPYEAIPQQINSTIVDLRLNENRIRSVQYASLSRFGNLTYLNLTKNEIGYIEDGAFSGQFNLQVLQLGYNRLRNLTEGMLRGLGKLEYLYLQANLIEVVMASSFWECPNIVNIDLSMNRIQQLNSGTFAGLAKLSVCELYSNPFYCSCELLGFLRWLAAFTNATQTYDRMQCESPPVYSGYYLLGQGRRGHRSILSKLQSVCTEDSYAAEVVGPPRPASGRSQPGRSPPPPPPPEPSDMPCADDECFSGDGTTPLVALPTLATQAEARPLIKVKQLTQNSATITVQLPSPFHRMYTLEHFNNSKASTVSRLTKAQEEIRLTNLFTLTNYTYCVVSTSAGLRHNHTCLTICLPRLPSPPGPVPSPSTATHYIMTILGCLFGMVLVLGAVYYCLRRRRRQEEKHKKAASAAAAGSLKKTIIELKYGPELEAPGLAPLSQGPLLGPEAVTRIPYLPAAGEVEQYKLVESADTPKASKGSYMEVRTGDPPERRDCELGRPGPDSQSSVAEISTIAKEVDKVNQIINNCIDALKSESTSFQGVKSGPVSVAEPPLVLLSEPLAAKHGFLAPGYKDAFGHSLQRHHSVEAAGPPRASTSSSGSVRSPRAFRAEAVGVHKAAAAEAKYIEKGSPAADAILTVTPAAAVLRAEAEKGRQYGEHRHSYPGSHPAEPPAPPGPPPPPPHEGLGRKASILEPLTRPRPRDLAYSQLSPQYHSLSYSSSPEYTCRASQSIWERFRLSRRRHKEEEEFMAAGHALRKKVQFAKDEDLHDILDYWKGVSAQHKS,828,"90,477",Chain (1); Domain (2); Glycosylation (6); Modified residue (2); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P48167,Glycine receptor subunit beta (Glycine receptor 58 kDa subunit),MKFLLTTAFLILISLWVEEAYSKEKSSKKGKGKKKQYLCPSQQSAEDLARVPANSTSNILNRLLVSYDPRIRPNFKGIPVDVVVNIFINSFGSIQETTMDYRVNIFLRQKWNDPRLKLPSDFRGSDALTVDPTMYKCLWKPDLFFANEKSANFHDVTQENILLFIFRDGDVLVSMRLSITLSCPLDLTLFPMDTQRCKMQLESFGYTTDDLRFIWQSGDPVQLEKIALPQFDIKKEDIEYGNCTKYYKGTGYYTCVEVIFTLRRQVGFYMMGVYAPTLLIVVLSWLSFWINPDASAARVPLGIFSVLSLASECTTLAAELPKVSYVKALDVWLIACLLFGFASLVEYAVVQVMLNNPKRVEAEKARIAKAEQADGKGGNVAKKNTVNGTGTPVHISTLQVGETRCKKVCTSKSDLRSNDFSIVGSLPRDFELSNYDCYGKPIEVNNGLGKSQAKNNKKPPPAKPVIPTAAKRIDLYARALFPFCFLFFNVIYWSIYL,497,"56,122",Alternative sequence (2); Chain (1); Disulfide bond (2); Glycosylation (2); Modified residue (1); Natural variant (4); Region (1); Signal peptide (1); Site (1); Topological domain (4); Transmembrane (4),"DISULFID 183..197;  /evidence=""ECO:0000250|UniProtKB:P23415""; DISULFID 243..255;  /evidence=""ECO:0000250|UniProtKB:P23415""","SIGNAL 1..22;  /evidence=""ECO:0000250"""
Q8NAU1,Fibronectin type III domain-containing protein 5 (Fibronectin type III repeat-containing protein 2) [Cleaved into: Irisin],MHPGSPSAWPPRARAALRLWLGCVCFALVQADSPSAPVNVTVRHLKANSAVVSWDVLEDEVVIGFAISQQKKDVRMLRFIQEVNTTTRSCALWDLEEDTEYIVHVQAISIQGQSPASEPVLFKTPREAEKMASKNKDEVTMKEMGRNQQLRTGEVLIIVVVLFMWAGVIALFCRQYDIIKDNEPNNNKEKTKSASETSTPEHQGGGLLRSKI,212,"23,659",Alternative sequence (4); Beta strand (7); Chain (2); Domain (1); Glycosylation (2); Motif (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9H0Q3,FXYD domain-containing ion transport regulator 6 (Phosphohippolin),MELVLVFLCSLLAPMVLASAAEKEKEMDPFHYDYQTLRIGGLVFAVVLFSVGILLILSRRCKCSFNQKPRAPGDEEAQVENLITANATEPQKAEN,95,"10,542",Alternative sequence (1); Chain (1); Frameshift (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000250|UniProtKB:Q91XV6"""
Q14802,FXYD domain-containing ion transport regulator 3 (Chloride conductance inducer protein Mat-8) (Mammary tumor 8 kDa protein) (Phospholemman-like) (Sodium/potassium-transporting ATPase subunit FXYD3),MQKVTLGLLVFLAGFPVLDANDLEDKNSPFYYDWHSLQVGGLICAGVLCAMGIIIVMSAKCKCKFGQKSGHHPGETPPLITPGSAQS,87,"9,263",Alternative sequence (4); Chain (1); Mutagenesis (4); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:17077088"""
Q9ULW2,Frizzled-10 (Fz-10) (hFz10) (FzE7) (CD antigen CD350),MQRPGPRLWLVLQVMGSCAAISSMDMERPGDGKCQPIEIPMCKDIGYNMTRMPNLMGHENQREAAIQLHEFAPLVEYGCHGHLRFFLCSLYAPMCTEQVSTPIPACRVMCEQARLKCSPIMEQFNFKWPDSLDCRKLPNKNDPNYLCMEAPNNGSDEPTRGSGLFPPLFRPQRPHSAQEHPLKDGGPGRGGCDNPGKFHHVEKSASCAPLCTPGVDVYWSREDKRFAVVWLAIWAVLCFFSSAFTVLTFLIDPARFRYPERPIIFLSMCYCVYSVGYLIRLFAGAESIACDRDSGQLYVIQEGLESTGCTLVFLVLYYFGMASSLWWVVLTLTWFLAAGKKWGHEAIEANSSYFHLAAWAIPAVKTILILVMRRVAGDELTGVCYVGSMDVNALTGFVLIPLACYLVIGTSFILSGFVALFHIRRVMKTGGENTDKLEKLMVRIGLFSVLYTVPATCVIACYFYERLNMDYWKILAAQHKCKMNNQTKTLDCLMAASIPAVEIFMVKIFMLLVVGITSGMWIWTSKTLQSWQQVCSRRLKKKSRRKPASVITSGGIYKKAQHPQKTHHGKYEIPAQSPTCV,581,"65,336",Chain (1); Disulfide bond (5); Domain (1); Glycosylation (3); Motif (2); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 34..95;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 42..88;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 79..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 106..147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 110..134;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P51841,"Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2)",MFLGLGRFSRLVLWFAAFRKLLGHHGLASAKFLWCLCLLSVMSLPQQVWTLPYKIGVVGPWACDSLFSKALPEVAARLAIERINRDPSFDLSYSFEYVILNEDCQTSRALSSFISHHQMASGFIGPTNPGYCEAASLLGNSWDKGIFSWACVNYELDNKISYPTFSRTLPSPIRVLVTVMKYFQWAHAGVISSDEDIWVHTANRVASALRSHGLPVGVVLTTGQDSQSMRKALQRIHQADRIRIIIMCMHSALIGGETQMHLLECAHDLKMTDGTYVFVPYDALLYSLPYKHTPYRVLRNNPKLREAYDAVLTITVESQEKTFYQAFTEAAARGEIPEKLEFDQVSPLFGTIYNSIYFIAQAMNNAMKENGQAGAASLVQHSRNMQFHGFNQLMRTDSNGNGISEYVILDTNLKEWELHSTYTVDMEMELLRFGGTPIHFPGGRPPRADAKCWFAEGKICHGGIDPAFAMMVCLTLLIALLSINGFAYFIRRRINKIQLIKGPNRILLTLEDVTFINPHFGSKRGSRASVSFQITSEVQSGRSPRLSFSSGSLTPATYENSNIAIYEGDWVWLKKFSLGDFGDLKSIKSRASDVFEMMKDLRHENINPLLGFFYDSGMFAIVTEFCSRGSLEDILTNQDVKLDWMFKSSLLLDLIKGMKYLHHREFVHGRLKSRNCVVDGRFVLKVTDYGFNDILEMLRLSEEESSMEELLWTAPELLRAPRGSRLGSFAGDVYSFAIIMQEVMVRGTPFCMMDLPAQEIINRLKKPPPVYRPVVPPEHAPPECLQLMKQCWAEAAEQRPTFDEIFNQFKTFNKGKKTNIIDSMLRMLEQYSSNLEDLIRERTEELEIEKQKTEKLLTQMLPPSVAESLKKGCTVEPEGFDLVTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPKRNGSRHAAEIANMSLDILSSVGTFKMRHMPEVPVRIRIGLHSGPVVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVSLSTVTILQNLSEGYEVELRGRTELKGKGTEETFWLIGKKGFMKPLPVPPPVDKDGQVGHGLQPVEIAAFQRRKAERQLVRNKP,1108,"124,850",Chain (1); Disulfide bond (3); Domain (2); Natural variant (18); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 104..132;  /evidence=""ECO:0000250""; DISULFID 452;  /note=""Interchain"";  /evidence=""ECO:0000250""; DISULFID 460;  /note=""Interchain"";  /evidence=""ECO:0000250""","SIGNAL 1..50;  /evidence=""ECO:0000255"""
Q9UKJ8,Disintegrin and metalloproteinase domain-containing protein 21 (ADAM 21) (EC 3.4.24.-),MAVDGTLVYIRVTLLLLWLGVFLSISGYCQAGPSQHFTSPEVVIPLKVISRGRSAKAPGWLSYSLRFGGQKHVVHMRVKKLLVSRHLPVFTYTDDRALLEDQLFIPDDCYYHGYVEAAPESLVVFSACFGGFRGVLKISGLTYEIEPIRHSATFEHLVYKINSNETQFPAMRCGLTEKEVARQQLEFEEAENSALEPKSAGDWWTHAWFLELVVVVNHDFFIYSQSNISKVQEDVFLVVNIVDSMYKQLGTYIILIGIEIWNQGNVFPMTSIEQVLNDFSQWKQISLSQLQHDAAHMFIKNSLISILGLAYVAGICRPPIDCGVDNFQGDTWSLFANTVAHELGHTLGMQHDEEFCFCGERGCIMNTFRVPAEKFTNCSYADFMKTTLNQGSCLHNPPRLGEIFMLKRCGNGVVEREEQCDCGSVQQCEQDACCLLNCTLRPGAACAFGLCCKDCKFMPSGELCRQEVNECDLPEWCNGTSHQCPEDRYVQDGIPCSDSAYCYQKRCNNHDQHCREIFGKDAKSASQNCYKEINSQGNRFGHCGINGTTYLKCHISDVFCGRVQCENVRDIPLLQDHFTLQHTHINGVTCWGIDYHLRMNISDIGEVKDGTVCGPGKICIHKKCVSLSVLSHVCLPETCNMKGICNNKHHCHCGYGWSPPYCQHRGYGGSIDSGPASAKRGVFLPLIVIPSLSVLTFLFTVGLLMYLRQCSGPKETKAHSSG,722,"80,834",Active site (1); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (3); Glycosylation (7); Metal binding (4); Motif (1); Propeptide (1); Sequence conflict (14); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 316..393;  /evidence=""ECO:0000250""; DISULFID 356..378;  /evidence=""ECO:0000250""; DISULFID 358..363;  /evidence=""ECO:0000250""; DISULFID 464..484;  /evidence=""ECO:0000250""; DISULFID 634..645;  /evidence=""ECO:0000250""; DISULFID 639..651;  /evidence=""ECO:0000250""; DISULFID 653..662;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9HAR2,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGRTDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQYECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGTWDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIHLDSELERPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRNRSTSTPSPAVEVLDDMTTHLPSASSQIPALEESCEAVEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNKAMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLHTVEESAFVLADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNIKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSASLNREGLLNNARDTSVMDTLPLNGNHGNSYSIASGEYLSNCVQIIDRGYNHNETALEKKILKELTSNYIPSYLNNHERSSEQNRNLMNKLVNNLGSGREDDAIVLDDATSFNHEESLGLELIHEESDAPLLPPRVYSTENHQPHHYTRRRIPQDHSESFFPLLTNEHTEDLQSPHRDSLYTSMPTLAGVAATESVTTSTQTEPPPAKCGDAEDVYYKSMPNLGSRNHVHQLHTYYQLGRGSSDGFIVPPNKDGTPPEGSSKGPAHLVTSL,1447,"161,812",Alternative sequence (6); Beta strand (6); Chain (1); Disulfide bond (5); Domain (3); Erroneous initiation (1); Glycosylation (8); Helix (2); Metal binding (4); Modified residue (1); Mutagenesis (2); Natural variant (4); Region (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 36..66;  /evidence=""ECO:0000244|PDB:5CMN, ECO:0000269|PubMed:26235030""; DISULFID 45..123;  /evidence=""ECO:0000244|PDB:5CMN, ECO:0000269|PubMed:26235030""; DISULFID 78..110;  /evidence=""ECO:0000244|PDB:5CMN, ECO:0000269|PubMed:26235030""; DISULFID 91..97;  /evidence=""ECO:0000244|PDB:5CMN, ECO:0000269|PubMed:26235030""; DISULFID 135..317;  /evidence=""ECO:0000244|PDB:5CMN, ECO:0000255|PROSITE-ProRule:PRU00446, ECO:0000269|PubMed:26235030""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8WVV5,Butyrophilin subfamily 2 member A2,MEPAAALHFSLPASLLLLLLLLLLSLCALVSAQFTVVGPANPILAMVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRITFVSKDINRGSVALVIHNVTAQENGIYRCYFQEGRSYDEAILRLVVAGLGSKPLIEIKAQEDGSIWLECISGGWYPEPLTVWRDPYGEVVPALKEVSIADADGLFMVTTAVIIRDKYVRNVSCSVNNTLLGQEKETVIFIPESFMPSASPWMVALAVILTASPWMVSMTVILAVFIIFMAVSICCIKKLQREKKILSGEKKVEQEEKEIAQQLQEELRWRRTFLHAADVVLDPDTAHPELFLSEDRRSVRRGPYRQRVPDNPERFDSQPCVLGWESFASGKHYWEVEVENVMVWTVGVCRHSVERKGEVLLIPQNGFWTLEMFGNQYRALSSPERILPLKESLCRVGVFLDYEAGDVSFYNMRDRSHIYTCPRSAFTVPVRPFFRLGSDDSPIFICPALTGASGVMVPEEGLKLHRVGTHQSL,523,"59,070",Alternative sequence (7); Chain (1); Coiled coil (1); Disulfide bond (1); Domain (3); Glycosylation (4); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 55..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q01151,CD83 antigen (hCD83) (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83),MSRGLQLLLLSCAYSLAPATPEVKVACSEDVDLPCTAPWDPQVPYTVSWVKLLEGGEERMETPQEDHLRGQHYHQKGQNGSFDAPNERPYSLKIRNTTSCNSGTYRCTLQDPDGQRNLSGKVILRVTGCPAQRKEETFKKYRAEIVLLLALVIFYLTLIIFTCKFARLQSIFPDFSKAGMERAFLPVTSPNKHLGLVTPHKTELV,205,"23,042",Beta strand (7); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (3); Helix (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
P33681,T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80),MGHTRRQGTSPSKCPYLNFFQLLVLAGLSHFCSGVIHVTKEVKEVATLSCGHNVSVEELAQTRIYWQKEKKMVLTMMSGDMNIWPEYKNRTIFDITNNLSIVILALRPSDEGTYECVVLKYEKDAFKREHLAEVTLSVKADFPTPSISDFEIPTSNIRRIICSTSGGFPEPHLSWLENGEELNAINTTVSQDPETELYAVSSKLDFNMTTNHSFMCLIKYGHLRVNQTFNWNTTKQEHFPDNLLPSWAITLISVNGIFVICCLTYCFAPRCRERRRNERLRRESVRPV,288,"33,048",Alternative sequence (3); Beta strand (16); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (8); Helix (3); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 50..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11279502""; DISULFID 162..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11279502""","SIGNAL 1..34;  /evidence=""ECO:0000269|PubMed:1714935"""
P20273,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLNDSGQLGLRMESKTEKWMERIHLNVSERPFPPHIQLPPEIQESQEVTLTCLLNFSCYGYPIQLQWLLEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSNDTVQLNVKHTPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYAPEPSTVQILHSPAVEGSQVEFLCMSLANPLPTNYTWYHNGKEMQGRTEEKVHIPKILPWHAGTYSCVAENILGTGQRGPGAELDVQYPPKKVTTVIQNPMPIREGDTVTLSCNYNSSNPSVTRYEWKPHGAWEEPSLGVLKIQNVGWDNTTIACAACNSWCSWASPVALNVQYAPRDVRVRKIKPLSEIHSGNSVSLQCDFSSSHPKEVQFFWEKNGRLLGKESQLNFDSISPEDAGSYSCWVNNSIGQTASKAWTLEVLYAPRRLRVSMSPGDQVMEGKSATLTCESDANPPVSHYTWFDWNNQSLPYHSQKLRLEPVKVQHSGAYWCQGTNSVGKGRSPLSTLTVYYSPETIGRRVAVGLGSCLAILILAICGLKLQRRWKRTQSQQGLQENSSGQSFFVRNKKVRRAPLSEGPHSLGCYNPMMEDGISYTTLRFPEMNIPRTGDAESSEMQRPPPDCDDTVTYSALHKRQVGDYENVIPDFPEDEGIHYSELIQFGVGERPQAQENVDYVILKH,847,"95,348",Alternative sequence (6); Beta strand (28); Binding site (1); Chain (1); Cross-link (1); Disulfide bond (8); Domain (7); Frameshift (1); Glycosylation (11); Helix (6); Modified residue (7); Motif (4); Natural variant (8); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 39..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 44..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 161..219;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 265..309;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 353..396;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 442..484;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 529..571;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 616..659;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9H5V8,CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318),MAGLNCGVSIALLGVLLLGAARLPRGAEAFEIALPRESNITVLIKLGTPTLLAKPCYIVISKRHITMLSIKSGERIVFTFSCQSPENHFVIEIQKNIDCMSGPCPFGEVQLQPSTSLLPTLNRTFIWDVKAHKSIGLELQFSIPRLRQIGPGESCPDGVTHSISGRIDATVVRIGTFCSNGTVSRIKMQEGVKMALHLPWFHPRNVSGFSIANRSSIKRLCIIESVFEGEGSATLMSANYPEGFPEDELMTWQFVVPAHLRASVSFLNFNLSNCERKEERVEYYIPGSTTNPEVFKLEDKQPGNMAGNFNLSLQGCDQDAQSPGILRLQFQVLVQHPQNESNKIYVVDLSNERAMSLTIEPRPVKQSRKFVPGCFVCLESRTCSSNLTLTSGSKHKISFLCDDLTRLWMNVEKTISCTDHRYCQRKSYSLQVPSDILHLPVELHDFSWKLLVPKDRLSLVLVPAQKLQQHTHEKPCNTSFSYLVASAIPSQDLYFGSFCPGGSIKQIQVKQNISVTLRTFAPSFQQEASRQGLTVSFIPYFKEEGVFTVTPDTKSKVYLRTPNWDRGLPSLTSVSWNISVPRDQVACLTFFKERSGVVCQTGRAFMIIQEQRTRAEEIFSLDEDVLPKPSFHHHSFWVNISNCSPTSGKQLDLLFSVTLTPRTVDLTVILIAAVGGGVLLLSALGLIICCVKKKKKKTNKGPAVGIYNDNINTEMPRQPKKFQKGRKDNDSHVYAVIEDTMVYGHLLQDSSGSFLQPEVDTYRPFQGTMGVCPPSPPTICSRAPTAKLATEEPPPRSPPESESEPYTFSHPNNGDVSSKDTDIPLLNTQEPMEPAE,836,"92,932",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (7); Modified residue (1); Mutagenesis (2); Natural variant (3); Sequence conflict (6); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 476..499;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:12660814, ECO:0000269|PubMed:16007225"""
P29320,Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1),MDCQLSILLLLSCSVLDSFGELIPQPSNEVNLLDSKTIQGELGWISYPSHGWEEISGVDEHYTPIRTYQVCNVMDHSQNNWLRTNWVPRNSAQKIYVELKFTLRDCNSIPLVLGTCKETFNLYYMESDDDHGVKFREHQFTKIDTIAADESFTQMDLGDRILKLNTEIREVGPVNKKGFYLAFQDVGACVALVSVRVYFKKCPFTVKNLAMFPDTVPMDSQSLVEVRGSCVNNSKEEDPPRMYCSTEGEWLVPIGKCSCNAGYEERGFMCQACRPGFYKALDGNMKCAKCPPHSSTQEDGSMNCRCENNYFRADKDPPSMACTRPPSSPRNVISNINETSVILDWSWPLDTGGRKDVTFNIICKKCGWNIKQCEPCSPNVRFLPRQFGLTNTTVTVTDLLAHTNYTFEIDAVNGVSELSSPPRQFAAVSITTNQAAPSPVLTIKKDRTSRNSISLSWQEPEHPNGIILDYEVKYYEKQEQETSYTILRARGTNVTISSLKPDTIYVFQIRARTAAGYGTNSRKFEFETSPDSFSISGESSQVVMIAISAAVAIILLTVVIYVLIGRFCGYKSKHGADEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQAVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKISTDDMKKVGVTVVGPQKKIISSIKALETQSKNGPVPV,983,"110,131",Active site (1); Alternative sequence (2); Beta strand (22); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (5); Helix (17); Modified residue (5); Motif (1); Mutagenesis (6); Natural variant (17); Nucleotide binding (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:1737782"""
Q6UW88,Epigen (Epithelial mitogen) (EPG),MALGVPISVYLLFNAMTALTEEAAVTVTPPITAQQGNWTVNKTEADNIEGPIALKFSHLCLEDHNSYCINGACAFHHELEKAICRCFTGYTGERCEHLTLTSYAVDSYEKYIAIGIGVGLLLSGFLVIFYCYIRKRCLKLKSPYNVCSGERRPL,154,"17,091",Alternative sequence (5); Beta strand (3); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 60..73;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 68..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 86..95;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
P54760,Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11),MELRVLLCWASLAAALEETLLNTKLETADLKWVTFPQVDGQWEELSGLDEEQHSVRTYEVCDVQRAPGQAHWLRTGWVPRRGAVHVYATLRFTMLECLSLPRAGRSCKETFTVFYYESDADTATALTPAWMENPYIKVDTVAAEHLTRKRPGAEATGKVNVKTLRLGPLSKAGFYLAFQDQGACMALLSLHLFYKKCAQLTVNLTRFPETVPRELVVPVAGSCVVDAVPAPGPSPSLYCREDGQWAEQPVTGCSCAPGFEAAEGNTKCRACAQGTFKPLSGEGSCQPCPANSHSNTIGSAVCQCRVGYFRARTDPRGAPCTTPPSAPRSVVSRLNGSSLHLEWSAPLESGGREDLTYALRCRECRPGGSCAPCGGDLTFDPGPRDLVEPWVVVRGLRPDFTYTFEVTALNGVSSLATGPVPFEPVNVTTDREVPPAVSDIRVTRSSPSSLSLAWAVPRAPSGAVLDYEVKYHEKGAEGPSSVRFLKTSENRAELRGLKRGASYLVQVRARSEAGYGPFGQEHHSQTQLDESEGWREQLALIAGTAVVGVVLVLVVIVVAVLCLRKQSNGREAEYSDKHGQYLIGHGTKVYIDPFTYEDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLLDQRQPHYSAFGSVGEWLRAIKMGRYEESFAAAGFGSFELVSQISAEDLLRIGVTLAGHQKKILASVQHMKSQAKPGTPGGTGGPAPQY,987,"108,270",Active site (1); Alternative sequence (6); Beta strand (30); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (5); Glycosylation (3); Helix (22); Modified residue (6); Motif (1); Mutagenesis (1); Natural variant (49); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),DISULFID 61..184; DISULFID 97..107,"SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q9ULV1,Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344),MAWRGAGPSVPGAPGGVGLSLGLLLQLLLLLGPARGFGDEEERRCDPIRISMCQNLGYNVTKMPNLVGHELQTDAELQLTTFTPLIQYGCSSQLQFFLCSVYVPMCTEKINIPIGPCGGMCLSVKRRCEPVLKEFGFAWPESLNCSKFPPQNDHNHMCMEGPGDEEVPLPHKTPIQPGEECHSVGTNSDQYIWVKRSLNCVLKCGYDAGLYSRSAKEFTDIWMAVWASLCFISTAFTVLTFLIDSSRFSYPERPIIFLSMCYNIYSIAYIVRLTVGRERISCDFEEAAEPVLIQEGLKNTGCAIIFLLMYFFGMASSIWWVILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVILIMRLVDADELTGLCYVGNQNLDALTGFVVAPLFTYLVIGTLFIAAGLVALFKIRSNLQKDGTKTDKLERLMVKIGVFSVLYTVPATCVIACYFYEISNWALFRYSADDSNMAVEMLKIFMSLLVGITSGMWIWSAKTLHTWQKCSNRLVNSGKVKREKRGNGWVKPGKGSETVV,537,"59,881",Beta strand (11); Chain (1); Disulfide bond (8); Domain (1); Glycosylation (2); Helix (24); Motif (2); Mutagenesis (20); Natural variant (25); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (2),"DISULFID 45..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 53..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 90..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 117..158;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 121..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 181..200;  /evidence=""ECO:0000269|PubMed:30135577""; DISULFID 204..282;  /evidence=""ECO:0000269|PubMed:30135577""; DISULFID 302..377;  /evidence=""ECO:0000269|PubMed:30135577""","SIGNAL 1..36;  /evidence=""ECO:0000255"""
Q6PRD1,Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1) (GPR158-like),MGTRGAVMPPPMWGLLGCCFVCAWALGGPRPIRSLPPLSSQVKPGSVPMQVPLEGAEAALAYLYSGDAQQLSQVNCSERYEARGAGAMPGLPPSLQGAAGTLAQAANFLNMLLQANDIRESSVEEDVEWYQALVRSVAEGDPRVYRALLTFNPPPGASHLQLALQATRTGEETILQDLSGNWVQEENPPGDLDTPALKKRVLTNDLGSLGSPKWPQADGYVGDTQQVRLSPPFLECQEGRLRPGWLITLSATFYGLKPDLSPEVRGQVQMDVDLQSVDINQCASGPGWYSNTHLCDLNSTQCVPLESQGFVLGRYLCRCRPGFYGASPSGGLEESDFQTTGQFGFPEGRSGRLLQCLPCPEGCTSCMDATPCLVEEAAVLRAAVLACQACCMLAIFLSMLVSYRCRRNKRIWASGVVLLETVLFGFLLLYFPVFILYFKPSVFRCIALRWVRLLGFAIVYGTIILKLYRVLQLFLSRTAQRSALLSSGRLLRRLGLLLLPVLGFLAVWTVGALERGIQHAPLVIRGHTPSGRHFYLCHHDRWDYIMVVAELLLLCWGSFLCYATRAVLSAFHEPRYMGIALHNELLLSAAFHTARFVLVPSLHPDWTLLLFFFHTHSTVTTTLALIFIPKFWKLGAPPREEMVDEVCEDELDLQHSGSYLGSSIASAWSEHSLDPGDIRDELKKLYAQLEVHKTKEMAANNPHLPKKRGSSCQGLGRSFMRYLAEFPEALARQHSRDSGSPGHGSLPGSSRRRLLSSSLQEPEGTPALHKSRSTYDQRREQDPPLLDSLLRRKLAKKASRTESRESVEGPPALGFRSASAHNLTVGERLPRARPASLQKSLSVASSREKALLMASQAYLEETYRQAKEREERKKAKAAMASLVRRPSARRLERPRGAPLSAPPSPAKSSSVDSSHTSGRLHEEARRRLPHPPIRHQVSTPILALSGGLGEPRMLSPTSTLAPALLPALAPTPAPALAPVPVSPQSPNLLTYICPWENAELPAKQENVPQEGPSGPERGHHSPAPARARLWRALSVAVEKSRAGENEMDAEDAHHQREANDVDEDRPKIFPKSHSLKAPVQQGSMRSLGLAIKALTRSRSTYREKESVEESPEGQNSGTAGESMGAPSRSPRLGRPKAVSKQAALIPSDDKESLQNQQNAHTSRMLQVCQREGSREQEDRGRRMTQGLGERKAERAGKTGLAMLRQVSRDKNIKQSKETPVGWQELPKAGLQSLGSADHRVAEVCPWEVTESETRQPDSGNKAEICPWETSEGAPESRALRQDPGDSQKKRGEARGKSEPIDVVPMMRKKPERLVREQEAVCPWESADRGGLSPGSAPQDPGRIRDKSEAGDSVEARKVEKPGWEAAGPEAHTPDITKAEPCPWEASEGGEDGKPAQEAVKDLPQEKQKTRKATFWKEQKPGGDLESLCPWESTDFRGPSAVSIQAPGSSECSGSLGSGIAEVCLWEAGDAPAIQKAEICPWELDDNVMGQEMLSLGTGRESLQEKEKASRKGSFGEMGEQTVKAVQKLSQQQESVCPRESTVPGHSSPCLDNSSSKAGSQFLCNGGSRATQVCPQEDLRPEAQEATPAKTEICPWEVNERTREEWTSAQVPRGGESQKDKEKMPGKSEIEDVTAWEKPEGQIQKQEAVGPWESVDPGSFSPQPRPQDTERPQTLLQMSGSVGSKAADICPLDVEENLTAGKAEICPWEVGAGAGEERALGAEAIRKSPNDTGKVSADLGPRERAVTAPEKPQKPTPEWEVACPWGSVGPGACSQHPGTLDADGPKAGFQELDHMGCRPGEVCPWEAQEAATSEKAKICPWEVSEGTTGKGLDQKAGSESAEQREKALEKGRLTSLGEDVSKGMAKLCQQQETICIWENKDLRESPAQAPKISDLPSSMSSEVAEGHSLEATEKGDLRQDPKTGSFPEHITQEKAPAADTEEFTTEDGEKTSHELQSVCPWETTAPADSVSHLDRQRPDQPKASSQRLVSTGGRAADVCPWDVPDAGVYKSDSSAKAETCPWEVTERIPVKGVSRQDGKGDSQEEKGRAPEKSEPKGVPVQKKPEMADFRQQEAVCPWESQDGKGLSPQPAPDASDRSRGSSEAAGSVETRVAEVCLWEVVEAPSAKKAEICPWEAGGGAAEEGEQERESQGQGEMFLQKAGPGGTEEHFSKAAAKPREQEAVCPGEGTGSGGLLPQSGALDPELKVSPKEAGSMGSRMAELCQWEITDPEGNKIKGTMADICPGEETGVPSEESGLLALTATRREFFPTAPEKPLCLLVHGPLDHFFPESKIPCPKVSRPASTFTLEGVRELQGPSGLEPRTSLAPEPSLQEAESQSSSLTEDSGQVAFEAQYEEFTPPTVYPWDWE,2367,"257,363",Chain (1); Compositional bias (2); Glycosylation (2); Natural variant (8); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q04844,Acetylcholine receptor subunit epsilon,MARAPLGVLLLLGLLGRGVGKNEELRLYHHLFNNYDPGSRPVREPEDTVTISLKVTLTNLISLNEKEETLTTSVWIGIDWQDYRLNYSKDDFGGIETLRVPSELVWLPEIVLENNIDGQFGVAYDANVLVYEGGSVTWLPPAIYRSVCAVEVTYFPFDWQNCSLIFRSQTYNAEEVEFTFAVDNDGKTINKIDIDTEAYTENGEWAIDFCPGVIRRHHGGATDGPGETDVIYSLIIRRKPLFYVINIIVPCVLISGLVLLAYFLPAQAGGQKCTVSINVLLAQTVFLFLIAQKIPETSLSVPLLGRFLIFVMVVATLIVMNCVIVLNVSQRTPTTHAMSPRLRHVLLELLPRLLGSPPPPEAPRAASPPRRASSVGLLLRAEELILKKPRSELVFEGQRHRQGTWTAAFCQSLGAAAPEVRCCVDAVNFVAESTRDQEATGEEVSDWVRMGNALDNICFWAALVLFSVGSSLIFLGAYFNRVPDLPYAPCIQP,493,"54,697",Chain (1); Disulfide bond (1); Glycosylation (2); Natural variant (14); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 148..162;  /evidence=""ECO:0000250""",SIGNAL 1..20
P28335,5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C),MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV,458,"51,821",Alternative sequence (1); Beta strand (2); Chain (1); Disulfide bond (2); Glycosylation (1); Helix (14); Motif (3); Mutagenesis (5); Natural variant (4); Region (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (3),"DISULFID 127..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""; DISULFID 337..341;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:22497996"""
Q86SQ3,Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16),MGSRFLLVLLSGASCPPCPKYASCHNSTHCTCEDGFRARSGRTYFHDSSEKCEDINECETGLAKCKYKAYCRNKVGGYICSCLVKYTLFNFLAGIIDYDHPDCYENNSQGTTQSNVDIWVSGVKPGFGKQLPGDKRTKHICVYWEGSEGGWSTEGCSHVHSNGSYTKCKCFHLSSFAVLVALAPKEDPVLTVITQVGLTISLLCLFLAILTFLLCRPIQNTSTSLHLELSLCLFLAHLLFLTGINRTEPEVLCSIIAGLLHFLYLACFTWMLLEGLHLFLTVRNLKVANYTSTGRFKKRFMYPVGYGIPAVIIAVSAIVGPQNYGTFTCWLKLDKGFIWSFMGPVAVIILINLVFYFQVLWILRSKLSSLNKEVSTIQDTRVMTFKAISQLFILGCSWGLGFFMVEEVGKTIGSIIAYSFTIINTLQGVLLFVVHCLLNRQVRLIILSVISLVPKSN,457,"50,903",Alternative sequence (3); Chain (1); Disulfide bond (6); Domain (3); Glycosylation (4); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 15..24;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 18..30;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 32..52;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 58..71;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 65..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 82..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q9P0K1,"Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2)",MQAAVAVSVPFLLLCVLGTCPPARCGQAGDASLMELEKRKENRFVERQSIVPLRLIYRSGGEDESRHDALDTRVRGDLGGPQLTHVDQASFQVDAFGTSFILDVVLNHDLLSSEYIERHIEHGGKTVEVKGGEHCYYQGHIRGNPDSFVALSTCHGLHGMFYDGNHTYLIEPEENDTTQEDFHFHSVYKSRLFEFSLDDLPSEFQQVNITPSKFILKPRPKRSKRQLRRYPRNVEEETKYIELMIVNDHLMFKKHRLSVVHTNTYAKSVVNMADLIYKDQLKTRIVLVAMETWATDNKFAISENPLITLREFMKYRRDFIKEKSDAVHLFSGSQFESSRSGAAYIGGICSLLKGGGVNEFGKTDLMAVTLAQSLAHNIGIISDKRKLASGECKCEDTWSGCIMGDTGYYLPKKFTQCNIEEYHDFLNSGGGACLFNKPSKLLDPPECGNGFIETGEECDCGTPAECVLEGAECCKKCTLTQDSQCSDGLCCKKCKFQPMGTVCREAVNDCDIRETCSGNSSQCAPNIHKMDGYSCDGVQGICFGGRCKTRDRQCKYIWGQKVTASDKYCYEKLNIEGTEKGNCGKDKDTWIQCNKRDVLCGYLLCTNIGNIPRLGELDGEITSTLVVQQGRTLNCSGGHVKLEEDVDLGYVEDGTPCGPQMMCLEHRCLPVASFNFSTCLSSKEGTICSGNGVCSNELKCVCNRHWIGSDCNTYFPHNDDAKTGITLSGNGVAGTNIIIGIIAGTILVLALILGITAWGYKNYREQRQLPQGDYVKKPGDGDSFYSDIPPGVSTNSASSSKKRSNGLSHSWSERIPDTKHISDICENGRPRSNSWQGNLGGNKKKIRGKRFRPRSNSTETLSPAKSPSSSTGSIASSRKYPYPMPPLPDEDKKVNRQSARLWETSI,906,"100,433",Alternative sequence (3); Beta strand (27); Chain (1); Compositional bias (1); Disulfide bond (20); Domain (3); Glycosylation (4); Helix (13); Modified residue (6); Mutagenesis (2); Natural variant (4); Propeptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 349..433;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 392..417;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 394..401;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 447..477;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 458..474;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 460..466;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 473..494;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 485..491;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 490..516;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 503..523;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 510..542;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 535..547;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 554..605;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 569..635;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 583..593;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 600..663;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 657..668;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 679..694;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 688..700;  /evidence=""ECO:0000269|PubMed:19692335""; DISULFID 702..711;  /evidence=""ECO:0000269|PubMed:19692335""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O60469,Down syndrome cell adhesion molecule (CHD2),MWILALSLFQSFANVFSEDLHSSLYFVNASLQEVVFASTTGTLVPCPAAGIPPVTLRWYLATGEEIYDVPGIRHVHPNGTLQIFPFPPSSFSTLIHDNTYYCTAENPSGKIRSQDVHIKAVLREPYTVRVEDQKTMRGNVAVFKCIIPSSVEAYITVVSWEKDTVSLVSGSRFLITSTGALYIKDVQNEDGLYNYRCITRHRYTGETRQSNSARLFVSDPANSAPSILDGFDHRKAMAGQRVELPCKALGHPEPDYRWLKDNMPLELSGRFQKTVTGLLIENIRPSDSGSYVCEVSNRYGTAKVIGRLYVKQPLKATISPRKVKSSVGSQVSLSCSVTGTEDQELSWYRNGEILNPGKNVRITGINHENLIMDHMVKSDGGAYQCFVRKDKLSAQDYVQVVLEDGTPKIISAFSEKVVSPAEPVSLMCNVKGTPLPTITWTLDDDPILKGGSHRISQMITSEGNVVSYLNISSSQVRDGGVYRCTANNSAGVVLYQARINVRGPASIRPMKNITAIAGRDTYIHCRVIGYPYYSIKWYKNSNLLPFNHRQVAFENNGTLKLSDVQKEVDEGEYTCNVLVQPQLSTSQSVHVTVKVPPFIQPFEFPRFSIGQRVFIPCVVVSGDLPITITWQKDGRPIPGSLGVTIDNIDFTSSLRISNLSLMHNGNYTCIARNEAAAVEHQSQLIVRVPPKFVVQPRDQDGIYGKAVILNCSAEGYPVPTIVWKFSKGAGVPQFQPIALNGRIQVLSNGSLLIKHVVEEDSGYYLCKVSNDVGADVSKSMYLTVKIPAMITSYPNTTLATQGQKKEMSCTAHGEKPIIVRWEKEDRIINPEMARYLVSTKEVGEEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQLTVQEPPDPPEIEIKDVKARTITLRWTMGFDGNSPITGYDIECKNKSDSWDSAQRTKDVSPQLNSATIIDIHPSSTYSIRMYAKNRIGKSEPSNELTITADEAAPDGPPQEVHLEPISSQSIRVTWKAPKKHLQNGIIRGYQIGYREYSTGGNFQFNIISVDTSGDSEVYTLDNLNKFTQYGLVVQACNRAGTGPSSQEIITTTLEDVPSYPPENVQAIATSPESISISWSTLSKEALNGILQGFRVIYWANLMDGELGEIKNITTTQPSLELDGLEKYTNYSIQVLAFTRAGDGVRSEQIFTRTKEDVPGPPAGVKAAAASASMVFVSWLPPLKLNGIIRKYTVFCSHPYPTVISEFEASPDSFSYRIPNLSRNRQYSVWVVAVTSAGRGNSSEIITVEPLAKAPARILTFSGTVTTPWMKDIVLPCKAVGDPSPAVKWMKDSNGTPSLVTIDGRRSIFSNGSFIIRTVKAEDSGYYSCIANNNWGSDEIILNLQVQVPPDQPRLTVSKTTSSSITLSWLPGDNGGSSIRGYILQYSEDNSEQWGSFPISPSERSYRLENLKCGTWYKFTLTAQNGVGPGRISEIIEAKTLGKEPQFSKEQELFASINTTRVRLNLIGWNDGGCPITSFTLEYRPFGTTVWTTAQRTSLSKSYILYDLQEATWYELQMRVCNSAGCAEKQANFATLNYDGSTIPPLIKSVVQNEEGLTTNEGLKMLVTISCILVGVLLLFVLLLVVRRRRREQRLKRLRDAKSLAEMLMSKNTRTSDTLSKQQQTLRMHIDIPRAQLLIEERDTMETIDDRSTVLLTDADFGEAAKQKSLTVTHTVHYQSVSQATGPLVDVSDARPGTNPTTRRNAKAGPTARNRYASQWTLNRPHPTISAHTLTTDWRLPTPRAAGSVDKESDSYSVSPSQDTDRARSSMVSTESASSTYEELARAYEHAKMEEQLRHAKFTITECFISDTSSEQLTAGTNEYTDSLTSSTPSESGICRFTASPPKPQDGGRVMNMAVPKAHRPGDLIHLPPYLRMDFLLNRGGPGTSRDLSLGQACLEPQKSRTLKRPTVLEPIPMEAASSASSTREGQSWQPGAVATLPQREGAELGQAAKMSSSQESLLDSRGHLKGNNPYAKSYTLV,2012,"222,260",Alternative sequence (2); Chain (1); Disulfide bond (10); Domain (16); Glycosylation (18); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 46..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 145..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 246..293;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 335..385;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 428..484;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 525..575;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 617..669;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 711..766;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 809..865;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1307..1359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P52799,Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L),MAVRRDSVWKYCWGVLMVLCRTAISKSIVLEPIYWNSSNSKFLPGQGLVLYPQIGDKLDIICPKVDSKTVGQYEYYKVYMVDKDQADRCTIKKENTPLLNCAKPDQDIKFTIKFQEFSPNLWGLEFQKNKDYYIISTSNGSLEGLDNQEGGVCQTRAMKILMKVGQDASSAGSTRNKDPTRRPELEAGTNGRSSTTSPFVKPNPGSSTDGNSAGHSGNNILGSEVALFAGIASGCIIFIVIIITLVVLLLKYRRRHRKHSPQHTTTLSLSTLATPKRSGNNNGSEPSDIIIPLRTADSVFCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,333,"36,923",Beta strand (11); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (2); Helix (3); Modified residue (3); Motif (1); Mutagenesis (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 62..101;  /evidence=""ECO:0000244|PDB:2VSK, ECO:0000244|PDB:2VSM, ECO:0000269|PubMed:16867992, ECO:0000269|PubMed:18488039, ECO:0000269|PubMed:19836338, ECO:0000269|PubMed:19875447, ECO:0000269|Ref.14""; DISULFID 89..153;  /evidence=""ECO:0000244|PDB:2VSK, ECO:0000244|PDB:2VSM, ECO:0000269|PubMed:16867992, ECO:0000269|PubMed:18488039, ECO:0000269|PubMed:19836338, ECO:0000269|PubMed:19875447, ECO:0000269|Ref.14""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q15768,Ephrin-B3 (EPH-related receptor transmembrane ligand ELK-L3) (EPH-related receptor tyrosine kinase ligand 8) (LERK-8),MGPPHSGPGGVRVGALLLLGVLGLVSGLSLEPVYWNSANKRFQAEGGYVLYPQIGDRLDLLCPRARPPGPHSSPNYEFYKLYLVGGAQGRRCEAPPAPNLLLTCDRPDLDLRFTIKFQEYSPNLWGHEFRSHHDYYIIATSDGTREGLESLQGGVCLTRGMKVLLRVGQSPRGGAVPRKPVSEMPMERDRGAAHSLEPGKENLPGDPTSNATSRGAEGPLPPPSMPAVAGAAGGLALLLLGVAGAGGAMCWRRRRAKPSESRHPGPGSFGRGGSLGLGGGGGMGPREAEPGELGIALRGGGAADPPFCPHYEKVSGDYGHPVYIVQDGPPQSPPNIYYKV,340,"35,835",Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Modified residue (2); Motif (1); Mutagenesis (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 62..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00884""; DISULFID 92..156;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00884""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:15340161"""
O75460,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],MPARRLLLLLTLLLPGLGIFGSTSTVTLPETLLFVSTLDGSLHAVSKRTGSIKWTLKEDPVLQVPTHVEEPAFLPDPNDGSLYTLGSKNNEGLTKLPFTIPELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSLCPSTSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVAFYVWQREGLRKVMHINVAVETLRYLTFMSGEVGRITKWKYPFPKETEAKSKLTPTLYVGKYSTSLYASPSMVHEGVAVVPRGSTLPLLEGPQTDGVTIGDKGECVITPSTDVKFDPGLKSKNKLNYLRNYWLLIGHHETPLSASTKMLERFPNNLPKHRENVIPADSEKKSFEEVINLVDQTSENAPTTVSRDVEEKPAHAPARPEAPVDSMLKDMATIILSTFLLIGWVAFIITYPLSMHQQQQLQHQQFQKELEKIQLLQQQQQQLPFHPPGDTAQDGELLDTSGPYSESSGTSSPSTSPRASNHSLCSGSSASKAGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL,977,"109,735",Active site (1); Alternative sequence (2); Beta strand (38); Binding site (2); Chain (1); Domain (2); Glycosylation (1); Helix (28); Modified residue (1); Mutagenesis (7); Natural variant (7); Nucleotide binding (3); Region (1); Sequence conflict (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (8),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q96DB9,FXYD domain-containing ion transport regulator 5 (Dysadherin),MSPSGRLCLLTIVGLILPTRGQTLKDTTSSSSADSTIMDIQVPTRAPDAVYTELQPTSPTPTWPADETPQPQTQTQQLEGTDGPLVTDPETHKSTKAAHPTDDTTTLSERPSPSTDVQTDPQTLKPSGFHEDDPFFYDEHTLRKRGLLVAAVLFITGIIILTSGKCRQLSRLCRNRCR,178,"19,472",Alternative sequence (1); Chain (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q06136,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),MLLLAAAFLVAFVLLLYMVSPLISPKPLALPGAHVVVTGGSSGIGKCIAIECYKQGAFITLVARNEDKLLQAKKEIEMHSINDKQVVLCISVDVSQDYNQVENVIKQAQEKLGPVDMLVNCAGMAVSGKFEDLEVSTFERLMSINYLGSVYPSRAVITTMKERRVGRIVFVSSQAGQLGLFGFTAYSASKFAIRGLAEALQMEVKPYNVYITVAYPPDTDTPGFAEENRTKPLETRLISETTSVCKPEQVAKQIVKDAIQGNFNSSLGSDGYMLSALTCGMAPVTSITEGLQQVVTMGLFRTIALFYLGSFDSIVRRCMMQREKSENADKTA,332,"36,187",Active site (2); Alternative sequence (1); Binding site (1); Chain (1); Natural variant (4); Nucleotide binding (1); Signal peptide (1); Topological domain (3); Transmembrane (2),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q8TDQ0,Hepatitis A virus cellular receptor 2 (HAVcr-2) (T-cell immunoglobulin and mucin domain-containing protein 3) (TIMD-3) (T-cell immunoglobulin mucin receptor 3) (TIM-3) (T-cell membrane protein 3) (CD antigen CD366),MFSHLPFDCVLLLLLLLLTRSSEVEYRAEVGQNAYLPCFYTPAAPGNLVPVCWGKGACPVFECGNVVLRTDERDVNYWTSRYWLNGDFRKGDVSLTIENVTLADSGIYCCRIQIPGIMNDEKFNLKLVIKPAKVTPAPTRQRDFTAAFPRMLTTRGHGPAETQTLGSLPDINLTQISTLANELRDSRLANDLRDSGATIRIGIYIGAGICAGLALALIFGALIFKWYSHSKEKIQNLSLISLANLPPSGLANAVAEGIRSEENIYTIEENVYEVEEPNEYYCYVSSRQQPSQPLGCRFAMP,301,"33,394",Alternative sequence (2); Beta strand (12); Binding site (2); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (2); Helix (2); Metal binding (2); Modified residue (1); Mutagenesis (4); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..110;  /evidence=""ECO:0000250|UniProtKB:Q8VIM0, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 52..63;  /evidence=""ECO:0000250|UniProtKB:Q8VIM0, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 58..109;  /evidence=""ECO:0000250|UniProtKB:Q8VIM0, ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P16871,Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127),MTILGTTFGMVFSLLQVVSGESGYAQNGDLEDAELDDYSFSCYSQLEVNGSQHSLTCAFEDPDVNITNLEFEICGALVEVKCLNFRKLQEIYFIETKKFLLIGKSNICVKVGEKSLTCKKIDLTTIVKPEAPFDLSVVYREGANDFVVTFNTSHLQKKYVKVLMHDVAYRQEKDENKWTHVNLSSTKLTLLQRKLQPAAMYEIKVRSIPDHYFKGFWSEWSPSYYFRTPEINNSSGEMDPILLTISILSFFSVALLVILACVLWKKRIKPIVWPSLPDHKKTLEHLCKKPRKNLNVSFNPESFLDCQIHRVDDIQARDEVEGFLQDTFPQQLEESEKQRLGGDVQSPNCPSEDVVITPESFGRDSSLTCLAGNVSACDAPILSSSRSLDCRESGKNGPHVYQDLLLSLGTTNSTLPPPFSLQSGILTLNPVAQGQPILTSLGSNQEEAYVTMSSFYQNQ,459,"51,579",Alternative sequence (4); Beta strand (16); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (1); Glycosylation (6); Helix (4); Modified residue (1); Motif (2); Natural variant (7); Sequence caution (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 42..57;  /evidence=""ECO:0000269|PubMed:19141282""; DISULFID 74..82;  /evidence=""ECO:0000269|PubMed:19141282""; DISULFID 108..118;  /evidence=""ECO:0000269|PubMed:19141282""",SIGNAL 1..20
P14778,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]",MKVLLRLICFIALLISSLEADKCKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEKLWFVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGLVCPYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTYLGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYWKWNGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGIDAAYIQLIYPVTNFQKHMIGICVTLTVIIVCSVFIYKIFKIDIVLWYRDSCYDFLPIKASDGKTYDAYILYPKTVGEGSTSDCDIFVFKVLPEVLEKQCGYKLFIYGRDDYVGEDIVEVINENVKKSRRLIIILVRETSGFSWLGGSSEEQIAMYNALVQDGIKVVLLELEKIQDYEKMPESIKFIKQKHGAIRWSGDFTQGPQSAKTRFWKNVRYHMPVQRRSPSSKHQLLSPATKEKLQREAHVPLG,569,"65,402",Active site (1); Beta strand (27); Chain (2); Disulfide bond (5); Domain (4); Glycosylation (6); Helix (7); Modified residue (1); Mutagenesis (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 23..104; DISULFID 44..96; DISULFID 121..164; DISULFID 142..196; DISULFID 248..312,SIGNAL 1..17
Q5VWK5,Interleukin-23 receptor (IL-23 receptor) (IL-23R),MNQVTIQWDAVIALYILFSWCHGGITNINCSGHIWVEPATIFKMGMNISIYCQAAIKNCQPRKLHFYKNGIKERFQITRINKTTARLWYKNFLEPHASMYCTAECPKHFQETLICGKDISSGYPPDIPDEVTCVIYEYSGNMTCTWNAGKLTYIDTKYVVHVKSLETEEEQQYLTSSYINISTDSLQGGKKYLVWVQAANALGMEESKQLQIHLDDIVIPSAAVISRAETINATVPKTIIYWDSQTTIEKVSCEMRYKATTNQTWNVKEFDTNFTYVQQSEFYLEPNIKYVFQVRCQETGKRYWQPWSSLFFHKTPETVPQVTSKAFQHDTWNSGLTVASISTGHLTSDNRGDIGLLLGMIVFAVMLSILSLIGIFNRSFRTGIKRRILLLIPKWLYEDIPNMKNSNVVKMLQENSELMNNNSSEQVLYVDPMITEIKEIFIPEHKPTDYKKENTGPLETRDYPQNSLFDNTTVVYIPDLNTGYKPQISNFLPEGSHLSNNNEITSLTLKPPVDSLDSGNNPRLQKHPNFAFSVSSVNSLSNTIFLGELSLILNQGECSSPDIQNSVEEETTMLLENDSPSETIPEQTLLPDEFVSCLGIVNEELPSINTYFPQNILESHFNRISLLEK,629,"71,722",Alternative sequence (10); Beta strand (24); Chain (1); Domain (2); Erroneous initiation (1); Glycosylation (8); Helix (1); Natural variant (4); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8N6P7,Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11),MRTLLTILTVGSLAAHAPEDPSDLLQHVKFQSSNFENILTWDSGPEGTPDTVYSIEYKTYGERDWVAKKGCQRITRKSCNLTVETGNLTELYYARVTAVSAGGRSATKMTDRFSSLQHTTLKPPDVTCISKVRSIQMIVHPTPTPIRAGDGHRLTLEDIFHDLFYHLELQVNRTYQMHLGGKQREYEFFGLTPDTEFLGTIMICVPTWAKESAPYMCRVKTLPDRTWTYSFSGAFLFSMGFLVAVLCYLSYRYVTKPPAPPNSLNVQRVLTFQPLRFIQEHVLIPVFDLSGPSSLAQPVQYSQIRVSGPREPAGAPQRHSLSEITYLGQPDISILQPSNVPPPQILSPLSYAPNAAPEVGPPSYAPQVTPEAQFPFYAPQAISKVQPSSYAPQATPDSWPPSYGVCMEGSGKDSPTGTLSSPKHLRPKGQLQKEPPAGSCMLGGLSLQEVTSLAMEESQEAKSLHQPLGICTDRTSDPNVLHSGEEGTPQYLKGQLPLLSSVQIEGHPMSLPLQPPSRPCSPSDQGPSPWGLLESLVCPKDEAKSPAPETSDLEQPTELDSLFRGLALTVQWES,574,"63,077",Beta strand (15); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (2); Helix (5); Mutagenesis (2); Natural variant (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 71..79;  /evidence=""ECO:0000269|PubMed:18675809""; DISULFID 128..217;  /evidence=""ECO:0000269|PubMed:18675809""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q9BUF7,Protein crumbs homolog 3,MANPGLGLLLALGLPFLLARWGRAWGQIQTTSANENSTVLPSSTSSSSDGNLRPEAITAIIVVFSLLAALLLAVGLALLVRKLREKRQTEGTYRPSSEEQVGARVPPTPNLKLPPEERLI,120,"12,854",Alternative sequence (1); Beta strand (1); Chain (1); Glycosylation (1); Motif (1); Mutagenesis (2); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P78310,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),MALLLCFVLLCGVVDFARSLSITTPEEMIEKAKGETAYLPCKFTLSPEDQGPLDIEWLISPADNQKVDQVIILYSGDKIYDDYYPDLKGRVHFTSNDLKSGDASINVTNLQLSDIGTYQCKVKKAPGVANKKIHLVVLVKPSGARCYVDGSEEIGSDFKIKCEPKEGSLPLQYEWQKLSDSQKMPTSWLAEMTSSVISVKNASSEYSGTYSCTVRNRVGSDQCLLRLNVVPPSNKAGLIAGAIIGTLLALALIGLIIFCCRKKRREEKYEKEVHHDIREDVPPPKSRTSTARSYIGSNHSSLGSMSPSNMEGYSKTQYNQVPSEDFERTPQSPTLPPAKVAAPNLSRMGAIPVMIPAQSKDGSIV,365,"40,030",Alternative sequence (10); Beta strand (18); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (2); Helix (3); Lipidation (2); Modified residue (6); Motif (1); Mutagenesis (4); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 41..120;  /evidence=""ECO:0000269|PubMed:10567268, ECO:0000269|PubMed:11080637, ECO:0000269|PubMed:14967025""; DISULFID 162..212;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:14967025""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",MVPGARGGGALARAAGRGLLALLLAVSAPLRLQAEELGDGCGHLVTYQDSGTMTSKNYPGTYPNHTVCEKTITVPKGKRLILRLGDLDIESQTCASDYLLFTSSSDQYGPYCGSMTVPKELLLNTSEVTVRFESGSHISGRGFLLTYASSDHPDLITCLERASHYLKTEYSKFCPAGCRDVAGDISGNMVDGYRDTSLLCKAAIHAGIIADELGGQISVLQRKGISRYEGILANGVLSRDGSLSDKRFLFTSNGCSRSLSFEPDGQIRASSSWQSVNESGDQVHWSPGQARLQDQGPSWASGDSSNNHKPREWLEIDLGEKKKITGIRTTGSTQSNFNFYVKSFVMNFKNNNSKWKTYKGIVNNEEKVFQGNSNFRDPVQNNFIPPIVARYVRVVPQTWHQRIALKVELIGCQITQGNDSLVWRKTSQSTSVSTKKEDETITRPIPSEETSTGINITTVAIPLVLLVVLVFAGMGIFAAFRKKKKKGSPYGSAEAQKTDCWKQIKYPFARHQSAEFTISYDNEKEMTQKLDLITSDMADYQQPLMIGTGTVTRKGSTFRPMDTDAEEAGVSTDAGGHYDCPQRAGRHEYALPLAPPEPEYATPIVERHVLRAHTFSAQSGYRVPGPQPGHKHSLSSGGFSPVAGVGAQDGDYQRPHSAQPADRGYDRPKAVSALATESGHPDSQKPPTHPGTSDSYSAPRDCLTPLNQTAMTALL,715,"77,920",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (3); Erroneous initiation (1); Frameshift (1); Glycosylation (6); Modified residue (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..68;  /evidence=""ECO:0000250""; DISULFID 94..112;  /evidence=""ECO:0000250""; DISULFID 158..174;  /evidence=""ECO:0000250""; DISULFID 178..200;  /evidence=""ECO:0000250""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q08345,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAARHSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGPPTPAWAKPTNTQAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV,913,"101,128",Active site (1); Alternative sequence (5); Beta strand (35); Binding site (1); Chain (1); Compositional bias (2); Disulfide bond (3); Domain (2); Erroneous initiation (1); Erroneous termination (1); Glycosylation (4); Helix (23); Metal binding (9); Modified residue (8); Motif (1); Mutagenesis (12); Natural variant (7); Nucleotide binding (1); Region (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 31..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00081, ECO:0000269|PubMed:22483115""; DISULFID 74..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00081, ECO:0000269|PubMed:22483115""; DISULFID 303..348;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00081, ECO:0000269|PubMed:22483115""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9H461,Frizzled-8 (Fz-8) (hFz8),MEWGYLLEVTSLLAALALLQRSSGAAAASAKELACQEITVPLCKGIGYNYTYMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLKFFLCSMYTPICLEDYKKPLPPCRSVCERAKAGCAPLMRQYGFAWPDRMRCDRLPEQGNPDTLCMDYNRTDLTTAAPSPPRRLPPPPPGEQPPSGSGHGRPPGARPPHRGGGRGGGGGDAAAPPARGGGGGGKARPPGGGAAPCEPGCQCRAPMVSVSSERHPLYNRVKTGQIANCALPCHNPFFSQDERAFTVFWIGLWSVLCFVSTFATVSTFLIDMERFKYPERPIIFLSACYLFVSVGYLVRLVAGHEKVACSGGAPGAGGAGGAGGAAAGAGAAGAGAGGPGGRGEYEELGAVEQHVRYETTGPALCTVVFLLVYFFGMASSIWWVILSLTWFLAAGMKWGNEAIAGYSQYFHLAAWLVPSVKSIAVLALSSVDGDPVAGICYVGNQSLDNLRGFVLAPLVIYLFIGTMFLLAGFVSLFRIRSVIKQQDGPTKTHKLEKLMIRLGLFTVLYTVPAAVVVACLFYEQHNRPRWEATHNCPCLRDLQPDQARRPDYAVFMLKYFMCLVVGITSGVWVWSGKTLESWRSLCTRCCWASKGAAVGGGAGATAAGGGGGPGGGGGGGPGGGGGPGGGGGSLYSDVSTGLTWRSGTASSVSYPKQMPLSQV,694,"73,300",Beta strand (4); Chain (1); Compositional bias (4); Disulfide bond (5); Domain (1); Glycosylation (3); Helix (6); Motif (2); Region (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 35..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 43..89;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 80..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 107..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 111..135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
P14784,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122),MAAPALSWRLPLLILLLPLATSWASAAVNGTSQFTCFYNSRANISCVWSQDGALQDTSCQVHAWPDRRRWNQTCELLPVSQASWACNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRLMAPISLQVVHVETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRTKPAALGKDTIPWLGHLLVGLSGAFGFIILVYLLINCRNTGPWLKKVLKCNTPDPSKFFSQLSSEHGGDVQKWLSSPFPSSSFSPGGLAPEISPLEVLERDKVTQLLLQQDKVPEPASLSSNHSLTSCFTNQGYFFFHLPDALEIEACQVYFTYDPYSEEDPDEGVAGAPTGSSPQPLQPLSGEDDAYCTFPSRDDLLLFSPSLLGGPSPPSTAPGGSGAGEERMPPSLQERVPRDWDPQPLGPPTPGVPDLVDFQPPPELVLREAGEEVPDAGPREGVSFPWSRPPGQGEFRALNARLPLNTDAYLSLQELQGQDPTHLV,551,"61,117",Beta strand (16); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (4); Helix (2); Motif (2); Mutagenesis (2); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 36..46; DISULFID 59..110; DISULFID 74..86,SIGNAL 1..26
P06756,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain],MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSRMFLLVGAPKANTTQPGIVEGGQVLKCDWSSTRRCQPIEFDATGNRDYAKDDPLEFKSHQWFGASVRSKQDKILACAPLYHWRTEMKQEREPVGTCFLQDGTKTVEYAPCRSQDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQGQLISDQVAEIVSKYDPNVYSIKYNNQLATRTAQAIFDDSYLGYSVAVGDFNGDGIDDFVSGVPRAARTLGMVYIYDGKNMSSLYNFTGEQMAAYFGFSVAATDINGDDYADVFIGAPLFMDRGSDGKLQEVGQVSVSLQRASGDFQTTKLNGFEVFARFGSAIAPLGDLDQDGFNDIAIAAPYGGEDKKGIVYIFNGRSTGLNAVPSQILEGQWAARSMPPSFGYSMKGATDIDKNGYPDLIVGAFGVDRAILYRARPVITVNAGLEVYPSILNQDNKTCSLPGTALKVSCFNVRFCLKADGKGVLPRKLNFQVELLLDKLKQKGAIRRALFLYSRSPSHSKNMTISRGGLMQCEELIAYLRDESEFRDKLTPITIFMEYRLDYRTAADTTGLQPILNQFTPANISRQAHILLDCGEDNVCKPKLEVSVDSDQKKIYIGDDNPLTLIVKAQNQGEGAYEAELIVSIPLQADFIGVVRNNEALARLSCAFKTENQTRQVVCDLGNPMKAGTQLLAGLRFSVHQQSEMDTSVKFDLQIQSSNLFDKVSPVVSHKVDLAVLAAVEIRGVSSPDHVFLPIPNWEHKENPETEEDVGPVVQHIYELRNNGPSSFSKAMLHLQWPYKYNNNTLLYILHYDIDGPMNCTSDMEINPLRIKISSLQTTEKNDTVAGQGERDHLITKRDLALSEGDIHTLGCGVAQCLKIVCQVGRLDRGKSAILYVKSLLWTETFMNKENQNHSYSLKSSASFNVIEFPYKNLPIEDITNSTLVTTNVTWGIQPAPMPVPVWVIILAVLAGLLLLAVLVFVMYRMGFFKRVRPPQEEQEREQLQPHENGEGNSET,1048,"116,038",Alternative sequence (2); Beta strand (89); Calcium binding (4); Chain (3); Disulfide bond (9); Erroneous initiation (1); Glycosylation (13); Helix (9); Motif (1); Natural variant (3); Repeat (7); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 89..97;  /evidence=""ECO:0000269|PubMed:14596610, ECO:0000269|PubMed:28117447""; DISULFID 138..158;  /evidence=""ECO:0000269|PubMed:14596610, ECO:0000269|PubMed:28117447""; DISULFID 172..185;  /evidence=""ECO:0000269|PubMed:14596610, ECO:0000269|PubMed:28117447""; DISULFID 491..502;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 508..565;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 626..632;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 698..711;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 852..914;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 904..909;  /evidence=""ECO:0000269|PubMed:14596610""","SIGNAL 1..30;  /evidence=""ECO:0000269|PubMed:2467745"""
Q15825,Neuronal acetylcholine receptor subunit alpha-6,MLTSKGQGFLHGGLCLWLCVFTPFFKGCVGCATEERLFHKLFSHYNQFIRPVENVSDPVTVHFEVAITQLANVDEVNQIMETNLWLRHIWNDYKLRWDPMEYDGIETLRVPADKIWKPDIVLYNNAVGDFQVEGKTKALLKYNGMITWTPPAIFKSSCPMDITFFPFDHQNCSLKFGSWTYDKAEIDLLIIGSKVDMNDFWENSEWEIIDASGYKHDIKYNCCEEIYTDITYSFYIRRLPMFYTINLIIPCLFISFLTVLVFYLPSDCGEKVTLCISVLLSLTVFLLVITETIPSTSLVVPLVGEYLLFTMIFVTLSIVVTVFVLNIHYRTPTTHTMPRWVKTVFLKLLPQVLLMRWPLDKTRGTGSDAVPRGLARRPAKGKLASHGEPRHLKECFHCHKSNELATSKRRLSHQPLQWVVENSEHSPEVEDVINSVQFIAENMKSHNETKEVEDDWKYVAMVVDRVFLWVFIIVCVFGTAGLFLQPLLGNTGKS,494,"56,898",Alternative sequence (1); Chain (1); Disulfide bond (2); Glycosylation (2); Modified residue (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 158..172;  /evidence=""ECO:0000250""; DISULFID 222..223;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q7KYR7,Butyrophilin subfamily 2 member A1,MESAAALHFSRPASLLLLLLSLCALVSAQFIVVGPTDPILATVGENTTLRCHLSPEKNAEDMEVRWFRSQFSPAVFVYKGGRERTEEQMEEYRGRTTFVSKDISRGSVALVIHNITAQENGTYRCYFQEGRSYDEAILHLVVAGLGSKPLISMRGHEDGGIRLECISRGWYPKPLTVWRDPYGGVAPALKEVSMPDADGLFMVTTAVIIRDKSVRNMSCSINNTLLGQKKESVIFIPESFMPSVSPCAVALPIIVVILMIPIAVCIYWINKLQKEKKILSGEKEFERETREIALKELEKERVQKEEELQVKEKLQEELRWRRTFLHAVDVVLDPDTAHPDLFLSEDRRSVRRCPFRHLGESVPDNPERFDSQPCVLGRESFASGKHYWEVEVENVIEWTVGVCRDSVERKGEVLLIPQNGFWTLEMHKGQYRAVSSPDRILPLKESLCRVGVFLDYEAGDVSFYNMRDRSHIYTCPRSAFSVPVRPFFRLGCEDSPIFICPALTGANGVTVPEEGLTLHRVGTHQSL,527,"59,633",Alternative sequence (8); Chain (1); Disulfide bond (1); Domain (2); Erroneous initiation (1); Glycosylation (3); Natural variant (6); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q6UXG3,CMRF35-like molecule 9 (CLM-9) (CD300 antigen-like family member G) (Triggering receptor expressed on myeloid cells 4) (TREM-4) (CD antigen CD300g),MRLLVLLWGCLLLPGYEALEGPEEISGFEGDTVSLQCTYREELRDHRKYWCRKGGILFSRCSGTIYAEEEGQETMKGRVSIRDSRQELSLIVTLWNLTLQDAGEYWCGVEKRGPDESLLISLFVFPGPCCPPSPSPTFQPLATTRLQPKAKAQQTQPPGLTSPGLYPAATTAKQGKTGAEAPPLPGTSQYGHERTSQYTGTSPHPATSPPAGSSRPPMQLDSTSAEDTSPALSSGSSKPRVSIPMVRILAPVLVLLSLLSAAGLIAFCSHLLLWRKEAQQATETQRNEKFCLSRLTAEEKEAPSQAPEGDVISMPPLHTSEEELGFSKFVSA,332,"36,060",Alternative sequence (4); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (25); Natural variant (2); Sequence conflict (11); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:15340161"""
P61550,Endogenous retrovirus group S71 member 1 Env polyprotein (Envelope polyprotein) (HERV-T Env protein) (HERV-T_19q13.11 provirus ancestral Env polyprotein) [Includes: Surface protein (SU); Transmembrane protein (TM)],MGPEAWVRPLKTAPKPGEAIRLILFIYLSCFFLPVMSSEPSYSFLLTSFTTGRVFANTTWRAGTSKEVSFAVDLCVLFPEPARTHEEQHNLPVIGAGSVDLAAGFGHSGSQTGCGSSKGAEKGLQNVDFYLCPGNHPDASCRDTYQFFCPDWTCVTLATYSGGSTRSSTLSISRVPHPKLCTRKNCNPLTITVHDPNAAQWYYGMSWGLRLYIPGFDVGTMFTIQKKILVSWSSPKPIGPLTDLGDPIFQKHPDKVDLTVPLPFLVPRPQLQQQHLQPSLMSILGGVHHLLNLTQPKLAQDCWLCLKAKPPYYVGLGVEATLKRGPLSCHTRPRALTIGDVSGNASCLISTGYNLSASPFQATCNQSLLTSISTSVSYQAPNNTWLACTSGLTRCINGTEPGPLLCVLVHVLPQVYVYSGPEGRQLIAPPELHPRLHQAVPLLVPLLAGLSIAGSAAIGTAALVQGETGLISLSQQVDADFSNLQSAIDILHSQVESLAEVVLQNCRCLDLLFLSQGGLCAALGESCCFYANQSGVIKGTVKKVRENLDRHQQERENNIPWYQSMFNWNPWLTTLITGLAGPLLILLLSLIFGPCILNSFLNFIKQRIASVKLTYLKTQYDTLVNN,626,"68,171",Chain (1); Disulfide bond (1); Motif (3); Region (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 520..527;  /evidence=""ECO:0000250""","SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q5UCC4,ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1),MAAASAGATRLLLLLLMAVAAPSRARGSGCRAGTGARGAGAEGREGEACGTVGLLLEHSFEIDDSANFRKRGSLLWNQQDGTLSLSQRQLSEEERGRLRDVAALNGLYRVRIPRRPGALDGLEAGGYVSSFVPACSLVESHLSDQLTLHVDVAGNVVGVSVVTHPGGCRGHEVEDVDLELFNTSVQLQPPTTAPGPETAAFIERLEMEQAQKAKNPQEQKSFFAKYWMYIIPVVLFLMMSGAPDTGGQGGGGGGGGGGGSGR,262,"27,347",Alternative sequence (1); Beta strand (9); Chain (1); Glycosylation (1); Helix (4); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:32439656"""
P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116),MLLLVTSLLLCELPHPAFLLIPEKSDLRTVAPASSLNVRFDSRTMNLSWDCQENTTFSKCFLTDKKNRVVEPRLSNNECSCTFREICLHEGVTFEVHVNTSQRGFQQKLLYPNSGREGTAAQNFSCFIYNADLMNCTWARGPTAPRDVQYFLYIRNSKRRREIRCPYYIQDSGTHVGCHLDNLSGLTSRNYFLVNGTSREIGIQFFDSLLDTKKIERFNPPSNVTVRCNTTHCLVRWKQPRTYQKLSYLDFQYQLDVHRKNTQPGTENLLINVSGDLENRYNFPSSEPRAKHSVKIRAADVRILNWSSWSEAIEFGSDDGNLGSVYIYVLLIVGTLVCGIVLGFLFKRFLRIQRLFPPVPQIKDKLNDNHEVEDEIIWEEFTPEEGKGYREEVLTVKEIT,400,"46,207",Alternative sequence (10); Beta strand (20); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (11); Helix (2); Motif (2); Natural variant (1); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 126..136;  /evidence=""ECO:0000250""; DISULFID 165..178;  /evidence=""ECO:0000250""",SIGNAL 1..22
P54764,Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK),MAGIFYFALFSCLFGICDAVTGSRVYPANEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEKDVPKMYCGADGEWLVPIGNCLCNAGHEERSGECQACKIGYYKALSTDATCAKCPPHSYSVWEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDISYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTKVSITDLLAHTNYTFEIWAVNGVSKYNPNPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYEKDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRIIGDGANSTVLLVSVSGSVVLVVILIAAFVISRRRSKYSKAKQEADEEKHLNQGVRTYVDPFTYEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGTESSRPNTALLDPSSPEFSAVVSVGDWLQAIKMDRYKDNFTAAGYTTLEAVVHVNQEDLARIGITAITHQNKILSSVQAMRTQMQQMHGRMVPV,986,"109,860",Active site (1); Alternative sequence (1); Beta strand (38); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (4); Helix (4); Modified residue (4); Motif (1); Mutagenesis (2); Natural variant (4); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
O00591,Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi),MNYSLHLAFVCLSLFTERMCIQGSQFNVEVGRSDKLSLPGFENLTAGYNKFLRPNFGGEPVQIALTLDIASISSISESNMDYTATIYLRQRWMDQRLVFEGNKSFTLDARLVEFLWVPDTYIVESKKSFLHEVTVGNRLIRLFSNGTVLYALRITTTVACNMDLSKYPMDTQTCKLQLESWGYDGNDVEFTWLRGNDSVRGLEHLRLAQYTIERYFTLVTRSQQETGNYTRLVLQFELRRNVLYFILETYVPSTFLVVLSWVSFWISLDSVPARTCIGVTTVLSMTTLMIGSRTSLPNTNCFIKAIDVYLGICFSFVFGALLEYAVAHYSSLQQMAAKDRGTTKEVEEVSITNIINSSISSFKRKISFASIEISSDNVDYSDLTMKTSDKFKFVFREKMGRIVDYFTIQNPSNVDHYSKLLFPLIFMLANVFYWAYYMYF,440,"50,640",Chain (1); Disulfide bond (1); Glycosylation (5); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 160..174;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
P47871,Glucagon receptor (GL-R),MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF,477,"54,009",Beta strand (9); Chain (1); Disulfide bond (4); Glycosylation (4); Helix (15); Modified residue (2); Mutagenesis (28); Natural variant (4); Region (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (4),"DISULFID 43..67;  /evidence=""ECO:0000244|PDB:4ERS, ECO:0000244|PDB:4LF3, ECO:0000269|PubMed:22908259, ECO:0000269|PubMed:28514451""; DISULFID 58..100;  /evidence=""ECO:0000244|PDB:4ERS, ECO:0000244|PDB:4LF3, ECO:0000269|PubMed:22908259, ECO:0000269|PubMed:28514451""; DISULFID 81..121;  /evidence=""ECO:0000244|PDB:4ERS, ECO:0000244|PDB:4LF3, ECO:0000269|PubMed:22908259, ECO:0000269|PubMed:28514451""; DISULFID 224..294;  /evidence=""ECO:0000244|PDB:4L6R, ECO:0000244|PDB:5EE7, ECO:0000269|PubMed:23863937, ECO:0000269|PubMed:27111510, ECO:0000269|PubMed:28514451""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q13255,Metabotropic glutamate receptor 1 (mGluR1),MVGLLLFFFPAIFLEVSLLPRSPGRKVLLAGASSQRSVARMDGDVIIGALFSVHHQPPAEKVPERKCGEIREQYGIQRVEAMFHTLDKINADPVLLPNITLGSEIRDSCWHSSVALEQSIEFIRDSLISIRDEKDGINRCLPDGQSLPPGRTKKPIAGVIGPGSSSVAIQVQNLLQLFDIPQIAYSATSIDLSDKTLYKYFLRVVPSDTLQARAMLDIVKRYNWTYVSAVHTEGNYGESGMDAFKELAAQEGLCIAHSDKIYSNAGEKSFDRLLRKLRERLPKARVVVCFCEGMTVRGLLSAMRRLGVVGEFSLIGSDGWADRDEVIEGYEVEANGGITIKLQSPEVRSFDDYFLKLRLDTNTRNPWFPEFWQHRFQCRLPGHLLENPNFKRICTGNESLEENYVQDSKMGFVINAIYAMAHGLQNMHHALCPGHVGLCDAMKPIDGSKLLDFLIKSSFIGVSGEEVWFDEKGDAPGRYDIMNLQYTEANRYDYVHVGTWHEGVLNIDDYKIQMNKSGVVRSVCSEPCLKGQIKVIRKGEVSCCWICTACKENEYVQDEFTCKACDLGWWPNADLTGCEPIPVRYLEWSNIESIIAIAFSCLGILVTLFVTLIFVLYRDTPVVKSSSRELCYIILAGIFLGYVCPFTLIAKPTTTSCYLQRLLVGLSSAMCYSALVTKTNRIARILAGSKKKICTRKPRFMSAWAQVIIASILISVQLTLVVTLIIMEPPMPILSYPSIKEVYLICNTSNLGVVAPLGYNGLLIMSCTYYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITTCFAVSLSVTVALGCMFTPKMYIIIAKPERNVRSAFTTSDVVRMHVGDGKLPCRSNTFLNIFRRKKAGAGNANSNGKSVSWSEPGGGQVPKGQHMWHRLSVHVKTNETACNQTAVIKPLTKSYQGSGKSLTFSDTSTKTLYNVEEEEDAQPIRFSPPGSPSMVVHRRVPSAATTPPLPSHLTAEETPLFLAEPALPKGLPPPLQQQQQPPPQQKSLMDQLQGVVSNFSTAIPDFHAVLAGPGGPGNGLRSLYPPPPPPQHLQMLPLQLSTFGEELVSPPADDDDDSERFKLLQEYVYEHEREGNTEEDELEEEEEDLQAASKLTPDDSPALTPPSPFRDSVASGSSVPSSPVSESVLCTPPNVSYASVILRDYKQSSSTL,1194,"132,357",Alternative sequence (4); Beta strand (22); Binding site (5); Chain (1); Compositional bias (4); Disulfide bond (6); Glycosylation (4); Helix (25); Modified residue (8); Natural variant (11); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (9),"DISULFID 67..109; DISULFID 140;  /note=""Interchain""; DISULFID 289..291;  /evidence=""ECO:0000250""; DISULFID 378..394; DISULFID 432..439; DISULFID 657..746","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q13003,"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)",MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVVAIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNKDTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKIRQLPIDSDDSRPLLKEMKRGREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSGVNLTGFRILNVDNPHVSAIVEKWSMERLQAAPRSESGLLDGVMMTDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGGRFMNFIKEAQWEGLTGRIVFNKTSGLRTDFDLDIISLKEDGLEKVGVWSPADGLNITEVAKGRGPNVTDSLTNRSLIVTTVLEEPFVMFRKSDRTLYGNDRFEGYCIDLLKELAHILGFSYEIRLVEDGKYGAQDDKGQWNGMVKELIDHKADLAVAPLTITHVREKAIDFSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFWFGMGSLMQQGSELMPKALSTRIIGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVKDGATMTFFKKSKISTFEKMWAFMSSKPSALVKNNEEGIQRALTADYALLMESTTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRGSGCPEEENKEASALGIQKIGGIFIVLAAGLVLSVLVAVGEFVYKLRKTAEREQRSFCSTVADEIRFSLTCQRRVKHKPQPPMMVKTDAVINMHTFNDRRLPGKDSMACSTSLAPVFP,919,"104,037",Alternative sequence (1); Binding site (3); Chain (1); Cross-link (1); Disulfide bond (1); Glycosylation (10); Modified residue (1); Natural variant (4); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (4); Transmembrane (3),"DISULFID 99..350;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q16478,"Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)",MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKARVEVDIFELQRDSQYETTDTMCQILPKGVVSVLGPSSSPASASTVSHICGEKEIPHIKVGPEETPRLQYLRFASVSLYPSNEDVSLAVSRILKSFNYPSASLICAKAECLLRLEELVRGFLISKETLSVRMLDDSRDPTPLLKEIRDDKVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWRENCEASTYLGPALSAALMFDAVHVVVSAVRELNRSQEIGVKPLACTSANIWPHGTSLMNYLRMVEYDGLTGRVEFNSKGQRTNYTLRILEKSRQGHREIGVWYSNRTLAMNATTLDINLSQTLANKTLVVTTILENPYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPNGSWTGMVGELINRKADLAVAAFTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLADQTNIEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLNSRYAFLLESTMNEYHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGGRCPKEEDHRAKGLGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRRSAESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRIQALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE,980,"109,265",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (3); Glycosylation (11); Sequence conflict (3); Signal peptide (1); Topological domain (4); Transmembrane (3),"DISULFID 36..292;  /evidence=""ECO:0000250""; DISULFID 83..334;  /evidence=""ECO:0000250""; DISULFID 165..170;  /evidence=""ECO:0000250""","SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q99075,Proheparin-binding EGF-like growth factor [Cleaved into: Heparin-binding EGF-like growth factor (HB-EGF) (HBEGF) (Diphtheria toxin receptor) (DT-R)],MKLLPSVVLKLFLAAVLSALVTGESLERLRRGLAAGTSNPDPPTVSTDQLLPLGGGRDRKVRDLQEADLDLLRVTLSSKPQALATPNKEEHGKRKKKGKGLGKKRDPCLRKYKDFCIHGECKYVKELRAPSCICHPGYHGERCHGLSLPVENRLYTYDHTTILAVVAVVLSSVCLLVIVGLLMFRYHRRGGYDVENEEKVKLGMTNSH,208,"23,067",Beta strand (4); Chain (2); Disulfide bond (3); Domain (1); Glycosylation (6); Propeptide (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 108..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 116..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 134..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q06481,Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP),MAATGTAAAAATGRLLLLLLVGLTAPALALAGYIEALAANAGTGFAVAEPQIAMFCGKLNMHVNIQTGKWEPDPTGTKSCFETKEEVLQYCQEMYPELQITNVMEANQRVSIDNWCRRDKKQCKSRFVTPFKCLVGEFVSDVLLVPEKCQFFHKERMEVCENHQHWHTVVKEACLTQGMTLYSYGMLLPCGVDQFHGTEYVCCPQTKIIGSVSKEEEEEDEEEEEEEDEEEDYDVYKSEFPTEADLEDFTEAAVDEDDEDEEEGEEVVEDRDYYYDTFKGDDYNEENPTEPGSDGTMSDKEITHDVKAVCSQEAMTGPCRAVMPRWYFDLSKGKCVRFIYGGCGGNRNNFESEDYCMAVCKAMIPPTPLPTNDVDVYFETSADDNEHARFQKAKEQLEIRHRNRMDRVKKEWEEAELQAKNLPKAERQTLIQHFQAMVKALEKEAASEKQQLVETHLARVEAMLNDRRRMALENYLAALQSDPPRPHRILQALRRYVRAENKDRLHTIRHYQHVLAVDPEKAAQMKSQVMTHLHVIEERRNQSLSLLYKVPYVAQEIQEEIDELLQEQRADMDQFTASISETPVDVRVSSEESEEIPPFHPFHPFPALPENEDTQPELYHPMKKGSGVGEQDGGLIGAEEKVINSKNKVDENMVIDETLDVKEMIFNAERVGGLEEERESVGPLREDFSLSSSALIGLLVIAVAIATVIVISLVMLRKRQYGTISHGIVEVDPMLTPEERHLNKMQNHGYENPTYKYLEQMQI,763,"86,956",Alternative sequence (5); Beta strand (3); Chain (1); Compositional bias (2); Disulfide bond (9); Domain (3); Frameshift (1); Helix (10); Metal binding (3); Modified residue (1); Motif (1); Natural variant (1); Region (3); Sequence conflict (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 56..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 91..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 116..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 149..203;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 160..190;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 174..202;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 310..360;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 319..343;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""; DISULFID 335..356;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00031""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P34998,Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1),MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTAV,444,"50,719",Alternative sequence (4); Beta strand (6); Chain (1); Disulfide bond (4); Glycosylation (5); Helix (19); Modified residue (1); Mutagenesis (9); Region (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (3),DISULFID 30..54; DISULFID 44..87; DISULFID 68..102; DISULFID 217..287,"SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:11425856"""
P01903,"HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)",MAISGVPVLGFFIIAVLMSAQESWAIKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFDAPSPLPETTENVVCALGLTVGLVGIIIGTIFIIKGLRKSNAAERRGPL,254,"28,621",Beta strand (15); Chain (1); Cross-link (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (2); Helix (2); Mutagenesis (15); Natural variant (2); Region (3); Sequence conflict (12); Signal peptide (1); Site (9); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 132..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11163233, ECO:0000269|PubMed:12244309, ECO:0000269|PubMed:16079912, ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:7477400""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:6600932, ECO:0000269|PubMed:6812963, ECO:0000269|PubMed:6955253"""
Q9UJA9,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),MTSKFLLVSFILAALSLSTTFSLQPDQQKVLLVSFDGFRWDYLYKVPTPHFHYIMKYGVHVKQVTNVFITKTYPNHYTLVTGLFAENHGIVANDMFDPIRNKSFSLDHMNIYDSKFWEEATPIWITNQRAGHTSGAAMWPGTDVKIHKRFPTHYMPYNESVSFEDRVAKIIEWFTSKEPINLGLLYWEDPDDMGHHLGPDSPLMGPVISDIDKKLGYLIQMLKKAKLWNTLNLIITSDHGMTQCSEERLIELDQYLDKDHYTLIDQSPVAAILPKEGKFDEVYEALTHAHPNLTVYKKEDVPERWHYKYNSRIQPIIAVADEGWHILQNKSDDFLLGNHGYDNALADMHPIFLAHGPAFRKNFSKEAMNSTDLYPLLCHLLNITAMPHNGSFWNVQDLLNSAMPRVVPYTQSTILLPGSVKPAEYDQEGSYPYFIGVSLGSIIVIVFFVIFIKHLIHSQIPALQDMHAEIAQPLLQA,477,"54,666",Active site (1); Beta strand (17); Chain (1); Glycosylation (8); Helix (18); Metal binding (7); Natural variant (5); Sequence conflict (1); Signal peptide (1); Transmembrane (1); Turn (4),,"SIGNAL 1..24;  /evidence=""ECO:0000250|UniProtKB:P84039"""
P54762,Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2),MALDYLLLLLLASAVAAMEETLMDTRTATAELGWTANPASGWEEVSGYDENLNTIRTYQVCNVFEPNQNNWLLTTFINRRGAHRIYTEMRFTVRDCSSLPNVPGSCKETFNLYYYETDSVIATKKSAFWSEAPYLKVDTIAADESFSQVDFGGRLMKVNTEVRSFGPLTRNGFYLAFQDYGACMSLLSVRVFFKKCPSIVQNFAVFPETMTGAESTSLVIARGTCIPNAEEVDVPIKLYCNGDGEWMVPIGRCTCKPGYEPENSVACKACPAGTFKASQEAEGCSHCPSNSRSPAEASPICTCRTGYYRADFDPPEVACTSVPSGPRNVISIVNETSIILEWHPPRETGGRDDVTYNIICKKCRADRRSCSRCDDNVEFVPRQLGLTECRVSISSLWAHTPYTFDIQAINGVSSKSPFPPQHVSVNITTNQAAPSTVPIMHQVSATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTDDDYKSELREQLPLIAGSAAAGVVFVVSLVAISIVCSRKRAYSKEAVYSDKLQHYSTGRGSPGMKIYIDPFTYEDPNEAVREFAKEIDVSFVKIEEVIGAGEFGEVYKGRLKLPGKREIYVAIKTLKAGYSEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAEMNYVHRDLAARNILVNSNLVCKVSDFGLSRYLQDDTSDPTYTSSLGGKIPVRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPMDCPAALHQLMLDCWQKDRNSRPRFAEIVNTLDKMIRNPASLKTVATITAVPSQPLLDRSIPDFTAFTTVDDWLSAIKMVQYRDSFLTAGFTSLQLVTQMTSEDLLRIGITLAGHQKKILNSIHSMRVQISQSPTAMA,984,"109,885",Active site (1); Alternative sequence (3); Beta strand (17); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (3); Helix (19); Modified residue (2); Motif (1); Mutagenesis (5); Natural variant (13); Nucleotide binding (1); Sequence caution (3); Sequence conflict (22); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..17;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8TDW7,Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3),MDIIMGHCVGTRPPACCLILLLFKLLATVSQGLPGTGPLGFHFTHSIYNATVYENSAARTYVNSQSRMGITLIDLSWDIKYRIVSGDEEGFFKAEEVIIADFCFLRIRTKGGNSAILNREIQDNYLLIVKGSVRGEDLEAWTKVNIQVLDMNDLRPLFSPTTYSVTIAESTPLRTSVAQVTATDADIGSNGEFYYYFKNKVDLFSVHPTSGVISLSGRLNYDEKNRYDLEILAVDRGMKLYGNNGVSSTAKLYVHIERINEHAPTIHVVTHVPFSLEKEPTYAVVTVDDLDDGANGEIESVSIVAGDPLDQFFLAKEGKWLNEYKIKERKQIDWESFPYGYNLTLQAKDKGSPQKCSALKAVYIGNPTRDTVPIRFEKEVYDVSISEFSPPGVVVAIVKLSPEPIDVEYKLSPGEDAVYFKINPRSGLIVTARPLNTVKKEVYKLEVTNKEGDLKAQVTISIEDANDHTPEFQQPLYDAYVNESVPVGTSVLTVSASDKDKGENGYITYSIASLNLLPFVINQFTGVISTTEELDFESSPEIYRFIVRASDWGSPYRHESEVNVTIRIGNVNDNSPLFEKVACQGVISYDFPVGGHITAVSAIDIDELELVKYKIISGNELGFFYLNPDSGVLQLKKSLTNSGIKNGNFALRITATDGENLADPMSINISVLHGKVSSKSFSCRETRVAQKLAEKLLIKAKANGKLNLEDGFLDFYSINRQGPYFDKSFPSDVAVKEDLPVGANILKIKAYDADSGFNGKVLFTISDGNTDSCFNIDMETGQLKVLMPMDREHTDLYLLNITIYDLGNPQKSSWRLLTINVEDANDNSPVFIQDSYSVNILESSGIGTEIIQVEARDKDLGSNGEVTYSVLTDTQQFAINSSTGIVYVADQLDRESKANYSLKIEARDKAESGQQLFSVVTLKVFLDDVNDCSPAFIPSSYSVKVLEDLPVGTVIAWLETHDPDLGLGGQVRYSLVNDYNGRFEIDKASGAIRLSKELDYEKQQFYNLTVRAKDKGRPVSLSSVSFVEVEVVDVNENLHTPYFPDFAVVGSVKENSRIGTSVLQVTARDEDSGRDGEIQYSIRDGSGLGRFSIDDESGVITAADILDRETMGSYWLTVYATDRGVVPLYSTIEVYIEVEDVNDNAPLTSEPIYYPVVMENSPKDVSVIQIQAEDPDSSSNEKLTYRITSGNPQNFFAINIKTGLITTTSRKLDREQQAEHFLEVTVTDGGPSPKQSTIWVVVQVLDENDNKPQFPEKVYQIKLPERDRKKRGEPIYRAFAFDRDEGPNAEISYSIVDGNDDGKFFIDPKTGMVSSRKQFTAGSYDILTIKAVDNGRPQKSSTARLHIEWIKKPPPSPIPLTFDEPFYNFTVMESDRVTEIVGVVSVQPANTPLWFDIVGGNFDSAFDAEKGVGTIVIAKPLDAEQRSIYNMSVEVTDGTNVAVTQVFIKVLDNNDNGPEFSQPNYDVTISEDVLPDTEILQIEATDRDEKHKLSYTVHSSIDSISMRKFRIDPSTGVLYTAERLDHEAQDKHILNIMVRDQEFPYRRNLARVIVNVEDANDHSPYFTNPLYEASVFESAALGSAVLQVTALDKDKGENAELIYTIEAGNTGNMFKIEPVLGIITICKEPDMTTMGQFVLSIKVTDQGSPPMSATAIVRISVTMSDNSHPKFIHKDYQAEVNENVDIGTSVILISAISQSTLIYEVKDGDINGIFTINPYSGVITTQKALDYERTSSYQLIIQATNMAGMASNATVNIQIVDENDNAPVFLFSQYSGSLSEAAPINSIVRSLDNSPLVIRATDADSNRNALLVYQIVESTAKKFFTVDSSTGAIRTIANLDHETIAHFHFHVHVRDSGSPQLTAESPVEVNIEVTDVNDNPPVFTQAVFETILLLPTYVGVEVLKVSATDPDSEVPPELTYSLMEGSLDHFLIDSNSGVLTIKNNNLSKDHYMLIVKVSDGKFYSTSMVTIMVKEAMDSGLHFTQSFYSTSISENNTNITKVAIVNAVGNRLNEPLKYSILNPGNKFKIKSTSGVIQTTGVPFDREEQELYELVVEASRELDHLRVARVVVRVNIEDINDNSPVFVGLPYYAAVQVDAEPGTLIYQVTAIDKDKGPNGEVTYVLQDDYGHFEINPNSGNVILKEAFNSDLSNIEYGVTILAKDGGKPSLSTSVELPITIVNKAMPVFDKPFYTASVNEDIRMNTPILSINATSPEGQGIIYIIIDGDPFKQFNIDFDTGVLKVVSPLDYEVTSAYKLTIRASDALTGARAEVTVDLLVNDVNDNPPIFDQPTYNTTLSEASLIGTPVLQVVSIDADSENNKMVHYQIVQDTYNSTDYFHIDSSSGLILTARMLDHELVQHCTLKVRSIDSGFPSLSSEVLVHIYISDVNDNPPVFNQLIYESYVSELAPRGHFVTCVQASDADSSDFDRLEYSILSGNDRTSFLMDSKSGVITLSNHRKQRMEPLYSLNVSVSDGLFTSTAQVHIRVLGANLYSPAFSQSTYVAEVRENVAAGTKVIHVRATDGDPGTYGQISYAIINDFAKDRFLIDSNGQVITTERLDRENPLEGDVSIFVRALDGGGRTTFCTVRVIVVDENDNAPQFMTVEYRASVRADVGRGHLVTQVQAIDPDDGANSRITYSLYSEASVSVADLLEIDPDNGWMVTKGNFNQLKNTVLSFFVKAVDGGIPVKHSLIPVYIHVLPPETFLPSFTQSQYSFTIAEDTAIGSTVDTLRILPSQNVWFSTVNGERPENNKGGIFVIEQETGTIKLDKRLDRETSPAFHFKVAATIPLDKVDIVFTVDVDIKVLDLNDNKPVFETSSYDTIIMEGMPVGTKLTQVRAIDMDWGANGQVTYSLHSDSQPEKVMEAFNIDSNTGWISTLKDLDHETDPTFTFSVVASDLGEAFSLSSTALVSVRVTDINDNAPVFAQEVYRGNVKESDPPGEVVAVLSTWDRDTSDVNRQVSYHITGGNPRGRFALGLVQSEWKVYVKRPLDREEQDIYFLNITATDGLFVTQAMVEVSVSDVNDNSPVCDQVAYTALLPEDIPSNKIILKVSAKDADIGSNGYIRYSLYGSGNSEFFLDPESGELKTLALLDRERIPVYSLMAKATDGGGRFCQSNIHLILEDVNDNPPVFSSDHYNTCVYENTATKALLTRVQAVDPDIGINRKVVYSLADSAGGVFSIDSSSGIIILEQPLDREQQSSYNISVRATDQSPGQSLSSLTTVTITVLDINDNPPVFERRDYLVTVPEDTSPGTQVLAVFATSKDIGTNAEITYLIRSGNEQGKFKINPKTGGISVSEVLDYELCKRFYLVVEAKDGGTPALSAVATVNINLTDVNDNPPKFSQDVYSAVISEDALVGDSVILLIAEDVDSQPNGQIHFSIVNGDRDNEFTVDPVLGLVKVKKKLDRERVSGYSLLVQAVDSGIPAMSSTATVNIDISDVNDNSPVFTPANYTAVIQENKPVGTSILQLVVTDRDSFHNGPPFSFSILSGNEEEEFVLDPHGILRSAVVFQHTESLEYVLCVQAKDSGKPQQVSHTYIRVRVIEESTHKPTAIPLEIFIVTMEDDFPGGVIGKIHATDQDMYDVLTFALKSEQKSLFKVNSHDGKIIALGGLDSGKYVLNVSVSDGRFQVPIDVVVHVEQLVHEMLQNTVTIRFENVSPEDFVGLHMHGFRRTLRNAVLTQKQDSLRIISIQPVAGTNQLDMLFAVEMHSSEFYKPAYLIQKLSNARRHLENIMRISAILEKNCSGLDCQEQHCEQGLSLDSHALMTYSTARISFVCPRFYRNVRCTCNGGLCPGSNDPCVEKPCPGDMQCVSYEASRRPFLCQCPPGKLGECSGHTSLSFAGNSYIKYRLSENSKEEDFKLALRLRTLQSNGIIMYTRANPCIILKIVDGKLWFQLDCGSGPGILGISGRAVNDGSWHSVFLELNRNFTSLSLDDSYVERRRAPLYFQTLSTESSIYFGALVQADNIRSLTDTRVTQVLSGFQGCLDSVILNNNELPLQNKRSSFAEVVGLTELKLGCVLYPDACKRSPCQHGGSCTGLPSGGYQCTCLSQFTGRNCESEITACFPNPCRNGGSCDPIGNTFICNCKAGLTGVTCEEDINECEREECENGGSCVNVFGSFLCNCTPGYVGQYCGLRPVVVPNIQAGHSYVGKEELIGIAVVLFVIFILVVLFIVFRKKVFRKNYSRNNITLVQDPATAALLNKSNGIPFRNLRGSGDGRNVYQEVGPPQVPVRPMAYTPCFQSDSRSNLDKIVDGLGGEHQEMTTFHPESPRILTARRGVVVCSVAPNLPAVSPCRSDCDSIRKNGWDAGTENKGVDDPGEVTCFAGSNKGSNSEVQSLSSFQSDSGDDNAYHWDTSDWMPGARLSDIEEVPNYENQDGGSAHQGSTRELESDYYLGGYDIDSEYPPPHEEEFLSQDQLPPPLPEDFPDQYEALPPSQPVSLASTLSPDCRRRPQFHPSQYLPPHPFPNETDLVGPPASCEFSTFAVSMNQGTEPTGPADSVSLSLHNSRGTSSSDVSANCGFDDSEVAMSDYESVGELSLASLHIPFVETQHQTQV,4557,"501,978",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (13); Domain (38); Erroneous initiation (1); Glycosylation (26); Modified residue (1); Natural variant (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 3799..3810;  /evidence=""ECO:0000250""; DISULFID 3804..3822;  /evidence=""ECO:0000250""; DISULFID 3824..3832;  /evidence=""ECO:0000250""; DISULFID 3985..4018;  /evidence=""ECO:0000250""; DISULFID 4025..4036;  /evidence=""ECO:0000250""; DISULFID 4030..4046;  /evidence=""ECO:0000250""; DISULFID 4048..4057;  /evidence=""ECO:0000250""; DISULFID 4064..4075;  /evidence=""ECO:0000250""; DISULFID 4069..4084;  /evidence=""ECO:0000250""; DISULFID 4086..4095;  /evidence=""ECO:0000250""; DISULFID 4102..4113;  /evidence=""ECO:0000250""; DISULFID 4107..4122;  /evidence=""ECO:0000250""; DISULFID 4124..4133;  /evidence=""ECO:0000250""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
O95866,Megakaryocyte and platelet inhibitory receptor G6b (Protein G6b),MAVFLQLLPLLLSRAQGNPGASLDGRPGDRVNLSCGGVSHPIRWVWAPSFPACKGLSKGRRPILWASSSGTPTVPPLQPFVGRLRSLDSGIRRLELLLSAGDSGTFFCKGRHEDESRTVLHVLGDRTYCKAPGPTHGSVYPQLLIPLLGAGLVLGLGALGLVWWLHRRLPPQPIRPLPRFAPLVKTEPQRPVKEEEPKIPGDLDQEPSLLYADLDHLALSRPRRLSTADPADASTIYAVVV,241,"26,163",Alternative sequence (6); Beta strand (7); Chain (1); Glycosylation (1); Modified residue (1); Motif (2); Mutagenesis (4); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..17;  /evidence=""ECO:0000269|PubMed:12665801"""
Q8WXA8,5-hydroxytryptamine receptor 3C (5-HT3-C) (5-HT3C) (Serotonin receptor 3C),MEGGWPARQSALLCLTVSLLLQGRGDAFTINCSGFDQHGVDPAVFQAVFDRKAFRPFTNYSIPTRVNISFTLSAILGVDAQLQLLTSFLWMDLVWDNPFINWNPKECVGINKLTVLAENLWLPDIFIVESMDVDQTPSGLTAYISSEGRIKYDKPMRVTSICNLDIFYFPFDQQNCTFTFSSFLYTVDSMLLGMDKEVWEITDTSRKVIQTQGEWELLGINKATPKMSMGNNLYDQIMFYVAIRRRPSLYIINLLVPSSFLVAIDALSFYLPAESENRAPFKITLLLGYNVFLLMMNDLLPASGTPLISVYFALCLSLMVVSLLETVFITYLLHVATTQPPPMPRWLHSLLLHCTSPGRCCPTAPQKGNKGLGLTLTHLPGPKEPGELAGKKLGPRETEPDGGSGWTKTQLMELWVQFSHAMDTLLFRLYLLFMASSILTVIVLWNT,447,"50,220",Chain (1); Disulfide bond (1); Natural variant (3); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 162..176;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8WWV6,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351),MPLFLILCLLQGSSFALPQKRPHPRWLWEGSLPSRTHLRAMGTLRPSSPLCWREESSFAAPNSLKGSRLVSGEPGGAVTIQCHYAPSSVNRHQRKYWCRLGPPRWICQTIVSTNQYTHHRYRDRVALTDFPQRGLFVVRLSQLSPDDIGCYLCGIGSENNMLFLSMNLTISAGPASTLPTATPAAGELTMRSYGTASPVANRWTPGTTQTLGQGTAWDTVASTPGTSKTTASAEGRRTPGATRPAAPGTGSWAEGSVKAPAPIPESPPSKSRSMSNTTEGVWEGTRSSVTNRARASKDRREMTTTKADRPREDIEGVRIALDAAKKVLGTIGPPALVSETLAWEILPQATPVSKQQSQGSIGETTPAAGMWTLGTPAADVWILGTPAADVWTSMEAASGEGSAAGDLDAATGDRGPQATLSQTPAVGPWGPPGKESSVKRTFPEDESSSRTLAPVSTMLALFMLMALVLLQRKLWRRRTSQEAERVTLIQMTHFLEVNPQADQLPHVERKMLQDDSLPAGASLTAPERNPGP,532,"57,144",Alternative sequence (6); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (2); Glycosylation (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 82..153;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q8N441,Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5),MTPSPLLLLLLPPLLLGAFPPAAAARGPPKMADKVVPRQVARLGRTVRLQCPVEGDPPPLTMWTKDGRTIHSGWSRFRVLPQGLKVKQVEREDAGVYVCKATNGFGSLSVNYTLVVLDDISPGKESLGPDSSSGGQEDPASQQWARPRFTQPSKMRRRVIARPVGSSVRLKCVASGHPRPDITWMKDDQALTRPEAAEPRKKKWTLSLKNLRPEDSGKYTCRVSNRAGAINATYKVDVIQRTRSKPVLTGTHPVNTTVDFGGTTSFQCKVRSDVKPVIQWLKRVEYGAEGRHNSTIDVGGQKFVVLPTGDVWSRPDGSYLNKLLITRARQDDAGMYICLGANTMGYSFRSAFLTVLPDPKPPGPPVASSSSATSLPWPVVIGIPAGAVFILGTLLLWLCQAQKKPCTPAPAPPLPGHRPPGTARDRSGDKDLPSLAALSAGPGVGLCEEHGSPAAPQHLLGPGPVAGPKLYPKLYTDIHTHTHTHSHTHSHVEGKVHQHIHYQC,504,"54,537",Chain (1); Compositional bias (1); Disulfide bond (3); Domain (3); Glycosylation (4); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 172..221;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 268..338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
P40197,Platelet glycoprotein V (GPV) (Glycoprotein 5) (CD antigen CD42d),MLRGTLLCAVLGLLRAQPFPCPPACKCVFRDAAQCSGGDVARISALGLPTNLTHILLFGMGRGVLQSQSFSGMTVLQRLMISDSHISAVAPGTFSDLIKLKTLRLSRNKITHLPGALLDKMVLLEQLFLDHNALRGIDQNMFQKLVNLQELALNQNQLDFLPASLFTNLENLKLLDLSGNNLTHLPKGLLGAQAKLERLLLHSNRLVSLDSGLLNSLGALTELQFHRNHIRSIAPGAFDRLPNLSSLTLSRNHLAFLPSALFLHSHNLTLLTLFENPLAELPGVLFGEMGGLQELWLNRTQLRTLPAAAFRNLSRLRYLGVTLSPRLSALPQGAFQGLGELQVLALHSNGLTALPDGLLRGLGKLRQVSLRRNRLRALPRALFRNLSSLESVQLDHNQLETLPGDVFGALPRLTEVLLGHNSWRCDCGLGPFLGWLRQHLGLVGGEEPPRCAGPGAHAGLPLWALPGGDAECPGPRGPPPRPAADSSSEAPVHPALAPNSSEPWVWAQPVTTGKGQDHSPFWGFYFLLLAVQAMITVIIVFAMIKIGQLFRKLIRERALG,560,"60,959",Chain (1); Domain (2); Glycosylation (8); Repeat (13); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q92643,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),MAVTDSLSRAATVLATVLLLSFGSVAASHIEDQAEQFFRSGHTNNWAVLVCTSRFWFNYRHVANTLSVYRSVKRLGIPDSHIVLMLADDMACNPRNPKPATVFSHKNMELNVYGDDVEVDYRSYEVTVENFLRVLTGRIPPSTPRSKRLLSDDRSNILIYMTGHGGNGFLKFQDSEEITNIELADAFEQMWQKRRYNELLFIIDTCQGASMYERFYSPNIMALASSQVGEDSLSHQPDPAIGVHLMDRYTFYVLEFLEEINPASQTNMNDLFQVCPKSLCVSTPGHRTDLFQRDPKNVLITDFFGSVRKVEITTETIKLQQDSEIMESSYKEDQMDEKLMEPLKYAEQLPVAQIIHQKPKLKDWHPPGGFILGLWALIIMVFFKTYGIKHMKFIF,395,"45,252",Active site (2); Alternative sequence (1); Chain (1); Disulfide bond (1); Mutagenesis (5); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 92;  /note=""Interchain (with C-182 in PIGT)"";  /evidence=""ECO:0000269|PubMed:12582175""","SIGNAL 1..27;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:11483512"""
P25101,Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR),METLCLRASFWLALVGCVISDNPERYSTNLSNHVDDFTTFRGTELSFLVTTHQPTNLVLPSNGSMHNYCPQQTKITSAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLVTAIEIVSIWILSFILAIPEAIGFVMVPFEYRGEQHKTCMLNATSKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYNEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCYQSKSLMTSVPMNGTSIQWKNHDQNNHNTDRSSHKDSMN,427,"48,722",Alternative sequence (6); Chain (1); Disulfide bond (1); Glycosylation (2); Modified residue (1); Natural variant (3); Sequence conflict (10); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 158..239;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P01133,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)],MLLTLIILLPVVSKFSFVSLSAPQHWSCPEGTLAGNGNSTCVGPAPFLIFSHGNSIFRIDTEGTNYEQLVVDAGVSVIMDFHYNEKRIYWVDLERQLLQRVFLNGSRQERVCNIEKNVSGMAINWINEEVIWSNQQEGIITVTDMKGNNSHILLSALKYPANVAVDPVERFIFWSSEVAGSLYRADLDGVGVKALLETSEKITAVSLDVLDKRLFWIQYNREGSNSLICSCDYDGGSVHISKHPTQHNLFAMSLFGDRIFYSTWKMKTIWIANKHTGKDMVRINLHSSFVPLGELKVVHPLAQPKAEDDTWEPEQKLCKLRKGNCSSTVCGQDLQSHLCMCAEGYALSRDRKYCEDVNECAFWNHGCTLGCKNTPGSYYCTCPVGFVLLPDGKRCHQLVSCPRNVSECSHDCVLTSEGPLCFCPEGSVLERDGKTCSGCSSPDNGGCSQLCVPLSPVSWECDCFPGYDLQLDEKSCAASGPQPFLLFANSQDIRHMHFDGTDYGTLLSQQMGMVYALDHDPVENKIYFAHTALKWIERANMDGSQRERLIEEGVDVPEGLAVDWIGRRFYWTDRGKSLIGRSDLNGKRSKIITKENISQPRGIAVHPMAKRLFWTDTGINPRIESSSLQGLGRLVIASSDLIWPSGITIDFLTDKLYWCDAKQSVIEMANLDGSKRRRLTQNDVGHPFAVAVFEDYVWFSDWAMPSVMRVNKRTGKDRVRLQGSMLKPSSLVVVHPLAKPGADPCLYQNGGCEHICKKRLGTAWCSCREGFMKASDGKTCLALDGHQLLAGGEVDLKNQVTPLDILSKTRVSEDNITESQHMLVAEIMVSDQDDCAPVGCSMYARCISEGEDATCQCLKGFAGDGKLCSDIDECEMGVPVCPPASSKCINTEGGYVCRCSEGYQGDGIHCLDIDECQLGEHSCGENASCTNTEGGYTCMCAGRLSEPGLICPDSTPPPHLREDDHHYSVRNSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELRHAGHGQQQKVIVVAVCVVVLVMLLLLSLWGAHYYRTQKLLSKNPKNPYEESSRDVRSRRPADTEDGMSSCPQPWFVVIKEHQDLKNGGQPVAGEDGQAADGSMQPTSWRQEPQLCGMGTEQGCWIPVSSDKGSCPQVMERSFHMPSYGTQTLEGGVEKPHSLLSANPLWQQRALDPPHQMELTQ,1207,"133,994",Alternative sequence (2); Beta strand (5); Chain (2); Disulfide bond (27); Domain (9); Erroneous gene model prediction (1); Glycosylation (9); Natural variant (15); Region (1); Repeat (9); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 318..330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 325..339;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 341..354;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 360..371;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 367..380;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 382..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 401..412;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 408..421;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 423..436;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 439..451;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 447..461;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 463..476;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 745..756;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 752..765;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 767..780;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 835..846;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 840..855;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 857..868;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 874..888;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 881..897;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 899..910;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 916..929;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 923..938;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 940..951;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 976..990; DISULFID 984..1001; DISULFID 1003..1012","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P30532,Neuronal acetylcholine receptor subunit alpha-5,MAARGSGPRALRLLLLVQLVAGRCGLAGAAGGAQRGLSEPSSIAKHEDSLLKDLFQDYERWVRPVEHLNDKIKIKFGLAISQLVDVDEKNQLMTTNVWLKQEWIDVKLRWNPDDYGGIKVIRVPSDSVWTPDIVLFDNADGRFEGTSTKTVIRYNGTVTWTPPANYKSSCTIDVTFFPFDLQNCSMKFGSWTYDGSQVDIILEDQDVDKRDFFDNGEWEIVSATGSKGNRTDSCCWYPYVTYSFVIKRLPLFYTLFLIIPCIGLSFLTVLVFYLPSNEGEKICLCTSVLVSLTVFLLVIEEIIPSSSKVIPLIGEYLVFTMIFVTLSIMVTVFAINIHHRSSSTHNAMAPLVRKIFLHTLPKLLCMRSHVDRYFTQKEETESGSGPKSSRNTLEAALDSIRYITRHIMKENDVREVVEDWKFIAQVLDRMFLWTFLFVSIVGSLGLFVPVIYKWANILIPVHIGNANK,468,"53,054",Chain (1); Disulfide bond (2); Glycosylation (3); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (3); Transmembrane (4),"DISULFID 170..184;  /evidence=""ECO:0000250""; DISULFID 234..235;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q99965,Disintegrin and metalloproteinase domain-containing protein 2 (ADAM 2) (Cancer/testis antigen 15) (CT15) (Fertilin subunit beta) (PH-30) (PH30) (PH30-beta),MWRVLFLLSGLGGLRMDSNFDSLPVQITVPEKIRSIIKEGIESQASYKIVIEGKPYTVNLMQKNFLPHNFRVYSYSGTGIMKPLDQDFQNFCHYQGYIEGYPKSVVMVSTCTGLRGVLQFENVSYGIEPLESSVGFEHVIYQVKHKKADVSLYNEKDIESRDLSFKLQSVEPQQDFAKYIEMHVIVEKQLYNHMGSDTTVVAQKVFQLIGLTNAIFVSFNITIILSSLELWIDENKIATTGEANELLHTFLRWKTSYLVLRPHDVAFLLVYREKSNYVGATFQGKMCDANYAGGVVLHPRTISLESLAVILAQLLSLSMGITYDDINKCQCSGAVCIMNPEAIHFSGVKIFSNCSFEDFAHFISKQKSQCLHNQPRLDPFFKQQAVCGNAKLEAGEECDCGTEQDCALIGETCCDIATCRFKAGSNCAEGPCCENCLFMSKERMCRPSFEECDLPEYCNGSSASCPENHYVQTGHPCGLNQWICIDGVCMSGDKQCTDTFGKEVEFGPSECYSHLNSKTDVSGNCGISDSGYTQCEADNLQCGKLICKYVGKFLLQIPRATIIYANISGHLCIAVEFASDHADSQKMWIKDGTSCGSNKVCRNQRCVSSSYLGYDCTTDKCNDRGVCNNKKHCHCSASYLPPDCSVQSDLWPGGSIDSGNFPPVAIPARLPERRYIENIYHSKPMRWPFFLFIPFFIIFCVLIAIMVKVNFQRKKWRTEDYSSDEQPESESEPKG,735,"82,457",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Modified residue (1); Natural variant (1); Propeptide (1); Sequence conflict (16); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 287..370;  /evidence=""ECO:0000250""; DISULFID 329..354;  /evidence=""ECO:0000250""; DISULFID 331..336;  /evidence=""ECO:0000250""; DISULFID 445..465;  /evidence=""ECO:0000250""; DISULFID 616..627;  /evidence=""ECO:0000250""; DISULFID 621..633;  /evidence=""ECO:0000250""; DISULFID 635..644;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q86XM0,Cation channel sperm-associated protein subunit delta (CatSper-delta) (CatSperdelta) (Transmembrane protein 146),MLMLMLVAAVTMWLRPLVTAQLCRSRTVRTGKVFNLIQDVQGDRLYFHPTTTRLIKHPCEKNIALYLGKQVFFTMDNFETSLLPFTIPTSMQVGVPEVTSAHFAGSLLLLVVDQKVYIYDYENNSWSMSLGIKHPVTHVSGDNCCYTGSLFCVHVSNLVFAYFRGDQISQTYIYYSNTGGFSFWKYHYDRQAEIIGSLGGIFHFFSLSQVAMLVVNQGKGMFKYSDHPLNRSFGLSFDYNGTLDILIAPGQRGILLLWFENSLLFSHNAGQLVDTVRVKKGDQTLFSSIFEAKITIHNIAVTENELAVITREDNLYYGNLGIVPSSIIKFADQYIWSEDVALMFRSPGTLEILTPLRDTAFPAFDFQKCLVNIQALLMDPELHVGKCKIEFLTGEFIYRMYTIDMHSQLELTASLIPQPGTSLIPLVMVSNPHSLGFQATFYENGYTSDGNTKYKLDIFLKQQQHWGRTDSNFTSSLKKATMSTLTVDIANKEISCVDIKPLSTLISVGCDLDKKIVIQNKVSACSMGILDPLTLQDNYSFIIEKEFYDPGFQGQQSSEDLHVFYSYQQLGCPLLVYYDTLWKPVVELWRKDSFQEVIDAEYVLLEVNGQFSYSYSLTAQSAMCTSQPQNWTTMIKEFGGPFFWNRENYVSCHDPNNNAPLRWPDVQYQILGGRTANQIIFGHNGFYVFYISIVDPYYSYCQLETIFSIYVYGAFPVQLVSAGVVILLIISSILGSVWLAYKTPKLLRTARGRRIKKCATQLCRRCKTVCQFRASATARAGTEPPGRHRTPHGGRSDH,798,"90,468",Alternative sequence (3); Chain (1); Erroneous initiation (1); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q02413,Desmoglein-1 (Cadherin family member 4) (Desmosomal glycoprotein 1) (DG1) (DGI) (Pemphigus foliaceus antigen),MDWSFFRVVAMLFIFLVVVEVNSEFRIQVRDYNTKNGTIKWHSIRRQKREWIKFAAACREGEDNSKRNPIAKIHSDCAANQQVTYRISGVGIDQPPYGIFVINQKTGEINITSIVDREVTPFFIIYCRALNSMGQDLERPLELRVRVLDINDNPPVFSMATFAGQIEENSNANTLVMILNATDADEPNNLNSKIAFKIIRQEPSDSPMFIINRNTGEIRTMNNFLDREQYGQYALAVRGSDRDGGADGMSAECECNIKILDVNDNIPYMEQSSYTIEIQENTLNSNLLEIRVIDLDEEFSANWMAVIFFISGNEGNWFEIEMNERTNVGILKVVKPLDYEAMQSLQLSIGVRNKAEFHHSIMSQYKLKASAISVTVLNVIEGPVFRPGSKTYVVTGNMGSNDKVGDFVATDLDTGRPSTTVRYVMGNNPADLLAVDSRTGKLTLKNKVTKEQYNMLGGKYQGTILSIDDNLQRTCTGTININIQSFGNDDRTNTEPNTKITTNTGRQESTSSTNYDTSTTSTDSSQVYSSEPGNGAKDLLSDNVHFGPAGIGLLIMGFLVLGLVPFLMICCDCGGAPRSAAGFEPVPECSDGAIHSWAVEGPQPEPRDITTVIPQIPPDNANIIECIDNSGVYTNEYGGREMQDLGGGERMTGFELTEGVKTSGMPEICQEYSGTLRRNSMRECREGGLNMNFMESYFCQKAYAYADEDEGRPSNDCLLIYDIEGVGSPAGSVGCCSFIGEDLDDSFLDTLGPKFKKLADISLGKESYPDLDPSWPPQSTEPVCLPQETEPVVSGHPPISPHFGTTTVISESTYPSGPGVLHPKPILDPLGYGNVTVTESYTTSDTLKPSVHVHDNRPASNVVVTERVVGPISGADLHGMLEMPDLRDGSNVIVTERVIAPSSSLPTSLTIHHPRESSNVVVTERVIQPTSGMIGSLSMHPELANAHNVIVTERVVSGAGVTGISGTTGISGGIGSSGLVGTSMGAGSGALSGAGISGGGIGLSSLGGTASIGHMRSSSDHHFNQTIGSASPSTARSRITKYSTVQYSK,1049,"113,748",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (4); Glycosylation (3); Modified residue (1); Natural variant (10); Propeptide (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9NQ60,Equatorin (Acrosome formation-associated factor),MNFILFIFIPGVFSLKSSTLKPTIEALPNVLPLNEDVNKQEEKNEDHTPNYAPANEKNGNYYKDIKQYVFTTQNPNGTESEISVRATTDLNFALKNDKTVNATTYEKSTIEEETTTSEPSHKNIQRSTPNVPAFWTMLAKAINGTAVVMDDKDQLFHPIPESDVNATQGENQPDLEDLKIKIMLGISLMTLLLFVVLLAFCSATLYKLRHLSYKSCESQYSVNPELATMSYFHPSEGVSDTSFSKSAESSTFLGTTSSDMRRSGTRTSESKIMTDIISIGSDNEMHENDESVTR,294,"32,840",Alternative sequence (3); Chain (1); Glycosylation (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLPALDGARVDFRCDPDFHLVGSSRSICSQGQWSTPKPHCQVNRTPHSERRAVYIGALFPMSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKCDPGQATKYLYELLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNLKRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDEMTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFYGYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGSRVHLLYK,961,"108,320",Alternative sequence (4); Beta strand (31); Binding site (6); Chain (1); Coiled coil (1); Disulfide bond (4); Domain (2); Glycosylation (7); Helix (27); Modified residue (2); Mutagenesis (6); Natural variant (3); Region (1); Sequence conflict (9); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (10),"DISULFID 100..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 131..157;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 220..246;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302, ECO:0000269|PubMed:24305054""; DISULFID 376..410;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302, ECO:0000269|PubMed:24305054""","SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q05901,Neuronal acetylcholine receptor subunit beta-3,MLPDFMLVLIVLGIPSSATTGFNSIAENEDALLRHLFQGYQKWVRPVLHSNDTIKVYFGLKISQLVDVDEKNQLMTTNVWLKQEWTDHKLRWNPDDYGGIHSIKVPSESLWLPDIVLFENADGRFEGSLMTKVIVKSNGTVVWTPPASYKSSCTMDVTFFPFDRQNCSMKFGSWTYDGTMVDLILINENVDRKDFFDNGEWEILNAKGMKGNRRDGVYSYPFITYSFVLRRLPLFYTLFLIIPCLGLSFLTVLVFYLPSDEGEKLSLSTSVLVSLTVFLLVIEEIIPSSSKVIPLIGEYLLFIMIFVTLSIIVTVFVINVHHRSSSTYHPMAPWVKRLFLQKLPKLLCMKDHVDRYSSPEKEESQPVVKGKVLEKKKQKQLSDGEKVLVAFLEKAADSIRYISRHVKKEHFISQVVQDWKFVAQVLDRIFLWLFLIVSVTGSVLIFTPALKMWLHSYH,458,"52,729",Chain (1); Disulfide bond (1); Glycosylation (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 153..167;  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9H013,Disintegrin and metalloproteinase domain-containing protein 19 (ADAM 19) (EC 3.4.24.-) (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker) (MADDAM),MPGGAGAARLCLLAFALQPLRPRAAREPGWTRGSEEGSPKLQHELIIPQWKTSESPVREKHPLKAELRVMAEGRELILDLEKNEQLFAPSYTETHYTSSGNPQTTTRKLEDHCFYHGTVRETELSSVTLSTCRGIRGLITVSSNLSYVIEPLPDSKGQHLIYRSEHLKPPPGNCGFEHSKPTTRDWALQFTQQTKKRPRRMKREDLNSMKYVELYLVADYLEFQKNRRDQDATKHKLIEIANYVDKFYRSLNIRIALVGLEVWTHGNMCEVSENPYSTLWSFLSWRRKLLAQKYHDNAQLITGMSFHGTTIGLAPLMAMCSVYQSGGVNMDHSENAIGVAATMAHEMGHNFGMTHDSADCCSASAADGGCIMAAATGHPFPKVFNGCNRRELDRYLQSGGGMCLSNMPDTRMLYGGRRCGNGYLEDGEECDCGEEEECNNPCCNASNCTLRPGAECAHGSCCHQCKLLAPGTLCREQARQCDLPEFCTGKSPHCPTNFYQMDGTPCEGGQAYCYNGMCLTYQEQCQQLWGPGARPAPDLCFEKVNVAGDTFGNCGKDMNGEHRKCNMRDAKCGKIQCQSSEARPLESNAVPIDTTIIMNGRQIQCRGTHVYRGPEEEGDMLDPGLVMTGTKCGYNHICFEGQCRNTSFFETEGCGKKCNGHGVCNNNQNCHCLPGWAPPFCNTPGHGGSIDSGPMPPESVGPVVAGVLVAILVLAVLMLMYYCCRQNNKLGQLKPSALPSKLRQQFSCPFRVSQNSGTGHANPTFKLQTPQGKRKVINTPEILRKPSQPPPRPPPDYLRGGSPPAPLPAHLSRAARNSPGPGSQIERTESSRRPPPSRPIPPAPNCIVSQDFSRPRPPQKALPANPVPGRRSLPRPGGASPLRPPGAGPQQSRPLAALAPKVSPREALKVKAGTRGLQGGRCRVEKTKQFMLLVVWTELPEQKPRAKHSCFLVPA,955,"104,997",Active site (1); Alternative sequence (1); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (3); Glycosylation (4); Metal binding (4); Motif (2); Natural variant (4); Propeptide (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 320..403;  /evidence=""ECO:0000250""; DISULFID 360..387;  /evidence=""ECO:0000250""; DISULFID 361..370;  /evidence=""ECO:0000250""; DISULFID 474..494;  /evidence=""ECO:0000250""; DISULFID 654..664;  /evidence=""ECO:0000250""; DISULFID 658..670;  /evidence=""ECO:0000250""; DISULFID 672..681;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q6QNK2,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),MEKLLRLCCWYSWLLLFYYNFQVRGVYSRSQDHPGFQVLASASHYWPLENVDGIHELQDTTGDIVEGKVNKGIYLKEEKGVTLLYYGRYNSSCISKPEQCGPEGVTFSFFWKTQGEQSRPIPSAYGGQVISNGFKVCSSGGRGSVELYTRDNSMTWEASFSPPGPYWTHVLFTWKSKEGLKVYVNGTLSTSDPSGKVSRDYGESNVNLVIGSEQDQAKCYENGAFDEFIIWERALTPDEIAMYFTAAIGKHALLSSTLPSLFMTSTASPVMPTDAYHPIITNLTEERKTFQSPGVILSYLQNVSLSLPSKSLSEQTALNLTKTFLKAVGEILLLPGWIALSEDSAVVLSLIDTIDTVMGHVSSNLHGSTPQVTVEGSSAMAEFSVAKILPKTVNSSHYRFPAHGQSFIQIPHEAFHRHAWSTVVGLLYHSMHYYLNNIWPAHTKIAEAMHHQDCLLFATSHLISLEVSPPPTLSQNLSGSPLITVHLKHRLTRKQHSEATNSSNRVFVYCAFLDFSSGEGVWSNHGCALTRGNLTYSVCRCTHLTNFAILMQVVPLELARGHQVALSSISYVGCSLSVLCLVATLVTFAVLSSVSTIRNQRYHIHANLSFAVLVAQVLLLISFRLEPGTTPCQVMAVLLHYFFLSAFAWMLVEGLHLYSMVIKVFGSEDSKHRYYYGMGWGFPLLICIISLSFAMDSYGTSNNCWLSLASGAIWAFVAPALFVIVVNIGILIAVTRVISQISADNYKIHGDPSAFKLTAKAVAVLLPILGTSWVFGVLAVNGCAVVFQYMFATLNSLQGLFIFLFHCLLNSEVRAAFKHKTKVWSLTSSSARTSNAKPFHSDLMNGTRPGMASTKLSPWDKSSHSAHRVDLSAV,874,"96,530",Alternative sequence (5); Chain (1); Domain (2); Glycosylation (9); Motif (1); Mutagenesis (6); Natural variant (105); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
O60241,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),MENTGWMGKGHRMTPACPLLLSVILSLRLATAFDPAPSACSALASGVLYGAFSLQDLFPTIASGCSWTLENPDPTKYSLYLRFNRQEQVCAHFAPRLLPLDHYLVNFTCLRPSPEEAVAQAESEVGRPEEEEAEAAAGLELCSGSGPFTFLHFDKNFVQLCLSAEPSEAPRLLAPAALAFRFVEVLLINNNNSSQFTCGVLCRWSEECGRAAGRACGFAQPGCSCPGEAGAGSTTTTSPGPPAAHTLSNALVPGGPAPPAEADLHSGSSNDLFTTEMRYGEEPEEEPKVKTQWPRSADEPGLYMAQTGDPAAEEWSPWSVCSLTCGQGLQVRTRSCVSSPYGTLCSGPLRETRPCNNSATCPVHGVWEEWGSWSLCSRSCGRGSRSRMRTCVPPQHGGKACEGPELQTKLCSMAACPVEGQWLEWGPWGPCSTSCANGTQQRSRKCSVAGPAWATCTGALTDTRECSNLECPATDSKWGPWNAWSLCSKTCDTGWQRRFRMCQATGTQGYPCEGTGEEVKPCSEKRCPAFHEMCRDEYVMLMTWKKAAAGEIIYNKCPPNASGSASRRCLLSAQGVAYWGLPSFARCISHEYRYLYLSLREHLAKGQRMLAGEGMSQVVRSLQELLARRTYYSGDLLFSVDILRNVTDTFKRATYVPSADDVQRFFQVVSFMVDAENKEKWDDAQQVSPGSVHLLRVVEDFIHLVGDALKAFQSSLIVTDNLVISIQREPVSAVSSDITFPMRGRRGMKDWVRHSEDRLFLPKEVLSLSSPGKPATSGAAGSPGRGRGPGTVPPGPGHSHQRLLPADPDESSYFVIGAVLYRTLGLILPPPRPPLAVTSRVMTVTVRPPTQPPAEPLITVELSYIINGTTDPHCASWDYSRADASSGDWDTENCQTLETQAAHTRCQCQHLSTFAVLAQPPKDLTLELAGSPSVPLVIGCAVSCMALLTLLAIYAAFWRFIKSERSIILLNFCLSILASNILILVGQSRVLSKGVCTMTAAFLHFFFLSSFCWVLTEAWQSYLAVIGRMRTRLVRKRFLCLGWGLPALVVAVSVGFTRTKGYGTSSYCWLSLEGGLLYAFVGPAAVIVLVNMLIGIIVFNKLMARDGISDKSKKQRAGSERCPWASLLLPCSACGAVPSPLLSSASARNAMASLWSSCVVLPLLALTWMSAVLAMTDRRSVLFQALFAVFNSAQGFVITAVHCFLRREVQDVVKCQMGVCRADESEDSPDSCKNGQLQILSDFEKDVDLACQTVLFKEVNTCNPSTITGTLSRLSLDEDEEPKSCLVGPEGSLSFSPLPGNILVPMAASPGLGEPPPPQEANPVYMCGEGGLRQLDLTWLRPTEPGSEGDYMVLPRRTLSLQPGGGGGGGEDAPRARPEGTPRRAAKTVAHTEGYPSFLSVDHSGLGLGPAYGSLQNPYGMTFQPPPPTPSARQVPEPGERSRTMPRTVPGSTMKMGSLERKKLRYSDLDFEKVMHTRKRHSELYHELNQKFHTFDRYRSQSTAKREKRWSVSSGGAAERSVCTDKPSPGERPSLSQHRRHQSWSTFKSMTLGSLPPKPRERLTLHRAAAWEPTEPPDGDFQTEV,1585,"172,656",Alternative sequence (3); Chain (1); Compositional bias (6); Disulfide bond (16); Domain (5); Erroneous initiation (1); Glycosylation (8); Modified residue (1); Mutagenesis (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 321..355;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 325..361;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 336..345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 376..411;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 380..416;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 391..401;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 431..466;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 435..471;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 446..456;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 487..522;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 491..527;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 502..512;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 534..569;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 557..587;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 874..906;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 894..908;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
P20023,Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21),MGAAGLLGVFLALVAPGVLGISCGSPPPILNGRISYYSTPIAVGTVIRYSCSGTFRLIGEKSLLCITKDKVDGTWDKPAPKCEYFNKYSSCPEPIVPGGYKIRGSTPYRHGDSVTFACKTNFSMNGNKSVWCQANNMWGPTRLPTCVSVFPLECPALPMIHNGHHTSENVGSIAPGLSVTYSCESGYLLVGEKIINCLSSGKWSAVPPTCEEARCKSLGRFPNGKVKEPPILRVGVTANFFCDEGYRLQGPPSSRCVIAGQGVAWTKMPVCEEIFCPSPPPILNGRHIGNSLANVSYGSIVTYTCDPDPEEGVNFILIGESTLRCTVDSQKTGTWSGPAPRCELSTSAVQCPHPQILRGRMVSGQKDRYTYNDTVIFACMFGFTLKGSKQIRCNAQGTWEPSAPVCEKECQAPPNILNGQKEDRHMVRFDPGTSIKYSCNPGYVLVGEESIQCTSEGVWTPPVPQCKVAACEATGRQLLTKPQHQFVRPDVNSSCGEGYKLSGSVYQECQGTIPWFMEIRLCKEITCPPPPVIYNGAHTGSSLEDFPYGTTVTYTCNPGPERGVEFSLIGESTIRCTSNDQERGTWSGPAPLCKLSLLAVQCSHVHIANGYKISGKEAPYFYNDTVTFKCYSGFTLKGSSQIRCKADNTWDPEIPVCEKETCQHVRQSLQELPAGSRVELVNTSCQDGYQLTGHAYQMCQDAENGIWFKKIPLCKVIHCHPPPVIVNGKHTGMMAENFLYGNEVSYECDQGFYLLGEKKLQCRSDSKGHGSWSGPSPQCLRSPPVTRCPNPEVKHGYKLNKTHSAYSHNDIVYVDCNPGFIMNGSRVIRCHTDNTWVPGVPTCIKKAFIGCPPPPKTPNGNHTGGNIARFSPGMSILYSCDQGYLLVGEALLLCTHEGTWSQPAPHCKEVNCSSPADMDGIQKGLEPRKMYQYGAVVTLECEDGYMLEGSPQSQCQSDHQWNPPLAVCRSRSLAPVLCGIAAGLILLTFLIVITLYVISKHRARNYYTDTSQKEAFHLEAREVYSVDPYNPAS,1033,"112,916",Alternative sequence (4); Beta strand (15); Chain (1); Disulfide bond (30); Domain (15); Frameshift (1); Glycosylation (11); Mutagenesis (3); Natural variant (3); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 23..65;  /evidence=""ECO:0000244|PDB:1GHQ, ECO:0000244|PDB:1LY2, ECO:0000244|PDB:3OED, ECO:0000269|PubMed:11387479, ECO:0000269|PubMed:12122212, ECO:0000269|PubMed:21527715""; DISULFID 51..82;  /evidence=""ECO:0000244|PDB:1GHQ, ECO:0000244|PDB:1LY2, ECO:0000244|PDB:3OED, ECO:0000269|PubMed:11387479, ECO:0000269|PubMed:12122212, ECO:0000269|PubMed:21527715""; DISULFID 91..132;  /evidence=""ECO:0000244|PDB:1GHQ, ECO:0000244|PDB:1LY2, ECO:0000244|PDB:3OED, ECO:0000269|PubMed:11387479, ECO:0000269|PubMed:12122212, ECO:0000269|PubMed:21527715""; DISULFID 118..146;  /evidence=""ECO:0000244|PDB:1GHQ, ECO:0000244|PDB:1LY2, ECO:0000244|PDB:3OED, ECO:0000269|PubMed:11387479, ECO:0000269|PubMed:12122212, ECO:0000269|PubMed:21527715""; DISULFID 154..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 183..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 215..256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 242..271;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 276..325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 305..342;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 351..393;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 379..406;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 410..453;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 439..466;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 471..509;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 495..522;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 527..576;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 556..593;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 602..644;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 630..657;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 662..699;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 685..714;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 719..762;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 748..779;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 788..830;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 816..843;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 851..894;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 880..907;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 912..955;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 941..968;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""",SIGNAL 1..20
P07333,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTLYSDGSSSILSTNNATFQNTGTYRCTEPGDPLGGSAAIHLYVKDPARPWNVLAQEVVVFEDQDALLPCLLTDPVLEAGVSLVRVRGRPLMRHTNYSFSPWHGFTIHRAKFIQSQDYQCSALMGGRKVMSISIRLKVQKVIPGPPALTLVPAELVRIRGEAAQIVCSASSVDVNFDVFLQHNNTKLAIPQQSDFHNNRYQKVLTLNLDQVDFQHAGNYSCVASNVQGKHSTSMFFRVVESAYLNLSSEQNLIQEVTVGEGLNLKVMVEAYPGLQGFNWTYLGPFSDHQPEPKLANATTKDTYRHTFTLSLPRLKPSEAGRYSFLARNPGGWRALTFELTLRYPPEVSVIWTFINGSGTLLCAASGYPQPNVTWLQCSGHTDRCDEAQVLQVWDDPYPEVLSQEPFHKVTVQSLLTVETLEHNQTYECRAHNSVGSGSWAFIPISAGAHTHPPDEFLFTPVVVACMSIMALLLLLLLLLLYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLSPGQDPEGGVDYKNIHLEKKYVRRDSGFSSQGVDTYVEMRPVSTSSNDSFSEQDLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERDYTNLPSSSRSGGSGSSSSELEEESSSEHLTCCEQGDIAQPLLQPNNYQFC,972,"107,984",Active site (1); Alternative sequence (2); Beta strand (55); Binding site (1); Chain (1); Disulfide bond (4); Domain (6); Glycosylation (11); Helix (21); Modified residue (9); Mutagenesis (5); Natural variant (37); Nucleotide binding (1); Region (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 42..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 127..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 224..278;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 419..485;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P09603,Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1],MTAPGAAGRCPPTTWLGSLLLLVCLLASRSITEEVSEYCSHMIGSGHLQSLQRLIDSQMETSCQITFEFVDQEQLKDPVCYLKKAFLLVQDIMEDTMRFRDNTPNAIAIVQLQELSLRLKSCFTKDYEEHDKACVRTFYETPLQLLEKVKNVFNETKNLLDKDWNIFSKNCNNSFAECSSQDVVTKPDCNCLYPKAIPSSDPASVSPHQPLAPSMAPVAGLTWEDSEGTEGSSLLPGEQPLHTVDPGSAKQRPPRSTCQSFEPPETPVVKDSTIGGSPQPRPSVGAFNPGMEDILDSAMGTNWVPEEASGEASEIPVPQGTELSPSRPGGGSMQTEPARPSNFLSASSPLPASAKGQQPADVTGTALPRVGPVRPTGQDWNHTPQKTDHPSALLRDPPEPGSPRISSLRPQGLSNPSTLSAQPQLSRSHSSGSVLPLGELEGRRSTRDRRSPAEPEGGPASEGAARPLPRFNSVPLTDTGHERQSEGSFSPQLQESVFHLLVPSVILVLLAVGGLLFYRWRRRSHQEPQRADSPLEQPEGSPLTQDDRQVELPV,554,"60,179",Alternative sequence (2); Beta strand (2); Chain (2); Disulfide bond (6); Glycosylation (4); Helix (9); Modified residue (1); Mutagenesis (1); Natural variant (6); Region (1); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 39..122;  /evidence=""ECO:0000269|PubMed:8422357""; DISULFID 63;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:8422357""; DISULFID 80..171;  /evidence=""ECO:0000269|PubMed:8422357""; DISULFID 134..178;  /evidence=""ECO:0000269|PubMed:8422357""; DISULFID 189;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:8422357""; DISULFID 191;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:8422357""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:3498652"""
P50895,Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239),MEPPDAPAQARGAPRLLLLAVLLAAHPDAQAEVRLSVPPLVEVMRGKSVILDCTPTGTHDHYMLEWFLTDRSGARPRLASAEMQGSELQVTMHDTRGRSPPYQLDSQGRLVLAEAQVGDERDYVCVVRAGAAGTAEATARLNVFAKPEATEVSPNKGTLSVMEDSAQEIATCNSRNGNPAPKITWYRNGQRLEVPVEMNPEGYMTSRTVREASGLLSLTSTLYLRLRKDDRDASFHCAAHYSLPEGRHGRLDSPTFHLTLHYPTEHVQFWVGSPSTPAGWVREGDTVQLLCRGDGSPSPEYTLFRLQDEQEEVLNVNLEGNLTLEGVTRGQSGTYGCRVEDYDAADDVQLSKTLELRVAYLDPLELSEGKVLSLPLNSSAVVNCSVHGLPTPALRWTKDSTPLGDGPMLSLSSITFDSNGTYVCEASLPTVPVLSRTQNFTLLVQGSPELKTAEIEPKADGSWREGDEVTLICSARGHPDPKLSWSQLGGSPAEPIPGRQGWVSSSLTLKVTSALSRDGISCEASNPHGNKRHVFHFGTVSPQTSQAGVAVMAVAVSVGLLLLVVAVFYCVRRKGGPCCRQRREKGAPPPGEPGLSHSGSEQPEQTGLLMGGASGGARGGSGGFGDEC,628,"67,405",Beta strand (18); Chain (1); Disulfide bond (5); Domain (5); Erroneous gene model prediction (1); Glycosylation (5); Helix (4); Modified residue (4); Mutagenesis (1); Natural variant (8); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17638854""; DISULFID 172..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17638854""; DISULFID 291..337;  /evidence=""ECO:0000305|PubMed:17638854""; DISULFID 384..424;  /evidence=""ECO:0000305|PubMed:17638854""; DISULFID 473..522;  /evidence=""ECO:0000305|PubMed:17638854""","SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:7777537"""
P56817,Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),MAQALPWLLLWMGAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTLMTIAYVMAAICALFMLPLCLMVCQWRCLRCLRQQHDDFADDISLLK,501,"55,764",Active site (2); Alternative sequence (4); Beta strand (26); Chain (1); Cross-link (1); Disulfide bond (3); Domain (1); Frameshift (1); Glycosylation (4); Helix (13); Lipidation (4); Modified residue (8); Motif (1); Mutagenesis (6); Natural variant (2); Propeptide (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 216..420;  /evidence=""ECO:0000269|PubMed:11953458""; DISULFID 278..443;  /evidence=""ECO:0000269|PubMed:11953458""; DISULFID 330..380;  /evidence=""ECO:0000269|PubMed:11953458""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P20594,Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B),MALPSLLLLVAALAGGVRPPGARNLTLAVVLPEHNLSYAWAWPRVGPAVALAVEALGRALPVDLRFVSSELEGACSEYLAPLSAVDLKLYHDPDLLLGPGCVYPAASVARFASHWRLPLLTAGAVASGFSAKNDHYRTLVRTGPSAPKLGEFVVTLHGHFNWTARAALLYLDARTDDRPHYFTIEGVFEALQGSNLSVQHQVYAREPGGPEQATHFIRANGRIVYICGPLEMLHEILLQAQRENLTNGDYVFFYLDVFGESLRAGPTRATGRPWQDNRTREQAQALREAFQTVLVITYREPPNPEYQEFQNRLLIRAREDFGVELGPSLMNLIAGCFYDGILLYAEVLNETIQEGGTREDGLRIVEKMQGRRYHGVTGLVVMDKNNDRETDFVLWAMGDLDSGDFQPAAHYSGAEKQIWWTGRPIPWVKGAPPSDNPPCAFDLDDPSCDKTPLSTLAIVALGTGITFIMFGVSSFLIFRKLMLEKELASMLWRIRWEELQFGNSERYHKGAGSRLTLSLRGSSYGSLMTAHGKYQIFANTGHFKGNVVAIKHVNKKRIELTRQVLFELKHMRDVQFNHLTRFIGACIDPPNICIVTEYCPRGSLQDILENDSINLDWMFRYSLINDLVKGMAFLHNSIISSHGSLKSSNCVVDSRFVLKITDYGLASFRSTAEPDDSHALYAKKLWTAPELLSGNPLPTTGMQKADVYSFGIILQEIALRSGPFYLEGLDLSPKEIVQKVRNGQRPYFRPSIDRTQLNEELVLLMERCWAQDPAERPDFGQIKGFIRRFNKEGGTSILDNLLLRMEQYANNLEKLVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAIIDNFDVYKVETIGDAYMVVSGLPGRNGQRHAPEIARMALALLDAVSSFRIRHRPHDQLRLRIGVHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGQALKIHVSSTTKDALDELGCFQLELRGDVEMKGKGKMRTYWLLGERKGPPGLL,1047,"117,022",Alternative sequence (1); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (7); Modified residue (7); Mutagenesis (1); Natural variant (24); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 75..101;  /evidence=""ECO:0000250""; DISULFID 439;  /note=""Interchain"";  /evidence=""ECO:0000305""; DISULFID 448;  /note=""Interchain"";  /evidence=""ECO:0000305""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P22223,Cadherin-3 (Placental cadherin) (P-cadherin),MGLPRGPLASLLLLQVCWLQCAASEPCRAVFREAEVTLEAGGAEQEPGQALGKVFMGCPGQEPALFSTDNDDFTVRNGETVQERRSLKERNPLKIFPSKRILRRHKRDWVVAPISVPENGKGPFPQRLNQLKSNKDRDTKIFYSITGPGADSPPEGVFAVEKETGWLLLNKPLDREEIAKYELFGHAVSENGASVEDPMNISIIVTDQNDHKPKFTQDTFRGSVLEGVLPGTSVMQVTATDEDDAIYTYNGVVAYSIHSQEPKDPHDLMFTIHRSTGTISVISSGLDREKVPEYTLTIQATDMDGDGSTTTAVAVVEILDANDNAPMFDPQKYEAHVPENAVGHEVQRLTVTDLDAPNSPAWRATYLIMGGDDGDHFTITTHPESNQGILTTRKGLDFEAKNQHTLYVEVTNEAPFVLKLPTSTATIVVHVEDVNEAPVFVPPSKVVEVQEGIPTGEPVCVYTAEDPDKENQKISYRILRDPAGWLAMDPDSGQVTAVGTLDREDEQFVRNNIYEVMVLAMDNGSPPTTGTGTLLLTLIDVNDHGPVPEPRQITICNQSPVRQVLNITDKDLSPHTSPFQAQLTDDSDIYWTAEVNEEGDTVVLSLKKFLKQDTYDVHLSLSDHGNKEQLTVIRATVCDCHGHVETCPGPWKGGFILPVLGAVLALLFLLLVLLLLVRKKRKIKEPLLLPEDDTRDNVFYYGEEGGGEEDQDYDITQLHRGLEARPEVVLRNDVAPTIIPTPMYRPRPANPDEIGNFIIENLKAANTDPTAPPYDTLLVFDYEGSGSDAASLSSLTSSASDQDQDYDYLNEWGSRFKKLADMYGGGEDD,829,"91,418",Alternative sequence (1); Beta strand (20); Chain (1); Compositional bias (1); Domain (5); Glycosylation (2); Helix (2); Natural variant (5); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9NPA0,ER membrane protein complex subunit 7,MAAALWGFFPVLLLLLLSGDVQSSEVPGAAAEGSGGSGVGIGDRFKIEGRAVVPGVKPQDWISAARVLVDGEEHVGFLKTDGSFVVHDIPSGSYVVEVVSPAYRFDPVRVDITSKGKMRARYVNYIKTSEVVRLPYPLQMKSSGPPSYFIKRESWGWTDFLMNPMVMMMVLPLLIFVLLPKVVNTSDPDMRREMEQSMNMLNSNHELPDVSEFMTRLFSSKSSGKSSSGSSKTGKSGAGKRR,242,"26,471",Beta strand (9); Chain (1); Helix (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..23;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:32439656"""
Q14517,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",MGRHLALLLLLLLLFQHFGDSDGSQRLEQTPLQFTHLEYNVTVQENSAAKTYVGHPVKMGVYITHPAWEVRYKIVSGDSENLFKAEEYILGDFCFLRIRTKGGNTAILNREVKDHYTLIVKALEKNTNVEARTKVRVQVLDTNDLRPLFSPTSYSVSLPENTAIRTSIARVSATDADIGTNGEFYYSFKDRTDMFAIHPTSGVIVLTGRLDYLETKLYEMEILAADRGMKLYGSSGISSMAKLTVHIEQANECAPVITAVTLSPSELDRDPAYAIVTVDDCDQGANGDIASLSIVAGDLLQQFRTVRSFPGSKEYKVKAIGGIDWDSHPFGYNLTLQAKDKGTPPQFSSVKVIHVTSPQFKAGPVKFEKDVYRAEISEFAPPNTPVVMVKAIPAYSHLRYVFKSTPGKAKFSLNYNTGLISILEPVKRQQAAHFELEVTTSDRKASTKVLVKVLGANSNPPEFTQTAYKAAFDENVPIGTTVMSLSAVDPDEGENGYVTYSIANLNHVPFAIDHFTGAVSTSENLDYELMPRVYTLRIRASDWGLPYRREVEVLATITLNNLNDNTPLFEKINCEGTIPRDLGVGEQITTVSAIDADELQLVQYQIEAGNELDFFSLNPNSGVLSLKRSLMDGLGAKVSFHSLRITATDGENFATPLYINITVAASHKLVNLQCEETGVAKMLAEKLLQANKLHNQGEVEDIFFDSHSVNAHIPQFRSTLPTGIQVKENQPVGSSVIFMNSTDLDTGFNGKLVYAVSGGNEDSCFMIDMETGMLKILSPLDRETTDKYTLNITVYDLGIPQKAAWRLLHVVVVDANDNPPEFLQESYFVEVSEDKEVHSEIIQVEATDKDLGPNGHVTYSIVTDTDTFSIDSVTGVVNIARPLDRELQHEHSLKIEARDQAREEPQLFSTVVVKVSLEDVNDNPPTFIPPNYRVKVREDLPEGTVIMWLEAHDPDLGQSGQVRYSLLDHGEGNFDVDKLSGAVRIVQQLDFEKKQVYNLTVRAKDKGKPVSLSSTCYVEVEVVDVNENLHPPVFSSFVEKGTVKEDAPVGSLVMTVSAHDEDARRDGEIRYSIRDGSGVGVFKIGEETGVIETSDRLDRESTSHYWLTVFATDQGVVPLSSFIEIYIEVEDVNDNAPQTSEPVYYPEIMENSPKDVSVVQIEAFDPDSSSNDKLMYKITSGNPQGFFSIHPKTGLITTTSRKLDREQQDEHILEVTVTDNGSPPKSTIARVIVKILDENDNKPQFLQKFYKIRLPEREKPDRERNARREPLYHVIATDKDEGPNAEISYSIEDGNEHGKFFIEPKTGVVSSKRFSAAGEYDILSIKAVDNGRPQKSSTTRLHIEWISKPKPSLEPISFEESFFTFTVMESDPVAHMIGVISVEPPGIPLWFDITGGNYDSHFDVDKGTGTIIVAKPLDAEQKSNYNLTVEATDGTTTILTQVFIKVIDTNDHRPQFSTSKYEVVIPEDTAPETEILQISAVDQDEKNKLIYTLQSSRDPLSLKKFRLDPATGSLYTSEKLDHEAVHQHTLTVMVRDQDVPVKRNFARIVVNVSDTNDHAPWFTASSYKGRVYESAAVGSVVLQVTALDKDKGKNAEVLYSIESGNIGNSFMIDPVLGSIKTAKELDRSNQAEYDLMVKATDKGSPPMSEITSVRIFVTIADNASPKFTSKEYSVELSETVSIGSFVGMVTAHSQSSVVYEIKDGNTGDAFDINPHSGTIITQKALDFETLPIYTLIIQGTNMAGLSTNTTVLVHLQDENDNAPVFMQAEYTGLISESASINSVVLTDRNVPLVIRAADADKDSNALLVYHIVEPSVHTYFAIDSSTGAIHTVLSLDYEETSIFHFTVQVHDMGTPRLFAEYAANVTVHVIDINDCPPVFAKPLYEASLLLPTYKGVKVITVNATDADSSAFSQLIYSITEGNIGEKFSMDYKTGALTVQNTTQLRSRYELTVRASDGRFAGLTSVKINVKESKESHLKFTQDVYSAVVKENSTEAETLAVITAIGNPINEPLFYHILNPDRRFKISRTSGVLSTTGTPFDREQQEAFDVVVEVTEEHKPSAVAHVVVKVIVEDQNDNAPVFVNLPYYAVVKVDTEVGHVIRYVTAVDRDSGRNGEVHYYLKEHHEHFQIGPLGEISLKKQFELDTLNKEYLVTVVAKDGGNPAFSAEVIVPITVMNKAMPVFEKPFYSAEIAESIQVHSPVVHVQANSPEGLKVFYSITDGDPFSQFTINFNTGVINVIAPLDFEAHPAYKLSIRATDSLTGAHAEVFVDIIVDDINDNPPVFAQQSYAVTLSEASVIGTSVVQVRATDSDSEPNRGISYQMFGNHSKSHDHFHVDSSTGLISLLRTLDYEQSRQHTIFVRAVDGGMPTLSSDVIVTVDVTDLNDNPPLFEQQIYEARISEHAPHGHFVTCVKAYDADSSDIDKLQYSILSGNDHKHFVIDSATGIITLSNLHRHALKPFYSLNLSVSDGVFRSSTQVHVTVIGGNLHSPAFLQNEYEVELAENAPLHTLVMEVKTTDGDSGIYGHVTYHIVNDFAKDRFYINERGQIFTLEKLDRETPAEKVISVRLMAKDAGGKVAFCTVNVILTDDNDNAPQFRATKYEVNIGSSAAKGTSVVKVLASDADEGSNADITYAIEADSESVKENLEINKLSGVITTKESLIGLENEFFTFFVRAVDNGSPSKESVVLVYVKILPPEMQLPKFSEPFYTFTVSEDVPIGTEIDLIRAEHSGTVLYSLVKGNTPESNRDESFVIDRQSGRLKLEKSLDHETTKWYQFSILARCTQDDHEMVASVDVSIQVKDANDNSPVFESSPYEAFIVENLPGGSRVIQIRASDADSGTNGQVMYSLDQSQSVEVIESFAINMETGWITTLKELDHEKRDNYQIKVVASDHGEKIQLSSTAIVDVTVTDVNDSPPRFTAEIYKGTVSEDDPQGGVIAILSTTDADSEEINRQVTYFITGGDPLGQFAVETIQNEWKVYVKKPLDREKRDNYLLTITATDGTFSSKAIVEVKVLDANDNSPVCEKTLYSDTIPEDVLPGKLIMQISATDADIRSNAEITYTLLGSGAEKFKLNPDTGELKTSTPLDREEQAVYHLLVRATDGGGRFCQASIVLTLEDVNDNAPEFSADPYAITVFENTEPGTLLTRVQATDADAGLNRKILYSLIDSADGQFSINELSGIIQLEKPLDRELQAVYTLSLKAVDQGLPRRLTATGTVIVSVLDINDNPPVFEYREYGATVSEDILVGTEVLQVYAASRDIEANAEITYSIISGNEHGKFSIDSKTGAVFIIENLDYESSHEYYLTVEATDGGTPSLSDVATVNVNVTDINDNTPVFSQDTYTTVISEDAVLEQSVITVMADDADGPSNSHIHYSIIDGNQGSSFTIDPVRGEVKVTKLLDRETISGYTLTVQASDNGSPPRVNTTTVNIDVSDVNDNAPVFSRGNYSVIIQENKPVGFSVLQLVVTDEDSSHNGPPFFFTIVTGNDEKAFEVNPQGVLLTSSAIKRKEKDHYLLQVKVADNGKPQLSSLTYIDIRVIEESIYPPAILPLEIFITSSGEEYSGGVIGKIHATDQDVYDTLTYSLDPQMDNLFSVSSTGGKLIAHKKLDIGQYLLNVSVTDGKFTTVADITVHIRQVTQEMLNHTIAIRFANLTPEEFVGDYWRNFQRALRNILGVRRNDIQIVSLQSSEPHPHLDVLLFVEKPGSAQISTKQLLHKINSSVTDIEEIIGVRILNVFQKLCAGLDCPWKFCDEKVSVDESVMSTHSTARLSFVTPRHHRAAVCLCKEGRCPPVHHGCEDDPCPEGSECVSDPWEEKHTCVCPSGRFGQCPGSSSMTLTGNSYVKYRLTENENKLEMKLTMRLRTYSTHAVVMYARGTDYSILEIHHGRLQYKFDCGSGPGIVSVQSIQVNDGQWHAVALEVNGNYARLVLDQVHTASGTAPGTLKTLNLDNYVFFGGHIRQQGTRHGRSPQVGNGFRGCMDSIYLNGQELPLNSKPRSYAHIEESVDVSPGCFLTATEDCASNPCQNGGVCNPSPAGGYYCKCSALYIGTHCEISVNPCSSKPCLYGGTCVVDNGGFVCQCRGLYTGQRCQLSPYCKDEPCKNGGTCFDSLDGAVCQCDSGFRGERCQSDIDECSGNPCLHGALCENTHGSYHCNCSHEYRGRHCEDAAPNQYVSTPWNIGLAEGIGIVVFVAGIFLLVVVFVLCRKMISRKKKHQAEPKDKHLGPATAFLQRPYFDSKLNKNIYSDIPPQVPVRPISYTPSIPSDSRNNLDRNSFEGSAIPEHPEFSTFNPESVHGHRKAVAVCSVAPNLPPPPPSNSPSDSDSIQKPSWDFDYDTKVVDLDPCLSKKPLEEKPSQPYSARESLSEVQSLSSFQSESCDDNGYHWDTSDWMPSVPLPDIQEFPNYEVIDEQTPLYSADPNAIDTDYYPGGYDIESDFPPPPEDFPAADELPPLPPEFSNQFESIHPPRDMPAAGSLGSSSRNRQRFNLNQYLPNFYPLDMSEPQTKGTGENSTCREPHAPYPPGYQRHFEAPAVESMPMSVYASTASCSDVSACCEVESEVMMSDYESGDDGHFEEVTIPPLDSQQHTEV,4588,"506,273",Chain (2); Disulfide bond (16); Domain (39); Glycosylation (22); Motif (2); Natural variant (12); Sequence conflict (17); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 3794..3805;  /evidence=""ECO:0000250""; DISULFID 3799..3816;  /evidence=""ECO:0000250""; DISULFID 3818..3826;  /evidence=""ECO:0000250""; DISULFID 3976..4009;  /evidence=""ECO:0000250""; DISULFID 4017..4028;  /evidence=""ECO:0000250""; DISULFID 4022..4038;  /evidence=""ECO:0000250""; DISULFID 4040..4049;  /evidence=""ECO:0000250""; DISULFID 4056..4067;  /evidence=""ECO:0000250""; DISULFID 4061..4076;  /evidence=""ECO:0000250""; DISULFID 4078..4087;  /evidence=""ECO:0000250""; DISULFID 4093..4104;  /evidence=""ECO:0000250""; DISULFID 4098..4113;  /evidence=""ECO:0000250""; DISULFID 4115..4124;  /evidence=""ECO:0000250""; DISULFID 4131..4142;  /evidence=""ECO:0000250""; DISULFID 4136..4151;  /evidence=""ECO:0000250""; DISULFID 4153..4162;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q86XS8,E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130),MSCAGRAGPARLAALALLTCSLWPARADNASQEYYTALINVTVQEPGRGAPLTFRIDRGRYGLDSPKAEVRGQVLAPLPLHGVADHLGCDPQTRFFVPPNIKQWIALLQRGNCTFKEKISRAAFHNAVAVVIYNNKSKEEPVTMTHPGTGDIIAVMITELRGKDILSYLEKNISVQMTIAVGTRMPPKNFSRGSLVFVSISFIVLMIISSAWLIFYFIQKIRYTNARDRNQRRLGDAAKKAISKLTTRTVKKGDKETDPDFDHCAVCIESYKQNDVVRILPCKHVFHKSCVDPWLSEHCTCPMCKLNILKALGIVPNLPCTDNVAFDMERLTRTQAVNRRSALGDLAGDNSLGLEPLRTSGISPLPQDGELTPRTGEINIAVTKEWFIIASFGLLSALTLCYMIIRATASLNANEVEWF,419,"46,405",Alternative sequence (2); Chain (1); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (6); Modified residue (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P36544,Neuronal acetylcholine receptor subunit alpha-7,MRCSPGGVWLALAASLLHVSLQGEFQRKLYKELVKNYNPLERPVANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQMSWTDHYLQWNVSEYPGVKTVRFPDGQIWKPDILLYNSADERFDATFHTNVLVNSSGHCQYLPPGIFKSSCYIDVRWFPFDVQHCKLKFGSWSYGGWSLDLQMQEADISGYIPNGEWDLVGIPGKRSERFYECCKEPYPDVTFTVTMRRRTLYYGLNLLIPCVLISALALLVFLLPADSGEKISLGITVLLSLTVFMLLVAEIMPATSDSVPLIAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGKMPKWTRVILLNWCAWFLRMKRPGEDKVRPACQHKQRRCSLASVEMSAVAPPPASNGNLLYIGFRGLDGVHCVPTPDSGVVCGRMACSPTHDEHLLHGGQPPEGDPDLAKILEEVRYIANRFRCQDESEAVCSEWKFAACVVDRLCLMAFSVFTIICTIGILMSAPNFVEAVSKDFA,502,"56,449",Alternative sequence (3); Beta strand (11); Chain (1); Disulfide bond (2); Erroneous translation (1); Glycosylation (3); Helix (6); Mutagenesis (1); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (2),"DISULFID 150..164;  /evidence=""ECO:0000250""; DISULFID 212..213;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000250"""
Q96KV6,Putative butyrophilin subfamily 2 member A3,MEPAAALHFSRPASLLLLLSLCALVSAQVTVVGPTDPILAMVGENTTLRCCLSPEENAEDMEVRWFQSQFSPAVFVYKGGRERTEEQKEEYRGRTTFVSKDSRGSVALIIHNVTAEDNGIYQCYFQEGRSCNEAILHLVVAGLDSEPVIEMRDHEDGGIQLECISGGWYPKPLTVWRDPYGEVVPALKEVSTPDADSLFMVTTAVIIRDKSVRNVSCSINDTLLGQKKESVIFIPESFMPSRSPCVVILPVIMIILMIPIAICIYWINNLQKEKKDSHLMTFNLCLSLAGWRRTFLHAANVVLDQDTGHPYLFVSEDKRSVTLDPSRESIPGNPERFDSQLCVLGQESFASGKHYLEVDVENVIEWTVGICRDNVERKWEVPLLPQNGFWTLEMHKRKYWALTSLKWILSLEEPLCQVGIFLDYEAGDVSFYNMRDRSHIYTFPHSAFSVPVRPFFSLGSYDSQILICSAFTGASGVTVPEEGWTLHRAGTHHSPQNQFPSLTAMETSPGHLSSHCTMPLVEDTPSSPLVTQENIFQLPLSHPLQTSAPVHLLIRCGFSSSFGCNYGMESRHRELVVPQLPARKKV,586,"65,713",Chain (1); Disulfide bond (1); Domain (2); Glycosylation (4); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q6UX41,Butyrophilin-like protein 8,MALMLSLVLSLLKLGSGQWQVFGPDKPVQALVGEDAAFSCFLSPKTNAEAMEVRFFRGQFSSVVHLYRDGKDQPFMQMPQYQGRTKLVKDSIAEGRISLRLENITVLDAGLYGCRISSQSYYQKAIWELQVSALGSVPLISITGYVDRDIQLLCQSSGWFPRPTAKWKGPQGQDLSTDSRTNRDMHGLFDVEISLTVQENAGSISCSMRHAHLSREVESRVQIGDTFFEPISWHLATKVLGILCCGLFFGIVGLKIFFSKFQWKIQAELDWRRKHGQAELRDARKHAVEVTLDPETAHPKLCVSDLKTVTHRKAPQEVPHSEKRFTRKSVVASQSFQAGKHYWEVDGGHNKRWRVGVCRDDVDRRKEYVTLSPDHGYWVLRLNGEHLYFTLNPRFISVFPRTPPTKIGVFLDYECGTISFFNINDQSLIYTLTCRFEGLLRPYIEYPSYNEQNGTPIVICPVTQESEKEASWQRASAIPETSNSESSSQATTPFLPRGEM,500,"56,748",Alternative sequence (8); Chain (1); Disulfide bond (2); Domain (3); Glycosylation (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 40..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 154..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000269|PubMed:15340161"""
P35070,Probetacellulin [Cleaved into: Betacellulin (BTC)],MDRAARCSGASSLPLLLALALGLVILHCVVADGNSTRSPETNGLLCGDPEENCAATTTQSKRKGHFSRCPKQYKHYCIKGRCRFVVAEQTPSCVCDEGYIGARCERVDLFYLRGDRGQILVICLIAVMVVFIILVIGVCTCCHPLRKRRKRKKKEEEMETLGKDITPINEDIEETNIA,178,"19,746",Beta strand (4); Chain (2); Compositional bias (1); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (1); Natural variant (3); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),DISULFID 69..82; DISULFID 77..93; DISULFID 95..104,"SIGNAL 1..31;  /evidence=""ECO:0000250"""
Q9H159,Cadherin-19,MNCYLLLRFMLGIPLLWPCLGATENSQTKKVKQPVRSHLRVKRGWVWNQFFVPEEMNTTSHHIGQLRSDLDNGNNSFQYKLLGAGAGSTFIIDERTGDIYAIQKLDREERSLYILRAQVIDIATGRAVEPESEFVIKVSDINDNEPKFLDEPYEAIVPEMSPEGTLVIQVTASDADDPSSGNNARLLYSLLQGQPYFSVEPTTGVIRISSKMDRELQDEYWVIIQAKDMIGQPGALSGTTSVLIKLSDVNDNKPIFKESLYRLTVSESAPTGTSIGTIMAYDNDIGENAEMDYSIEEDDSQTFDIITNHETQEGIVILKKKVDFEHQNHYGIRAKVKNHHVPEQLMKYHTEASTTFIKIQVEDVDEPPLFLLPYYVFEVFEETPQGSFVGVVSATDPDNRKSPIRYSITRSKVFNINDNGTITTSNSLDREISAWYNLSITATEKYNIEQISSIPLYVQVLNINDHAPEFSQYYETYVCENAGSGQVIQTISAVDRDESIEEHHFYFNLSVEDTNNSSFTIIDNQDNTAVILTNRTGFNLQEEPVFYISILIADNGIPSLTSTNTLTIHVCDCGDSGSTQTCQYQELVLSMGFKTEVIIAILICIMIIFGFIFLTLGLKQRRKQILFPEKSEDFRENIFQYDDEGGGEEDTEAFDIAELRSSTIMRERKTRKTTSAEIRSLYRQSLQVGPDSAIFRKFILEKLEEANTDPCAPPFDSLQTYAFEGTGSLAGSLSSLESAVSDQDESYDYLNELGPRFKRLACMFGSAVQSNN,772,"87,002",Alternative sequence (2); Chain (1); Domain (5); Glycosylation (8); Propeptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P55283,Cadherin-4 (Retinal cadherin) (R-CAD) (R-cadherin),MTAGAGVLLLLLSLSGALRAHNEDLTTRETCKAGFSEDDYTALISQNILEGEKLLQVKFSSCVGTKGTQYETNSMDFKVGADGTVFATRELQVPSEQVAFTVTAWDSQTAEKWDAVVRLLVAQTSSPHSGHKPQKGKKVVALDPSPPPKDTLLPWPQHQNANGLRRRKRDWVIPPINVPENSRGPFPQQLVRIRSDKDNDIPIRYSITGVGADQPPMEVFSIDSMSGRMYVTRPMDREEHASYHLRAHAVDMNGNKVENPIDLYIYVIDMNDNRPEFINQVYNGSVDEGSKPGTYVMTVTANDADDSTTANGMVRYRIVTQTPQSPSQNMFTINSETGDIVTVAAGLDREKVQQYTVIVQATDMEGNLNYGLSNTATAIITVTDVNDNPPEFTASTFAGEVPENRVETVVANLTVMDRDQPHSPNWNAVYRIISGDPSGHFSVRTDPVTNEGMVTVVKAVDYELNRAFMLTVMVSNQAPLASGIQMSFQSTAGVTISIMDINEAPYFPSNHKLIRLEEGVPPGTVLTTFSAVDPDRFMQQAVRYSKLSDPASWLHINATNGQITTAAVLDRESLYTKNNVYEATFLAADNGIPPASGTGTLQIYLIDINDNAPELLPKEAQICEKPNLNAINITAADADVDPNIGPYVFELPFVPAAVRKNWTITRLNGDYAQLSLRILYLEAGMYDVPIIVTDSGNPPLSNTSIIKVKVCPCDDNGDCTTIGAVAAAGLGTGAIVAILICILILLTMVLLFVMWMKRREKERHTKQLLIDPEDDVRDNILKYDEEGGGEEDQDYDLSQLQQPEAMGHVPSKAPGVRRVDERPVGAEPQYPIRPMVPHPGDIGDFINEGLRAADNDPTAPPYDSLLVFDYEGSGSTAGSVSSLNSSSSGDQDYDYLNDWGPRFKKLADMYGGGEED,916,"100,281",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (6); Natural variant (2); Propeptide (1); Sequence conflict (19); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P79483,"HLA class II histocompatibility antigen, DR beta 3 chain (MHC class II antigen DRB3)",MVCLKLPGGSSLAALTVTLMVLSSRLAFAGDTRPRFLELRKSECHFFNGTERVRYLDRYFHNQEEFLRFDSDVGEYRAVTELGRPVAESWNSQKDLLEQKRGRVDNYCRHNYGVGESFTVQRRVHPQVTVYPAKTQPLQHHNLLVCSVSGFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSALTVEWRARSESAQSKMLSGVGGFVLGLLFLGAGLFIYFRNQKGHSGLQPTGFLS,266,"29,962",Beta strand (13); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (5); Natural variant (42); Region (2); Signal peptide (1); Site (5); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 44..108;  /evidence=""ECO:0000244|PDB:2Q6W, ECO:0000244|PDB:3C5J, ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:18697946""; DISULFID 146..202;  /evidence=""ECO:0000244|PDB:2Q6W, ECO:0000244|PDB:3C5J, ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:18697946""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y6X5,Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),MKLLVILLFSGLITGFRSDSSSSLPPKLLLVSFDGFRADYLKNYEFPHLQNFIKEGVLVEHVKNVFITKTFPNHYSIVTGLYEESHGIVANSMYDAVTKKHFSDSNDKDPFWWNEAVPIWVTNQLQENRSSAAAMWPGTDVPIHDTISSYFMNYNSSVSFEERLNNITMWLNNSNPPVTFATLYWEEPDASGHKYGPEDKENMSRVLKKIDDLIGDLVQRLKMLGLWENLNVIITSDHGMTQCSQDRLINLDSCIDHSYYTLIDLSPVAAILPKINRTEVYNKLKNCSPHMNVYLKEDIPNRFYYQHNDRIQPIILVADEGWTIVLNESSQKLGDHGYDNSLPSMHPFLAAHGPAFHKGYKHSTINIVDIYPMMCHILGLKPHPNNGTFGHTKCLLVDQWCINLPEAIAIVIGSLLVLTMLTCLIIIMQNRLSVPRPFSRLQLQEDDDDPLIG,453,"51,641",Active site (1); Beta strand (16); Binding site (3); Chain (1); Disulfide bond (2); Glycosylation (4); Helix (18); Metal binding (7); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 254..287;  /evidence=""ECO:0000269|PubMed:24338010""; DISULFID 394..401;  /evidence=""ECO:0000269|PubMed:24338010""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q96LA5,Fc receptor-like protein 2 (FcR-like protein 2) (FcRL2) (Fc receptor homolog 2) (FcRH2) (IFGP family protein 4) (Immunoglobulin receptor translocation-associated protein 4) (SH2 domain-containing phosphatase anchor protein 1) (CD antigen CD307b),MLLWSLLVIFDAVTEQADSLTLVAPSSVFEGDSIVLKCQGEQNWKIQKMAYHKDNKELSVFKKFSDFLIQSAVLSDSGNYFCSTKGQLFLWDKTSNIVKIKVQELFQRPVLTASSFQPIEGGPVSLKCETRLSPQRLDVQLQFCFFRENQVLGSGWSSSPELQISAVWSEDTGSYWCKAETVTHRIRKQSLQSQIHVQRIPISNVSLEIRAPGGQVTEGQKLILLCSVAGGTGNVTFSWYREATGTSMGKKTQRSLSAELEIPAVKESDAGKYYCRADNGHVPIQSKVVNIPVRIPVSRPVLTLRSPGAQAAVGDLLELHCEALRGSPPILYQFYHEDVTLGNSSAPSGGGASFNLSLTAEHSGNYSCEANNGLGAQCSEAVPVSISGPDGYRRDLMTAGVLWGLFGVLGFTGVALLLYALFHKISGESSATNEPRGASRPNPQEFTYSSPTPDMEELQPVYVNVGSVDVDVVYSQVWSMQQPESSANIRTLLENKDSQVIYSSVKKS,508,"55,542",Alternative sequence (8); Chain (1); Disulfide bond (3); Domain (4); Glycosylation (5); Motif (4); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 128..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 226..275;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 321..368;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q6V0I7,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),MDLAPDRATGRPWLPLHTLSVSQLLRVFWLLSLLPGQAWVHGAEPRQVFQVLEEQPPGTLVGTIQTRPGFTYRLSESHALFAINSSTGALYTTSTIDRESLPSDVINLVVLSSAPTYPTEVRVLVRDLNDNAPVFPDPSIVVTFKEDSSSGRQVILDTATDSDIGSNGVDHRSYRIIRGNEAGRFRLDITLNPSGEGAFLHLVSKGGLDREVTPQYQLLVEVEDKGEPKRRGYLQVNVTVQDINDNPPVFGSSHYQAGVPEDAVVGSSVLQVAAADADEGTNADIRYRLQDEGTPFQMDPETGLITVREPLDFEARRQYSLTVQAMDRGVPSLTGRAEALIQLLDVNDNDPVVKFRYFPATSRYASVDENAQVGTVVALLTVTDADSPAANGNISVQILGGNEQRHFEVQSSKVPNLSLIKVASALDRERIPSYNLTVSVSDNYGAPPGAAVQARSSVASLVIFVNDINDHPPVFSQQVYRVNLSEEAPPGSYVSGISATDGDSGLNANLRYSIVSGNGLGWFHISEHSGLVTTGSSGGLDRELASQIVLNISARDQGVHPKVSYAQLVVTLLDVNDEKPVFSQPEGYDVSVVENAPTGTELLMLRATDGDLGDNGTVRFSLQEAETDRRSFRLDPVSGRLSTISSLDREEQAFYSLLVLATDLGSPPQSSMARINVSLLDINDNSPVFYPVQYFAHIKENEPGGSYITTVSATDPDLGTNGTVKYSISAGDRSRFQVNAQSGVISTRMALDREEKTAYQLQIVATDGGNLQSPNQAIVTITVLDTQDNPPVFSQVAYSFVVFENVALGYHVGSVSASTMDLNSNISYLITTGDQKGMFAINQVTGQLTTANVIDREEQSFYQLKVVASGGTVTGDTMVNITVKDLNDNSPHFLQAIESVNVVENWQAGHSIFQAKAVDPDEGVNGMVLYSLKQNPKNLFAINEKNGTISLLGPLDVHAGSYQIEILASDMGVPQLSSSVILTVYVHDVNDNSPVFDQLSYEVTLSESEPVNSRFFKVQASDKDSGANGEIAYTIAEGNTGDAFGIFPDGQLYIKSELDRELQDRYVLMVVASDRAVEPLSATVNVTVILEDVNDNRPLFNSTNYTFYFEEEQRAGSFVGKVSAVDKDFGPNGEVRYSFEMVQPDFELHAISGEITNTHQFDRESLMRRRGTAVFSFTVIATDQGIPQPLKDQATVHVYMKDINDNAPKFLKDFYQATISESAANLTQVLRVSASDVDEGNNGLIHYSIIKGNEERQFAIDSTSGQVTLIGKLDYEATPAYSLVIQAVDSGTIPLNSTCTLNIDILDENDNTPSFPKSTLFVDVLENMRIGELVSSVTATDSDSGDNADLYYSITGTNNHGTFSISPNTGSIFLAKKLDFETQSLYKLNITAKDQGRPPRSSTMSVVIHVRDFNDNPPSFPPGDIFKSIVENIPIGTSVISVTAHDPDADINGQLSYTIIQQMPRGNHFTIDEVKGTIYTNAEIDREFANLFELTVKANDQAVPIETRRYALKNVTILVTDLNDNVPMFISQNALAADPSAVIGSVLTTIMAADPDEGANGEIEYEIINGDTDTFIVDRYSGDLRVASALVPSQLIYNLIVSATDLGPERRKSTTELTIILQGLDGPVFTQPKYITILKEGEPIGTNVISIEAASPRGSEAPVEYYIVSVRCEEKTVGRLFTIGRHTGIIQTAAILDREQGACLYLVDVYAIEKSTAFPRTQRAEVEITLQDINDNPPVFPTDMLDLTVEENIGDGSKIMQLTAMDADEGANALVTYTIISGADDSFRIDPESGDLIATRRLDRERRSKYSLLVRADDGLQSSDMRINITVSDVNDHTPKFSRPVYSFDIPEDTIPGSLVAAILATDDDSGVNGEITYIVNEDDEDGIFFLNPITGVFNLTRLLDYEVQQYYILTVRAEDGGGQFTTIRVYFNILDVNDNPPIFSLNSYSTSLMENLPVGSTVLVFNVTDADDGINSQLTYSIASGDSLGQFTVDKNGVLKVLKALDRESQSFYNLVVQVHDLPQIPASRFTSTAQVSIILLDVNDNPPTFLSPKLTYIPENTPIDTVVFKAQATDPDSGPNSYIEYTLLNPLGNKFSIGTIDGEVRLTGELDREEVSNYTLTVVATDKGQPSLSSSTEVVVMVLDINDNNPIFAQALYKVEINENTLTGTDIIQVFAADGDEGTNGQVRYGIVNGNTNQEFRIDSVTGAITVAKPLDREKTPTYHLTVQATDRGSTPRTDTSTVSIVLLDINDFVPVFELSPYSVNVPENLGTLPRTILQVVARDDDRGSNSKLSYVLFGGNEDNAFTLSASGELGVTQSLDRETKERFVLMITATDSGSPALTGTGTINVIVDDVNDNVPTFASKAYFTTIPEDAPTGTDVLLVNASDADASKNAVIRIIGGNSQFTINPSTGQIITSALLDRETKDNYTLVVVCSDAGSPEPLSSSTSVLVTVTDVNDNPPRFQHHPYVTHIPSPTLPGSFVFAVTVTDADIGPNSELHYSLSGRNSEKFHIDPLRGAIMAAGPLNGASEVTFSVHVKDGGSFPKTDSTTVTVRFVNKADFPKVRAKEQTFMFPENQPVSSLVTTITGSSLRGEPMSYYIASGNLGNTFQIDQLTGQVSISQPLDFEKIQKYVVWIEARDGGFPPFSSYEKLDITVLDVNDNAPIFKEDPFISEILENLSPRKILTVSAMDKDSGPNGQLDYEIVNGNMENSFSINHATGEIRSVRPLDREKVSHYVLTIKSSDKGSPSQSTSVKVMINILDENDNAPRFSQIFSAHVPENSPLGYTVTRVTTSDEDIGINAISRYSIMDASLPFTINPSTGDIVISRPLNREDTDRYRIRVSAHDSGWTVSTDVTIFVTDINDNAPRFSRTSYYLDCPELTEIGSKVTQVFATDPDEGSNGQVFYFIKSQSEYFRINATTGEIFNKQILKYQNVTGFSNVNINRHSFIVTSSDRGKPSLISETTVTINIVDSNDNAPQFLKSKYFTPVTKNVKVGTKLIRVTAIDDKDFGLNSEVEYFISNDNHLGKFKLDNDTGWISVASSLISDLNQNFFITVTAKDKGNPPLSSQATVHITVTEENYHTPEFSQSHMSATIPESHSIGSIVRTVSARDRDAAMNGLIKYSISSGNEEGIFAINSSTGILTLAKALDYELCQKHEMTISAIDGGWVARTGYCSVTVNVIDVNDNSPVFLSDDYFPTVLENAPSGTTVIHLNATDADSGTNAVIAYTVQSSDSDLFVIDPNTGVITTQGFLDFETKQSYHLTVKAFNVPDEERCSFATVNIQLKGTNEYVPRFVSKLYYFEISEAAPKGTIVGEVFASDRDLGTDGEVHYLIFGNSRKKGFQINKKTGQIYVSGILDREKEERVSLKVLAKNFGSIRGADIDEVTVNVTVLDANDPPIFTLNIYSVQISEGVPIGTHVTFVSAFDSDSIPSWSRFSYFIGSGNENGAFSINPQTGQITVTAELDRETLPIYNLSVLAVDSGTPSATGSASLLVTLEDINDNGPMLTVSEGEVMENKRPGTLVMTLQSTDPDLPPNQGPFTYYLLSTGPATSYFSLSTAGVLSTTREIDREQIADFYLSVVTKDSGVPQMSSTGTVHITVIDQNDNPSQSRTVEIFVNYYGNLFPGGILGSVKPQDPDVLDSFHCSLTSGVTSLFSIPGGTCDLNSQPRSTDGTFDLTVLSNDGVHSTVTSNIRVFFAGFSNATVDNSILLRLGVPTVKDFLTNHYLHFLRIASSQLTGLGTAVQLYSAYEENNRTFLLAAVKRNHNQYVNPSGVATFFESIKEILLRQSGVKVESVDHDSCVHGPCQNGGSCLRRLAVSSVLKSRESLPVIIVANEPLQPFLCKCLPGYAGSWCEIDIDECLPSPCHSGGTCHNLVGGFSCSCPDGFTGRACERDINECLQSPCKNGAICQNFPGSFNCVCKTGYTGKMCESSVNYCECNPCFNGGSCQSGVDSYYCHCPFGVFGKHCELNSYGFEELSYMEFPSLDPNNNYIYVKFATIKSHALLLYNYDNQTGDRAEFLALEIAEERLRFSYNLGSGTYKLTTMKKVSDGHFHTVIARRAGMAASLTVDSCSENQEPGYCTVSNVAVSDDWTLDVQPNRVTVGGIRSLEPILQRRGHVESHDFVGCIMEFAVNGRPLEPSQALAAQGILDQCPRLEGACTRSPCQHGGTCMDYWSWQQCHCKEGLTGKYCEKSVTPDTALSLEGKGRLDYHMSQNEKREYLLRQSLRGAMLEPFGVNSLEVKFRTRSENGVLIHIQESSNYTTVKIKNGKVYFTSDAGIAGKVERNIPEVYVADGHWHTFLIGKNGTATVLSVDRIYNRDIIHPTQDFGGLDVLTISLGGIPPNQAHRDAQTAGFDGCIASMWYGGESLPFSGKHSLASISKTDPSVKIGCRGPNICASNPCWGDLLCINQWYAYRCVPPGDCASHPCQNGGSCEPGLHSGFTCSCPDSHTGRTCEMVVACLGVLCPQGKVCKAGSPAGHVCVLSQGPEEISLPLWAVPAIVGSCATVLALLVLSLILCNQCRGKKAKNPKEEKKPKEKKKKGSENVAFDDPDNIPPYGDDMTVRKQPEGNPKPDIIERENPYLIYDETDIPHNSETIPSAPLASPEQEIEHYDIDNASSIAPSDADIIQHYKQFRSHTPKFSIQRHSPLGFARQSPMPLGASSLTYQPSYGQGLRTSSLSHSACPTPNPLSRHSPAPFSKSSTFYRNSPARELHLPIRDGNTLEMHGDTCQPGIFNYATRLGRRSKSPQAMASHGSRPGSRLKQPIGQIPLESSPPVGLSIEEVERLNTPRPRNPSICSADHGRSSSEEDCRRPLSRTRNPADGIPAPESSSDSDSHESFTCSEMEYDREKPMVYTSRMPKLSQVNESDADDEDNYGARLKPRRYHGRRAEGGPVGTQAAAPGTADNTLPMKLGQQAGTFNWDNLLNWGPGFGHYVDVFKDLASLPEKAAANEEGKAGTTKPVPKDGEAEQYV,4981,"542,687",Alternative sequence (5); Chain (1); Disulfide bond (20); Domain (42); Erroneous initiation (2); Frameshift (1); Glycosylation (38); Modified residue (1); Natural variant (15); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 3806..3817;  /evidence=""ECO:0000250""; DISULFID 3811..3848;  /evidence=""ECO:0000250""; DISULFID 3850..3859;  /evidence=""ECO:0000250""; DISULFID 3866..3877;  /evidence=""ECO:0000250""; DISULFID 3871..3886;  /evidence=""ECO:0000250""; DISULFID 3888..3897;  /evidence=""ECO:0000250""; DISULFID 3904..3915;  /evidence=""ECO:0000250""; DISULFID 3909..3924;  /evidence=""ECO:0000250""; DISULFID 3926..3935;  /evidence=""ECO:0000250""; DISULFID 3942..3953;  /evidence=""ECO:0000250""; DISULFID 3947..3962;  /evidence=""ECO:0000250""; DISULFID 3964..3973;  /evidence=""ECO:0000250""; DISULFID 4133..4159;  /evidence=""ECO:0000250""; DISULFID 4166..4177;  /evidence=""ECO:0000250""; DISULFID 4171..4186;  /evidence=""ECO:0000250""; DISULFID 4188..4197;  /evidence=""ECO:0000250""; DISULFID 4365..4398;  /evidence=""ECO:0000250""; DISULFID 4430..4441;  /evidence=""ECO:0000250""; DISULFID 4435..4451;  /evidence=""ECO:0000250""; DISULFID 4453..4462;  /evidence=""ECO:0000250""","SIGNAL 1..38;  /evidence=""ECO:0000255"""
P15514,Amphiregulin (AR) (Colorectum cell-derived growth factor) (CRDGF),MRAPLLPPAPVVLSLLILGSGHYAAGLDLNDTYSGKREPFSGDHSADGFEVTSRSEMSSGSEISPVSEMPSSSEPSSGADYDYSEEYDNEPQIPGYIVDDSVRVEQVVKPPQNKTESENTSDKPKRKKKGGKNGKNRRNRKKKNPCNAEFQNFCIHGECKYIEHLEAVTCKCQQEYFGERCGEKSMKTHSMIDSSLSKIALAAIAAFMSAVILTAVAVITVQLRRQYVRKYEGEAEERKKLRQENGNVHAIA,252,"27,895",Beta strand (3); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (3); Helix (1); Natural variant (2); Propeptide (2); Signal peptide (1); Transmembrane (1); Turn (2),"DISULFID 146..159;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|Ref.14""; DISULFID 154..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|Ref.14""; DISULFID 172..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|Ref.14""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q08708,CMRF35-like molecule 6 (CLM-6) (CD300 antigen-like family member C) (CMRF35-A1) (CMRF-35) (Immunoglobulin superfamily member 16) (IgSF16) (CD antigen CD300c),MTARAWASWRSSALLLLLVPGYFPLSHPMTVAGPVGGSLSVQCRYEKEHRTLNKFWCRPPQILRCDKIVETKGSAGKRNGRVSIRDSPANLSFTVTLENLTEEDAGTYWCGVDTPWLRDFHDPIVEVEVSVFPAGTTTASSPQSSMGTSGPPTKLPVHTWPSVTRKDSPEPSPHPGSLFSNVRFLLLVLLELPLLLSMLGAVLWVNRPQRSSRSRQNWPKGENQ,224,"24,830",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (1); Glycosylation (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 57..65;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P78410,Butyrophilin subfamily 3 member A2,MKMASSLAFLLLNFHVSLLLVQLLTPCSAQFSVLGPSGPILAMVGEDADLPCHLFPTMSAETMELKWVSSSLRQVVNVYADGKEVEDRQSAPYRGRTSILRDGITAGKAALRIHNVTASDSGKYLCYFQDGDFYEKALVELKVAALGSNLHVEVKGYEDGGIHLECRSTGWYPQPQIQWSNAKGENIPAVEAPVVADGVGLYEVAASVIMRGGSGEGVSCIIRNSLLGLEKTASISIADPFFRSAQPWIAALAGTLPILLLLLAGASYFLWRQQKEITALSSEIESEQEMKEMGYAATEREISLRESLQEELKRKKIQYLTRGEESSSDTNKSA,334,"36,428",Alternative sequence (2); Beta strand (15); Chain (1); Coiled coil (1); Disulfide bond (2); Domain (1); Frameshift (3); Glycosylation (1); Helix (4); Modified residue (2); Natural variant (5); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 52..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""; DISULFID 166..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22846996""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q16602,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor),MEKKCTLNFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAAGTESMQLCPDYFQDFDPSEKVTKICDQDGNWFRHPASNRTWTNYTQCNVNTHEKVKTALNLFYLTIIGHGLSIASLLISLGIFFYFKSLSCQRITLHKNLFFSFVCNSVVTIIHLTAVANNQALVATNPVSCKVSQFIHLYLMGCNYFWMLCEGIYLHTLIVVAVFAEKQHLMWYYFLGWGFPLIPACIHAIARSLYYNDNCWISSDTHLLYIIHGPICAALLVNLFFLLNIVRVLITKLKVTHQAESNLYMKAVRATLILVPLLGIEFVLIPWRPEGKIAEEVYDYIMHILMHFQGLLVSTIFCFFNGEVQAILRRNWNQYKIQFGNSFSNSEALRSASYTVSTISDGPGYSHDCPSEHLNGKSIHDIENVLLKPENLYN,461,"52,929",Beta strand (8); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (3); Helix (15); Modified residue (2); Mutagenesis (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (7),DISULFID 48..74; DISULFID 65..105; DISULFID 88..127,"SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
P12830,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3],MGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFTVPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFIIERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSVMEVTATDADDDVNTYNAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDNPPIFNPTTYKGQVPENEANVVITTLKVTDADAPNTPAWEAVYTILNDDGGQFVVTTNPVNNDGILKTAKGLDFEAKQQYILHVAVTNVVPFEVSLTTSTATVTVDVLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKITYRIWRDTANWLEINPDTGAISTRAELDREDFEHVKNSTYTALIIATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFTAELTHGASANWTIQYNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVEAGLQIPAILGILGGILALLILILLLLLFLRRRAVVKEPLLPPEDDTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLMSVPRYLPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYGGGEDD,882,"97,456",Alternative sequence (1); Beta strand (17); Chain (4); Compositional bias (1); Disulfide bond (1); Domain (5); Frameshift (1); Glycosylation (13); Helix (3); Metal binding (3); Modified residue (8); Mutagenesis (7); Natural variant (34); Propeptide (1); Region (2); Sequence conflict (11); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 163;  /note=""Interchain""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
A0A0K2S4Q6,Protein CD300H (CD300 antigen-like family member H),MTQRAGAAMLPSALLLLCVPGCLTVSGPSTVMGAVGESLSVQCRYEEKYKTFNKYWCRQPCLPIWHEMVETGGSEGVVRSDQVIITDHPGDLTFTVTLENLTADDAGKYRCGIATILQEDGLSGFLPDPFFQVQVLVSSASSTENSVKTPASPTRPSQCQGSLPSSTCFLLLPLLKVPLLLSILGAILWVNRPWRTPWTES,201,"21,806",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q6ZTQ4,Cadherin-related family member 3 (Cadherin-like protein 28),MQEAIILLALLGAMSGGEALHLILLPATGNVAENSPPGTSVHKFSVKLSASLSPVIPGFPQIVNSNPLTEAFRVNWLSGTYFEVVTTGMEQLDFETGPNIFDLQIYVKDEVGVTDLQVLTVQVTDVNEPPQFQGNLAEGLHLYIVERANPGFIYQVEAFDPEDTSRNIPLSYFLISPPKSFRMSANGTLFSTTELDFEAGHRSFHLIVEVRDSGGLKASTELQVNIVNLNDEVPRFTSPTRVYTVLEELSPGTIVANITAEDPDDEGFPSHLLYSITTVSKYFMINQLTGTIQVAQRIDRDAGELRQNPTISLEVLVKDRPYGGQENRIQITFIVEDVNDNPATCQKFTFSIMVPERTAKGTLLLDLNKFCFDDDSEAPNNRFNFTMPSGVGSGSRFLQDPAGSGKIVLIGDLDYENPSNLAAGNKYTVIIQVQDVAPPYYKNNVYVYILTSPENEFPLIFDRPSYVFDVSERRPARTRVGQVRATDKDLPQSSLLYSISTGGASLQYPNVFWINPKTGELQLVTKVDCETTPIYILRIQATNNEDTSSVTVTVNILEENDEKPICTPNSYFLALPVDLKVGTNIQNFKLTCTDLDSSPRSFRYSIGPGNVNNHFTFSPNAGSNVTRLLLTSRFDYAGGFDKIWDYKLLVYVTDDNLMSDRKKAEALVETGTVTLSIKVIPHPTTIITTTPRPRVTYQVLRKNVYSPSAWYVPFVITLGSILLLGLLVYLVVLLAKAIHRHCPCKTGKNKEPLTKKGETKTAERDVVVETIQMNTIFDGEAIDPVTGETYEFNSKTGARKWKDPLTQMPKWKESSHQGAAPRRVTAGEGMGSLRSANWEEDELSGKAWAEDAGLGSRNEGGKLGNPKNRNPAFMNRAYPKPHPGK,885,"97,977",Alternative sequence (3); Beta strand (11); Chain (1); Domain (6); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P29016,T-cell surface glycoprotein CD1b (CD antigen CD1b),MLLLPFQLLAVLFPGGNSEHAFQGPTSFHVIQTSSFTNSTWAQTQGSGWLDDLQIHGWDSDSGTAIFLKPWSKGNFSDKEVAELEEIFRVYIFGFAREVQDFAGDFQMKYPFEIQGIAGCELHSGGAIVSFLRGALGGLDFLSVKNASCVPSPEGGSRAQKFCALIIQYQGIMETVRILLYETCPRYLLGVLNAGKADLQRQVKPEAWLSSGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQLGDILPNANWTWYLRATLDVADGEAAGLSCRVKHSSLEGQDIILYWRNPTSIGSIVLAIIVPSLLLLLCLALWYMRRRSYQNIP,333,"36,939",Alternative sequence (1); Beta strand (16); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (4); Helix (8); Motif (1); Mutagenesis (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 120..184;  /evidence=""ECO:0000244|PDB:1GZP, ECO:0000244|PDB:1UQS, ECO:0000244|PDB:2H26, ECO:0000269|PubMed:12118248, ECO:0000269|PubMed:14764708, ECO:0000269|PubMed:16874306""; DISULFID 149..163;  /evidence=""ECO:0000244|PDB:1GZP, ECO:0000244|PDB:1UQS, ECO:0000244|PDB:2H26, ECO:0000269|PubMed:12118248, ECO:0000269|PubMed:14764708, ECO:0000269|PubMed:16874306""; DISULFID 224..279;  /evidence=""ECO:0000244|PDB:1GZP, ECO:0000244|PDB:1UQS, ECO:0000244|PDB:2H26, ECO:0000269|PubMed:12118248, ECO:0000269|PubMed:14764708, ECO:0000269|PubMed:16874306""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9UL01,Dermatan-sulfate epimerase (DS epimerase) (EC 5.1.3.19) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2),MRTHTRGAPSVFFIYLLCFVSAYITDENPEVMIPFTNANYDSHPMLYFSRAEVAELQLRAASSHEHIAARLTEAVHTMLSSPLEYLPPWDPKDYSARWNEIFGNNLGALAMFCVLYPENIEARDMAKDYMERMAAQPSWLVKDAPWDEVPLAHSLVGFATAYDFLYNYLSKTQQEKFLEVIANASGYMYETSYRRGWGFQYLHNHQPTNCMALLTGSLVLMNQGYLQEAYLWTKQVLTIMEKSLVLLREVTDGSLYEGVAYGSYTTRSLFQYMFLVQRHFNINHFGHPWLKQHFAFMYRTILPGFQRTVAIADSNYNWFYGPESQLVFLDKFVMRNGSGNWLADQIRRNRVVEGPGTPSKGQRWCTLHTEFLWYDGSLKSVPPPDFGTPTLHYFEDWGVVTYGSALPAEINRSFLSFKSGKLGGRAIYDIVHRNKYKDWIKGWRNFNAGHEHPDQNSFTFAPNGVPFITEALYGPKYTFFNNVLMFSPAVSKSCFSPWVGQVTEDCSSKWSKYKHDLAASCQGRVVAAEEKNGVVFIRGEGVGAYNPQLNLKNVQRNLILLHPQLLLLVDQIHLGEESPLETAASFFHNVDVPFEETVVDGVHGAFIRQRDGLYKMYWMDDTGYSEKATFASVTYPRGYPYNGTNYVNVTMHLRSPITRAAYLFIGPSIDVQSFTVHGDSQQLDVFIATSKHAYATYLWTGEATGQSAFAQVIADRHKILFDRNSAIKSSIVPEVKDYAAIVEQNLQHFKPVFQLLEKQILSRVRNTASFRKTAERLLRFSDKRQTEEAIDRIFAISQQQQQQSKSKKNRRAGKRYKFVDAVPDIFAQIEVNEKKIRQKAQILAQKELPIDEDEEMKDLLDFADVTYEKHKNGGLIKGRFGQARMVTTTHSRAPSLSASYTRLFLILNIAIFFVMLAMQLTYFQRAQSLHGQRCLYAVLLIDSCILLWLYSSCSQSQC,958,"109,773",Beta strand (25); Chain (1); Glycosylation (1); Helix (28); Natural variant (4); Signal peptide (1); Transmembrane (2); Turn (5),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9NZJ5,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK),MERAISPGLLVRALLLLLLLLGLAARTVAAGRARGLPAPTAEAAFGLGAAAAPTSATRVPAAGAVAAAEVTVEDAEALPAAAGEQEPRGPEPDDETELRPRGRSLVIISTLDGRIAALDPENHGKKQWDLDVGSGSLVSSSLSKPEVFGNKMIIPSLDGALFQWDQDRESMETVPFTVESLLESSYKFGDDVVLVGGKSLTTYGLSAYSGKVRYICSALGCRQWDSDEMEQEEDILLLQRTQKTVRAVGPRSGNEKWNFSVGHFELRYIPDMETRAGFIESTFKPNENTEESKIISDVEEQEAAIMDIVIKVSVADWKVMAFSKKGGHLEWEYQFCTPIASAWLLKDGKVIPISLFDDTSYTSNDDVLEDEEDIVEAARGATENSVYLGMYRGQLYLQSSVRISEKFPSSPKALESVTNENAIIPLPTIKWKPLIHSPSRTPVLVGSDEFDKCLSNDKFSHEEYSNGALSILQYPYDNGYYLPYYKRERNKRSTQITVRFLDNPHYNKNIRKKDPVLLLHWWKEIVATILFCIIATTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN,1116,"125,216",Active site (1); Beta strand (27); Binding site (1); Chain (1); Compositional bias (1); Domain (1); Glycosylation (1); Helix (16); Modified residue (4); Natural variant (6); Nucleotide binding (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q99795,Cell surface A33 antigen (Glycoprotein A33),MVGKMWPVLWTLCAVRVTVDAISVETPQDVLRASQGKSVTLPCTYHTSTSSREGLIQWDKLLLTHTERVVIWPFSNKNYIHGELYKNRVSISNNAEQSDASITIDQLTMADNGTYECSVSLMSDLEGNTKSRVRLLVLVPPSKPECGIEGETIIGNNIQLTCQSKEGSPTPQYSWKRYNILNQEQPLAQPASGQPVSLKNISTDTSGYYICTSSNEEGTQFCNITVAVRSPSMNVALYVGIAVGVVAALIIIGIIIYCCCCRGKDDNTEDKEDARPNREAYEEPPEQLRELSREREEEDDYRQEEQRSTGRESPDHLDQ,319,"35,632",Chain (1); Compositional bias (1); Disulfide bond (3); Domain (2); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 162..211;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..21
P14770,Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a),MPAWGALFLLWATAEATKDCPSPCTCRALETMGLWVDCRGHGLTALPALPARTRHLLLANNSLQSVPPGAFDHLPQLQTLDVTQNPWHCDCSLTYLRLWLEDRTPEALLQVRCASPSLAAHGPLGRLTGYQLGSCGWQLQASWVRPGVLWDVALVAVAALGLALLAGLLCATTEALD,177,"19,046",Chain (1); Domain (2); Glycosylation (1); Helix (1); Natural variant (8); Repeat (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..16;  /evidence=""ECO:0000269|PubMed:12665801, ECO:0000269|PubMed:2253772, ECO:0000269|PubMed:2771955, ECO:0000269|PubMed:3056407"""
Q6PCB8,Embigin,MRALPGLLEARARTPRLLLLQCLLAAARPSSADGSAPDSPFTSPPLREEIMANNFSLESHNISLTEHSSMPVEKNITLERPSNVNLTCQFTTSGDLNAVNVTWKKDGEQLENNYLVSATGSTLYTQYRFTIINSKQMGSYSCFFREEKEQRGTFNFKVPELHGKNKPLISYVGDSTVLTCKCQNCFPLNWTWYSSNGSVKVPVGVQMNKYVINGTYANETKLKITQLLEEDGESYWCRALFQLGESEEHIELVVLSYLVPLKPFLVIVAEVILLVATILLCEKYTQKKKKHSDEGKEFEQIEQLKSDDSNGIENNVPRHRKNESLGQ,327,"36,881",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (9); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 88..142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 180..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
P46098,5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor),MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPEDFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYIRHQGEVQNYKPLQVVTACSLDIYNFPFDVQNCSLTFTSWLHTIQDINISLWRLPEKVKSDRSVFMNQGEWELLGVLPYFREFSMESSNYYAEMKFYVVIRRRPLFYVVSLLLPSIFLMVMDIVGFYLPPNSGERVSFKITLLLGYSVFLIIVSDTLPATAIGTPLIGVYFVVCMALLVISLAETIFIVRLVHKQDLQQPVPAWLRHLVLERIAWLLCLREQSTSQRPPATSQATKTDDCSAMGNHCSHMGGPQDFEKSPRDRCSPPPPPREASLAVCGLLQELSSIRQFLEKRDEIREVARDWLRVGSVLDKLLFHIYLLAVLAYSITLVMLWSIWQYA,478,"55,280",Alternative sequence (3); Chain (1); Disulfide bond (1); Glycosylation (4); Mutagenesis (4); Natural variant (5); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 157..171;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8IZF5,Adhesion G-protein coupled receptor F3 (G-protein coupled receptor 113) (G-protein coupled receptor PGR23),MVCSAAPLLLLATTLPLLGSPVAQASQPVSETGVRPREGLQRRQWGPLIGRDKAWNERIDRPFPACPIPLSSSFGRWPKGQTMWAQTSTLTLTEEELGQSQAGGESGSGQLLDQENGAGESALVSVYVHLDFPDKTWPPELSRTLTLPAASASSSPRPLLTGLRLTTECNVNHKGNFYCACLSGYQWNTSICLHYPPCQSLHNHQPCGCLVFSHPEPGYCQLLPPGSPVTCLPAVPGILNLNSQLQMPGDTLSLTLHLSQEATNLSWFLRHPGSPSPILLQPGTQVSVTSSHGQAALSVSNMSHHWAGEYMSCFEAQGFKWNLYEVVRVPLKATDVARLPYQLSISCATSPGFQLSCCIPSTNLAYTAAWSPGEGSKASSFNESGSQCFVLAVQRCPMADTTYACDLQSLGLAPLRVPISITIIQDGDITCPEDASVLTWNVTKAGHVAQAPCPESKRGIVRRLCGADGVWGPVHSSCTDARLLALFTRTKLLQAGQGSPAEEVPQILAQLPGQAAEASSPSDLLTLLSTMKYVAKVVAEARIQLDRRALKNLLIATDKVLDMDTRSLWTLAQARKPWAGSTLLLAVETLACSLCPQDHPFAFSLPNVLLQSQLFGPTFPADYSISFPTRPPLQAQIPRHSLAPLVRNGTEISITSLVLRKLDHLLPSNYGQGLGDSLYATPGLVLVISIMAGDRAFSQGEVIMDFGNTDGSPHCVFWDHSLFQGRGGWSKEGCQAQVASASPTAQCLCQHLTAFSVLMSPHTVPEEPALALLTQVGLGASILALLVCLGVYWLVWRVVVRNKISYFRHAALLNMVFCLLAADTCFLGAPFLSPGPRSPLCLAAAFLCHFLYLATFFWMLAQALVLAHQLLFVFHQLAKHRVLPLMVLLGYLCPLGLAGVTLGLYLPQGQYLREGECWLDGKGGALYTFVGPVLAIIGVNGLVLAMAMLKLLRPSLSEGPPAEKRQALLGVIKALLILTPIFGLTWGLGLATLLEEVSTVPHYIFTILNTLQGVFILLFGCLMDRKIQEALRKRFCRAQAPSSTISLVSCCLQILSCASKSMSEGIPWPSSEDMGTARS,1079,"116,341",Alternative sequence (5); Chain (1); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (1); Glycosylation (6); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q86Y34,Adhesion G protein-coupled receptor G3 (G-protein coupled receptor 97) (G-protein coupled receptor PGR26),MATPRGLGALLLLLLLPTSGQEKPTEGPRNTCLGSNNMYDIFNLNDKALCFTKCRQSGSDSCNVENLQRYWLNYEAHLMKEGLTQKVNTPFLKALVQNLSTNTAEDFYFSLEPSQVPRQVMKDEDKPPDRVRLPKSLFRSLPGNRSVVRLAVTILDIGPGTLFKGPRLGLGDGSGVLNNRLVGLSVGQMHVTKLAEPLEIVFSHQRPPPNMTLTCVFWDVTKGTTGDWSSEGCSTEVRPEGTVCCCDHLTFFALLLRPTLDQSTVHILTRISQAGCGVSMIFLAFTIILYAFLRLSRERFKSEDAPKIHVALGGSLFLLNLAFLVNVGSGSKGSDAACWARGAVFHYFLLCAFTWMGLEAFHLYLLAVRVFNTYFGHYFLKLSLVGWGLPALMVIGTGSANSYGLYTIRDRENRTSLELCWFREGTTMYALYITVHGYFLITFLFGMVVLALVVWKIFTLSRATAVKERGKNRKKVLTLLGLSSLVGVTWGLAIFTPLGLSTVYIFALFNSLQGVFICCWFTILYLPSQSTTVSSSTARLDQAHSASQE,549,"60,861",Chain (1); Domain (1); Frameshift (1); Glycosylation (4); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9Y653,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)],MTPQSLLQTTLFLLSLLFLVQGAHGRGHREDFRFCSQRNQTHRSSLHYKPTPDLRISIENSEEALTVHAPFPAAHPASRSFPDPRGLYHFCLYWNRHAGRLHLLYGKRDFLLSDKASSLLCFQHQEESLAQGPPLLATSVTSWWSPQNISLPSAASFTFSFHSPPHTAAHNASVDMCELKRDLQLLSQFLKHPQKASRRPSAAPASQQLQSLESKLTSVRFMGDMVSFEEDRINATVWKLQPTAGLQDLHIHSRQEEEQSEIMEYSVLLPRTLFQRTKGRSGEAEKRLLLVDFSSQALFQDKNSSQVLGEKVLGIVVQNTKVANLTEPVVLTFQHQLQPKNVTLQCVFWVEDPTLSSPGHWSSAGCETVRRETQTSCFCNHLTYFAVLMVSSVEVDAVHKHYLSLLSYVGCVVSALACLVTIAAYLCSRVPLPCRRKPRDYTIKVHMNLLLAVFLLDTSFLLSEPVALTGSEAGCRASAIFLHFSLLTCLSWMGLEGYNLYRLVVEVFGTYVPGYLLKLSAMGWGFPIFLVTLVALVDVDNYGPIILAVHRTPEGVIYPSMCWIRDSLVSYITNLGLFSLVFLFNMAMLATMVVQILRLRPHTQKWSHVLTLLGLSLVLGLPWALIFFSFASGTFQLVVLYLFSIITSFQGFLIFIWYWSMRLQARGGPSPLKSNSDSARLPISSGSTSSSRI,693,"77,738",Alternative sequence (4); Chain (3); Domain (1); Glycosylation (7); Mutagenesis (5); Natural variant (13); Region (2); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15340161"""
Q14CN2,"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]",MGLFRGFVFLLVLCLLHQSNTSFIKLNNNGFEDIVIVIDPSVPEDEKIIEQIEDMVTTASTYLFEATEKRFFFKNVSILIPENWKENPQYKRPKHENHKHADVIVAPPTLPGRDEPYTKQFTECGEKGEYIHFTPDLLLGKKQNEYGPPGKLFVHEWAHLRWGVFDEYNEDQPFYRAKSKKIEATRCSAGISGRNRVYKCQGGSCLSRACRIDSTTKLYGKDCQFFPDKVQTEKASIMFMQSIDSVVEFCNEKTHNQEAPSLQNIKCNFRSTWEVISNSEDFKNTIPMVTPPPPPVFSLLKISQRIVCLVLDKSGSMGGKDRLNRMNQAAKHFLLQTVENGSWVGMVHFDSTATIVNKLIQIKSSDERNTLMAGLPTYPLGGTSICSGIKYAFQVIGELHSQLDGSEVLLLTDGEDNTASSCIDEVKQSGAIVHFIALGRAADEAVIEMSKITGGSHFYVSDEAQNNGLIDAFGALTSGNTDLSQKSLQLESKGLTLNSNAWMNDTVIIDSTVGKDTFFLITWNSLPPSISLWDPSGTIMENFTVDATSKMAYLSIPGTAKVGTWAYNLQAKANPETLTITVTSRAANSSVPPITVNAKMNKDVNSFPSPMIVYAEILQGYVPVLGANVTAFIESQNGHTEVLELLDNGAGADSFKNDGVYSRYFTAYTENGRYSLKVRAHGGANTARLKLRPPLNRAAYIPGWVVNGEIEANPPRPEIDEDTQTTLEDFSRTASGGAFVVSQVPSLPLPDQYPPSQITDLDATVHEDKIILTWTAPGDNFDVGKVQRYIIRISASILDLRDSFDDALQVNTTDLSPKEANSKESFAFKPENISEENATHIFIAIKSIDKSNLTSKVSNIAQVTLFIPQANPDDIDPTPTPTPTPTPDKSHNSGVNISTLVLSVIGSVVIVNFILSTTI,919,"101,283",Active site (1); Alternative sequence (3); Chain (3); Domain (1); Glycosylation (10); Metal binding (3); Natural variant (5); Region (1); Sequence conflict (1); Signal peptide (1); Site (1); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q8NEA5,Uncharacterized protein C19orf18,MDKVQSGFLILFLFLMECQLHLCLPYADGLHPTGNITGLPGSKRSQPPRNITKEPKVFFHKTQLPGIQGAASRSTAASPTNPMKFLRNKAIIRHRPALVKVILISSVAFSIALICGMAISYMIYRLAQAEERQQLESLYKNLRIPLLGDEEEGSEDEGESTHLLPENENELEKFIHSVIISKRSKNIKKKLKEEQNSVTENKTKNASHNGKMEDL,215,"24,151",Chain (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6ZRH7,Cation channel sperm-associated protein subunit gamma,MCGPAMFPAGPPWPRVRVVQVLWALLAVLLASWRLWAIKDFQECTWQVVLNEFKRVGESGVSDSFFEQEPVDTVSSLFHMLVDSPIDPSEKYLGFPYYLKINYSCEEKPSEDLVRMGHLTGLKPLVLVTFQSPVNFYRWKIEQLQIQMEAAPFRSKEPCMAEEVCSMSWYTPMPIKKGSVVMRVDISSNGLGTFIPDKRFQMNINGFLKRDRDNNIQFTVGEELFNLMPQYFVGVSSRPLWHTVDQSPVLILGGIPNEKYVLMTDTSFKDFSLVELSIDSCWVGSFYCPHSGFTATIYDTIATESTLFIRQNQLVYYFTGTYTTLYERNRGSGSWIRVLASECIKKLCPVYFHSNGSEYIMALTTGKHEGYVHFGTIRDGQVSFEMLPRQWSVCEQIGVTTCSIIWSEYIAGEYTLLLLVESGYGNASKRFQVVSYNTASDDLELLYHIPEFIPEARGLEFLMILGTESYTSTAMAPKGIFCNPYNNLIFIWGNFLLQSSNKENFIYLADFPKELSIKYMARSFRGAVAIVTETEEIWYLLEGSYRVYQLFPSKGWQVHISLKLMQQSSLYASNETMLTLFYEDSKLYQLVYLMNNQKGQLVKRLVPVEQLLMYQQHTSHYDLERKGGYLMLSFIDFCPFSVMRLRSLPSPQRYTRQERYRARPPRVLERSGFHNENSLAIYQGLVYYLLWLHSVYDKPYADPVHDPTWRWWANNKQDQDYYFFLASNWRSAGGVSIEMDSYEKIYNLESAYELPERIFLDKGTEYSFAIFLSAQGHSFRTQSELGTAFQLHSQVDVGVVLADPGCIEASVKQEVLINRNSVLFSITLKDKKLCYDQGISGHHLMETSMTVNVVGSSGLCFQETHLGPHMQGNLMVPVFIGCPPGKRLAFDITYTLEYSRLKNKHYFDCVNVNPEMPCFLFRDIFYPFFLIQDLVTGDSGSFQGSYVLLVVGGGPTLDSLKDYSEDEIYRFNSPLDKTNSLIWTTRTTRTTKDSAFHIMSHESPGIEWLCLENAPCYDNVPQGIFAPEFFFKVLVSNRGVDTSTYCNYQLTFLLHIHGLPLSPKRALFIIMVSASVFVGLVIFYIAFCLLWPLVVKGCTMIRWKINNLIASESYYTYASISGISSMPSLRHSRMGSMFSSRMTEDRAEPKEAVERQLMT,1159,"133,032",Chain (1); Erroneous initiation (1); Glycosylation (2); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P43146,Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC),MENSLRCVWVPKLAFVLFGASLFSAHLQVTGFQIKAFTALRFLSEPSDAVTMRGGNVLLDCSAESDRGVPVIKWKKDGIHLALGMDERKQQLSNGSLLIQNILHSRHHKPDEGLYQCEASLGDSGSIISRTAKVAVAGPLRFLSQTESVTAFMGDTVLLKCEVIGEPMPTIHWQKNQQDLTPIPGDSRVVVLPSGALQISRLQPGDIGIYRCSARNPASSRTGNEAEVRILSDPGLHRQLYFLQRPSNVVAIEGKDAVLECCVSGYPPPSFTWLRGEEVIQLRSKKYSLLGGSNLLISNVTDDDSGMYTCVVTYKNENISASAELTVLVPPWFLNHPSNLYAYESMDIEFECTVSGKPVPTVNWMKNGDVVIPSDYFQIVGGSNLRILGVVKSDEGFYQCVAENEAGNAQTSAQLIVPKPAIPSSSVLPSAPRDVVPVLVSSRFVRLSWRPPAEAKGNIQTFTVFFSREGDNRERALNTTQPGSLQLTVGNLKPEAMYTFRVVAYNEWGPGESSQPIKVATQPELQVPGPVENLQAVSTSPTSILITWEPPAYANGPVQGYRLFCTEVSTGKEQNIEVDGLSYKLEGLKKFTEYSLRFLAYNRYGPGVSTDDITVVTLSDVPSAPPQNVSLEVVNSRSIKVSWLPPPSGTQNGFITGYKIRHRKTTRRGEMETLEPNNLWYLFTGLEKGSQYSFQVSAMTVNGTGPPSNWYTAETPENDLDESQVPDQPSSLHVRPQTNCIIMSWTPPLNPNIVVRGYIIGYGVGSPYAETVRVDSKQRYYSIERLESSSHYVISLKAFNNAGEGVPLYESATTRSITDPTDPVDYYPLLDDFPTSVPDLSTPMLPPVGVQAVALTHDAVRVSWADNSVPKNQKTSEVRLYTVRWRTSFSASAKYKSEDTTSLSYTATGLKPNTMYEFSVMVTKNRRSSTWSMTAHATTYEAAPTSAPKDLTVITREGKPRAVIVSWQPPLEANGKITAYILFYTLDKNIPIDDWIMETISGDRLTHQIMDLNLDTMYYFRIQARNSKGVGPLSDPILFRTLKVEHPDKMANDQGRHGDGGYWPVDTNLIDRSTLNEPPIGQMHPPHGSVTPQKNSNLLVIIVVTVGVITVLVVVIVAVICTRRSSAQQRKKRATHSAGKRKGSQKDLRPPDLWIHHEEMEMKNIEKPSGTDPAGRDSPIQSCQDLTPVSHSQSETQLGSKSTSHSGQDTEEAGSSMSTLERSLAARRAPRAKLMIPMDAQSNNPAVVSAIPVPTLESAQYPGILPSPTCGYPHPQFTLRPVPFPTLSVDRGFGAGRSQSVSEGPTTQQPPMLPPSQPEHSSSEEAPSRTIPTACVRPTHPLRSFANPLLPPPMSAIEPKVPYTPLLSQPGPTLPKTHVKTASLGLAGKARSPLLPVSVPTAPEVSEESHKPTEDSANVYEQDDLSEQMASLEGLMKQLNAITGSAF,1447,"158,457",Beta strand (51); Chain (1); Disulfide bond (4); Domain (10); Erroneous gene model prediction (1); Erroneous initiation (3); Glycosylation (6); Helix (3); Modified residue (3); Mutagenesis (3); Natural variant (19); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 61..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 161..212;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 261..310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 352..400;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
B6SEH9,Endogenous retrovirus group V member 2 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 2),MTEKFLFLYLSLLPMPLLSQAQWNENSLVSFSKIIASGNHLSNCWICHNFITRSSSYQYILVRNFSLNLTFGSGIPEGQHKSVPLQVSLANSAHQVPCLDLTPPFNQSSKTSFYFYNCSSLNQTCCPCPEGHCDRKNTSEEGFPSPTIHPMSFSPAGCHPNLTHWCPAKQMNDYRDKSPQNRCAAWEGKELITWRVLYSLPKAHTVPTWPKSTVPLGGPLSPACNQTIPAGWKSQLHKWFDSHIPRWACTPPGYVFLCGPQKNKLPFDGSPKITYSTPPVANLYTCINNIQHTGECAVGLLGPRGIGVTIYNTTQPRQKRALGLILAGMGAAIGMIAPWGGFTYHDVTLRNLSRQIDNIAKSTRDSISKLKASIDSLANVVMDNRLALDYLLAEQGGVCAVINKSCCVYVNNSGAIEEDIKKIYDEATWLHDFGKGGASARAIWEAVKSALPSLNWFVPLLGPATVILLLFLFGPCFFNLLIKCVSSRIKQFHMKSPQMERYQLSVIGGPSTYKHISPLDASGQRFRETMEEFSL,535,"59,317",Chain (1); Glycosylation (1); Signal peptide (1); Topological domain (3); Transmembrane (2),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
A8MVW0,Protein FAM171A2,MPPASGPSVLARLLPLLGLLLGSASRAPGKSPPEPPSPQEILIKVQVYVSGELVPLARASVDVFGNRTLLAAGTTDSEGVATLPLSYRLGTWVLVTAARPGFLTNSVPWRVDKLPLYASVSLYLLPERPATLILYEDLVHILLGSPGARSQPLVQFQRRAARLPVSSTYSQLWASLTPASTQQEMRAFPAFLGTEASSSGNGSWLELMPLTAVSVHLLTGNGTEVPLSGPIHLSLPVPSETRALTVGTSIPAWRFDPKSGLWVRNGTGVIRKEGRQLYWTFVSPQLGYWVAAMASPTAGLVTITSGIQDIGTYHTIFLLTILAALALLVLILLCLLIYYCRRRCLKPRQQHRKLQLSGPSDGNKRDQATSMSQLHLICGGPLEPAPSGDPEAPPPGPLHSAFSSSRDLASSRDDFFRTKPRSASRPAAEPSGARGGESAGLKGARSAEGPGGLEPGLEEHRRGPSGAAAFLHEPPSPPPPFDHYLGHKGAAEGKTPDFLLSQSVDQLARPPSLGQAGQLIFCGSIDHLKDNVYRNVMPTLVIPAHYVRLGGEAGAAGVGDEPAPPEGTAPGPARAFPQPDPQRPQMPGHSGPGGEGGGGGGEGWGAGRAAPVSGSVTIPVLFNESTMAQLNGELQALTEKKLLELGVKPHPRAWFVSLDGRSNSQVRHSYIDLQAGGGARSTDASLDSGVDVHEARPARRRPAREERERAPPAAPPPPPAPPRLALSEDTEPSSSESRTGLCSPEDNSLTPLLDEVAAPEGRAATVPRGRGRSRGDSSRSSASELRRDSLTSPEDELGAEVGDEAGDKKSPWQRREERPLMVFNVK,826,"87,435",Chain (1); Compositional bias (3); Glycosylation (4); Modified residue (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UP38,Frizzled-1 (Fz-1) (hFz1) (FzE1),MAEEEAPKKSRAAGGGASWELCAGALSARLAEEGSGDAGGRRRPPVDPRRLARQLLLLLWLLEAPLLLGVRAQAAGQGPGQGPGPGQQPPPPPQQQQSGQQYNGERGISVPDHGYCQPISIPLCTDIAYNQTIMPNLLGHTNQEDAGLEVHQFYPLVKVQCSAELKFFLCSMYAPVCTVLEQALPPCRSLCERARQGCEALMNKFGFQWPDTLKCEKFPVHGAGELCVGQNTSDKGTPTPSLLPEFWTSNPQHGGGGHRGGFPGGAGASERGKFSCPRALKVPSYLNYHFLGEKDCGAPCEPTKVYGLMYFGPEELRFSRTWIGIWSVLCCASTLFTVLTYLVDMRRFSYPERPIIFLSGCYTAVAVAYIAGFLLEDRVVCNDKFAEDGARTVAQGTKKEGCTILFMMLYFFSMASSIWWVILSLTWFLAAGMKWGHEAIEANSQYFHLAAWAVPAIKTITILALGQVDGDVLSGVCFVGLNNVDALRGFVLAPLFVYLFIGTSFLLAGFVSLFRIRTIMKHDGTKTEKLEKLMVRIGVFSVLYTVPATIVIACYFYEQAFRDQWERSWVAQSCKSYAIPCPHLQAGGGAPPHPPMSPDFTVFMIKYLMTLIVGITSGFWIWSGKTLNSWRKFYTRLTNSKQGETTV,647,"71,158",Chain (1); Compositional bias (1); Disulfide bond (5); Domain (1); Glycosylation (2); Motif (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 116..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 124..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 161..198;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 187..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 191..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..69;  /evidence=""ECO:0000255"""
P23945,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),MALLLVSLLAFLSLGSGCHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDVTCSPKPDAFNPCEDIMGYNILRVLIWFISILAITGNIIVLVILTTSQYKLTVPRFLMCNLAFADLCIGIYLLLIASVDIHTKSQYHNYAIDWQTGAGCDAAGFFTVFASELSVYTLTAITLERWHTITHAMQLDCKVQLRHAASVMVMGWIFAFAAALFPIFGISSYMKVSICLPMDIDSPLSQLYVMSLLVLNVLAFVVICGCYIHIYLTVRNPNIVSSSSDTRIAKRMAMLIFTDFLCMAPISFFAISASLKVPLITVSKAKILLVLFHPINSCANPFLYAIFTKNFRRDFFILLSKCGCYEMQAQIYRTETSSTVHNTHPRNGHCSSAPRVTNGSTYILVPLSHLAQN,695,"78,265",Alternative sequence (3); Beta strand (19); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (4); Helix (1); Modified residue (1); Mutagenesis (2); Natural variant (21); Repeat (9); Sequence conflict (4); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (5),"DISULFID 18..25;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:15662415, ECO:0000269|PubMed:24692546""; DISULFID 23..32;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000255|PROSITE-ProRule:PRU00521, ECO:0000269|PubMed:15662415, ECO:0000269|PubMed:24692546""; DISULFID 275..346;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000269|PubMed:24692546""; DISULFID 276..356;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000269|PubMed:24692546""; DISULFID 276..292;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000269|PubMed:24692546""; DISULFID 292..338;  /evidence=""ECO:0000244|PDB:4MQW, ECO:0000269|PubMed:24692546""; DISULFID 442..517;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q86XX4,Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein),MGVLKVWLGLALALAEFAVLPHHSEGACVYQDSLLADATIWKPDSCQSCRCHGDIVICKPAVCRNPQCAFEKGEVLQIAANQCCPECVLRTPGSCHHEKKIHEHGTEWASSPCSVCSCNHGEVRCTPQPCPPLSCGHQELAFIPEGSCCPVCVGLGKPCSYEGHVFQDGEDWRLSRCAKCLCRNGVAQCFTAQCQPLFCNQDETVVRVPGKCCPQCSARSCSAAGQVYEHGEQWSENACTTCICDRGEVRCHKQACLPLRCGKGQSRARRHGQCCEECVSPAGSCSYDGVVRYQDEMWKGSACEFCMCDHGQVTCQTGECAKVECARDEELIHLDGKCCPECISRNGYCVYEETGEFMSSNASEVKRIPEGEKWEDGPCKVCECRGAQVTCYEPSCPPCPVGTLALEVKGQCCPDCTSVHCHPDCLTCSQSPDHCDLCQDPTKLLQNGWCVHSCGLGFYQAGSLCLACQPQCSTCTSGLECSSCQPPLLMRHGQCVPTCGDGFYQDRHSCAVCHESCAGCWGPTEKHCLACRDPLHVLRDGGCESSCGKGFYNRQGTCSACDQSCDSCGPSSPRCLTCTEKTVLHDGKCMSECPGGYYADATGRCKVCHNSCASCSGPTPSHCTACSPPKALRQGHCLPRCGEGFYSDHGVCKACHSSCLACMGPAPSHCTGCKKPEEGLQVEQLSDVGIPSGECLAQCRAHFYLESTGICEACHQSCFRCAGKSPHNCTDCGPSHVLLDGQCLSQCPDGYFHQEGSCTECHPTCRQCHGPLESDCISCYPHISLTNGNCRTSCREEQFLNLVGYCADCHHLCQHCAADLHNTGSICLRCQNAHYLLLGDHCVPDCPSGYYAERGACKKCHSSCRTCQGRGPFSCSSCDTNLVLSHTGTCSTTCFPGHYLDDNHVCQPCNTHCGSCDSQASCTSCRDPNKVLLFGECQYESCAPQYYLDFSTNTCKECDWSCSACSGPLKTDCLQCMDGYVLQDGACVEQCLSSFYQDSGLCKNCDSYCLQCQGPHECTRCKGPFLLLEAQCVQECGKGYFADHAKHKCTACPQGCLQCSHRDRCHLCDHGFFLKSGLCVYNCVPGFSVHTSNETCSGKIHTPSLHVNGSLILPIGSIKPLDFSLLNVQDQEGRVEDLLFHVVSTPTNGQLVLSRNGKEVQLDKAGRFSWKDVNEKKVRFVHSKEKLRKGYLFLKISDQQFFSEPQLINIQAFSTQAPYVLRNEVLHISRGERATITTQMLDIRDDDNPQDVVIEIIDPPLHGQLLQTLQSPATPIYQFQLDELSRGLLHYAHDGSDSTSDVAVLQANDGHSFHNILFQVKTVPQNDRGLQLVANSMVWVPEGGMLQITNRILQAEAPGASAEEIIYKITQDYPQFGEVVLLVNMPADSPADEGQHLPDGRTATPTSTFTQQDINEGIVWYRHSGAPAQSDSFRFEVSSASNAQTRLESHMFNIAILPQTPEAPKVSLEASLHMTAREDGLTVIQPHSLSFINSEKPSGKIVYNITLPLHPNQGIIEHRDHPHSPIRYFTQEDINQGKVMYRPPPAAPHLQELMAFSFAGLPESVKFHFTVSDGEHTSPEMVLTIHLLPSDQQLPVFQVTAPRLAVSPGGSTSVGLQVVVRDAETAPKELFFELRRPPQHGVLLKHTAEFRRPMATGDTFTYEDVEKNALQYIHDGSSTREDSMEISVTDGLTVTMLEVRVEVSLSEDRGPRLAAGSSLSITVASKSTAIITRSHLAYVDDSSPDPEIWIQLNYLPSYGTLLRISGSEVEELSEVSNFTMEDINNKKIRYSAVFETDGHLVTDSFYFSVSDMDHNHLDNQIFTIMITPAENPPPVIAFADLITVDEGGRAPLSFHHFFATDDDDNLQRDAIIKLSALPKYGCIENTGTGDRFGPETASDLEASFPIQDVLENYIYYFQSVHESIEPTHDIFSFYVSDGTSRSEIHSINITIERKNDEPPRMTLQPLRVQLSSGVVISNSSLSLQDLDTPDNELIFVLTKKPDHGHVLWRQTASEPLENGRVLVQGSTFTYQDILAGLVGYVPSVPGMVVDEFQFSLTDGLHVDTGRMKIYTELPASDTPHLAINQGLQLSAGSVARITEQHLKVTDIDSDDHQVMYIMKEDPGAGRLQMMKHGNLEQISIKGPIRSFTQADISQGQPEYSHGTGEPGGSFAFKFDVVDGEGNRLIDKSFSISISEDKSPPVITTNKGLVLDENSVKKITTLQLSATDQDSGPTELIYRITRQPQLGHLEHAASPGIQISSFTQADLTSRNVQYVHSSEAEKHSDAFSFTLSDGVSEVTQTFHITLHPVDDSLPVVQNLGMRVQEGMRKTITEFELKAVDADTEAESVTFTIVQPPRHGTIERTSNGQHFHLTSTFTMKDIYQNRVSYSHDGSNSLKDRFTFTVSDGTNPFFIIEEGGKEIMTAAPQPFRVDILPVDDGTPRIVTNLGLQWLEYMDGKATNLITKKELLTMDPDTEDAQLVYEITTGPKHGFVENKLQPGRAAATFTQEDVNLGLIRYVLHKEKIREMMDSFQFLVKDSKPNVVSDNVFHIQWSLISFKYTSYNVSEKAGSVSVTVQRTGNLNQYAIVLCRTEQGTASSSSQPGQQDYVEYAGQVQFDEREDTKSCTIVINDDDVFENVESFTVELSMPAYALLGEFTQAKVIINDTEDEPTLEFDKKIYWVNESAGFLFAPIERKGDASSIVSAICYTVPKSAMGSLFYALESGSDFKSRGMSAASRVIFGPGVTMSTCDVMLIDDSEYEEEEEFEIALADASDNARIGRVATAKVLISGPNDASTVSLGNTAFTVSEDAGTVKIPVIRHGTDLSTFASVWCATRPSDPASATPGVDYVPSSRKVEFGPGVIEQYCTLTILDDTQYPVIEGLETFVVFLSSAQGAELTKPFQAVIAINDTFQDVPSMQFAKDLLLVKEKEGVLHVPITRSGDLSYESSVRCYTQSHSAQVMEDFEERQNADSSRITFLKGDKVKNCTVYIHDDSMFEPEEQFRVYLGLPLGNHWSGARIGKNNMATITISNDEDAPTIEFEEAAYQVREPAGPDAIAILNIKVIRRGDQNRTSKVRCSTRDGSAQSGVDYYPKSRVLKFSPGVDHIFFKVEILSNEDREWHESFSLVLGPDDPVEAVLGDVTTATVTILDQEAAGSLILPAPPIVVTLADYDHVEEVTKEGVKKSPSPGYPLVCVTPCDPHFPRYAVMKERCSEAGINQTSVQFSWEVAAPTDGNGARSPFETITDNTPFTSVNHMVLDSIYFSRRFHVRCVAKAVDKVGHVGTPLRSNIVTIGTDSAICHTPVVAGTSRGFQAQSFIATLKYLDVKHKEHPNRIHISVQIPHQDGMLPLISTMPLHNLHFLLSESIYRHQHVCSNLVTTYDLRGLAEAGFLDDVVYDSTALGPGYDRPFQFDPSVREPKTIQLYKHLNLKSCVWTFDAYYDMTELIDVCGGSVTADFQVRDSAQSFLTVHVPLYVSYIYVTAPRGWASLEHHTEMEFSFFYDTVLWRTGIQTDSVLSARLQIIRIYIREDGRLVIEFKTHAKFRGQFVMEHHTLPEVKSFVLTPDHLGGIEFDLQLLWSAQTFDSPHQLWRATSSYNRKDYSGEYTIYLIPCTVQPTQPWVDPGEKPLACTAHAPERFLIPIAFQQTNRPVPVVYSLNTEFQLCNNEKVFLMDPNTSDMSLAEMDYKGAFSKGQILYGRVLWNPEQNLNSAYKLQLEKVYLCTGKDGYVPFFDPTGTIYNEGPQYGCIQPNKHLKHRFLLLDRNQPEVTDKYFHDVPFEAHFASELPDFHVVSNMPGVDGFTLKVDALYKVEAGHQWYLQVIYIIGPDTISGPRVQRSLTAPLRRNRRDLVEPDGQLILDDSLIYDNEGDQVKNGTNMKSLNLEMQELAVAASLSQTGASIGSALAAIMLLLLVFLVACFINRKCQKQRKKKPAEDILEEYPLNTKVEVPKRHPDRVEKNVNRHYCTVRNVNILSEPEAAYTFKGAKVKRLNLEVRVHNNLQDGTEV,4008,"443,214",Alternative sequence (11); Chain (1); Domain (11); Frameshift (1); Glycosylation (17); Modified residue (1); Natural variant (16); Repeat (26); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P55286,Cadherin-8,MPERLAEMLLDLWTPLIILWITLPPCIYMAPMNQSQVLMSGSPLELNSLGEEQRILNRSKRGWVWNQMFVLEEFSGPEPILVGRLHTDLDPGSKKIKYILSGDGAGTIFQINDVTGDIHAIKRLDREEKAEYTLTAQAVDWETSKPLEPPSEFIIKVQDINDNAPEFLNGPYHATVPEMSILGTSVTNVTATDADDPVYGNSAKLVYSILEGQPYFSIEPETAIIKTALPNMDREAKEEYLVVIQAKDMGGHSGGLSGTTTLTVTLTDVNDNPPKFAQSLYHFSVPEDVVLGTAIGRVKANDQDIGENAQSSYDIIDGDGTALFEITSDAQAQDGIIRLRKPLDFETKKSYTLKVEAANVHIDPRFSGRGPFKDTATVKIVVEDADEPPVFSSPTYLLEVHENAALNSVIGQVTARDPDITSSPIRFSIDRHTDLERQFNINADDGKITLATPLDRELSVWHNITIIATEIRNHSQISRVPVAIKVLDVNDNAPEFASEYEAFLCENGKPGQVIQTVSAMDKDDPKNGHYFLYSLLPEMVNNPNFTIKKNEDNSLSILAKHNGFNRQKQEVYLLPIIISDSGNPPLSSTSTLTIRVCGCSNDGVVQSCNVEAYVLPIGLSMGALIAILACIILLLVIVVLFVTLRRHKNEPLIIKDDEDVRENIIRYDDEGGGEEDTEAFDIATLQNPDGINGFLPRKDIKPDLQFMPRQGLAPVPNGVDVDEFINVRLHEADNDPTAPPYDSIQIYGYEGRGSVAGSLSSLESTTSDSDQNFDYLSDWGPRFKRLGELYSVGESDKET,799,"88,253",Chain (1); Domain (5); Erroneous initiation (1); Glycosylation (6); Modified residue (1); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y6N8,Cadherin-10 (T2-cadherin),MTIHQFLLLFLFWVCLPHFCSPEIMFRRTPVPQQRILSSRVPRSDGKILHRQKRGWMWNQFFLLEEYTGSDYQYVGKLHSDQDKGDGSLKYILSGDGAGTLFIIDEKTGDIHATRRIDREEKAFYTLRAQAINRRTLRPVEPESEFVIKIHDINDNEPTFPEEIYTASVPEMSVVGTSVVQVTATDADDPSYGNSARVIYSILQGQPYFSVEPETGIIRTALPNMNRENREQYQVVIQAKDMGGQMGGLSGTTTVNITLTDVNDNPPRFPQNTIHLRVLESSPVGTAIGSVKATDADTGKNAEVEYRIIDGDGTDMFDIVTEKDTQEGIITVKKPLDYESRRLYTLKVEAENTHVDPRFYYLGPFKDTTIVKISIEDVDEPPVFSRSSYLFEVHEDIEVGTIIGTVMARDPDSISSPIRFSLDRHTDLDRIFNIHSGNGSLYTSKPLDRELSQWHNLTVIAAEINNPKETTRVAVFVRILDVNDNAPQFAVFYDTFVCENARPGQLIQTISAVDKDDPLGGQKFFFSLAAVNPNFTVQDNEDNTARILTRKNGFNRHEISTYLLPVVISDNDYPIQSSTGTLTIRVCACDSQGNMQSCSAEALLLPAGLSTGALIAILLCIIILLVIVVLFAALKRQRKKEPLILSKEDIRDNIVSYNDEGGGEEDTQAFDIGTLRNPAAIEEKKLRRDIIPETLFIPRRTPTAPDNTDVRDFINERLKEHDLDPTAPPYDSLATYAYEGNDSIAESLSSLESGTTEGDQNYDYLREWGPRFNKLAEMYGGGESDKDS,788,"88,451",Chain (1); Domain (5); Glycosylation (4); Modified residue (2); Natural variant (2); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9HBJ8,Collectrin (Transmembrane protein 27),MLWLLFFLVTAIHAELCQPGAENAFKVRLSIRTALGDKAYAWDTNEEYLFKAMVAFSMRKVPNREATEISHVLLCNVTQRVSFWFVVTDPSKNHTLPAVEVQSAIRMNKNRINNAFFLNDQTLEFLKIPSTLAPPMDPSVPIWIIIFGVIFCIIIVAIALLILSGIWQRRRKNKEPSEVDDAEDKCENMITIENGIPSDPLDMKGGHINDAFMTEDERLTPL,222,"25,235",Chain (1); Frameshift (1); Glycosylation (2); Modified residue (2); Mutagenesis (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q96J86,Cysteine and tyrosine-rich protein 1 (Proline-rich domain-containing protein),MDAPRLPVRPGVLLPKLVLLFVYADDCLAQCGKDCKSYCCDGTTPYCCSYYAYIGNILSGTAIAGIVFGIVFIMGVIAGIAICICMCMKNHRATRVGILRTTHINTVSSYPGPPPYGHDHEMEYCADLPPPYSPTPQGPAQRSPPPPYPGNARK,154,"16,626",Alternative sequence (9); Chain (1); Compositional bias (1); Erroneous initiation (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q5SY80,Cation channel sperm-associated protein subunit epsilon (CatSper-epsilon) (CatSperepsilon),MSAREVAVLLLWLSCYGSALWRYSTNSPNYRIFSTRSTIKLEYEGTLFTEWSVPETCFVLNKSSPTTELRCSSPGVHAIKPIVTGPDEEERYLFVESSHTCFLWYYRVRHFFNNFTQLITVWAYDPESADPDELLGNAEEPSINSIVLSTQMATLGQKPVIHTVLKRKVYSSNEKMRRGTWRIVVPMTKDDALKEIRGNQVTFQDCFIADFLILLTFPLLTIPEIPGYLPISSPRGSQLMASWDACVVASAVLVTDMETFHTTDSFKSWTRIRVPPDILSDDERRSVAHVILSRDGIVFLINGVLYIKSFRGFIRLGGIVNLPDGGITGISSRKWCWVNYLLKAKGRRSTFAVWTENEIYLGSILLKFARLVTTTELKNILSLSVTATLTIDRVEYTGHPLEIAVFLNYCTVCNVTKKIFLVIYNEDTKQWVSQDFTLDAPIDSVTMPHFTFSALPGLLLWNKHSIYYCYHNFTFTGILQTPAGHGNLSMLSNDSIIHEVFIDYYGDILVKMENNVIFYSKINTRDAVKLHLWTNYTTRAFIFLSTSGQTYFLYALDDGTIQIQDYPLHLEAQSIAFTTKDKCPYMAFHNNVAHVFYFLDKGEALTVWTQIVYPENTGLYVIVESYGPKILQESHEISFEAAFGYCTKTLTLTFYQNVDYERISDYFETQDKHTGLVLVQFRPSEYSKACPIAQKVFQIAVGCDDKKFIAIKGFSKKGCHHHDFSYVIEKSYLRHQPSKNLRVRYIWGEYGCPLRLDFTEKFQPVVQLFDDNGYVKDVEANFIVWEIHGRDDYSFNNTMAQSGCLHEAQTWKSMIELNKHLPLEEVWGPENYKHCFSYAIGKPGDLNQPYEIINSSNGNHIFWPMGHSGMYVFRVKILDPNYSFCNLTAMFAIETFGLIPSPSVYLVASFLFVLMLLFFTILVLSYFRYMRIYRRYIYEPLHKPQRKRKKN,951,"109,662",Alternative sequence (3); Chain (1); Frameshift (1); Glycosylation (4); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P61565,Endogenous retrovirus group K member 21 Env polyprotein (EnvK1 protein) (Envelope polyprotein) (HERV-K_12q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MHPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTNWAYVPFPPLIRAVTWMDNPIEVYVNDSVWVHGPIDDRCPAKPEEEGMMINISIGYHYPPICLGRAPGCLMPAVQNWLVEVPTVSPISRFTYNMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSVVILQNNEFGTIIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTPRPKIISPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTVDLNSSLTVPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSIHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTAMAAVAGVALHSFVQSVNFVNDWQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNESEHHWDMVRRHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQLRRDSDHRERAMMTMVVLSKRKGGNVGKSKRDQIVTVSV,698,"79,236",Chain (3); Compositional bias (2); Glycosylation (11); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..88;  /evidence=""ECO:0000255"""
P29323,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2],MALRRLGAALLLLPLLAAVEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFIRRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADFDSATKTFPNWMENPWVKVDTIAADESFSQVDLGGRVMKINTEVRSFGPVSRSGFYLAFQDYGGCMSLIAVRVFYRKCPRIIQNGAIFQETLSGAESTSLVAARGSCIANAEEVDVPIKLYCNGDGEWLVPIGRCMCKAGFEAVENGTVCRGCPSGTFKANQGDEACTHCPINSRTTSEGATNCVCRNGYYRADLDPLDMPCTTIPSAPQAVISSVNETSLMLEWTPPRDSGGREDLVYNIICKSCGSGRGACTRCGDNVQYAPRQLGLTEPRIYISDLLAHTQYTFEIQAVNGVTDQSPFSPQFASVNITTNQAAPSAVSIMHQVSRTVDSITLSWSQPDQPNGVILDYELQYYEKELSEYNATAIKSPTNTVTVQGLKAGAIYVFQVRARTVAGYGRYSGKMYFQTMTEAEYQTSIQEKLPLIIGSSAAGLVFLIAVVVIAIVCNRRGFERADSEYTDKLQHYTSGHMTPGMKIYIDPFTYEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSSGINLPLLDRTIPDYTSFNTVDEWLEAIKMGQYKESFANAGFTSFDVVSQMMMEDILRVGVTLAGHQKKILNSIQVMRAQMNQIQSVEGQPLARRPRATGRTKRCQPRDVTKKTCNSNDGKKKGMGKKKTDPGRGREIQGIFFKEDSHKESNDCSCGG,1055,"117,493",Active site (1); Alternative sequence (3); Beta strand (21); Binding site (1); Chain (3); Compositional bias (1); Disulfide bond (2); Domain (5); Glycosylation (4); Helix (20); Modified residue (2); Motif (1); Natural variant (11); Nucleotide binding (1); Sequence conflict (15); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 62..184;  /evidence=""ECO:0000269|PubMed:17897949""; DISULFID 97..107;  /evidence=""ECO:0000269|PubMed:17897949""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q5VUB5,Protein FAM171A1 (Astroprincin) (APCN),MSRSATLLLCLLGCHVWKAVTKTLREPGAGAQEVTLKVHISDASTHQPVADALIEIFTNQASIASGTSGTDGVAFIKFQYKLGSQLIVTASKHAYVPNSAPWKPIRLPVFSSLSLGLLPERSATLMVYEDVVQIVSGFQGARPQPRVHFQRRALRLPENTSYSDLTAFLTAASSPSEVDSFPYLRGLDGNGTGNSTRHDLTPVTAVSVHLLSSNGTPVLVDGPIYVTVPLATQSSLRHNAYVAAWRFDQKLGTWLKSGLGLVHQEGSQLTWTYIAPQLGYWVAAMSPPIPGPVVTQDITTYHTVFLLAILGGMAFILLVLLCLLLYYCRRKCLKPRQHHRKLQLPAGLESSKRDQSTSMSHINLLFSRRASEFPGPLSVTSHGRPEAPGTKELMSGVHLEMMSPGGEGDLHTPMLKLSYSTSQEFSSREELLSCKEEDKSQISFDNLTPSGTLGKDYHKSVEVFPLKARKSMEREGYESSGNDDYRGSYNTVLSQPLFEKQDREGPASTGSKLTIQEHLYPAPSSPEKEQLLDRRPTECMMSRSVDHLERPTSFPRPGQLICCSSVDQVNDSVYRKVLPALVIPAHYMKLPGDHSYVSQPLVVPADQQLEIERLQAELSNPHAGIFPHPSSQIQPQPLSSQAISQQHLQDAGTREWSPQNASMSESLSIPASLNDAALAQMNSEVQLLTEKALMELGGGKPLPHPRAWFVSLDGRSNAHVRHSYIDLQRAGRNGSNDASLDSGVDMNEPKSARKGRGDALSLQQNYPPVQEHQQKEPRAPDSTAYTQLVYLDDVEQSGSECGTTVCTPEDSALRCLLEGSSRRSGGQLPSLQEETTRRTADAPSEPAASPHQRRSAHEEEEDDDDDDQGEDKKSPWQKREERPLMAFNIK,890,"97,854",Chain (1); Glycosylation (3); Modified residue (8); Mutagenesis (4); Natural variant (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9BVV8,Protein FAM174C,MGPRVLQPPLLLLLLALLLAALPCGAEEASPLRPAQVTLSPPPAVTNGSQPGAPHNSTHTRPPGASGSALTRSFYVILGFCGLTALYFLIRAFRLKKPQRRRYGLLANTEDPTEMASLDSDEETVFESRNLR,132,"14,249",Chain (1); Glycosylation (1); Modified residue (3); Sequence caution (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P30273,High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma),MIPAVVLLLLLLVEQAAALGEPQLCYILDAILFLYGIVLTLLYCRLKIQVRKAAITSYEKSDGVYTGLSTRNQETYETLKHEKPPQ,86,"9,667",Chain (1); Disulfide bond (1); Domain (1); Modified residue (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 25;  /note=""Interchain"";  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
O43155,Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2),MGLQTTKWPSHGAFFLKSWLIISLGLYSQVSKLLACPSVCRCDRNFVYCNERSLTSVPLGIPEGVTVLYLHNNQINNAGFPAELHNVQSVHTVYLYGNQLDEFPMNLPKNVRVLHLQENNIQTISRAALAQLLKLEELHLDDNSISTVGVEDGAFREAISLKLLFLSKNHLSSVPVGLPVDLQELRVDENRIAVISDMAFQNLTSLERLIVDGNLLTNKGIAEGTFSHLTKLKEFSIVRNSLSHPPPDLPGTHLIRLYLQDNQINHIPLTAFSNLRKLERLDISNNQLRMLTQGVFDNLSNLKQLTARNNPWFCDCSIKWVTEWLKYIPSSLNVRGFMCQGPEQVRGMAVRELNMNLLSCPTTTPGLPLFTPAPSTASPTTQPPTLSIPNPSRSYTPPTPTTSKLPTIPDWDGRERVTPPISERIQLSIHFVNDTSIQVSWLSLFTVMAYKLTWVKMGHSLVGGIVQERIVSGEKQHLSLVNLEPRSTYRICLVPLDAFNYRAVEDTICSEATTHASYLNNGSNTASSHEQTTSHSMGSPFLLAGLIGGAVIFVLVVLLSVFCWHMHKKGRYTSQKWKYNRGRRKDDYCEAGTKKDNSILEMTETSFQIVSLNNDQLLKGDFRLQPIYTPNGGINYTDCHIPNNMRYCNSSVPDLEHCHT,660,"74,049",Chain (1); Disulfide bond (4); Domain (3); Erroneous initiation (1); Glycosylation (4); Natural variant (1); Repeat (10); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..42;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""; DISULFID 40..49;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""; DISULFID 314..339;  /evidence=""ECO:0000250|UniProtKB:Q8BGT1""; DISULFID 316..360;  /evidence=""ECO:0000250|UniProtKB:Q8BLU0""","SIGNAL 1..35;  /evidence=""ECO:0000269|PubMed:15340161"""
P18505,Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1),MWTVQNRESLGLLSFPVMITMVCCAHSTNEPSNMSYVKETVDRLLKGYDIRLRPDFGGPPVDVGMRIDVASIDMVSEVNMDYTLTMYFQQSWKDKRLSYSGIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWNGGEGAVTGVNKIELPQFSIVDYKMVSKKVEFTTGAYPRLSLSFRLKRNIGYFILQTYMPSTLITILSWVSFWINYDASAARVALGITTVLTMTTISTHLRETLPKIPYVKAIDIYLMGCFVFVFLALLEYAFVNYIFFGKGPQKKGASKQDQSANEKNKLEMNKVQVDAHGNILLSTLEIRNETSGSEVLTSVSDPKATMYSYDSASIQYRKPLSSREAYGRALDRHGVPSKGRIRRRASQLKVKIPDLTDVNSIDKWSRMFFPITFSLFNVVYWLYYVH,474,"54,235",Alternative sequence (2); Binding site (1); Chain (1); Disulfide bond (1); Glycosylation (2); Natural variant (4); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 161..175;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O75129,Astrotactin-2,MAAAGARLSPGPGSGLRGRPRLCFHPGPPPLLPLLLLFLLLLPPPPLLAGATAAASREPDSPCRLKTVTVSTLPALRESDIGWSGARAGAGAGTGAGAAAAAASPGSPGSAGTAAESRLLLFVRNELPGRIAVQDDLDNTELPFFTLEMSGTAADISLVHWRQQWLENGTLYFHVSMSSSGQLAQATAPTLQEPSEIVEEQMHILHISVMGGLIALLLLLLVFTVALYAQRRWQKRRRIPQKSASTEATHEIHYIPSVLLGPQARESFRSSRLQTHNSVIGVPIRETPILDDYDCEEDEEPPRRANHVSREDEFGSQVTHTLDSLGHPGEEKVDFEKKAAAEATQETVESLMQKFKESFRANTPIEIGQLQPPLRSTSAGKRKRRSKSRGGISFGRAKGTSGSEADDETQLTFYTEQYRSRRRSKGLLKSPVNKTALTLIAVSSCILAMVCGSQMSCPLTVKVTLHVPEHFIADGSSFVVSEGSYLDISDWLNPAKLSLYYQINATSPWVRDLCGQRTTDACEQLCDPETGECSCHEGYAPDPVHRHLCVRSDWGQSEGPWPYTTLERGYDLVTGEQAPEKILRSTFSLGQGLWLPVSKSFVVPPVELSINPLASCKTDVLVTEDPADVREEAMLSTYFETINDLLSSFGPVRDCSRNNGGCTRNFKCVSDRQVDSSGCVCPEELKPMKDGSGCYDHSKGIDCSDGFNGGCEQLCLQQTLPLPYDATSSTIFMFCGCVEEYKLAPDGKSCLMLSDVCEGPKCLKPDSKFNDTLFGEMLHGYNNRTQHVNQGQVFQMTFRENNFIKDFPQLADGLLVIPLPVEEQCRGVLSEPLPDLQLLTGDIRYDEAMGYPMVQQWRVRSNLYRVKLSTITLAAGFTNVLKILTKESSREELLSFIQHYGSHYIAEALYGSELTCIIHFPSKKVQQQLWLQYQKETTELGSKKELKSMPFITYLSGLLTAQMLSDDQLISGVEIRCEEKGRCPSTCHLCRRPGKEQLSPTPVLLEINRVVPLYTLIQDNGTKEAFKSALMSSYWCSGKGDVIDDWCRCDLSAFDANGLPNCSPLLQPVLRLSPTVEPSSTVVSLEWVDVQPAIGTKVSDYILQHKKVDEYTDTDLYTGEFLSFADDLLSGLGTSCVAAGRSHGEVPEVSIYSVIFKCLEPDGLYKFTLYAVDTRGRHSELSTVTLRTACPLVDDNKAEEIADKIYNLYNGYTSGKEQQMAYNTLMEVSASMLFRVQHHYNSHYEKFGDFVWRSEDELGPRKAHLILRRLERVSSHCSSLLRSAYIQSRVETVPYLFCRSEEVRPAGMVWYSILKDTKITCEEKMVSMARNTYGESKGR,1339,"148,243",Alternative sequence (6); Beta strand (28); Chain (1); Disulfide bond (17); Domain (4); Erroneous initiation (2); Glycosylation (4); Helix (16); Mutagenesis (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (3); Transmembrane (2); Turn (7),"DISULFID 514..526;  /evidence=""ECO:0000250""; DISULFID 522..533;  /evidence=""ECO:0000250""; DISULFID 535..549;  /evidence=""ECO:0000250""; DISULFID 655..668;  /evidence=""ECO:0000250""; DISULFID 662..679;  /evidence=""ECO:0000250""; DISULFID 681..694;  /evidence=""ECO:0000250""; DISULFID 703..715;  /evidence=""ECO:0000250""; DISULFID 711..735;  /evidence=""ECO:0000250""; DISULFID 737..750;  /evidence=""ECO:0000250""; DISULFID 825..987;  /evidence=""ECO:0000269|Ref.6""; DISULFID 916..977;  /evidence=""ECO:0000269|Ref.6""; DISULFID 983..990;  /evidence=""ECO:0000269|Ref.6""; DISULFID 1036..1047;  /evidence=""ECO:0000269|Ref.6""; DISULFID 1049..1062;  /evidence=""ECO:0000269|Ref.6""; DISULFID 1136..1158;  /evidence=""ECO:0000269|Ref.6""; DISULFID 1190..1277;  /evidence=""ECO:0000269|Ref.6""; DISULFID 1298..1321;  /evidence=""ECO:0000269|Ref.6""","SIGNAL 1..49;  /evidence=""ECO:0000255"""
A0A1B0GVN3,Uncharacterized protein C2orf92 (Long intergenic non-protein coding RNA 1125),MSRAMALFFVLCWIQDEIVLQVFSKVPYDPSFDETRTAVRSITKRDTQKSYSQQKSLNNAAFASGSNEREEHLAKIFDEILLQVFPKFPYDPSFNEATAVRSITKTDMRKGTSIAWNSPKPEYFLGSVDKIPDKDHLSEEKNFKESCLFDRDLREQLTTIDKETLQGAAKPDAHFRTMPCGQLLHFLQRNTIIAAVSGVAILMAIVLLLLGLASYIRKKQPSSPLANTTYNIFIMDGKTWWHNSEEKNFTKLAKKQKQLKSSSCV,265,"30,198",Chain (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P55287,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),MKENYCLQAALVCLGMLCHSHAFAPERRGHLRPSFHGHHEKGKEGQVLQRSKRGWVWNQFFVIEEYTGPDPVLVGRLHSDIDSGDGNIKYILSGEGAGTIFVIDDKSGNIHATKTLDREERAQYTLMAQAVDRDTNRPLEPPSEFIVKVQDINDNPPEFLHETYHANVPERSNVGTSVIQVTASDADDPTYGNSAKLVYSILEGQPYFSVEAQTGIIRTALPNMDREAKEEYHVVIQAKDMGGHMGGLSGTTKVTITLTDVNDNPPKFPQSVYQMSVSEAAVPGEEVGRVKAKDPDIGENGLVTYNIVDGDGMESFEITTDYETQEGVIKLKKPVDFETKRAYSLKVEAANVHIDPKFISNGPFKDTVTVKISVEDADEPPMFLAPSYIHEVQENAAAGTVVGRVHAKDPDAANSPIRYSIDRHTDLDRFFTINPEDGFIKTTKPLDREETAWLNITVFAAEIHNRHQEAKVPVAIRVLDVNDNAPKFAAPYEGFICESDQTKPLSNQPIVTISADDKDDTANGPRFIFSLPPEIIHNPNFTVRDNRDNTAGVYARRGGFSRQKQDLYLLPIVISDGGIPPMSSTNTLTIKVCGCDVNGALLSCNAEAYILNAGLSTGALIAILACIVILLVIVVLFVTLRRQKKEPLIVFEEEDVRENIITYDDEGGGEEDTEAFDIATLQNPDGINGFIPRKDIKPEYQYMPRPGLRPAPNSVDVDDFINTRIQEADNDPTAPPYDSIQIYGYEGRGSVAGSLSSLESATTDSDLDYDYLQNWGPRFKKLADLYGSKDTFDDDS,796,"87,965",Alternative sequence (2); Chain (1); Domain (5); Glycosylation (2); Modified residue (2); Natural variant (4); Propeptide (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N126,Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1),MGAPAASLLLLLLLFACCWAPGGANLSQDDSQPWTSDETVVAGGTVVLKCQVKDHEDSSLQWSNPAQQTLYFGEKRALRDNRIQLVTSTPHELSISISNVALADEGEYTCSIFTMPVRTAKSLVTVLGIPQKPIITGYKSSLREKDTATLNCQSSGSKPAARLTWRKGDQELHGEPTRIQEDPNGKTFTVSSSVTFQVTREDDGASIVCSVNHESLKGADRSTSQRIEVLYTPTAMIRPDPPHPREGQKLLLHCEGRGNPVPQQYLWEKEGSVPPLKMTQESALIFPFLNKSDSGTYGCTATSNMGSYKAYYTLNVNDPSPVPSSSSTYHAIIGGIVAFIVFLLLIMLIFLGHYLIRHKGTYLTHEAKGSDDAPDADTAIINAEGGQSGGDDKKEYFI,398,"43,300",Alternative sequence (2); Beta strand (9); Chain (1); Disulfide bond (3); Domain (3); Erroneous initiation (1); Glycosylation (1); Helix (1); Modified residue (1); Natural variant (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 50..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16467305""; DISULFID 152..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 254..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
A6NJW9,T-cell surface glycoprotein CD8 beta-2 chain (CD8b pseudogene),MRPRLWLLLAAQLTVLHGNSVLQQTPAYIKVQTNKMVMLSCEAKISLSNMCIYWLRQRQAPSSDSHHEFLTLWDSAKGTIHGEEVEQEKIAVFRDASRFILNLTSVKPEDSGIYFCMIVGSPELTFGKGTQLSVVDFLPTTAQPTKKSTLKKRVCRLPRPETQKGPLCSPVTLGLLVAGVLVLLVSLGVAMHLCCRRRRARLRFMKQFYK,210,"23,703",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9NYQ7,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),MMARRPPWRGLGGRSTPILLLLLLSLFPLSQEELGGGGHQGWDPGLAATTGPRAHIGGGALALCPESSGVREDGGPGLGVREPIFVGLRGRRQSARNSRGPPEQPNEELGIEHGVQPLGSRERETGQGPGSVLYWRPEVSSCGRTGPLQRGSLSPGALSSGVPGSGNSSPLPSDFLIRHHGPKPVSSQRNAGTGSRKRVGTARCCGELWATGSKGQGERATTSGAERTAPRRNCLPGASGSGPELDSAPRTARTAPASGSAPRESRTAPEPAPKRMRSRGLFRCRFLPQRPGPRPPGLPARPEARKVTSANRARFRRAANRHPQFPQYNYQTLVPENEAAGTAVLRVVAQDPDAGEAGRLVYSLAALMNSRSLELFSIDPQSGLIRTAAALDRESMERHYLRVTAQDHGSPRLSATTMVAVTVADRNDHSPVFEQAQYRETLRENVEEGYPILQLRATDGDAPPNANLRYRFVGPPAARAAAAAAFEIDPRSGLISTSGRVDREHMESYELVVEASDQGQEPGPRSATVRVHITVLDENDNAPQFSEKRYVAQVREDVRPHTVVLRVTATDRDKDANGLVHYNIISGNSRGHFAIDSLTGEIQVVAPLDFEAEREYALRIRAQDAGRPPLSNNTGLASIQVVDINDHIPIFVSTPFQVSVLENAPLGHSVIHIQAVDADHGENARLEYSLTGVAPDTPFVINSATGWVSVSGPLDRESVEHYFFGVEARDHGSPPLSASASVTVTVLDVNDNRPEFTMKEYHLRLNEDAAVGTSVVSVTAVDRDANSAISYQITGGNTRNRFAISTQGGVGLVTLALPLDYKQERYFKLVLTASDRALHDHCYVHINITDANTHRPVFQSAHYSVSVNEDRPMGSTIVVISASDDDVGENARITYLLEDNLPQFRIDADSGAITLQAPLDYEDQVTYTLAITARDNGIPQKADTTYVEVMVNDVNDNAPQFVASHYTGLVSEDAPPFTSVLQISATDRDAHANGRVQYTFQNGEDGDGDFTIEPTSGIVRTVRRLDREAVSVYELTAYAVDRGVPPLRTPVSIQVMVQDVNDNAPVFPAEEFEVRVKENSIVGSVVAQITAVDPDEGPNAHIMYQIVEGNIPELFQMDIFSGELTALIDLDYEARQEYVIVVQATSAPLVSRATVHVRLVDQNDNSPVLNNFQILFNNYVSNRSDTFPSGIIGRIPAYDPDVSDHLFYSFERGNELQLLVVNQTSGELRLSRKLDNNRPLVASMLVTVTDGLHSVTAQCVLRVVIITEELLANSLTVRLENMWQERFLSPLLGRFLEGVAAVLATPAEDVFIFNIQNDTDVGGTVLNVSFSALAPRGAGAGAAGPWFSSEELQEQLYVRRAALAARSLLDVLPFDDNVCLREPCENYMKCVSVLRFDSSAPFLASASTLFRPIQPIAGLRCRCPPGFTGDFCETELDLCYSNPCRNGGACARREGGYTCVCRPRFTGEDCELDTEAGRCVPGVCRNGGTCTDAPNGGFRCQCPAGGAFEGPRCEVAARSFPPSSFVMFRGLRQRFHLTLSLSFATVQQSGLLFYNGRLNEKHDFLALELVAGQVRLTYSTGESNTVVSPTVPGGLSDGQWHTVHLRYYNKPRTDALGGAQGPSKDKVAVLSVDDCDVAVALQFGAEIGNYSCAAAGVQTSSKKSLDLTGPLLLGGVPNLPENFPVSHKDFIGCMRDLHIDGRRVDMAAFVANNGTMAGCQAKLHFCDSGPCKNSGFCSERWGSFSCDCPVGFGGKDCQLTMAHPHHFRGNGTLSWNFGSDMAVSVPWYLGLAFRTRATQGVLMQVQAGPHSTLLCQLDRGLLSVTVTRGSGRASHLLLDQVTVSDGRWHDLRLELQEEPGGRRGHHVLMVSLDFSLFQDTMAVGSELQGLKVKQLHVGGLPPGSAEEAPQGLVGCIQGVWLGSTPSGSPALLPPSHRVNAEPGCVVTNACASGPCPPHADCRDLWQTFSCTCQPGYYGPGCVDACLLNPCQNQGSCRHLPGAPHGYTCDCVGGYFGHHCEHRMDQQCPRGWWGSPTCGPCNCDVHKGFDPNCNKTNGQCHCKEFHYRPRGSDSCLPCDCYPVGSTSRSCAPHSGQCPCRPGALGRQCNSCDSPFAEVTASGCRVLYDACPKSLRSGVWWPQTKFGVLATVPCPRGALGAAVRLCDEAQGWLEPDLFNCTSPAFRELSLLLDGLELNKTALDTMEAKKLAQRLREVTGHTDHYFSQDVRVTARLLAHLLAFESHQQGFGLTATQDAHFNENLLWAGSALLAPETGDLWAALGQRAPGGSPGSAGLVRHLEEYAATLARNMELTYLNPMGLVTPNIMLSIDRMEHPSSPRGARRYPRYHSNLFRGQDAWDPHTHVLLPSQSPRPSPSEVLPTSSSIENSTTSSVVPPPAPPEPEPGISIIILLVYRTLGGLLPAQFQAERRGARLPQNPVMNSPVVSVAVFHGRNFLRGILESPISLEFRLLQTANRSKAICVQWDPPGLAEQHGVWTARDCELVHRNGSHARCRCSRTGTFGVLMDASPRERLEGDLELLAVFTHVVVAVSVAALVLTAAILLSLRSLKSNVRGIHANVAAALGVAELLFLLGIHRTHNQLVCTAVAILLHYFFLSTFAWLFVQGLHLYRMQVEPRNVDRGAMRFYHALGWGVPAVLLGLAVGLDPEGYGNPDFCWISVHEPLIWSFAGPVVLVIVMNGTMFLLAARTSCSTGQREAKKTSALTLRSSFLLLLLVSASWLFGLLAVNHSILAFHYLHAGLCGLQGLAVLLLFCVLNADARAAWMPACLGRKAAPEEARPAPGLGPGAYNNTALFEESGLIRITLGASTVSSVSSARSGRTQDQDSQRGRSYLRDNVLVRHGSAADHTDHSLQAHAGPTDLDVAMFHRDAGADSDSDSDLSLEEERSLSIPSSESEDNGRTRGRFQRPLCRAAQSERLLTHPKDVDGNDLLSYWPALGECEAAPCALQTWGSERRLGLDTSKDAANNNQPDPALTSGDETSLGRAQRQRKGILKNRLQYPLVPQTRGAPELSWCRAATLGHRAVPAASYGRIYAGGGTGSLSQPASRYSSREQLDLLLRRQLSRERLEEAPAPVLRPLSRPGSQECMDAAPGRLEPKDRGSTLPRRQPPRDYPGAMAGRFGSRDALDLGAPREWLSTLPPPRRTRDLDPQPPPLPLSPQRQLSRDPLLPSRPLDSLSRSSNSREQLDQVPSRHPSREALGPLPQLLRAREDSVSGPSHGPSTEQLDILSSILASFNSSALSSVQSSSTPLGPHTTATPSATASVLGPSTPRSATSHSISELSPDSEVPRSEGHS,3312,"358,185",Alternative sequence (1); Chain (1); Disulfide bond (27); Domain (21); Glycosylation (15); Modified residue (4); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 1379..1390;  /evidence=""ECO:0000250""; DISULFID 1384..1421;  /evidence=""ECO:0000250""; DISULFID 1423..1432;  /evidence=""ECO:0000250""; DISULFID 1439..1450;  /evidence=""ECO:0000250""; DISULFID 1444..1459;  /evidence=""ECO:0000250""; DISULFID 1461..1470;  /evidence=""ECO:0000250""; DISULFID 1479..1490;  /evidence=""ECO:0000250""; DISULFID 1484..1500;  /evidence=""ECO:0000250""; DISULFID 1502..1513;  /evidence=""ECO:0000250""; DISULFID 1693..1719;  /evidence=""ECO:0000250""; DISULFID 1726..1737;  /evidence=""ECO:0000250""; DISULFID 1731..1746;  /evidence=""ECO:0000250""; DISULFID 1748..1757;  /evidence=""ECO:0000250""; DISULFID 1915..1944;  /evidence=""ECO:0000250""; DISULFID 1950..1961;  /evidence=""ECO:0000250""; DISULFID 1955..1970;  /evidence=""ECO:0000250""; DISULFID 1972..1981;  /evidence=""ECO:0000250""; DISULFID 1985..1996;  /evidence=""ECO:0000250""; DISULFID 1990..2008;  /evidence=""ECO:0000250""; DISULFID 2010..2019;  /evidence=""ECO:0000250""; DISULFID 2027..2040;  /evidence=""ECO:0000250""; DISULFID 2042..2052;  /evidence=""ECO:0000250""; DISULFID 2059..2074;  /evidence=""ECO:0000250""; DISULFID 2061..2077;  /evidence=""ECO:0000250""; DISULFID 2079..2089;  /evidence=""ECO:0000250""; DISULFID 2098..2107;  /evidence=""ECO:0000250""; DISULFID 2110..2122;  /evidence=""ECO:0000250""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q6NUJ2,Uncharacterized protein C11orf87,MSARAPKELRLALPPCLLNRTFASPNASGSGNTGARGPGAVGSGTCITQVGQQLFQSFSSTLVLIVLVTLIFCLIVLSLSTFHIHKRRMKKRKMQRAQEEYERDHCSGSRGGGGLPRPGRQAPTHAKETRLERQPRDSPFCAPSNASSLSSSSPGLPCQGPCAPPPPPPASSPQGAHAASSCLDTAGEGLLQTVVLS,197,"20,623",Chain (1); Glycosylation (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P48060,Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1),MRVTLATIAWMVSFVSNYSHTANILPDIENEDFIKDCVRIHNKFRSEVKPTASDMLYMTWDPALAQIAKAWASNCQFSHNTRLKPPHKLHPNFTSLGENIWTGSVPIFSVSSAITNWYDEIQDYDFKTRICKKVCGHYTQVVWADSYKVGCAVQFCPKVSGFDALSNGAHFICNYGPGGNYPTWPYKRGATCSACPNNDKCLDNLCVNRQRDQVKRYYSVVYPGWPIYPRNRYTSLFLIVNSVILILSVIITILVQHKYPNLVLLD,266,"30,366",Alternative sequence (1); Beta strand (9); Chain (1); Domain (1); Frameshift (1); Helix (6); Natural variant (2); Sequence conflict (1); Signal peptide (1); Transmembrane (1); Turn (3),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
O00144,Frizzled-9 (Fz-9) (hFz9) (FzE6) (CD antigen CD349),MAVAPLRGALLLWQLLAAGGAALEIGRFDPERGRGAAPCQAVEIPMCRGIGYNLTRMPNLLGHTSQGEAAAELAEFAPLVQYGCHSHLRFFLCSLYAPMCTDQVSTPIPACRPMCEQARLRCAPIMEQFNFGWPDSLDCARLPTRNDPHALCMEAPENATAGPAEPHKGLGMLPVAPRPARPPGDLGPGAGGSGTCENPEKFQYVEKSRSCAPRCGPGVEVFWSRRDKDFALVWMAVWSALCFFSTAFTVLTFLLEPHRFQYPERPIIFLSMCYNVYSLAFLIRAVAGAQSVACDQEAGALYVIQEGLENTGCTLVFLLLYYFGMASSLWWVVLTLTWFLAAGKKWGHEAIEAHGSYFHMAAWGLPALKTIVILTLRKVAGDELTGLCYVASTDAAALTGFVLVPLSGYLVLGSSFLLTGFVALFHIRKIMKTGGTNTEKLEKLMVKIGVFSILYTVPATCVIVCYVYERLNMDFWRLRATEQPCAAAAGPGGRRDCSLPGGSVPTVAVFMLKIFMSLVVGITSGVWVWSSKTFQTWQSLCYRKIAAGRARAKACRAPGSYGRGTHCHYKAPTVVLHMTKTDPSLENPTHL,591,"64,466",Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Motif (1); Region (2); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 39..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 47..93;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 84..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 111..152;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 115..139;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1),MGPLKAFLFSPFLLRSQSRGVRLVFLLLTLHLGNCVDKADDEDDEDLTVNKTWVLAPKIHEGDITQILNSLLQGYDNKLRPDIGVRPTVIETDVYVNSIGPVDPINMEYTIDIIFAQTWFDSRLKFNSTMKVLMLNSNMVGKIWIPDTFFRNSRKSDAHWITTPNRLLRIWNDGRVLYTLRLTINAECYLQLHNFPMDEHSCPLEFSSYGYPKNEIEYKWKKPSVEVADPKYWRLYQFAFVGLRNSTEITHTISGDYVIMTIFFDLSRRMGYFTIQTYIPCILTVVLSWVSFWINKDAVPARTSLGITTVLTMTTLSTIARKSLPKVSYVTAMDLFVSVCFIFVFAALMEYGTLHYFTSNQKGKTATKDRKLKNKASMTPGLHPGSTLIPMNNISVPQEDDYGYQCLEGKDCASFFCCFEDCRTGSWREGRIHIRIAKIDSYSRIFFPTAFALFNLVYWVGYLYL,465,"53,595",Chain (1); Disulfide bond (1); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 188..202;  /evidence=""ECO:0000250""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
P25092,Heat-stable enterotoxin receptor (STA receptor) (hSTAR) (EC 4.6.1.2) (Guanylyl cyclase C) (GC-C) (Intestinal guanylate cyclase),MKTLLLDLALWSLLFQPGWLSFSSQVSQNCHNGSYEISVLMMGNSAFAEPLKNLEDAVNEGLEIVRGRLQNAGLNVTVNATFMYSDGLIHNSGDCRSSTCEGLDLLRKISNAQRMGCVLIGPSCTYSTFQMYLDTELSYPMISAGSFGLSCDYKETLTRLMSPARKLMYFLVNFWKTNDLPFKTYSWSTSYVYKNGTETEDCFWYLNALEASVSYFSHELGFKVVLRQDKEFQDILMDHNRKSNVIIMCGGPEFLYKLKGDRAVAEDIVIILVDLFNDQYFEDNVTAPDYMKNVLVLTLSPGNSLLNSSFSRNLSPTKRDFALAYLNGILLFGHMLKIFLENGENITTPKFAHAFRNLTFEGYDGPVTLDDWGDVDSTMVLLYTSVDTKKYKVLLTYDTHVNKTYPVDMSPTFTWKNSKLPNDITGRGPQILMIAVFTLTGAVVLLLLVALLMLRKYRKDYELRQKKWSHIPPENIFPLETNETNHVSLKIDDDKRRDTIQRLRQCKYDKKRVILKDLKHNDGNFTEKQKIELNKLLQIDYYNLTKFYGTVKLDTMIFGVIEYCERGSLREVLNDTISYPDGTFMDWEFKISVLYDIAKGMSYLHSSKTEVHGRLKSTNCVVDSRMVVKITDFGCNSILPPKKDLWTAPEHLRQANISQKGDVYSYGIIAQEIILRKETFYTLSCRDRNEKIFRVENSNGMKPFRPDLFLETAEEKELEVYLLVKNCWEEDPEKRPDFKKIETTLAKIFGLFHDQKNESYMDTLIRRLQLYSRNLEHLVEERTQLYKAERDRADRLNFMLLPRLVVKSLKEKGFVEPELYEEVTIYFSDIVGFTTICKYSTPMEVVDMLNDIYKSFDHIVDHHDVYKVETIGDAYMVASGLPKRNGNRHAIDIAKMALEILSFMGTFELEHLPGLPIWIRIGVHSGPCAAGVVGIKMPRYCLFGDTVNTASRMESTGLPLRIHVSGSTIAILKRTECQFLYEVRGETYLKGRGNETTYWLTGMKDQKFNLPTPPTVENQQRLQAEFSDMIANSLQKRQAAGIRSQKPRRVASYKKGTLEYLQLNTTDKESTYF,1073,"123,403",Chain (1); Domain (2); Glycosylation (8); Natural variant (11); Sequence conflict (4); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
O00222,Metabotropic glutamate receptor 8 (mGluR8),MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVCIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQSGHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVEDMQWAHREHTHPASVCSLPCKPGERKKTVKGVPCCWHCERCEGYNYQVDELSCELCPLDQRPNMNRTGCQLIPIIKLEWHSPWAVVPVFVAILGIIATTFVIVTFVRYNDTPIVRASGRELSYVLLTGIFLCYSITFLMIAAPDTIICSFRRVFLGLGMCFSYAALLTKTNRIHRIFEQGKKSVTAPKFISPASQLVITFSLISVQLLGVFVWFVVDPPHIIIDYGEQRTLDPEKARGVLKCDISDLSLICSLGYSILLMVTCTVYAIKTRGVPETFNEAKPIGFTMYTTCIIWLAFIPIFFGTAQSAEKMYIQTTTLTVSMSLSASVSLGMLYMPKVYIIIFHPEQNVQKRKRSFKAVVTAATMQSKLIQKGNDRPNGEVKSELCESLETNTSSTKTTYISYSNHSI,908,"101,741",Alternative sequence (3); Beta strand (20); Binding site (4); Chain (1); Cross-link (1); Disulfide bond (8); Glycosylation (5); Helix (15); Natural variant (11); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (11),"DISULFID 64..106;  /evidence=""ECO:0000250""; DISULFID 246..534;  /evidence=""ECO:0000250""; DISULFID 369..384;  /evidence=""ECO:0000250""; DISULFID 424..431;  /evidence=""ECO:0000250""; DISULFID 516..535;  /evidence=""ECO:0000250""; DISULFID 520..538;  /evidence=""ECO:0000250""; DISULFID 541..553;  /evidence=""ECO:0000250""; DISULFID 556..569;  /evidence=""ECO:0000250""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
P02708,Acetylcholine receptor subunit alpha,MEPWPLLLLFSLCSAGLVLGSEHETRLVAKLFKDYSSVVRPVEDHRQVVEVTVGLQLIQLINVDEVNQIVTTNVRLKQGDMVDLPRPSCVTLGVPLFSHLQNEQWVDYNLKWNPDDYGGVKKIHIPSEKIWRPDLVLYNNADGDFAIVKFTKVLLQYTGHITWTPPAIFKSYCEIIVTHFPFDEQNCSMKLGTWTYDGSVVAINPESDQPDLSNFMESGEWVIKESRGWKHSVTYSCCPDTPYLDITYHFVMQRLPLYFIVNVIIPCLLFSFLTGLVFYLPTDSGEKMTLSISVLLSLTVFLLVIVELIPSTSSAVPLIGKYMLFTMVFVIASIIITVIVINTHHRSPSTHVMPNWVRKVFIDTIPNIMFFSTMKRPSREKQDKKIFTEDIDISDISGKPGPPPMGFHSPLIKHPEVKSAIEGIKYIAETMKSDQESNNAAAEWKYVAMVMDHILLGVFMLVCIIGTLAVFAGRLIELNQQG,482,"54,546",Alternative sequence (1); Beta strand (14); Chain (1); Disulfide bond (2); Frameshift (1); Glycosylation (1); Helix (3); Mutagenesis (1); Natural variant (13); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (2),"DISULFID 173..187; DISULFID 237..238;  /note=""Associated with receptor activation""","SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:2449458"""
P29017,T-cell surface glycoprotein CD1c (CD antigen CD1c),MLFLQFLLLALLLPGGDNADASQEHVSFHVIQIFSFVNQSWARGQGSGWLDELQTHGWDSESGTIIFLHNWSKGNFSNEELSDLELLFRFYLFGLTREIQDHASQDYSKYPFEVQVKAGCELHSGKSPEGFFQVAFNGLDLLSFQNTTWVPSPGCGSLAQSVCHLLNHQYEGVTETVYNLIRSTCPRFLLGLLDAGKMYVHRQVRPEAWLSSRPSLGSGQLLLVCHASGFYPKPVWVTWMRNEQEQLGTKHGDILPNADGTWYLQVILEVASEEPAGLSCRVRHSSLGGQDIILYWGHHFSMNWIALVVIVPLVILIVLVLWFKKHCSYQDIL,333,"37,654",Beta strand (18); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (6); Motif (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 120..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21167756""; DISULFID 225..280;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q15762,CD226 antigen (DNAX accessory molecule 1) (DNAM-1) (CD antigen CD226),MDYPTLLLALLHVYRALCEEVLWHTSVPFAENMSLECVYPSMGILTQVEWFKIGTQQDSIAIFSPTHGMVIRKPYAERVYFLNSTMASNNMTLFFRNASEDDVGYYSCSLYTYPQGTWQKVIQVVQSDSFEAAVPSNSHIVSEPGKNVTLTCQPQMTWPVQAVRWEKIQPRQIDLLTYCNLVHGRNFTSKFPRQIVSNCSHGRWSVIVIPDVTVSDSGLYRCYLQASAGENETFVMRLTVAEGKTDNQYTLFVAGGTVLLLLFVISITTIIVIFLNRRRRRERRDLFTESWDTQKAPNNYRSPISTSQPTNQSMDDTREDIYVNYPTFSRRPKTRV,336,"38,614",Beta strand (16); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (8); Helix (4); Modified residue (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 37..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 152..222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:8673704"""
Q9UGN4,CMRF35-like molecule 8 (CLM-8) (CD300 antigen-like family member A) (CMRF-35-H9) (CMRF35-H9) (CMRF35-H) (IRC1/IRC2) (Immunoglobulin superfamily member 12) (IgSF12) (Inhibitory receptor protein 60) (IRp60) (NK inhibitory receptor) (CD antigen CD300a),MWLPWALLLLWVPGCFALSKCRTVAGPVGGSLSVQCPYEKEHRTLNKYWCRPPQIFLCDKIVETKGSAGKRNGRVSIRDSPANLSFTVTLENLTEEDAGTYWCGVDTPWLRDFHDPVVEVEVSVFPASTSMTPASITAAKTSTITTAFPPVSSTTLFAVGATHSASIQEETEEVVNSQLPLLLSLLALLLLLLVGASLLAWRMFQKWIKAGDHSELSQNPKQAATQSELHYANLELLMWPLQEKPAPPREVEVEYSTVASPREELHYASVVFDSNTNRIAAQRPREEEPDSDYSVIRKT,299,"33,201",Alternative sequence (3); Beta strand (10); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (2); Helix (3); Modified residue (1); Natural variant (1); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q96S66,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),MLCSLLLCECLLLVAGYAHDDDWIDPTDMLNYDAASGTMRKSQAKYGISGEKDVSPDLSCADEISECYHKLDSLTYKIDECEKKKREDYESQSNPVFRRYLNKILIEAGKLGLPDENKGDMHYDAEIILKRETLLEIQKFLNGEDWKPGALDDALSDILINFKFHDFETWKWRFEDSFGVDPYNVLMVLLCLLCIVVLVATELWTYVRWYTQLRRVLIISFLFSLGWNWMYLYKLAFAQHQAEVAKMEPLNNVCAKKMDWTGSIWEWFRSSWTYKDDPCQKYYELLLVNPIWLVPPTKALAVTFTTFVTEPLKHIGKGTGEFIKALMKEIPALLHLPVLIIMALAILSFCYGAGKSVHVLRHIGGPESEPPQALRPRDRRRQEEIDYRPDGGAGDADFHYRGQMGPTEQGPYAKTYEGRREILRERDVDLRFQTGNKSPEVLRAFDVPDAEAREHPTVVPSHKSPVLDTKPKETGGILGEGTPKESSTESSQSAKPVSGQDTSGNTEGSPAAEKAQLKSEAAGSPDQGSTYSPARGVAGPRGQDPVSSPCG,551,"62,023",Alternative sequence (3); Chain (1); Modified residue (6); Natural variant (2); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q30154,"HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)",MVCLKLPGGSYMAKLTVTLMVLSSPLALAGDTRPRFLQQDKYECHFFNGTERVRFLHRDIYNQEEDLRFDSDVGEYRAVTELGRPDAEYWNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPARTQTLQHHNLLVCSVNGFYPGSIEVRWFRNSQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRAQSESAQSKMLSGVGGFVLGLLFLGAGLFIYFKNQKGHSGLHPTGLVS,266,"30,056",Beta strand (12); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (6); Natural variant (37); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),DISULFID 44..108; DISULFID 146..202,"SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:6576979"""
Q6UWV6,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase),MRGLAVLLTVALATLLAPGAGAPVQSQGSQNKLLLVSFDGFRWNYDQDVDTPNLDAMARDGVKARYMTPAFVTMTSPCHFTLVTGKYIENHGVVHNMYYNTTSKVKLPYHATLGIQRWWDNGSVPIWITAQRQGLRAGSFFYPGGNVTYQGVAVTRSRKEGIAHNYKNETEWRANIDTVMAWFTEEDLDLVTLYFGEPDSTGHRYGPESPERREMVRQVDRTVGYLRESIARNHLTDRLNLIITSDHGMTTVDKRAGDLVEFHKFPNFTFRDIEFELLDYGPNGMLLPKEGRLEKVYDALKDAHPKLHVYKKEAFPEAFHYANNPRVTPLLMYSDLGYVIHGRINVQFNNGEHGFDNKDMDMKTIFRAVGPSFRAGLEVEPFESVHVYELMCRLLGIVPEANDGHLATLLPMLHTESALPPDGRPTLLPKGRSALPPSSRPLLVMGLLGTVILLSEVA,458,"51,494",Active site (1); Beta strand (15); Binding site (1); Chain (1); Glycosylation (5); Helix (19); Metal binding (7); Mutagenesis (14); Natural variant (1); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),,"SIGNAL 1..21;  /evidence=""ECO:0000255, ECO:0000269|PubMed:15340161"""
Q9NZV1,Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein],MYLVAGDRGLAGCGHLLVSLLGLLLLLARSGTRALVCLPCDESKCEEPRNCPGSIVQGVCGCCYTCASQRNESCGGTFGIYGTCDRGLRCVIRPPLNGDSLTEYEAGVCEDENWTDDQLLGFKPCNENLIAGCNIINGKCECNTIRTCSNPFEFPSQDMCLSALKRIEEEKPDCSKARCEVQFSPRCPEDSVLIEGYAPPGECCPLPSRCVCNPAGCLRKVCQPGNLNILVSKASGKPGECCDLYECKPVFGVDCRTVECPPVQQTACPPDSYETQVRLTADGCCTLPTRCECLSGLCGFPVCEVGSTPRIVSRGDGTPGKCCDVFECVNDTKPACVFNNVEYYDGDMFRMDNCRFCRCQGGVAICFTAQCGEINCERYYVPEGECCPVCEDPVYPFNNPAGCYANGLILAHGDRWREDDCTFCQCVNGERHCVATVCGQTCTNPVKVPGECCPVCEEPTIITVDPPACGELSNCTLTGKDCINGFKRDHNGCRTCQCINTEELCSERKQGCTLNCPFGFLTDAQNCEICECRPRPKKCRPIICDKYCPLGLLKNKHGCDICRCKKCPELSCSKICPLGFQQDSHGCLICKCREASASAGPPILSGTCLTVDGHHHKNEESWHDGCRECYCLNGREMCALITCPVPACGNPTIHPGQCCPSCADDFVVQKPELSTPSICHAPGGEYFVEGETWNIDSCTQCTCHSGRVLCETEVCPPLLCQNPSRTQDSCCPQCTDQPFRPSLSRNNSVPNYCKNDEGDIFLAAESWKPDVCTSCICIDSVISCFSESCPSVSCERPVLRKGQCCPYCIEDTIPKKVVCHFSGKAYADEERWDLDSCTHCYCLQGQTLCSTVSCPPLPCVEPINVEGSCCPMCPEMYVPEPTNIPIEKTNHRGEVDLEVPLWPTPSENDIVHLPRDMGHLQVDYRDNRLHPSEDSSLDSIASVVVPIIICLSIIIAFLFINQKKQWIPLLCWYRTPTKPSSLNNQLVSVDCKKGTRVQVDSSQRMLRIAEPDARFSGFYSMQKQNHLQADNFYQTV,1036,"113,738",Chain (2); Domain (11); Erroneous initiation (1); Glycosylation (5); Modified residue (1); Motif (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000269|PubMed:12805376, ECO:0000269|PubMed:15340161"""
Q5JZY3,Ephrin type-A receptor 10 (EC 2.7.10.1),METCAGPHPLRLFLCRMQLCLALLLGPWRPGTAEEVILLDSKASQAELGWTALPSNGWEEISGVDEHDRPIRTYQVCNVLEPNQDNWLQTGWISRGRGQRIFVELQFTLRDCSSIPGAAGTCKETFNVYYLETEADLGRGRPRLGGSRPRKIDTIAADESFTQGDLGERKMKLNTEVREIGPLSRRGFHLAFQDVGACVALVSVRVYYKQCRATVRGLATFPATAAESAFSTLVEVAGTCVAHSEGEPGSPPRMHCGADGEWLVPVGRCSCSAGFQERGDFCEACPPGFYKVSPRRPLCSPCPEHSRALENASTFCVCQDSYARSPTDPPSASCTRPPSAPRDLQYSLSRSPLVLRLRWLPPADSGGRSDVTYSLLCLRCGREGPAGACEPCGPRVAFLPRQAGLRERAATLLHLRPGARYTVRVAALNGVSGPAAAAGTTYAQVTVSTGPGAPWEEDEIRRDRVEPQSVSLSWREPIPAGAPGANDTEYEIRYYEKGQSEQTYSMVKTGAPTVTVTNLKPATRYVFQIRAASPGPSWEAQSFNPSIEVQTLGEAASGSRDQSPAIVVTVVTISALLVLGSVMSVLAIWRRPCSYGKGGGDAHDEEELYFHFKVPTRRTFLDPQSCGDLLQAVHLFAKELDAKSVTLERSLGGGRFGELCCGCLQLPGRQELLVAVHMLRDSASDSQRLGFLAEALTLGQFDHSHIVRLEGVVTRGSTLMIVTEYMSHGALDGFLRRHEGQLVAGQLMGLLPGLASAMKYLSEMGYVHRGLAARHVLVSSDLVCKISGFGRGPRDRSEAVYTTMSGRSPALWAAPETLQFGHFSSASDVWSFGIIMWEVMAFGERPYWDMSGQDVIKAVEDGFRLPPPRNCPNLLHRLMLDCWQKDPGERPRFSQIHSILSKMVQDPEPPKCALTTCPRPPTPLADRAFSTFPSFGSVGAWLEALDLCRYKDSFAAAGYGSLEAVAEMTAQDLVSLGISLAEHREALLSGISALQARVLQLQGQGVQV,1008,"109,716",Alternative sequence (4); Chain (1); Domain (5); Erroneous initiation (1); Glycosylation (2); Natural variant (11); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q14416,Metabotropic glutamate receptor 2 (mGluR2),MGSLLALLALLLLWGAVAEGPAKKVLTLEGDLVLGGLFPVHQKGGPAEDCGPVNEHRGIQRLEAMLFALDRINRDPHLLPGVRLGAHILDSCSKDTHALEQALDFVRASLSRGADGSRHICPDGSYATHGDAPTAITGVIGGSYSDVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFFQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFELEARARNICVATSEKVGRAMSRAAFEGVVRALLQKPSARVAVLFTRSEDARELLAASQRLNASFTWVASDGWGALESVVAGSEGAAEGAITIELASYPISDFASYFQSLDPWNNSRNPWFREFWEQRFRCSFRQRDCAAHSLRAVPFEQESKIMFVVNAVYAMAHALHNMHRALCPNTTRLCDAMRPVNGRRLYKDFVLNVKFDAPFRPADTHNEVRFDRFGDGIGRYNIFTYLRAGSGRYRYQKVGYWAEGLTLDTSLIPWASPSAGPLPASRCSEPCLQNEVKSVQPGEVCCWLCIPCQPYEYRLDEFTCADCGLGYWPNASLTGCFELPQEYIRWGDAWAVGPVTIACLGALATLFVLGVFVRHNATPVVKASGRELCYILLGGVFLCYCMTFIFIAKPSTAVCTLRRLGLGTAFSVCYSALLTKTNRIARIFGGAREGAQRPRFISPASQVAICLALISGQLLIVVAWLVVEAPGTGKETAPERREVVTLRCNHRDASMLGSLAYNVLLIALCTLYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCVSVSLSGSVVLGCLFAPKLHIILFQPQKNVVSHRAPTSRFGSAAARASSSLGQGSGSQFVPTVCNGREVVDSTTSSL,872,"95,568",Beta strand (24); Binding site (4); Chain (1); Disulfide bond (8); Glycosylation (5); Helix (18); Mutagenesis (3); Region (2); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (9),"DISULFID 50..92;  /evidence=""ECO:0000250""; DISULFID 234..518;  /evidence=""ECO:0000250""; DISULFID 355..362;  /evidence=""ECO:0000250""; DISULFID 400..407;  /evidence=""ECO:0000250""; DISULFID 500..519;  /evidence=""ECO:0000250""; DISULFID 504..522;  /evidence=""ECO:0000250""; DISULFID 525..537;  /evidence=""ECO:0000250""; DISULFID 540..553;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P26006,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain],MGPGPSRAPRAPRLMLCALALMVAAGGCVVSAFNLDTRFLVVKEAGNPGSLFGYSVALHRQTERQQRYLLLAGAPRELAVPDGYTNRTGAVYLCPLTAHKDDCERMNITVKNDPGHHIIEDMWLGVTVASQGPAGRVLVCAHRYTQVLWSGSEDQRRMVGKCYVRGNDLELDSSDDWQTYHNEMCNSNTDYLETGMCQLGTSGGFTQNTVYFGAPGAYNWKGNSYMIQRKEWDLSEYSYKDPEDQGNLYIGYTMQVGSFILHPKNITIVTGAPRHRHMGAVFLLSQEAGGDLRRRQVLEGSQVGAYFGSAIALADLNNDGWQDLLVGAPYYFERKEEVGGAIYVFMNQAGTSFPAHPSLLLHGPSGSAFGLSVASIGDINQDGFQDIAVGAPFEGLGKVYIYHSSSKGLLRQPQQVIHGEKLGLPGLATFGYSLSGQMDVDENFYPDLLVGSLSDHIVLLRARPVINIVHKTLVPRPAVLDPALCTATSCVQVELCFAYNQSAGNPNYRRNITLAYTLEADRDRRPPRLRFAGSESAVFHGFFSMPEMRCQKLELLLMDNLRDKLRPIIISMNYSLPLRMPDRPRLGLRSLDAYPILNQAQALENHTEVQFQKECGPDNKCESNLQMRAAFVSEQQQKLSRLQYSRDVRKLLLSINVTNTRTSERSGEDAHEALLTLVVPPALLLSSVRPPGACQANETIFCELGNPFKRNQRMELLIAFEVIGVTLHTRDLQVQLQLSTSSHQDNLWPMILTLLVDYTLQTSLSMVNHRLQSFFGGTVMGESGMKTVEDVGSPLKYEFQVGPMGEGLVGLGTLVLGLEWPYEVSNGKWLLYPTEITVHGNGSWPCRPPGDLINPLNLTLSDPGDRPSSPQRRRRQLDPGGGQGPPPVTLAAAKKAKSETVLTCATGRAHCVWLECPIPDAPVVTNVTVKARVWNSTFIEDYRDFDRVRVNGWATLFLRTSIPTINMENKTTWFSVDIDSELVEELPAEIELWLVLVAVGAGLLLLGLIILLLWKCGFFKRARTRALYEAKRQKAEMKSQPSETERLTDDY,1051,"116,612",Alternative sequence (1); Calcium binding (3); Chain (3); Disulfide bond (9); Glycosylation (14); Lipidation (1); Motif (1); Mutagenesis (1); Natural variant (6); Region (1); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 94..103;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 140..162;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 185..197;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 485..490;  /evidence=""ECO:0000250""; DISULFID 496..550;  /evidence=""ECO:0000250""; DISULFID 615..621;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 694..702;  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 846..904;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000269|PubMed:14596610""; DISULFID 911..916;  /evidence=""ECO:0000269|PubMed:14596610""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:3033641, ECO:0000269|PubMed:8187758"""
O60242,Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3),MKAVRNLLIYIFSTYLLVMFGFNAAQDFWCSTLVKGVIYGSYSVSEMFPKNFTNCTWTLENPDPTKYSIYLKFSKKDLSCSNFSLLAYQFDHFSHEKIKDLLRKNHSIMQLCNSKNAFVFLQYDKNFIQIRRVFPTNFPGLQKKGEEDQKSFFEFLVLNKVSPSQFGCHVLCTWLESCLKSENGRTESCGIMYTKCTCPQHLGEWGIDDQSLILLNNVVLPLNEQTEGCLTQELQTTQVCNLTREAKRPPKEEFGMMGDHTIKSQRPRSVHEKRVPQEQADAAKFMAQTGESGVEEWSQWSTCSVTCGQGSQVRTRTCVSPYGTHCSGPLRESRVCNNTALCPVHGVWEEWSPWSLCSFTCGRGQRTRTRSCTPPQYGGRPCEGPETHHKPCNIALCPVDGQWQEWSSWSQCSVTCSNGTQQRSRQCTAAAHGGSECRGPWAESRECYNPECTANGQWNQWGHWSGCSKSCDGGWERRIRTCQGAVITGQQCEGTGEEVRRCNEQRCPAPYEICPEDYLMSMVWKRTPAGDLAFNQCPLNATGTTSRRCSLSLHGVAFWEQPSFARCISNEYRHLQHSIKEHLAKGQRMLAGDGMSQVTKTLLDLTQRKNFYAGDLLMSVEILRNVTDTFKRASYIPASDGVQNFFQIVSNLLDEENKEKWEDAQQIYPGSIELMQVIEDFIHIVGMGMMDFQNSYLMTGNVVASIQKLPAASVLTDINFPMKGRKGMVDWARNSEDRVVIPKSIFTPVSSKELDESSVFVLGAVLYKNLDLILPTLRNYTVINSKIIVVTIRPEPKTTDSFLEIELAHLANGTLNPYCVLWDDSKTNESLGTWSTQGCKTVLTDASHTKCLCDRLSTFAILAQQPREIIMESSGTPSVTLIVGSGLSCLALITLAVVYAALWRYIRSERSIILINFCLSIISSNILILVGQTQTHNKSICTTTTAFLHFFFLASFCWVLTEAWQSYMAVTGKIRTRLIRKRFLCLGWGLPALVVATSVGFTRTKGYGTDHYCWLSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSRDGILDKKLKHRAGQMSEPHSGLTLKCAKCGVVSTTALSATTASNAMASLWSSCVVLPLLALTWMSAVLAMTDKRSILFQILFAVFDSLQGFVIVMVHCILRREVQDAFRCRLRNCQDPINADSSSSFPNGHAQIMTDFEKDVDIACRSVLHKDIGPCRAATITGTLSRISLNDDEEEKGTNPEGLSYSTLPGNVISKVIIQQPTGLHMPMSMNELSNPCLKKENSELRRTVYLCTDDNLRGADMDIVHPQERMMESDYIVMPRSSVNNQPSMKEESKMNIGMETLPHERLLHYKVNPEFNMNPPVMDQFNMNLEQHLAPQEHMQNLPFEPRTAVKNFMASELDDNAGLSRSETGSTISMSSLERRKSRYSDLDFEKVMHTRKRHMELFQELNQKFQTLDRFRDIPNTSSMENPAPNKNPWDTFKNPSEYPHYTTINVLDTEAKDALELRPAEWEKCLNLPLDVQEGDFQTEV,1522,"171,518",Alternative sequence (1); Beta strand (17); Chain (1); Compositional bias (2); Disulfide bond (17); Domain (6); Erroneous initiation (1); Glycosylation (13); Helix (10); Modified residue (3); Natural variant (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (3),"DISULFID 30..55;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 303..336;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 307..342;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 318..326;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 357..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 361..397;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 372..382;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 412..447;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 416..452;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 427..437;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 467..502;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 471..507;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 482..492;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 514..549;  /evidence=""ECO:0000269|PubMed:22333914""; DISULFID 537..567;  /evidence=""ECO:0000269|PubMed:22333914""; DISULFID 819..851;  /evidence=""ECO:0000269|PubMed:22333914""; DISULFID 839..853;  /evidence=""ECO:0000269|PubMed:22333914""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9UKF2,Disintegrin and metalloproteinase domain-containing protein 30 (ADAM 30) (EC 3.4.24.-),MRSVQIFLSQCRLLLLLVPTMLLKSLGEDVIFHPEGEFDSYEVTIPEKLSFRGEVQGVVSPVSYLLQLKGKKHVLHLWPKRLLLPRHLRVFSFTEHGELLEDHPYIPKDCNYMGSVKESLDSKATISTCMGGLRGVFNIDAKHYQIEPLKASPSFEHVVYLLKKEQFGNQVCGLSDDEIEWQMAPYENKARLRDFPGSYKHPKYLELILLFDQSRYRFVNNNLSQVIHDAILLTGIMDTYFQDVRMRIHLKALEVWTDFNKIRVGYPELAEVLGRFVIYKKSVLNARLSSDWAHLYLQRKYNDALAWSFGKVCSLEYAGSVSTLLDTNILAPATWSAHELGHAVGMSHDEQYCQCRGRLNCIMGSGRTGFSNCSYISFFKHISSGATCLNNIPGLGYVLKRCGNKIVEDNEECDCGSTEECQKDRCCQSNCKLQPGANCSIGLCCHDCRFRPSGYVCRQEGNECDLAEYCDGNSSSCPNDVYKQDGTPCKYEGRCFRKGCRSRYMQCQSIFGPDAMEAPSECYDAVNLIGDQFGNCEITGIRNFKKCESANSICGRLQCINVETIPDLPEHTTIISTHLQAENLMCWGTGYHLSMKPMGIPDLGMINDGTSCGEGRVCFKKNCVNSSVLQFDCLPEKCNTRGVCNNRKNCHCMYGWAPPFCEEVGYGGSIDSGPPGLLRGAIPSSIWVVSIIMFRLILLILSVVFVFFRQVIGNHLKPKQEKMPLSKAKTEQEESKTKTVQEESKTKTGQEESEAKTGQEESKAKTGQEESKANIESKRPKAKSVKKQKK,790,"88,940",Active site (1); Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Metal binding (4); Motif (1); Mutagenesis (3); Natural variant (2); Propeptide (1); Region (1); Repeat (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 313..388;  /evidence=""ECO:0000250""; DISULFID 353..373;  /evidence=""ECO:0000250""; DISULFID 355..361;  /evidence=""ECO:0000250""; DISULFID 457..477;  /evidence=""ECO:0000250""; DISULFID 633..644;  /evidence=""ECO:0000250""; DISULFID 638..650;  /evidence=""ECO:0000250""; DISULFID 652..661;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9NYL5,24-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.26) (Cytochrome P450 39A1) (hCYP39A1) (Oxysterol 7-alpha-hydroxylase),MELISPTVIIILGCLALFLLLQRKNLRRPPCIKGWIPWIGVGFEFGKAPLEFIEKARIKYGPIFTVFAMGNRMTFVTEEEGINVFLKSKKVDFELAVQNIVYRTASIPKNVFLALHEKLYIMLKGKMGTVNLHQFTGQLTEELHEQLENLGTHGTMDLNNLVRHLLYPVTVNMLFNKSLFSTNKKKIKEFHQYFQVYDEDFEYGSQLPECLLRNWSKSKKWFLELFEKNIPDIKACKSAKDNSMTLLQATLDIVETETSKENSPNYGLLLLWASLSNAVPVAFWTLAYVLSHPDIHKAIMEGISSVFGKAGKDKIKVSEDDLENLLLIKWCVLETIRLKAPGVITRKVVKPVEILNYIIPSGDLLMLSPFWLHRNPKYFPEPELFKPERWKKANLEKHSFLDCFMAFGSGKFQCPARWFALLEVQMCIILILYKYDCSLLDPLPKQSYLHLVGVPQPEGQCRIEYKQRI,469,"54,116",Chain (1); Metal binding (1); Natural variant (5); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q08554,Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3) (DG2/DG3),MALASAAPGSIFCKQLLFSLLVLTLLCDACQKVYLRVPSHLQAETLVGKVNLEECLKSASLIRSSDPAFRILEDGSIYTTHDLILSSERKSFSIFLSDGQRREQQEIKVVLSARENKSPKKRHTKDTALKRSKRRWAPIPASLMENSLGPFPQHVQQIQSDAAQNYTIFYSISGPGVDKEPFNLFYIEKDTGDIFCTRSIDREKYEQFALYGYATTADGYAPEYPLPLIIKIEDDNDNAPYFEHRVTIFTVPENCRSGTSVGKVTATDLDEPDTLHTRLKYKILQQIPDHPKHFSIHPDTGVITTTTPFLDREKCDTYQLIMEVRDMGGQPFGLFNTGTITISLEDENDNPPSFTETSYVTEVEENRIDVEILRMKVQDQDLPNTPHSKAVYKILQGNENGNFIISTDPNTNEGVLCVVKPLNYEVNRQVILQVGVINEAQFSKAASSQTPTMCTTTVTVKIIDSDEGPECHPPVKVIQSQDGFPAGQELLGYKALDPEISSGEGLRYQKLGDEDNWFEINQHTGDLRTLKVLDRESKFVKNNQYNISVVAVDAVGRSCTGTLVVHLDDYNDHAPQIDKEVTICQNNEDFAVLKPVDPDGPENGPPFQFFLDNSASKNWNIEEKDGKTAILRQRQNLDYNYYSVPIQIKDRHGLVATHMLTVRVCDCSTPSECRMKDKSTRDVRPNVILGRWAILAMVLGSVLLLCILFTCFCVTAKRTVKKCFPEDIAQQNLIVSNTEGPGEEVTEANIRLPMQTSNICDTSMSVGTVGGQGIKTQQSFEMVKGGYTLDSNKGGGHQTLESVKGVGQGDTGRYAYTDWQSFTQPRLGEKVYLCGQDEEHKHCEDYVCSYNYEGKGSLAGSVGCCSDRQEEEGLEFLDHLEPKFRTLAKTCIKK,894,"99,987",Alternative sequence (2); Beta strand (41); Chain (1); Domain (5); Glycosylation (2); Helix (2); Modified residue (1); Natural variant (3); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9NZH0,G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein) (RAIG-2),MFVASERKMRAHQVLTFLLLFVITSVASENASTSRGCGLDLLPQYVSLCDLDAIWGIVVEAVAGAGALITLLLMLILLVRLPFIKEKEKKSPVGLHFLFLLGTLGLFGLTFAFIIQEDETICSVRRFLWGVLFALCFSCLLSQAWRVRRLVRHGTGPAGWQLVGLALCLMLVQVIIAVEWLVLTVLRDTRPACAYEPMDFVMALIYDMVLLVVTLGLALFTLCGKFKRWKLNGAFLLITAFLSVLIWVAWMTMYLFGNVKLQQGDAWNDPTLAITLAASGWVFVIFHAIPEIHCTLLPALQENTPNYFDTSQPRMRETAFEEDVQLPRAYMENKAFSMDEHNAALRTAGFPNGSLGKRPSGSLGKRPSAPFRSNVYQPTEMAVVLNGGTIPTAPPSHTGRHLW,403,"44,795",Alternative sequence (1); Chain (1); Glycosylation (1); Modified residue (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
O71037,Endogenous retrovirus group K member 19 Env polyprotein (EnvK3 protein) (Envelope polyprotein) (HERV-K(C19) envelope protein) (HERV-K_19q11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTYWAYVPFPPLIRAVTWMDNPIEVYVNDSVWVPGPTDDHCPAKPEEEGMMINISIGYRYPPICLGRAPGCLMPAVQNWLVEVPTVSPISRFTYHMVSGMSLRPRVNYLQDFSYQRSFKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTIIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTPRPKIISPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTVDLNSSVTVPLQSCIKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWETSPSIHTLTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATAAVAGVALHSSVQSVNFVNDWQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFSITPQIYNESEHHWDMVRRHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQLRRDSDHRERAMMTMAVLSKRKGGNVGKSKRDQIVTVSV,699,"79,252",Chain (3); Compositional bias (2); Erroneous initiation (1); Glycosylation (11); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
P58550,Putative FXYD domain-containing ion transport regulator 8,MEVVLIFVYSLLVPVVLASAAKEKEIDPFHYNYQTLRIGGLVFDVVLFLVPSCHLLSHRCKCSFNQKPQDPGDKEAQVENFITANAKEPQKAKN,94,"10,590",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
O75084,Frizzled-7 (Fz-7) (hFz7) (FzE3),MRDPGAAAPLSSLGLCALVLALLGALSAGAGAQPYHGEKGISVPDHGFCQPISIPLCTDIAYNQTILPNLLGHTNQEDAGLEVHQFYPLVKVQCSPELRFFLCSMYAPVCTVLDQAIPPCRSLCERARQGCEALMNKFGFQWPERLRCENFPVHGAGEICVGQNTSDGSGGPGGGPTAYPTAPYLPDLPFTALPPGASDGRGRPAFPFSCPRQLKVPPYLGYRFLGERDCGAPCEPGRANGLMYFKEEERRFARLWVGVWSVLCCASTLFTVLTYLVDMRRFSYPERPIIFLSGCYFMVAVAHVAGFLLEDRAVCVERFSDDGYRTVAQGTKKEGCTILFMVLYFFGMASSIWWVILSLTWFLAAGMKWGHEAIEANSQYFHLAAWAVPAVKTITILAMGQVDGDLLSGVCYVGLSSVDALRGFVLAPLFVYLFIGTSFLLAGFVSLFRIRTIMKHDGTKTEKLEKLMVRIGVFSVLYTVPATIVLACYFYEQAFREHWERTWLLQTCKSYAVPCPPGHFPPMSPDFTVFMIKYLMTMIVGITTGFWIWSGKTLQSWRRFYHRLSHSSKGETAV,574,"63,620",Beta strand (6); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Helix (8); Motif (2); Mutagenesis (1); Natural variant (4); Sequence conflict (9); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 49..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 57..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 94..131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 120..160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 124..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
P10912,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)],MDLWQLLLTLALAGSSDAFSGSEATAAILSRAPWSLQSVNPGLKTNSSKEPKFTKCRSPERETFSCHWTDEVHHGTKNLGPIQLFYTRRNTQEWTQEWKECPDYVSAGENSCYFNSSFTSIWIPYCIKLTSNGGTVDEKCFSVDEIVQPDPPIALNWTLLNVSLTGIHADIQVRWEAPRNADIQKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYGEFSEVLYVTLPQMSQFTCEEDFYFPWLLIIIFGIFGLTVMLFVFLFSKQQRIKMLILPPVPVPKIKGIDPDLLKEGKLEEVNTILAIHDSYKPEFHSDDSWVEFIELDIDEPDEKTEESDTDRLLSSDHEKSHSNLGVKDGDSGRTSCCEPDILETDFNANDIHEGTSEVAQPQRLKGEADLLCLDQKNQNNSPYHDACPATQQPSVIQAEKNKPQPLPTEGAESTHQAAHIQLSNPSSLSNIDFYAQVSDITPAGSVVLSPGQKNKAGMSQCDMHPEMVSLCQENFLMDNAYFCEADAKKCIPVAPHIKVESHIQPSLNQEDIYITTESLTTAAGRPGTGEHVPGSEMPVPDYTSIHIVQSPQGLILNATALPLPDKEFLSSCGYVSTDQLNKIMP,638,"71,500",Alternative sequence (6); Beta strand (13); Chain (2); Disulfide bond (3); Domain (1); Glycosylation (5); Helix (4); Modified residue (1); Motif (3); Mutagenesis (3); Natural variant (28); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 56..66;  /evidence=""ECO:0000269|PubMed:2406245""; DISULFID 101..112;  /evidence=""ECO:0000269|PubMed:2406245""; DISULFID 126..140;  /evidence=""ECO:0000269|PubMed:2406245""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P34903,Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3),MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSPKHAPDIPDDSTDNITIFTRILDRLLDGYDNRLRPGLGDAVTEVKTDIYVTSFGPVSDTDMEYTIDVFFRQTWHDERLKFDGPMKILPLNNLLASKIWTPDTFFHNGKKSVAHNMTTPNKLLRLVDNGTLLYTMRLTIHAECPMHLEDFPMDVHACPLKFGSYAYTTAEVVYSWTLGKNKSVEVAQDGSRLNQYDLLGHVVGTEIIRSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRSWAWEGKKVPEALEMKKKTPAAPAKKTSTTFNIVGTTYPINLAKDTEFSTISKGAAPSASSTPTIIASPKATYVQDSPTETKTYNSVSKVDKISRIIFPVLFAIFNLVYWATYVNRESAIKGMIRKQ,492,"55,165",Chain (1); Disulfide bond (1); Glycosylation (4); Modified residue (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 191..205;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9NYM4,Probable G-protein coupled receptor 83 (G-protein coupled receptor 72),MVPHLLLLCLLPLVRATEPHEGRADEQSAEAALAVPNASHFFSWNNYTFSDWQNFVGRRRYGAESQNPTVKALLIVAYSFIIVFSLFGNVLVCHVIFKNQRMHSATSLFIVNLAVADIMITLLNTPFTLVRFVNSTWIFGKGMCHVSRFAQYCSLHVSALTLTAIAVDRHQVIMHPLKPRISITKGVIYIAVIWTMATFFSLPHAICQKLFTFKYSEDIVRSLCLPDFPEPADLFWKYLDLATFILLYILPLLIISVAYARVAKKLWLCNMIGDVTTEQYFALRRKKKKTIKMLMLVVVLFALCWFPLNCYVLLLSSKVIRTNNALYFAFHWFAMSSTCYNPFIYCWLNENFRIELKALLSMCQRPPKPQEDRPPSPVPSFRVAWTEKNDGQRAPLANNLLPTSQLQSGKTDLSSVEPIVTMS,423,"48,339",Chain (1); Disulfide bond (1); Erroneous initiation (1); Glycosylation (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 144..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q5DX21,Immunoglobulin superfamily member 11 (IgSF11) (Brain and testis-specific immunoglobulin superfamily protein) (Bt-IGSF) (V-set and immunoglobulin domain-containing protein 3),MTSQRSPLAPLLLLSLHGVAASLEVSESPGSIQVARGQPAVLPCTFTTSAALINLNVIWMVTPLSNANQPEQVILYQGGQMFDGAPRFHGRVGFTGTMPATNVSIFINNTQLSDTGTYQCLVNNLPDIGGRNIGVTGLTVLVPPSAPHCQIQGSQDIGSDVILLCSSEEGIPRPTYLWEKLDNTLKLPPTATQDQVQGTVTIRNISALSSGLYQCVASNAIGTSTCLLDLQVISPQPRNIGLIAGAIGTGAVIIIFCIALILGAFFYWRSKNKEEEEEEIPNEIREDDLPPKCSSAKAFHTEISSSDNNTLTSSNAYNSRYWSNNPKVHRNTESVSHFSDLGQSFSFHSGNANIPSIYANGTHLVPGQHKTLVVTANRGSSPQVMSRSNGSVSRKPRPPHTHSYTISHATLERIGAVPVMVPAQSRAGSLV,431,"46,120",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Modified residue (1); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 165..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P43627,Killer cell immunoglobulin-like receptor 2DL2 (CD158 antigen-like family member B1) (MHC class I NK cell receptor) (Natural killer-associated transcript 6) (NKAT-6) (p58 natural killer cell receptor clone CL-43) (p58 NK receptor CL-43) (CD antigen CD158b1),MSLMVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGRLVKSEETVILQCWSDVRFEHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHECRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVIGNPSNSWPSPTEPSSKTGNPRHLHILIGTSVVIILFILLFFLLHRWCSNKKNAAVMDQESAGNRTANSEDSDEQDPQEVTYTQLNHCVFTQRKITRPSQRPKTPPTDIIVYAELPNAESRSKVVSCP,348,"38,472",Beta strand (22); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..100;  /evidence=""ECO:0000244|PDB:1EFX, ECO:0000244|PDB:2DL2, ECO:0000244|PDB:2DLI, ECO:0000269|PubMed:10097129, ECO:0000269|PubMed:10850706""; DISULFID 149..198;  /evidence=""ECO:0000244|PDB:1EFX, ECO:0000244|PDB:2DL2, ECO:0000244|PDB:2DLI, ECO:0000269|PubMed:10097129, ECO:0000269|PubMed:10850706""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q86UP6,CUB and zona pellucida-like domain-containing protein 1 (CUB and ZP domain-containing protein 1) (Transmembrane protein UO-44),MELVRRLMPLTLLILSCLAELTMAEAEGNASCTVSLGGANMAETHKAMILQLNPSENCTWTIERPENKSIRIIFSYVQLDPDGSCESENIKVFDGTSSNGPLLGQVCSKNDYVPVFESSSSTLTFQIVTDSARIQRTVFVFYYFFSPNISIPNCGGYLDTLEGSFTSPNYPKPHPELAYCVWHIQVEKDYKIKLNFKEIFLEIDKQCKFDFLAIYDGPSTNSGLIGQVCGRVTPTFESSSNSLTVVLSTDYANSYRGFSASYTSIYAENINTTSLTCSSDRMRVIISKSYLEAFNSNGNNLQLKDPTCRPKLSNVVEFSVPLNGCGTIRKVEDQSITYTNIITFSASSTSEVITRQKQLQIIVKCEMGHNSTVEIIYITEDDVIQSQNALGKYNTSMALFESNSFEKTILESPYYVDLNQTLFVQVSLHTSDPNLVVFLDTCRASPTSDFASPTYDLIKSGCSRDETCKVYPLFGHYGRFQFNAFKFLRSMSSVYLQCKVLICDSSDHQSRCNQGCVSRSKRDISSYKWKTDSIIGPIRLKRDRSASGNSGFQHETHAEETPNQPFNSVHLFSFMVLALNVVTVATITVRHFVNQRADYKYQKLQNY,607,"68,153",Alternative sequence (2); Chain (1); Disulfide bond (5); Domain (3); Frameshift (1); Glycosylation (5); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 17..58;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 85..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 154..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 207..229;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 442..498;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9NRD8,Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 2) (Long NOX 2) (NADH/NADPH thyroid oxidase p138-tox) (NADPH oxidase/peroxidase DUOX2) (NADPH thyroid oxidase 2) (Thyroid oxidase 2) (p138 thyroid oxidase),MLRARPEALMLLGALLTGSLGPSGNQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYEWLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYYYGFASPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF,1548,"175,364",Calcium binding (2); Chain (1); Disulfide bond (3); Domain (5); Glycosylation (5); Natural variant (8); Region (2); Sequence conflict (3); Signal peptide (1); Topological domain (7); Transmembrane (7),"DISULFID 124..1162;  /evidence=""ECO:0000269|PubMed:25761904""; DISULFID 568;  /note=""Interchain (with C-167 in DUOXA2)"";  /evidence=""ECO:0000269|PubMed:25761904""; DISULFID 582;  /note=""Interchain (with C-233 in DUOXA2)"";  /evidence=""ECO:0000269|PubMed:25761904""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q9UKH3,Endogenous retrovirus group K member 9 Env polyprotein (EnvK4 protein) (Envelope polyprotein) (HERV-K(C6) envelope protein) (HERV-K109 envelope protein) (HERV-K_6q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTNWAYVPFPPLIRAVTWMDNPIEVYVNDSVWVPGPIDDRCPAKPEEEGMMINISIGYRYPICLGRAPGCLMPAVQNWLVEVPIVSPICRFTYHMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTIIDWTPQGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTPRPKIISPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTVDLNSSLTLPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSIHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATAAVAGVALHSSVQSVNFVNDGQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNESEHHWDMVRRHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQLRRDSDHRERAMMTMAVLSKRKGGNVGKSKRDQIVTVSV,698,"79,016",Chain (3); Compositional bias (2); Glycosylation (11); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
Q96AP7,Endothelial cell-selective adhesion molecule,MISLPGPLVTNLLRFLFLGLSALAPPSRAQLQLHLPANRLQAVEGGEVVLPAWYTLHGEVSSSQPWEVPFVMWFFKQKEKEDQVLSYINGVTTSKPGVSLVYSMPSRNLSLRLEGLQEKDSGPYSCSVNVQDKQGKSRGHSIKTLELNVLVPPAPPSCRLQGVPHVGANVTLSCQSPRSKPAVQYQWDRQLPSFQTFFAPALDVIRGSLSLTNLSSSMAGVYVCKAHNEVGTAQCNVTLEVSTGPGAAVVAGAVVGTLVGLGLLAGLVLLYHRRGKALEEPANDIKEDAIAPRTLPWPKSSDTISKNGTLSSVTSARALRPPHGPPRPGALTPTPSLSSQALPSPRLPTTDGAHPQPISPIPGGVSSSGLSRMGAVPVMVPAQSQAGSLV,390,"41,176",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (4); Modified residue (7); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 174..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
P36888,Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135),MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAAVEVDVSASITLQVLVDAPGNISCLWVFKHSSLNCQPHFDLQNRGVVSMVILKMTETQAGEYLLFIQSEATNYTILFTVSIRNTLLYTLRRPYFRKMENQDALVCISESVPEPIVEWVLCDSQGESCKEESPAVVKKEEKVLHELFGTDIRCCARNELGRECTRLFTIDLNQTPQTTLPQLFLKVGEPLWIRCKAVHVNHGFGLTWELENKALEEGNYFEMSTYSTNRTMIRILFAFVSSVARNDTGYYTCSSSKHPSQSALVTIVEKGFINATNSSEDYEIDQYEEFCFSVRFKAYPQIRCTWTFSRKSFPCEQKGLDNGYSISKFCNHKHQPGEYIFHAENDDAQFTKMFTLNIRRKPQVLAEASASQASCFSDGYPLPSWTWKKCSDKSPNCTEEITEGVWNRKANRKVFGQWVSSSTLNMSEAIKGFLVKCCAYNSLGTSCETILLNSPGPFPFIQDNISFYATIGVCLLFIVVLTLLICHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNVDGRVSECPHTYQNRRPFSREMDLGLLSPQAQVEDS,993,"112,903",Active site (1); Alternative sequence (1); Beta strand (15); Binding site (1); Chain (1); Disulfide bond (7); Domain (2); Glycosylation (10); Helix (16); Modified residue (13); Mutagenesis (4); Natural variant (14); Nucleotide binding (1); Region (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 35..65;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 103..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 199..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 232..241;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 272..330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 368..407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""; DISULFID 381..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21389326""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P59646,FXYD domain-containing ion transport regulator 4,MERVTLALLLLAGLTALEANDPFANKDDPFYYDWKNLQLSGLICGGLLAIAGIAAVLSGKCKCKSSQKQHSPVPEKAIPLITPGSATTC,89,"9,373",Chain (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9UN88,Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta),MGIRGMLRAAVILLLIRTWLAEGNYPSPIPKFHFEFSSAVPEVVLNLFNCKNCANEAVVQKILDRVLSRYDVRLRPNFGGAPVPVRISIYVTSIEQISEMNMDYTITMFFHQTWKDSRLAYYETTLNLTLDYRMHEKLWVPDCYFLNSKDAFVHDVTVENRVFQLHPDGTVRYGIRLTTTAACSLDLHKFPMDKQACNLVVESYGYTVEDIILFWDDNGNAIHMTEELHIPQFTFLGRTITSKEVYFYTGSYIRLILKFQVQREVNSYLVQVYWPTVLTTITSWISFWMNYDSSAARVTIGLTSMLILTTIDSHLRDKLPNISCIKAIDIYILVCLFFVFLSLLEYVYINYLFYSRGPRRQPRRHRRPRRVIARYRYQQVVVGNVQDGLINVEDGVSSLPITPAQAPLASPESLGSLTSTSEQAQLATSESLSPLTSLSGQAPLATGESLSDLPSTSEQARHSYGVRFNGFQADDSIFPTEIRNRVEAHGHGVTHDHEDSNESLSSDERHGHGPSGKPMLHHGEKGVQEAGWDLDDNNDKSDCLAIKEQFKCDTNSTWGLNDDELMAHGQEKDSSSESEDSCPPSPGCSFTEGFSFDLFNPDYVPKVDKWSRFLFPLAFGLFNIVYWVYHMY,632,"72,022",Chain (1); Disulfide bond (1); Glycosylation (1); Natural variant (2); Signal peptide (1); Topological domain (1); Transmembrane (3),"DISULFID 183..197;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q13651,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210),MLPCLVVLLAALLSLRLGSDAHGTELPSPPSVWFEAEFFHHILHWTPIPNQSESTCYEVALLRYGIESWNSISNCSQTLSYDLTAVTLDLYHSNGYRARVRAVDGSRHSNWTVTNTRFSVDEVTLTVGSVNLEIHNGFILGKIQLPRPKMAPANDTYESIFSHFREYEIAIRKVPGNFTFTHKKVKHENFSLLTSGEVGEFCVQVKPSVASRSNKGMWSKEECISLTRQYFTVTNVIIFFAFVLLLSGALAYCLALQLYVRRRKKLPSVLLFKKPSPFIFISQRPSPETQDTIHPLDEEAFLKVSPELKNLDLHGSTDSGFGSTKPSLQTEEPQFLLPDPHPQADRTLGNREPPVLGDSCSSGSSNSTDSGICLQEPSLSPSTGPTWEQQVGSNSRGQDDSGIDLVQNSEGRAGDTQGGSALGHHSPPEPEVPGEEDPAAVAFQGYLRQTRCAEEKATKTGCLEEESPLTDGLGPKFGRCLVDEAGLHPPALAKGYLKQDPLEMTLASSGAPTGQWNQPTEEWSLLALSSCSDLGISDWSFAHDLAPLGCVAAPGGLLGSFNSDLVTLPLISSLQSSE,578,"63,003",Beta strand (13); Chain (1); Disulfide bond (2); Glycosylation (6); Helix (5); Motif (1); Natural variant (15); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 56..75;  /evidence=""ECO:0000269|PubMed:11485736""; DISULFID 202..223;  /evidence=""ECO:0000269|PubMed:11485736""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9NZN1,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1),MKAPIPHLILLYATFTQSLKVVTKRGSADGCTDWSIDIKKYQVLVGEPVRIKCALFYGYIRTNYSLAQSAGLSLMWYKSSGPGDFEEPIAFDGSRMSKEEDSIWFRPTLLQDSGLYACVIRNSTYCMKVSISLTVGENDTGLCYNSKMKYFEKAELSKSKEISCRDIEDFLLPTREPEILWYKECRTKTWRPSIVFKRDTLLIREVREDDIGNYTCELKYGGFVVRRTTELTVTAPLTDKPPKLLYPMESKLTIQETQLGDSANLTCRAFFGYSGDVSPLIYWMKGEKFIEDLDENRVWESDIRILKEHLGEQEVSISLIVDSVEEGDLGNYSCYVENGNGRRHASVLLHKRELMYTVELAGGLGAILLLLVCLVTIYKCYKIEIMLFYRNHFGAEELDGDNKDYDAYLSYTKVDPDQWNQETGEEERFALEILPDMLEKHYGYKLFIPDRDLIPTGTYIEDVARCVDQSKRLIIVMTPNYVVRRGWSIFELETRLRNMLVTGEIKVILIECSELRGIMNYQEVEALKHTIKLLTVIKWHGPKCNKLNSKFWKRLQYEMPFKRIEPITHEQALDVSEQGPFGELQTVSAISMAAATSTALATAHPDLRSTFHNTYHSQMRQKHYYRSYEYDVPPTGTLPLTSIGNQHTYCNIPMTLINGQRPQTKSSREQNPDEAHTNSAILPLLPRETSISSVIW,696,"79,969",Active site (1); Beta strand (30); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (6); Helix (15); Natural variant (4); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 31..126;  /evidence=""ECO:0000250|UniProtKB:P59823""; DISULFID 53..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..185;  /evidence=""ECO:0000250|UniProtKB:P59823""; DISULFID 164..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 267..334;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9UJQ1,Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein) (BAD-LAMP) (Lysosome-associated membrane protein 5) (LAMP-5),MDLQGRGVPSIDRLRVLLMLFHTMAQIMAEQEVENLSGLSTNPEKDIFVVRENGTTCLMAEFAAKFIVPYDVWASNYVDLITEQADIALTRGAEVKGRCGHSQSELQVFWVDRAYALKMLFVKESHNMSKGPEATWRLSKVQFVYDSSEKTHFKDAVSAGKHTANSHHLSALVTPAGKSYECQAQQTISLASSDPQKTVTMILSAVHIQPFDIISDFVFSEEHKCPVDEREQLEETLPLILGLILGLVIMVTLAIYHVHHKMTANQVQIPRDRSQYKHMG,280,"31,472",Alternative sequence (1); Chain (1); Glycosylation (3); Mutagenesis (1); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q6UXC1,Apical endosomal glycoprotein (MAM domain-containing protein 4),MPLSSHLLPALVLFLAGSSGWAWVPNHCRSPGQAVCNFVCDCRDCSDEAQCGYHGASPTLGAPFACDFEQDPCGWRDISTSGYSWLRDRAGAALEGPGPHSDHTLGTDLGWYMAVGTHRGKEASTAALRSPTLREAASSCKLRLWYHAASGDVAELRVELTHGAETLTLWQSTGPWGPGWQELAVTTGRIRGDFRVTFSATRNATHRGAVALDDLEFWDCGLPTPQANCPPGHHHCQNKVCVEPQQLCDGEDNCGDLSDENPLTCGRHIATDFETGLGPWNRSEGWSRNHRAGGPERPSWPRRDHSRNSAQGSFLVSVAEPGTPAILSSPEFQASGTSNCSLVFYQYLSGSEAGCLQLFLQTLGPGAPRAPVLLRRRRGELGTAWVRDRVDIQSAYPFQILLAGQTGPGGVVGLDDLILSDHCRPVSEVSTLQPLPPGPRAPAPQPLPPSSRLQDSCKQGHLACGDLCVPPEQLCDFEEQCAGGEDEQACGTTDFESPEAGGWEDASVGRLQWRRVSAQESQGSSAAAAGHFLSLQRAWGQLGAEARVLTPLLGPSGPSCELHLAYYLQSQPRGFLALVVVDNGSRELAWQALSSSAGIWKVDKVLLGARRRPFRLEFVGLVDLDGPDQQGAGVDNVTLRDCSPTVTTERDREVSCNFERDTCSWYPGHLSDTHWRWVESRGPDHDHTTGQGHFVLLDPTDPLAWGHSAHLLSRPQVPAAPTECLSFWYHLHGPQIGTLRLAMRREGEETHLWSRSGTQGNRWHEAWATLSHQPGSHAQYQLLFEGLRDGYHGTMALDDVAVRPGPCWAPNYCSFEDSDCGFSPGGQGLWRRQANASGHAAWGPPTDHTTETAQGHYMVVDTSPDALPRGQTASLTSKEHRPLAQPACLTFWYHGSLRSPGTLRVYLEERGRHQVLSLSAHGGLAWRLGSMDVQAERAWRVVFEAVAAGVAHSYVALDDLLLQDGPCPQPGSCDFESGLCGWSHLAWPGLGGYSWDWGGGATPSRYPQPPVDHTLGTEAGHFAFFETGVLGPGGRAAWLRSEPLPATPASCLRFWYHMGFPEHFYKGELKVLLHSAQGQLAVWGAGGHRRHQWLEAQVEVASAKEFQIVFEATLGGQPALGPIALDDVEYLAGQHCQQPAPSPGNTAAPGSVPAVVGSALLLLMLLVLLGLGGRRWLQKKGSCPFQSNTEATAPGFDNILFNADGVTLPASVTSDP,1216,"131,499",Alternative sequence (3); Chain (1); Disulfide bond (6); Domain (9); Glycosylation (6); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 229..241;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 236..254;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 248..265;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 457..468;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 464..481;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 475..490;  /evidence=""ECO:0000250|UniProtKB:P01130, ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q86SQ4,Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],MMFRSDRMWSCHWKWKPSPLLFLFALYIMCVPHSVWGCANCRVVLSNPSGTFTSPCYPNDYPNSQACMWTLRAPTGYIIQITFNDFDIEEAPNCIYDSLSLDNGESQTKFCGATAKGLSFNSSANEMHVSFSSDFSIQKKGFNASYIRVAVSLRNQKVILPQTSDAYQVSVAKSISIPELSAFTLCFEATKVGHEDSDWTAFSYSNASFTQLLSFGKAKSGYFLSISDSKCLLNNALPVKEKEDIFAESFEQLCLVWNNSLGSIGVNFKRNYETVPCDSTISKVIPGNGKLLLGSNQNEIVSLKGDIYNFRLWNFTMNAKILSNLSCNVKGNVVDWQNDFWNIPNLALKAESNLSCGSYLIPLPAAELASCADLGTLCQATVNSPSTTPPTVTTNMPVTNRIDKQRNDGIIYRISVVIQNILRHPEVKVQSKVAEWLNSTFQNWNYTVYVVNISFHLSAGEDKIKVKRSLEDEPRLVLWALLVYNATNNTNLEGKIIQQKLLKNNESLDEGLRLHTVNVRQLGHCLAMEEPKGYYWPSIQPSEYVLPCPDKPGFSASRICFYNATNPLVTYWGPVDISNCLKEANEVANQILNLTADGQNLTSANITNIVEQVKRIVNKEENIDITLGSTLMNIFSNILSSSDSDLLESSSEALKTIDELAFKIDLNSTSHVNITTRNLALSVSSLLPGTNAISNFSIGLPSNNESYFQMDFESGQVDPLASVILPPNLLENLSPEDSVLVRRAQFTFFNKTGLFQDVGPQRKTLVSYVMACSIGNITIQNLKDPVQIKIKHTRTQEVHHPICAFWDLNKNKSFGGWNTSGCVAHRDSDASETVCLCNHFTHFGVLMDLPRSASQLDARNTKVLTFISYIGCGISAIFSAATLLTYVAFEKLRRDYPSKILMNLSTALLFLNLLFLLDGWITSFNVDGLCIAVAVLLHFFLLATFTWMGLEAIHMYIALVKVFNTYIRRYILKFCIIGWGLPALVVSVVLASRNNNEVYGKESYGKEKGDEFCWIQDPVIFYVTCAGYFGVMFFLNIAMFIVVMVQICGRNGKRSNRTLREEVLRNLRSVVSLTFLLGMTWGFAFFAWGPLNIPFMYLFSIFNSLQGLFIFIFHCAMKENVQKQWRQHLCCGRFRLADNSDWSKTATNIIKKSSDNLGKSLSSSSIGSNSTYLTSKSKSSSTTYFKRNSHTDNVSYEHSFNKSGSLRQCFHGQVLVKTGPC,1221,"136,695",Alternative sequence (2); Chain (3); Compositional bias (1); Disulfide bond (3); Domain (3); Erroneous initiation (3); Glycosylation (25); Modified residue (2); Motif (1); Mutagenesis (12); Natural variant (6); Region (3); Sequence caution (1); Sequence conflict (5); Signal peptide (1); Site (2); Topological domain (8); Transmembrane (7),"DISULFID 41..67;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 94..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 186..254;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01172""","SIGNAL 1..37;  /evidence=""ECO:0000255"""
O14672,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),MVLLRVLILLLSWAAGMGGQYGNPLNKYIRHYEGLSYNVDSLHQKHQRAKRAVSHEDQFLRLDFHAHGRHFNLRMKRDTSLFSDEFKVETSNKVLDYDTSHIYTGHIYGEEGSFSHGSVIDGRFEGFIQTRGGTFYVEPAERYIKDRTLPFHSVIYHEDDINYPHKYGPQGGCADHSVFERMRKYQMTGVEEVTQIPQEEHAANGPELLRKKRTTSAEKNTCQLYIQTDHLFFKYYGTREAVIAQISSHVKAIDTIYQTTDFSGIRNISFMVKRIRINTTADEKDPTNPFRFPNIGVEKFLELNSEQNHDDYCLAYVFTDRDFDDGVLGLAWVGAPSGSSGGICEKSKLYSDGKKKSLNTGIITVQNYGSHVPPKVSHITFAHEVGHNFGSPHDSGTECTPGESKNLGQKENGNYIMYARATSGDKLNNNKFSLCSIRNISQVLEKKRNNCFVESGQPICGNGMVEQGEECDCGYSDQCKDECCFDANQPEGRKCKLKPGKQCSPSQGPCCTAQCAFKSKSEKCRDDSDCAREGICNGFTALCPASDPKPNFTDCNRHTQVCINGQCAGSICEKYGLEECTCASSDGKDDKELCHVCCMKKMDPSTCASTGSVQWSRHFSGRTITLQPGSPCNDFRGYCDVFMRCRLVDADGPLARLKKAIFSPELYENIAEWIVAHWWAVLLMGIALIMLMAGFIKICSVHTPSSNPKLPPPKPLPGTLKRRRPPQPIQQPQRQRPRESYQMGHMRR,748,"84,142",Active site (1); Alternative sequence (1); Beta strand (19); Chain (1); Compositional bias (1); Disulfide bond (17); Domain (2); Glycosylation (4); Helix (14); Metal binding (4); Modified residue (1); Motif (3); Mutagenesis (1); Natural variant (5); Propeptide (1); Region (1); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 222..313;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 344..451;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 399..435;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 460..495;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 471..484;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 473..479;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 483..515;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 503..511;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 510..536;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 524..543;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 530..562;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 555..567;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 572..598;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 580..607;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 582..597;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 594..639;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""; DISULFID 632..645;  /evidence=""ECO:0000244|PDB:6BDZ, ECO:0000244|PDB:6BE6, ECO:0000269|PubMed:29224781""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
O14525,Astrotactin-1,MALAGLCALLACCWGPAAVLATAAGDVDPSKELECKLKSITVSALPFLRENDLSIMHSPSASEPKLLFSVRNDFPGEMVVVDDLENTELPYFVLEISGNTEDIPLVRWRQQWLENGTLLFHIHHQDGAPSLPGQDPTEEPQHESAEEELRILHISVMGGMIALLLSILCLVMILYTRRRWCKRRRVPQPQKSASAEAANEIHYIPSVLIGGHGRESLRNARVQGHNSSGTLSIRETPILDGYEYDITDLRHHLQRECMNGGEDFASQVTRTLDSLQGCNEKSGMDLTPGSDNAKLSLMNKYKDNIIATSPVDSNHQQATLLSHTSSSQRKRINNKARAGSAFLNPEGDSGTEAENDPQLTFYTDPSRSRRRSRVGSPRSPVNKTTLTLISITSCVIGLVCSSHVNCPLVVKITLHVPEHLIADGSRFILLEGSQLDASDWLNPAQVVLFSQQNSSGPWAMDLCARRLLDPCEHQCDPETGRREHRAAGECLCYEGYMKDPVHKHLCIRNEWGTNQGPWPYTIFQRGFDLVLGEQPSDKIFRFTYTLGEGMWLPLSKSFVIPPAELAINPSAKCKTDMTVMEDAVEVREELMTSSSFDSLEVLLDSFGPVRDCSKDNGGCSKNFRCISDRKLDSTGCVCPSGLSPMKDSSGCYDRHIGVDCSDGFNGGCEQLCLQQMAPFPDDPTLYNILMFCGCIEDYKLGVDGRSCQLITETCPEGSDCGESRELPMNQTLFGEMFFGYNNHSKEVAAGQVLKGTFRQNNFARGLDQQLPDGLVVATVPLENQCLEEISEPTPDPDFLTGMVNFSEVSGYPVLQHWKVRSVMYHIKLNQVAISQALSNALHSLDGATSRADFVALLDQFGNHYIQEAIYGFEESCSIWYPNKQVQRRLWLEYEDISKGNSPSDESEERERDPKVLTFPEYITSLSDSGTKHMAAGVRMECHSKGRCPSSCPLCHVTSSPDTPAEPVLLEVTKAAPIYELVTNNQTQRLLQEATMSSLWCSGTGDVIEDWCRCDSTAFGADGLPTCAPLPQPVLRLSTVHEPSSTLVVLEWEHSEPPIGVQIVDYLLRQEKVTDRMDHSKVETETVLSFVDDIISGAKSPCAMPSQVPDKQLTTISLIIRCLEPDTIYMFTLWGVDNTGRRSRPSDVIVKTPCPVVDDVKAQEIADKIYNLFNGYTSGKEQQTAYNTLLDLGSPTLHRVLYHYNQHYESFGEFTWRCEDELGPRKAGLILSQLGDLSSWCNGLLQEPKISLRRSSLKYLGCRYSEIKPYGLDWAELSRDLRKTCEEQTLSIPYNDYGDSKEI,1302,"144,913",Alternative sequence (2); Chain (1); Disulfide bond (17); Domain (4); Erroneous initiation (1); Glycosylation (6); Modified residue (2); Natural variant (4); Sequence conflict (3); Signal peptide (1); Topological domain (3); Transmembrane (2),"DISULFID 463..475;  /evidence=""ECO:0000250""; DISULFID 471..490;  /evidence=""ECO:0000250""; DISULFID 492..506;  /evidence=""ECO:0000250""; DISULFID 612..625;  /evidence=""ECO:0000250""; DISULFID 619..636;  /evidence=""ECO:0000250""; DISULFID 638..651;  /evidence=""ECO:0000250""; DISULFID 660..672;  /evidence=""ECO:0000250""; DISULFID 668..692;  /evidence=""ECO:0000250""; DISULFID 694..707;  /evidence=""ECO:0000250""; DISULFID 785..951;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 876..941;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 947..954;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 1000..1011;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 1013..1026;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 1101..1121;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 1153..1240;  /evidence=""ECO:0000250|UniProtKB:O75129""; DISULFID 1261..1284;  /evidence=""ECO:0000250|UniProtKB:O75129""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P78357,Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190),MMHLRLFCILLAAVSGAEGWGYYGCDEELVGPLYARSLGASSYYSLLTAPRFARLHGISGWSPRIGDPNPWLQIDLMKKHRIRAVATQGSFNSWDWVTRYMLLYGDRVDSWTPFYQRGHNSTFFGNVNESAVVRHDLHFHFTARYIRIVPLAWNPRGKIGLRLGLYGCPYKADILYFDGDDAISYRFPRGVSRSLWDVFAFSFKTEEKDGLLLHAEGAQGDYVTLELEGAHLLLHMSLGSSPIQPRPGHTTVSAGGVLNDQHWHYVRVDRFGRDVNFTLDGYVQRFILNGDFERLNLDTEMFIGGLVGAARKNLAYRHNFRGCIENVIFNRVNIADLAVRRHSRITFEGKVAFRCLDPVPHPINFGGPHNFVQVPGFPRRGRLAVSFRFRTWDLTGLLLFSRLGDGLGHVELTLSEGQVNVSIAQSGRKKLQFAAGYRLNDGFWHEVNFVAQENHAVISIDDVEGAEVRVSYPLLIRTGTSYFFGGCPKPASRWDCHSNQTAFHGCMELLKVDGQLVNLTLVEGRRLGFYAEVLFDTCGITDRCSPNMCEHDGRCYQSWDDFICYCELTGYKGETCHTPLYKESCEAYRLSGKTSGNFTIDPDGSGPLKPFVVYCDIRENRAWTVVRHDRLWTTRVTGSSMERPFLGAIQYWNASWEEVSALANASQHCEQWIEFSCYNSRLLNTAGGYPYSFWIGRNEEQHFYWGGSQPGIQRCACGLDRSCVDPALYCNCDADQPQWRTDKGLLTFVDHLPVTQVVIGDTNRSTSEAQFFLRPLRCYGDRNSWNTISFHTGAALRFPPIRANHSLDVSFYFRTSAPSGVFLENMGGPYCQWRRPYVRVELNTSRDVVFAFDVGNGDENLTVHSDDFEFNDDEWHLVRAEINVKQARLRVDHRPWVLRPMPLQTYIWMEYDQPLYVGSAELKRRPFVGCLRAMRLNGVTLNLEGRANASEGTSPNCTGHCAHPRLPCFHGGRCVERYSYYTCDCDLTAFDGPYCNHDIGGFFEPGTWMRYNLQSALRSAAREFSHMLSRPVPGYEPGYIPGYDTPGYVPGYHGPGYRLPDYPRPGRPVPGYRGPVYNVTGEEVSFSFSTSSAPAVLLYVSSFVRDYMAVLIKDDGTLQLRYQLGTSPYVYQLTTRPVTDGQPHSINITRVYRNLFIQVDYFPLTEQKFSLLVDSQLDSPKALYLGRVMETGVIDPEIQRYNTPGFSGCLSGVRFNNVAPLKTHFRTPRPMTAELAEALRVQGELSESNCGAMPRLVSEVPPELDPWYLPPDFPYYHDEGWVAILLGFLVAFLLLGLVGMLVLFYLQNHRYKGSYHTNEPKAAHEYHPGSKPPLPTSGPAQVPTPTAAPNQAPASAPAPAPTPAPAPGPRDQNLPQILEESRSE,1384,"156,267",Chain (1); Disulfide bond (11); Domain (8); Glycosylation (17); Modified residue (1); Motif (1); Natural variant (14); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 25..168;  /evidence=""ECO:0000250""; DISULFID 323..355;  /evidence=""ECO:0000250""; DISULFID 506..538;  /evidence=""ECO:0000250""; DISULFID 544..555;  /evidence=""ECO:0000250""; DISULFID 549..564;  /evidence=""ECO:0000250""; DISULFID 566..576;  /evidence=""ECO:0000250""; DISULFID 930..957;  /evidence=""ECO:0000250""; DISULFID 961..974;  /evidence=""ECO:0000250""; DISULFID 968..983;  /evidence=""ECO:0000250""; DISULFID 985..995;  /evidence=""ECO:0000250""; DISULFID 1209..1250;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q99928,Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3),MAPKLLLLLCLFSGLHARSRKVEEDEYEDSSSNQKWVLAPKSQDTDVTLILNKLLREYDKKLRPDIGIKPTVIDVDIYVNSIGPVSSINMEYQIDIFFAQTWTDSRLRFNSTMKILTLNSNMVGLIWIPDTIFRNSKTAEAHWITTPNQLLRIWNDGKILYTLRLTINAECQLQLHNFPMDEHSCPLIFSSYGYPKEEMIYRWRKNSVEAADQKSWRLYQFDFMGLRNTTEIVTTSAGDYVVMTIYFELSRRMGYFTIQTYIPCILTVVLSWVSFWIKKDATPARTALGITTVLTMTTLSTIARKSLPRVSYVTAMDLFVTVCFLFVFAALMEYATLNYYSSCRKPTTTKKTTSLLHPDSSRWIPERISLQAPSNYSLLDMRPPPTAMITLNNSVYWQEFEDTCVYECLDGKDCQSFFCCYEECKSGSWRKGRIHIDILELDSYSRVFFPTSFLLFNLVYWVGYLYL,467,"54,289",Alternative sequence (2); Chain (1); Disulfide bond (1); Glycosylation (2); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 171..185;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P17301,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b),MGPERTGAAPLPLLLVLALSQGILNCCLAYNVGLPEAKIFSGPSSEQFGYAVQQFINPKGNWLLVGSPWSGFPENRMGDVYKCPVDLSTATCEKLNLQTSTSIPNVTEMKTNMSLGLILTRNMGTGGFLTCGPLWAQQCGNQYYTTGVCSDISPDFQLSASFSPATQPCPSLIDVVVVCDESNSIYPWDAVKNFLEKFVQGLDIGPTKTQVGLIQYANNPRVVFNLNTYKTKEEMIVATSQTSQYGGDLTNTFGAIQYARKYAYSAASGGRRSATKVMVVVTDGESHDGSMLKAVIDQCNHDNILRFGIAVLGYLNRNALDTKNLIKEIKAIASIPTERYFFNVSDEAALLEKAGTLGEQIFSIEGTVQGGDNFQMEMSQVGFSADYSSQNDILMLGAVGAFGWSGTIVQKTSHGHLIFPKQAFDQILQDRNHSSYLGYSVAAISTGESTHFVAGAPRANYTGQIVLYSVNENGNITVIQAHRGDQIGSYFGSVLCSVDVDKDTITDVLLVGAPMYMSDLKKEEGRVYLFTIKKGILGQHQFLEGPEGIENTRFGSAIAALSDINMDGFNDVIVGSPLENQNSGAVYIYNGHQGTIRTKYSQKILGSDGAFRSHLQYFGRSLDGYGDLNGDSITDVSIGAFGQVVQLWSQSIADVAIEASFTPEKITLVNKNAQIILKLCFSAKFRPTKQNNQVAIVYNITLDADGFSSRVTSRGLFKENNERCLQKNMVVNQAQSCPEHIIYIQEPSDVVNSLDLRVDISLENPGTSPALEAYSETAKVFSIPFHKDCGEDGLCISDLVLDVRQIPAAQEQPFIVSNQNKRLTFSVTLKNKRESAYNTGIVVDFSENLFFASFSLPVDGTEVTCQVAASQKSVACDVGYPALKREQQVTFTINFDFNLQNLQNQASLSFQALSESQEENKADNLVNLKIPLLYDAEIHLTRSTNINFYEISSDGNVPSIVHSFEDVGPKFIFSLKVTTGSVPVSMATVIIHIPQYTKEKNPLMYLTGVQTDKAGDISCNADINPLKIGQTSSSVSFKSENFRHTKELNCRTASCSNVTCWLKDVHMKGEYFVNVTTRIWNGTFASSTFQTVQLTAAAEINTYNPEIYVIEDNTVTIPLMIMKPDEKAEVPTGVIIGSIIAGILLLLALVAILWKLGFFKRKYEKMTKNPDEIDETTELSS,1181,"129,295",Beta strand (5); Calcium binding (3); Chain (1); Disulfide bond (6); Domain (1); Glycosylation (10); Helix (11); Motif (1); Mutagenesis (7); Natural variant (5); Region (1); Repeat (7); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 83..92;  /evidence=""ECO:0000250""; DISULFID 680..737;  /evidence=""ECO:0000250""; DISULFID 789..795;  /evidence=""ECO:0000250""; DISULFID 865..876;  /evidence=""ECO:0000250""; DISULFID 1019..1050;  /evidence=""ECO:0000250""; DISULFID 1055..1060;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:2545729"""
P48551,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2),MLLSQNAFIFRSLNLVLMVYISLVFGISYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYVTVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKGNMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESESAESAKIGGIITVFLIALVLTSTIVTLKWIGYICLRNSLPKVLNFHNFLAWPFPNLPPLEAMDMVEVIYINRKKKVWDYNYDDESDSDTEAAPRTSGGGYTMHGLTVRPLGQASATSTESQLIDPESEEEPDLPEVDVELPTMPKDSPQQLELLSGPCERRKSPLQDPFPEEDYSSTEGSGGRITFNVDLNSVFLRVLDDEDSDDLEAPLMLSSHLEEMVDPEDPDNVQSNHLLASGEGTQPTFPSPSSEGLWSEDAPSDQSDTSESDVDLGDGYIMR,515,"57,759",Alternative sequence (4); Beta strand (17); Chain (1); Disulfide bond (3); Glycosylation (5); Helix (3); Modified residue (4); Mutagenesis (7); Natural variant (15); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 39..122;  /evidence=""ECO:0000244|PDB:1N6U, ECO:0000244|PDB:1N6V, ECO:0000244|PDB:2HYM, ECO:0000244|PDB:2KZ1, ECO:0000244|PDB:2LAG, ECO:0000244|PDB:3S9D, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:17001036, ECO:0000269|PubMed:20496919, ECO:0000269|PubMed:21819146, ECO:0000269|PubMed:21854986""; DISULFID 85..93;  /evidence=""ECO:0000244|PDB:1N6U, ECO:0000244|PDB:1N6V, ECO:0000244|PDB:2HYM, ECO:0000244|PDB:2KZ1, ECO:0000244|PDB:2LAG, ECO:0000244|PDB:3S9D, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:17001036, ECO:0000269|PubMed:20496919, ECO:0000269|PubMed:21819146, ECO:0000269|PubMed:21854986""; DISULFID 207..227;  /evidence=""ECO:0000244|PDB:1N6U, ECO:0000244|PDB:1N6V, ECO:0000244|PDB:2HYM, ECO:0000244|PDB:2KZ1, ECO:0000244|PDB:2LAG, ECO:0000244|PDB:3S8W, ECO:0000244|PDB:3S9D, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:17001036, ECO:0000269|PubMed:20496919, ECO:0000269|PubMed:21819146, ECO:0000269|PubMed:21854986""",SIGNAL 1..26
Q9H4D0,Calsyntenin-2 (Alcadein-gamma) (Alc-gamma),MLPGRLCWVPLLLALGVGSGSGGGGDSRQRRLLAAKVNKHKPWIETSYHGVITENNDTVILDPPLVALDKDAPVPFAGEICAFKIHGQELPFEAVVLNKTSGEGRLRAKSPIDCELQKEYTFIIQAYDCGAGPHETAWKKSHKAVVHIQVKDVNEFAPTFKEPAYKAVVTEGKIYDSILQVEAIDEDCSPQYSQICNYEIVTTDVPFAIDRNGNIRNTEKLSYDKQHQYEILVTAYDCGQKPAAQDTLVQVDVKPVCKPGWQDWTKRIEYQPGSGSMPLFPSIHLETCDGAVSSLQIVTELQTNYIGKGCDRETYSEKSLQKLCGASSGIIDLLPSPSAATNWTAGLLVDSSEMIFKFDGRQGAKVPDGIVPKNLTDQFTITMWMKHGPSPGVRAEKETILCNSDKTEMNRHHYALYVHNCRLVFLLRKDFDQADTFRPAEFHWKLDQICDKEWHYYVINVEFPVVTLYMDGATYEPYLVTNDWPIHPSHIAMQLTVGACWQGGEVTKPQFAQFFHGSLASLTIRPGKMESQKVISCLQACKEGLDINSLESLGQGIKYHFNPSQSILVMEGDDIGNINRALQKVSYINSRQFPTAGVRRLKVSSKVQCFGEDVCISIPEVDAYVMVLQAIEPRITLRGTDHFWRPAAQFESARGVTLFPDIKIVSTFAKTEAPGDVKTTDPKSEVLEEMLHNLDFCDILVIGGDLDPRQECLELNHSELHQRHLDATNSTAGYSIYGVGSMSRYEQVLHHIRYRNWRPASLEARRFRIKCSELNGRYTSNEFNLEVSILHEDQVSDKEHVNHLIVQPPFLQSVHHPESRSSIQHSSVVPSIATVVIIISVCMLVFVVAMGVYRVRIAHQHFIQETEAAKESEMDWDDSALTITVNPMEKHEGPGHGEDETEGEEEEEAEEEMSSSSGSDDSEEEEEEEGMGRGRHGQNGARQAQLEWDDSTLPY,955,"107,006",Chain (1); Compositional bias (1); Domain (2); Glycosylation (6); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8NFT8,Delta and Notch-like epidermal growth factor-related receptor,MQPRRAQAPGAQLLPALALLLLLLGAGPRGSSLANPVPAAPLSAPGPCAAQPCRNGGVCTSRPEPDPQHPAPAGEPGYSCTCPAGISGANCQLVADPCASNPCHHGNCSSSSSSSSDGYLCICNEGYEGPNCEQALPSLPATGWTESMAPRQLQPVPATQEPDKILPRSQATVTLPTWQPKTGQKVVEMKWDQVEVIPDIACGNASSNSSAGGRLVSFEVPQNTSVKIRQDATASLILLWKVTATGFQQCSLIDGRSVTPLQASGGLVLLEEMLALGNNHFIGFVNDSVTKSIVALRLTLVVKVSTCVPGESHANDLECSGKGKCTTKPSEATFSCTCEEQYVGTFCEEYDACQRKPCQNNASCIDANEKQDGSNFTCVCLPGYTGELCQSKIDYCILDPCRNGATCISSLSGFTCQCPEGYFGSACEEKVDPCASSPCQNNGTCYVDGVHFTCNCSPGFTGPTCAQLIDFCALSPCAHGTCRSVGTSYKCLCDPGYHGLYCEEEYNECLSAPCLNAATCRDLVNGYECVCLAEYKGTHCELYKDPCANVSCLNGATCDSDGLNGTCICAPGFTGEECDIDINECDSNPCHHGGSCLDQPNGYNCHCPHGWVGANCEIHLQWKSGHMAESLTNMPRHSLYIIIGALCVAFILMLIILIVGICRISRIEYQGSSRPAYEEFYNCRSIDSEFSNAIASIRHARFGKKSRPAMYDVSPIAYEDYSPDDKPLVTLIKTKDL,737,"78,475",Chain (1); Disulfide bond (29); Domain (11); Glycosylation (2); Modified residue (4); Natural variant (1); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 48..59;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 53..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 82..91;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 98..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 103..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 123..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 319..336;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 338..347;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 353..364;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 358..378;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 380..389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 396..407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 401..416;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 418..427;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 434..445;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 439..454;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 456..465;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 472..482;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 477..491;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 493..502;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 509..520;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 514..529;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 531..540;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 547..558;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 552..567;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 569..578;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 585..596;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 590..605;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 607..616;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
P24530,Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type),MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKSCLCCWCQSFEEKQSLEEKQSCLKFKANDHGYDNFRSSNKYSSS,442,"49,644",Alternative sequence (2); Beta strand (5); Chain (1); Disulfide bond (1); Erroneous initiation (1); Glycosylation (1); Helix (11); Lipidation (3); Modified residue (6); Mutagenesis (3); Natural variant (18); Sequence conflict (9); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 174..255;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P54753,Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6),MARARPPPPPSPPPGLLPLLPPLLLLPLLLLPAGCRALEETLMDTKWVTSELAWTSHPESGWEEVSGYDEAMNPIRTYQVCNVRESSQNNWLRTGFIWRRDVQRVYVELKFTVRDCNSIPNIPGSCKETFNLFYYEADSDVASASSPFWMENPYVKVDTIAPDESFSRLDAGRVNTKVRSFGPLSKAGFYLAFQDQGACMSLISVRAFYKKCASTTAGFALFPETLTGAEPTSLVIAPGTCIPNAVEVSVPLKLYCNGDGEWMVPVGACTCATGHEPAAKESQCRPCPPGSYKAKQGEGPCLPCPPNSRTTSPAASICTCHNNFYRADSDSADSACTTVPSPPRGVISNVNETSLILEWSEPRDLGGRDDLLYNVICKKCHGAGGASACSRCDDNVEFVPRQLGLTERRVHISHLLAHTRYTFEVQAVNGVSGKSPLPPRYAAVNITTNQAAPSEVPTLRLHSSSGSSLTLSWAPPERPNGVILDYEMKYFEKSEGIASTVTSQMNSVQLDGLRPDARYVVQVRARTVAGYGQYSRPAEFETTSERGSGAQQLQEQLPLIVGSATAGLVFVVAVVVIAIVCLRKQRHGSDSEYTEKLQQYIAPGMKVYIDPFTYEDPNEAVREFAKEIDVSCVKIEEVIGAGEFGEVCRGRLKQPGRREVFVAIKTLKVGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMILTEFMENCALDSFLRLNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDPSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAVEQDYRLPPPMDCPTALHQLMLDCWVRDRNLRPKFSQIVNTLDKLIRNAASLKVIASAQSGMSQPLLDRTVPDYTTFTTVGDWLDAIKMGRYKESFVSAGFASFDLVAQMTAEDLLRIGVTLAGHQKKILSSIQDMRLQMNQTLPVQV,998,"110,330",Active site (1); Beta strand (23); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (5); Glycosylation (2); Helix (13); Modified residue (1); Motif (1); Mutagenesis (2); Natural variant (5); Nucleotide binding (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 81..199;  /evidence=""ECO:0000269|Ref.7""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q30201,Hereditary hemochromatosis protein (HLA-H),MGPRARPALLLLMLLQTAVLQGRLLRSHSLHYLFMGASEQDLGLSLFEALGYVDDQLFVFYDHESRRVEPRTPWVSSRISSQMWLQLSQSLKGWDHMFTVDFWTIMENHNHSKESHTLQVILGCEMQEDNSTEGYWKYGYDGQDHLEFCPDTLDWRAAEPRAWPTKLEWERHKIRARQNRAYLERDCPAQLQQLLELGRGVLDQQVPPLVKVTHHVTSSVTTLRCRALNYYPQNITMKWLKDKQPMDAKEFEPKDVLPNGDGTYQGWITLAVPPGEEQRYTCQVEHPGLDQPLIVIWEPSPSGTLVIGVISGIAVFVVILFIGILFIILRKRQGSRGAMGHYVLAERE,348,"40,108",Alternative sequence (13); Beta strand (18); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (3); Helix (9); Natural variant (19); Region (4); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),DISULFID 124..187; DISULFID 225..282,SIGNAL 1..22
Q8IVU1,Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule),MAVQRAASPRRPPAPLWPRLLLPLLLLLLPAPSEGLGHSAELAFAVEPSDDVAVPGQPIVLDCRVEGTPPVRITWRKNGVELPESTHSTLLANGSLMIRHFRLEPGGSPSDEGDYECVAQNRFGLVVSRKARIQAATMSDFHVHPQATVGEEGGVARFQCQIHGLPKPLITWEKNRVPIDTDNERYTLLPKGVLQITGLRAEDGGIFHCVASNIASIRISHGARLTVSGSGSGAYKEPAILVGPENLTLTVHQTAVLECVATGNPRPIVSWSRLDGRPIGVEGIQVLGTGNLIISDVTVQHSGVYVCAANRPGTRVRRTAQGRLVVQAPAEFVQHPQSISRPAGTTAMFTCQAQGEPPPHVTWLKNGQVLGPGGHVRLKNNNSTLTISGIGPEDEAIYQCVAENSAGSSQASARLTVLWAEGLPGPPRNVRAVSVSSTEVRVSWSEPLANTKEIIGYVLHIRKAADPPELEYQEAVSKSTFQHLVSDLEPSTAYSFYIKAYTPRGASSASVPTLASTLGEAPAPPPLSVRVLGSSSLQLLWEPWPRLAQHEGGFKLFYRPASKTSFTGPILLPGTVSSYNLSQLDPTAVYEVKLLAYNQHGDGNATVRFVSLRGASERTALSPPCDCRKEEAANQTSTTGIVIGIHIGVTCIIFCVLFLLFGQRGRVLLCKDVENQLSPPQGPRSQRDPGILALNGARRGQRGQLGRDEKRVDMKELEQLFPPASAAGQPDPRPTQDPAAPAPCEETQLSVLPLQGCGLMEGKTTEAKTTEATAPCAGLAAAPPPPDGGPGLLSEGQASRPAAARVTQPAHSEQ,814,"86,724",Chain (1); Compositional bias (1); Disulfide bond (4); Domain (6); Glycosylation (7); Natural variant (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 63..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 259..307;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 351..400;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q5VZ72,Izumo sperm-egg fusion protein 3,MGDLWLFLLLPLSAFHGVKGCLECDPKFIEDVGSLLGNLIPSEVPGRTQLLERQIKEMIHLSFKVSHSDKRLRVLAVQQVVKLRTWLKNEFYKLGNETWKGVFIYQGKLLDVCQNLESKLKELLKNFSEIACSEDCIVVEGPILDCWTCLRMTNRCFKGEYCGDEDPRKAENREIALFLILLATAVILGSAVLLFHFCIFHRRKMKAIRRSLKEYVEKKLEELMGKIDEKEEKDFRLRK,239,"27,768",Chain (1); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P26010,Integrin beta-7 (Gut homing receptor beta subunit),MVALPMVLVLLLVLSRGESELDAKIPSTGDATEWRNPHLSMLGSCQPAPSCQKCILSHPSCAWCKQLNFTASGEAEARRCARREELLARGCPLEELEEPRGQQEVLQDQPLSQGARGEGATQLAPQRVRVTLRPGEPQQLQVRFLRAEGYPVDLYYLMDLSYSMKDDLERVRQLGHALLVRLQEVTHSVRIGFGSFVDKTVLPFVSTVPSKLRHPCPTRLERCQSPFSFHHVLSLTGDAQAFEREVGRQSVSGNLDSPEGGFDAILQAALCQEQIGWRNVSRLLVFTSDDTFHTAGDGKLGGIFMPSDGHCHLDSNGLYSRSTEFDYPSVGQVAQALSAANIQPIFAVTSAALPVYQELSKLIPKSAVGELSEDSSNVVQLIMDAYNSLSSTVTLEHSSLPPGVHISYESQCEGPEKREGKAEDRGQCNHVRINQTVTFWVSLQATHCLPEPHLLRLRALGFSEELIVELHTLCDCNCSDTQPQAPHCSDGQGHLQCGVCSCAPGRLGRLCECSVAELSSPDLESGCRAPNGTGPLCSGKGHCQCGRCSCSGQSSGHLCECDDASCERHEGILCGGFGRCQCGVCHCHANRTGRACECSGDMDSCISPEGGLCSGHGRCKCNRCQCLDGYYGALCDQCPGCKTPCERHRDCAECGAFRTGPLATNCSTACAHTNVTLALAPILDDGWCKERTLDNQLFFFLVEDDARGTVVLRVRPQEKGADHTQAIVLGCVGGIVAVGLGLVLAYRLSVEIYDRREYSRFEKEQQQLNWKQDSNPLYKSAITTTINPRFQEADSPTL,798,"86,903",Alternative sequence (1); Beta strand (22); Chain (1); Disulfide bond (26); Domain (1); Glycosylation (8); Helix (12); Metal binding (10); Modified residue (1); Mutagenesis (1); Natural variant (1); Region (1); Repeat (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 45..476;  /evidence=""ECO:0000250""; DISULFID 51..61;  /evidence=""ECO:0000250""; DISULFID 54..91;  /evidence=""ECO:0000250""; DISULFID 64..80;  /evidence=""ECO:0000250""; DISULFID 216..223;  /evidence=""ECO:0000250""; DISULFID 271..311;  /evidence=""ECO:0000250""; DISULFID 412..428;  /evidence=""ECO:0000250""; DISULFID 448..688;  /evidence=""ECO:0000250""; DISULFID 474..478;  /evidence=""ECO:0000250""; DISULFID 488..500;  /evidence=""ECO:0000250""; DISULFID 497..537;  /evidence=""ECO:0000250""; DISULFID 502..511;  /evidence=""ECO:0000250""; DISULFID 513..527;  /evidence=""ECO:0000250""; DISULFID 543..548;  /evidence=""ECO:0000250""; DISULFID 545..574;  /evidence=""ECO:0000250""; DISULFID 550..559;  /evidence=""ECO:0000250""; DISULFID 561..566;  /evidence=""ECO:0000250""; DISULFID 580..585;  /evidence=""ECO:0000250""; DISULFID 582..613;  /evidence=""ECO:0000250""; DISULFID 587..596;  /evidence=""ECO:0000250""; DISULFID 598..605;  /evidence=""ECO:0000250""; DISULFID 619..624;  /evidence=""ECO:0000250""; DISULFID 621..666;  /evidence=""ECO:0000250""; DISULFID 626..635;  /evidence=""ECO:0000250""; DISULFID 638..641;  /evidence=""ECO:0000250""; DISULFID 645..654;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:1542691, ECO:0000269|PubMed:1750505"""
Q9NP60,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1),MKPPFLLALVVCSVVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSTAQSTGLRLMWYKNKGDLEEPIIFSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELALIFDSVVEADLANYTCHVENRNGRKHASVLLRKKDLIYKIELAGGLGAIFLLLVLLVVIYKCYNIELMLFYRQHFGADETNDDNKEYDAYLSYTKVDQDTLDCDNPEEEQFALEVLPDVLEKHYGYKLFIPERDLIPSGTYMEDLTRYVEQSRRLIIVLTPDYILRRGWSIFELESRLHNMLVSGEIKVILIECTELKGKVNCQEVESLKRSIKLLSLIKWKGSKSSKLNSKFWKHLVYEMPIKKKEMLPRCHVLDSAEQGLFGELQPIPSIAMTSTSATLVSSQADLPEFHPSDSMQIRHCCRGYKHEIPATTLPVPSLGNHHTYCNLPLTLLNGQLPLNNTLKDTQEFHRNSSLLPLSSKELSFTSDIW,686,"78,670",Active site (1); Chain (1); Disulfide bond (3); Domain (4); Glycosylation (5); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 162..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 265..331;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],MAGPGSPRRASRGASALLAAALLYAALGDVVRSEQQIPLSVVKLWASAFGGEIKSIAAKYSGSQLLQKKYKEYEKDVAIEEIDGLQLVKKLAKNMEEMFHKKSEAVRRLVEAAEEAHLKHEFDADLQYEYFNAVLINERDKDGNFLELGKEFILAPNDHFNNLPVNISLSDVQVPTNMYNKDPAIVNGVYWSESLNKVFVDNFDRDPSLIWQYFGSAKGFFRQYPGIKWEPDENGVIAFDCRNRKWYIQAATSPKDVVILVDVSGSMKGLRLTIAKQTVSSILDTLGDDDFFNIIAYNEELHYVEPCLNGTLVQADRTNKEHFREHLDKLFAKGIGMLDIALNEAFNILSDFNHTGQGSICSQAIMLITDGAVDTYDTIFAKYNWPDRKVRIFTYLIGREAAFADNLKWMACANKGFFTQISTLADVQENVMEYLHVLSRPKVIDQEHDVVWTEAYIDSTLPQAQKLTDDQGPVLMTTVAMPVFSKQNETRSKGILLGVVGTDVPVKELLKTIPKYKLGIHGYAFAITNNGYILTHPELRLLYEEGKKRRKPNYSSVDLSEVEWEDRDDVLRNAMVNRKTGKFSMEVKKTVDKGKRVLVMTNDYYYTDIKGTPFSLGVALSRGHGKYFFRGNVTIEEGLHDLEHPDVSLADEWSYCNTDLHPEHRHLSQLEAIKLYLKGKEPLLQCDKELIQEVLFDAVVSAPIEAYWTSLALNKSENSDKGVEVAFLGTRTGLSRINLFVGAEQLTNQDFLKAGDKENIFNADHFPLWYRRAAEQIPGSFVYSIPFSTGPVNKSNVVTASTSIQLLDERKSPVVAAVGIQMKLEFFQRKFWTASRQCASLDGKCSISCDDETVNCYLIDNNGFILVSEDYTQTGDFFGEIEGAVMNKLLTMGSFKRITLYDYQAMCRANKESSDGAHGLLDPYNAFLSAVKWIMTELVLFLVEFNLCSWWHSDMTAKAQKLKQTLEPCDTEYPAFVSERTIKETTGNIACEDCSKSFVIQQIPSSNLFMVVVDSSCLCESVAPITMAPIEIRYNESLKCERLKAQKIRRRPESCHGFHPEENARECGGAPSLQAQTVLLLLPLLLMLFSR,1091,"123,011",Alternative sequence (4); Chain (3); Disulfide bond (1); Domain (2); Glycosylation (5); Metal binding (3); Modified residue (1); Motif (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 412..1055;  /note=""Interchain (between alpha-2-3 and delta-3 chains)"";  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9HBT6,Cadherin-20,MWTSGRMSNAKNWLGLGMSLYFWGLMDLTTTVLSDTPTPQGELEALLSDKPQSHQRTKRSWVWNQFFVLEEYTGTDPLYVGKLHSDMDRGDGSIKYILSGEGAGIVFTIDDTTGDIHAIQRLDREERAQYTLRAQALDRRTGRPMEPESEFIIKIQDINDNEPKFLDGPYVATVPEMSPVGTSVIQVTATDADDPTYGNSARVVYSILQGQPYFSVDSKTGVIRTALMNMDREAKEYYEVIIQAKDMGGQLGGLAGTTTVNITLSDVNDNPPRFPQKHYQMSVLESAPISSTVGRVFAKDLDEGINAEMKYTIVDGDGADAFDISTDPNFQVGIITVKKPLSFESKKSYTLKVEGANPHLEMRFLNLGPFQDTTTVHISVEDVDEPPVFEPGFYFVEVPEDVAIGTTIQIISAKDPDVTNNSIRYSIDRSSDPGRFFYVDITTGALMTARPLDREEFSWHNITVLAMEMNNPSQVGSVPVTIKVLDVNDNAPEFPRFYEAFVCENAKAGQLIQTVSAVDQDDPRNGQHFYYSLAPEAANNPNFTIRDNQDNTARILTRRSGFRQQEQSVFHLPILIADSGQPVLSSTGTLTIQVCSCDDDGHVMSCSPEAYMLPVSLSRGALIAILACIFVLLVLVLLILSMRRHRKQPYIIDDEENIHENIVRYDDEGGGEEDTEAFDIAAMWNPREAQAGAAPKTRQDMLPEIESLSRYVPQTCAVNSTVHSYVLAKLYEADMDLWAPPFDSLQTYMFEGDGSVAGSLSSLQSATSDSEQSFDFLTDWGPRFRKLAELYGASEGPAPLW,801,"88,993",Chain (1); Domain (5); Glycosylation (4); Natural variant (6); Propeptide (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
O75976,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),MASGRDERPPWRLGRLLLLMCLLLLGSSARAAHIKKAEATTTTTSAGAEAAEGQFDRYYHEEELESALREAAAAGLPGLARLFSIGRSVEGRPLWVLRLTAGLGSLIPEGDAGPDAAGPDAAGPLLPGRPQVKLVGNMHGDETVSRQVLIYLARELAAGYRRGDPRLVRLLNTTDVYLLPSLNPDGFERAREGDCGFGDGGPSGASGRDNSRGRDLNRSFPDQFSTGEPPALDEVPEVRALIEWIRRNKFVLSGNLHGGSVVASYPFDDSPEHKATGIYSKTSDDEVFKYLAKAYASNHPIMKTGEPHCPGDEDETFKDGITNGAHWYDVEGGMQDYNYVWANCFEITLELSCCKYPPASQLRQEWENNRESLITLIEKVHIGVKGFVKDSITGSGLENATISVAGINHNITTGRFGDFYRLLVPGTYNLTVVLTGYMPLTVTNVVVKEGPATEVDFSLRPTVTSVIPDTTEAVSTASTVAIPNILSGTSSSYQPIQPKDFHHHHFPDMEIFLRRFANEYPNITRLYSLGKSVESRELYVMEISDNPGVHEPGEPEFKYIGNMHGNEVVGRELLLNLIEYLCKNFGTDPEVTDLVHNTRIHLMPSMNPDGYEKSQEGDSISVIGRNNSNNFDLNRNFPDQFVQITDPTQPETIAVMSWMKSYPFVLSANLHGGSLVVNYPFDDDEQGLATYSKSPDDAVFQQIALSYSKENSQMFQGRPCKNMYPNEYFPHGITNGASWYNVPGGMQDWNYLQTNCFEVTIELGCVKYPLEKELPNFWEQNRRSLIQFMKQVHQGVRGFVLDATDGRGILNATISVAEINHPVTTYKTGDYWRLLVPGTYKITASARGYNPVTKNVTVKSEGAIQVNFTLVRSSTDSNNESKKGKGASSSTNDASDPTTKEFETLIKDLSAENGLESLMLRSSSNLALALYRYHSYKDLSEFLRGLVMNYPHITNLTNLGQSTEYRHIWSLEISNKPNVSEPEEPKIRFVAGIHGNAPVGTELLLALAEFLCLNYKKNPAVTQLVDRTRIVIVPSLNPDGRERAQEKDCTSKIGQTNARGKDLDTDFTNNASQPETKAIIENLIQKQDFSLSVALDGGSMLVTYPYDKPVQTVENKETLKHLASLYANNHPSMHMGQPSCPNKSDENIPGGVMRGAEWHSHLGSMKDYSVTYGHCPEITVYTSCCYFPSAARLPSLWADNKRSLLSMLVEVHKGVHGFVKDKTGKPISKAVIVLNEGIKVQTKEGGYFHVLLAPGVHNIIAIADGYQQQHSQVFVHHDAASSVVIVFDTDNRIFGLPRELVVTVSGATMSALILTACIIWCICSIKSNRHKDGFHRLRQHHDEYEDEIRMMSTGSKKSLLSHEFQDETDTEEETLYSSKH,1380,"152,931",Active site (1); Alternative sequence (2); Beta strand (7); Chain (1); Glycosylation (15); Lipidation (3); Metal binding (6); Modified residue (6); Motif (1); Natural variant (4); Region (3); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q5ZPR3,CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276),MLRRRGSPGMGVHVGAALGALWFCLTGALEVQVPEDPVVALVGTDATLCCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFAEGQDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYQGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSILRVVLGANGTYSCLVRNPVLQQDAHSSVTITPQRSPTGAVEVQVPEDPVVALVGTDATLRCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFTEGRDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYRGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSVLRVVLGANGTYSCLVRNPVLQQDAHGSVTITGQPMTFPPEALWVTVGLSVCLIALLVALAFVCWRKIKQSCEEENAGAEDQDGEGEGSKTALQPLKHSDSKEDDGQEIA,534,"57,235",Alternative sequence (4); Chain (1); Disulfide bond (4); Domain (4); Erroneous initiation (1); Glycosylation (6); Modified residue (1); Natural variant (9); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 165..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 268..340;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 383..438;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:15340161"""
P09564,T-cell antigen CD7 (GP40) (T-cell leukemia antigen) (T-cell surface antigen Leu-9) (TP41) (CD antigen CD7),MAGPPRLLLLPLLLALARGLPGALAAQEVQQSPHCTTVPVGASVNITCSTSGGLRGIYLRQLGPQPQDIIYYEDGVVPTTDRRFRGRIDFSGSQDNLTITMHRLQLSDTGTYTCQAITEVNVYGSGTLVLVTEEQSQGWHRCSDAPPRASALPAPPTGSALPDPQTASALPDPPAASALPAALAVISFLLGLGLGVACVLARTQIKKLCSWRDKNSAACVVYEDMSHSRCNTLSSPNQYQ,240,"25,409",Chain (1); Disulfide bond (2); Domain (1); Glycosylation (2); Lipidation (1); Natural variant (1); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 48..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..25
Q9BZ76,Contactin-associated protein-like 3 (Cell recognition molecule Caspr3),MASVAWAVLKVLLLLPTQTWSPVGAGNPPDCDAPLASALPRSSFSSSSELSSSHGPGFSRLNRRDGAGGWTPLVSNKYQWLQIDLGERMEVTAVATQGGYGSSDWVTSYLLMFSDGGRNWKQYRREESIWGFPGNTNADSVVHYRLQPPFEARFLRFLPLAWNPRGRIGMRIEVYGCAYKSEVVYFDGQSALLYRLDKKPLKPIRDVISLKFKAMQSNGILLHREGQHGNHITLELIKGKLVFFLNSGNAKLPSTIAPVTLTLGSLLDDQHWHSVLIELLDTQVNFTVDKHTHHFQAKGDSSYLDLNFEISFGGIPTPGRSRAFRRKSFHGCLENLYYNGVDVTELAKKHKPQILMMGNVSFSCPQPQTVPVTFLSSRSYLALPGNSGEDKVSVTFQFRTWNRAGHLLFGELRRGSGSFVLFLKDGKLKLSLFQPGQSPRNVTAGAGLNDGQWHSVSFSAKWSHMNVVVDDDTAVQPLVAVLIDSGDTYYFGGCLDNSSGSGCKSPLGGFQGCLRLITIGDKAVDPILVQQGALGSFRDLQIDSCGITDRCLPSYCEHGGECSQSWDTFSCDCLGTGYTGETCHSSLYEQSCEAHKHRGNPSGLYYIDADGSGPLGPFLVYCNMTADAAWTVVQHGGPDAVTLRGAPSGHPRSAVSFAYAAGAGQLRSAVNLAERCEQRLALRCGTARRPDSRDGTPLSWWVGRTNETHTSWGGSLPDAQKCTCGLEGNCIDSQYYCNCDAGRNEWTSDTIVLSQKEHLPVTQIVMTDAGRPHSEAAYTLGPLLCRGDQSFWNSASFNTETSYLHFPAFHGELTADVCFFFKTTVSSGVFMENLGITDFIRIELRAPTEVTFSFDVGNGPCEVTVQSPTPFNDNQWHHVRAERNVKGASLQVDQLPQKMQPAPADGHVRLQLNSQLFIGGTATRQRGFLGCIRSLQLNGVALDLEERATVTPGVEPGCAGHCSTYGHLCRNGGRCREKRRGVTCDCAFSAYDGPFCSNEISAYFATGSSMTYHFQEHYTLSENSSSLVSSLHRDVTLTREMITLSFRTTRTPSLLLYVSSFYEEYLSVILANNGSLQIRYKLDRHQNPDAFTFDFKNMADGQLHQVKINREEAVVMVEVNQSTKKQVILSSGTEFNAVKSLILGKVLEAAGADPDTRRAATSGFTGCLSAVRFGRAAPLKAALRPSGPSRVTVRGHVAPMARCAAGAASGSPARELAPRLAGGAGRSGPADEGEPLVNADRRDSAVIGGVIAVVIFILLCITAIAIRIYQQRKLRKENESKVSKKEEC,1288,"140,690",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (11); Domain (8); Erroneous initiation (1); Glycosylation (9); Natural variant (2); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 31..177;  /evidence=""ECO:0000250""; DISULFID 332..364;  /evidence=""ECO:0000250""; DISULFID 513..545;  /evidence=""ECO:0000250""; DISULFID 551..562;  /evidence=""ECO:0000250""; DISULFID 556..571;  /evidence=""ECO:0000250""; DISULFID 573..583;  /evidence=""ECO:0000250""; DISULFID 931..958;  /evidence=""ECO:0000250""; DISULFID 962..975;  /evidence=""ECO:0000250""; DISULFID 969..984;  /evidence=""ECO:0000250""; DISULFID 986..996;  /evidence=""ECO:0000250""; DISULFID 1167..1203;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q5T848,Probable G-protein coupled receptor 158,MGAMAYPLLLCLLLAQLGLGAVGASRDPQGRPDSPRERTPKGKPHAQQPGRASASDSSAPWSRSTDGTILAQKLAEEVPMDVASYLYTGDSHQLKRANCSGRYELAGLPGKWPALASAHPSLHRALDTLTHATNFLNVMLQSNKSREQNLQDDLDWYQALVWSLLEGEPSISRAAITFSTDSLSAPAPQVFLQATREESRILLQDLSSSAPHLANATLETEWFHGLRRKWRPHLHRRGPNQGPRGLGHSWRRKDGLGGDKSHFKWSPPYLECENGSYKPGWLVTLSSAIYGLQPNLVPEFRGVMKVDINLQKVDIDQCSSDGWFSGTHKCHLNNSECMPIKGLGFVLGAYECICKAGFYHPGVLPVNNFRRRGPDQHISGSTKDVSEEAYVCLPCREGCPFCADDSPCFVQEDKYLRLAIISFQALCMLLDFVSMLVVYHFRKAKSIRASGLILLETILFGSLLLYFPVVILYFEPSTFRCILLRWARLLGFATVYGTVTLKLHRVLKVFLSRTAQRIPYMTGGRVMRMLAVILLVVFWFLIGWTSSVCQNLEKQISLIGQGKTSDHLIFNMCLIDRWDYMTAVAEFLFLLWGVYLCYAVRTVPSAFHEPRYMAVAVHNELIISAIFHTIRFVLASRLQSDWMLMLYFAHTHLTVTVTIGLLLIPKFSHSSNNPRDDIATEAYEDELDMGRSGSYLNSSINSAWSEHSLDPEDIRDELKKLYAQLEIYKRKKMITNNPHLQKKRCSKKGLGRSIMRRITEIPETVSRQCSKEDKEGADHGTAKGTALIRKNPPESSGNTGKSKEETLKNRVFSLKKSHSTYDHVRDQTEESSSLPTESQEEETTENSTLESLSGKKLTQKLKEDSEAESTESVPLVCKSASAHNLSSEKKTGHPRTSMLQKSLSVIASAKEKTLGLAGKTQTAGVEERTKSQKPLPKDKETNRNHSNSDNTETKDPAPQNSNPAEEPRKPQKSGIMKQQRVNPTTANSDLNPGTTQMKDNFDIGEVCPWEVYDLTPGPVPSESKVQKHVSIVASEMEKNPTFSLKEKSHHKPKAAEVCQQSNQKRIDKAEVCLWESQGQSILEDEKLLISKTPVLPERAKEENGGQPRAANVCAGQSEELPPKAVASKTENENLNQIGHQEKKTSSSEENVRGSYNSSNNFQQPLTSRAEVCPWEFETPAQPNAGRSVALPASSALSANKIAGPRKEEIWDSFKV,1215,"135,489",Chain (1); Cross-link (1); Erroneous initiation (1); Glycosylation (5); Modified residue (6); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P13224,Platelet glycoprotein Ib beta chain (GP-Ib beta) (GPIb-beta) (GPIbB) (Antigen CD42b-beta) (CD antigen CD42c),MGSGPRGALSLLLLLLAPPSRPAAGCPAPCSCAGTLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAPYRDLRCVAPPALRGRLLPYLAEDELRAACAPGPLCWGALAAQLALLGLGLLHALLLVLLLCRLRRLRARARARAAARLSLTDPLVAERAGTDES,206,"21,718",Alternative sequence (1); Beta strand (5); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (1); Helix (6); Modified residue (2); Natural variant (2); Repeat (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 26..32;  /evidence=""ECO:0000269|PubMed:21908432""; DISULFID 30..39;  /evidence=""ECO:0000269|PubMed:21908432""; DISULFID 93..118;  /evidence=""ECO:0000269|PubMed:21908432""; DISULFID 95..141;  /evidence=""ECO:0000269|PubMed:21908432""; DISULFID 147;  /note=""Interchain (with C-500 or C-501 in GP1BA)"";  /evidence=""ECO:0000269|PubMed:21908432""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:3632685"""
Q13261,Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)],MAPRRARGCRTLGLPALLLLLLLRPPATRGITCPPPMSVEHADIWVKSYSLYSRERYICNSGFKRKAGTSSLTECVLNKATNVAHWTTPSLKCIRDPALVHQRPAPPSTVTTAGVTPQPESLSPSGKEPAASSPSSNNTAATTAAIVPGSQLMPSKSPSTGTTEISSHESSHGTPSQTTAKNWELTASASHQPPGVYPQGHSDTTVAISTSTVLLCGLSAVSLLACYLKSRQTPPLASVEMEAMEALPVTWGTSSRDEDLENCSHHL,267,"28,233",Alternative sequence (5); Beta strand (6); Chain (2); Disulfide bond (2); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (1); Glycosylation (1); Helix (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 33..75; DISULFID 59..93,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
P01130,Low-density lipoprotein receptor (LDL receptor),MGPWGWKLRWTVALLLAAAGTAVGDRCERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDIDECQDPDTCSQLCVNLEGGYKCQCEEGFQLDPHTKACKAVGSIAYLFFTNRHEVRKMTLDRSEYTSLIPNLRNVVALDTEVASNRIYWSDLSQRMICSTQLDRAHGVSSYDTVISRDIQAPDGLAVDWIHSNIYWTDSVLGTVSVADTKGVKRKTLFRENGSKPRAIVVDPVHGFMYWTDWGTPAKIKKGGLNGVDIYSLVTENIQWPNGITLDLLSGRLYWVDSKLHSISSIDVNGGNRKTILEDEKRLAHPFSLAVFEDKVFWTDIINEAIFSANRLTGSDVNLLAENLLSPEDMVLFHNLTQPRGVNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLARDMRSCLTEAEAAVATQETSTVRLKVSSTAVRTQHTTTRPVPDTSRLPGATPGLTTVEIVTMSHQALGDVAGRGNEKKPSSVRALSIVLPIVLLVFLCLGVFLLWKNWRLKNINSINFDNPVYQKTTEDEVHICHNQDGYSYPSRQMVSLEDDVA,860,"95,376",Alternative sequence (7); Beta strand (72); Chain (1); Disulfide bond (30); Domain (10); Erroneous initiation (1); Glycosylation (5); Helix (17); Modified residue (1); Motif (1); Mutagenesis (10); Natural variant (195); Region (2); Repeat (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (22),"DISULFID 27..39; DISULFID 34..52; DISULFID 46..63; DISULFID 68..82; DISULFID 75..95; DISULFID 89..104; DISULFID 109..121;  /evidence=""ECO:0000250""; DISULFID 116..134; DISULFID 128..143; DISULFID 148..160; DISULFID 155..173; DISULFID 167..184; DISULFID 197..209; DISULFID 204..222; DISULFID 216..231; DISULFID 236..248; DISULFID 243..261; DISULFID 255..270; DISULFID 276..289; DISULFID 284..302; DISULFID 296..313; DISULFID 318..329; DISULFID 325..338; DISULFID 340..352; DISULFID 358..368; DISULFID 364..377; DISULFID 379..392; DISULFID 667..681; DISULFID 677..696; DISULFID 698..711","SIGNAL 1..21;  /evidence=""ECO:0000250|UniProtKB:P01131"""
Q8TBP5,Membrane protein FAM174A (Hepatitis C virus NS5A-transactivated protein 6) (HCV NS5A-transactivated protein 6) (Transmembrane protein 157),MKASQCCCCLSHLLASVLLLLLLPELSGPLAVLLQAAEAAPGLGPPDPRPRTLPPLPPGPTPAQQPGRGLAEAAGPRGSEGGNGSNPVAGLETDDHGGKAGEGSVGGGLAVSPNPGDKPMTQRALTVLMVVSGAVLVYFVVRTVRMRRRNRKTRRYGVLDTNIENMELTPLEQDDEDDDNTLFDANHPRR,190,"19,954",Chain (1); Compositional bias (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q17R55,Protein FAM187B (Transmembrane protein 162),MPPMLWLLLHFAAPALGFYFSISCPSGKQCQQALLSGNDILLYCNSSGAHWYYLFTQGKKGRLTSLTNISNMEIMPEGSLLIKDPLPSQTGLYHCWNKNGRQVVQYEIDFQDVTTLHITHKDLGQRPLQNETLHLGSKQLIFTWWEPWQDCNRCEEPGECKRLGYRYIEEPLEEAMPCWLYLGEVLVWSSRLRPELQVEACHVQCTNNTQLRVDYVIFDNFRLDEKTEFVWLDCPLGSMYRPVNWRANDTPLTWESQLSGQDFTTFLDPSTGGRQLQVFQPAVYKCFVQQELVAQFKPAASLETLEAQWRENDAQWREARKALRGRADSVLKGLKLVLLVVTVLALLGALLKCIHPSPGRRSTQVLVVK,369,"42,387",Chain (1); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q96PJ5,Fc receptor-like protein 4 (FcR-like protein 4) (FcRL4) (Fc receptor homolog 4) (FcRH4) (IFGP family protein 2) (hIFGP2) (Immune receptor translocation-associated protein 1) (CD antigen CD307d),MLLWASLLAFAPVCGQSAAAHKPVISVHPPWTTFFKGERVTLTCNGFQFYATEKTTWYHRHYWGEKLTLTPGNTLEVRESGLYRCQARGSPRSNPVRLLFSSDSLILQAPYSVFEGDTLVLRCHRRRKEKLTAVKYTWNGNILSISNKSWDLLIPQASSNNNGNYRCIGYGDENDVFRSNFKIIKIQELFPHPELKATDSQPTEGNSVNLSCETQLPPERSDTPLHFNFFRDGEVILSDWSTYPELQLPTVWRENSGSYWCGAETVRGNIHKHSPSLQIHVQRIPVSGVLLETQPSGGQAVEGEMLVLVCSVAEGTGDTTFSWHREDMQESLGRKTQRSLRAELELPAIRQSHAGGYYCTADNSYGPVQSMVLNVTVRETPGNRDGLVAAGATGGLLSALLLAVALLFHCWRRRKSGVGFLGDETRLPPAPGPGESSHSICPAQVELQSLYVDVHPKKGDLVYSEIQTTQLGEEEEANTSRTLLEDKDVSVVYSEVKTQHPDNSAGKISSKDEES,515,"57,224",Alternative sequence (1); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (1); Motif (3); Mutagenesis (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 44..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 123..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 212..261;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 310..359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NPR9,Protein GPR108 (Lung seven transmembrane receptor 2),MAVSERRGLGRGSPAEWGQRLLLVLLLGGCSGRIHQLALTGEKRADIQLNSFGFYTNGSLEVELSVLRLGLREAEEKSLLVGFSLSRVRSGRVRSYSTRDFQDCPLQKNSSSFLVLFLINTKDLQVQVRKYGEQKTLFIFPGLLPEAPSKPGLPKPQATVPRKVDGGGTSAASKPKSTPAVIQGPSGKDKDLVLGLSHLNNSYNFSFHVVIGSQAEEGQYSLNFHNCNNSVPGKEHPFDITVMIREKNPDGFLSAAEMPLFKLYMVMSACFLAAGIFWVSILCRNTYSVFKIHWLMAALAFTKSISLLFHSINYYFINSQGHPIEGLAVMYYIAHLLKGALLFITIALIGSGWAFIKYVLSDKEKKVFGIVIPMQVLANVAYIIIESREEGASDYVLWKEILFLVDLICCGAILFPVVWSIRHLQDASGTDGKVAVNLAKLKLFRHYYVMVICYVYFTRIIAILLQVAVPFQWQWLYQLLVEGSTLAFFVLTGYKFQPTGNNPYLQLPQEDEEDVQMEQVMTDSGFREGLSKVNKTASGRELL,543,"60,633",Chain (1); Glycosylation (6); Natural variant (2); Signal peptide (1); Transmembrane (7),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
P23415,Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit),MYSFNTLRLYLWETIVFFSLAASKEAEAARSAPKPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVSCNIFINSFGSIAETTMDYRVNIFLRQQWNDPRLAYNEYPDDSLDLDPSMLDSIWKPDLFFANEKGAHFHEITTDNKLLRISRNGNVLYSIRITLTLACPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQEQGAVQVADGLTLPQFILKEEKDLRYCTKHYNTGKFTCIEARFHLERQMGYYLIQMYIPSLLIVILSWISFWINMDAAPARVGLGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRRHHKSPMLNLFQEDEAGEGRFNFSAYGMGPACLQAKDGISVKGANNSNTTNPPPAPSKSPEEMRKLFIQRAKKIDKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNQ,457,"52,624",Alternative sequence (1); Chain (1); Disulfide bond (2); Glycosylation (1); Helix (12); Metal binding (3); Mutagenesis (9); Natural variant (18); Region (1); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (4); Turn (5),"DISULFID 166..180;  /evidence=""ECO:0000269|PubMed:19861413""; DISULFID 226..237;  /evidence=""ECO:0000269|PubMed:19861413""","SIGNAL 1..28;  /evidence=""ECO:0000250|UniProtKB:P07727, ECO:0000255"""
P56199,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a),MAPRPRARPGVAVACCWLLTVVLRCCVSFNVDVKNSMTFSGPVEDMFGYTVQQYENEEGKWVLIGSPLVGQPKNRTGDVYKCPVGRGESLPCVKLDLPVNTSIPNVTEVKENMTFGSTLVTNPNGGFLACGPLYAYRCGHLHYTTGICSDVSPTFQVVNSIAPVQECSTQLDIVIVLDGSNSIYPWDSVTAFLNDLLERMDIGPKQTQVGIVQYGENVTHEFNLNKYSSTEEVLVAAKKIVQRGGRQTMTALGIDTARKEAFTEARGARRGVKKVMVIVTDGESHDNHRLKKVIQDCEDENIQRFSIAILGSYNRGNLSTEKFVEEIKSIASEPTEKHFFNVSDELALVTIVKTLGERIFALEATADQSAASFEMEMSQTGFSAHYSQDWVMLGAVGAYDWNGTVVMQKASQIIIPRNTTFNVESTKKNEPLASYLGYTVNSATASSGDVLYIAGQPRYNHTGQVIIYRMEDGNIKILQTLSGEQIGSYFGSILTTTDIDKDSNTDILLVGAPMYMGTEKEEQGKVYVYALNQTRFEYQMSLEPIKQTCCSSRQHNSCTTENKNEPCGARFGTAIAAVKDLNLDGFNDIVIGAPLEDDHGGAVYIYHGSGKTIRKEYAQRIPSGGDGKTLKFFGQSIHGEMDLNGDGLTDVTIGGLGGAALFWSRDVAVVKVTMNFEPNKVNIQKKNCHMEGKETVCINATVCFDVKLKSKEDTIYEADLQYRVTLDSLRQISRSFFSGTQERKVQRNITVRKSECTKHSFYMLDKHDFQDSVRITLDFNLTDPENGPVLDDSLPNSVHEYIPFAKDCGNKEKCISDLSLHVATTEKDLLIVRSQNDKFNVSLTVKNTKDSAYNTRTIVHYSPNLVFSGIEAIQKDSCESNHNITCKVGYPFLRRGEMVTFKILFQFNTSYLMENVTIYLSATSDSEEPPETLSDNVVNISIPVKYEVGLQFYSSASEYHISIAANETVPEVINSTEDIGNEINIFYLIRKSGSFPMPELKLSISFPNMTSNGYPVLYPTGLSSSENANCRPHIFEDPFSINSGKKMTTSTDHLKRGTILDCNTCKFATITCNLTSSDISQVNVSLILWKPTFIKSYFSSLNLTIRGELRSENASLVLSSSNQKRELAIQISKDGLPGRVPLWVILLSAFAGLLLLMLLILALWKIGFFKRPLKKKMEK,1179,"130,848",Beta strand (5); Calcium binding (3); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (26); Helix (12); Motif (1); Natural variant (4); Repeat (7); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 82..92;  /evidence=""ECO:0000250""; DISULFID 688..697;  /evidence=""ECO:0000250""; DISULFID 703..756;  /evidence=""ECO:0000250""; DISULFID 808..814;  /evidence=""ECO:0000250""; DISULFID 878..886;  /evidence=""ECO:0000250""; DISULFID 1030..1062;  /evidence=""ECO:0000250""; DISULFID 1065..1072;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
O15354,Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR),MRAPGALLARMSRLLLLLLLKVSASSALGVAPASRNETCLGESCAPTVIQRRGRDAWGPGNSARDVLRARAPREEQGAAFLAGPSWDLPAAPGRDPAAGRGAEASAAGPPGPPTRPPGPWRWKGARGQEPSETLGRGNPTALQLFLQISEEEEKGPRGAGISGRSQEQSVKTVPGASDLFYWPRRAGKLQGSHHKPLSKTANGLAGHEGWTIALPGRALAQNGSLGEGIHEPGGPRRGNSTNRRVRLKNPFYPLTQESYGAYAVMCLSVVIFGTGIIGNLAVMCIVCHNYYMRSISNSLLANLAFWDFLIIFFCLPLVIFHELTKKWLLEDFSCKIVPYIEVASLGVTTFTLCALCIDRFRAATNVQMYYEMIENCSSTTAKLAVIWVGALLLALPEVVLRQLSKEDLGFSGRAPAERCIIKISPDLPDTIYVLALTYDSARLWWYFGCYFCLPTLFTITCSLVTARKIRKAEKACTRGNKRQIQLESQMNCTVVALTILYGFCIIPENICNIVTAYMATGVSQQTMDLLNIISQFLLFFKSCVTPVLLFCLCKPFSRAFMECCCCCCEECIQKSSTVTSDDNDNEYTTELELSPFSTIRREMSTFASVGTHC,613,"67,114",Chain (1); Compositional bias (1); Disulfide bond (1); Glycosylation (3); Sequence conflict (11); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 334..419;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P42263,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)",MARQKKMGQSVLRAVFFLVLGLLGHSHGGFPNTISIGGLFMRNTVQEHSAFRFAVQLYNTNQNTTEKPFHLNYHVDHLDSSNSFSVTNAFCSQFSRGVYAIFGFYDQMSMNTLTSFCGALHTSFVTPSFPTDADVQFVIQMRPALKGAILSLLGHYKWEKFVYLYDTERGFSILQAIMEAAVQNNWQVTARSVGNIKDVQEFRRIIEEMDRRQEKRYLIDCEVERINTILEQVVILGKHSRGYHYMLANLGFTDILLERVMHGGANITGFQIVNNENPMVQQFIQRWVRLDEREFPEAKNAPLKYTSALTHDAILVIAEAFRYLRRQRVDVSRRGSAGDCLANPAVPWSQGIDIERALKMVQVQGMTGNIQFDTYGRRTNYTIDVYEMKVSGSRKAGYWNEYERFVPFSDQQISNDSASSENRTIVVTTILESPYVMYKKNHEQLEGNERYEGYCVDLAYEIAKHVRIKYKLSIVGDGKYGARDPETKIWNGMVGELVYGRADIAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHLEDNNEEPRDPQSPPDPPNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIAYGTLDSGSTKEFFRRSKIAVYEKMWSYMKSAEPSVFTKTTADGVARVRKSKGKFAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGVATPKGSALRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKDKTSALSLSNVAGVFYILVGGLGLAMMVALIEFCYKSRAESKRMKLTKNTQNFKPAPATNTQNYATYREGYNVYGTESVKI,894,"101,157",Alternative sequence (1); Binding site (3); Chain (1); Disulfide bond (2); Glycosylation (5); Intramembrane (2); Lipidation (2); Modified residue (2); Natural variant (6); Region (2); Sequence conflict (5); Signal peptide (1); Topological domain (5); Transmembrane (3),"DISULFID 91..340;  /evidence=""ECO:0000250""; DISULFID 750..805;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P48058,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",MRIISRQIVLLFSGFWGLAMGAFPSSVQIGGLFIRNTDQEYTAFRLAIFLHNTSPNASEAPFNLVPHVDNIETANSFAVTNAFCSQYSRGVFAIFGLYDKRSVHTLTSFCSALHISLITPSFPTEGESQFVLQLRPSLRGALLSLLDHYEWNCFVFLYDTDRGYSILQAIMEKAGQNGWHVSAICVENFNDVSYRQLLEELDRRQEKKFVIDCEIERLQNILEQIVSVGKHVKGYHYIIANLGFKDISLERFIHGGANVTGFQLVDFNTPMVIKLMDRWKKLDQREYPGSETPPKYTSALTYDGVLVMAETFRSLRRQKIDISRRGNAGDCLANPAAPWGQGIDMERTLKQVRIQGLTGNVQFDHYGRRVNYTMDVFELKSTGPRKVGYWNDMDKLVLIQDVPTLGNDTAAIENRTVVVTTIMESPYVMYKKNHEMFEGNDKYEGYCVDLASEIAKHIGIKYKIAIVPDGKYGARDADTKIWNGMVGELVYGKAEIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEPEDGKEGPSDQPPNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIAYGTLDSGSTKEFFRRSKIAVYEKMWTYMRSAEPSVFTRTTAEGVARVRKSKGKFAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGVATPKGSSLRTPVNLAVLKLSEAGVLDKLKNKWWYDKGECGPKDSGSKDKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKSRAEAKRMKLTFSEAIRNKARLSITGSVGENGRVLTPDCPKAVHTGTAIRQSSGLAVIASDLP,902,"100,871",Alternative sequence (2); Binding site (3); Chain (1); Disulfide bond (2); Glycosylation (6); Intramembrane (2); Lipidation (2); Modified residue (1); Natural variant (5); Region (2); Sequence conflict (4); Signal peptide (1); Topological domain (5); Transmembrane (3),"DISULFID 84..331;  /evidence=""ECO:0000250""; DISULFID 740..795;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P27930,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]",MLRLYVLVMGVSAFTLQPAAHTGAARSCRFRGRHYKREFRLEGEPVALRCPQVPYWLWASVSPRINLTWHKNDSARTVPGEEETRMWAQDGALWLLPALQEDSGTYVCTTRNASYCDKMSIELRVFENTDAFLPFISYPQILTLSTSGVLVCPDLSEFTRDKTDVKIQWYKDSLLLDKDNEKFLSVRGTTHLLVHDVALEDAGYYRCVLTFAHEGQQYNITRSIELRIKKKKEETIPVIISPLKTISASLGSRLTIPCKVFLGTGTPLTTMLWWTANDTHIESAYPGGRVTEGPRQEYSENNENYIEVPLIFDPVTREDLHMDFKCVVHNTLSFQTLRTTVKEASSTFSWGIVLAPLSLAFLVLGGIWMHRRCKHRTGKADGLTVLWPHHQDFQSYPK,398,"45,421",Alternative sequence (1); Beta strand (26); Chain (2); Disulfide bond (4); Domain (3); Glycosylation (5); Helix (3); Natural variant (2); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 28..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 50..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 152..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""; DISULFID 258..326;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20802483""","SIGNAL 1..13;  /evidence=""ECO:0000255"""
Q14626,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)],MSSSCSGLSRVLVAVATALVSASSPCPQAWGPPGVQYGQPGRSVKLCCPGVTAGDPVSWFRDGEPKLLQGPDSGLGHELVLAQADSTDEGTYICQTLDGALGGTVTLQLGYPPARPVVSCQAADYENFSCTWSPSQISGLPTRYLTSYRKKTVLGADSQRRSPSTGPWPCPQDPLGAARCVVHGAEFWSQYRINVTEVNPLGASTRLLDVSLQSILRPDPPQGLRVESVPGYPRRLRASWTYPASWPCQPHFLLKFRLQYRPAQHPAWSTVEPAGLEEVITDAVAGLPHAVRVSARDFLDAGTWSTWSPEAWGTPSTGTIPKEIPAWGQLHTQPEVEPQVDSPAPPRPSLQPHPRLLDHRDSVEQVAVLASLGILSFLGLVAGALALGLWLRLRRGGKDGSPKPGFLASVIPVDRRPGAPNL,422,"45,222",Alternative sequence (1); Beta strand (21); Chain (2); Disulfide bond (3); Domain (3); Glycosylation (2); Motif (1); Mutagenesis (1); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 48..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 120..130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 170..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P18564,Integrin beta-6,MGIELLCLFFLFLGRNDHVQGGCALGGAETCEDCLLIGPQCAWCAQENFTHPSGVGERCDTPANLLAKGCQLNFIENPVSQVEILKNKPLSVGRQKNSSDIVQIAPQSLILKLRPGGAQTLQVHVRQTEDYPVDLYYLMDLSASMDDDLNTIKELGSRLSKEMSKLTSNFRLGFGSFVEKPVSPFVKTTPEEIANPCSSIPYFCLPTFGFKHILPLTNDAERFNEIVKNQKISANIDTPEGGFDAIMQAAVCKEKIGWRNDSLHLLVFVSDADSHFGMDSKLAGIVIPNDGLCHLDSKNEYSMSTVLEYPTIGQLIDKLVQNNVLLIFAVTQEQVHLYENYAKLIPGATVGLLQKDSGNILQLIISAYEELRSEVELEVLGDTEGLNLSFTAICNNGTLFQHQKKCSHMKVGDTASFSVTVNIPHCERRSRHIIIKPVGLGDALELLVSPECNCDCQKEVEVNSSKCHHGNGSFQCGVCACHPGHMGPRCECGEDMLSTDSCKEAPDHPSCSGRGDCYCGQCICHLSPYGNIYGPYCQCDNFSCVRHKGLLCGGNGDCDCGECVCRSGWTGEYCNCTTSTDSCVSEDGVLCSGRGDCVCGKCVCTNPGASGPTCERCPTCGDPCNSKRSCIECHLSAAGQAREECVDKCKLAGATISEEEDFSKDGSVSCSLQGENECLITFLITTDNEGKTIIHSINEKDCPKPPNIPMIMLGVSLAILLIGVVLLCIWKLLVSFHDRKEVAKFEAERSKAKWQTGTNPLYRGSTSTFKNVTYKHREKQKVDLSTDC,788,"85,936",Alternative sequence (1); Beta strand (20); Chain (1); Disulfide bond (28); Domain (1); Glycosylation (9); Helix (16); Natural variant (4); Region (2); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 23..454;  /evidence=""ECO:0000250""; DISULFID 31..41;  /evidence=""ECO:0000250""; DISULFID 34..70;  /evidence=""ECO:0000250""; DISULFID 44..59;  /evidence=""ECO:0000250""; DISULFID 197..204;  /evidence=""ECO:0000269|PubMed:28117447""; DISULFID 252..293;  /evidence=""ECO:0000269|PubMed:28117447""; DISULFID 394..406;  /evidence=""ECO:0000250""; DISULFID 426..670;  /evidence=""ECO:0000250""; DISULFID 452..456;  /evidence=""ECO:0000250""; DISULFID 467..479;  /evidence=""ECO:0000250""; DISULFID 476..511;  /evidence=""ECO:0000250""; DISULFID 481..490;  /evidence=""ECO:0000250""; DISULFID 492..502;  /evidence=""ECO:0000250""; DISULFID 517..522;  /evidence=""ECO:0000250""; DISULFID 519..552;  /evidence=""ECO:0000250""; DISULFID 524..537;  /evidence=""ECO:0000250""; DISULFID 539..544;  /evidence=""ECO:0000250""; DISULFID 558..563;  /evidence=""ECO:0000250""; DISULFID 560..591;  /evidence=""ECO:0000250""; DISULFID 565..574;  /evidence=""ECO:0000250""; DISULFID 576..583;  /evidence=""ECO:0000250""; DISULFID 597..602;  /evidence=""ECO:0000250""; DISULFID 599..645;  /evidence=""ECO:0000250""; DISULFID 604..614;  /evidence=""ECO:0000250""; DISULFID 617..620;  /evidence=""ECO:0000250""; DISULFID 624..633;  /evidence=""ECO:0000250""; DISULFID 630..702;  /evidence=""ECO:0000250""; DISULFID 649..678;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
O75019,Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6) (LIR-6) (CD antigen CD85i),MTPIVTVLICLRLSLGPRTHVQAGTLPKPTLWAEPGSVITQGSPVTLWCQGILETQEYRLYREKKTAPWITRIPQEIVKKGQFPIPSITWEHTGRYRCFYGSHTAGWSEPSDPLELVVTGAYIKPTLSALPSPVVTSGGNVTLHCVSQVAFGSFILCKEGEDEHPQCLNSQPRTHGWSRAIFSVGPVSPSRRWSYRCYAYDSNSPHVWSLPSDLLELLVLGVSKKPSLSVQPGPIVAPGESLTLQCVSDVSYDRFVLYKEGERDFLQLPGPQPQAGLSQANFTLGPVSRSYGGQYRCSGAYNLSSEWSAPSDPLDILIAGQFRGRPFISVHPGPTVASGENVTLLCQSWGPFHTFLLTKAGAADAPLRLRSIHEYPKYQAEFPMSPVTSAHSGTYRCYGSLSSNPYLLSHPSDSLELMVSGAAETLSPPQNKSDSKAGAANTLSPSQNKTASHPQDYTVENLIRMGIAGLVLVVLGILLFEAQHSQRSL,489,"53,275",Alternative sequence (1); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (6); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 145..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 157..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 246..297;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 346..397;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
A8MWY0,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),MLFRARGPVRGRGWGRPAEAPRRGRSPPWSPAWICCWALAGCQAAWAGDLPSSSSRPLPPCQEKDYHFEYTECDSSGSRWRVAIPNSAVDCSGLPDPVRGKECTFSCASGEYLEMKNQVCSKCGEGTYSLGSGIKFDEWDELPAGFSNIATFMDTVVGPSDSRPDGCNNSSWIPRGNYIESNRDDCTVSLIYAVHLKKSGYVFFEYQYVDNNIFFEFFIQNDQCQEMDTTTDKWVKLTDNGEWGSHSVMLKSGTNILYWRTTGILMGSKAVKPVLVKNITIEGVAYTSECFPCKPGTFSNKPGSFNCQVCPRNTYSEKGAKECIRCKDDSQFSEEGSSECTERPPCTTKDYFQIHTPCDEEGKTQIMYKWIEPKICREDLTDAIRLPPSGEKKDCPPCNPGFYNNGSSSCHPCPPGTFSDGTKECRPCPAGTEPALGFEYKWWNVLPGNMKTSCFNVGNSKCDGMNGWEVAGDHIQSGAGGSDNDYLILNLHIPGFKPPTSMTGATGSELGRITFVFETLCSADCVLYFMVDINRKSTNVVESWGGTKEKQAYTHIIFKNATFTFTWAFQRTNQGQDNRRFINDMVKIYSITATNAVDGVASSCRACALGSEQSGSSCVPCPPGHYIEKETNQCKECPPDTYLSIHQVYGKEACIPCGPGSKNNQDHSVCYSDCFFYHEKENQSLHYDFSNLSSVGSLMNGPSFTSKGTKYFHFFNISLCGHEGKKMALCTNNITDFTVKEIVAGSDDYTNLVGAFVCQSTIIPSESKGFRAALSSQSIILADTFIGVTVETTLKNINIKEDMFPVPTSQIPDVHFFYKSSTATTSCINGRSTAVKMRCNPTKSGAGVISVPSKCPAGTCDGCTFYFLWESAEACPLCTEHDFHEIEGACKRGFQETLYVWNEPKWCIKGISLPEKKLATCETVDFWLKVGAGVGAFTAVLLVALTCYFWKKNQKLEYKYSKLVMTTNSKECELPAADSCAIMEGEDNEEEVVYSNKQSLLGKLKSLATKEKEDHFESVQLKTSRSPNI,1029,"113,842",Alternative sequence (4); Chain (1); Disulfide bond (7); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (3); Modified residue (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 293..310;  /evidence=""ECO:0000250""; DISULFID 323..346;  /evidence=""ECO:0000250""; DISULFID 326..358;  /evidence=""ECO:0000250""; DISULFID 674..720;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 730..758;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 827..863;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 839..875;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""","SIGNAL 1..47;  /evidence=""ECO:0000255"""
Q6UXG2,Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein),MAEPGHSHHLSARVRGRTERRIPRLWRLLLWAGTAFQVTQGTGPELHACKESEYHYEYTACDSTGSRWRVAVPHTPGLCTSLPDPIKGTECSFSCNAGEFLDMKDQSCKPCAEGRYSLGTGIRFDEWDELPHGFASLSANMELDDSAAESTGNCTSSKWVPRGDYIASNTDECTATLMYAVNLKQSGTVNFEYYYPDSSIIFEFFVQNDQCQPNADDSRWMKTTEKGWEFHSVELNRGNNVLYWRTTAFSVWTKVPKPVLVRNIAITGVAYTSECFPCKPGTYADKQGSSFCKLCPANSYSNKGETSCHQCDPDKYSEKGSSSCNVRPACTDKDYFYTHTACDANGETQLMYKWAKPKICSEDLEGAVKLPASGVKTHCPPCNPGFFKTNNSTCQPCPYGSYSNGSDCTRCPAGTEPAVGFEYKWWNTLPTNMETTVLSGINFEYKGMTGWEVAGDHIYTAAGASDNDFMILTLVVPGFRPPQSVMADTENKEVARITFVFETLCSVNCELYFMVGVNSRTNTPVETWKGSKGKQSYTYIIEENTTTSFTWAFQRTTFHEASRKYTNDVAKIYSINVTNVMNGVASYCRPCALEASDVGSSCTSCPAGYYIDRDSGTCHSCPTNTILKAHQPYGVQACVPCGPGTKNNKIHSLCYNDCTFSRNTPTRTFNYNFSALANTVTLAGGPSFTSKGLKYFHHFTLSLCGNQGRKMSVCTDNVTDLRIPEGESGFSKSITAYVCQAVIIPPEVTGYKAGVSSQPVSLADRLIGVTTDMTLDGITSPAELFHLESLGIPDVIFFYRSNDVTQSCSSGRSTTIRVRCSPQKTVPGSLLLPGTCSDGTCDGCNFHFLWESAAACPLCSVADYHAIVSSCVAGIQKTTYVWREPKLCSGGISLPEQRVTICKTIDFWLKVGISAGTCTAILLTVLTCYFWKKNQKLEYKYSKLVMNATLKDCDLPAADSCAIMEGEDVEDDLIFTSKKSLFGKIKSFTSKRTPDGFDSVPLKTSSGGLDMDL,1013,"111,382",Alternative sequence (3); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 278..295;  /evidence=""ECO:0000250""; DISULFID 308..330;  /evidence=""ECO:0000250""; DISULFID 311..342;  /evidence=""ECO:0000250""; DISULFID 658..704;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 714..739;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 808..844;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 820..856;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
I3L273,Golgi-associated olfactory signaling regulator (Golgi protein in olfactory neurons) (Goofy),MKSFSRILFLVFLLAGLRSKAAPSAPLPLGCGFPDMAHPSETSPLKGASENSKRDRLNPEFPGTPYPEPSKLPHTVSLETFPLDFTEPLNPDLRETPHPESPETPKADSLTTSISESLDMPKTNLSKMAHPESSETPTPGPTEMPHPGSPETPKPNFSKTSRPEFPETPNTDLMQTTPQESPEILQLNATEVSQAELPETSNTNPTKTPDPKSPEKHDLNSTETPNSEFLQALHPDPSKTPHPESHVTHNPSPTEISQTEFPTTYYQNATDVPRTSDPQISTSLYPETPVPFKDDATALNELSLNPKPGTPAAIQPDSPKLPTSDSPGMVELKAPQNSGPKESNVPPPSARIAGPPALPGRPSQLAPATLRAPQRHSRGEGVNTIIVVERVKETGVTLVGRPRGAAGGALCLFFAGTALLIGIFVLLWCLYRRAARQRPFAHHRLPDDGDEPVLHLDAPKDPYDLYFYAPDTWVPSHIATKQPPPTPPLPPKLPPPPRGGRPQRLEALSPATLPNNFV,518,"56,104",Chain (1); Compositional bias (2); Glycosylation (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P47870,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2),MWRVRKRGYFGIWSFPLIIAAVCAQSVNDPSNMSLVKETVDRLLKGYDIRLRPDFGGPPVAVGMNIDIASIDMVSEVNMDYTLTMYFQQAWRDKRLSYNVIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGDDNAVTGVTKIELPQFSIVDYKLITKKVVFSTGSYPRLSLSFKLKRNIGYFILQTYMPSILITILSWVSFWINYDASAARVALGITTVLTMTTINTHLRETLPKIPYVKAIDMYLMGCFVFVFMALLEYALVNYIFFGRGPQRQKKAAEKAASANNEKMRLDVNKIFYKDIKQNGTQYRSLWDPTGNLSPTRRTTNYDFSLYTMDPHENILLSTLEIKNEMATSEAVMGLGDPRSTMLAYDASSIQYRKAGLPRHSFGRNALERHVAQKKSRLRRRASQLKITIPDLTDVNAIDRWSRIFFPVVFSFFNIVYWLYYVN,512,"59,150",Alternative sequence (6); Binding site (1); Chain (1); Disulfide bond (1); Glycosylation (3); Modified residue (1); Mutagenesis (1); Natural variant (9); Region (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 160..174;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000250"""
Q71H61,Immunoglobulin-like domain-containing receptor 2,MDRVLLRWISLFWLTAMVEGLQVTVPDKKKVAMLFQPTVLRCHFSTSSHQPAVVQWKFKSYCQDRMGESLGMSSTRAQSLSKRNLEWDPYLDCLDSRRTVRVVASKQGSTVTLGDFYRGREITIVHDADLQIGKLMWGDSGLYYCIITTPDDLEGKNEDSVELLVLGRTGLLADLLPSFAVEIMPEWVFVGLVLLGVFLFFVLVGICWCQCCPHSCCCYVRCPCCPDSCCCPQALYEAGKAAKAGYPPSVSGVPGPYSIPSVPLGGAPSSGMLMDKPHPPPLAPSDSTGGSHSVRKGYRIQADKERDSMKVLYYVEKELAQFDPARRMRGRYNNTISELSSLHEEDSNFRQSFHQMRSKQFPVSGDLESNPDYWSGVMGGSSGASRGPSAMEYNKEDRESFRHSQPRSKSEMLSRKNFATGVPAVSMDELAAFADSYGQRPRRADGNSHEARGGSRFERSESRAHSGFYQDDSLEEYYGQRSRSREPLTDADRGWAFSPARRRPAEDAHLPRLVSRTPGTAPKYDHSYLGSARERQARPEGASRGGSLETPSKRSAQLGPRSASYYAWSPPGTYKAGSSQDDQEDASDDALPPYSELELTRGPSYRGRDLPYHSNSEKKRKKEPAKKTNDFPTRMSLVV,639,"71,200",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Modified residue (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..145;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q96J84,Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1),MLSLLVWILTLSDTFSQGTQTRFSQEPADQTVVAGQRAVLPCVLLNYSGIVQWTKDGLALGMGQGLKAWPRYRVVGSADAGQYNLEITDAELSDDASYECQATEAALRSRRAKLTVLIPPEDTRIDGGPVILLQAGTPHNLTCRAFNAKPAATIIWFRDGTQQEGAVASTELLKDGKRETTVSQLLINPTDLDIGRVFTCRSMNEAIPSGKETSIELDVHHPPTVTLSIEPQTVQEGERVVFTCQATANPEILGYRWAKGGFLIEDAHESRYETNVDYSFFTEPVSCEVHNKVGSTNVSTLVNVHFAPRIVVDPKPTTTDIGSDVTLTCVWVGNPPLTLTWTKKDSNMVLSNSNQLLLKSVTQADAGTYTCRAIVPRIGVAEREVPLYVNGPPIISSEAVQYAVRGDGGKVECFIGSTPPPDRIAWAWKENFLEVGTLERYTVERTNSGSGVLSTLTINNVMEADFQTHYNCTAWNSFGPGTAIIQLEEREVLPVGIIAGATIGASILLIFFFIALVFFLYRRRKGSRKDVTLRKLDIKVETVNREPLTMHSDREDDTASVSTATRVMKAIYSSFKDDVDLKQDLRCDTIDTREEYEMKDPTNGYYNVRAHEDRPSSRAVLYADYRAPGPARFDGRPSSRLSHSSGYAQLNTYSRGPASDYGPEPTPPGPAAPAGTDTTSQLSYENYEKFNSHPFPGAAGYPTYRLGYPQAPPSGLERTPYEAYDPIGKYATATRFSYTSQHSDYGQRFQQRMQTHV,757,"83,536",Alternative sequence (2); Chain (1); Disulfide bond (5); Domain (5); Erroneous initiation (2); Frameshift (1); Glycosylation (4); Modified residue (6); Motif (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 244..287;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 329..371;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 413..472;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q86VH4,Leucine-rich repeat transmembrane neuronal protein 4,MGFHLITQLKGMSVVLVLLPTLLLVMLTGAQRACPKNCRCDGKIVYCESHAFADIPENISGGSQGLSLRFNSIQKLKSNQFAGLNQLIWLYLDHNYISSVDEDAFQGIRRLKELILSSNKITYLHNKTFHPVPNLRNLDLSYNKLQTLQSEQFKGLRKLIILHLRSNSLKTVPIRVFQDCRNLDFLDLGYNRLRSLSRNAFAGLLKLKELHLEHNQFSKINFAHFPRLFNLRSIYLQWNRIRSISQGLTWTWSSLHNLDLSGNDIQGIEPGTFKCLPNLQKLNLDSNKLTNISQETVNAWISLISITLSGNMWECSRSICPLFYWLKNFKGNKESTMICAGPKHIQGEKVSDAVETYNICSEVQVVNTERSHLVPQTPQKPLIIPRPTIFKPDVTQSTFETPSPSPGFQIPGAEQEYEHVSFHKIIAGSVALFLSVAMILLVIYVSWKRYPASMKQLQQHSLMKRRRKKARESERQMNSPLQEYYVDYKPTNSETMDISVNGSGPCTYTISGSRECEMPHHMKPLPYYSYDQPVIGYCQAHQPLHVTKGYETVSPEQDESPGLELGRDHSFIATIARSAAPAIYLERIAN,590,"67,217",Alternative sequence (2); Chain (1); Domain (2); Glycosylation (3); Repeat (10); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
A8MVS5,Protein HIDE1,MPWTILLFAAGSLAIPAPSIRLVPPYPSSQEDPIHIACMAPGNFPGANFTLYRGGQVVQLLQAPTDQRGVTFNLSGGSSKAPGGPFHCQYGVLGELNQSQLSDLSEPVNVSFPVPTWILVLSLSLAGALFLLAGLVAVALVVRKVKLRNLQKKRDRESCWAQINFDSTDMSFDNSLFTVSAKTMPEEDPATLDDHSGTTATPSNSRTRKRPTSTSSSPETPEFSTFRACQ,230,"24,753",Chain (1); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q86SU0,Immunoglobulin-like domain-containing receptor 1,MAWPKLPAPWLLLCTWLPAGCLSLLVTVQHTERYVTLFASIILKCDYTTSAQLQDVVVTWRFKSFCKDPIFDYYSASYQAALSLGQDPSNDCNDNQREVRIVAQRRGQNEPVLGVDYRQRKITIQNRADLVINEVMWWDHGVYYCTIEAPGDTSGDPDKEVKLIVLHWLTVIFIILGALLLLLLIGVCWCQCCPQYCCCYIRCPCCPAHCCCPEEALARHRYMKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQRDLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGRFGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPSRPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLNGSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRHGRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKPPSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI,546,"62,815",Alternative sequence (9); Chain (1); Compositional bias (2); Disulfide bond (1); Domain (1); Modified residue (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 45..145;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P13747,"HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)]",MVDGTLLLLLSEALALTQTWAGSHSLKYFHTSVSRPGRGEPRFISVGYVDDTQFVRFDNDAASPRMVPRAPWMEQEGSEYWDRETRSARDTAQIFRVNLRTLRGYYNQSEAGSHTLQWMHGCELGPDGRFLRGYEQFAYDGKDYLTLNEDLRSWTAVDTAAQISEQKSNDASEAEHQRAYLEDTCVEWLHKYLEKGKETLLHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPVTLRWKPASQPTIPIVGIIAGLVLLGSVVSGAVVAAVIWRKKSSGGKGGSYSKAEWSDSAQGSESHSL,358,"40,058",Beta strand (21); Binding site (8); Chain (2); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (7); Modified residue (1); Mutagenesis (17); Natural variant (3); Region (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 122..185;  /evidence=""ECO:0000269|PubMed:18339401, ECO:0000269|PubMed:30087334""; DISULFID 224..280;  /evidence=""ECO:0000269|PubMed:18339401, ECO:0000269|PubMed:30087334""",SIGNAL 1..21
Q9NRM6,Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor),MSLVLLSLAALCRSAVPREPTVQCGSETGPSPEWMLQHDLIPGDLRDLRVEPVTTSVATGDYSILMNVSWVLRADASIRLLKATKICVTGKSNFQSYSCVRCNYTEAFQTQTRPSGGKWTFSYIGFPVELNTVYFIGAHNIPNANMNEDGPSMSVNFTSPGCLDHIMKYKKKCVKAGSLWDPNITACKKNEETVEVNFTTTPLGNRYMALIQHSTIIGFSQVFEPHQKKQTRASVVIPVTGDSEGATVQLTPYFPTCGSDCIRHKGTVVLCPQTGVPFPLDNNKSKPGGWLPLLLLSLLVATWVLVAGIYLMWRHERIKKTSFSTTTLLPPIKVLVVYPSEICFHHTICYFTEFLQNHCRSEVILEKWQKKKIAEMGPVQWLATQKKAADKVVFLLSNDVNSVCDGTCGKSEGSPSENSQDLFPLAFNLFCSDLRSQIHLHKYVVVYFREIDTKDDYNALSVCPKYHLMKDATAFCAELLHVKQQVSAGKRSQACHDGCCSL,502,"55,885",Alternative sequence (2); Chain (1); Domain (1); Glycosylation (6); Natural variant (7); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000269|PubMed:10749887, ECO:0000269|PubMed:15340161"""
P24394,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)],MGWLCSGLLFPVSCLVLLQVASSGNMKVLQEPTCVSDYMSISTCEWKMNGPTNCSTELRLLYQLVFLLSEAHTCIPENNGGAGCVCHLLMDDVVSADNYTLDLWAGQQLLWKGSFKPSEHVKPRAPGNLTVHTNVSDTLLLTWSNPYPPDNYLYNHLTYAVNIWSENDPADFRIYNVTYLEPSLRIAASTLKSGISYRARVRAWAQCYNTTWSEWSPSTKWHNSYREPFEQHLLLGVSVSCIVILAVCLLCYVSITKIKKEWWDQIPNPARSRLVAIIIQDAQGSQWEKRSRGQEPAKCPHWKNCLTKLLPCFLEHNMKRDEDPHKAAKEMPFQGSGKSAWCPVEISKTVLWPESISVVRCVELFEAPVECEEEEEVEEEKGSFCASPESSRDDFQEGREGIVARLTESLFLDLLGEENGGFCQQDMGESCLLPPSGSTSAHMPWDEFPSAGPKEAPPWGKEQPLHLEPSPPASPTQSPDNLTCTETPLVIAGNPAYRSFSNSLSQSPCPRELGPDPLLARHLEEVEPEMPCVPQLSEPTTVPQPEPETWEQILRRNVLQHGAAAAPVSAPTSGYQEFVHAVEQGGTQASAVVGLGPPGEAGYKAFSSLLASSAVSPEKCGFGASSGEEGYKPFQDLIPGCPGDPAPVPVPLFTFGLDREPPRSPQSSHLPSSSPEHLGLEPGEKVEDMPKPPLPQEQATDPLVDSLGSGIVYSALTCHLCGHLKQCHGQEDGGQTPVMASPCCGCCCGDRSSPPTTPLRAPDPSPGGVPLEASLCPASLAPSGISEKSKSSSSFHPAPGNAQSSSQTPKIVNFVSVGPTYMRVS,825,"89,658",Alternative sequence (3); Beta strand (16); Chain (2); Compositional bias (3); Disulfide bond (2); Domain (1); Glycosylation (6); Helix (6); Modified residue (4); Motif (3); Mutagenesis (33); Natural variant (15); Region (2); Signal peptide (1); Site (8); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 34..44;  /evidence=""ECO:0000250""; DISULFID 74..86;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000250"""
Q8TBQ9,Protein kish-A (Transmembrane protein 167) (Transmembrane protein 167A),MSAIFNFQSLLTVILLLICTCAYIRSLAPSLLDRNKTGLLGIFWKCARIGERKSPYVAVCCIVMAFSILFIQ,72,"8,060",Chain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8NCW0,Kremen protein 2 (Dickkopf receptor 2) (Kringle domain-containing transmembrane protein 2) (Kringle-containing protein marking the eye and the nose),MGTQALQGFLFLLFLPLLQPRGASAGSLHSPGLSECFQVNGADYRGHQNRTGPRGAGRPCLFWDQTQQHSYSSASDPHGRWGLGAHNFCRNPDGDVQPWCYVAETEEGIYWRYCDIPSCHMPGYLGCFVDSGAPPALSGPSGTSTKLTVQVCLRFCRMKGYQLAGVEAGYACFCGSESDLARGRLAPATDCDQICFGHPGQLCGGDGRLGVYEVSVGSCQGNWTAPQGVIYSPDFPDEYGPDRNCSWALGPPGAALELTFRLFELADPRDRLELRDAASGSLLRAFDGARPPPSGPLRLGTAALLLTFRSDARGHAQGFALTYRGLQDAAEDPEAPEGSAQTPAAPLDGANVSCSPRPGAPPAAIGARVFSTVTAVSVLLLLLLGLLRPLRRRSCLLAPGKGPPALGASRGPRRSWAVWYQQPRGVALPCSPGDPQAEGSAAGYRPLSASSQSSLRSLISAL,462,"48,849",Alternative sequence (8); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (4); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..119;  /evidence=""ECO:0000250""; DISULFID 60..100;  /evidence=""ECO:0000250""; DISULFID 89..114;  /evidence=""ECO:0000250""; DISULFID 219..245;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P13473,Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b),MVCFRLFPVPGSGLVLVCLVLGAVRSYALELNLTDSENATCLYAKWQMNFTVRYETTNKTYKTVTISDHGTVTYNGSICGDDQNGPKIAVQFGPGFSWIANFTKAASTYSIDSVSFSYNTGDNTTFPDAEDKGILTVDELLAIRIPLNDLFRCNSLSTLEKNDVVQHYWDVLVQAFVQNGTVSTNEFLCDKDKTSTVAPTIHTTVPSPTTTPTPKEKPEAGTYSVNNGNDTCLLATMGLQLNITQDKVASVININPNTTHSTGSCRSHTALLRLNSSTIKYLDFVFAVKNENRFYLKEVNISMYLVNGSVFSIANNNLSYWDAPLGSSYMCNKEQTVSVSGAFQINTFDLRVQPFNVTQGKYSTAQDCSADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF,410,"44,961",Alternative sequence (2); Beta strand (1); Chain (1); Disulfide bond (4); Glycosylation (26); Helix (1); Mutagenesis (1); Natural variant (2); Region (4); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..79;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""; DISULFID 153..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""; DISULFID 232..265;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""; DISULFID 331..368;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""","SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:2912382, ECO:0000269|PubMed:3198605"""
P16070,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),MDKFWWHAAWGLCLVPLSLAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDVSSGSSSERSSTSGGYIFYTFSTVHPIPDEDSPWITDSTDRIPATTLMSTSATATETATKRQETWDWFSWLFLPSESKNHLHTTTQMAGTSSNTISAGWEPNEENEDERDRHLSFSGSGIDDDEDFISSTISTTPRAFDHTKQNQDWTQWNPSHSNPEVLLQTTTRMTDVDRNGTTAYEGNWNPEAHPPLIHHEHHEEEETPHSTSTIQATPSSTTEETATQKEQWFGNRWHEGYRQTPKEDSHSTTGTAAASAHTSHPMQGRTTPSPEDSSWTDFFNPISHPMGRGHQAGRRMDMDSSHSITLQPTANPNTGLVEDLDRTGPLSMTTQQSNSQSFSTSHEGLEEDKDHPTTSTLTSSNRNDVTGGRRDPNHSEGSTTLLEGYTSHYPHTKESRTFIPVTSAKTGSFGVTAVTVGDSNSNVNRSLSGDQDTFHPSGGSHTTHGSESDGHSHGSQEGGANTTSGPIRTPQIPEWLIILASLLALALILAVCIAVNSRRRCGQKKKLVINSGNGAVEDRKPSGLNGEASKSQEMVHLVNKESSETPDQFMTADETRNLQNVDMKIGV,742,"81,538",Alternative sequence (23); Beta strand (13); Binding site (4); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (1); Glycosylation (9); Helix (4); Modified residue (4); Natural variant (5); Region (2); Sequence conflict (13); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 28..129;  /evidence=""ECO:0000244|PDB:4PZ3, ECO:0000244|PDB:4PZ4, ECO:0000269|PubMed:25195884""; DISULFID 53..118;  /evidence=""ECO:0000244|PDB:4PZ3, ECO:0000244|PDB:4PZ4, ECO:0000269|PubMed:25195884""; DISULFID 77..97;  /evidence=""ECO:0000244|PDB:4PZ3, ECO:0000244|PDB:4PZ4, ECO:0000269|PubMed:25195884""","SIGNAL 1..20;  /evidence=""ECO:0000250"""
Q9UQC9,"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]",MTQRSIAGPICNLKFVTLLVALSSELPFLGAGVQLQDNGYNGLLIAINPQVPENQNLISNIKEMITEASFYLFNATKRRVFFRNIKILIPATWKANNNSKIKQESYEKANVIVTDWYGAHGDDPYTLQYRGCGKEGKYIHFTPNFLLNDNLTAGYGSRGRVFVHEWAHLRWGVFDEYNNDKPFYINGQNQIKVTRCSSDITGIFVCEKGPCPQENCIISKLFKEGCTFIYNSTQNATASIMFMQSLSSVVEFCNASTHNQEAPNLQNQMCSLRSAWDVITDSADFHHSFPMNGTELPPPPTFSLVQAGDKVVCLVLDVSSKMAEADRLLQLQQAAEFYLMQIVEIHTFVGIASFDSKGEIRAQLHQINSNDDRKLLVSYLPTTVSAKTDISICSGLKKGFEVVEKLNGKAYGSVMILVTSGDDKLLGNCLPTVLSSGSTIHSIALGSSAAPNLEELSRLTGGLKFFVPDISNSNSMIDAFSRISSGTGDIFQQHIQLESTGENVKPHHQLKNTVTVDNTVGNDTMFLVTWQASGPPEIILFDPDGRKYYTNNFITNLTFRTASLWIPGTAKPGHWTYTLNNTHHSLQALKVTVTSRASNSAVPPATVEAFVERDSLHFPHPVMIYANVKQGFYPILNATVTATVEPETGDPVTLRLLDDGAGADVIKNDGIYSRYFFSFAANGRYSLKVHVNHSPSISTPAHSIPGSHAMYVPGYTANGNIQMNAPRKSVGRNEEERKWGFSRVSSGGSFSVLGVPAGPHPDVFPPCKIIDLEAVKVEEELTLSWTAPGEDFDQGQATSYEIRMSKSLQNIQDDFNNAILVNTSKRNPQQAGIREIFTFSPQISTNGPEHQPNGETHESHRIYVAIRAMDRNSLQSAVSNIAQAPLFIPPNSDPVPARDYLILKGVLTAMGLIGIICLIIVVTHHTLSRKKRADKKENGTKLL,943,"103,941",Active site (1); Chain (3); Domain (1); Glycosylation (5); Metal binding (3); Mutagenesis (6); Natural variant (4); Region (1); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
O14967,Calmegin,MHFQAFWLCLGLLFISINAEFMDDDVETEDFEENSEEIDVNESELSSEIKYKTPQPIGEVYFAETFDSGRLAGWVLSKAKKDDMDEEISIYDGRWEIEELKENQVPGDRGLVLKSRAKHHAISAVLAKPFIFADKPLIVQYEVNFQDGIDCGGAYIKLLADTDDLILENFYDKTSYIIMFGPDKCGEDYKLHFIFRHKHPKTGVFEEKHAKPPDVDLKKFFTDRKTHLYTLVMNPDDTFEVLVDQTVVNKGSLLEDVVPPIKPPKEIEDPNDKKPEEWDERAKIPDPSAVKPEDWDESEPAQIEDSSVVKPAGWLDDEPKFIPDPNAEKPDDWNEDTDGEWEAPQILNPACRIGCGEWKPPMIDNPKYKGVWRPPLVDNPNYQGIWSPRKIPNPDYFEDDHPFLLTSFSALGLELWSMTSDIYFDNFIICSEKEVADHWAADGWRWKIMIANANKPGVLKQLMAAAEGHPWLWLIYLVTAGVPIALITSFCWPRKVKKKHKDTEYKKTDICIPQTKGVLEQEEKEEKAALEKPMDLEEEKKQNDGEMLEKEEESEPEEKSEEEIEIIEGQEESNQSNKSGSEDEMKEADESTGSGDGPIKSVRKRRVRKD,610,"70,039",Alternative sequence (2); Chain (1); Disulfide bond (2); Modified residue (8); Natural variant (3); Region (1); Repeat (8); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 151..185;  /evidence=""ECO:0000250""; DISULFID 351..355;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P22794,Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A),MPTDMEHTGHYLHLAFLMTTVFSLSPGTKANYTRLWANSTSSWDSVIQNKTGRNQNENINTNPITPEVDYKGNSTNMPETSHIVALTSKSEQELYIPSVVSNSPSTVQSIENTSKSHGEIFKKDVCAENNNNMAMLICLIIIAVLFLICTFLFLSTVVLANKVSSLRRSKQVGKRQPRSNGDFLASGLWPAESDTWKRTKQLTGPNLVMQSTGVLTATRERKDEEGTEKLTNKQIG,236,"26,213",Alternative sequence (1); Chain (1); Erroneous initiation (2); Glycosylation (5); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q3ZCQ3,Membrane protein FAM174B,MRAVPLPAPLLPLLLLALLAAPAARASRAESVSAPWPEPERESRPPPGPGPGNTTRFGSGAAGGSGSSSSNSSGDALVTRISILLRDLPTLKAAVIVAFAFTTLLIACLLLRVFRSGKRLKKTRKYDIITTPAERVEMAPLNEEDDEDEDSTVFDIKYR,159,"16,967",Chain (1); Erroneous initiation (1); Glycosylation (1); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P11230,Acetylcholine receptor subunit beta,MTPGALLMLLGALGAPLAPGVRGSEAEGRLREKLFSGYDSSVRPAREVGDRVRVSVGLILAQLISLNEKDEEMSTKVYLDLEWTDYRLSWDPAEHDGIDSLRITAESVWLPDVVLLNNNDGNFDVALDISVVVSSDGSVRWQPPGIYRSSCSIQVTYFPFDWQNCTMVFSSYSYDSSEVSLQTGLGPDGQGHQEIHIHEGTFIENGQWEIIHKPSRLIQPPGDPRGGREGQRQEVIFYLIIRRKPLFYLVNVIAPCILITLLAIFVFYLPPDAGEKMGLSIFALLTLTVFLLLLADKVPETSLSVPIIIKYLMFTMVLVTFSVILSVVVLNLHHRSPHTHQMPLWVRQIFIHKLPLYLRLKRPKPERDLMPEPPHCSSPGSGWGRGTDEYFIRKPPSDFLFPKPNRFQPELSAPDLRRFIDGPNRAVALLPELREVVSSISYIARQLQEQEDHDALKEDWQFVAMVVDRLFLWTFIIFTSVGTLVIFLDATYHLPPPDPFP,501,"56,698",Alternative sequence (1); Chain (1); Disulfide bond (1); Glycosylation (1); Modified residue (1); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 151..165;  /evidence=""ECO:0000250""",SIGNAL 1..23
Q8WV48,Coiled-coil domain-containing protein 107,MAGAVSLLGVVGLLLVSALSGVLGDRANPDLRAHPGNAAHPGSGATEPRRRPPLKDQRERTRAGSLPLGALYTAAVAAFVLYKCLQGKDETAVLHEEASKQQPLQSEQQLAQLTQQLAQTEQHLNNLMAQLDPLFERVTTLAGAQQELLNMKLWTIHELLQDSKPDKDMEASEPGEGSGGESAGGGDKVSETGTFLISPHTEASRPLPEDFCLKEDEEEIGDSQAWEEPTNWSTETWNLATSWEVGRGLRRRCSQAVAKGPSHSLGWEGGTTAEGRLKQSLFS,283,"30,509",Alternative sequence (7); Chain (1); Coiled coil (1); Natural variant (3); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q6UY09,Carcinoembryonic antigen-related cell adhesion molecule 20,MGPADSWGHHWMGILLSASLCTVWSPPAAAQLTLNANPLDATQSEDVVLPVFGTPRTPQIHGRSRELAKPSIAVSPGTAIEQKDMVTFYCTTKDVNITIHWVSNNLSIVFHERMQLSKDGKILTILIVQREDSGTYQCEARDALLSQRSDPIFLDVKYGPDPVEIKLESGVASGEVVEVMEGSSMTFLAETKSHPPCAYTWFLLDSILSHTTRTFTIHAVSREHEGLYRCLVSNSATHLSSLGTLKVRVLETLTMPQVVPSSLNLVENARSVDLTCQTVNQSVNVQWFLSGQPLLPSEHLQLSADNRTLIIHGLQRNDTGPYACEVWNWGSRARSEPLELTINYGPDQVHITRESASEMISTIEAELNSSLTLQCWAESKPGAEYRWTLEHSTGEHLGEQLIIRALTWEHDGIYNCTASNSLTGLARSTSVLVKVVGPQSSSLSSGAIAGIVIGILAVIAVASELGYFLCIRNARRPSRKTTEDPSHETSQPIPKEEHPTEPSSESLSPEYRNISQLQGRIRVELMQPPDLPEETYETKLPSASRRGNSFSPWKPPPKPLMPPLRLVSTVPKNMESIYEELVNPEPNTYIQINPSV,596,"65,808",Alternative sequence (3); Chain (1); Disulfide bond (3); Domain (4); Glycosylation (7); Modified residue (2); Natural variant (7); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 90..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 276..324;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 375..416;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P11912,B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a),MPGGPGVLQALPATIFLLFLLSAVYLGPGCQALWMHKVPASLMVSLGEDAHFQCPHNSSNNANVTWWRVLHGNYTWPPEFLGPGEDPNGTLIIQNVNKSHGGIYVCRVQEGNESYQQSCGTYLRVRQPPPRPFLDMGEGTKNRIITAEGIILLFCAVVPGTLLLFRKRWQNEKLGLDAGDEYEDENLYEGLNLDDCSMYEDISRGLQGTYQDVGSLNIGDVQLEKP,226,"25,038",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (6); Modified residue (4); Mutagenesis (3); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 54..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 119;  /note=""Interchain (with C-136 in beta chain)"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:7514267"""
P82279,Protein crumbs homolog 1,MALKNINYLLIFYLSFSLLIYIKNSFCNKNNTRCLSNSCQNNSTCKDFSKDNDCSCSDTANNLDKDCDNMKDPCFSNPCQGSATCVNTPGERSFLCKCPPGYSGTICETTIGSCGKNSCQHGGICHQDPIYPVCICPAGYAGRFCEIDHDECASSPCQNGAVCQDGIDGYSCFCVPGYQGRHCDLEVDECASDPCKNEATCLNEIGRYTCICPHNYSGVNCELEIDECWSQPCLNGATCQDALGAYFCDCAPGFLGDHCELNTDECASQPCLHGGLCVDGENRYSCNCTGSGFTGTHCETLMPLCWSKPCHNNATCEDSVDNYTCHCWPGYTGAQCEIDLNECNSNPCQSNGECVELSSEKQYGRITGLPSSFSYHEASGYVCICQPGFTGIHCEEDVNECSSNPCQNGGTCENLPGNYTCHCPFDNLSRTFYGGRDCSDILLGCTHQQCLNNGTCIPHFQDGQHGFSCLCPSGYTGSLCEIATTLSFEGDGFLWVKSGSVTTKGSVCNIALRFQTVQPMALLLFRSNRDVFVKLELLSGYIHLSIQVNNQSKVLLFISHNTSDGEWHFVEVIFAEAVTLTLIDDSCKEKCIAKAPTPLESDQSICAFQNSFLGGLPVGMTSNGVALLNFYNMPSTPSFVGCLQDIKIDWNHITLENISSGSSLNVKAGCVRKDWCESQPCQSRGRCINLWLSYQCDCHRPYEGPNCLREYVAGRFGQDDSTGYVIFTLDESYGDTISLSMFVRTLQPSGLLLALENSTYQYIRVWLERGRLAMLTPNSPKLVVKFVLNDGNVHLISLKIKPYKIELYQSSQNLGFISASTWKIEKGDVIYIGGLPDKQETELNGGFFKGCIQDVRLNNQNLEFFPNPTNNASLNPVLVNVTQGCAGDNSCKSNPCHNGGVCHSRWDDFSCSCPALTSGKACEEVQWCGFSPCPHGAQCQPVLQGFECIANAVFNGQSGQILFRSNGNITRELTNITFGFRTRDANVIILHAEKEPEFLNISIQDSRLFFQLQSGNSFYMLSLTSLQSVNDGTWHEVTLSMTDPLSQTSRWQMEVDNETPFVTSTIATGSLNFLKDNTDIYVGDRAIDNIKGLQGCLSTIEIGGIYLSYFENVHGFINKPQEEQFLKISTNSVVTGCLQLNVCNSNPCLHGGNCEDIYSSYHCSCPLGWSGKHCELNIDECFSNPCIHGNCSDRVAAYHCTCEPGYTGVNCEVDIDNCQSHQCANGATCISHTNGYSCLCFGNFTGKFCRQSRLPSTVCGNEKTNLTCYNGGNCTEFQTELKCMCRPGFTGEWCEKDIDECASDPCVNGGLCQDLLNKFQCLCDVAFAGERCEVDLADDLISDIFTTIGSVTVALLLILLLAIVASVVTSNKRATQGTYSPSRQEKEGSRVEMWNLMPPPAMERLI,1406,"154,183",Alternative sequence (7); Beta strand (1); Chain (1); Disulfide bond (59); Domain (22); Erroneous termination (1); Glycosylation (23); Mutagenesis (2); Natural variant (99); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 34..45;  /evidence=""ECO:0000250""; DISULFID 39..54;  /evidence=""ECO:0000250""; DISULFID 56..67;  /evidence=""ECO:0000250""; DISULFID 74..85;  /evidence=""ECO:0000250""; DISULFID 79..96;  /evidence=""ECO:0000250""; DISULFID 98..107;  /evidence=""ECO:0000250""; DISULFID 114..125;  /evidence=""ECO:0000250""; DISULFID 119..134;  /evidence=""ECO:0000250""; DISULFID 136..145;  /evidence=""ECO:0000250""; DISULFID 152..163;  /evidence=""ECO:0000250""; DISULFID 157..172;  /evidence=""ECO:0000250""; DISULFID 174..183;  /evidence=""ECO:0000250""; DISULFID 190..201;  /evidence=""ECO:0000250""; DISULFID 195..210;  /evidence=""ECO:0000250""; DISULFID 212..221;  /evidence=""ECO:0000250""; DISULFID 228..239;  /evidence=""ECO:0000250""; DISULFID 233..248;  /evidence=""ECO:0000250""; DISULFID 250..259;  /evidence=""ECO:0000250""; DISULFID 266..277;  /evidence=""ECO:0000250""; DISULFID 271..286;  /evidence=""ECO:0000250""; DISULFID 288..298;  /evidence=""ECO:0000250""; DISULFID 305..316;  /evidence=""ECO:0000250""; DISULFID 310..325;  /evidence=""ECO:0000250""; DISULFID 327..336;  /evidence=""ECO:0000250""; DISULFID 343..354;  /evidence=""ECO:0000250""; DISULFID 348..383;  /evidence=""ECO:0000250""; DISULFID 385..394;  /evidence=""ECO:0000250""; DISULFID 401..412;  /evidence=""ECO:0000250""; DISULFID 406..421;  /evidence=""ECO:0000250""; DISULFID 423..438;  /evidence=""ECO:0000250""; DISULFID 445..456;  /evidence=""ECO:0000250""; DISULFID 450..469;  /evidence=""ECO:0000250""; DISULFID 471..480;  /evidence=""ECO:0000250""; DISULFID 642..670;  /evidence=""ECO:0000250""; DISULFID 676..687;  /evidence=""ECO:0000250""; DISULFID 681..696;  /evidence=""ECO:0000250""; DISULFID 698..707;  /evidence=""ECO:0000250""; DISULFID 851..885;  /evidence=""ECO:0000250""; DISULFID 891..902;  /evidence=""ECO:0000250""; DISULFID 896..911;  /evidence=""ECO:0000250""; DISULFID 913..922;  /evidence=""ECO:0000250""; DISULFID 928..939;  /evidence=""ECO:0000250""; DISULFID 933..948;  /evidence=""ECO:0000250""; DISULFID 1096..1137;  /evidence=""ECO:0000250""; DISULFID 1143..1154;  /evidence=""ECO:0000250""; DISULFID 1148..1163;  /evidence=""ECO:0000250""; DISULFID 1165..1174;  /evidence=""ECO:0000250""; DISULFID 1181..1191;  /evidence=""ECO:0000250""; DISULFID 1186..1200;  /evidence=""ECO:0000250""; DISULFID 1202..1211;  /evidence=""ECO:0000250""; DISULFID 1218..1229;  /evidence=""ECO:0000250""; DISULFID 1223..1238;  /evidence=""ECO:0000250""; DISULFID 1240..1249;  /evidence=""ECO:0000250""; DISULFID 1259..1274;  /evidence=""ECO:0000250""; DISULFID 1268..1283;  /evidence=""ECO:0000250""; DISULFID 1285..1294;  /evidence=""ECO:0000250""; DISULFID 1301..1312;  /evidence=""ECO:0000250""; DISULFID 1306..1321;  /evidence=""ECO:0000250""; DISULFID 1323..1332;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P06340,"HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)",MALRAGLVLGFHTLMTLLSPQEAGATKADHMGSYGPAFYQSYGASGQFTHEFDEEQLFSVDLKKSEAVWRLPEFGDFARFDPQGGLAGIAAIKAHLDILVERSNRSRAINVPPRVTVLPKSRVELGQPNILICIVDNIFPPVINITWLRNGQTVTEGVAQTSFYSQPDHLFRKFHYLPFVPSAEDVYDCQVEHWGLDAPLLRHWELQVPIPPPDAMETLVCALGLAIGLVGFLVGTVLIIMGTYVSSVPR,250,"27,599",Beta strand (13); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Helix (4); Natural variant (2); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 133..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O60667,Fas apoptotic inhibitory molecule 3 (IgM Fc fragment receptor) (Regulator of Fas-induced apoptosis Toso),MDFWLWPLYFLPVSGALRILPEVKVEGELGGSVTIKCPLPEMHVRIYLCREMAGSGTCGTVVSTTNFIKAEYKGRVTLKQYPRKNLFLVEVTQLTESDSGVYACGAGMNTDRGKTQKVTLNVHSEYEPSWEEQPMPETPKWFHLPYLFQMPAYASSSKFVTRVTTPAQRGKVPPVHHSSPTTQITHRPRVSRASSVAGDKPRTFLPSTTASKISALEGLLKPQTPSYNHHTRLHRQRALDYGSQSGREGQGFHILIPTILGLFLLALLGLVVKRAVERRKALSRRARRLAVRMRALESSQRPRGSPRPRSQNNIYSACPRRARGADAAGTGEAPVPGPGAPLPPAPLQVSESPWLHAPSLKTSCEYVSLYHQPAAMMEDSDSDDYINVPA,390,"43,146",Alternative sequence (3); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..104;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P34910,Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361),MDPKYFILILFCGHLNNTFFSKTETITTEKQSQPTLFTSSMSQVLANSQNTTGNPLGQPTQFSDTFSGQSISPAKVTAGQPTPAVYTSSEKPEAHTSAGQPLAYNTKQPTPIANTSSQQAVFTSARQLPSARTSTTQPPKSFVYTFTQQSSSVQIPSRKQITVHNPSTQPTSTVKNSPRSTPGFILDTTSNKQTPQKNNYNSIAAILIGVLLTSMLVAIIIIVLWKCLRKPVLNDQNWAGRSPFADGETPDICMDNIRENEISTKRTSIISLTPWKPSKSTLLADDLEIKLFESSENIEDSNNPKTEKIKDQVNGTSEDSADGSTVGTAVSSSDDADLPPPPPLLDLEGQESNQSDKPTMTIVSPLPNDSTSLPPSLDCLNQDCGDHKSEIIQSFPPLDSLNLPLPPVDFMKNQEDSNLEIQCQEFSIPPNSDQDLNESLPPPPAELL,448,"48,666",Alternative sequence (1); Chain (1); Glycosylation (3); Modified residue (5); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q6P995,Protein FAM171B,MARLCRRVPCTLLLGLAVVLLKARLVPAAARAELSRSDLSLIQQQQQQQQQQQQQQKQLEEAEEERTEVPGATSTLTVPVSVFMLKVQVNDIISRQYLSQAVVEVFVNYTKTNSTVTKSNGAVLIKVPYKLGLSLTIIAYKDGYVLTPLPWKTRRMPIYSSVTLSLFPQSQANIWLFEDTVLITGKLADAKSQPSVQFSKALIKLPDNHHISNVTGYLTVLQQFLKVDNFLHTTGITLNKPGFENIELTPLAAICVKIYSGGKELKVNGSIQVSLPLLRLNDISAGDRIPAWTFDMNTGAWVNHGRGMVKEHNNHLIWTYDAPHLGYWIAAPLPGTRGSGINEDSKDITAYHTVFLTAILGGTIVIVIGFFAVLLCYCRDKCGTPQKRERNITKLEVLKRDQTTSTTHINHISTVKVALKAEDKSQLFNAKNSSYSPQKKEPSKAETEERVSMVKTRDDFKIYNEDVSFLSVNQNNYSRNPTQSLEPNVGSKQPKHINNNLSSSLGDAQDEKRYLTGNEEAYGRSHIPEQLMHIYSQPIAILQTSDLFSTPEQLHTAKSATLPRKGQLVYGQLMEPVNRENFTQTLPKMPIHSHAQPPDAREEDIILEGQQSLPSQASDWSRYSSSLLESVSVPGTLNEAVVMTPFSSELQGISEQTLLELSKGKPSPHPRAWFVSLDGKPVAQVRHSFIDLKKGKRTQSNDTSLDSGVDMNELHSSRKLEREKTFIKSMHQPKILYLEDLDLSSSESGTTVCSPEDPALRHILDGGSGVIMEHPGEESPGRKSTVEDFEANTSPTKRRGRPPLAKRDSKTNIWKKREERPLIPIN,826,"92,181",Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (2); Frameshift (1); Glycosylation (4); Modified residue (1); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9NYL4,Peptidyl-prolyl cis-trans isomerase FKBP11 (PPIase FKBP11) (EC 5.2.1.8) (19 kDa FK506-binding protein) (19 kDa FKBP) (FKBP-19) (FK506-binding protein 11) (FKBP-11) (Rotamase),MTLRPSLLPLHLLLLLLLSAAVCRAEAGLETESPVRTLQVETLVEPPEPCAEPAAFGDTLHIHYTGSLVDGRIIDTSLTRDPLVIELGQKQVIPGLEQSLLDMCVGEKRRAIIPSHLAYGKRGFPPSVPADAVVQYDVELIALIRANYWLKLVKGILPLVGMAMVPALLGLIGYHLYRKANRPKVSKKKLKEEKRNKSKKK,201,"22,180",Alternative sequence (1); Chain (1); Domain (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P04234,T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d),MEHSTFLSGLVLATLLSQVSPFKIPIEELEDRVFVNCNTSITWVEGTVGTLLSDITRLDLGKRILDPRGIYRCNGTDIYKDKESTVQVHYRMCQSCVELDPATVAGIIVTDVIATLLLALGVFCFAGHETGRLSGAADTQALLRNDQVYQPLRDRDDAQYSHLGGNWARNK,171,"18,930",Alternative sequence (1); Beta strand (7); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Helix (2); Modified residue (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..73;  /evidence=""ECO:0000269|PubMed:15534202""",SIGNAL 1..21
P34810,Macrosialin (Gp110) (CD antigen CD68),MRLAVLFSGALLGLLAAQGTGNDCPHKKSATLLPSFTVTPTVTESTGTTSHRTTKSHKTTTHRTTTTGTTSHGPTTATHNPTTTSHGNVTVHPTSNSTATSQGPSTATHSPATTSHGNATVHPTSNSTATSPGFTSSAHPEPPPPSPSPSPTSKETIGDYTWTNGSQPCVHLQAQIQIRVMYTTQGGGEAWGISVLNPNKTKVQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQKVVYLSYMAVEYNVSFPHAAQWTFSAQNASLRDLQAPLGQSFSCSNSSIILSPAVHLDLLSLRLQAAQLPHTGVFGQSFSCPSDRSILLPLIIGLILLGLLALVLIAFCIIRRRPSAYQAL,354,"37,408",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (2); Glycosylation (9); Natural variant (4); Region (2); Repeat (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 169..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""; DISULFID 277..314;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00740""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9NR61,Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4),MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPEALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHYVCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTCSTPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDSNPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTGSNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGLMCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLPPSFPWVAVSLGVGLAVLLVLLGMVAVAVRQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKELEVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICSPRDSMYQSVCLISEERNECVIATEV,685,"74,605",Beta strand (23); Chain (1); Disulfide bond (29); Domain (9); Glycosylation (4); Helix (2); Natural variant (7); Region (2); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 50..54;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1""; DISULFID 61..74;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1""; DISULFID 175..184;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00377""; DISULFID 188..200;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00377""; DISULFID 208..217;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00377""; DISULFID 222..233;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 226..239;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 241..250;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 253..264;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1""; DISULFID 259..270;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1""; DISULFID 272..281;  /evidence=""ECO:0000250|UniProtKB:D3ZHH1, ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 288..300;  /evidence=""ECO:0000250""; DISULFID 294..310;  /evidence=""ECO:0000250""; DISULFID 312..321;  /evidence=""ECO:0000250""; DISULFID 328..339;  /evidence=""ECO:0000250""; DISULFID 333..348;  /evidence=""ECO:0000250""; DISULFID 350..359;  /evidence=""ECO:0000250""; DISULFID 366..377;  /evidence=""ECO:0000250""; DISULFID 371..388;  /evidence=""ECO:0000250""; DISULFID 390..399;  /evidence=""ECO:0000250""; DISULFID 406..417;  /evidence=""ECO:0000250""; DISULFID 411..426;  /evidence=""ECO:0000250""; DISULFID 428..437;  /evidence=""ECO:0000250""; DISULFID 444..455;  /evidence=""ECO:0000250""; DISULFID 449..464;  /evidence=""ECO:0000250""; DISULFID 466..475;  /evidence=""ECO:0000250""; DISULFID 484..495;  /evidence=""ECO:0000250""; DISULFID 489..506;  /evidence=""ECO:0000250""; DISULFID 508..517;  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9UM73,ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246),MGAIGLLWLLPLLLSTAAVGSGMGTGQRAGSPAAGPPLQPREPLSYSRLQRKSLAVDFVVPSLFRVYARDLLLPPSSSELKAGRPEARGSLALDCAPLLRLLGPAPGVSWTAGSPAPAEARTLSRVLKGGSVRKLRRAKQLVLELGEEAILEGCVGPPGEAAVGLLQFNLSELFSWWIRQGEGRLRIRLMPEKKASEVGREGRLSAAIRASQPRLLFQIFGTGHSSLESPTNMPSPSPDYFTWNLTWIMKDSFPFLSHRSRYGLECSFDFPCELEYSPPLHDLRNQSWSWRRIPSEEASQMDLLDGPGAERSKEMPRGSFLLLNTSADSKHTILSPWMRSSSEHCTLAVSVHRHLQPSGRYIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPFRVALEYISSGNRSLSAVDFFALKNCSEGTSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDESQMCRKLPVGFYCNFEDGFCGWTQGTLSPHTPQWQVRTLKDARFQDHQDHALLLSTTDVPASESATVTSATFPAPIKSSPCELRMSWLIRGVLRGNVSLVLVENKTGKEQGRMVWHVAAYEGLSLWQWMVLPLLDVSDRFWLQMVAWWGQGSRAIVAFDNISISLDCYLTISGEDKILQNTAPKSRNLFERNPNKELKPGENSPRQTPIFDPTVHWLFTTCGASGPHGPTQAQCNNAYQNSNLSVEVGSEGPLKGIQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGVSVLGIFNLEKDDMLYILVGQQGEDACPSTNQLIQKVCIGENNVIEEEIRVNRSVHEWAGGGGGGGGATYVFKMKDGVPVPLIIAAGGGGRAYGAKTDTFHPERLENNSSVLGLNGNSGAAGGGGGWNDNTSLLWAGKSLQEGATGGHSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAASNNDPEMDGEDGVSFISPLGILYTPALKVMEGHGEVNIKHYLNCSHCEVDECHMDPESHKVICFCDHGTVLAEDGVSCIVSPTPEPHLPLSLILSVVTSALVAALVLAFSGIMIVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAAPPPLPTTSSGKAAKKPTAAEISVRVPRGPAVEGGHVNMAFSQSNPPSELHKVHGSRNKPTSLWNPTYGSWFTEKPTKKNNPIAKKEPHDRGNLGLEGSCTVPPNVATGRLPGASLLLEPSSLTANMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAATAPGAGHYEDTILKSKNSMNQPGP,1620,"176,442",Active site (1); Beta strand (15); Binding site (7); Chain (1); Compositional bias (1); Domain (4); Erroneous initiation (1); Glycosylation (16); Helix (17); Modified residue (7); Mutagenesis (1); Natural variant (38); Nucleotide binding (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
P33151,Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144),MQRLMMLLATSGACLGLLAVAAVAAAGANPAQRDTHSLLPTHRRQKRDWIWNQMHIDEEKNTSLPHHVGKIKSSVSRKNAKYLLKGEYVGKVFRVDAETGDVFAIERLDRENISEYHLTAVIVDKDTGENLETPSSFTIKVHDVNDNWPVFTHRLFNASVPESSAVGTSVISVTAVDADDPTVGDHASVMYQILKGKEYFAIDNSGRIITITKSLDREKQARYEIVVEARDAQGLRGDSGTATVLVTLQDINDNFPFFTQTKYTFVVPEDTRVGTSVGSLFVEDPDEPQNRMTKYSILRGDYQDAFTIETNPAHNEGIIKPMKPLDYEYIQQYSFIVEATDPTIDLRYMSPPAGNRAQVIINITDVDEPPIFQQPFYHFQLKENQKKPLIGTVLAMDPDAARHSIGYSIRRTSDKGQFFRVTKKGDIYNEKELDREVYPWYNLTVEAKELDSTGTPTGKESIVQVHIEVLDENDNAPEFAKPYQPKVCENAVHGQLVLQISAIDKDITPRNVKFKFILNTENNFTLTDNHDNTANITVKYGQFDREHTKVHFLPVVISDNGMPSRTGTSTLTVAVCKCNEQGEFTFCEDMAAQVGVSIQAVVAILLCILTITVITLLIFLRRRLRKQARAHGKSVPEIHEQLVTYDEEGGGEMDTTSYDVSVLNSVRRGGAKPPRPALDARPSLYAQVQKPPRHAPGAHGGPGEMAAMIEVKKDEADHDGDGPPYDTLHIYGYEGSESIAESLSSLGTDSSDSDVDYDFLNDWGPRFKMLAELYGSDPREELLY,784,"87,528",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (7); Metal binding (17); Natural variant (2); Propeptide (1); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
P01730,T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4),MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKASSIVYKKEGEQVEFSFPLAFTVEKLTGSGELWWQAERASSSKSWITFDLKNKEVSVKRVTQDPKLQMGKKLPLHLTLPQALPQYAGSGNLTLALEAKTGKLHQEVNLVVMRATQLQKNLTCEVWGPTSPKLMLSLKLENKEAKVSKREKAVWVLNPEAGMWQCLLSDSGQVLLESNIKVLPTWSTPVQPMALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI,458,"51,111",Beta strand (22); Chain (1); Disulfide bond (3); Domain (4); Glycosylation (2); Helix (6); Lipidation (2); Modified residue (3); Mutagenesis (14); Natural variant (3); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:2592374""; DISULFID 155..184;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:2592374""; DISULFID 328..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:2592374""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:2592374"""
P07766,T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e),MQSGTHWRVLGLCLLSVGVWGQDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCENCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERPPPVPNPDYEPIRKGQRDLYSGLNQRRI,207,"23,147",Beta strand (8); Chain (1); Disulfide bond (1); Domain (2); Helix (3); Modified residue (2); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000269|PubMed:15136729, ECO:0000269|PubMed:15534202""",SIGNAL 1..22
Q9HC73,Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor) (TSLP receptor),MGRLVLLWGAAVFLLGGWMALGQGGAAEGVQIQIIYFNLETVQVTWNASKYSRTNLTFHYRFNGDEAYDQCTNYLLQEGHTSGCLLDAEQRDDILYFSIRNGTHPVFTASRWMVYYLKPSSPKHVRFSWHQDAVTVTCSDLSYGDLLYEVQYRSPFDTEWQSKQENTCNVTIEGLDAEKCYSFWVRVKAMEDVYGPDTYPSDWSEVTCWQRGEIRDACAETPTPPKPKLSKFILISSLAILLMVSLLLLSLWKLWRVKKFLIPSVPDPKSIFPGLFEIHQGNFQEWITDTQNVAHLHKMAGAEQESGPEEPLVVQLAKTEAESPRMLDPQTEEKEASGGSLQLPHQPLQGGDVVTIGGFTFVMNDRSYVAL,371,"42,013",Alternative sequence (3); Beta strand (14); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (3); Motif (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 71..84;  /evidence=""ECO:0000250|UniProtKB:Q8CII9""; DISULFID 180..218;  /evidence=""ECO:0000250|UniProtKB:Q8CII9""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q6UVK1,Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan),MQSGPRPPLPAPGLALALTLTMLARLASAASFFGENHLEVPVATALTDIDLQLQFSTSQPEALLLLAAGPADHLLLQLYSGRLQVRLVLGQEELRLQTPAETLLSDSIPHTVVLTVVEGWATLSVDGFLNASSAVPGAPLEVPYGLFVGGTGTLGLPYLRGTSRPLRGCLHAATLNGRSLLRPLTPDVHEGCAEEFSASDDVALGFSGPHSLAAFPAWGTQDEGTLEFTLTTQSRQAPLAFQAGGRRGDFIYVDIFEGHLRAVVEKGQGTVLLHNSVPVADGQPHEVSVHINAHRLEISVDQYPTHTSNRGVLSYLEPRGSLLLGGLDAEASRHLQEHRLGLTPEATNASLLGCMEDLSVNGQRRGLREALLTRNMAAGCRLEEEEYEDDAYGHYEAFSTLAPEAWPAMELPEPCVPEPGLPPVFANFTQLLTISPLVVAEGGTAWLEWRHVQPTLDLMEAELRKSQVLFSVTRGARHGELELDIPGAQARKMFTLLDVVNRKARFIHDGSEDTSDQLVLEVSVTARVPMPSCLRRGQTYLLPIQVNPVNDPPHIIFPHGSLMVILEHTQKPLGPEVFQAYDPDSACEGLTFQVLGTSSGLPVERRDQPGEPATEFSCRELEAGSLVYVHRGGPAQDLTFRVSDGLQASPPATLKVVAIRPAIQIHRSTGLRLAQGSAMPILPANLSVETNAVGQDVSVLFRVTGALQFGELQKQGAGGVEGAEWWATQAFHQRDVEQGRVRYLSTDPQHHAYDTVENLALEVQVGQEILSNLSFPVTIQRATVWMLRLEPLHTQNTQQETLTTAHLEATLEEAGPSPPTFHYEVVQAPRKGNLQLQGTRLSDGQGFTQDDIQAGRVTYGATARASEAVEDTFRFRVTAPPYFSPLYTFPIHIGGDPDAPVLTNVLLVVPEGGEGVLSADHLFVKSLNSASYLYEVMERPRHGRLAWRGTQDKTTMVTSFTNEDLLRGRLVYQHDDSETTEDDIPFVATRQGESSGDMAWEEVRGVFRVAIQPVNDHAPVQTISRIFHVARGGRRLLTTDDVAFSDADSGFADAQLVLTRKDLLFGSIVAVDEPTRPIYRFTQEDLRKRRVLFVHSGADRGWIQLQVSDGQHQATALLEVQASEPYLRVANGSSLVVPQGGQGTIDTAVLHLDTNLDIRSGDEVHYHVTAGPRWGQLVRAGQPATAFSQQDLLDGAVLYSHNGSLSPRDTMAFSVEAGPVHTDATLQVTIALEGPLAPLKLVRHKKIYVFQGEAAEIRRDQLEAAQEAVPPADIVFSVKSPPSAGYLVMVSRGALADEPPSLDPVQSFSQEAVDTGRVLYLHSRPEAWSDAFSLDVASGLGAPLEGVLVELEVLPAAIPLEAQNFSVPEGGSLTLAPPLLRVSGPYFPTLLGLSLQVLEPPQHGALQKEDGPQARTLSAFSWRMVEEQLIRYVHDGSETLTDSFVLMANASEMDRQSHPVAFTVTVLPVNDQPPILTTNTGLQMWEGATAPIPAEALRSTDGDSGSEDLVYTIEQPSNGRVVLRGAPGTEVRSFTQAQLDGGLVLFSHRGTLDGGFRFRLSDGEHTSPGHFFRVTAQKQVLLSLKGSQTLTVCPGSVQPLSSQTLRASSSAGTDPQLLLYRVVRGPQLGRLFHAQQDSTGEALVNFTQAEVYAGNILYEHEMPPEPFWEAHDTLELQLSSPPARDVAATLAVAVSFEAACPQRPSHLWKNKGLWVPEGQRARITVAALDASNLLASVPSPQRSEHDVLFQVTQFPSRGQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFRAHLQGPAGASVAGPQTSEAFAITVRDVNERPPQPQASVPLRLTRGSRAPISRAQLSVVDPDSAPGEIEYEVQRAPHNGFLSLVGGGLGPVTRFTQADVDSGRLAFVANGSSVAGIFQLSMSDGASPPLPMSLAVDILPSAIEVQLRAPLEVPQALGRSSLSQQQLRVVSDREEPEAAYRLIQGPQYGHLLVGGRPTSAFSQFQIDQGEVVFAFTNFSSSHDHFRVLALARGVNASAVVNVTVRALLHVWAGGPWPQGATLRLDPTVLDAGELANRTGSVPRFRLLEGPRHGRVVRVPRARTEPGGSQLVEQFTQQDLEDGRLGLEVGRPEGRAPGPAGDSLTLELWAQGVPPAVASLDFATEPYNAARPYSVALLSVPEAARTEAGKPESSTPTGEPGPMASSPEPAVAKGGFLSFLEANMFSVIIPMCLVLLLLALILPLLFYLRKRNKTGKHDVQVLTAKPRNGLAGDTETFRKVEPGQAIPLTAVPGQGPPPGGQPDPELLQFCRTPNPALKNGQYWV,2322,"250,537",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (16); Modified residue (1); Motif (1); Natural variant (1); Region (6); Repeat (15); Sequence conflict (10); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 169..192;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""; DISULFID 354..380;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q96KC8,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),MTAPCSQPAQLPGRRQLGLVPFPPPPPRTPLLWLLLLLLAAVAPARGWESGDLELFDLVEEVQLNFYQFLGVQQDASSADIRKAYRKLSLTLHPDKNKDENAETQFRQLVAIYEVLKDDERRQRYDDILINGLPDWRQPVFYYRRVRKMSNAELALLLFIILTVGHYAVVWSIYLEKQLDELLSRKKREKKKKTGSKSVDVSKLGASEKNERLLMKPQWHDLLPCKLGIWFCLTLKALPHLIQDAGQFYAKYKETRLKEKEDALTRTELETLQKQKKVKKPKPEFPVYTPLETTYIQSYDHGTSIEEIEEQMDDWLENRNRTQKKQAPEWTEEDLSQLTRSMVKFPGGTPGRWEKIAHELGRSVTDVTTKAKQLKDSVTCSPGMVRLSELKSTVQNSRPIKTATTLPDDMITQREDAEGVAAEEEQEGDSGEQETGATDARPRRRKPARLLEATAKPEPEEKSRAKRQKDFDIAEQNESSDEESLRKERARSAEEPWTQNQQKLLELALQQYPRGSSDRWDKIARCVPSKSKEDCIARYKLLVELVQKKKQAKS,554,"63,883",Beta strand (2); Chain (1); Domain (3); Helix (7); Modified residue (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..47;  /evidence=""ECO:0000255"""
A6NFU0,Ig-like V-type domain-containing protein FAM187A,MHLALTTVLLWAWGLQAFEIVEKENIFQRTPCPAFLMFENAAYLADMSFELPCHCKPEEVPAVVWFYQKHLGSSHTKVLTDFDGRVLTEAAQVRVGSDMLTRFSIRMFSLLVFRAQSEDSGLYFCGTRKGDYFYAYDVDIQNSEGMVATFQDKGQEPFADEYYGHLHVFTTFWEWTPCDRCGVRGEQWRIGLCYLQSPDLSPRYLKAVPDVVSCGSRAVPRKLRTKARDHTPEVLVRSCLVPCEKTKTIREGVLAIINYVSKVGSRPWVPQVPIQFHQQRLGHGLIISCPGARPEHAVAWDKDRQHLYRTQYLKGVNRSMRVFIDHGNQLHIRFTQLDDRGIYYCWRQGVLVAGFRLGVTSHGHYPASFSDPETRSAVELTLIGYLLITAVFVTIHFCRCCCYLFHCCPSFSP,413,"47,349",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 289..345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P12319,High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha) (FcERI) (IgE Fc receptor subunit alpha),MAPAMESPTLLCVALLFFAPDGVLAVPQKPKVSLNPPWNRIFKGENVTLTCNGNNFFEVSSTKWFHNGSLSEETNSSLNIVNAKFEDSGEYKCQHQQVNESEPVYLEVFSDWLLLQASAEVVMEGQPLFLRCHGWRNWDVYKVIYYKDGEALKYWYENHNISITNATVEDSGTYYCTGKVWQLDYESEPLNITVIKAPREKYWLQFFIPLLVVILFAVDTGLFISTQQQVTFLLKIKRTRKGFRLLNPHPKPNPKNN,257,"29,596",Beta strand (19); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (7); Helix (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..93;  /evidence=""ECO:0000244|PDB:1F2Q, ECO:0000269|PubMed:11531339, ECO:0000269|PubMed:9875849""; DISULFID 132..176;  /evidence=""ECO:0000244|PDB:1F2Q, ECO:0000269|PubMed:11531339, ECO:0000269|PubMed:9875849""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:8125119"""
P22607,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333),MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAEDTGVDTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT,806,"87,710",Active site (1); Alternative sequence (3); Beta strand (23); Binding site (1); Chain (1); Disulfide bond (3); Domain (4); Erroneous initiation (1); Glycosylation (6); Helix (16); Modified residue (6); Mutagenesis (7); Natural variant (28); Nucleotide binding (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 61..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 176..228;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 275..339;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..22
P22455,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334),MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQELTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVRGWRGRLEIASFLPEDAGRYLCLARGSMIVLQNLTLITGDSLTSSNDDEDPKSHRDPSNRHSYPQQAPYWTHPQRMEKKLHAVPAGNTVKFRCPAAGNPTPTIRWLKDGQAFHGENRIGGIRLRHQHWSLVMESVVPSDRGTYTCLVENAVGSIRYNYLLDVLERSPHRPILQAGLPANTTAVVGSDVELLCKVYSDAQPHIQWLKHIVINGSSFGADGFPYVQVLKTADINSSEVEVLYLRNVSAEDAGEYTCLAGNSIGLSYQSAWLTVLPEEDPTWTAAAPEARYTDIILYASGSLALAVLLLLAGLYRGQALHGRHPRPPATVQKLSRFPLARQFSLESGSSGKSSSSLVRGVRLSSSGPALLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEEYLDLRLTFGPYSPSGGDASSTCSSSDSVFSHDPLPLGSSSFPFGSGVQT,802,"87,954",Active site (1); Alternative sequence (2); Beta strand (22); Binding site (1); Chain (1); Disulfide bond (3); Domain (4); Glycosylation (5); Helix (16); Modified residue (4); Mutagenesis (2); Natural variant (10); Nucleotide binding (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 57..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 172..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 271..333;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9NYQ8,Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1),MTIALLGFAIFLLHCATCEKPLEGILSSSAWHFTHSHYNATIYENSSPKTYVESFEKMGIYLAEPQWAVRYRIISGDVANVFKTEEYVVGNFCFLRIRTKSSNTALLNREVRDSYTLIIQATEKTLELEALTRVVVHILDQNDLKPLFSPPSYRVTISEDMPLKSPICKVTATDADLGQNAEFYYAFNTRSEMFAIHPTSGVVTVAGKLNVTWRGKHELQVLAVDRMRKISEGNGFGSLAALVVHVEPALRKPPAIASVVVTPPDSNDGTTYATVLVDANSSGAEVESVEVVGGDPGKHFKAIKSYARSNEFSLVSVKDINWMEYLHGFNLSLQARSGSGPYFYSQIRGFHLPPSKLSSLKFEKAVYRVQLSEFSPPGSRVVMVRVTPAFPNLQYVLKPSSENVGFKLNARTGLITTTKLMDFHDRAHYQLHIRTSPGQASTVVVIDIVDCNNHAPLFNRSSYDGTLDENIPPGTSVLAVTATDRDHGENGYVTYSIAGPKALPFSIDPYLGIISTSKPMDYELMKRIYTFRVRASDWGSPFRREKEVSIFLQLRNLNDNQPMFEEVNCTGSIRQDWPVGKSIMTMSAIDVDELQNLKYEIVSGNELEYFDLNHFSGVISLKRPFINLTAGQPTSYSLKITASDGKNYASPTTLNITVVKDPHFEVPVTCDKTGVLTQFTKTILHFIGLQNQESSDEEFTSLSTYQINHYTPQFEDHFPQSIDVLESVPINTPLARLAATDPDAGFNGKLVYVIADGNEEGCFDIELETGLLTVAAPLDYEATNFYILNVTVYDLGTPQKSSWKLLTVNVKDWNDNAPRFPPGGYQLTISEDTEVGTTIAELTTKDADSEDNGRVRYTLLSPTEKFSLHPLTGELVVTGHLDRESEPRYILKVEARDQPSKGHQLFSVTDLIITLEDVNDNSPQCITEHNRLKVPEDLPPGTVLTFLDASDPDLGPAGEVRYVLMDGAHGTFRVDLMTGALILERELDFERRAGYNLSLWASDGGRPLARRTLCHVEVIVLDVNENLHPPHFASFVHQGQVQENSPSGTQVIVVAAQDDDSGLDGELQYFLRAGTGLAAFSINQDTGMIQTLAPLDREFASYYWLTVLAVDRGSVPLSSVTEVYIEVTDANDNPPQMSQAVFYPSIQEDAPVGTSVLQLDAWDPDSSSKGKLTFNITSGNYMGFFMIHPVTGLLSTAQQLDRENKDEHILEVTVLDNGEPSLKSTSRVVVGILDVNDNPPIFSHKLFNVRLPERLSPVSPGPVYRLVASDLDEGLNGRVTYSIEDSDEEAFSIDLVTGVVSSSSTFTAGEYNILTIKATDSGQPPLSASVRLHIEWIPWPRPSSIPLAFDETYYSFTVMETDPVNHMVGVISVEGRPGLFWFNISGGDKDMDFDIEKTTGSIVIARPLDTRRRSNYNLTVEVTDGSRTIATQVHIFMIANINHHRPQFLETRYEVRVPQDTVPGVELLRVQAIDQDKGKSLIYTIHGSQDPGSASLFQLDPSSGVLVTVGKLDLGSGPSQHTLTVMVRDQEIPIKRNFVWVTIHVEDGNLHPPRFTQLHYEASVPDTIAPGTELLQVRAMDADRGVNAEVHYSLLKGNSEGFFNINALLGIITLAQKLDQANHAPHTLTVKAEDQGSPQWHDLATVIIHVYPSDRSAPIFSKSEYFVEIPESIPVGSPILLVSAMSPSEVTYELREGNKDGVFSMNSYSGLISTQKKLDHEKISSYQLKIRGSNMAGAFTDVMVVVDIIDENDNAPMFLKSTFVGQISEAAPLYSMIMDKNNNPFVIHASDSDKEANSLLVYKILEPEALKFFKIDPSMGTLTIVSEMDYESMPSFQFCVYVHDQGSPVLFAPRPAQVIIHVRDVNDSPPRFSEQIYEVAIVGPIHPGMELLMVRASDEDSEVNYSIKTGNADEAVTIHPVTGSISVLNPAFLGLSRKLTIRASDGLYQDTALVKISLTQVLDKSLQFDQDVYWAAVKENLQDRKALVILGAQGNHLNDTLSYFLLNGTDMFHMVQSAGVLQTRGVAFDREQQDTHELAVEVRDNRTPQRVAQGLVRVSIEDVNDNPPKFKHLPYYTIIQDGTEPGDVLFQVSATDEDLGTNGAVTYEFAEDYTYFRIDPYLGDISLKKPFDYQALNKYHLKVIARDGGTPSLQSEEEVLVTVRNKSNPLFQSPYYKVRVPENITLYTPILHTQARSPEGLRLIYNIVEEEPLMLFTTDFKTGVLTVTGPLDYESKTKHVFTVRATDTALGSFSEATVEVLVEDVNDNPPTFSQLVYTTSISEGLPAQTPVIQLLASDQDSGRNRDVSYQIVEDGSDVSKFFQINGSTGEMSTVQELDYEAQQHFHVKVRAMDKGDPPLTGETLVVVNVSDINDNPPEFRQPQYEANVSELATCGHLVLKVQAIDPDSRDTSRLEYLILSGNQDRHFFINSSSGIISMFNLCKKHLDSSYNLRVGASDGVFRATVPVYINTTNANKYSPEFQQHLYEAELAENAMVGTKVIDLLAIDKDSGPYGTIDYTIINKLASEKFSINPNGQIATLQKLDRENSTERVIAIKVMARDGGGRVAFCTVKIILTDENDNPPQFKASEYTVSIQSNVSKDSPVIQVLAYDADEGQNADVTYSVNPEDLVKDVIEINPVTGVVKVKDSLVGLENQTLDFFIKAQDGGPPHWNSLVPVRLQVVPKKVSLPKFSEPLYTFSAPEDLPEGSEIGIVKAVAAQDPVIYSLVRGTTPESNKDGVFSLDPDTGVIKVRKPMDHESTKLYQIDVMAHCLQNTDVVSLVSVNIQVGDVNDNRPVFEADPYKAVLTENMPVGTSVIQVTAIDKDTGRDGQVSYRLSADPGSNVHELFAIDSESGWITTLQELDCETCQTYHFHVVAYDHGQTIQLSSQALVQVSITDENDNAPRFASEEYRGSVVENSEPGELVATLKTLDADISEQNRQVTCYITEGDPLGQFGISQVGDEWRISSRKTLDREHTAKYLLRVTASDGKFQASVTVEIFVLDVNDNSPQCSQLLYTGKVHEDVFPGHFILKVSATDLDTDTNAQITYSLHGPGAHEFKLDPHTGELTTLTALDRERKDVFNLVAKATDGGGRSCQADITLHVEDVNDNAPRFFPSHCAVAVFDNTTVKTPVAVVFARDPDQGANAQVVYSLPDSAEGHFSIDATTGVIRLEKPLQVRPQAPLELTVRASDLGTPIPLSTLGTVTVSVVGLEDYLPVFLNTEHSVQVPEDAPPGTEVLQLATLTRPGAEKTGYRVVSGNEQGRFRLDARTGILYVNASLDFETSPKYFLSIECSRKSSSSLSDVTTVMVNITDVNEHRPQFPQDPYSTRVLENALVGDVILTVSATDEDGPLNSDITYSLIGGNQLGHFTIHPKKGELQVAKALDREQASSYSLKLRATDSGQPPLHEDTDIAIQVADVNDNPPRFFQLNYSTTVQENSPIGSKVLQLILSDPDSPENGPPYSFRITKGNNGSAFRVTPDGWLVTAEGLSRRAQEWYQLQIQASDSGIPPLSSLTSVRVHVTEQSHYAPSALPLEIFITVGEDEFQGGMVGKIHATDRDPQDTLTYSLAEEETLGRHFSVGAPDGKIIAAQGLPRGHYSFNVTVSDGTFTTTAGVHVYVWHVGQEALQQAMWMGFYQLTPEELVSDHWRNLQRFLSHKLDIKRANIHLASLQPAEAVAGVDVLLVFEGHSGTFYEFQELASIITHSAKEMEHSVGVQMRSAMPMVPCQGPTCQGQICHNTVHLDPKVGPTYSTARLSILTPRHHLQRSCSCNGTATRFSGQSYVRYRAPAARNWHIHFYLKTLQPQAILLFTNETASVSLKLASGVPQLEYHCLGGFYGNLSSQRHVNDHEWHSILVEEMDASIRLMVDSMGNTSLVVPENCRGLRPERHLLLGGLILLHSSSNVSQGFEGCLDAVVVNEEALDLLAPGKTVAGLLETQALTQCCLHSDYCSQNTCLNGGKCSWTHGAGYVCKCPPQFSGKHCEQGRENCTFAPCLEGGTCILSPKGASCNCPHPYTGDRCEMEARGCSEGHCLVTPEIQRGDWGQQELLIITVAVAFIIISTVGLLFYCRRCKSHKPVAMEDPDLLARSVGVDTQAMPAIELNPLSASSCNNLNQPEPSKASVPNELVTFGPNSKQRPVVCSVPPRLPPAAVPSHSDNEPVIKRTWSSEEMVYPGGAMVWPPTYSRNERWEYPHSEVTQGPLPPSAHRHSTPVVMPEPNGLYGGFPFPLEMENKRAPLPPRYSNQNLEDLMPSRPPSPRERLVAPCLNEYTAISYYHSQFRQGGGGPCLADGGYKGVGMRLSRAGPSYAVCEVEGAPLAGQGQPRVPPNYEGSDMVESDYGSCEEVMF,4349,"479,317",Chain (1); Compositional bias (1); Disulfide bond (7); Domain (35); Glycosylation (38); Natural variant (25); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 3912..3944;  /evidence=""ECO:0000250""; DISULFID 3951..3962;  /evidence=""ECO:0000250""; DISULFID 3956..3972;  /evidence=""ECO:0000250""; DISULFID 3974..3983;  /evidence=""ECO:0000250""; DISULFID 3990..4001;  /evidence=""ECO:0000250""; DISULFID 3995..4010;  /evidence=""ECO:0000250""; DISULFID 4012..4021;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P20138,Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33),MPLLLLLPLLWAGALAMDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTHRPKILIPGTLEPGHSKNLTCSVSWACEQGTPPIFSWLSAAPTSLGPRTTHSSVLIITPRPQDHGTNLTCQVKFAGAGVTTERTIQLNVTYVPQNPTTGIFPGDGSGKQETRAGVVHGAIGGAGVTALLALCLCLIFFIVKTHRRKAARTAVGRNDTHPTTGSASPKHQKKSKLHGPTETSSCSGAAPTVEMDEELHYASLNFHGMNPSKDTSTEYSEVRTQ,364,"39,825",Alternative sequence (2); Beta strand (18); Binding site (2); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (5); Helix (4); Modified residue (2); Motif (2); Mutagenesis (5); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 36..169;  /evidence=""ECO:0000269|Ref.18""; DISULFID 41..101;  /evidence=""ECO:0000269|Ref.18""; DISULFID 163..212;  /evidence=""ECO:0000269|Ref.18""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P20963,T-cell surface glycoprotein CD3 zeta chain (T-cell receptor T3 zeta chain) (CD antigen CD247),MKWKALFTAAILQAQLPITEAQSFGLLDPKLCYLLDGILFIYGVILTALFLRVKFSRSADAPAYQQGQNQLYNELNLGRREEYDVLDKRRGRDPEMGGKPQRRKNPQEGLYNELQKDKMAEAYSEIGMKGERRRGKGHDGLYQGLSTATKDTYDALHMQALPPR,164,"18,696",Alternative sequence (1); Chain (1); Domain (3); Helix (3); Modified residue (8); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,SIGNAL 1..21
Q9HBB8,Cadherin-related family member 5 (Mu-protocadherin) (Mucin and cadherin-like protein) (Mucin-like protocadherin) (MLPCDH),MGSWALLWPPLLFTGLLVRPPGTMAQAQYCSVNKDIFEVEENTNVTEPLVDIHVPEGQEVTLGALSTPFAFRIQGNQLFLNVTPDYEEKSLLEAQLLCQSGGTLVTQLRVFVSVLDVNDNAPEFPFKTKEIRVEEDTKVNSTVIPETQLQAEDRDKDDILFYTLQEMTAGASDYFSLVSVNRPALRLDRPLDFYERPNMTFWLLVRDTPGENVEPSHTATATLVLNVVPADLRPPWFLPCTFSDGYVCIQAQYHGAVPTGHILPSPLVLRPGPIYAEDGDRGINQPIIYSIFRGNVNGTFIIHPDSGNLTVARSVPSPMTFLLLVKGQQADLARYSVTQVTVEAVAAAGSPPRFPQRLYRGTVARGAGAGVVVKDAAAPSQPLRIQAQDPEFSDLNSAITYRITNHSHFRMEGEVVLTTTTLAQAGAFYAEVEAHNTVTSGTATTVIEIQVSEQEPPSTDVPPSPEAGGTTGPWTSTTSEVPRPPEPSQGPSTTSSGGGTGPHPPSGTTLRPPTSSTPGGPPGAENSTSHQPATPGGDTAQTPKPGTSQPMPPGVGTSTSHQPATPSGGTAQTPEPGTSQPMPPSMGTSTSHQPATPGGGTAQTPEAGTSQPMPPGMGTSTSHQPTTPGGGTAQTPEPGTSQPMPLSKSTPSSGGGPSEDKRFSVVDMAALGGVLGALLLLALLGLAVLVHKHYGPRLKCCCGKAPEPQPQGFDNQAFLPDHKANWAPVPSPTHDPKPAEAPMPAEPAPPGPASPGGAPEPPAAARAGGSPTAVRSILTKERRPEGGYKAVWFGEDIGTEADVVVLNAPTLDVDGASDSGSGDEGEGAGRGGGPYDAPGGDDSYI,845,"88,223",Alternative sequence (2); Beta strand (14); Chain (1); Domain (4); Erroneous gene model prediction (1); Erroneous initiation (1); Frameshift (2); Glycosylation (8); Helix (2); Modified residue (5); Mutagenesis (2); Natural variant (5); Region (2); Repeat (4); Sequence caution (2); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q15375,Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11),MVFQTRYPSWIILCYIWLLRFAHTGEAQAAKEVLLLDSKAQQTELEWISSPPNGWEEISGLDENYTPIRTYQVCQVMEPNQNNWLRTNWISKGNAQRIFVELKFTLRDCNSLPGVLGTCKETFNLYYYETDYDTGRNIRENLYVKIDTIAADESFTQGDLGERKMKLNTEVREIGPLSKKGFYLAFQDVGACIALVSVKVYYKKCWSIIENLAIFPDTVTGSEFSSLVEVRGTCVSSAEEEAENAPRMHCSAEGEWLVPIGKCICKAGYQQKGDTCEPCGRGFYKSSSQDLQCSRCPTHSFSDKEGSSRCECEDGYYRAPSDPPYVACTRPPSAPQNLIFNINQTTVSLEWSPPADNGGRNDVTYRILCKRCSWEQGECVPCGSNIGYMPQQTGLEDNYVTVMDLLAHANYTFEVEAVNGVSDLSRSQRLFAAVSITTGQAAPSQVSGVMKERVLQRSVELSWQEPEHPNGVITEYEIKYYEKDQRERTYSTVKTKSTSASINNLKPGTVYVFQIRAFTAAGYGNYSPRLDVATLEEATGKMFEATAVSSEQNPVIIIAVVAVAGTIILVFMVFGFIIGRRHCGYSKADQEGDEELYFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNSLKTPLGTCSRPISPLLDQNTPDFTTFCSVGEWLQAIKMERYKDNFTAAGYNSLESVARMTIEDVMSLGITLVGHQKKIMSSIQTMRAQMLHLHGTGIQV,998,"112,097",Active site (1); Alternative sequence (6); Beta strand (22); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Erroneous initiation (1); Glycosylation (2); Helix (22); Modified residue (4); Motif (1); Natural variant (6); Nucleotide binding (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q96P31,Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c),MLLWLLLLILTPGREQSGVAPKAVLLLNPPWSTAFKGEKVALICSSISHSLAQGDTYWYHDEKLLKIKHDKIQITEPGNYQCKTRGSSLSDAVHVEFSPDWLILQALHPVFEGDNVILRCQGKDNKNTHQKVYYKDGKQLPNSYNLEKITVNSVSRDNSKYHCTAYRKFYILDIEVTSKPLNIQVQELFLHPVLRASSSTPIEGSPMTLTCETQLSPQRPDVQLQFSLFRDSQTLGLGWSRSPRLQIPAMWTEDSGSYWCEVETVTHSIKKRSLRSQIRVQRVPVSNVNLEIRPTGGQLIEGENMVLICSVAQGSGTVTFSWHKEGRVRSLGRKTQRSLLAELHVLTVKESDAGRYYCAADNVHSPILSTWIRVTVRIPVSHPVLTFRAPRAHTVVGDLLELHCESLRGSPPILYRFYHEDVTLGNSSAPSGGGASFNLSLTAEHSGNYSCDADNGLGAQHSHGVSLRVTVPVSRPVLTLRAPGAQAVVGDLLELHCESLRGSFPILYWFYHEDDTLGNISAHSGGGASFNLSLTTEHSGNYSCEADNGLGAQHSKVVTLNVTGTSRNRTGLTAAGITGLVLSILVLAAAAALLHYARARRKPGGLSATGTSSHSPSECQEPSSSRPSRIDPQEPTHSKPLAPMELEPMYSNVNPGDSNPIYSQIWSIQHTKENSANCPMMHQEHEELTVLYSELKKTHPDDSAGEASSRGRAHEEDDEENYENVPRVLLASDH,734,"80,856",Alternative sequence (9); Chain (1); Disulfide bond (6); Domain (6); Glycosylation (1); Modified residue (4); Motif (4); Mutagenesis (4); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 120..163;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 211..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 309..358;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 404..451;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 497..544;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q96LA6,Fc receptor-like protein 1 (FcR-like protein 1) (FcRL1) (Fc receptor homolog 1) (FcRH1) (IFGP family protein 1) (hIFGP1) (Immune receptor translocation-associated protein 5) (CD antigen CD307a),MLPRLLLLICAPLCEPAELFLIASPSHPTEGSPVTLTCKMPFLQSSDAQFQFCFFRDTRALGPGWSSSPKLQIAAMWKEDTGSYWCEAQTMASKVLRSRRSQINVHRVPVADVSLETQPPGGQVMEGDRLVLICSVAMGTGDITFLWYKGAVGLNLQSKTQRSLTAEYEIPSVRESDAEQYYCVAENGYGPSPSGLVSITVRIPVSRPILMLRAPRAQAAVEDVLELHCEALRGSPPILYWFYHEDITLGSRSAPSGGGASFNLSLTEEHSGNYSCEANNGLGAQRSEAVTLNFTVPTGARSNHLTSGVIEGLLSTLGPATVALLFCYGLKRKIGRRSARDPLRSLPSPLPQEFTYLNSPTPGQLQPIYENVNVVSGDEVYSLAYYNQPEQESVAAETLGTHMEDKVSLDIYSRLRKANITDVDYEDAM,429,"46,936",Alternative sequence (6); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (1); Motif (5); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 134..183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 229..276;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
P37023,Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I),MTLGSPRKGLLMLLMALVTQGDPVKPSRGPLVTCTCESPHCKGPTCRGAWCTVVLVREEGRHPQEHRGCGNLHRELCRGRPTEFVNHYCCDSHLCNHNVSLVLEATQPPSEQPGTDGQLALILGPVLALLALVALGVLGLWHVRRRQEKQRGLHSELGESSLILKASEQGDSMLGDLLDSDCTTGSGSGLPFLVQRTVARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISNSPEKPKVIQ,503,"56,124",Active site (1); Beta strand (17); Binding site (1); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (1); Helix (14); Modified residue (3); Mutagenesis (1); Natural variant (102); Nucleotide binding (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 34..51;  /evidence=""ECO:0000244|PDB:2LCR, ECO:0000244|PDB:4FAO, ECO:0000269|PubMed:22718755, ECO:0000269|PubMed:22799562""; DISULFID 36..41;  /evidence=""ECO:0000244|PDB:2LCR, ECO:0000244|PDB:4FAO, ECO:0000269|PubMed:22718755, ECO:0000269|PubMed:22799562""; DISULFID 46..69;  /evidence=""ECO:0000244|PDB:2LCR, ECO:0000244|PDB:4FAO, ECO:0000269|PubMed:22718755, ECO:0000269|PubMed:22799562""; DISULFID 77..89;  /evidence=""ECO:0000244|PDB:2LCR, ECO:0000244|PDB:4FAO, ECO:0000269|PubMed:22718755, ECO:0000269|PubMed:22799562""; DISULFID 90..95;  /evidence=""ECO:0000244|PDB:2LCR, ECO:0000244|PDB:4FAO, ECO:0000269|PubMed:22718755, ECO:0000269|PubMed:22799562""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UKQ2,"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)",MLQGLLPVSLLLSVAVSAIKELPGVKKYEVVYPIRLHPLHKREAKEPEQQEQFETELKYKMTINGKIAVLYLKKNKNLLAPGYTETYYNSTGKEITTSPQIMDDCYYQGHILNEKVSDASISTCRGLRGYFSQGDQRYFIEPLSPIHRDGQEHALFKYNPDEKNYDSTCGMDGVLWAHDLQQNIALPATKLVKLKDRKVQEHEKYIEYYLVLDNGEFKRYNENQDEIRKRVFEMANYVNMLYKKLNTHVALVGMEIWTDKDKIKITPNASFTLENFSKWRGSVLSRRKRHDIAQLITATELAGTTVGLAFMSTMCSPYSVGVVQDHSDNLLRVAGTMAHEMGHNFGMFHDDYSCKCPSTICVMDKALSFYIPTDFSSCSRLSYDKFFEDKLSNCLFNAPLPTDIISTPICGNQLVEMGEDCDCGTSEECTNICCDAKTCKIKATFQCALGECCEKCQFKKAGMVCRPAKDECDLPEMCNGKSGNCPDDRFQVNGFPCHHGKGHCLMGTCPTLQEQCTELWGPGTEVADKSCYNRNEGGSKYGYCRRVDDTLIPCKANDTMCGKLFCQGGSDNLPWKGRIVTFLTCKTFDPEDTSQEIGMVANGTKCGDNKVCINAECVDIEKAYKSTNCSSKCKGHAVCDHELQCQCEEGWIPPDCDDSSVVFHFSIVVGVLFPMAVIFVVVAMVIRHQSSREKQKKDQRPLSTTGTRPHKQKRKPQMVKAVQPQEMSQMKPHVYDLPVEGNEPPASFHKDTNALPPTVFKDNPVSTPKDSNPKA,775,"87,148",Active site (1); Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Metal binding (4); Motif (1); Natural variant (12); Propeptide (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 315..394;  /evidence=""ECO:0000250""; DISULFID 354..378;  /evidence=""ECO:0000250""; DISULFID 356..361;  /evidence=""ECO:0000250""; DISULFID 465..485;  /evidence=""ECO:0000250""; DISULFID 629..639;  /evidence=""ECO:0000250""; DISULFID 633..645;  /evidence=""ECO:0000250""; DISULFID 647..656;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P51693,Amyloid-like protein 1 (APLP) (APLP-1) [Cleaved into: C30],MGPASPAARGLSRRPGQPPLPLLLPLLLLLLRAQPAIGSLAGGSPGAAEAPGSAQVAGLCGRLTLHRDLRTGRWEPDPQRSRRCLRDPQRVLEYCRQMYPELQIARVEQATQAIPMERWCGGSRSGSCAHPHHQVVPFRCLPGEFVSEALLVPEGCRFLHQERMDQCESSTRRHQEAQEACSSQGLILHGSGMLLPCGSDRFRGVEYVCCPPPGTPDPSGTAVGDPSTRSWPPGSRVEGAEDEEEEESFPQPVDDYFVEPPQAEEEEETVPPPSSHTLAVVGKVTPTPRPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSELEAPAPGGSSEDKGGLQPPDSKDDTPMTLPKGSTEQDAASPEKEKMNPLEQYERKVNASVPRGFPFHSSEIQRDELAPAGTGVSREAVSGLLIMGAGGGSLIVLSMLLLRRKKPYGAISHGVVEVDPMLTLEEQQLRELQRHGYENPTYRFLEERP,650,"72,176",Alternative sequence (1); Beta strand (2); Chain (1); Compositional bias (2); Disulfide bond (6); Domain (2); Glycosylation (6); Helix (7); Motif (3); Mutagenesis (3); Peptide (1); Region (10); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 60..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 95..140;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 120..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 156..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 167..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 181..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01217""","SIGNAL 1..38;  /evidence=""ECO:0000255"""
O75871,Carcinoembryonic antigen-related cell adhesion molecule 4 (Carcinoembryonic antigen CGM7) (Non-specific cross-reacting antigen W236),MGPPSAAPRGGHRPWQGLLITASLLTFWHPPTTVQFTIEALPSSAAEGKDVLLLACNISETIQAYYWHKGKTAEGSPLIAGYITDIQANIPGAAYSGRETVYPNGSLLFQNITLEDAGSYTLRTINASYDSDQATGQLHVHQNNVPGLPVGAVAGIVTGVLVGVALVAALVCFLLLSRTGRASIQRDLREQPPPASTPGHGPSHRSTFSAPLPSPRTATPIYEELLYSDANIYCQIDHKADVVS,244,"25,909",Chain (1); Domain (1); Glycosylation (4); Motif (1); Mutagenesis (2); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q4KMG0,Cell adhesion molecule-related/down-regulated by oncogenes,MHPDLGPLCTLLYVTLTILCSSVSSDLAPYFTSEPLSAVQKLGGPVVLHCSAQPVTTRISWLHNGKTLDGNLEHVKIHQGTLTILSLNSSLLGYYQCLANNSIGAIVSGPATVSVAVLGDFGSSTKHVITAEEKSAGFIGCRVPESNPKAEVRYKIRGKWLEHSTENYLILPSGNLQILNVSLEDKGSYKCAAYNPVTHQLKVEPIGRKLLVSRPSSDDVHILHPTHSQALAVLSRSPVTLECVVSGVPAPQVYWLKDGQDIAPGSNWRRLYSHLATDSVDPADSGNYSCMAGNKSGDVKYVTYMVNVLEHASISKGLQDQIVSLGATVHFTCDVHGNPAPNCTWFHNAQPIHPSARHLTAGNGLKISGVTVEDVGMYQCVADNGIGFMHSTGRLEIENDGGFKPVIITAPVSAKVADGDFVTLSCNASGLPVPVIRWYDSHGLITSHPSQVLRSKSRKSQLSRPEGLNLEPVYFVLSQAGASSLHIQAVTQEHAGKYICEAANEHGTTQAEASLMVVPFETNTKAETVTLPDAAQNDDRSKRDGSETGLLSSFPVKVHPSAVESAPEKNASGISVPDAPIILSPPQTHTPDTYNLVWRAGKDGGLPINAYFVKYRKLDDGVGMLGSWHTVRVPGSENELHLAELEPSSLYEVLMVARSAAGEGQPAMLTFRTSKEKTASSKNTQASSPPVGIPKYPVVSEAANNNFGVVLTDSSRHSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFKVEYKRMRTSNWLVAAEDIPPSKLSVEVRSLEPGSTYKFRVIAINHYGESFRSSASRPYQVVGFPNRFSSRPITGPHIAYTEAVSDTQIMLKWTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQCFNEGGESEFSNVMICETKVKRVPGASEYPVKDLSTPPNSLGSGGNVGPATSPARSSDMLYLIVGCVLGVMVLILMVFIAMCLWKNRQQNTIQKYDPPGYLYQGSDMNGQMVDYTTLSGASQINGNVHGGFLTNGGLSSGYSHLHHKVPNAVNGIVNGSLNGGLYSGHSNSLTRTHVDFEHPHHLVNGGGMYTAVPQIDPLECVNCRNCRNNNRCFTKTNSTFSSSPPPVVPVVAPYPQDGLEMKPLSHVKVPVCLTSAVPDCGQLPEESVKDNVEPVPTQRTCCQDIVNDVSSDGSEDPAEFSRGQEGMINLRIPDHLQLAKSCVWEGDSCAHSETEINIVSWNALILPPVPEGCAEKTMWSPPGIPLDSPTEVLQQPRET,1287,"139,147",Alternative sequence (1); Beta strand (8); Chain (1); Disulfide bond (5); Domain (8); Glycosylation (9); Helix (2); Natural variant (10); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 141..191;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 243..290;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 333..380;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 426..500;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q96F05,Uncharacterized protein C11orf24 (Protein DM4E3),MWTALVLIWIFSLSLSESHAASNDPRNFVPNKMWKGLVKRNASVETVDNKTSEDVTMAAASPVTLTKGTSAAHLNSMEVTTEDTSRTDVSEPATSGGAADGVTSIAPTAVASSTTAASITTAASSMTVASSAPTTAASSTTVASIAPTTAASSMTAASSTPMTLALPAPTSTSTGRTPSTTATGHPSLSTALAQVPKSSALPRTATLATLATRAQTVATTANTSSPMSTRPSPSKHMPSDTAASPVPPMRPQAQGPISQVSVDQPVVNTTNKSTPMPSNTTPEPAPTPTVVTTTKAQAREPTASPVPVPHTSPIPEMEAMSPTTQPSPMPYTQRAAGPGTSQAPEQVETEATPGTDSTGPTPRSSGGTKMPATDSCQPSTQGQYMVVTTEPLTQAVVDKTLLLVVLLLGVTLFITVLVLFALQAYESYKKKDYTQVDYLINGMYADSEM,449,"46,101",Chain (1); Compositional bias (1); Glycosylation (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P55899,IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor),MGVPRPQPWALGLLLFLLPGSLGAESHLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWVWENQVSWYWEKETTDLRIKEKLFLEAFKALGGKGPYTLQGLLGCELGPDNTSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSCPHRLREHLERGRGNLEWKEPPSMRLKARPSSPGFSVLTCSAFSFYPPELQLRFLRNGLAAGTGQGDFGPNSDGSFHASSSLTVKSGDEHHYCCIVQHAGLAQPLRVELESPAKSSVLVVGIVIGVLLLTAAAVGGALLWRRMRSGLPAPWISLRGDDTGVLLPTPGEAQDADLKDVNVIPATA,365,"39,743",Beta strand (21); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (8); Modified residue (1); Region (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 119..182;  /evidence=""ECO:0000244|PDB:1EXU, ECO:0000244|PDB:4N0F, ECO:0000244|PDB:4N0U, ECO:0000244|PDB:5BJT, ECO:0000269|PubMed:10933786, ECO:0000269|PubMed:24469444, ECO:0000269|PubMed:28330995""; DISULFID 221..275;  /evidence=""ECO:0000244|PDB:1EXU, ECO:0000244|PDB:4N0F, ECO:0000244|PDB:4N0U, ECO:0000244|PDB:5BJT, ECO:0000269|PubMed:10933786, ECO:0000269|PubMed:24469444, ECO:0000269|PubMed:28330995""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
Q15822,Neuronal acetylcholine receptor subunit alpha-2,MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETEDRLFKHLFRGYNRWARPVPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQEWSDYKLRWNPTDFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWVPPAIYKSSCSIDVTFFPFDQQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWESGEWAIVNATGTYNSKKYDCCAEIYPDVTYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSDCGEKITLCISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPSTHTMPHWVRGALLGCVPRWLLMNRPPPPVELCHPLRLKLSPSYHWLESNVDAEEREVVVEEEDRWACAGHVAPSVGTLCSHGHLHSGASGPKAEALLQEGELLLSPHMQKALEGVHYIADHLRSEDADSSVKEDWKYVAMVIDRIFLWLFIIVCFLGTIGLFLPPFLAGMI,529,"59,765",Alternative sequence (1); Beta strand (14); Chain (1); Disulfide bond (2); Glycosylation (3); Helix (2); Mutagenesis (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (7),"DISULFID 183..197;  /evidence=""ECO:0000250""; DISULFID 247..248;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P13688,Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a),MGHLSAPLHRVRVPWQGLLLTASLLTFWNPPTTAQLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWINNQSLPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVTYGPDTPTISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQELFIPNITVNNSGSYTCHANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASKTTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSINPVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALPQENGLSPGAIAGIVIGVVALVALIAVALACFLHFGKTGRASDQRDLTEHKPSVSNHTQDHSNDPPNKMNEVTYSTLNFEAQQPTQPTSASPSLTATEIIYSEVKKQ,526,"57,560",Alternative sequence (14); Beta strand (9); Chain (1); Disulfide bond (3); Domain (4); Erroneous gene model prediction (1); Glycosylation (20); Helix (2); Modified residue (4); Mutagenesis (6); Natural variant (4); Region (5); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 167..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 259..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 348..396;  /evidence=""ECO:0000250|UniProtKB:P31809, ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..34
P40198,Carcinoembryonic antigen-related cell adhesion molecule 3 (Carcinoembryonic antigen CGM1) (CD antigen CD66d),MGPPSASPHRECIPWQGLLLTASLLNFWNPPTTAKLTIESMPLSVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNSLIVGYVIGTQQATPGAAYSGRETIYTNASLLIQNVTQNDIGFYTLQVIKSDLVNEEATGQFHVYQENAPGLPVGAVAGIVTGVLVGVALVAALVCFLLLAKTGRTSIQRDLKEQQPQALAPGRGPSHSSAFSMSPLSTAQAPLPNPRTAASIYEELLKHDTNIYCRMDHKAEVAS,252,"27,091",Alternative sequence (2); Beta strand (9); Chain (1); Domain (1); Glycosylation (2); Helix (2); Mutagenesis (2); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),,"SIGNAL 1..34;  /evidence=""ECO:0000250"""
P00533,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA,1210,"134,277",Active site (1); Alternative sequence (6); Beta strand (75); Binding site (2); Chain (1); Cross-link (6); Disulfide bond (25); Domain (1); Glycosylation (13); Helix (39); Lipidation (2); Modified residue (23); Mutagenesis (37); Natural variant (40); Nucleotide binding (2); Region (1); Repeat (2); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (15),"DISULFID 31..58;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 157..187;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 190..199;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 194..207;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 215..223;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 219..231;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 232..240;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 236..248;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 251..260;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 264..291;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 295..307;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD""; DISULFID 311..326;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3G5V, ECO:0000244|PDB:3G5Y, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 329..333;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD""; DISULFID 337..362;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2U, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3C09, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3P0Y, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRL, ECO:0000244|PDB:4KRM, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5SX4, ECO:0000244|PDB:5SX5, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000244|PDB:6B3S, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 470..499;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2U, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3C09, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3P0Y, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRL, ECO:0000244|PDB:4KRM, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5SX4, ECO:0000244|PDB:5SX5, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000244|PDB:6B3S""; DISULFID 506..515;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2U, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3P0Y, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRL, ECO:0000244|PDB:4KRM, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5SX4, ECO:0000244|PDB:5SX5, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000244|PDB:6B3S, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 510..523;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1MOX, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2U, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3C09, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3P0Y, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRL, ECO:0000244|PDB:4KRM, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5SX4, ECO:0000244|PDB:5SX5, ECO:0000244|PDB:5WB7, ECO:0000244|PDB:5WB8, ECO:0000244|PDB:5XWD, ECO:0000244|PDB:6B3S, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 526..535;  /evidence=""ECO:0000244|PDB:1IVO, ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRL, ECO:0000244|PDB:4KRM, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 539..555;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 558..571;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 562..579;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 582..591;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 595..617;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 620..628;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRO, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UIP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""; DISULFID 624..636;  /evidence=""ECO:0000244|PDB:1NQL, ECO:0000244|PDB:1YY9, ECO:0000244|PDB:3B2V, ECO:0000244|PDB:3NJP, ECO:0000244|PDB:3QWQ, ECO:0000244|PDB:4KRP, ECO:0000244|PDB:4UV7, ECO:0000244|PDB:5XWD, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:15837620, ECO:0000269|PubMed:20837704""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:6328312, ECO:0000269|Ref.16"""
Q5JX71,Protein FAM209A,MWTLKSSLVLLLCLTCSYAFMFSSLRQKTSEPQGKVQYGEHFRIRQNLPEHTQGWLGSKWLWLLFVVVPFVILQCQRDSEKNKEQSPPGLRGGQLHSPLKKKRNASPNKDCAFNTLMELEVELMKFVSKVRNLKRAMATGSGSNLRLRKSEMPADPYHVTICEIWGEESSS,171,"19,603",Chain (1); Coiled coil (1); Natural variant (5); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8IZP9,Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6),MVFSVRQCGHVGRTEEVLLTFKIFLVIICLHVVLVTSLEEDTDNSSLSPPPAKLSVVSFAPSSNGTPEVETTSLNDVTLSLLPSNETEKTKITIVKTFNASGVKPQRNICNLSSICNDSAFFRGEIMFQYDKESTVPQNQHITNGTLTGVLSLSELKRSELNKTLQTLSETYFIMCATAEAQSTLNCTFTIKLNNTMNACAVIAALERVKIRPMEHCCCSVRIPCPSSPEELEKLQCDLQDPIVCLADHPRGPPFSSSQSIPVVPRATVLSQVPKATSFAEPPDYSPVTHNVPSPIGEIQPLSPQPSAPIASSPAIDMPPQSETISSPMPQTHVSGTPPPVKASFSSPTVSAPANVNTTSAPPVQTDIVNTSSISDLENQVLQMEKALSLGSLEPNLAGEMINQVSRLLHSPPDMLAPLAQRLLKVVDDIGLQLNFSNTTISLTSPSLALAVIRVNASSFNTTTFVAQDPANLQVSLETQAPENSIGTITLPSSLMNNLPAHDMELASRVQFNFFETPALFQDPSLENLSLISYVISSSVANLTVRNLTRNVTVTLKHINPSQDELTVRCVFWDLGRNGGRGGWSDNGCSVKDRRLNETICTCSHLTSFGVLLDLSRTSVLPAQMMALTFITYIGCGLSSIFLSVTLVTYIAFEKIRRDYPSKILIQLCAALLLLNLVFLLDSWIALYKMQGLCISVAVFLHYFLLVSFTWMGLEAFHMYLALVKVFNTYIRKYILKFCIVGWGVPAVVVTIILTISPDNYGLGSYGKFPNGSPDDFCWINNNAVFYITVVGYFCVIFLLNVSMFIVVLVQLCRIKKKKQLGAQRKTSIQDLRSIAGLTFLLGITWGFAFFAWGPVNVTFMYLFAIFNTLQGFFIFIFYCVAKENVRKQWRRYLCCGKLRLAENSDWSKTATNGLKKQTVNQGVSSSSNSLQSSSNSTNSTTLLVNNDCSVHASGNGNASTERNGVSFSVQNGDVCLHDFTGKQHMFNEKEDSCNGKGRMALRRTSKRGSLHFIEQM,1017,"111,593",Alternative sequence (9); Chain (1); Compositional bias (3); Domain (1); Glycosylation (21); Modified residue (1); Natural variant (4); Sequence conflict (18); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..37;  /evidence=""ECO:0000255"""
Q86TY3,Armadillo-like helical domain-containing protein 4,MRGPIVLHICLAFCSLLLFSVATQCLAFPKIERRREIAHVHAEKGQSDKMNTDDLENSSVTSKQTPQLVVSEDPMMMSAVPSATSLNKAFSINKETQPGQAGLMQTERPGVSTPTESGVPSAEEVFGSSQPERISPESGLAKAMLTIAITATPSLTVDEKEELLTSTNFQPIVEEITETTKGFLKYMDNQSFATESQEGVGLGHSPSSYVNTKEMLTTNPKTEKFEADTDHRTTSFPGAESTAGSEPGSLTPDKEKPSQMTADNTQAAATKQPLETSEYTLSVEPETDSLLGAPEVTVSVSTAVPAASALSDEWDDTKLESVSRIRTPKLGDNEETQVRTEMSQTAQVSHEGMEGGQPWTEAAQVALGLPEGETHTGTALLIAHGNERSPAFTDQSSFTPTSLMEDMKVSIVNLLQSTGDFTESTKENDALFFLETTVSVSVYESEADQLLGNTMKDIITQEMTTAVQEPDATLSMVTQEQVATLELIRDSGKTEEEKEDPSPVSDVPGVTQLSRRWEPLATTISTTVVPLSFEVTPTVEEQMDTVTGPNEEFTPVLGSPVTPPGIMVGEPSISPALPALEASSERRTVVPSITRVNTAASYGLDQLESEEGQEDEDEEDEEDEDEEEEDEEEDEEDKDADSLDEGLDGDTELPGFTLPGITSQEPGLEEGNMDLLEGATYQVPDALEWEQQNQGLVRSWMEKLKDKAGYMSGMLVPVGVGIAGALFILGALYSIKVMNRRRRNGFKRHKRKQREFNSMQDRVMLLADSSEDEF,774,"84,173",Alternative sequence (3); Chain (1); Compositional bias (2); Glycosylation (2); Modified residue (2); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P27037,Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA),MGAAAKLAFAVFLISCSSGAILGRSETQECLFFNANWEKDRTNQTGVEPCYGDKDKRRHCFATWKNISGSIEIVKQGCWLDDINCYDRTDCVEKKDSPEVYFCCCEGNMCNEKFSYFPEMEVTQPTSNPVTPKPPYYNILLYSLVPLMLIAGIVICAFWVYRHHKMAYPPVLVPTQDPGPPPPSPLLGLKPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNIITTEDIVTVVTMVTNVDFPPKESSL,513,"57,848",Active site (1); Alternative sequence (1); Beta strand (18); Binding site (1); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Helix (15); Natural variant (3); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 30..60;  /evidence=""ECO:0000250|UniProtKB:P27038""; DISULFID 50..78;  /evidence=""ECO:0000250|UniProtKB:P27038""; DISULFID 85..104;  /evidence=""ECO:0000250|UniProtKB:P27038""; DISULFID 91..103;  /evidence=""ECO:0000250|UniProtKB:P27038""; DISULFID 105..110;  /evidence=""ECO:0000250|UniProtKB:P27038""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q99467,CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180),MAFDVSCFFWVVLFSAGCKVITSWDQMCIEKEANKTYNCENLGLSEIPDTLPNTTEFLEFSFNFLPTIHNRTFSRLMNLTFLDLTRCQINWIHEDTFQSHHQLSTLVLTGNPLIFMAETSLNGPKSLKHLFLIQTGISNLEFIPVHNLENLESLYLGSNHISSIKFPKDFPARNLKVLDFQNNAIHYISREDMRSLEQAINLSLNFNGNNVKGIELGAFDSTIFQSLNFGGTPNLSVIFNGLQNSTTQSLWLGTFEDIDDEDISSAMLKGLCEMSVESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKGLPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNLTYCFLDTSNQHLLAGLPVLRHLNLKGNHFQDGTITKTNLLQTVGSLEVLILSSCGLLSIDQQAFHSLGKMSHVDLSHNSLTCDSIDSLSHLKGIYLNLAANSINIISPRLLPILSQQSTINLSHNPLDCTCSNIHFLTWYKENLHKLEGSEETTCANPPSLRGVKLSDVKLSCGITAIGIFFLIVFLLLLAILLFFAVKYLLRWKYQHI,661,"74,179",Beta strand (30); Chain (1); Domain (2); Glycosylation (11); Helix (13); Natural variant (7); Repeat (19); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (16),,"SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
P29317,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),MELQAARACFALLWGCALAAAAAAQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSPEGSGNLAVIGGVAVGVVLLLVLAGVGFFIHRRRKNQRARQSPEDVYFSKSEQLKPLKTYVDPHTYEDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSGSEGVPFRTVSEWLESIKMQQYTEHFMAAGYTAIEKVVQMTNDDIKRIGVRLPGHQKRIAYSLLGLKDQVNTVGIPI,976,"108,266",Active site (1); Alternative sequence (2); Beta strand (51); Binding site (1); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (5); Glycosylation (2); Helix (29); Modified residue (15); Motif (1); Mutagenesis (4); Natural variant (10); Nucleotide binding (1); Region (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),DISULFID 70..188; DISULFID 105..115,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P21860,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),MRANDALQVLGLLFSLARGSEVGNSQAVCPGTLNGLSVTGDAENQYQTLYKLYERCEVVMGNLEIVLTGHNADLSFLQWIREVTGYVLVAMNEFSTLPLPNLRVVRGTQVYDGKFAIFVMLNYNTNSSHALRQLRLTQLTEILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNGRSCPPCHEVCKGRCWGPGSEDCQTLTKTICAPQCNGHCFGPNPNQCCHDECAGGCSGPQDTDCFACRHFNDSGACVPRCPQPLVYNKLTFQLEPNPHTKYQYGGVCVASCPHNFVVDQTSCVRACPPDKMEVDKNGLKMCEPCGGLCPKACEGTGSGSRFQTVDSSNIDGFVNCTKILGNLDFLITGLNGDPWHKIPALDPEKLNVFRTVREITGYLNIQSWPPHMHNFSVFSNLTTIGGRSLYNRGFSLLIMKNLNVTSLGFRSLKEISAGRIYISANRQLCYHHSLNWTKVLRGPTEERLDIKHNRPRRDCVAEGKVCDPLCSSGGCWGPGPGQCLSCRNYSRGGVCVTHCNFLNGEPREFAHEAECFSCHPECQPMEGTATCNGSGSDTCAQCAHFRDGPHCVSSCPHGVLGAKGPIYKYPDVQNECRPCHENCTQGCKGPELQDCLGQTLVLIGKTHLTMALTVIAGLVVIFMMLGGTFLYWRGRRIQNKRAMRRYLERGESIEPLDPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAEEDNLATTTLGSALSLPVGTLNRPRGSQSLLSPSSGYMPMNQGNLGESCQESAVSGSSERCPRPVSLHPMPRGCLASESSEGHVTGSEAELQEKVSMCRSRSRSRSPRPRGDSAYHSQRHSLLTPVTPLSPPGLEEEDVNGYVMPDTHLKGTPSSREGTLSSVGLSSVLGTEEEDEDEEYEYMNRRRRHSPPHPPRPSSLEELGYEYMDVGSDLSASLGSTQSCPLHPVPIMPTAGTTPDEDYEYMNRQRDGGGPGGDYAAMGACPASEQGYEEMRAFQGPGHQAPHVHYARLKTLRSLEATDSAFDNPDYWHSRLFPKANAQRT,1342,"148,098",Active site (1); Alternative sequence (6); Beta strand (61); Binding site (1); Chain (1); Disulfide bond (23); Domain (1); Glycosylation (10); Helix (32); Modified residue (2); Mutagenesis (2); Natural variant (15); Nucleotide binding (3); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (10),"DISULFID 29..56;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 156..183;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 186..194;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 190..202;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 210..218;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 214..226;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 227..235;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 231..243;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 246..255;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 259..286;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 290..301;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 305..320;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 323..327;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 500..509;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 504..517;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 520..529;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 533..549;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 552..565;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 556..573;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 576..585;  /evidence=""ECO:0000269|PubMed:12154198""; DISULFID 589..610;  /evidence=""ECO:0000250""; DISULFID 613..621;  /evidence=""ECO:0000250""; DISULFID 617..629;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q15884,Protein FAM189A2 (Protein X123),MILLVNLFVLLSVVCVLLNLAGFILGCQGAQFVSSVPRCDLVDLGEGKICFCCEEFQPAKCTDKENALKLFPVQPCSAVHLLLKKVLFALCALNALTTTVCLVAAALRYLQIFATRRSCIDESQISAEEAEDHGRIPDPDDFVPPVPPPSYFATFYSCTPRMNRRMVGPDVIPLPHIYGARIKGVEVFCPLDPPPPYEAVVSQMDQEQGSSFQMSEGSEAAVIPLDLGCTQVTQDGDIPNIPAEENASTSTPSSTLVRPIRSRRALPPLRTRSKSDPVLHPSEERAAPVLSCEAATQTERRLDLAAVTLRRGLRSRASRCRPRSLIDYKSYMDTKLLVARFLEQSSCTMTPDIHELVENIKSVLKSDEEHMEEAITSASFLEQIMAPLQPSTSRAHKLPSRRQPGLLHLQSCGDLHTFTPAGRPRAERRPRRVEAERPHSLIGVIRETVL,450,"49,703",Alternative sequence (3); Chain (1); Erroneous initiation (1); Modified residue (1); Natural variant (2); Sequence conflict (7); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q5JX69,Protein FAM209B,MWTLKSSLVLLLCLTCSYAFMFSSLRQKTSEPQGKVPCGEHFRIRQNLPEHTQGWLGSKWLWLLFAVVPFVILQCQRDSEKNKEQSPPGLRGFPFRTPLKKNQNASLYKDCVFNTLNELEVELLKFVSEVQNLKGAMATGSGSNLKLRRSEMPADPYHVTICKIWGEESSS,171,"19,499",Chain (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P19235,Erythropoietin receptor (EPO-R),MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPLELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTHKGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVGSEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGASAASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGLSDGPYSNPYENSLIPAAEPLPPSYVACS,508,"55,065",Alternative sequence (4); Beta strand (23); Chain (1); Cross-link (2); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (7); Modified residue (8); Motif (3); Mutagenesis (17); Natural variant (3); Region (1); Sequence conflict (3); Signal peptide (1); Site (6); Topological domain (2); Transmembrane (1); Turn (5),DISULFID 52..62; DISULFID 91..107,SIGNAL 1..24
Q16671,Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII),MLGSLGLWALLPTAVEAPPNRRTCVFFEAPGVRGSTKTLGELLDTGTELPRAIRCLYSRCCFGIWNLTQDRAQVEMQGCRDSDEPGCESLHCDPSPRAHPSPGSTLFTCSCGTDFCNANYSHLPPPGSPGTPGSQGPQAAPGESIWMALVLLGLFLLLLLLLGSIILALLQRKNYRVRGEPVPEPRPDSGRDWSVELQELPELCFSQVIREGGHAVVWAGQLQGKLVAIKAFPPRSVAQFQAERALYELPGLQHDHIVRFITASRGGPGRLLSGPLLVLELHPKGSLCHYLTQYTSDWGSSLRMALSLAQGLAFLHEERWQNGQYKPGIAHRDLSSQNVLIREDGSCAIGDLGLALVLPGLTQPPAWTPTQPQGPAAIMEAGTQRYMAPELLDKTLDLQDWGMALRRADIYSLALLLWEILSRCPDLRPDSSPPPFQLAYEAELGNTPTSDELWALAVQERRRPYIPSTWRCFATDPDGLRELLEDCWDADPEARLTAECVQQRLAALAHPQESHPFPESCPRGCPPLCPEDCTSIPAPTILPCRPQRSACHFSVQQGPCSRNPQPACTLSPV,573,"62,750",Active site (1); Alternative sequence (2); Binding site (1); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (2); Natural variant (10); Nucleotide binding (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 55..79;  /evidence=""ECO:0000250|UniProtKB:P37023""; DISULFID 92..109;  /evidence=""ECO:0000250|UniProtKB:P37023""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9BXJ7,Protein amnionless [Cleaved into: Soluble protein amnionless],MGVLGRVLLWLQLCALTQAVSKLWVPNTDFDVAANWSQNRTPCAGGAVEFPADKMVSVLVQEGHAVSDMLLPLDGELVLASGAGFGVSDVGSHLDCGAGEPAVFRDSDRFSWHDPHLWRSGDEAPGLFFVDAERVPCRHDDVFFPPSASFRVGLGPGASPVRVRSISALGRTFTRDEDLAVFLASRAGRLRFHGPGALSVGPEDCADPSGCVCGNAEAQPWICAALLQPLGGRCPQAACHSALRPQGQCCDLCGAVVLLTHGPAFDLERYRARILDTFLGLPQYHGLQVAVSKVPRSSRLREADTEIQVVLVENGPETGGAGRLARALLADVAENGEALGVLEATMRESGAHVWGSSAAGLAGGVAAAVLLALLVLLVAPPLLRRAGRLRWRRHEAAAPAGAPLGFRNPVFDVTASEELPLPRRLSLVPKAAADSTSHSYFVNPLFAGAEAEA,453,"47,754",Beta strand (18); Chain (2); Disulfide bond (6); Domain (1); Glycosylation (1); Helix (11); Mutagenesis (4); Natural variant (3); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 43..96;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""; DISULFID 137..213;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""; DISULFID 205..211;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""; DISULFID 223..249;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""; DISULFID 234..250;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""; DISULFID 239..253;  /evidence=""ECO:0000244|PDB:6GJE, ECO:0000269|PubMed:30523278""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:14576052"""
O75078,"Disintegrin and metalloproteinase domain-containing protein 11 (ADAM 11) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein) (MDC)",MRLLRRWAFAALLLSLLPTPGLGTQGPAGALRWGGLPQLGGPGAPEVTEPSRLVRESSGGEVRKQQLDTRVRQEPPGGPPVHLAQVSFVIPAFNSNFTLDLELNHHLLSSQYVERHFSREGTTQHSTGAGDHCYYQGKLRGNPHSFAALSTCQGLHGVFSDGNLTYIVEPQEVAGPWGAPQGPLPHLIYRTPLLPDPLGCREPGCLFAVPAQSAPPNRPRLRRKRQVRRGHPTVHSETKYVELIVINDHQLFEQMRQSVVLTSNFAKSVVNLADVIYKEQLNTRIVLVAMETWADGDKIQVQDDLLETLARLMVYRREGLPEPSDATHLFSGRTFQSTSSGAAYVGGICSLSHGGGVNEYGNMGAMAVTLAQTLGQNLGMMWNKHRSSAGDCKCPDIWLGCIMEDTGFYLPRKFSRCSIDEYNQFLQEGGGSCLFNKPLKLLDPPECGNGFVEAGEECDCGSVQECSRAGGNCCKKCTLTHDAMCSDGLCCRRCKYEPRGVSCREAVNECDIAETCTGDSSQCPPNLHKLDGYYCDHEQGRCYGGRCKTRDRQCQVLWGHAAADRFCYEKLNVEGTERGSCGRKGSGWVQCSKQDVLCGFLLCVNISGAPRLGDLVGDISSVTFYHQGKELDCRGGHVQLADGSDLSYVEDGTACGPNMLCLDHRCLPASAFNFSTCPGSGERRICSHHGVCSNEGKCICQPDWTGKDCSIHNPLPTSPPTGETERYKGPSGTNIIIGSIAGAVLVAAIVLGGTGWGFKNIRRGRSGGA,769,"83,418",Alternative sequence (4); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (4); Natural variant (1); Propeptide (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 349..433;  /evidence=""ECO:0000250""; DISULFID 392..417;  /evidence=""ECO:0000250""; DISULFID 394..401;  /evidence=""ECO:0000250""; DISULFID 503..523;  /evidence=""ECO:0000250""; DISULFID 677..692;  /evidence=""ECO:0000250""; DISULFID 686..698;  /evidence=""ECO:0000250""; DISULFID 700..709;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P35613,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),MAAALFVLLGFALLGTHGASGAAGFVQAPLSQQRWVGGSVELHCEAVGSPVPEIQWWFEGQGPNDTCSQLWDGARLDRVHIHATYHQHAASTISIDTLVEEDTGTYECRASNDPDRNHLTRAPRVKWVRAQAVVLVLEPGTVFTTVEDLGSKILLTCSLNDSATEVTGHRWLKGGVVLKEDALPGQKTEFKVDSDDQWGEYSCVFLPEPMGTANIQLHGPPRVKAVKSSEHINEGETAMLVCKSESVPPVTDWAWYKITDSEDKALMNGSESRFFVSSSQGRSELHIENLNMEADPGQYRCNGTSSKGSDQAIITLRVRSHLAALWPFLGIVAEVLVLVTIIFIYEKRRKPEDVLDDDDAGSAPLKSSGQHQNDKGKNVRQRNSS,385,"42,200",Alternative sequence (4); Beta strand (25); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (3); Glycosylation (3); Helix (4); Modified residue (2); Mutagenesis (16); Natural variant (5); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 44..108;  /evidence=""ECO:0000244|PDB:3QQN, ECO:0000244|PDB:3QR2, ECO:0000269|PubMed:21620857""; DISULFID 157..203;  /evidence=""ECO:0000244|PDB:3B5H, ECO:0000244|PDB:3I84, ECO:0000244|PDB:4U0Q, ECO:0000244|PDB:5X0T, ECO:0000269|PubMed:18430721, ECO:0000269|PubMed:19768682, ECO:0000269|PubMed:25132548, ECO:0000269|Ref.58""; DISULFID 242..301;  /evidence=""ECO:0000244|PDB:3B5H, ECO:0000244|PDB:4U0Q, ECO:0000269|PubMed:18430721, ECO:0000269|PubMed:25132548""",SIGNAL 1..21
O75309,Cadherin-16 (Kidney-specific cadherin) (Ksp-cadherin),MVPAWLWLLCVSVPQALPKAQPAELSVEVPENYGGNFPLYLTKLPLPREGAEGQIVLSGDSGKATEGPFAMDPDSGFLLVTRALDREEQAEYQLQVTLEMQDGHVLWGPQPVLVHVKDENDQVPHFSQAIYRARLSRGTRPGIPFLFLEASDRDEPGTANSDLRFHILSQAPAQPSPDMFQLEPRLGALALSPKGSTSLDHALERTYQLLVQVKDMGDQASGHQATATVEVSIIESTWVSLEPIHLAENLKVLYPHHMAQVHWSGGDVHYHLESHPPGPFEVNAEGNLYVTRELDREAQAEYLLQVRAQNSHGEDYAAPLELHVLVMDENDNVPICPPRDPTVSIPELSPPGTEVTRLSAEDADAPGSPNSHVVYQLLSPEPEDGVEGRAFQVDPTSGSVTLGVLPLRAGQNILLLVLAMDLAGAEGGFSSTCEVEVAVTDINDHAPEFITSQIGPISLPEDVEPGTLVAMLTAIDADLEPAFRLMDFAIERGDTEGTFGLDWEPDSGHVRLRLCKNLSYEAAPSHEVVVVVQSVAKLVGPGPGPGATATVTVLVERVMPPPKLDQESYEASVPISAPAGSFLLTIQPSDPISRTLRFSLVNDSEGWLCIEKFSGEVHTAQSLQGAQPGDTYTVLVEAQDTDEPRLSASAPLVIHFLKAPPAPALTLAPVPSQYLCTPRQDHGLIVSGPSKDPDLASGHGPYSFTLGPNPTVQRDWRLQTLNGSHAYLTLALHWVEPREHIIPVVVSHNAQMWQLLVRVIVCRCNVEGQCMRKVGRMKGMPTKLSAVGILVGTLVAIGIFLILIFTHWTMSRKKDPDQPADSVPLKATV,829,"89,923",Alternative sequence (3); Chain (1); Domain (6); Glycosylation (3); Modified residue (1); Natural variant (3); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8NFZ8,Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2),MGRARRFQWPLLLLWAAAAGPGAGQEVQTENVTVAEGGVAEITCRLHQYDGSIVVIQNPARQTLFFNGTRALKDERFQLEEFSPRRVRIRLSDARLEDEGGYFCQLYTEDTHHQIATLTVLVAPENPVVEVREQAVEGGEVELSCLVPRSRPAATLRWYRDRKELKGVSSSQENGKVWSVASTVRFRVDRKDDGGIIICEAQNQALPSGHSKQTQYVLDVQYSPTARIHASQAVVREGDTLVLTCAVTGNPRPNQIRWNRGNESLPERAEAVGETLTLPGLVSADNGTYTCEASNKHGHARALYVLVVYDPGAVVEAQTSVPYAIVGGILALLVFLIICVLVGMVWCSVRQKGSYLTHEASGLDEQGEAREAFLNGSDGHKRKEEFFI,388,"42,785",Chain (1); Disulfide bond (3); Domain (3); Erroneous gene model prediction (1); Glycosylation (3); Modified residue (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 145..199;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 245..291;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q86UP0,Cadherin-24,MWGLVRLLLAWLGGWGCMGRLAAPARAWAGSREHPGPALLRTRRSWVWNQFFVIEEYAGPEPVLIGKLHSDVDRGEGRTKYLLTGEGAGTVFVIDEATGNIHVTKSLDREEKAQYVLLAQAVDRASNRPLEPPSEFIIKVQDINDNPPIFPLGPYHATVPEMSNVGTSVIQVTAHDADDPSYGNSAKLVYTVLDGLPFFSVDPQTGVVRTAIPNMDRETQEEFLVVIQAKDMGGHMGGLSGSTTVTVTLSDVNDNPPKFPQSLYQFSVVETAGPGTLVGRLRAQDPDLGDNALMAYSILDGEGSEAFSISTDLQGRDGLLTVRKPLDFESQRSYSFRVEATNTLIDPAYLRRGPFKDVASVRVAVQDAPEPPAFTQAAYHLTVPENKAPGTLVGQISAADLDSPASPIRYSILPHSDPERCFSIQPEEGTIHTAAPLDREARAWHNLTVLATELGWSWGPERGWVPLLVAEWSAPAAPPQRSPVGSAVGIPQDSSAQASRVQVAIQTLDENDNAPQLAEPYDTFVCDSAAPGQLIQVIRALDRDEVGNSSHVSFQGPLGPDANFTVQDNRDGSASLLLPSRPAPPRHAPYLVPIELWDWGQPALSSTATVTVSVCRCQPDGSVASCWPEAHLSAAGLSTGALLAIITCVGALLALVVLFVALRRQKQEALMVLEEEDVRENIITYDDEGGGEEDTEAFDITALQNPDGAAPPAPGPPARRDVLPRARVSRQPRPPGPADVAQLLALRLREADEDPGVPPYDSVQVYGYEGRGSSCGSLSSLGSGSEAGGAPGPAEPLDDWGPLFRTLAELYGAKEPPAP,819,"87,752",Alternative sequence (3); Chain (1); Domain (5); Glycosylation (3); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
O95727,Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355),MWWRVLSLLAWFPLQEASLTNHTETITVEEGQTLTLKCVTSLRKNSSLQWLTPSGFTIFLNEYPALKNSKYQLLHHSANQLSITVPNVTLQDEGVYKCLHYSDSVSTKEVKVIVLATPFKPILEASVIRKQNGEEHVVLMCSTMRSKPPPQITWLLGNSMEVSGGTLHEFETDGKKCNTTSTLIIHTYGKNSTVDCIIRHRGLQGRKLVAPFRFEDLVTDEETASDALERNSLSSQDPQQPTSTVSVTEDSSTSEIDKEEKEQTTQDPDLTTEANPQYLGLARKKSGILLLTLVSFLIFILFIIVQLFIMKLRKAHVIWKKENEVSEHTLESYRSRSNNEETSSEEKNGQSSHPMRCMNYITKLYSEAKTKRKENVQHSKLEEKHIQVPESIV,393,"44,641",Alternative sequence (2); Beta strand (7); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (3); Helix (1); Motif (1); Mutagenesis (4); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..98;  /evidence=""ECO:0000244|PDB:3RBG, ECO:0000244|PDB:4H5S, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23583034, ECO:0000269|PubMed:23871486""; DISULFID 141..196;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q5JRM2,Uncharacterized protein CXorf66,MNLVICVLLLSIWKNNCMTTNQTNGSSTTGDKPVESMQTKLNYLRRNLLILVGIIIMVFVFICFCYLHYNCLSDDASKAGMVKKKGIAAKSSKTSFSEAKTASQCSPETQPMLSTADKSSDSSSPERASAQSSTEKLIRPSSLQKPSIPNSAGKLTRPSYPKRSSKSSCSKKLSKSSHLEKAHKKGSLEKLCKLDYACKLASSDKPVRPPQLFKPLYSSHPQNEISPSKPFGPQELAKPPKHFNPKRSVSLGRAALLSNSELAETCQPYKKKHLVAKTYRPLVNDISEAKEKNTQNLHVSSKVKSSSRSFRKLDSRNNAYGDHVNDSDTMKYYSEVDSDKVIIITCDRGYNQVTSEVTLND,361,"39,944",Chain (1); Compositional bias (1); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
O95264,5-hydroxytryptamine receptor 3B (5-HT3-B) (5-HT3B) (Serotonin receptor 3B),MLSSVMAPLWACILVAAGILATDTHHPQDSALYHLSKQLLQKYHKEVRPVYNWTKATTVYLDLFVHAILDVDAENQILKTSVWYQEVWNDEFLSWNSSMFDEIREISLPLSAIWAPDIIINEFVDIERYPDLPYVYVNSSGTIENYKPIQVVSACSLETYAFPFDVQNCSLTFKSILHTVEDVDLAFLRSPEDIQHDKKAFLNDSEWELLSVSSTYSILQSSAGGFAQIQFNVVMRRHPLVYVVSLLIPSIFLMLVDLGSFYLPPNCRARIVFKTSVLVGYTVFRVNMSNQVPRSVGSTPLIGHFFTICMAFLVLSLAKSIVLVKFLHDEQRGGQEQPFLCLRGDTDADRPRVEPRAQRAVVTESSLYGEHLAQPGTLKEVWSQLQSISNYLQTQDQTDQQEAEWLVLLSRFDRLLFQSYLFMLGIYTITLCSLWALWGGV,441,"50,292",Alternative sequence (1); Chain (1); Disulfide bond (1); Glycosylation (6); Mutagenesis (5); Natural variant (4); Region (1); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 155..169;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9NR16,Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b),MMLPQNSWHIDFGRCCCHQNLFSAVVTCILLLNSCFLISSFNGTDLELRLVNGDGPCSGTVEVKFQGQWGTVCDDGWNTTASTVVCKQLGCPFSFAMFRFGQAVTRHGKIWLDDVSCYGNESALWECQHREWGSHNCYHGEDVGVNCYGEANLGLRLVDGNNSCSGRVEVKFQERWGTICDDGWNLNTAAVVCRQLGCPSSFISSGVVNSPAVLRPIWLDDILCQGNELALWNCRHRGWGNHDCSHNEDVTLTCYDSSDLELRLVGGTNRCMGRVELKIQGRWGTVCHHKWNNAAADVVCKQLGCGTALHFAGLPHLQSGSDVVWLDGVSCSGNESFLWDCRHSGTVNFDCLHQNDVSVICSDGADLELRLADGSNNCSGRVEVRIHEQWWTICDQNWKNEQALVVCKQLGCPFSVFGSRRAKPSNEARDIWINSISCTGNESALWDCTYDGKAKRTCFRRSDAGVICSDKADLDLRLVGAHSPCYGRLEVKYQGEWGTVCHDRWSTRNAAVVCKQLGCGKPLHVFGMTYFKEASGPIWLDDVSCIGNESNIWDCEHSGWGKHNCVHREDVIVTCSGDATWGLRLVGGSNRCSGRLEVYFQGRWGTVCDDGWNSKAAAVVCSQLDCPSSIIGMGLGNASTGYGKIWLDDVSCDGDESDLWSCRNSGWGNNDCSHSEDVGVICSDASDMELRLVGGSSRCAGKVEVNVQGAVGILCANGWGMNIAEVVCRQLECGSAIRVSREPHFTERTLHILMSNSGCTGGEASLWDCIRWEWKQTACHLNMEASLICSAHRQPRLVGADMPCSGRVEVKHADTWRSVCDSDFSLHAANVLCRELNCGDAISLSVGDHFGKGNGLTWAEKFQCEGSETHLALCPIVQHPEDTCIHSREVGVVCSRYTDVRLVNGKSQCDGQVEINVLGHWGSLCDTHWDPEDARVLCRQLSCGTALSTTGGKYIGERSVRVWGHRFHCLGNESLLDNCQMTVLGAPPCIHGNTVSVICTGSLTQPLFPCLANVSDPYLSAVPEGSALICLEDKRLRLVDGDSRCAGRVEIYHDGFWGTICDDGWDLSDAHVVCQKLGCGVAFNATVSAHFGEGSGPIWLDDLNCTGMESHLWQCPSRGWGQHDCRHKEDAGVICSEFTALRLYSETETESCAGRLEVFYNGTWGSVGRRNITTAIAGIVCRQLGCGENGVVSLAPLSKTGSGFMWVDDIQCPKTHISIWQCLSAPWERRISSPAEETWITCEDRIRVRGGDTECSGRVEIWHAGSWGTVCDDSWDLAEAEVVCQQLGCGSALAALRDASFGQGTGTIWLDDMRCKGNESFLWDCHAKPWGQSDCGHKEDAGVRCSGQSLKSLNASSGHLALILSSIFGLLLLVLFILFLTWCRVQKQKHLPLRVSTRRRGSLEENLFHEMETCLKREDPHGTRTSDDTPNHGCEDASDTSLLGVLPASEATK,1453,"159,239",Alternative sequence (4); Beta strand (8); Chain (1); Disulfide bond (35); Domain (12); Glycosylation (17); Helix (3); Natural variant (5); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 73..137;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 86..147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 117..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 180..244;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 193..254;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 224..234;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 287..351;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 300..361;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 331..341;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 394..458;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 407..468;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 438..448;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 501..565;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 514..575;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 545..555;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 608..672;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 621..682;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 652..662;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 715..779;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 728..789;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 759..769;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 820..884;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 833..894;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 864..874;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 925..989;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 938..999;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 969..979;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1061..1125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1074..1135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1105..1115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1181..1242;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1212..1222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1271..1335;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1284..1345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 1315..1325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""","SIGNAL 1..40;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9H251,Cadherin-23 (Otocadherin),MGRHVATSCHVAWLLVLISGCWGQVNRLPFFTNHFFDTYLLISEDTPVGSSVTQLLAQDMDNDPLVFGVSGEEASRFFAVEPDTGVVWLRQPLDRETKSEFTVEFSVSDHQGVITRKVNIQVGDVNDNAPTFHNQPYSVRIPENTPVGTPIFIVNATDPDLGAGGSVLYSFQPPSQFFAIDSARGIVTVIRELDYETTQAYQLTVNATDQDKTRPLSTLANLAIIITDVQDMDPIFINLPYSTNIYEHSPPGTTVRIITAIDQDKGRPRGIGYTIVSGNTNSIFALDYISGVLTLNGLLDRENPLYSHGFILTVKGTELNDDRTPSDATVTTTFNILVIDINDNAPEFNSSEYSVAITELAQVGFALPLFIQVVDKDENLGLNSMFEVYLVGNNSHHFIISPTSVQGKADIRIRVAIPLDYETVDRYDFDLFANESVPDHVGYAKVKITLINENDNRPIFSQPLYNISLYENVTVGTSVLTVLATDNDAGTFGEVSYFFSDDPDRFSLDKDTGLIMLIARLDYELIQRFTLTIIARDGGGEETTGRVRINVLDVNDNVPTFQKDAYVGALRENEPSVTQLVRLRATDEDSPPNNQITYSIVSASAFGSYFDISLYEGYGVISVSRPLDYEQISNGLIYLTVMAMDAGNPPLNSTVPVTIEVFDENDNPPTFSKPAYFVSVVENIMAGATVLFLNATDLDRSREYGQESIIYSLEGSTQFRINARSGEITTTSLLDRETKSEYILIVRAVDGGVGHNQKTGIATVNITLLDINDNHPTWKDAPYYINLVEMTPPDSDVTTVVAVDPDLGENGTLVYSIQPPNKFYSLNSTTGKIRTTHAMLDRENPDPHEAELMRKIVVSVTDCGRPPLKATSSATVFVNLLDLNDNDPTFQNLPFVAEVLEGIPAGVSIYQVVAIDLDEGLNGLVSYRMPVGMPRMDFLINSSSGVVVTTTELDRERIAEYQLRVVASDAGTPTKSSTSTLTIHVLDVNDETPTFFPAVYNVSVSEDVPREFRVVWLNCTDNDVGLNAELSYFITGGNVDGKFSVGYRDAVVRTVVGLDRETTAAYMLILEAIDNGPVGKRHTGTATVFVTVLDVNDNRPIFLQSSYEASVPEDIPEGHSILQLKATDADEGEFGRVWYRILHGNHGNNFRIHVSNGLLMRGPRPLDRERNSSHVLIVEAYNHDLGPMRSSVRVIVYVEDINDEAPVFTQQQYSRLGLRETAGIGTSVIVVQATDRDSGDGGLVNYRILSGAEGKFEIDESTGLIITVNYLDYETKTSYMMNVSATDQAPPFNQGFCSVYITLLNELDEAVQFSNASYEAAILENLALGTEIVRVQAYSIDNLNQITYRFNAYTSTQAKALFKIDAITGVITVQGLVDREKGDFYTLTVVADDGGPKVDSTVKVYITVLDENDNSPRFDFTSDSAVSIPEDCPVGQRVATVKAWDPDAGSNGQVVFSLASGNIAGAFEIVTTNDSIGEVFVARPLDREELDHYILQVVASDRGTPPRKKDHILQVTILDINDNPPVIESPFGYNVSVNENVGGGTAVVQVRATDRDIGINSVLSYYITEGNKDMAFRMDRISGEIATRPAPPDRERQSFYHLVATVEDEGTPTLSATTHVYVTIVDENDNAPMFQQPHYEVLLDEGPDTLNTSLITIQALDLDEGPNGTVTYAIVAGNIVNTFRIDRHMGVITAAKELDYEISHGRYTLIVTATDQCPILSHRLTSTTTVLVNVNDINDNVPTFPRDYEGPFEVTEGQPGPRVWTFLAHDRDSGPNGQVEYSIMDGDPLGEFVISPVEGVLRVRKDVELDRETIAFYNLTICARDRGMPPLSSTMLVGIRVLDINDNDPVLLNLPMNITISENSPVSSFVAHVLASDADSGCNARLTFNITAGNRERAFFINATTGIVTVNRPLDRERIPEYKLTISVKDNPENPRIARRDYDLLLIFLSDENDNHPLFTKSTYQAEVMENSPAGTPLTVLNGPILALDADQDIYAVVTYQLLGAQSGLFDINSSTGVVTVRSGVIIDREAFSPPILELLLLAEDIGLLNSTAHLLITILDDNDNRPTFSPATLTVHLLENCPPGFSVLQVTATDEDSGLNGELVYRIEAGAQDRFLIHLVTGVIRVGNATIDREEQESYRLTVVATDRGTVPLSGTAIVTILIDDINDSRPEFLNPIQTVSVLESAEPGTVIANITAIDHDLNPKLEYHIVGIVAKDDTDRLVPNQEDAFAVNINTGSVMVKSPMNRELVATYEVTLSVIDNASDLPERSVSVPNAKLTVNVLDVNDNTPQFKPFGITYYMERILEGATPGTTLIAVAAVDPDKGLNGLVTYTLLDLVPPGYVQLEDSSAGKVIANRTVDYEEVHWLNFTVRASDNGSPPRAAEIPVYLEIVDINDNNPIFDQPSYQEAVFEDVPVGTIILTVTATDADSGNFALIEYSLGDGESKFAINPTTGDIYVLSSLDREKKDHYILTALAKDNPGDVASNRRENSVQVVIQVLDVNDCRPQFSKPQFSTSVYENEPAGTSVITMMATDQDEGPNGELTYSLEGPGVEAFHVDMDSGLVTTQRPLQSYEKFSLTVVATDGGEPPLWGTTMLLVEVIDVNDNRPVFVRPPNGTILHIREEIPLRSNVYEVYATDKDEGLNGAVRYSFLKTAGNRDWEFFIIDPISGLIQTAQRLDRESQAVYSLILVASDLGQPVPYETMQPLQVALEDIDDNEPLFVRPPKGSPQYQLLTVPEHSPRGTLVGNVTGAVDADEGPNAIVYYFIAAGNEEKNFHLQPDGCLLVLRDLDREREAIFSFIVKASSNRSWTPPRGPSPTLDLVADLTLQEVRVVLEDINDQPPRFTKAEYTAGVATDAKVGSELIQVLALDADIGNNSLVFYSILAIHYFRALANDSEDVGQVFTMGSMDGILRTFDLFMAYSPGYFVVDIVARDLAGHNDTAIIGIYILRDDQRVKIVINEIPDRVRGFEEEFIHLLSNITGAIVNTDNVQFHVDKKGRVNFAQTELLIHVVNRDTNRILDVDRVIQMIDENKEQLRNLFRNYNVLDVQPAISVRLPDDMSALQMAIIVLAILLFLAAMLFVLMNWYYRTVHKRKLKAIVAGSAGNRGFIDIMDMPNTNKYSFDGANPVWLDPFCRNLELAAQAEHEDDLPENLSEIADLWNSPTRTHGTFGREPAAVKPDDDRYLRAAIQEYDNIAKLGQIIREGPIKGSLLKVVLEDYLRLKKLFAQRMVQKASSCHSSISELIQTELDEEPGDHSPGQGSLRFRHKPPVELKGPDGIHVVHGSTGTLLATDLNSLPEEDQKGLGRSLETLTAAEATAFERNARTESAKSTPLHKLRDVIMETPLEITEL,3354,"369,494",Alternative sequence (11); Beta strand (41); Chain (1); Domain (27); Glycosylation (41); Helix (12); Natural variant (126); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9H9P2,Chondrolectin (Transmembrane protein MT75),MSRVVSLLLGAALLCGHGAFCRRVVSGQKVCFADFKHPCYKMAYFHELSSRVSFQEARLACESEGGVLLSLENEAEQKLIESMLQNLTKPGTGISDGDFWIGLWRNGDGQTSGACPDLYQWSDGSNSQYRNWYTDEPSCGSEKCVVMYHQPTANPGLGGPYLYQWNDDRCNMKHNYICKYEPEINPTAPVEKPYLTNQPGDTHQNVVVTEAGIIPNLIYVVIPTIPLLLLILVAFGTCCFQMLHKSKGRTKTSPNQSTLWISKSTRKESGMEV,273,"30,431",Alternative sequence (3); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 61..178;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 144..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q08722,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),MWPLVAALLLGSACCGSAQLLFNKTKSVEFTFCNDTVVIPCFVTNMEAQNTTEVYVKWKFKGRDIYTFDGALNKSTVPTDFSSAKIEVSQLLKGDASLKMDKSDAVSHTGNYTCEVTELTREGETIIELKYRVVSWFSPNENILIVIFPIFAILLFWGQFGIKTLKYRSGGMDEKTIALLVAGLVITVIVIVGAILFVPGEYSLKNATGLGLIVTSTGILILLHYYVFSTAIGLTSFVIAILVIQVIAYILAVVGLSLCIAACIPMHGPLLISGLSILALAQLLGLVYMKFVASNQKTIQPPRKAVEEPLNAFKESKGMMNDE,323,"35,214",Alternative sequence (4); Beta strand (9); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (6); Helix (5); Modified residue (2); Signal peptide (1); Topological domain (6); Transmembrane (5),"DISULFID 33..263;  /evidence=""ECO:0000269|PubMed:11454874""; DISULFID 41..114;  /evidence=""ECO:0000269|PubMed:18657508""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P06126,T-cell surface glycoprotein CD1a (T-cell surface antigen T6/Leu-6) (hTa1 thymocyte antigen) (CD antigen CD1a),MLFLLLPLLAVLPGDGNADGLKEPLSFHVTWIASFYNHSWKQNLVSGWLSDLQTHTWDSNSSTIVFLCPWSRGNFSNEEWKELETLFRIRTIRSFEGIRRYAHELQFEYPFEIQVTGGCELHSGKVSGSFLQLAYQGSDFVSFQNNSWLPYPVAGNMAKHFCKVLNQNQHENDITHNLLSDTCPRFILGLLDAGKAHLQRQVKPEAWLSHGPSPGPGHLQLVCHVSGFYPKPVWVMWMRGEQEQQGTQRGDILPSADGTWYLRATLEVAAGEAADLSCRVKHSSLEGQDIVLYWEHHSSVGFIILAVIVPLLLLIGLALWFRKRCFC,327,"37,077",Beta strand (15); Binding site (2); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (9); Natural variant (3); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 119..183;  /evidence=""ECO:0000244|PDB:4X6C, ECO:0000269|PubMed:25642819""; DISULFID 223..278;  /evidence=""ECO:0000244|PDB:1ONQ, ECO:0000244|PDB:1XZ0, ECO:0000244|PDB:4X6C, ECO:0000269|PubMed:12833155, ECO:0000269|PubMed:15723809, ECO:0000269|PubMed:25642819""",SIGNAL 1..16
Q9Y2G8,DnaJ homolog subfamily C member 16,MEVRKLSISWQFLIVLVLILQILSALDFDPYRVLGVSRTASQADIKKAYKKLAREWHPDKNKDPGAEDKFIQISKAYEILSNEEKRSNYDQYGDAGENQGYQKQQQQREYRFRHFHENFYFDESFFHFPFNSERRDSIDEKYLLHFSHYVNEVVPDSFKKPYLIKITSDWCFSCIHIEPVWKEVIQELEELGVGIGVVHAGYERRLAHHLGAHSTPSILGIINGKISFFHNAVVRENLRQFVESLLPGNLVEKVTNKNYVRFLSGWQQENKPHVLLFDQTPIVPLLYKLTAFAYKDYLSFGYVYVGLRGTEEMTRRYNINIYAPTLLVFKEHINRPADVIQARGMKKQIIDDFITRNKYLLAARLTSQKLFHELCPVKRSHRQRKYCVVLLTAETTKLSKPFEAFLSFALANTQDTVRFVHVYSNRQQEFADTLLPDSEAFQGKSAVSILERRNTAGRVVYKTLEDPWIGSESDKFILLGYLDQLRKDPALLSSEAVLPDLTDELAPVFLLRWFYSASDYISDCWDSIFHNNWREMMPLLSLIFSALFILFGTVIVQAFSDSNDERESSPPEKEEAQEKTGKTEPSFTKENSSKIPKKGFVEVTELTDVTYTSNLVRLRPGHMNVVLILSNSTKTSLLQKFALEVYTFTGSSCLHFSFLSLDKHREWLEYLLEFAQDAAPIPNQYDKHFMERDYTGYVLALNGHKKYFCLFKPQKTVEEEEAIGSCSDVDSSLYLGESRGKPSCGLGSRPIKGKLSKLSLWMERLLEGSLQRFYIPSWPELD,782,"90,591",Alternative sequence (1); Chain (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q19T08,Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2),MGTAGAMQLCWVILGFLLFRGHNSQPTMTQTSSSQGGLGGLSLTTEPVSSNPGYIPSSEANRPSHLSSTGTPGAGVPSSGRDGGTSRDTFQTVPPNSTTMSLSMREDATILPSPTSETVLTVAAFGVISFIVILVVVVIILVGVVSLRFKCRKSKESEDPQKPGSSGLSESCSTANGEKDSITLISMKNINMNNGKQSLSAEKVL,205,"21,295",Chain (1); Compositional bias (1); Modified residue (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q8N3J6,Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2),MIWKRSAVLRFYSVCGLLLQGSQGQFPLTQNVTVVEGGTAILTCRVDQNDNTSLQWSNPAQQTLYFDDKKALRDNRIELVRASWHELSISVSDVSLSDEGQYTCSLFTMPVKTSKAYLTVLGVPEKPQISGFSSPVMEGDLMQLTCKTSGSKPAADIRWFKNDKEIKDVKYLKEEDANRKTFTVSSTLDFRVDRSDDGVAVICRVDHESLNATPQVAMQVLEIHYTPSVKIIPSTPFPQEGQPLILTCESKGKPLPEPVLWTKDGGELPDPDRMVVSGRELNILFLNKTDNGTYRCEATNTIGQSSAEYVLIVHDVPNTLLPTTIIPSLTTATVTTTVAITTSPTTSATTSSIRDPNALAGQNGPDHALIGGIVAVVVFVTLCSIFLLGRYLARHKGTYLTNEAKGAEDAPDADTAIINAEGSQVNAEEKKEYFI,435,"47,554",Alternative sequence (5); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (3); Glycosylation (3); Modified residue (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..203;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 248..296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P28906,Hematopoietic progenitor cell antigen CD34 (CD antigen CD34),MLVRRGARAGPRMPRGWTALCLLSLLPSGFMSLDNNGTATPELPTQGTFSNVSTNVSYQETTTPSTLGSTSLHPVSQHGNEATTNITETTVKFTSTSVITSVYGNTNSSVQSQTSVISTVFTTPANVSTPETTLKPSLSPGNVSDLSTTSTSLATSPTKPYTSSSPILSDIKAEIKCSGIREVKLTQGICLEQNKTSSCAEFKKDRGEGLARVLCGEEQADADAGAQVCSLLLAQSEVRPQCLLLVLANRTEISSKLQLMKKHQSDLKKLGILDFTEQDVASHQSYSQKTLIALVTSGALLAVLGITGYFLMNRRSWSPTGERLGEDPYYTENGGGQGYSSGPGTSPEAQGKASVNRGAQENGTGQATSRNGHSARQHVVADTEL,385,"40,716",Alternative sequence (2); Chain (1); Erroneous initiation (1); Glycosylation (9); Modified residue (3); Natural variant (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:1370171, ECO:0000269|PubMed:2462139"""
P15391,B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19),MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGELFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSLNQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMWVMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYLIFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSGLGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEFYENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLSPHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGPDPAWGGGGRMGTWSTR,556,"61,128",Alternative sequence (1); Beta strand (18); Chain (1); Disulfide bond (3); Domain (2); Frameshift (1); Glycosylation (5); Helix (2); Modified residue (7); Mutagenesis (9); Natural variant (2); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..261;  /evidence=""ECO:0000244|PDB:6AL5, ECO:0000269|PubMed:29490423""; DISULFID 97..200;  /evidence=""ECO:0000244|PDB:6AL5, ECO:0000269|PubMed:29490423""; DISULFID 134..173;  /evidence=""ECO:0000244|PDB:6AL5, ECO:0000269|PubMed:29490423""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q96JP9,Cadherin-related family member 1 (Photoreceptor cadherin) (prCAD) (Protocadherin-21),MRRCRWAALALGLLRLCLAQANFAPHFFDNGVGSTNGNMALFSLPEDTPVGSHVYTLNGTDPEGDPISYHISFDPSTRSVFSVDPTFGNITLVEELDREREDEIEAIISISDGLNLVAEKVVILVTDANDEAPRFIQEPYVALVPEDIPAGSIIFKVHAVDRDTGSGGSVTYFLQNLHSPFAVDRHSGVLRLQAGATLDYERSRTHYITVVAKDGGGRLHGADVVFSATTTVTVNVEDVQDMAPVFVGTPYYGYVYEDTLPGSEVLKVVAMDGDRGKPNRILYSLVNGNDGAFEINETSGAISITQSPAQLQREVYELHVQVTEMSPAGSPAAQATVPVTIRIVDLNNHPPTFYGESGPQNRFELSMNEHPPQGEILRGLKITVNDSDQGANAKFNLQLVGPRGIFRVVPQTVLNEAQVTIIVENSAAIDFEKSKVLTFKLLAVEVNTPEKFSSTADVVIQLLDTNDNVPKFDSLYYVARIPENAPGGSSVVAVTAVDPDTGPWGEVKYSTYGTGADLFLIHPSTGLIYTQPWASLDAEATARYNFYVKAEDMEGKYSVAEVFITLLDVNDHPPQFGKSVQKKTMVLGTPVKIEAIDEDAEEPNNLVDYSITHAEPANVFDINSHTGEIWLKNSIRSLDALHNITPGRDCLWSLEVQAKDRGSPSFSTTALLKIDITDAETLSRSPMAAFLIQTKDNPMKAVGVLAGTMATVVAITVLISTATFWRNKKSNKVLPMRRVLRKRPSPAPRTIRIEWLKSKSTKAATKFMLKEKPPNENCNNNSPESSLLPRAPALPPPPSVAPSTGAAQWTVPTVSGSLTPQPTQPPPKPKTMGSPVQSTLISELKQKFEKKSVHNKAYF,859,"93,595",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (7); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8WYK1,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),MDSLPRLTSVLTLLFSGLWHLGLTATNYNCDDPLASLLSPMAFSSSSDLTGTHSPAQLNWRVGTGGWSPADSNAQQWLQMDLGNRVEITAVATQGRYGSSDWVTSYSLMFSDTGRNWKQYKQEDSIWTFAGNMNADSVVHHKLLHSVRARFVRFVPLEWNPSGKIGMRVEVYGCSYKSDVADFDGRSSLLYRFNQKLMSTLKDVISLKFKSMQGDGVLFHGEGQRGDHITLELQKGRLALHLNLGDSKARLSSSLPSATLGSLLDDQHWHSVLIERVGKQVNFTVDKHTQHFRTKGETDALDIDYELSFGGIPVPGKPGTFLKKNFHGCIENLYYNGVNIIDLAKRRKHQIYTGNVTFSCSEPQIVPITFVNSSGSYLLLPGTPQIDGLSVSFQFRTWNKDGLLLSTELSEGSGTLLLSLEGGILRLVIQKMTERVAEILTGSNLNDGLWHSVSINARRNRITLTLDDEAAPPAPDSTWVQIYSGNSYYFGGCPDNLTDSQCLNPIKAFQGCMRLIFIDNQPKDLISVQQGSLGNFSDLHIDLCSIKDRCLPNYCEHGGSCSQSWTTFYCNCSDTSYTGATCHNSIYEQSCEVYRHQGNTAGFFYIDSDGSGPLGPLQVYCNITEDKIWTSVQHNNTELTRVRGANPEKPYAMALDYGGSMEQLEAVIDGSEHCEQEVAYHCRRSRLLNTPDGTPFTWWIGRSNERHPYWGGSPPGVQQCECGLDESCLDIQHFCNCDADKDEWTNDTGFLSFKDHLPVTQIVITDTDRSNSEAAWRIGPLRCYGDRRFWNAVSFYTEASYLHFPTFHAEFSADISFFFKTTALSGVFLENLGIKDFIRLEISSPSEITFAIDVGNGPVELVVQSPSLLNDNQWHYVRAERNLKETSLQVDNLPRSTRETSEEGHFRLQLNSQLFVGGTSSRQKGFLGCIRSLHLNGQKMDLEERAKVTSGVRPGCPGHCSSYGSICHNGGKCVEKHNGYLCDCTNSPYEGPFCKKEVSAVFEAGTSVTYMFQEPYPVTKNISLSSSAIYTDSAPSKENIALSFVTTQAPSLLLFINSSSQDFVVVLLCKNGSLQVRYHLNKEETHVFTIDADNFANRRMHHLKINREGRELTIQMDQQLRLSYNFSPEVEFRVIRSLTLGKVTENLGLDSEVAKANAMGFAGCMSSVQYNHIAPLKAALRHATVAPVTVHGTLTESSCGFMVDSDVNAVTTVHSSSDPFGKTDEREPLTNAVRSDSAVIGGVIAVVIFIIFCIIGIMTRFLYQHKQSHRTSQMKEKEYPENLDSSFRNEIDLQNTVSECKREYFI,1306,"145,623",Chain (1); Compositional bias (1); Disulfide bond (11); Domain (8); Glycosylation (5); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 30..174;  /evidence=""ECO:0000250""; DISULFID 329..360;  /evidence=""ECO:0000250""; DISULFID 512..544;  /evidence=""ECO:0000250""; DISULFID 550..561;  /evidence=""ECO:0000250""; DISULFID 555..570;  /evidence=""ECO:0000250""; DISULFID 572..582;  /evidence=""ECO:0000250""; DISULFID 929..956;  /evidence=""ECO:0000250""; DISULFID 960..973;  /evidence=""ECO:0000250""; DISULFID 967..982;  /evidence=""ECO:0000250""; DISULFID 984..994;  /evidence=""ECO:0000250""; DISULFID 1164..1199;  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q86T13,C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5),MRPAFALCLLWQALWPGPGGGEHPTADRAGCSASGACYSLHHATMKRQAAEEACILRGGALSTVRAGAELRAVLALLRAGPGPGGGSKDLLFWVALERRRSHCTLENEPLRGFSWLSSDPGGLESDTLQWVEEPQRSCTARRCAVLQATGGVEPAGWKEMRCHLRANGYLCKYQFEVLCPAPRPGAASNLSYRAPFQLHSAALDFSPPGTEVSALCRGQLPISVTCIADEIGARWDKLSGDVLCPCPGRYLRAGKCAELPNCLDDLGGFACECATGFELGKDGRSCVTSGEGQPTLGGTGVPTRRPPATATSPVPQRTWPIRVDEKLGETPLVPEQDNSVTSIPEIPRWGSQSTMSTLQMSLQAESKATITPSGSVISKFNSTTSSATPQAFDSSSAVVFIFVSTAVVVLVILTMTVLGLVKLCFHESPSSQPRKESMGPPGLESDPEPAALGSSSAHCTNNGVKVGDCDLRDRAEGALLAESPLGSSDA,490,"51,636",Chain (1); Disulfide bond (1); Domain (2); Glycosylation (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 143..162;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
P01911,"HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1) (HLA-DRB1)",MVCLKLPGGSCMTALTVTLMVLSSPLALSGDTRPRFLWQPKRECHFFNGTERVRFLDRYFYNQEESVRFDSDVGEFRAVTELGRPDAEYWNSQKDILEQARAAVDTYCRHNYGVVESFTVQRRVQPKVTVYPSKTQPLQHHNLLVCSVSGFYPGSIEVRWFLNGQEEKAGMVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSVTSPLTVEWRARSESAQSKMLSGVGGFVLGLLFLGAGLFIYFRNQKGHSGLQPTGFLS,266,"29,966",Beta strand (15); Chain (1); Cross-link (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (5); Mutagenesis (8); Natural variant (85); Region (2); Signal peptide (1); Site (5); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 44..108;  /evidence=""ECO:0000269|PubMed:24190431, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:7477400, ECO:0000269|PubMed:9782128""; DISULFID 146..202;  /evidence=""ECO:0000269|PubMed:24190431, ECO:0000269|PubMed:31619516, ECO:0000269|PubMed:7477400, ECO:0000269|PubMed:9782128""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:6600932, ECO:0000269|PubMed:6947956"""
P13762,"HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4)",MVCLKLPGGSCMAALTVTLTVLSSPLALAGDTQPRFLEQAKCECHFLNGTERVWNLIRYIYNQEEYARYNSDLGEYQAVTELGRPDAEYWNSQKDLLERRRAEVDTYCRYNYGVVESFTVQRRVQPKVTVYPSKTQPLQHHNLLVCSVNGFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSMMSPLTVQWSARSESAQSKMLSGVGGFVLGLLFLGTGLFIYFRNQKGHSGLQPTGLLS,266,"29,941",Chain (1); Cross-link (1); Disulfide bond (2); Domain (1); Glycosylation (1); Mutagenesis (3); Natural variant (6); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..202;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..29
P60507,Endogenous retrovirus group FC1 Env polyprotein (Envelope polyprotein) (Fc1env) (HERV-F(c)1_Xq21.33 provirus ancestral Env polyprotein) (HERV-Fc1env) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MARPSPLCLLLLLTLLTPIVPSNSLLTEPPFRWRFYLHETWTQGNRLSTVTLATVDCQPHGCQAQVTFNFTSFKSVLRGWSNPTICFVYDQTHSNCRDYWVDTNGGCPYAYCRMHVTQLHTAKKLQHTYRLTSDGRTTYFLTIPDPWDSRWVSGVTGRLYRWPTDSYPVGKLRIFLTYIRVIPQVLSNLKDQADNIKHQEEVINTLVQSHPKADMVTYDDKAEAGPFSWITLVRHGARLVNMAGLVNLSHCFLCTALSQPPLVAVPLPQAFNTSGNHTAHPSGVFSEQVPLFRDPLQPQFPFCYTTPNSSWCNQTYSGSLSNLSAPAGGYFWCNFTLTKHLNISSNNTLSRNLCLPISLVPRLTLYSEAELSSLVNPPMRQKRAVFPPLVIGVSLTSSLVASGLGTGAIVHFISSSQDLSIKLQMAIEASAESLASLQRQITSVAKVAMQNRRALDLLTADKGGTCMFLGEECCYYINESGLVETSLLTLDKIRDGLHRPSSTPNYGGGWWQSPLTTWIIPFISPILIICLLLLIAPCVLKFIKNRISEVSRVTVNQMLLHPYSRLPTSEDHYDDALTQQEAAR,584,"65,248",Chain (3); Disulfide bond (1); Glycosylation (11); Motif (3); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 466..473;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9Y3Q7,"Disintegrin and metalloproteinase domain-containing protein 18 (ADAM 18) (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III) (tMDC III)",MFLLLALLTELGRLQAHEGSEGIFLHVTVPRKIKSNDSEVSERKMIYIITIDGQPYTLHLGKQSFLPQNFLVYTYNETGSLHSVSPYFMMHCHYQGYAAEFPNSFVTLSICSGLRGFLQFENISYGIEPVESSARFEHIIYQMKNNDPNVSILAVNYSHIWQKDQPYKVPLNSQIKNLSKLLPQYLEIYIIVEKALYDYMGSEMMAVTQKIVQVIGLVNTMFTQFKLTVILSSLELWSNENQISTSGDADDILQRFLAWKRDYLILRPHDIAYLLVYRKHPKYVGATFPGTVCNKSYDAGIAMYPDAIGLEGFSVIIAQLLGLNVGLTYDDITQCFCLRATCIMNHEAVSASGRKIFSNCSMHDYRYFVSKFETKCLQKLSNLQPLHQNQPVCGNGILESNEECDCGNKNECQFKKCCDYNTCKLKGSVKCGSGPCCTSKCELSIAGTPCRKSIDPECDFTEYCNGTSSNCVPDTYALNGRLCKLGTAYCYNGQCQTTDNQCAKIFGKGAQGAPFACFKEVNSLHERSENCGFKNSQPLPCERKDVLCGKLACVQPHKNANKSDAQSTVYSYIQDHVCVSIATGSSMRSDGTDNAYVADGTMCGPEMYCVNKTCRKVHLMGYNCNATTKCKGKGICNNFGNCQCFPGHRPPDCKFQFGSPGGSIDDGNFQKSGDFYTEKGYNTHWNNWFILSFCIFLPFFIVFTTVIFKRNEISKSCNRENAEYNRNSSVVSESDDVGH,739,"82,856",Alternative sequence (3); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (12); Natural variant (6); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 293..376;  /evidence=""ECO:0000250""; DISULFID 335..360;  /evidence=""ECO:0000250""; DISULFID 337..342;  /evidence=""ECO:0000250""; DISULFID 450..471;  /evidence=""ECO:0000250""; DISULFID 624..636;  /evidence=""ECO:0000250""; DISULFID 630..642;  /evidence=""ECO:0000250""; DISULFID 644..653;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
O95490,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),MVSSGCRMRSLWFIIVISFLPNTEGFSRAALPFGLVRRELSCEGYSIDLRCPGSDVIMIESANYGRTDDKICDADPFQMENTDCYLPDAFKIMTQRCNNRTQCIVVTGSDVFPDPCPGTYKYLEVQYECVPYIFVCPGTLKAIVDSPCIYEAEQKAGAWCKDPLQAADKIYFMPWTPYRTDTLIEYASLEDFQNSRQTTTYKLPNRVDGTGFVVYDGAVFFNKERTRNIVKFDLRTRIKSGEAIINYANYHDTSPYRWGGKTDIDLAVDENGLWVIYATEQNNGMIVISQLNPYTLRFEATWETVYDKRAASNAFMICGVLYVVRSVYQDNESETGKNSIDYIYNTRLNRGEYVDVPFPNQYQYIAAVDYNPRDNQLYVWNNNFILRYSLEFGPPDPAQVPTTAVTITSSAELFKTIISTTSTTSQKGPMSTTVAGSQEGSKGTKPPPAVSTTKIPPITNIFPLPERFCEALDSKGIKWPQTQRGMMVERPCPKGTRGTASYLCMISTGTWNPKGPDLSNCTSHWVNQLAQKIRSGENAASLANELAKHTKGPVFAGDVSSSVRLMEQLVDILDAQLQELKPSEKDSAGRSYNKLQKREKTCRAYLKAIVDTVDNLLRPEALESWKHMNSSEQAHTATMLLDTLEEGAFVLADNLLEPTRVSMPTENIVLEVAVLSTEGQIQDFKFPLGIKGAGSSIQLSANTVKQNSRNGLAKLVFIIYRSLGQFLSTENATIKLGADFIGRNSTIAVNSHVISVSINKESSRVYLTDPVLFTLPHIDPDNYFNANCSFWNYSERTMMGYWSTQGCKLVDTNKTRTTCACSHLTNFAILMAHREIAYKDGVHELLLTVITWVGIVISLVCLAICIFTFCFFRGLQSDRNTIHKNLCINLFIAEFIFLIGIDKTKYAIACPIFAGLLHFFFLAAFAWMCLEGVQLYLMLVEVFESEYSRKKYYYVAGYLFPATVVGVSAAIDYKSYGTEKACWLHVDNYFIWSFIGPVTFIILLNIIFLVITLCKMVKHSNTLKPDSSRLENIKSWVLGAFALLCLLGLTWSFGLLFINEETIVMAYLFTIFNAFQGVFIFIFHCALQKKVRKEYGKCFRHSYCCGGLPTESPHSSVKASTTRTSARYSSGTQSRIRRMWNDTVRKQSESSFISGDINSTSTLNQGMTGNYLLTNPLLRPHGTNNPYNTLLAETVVCNAPSAPVFNSPGHSLNNARDTSAMDTLPLNGNFNNSYSLHKGDYNDSVQVVDCGLSLNDTAFEKMIISELVHNNLRGSSKTHNLELTLPVKPVIGGSSSEDDAIVADASSLMHSDNPGLELHHKELEAPLIPQRTHSLLYQPQKKVKSEGTDSYVSQLTAEAEDHLQSPNRDSLYTSMPNLRDSPYPESSPDMEEDLSPSRRSENEDIYYKSMPNLGAGHQLQMCYQISRGNSDGYIIPINKEGCIPEGDVREGQMQLVTSL,1459,"163,349",Alternative sequence (7); Chain (1); Disulfide bond (1); Domain (3); Glycosylation (9); Modified residue (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 136..318;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q5VV63,Attractin-like protein 1,METGGRARTGTPQPAAPGVWRARPAGGGGGGASSWLLDGNSWLLCYGFLYLALYAQVSQSKPCERTGSCFSGRCVNSTCLCDPGWVGDQCQHCQGRFKLTEPSGYLTDGPINYKYKTKCTWLIEGYPNAVLRLRFNHFATECSWDHMYVYDGDSIYAPLIAVLSGLIVPEIRGNETVPEVVTTSGYALLHFFSDAAYNLTGFNIFYSINSCPNNCSGHGKCTTSVSVPSQVYCECDKYWKGEACDIPYCKANCGSPDHGYCDLTGEKLCVCNDSWQGPDCSLNVPSTESYWILPNVKPFSPSVGRASHKAVLHGKFMWVIGGYTFNYSSFQMVLNYNLESSIWNVGTPSRGPLQRYGHSLALYQENIFMYGGRIETNDGNVTDELWVFNIHSQSWSTKTPTVLGHGQQYAVEGHSAHIMELDSRDVVMIIIFGYSAIYGYTSSIQEYHISSNTWLVPETKGAIVQGGYGHTSVYDEITKSIYVHGGYKALPGNKYGLVDDLYKYEVNTKTWTILKESGFARYLHSAVLINGAMLIFGGNTHNDTSLSNGAKCFSADFLAYDIACDEWKILPKPNLHRDVNRFGHSAVVINGSMYIFGGFSSVLLNDILVYKPPNCKAFRDEELCKNAGPGIKCVWNKNHCESWESGNTNNILRAKCPPKTAASDDRCYRYADCASCTANTNGCQWCDDKKCISANSNCSMSVKNYTKCHVRNEQICNKLTSCKSCSLNLNCQWDQRQQECQALPAHLCGEGWSHIGDACLRVNSSRENYDNAKLYCYNLSGNLASLTTSKEVEFVLDEIQKYTQQKVSPWVGLRKINISYWGWEDMSPFTNTTLQWLPGEPNDSGFCAYLERAAVAGLKANPCTSMANGLVCEKPVVSPNQNARPCKKPCSLRTSCSNCTSNGMECMWCSSTKRCVDSNAYIISFPYGQCLEWQTATCSPQNCSGLRTCGQCLEQPGCGWCNDPSNTGRGHCIEGSSRGPMKLIGMHHSEMVLDTNLCPKEKNYEWSFIQCPACQCNGHSTCINNNVCEQCKNLTTGKQCQDCMPGYYGDPTNGGQCTACTCSGHANICHLHTGKCFCTTKGIKGDQCQLCDSENRYVGNPLRGTCYYSLLIDYQFTFSLLQEDDRHHTAINFIANPEQSNKNLDISINASNNFNLNITWSVGSTAGTISGEETSIVSKNNIKEYRDSFSYEKFNFRSNPNITFYVYVSNFSWPIKIQIAFSQHNTIMDLVQFFVTFFSCFLSLLLVAAVVWKIKQTCWASRRREQLLRERQQMASRPFASVDVALEVGAEQTEFLRGPLEGAPKPIAIEPCAGNRAAVLTVFLCLPRGSSGAPPPGQSGLAIASALIDISQQKASDSKDKTSGVRNRKHLSTRQGTCV,1379,"152,639",Alternative sequence (2); Chain (1); Disulfide bond (15); Domain (11); Erroneous initiation (1); Glycosylation (8); Natural variant (1); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 63..79;  /evidence=""ECO:0000250""; DISULFID 81..90;  /evidence=""ECO:0000250""; DISULFID 93..119;  /evidence=""ECO:0000250""; DISULFID 211..221;  /evidence=""ECO:0000250""; DISULFID 215..233;  /evidence=""ECO:0000250""; DISULFID 235..244;  /evidence=""ECO:0000250""; DISULFID 776..872;  /evidence=""ECO:0000250""; DISULFID 1014..1022;  /evidence=""ECO:0000250""; DISULFID 1016..1028;  /evidence=""ECO:0000250""; DISULFID 1031..1040;  /evidence=""ECO:0000250""; DISULFID 1043..1057;  /evidence=""ECO:0000250""; DISULFID 1060..1069;  /evidence=""ECO:0000250""; DISULFID 1062..1076;  /evidence=""ECO:0000250""; DISULFID 1078..1088;  /evidence=""ECO:0000250""; DISULFID 1091..1106;  /evidence=""ECO:0000250""","SIGNAL 1..52;  /evidence=""ECO:0000255"""
O00238,Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293),MLLRSAGKLNVGTKKEDGESTAPTPRPKVLRCKCHHHCPEDSVNNICSTDGYCFTMIEEDDSGLPVVTSGCLGLEGSDFQCRDTPIPHQRRSIECCTERNECNKDLHPTLPPLKNRDFVDGPIHHRALLISVTVCSLLLVLIILFCYFRYKRQETRPRYSIGLEQDETYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIKL,502,"56,930",Active site (1); Alternative sequence (1); Beta strand (8); Binding site (1); Chain (1); Disulfide bond (5); Domain (2); Helix (16); Natural variant (11); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 32..53;  /evidence=""ECO:0000250|UniProtKB:P36898""; DISULFID 34..38;  /evidence=""ECO:0000250|UniProtKB:P36898""; DISULFID 47..71;  /evidence=""ECO:0000250|UniProtKB:P36898""; DISULFID 81..95;  /evidence=""ECO:0000250|UniProtKB:P36898""; DISULFID 96..102;  /evidence=""ECO:0000250|UniProtKB:P36898""","SIGNAL 1..13;  /evidence=""ECO:0000255"""
P55285,Cadherin-6 (Kidney cadherin) (K-cadherin),MRTYRYFLLLFWVGQPYPTLSTPLSKRTSGFPAKKRALELSGNSKNELNRSKRSWMWNQFFLLEEYTGSDYQYVGKLHSDQDRGDGSLKYILSGDGAGDLFIINENTGDIQATKRLDREEKPVYILRAQAINRRTGRPVEPESEFIIKIHDINDNEPIFTKEVYTATVPEMSDVGTFVVQVTATDADDPTYGNSAKVVYSILQGQPYFSVESETGIIKTALLNMDRENREQYQVVIQAKDMGGQMGGLSGTTTVNITLTDVNDNPPRFPQSTYQFKTPESSPPGTPIGRIKASDADVGENAEIEYSITDGEGLDMFDVITDQETQEGIITVKKLLDFEKKKVYTLKVEASNPYVEPRFLYLGPFKDSATVRIVVEDVDEPPVFSKLAYILQIREDAQINTTIGSVTAQDPDAARNPVKYSVDRHTDMDRIFNIDSGNGSIFTSKLLDRETLLWHNITVIATEINNPKQSSRVPLYIKVLDVNDNAPEFAEFYETFVCEKAKADQLIQTLHAVDKDDPYSGHQFSFSLAPEAASGSNFTIQDNKDNTAGILTRKNGYNRHEMSTYLLPVVISDNDYPVQSSTGTVTVRVCACDHHGNMQSCHAEALIHPTGLSTGALVAILLCIVILLVTVVLFAALRRQRKKEPLIISKEDIRDNIVSYNDEGGGEEDTQAFDIGTLRNPEAIEDNKLRRDIVPEALFLPRRTPTARDNTDVRDFINQRLKENDTDPTAPPYDSLATYAYEGTGSVADSLSSLESVTTDADQDYDYLSDWGPRFKKLADMYGGVDSDKDS,790,"88,309",Alternative sequence (2); Beta strand (9); Chain (1); Domain (5); Glycosylation (6); Modified residue (2); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1],MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL,1103,"124,568",Alternative sequence (3); Chain (3); Disulfide bond (1); Domain (2); Glycosylation (16); Metal binding (3); Modified residue (1); Motif (1); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 404..1059;  /note=""Interchain (between alpha-2-1 and delta-1 chains)""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q7Z692,Carcinoembryonic antigen-related cell adhesion molecule 19 (Carcinoembryonic antigen-like 1),MEIPMGTQGCFSKSLLLSASILVLWMLQGSQAALYIQKIPEQPQKNQDLLLSVQGVPDTFQDFNWYLGEETYGGTRLFTYIPGIQRPQRDGSAMGQRDIVGFPNGSMLLRRAQPTDSGTYQVAITINSEWTMKAKTEVQVAEKNKELPSTHLPTNAGILAATIIGSLAAGALLISCIAYLLVTRNWRGQSHRLPAPRGQGSLSILCSAVSPVPSVTPSTWMATTEKPELGPAHDAGDNNIYEVMPSPVLLVSPISDTRSINPARPLPTPPHLQAEPENHQYQQDLLNPDPAPYCQLVPTS,300,"32,638",Alternative sequence (3); Chain (1); Erroneous initiation (2); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
P09693,T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g),MEQGKGLAVLILAIILLQGTLAQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKDPRGMYQCKGSQNKSKPLQVYYRMCQNCIELNAATISGFLFAEIVSIFVLAVGVYFIAGQDGVRQSRASDKQTLLPNDQLYQPLKDREDDQYSHLQGNQLRRN,182,"20,469",Beta strand (7); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (2); Helix (1); Modified residue (2); Motif (1); Mutagenesis (7); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 46..87;  /evidence=""ECO:0000269|PubMed:15136729""",SIGNAL 1..22
P30988,Calcitonin receptor (CT-R),MRFTFTSRCLALFLLLNHPTPILPAFSNQTYPTIEPKPFLYVVGRKKMMDAQYKCYDRMQQLPAYQGEGPYCNRTWDGWLCWDDTPAGVLSYQFCPDYFPDFDPSEKVTKYCDEKGVWFKHPENNRTWSNYTMCNAFTPEKLKNAYVLYYLAIVGHSLSIFTLVISLGIFVFFRSLGCQRVTLHKNMFLTYILNSMIIIIHLVEVVPNGELVRRDPVSCKILHFFHQYMMACNYFWMLCEGIYLHTLIVVAVFTEKQRLRWYYLLGWGFPLVPTTIHAITRAVYFNDNCWLSVETHLLYIIHGPVMAALVVNFFFLLNIVRVLVTKMRETHEAESHMYLKAVKATMILVPLLGIQFVVFPWRPSNKMLGKIYDYVMHSLIHFQGFFVATIYCFCNNEVQTTVKRQWAQFKIQWNQRWGRRPSNRSARAAAAAAEAGDIPIYICHQEPRNEPANNQGEESAEIIPLNIIEQESSA,474,"55,329",Alternative sequence (5); Beta strand (4); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (4); Helix (16); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (2),"DISULFID 55..81;  /evidence=""ECO:0000250""; DISULFID 72..112;  /evidence=""ECO:0000250""; DISULFID 95..134;  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
F5H4A9,Uncharacterized membrane protein C3orf80,MWGPGVTAEGLSVAPAPPPLLPLLLLLALALVAPSRGGGGCAELACGERERCCDATNATAVRCCKLPLHAFLDNVGWFVRKLSGLLILLVLFAIGYFLQRIICPSPRRYPRGQARPGQRPGPPGGAGPLGGAGPPDDDDDSPALLRDEAAAGSQDSLLDSGGGGRGRGGGGRSDPSCASEHEMRVVSPVFLQLPSYEEVKYLPTYEESMRLQQLSPGEVVLPVSVLGRPRGGVAAEPDGGEGRYPLI,247,"25,682",Chain (1); Compositional bias (1); Glycosylation (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P32926,Desmoglein-3 (130 kDa pemphigus vulgaris antigen) (PVA) (Cadherin family member 6),MMGLFPRTTGALAIFVVVILVHGELRIETKGQYDEEEMTMQQAKRRQKREWVKFAKPCREGEDNSKRNPIAKITSDYQATQKITYRISGVGIDQPPFGIFVVDKNTGDINITAIVDREETPSFLITCRALNAQGLDVEKPLILTVKILDINDNPPVFSQQIFMGEIEENSASNSLVMILNATDADEPNHLNSKIAFKIVSQEPAGTPMFLLSRNTGEVRTLTNSLDREQASSYRLVVSGADKDGEGLSTQCECNIKVKDVNDNFPMFRDSQYSARIEENILSSELLRFQVTDLDEEYTDNWLAVYFFTSGNEGNWFEIQTDPRTNEGILKVVKALDYEQLQSVKLSIAVKNKAEFHQSVISRYRVQSTPVTIQVINVREGIAFRPASKTFTVQKGISSKKLVDYILGTYQAIDEDTNKAASNVKYVMGRNDGGYLMIDSKTAEIKFVKNMNRDSTFIVNKTITAEVLAIDEYTGKTSTGTVYVRVPDFNDNCPTAVLEKDAVCSSSPSVVVSARTLNNRYTGPYTFALEDQPVKLPAVWSITTLNATSALLRAQEQIPPGVYHISLVLTDSQNNRCEMPRSLTLEVCQCDNRGICGTSYPTTSPGTRYGRPHSGRLGPAAIGLLLLGLLLLLLAPLLLLTCDCGAGSTGGVTGGFIPVPDGSEGTIHQWGIEGAHPEDKEITNICVPPVTANGADFMESSEVCTNTYARGTAVEGTSGMEMTTKLGAATESGGAAGFATGTVSGAASGFGAATGVGICSSGQSGTMRTRHSTGGTNKDYADGAISMNFLDSYFSQKAFACAEEDDGQEANDCLLIYDNEGADATGSPVGSVGCCSFIADDLDDSFLDSLGPKFKKLAEISLGVDGEGKEVQPPSKDSGYGIESCGHPIEVQQTGFVKCQTLSGSQGASALSTSGSVQPAVSIPDPLQHGNYLVTETYSASGSLVQPSTAGFDPLLTQNVIVTERVICPISSVPGNLAGPTQLRGSHTMLCTEDPCSRLI,999,"107,533",Beta strand (32); Chain (1); Domain (4); Glycosylation (4); Helix (4); Natural variant (2); Propeptide (1); Repeat (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (14),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8TD84,Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2),MWLVTFLLLLDSLHKARPEDVGTSLYFVNDSLQQVTFSSSVGVVVPCPAAGSPSAALRWYLATGDDIYDVPHIRHVHANGTLQLYPFSPSAFNSFIHDNDYFCTAENAAGKIRSPNIRVKAVFREPYTVRVEDQRSMRGNVAVFKCLIPSSVQEYVSVVSWEKDTVSIIPEHRFFITYHGGLYISDVQKEDALSTYRCITKHKYSGETRQSNGARLSVTDPAESIPTILDGFHSQEVWAGHTVELPCTASGYPIPAIRWLKDGRPLPADSRWTKRITGLTISDLRTEDSGTYICEVTNTFGSAEATGILMVIDPLHVTLTPKKLKTGIGSTVILSCALTGSPEFTIRWYRNTELVLPDEAISIRGLSNETLLITSAQKSHSGAYQCFATRKAQTAQDFAIIALEDGTPRIVSSFSEKVVNPGEQFSLMCAAKGAPPPTVTWALDDEPIVRDGSHRTNQYTMSDGTTISHMNVTGPQIRDGGVYRCTARNLVGSAEYQARINVRGPPSIRAMRNITAVAGRDTLINCRVIGYPYYSIKWYKDALLLPDNHRQVVFENGTLKLTDVQKGMDEGEYLCSVLIQPQLSISQSVHVAVKVPPLIQPFEFPPASIGQLLYIPCVVSSGDMPIRITWRKDGQVIISGSGVTIESKEFMSSLQISSVSLKHNGNYTCIASNAAATVSRERQLIVRVPPRFVVQPNNQDGIYGKAGVLNCSVDGYPPPKVMWKHAKGSGNPQQYHPVPLTGRIQILPNSSLLIRHVLEEDIGYYLCQASNGVGTDISKSMFLTVKIPAMITSHPNTTIAIKGHAKELNCTARGERPIIIRWEKGDTVIDPDRVMRYAIATKDNGDEVVSTLKLKPADRGDSVFFSCHAINSYGEDRGLIQLTVQEPPDPPELEIREVKARSMNLRWTQRFDGNSIITGFDIEYKNKSDSWDFKQSTRNISPTINQANIVDLHPASVYSIRMYSFNKIGRSEPSKELTISTEEAAPDGPPMDVTLQPVTSQSIQVTWKAPKKELQNGVIRGYQIGYRENSPGSNGQYSIVEMKATGDSEVYTLDNLKKFAQYGVVVQAFNRAGTGPSSSEINATTLEDVPSQPPENVRALSITSDVAVISWSEPPRSTLNGVLKGYRVIFWSLYVDGEWGEMQNITTTRERVELRGMEKFTNYSVQVLAYTQAGDGVRSSVLYIQTKEDVPGPPAGIKAVPSSASSVVVSWLPPTKPNGVIRKYTIFCSSPGSGQPAPSEYETSPEQLFYRIAHLNRGQQYLLWVAAVTSAGRGNSSEKVTIEPAGKAPAKIISFGGTVTTPWMKDVRLPCNSVGDPAPAVKWTKDSEDSAIPVSMDGHRLIHTNGTLLLRAVKAEDSGYYTCTATNTGGFDTIIVNLLVQVPPDQPRLTVSKTSASSITLTWIPGDNGGSSIRGFVLQYSVDNSEEWKDVFISSSERSFKLDSLKCGTWYKVKLAAKNSVGSGRISEIIEAKTHGREPSFSKDQHLFTHINSTHARLNLQGWNNGGCPITAIVLEYRPKGTWAWQGLRANSSGEVFLTELREATWYELRMRACNSAGCGNETAQFATLDYDGSTIPPIKSAQGEGDDVKKLFTIGCPVILATLGVALLFIVRKKRKEKRLKRLRDAKSLAEMLISKNNRSFDTPVKGPPQGPRLHIDIPRVQLLIEDKEGIKQLGDDKATIPVTDAEFSQAVNPQSFCTGVSLHHPTLIQSTGPLIDMSDIRPGTNPVSRKNVKSAHSTRNRYSSQWTLTKCQASTPARTLTSDWRTVGSQHGVTVTESDSYSASLSQDTDKGRNSMVSTESASSTYEELARAYEHAKLEEQLQHAKFEITECFISDSSSDQMTTGTNENADSMTSMSTPSEPGICRFTASPPKPQDADRGKNVAVPIPHRANKSDYCNLPLYAKSEAFFRKADGREPCPVVPPREASIRNLARTYHTQARHLTLDPASKSLGLPHPGAPAAASTATLPQRTLAMPAPPAGTAPPAPGPTPAEPPTAPSAAPPAPSTEPPRAGGPHTKMGGSRDSLLEMSTSGVGRSQKQGAGAYSKSYTLV,2053,"224,463",Alternative sequence (1); Beta strand (5); Chain (1); Compositional bias (1); Disulfide bond (10); Domain (16); Erroneous initiation (2); Glycosylation (20); Natural variant (2); Sequence caution (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..198;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 247..294;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 336..386;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 429..485;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 526..575;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 617..669;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 711..767;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 810..867;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1311..1363;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P30926,Neuronal acetylcholine receptor subunit beta-4,MRRAPSLVLFFLVALCGRGNCRVANAEEKLMDDLLNKTRYNNLIRPATSSSQLISIKLQLSLAQLISVNEREQIMTTNVWLKQEWTDYRLTWNSSRYEGVNILRIPAKRIWLPDIVLYNNADGTYEVSVYTNLIVRSNGSVLWLPPAIYKSACKIEVKYFPFDQQNCTLKFRSWTYDHTEIDMVLMTPTASMDDFTPSGEWDIVALPGRRTVNPQDPSYVDVTYDFIIKRKPLFYTINLIIPCVLTTLLAILVFYLPSDCGEKMTLCISVLLALTFFLLLISKIVPPTSLDVPLIGKYLMFTMVLVTFSIVTSVCVLNVHHRSPSTHTMAPWVKRCFLHKLPTFLFMKRPGPDSSPARAFPPSKSCVTKPEATATSTSPSNFYGNSMYFVNPASAASKSPAGSTPVAIPRDFWLRSSGRFRQDVQEALEGVSFIAQHMKNDDEDQSVVEDWKYVAMVVDRLFLWVFMFVCVLGTVGLFLPPLFQTHAASEGPYAAQRD,498,"56,380",Alternative sequence (2); Beta strand (15); Chain (1); Disulfide bond (1); Glycosylation (4); Helix (8); Natural variant (4); Sequence conflict (2); Signal peptide (1); Site (2); Topological domain (5); Transmembrane (4); Turn (7),"DISULFID 153..167;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q14246,Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),MRGFNLLLFWGCCVMHSWEGHIRPTRKPNTKGNNCRDSTLCPAYATCTNTVDSYYCACKQGFLSSNGQNHFKDPGVRCKDIDECSQSPQPCGPNSSCKNLSGRYKCSCLDGFSSPTGNDWVPGKPGNFSCTDINECLTSSVCPEHSDCVNSMGSYSCSCQVGFISRNSTCEDVDECADPRACPEHATCNNTVGNYSCFCNPGFESSSGHLSFQGLKASCEDIDECTEMCPINSTCTNTPGSYFCTCHPGFAPSNGQLNFTDQGVECRDIDECRQDPSTCGPNSICTNALGSYSCGCIAGFHPNPEGSQKDGNFSCQRVLFKCKEDVIPDNKQIQQCQEGTAVKPAYVSFCAQINNIFSVLDKVCENKTTVVSLKNTTESFVPVLKQISTWTKFTKEETSSLATVFLESVESMTLASFWKPSANITPAVRTEYLDIESKVINKECSEENVTLDLVAKGDKMKIGCSTIEESESTETTGVAFVSFVGMESVLNERFFKDHQAPLTTSEIKLKMNSRVVGGIMTGEKKDGFSDPIIYTLENIQPKQKFERPICVSWSTDVKGGRWTSFGCVILEASETYTICSCNQMANLAVIMASGELTMDFSLYIISHVGIIISLVCLVLAIATFLLCRSIRNHNTYLHLHLCVCLLLAKTLFLAGIHKTDNKMGCAIIAGFLHYLFLACFFWMLVEAVILFLMVRNLKVVNYFSSRNIKMLHICAFGYGLPMLVVVISASVQPQGYGMHNRCWLNTETGFIWSFLGPVCTVIVINSLLLTWTLWILRQRLSSVNAEVSTLKDTRLLTFKAFAQLFILGCSWVLGIFQIGPVAGVMAYLFTIINSLQGAFIFLIHCLLNGQVREEYKRWITGKTKPSSQSQTSRILLSSMPSASKTG,886,"97,683",Alternative sequence (5); Chain (1); Compositional bias (1); Disulfide bond (18); Domain (7); Erroneous gene model prediction (1); Glycosylation (12); Natural variant (14); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 35..47;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 41..56;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 58..78;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 84..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 91..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 108..130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 136..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 142..157;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 159..170;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 176..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 182..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 199..219;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 225..235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 229..244;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 246..266;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 272..285;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 279..294;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 296..315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
A8MVZ5,Butyrophilin-like protein 10,MAVTCDPEAFLSICFVTLVFLQLPLASIWKADFDVTGPHAPILAMAGGHVELQCQLFPNISAEDMELRWYRCQPSLAVHMHERGMDMDGEQKWQYRGRTTFMSDHVARGKAMVRSHRVTTFDNRTYCCRFKDGVKFGEATVQVQVAGLGREPRIQVTDQQDGVRAECTSAGCFPKSWVERRDFRGQARPAVTNLSASATTRLWAVASSLTLWDRAVEGLSCSISSPLLPERRKVAESHLPATFSRSSQFTAWKAALPLILVAMGLVIAGGICIFWKRQREKNKASLEEERE,291,"32,612",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9H6B4,CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein) (CAR-like membrane protein),MSLLLLLLLVSYYVGTLGTHTEIKRVAEEKVTLPCHHQLGLPEKDTLDIEWLLTDNEGNQKVVITYSSRHVYNNLTEEQKGRVAFASNFLAGDASLQIEPLKPSDEGRYTCKVKNSGRYVWSHVILKVLVRPSKPKCELEGELTEGSDLTLQCESSSGTEPIVYYWQRIREKEGEDERLPPKSRIDYNHPGRVLLQNLTMSYSGLYQCTAGNEAGKESCVVRVTVQYVQSIGMVAGAVTGIVAGALLIFLLVWLLIRRKDKERYEEEERPNEIREDAEAPKARLVKPSSSSSGSRSSRSGSSSTRSTANSASRSQRTLSTDAAPQPGLATQAYSLVGPEVRGSEPKKVHHANLTKAETTPSMIPSQSRAFQTV,373,"41,281",Chain (1); Compositional bias (2); Disulfide bond (2); Domain (2); Glycosylation (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 153..208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8N766,ER membrane protein complex subunit 1,MAAEWASRFWLWATLLIPAAAVYEDQVGKFDWRQQYVGKVKFASLEFSPGSKKLVVATEKNVIAALNSRTGEILWRHVDKGTAEGAVDAMLLHGQDVITVSNGGRIMRSWETNIGGLNWEITLDSGSFQALGLVGLQESVRYIAVLKKTTLALHHLSSGHLKWVEHLPESDSIHYQMVYSYGSGVVWALGVVPFSHVNIVKFNVEDGEIVQQVRVSTPWLQHLSGACGVVDEAVLVCPDPSSRSLQTLALETEWELRQIPLQSLDLEFGSGFQPRVLPTQPNPVDASRAQFFLHLSPSHYALLQYHYGTLSLLKNFPQTALVSFATTGEKTVAAVMACRNEVQKSSSSEDGSMGSFSEKSSSKDSLACFNQTYTINLYLVETGRRLLDTTITFSLEQSGTRPERLYIQVFLKKDDSVGYRALVQTEDHLLLFLQQLAGKVVLWSREESLAEVVCLEMVDLPLTGAQAELEGEFGKKADGLLGMFLKRLSSQLILLQAWTSHLWKMFYDARKPRSQIKNEINIDTLARDEFNLQKMMVMVTASGKLFGIESSSGTILWKQYLPNVKPDSSFKLMVQRTTAHFPHPPQCTLLVKDKESGMSSLYVFNPIFGKWSQVAPPVLKRPILQSLLLPVMDQDYAKVLLLIDDEYKVTAFPATRNVLRQLHELAPSIFFYLVDAEQGRLCGYRLRKDLTTELSWELTIPPEVQRIVKVKGKRSSEHVHSQGRVMGDRSVLYKSLNPNLLAVVTESTDAHHERTFIGIFLIDGVTGRIIHSSVQKKAKGPVHIVHSENWVVYQYWNTKARRNEFTVLELYEGTEQYNATAFSSLDRPQLPQVLQQSYIFPSSISAMEATITERGITSRHLLIGLPSGAILSLPKALLDPRRPEIPTEQSREENLIPYSPDVQIHAERFINYNQTVSRMRGIYTAPSGLESTCLVVAYGLDIYQTRVYPSKQFDVLKDDYDYVLISSVLFGLVFATMITKRLAQVKLLNRAWR,993,"111,759",Alternative sequence (3); Beta strand (69); Chain (1); Disulfide bond (2); Glycosylation (3); Helix (10); Natural variant (7); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (18),"DISULFID 227..237;  /evidence=""ECO:0000244|PDB:6WW7, ECO:0000269|PubMed:32439656""; DISULFID 338..368;  /evidence=""ECO:0000244|PDB:6WW7, ECO:0000269|PubMed:32439656""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:32439656"""
Q86WK6,Amphoterin-induced protein 1 (AMIGO-1) (Alivin-2),MHPHRDPRGLWLLLPSLSLLLFEVARAGRAVVSCPAACLCASNILSCSKQQLPNVPHSLPSYTALLDLSHNNLSRLRAEWTPTRLTQLHSLLLSHNHLNFISSEAFSPVPNLRYLDLSSNQLRTLDEFLFSDLQVLEVLLLYNNHIMAVDRCAFDDMAQLQKLYLSQNQISRFPLELVKEGAKLPKLTLLDLSSNKLKNLPLPDLQKLPAWIKNGLYLHNNPLNCDCELYQLFSHWQYRQLSSVMDFQEDLYCMNSKKLHNVFNLSFLNCGEYKERAWEAHLGDTLIIKCDTKQQGMTKVWVTPSNERVLDEVTNGTVSVSKDGSLLFQQVQVEDGGVYTCYAMGETFNETLSVELKVHNFTLHGHHDTLNTAYTTLVGCILSVVLVLIYLYLTPCRCWCRGVEKPSSHQGDSLSSSMLSTTPNHDPMAGGDKDDGFDRRVAFLEPAGPGQGQNGKLKPGNTLPVPEATGKGQRRMSDPESVSSVFSDTPIVV,493,"55,239",Chain (1); Disulfide bond (5); Domain (3); Glycosylation (5); Modified residue (2); Repeat (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..40;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 38..47;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 225..253;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 227..270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 290..341;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
O43184,Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha),MAARPLPVSPARALLLALAGALLAPCEARGVSLWNQGRADEVVSASVGSGDLWIPVKSFDSKNHPEVLNIRLQRESKELIINLERNEGLIASSFTETHYLQDGTDVSLARNYTVILGHCYYHGHVRGYSDSAVSLSTCSGLRGLIVFENESYVLEPMKSATNRYKLFPAKKLKSVRGSCGSHHNTPNLAAKNVFPPPSQTWARRHKRETLKATKYVELVIVADNREFQRQGKDLEKVKQRLIEIANHVDKFYRPLNIRIVLVGVEVWNDMDKCSVSQDPFTSLHEFLDWRKMKLLPRKSHDNAQLVSGVYFQGTTIGMAPIMSMCTADQSGGIVMDHSDNPLGAAVTLAHELGHNFGMNHDTLDRGCSCQMAVEKGGCIMNASTGYPFPMVFSSCSRKDLETSLEKGMGVCLFNLPEVRESFGGQKCGNRFVEEGEECDCGEPEECMNRCCNATTCTLKPDAVCAHGLCCEDCQLKPAGTACRDSSNSCDLPEFCTGASPHCPANVYLHDGHSCQDVDGYCYNGICQTHEQQCVTLWGPGAKPAPGICFERVNSAGDPYGNCGKVSKSSFAKCEMRDAKCGKIQCQGGASRPVIGTNAVSIETNIPLQQGGRILCRGTHVYLGDDMPDPGLVLAGTKCADGKICLNRQCQNISVFGVHECAMQCHGRGVCNNRKNCHCEAHWAPPFCDKFGFGGSTDSGPIRQADNQGLTIGILVTILCLLAAGFVVYLKRKTLIRLLFTNKKTTIEKLRCVRPSRPPRGFQPCQAHLGHLGKGLMRKPPDSYPPKDNPRRLLQCQNVDISRPLNGLNVPQPQSTQRVLPPLHRAPRAPSVPARPLPAKPALRQAQGTCKPNPPQKPLPADPLARTTRLTHALARTPGQWETGLRLAPLRPAPQYPHQVPRSTHTAYIK,909,"99,542",Active site (1); Alternative sequence (5); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Metal binding (4); Modified residue (1); Motif (4); Natural variant (6); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 325..411;  /evidence=""ECO:0000250""; DISULFID 367..395;  /evidence=""ECO:0000250""; DISULFID 369..378;  /evidence=""ECO:0000250""; DISULFID 482..502;  /evidence=""ECO:0000250""; DISULFID 660..670;  /evidence=""ECO:0000250""; DISULFID 664..676;  /evidence=""ECO:0000250""; DISULFID 678..687;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q96K78,Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128),MASCRAWNLRVLVAVVCGLLTGIILGLGIWRIVIRIQRGKSTSSSSTPTEFCRNGGTWENGRCICTEEWKGLRCTIANFCENSTYMGFTFARIPVGRYGPSLQTCGKDTPNAGNPMAVRLCSLSLYGEIELQKVTIGNCNENLETLEKQVKDVTAPLNNISSEVQILTSDANKLTAENITSATRVVGQIFNTSRNASPEAKKVAIVTVSQLLDASEDAFQRVAATANDDALTTLIEQMETYSLSLGNQSVVEPNIAIQSANFSSENAVGPSNVRFSVQKGASSSLVSSSTFIHTNVDGLNPDAQTELQVLLNMTKNYTKTCGFVVYQNDKLFQSKTFTAKSDFSQKIISSKTDENEQDQSASVDMVFSPKYNQKEFQLYSYACVYWNLSAKDWDTYGCQKDKGTDGFLRCRCNHTTNFAVLMTFKKDYQYPKSLDILSNVGCALSVTGLALTVIFQIVTRKVRKTSVTWVLVNLCISMLIFNLLFVFGIENSNKNLQTSDGDINNIDFDNNDIPRTDTINIPNPMCTAIAALLHYFLLVTFTWNALSAAQLYYLLIRTMKPLPRHFILFISLIGWGVPAIVVAITVGVIYSQNGNNPQWELDYRQEKICWLAIPEPNGVIKSPLLWSFIVPVTIILISNVVMFITISIKVLWKNNQNLTSTKKVSSMKKIVSTLSVAVVFGITWILAYLMLVNDDSIRIVFSYIFCLFNTTQGLQIFILYTVRTKVFQSEASKVLMLLSSIGRRKSLPSVTRPRLRVKMYNFLRSLPTLHERFRLLETSPSTEEITLSESDNAKESI,797,"88,909",Chain (1); Domain (1); Erroneous initiation (1); Glycosylation (10); Natural variant (3); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8J025,Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein),MSWPRRLLLRYLFPALLLHGLGEGSALLHPDSRSHPRSLEKSAWRAFKESQCHHMLKHLHNGARITVQMPPTIEGHWVSTGCEVRSGPEFITRSYRFYHNNTFKAYQFYYGSNRCTNPTYTLIIRGKIRLRQASWIIRGGTEADYQLHNVQVICHTEAVAEKLGQQVNRTCPGFLADGGPWVQDVAYDLWREENGCECTKAVNFAMHELQLIRVEKQYLHHNLDHLVEELFLGDIHTDATQRMFYRPSSYQPPLQNAKNHDHACIACRIIYRSDEHHPPILPPKADLTIGLHGEWVSQRCEVRPEVLFLTRHFIFHDNNNTWEGHYYHYSDPVCKHPTFSIYARGRYSRGVLSSRVMGGTEFVFKVNHMKVTPMDAATASLLNVFNGNECGAEGSWQVGIQQDVTHTNGCVALGIKLPHTEYEIFKMEQDARGRYLLFNGQRPSDGSSPDRPEKRATSYQMPLVQCASSSPRAEDLAEDSGSSLYGRAPGRHTWSLLLAALACLVPLLHWNIRR,514,"58,797",Chain (1); Erroneous initiation (2); Frameshift (1); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9ULB5,Cadherin-7,MKLGKVEFCHFLQLIALFLCFSGMSQAELSRSRSKPYFQSGRSRTKRSWVWNQFFVLEEYMGSDPLYVGKLHSDVDKGDGSIKYILSGEGASSIFIIDENTGDIHATKRLDREEQAYYTLRAQALDRLTNKPVEPESEFVIKIQDINDNEPKFLDGPYTAGVPEMSPVGTSVVQVTATDADDPTYGNSARVVYSILQGQPYFSVEPKTGVIKTALPNMDREAKDQYLLVIQAKDMVGQNGGLSGTTSVTVTLTDVNDNPPRFPRRSYQYNVPESLPVASVVARIKAADADIGANAEMEYKIVDGDGLGIFKISVDKETQEGIITIQKELDFEAKTSYTLRIEAANKDADPRFLSLGPFSDTTTVKIIVEDVDEPPVFSSPLYPMEVSEATQVGNIIGTVAAHDPDSSNSPVRYSIDRNTDLERYFNIDANSGVITTAKSLDRETNAIHNITVLAMESQNPSQVGRGYVAITILDINDNAPEFAMDYETTVCENAQPGQVIQKISAVDKDEPSNGHQFYFSLTTDATNNHNFSLKDNKDNTASILTRRNGFRRQEQSVYYLPIFIVDSGSPSLSSTNTLTIRVCDCDADGVAQTCNAEAYVLPAGLSTGALIAILACVLTLLVLILLIVTMRRRKKEPLIFDEERDIRENIVRYDDEGGGEEDTEAFDMAALRNLNVIRDTKTRRDVTPEIQFLSRPAFKSIPDNVIFREFIWERLKEADVDPGAPPYDSLQTYAFEGNGSVAESLSSLDSISSNSDQNYDYLSDWGPRFKRLADMYGTGQESLYS,785,"87,086",Chain (1); Domain (5); Glycosylation (2); Natural variant (2); Propeptide (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9ULB4,Cadherin-9,MRTYHYIPLFIWTYMFHTVDTILLQEKPNSYLSSKKIAGLTKDDGKMLRRTKRGWMWNQFFLLEEYTGTDTQYVGKLHTDQDKGDGNLKYILTGDGAGSLFVIDENTGDIHAAKKLDREEKSLYILRAKAIDRKTGRQVEPESEFIIKIHDINDNEPKFTKDLYTASVPEMSGVGTSVIQVTATDADDANYGNSAKVVYSILQGQPYFSVDPESGIIKTALPDMSRENREQYQVVIQAKDMGGQMGGLSGTTTVNITLTDVNNNPPRFPQSTYQFNSPESVPLGTHLGRIKANDPDVGENAEMEYSIAEGDGADMFDVITDKDTQEGIITVKQNLDFENQMLYTLRVDASNTHPDPRFLHLGPFKDTAVVKISVEDIDEPPVFTKVSYLIEVDEDVKEGSIIGQVTAYDPDARNNLIKYSVDRHTDMDRIFGIHSENGSIFTLKALDRESSPWHNITVTATEINNPKQSSHIPVFIRILDINDHAPEFAMYYETFVCENAKPGQLIQTVSVMDKDDPPRGHKFFFEPVPEFTLNPNFTIVDNKDNTAGIMTRKDGYSRNKMSTYLLPILIFDNDYPIQSSTGTLTIRVCACDNQGNMQSCTAEALILSAGLSTGALVAILLCVLILLILVVLFAALKRQRKKEPLIISKDDVRDNIVTYNDEGGGEEDTQAFDIGTLRNPEAREDSKLRRDVMPETIFQIRRTVPLWENIDVQDFIHRRLKENDADPSAPPYDSLATYAYEGNDSIADSLSSLESLTADCNQDYDYLSDWGPRFKKLADMYGGDDSDRD,789,"88,689",Chain (1); Domain (5); Glycosylation (4); Modified residue (1); Natural variant (2); Propeptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P42081,T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86),MDPQCTMGLSNILFVMAFLLSGAAPLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKDKGLYQCIIHHKKPTGMIRIHQMNSELSVLANFSQPEIVPISNITENVYINLTCSSIHGYPEPKKMSVLLRTKNSTIEYDGVMQKSQDNVTELYDVSISLSVSFPDVTSNMTIFCILETDKTRLLSSPFSIELEDPQPPPDHIPWITAVLPTVIICVMVFCLILWKWKKKKRPRNSYKCGTNTMEREESEQTKKREKIHIPERSDEAQRVFKSSKTSSCDKSDTCF,329,"37,682",Alternative sequence (5); Beta strand (10); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (8); Helix (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 40..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12606712""; DISULFID 157..218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P19021,Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)],MAGRVPSLLVLLVFPSSCLAFRSPLSVFKRFKETTRPFSNECLGTTRPVVPIDSSDFALDIRMPGVTPKQSDTYFCMSMRIPVDEEAFVIDFKPRASMDTVHHMLLFGCNMPSSTGSYWFCDEGTCTDKANILYAWARNAPPTRLPKGVGFRVGGETGSKYFVLQVHYGDISAFRDNNKDCSGVSLHLTRLPQPLIAGMYLMMSVDTVIPAGEKVVNSDISCHYKNYPMHVFAYRVHTHHLGKVVSGYRVRNGQWTLIGRQSPQLPQAFYPVGHPVDVSFGDLLAARCVFTGEGRTEATHIGGTSSDEMCNLYIMYYMEAKHAVSFMTCTQNVAPDMFRTIPPEANIPIPVKSDMVMMHEHHKETEYKDKIPLLQQPKREEEEVLDQGDFYSLLSKLLGEREDVVHVHKYNPTEKAESESDLVAEIANVVQKKDLGRSDAREGAEHERGNAILVRDRIHKFHRLVSTLRPPESRVFSLQQPPPGEGTWEPEHTGDFHMEEALDWPGVYLLPGQVSGVALDPKNNLVIFHRGDHVWDGNSFDSKFVYQQIGLGPIEEDTILVIDPNNAAVLQSSGKNLFYLPHGLSIDKDGNYWVTDVALHQVFKLDPNNKEGPVLILGRSMQPGSDQNHFCQPTDVAVDPGTGAIYVSDGYCNSRIVQFSPSGKFITQWGEESSGSSPLPGQFTVPHSLALVPLLGQLCVADRENGRIQCFKTDTKEFVREIKHSSFGRNVFAISYIPGLLFAVNGKPHFGDQEPVQGFVMNFSNGEIIDIFKPVRKHFDMPHDIVASEDGTVYIGDAHTNTVWKFTLTEKLEHRSVKKAGIEVQEIKEAEAVVETKMENKPTSSELQKMQEKQKLIKEPGSGVPVVLITTLLVIPVVVLLAIAIFIRWKKSRAFGDSEHKLETSSGRVLGRFRGKGSGGLNLGNFFASRKGYSRKGFDRLSTEGSDQEKEDDGSESEEEYSAPLPALAPSSS,973,"108,332",Alternative sequence (5); Binding site (3); Chain (1); Disulfide bond (7); Erroneous initiation (1); Glycosylation (1); Metal binding (12); Modified residue (8); Natural variant (1); Propeptide (1); Region (3); Repeat (5); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..181;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 76..121;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 109..126;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 222..329;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 288..310;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 631..652;  /evidence=""ECO:0000250|UniProtKB:P14925""; DISULFID 699..710;  /evidence=""ECO:0000250|UniProtKB:P14925""","SIGNAL 1..20;  /evidence=""ECO:0000305"""
Q9NYQ6,Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2),MAPPPPPVLPVLLLLAAAAALPAMGLRAAAWEPRVPGGTRAFALRPGCTYAVGAACTPRAPRELLDVGRDGRLAGRRRVSGAGRPLPLQVRLVARSAPTALSRRLRARTHLPGCGARARLCGTGARLCGALCFPVPGGCAAAQHSALAAPTTLPACRCPPRPRPRCPGRPICLPPGGSVRLRLLCALRRAAGAVRVGLALEAATAGTPSASPSPSPPLPPNLPEARAGPARRARRGTSGRGSLKFPMPNYQVALFENEPAGTLILQLHAHYTIEGEEERVSYYMEGLFDERSRGYFRIDSATGAVSTDSVLDRETKETHVLRVKAVDYSTPPRSATTYITVLVKDTNDHSPVFEQSEYRERVRENLEVGYEVLTIRASDRDSPINANLRYRVLGGAWDVFQLNESSGVVSTRAVLDREEAAEYQLLVEANDQGRNPGPLSATATVYIEVEDENDNYPQFSEQNYVVQVPEDVGLNTAVLRVQATDRDQGQNAAIHYSILSGNVAGQFYLHSLSGILDVINPLDFEDVQKYSLSIKAQDGGRPPLINSSGVVSVQVLDVNDNEPIFVSSPFQATVLENVPLGYPVVHIQAVDADSGENARLHYRLVDTASTFLGGGSAGPKNPAPTPDFPFQIHNSSGWITVCAELDREEVEHYSFGVEAVDHGSPPMSSSTSVSITVLDVNDNDPVFTQPTYELRLNEDAAVGSSVLTLQARDRDANSVITYQLTGGNTRNRFALSSQRGGGLITLALPLDYKQEQQYVLAVTASDGTRSHTAHVLINVTDANTHRPVFQSSHYTVSVSEDRPVGTSIATLSANDEDTGENARITYVIQDPVPQFRIDPDSGTMYTMMELDYENQVAYTLTIMAQDNGIPQKSDTTTLEILILDANDNAPQFLWDFYQGSIFEDAPPSTSILQVSATDRDSGPNGRLLYTFQGGDDGDGDFYIEPTSGVIRTQRRLDRENVAVYNLWALAVDRGSPTPLSASVEIQVTILDINDNAPMFEKDELELFVEENNPVGSVVAKIRANDPDEGPNAQIMYQIVEGDMRHFFQLDLLNGDLRAMVELDFEVRREYVLVVQATSAPLVSRATVHILLVDQNDNPPVLPDFQILFNNYVTNKSNSFPTGVIGCIPAHDPDVSDSLNYTFVQGNELRLLLLDPATGELQLSRDLDNNRPLEALMEVSVSDGIHSVTAFCTLRVTIITDDMLTNSITVRLENMSQEKFLSPLLALFVEGVAAVLSTTKDDVFVFNVQNDTDVSSNILNVTFSALLPGGVRGQFFPSEDLQEQIYLNRTLLTTISTQRVLPFDDNICLREPCENYMKCVSVLRFDSSAPFLSSTTVLFRPIHPINGLRCRCPPGFTGDYCETEIDLCYSDPCGANGRCRSREGGYTCECFEDFTGEHCEVDARSGRCANGVCKNGGTCVNLLIGGFHCVCPPGEYERPYCEVTTRSFPPQSFVTFRGLRQRFHFTISLTFATQERNGLLLYNGRFNEKHDFIALEIVDEQVQLTFSAGETTTTVAPKVPSGVSDGRWHSVQVQYYNKPNIGHLGLPHGPSGEKMAVVTVDDCDTTMAVRFGKDIGNYSCAAQGTQTGSKKSLDLTGPLLLGGVPNLPEDFPVHNRQFVGCMRNLSVDGKNVDMAGFIANNGTREGCAARRNFCDGRRCQNGGTCVNRWNMYLCECPLRFGGKNCEQAMPHPQLFSGESVVSWSDLNIIISVPWYLGLMFRTRKEDSVLMEATSGGPTSFRLQILNNYLQFEVSHGPSDVESVMLSGLRVTDGEWHHLLIELKNVKEDSEMKHLVTMTLDYGMDQNKADIGGMLPGLTVRSVVVGGASEDKVSVRRGFRGCMQGVRMGGTPTNVATLNMNNALKVRVKDGCDVDDPCTSSPCPPNSRCHDAWEDYSCVCDKGYLGINCVDACHLNPCENMGACVRSPGSPQGYVCECGPSHYGPYCENKLDLPCPRGWWGNPVCGPCHCAVSKGFDPDCNKTNGQCQCKENYYKLLAQDTCLPCDCFPHGSHSRTCDMATGQCACKPGVIGRQCNRCDNPFAEVTTLGCEVIYNGCPKAFEAGIWWPQTKFGQPAAVPCPKGSVGNAVRHCSGEKGWLPPELFNCTTISFVDLRAMNEKLSRNETQVDGARALQLVRALRSATQHTGTLFGNDVRTAYQLLGHVLQHESWQQGFDLAATQDADFHEDVIHSGSALLAPATRAAWEQIQRSEGGTAQLLRRLEGYFSNVARNVRRTYLRPFVIVTANMILAVDIFDKFNFTGARVPRFDTIHEEFPRELESSVSFPADFFRPPEEKEGPLLRPAGRRTTPQTTRPGPGTEREAPISRRRRHPDDAGQFAVALVIIYRTLGQLLPERYDPDRRSLRLPHRPIINTPMVSTLVYSEGAPLPRPLERPVLVEFALLEVEERTKPVCVFWNHSLAVGGTGGWSARGCELLSRNRTHVACQCSHTASFAVLMDISRRENGEVLPLKIVTYAAVSLSLAALLVAFVLLSLVRMLRSNLHSIHKHLAVALFLSQLVFVIGINQTENPFLCTVVAILLHYIYMSTFAWTLVESLHVYRMLTEVRNIDTGPMRFYYVVGWGIPAIVTGLAVGLDPQGYGNPDFCWLSLQDTLIWSFAGPIGAVIIINTVTSVLSAKVSCQRKHHYYGKKGIVSLLRTAFLLLLLISATWLLGLLAVNRDALSFHYLFAIFSGLQGPFVLLFHCVLNQEVRKHLKGVLGGRKLHLEDSATTRATLLTRSLNCNTTFGDGPDMLRTDLGESTASLDSIVRDEGIQKLGVSSGLVRGSHGEPDASLMPRSCKDPPGHDSDSDSELSLDEQSSSYASSHSSDSEDDGVGAEEKWDPARGAVHSTPKGDAVANHVPAGWPDQSLAESDSEDPSGKPRLKVETKVSVELHREEQGSHRGEYPPDQESGGAARLASSQPPEQRKGILKNKVTYPPPLTLTEQTLKGRLREKLADCEQSPTSSRTSSLGSGGPDCAITVKSPGREPGRDHLNGVAMNVRTGSAQADGSDSEKP,3014,"329,486",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (27); Domain (21); Glycosylation (20); Modified residue (6); Natural variant (20); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 1307..1318;  /evidence=""ECO:0000250""; DISULFID 1312..1349;  /evidence=""ECO:0000250""; DISULFID 1351..1360;  /evidence=""ECO:0000250""; DISULFID 1367..1378;  /evidence=""ECO:0000250""; DISULFID 1372..1387;  /evidence=""ECO:0000250""; DISULFID 1389..1398;  /evidence=""ECO:0000250""; DISULFID 1407..1418;  /evidence=""ECO:0000250""; DISULFID 1412..1428;  /evidence=""ECO:0000250""; DISULFID 1430..1440;  /evidence=""ECO:0000250""; DISULFID 1620..1646;  /evidence=""ECO:0000250""; DISULFID 1653..1664;  /evidence=""ECO:0000250""; DISULFID 1658..1673;  /evidence=""ECO:0000250""; DISULFID 1675..1684;  /evidence=""ECO:0000250""; DISULFID 1840..1870;  /evidence=""ECO:0000250""; DISULFID 1876..1887;  /evidence=""ECO:0000250""; DISULFID 1881..1896;  /evidence=""ECO:0000250""; DISULFID 1898..1907;  /evidence=""ECO:0000250""; DISULFID 1911..1922;  /evidence=""ECO:0000250""; DISULFID 1916..1934;  /evidence=""ECO:0000250""; DISULFID 1936..1945;  /evidence=""ECO:0000250""; DISULFID 1953..1966;  /evidence=""ECO:0000250""; DISULFID 1968..1978;  /evidence=""ECO:0000250""; DISULFID 1985..2000;  /evidence=""ECO:0000250""; DISULFID 1987..2003;  /evidence=""ECO:0000250""; DISULFID 2005..2015;  /evidence=""ECO:0000250""; DISULFID 2024..2033;  /evidence=""ECO:0000250""; DISULFID 2036..2048;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9H2A7,C-X-C motif chemokine 16 (Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein) (SR-PSOX) (Small-inducible cytokine B16) (Transmembrane chemokine CXCL16),MGRDLRPGSRVLLLLLLLLLVYLTQPGNGNEGSVTGSCYCGKRISSDSPPSVQFMNRLRKHLRAYHRCLYYTRFQLLSWSVCGGNKDPWVQELMSCLDLKECGHAYSGIVAHQKHLLPTSPPISQASEGASSDIHTPAQMLLSTLQSTQRPTLPVGSLSSDKELTRPNETTIHTAGHSLAAGPEAGENQKQPEKNAGPTARTSATVPVLCLLAIIFILTAALSYVLCKRRRGQSPQSSPDLPVHYIPVAPDSNT,254,"27,579",Chain (1); Disulfide bond (2); Erroneous initiation (7); Glycosylation (1); Natural variant (2); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 38..68;  /evidence=""ECO:0000250""; DISULFID 40..82;  /evidence=""ECO:0000250""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
A6NF34,Anthrax toxin receptor-like,MGSHESLGPYFLVFLLLLLLPPPLFRAGSLRYHGPDWRIFHRLALGSRRAHHHHGPGWRQHWRQGQAGHRCQGSFDLYFILDKSGSVNNNWIDLYMWVEETVARFQSPNIRMCFITYSTDGQTVLPLTSDKNRIKNGLDQLQKIVPDGHTFMQAGFRKAIQQIESFNSGNKVPSMIIAMTDGELVAHAFQDTLREAQKARKLGANVYTLGVADYNLDQITAIADSPGHVFAVENGFKALRSTIDALTSKVCLDVTSVEPSSECVGEPYHVVIHGNGFQNLKKRDEVICRFIFNESTIIDEKPTSIDNNSMNCPGPKLEKPGEEYSIEVSLNKGKTFFKSNVSITSTTCGIFRNWLYFVPLLLLVPLLLCCVWRLCRKQTVKEPPPVQKPEKEPEQEKPPSPPPPPPPPPPPLPPPPPAPVNTCPTVIICCCGCQGVGGMRRIEGNLDTFCDLSHASCHQVPWMCCQSRDQGRYLSLALAQSQYAQAPCCPRICFPHSQECLSLPQAPCSPRMCLRHSRECLALKQARCSPNICLRHSQHSRECLARKQAPCSPRICLRHSPEYFSQAQTLCNPKSCLQPSRECLPLTCSSRCRLPPARCLRPPSRMLPLLSPLLRHTAEPPLSLPPSEPNF,631,"70,629",Chain (1); Compositional bias (2); Domain (1); Metal binding (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q13410,Butyrophilin subfamily 1 member A1 (BT),MAVFPSSGLPRCLLTLILLQLPKLDSAPFDVIGPPEPILAVVGEDAELPCRLSPNASAEHLELRWFRKKVSPAVLVHRDGREQEAEQMPEYRGRATLVQDGIAKGRVALRIRGVRVSDDGEYTCFFREDGSYEEALVHLKVAALGSDPHISMQVQENGEICLECTSVGWYPEPQVQWRTSKGEKFPSTSESRNPDEEGLFTVAASVIIRDTSAKNVSCYIQNLLLGQEKKVEISIPASSLPRLTPWIVAVAVILMVLGLLTIGSIFFTWRLYNERPRERRNEFSSKERLLEELKWKKATLHAVDVTLDPDTAHPHLFLYEDSKSVRLEDSRQKLPEKTERFDSWPCVLGRETFTSGRHYWEVEVGDRTDWAIGVCRENVMKKGFDPMTPENGFWAVELYGNGYWALTPLRTPLPLAGPPRRVGIFLDYESGDISFYNMNDGSDIYTFSNVTFSGPLRPFFCLWSSGKKPLTICPIADGPERVTVIANAQDLSKEIPLSPMGEDSAPRDADTLHSKLIPTQPSQGAP,526,"58,960",Chain (1); Disulfide bond (2); Domain (3); Glycosylation (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 164..218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..26;  /evidence=""ECO:0000250"""
Q9BWV1,Brother of CDO (Protein BOC),MLRGTMTAWRGMRPEVTLACLLLATAGCFADLNEVPQVTVQPASTVQKPGGTVILGCVVEPPRMNVTWRLNGKELNGSDDALGVLITHGTLVITALNNHTVGRYQCVARMPAGAVASVPATVTLANLQDFKLDVQHVIEVDEGNTAVIACHLPESHPKAQVRYSVKQEWLEASRGNYLIMPSGNLQIVNASQEDEGMYKCAAYNPVTQEVKTSGSSDRLRVRRSTAEAARIIYPPEAQTIIVTKGQSLILECVASGIPPPRVTWAKDGSSVTGYNKTRFLLSNLLIDTTSEEDSGTYRCMADNGVGQPGAAVILYNVQVFEPPEVTMELSQLVIPWGQSAKLTCEVRGNPPPSVLWLRNAVPLISSQRLRLSRRALRVLSMGPEDEGVYQCMAENEVGSAHAVVQLRTSRPSITPRLWQDAELATGTPPVSPSKLGNPEQMLRGQPALPRPPTSVGPASPQCPGEKGQGAPAEAPIILSSPRTSKTDSYELVWRPRHEGSGRAPILYYVVKHRKVTNSSDDWTISGIPANQHRLTLTRLDPGSLYEVEMAAYNCAGEGQTAMVTFRTGRRPKPEIMASKEQQIQRDDPGASPQSSSQPDHGRLSPPEAPDRPTISTASETSVYVTWIPRGNGGFPIQSFRVEYKKLKKVGDWILATSAIPPSRLSVEITGLEKGTSYKFRVRALNMLGESEPSAPSRPYVVSGYSGRVYERPVAGPYITFTDAVNETTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDKYWHSISHLQPETSYDIKMQCFNEGGESEFSNVMICETKARKSSGQPGRLPPPTLAPPQPPLPETIERPVGTGAMVARSSDLPYLIVGVVLGSIVLIIVTFIPFCLWRAWSKQKHTTDLGFPRSALPPSCPYTMVPLGGLPGHQASGQPYLSGISGRACANGIHMNRGCPSAAVGYPGMKPQQHCPGELQQQSDTSSLLRQTHLGNGYDPQSHQITRGPKSSPDEGSFLYTLPDDSTHQLLQPHHDCCQRQEQPAAVGQSGVRRAPDSPVLEAVWDPPFHSGPPCCLGLVPVEEVDSPDSCQVSGGDWCPQHPVGAYVGQEPGMQLSPGPLVRVSFETPPLTI,1114,"121,059",Alternative sequence (3); Beta strand (7); Chain (1); Disulfide bond (4); Domain (7); Erroneous initiation (1); Glycosylation (8); Helix (2); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 57..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 150..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 252..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..391;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000269|PubMed:15340161"""
P15813,Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d),MGCLLFLLLWALLQAWGSAEVPQRLFPLRCLQISSFANSSWTRTDGLAWLGELQTHSWSNDSDTVRSLKPWSQGTFSDQQWETLQHIFRVYRSSFTRDVKEFAKMLRLSYPLELQVSAGCEVHPGNASNNFFHVAFQGKDILSFQGTSWEPTQEAPLWVNLAIQVLNQDKWTRETVQWLLNGTCPQFVSGLLESGKSELKKQVKPKAWLSRGPSPGPGRLLLVCHVSGFYPKPVWVKWMRGEQEQQGTQPGDILPNADETWYLRATLDVVAGEAAGLSCRVKHSSLEGQDIVLYWGGSYTSMGLIALAVLACLLFLLIVGFTSRFKRQTSYQGVL,335,"37,717",Beta strand (17); Binding site (1); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (4); Helix (6); Motif (1); Mutagenesis (2); Natural variant (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 120..184;  /evidence=""ECO:0000244|PDB:1ZT4, ECO:0000244|PDB:2PO6, ECO:0000269|PubMed:16007090, ECO:0000269|PubMed:17581592""; DISULFID 224..279;  /evidence=""ECO:0000244|PDB:1ZT4, ECO:0000244|PDB:2PO6, ECO:0000269|PubMed:16007090, ECO:0000269|PubMed:17581592""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q96PD2,"Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)",MASRAVVRARRCPQCPQVRAAAAAPAWAALPLSRSLPPCSNSSSFSMPLFLLLLLVLLLLLEDAGAQQGDGCGHTVLGPESGTLTSINYPQTYPNSTVCEWEIRVKMGERVRIKFGDFDIEDSDSCHFNYLRIYNGIGVSRTEIGKYCGLGLQMNHSIESKGNEITLLFMSGIHVSGRGFLASYSVIDKQDLITCLDTASNFLEPEFSKYCPAGCLLPFAEISGTIPHGYRDSSPLCMAGVHAGVVSNTLGGQISVVISKGIPYYESSLANNVTSVVGHLSTSLFTFKTSGCYGTLGMESGVIADPQITASSVLEWTDHTGQENSWKPKKARLKKPGPPWAAFATDEYQWLQIDLNKEKKITGIITTGSTMVEHNYYVSAYRILYSDDGQKWTVYREPGVEQDKIFQGNKDYHQDVRNNFLPPIIARFIRVNPTQWQQKIAMKMELLGCQFIPKGRPPKLTQPPPPRNSNDLKNTTAPPKIAKGRAPKFTQPLQPRSSNEFPAQTEQTTASPDIRNTTVTPNVTKDVALAAVLVPVLVMVLTTLILILVCAWHWRNRKKKTEGTYDLPYWDRAGWWKGMKQFLPAKAVDHEETPVRYSSSEVNHLSPREVTTVLQADSAEYAQPLVGGIVGTLHQRSTFKPEEGKEAGYADLDPYNSPGQEVYHAYAEPLPITGPEYATPIIMDMSGHPTTSVGQPSTSTFKATGNQPPPLVGTYNTLLSRTDSCSSAQAQYDTPKAGKPGLPAPDELVYQVPQSTQEVSGAGRDGECDVFKEIL,775,"85,035",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (3); Glycosylation (6); Modified residue (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 72..99;  /evidence=""ECO:0000250""; DISULFID 126..148;  /evidence=""ECO:0000250""; DISULFID 215..237;  /evidence=""ECO:0000250""; DISULFID 292..449;  /evidence=""ECO:0000250""","SIGNAL 1..66;  /evidence=""ECO:0000255"""
P80370,Protein delta homolog 1 (DLK-1) (pG2) [Cleaved into: Fetal antigen 1 (FA1)],MTATEALLRVLLLLLAFGHSTYGAECFPACNPQNGFCEDDNVCRCQPGWQGPLCDQCVTSPGCLHGLCGEPGQCICTDGWDGELCDRDVRACSSAPCANNRTCVSLDDGLYECSCAPGYSGKDCQKKDGPCVINGSPCQHGGTCVDDEGRASHASCLCPPGFSGNFCEIVANSCTPNPCENDGVCTDIGGDFRCRCPAGFIDKTCSRPVTNCASSPCQNGGTCLQHTQVSYECLCKPEFTGLTCVKKRALSPQQVTRLPSGYGLAYRLTPGVHELPVQQPEHRILKVSMKELNKKTPLLTEGQAICFTILGVLTSLVVLGTVGIVFLNKCETWVSNLRYNHMLRKKKNLLLQYNSGEDLAVNIIFPEKIDMTTFSKEAGDEEI,383,"41,300",Alternative sequence (1); Chain (2); Disulfide bond (18); Domain (6); Frameshift (1); Glycosylation (11); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 26..37;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 30..43;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 45..54;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 57..68;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 63..74;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 76..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 92..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 97..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 115..124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 131..144;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 138..156;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 158..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 174..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 179..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 196..205;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 212..223;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 217..233;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 235..244;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:7925474, ECO:0000269|PubMed:8501199"""
Q70Z44,5-hydroxytryptamine receptor 3D (5-HT3-D) (5-HT3D) (Serotonin receptor 3D),MQKHSPGPPALALLSQSLLTTGNGDTLIINCPGFGQHRVDPAAFQAVFDRKAIGPVTNYSVATHVNISFTLSAIWNCYSRIHTFNCHHARPWHNQFVQWNPDECGGIKKSGMATENLWLSDVFIEESVDQTPAGLMASMSIVKATSNTISQCGWSASANWTPSISPSMDRARAWRRMSRSFQIHHRTSFRTRREWVLLGIQKRTIKVTVATNQYEQAIFHVAIRRRCRPSPYVVNFLVPSGILIAIDALSFYLPLESGNCAPFKMTVLLGYSVFLLMMNDLLPATSTSSHASLVAPLALMQTPLPAGVYFALCLSLMVGSLLETIFITHLLHVATTQPLPLPRWLHSLLLHCTGQGRCCPTAPQKGNKGPGLTPTHLPGVKEPEVSAGQMPGPGEAELTGGSEWTRAQREHEAQKQHSVELWVQFSHAMDALLFRLYLLFMASSIITVICLWNT,454,"50,191",Alternative sequence (8); Chain (1); Glycosylation (1); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (5); Transmembrane (4),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P16066,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),MPGPRRPAGSRLRLLLLLLLPPLLLLLRGSHAGNLTVAVVLPLANTSYPWSWARVGPAVELALAQVKARPDLLPGWTVRTVLGSSENALGVCSDTAAPLAAVDLKWEHNPAVFLGPGCVYAAAPVGRFTAHWRVPLLTAGAPALGFGVKDEYALTTRAGPSYAKLGDFVAALHRRLGWERQALMLYAYRPGDEEHCFFLVEGLFMRVRDRLNITVDHLEFAEDDLSHYTRLLRTMPRKGRVIYICSSPDAFRTLMLLALEAGLCGEDYVFFHLDIFGQSLQGGQGPAPRRPWERGDGQDVSARQAFQAAKIITYKDPDNPEYLEFLKQLKHLAYEQFNFTMEDGLVNTIPASFHDGLLLYIQAVTETLAHGGTVTDGENITQRMWNRSFQGVTGYLKIDSSGDRETDFSLWDMDPENGAFRVVLNYNGTSQELVAVSGRKLNWPLGYPPPDIPKCGFDNEDPACNQDHLSTLEVLALVGSLSLLGILIVSFFIYRKMQLEKELASELWRVRWEDVEPSSLERHLRSAGSRLTLSGRGSNYGSLLTTEGQFQVFAKTAYYKGNLVAVKRVNRKRIELTRKVLFELKHMRDVQNEHLTRFVGACTDPPNICILTEYCPRGSLQDILENESITLDWMFRYSLTNDIVKGMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDLDPEQGHTVYAKKLWTAPELLRMASPPVRGSQAGDVYSFGIILQEIALRSGVFHVEGLDLSPKEIIERVTRGEQPPFRPSLALQSHLEELGLLMQRCWAEDPQERPPFQQIRLTLRKFNRENSSNILDNLLSRMEQYANNLEELVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAVIDNFDVYKVETIGDAYMVVSGLPVRNGRLHACEVARMALALLDAVRSFRIRHRPQEQLRLRIGIHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGEALKIHLSSETKAVLEEFGGFELELRGDVEMKGKGKVRTYWLLGERGSSTRG,1061,"118,919",Binding site (3); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (7); Modified residue (7); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 92..118;  /evidence=""ECO:0000250""; DISULFID 196..245;  /evidence=""ECO:0000250""; DISULFID 455..464;  /evidence=""ECO:0000250""",SIGNAL 1..32
Q12864,Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin),MILQAHLHSLCLLMLYLATGYGQEGKFSGPLKPMTFSIYEGQEPSQIIFQFKANPPAVTFELTGETDNIFVIEREGLLYYNRALDRETRSTHNLQVAALDANGIIVEGPVPITIKVKDINDNRPTFLQSKYEGSVRQNSRPGKPFLYVNATDLDDPATPNGQLYYQIVIQLPMINNVMYFQINNKTGAISLTREGSQELNPAKNPSYNLVISVKDMGGQSENSFSDTTSVDIIVTENIWKAPKPVEMVENSTDPHPIKITQVRWNDPGAQYSLVDKEKLPRFPFSIDQEGDIYVTQPLDREEKDAYVFYAVAKDEYGKPLSYPLEIHVKVKDINDNPPTCPSPVTVFEVQENERLGNSIGTLTAHDRDEENTANSFLNYRIVEQTPKLPMDGLFLIQTYAGMLQLAKQSLKKQDTPQYNLTIEVSDKDFKTLCFVQINVIDINDQIPIFEKSDYGNLTLAEDTNIGSTILTIQATDADEPFTGSSKILYHIIKGDSEGRLGVDTDPHTNTGYVIIKKPLDFETAAVSNIVFKAENPEPLVFGVKYNASSFAKFTLIVTDVNEAPQFSQHVFQAKVSEDVAIGTKVGNVTAKDPEGLDISYSLRGDTRGWLKIDHVTGEIFSVAPLDREAGSPYRVQVVATEVGGSSLSSVSEFHLILMDVNDNPPRLAKDYTGLFFCHPLSAPGSLIFEATDDDQHLFRGPHFTFSLGSGSLQNDWEVSKINGTHARLSTRHTEFEEREYVVLIRINDGGRPPLEGIVSLPVTFCSCVEGSCFRPAGHQTGIPTVGMAVGILLTTLLVIGIILAVVFIRIKKDKGKDNVESAQASEVKPLRS,832,"92,219",Chain (1); Domain (7); Glycosylation (8); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P14209,CD99 antigen (12E7) (E2 antigen) (Protein MIC2) (T-cell surface glycoprotein E2) (CD antigen CD99),MARGAALALLLFGLLGVLVAAPDGGFDLSDALPDNENKKPTAIPKKPSAGDDFDLGDAVVDGENDDPRPPNPPKPMPNPNPNHPSSSGSFSDADLADGVSGGEGKGGSDGGGSHRKEGEEADAPGVIPGIVGAVVVAVAGAISSFIAYQKKKLCFKENAEQGEVDMESHRNANAEPAVQRTLLEK,185,"18,848",Alternative sequence (2); Chain (1); Modified residue (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:2479542"""
Q9BYE9,Cadherin-related family member 2 (Protocadherin LKC) (PC-LKC) (Protocadherin-24),MAQLWLSCFLLPALVVSVAANVAPKFLANMTSVILPEDLPVGAQAFWLVAEDQDNDPLTYGMSGPNAYFFAVTPKTGEVKLASALDYETLYTFKVTISVSDPYIQVQREMLVIVEDRNDNAPVFQNTAFSTSINETLPVGSVVFSVLAVDKDMGSAGMVVYSIEKVIPSTGDSEHLFRILANGSIVLNGSLSYNNKSAFYQLELKACDLGGMYHNTFTIQCSLPVFLSISVVDQPDLDPQFVREFYSASVAEDAAKGTSVLTVEAVDGDKGINDPVIYSISYSTRPGWFDIGADGVIRVNGSLDREQLLEADEEVQLQVTATETHLNIYGQEAKVSIWVTVRVMDVNDHKPEFYNCSLPACTFTPEEAQVNFTGYVDEHASPRIPIDDLTMVVYDPDKGSNGTFLLSLGGPDAEAFSVSPERAVGSASVQVLVRVSALVDYERQTAMAVQVVATDSVSQNFSVAMVTIHLRDINDHRPTFPQSLYVLTVPEHSATGSVVTDSIHATDPDTGAWGQITYSLLPGNGADLFQVDPVSGTVTVRNGELLDRESQAVYYLTLQATDGGNLSSSTTLQIHLLDINDNAPVVSGSYNIFVQEEEGNVSVTIQAHDNDEPGTNNSRLLFNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGVLVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDVNDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVTLVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATIPFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAALTQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGVALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDDNSVDVDKNSQEIKEHRPPHTPPEPDPEPLSVVLLGRQAGASGQLEGPSYTNAGLDTTDL,1310,"141,543",Beta strand (17); Chain (1); Domain (9); Erroneous initiation (1); Glycosylation (24); Helix (4); Modified residue (2); Mutagenesis (1); Natural variant (9); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q16832,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)",MILIPRMLLVLFLLLPILSSAKAQVNPAICRYPLGMSGGQIPDEDITASSQWSESTAAKYGRLDSEEGDGAWCPEIPVEPDDLKEFLQIDLHTLHFITLVGTQGRHAGGHGIEFAPMYKINYSRDGTRWISWRNRHGKQVLDGNSNPYDIFLKDLEPPIVARFVRFIPVTDHSMNVCMRVELYGCVWLDGLVSYNAPAGQQFVLPGGSIIYLNDSVYDGAVGYSMTEGLGQLTDGVSGLDDFTQTHEYHVWPGYDYVGWRNESATNGYIEIMFEFDRIRNFTTMKVHCNNMFAKGVKIFKEVQCYFRSEASEWEPNAISFPLVLDDVNPSARFVTVPLHHRMASAIKCQYHFADTWMMFSEITFQSDAAMYNNSEALPTSPMAPTTYDPMLKVDDSNTRILIGCLVAIIFILLAIIVIILWRQFWQKMLEKASRRMLDDEMTVSLSLPSDSSMFNNNRSSSPSEQGSNSTYDRIFPLRPDYQEPSRLIRKLPEFAPGEEESGCSGVVKPVQPSGPEGVPHYAEADIVNLQGVTGGNTYSVPAVTMDLLSGKDVAVEEFPRKLLTFKEKLGEGQFGEVHLCEVEGMEKFKDKDFALDVSANQPVLVAVKMLRADANKNARNDFLKEIKIMSRLKDPNIIHLLAVCITDDPLCMITEYMENGDLNQFLSRHEPPNSSSSDVRTVSYTNLKFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRRDTKNRPSFQEIHLLLLQQGDE,855,"96,736",Active site (1); Beta strand (21); Binding site (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (5); Helix (17); Modified residue (4); Mutagenesis (5); Natural variant (11); Nucleotide binding (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),DISULFID 30..185; DISULFID 73..177,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q8NER5,Activin receptor type-1C (EC 2.7.11.30) (Activin receptor type IC) (ACTR-IC) (Activin receptor-like kinase 7) (ALK-7),MTRALCSALRQALLLLAAAAELSPGLKCVCLLCDSSNFTCQTEGACWASVMLTNGKEQVIKSCVSLPELNAQVFCHSSNNVTKTECCFTDFCNNITLHLPTASPNAPKLGPMELAIIITVPVCLLSIAAMLTVWACQGRQCSYRKKKRPNVEEPLSECNLVNAGKTLKDLIYDVTASGSGSGLPLLVQRTIARTIVLQEIVGKGRFGEVWHGRWCGEDVAVKIFSSRDERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSEYHEQGSLYDYLNRNIVTVAGMIKLALSIASGLAHLHMEIVGTQGKPAIAHRDIKSKNILVKKCETCAIADLGLAVKHDSILNTIDIPQNPKVGTKRYMAPEMLDDTMNVNIFESFKRADIYSVGLVYWEIARRCSVGGIVEEYQLPYYDMVPSDPSIEEMRKVVCDQKFRPSIPNQWQSCEALRVMGRIMRECWYANGAARLTALRIKKTISQLCVKEDCKA,493,"54,871",Active site (1); Alternative sequence (3); Binding site (1); Chain (1); Domain (2); Mutagenesis (2); Natural variant (5); Nucleotide binding (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q13443,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQVSYVIQAEGKEHIIHLERNKDLLPEDFVVYTYNKEGTLITDHPNIQNHCHYRGYVEGVHNSSIALSDCFGLRGLLHLENASYGIEPLQNSSHFEHIIYRMDDVYKEPLKCGVSNKDIEKETAKDEEEEPPSMTQLLRRRRAVLPQTRYVELFIVVDKERYDMMGRNQTAVREEMILLANYLDSMYIMLNIRIVLVGLEIWTNGNLINIVGGAGDVLGNFVQWREKFLITRRRHDSAQLVLKKGFGGTAGMAFVGTVCSRSHAGGINVFGQITVETFASIVAHELGHNLGMNHDDGRDCSCGAKSCIMNSGASGSRNFSSCSAEDFEKLTLNKGGNCLLNIPKPDEAYSAPSCGNKLVDAGEECDCGTPKECELDPCCEGSTCKLKSFAECAYGDCCKDCRFLPGGTLCRGKTSECDVPEYCNGSSQFCQPDVFIQNGYPCQNNKAYCYNGMCQYYDAQCQVIFGSKAKAAPKDCFIEVNSKGDRFGNCGFSGNEYKKCATGNALCGKLQCENVQEIPVFGIVPAIIQTPSRGTKCWGVDFQLGSDVPDPGMVNEGTKCGAGKICRNFQCVDASVLNYDCDVQKKCHGHGVCNSNKNCHCENGWAPPNCETKGYGGSVDSGPTYNEMNTALRDGLLVFFFLIVPLIVCAIFIFIKRDQLWRSYFRKKRSQTYESDGKNQANPSRQPGSVPRHVSPVTPPREVPIYANRFAVPTYAAKQPQQFPSRPPPPQPKVSSQGNLIPARPAPAPPLYSSLT,819,"90,556",Active site (1); Alternative sequence (2); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (3); Glycosylation (6); Metal binding (3); Modified residue (2); Sequence conflict (7); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),"DISULFID 322..401;  /evidence=""ECO:0000250""; DISULFID 363..385;  /evidence=""ECO:0000250""; DISULFID 365..370;  /evidence=""ECO:0000250""; DISULFID 473..493;  /evidence=""ECO:0000250""; DISULFID 644..656;  /evidence=""ECO:0000250""; DISULFID 650..662;  /evidence=""ECO:0000250""; DISULFID 664..673;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q7Z6A9,B- and T-lymphocyte attenuator (B- and T-lymphocyte-associated protein) (CD antigen CD272),MKTLPAMLGTGKLFWVFFLIPYLDIWNIHGKESCDVQLYIKRQSEHSILAGDPFELECPVKYCANRPHVTWCKLNGTTCVKLEDRQTSWKEEKNISFFILHFEPVLPNDNGSYRCSANFQSNLIESHSTTLYVTDVKSASERPSKDEMASRPWLLYRLLPLGGLPLLITTCFCLFCCLRRHQGKQNELSDTAGREINLVDAHLKSEQTEASTRQNSQVLLSETGIYDNDPDLCFRMQEGSEVYSNPCLEENKPGIVYASLNHSVIGPNSRLARNVKEAPTEYASICVRS,289,"32,834",Alternative sequence (1); Beta strand (10); Chain (1); Disulfide bond (3); Domain (1); Erroneous initiation (1); Glycosylation (3); Helix (1); Mutagenesis (3); Natural variant (3); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..63;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16169851""; DISULFID 58..115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16169851""; DISULFID 72..79;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16169851""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P10747,T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28),MLRLLLALNLFPSIQVTGNKILVKQSPMLVAYDNAVNLSCKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYSKTGFNCDGKLGNESVTFYLQNLYVNQTDIYFCKIEVMYPPPYLDNEKSNGTIIHVKGKHLCPSPLFPGPSKPFWVLVVVGGVLACYSLLVTVAFIIFWVRSKRSRLLHSDYMNMTPRRPGPTRKHYQPYAPPRDFAAYRS,220,"25,066",Alternative sequence (7); Beta strand (11); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (5); Helix (1); Modified residue (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 40..112;  /evidence=""ECO:0000269|PubMed:15696168""; DISULFID 66..86;  /evidence=""ECO:0000269|PubMed:15696168""",SIGNAL 1..18
Q9UHC6,Contactin-associated protein-like 2 (Cell recognition molecule Caspr2),MQAAPRAGCGAALLLWIVSSCLCRAWTAPSTSQKCDEPLVSGLPHVAFSSSSSISGSYSPGYAKINKRGGAGGWSPSDSDHYQWLQVDFGNRKQISAIATQGRYSSSDWVTQYRMLYSDTGRNWKPYHQDGNIWAFPGNINSDGVVRHELQHPIIARYVRIVPLDWNGEGRIGLRIEVYGCSYWADVINFDGHVVLPYRFRNKKMKTLKDVIALNFKTSESEGVILHGEGQQGDYITLELKKAKLVLSLNLGSNQLGPIYGHTSVMTGSLLDDHHWHSVVIERQGRSINLTLDRSMQHFRTNGEFDYLDLDYEITFGGIPFSGKPSSSSRKNFKGCMESINYNGVNITDLARRKKLEPSNVGNLSFSCVEPYTVPVFFNATSYLEVPGRLNQDLFSVSFQFRTWNPNGLLVFSHFADNLGNVEIDLTESKVGVHINITQTKMSQIDISSGSGLNDGQWHEVRFLAKENFAILTIDGDEASAVRTNSPLQVKTGEKYFFGGFLNQMNNSSHSVLQPSFQGCMQLIQVDDQLVNLYEVAQRKPGSFANVSIDMCAIIDRCVPNHCEHGGKCSQTWDSFKCTCDETGYSGATCHNSIYEPSCEAYKHLGQTSNYYWIDPDGSGPLGPLKVYCNMTEDKVWTIVSHDLQMQTPVVGYNPEKYSVTQLVYSASMDQISAITDSAEYCEQYVSYFCKMSRLLNTPDGSPYTWWVGKANEKHYYWGGSGPGIQKCACGIERNCTDPKYYCNCDADYKQWRKDAGFLSYKDHLPVSQVVVGDTDRQGSEAKLSVGPLRCQGDRNYWNAASFPNPSSYLHFSTFQGETSADISFYFKTLTPWGVFLENMGKEDFIKLELKSATEVSFSFDVGNGPVEIVVRSPTPLNDDQWHRVTAERNVKQASLQVDRLPQQIRKAPTEGHTRLELYSQLFVGGAGGQQGFLGCIRSLRMNGVTLDLEERAKVTSGFISGCSGHCTSYGTNCENGGKCLERYHGYSCDCSNTAYDGTFCNKDVGAFFEEGMWLRYNFQAPATNARDSSSRVDNAPDQQNSHPDLAQEEIRFSFSTTKAPCILLYISSFTTDFLAVLVKPTGSLQIRYNLGGTREPYNIDVDHRNMANGQPHSVNITRHEKTIFLKLDHYPSVSYHLPSSSDTLFNSPKSLFLGKVIETGKIDQEIHKYNTPGFTGCLSRVQFNQIAPLKAALRQTNASAHVHIQGELVESNCGASPLTLSPMSSATDPWHLDHLDSASADFPYNPGQGQAIRNGVNRNSAIIGGVIAVVIFTILCTLVFLIRYMFRHKGTYHTNEAKGAESAESADAAIMNNDPNFTETIDESKKEWLI,1331,"148,167",Alternative sequence (1); Beta strand (8); Chain (1); Disulfide bond (11); Domain (8); Erroneous initiation (1); Glycosylation (12); Helix (3); Modified residue (2); Natural variant (22); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..181;  /evidence=""ECO:0000250""; DISULFID 336..368;  /evidence=""ECO:0000250""; DISULFID 520..552;  /evidence=""ECO:0000250""; DISULFID 558..569;  /evidence=""ECO:0000250""; DISULFID 563..578;  /evidence=""ECO:0000250""; DISULFID 580..590;  /evidence=""ECO:0000250""; DISULFID 936..963;  /evidence=""ECO:0000250""; DISULFID 967..980;  /evidence=""ECO:0000250""; DISULFID 974..989;  /evidence=""ECO:0000250""; DISULFID 991..1001;  /evidence=""ECO:0000250""; DISULFID 1178..1214;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9H2U9,Disintegrin and metalloproteinase domain-containing protein 7 (ADAM 7) (Sperm maturation-related glycoprotein GP-83),MLPGCIFLMILLIPQVKEKFILGVEGQQLVRPKKLPLIQKRDTGHTHDDDILKTYEEELLYEIKLNRKTLVLHLLRSREFLGSNYSETFYSMKGEAFTRHPQIMDHCFYQGSIVHEYDSAASISTCNGLRGFFRINDQRYLIEPVKYSDEGEHLVFKYNLRVPYGANYSCTELNFTRKTVPGDNESEEDSKIKGIHDEKYVELFIVADDTVYRRNGHPHNKLRNRIWGMVNFVNMIYKTLNIHVTLVGIEIWTHEDKIELYSNIETTLLRFSFWQEKILKTRKDFDHVVLLSGKWLYSHVQGISYPGGMCLPYYSTSIIKDLLPDTNIIANRMAHQLGHNLGMQHDEFPCTCPSGKCVMDSDGSIPALKFSKCSQNQYHQYLKDYKPTCMLNIPFPYNFHDFQFCGNKKLDEGEECDCGPAQECTNPCCDAHTCVLKPGFTCAEGECCESCQIKKAGSICRPAKDECDFPEMCTGHSPACPKDQFRVNGFPCKNSEGYCFMGKCPTREDQCSELFDDEAIESHDICYKMNTKGNKFGYCKNKENRFLPCEEKDVRCGKIYCTGGELSSLLGEDKTYHLKDPQKNATVKCKTIFLYHDSTDIGLVASGTKCGEGMVCNNGECLNMEKVYISTNCPSQCNENPVDGHGLQCHCEEGQAPVACEETLHVTNITILVVVLVLVIVGIGVLILLVRYRKCIKLKQVQSPPTETLGVENKGYFGDEQQIRTEPILPEIHFLNKPASKDSRGIADPNQSAK,754,"85,669",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (2); Glycosylation (6); Natural variant (20); Propeptide (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 310..389;  /evidence=""ECO:0000250""; DISULFID 350..373;  /evidence=""ECO:0000250""; DISULFID 352..357;  /evidence=""ECO:0000250""; DISULFID 460..480;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q5T601,Adhesion G-protein coupled receptor F1 (G protein-coupled receptor 110) (G protein-coupled receptor KPG_012) (G protein-coupled receptor PGR19),MKVGVLWLISFFTFTDGHGGFLGKNDGIKTKKELIVNKKKHLGPVEEYQLLLQVTYRDSKEKRDLRNFLKLLKPPLLWSHGLIRIIRAKATTDCNSLNGVLQCTCEDSYTWFPPSCLDPQNCYLHTAGALPSCECHLNNLSQSVNFCERTKIWGTFKINERFTNDLLNSSSAIYSKYANGIEIQLKKAYERIQGFESVQVTQFRNGSIVAGYEVVGSSSASELLSAIEHVAEKAKTALHKLFPLEDGSFRVFGKAQCNDIVFGFGSKDDEYTLPCSSGYRGNITAKCESSGWQVIRETCVLSLLEELNKNFSMIVGNATEAAVSSFVQNLSVIIRQNPSTTVGNLASVVSILSNISSLSLASHFRVSNSTMEDVISIADNILNSASVTNWTVLLREEKYASSRLLETLENISTLVPPTALPLNFSRKFIDWKGIPVNKSQLKRGYSYQIKMCPQNTSIPIRGRVLIGSDQFQRSLPETIISMASLTLGNILPVSKNGNAQVNGPVISTVIQNYSINEVFLFFSKIESNLSQPHCVFWDFSHLQWNDAGCHLVNETQDIVTCQCTHLTSFSILMSPFVPSTIFPVVKWITYVGLGISIGSLILCLIIEALFWKQIKKSQTSHTRRICMVNIALSLLIADVWFIVGATVDTTVNPSGVCTAAVFFTHFFYLSLFFWMLMLGILLAYRIILVFHHMAQHLMMAVGFCLGYGCPLIISVITIAVTQPSNTYKRKDVCWLNWSNGSKPLLAFVVPALAIVAVNFVVVLLVLTKLWRPTVGERLSRDDKATIIRVGKSLLILTPLLGLTWGFGIGTIVDSQNLAWHVIFALLNAFQGFFILCFGILLDSKLRQLLFNKLSALSSWKQTEKQNSSDLSAKPKFSKPFNPLQNKGHYAFSHTGDSSDNIMLTQFVSNE,910,"101,365",Alternative sequence (2); Chain (1); Domain (2); Erroneous gene model prediction (2); Erroneous initiation (1); Glycosylation (19); Natural variant (1); Sequence caution (1); Sequence conflict (4); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q13705,Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB),MTAPWVALALLWGSLCAGSGRGEAETRECIYYNANWELERTNQSGLERCEGEQDKRLHCYASWRNSSGTIELVKKGCWLDDFNCYDRQECVATEENPQVYFCCCEGNFCNERFTHLPEAGGPEVTYEPPPTAPTLLTVLAYSLLPIGGLSLIVLLAFWMYRHRKPPYGHVDIHEDPGPPPPSPLVGLKPLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVSLIRRSVNGTTSDCLVSLVTSVTNVDLPPKESSI,512,"57,724",Active site (1); Beta strand (20); Binding site (1); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Helix (15); Natural variant (4); Nucleotide binding (1); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 29..59;  /evidence=""ECO:0000269|PubMed:22718755""; DISULFID 49..77;  /evidence=""ECO:0000269|PubMed:22718755""; DISULFID 84..103;  /evidence=""ECO:0000269|PubMed:22718755""; DISULFID 90..102;  /evidence=""ECO:0000269|PubMed:22718755""; DISULFID 104..109;  /evidence=""ECO:0000269|PubMed:22718755""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q6UXE8,Butyrophilin-like protein 3 (Butyrophilin-like receptor),MAFVLILVLSFYELVSGQWQVTGPGKFVQALVGEDAVFSCSLFPETSAEAMEVRFFRNQFHAVVHLYRDGEDWESKQMPQYRGRTEFVKDSIAGGRVSLRLKNITPSDIGLYGCWFSSQIYDEEATWELRVAALGSLPLISIVGYVDGGIQLLCLSSGWFPQPTAKWKGPQGQDLSSDSRANADGYSLYDVEISIIVQENAGSILCSIHLAEQSHEVESKVLIGETFFQPSPWRLASILLGLLCGALCGVVMGMIIVFFKSKGKIQAELDWRRKHGQAELRDARKHAVEVTLDPETAHPKLCVSDLKTVTHRKAPQEVPHSEKRFTRKSVVASQGFQAGKHYWEVDVGQNVGWYVGVCRDDVDRGKNNVTLSPNNGYWVLRLTTEHLYFTFNPHFISLPPSTPPTRVGVFLDYEGGTISFFNTNDQSLIYTLLTCQFEGLLRPYIQHAMYDEEKGTPIFICPVSWG,466,"52,251",Alternative sequence (2); Chain (1); Domain (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9C0A0,Contactin-associated protein-like 4 (Cell recognition molecule Caspr4),MGSVTGAVLKTLLLLSTQNWNRVEAGNSYDCDDPLVSALPQASFSSSSELSSSHGPGFARLNRRDGAGGWSPLVSNKYQWLQIDLGERMEVTAVATQGGYGSSNWVTSYLLMFSDSGWNWKQYRQEDSIWGFSGNANADSVVYYRLQPSIKARFLRFIPLEWNPKGRIGMRIEVFGCAYRSEVVDLDGKSSLLYRFDQKSLSPIKDIISLKFKTMQSDGILLHREGPNGDHITLQLRRARLFLLINSGEAKLPSTSTLVNLTLGSLLDDQHWHSVLIQRLGKQVNFTVDEHRHHFHARGEFNLMNLDYEISFGGIPAPGKSVSFPHRNFHGCLENLYYNGVDIIDLAKQQKPQIIAMGNVSFSCSQPQSMPVTFLSSRSYLALPDFSGEEEVSATFQFRTWNKAGLLLFSELQLISGGILLFLSDGKLKSNLYQPGKLPSDITAGVELNDGQWHSVSLSAKKNHLSVAVDGQMASAAPLLGPEQIYSGGTYYFGGCPDKSFGSKCKSPLGGFQGCMRLISISGKVVDLISVQQGSLGNFSDLQIDSCGISDRCLPNYCEHGGECSQSWSTFHCNCTNTGYRGATCHNSIYEQSCEAYKHRGNTSGFYYIDSDGSGPLEPFLLYCNMTETAWTIIQHNGSDLTRVRNTNPENPYAGFFEYVASMEQLQATINRAEHCEQEFTYYCKKSRLVNKQDGTPLSWWVGRTNETQTYWGGSSPDLQKCTCGLEGNCIDSQYYCNCDADRNEWTNDTGLLAYKEHLPVTKIVITDTGRLHSEAAYKLGPLLCQGDRSFWNSASFDTEASYLHFPTFHGELSADVSFFFKTTASSGVFLENLGIADFIRIELRSPTVVTFSFDVGNGPFEISVQSPTHFNDNQWHHVRVERNMKEASLQVDQLTPKTQPAPADGHVLLQLNSQLFVGGTATRQRGFLGCIRSLQLNGMTLDLEERAQVTPEVQPGCRGHCSSYGKLCRNGGKCRERPIGFFCDCTFSAYTGPFCSNEISAYFGSGSSVIYNFQENYLLSKNSSSHAASFHGDMKLSREMIKFSFRTTRTPSLLLFVSSFYKEYLSVIIAKNGSLQIRYKLNKYQEPDVVNFDFKNMADGQLHHIMINREEGVVFIEIDDNRRRQVHLSSGTEFSAVKSLVLGRILEHSDVDQDTALAGAQGFTGCLSAVQLSHVAPLKAALHPSHPDPVTVTGHVTESSCMAQPGTDATSRERTHSFADHSGTIDDREPLANAIKSDSAVIGGLIAVVIFILLCITAIAVRIYQQKRLYKRSEAKRSENVDSAEAVLKSELNIQNAVNENQKEYFF,1308,"145,274",Alternative sequence (2); Beta strand (1); Chain (1); Disulfide bond (11); Domain (8); Erroneous initiation (1); Glycosylation (12); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 31..177;  /evidence=""ECO:0000250""; DISULFID 332..364;  /evidence=""ECO:0000250""; DISULFID 515..547;  /evidence=""ECO:0000250""; DISULFID 553..564;  /evidence=""ECO:0000250""; DISULFID 558..573;  /evidence=""ECO:0000250""; DISULFID 575..585;  /evidence=""ECO:0000250""; DISULFID 931..958;  /evidence=""ECO:0000250""; DISULFID 962..975;  /evidence=""ECO:0000250""; DISULFID 969..984;  /evidence=""ECO:0000250""; DISULFID 986..996;  /evidence=""ECO:0000250""; DISULFID 1167..1202;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q96HD1,Protein disulfide isomerase CRELD1 (EC 5.3.4.1) (Cysteine-rich with EGF-like domain protein 1),MAPWPPKGLVPAMLWGLSLFLNLPGPIWLQPSPPPQSSPPPQPHPCHTCRGLVDSFNKGLERTIRDNFGGGNTAWEEENLSKYKDSETRLVEVLEGVCSKSDFECHRLLELSEELVESWWFHKQQEAPDLFQWLCSDSLKLCCPAGTFGPSCLPCPGGTERPCGGYGQCEGEGTRGGSGHCDCQAGYGGEACGQCGLGYFEAERNASHLVCSACFGPCARCSGPEESNCLQCKKGWALHHLKCVDIDECGTEGANCGADQFCVNTEGSYECRDCAKACLGCMGAGPGRCKKCSPGYQQVGSKCLDVDECETEVCPGENKQCENTEGGYRCICAEGYKQMEGICVKEQIPESAGFFSEMTEDELVVLQQMFFGIIICALATLAAKGDLVFTAIFIGAVAAMTGYWLSERSDRVLEGFIKGR,420,"45,440",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (8); Domain (2); Glycosylation (2); Motif (2); Natural variant (6); Repeat (2); Sequence conflict (6); Signal peptide (1); Topological domain (3); Transmembrane (2),"DISULFID 46..49;  /note=""Redox-active"";  /evidence=""ECO:0000250|UniProtKB:Q9CYA0""; DISULFID 155..169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 163..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 183..192;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 278..281;  /note=""Redox-active"";  /evidence=""ECO:0000250|UniProtKB:Q9CYA0""; DISULFID 309..321;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 314..330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 332..343;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q14574,Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP),MAAAGPRRSVRGAVCLHLLLTLVIFSRAGEACKKVILNVPSKLEADKIIGRVNLEECFRSADLIRSSDPDFRVLNDGSVYTARAVALSDKKRSFTIWLSDKRKQTQKEVTVLLEHQKKVSKTRHTRETVLRRAKRRWAPIPCSMQENSLGPFPLFLQQVESDAAQNYTVFYSISGRGVDKEPLNLFYIERDTGNLFCTRPVDREEYDVFDLIAYASTADGYSADLPLPLPIRVEDENDNHPVFTEAIYNFEVLESSRPGTTVGVVCATDRDEPDTMHTRLKYSILQQTPRSPGLFSVHPSTGVITTVSHYLDREVVDKYSLIMKVQDMDGQFFGLIGTSTCIITVTDSNDNAPTFRQNAYEAFVEENAFNVEILRIPIEDKDLINTANWRVNFTILKGNENGHFKISTDKETNEGVLSVVKPLNYEENRQVNLEIGVNNEAPFARDIPRVTALNRALVTVHVRDLDEGPECTPAAQYVRIKENLAVGSKINGYKAYDPENRNGNGLRYKKLHDPKGWITIDEISGSIITSKILDREVETPKNELYNITVLAIDKDDRSCTGTLAVNIEDVNDNPPEILQEYVVICKPKMGYTDILAVDPDEPVHGAPFYFSLPNTSPEISRLWSLTKVNDTAARLSYQKNAGFQEYTIPITVKDRAGQAATKLLRVNLCECTHPTQCRATSRSTGVILGKWAILAILLGIALLFSVLLTLVCGVFGATKGKRFPEDLAQQNLIISNTEAPGDDRVCSANGFMTQTTNNSSQGFCGTMGSGMKNGGQETIEMMKGGNQTLESCRGAGHHHTLDSCRGGHTEVDNCRYTYSEWHSFTQPRLGEKLHRCNQNEDRMPSQDYVLTYNYEGRGSPAGSVGCCSEKQEEDGLDFLNNLEPKFITLAEACTKR,896,"99,969",Alternative sequence (2); Chain (1); Domain (5); Glycosylation (4); Natural variant (6); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9UNE0,Tumor necrosis factor receptor superfamily member EDAR (Anhidrotic ectodysplasin receptor 1) (Downless homolog) (EDA-A1 receptor) (Ectodermal dysplasia receptor) (Ectodysplasin-A receptor),MAHVGDCTQTPWLPVLVVSLMCSARAEYSNCGENEYYNQTTGLCQECPPCGPGEEPYLSCGYGTKDEDYGCVPCPAEKFSKGGYQICRRHKDCEGFFRATVLTPGDMENDAECGPCLPGYYMLENRPRNIYGMVCYSCLLAPPNTKECVGATSGASANFPGTSGSSTLSPFQHAHKELSGQGHLATALIIAMSTIFIMAIAIVLIIMFYILKTKPSAPACCTSHPGKSVEAQVSKDEEKKEAPDNVVMFSEKDEFEKLTATPAKPTKSENDASSENEQLLSRSVDSDEEPAPDKQGSPELCLLSLVHLAREKSATSNKSAGIQSRRKKILDVYANVCGVVEGLSPTELPFDCLEKTSRMLSSTYNSEKAVVKTWRHLAESFGLKRDEIGGMTDGMQLFDRISTAGYSIPELLTKLVQIERLDAVESLCADILEWAGVVPPASQPHAAS,448,"48,582",Alternative sequence (1); Chain (1); Disulfide bond (6); Domain (1); Glycosylation (1); Mutagenesis (1); Natural variant (20); Repeat (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 31..44;  /evidence=""ECO:0000250""; DISULFID 47..60;  /evidence=""ECO:0000250""; DISULFID 50..71;  /evidence=""ECO:0000250""; DISULFID 74..87;  /evidence=""ECO:0000250""; DISULFID 93..113;  /evidence=""ECO:0000250""; DISULFID 135..148;  /evidence=""ECO:0000250""","SIGNAL 1..26;  /evidence=""ECO:0000269|PubMed:15340161"""
Q86V85,Integral membrane protein GPR180 (Intimal thickness-related receptor),MGGLRLLAVALTCCWWPQGSQGKTLRGSFSSTAAQDAQGQRIGHFEFHGDHALLCVRINNIAVAVGKEAKLYLFQAQEWLKLQQSSHGYSCSEKLSKAQLTMTMNQTEHNLTVSQIPSPQTWHVFYADKYTCQDDKENSQVEDIPFEMVLLNPDAEGNPFDHFSAGESGLHEFFFLLVLVYFVIACIYAQSLWQAIKKGGPMHMILKVLTTALLLQAGSALANYIHFSSYSKDGIGVPFMGSLAEFFDIASQIQMLYLLLSLCMGWTIVRMKKSQSRPLQWDSTPASTGIAVFIVMTQSVLLLWEQFEDISHHSYHSHHNLAGILLIVLRICLALSLGCGLYQIITVERSTLKREFYITFAKGCILWFLCHPVLACISVIFSDYQRDKVITIGVILCQSVSMVILYRLFLSHSLYWEVSSLSSVTLPLTISSGHKSRPHF,440,"49,395",Chain (1); Glycosylation (2); Natural variant (1); Signal peptide (1); Transmembrane (7),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q6MZM0,Ferroxidase HEPHL1 (EC 1.16.3.1) (Hephaestin-like protein 1),MPRKQPAGCIFLLTFLGLSGLVGTVTRTYYIGIVEEYWNYVPQGKNVITGKSFTEDKLATLFLERGPNRIGSIYKKAVYRRFTDGTYSIEIPKPPWLGFLGPILRAEVGDVIVIHLKNFASRPYSLHPHGVFYNKDSEGALYPDGTSGRNKNDDMVPPGKNYTYVWPVREEYAPTPADANCLTWVYHSHIDAPKDICSGLIGPLLVCKEGILNRYSGTRNDVDREFVIMFTLVDENQSWYLNENIKHFCTNPDSVDKKDAVFQRSNKMHALNGYLFGNFPEPDMCVGESVSWHLFGMGNEIDIHSIYFYGNTFISRGHRTDVVNLFPATFLTTEMIAENPGKWMITCQVSDHLQAGMLGQYNVDNCKSDIFYPKMKGQQRRYFIAAEKILWDYAPQGYNKFSGLPLNASGSDSDLYFTQGDNRIGGKYWKVRYTEFVDATFTKRKRLSAEEAHLGILGPVIKAEVGDTLLVTFANKADKVYSILPHGVIYDKASDAAPNLDGFVKPGAHVKPGETFTYKWTVPESVSPTAGDPPCLTYLYFSAVDPIKDTSSGLVGPLLVCKKGVLNADGTQKGIDKEFYLLFTVFDENLSRYFDENIQKFIWHPFSIDKEDKEFVKSNRMHAVNGYMYGNQPGLNMCKRDRVSWHLIGLGTDTDMHGIVFQGNTIHLRGTHRDSLALFPHMATTAFMQPDHAGIFRVFCATMPHLSRGMGQIYEVSSCDNRDPSEQRYGMIRTFYIAAEEVEWDYAPNKNWEFEKQHVDARGERHGDIFMNRTENWIGSQYKKVVYREYTDGEFVEIKARPPREEHLELLGPMIHAEVGNTVLIIFKNKASRPYSISAQGVEEMDSGKQFQVPMTKPGEVKTYRWNIPKRSGPGPSDPNCIPWVYYSTVNFVKDTYSGLMGPLITCRKGVLNEKGRRSDVDYEFALLFLVFNENESWYLDDNIKKYLNKDPRDFKRTDDFEESNRMHAINGKIFGNLHGLIMNEDTMTNWYLLGIGSEVDIHTIHYHAESFLFKIDKSYREDVYDLFPGTFQTIELFADHPGTWLLHCHVSDHIHAGMETTYTVLRNIDNRIPYSTTSPGVASHPATVPSNERPGKEQLYFFGKNLGPTGAKAALVILFIIGLLLLITTVILSLRLCSAMKQTDYQQVQSCALPTDAL,1159,"131,603",Chain (1); Compositional bias (1); Disulfide bond (5); Domain (6); Glycosylation (6); Metal binding (19); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 181..207;  /evidence=""ECO:0000255""; DISULFID 285..366;  /evidence=""ECO:0000255""; DISULFID 535..561;  /evidence=""ECO:0000255""; DISULFID 638..719;  /evidence=""ECO:0000255""; DISULFID 881..907;  /evidence=""ECO:0000255""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P17693,"HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain G (sHLA-G)]",MVVMAPRTLFLLLSGALTLTETWAGSHSMRYFSAAVSRPGRGEPRFIAMGYVDDTQFVRFDSDSACPRMEPRAPWVEQEGPEYWEEETRNTKAHAQTDRMNLQTLRGYYNQSEASSHTLQWMIGCDLGSDGRLLRGYEQYAYDGKDYLALNEDLRSWTAADTAAQISKRKCEAANVAEQRRAYLEGTCVEWLHRYLENGKEMLQRADPPKTHVTHHPVFDYEATLRCWALGFYPAEIILTWQRDGEDQTQDVELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLMLRWKQSSLPTIPIMGIVAGLVVLAAVVTGAAVAAVLWRKKSSD,338,"38,224",Alternative sequence (7); Beta strand (20); Binding site (10); Chain (2); Disulfide bond (4); Domain (1); Glycosylation (1); Helix (8); Motif (1); Mutagenesis (5); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 66;  /note=""Interchain"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12454284, ECO:0000269|PubMed:12874224""; DISULFID 125..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:15718280, ECO:0000269|PubMed:16455647, ECO:0000269|PubMed:17056715, ECO:0000269|PubMed:20122941""; DISULFID 171;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:12874224""; DISULFID 227..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:15718280, ECO:0000269|PubMed:16455647, ECO:0000269|PubMed:17056715, ECO:0000269|PubMed:20122941""",SIGNAL 1..24
P01893,"Putative HLA class I histocompatibility antigen, alpha chain H (HLA-12.4) (HLA-AR) (MHC class I antigen H)",MVLMAPRTLLLLLSGALALTQTWARSHSMRYFYTTMSRPGAGEPRFISVGYVDDTQFVRFDSDDASPREEPRAPWMEREGPKYWDRNTQICKAQAQTERENLRIALRYYNQSEGGSHTMQVMYGCDVGPDGPFLRGYEQHAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAARRAEQRRVYLEGEFVEWLRRYLENGKETLQRADPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWEPSSQPTVPIVGIVAGLVLLVAVVTGAVVAAVMWRKKSSDRKGGSYSQAASSNSAQGSDVSLTA,362,"40,892",Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (1); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 227..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q6GPH6,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1",MNVDAEASMAVISLLFLAVMYVVHHPLMVSDRMDLDTLARSRQLEKRMSEEMRLLEMEFEERKRAAEQRQKAENFWTGDTSSDQLVLGKKDMGWPFQADGQEGPLGWMLGNLWNTGLFCLFLVFELLRQNMQHEPAFDSSSEEEEEEVRVVPVTSYNWLTDFPSQEALDSFYKHYVQNAIRDLPCTCEFVESFVDDLIEACRVLSRQEAHPQLEDCLGIGAAFEKWGTLHETQKFDILVPIVPPQGTMFVLEMRDPALGRRCGCVLVESECVCKREKLLGDVLCLVHHHRDPSAVLGKCSSSIKAALCTGFHLDVCKTVQWFRNMMGNAWALVAHKYDFKLSLPPSTTSCKLRLDYRSGRFLSIHLVLGVQREDTLVYLVSQAPDQEQLTSVDWPESFVACEHLFLKLVGRFAPENTCHLKCLQIILSLRQHQSLPHGASRPILTSYHFKTALMHLLLRLPLTDWAHNMLSQRLQDILWFLGRGLQQRSLHHFLIGNNFLPLTIPIPKTFRNAEPVNLFQHLVLNPKAHSQAVEEFQNLLTQVKTLPHAPLAAAP,555,"63,395",Alternative sequence (2); Chain (1); Coiled coil (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q6UWL6,Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3),MLRMRVPALLVLLFCFRGRAGPSPHFLQQPEDLVVLLGEEARLPCALGAYWGLVQWTKSGLALGGQRDLPGWSRYWISGNAANGQHDLHIRPVELEDEASYECQATQAGLRSRPAQLHVLVPPEAPQVLGGPSVSLVAGVPANLTCRSRGDARPTPELLWFRDGVLLDGATFHQTLLKEGTPGSVESTLTLTPFSHDDGATFVCRARSQALPTGRDTAITLSLQYPPEVTLSASPHTVQEGEKVIFLCQATAQPPVTGYRWAKGGSPVLGARGPRLEVVADASFLTEPVSCEVSNAVGSANRSTALDVLFGPILQAKPEPVSVDVGEDASFSCAWRGNPLPRVTWTRRGGAQVLGSGATLRLPSVGPEDAGDYVCRAEAGLSGLRGGAAEARLTVNAPPVVTALHSAPAFLRGPARLQCLVFASPAPDAVVWSWDEGFLEAGSQGRFLVETFPAPESRGGLGPGLISVLHISGTQESDFSRSFNCSARNRLGEGGAQASLGRRDLLPTVRIVAGVAAATTTLLMVITGVALCCWRHSKASASFSEQKNLMRIPGSSDGSSSRGPEEEETGSREDRGPIVHTDHSDLVLEEKGTLETKDPTNGYYKVRGVSVSLSLGEAPGGGLFLPPPSPLGPPGTPTFYDFNPHLGMVPPCRLYRARAGYLTTPHPRAFTSYIKPTSFGPPDLAPGTPPFPYAAFPTPSHPRLQTHV,708,"75,092",Alternative sequence (5); Chain (1); Compositional bias (2); Disulfide bond (5); Domain (5); Glycosylation (3); Modified residue (4); Motif (1); Natural variant (5); Sequence caution (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 45..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..204;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 248..291;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 333..375;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 419..485;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
Q496F6,CMRF35-like molecule 2 (CLM-2) (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2) (IREM-2) (Polymeric immunoglobulin receptor 2) (PIgR-2) (PIgR2) (Poly-Ig receptor 2) (CD antigen CD300e),MWLLPALLLLCLSGCLSLKGPGSVTGTAGDSLTVWCQYESMYKGYNKYWCRGQYDTSCESIVETKGEEKVERNGRVSIRDHPEALAFTVTMQNLNEDDAGSYWCKIQTVWVLDSWSRDPSDLVRVYVSPAITTPRRTTHPATPPIFLVVNPGRNLSTGEVLTQNSGFRLSSPHFLLVVLLKLPLLLSMLGAVFWVNRPQWAPPGR,205,"22,918",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 36..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q6UXZ3,CMRF35-like molecule 5 (CLM-5) (CD300 antigen-like family member D) (CMRF35-A4) (CD antigen CD300d),MWLSPSLLLLILPGYSIAAKITGPTTVNGSEQGSLTVQCAYGSGWETYLKWRCQGADWNYCNILVKTNGSEQEVKKNRVSIRDNQKNHVFTVTMENLKRDDADSYWCGTERPGIDLGVKVQVTINPGTQTAVSEWTTTTASLAFTAAATQKTSSPLTRSPLKSTHFLFLFLLELPLLLSMLGTVLWVNRPQRRS,194,"21,558",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Glycosylation (1); Mutagenesis (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 39..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q4G0I0,Protein CCSMST1,MNRVLCAPAAGAVRALRLIGWASRSLHPLPGSRDRAHPAAEEEDDPDRPIEFSSSKANPHRWSVGHTMGKGHQRPWWKVLPLSCFLVALIIWCYLREESEADQWLRQVWGEVPEPSDRSEEPETPAAYRART,132,"15,004",Chain (1); Erroneous gene model prediction (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..15;  /evidence=""ECO:0000255"""
O00548,Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1),MGSRCALALAVLSALLCQVWSSGVFELKLQEFVNKKGLLGNRNCCRGGAGPPPCACRTFFRVCLKHYQASVSPEPPCTYGSAVTPVLGVDSFSLPDGGGADSAFSNPIRFPFGFTWPGTFSLIIEALHTDSPDDLATENPERLISRLATQRHLTVGEEWSQDLHSSGRTDLKYSYRFVCDEHYYGEGCSVFCRPRDDAFGHFTCGERGEKVCNPGWKGPYCTEPICLPGCDEQHGFCDKPGECKCRVGWQGRYCDECIRYPGCLHGTCQQPWQCNCQEGWGGLFCNQDLNYCTHHKPCKNGATCTNTGQGSYTCSCRPGYTGATCELGIDECDPSPCKNGGSCTDLENSYSCTCPPGFYGKICELSAMTCADGPCFNGGRCSDSPDGGYSCRCPVGYSGFNCEKKIDYCSSSPCSNGAKCVDLGDAYLCRCQAGFSGRHCDDNVDDCASSPCANGGTCRDGVNDFSCTCPPGYTGRNCSAPVSRCEHAPCHNGATCHERGHRYVCECARGYGGPNCQFLLPELPPGPAVVDLTEKLEGQGGPFPWVAVCAGVILVLMLLLGCAAVVVCVRLRLQKHRPPADPCRGETETMNNLANCQREKDISVSIIGATQIKNTNKKADFHGDHSADKNGFKARYPAVDYNLVQDLKGDDTAVRDAHSKRDTKCQPQGSSGEEKGTPTTLRGGEASERKRPDSGCSTSKDTKYQSVYVISEEKDECVIATEV,723,"78,056",Alternative sequence (2); Beta strand (33); Chain (1); Cross-link (1); Disulfide bond (27); Domain (9); Glycosylation (1); Helix (2); Modified residue (2); Natural variant (7); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 179..188;  /evidence=""ECO:0000250""; DISULFID 192..204;  /evidence=""ECO:0000250""; DISULFID 212..221;  /evidence=""ECO:0000250""; DISULFID 226..237;  /evidence=""ECO:0000250""; DISULFID 230..243;  /evidence=""ECO:0000250""; DISULFID 245..254;  /evidence=""ECO:0000250""; DISULFID 257..268;  /evidence=""ECO:0000250""; DISULFID 263..274;  /evidence=""ECO:0000250""; DISULFID 276..285;  /evidence=""ECO:0000250""; DISULFID 292..304;  /evidence=""ECO:0000250""; DISULFID 298..314;  /evidence=""ECO:0000250""; DISULFID 316..325;  /evidence=""ECO:0000250""; DISULFID 332..343;  /evidence=""ECO:0000250""; DISULFID 337..352;  /evidence=""ECO:0000250""; DISULFID 354..363;  /evidence=""ECO:0000250""; DISULFID 370..381;  /evidence=""ECO:0000250""; DISULFID 375..391;  /evidence=""ECO:0000250""; DISULFID 393..402;  /evidence=""ECO:0000250""; DISULFID 409..420;  /evidence=""ECO:0000250""; DISULFID 414..429;  /evidence=""ECO:0000250""; DISULFID 431..440;  /evidence=""ECO:0000250""; DISULFID 447..458;  /evidence=""ECO:0000250""; DISULFID 452..467;  /evidence=""ECO:0000250""; DISULFID 469..478;  /evidence=""ECO:0000250""; DISULFID 485..496;  /evidence=""ECO:0000250""; DISULFID 490..505;  /evidence=""ECO:0000250""; DISULFID 507..516;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9ULK0,"Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit)",MEALTLWLLPWICQCVSVRADSIIHIGAIFEENAAKDDRVFQLAVSDLSLNDDILQSEKITYSIKVIEANNPFQAVQEACDLMTQGILALVTSTGCASANALQSLTDAMHIPHLFVQRNPGGSPRTACHLNPSPDGEAYTLASRPPVRLNDVMLRLVTELRWQKFVMFYDSEYDIRGLQSFLDQASRLGLDVSLQKVDKNISHVFTSLFTTMKTEELNRYRDTLRRAILLLSPQGAHSFINEAVETNLASKDSHWVFVNEEISDPEILDLVHSALGRMTVVRQIFPSAKDNQKCTRNNHRISSLLCDPQEGYLQMLQISNLYLYDSVLMLANAFHRKLEDRKWHSMASLNCIRKSTKPWNGGRSMLDTIKKGHITGLTGVMEFREDSSNPYVQFEILGTTYSETFGKDMRKLATWDSEKGLNGSLQERPMGSRLQGLTLKVVTVLEEPFVMVAENILGQPKRYKGFSIDVLDALAKALGFKYEIYQAPDGRYGHQLHNTSWNGMIGELISKRADLAISAITITPERESVVDFSKRYMDYSVGILIKKPEEKISIFSLFAPFDFAVWACIAAAIPVVGVLIFVLNRIQAVRAQSAAQPRPSASATLHSAIWIVYGAFVQQGGESSVNSMAMRIVMGSWWLFTLIVCSSYTANLAAFLTVSRMDNPIRTFQDLSKQVEMSYGTVRDSAVYEYFRAKGTNPLEQDSTFAELWRTISKNGGADNCVSSPSEGIRKAKKGNYAFLWDVAVVEYAALTDDDCSVTVIGNSISSKGYGIALQHGSPYRDLFSQRILELQDTGDLDVLKQKWWPHMGRCDLTSHASAQADGKSLKLHSFAGVFCILAIGLLLACLVAALELWWNSNRCHQETPKEDKEVNLEQVHRRMNSLMDEDIAHKQISPASIELSALEMGGLAPTQTLEPTREYQNTQLSVSTFLPEQSSHGTSRTLSSGPSSNLPLPLSSSATMPSMQCKHRSPNGGLFRQSPVKTPIPMSFQPVPGGVLPEALDTSHGTSI,1009,"112,131",Alternative sequence (1); Chain (1); Disulfide bond (3); Glycosylation (4); Natural variant (1); Region (1); Signal peptide (1); Site (1); Topological domain (4); Transmembrane (3),"DISULFID 80..351;  /evidence=""ECO:0000250|UniProtKB:Q61627""; DISULFID 96..128;  /evidence=""ECO:0000250|UniProtKB:Q61627""; DISULFID 294..306;  /evidence=""ECO:0000250|UniProtKB:Q61627""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9HBE5,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360),MPRGWAAPLLLLLLQGGWGCPDLVCYTDYLQTVICILEMWNLHPSTLTLTWQDQYEELKDEATSCSLHRSAHNATHATYTCHMDVFHFMADDIFSVNITDQSGNYSQECGSFLLAESIKPAPPFNVTVTFSGQYNISWRSDYEDPAFYMLKGKLQYELQYRNRGDPWAVSPRRKLISVDSRSVSLLPLEFRKDSSYELQVRAGPMPGSSYQGTWSEWSDPVIFQTQSEELKEGWNPHLLLLLLLVIVFIPAFWSLKTHPLWRLWKKIWAVPSPERFFMPLYKGCSGDFKKWVGAPFTGSSLELGPWSPEVPSTLEVYSCHPPRSPAKRLQLTELQEPAELVESDGVPKPSFWPTAQNSGGSAYSEERDRPYGLVSIDTVTVLDAEGPCTWPCSCEDDGYPALDLDAGLEPSPGLEDPLLDAGTTVLSCGCVSAGSPGLGGPLGSLLDRLKPPLADGEDWAGGLPWGGRSPGGVSESEAGSPLAGLDMDTFDSGFVGSDCSSPVECDFTSPGDEGPPRSYLRQWVVIPPPLSSPGPQAS,538,"59,130",Beta strand (15); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (6); Helix (4); Motif (2); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 20..109;  /evidence=""ECO:0000269|PubMed:22235133""; DISULFID 25..35;  /evidence=""ECO:0000269|PubMed:22235133""; DISULFID 65..81;  /evidence=""ECO:0000269|PubMed:22235133""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BX67,Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)],MALRRPPRLRLCARLPDFFLLLLFRGCLIGAVNLKSSNRTPVVQEFESVELSCIITDSQTSDPRIEWKKIQDEQTTYVFFDNKIQGDLAGRAEILGKTSLKIWNVTRRDSALYRCEVVARNDRKEIDEIVIELTVQVKPVTPVCRVPKAVPVGKMATLHCQESEGHPRPHYSWYRNDVPLPTDSRANPRFRNSSFHLNSETGTLVFTAVHKDDSGQYYCIASNDAGSARCEEQEMEVYDLNIGGIIGGVLVVLAVLALITLGICCAYRRGYFINNKQDGESYKNPGKPDGVNYIRTDEEGDFRHKSSFVI,310,"35,020",Alternative sequence (1); Chain (2); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (2); Lipidation (2); Mutagenesis (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..219;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:15340161"""
Q6UWM7,Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein),MKPVWVATLLWMLLLVPRLGAARKGSPEEASFYYGTFPLGFSWGVGSSAYQTEGAWDQDGKGPSIWDVFTHSGKGKVLGNETADVACDGYYKVQEDIILLRELHVNHYRFSLSWPRLLPTGIRAEQVNKKGIEFYSDLIDALLSSNITPIVTLHHWDLPQLLQVKYGGWQNVSMANYFRDYANLCFEAFGDRVKHWITFSDPRAMAEKGYETGHHAPGLKLRGTGLYKAAHHIIKAHAKAWHSYNTTWRSKQQGLVGISLNCDWGEPVDISNPKDLEAAERYLQFCLGWFANPIYAGDYPQVMKDYIGRKSAEQGLEMSRLPVFSLQEKSYIKGTSDFLGLGHFTTRYITERNYPSRQGPSYQNDRDLIELVDPNWPDLGSKWLYSVPWGFRRLLNFAQTQYGDPPIYVMENGASQKFHCTQLCDEWRIQYLKGYINEMLKAIKDGANIKGYTSWSLLDKFEWEKGYSDRYGFYYVEFNDRNKPRYPKASVQYYKKIIIANGFPNPREVESWYLKALETCSINNQMLAAEPLLSHMQMVTEIVVPTVCSLCVLITAVLLMLLLRRQS,567,"65,088",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q86YD5,Low-density lipoprotein receptor class A domain-containing protein 3 (LDLR class A domain-containing protein 3),MWLLGPLCLLLSSAAESQLLPGNNFTNECNIPGNFMCSNGRCIPGAWQCDGLPDCFDKSDEKECPKAKSKCGPTFFPCASGIHCIIGRFRCNGFEDCPDGSDEENCTANPLLCSTARYHCKNGLCIDKSFICDGQNNCQDNSDEESCESSQEPGSGQVFVTSENQLVYYPSITYAIIGSSVIFVLVVALLALVLHHQRKRNNLMTLPVHRLQHPVLLSRLVVLDHPHHCNVTYNVNNGIQYVASQAEQNASEVGSPPSYSEALLDQRPAWYDLPPPPYSSDTESLNQADLPPYRSRSGSANSASSQAASSLLSVEDTSHSPGQPGPQEGTAEPRDSEPSQGTEEV,345,"37,419",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (9); Domain (3); Glycosylation (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 29..42;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 37..55;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 49..64;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 71..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 78..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 91..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 113..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 120..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 132..147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q9H756,Leucine-rich repeat-containing protein 19,MKVTGITILFWPLSMILLSDKIQSSKREVQCNFTEKNYTLIPADIKKDVTILDLSYNQITLNGTDTRVLQTYFLLTELYLIENKVTILHNNGFGNLSSLEILNICRNSIYVIQQGAFLGLNKLKQLYLCQNKIEQLNADVFVPLRSLKLLNLQGNLISYLDVPPLFHLELITLYGNLWNCSCSLFNLQNWLNTSNVTLENENITMCSYPNSLQSYNIKTVPHKAECHSKFPSSVTEDLYIHFQPISNSIFNSSSNNLTRNSEHEPLGKSWAFLVGVVVTVLTTSLLIFIAIKCPIWYNILLSYNHHRLEEHEAETYEDGFTGNPSSLSQIPETNSEETTVIFEQLHSFVVDDDGFIEDKYIDIHELCEEN,370,"42,334",Chain (1); Domain (1); Glycosylation (10); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P58658,Protein eva-1 homolog C (Protein FAM176C) (SUE21),MLLPGRARQPPTPQPVQHPGLRRQVEPPGQLLRLFYCTVLVCSKEISALTDFSGYLTKLLQNHTTYACDGDYLNLQCPRHSTISVQSAFYGQDYQMCSSQKPASQREDSLTCVAATTFQKVLDECQNQRACHLLVNSRVFGPDLCPGSSKYLLVSFKCQPNELKNKTVCEDQELKLHCHESKFLNIYSATYGRRTQERDICSSKAERLPPFDCLSYSALQVLSRRCYGKQRCKIIVNNHHFGSPCLPGVKKYLTVTYACVPKNILTAIDPAIANLKPSLKQKDGEYGINFDPSGSKVLRKDGILVSNSLAAFAYIRAHPERAALLFVSSVCIGLALTLCALVIRESCAKDFRDLQLGREQLVPGSDKVEEDSEDEEEEEDPSESDFPGELSGFCRTSYPIYSSIEAAELAERIERREQIIQEIWMNSGLDTSLPRNMGQFY,441,"49,483",Alternative sequence (3); Chain (1); Compositional bias (1); Domain (2); Glycosylation (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..48;  /evidence=""ECO:0000255"""
Q76MJ5,Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],MASAVRGSRPWPRLGLQLQFAALLLGTLSPQVHTLRPENLLLVSTLDGSLHALSKQTGDLKWTLRDDPVIEGPMYVTEMAFLSDPADGSLYILGTQKQQGLMKLPFTIPELVHASPCRSSDGVFYTGRKQDAWFVVDPESGETQMTLTTEGPSTPRLYIGRTQYTVTMHDPRAPALRWNTTYRRYSAPPMDGSPGKYMSHLASCGMGLLLTVDPGSGTVLWTQDLGVPVMGVYTWHQDGLRQLPHLTLARDTLHFLALRWGHIRLPASGPRDTATLFSTLDTQLLMTLYVGKDETGFYVSKALVHTGVALVPRGLTLAPADGPTTDEVTLQVSGEREGSPSTAVRYPSGSVALPSQWLLIGHHELPPVLHTTMLRVHPTLGSGTAETRPPENTQAPAFFLELLSLSREKLWDSELHPEEKTPDSYLGLGPQDLLAASLTAVLLGGWILFVMRQQQPQVVEKQQETPLAPADFAHISQDAQSLHSGASRRSQKRLQSPSKQAQPLDDPEAEQLTVVGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNVLRYFCTERGPQFHYIALELCRASLQEYVENPDLDRGGLEPEVVLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGRVVLSDFGLCKKLPAGRCSFSLHSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYYVLSGGSHPFGDSLYRQANILTGAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQVLAHPFFWSRAKQLQFFQDVSDWLEKESEQEPLVRALEAGGCAVVRDNWHEHISMPLQTDLRKFRSYKGTSVRDLLRAVRNKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHTHRAMRSCASESLFLPYYPPDSEARRPCPGATGR,926,"102,480",Active site (1); Binding site (1); Chain (1); Domain (2); Erroneous initiation (1); Mutagenesis (1); Natural variant (10); Nucleotide binding (1); Sequence conflict (28); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
P12314,High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64),MWFLTTLLLWVPVDGQVDTTKAVITLQPPWVSVFQEETVTLHCEVLHLPGSSSTQWFLNGTATQTSTPSYRITSASVNDSGEYRCQRGLSGRSDPIQLEIHRGWLLLQVSSRVFTEGEPLALRCHAWKDKLVYNVLYYRNGKAFKFFHWNSNLTILKTNISHNGTYHCSGMGKHRYTSAGISVTVKELFPAPVLNASVTSPLLEGNLVTLSCETKLLLQRPGLQLYFSFYMGSKTLRGRNTSSEYQILTARREDSGLYWCEAATEDGNVLKRSPELELQVLGLQLPTPVWFHVLFYLAVGIMFLVNTVLWVTIRKELKRKKKWDLEISLDSGHEKKVISSLQEDRHLEEELKCQEQKEEQLQEGVHRKEPQGAT,374,"42,632",Alternative sequence (1); Beta strand (25); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (7); Helix (4); Mutagenesis (2); Natural variant (1); Region (1); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21965667""; DISULFID 124..168;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21965667""; DISULFID 212..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21965667""","SIGNAL 1..15;  /evidence=""ECO:0000269|PubMed:15340161"""
P31995,Low affinity immunoglobulin gamma Fc region receptor II-c (IgG Fc receptor II-c) (CDw32) (Fc-gamma RII-c) (Fc-gamma-RIIc) (FcRII-c) (CD antigen CD32),MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIVLRCHSWKDKPLVKVTFFQNGKSKKFSRSDPNFSIPQANHSHSGDYHCTGNIGYTLYSSKPVTITVQAPSSSPMGIIVAVVTGIAVAAIVAAVVALIYCRKKRISANSTDPVKAAQFEPPGRQMIAIRKRQPEETNNDYETADGGYMTLNPRAPTDDDKNIYLTLPPNDHVNSNN,323,"35,578",Alternative sequence (3); Beta strand (18); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (3); Helix (3); Modified residue (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 71..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23744091""; DISULFID 152..196;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23744091""","SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q96RD9,Fc receptor-like protein 5 (FcR-like protein 5) (FcRL5) (BXMAS1) (Fc receptor homolog 5) (FcRH5) (Immune receptor translocation-associated protein 2) (CD antigen CD307e),MLLWVILLVLAPVSGQFARTPRPIIFLQPPWTTVFQGERVTLTCKGFRFYSPQKTKWYHRYLGKEILRETPDNILEVQESGEYRCQAQGSPLSSPVHLDFSSASLILQAPLSVFEGDSVVLRCRAKAEVTLNNTIYKNDNVLAFLNKRTDFHIPHACLKDNGAYRCTGYKESCCPVSSNTVKIQVQEPFTRPVLRASSFQPISGNPVTLTCETQLSLERSDVPLRFRFFRDDQTLGLGWSLSPNFQITAMWSKDSGFYWCKAATMPYSVISDSPRSWIQVQIPASHPVLTLSPEKALNFEGTKVTLHCETQEDSLRTLYRFYHEGVPLRHKSVRCERGASISFSLTTENSGNYYCTADNGLGAKPSKAVSLSVTVPVSHPVLNLSSPEDLIFEGAKVTLHCEAQRGSLPILYQFHHEGAALERRSANSAGGVAISFSLTAEHSGNYYCTADNGFGPQRSKAVSLSVTVPVSHPVLTLSSAEALTFEGATVTLHCEVQRGSPQILYQFYHEDMPLWSSSTPSVGRVSFSFSLTEGHSGNYYCTADNGFGPQRSEVVSLFVTVPVSRPILTLRVPRAQAVVGDLLELHCEAPRGSPPILYWFYHEDVTLGSSSAPSGGEASFNLSLTAEHSGNYSCEANNGLVAQHSDTISLSVIVPVSRPILTFRAPRAQAVVGDLLELHCEALRGSSPILYWFYHEDVTLGKISAPSGGGASFNLSLTTEHSGIYSCEADNGLEAQRSEMVTLKVAVPVSRPVLTLRAPGTHAAVGDLLELHCEALRGSPLILYRFFHEDVTLGNRSSPSGGASLNLSLTAEHSGNYSCEADNGLGAQRSETVTLYITGLTANRSGPFATGVAGGLLSIAGLAAGALLLYCWLSRKAGRKPASDPARSPSDSDSQEPTYHNVPAWEELQPVYTNANPRGENVVYSEVRIIQEKKKHAVASDPRHLRNKGSPIIYSEVKVASTPVSGSLFLASSAPHR,977,"106,437",Alternative sequence (8); Chain (1); Disulfide bond (8); Domain (8); Glycosylation (1); Motif (4); Natural variant (7); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 211..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 308..355;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 401..448;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 494..541;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 587..634;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 680..727;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 773..819;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
P43220,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R),MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS,463,"53,026",Beta strand (7); Chain (1); Disulfide bond (4); Glycosylation (3); Helix (16); Modified residue (2); Mutagenesis (14); Natural variant (9); Region (1); Sequence conflict (10); Signal peptide (1); Site (2); Topological domain (8); Transmembrane (7); Turn (6),"DISULFID 46..71;  /evidence=""ECO:0000244|PDB:3C59, ECO:0000244|PDB:3C5T, ECO:0000244|PDB:3IOL, ECO:0000244|PDB:4ZGM, ECO:0000244|PDB:5E94, ECO:0000269|PubMed:19861722, ECO:0000269|PubMed:26308095, ECO:0000269|PubMed:27196125""; DISULFID 62..104;  /evidence=""ECO:0000244|PDB:3C59, ECO:0000244|PDB:3C5T, ECO:0000244|PDB:3IOL, ECO:0000244|PDB:4ZGM, ECO:0000244|PDB:5E94, ECO:0000269|PubMed:19861722, ECO:0000269|PubMed:26308095, ECO:0000269|PubMed:27196125""; DISULFID 85..126;  /evidence=""ECO:0000244|PDB:3C59, ECO:0000244|PDB:3C5T, ECO:0000244|PDB:3IOL, ECO:0000244|PDB:4ZGM, ECO:0000244|PDB:5E94, ECO:0000269|PubMed:19861722, ECO:0000269|PubMed:26308095, ECO:0000269|PubMed:27196125""; DISULFID 226..296;  /evidence=""ECO:0000244|PDB:3C59, ECO:0000244|PDB:3C5T, ECO:0000244|PDB:3IOL, ECO:0000244|PDB:4ZGM, ECO:0000244|PDB:5E94, ECO:0000244|PDB:5VEW, ECO:0000244|PDB:5VEX, ECO:0000269|PubMed:19861722, ECO:0000269|PubMed:26308095, ECO:0000269|PubMed:27196125, ECO:0000269|PubMed:28514449""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O43424,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)",MEVFPFLLVLSVWWSRTWDSANADSIIHIGAIFDESAKKDDEVFRTAVGDLNQNEEILQTEKITFSVTFVDGNNPFQAVQEACELMNQGILALVSSIGCTSAGSLQSLADAMHIPHLFIQRSTAGTPRSGCGLTRSNRNDDYTLSVRPPVYLHDVILRVVTEYAWQKFIIFYDSEYDIRGIQEFLDKVSQQGMDVALQKVENNINKMITTLFDTMRIEELNRYRDTLRRAILVMNPATAKSFITEVVETNLVAFDCHWIIINEEINDVDVQELVRRSIGRLTIIRQTFPVPQNISQRCFRGNHRISSTLCDPKDPFAQNMEISNLYIYDTVLLLANAFHKKLEDRKWHSMASLSCIRKNSKPWQGGRSMLETIKKGGVSGLTGELEFGENGGNPNVHFEILGTNYGEELGRGVRKLGCWNPVTGLNGSLTDKKLENNMRGVVLRVVTVLEEPFVMVSENVLGKPKKYQGFSIDVLDALSNYLGFNYEIYVAPDHKYGSPQEDGTWNGLVGELVFKRADIGISALTITPDRENVVDFTTRYMDYSVGVLLRRAEKTVDMFACLAPFDLSLWACIAGTVLLVGLLVYLLNWLNPPRLQMGSMTSTTLYNSMWFVYGSFVQQGGEVPYTTLATRMMMGAWWLFALIVISSYTANLAAFLTITRIESSIQSLQDLSKQTEIPYGTVLDSAVYEHVRMKGLNPFERDSMYSQMWRMINRSNGSENNVLESQAGIQKVKYGNYAFVWDAAVLEYVAINDPDCSFYTIGNTVADRGYGIALQHGSPYRDVFSQRILELQQNGDMDILKHKWWPKNGQCDLYSSVDTKQKGGALDIKSFAGVFCILAAGIVLSCFIAMLETWWNKRKGSRVPSKEDDKEIDLEHLHRRVNSLCTDDDSPHKQFSTSSIDLTPLDIDTLPTRQALEQISDFRNTHITTTTFIPEQIQTLSRTLSAKAASGFTFGNVPEHRTGPFRHRAPNGGFFRSPIKTMSSIPYQPTPTLGLNLGNDPDRGTSI,1007,"113,356",Alternative sequence (1); Beta strand (18); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (4); Helix (15); Modified residue (4); Motif (1); Mutagenesis (17); Natural variant (7); Region (2); Sequence conflict (9); Signal peptide (1); Site (1); Topological domain (4); Transmembrane (3); Turn (1),"DISULFID 83..355;  /evidence=""ECO:0000244|PDB:5KC8, ECO:0000244|PDB:5KCA, ECO:0000269|PubMed:27418511""; DISULFID 99..131;  /evidence=""ECO:0000244|PDB:5KC8, ECO:0000244|PDB:5KCA, ECO:0000269|PubMed:27418511""; DISULFID 298..310;  /evidence=""ECO:0000244|PDB:5KC8, ECO:0000244|PDB:5KCA, ECO:0000269|PubMed:27418511""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9ULI3,Protein HEG homolog 1,MASPRASRWPPPLLLLLLPLLLLPPAAPGTRDPPPSPARRALSLAPLAGAGLELQLERRPEREPPPTPPRERRGPATPGPSYRAPEPGAATQRGPSGRAPRGGSADAAWKHWPESNTEAHVENITFYQNQEDFSTVSSKEGVMVQTSGKSHAASDAPENLTLLAETADARGRSGSSSRTNFTILPVGYSLEIATALTSQSGNLASESLHLPSSSSEFDERIAAFQTKSGTASEMGTERAMGLSEEWTVHSQEATTSAWSPSFLPALEMGELTTPSRKRNSSGPDLSWLHFYRTAASSPLLDLSSSSESTEKLNNSTGLQSSSVSQTKTMHVATVFTDGGPRTLRSLTVSLGPVSKTEGFPKDSRIATTSSSVLLSPSAVESRRNSRVTGNPGDEEFIEPSTENEFGLTSLRWQNDSPTFGEHQLASSSEVQNGSPMSQTETVSRSVAPMRGGEITAHWLLTNSTTSADVTGSSASYPEGVNASVLTQFSDSTVQSGGSHTALGDRSYSESSSTSSSESLNSSAPRGERSIAGISYGQVRGTAIEQRTSSDHTDHTYLSSTFTKGERALLSITDNSSSSDIVESSTSYIKISNSSHSEYSSFFHAQTERSNISSYDGEYAQPSTESPVLHTSNLPSYTPTINMPNTSVVLDTDAEFVSDSSSSSSSSSSSSSSGPPLPLPSVSQSHHLFSSILPSTRASVHLLKSTSDASTPWSSSPSPLPVSLTTSTSAPLSVSQTTLPQSSSTPVLPRARETPVTSFQTSTMTSFMTMLHSSQTADLKSQSTPHQEKVITESKSPSLVSLPTESTKAVTTNSPLPPSLTESSTEQTLPATSTNLAQMSPTFTTTILKTSQPLMTTPGTLSSTASLVTGPIAVQTTAGKQLSLTHPEILVPQISTEGGISTERNRVIVDATTGLIPLTSVPTSAKEMTTKLGVTAEYSPASRSLGTSPSPQTTVVSTAEDLAPKSATFAVQSSTQSPTTVSSSASVNSCAVNPCLHNGECVADNTSRGYHCRCPPSWQGDDCSVDVNECLSNPCPSTAMCNNTQGSFICKCPVGYQLEKGICNLVRTFVTEFKLKRTFLNTTVEKHSDLQEVENEITKTLNMCFSALPSYIRSTVHASRESNAVVISLQTTFSLASNVTLFDLADRMQKCVNSCKSSAEVCQLLGSQRRIFRAGSLCKRKSPECDKDTSICTDLDGVALCQCKSGYFQFNKMDHSCRACEDGYRLENETCMSCPFGLGGLNCGNPYQLITVVIAAAGGGLLLILGIALIVTCCRKNKNDISKLIFKSGDFQMSPYAEYPKNPRSQEWGREAIEMHENGSTKNLLQMTDVYYSPTSVRNPELERNGLYPAYTGLPGSRHSCIFPGQYNPSFISDESRRRDYF,1381,"147,461",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (2); Erroneous initiation (2); Glycosylation (9); Modified residue (1); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 989..1000;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 994..1011;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1013..1022;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1029..1040;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1034..1049;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1051..1062;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
P43631,Killer cell immunoglobulin-like receptor 2DS2 (CD158 antigen-like family member J) (MHC class I NK cell receptor) (NK receptor 183 ActI) (Natural killer-associated transcript 5) (NKAT-5) (p58 natural killer cell receptor clone CL-49) (p58 NK receptor CL-49) (CD antigen CD158j),MSLMVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFEHFLLHREGKYKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSKTGNPRHLHVLIGTSVVKIPFTILLFFLLHRWCSNKKNAAVMDQEPAGNRTVNSEDSDEQDHQEVSYA,304,"33,502",Beta strand (18); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (3); Helix (1); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000269|PubMed:12668644""; DISULFID 149..198;  /evidence=""ECO:0000269|PubMed:12668644""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
P17927,Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35),MGASSPRSPEPVGPPAPGLPFCCGGSLLAVVVLLALPVAWGQCNAPEWLPFARPTNLTDEFEFPIGTYLNYECRPGYSGRPFSIICLKNSVWTGAKDRCRRKSCRNPPDPVNGMVHVIKGIQFGSQIKYSCTKGYRLIGSSSATCIISGDTVIWDNETPICDRIPCGLPPTITNGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPDVLHAERTQRDKDNFSPGQEVFYSCEPGYDLRGAASMRCTPQGDWSPAAPTCEVKSCDDFMGQLLNGRVLFPVNLQLGAKVDFVCDEGFQLKGSSASYCVLAGMESLWNSSVPVCEQIFCPSPPVIPNGRHTGKPLEVFPFGKTVNYTCDPHPDRGTSFDLIGESTIRCTSDPQGNGVWSSPAPRCGILGHCQAPDHFLFAKLKTQTNASDFPIGTSLKYECRPEYYGRPFSITCLDNLVWSSPKDVCKRKSCKTPPDPVNGMVHVITDIQVGSRINYSCTTGHRLIGHSSAECILSGNAAHWSTKPPICQRIPCGLPPTIANGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPDVLHAERTQRDKDNFSPGQEVFYSCEPGYDLRGAASMRCTPQGDWSPAAPTCEVKSCDDFMGQLLNGRVLFPVNLQLGAKVDFVCDEGFQLKGSSASYCVLAGMESLWNSSVPVCEQIFCPSPPVIPNGRHTGKPLEVFPFGKAVNYTCDPHPDRGTSFDLIGESTIRCTSDPQGNGVWSSPAPRCGILGHCQAPDHFLFAKLKTQTNASDFPIGTSLKYECRPEYYGRPFSITCLDNLVWSSPKDVCKRKSCKTPPDPVNGMVHVITDIQVGSRINYSCTTGHRLIGHSSAECILSGNTAHWSTKPPICQRIPCGLPPTIANGDFISTNRENFHYGSVVTYRCNLGSRGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPEILHGEHTPSHQDNFSPGQEVFYSCEPGYDLRGAASLHCTPQGDWSPEAPRCAVKSCDDFLGQLPHGRVLFPLNLQLGAKVSFVCDEGFRLKGSSVSHCVLVGMRSLWNNSVPVCEHIFCPNPPAILNGRHTGTPSGDIPYGKEISYTCDPHPDRGMTFNLIGESTIRCTSDPHGNGVWSSPAPRCELSVRAGHCKTPEQFPFASPTIPINDFEFPVGTSLNYECRPGYFGKMFSISCLENLVWSSVEDNCRRKSCGPPPEPFNGMVHINTDTQFGSTVNYSCNEGFRLIGSPSTTCLVSGNNVTWDKKAPICEIISCEPPPTISNGDFYSNNRTSFHNGTVVTYQCHTGPDGEQLFELVGERSIYCTSKDDQVGVWSSPPPRCISTNKCTAPEVENAIRVPGNRSFFSLTEIIRFRCQPGFVMVGSHTVQCQTNGRWGPKLPHCSRVCQPPPEILHGEHTLSHQDNFSPGQEVFYSCEPSYDLRGAASLHCTPQGDWSPEAPRCTVKSCDDFLGQLPHGRVLLPLNLQLGAKVSFVCDEGFRLKGRSASHCVLAGMKALWNSSVPVCEQIFCPNPPAILNGRHTGTPFGDIPYGKEISYACDTHPDRGMTFNLIGESSIRCTSDPQGNGVWSSPAPRCELSVPAACPHPPKIQNGHYIGGHVSLYLPGMTISYICDPGYLLVGKGFIFCTDQGIWSQLDHYCKEVNCSFPLFMNGISKELEMKKVYHYGDYVTLKCEDGYTLEGSPWSQCQADDRWDPPLAKCTSRTHDALIVGTLSGTIFFILLIIFLSWIILKHRKGNNAHENPKEVAIHLHSQGGSSVHPRTLQTNEENSRVLP,2039,"223,663",Beta strand (33); Chain (1); Disulfide bond (60); Domain (30); Glycosylation (20); Modified residue (1); Natural variant (11); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 43..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 73..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 104..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 131..161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 166..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 195..232;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 238..280;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 266..293;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 297..340;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 326..353;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 358..400;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 386..416;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 421..470;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 450..487;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 493..536;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 523..549;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 554..595;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 581..611;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 616..665;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 645..682;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 688..730;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 716..743;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 747..790;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 776..803;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 808..850;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 836..866;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 871..920;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 900..937;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 943..986;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 973..999;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1004..1045; DISULFID 1031..1061; DISULFID 1066..1115; DISULFID 1095..1132; DISULFID 1138..1180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1166..1193;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1197..1240;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1226..1253;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1258..1300;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1286..1316;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1321..1370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1350..1387;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1396..1439;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1426..1452;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1457..1498;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1484..1514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1519..1568;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1548..1585;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1591..1633;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1619..1646;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1650..1693;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1679..1706;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1711..1753;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1739..1769;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1774..1823;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1803..1840;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1848..1891;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1877..1904;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1909..1952;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1938..1965;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""",SIGNAL 1..41
Q9N2K0,HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MIFAGKAPSNTSTLMKFYSLLLYSLLFSFPFLCHPLPLPSYLHHTINLTHSLLAASNPSLVNNCWLCISLSSSAYTAVPAVQTDWATSPISLHLRTSFNSPHLYPPEELIYFLDRSSKTSPDISHQQAAALLRTYLKNLSPYINSTPPIFGPLTTQTTIPVAAPLCISWQRPTGIPLGNLSPSRCSFTLHLRSPTTNINETIGAFQLHITDKPSINTDKLKNISSNYCLGRHLPCISLHPWLSSPCSSDSPPRPSSCLLIPSPENNSERLLVDTRRFLIHHENRTFPSTQLPHQSPLQPLTAAALAGSLGVWVQDTPFSTPSHLFTLHLQFCLAQGLFFLCGSSTYMCLPANWTGTCTLVFLTPKIQFANGTEELPVPLMTPTQQKRVIPLIPLMVGLGLSASTVALGTGIAGISTSVMTFRSLSNDFSASITDISQTLSVLQAQVDSLAAVVLQNRRGLDLLTAEKGGLCIFLNEECCFYLNQSGLVYDNIKKLKDRAQKLANQASNYAEPPWALSNWMSWVLPIVSPLIPIFLLLLFGPCIFRLVSQFIQNRIQAITNHSIRQMFLLTSPQYHPLPQDLPSA,584,"64,318",Chain (3); Disulfide bond (1); Glycosylation (8); Motif (3); Natural variant (2); Region (1); Sequence conflict (4); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 471..478;  /evidence=""ECO:0000250""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q902F8,Endogenous retrovirus group K member 8 Env polyprotein (EnvK6 protein) (Envelope polyprotein) (HERV-K115 envelope protein) (HERV-K_8p23.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAVANYTNWAYVPFPPLIRAVTWMDNPIEVYVNDSVWVPGPIDDRCPAKPEEEGMMINISIGYRYPPICLGRAPGCLMPAVQNWLVEVPTVSPISRFTYHMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTIIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKRISTPRPKIVSPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTVDLNSSLTLPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSVHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATAAVAGVALHSSVQSVNFVNDGQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNDSEHHWDMVRRHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQLRRDSDHRERAMMTMAVLSKRKGGNVGKSKRDQIVTVSV,699,"79,168",Chain (3); Compositional bias (1); Glycosylation (11); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
F2Z333,Fibronectin type III domain-containing protein 10,MRAPPLLLLLAACAPPPCAAAAPTPPGWEPTPDAPWCPYKVLPEGPEAGGGRLCFRSPARGFRCQAPGCVLHAPAGRSLRASVLRNRSVLLQWRLAPAAARRVRAFALNCSWRGAYTRFPCERVLLGASCRDYLLPDVHDSVLYRLCLQPLPLRAGPAAAAPETPEPAECVEFTAEPAGMQDIVVAMTAVGGSICVMLVVICLLVAYITENLMRPALARPGLRRHP,226,"24,218",Chain (1); Domain (1); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q86VZ4,Low-density lipoprotein receptor-related protein 11 (LRP-11),MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHAQLSGVEQLLEEFRRQLQQERPQEELELELRAGGGPQEDCPGPGSGGYSAMPDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRRPAPPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALATARASPRQEKDAPPLSKAGQDVVLHLPTDGVVLDGRESTDDHAIVQYEWALLQGDPSVDMKVPQSGTLKLSHLQEGTYTFQLTVTDTAGQRSSDNVSVTVLRAAYSTGGCLHTCSRYHFFCDDGCCIDITLACDGVQQCPDGSDEDFCQNLGLDRKMVTHTAASPALPRTTGPSEDAGGDSLVEKSQKATAPNKPPALSNTEKRNHSAFWGPESQIIPVMPDSSSSGKNRKEESYIFESKGDGGGGEHPAPETGAVLPLALGLAITALLLLMVACRLRLVKQKLKKARPITSEESDYLINGMYL,500,"53,311",Alternative sequence (2); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (3); Modified residue (1); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 310..322;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 317..335;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 329..344;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..37;  /evidence=""ECO:0000255"""
Q8N149,Leukocyte immunoglobulin-like receptor subfamily A member 2 (CD85 antigen-like family member H) (Immunoglobulin-like transcript 1) (ILT-1) (Leukocyte immunoglobulin-like receptor 7) (LIR-7) (CD antigen CD85h),MTPILTVLICLGLSLGPRTHVQAGHLPKPTLWAEPGSVIIQGSPVTLRCQGSLQAEEYHLYRENKSASWVRRIQEPGKNGQFPIPSITWEHAGRYHCQYYSHNHSSEYSDPLELVVTGAYSKPTLSALPSPVVTLGGNVTLQCVSQVAFDGFILCKEGEDEHPQRLNSHSHARGWSWAIFSVGPVSPSRRWSYRCYAYDSNSPYVWSLPSDLLELLVPGVSKKPSLSVQPGPMVAPGESLTLQCVSDVGYDRFVLYKEGERDFLQRPGWQPQAGLSQANFTLGPVSPSHGGQYRCYSAHNLSSEWSAPSDPLDILITGQFYDRPSLSVQPVPTVAPGKNVTLLCQSRGQFHTFLLTKEGAGHPPLHLRSEHQAQQNQAEFRMGPVTSAHVGTYRCYSSLSSNPYLLSLPSDPLELVVSEAAETLSPSQNKTDSTTTSLGQHPQDYTVENLIRMGVAGLVLVVLGILLFEAQHSQRSLQDAAGR,483,"52,992",Alternative sequence (3); Beta strand (15); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (7); Modified residue (1); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:19230061""; DISULFID 143..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:19230061""; DISULFID 244..295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..395;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
A6BM72,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),MVLSLTGLIAFSFLQATLALNPEDPNVCSHWESYAVTVQESYAHPFDQIYYTRCTDILNWFKCTRHRISYKTAYRRGLRTMYRRRSQCCPGYYESGDFCIPLCTEECVHGRCVSPDTCHCEPGWGGPDCSSGCDSDHWGPHCSNRCQCQNGALCNPITGACVCAAGFRGWRCEELCAPGTHGKGCQLPCQCRHGASCDPRAGECLCAPGYTGVYCEELCPPGSHGAHCELRCPCQNGGTCHHITGECACPPGWTGAVCAQPCPPGTFGQNCSQDCPCHHGGQCDHVTGQCHCTAGYMGDRCQEECPFGSFGFQCSQHCDCHNGGQCSPTTGACECEPGYKGPRCQERLCPEGLHGPGCTLPCPCDADNTISCHPVTGACTCQPGWSGHHCNESCPVGYYGDGCQLPCTCQNGADCHSITGGCTCAPGFMGEVCAVSCAAGTYGPNCSSICSCNNGGTCSPVDGSCTCKEGWQGLDCTLPCPSGTWGLNCNESCTCANGAACSPIDGSCSCTPGWLGDTCELPCPDGTFGLNCSEHCDCSHADGCDPVTGHCCCLAGWTGIRCDSTCPPGRWGPNCSVSCSCENGGSCSPEDGSCECAPGFRGPLCQRICPPGFYGHGCAQPCPLCVHSSRPCHHISGICECLPGFSGALCNQVCAGGYFGQDCAQLCSCANNGTCSPIDGSCQCFPGWIGKDCSQACPPGFWGPACFHACSCHNGASCSAEDGACHCTPGWTGLFCTQRCPAAFFGKDCGRVCQCQNGASCDHISGKCTCRTGFTGQHCEQRCAPGTFGYGCQQLCECMNNSTCDHVTGTCYCSPGFKGIRCDQAALMMEELNPYTKISPALGAERHSVGAVTGIMLLLFLIVVLLGLFAWHRRRQKEKGRDLAPRVSYTPAMRMTSTDYSLSGACGMDRRQNTYIMDKGFKDYMKESVCSSSTCSLNSSENPYATIKDPPILTCKLPESSYVEMKSPVHMGSPYTDVPSLSTSNKNIYEVEPTVSVVQEGCGHNSSYIQNAYDLPRNSHIPGHYDLLPVRQSPANGPSQDKQS,1044,"110,844",Alternative sequence (7); Chain (1); Disulfide bond (44); Domain (15); Erroneous initiation (2); Glycosylation (2); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 28..89;  /evidence=""ECO:0000255""; DISULFID 54..63;  /evidence=""ECO:0000255""; DISULFID 88..99;  /evidence=""ECO:0000255""; DISULFID 103..118;  /evidence=""ECO:0000250""; DISULFID 120..129;  /evidence=""ECO:0000250""; DISULFID 146..154;  /evidence=""ECO:0000250""; DISULFID 148..161;  /evidence=""ECO:0000250""; DISULFID 163..172;  /evidence=""ECO:0000250""; DISULFID 185..197;  /evidence=""ECO:0000250""; DISULFID 191..204;  /evidence=""ECO:0000250""; DISULFID 206..215;  /evidence=""ECO:0000250""; DISULFID 228..240;  /evidence=""ECO:0000250""; DISULFID 234..247;  /evidence=""ECO:0000250""; DISULFID 249..258;  /evidence=""ECO:0000250""; DISULFID 271..283;  /evidence=""ECO:0000250""; DISULFID 277..290;  /evidence=""ECO:0000250""; DISULFID 292..301;  /evidence=""ECO:0000250""; DISULFID 314..326;  /evidence=""ECO:0000250""; DISULFID 320..333;  /evidence=""ECO:0000250""; DISULFID 335..344;  /evidence=""ECO:0000250""; DISULFID 403..415;  /evidence=""ECO:0000250""; DISULFID 409..422;  /evidence=""ECO:0000250""; DISULFID 424..433;  /evidence=""ECO:0000250""; DISULFID 446..458;  /evidence=""ECO:0000250""; DISULFID 452..465;  /evidence=""ECO:0000250""; DISULFID 467..476;  /evidence=""ECO:0000250""; DISULFID 493..501;  /evidence=""ECO:0000250""; DISULFID 495..508;  /evidence=""ECO:0000250""; DISULFID 510..519;  /evidence=""ECO:0000250""; DISULFID 575..587;  /evidence=""ECO:0000250""; DISULFID 581..594;  /evidence=""ECO:0000250""; DISULFID 596..605;  /evidence=""ECO:0000250""; DISULFID 663..675;  /evidence=""ECO:0000250""; DISULFID 669..682;  /evidence=""ECO:0000250""; DISULFID 684..693;  /evidence=""ECO:0000250""; DISULFID 710..718;  /evidence=""ECO:0000250""; DISULFID 712..725;  /evidence=""ECO:0000250""; DISULFID 727..736;  /evidence=""ECO:0000250""; DISULFID 753..761;  /evidence=""ECO:0000250""; DISULFID 755..768;  /evidence=""ECO:0000250""; DISULFID 770..779;  /evidence=""ECO:0000250""; DISULFID 792..804;  /evidence=""ECO:0000250""; DISULFID 798..811;  /evidence=""ECO:0000250""; DISULFID 813..822;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q01344,Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125),MIIVAHVLLILLGATEILQADLLPDEKISLLPPVNFTIKVTGLAQVLLQWKPNPDQEQRNVNLEYQVKINAPKEDDYETRITESKCVTILHKGFSASVRTILQNDHSLLASSWASAELHAPPGSPGTSIVNLTCTTNTTEDNYSRLRSYQVSLHCTWLVGTDAPEDTQYFLYYRYGSWTEECQEYSKDTLGRNIACWFPRTFILSKGRDWLAVLVNGSSKHSAIRPFDQLFALHAIDQINPPLNVTAEIEGTRLSIQWEKPVSAFPIHCFDYEVKIHNTRNGYLQIEKLMTNAFISIIDDLSKYDVQVRAAVSSMCREAGLWSEWSQPIYVGNDEHKPLREWFVIVIMATICFILLILSLICKICHLWIKLFPPIPAPKSNIKDLFVTTNYEKAGSSETEIEVICYIEKPGVETLEDSVF,420,"47,685",Alternative sequence (6); Beta strand (28); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (4); Helix (3); Motif (2); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 134..155;  /evidence=""ECO:0000269|PubMed:22153509""; DISULFID 182..196;  /evidence=""ECO:0000269|PubMed:22153509""; DISULFID 269..316;  /evidence=""ECO:0000269|PubMed:22153509""",SIGNAL 1..20
Q13478,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a),MNCRELPLTLWVLISVSTAESCTSRPHITVVEGEPFYLKHCSCSLAHEIETTTKSWYKSSGSQEHVELNPRSSSRIALHDCVLEFWPVELNDTGSYFFQMKNYTQKWKLNVIRRNKHSCFTERQVTSKIVEVKKFFQITCENSYYQTLVNSTSLYKNCKKLLLENNKNPTIKKNAEFEDQGYYSCVHFLHHNGKLFNITKTFNITIVEDRSNIVPVLLGPKLNHVAVELGKNVRLNCSALLNEEDVIYWMFGEENGSDPNIHEEKEMRIMTPEGKWHASKVLRIENIGESNLNVLYNCTVASTGGTDTKSFILVRKADMADIPGHVFTRGMIIAVLILVAVVCLVTVCVIYRVDLVLFYRHLTRRDETLTDGKTYDAFVSYLKECRPENGEEHTFAVEILPRVLEKHFGYKLCIFERDVVPGGAVVDEIHSLIEKSRRLIIVLSKSYMSNEVRYELESGLHEALVERKIKIILIEFTPVTDFTFLPQSLKLLKSHRVLKWKADKSLSYNSRFWKNLLYLMPAKTVKPGRDEPEVLPVLSES,541,"62,304",Active site (1); Beta strand (24); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (8); Helix (4); Mutagenesis (1); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 22..41;  /evidence=""ECO:0000244|PDB:3WO3, ECO:0000244|PDB:3WO4, ECO:0000244|PDB:4R6U, ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532""; DISULFID 43..81;  /evidence=""ECO:0000244|PDB:3WO3, ECO:0000244|PDB:3WO4, ECO:0000244|PDB:4R6U, ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532""; DISULFID 119..158;  /evidence=""ECO:0000244|PDB:3WO3, ECO:0000244|PDB:3WO4, ECO:0000244|PDB:4R6U, ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532""; DISULFID 140..185;  /evidence=""ECO:0000244|PDB:3WO3, ECO:0000244|PDB:3WO4, ECO:0000244|PDB:4R6U, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532""; DISULFID 237..298;  /evidence=""ECO:0000244|PDB:3WO3, ECO:0000244|PDB:3WO4, ECO:0000244|PDB:4R6U, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:9325300"""
Q9UMF0,Intercellular adhesion molecule 5 (ICAM-5) (Telencephalin),MPGPSPGLRRALLGLWAALGLGLFGLSAVSQEPFWADLQPRVAFVERGGSLWLNCSTNCPRPERGGLETSLRRNGTQRGLRWLARQLVDIREPETQPVCFFRCARRTLQARGLIRTFQRPDRVELMPLPPWQPVGENFTLSCRVPGAGPRASLTLTLLRGAQELIRRSFAGEPPRARGAVLTATVLARREDHGANFSCRAELDLRPHGLGLFENSSAPRELRTFSLSPDAPRLAAPRLLEVGSERPVSCTLDGLFPASEARVYLALGDQNLSPDVTLEGDAFVATATATASAEQEGARQLVCNVTLGGENRETRENVTIYSFPAPLLTLSEPSVSEGQMVTVTCAAGAQALVTLEGVPAAVPGQPAQLQLNATENDDRRSFFCDATLDVDGETLIKNRSAELRVLYAPRLDDSDCPRSWTWPEGPEQTLRCEARGNPEPSVHCARSDGGAVLALGLLGPVTRALSGTYRCKAANDQGEAVKDVTLTVEYAPALDSVGCPERITWLEGTEASLSCVAHGVPPPDVICVRSGELGAVIEGLLRVAREHAGTYRCEATNPRGSAAKNVAVTVEYGPRFEEPSCPSNWTWVEGSGRLFSCEVDGKPQPSVKCVGSGGATEGVLLPLAPPDPSPRAPRIPRVLAPGIYVCNATNRHGSVAKTVVVSAESPPEMDESTCPSHQTWLEGAEASALACAARGRPSPGVRCSREGIPWPEQQRVSREDAGTYHCVATNAHGTDSRTVTVGVEYRPVVAELAASPPGGVRPGGNFTLTCRAEAWPPAQISWRAPPGALNIGLSSNNSTLSVAGAMGSHGGEYECAATNAHGRHARRITVRVAGPWLWVAVGGAAGGAALLAAGAGLAFYVQSTACKKGEYNVQEAESSGEAVCLNGAGGGAGGAAGAEGGPEAAGGAAESPAEGEVFAIQLTSA,924,"97,116",Beta strand (33); Chain (1); Disulfide bond (10); Domain (9); Glycosylation (14); Helix (5); Modified residue (2); Natural variant (5); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 55..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18691975""; DISULFID 59..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18691975""; DISULFID 142..198;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18691975""; DISULFID 249..302;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 344..383;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 415..470;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 498..552;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 580..645;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 673..725;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 769..814;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9UKX5,Integrin alpha-11,MDLPRGLVVAWALSLWPGFTDTFNMDTRKPRVIPGSRTAFFGYTVQQHDISGNKWLVVGAPLETNGYQKTGDVYKCPVIHGNCTKLNLGRVTLSNVSERKDNMRLGLSLATNPKDNSFLACSPLWSHECGSSYYTTGMCSRVNSNFRFSKTVAPALQRCQTYMDIVIVLDGSNSIYPWVEVQHFLINILKKFYIGPGQIQVGVVQYGEDVVHEFHLNDYRSVKDVVEAASHIEQRGGTETRTAFGIEFARSEAFQKGGRKGAKKVMIVITDGESHDSPDLEKVIQQSERDNVTRYAVAVLGYYNRRGINPETFLNEIKYIASDPDDKHFFNVTDEAALKDIVDALGDRIFSLEGTNKNETSFGLEMSQTGFSSHVVEDGVLLGAVGAYDWNGAVLKETSAGKVIPLRESYLKEFPEELKNHGAYLGYTVTSVVSSRQGRVYVAGAPRFNHTGKVILFTMHNNRSLTIHQAMRGQQIGSYFGSEITSVDIDGDGVTDVLLVGAPMYFNEGRERGKVYVYELRQNLFVYNGTLKDSHSYQNARFGSSIASVRDLNQDSYNDVVVGAPLEDNHAGAIYIFHGFRGSILKTPKQRITASELATGLQYFGCSIHGQLDLNEDGLIDLAVGALGNAVILWSRPVVQINASLHFEPSKINIFHRDCKRSGRDATCLAAFLCFTPIFLAPHFQTTTVGIRYNATMDERRYTPRAHLDEGGDRFTNRAVLLSSGQELCERINFHVLDTADYVKPVTFSVEYSLEDPDHGPMLDDGWPTTLRVSVPFWNGCNEDEHCVPDLVLDARSDLPTAMEYCQRVLRKPAQDCSAYTLSFDTTVFIIESTRQRVAVEATLENRGENAYSTVLNISQSANLQFASLIQKEDSDGSIECVNEERRLQKQVCNVSYPFFRAKAKVAFRLDFEFSKSIFLHHLEIELAAGSDSNERDSTKEDNVAPLRFHLKYEADVLFTRSSSLSHYEVKPNSSLERYDGIGPPFSCIFRIQNLGLFPIHGMMMKITIPIATRSGNRLLKLRDFLTDEANTSCNIWGNSTEYRPTPVEEDLRRAPQLNHSNSDVVSINCNIRLVPNQEINFHLLGNLWLRSLKALKYKSMKIMVNAALQRQFHSPFIFREEDPSRQIVFEISKQEDWQVPIWIIVGSTLGGLLLLALLVLALWKLGFFRSARRRREPGLDPTPKVLE,1188,"133,470",Alternative sequence (1); Calcium binding (3); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (1); Erroneous initiation (1); Glycosylation (16); Mutagenesis (1); Natural variant (7); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 76..83;  /evidence=""ECO:0000250""; DISULFID 121..139;  /evidence=""ECO:0000255""; DISULFID 129..159;  /evidence=""ECO:0000255""; DISULFID 659..668;  /evidence=""ECO:0000250""; DISULFID 674..729;  /evidence=""ECO:0000250""; DISULFID 781..787;  /evidence=""ECO:0000250""; DISULFID 881..893;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9HBX8,Leucine-rich repeat-containing G-protein coupled receptor 6,MPSPPGLRALWLCAALCASRRAGGAPQPGPGPTACPAPCHCQEDGIMLSADCSELGLSAVPGDLDPLTAYLDLSMNNLTELQPGLFHHLRFLEELRLSGNHLSHIPGQAFSGLYSLKILMLQNNQLGGIPAEALWELPSLQSLRLDANLISLVPERSFEGLSSLRHLWLDDNALTEIPVRALNNLPALQAMTLALNRISHIPDYAFQNLTSLVVLHLHNNRIQHLGTHSFEGLHNLETLDLNYNKLQEFPVAIRTLGRLQELGFHNNNIKAIPEKAFMGNPLLQTIHFYDNPIQFVGRSAFQYLPKLHTLSLNGAMDIQEFPDLKGTTSLEILTLTRAGIRLLPSGMCQQLPRLRVLELSHNQIEELPSLHRCQKLEEIGLQHNRIWEIGADTFSQLSSLQALDLSWNAIRSIHPEAFSTLHSLVKLDLTDNQLTTLPLAGLGGLMHLKLKGNLALSQAFSKDSFPKLRILEVPYAYQCCPYGMCASFFKASGQWEAEDLHLDDEESSKRPLGLLARQAENHYDQDLDELQLEMEDSKPHPSVQCSPTPGPFKPCEYLFESWGIRLAVWAIVLLSVLCNGLVLLTVFAGGPVPLPPVKFVVGAIAGANTLTGISCGLLASVDALTFGQFSEYGARWETGLGCRATGFLAVLGSEASVLLLTLAAVQCSVSVSCVRAYGKSPSLGSVRAGVLGCLALAGLAAALPLASVGEYGASPLCLPYAPPEGQPAALGFTVALVMMNSFCFLVVAGAYIKLYCDLPRGDFEAVWDCAMVRHVAWLIFADGLLYCPVAFLSFASMLGLFPVTPEAVKSVLLVVLPLPACLNPLLYLLFNPHFRDDLRRLRPRAGDSGPLAYAAAGELEKSSCDSTQALVAFSDVDLILEASEAGRPPGLETYGFPSVTLISCQQPGAPRLEGSHCVEPEGNHFGNPQPSMDGELLLRAEGSTPAGGGLSGGGGFQPSGLAFASHV,967,"104,298",Alternative sequence (3); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (2); Natural variant (5); Repeat (15); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 642..717;  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9Y561,Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein),MACRWSTKESPRWRSALLLLFLAGVYGNGALAEHSENVHISGVSTACGETPEQIRAPSGIITSPGWPSEYPAKINCSWFIRANPGEIITISFQDFDIQGSRRCNLDWLTIETYKNIESYRACGSTIPPPYISSQDHIWIRFHSDDNISRKGFRLAYFSGKSEEPNCACDQFRCGNGKCIPEAWKCNNMDECGDSSDEEICAKEANPPTAAAFQPCAYNQFQCLSRFTKVYTCLPESLKCDGNIDCLDLGDEIDCDVPTCGQWLKYFYGTFNSPNYPDFYPPGSNCTWLIDTGDHRKVILRFTDFKLDGTGYGDYVKIYDGLEENPHKLLRVLTAFDSHAPLTVVSSSGQIRVHFCADKVNAARGFNATYQVDGFCLPWEIPCGGNWGCYTEQQRCDGYWHCPNGRDETNCTMCQKEEFPCSRNGVCYPRSDRCNYQNHCPNGSDEKNCFFCQPGNFHCKNNRCVFESWVCDSQDDCGDGSDEENCPVIVPTRVITAAVIGSLICGLLLVIALGCTCKLYSLRMFERRSFETQLSRVEAELLRREAPPSYGQLIAQGLIPPVEDFPVCSPNQASVLENLRLAVRSQLGFTSVRLPMAGRSSNIWNRIFNFARSRHSGSLALVSADGDEVVPSQSTSREPERNHTHRSLFSVESDDTDTENERRDMAGASGGVAAPLPQKVPPTTAVEATVGACASSSTQSTRGGHADNGRDVTSVEPPSVSPARHQLTSALSRMTQGLRWVRFTLGRSSSLSQNQSPLRQLDNGVSGREDDDDVEMLIPISDGSSDFDVNDCSRPLLDLASDQGQGLRQPYNATNPGVRPSNRDGPCERCGIVHTAQIPDTCLEVTLKNETSDDEALLLC,859,"94,984",Alternative sequence (1); Chain (1); Disulfide bond (18); Domain (7); Glycosylation (6); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..76;  /evidence=""ECO:0000250""; DISULFID 103..122;  /evidence=""ECO:0000250""; DISULFID 166..178;  /evidence=""ECO:0000250""; DISULFID 173..191;  /evidence=""ECO:0000250""; DISULFID 185..200;  /evidence=""ECO:0000250""; DISULFID 215..232;  /evidence=""ECO:0000250""; DISULFID 222..245;  /evidence=""ECO:0000250""; DISULFID 239..254;  /evidence=""ECO:0000250""; DISULFID 259..285;  /evidence=""ECO:0000250""; DISULFID 375..388;  /evidence=""ECO:0000250""; DISULFID 382..401;  /evidence=""ECO:0000250""; DISULFID 395..410;  /evidence=""ECO:0000250""; DISULFID 413..426;  /evidence=""ECO:0000250""; DISULFID 420..439;  /evidence=""ECO:0000250""; DISULFID 433..448;  /evidence=""ECO:0000250""; DISULFID 451..463;  /evidence=""ECO:0000250""; DISULFID 458..476;  /evidence=""ECO:0000250""; DISULFID 470..485;  /evidence=""ECO:0000250""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9NZR2,Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT),MSEFLLALLTLSGLLPIARVLTVGADRDQQLCDPGEFLCHDHVTCVSQSWLCDGDPDCPDDSDESLDTCPEEVEIKCPLNHIACLGTNKCVHLSQLCNGVLDCPDGYDEGVHCQELLSNCQQLNCQYKCTMVRNSTRCYCEDGFEITEDGRSCKDQDECAVYGTCSQTCRNTHGSYTCSCVEGYLMQPDNRSCKAKIEPTDRPPILLIANFETIEVFYLNGSKMATLSSVNGNEIHTLDFIYNEDMICWIESRESSNQLKCIQITKAGGLTDEWTINILQSFHNVQQMAIDWLTRNLYFVDHVGDRIFVCNSNGSVCVTLIDLELHNPKAIAVDPIAGKLFFTDYGNVAKVERCDMDGMNRTRIIDSKTEQPAALALDLVNKLVYWVDLYLDYVGVVDYQGKNRHTVIQGRQVRHLYGITVFEDYLYATNSDNYNIVRINRFNGTDIHSLIKIENAWGIRIYQKRTQPTVRSHACEVDPYGMPGGCSHICLLSSSYKTRTCRCRTGFNLGSDGRSCKRPKNELFLFYGKGRPGIVRGMDLNTKIADEYMIPIENLVNPRALDFHAETNYIYFADTTSFLIGRQKIDGTERETILKDDLDNVEGIAVDWIGNNLYWTNDGHRKTINVARLEKASQSRKTLLEGEMSHPRGIVVDPVNGWMYWTDWEEDEIDDSVGRIEKAWMDGFNRQIFVTSKMLWPNGLTLDFHTNTLYWCDAYYDHIEKVFLNGTHRKIVYSGRELNHPFGLSHHGNYVFWTDYMNGSIFQLDLITSEVTLLRHERPPLFGLQIYDPRKQQGDNMCRVNNGGCSTLCLAIPGGRVCACADNQLLDENGTTCTFNPGEALPHICKAGEFRCKNRHCIQARWKCDGDDDCLDGSDEDSVNCFNHSCPDDQFKCQNNRCIPKRWLCDGANDCGSNEDESNQTCTARTCQVDQFSCGNGRCIPRAWLCDREDDCGDQTDEMASCEFPTCEPLTQFVCKSGRCISSKWHCDSDDDCGDGSDEVGCVHSCFDNQFRCSSGRCIPGHWACDGDNDCGDFSDEAQINCTKEEIHSPAGCNGNEFQCHPDGNCVPDLWRCDGEKDCEDGSDEKGCNGTIRLCDHKTKFSCWSTGRCINKAWVCDGDIDCEDQSDEDDCDSFLCGPPKHPCANDTSVCLQPEKLCNGKKDCPDGSDEGYLCDECSLNNGGCSNHCSVVPGRGIVCSCPEGLQLNKDNKTCEIVDYCSNHLKCSQVCEQHKHTVKCSCYEGWKLDVDGESCTSVDPFEAFIIFSIRHEIRRIDLHKRDYSLLVPGLRNTIALDFHFNQSLLYWTDVVEDRIYRGKLSESGGVSAIEVVVEHGLATPEGLTVDWIAGNIYWIDSNLDQIEVAKLDGSLRTTLIAGAMEHPRAIALDPRYGILFWTDWDANFPRIESASMSGAGRKTIYKDMKTGAWPNGLTVDHFEKRIVWTDARSDAIYSALYDGTNMIEIIRGHEYLSHPFAVSLYGSEVYWTDWRTNTLSKANKWTGQNVSVIQKTSAQPFDLQIYHPSRQPQAPNPCAANDGKGPCSHMCLINHNRSAACACPHLMKLSSDKKTCYEMKKFLLYARRSEIRGVDIDNPYFNFITAFTVPDIDDVTVIDFDASEERLYWTDIKTQTIKRAFINGTGLETVISRDIQSIRGLAVDWVSRNLYWISSEFDETQINVARLDGSLKTSIIHGIDKPQCLAAHPVRGKLYWTDGNTINMANMDGSNSKILFQNQKEPVGLSIDYVENKLYWISSGNGTINRCNLDGGNLEVIESMKEELTKATALTIMDKKLWWADQNLAQLGTCSKRDGRNPTILRNKTSGVVHMKVYDKEAQQGSNSCQLNNGGCSQLCLPTSETTRTCMCTVGYYLQKNRMSCQGIESFLMYSVHEGIRGIPLEPSDKMDALMPISGTSFAVGIDFHAENDTIYWTDMGFNKISRAKRDQTWKEDIITNGLGRVEGIAVDWIAGNIYWTDHGFNLIEVARLNGSFRYVIISQGLDQPRSIAVHPEKGLLFWTEWGQMPCIGKARLDGSEKVVLVSMGIAWPNGISIDYEENKLYWCDARTDKIERIDLETGGNREMVLSGSNVDMFSVAVFGAYIYWSDRAHANGSVRRGHKNDATETITMRTGLGVNLKEVKIFNRVREKGTNVCARDNGGCKQLCLYRGNSRRTCACAHGYLAEDGVTCLRHEGYLLYSGRTILKSIHLSDETNLNSPIRPYENPRYFKNVIALAFDYNQRRKGTNRIFYSDAHFGNIQLIKDNWEDRQVIVENVGSVEGLAYHRAWDTLYWTSSTTSSITRHTVDQTRPGAFDREAVITMSEDDHPHVLALDECQNLMFWTNWNEQHPSIMRSTLTGKNAQVVVSTDILTPNGLTIDYRAEKLYFSDGSLGKIERCEYDGSQRHVIVKSGPGTFLSLAVYDNYIFWSDWGRRAILRSNKYTGGDTKILRSDIPHQPMGIIAVANDTNSCELSPCALLNGGCHDLCLLTPNGRVNCSCRGDRILLEDNRCVTKNSSCNAYSEFECGNGECIDYQLTCDGIPHCKDKSDEKLLYCENRSCRRGFKPCYNRRCIPHGKLCDGENDCGDNSDELDCKVSTCATVEFRCADGTCIPRSARCNQNIDCADASDEKNCNNTDCTHFYKLGVKTTGFIRCNSTSLCVLPTWICDGSNDCGDYSDELKCPVQNKHKCEENYFSCPSGRCILNTWICDGQKDCEDGRDEFHCDSSCSWNQFACSAQKCISKHWICDGEDDCGDGLDESDSICGAITCAADMFSCQGSRACVPRHWLCDGERDCPDGSDELSTAGCAPNNTCDENAFMCHNKVCIPKQFVCDHDDDCGDGSDESPQCGYRQCGTEEFSCADGRCLLNTQWQCDGDFDCPDHSDEAPLNPKCKSAEQSCNSSFFMCKNGRCIPSGGLCDNKDDCGDGSDERNCHINECLSKKVSGCSQDCQDLPVSYKCKCWPGFQLKDDGKTCVDIDECSSGFPCSQQCINTYGTYKCLCTDGYEIQPDNPNGCKSLSDEEPFLILADHHEIRKISTDGSNYTLLKQGLNNVIAIDFDYREEFIYWIDSSRPNGSRINRMCLNGSDIKVVHNTAVPNALAVDWIGKNLYWSDTEKRIIEVSKLNGLYPTILVSKRLKFPRDLSLDPQAGYLYWIDCCEYPHIGRVGMDGTNQSVVIETKISRPMALTIDYVNRRLYWADENHIEFSNMDGSHRHKVPNQDIPGVIALTLFEDYIYWTDGKTKSLSRAHKTSGADRLSLIYSWHAITDIQVYHSYRQPDVSKHLCMINNGGCSHLCLLAPGKTHTCACPTNFYLAADNRTCLSNCTASQFRCKTDKCIPFWWKCDTVDDCGDGSDEPDDCPEFRCQPGRFQCGTGLCALPAFICDGENDCGDNSDELNCDTHVCLSGQFKCTKNQKCIPVNLRCNGQDDCGDEEDERDCPENSCSPDYFQCKTTKHCISKLWVCDEDPDCADASDEANCDKKTCGPHEFQCKNNNCIPDHWRCDSQNDCSDNSDEENCKPQTCTLKDFLCANGDCVSSRFWCDGDFDCADGSDERNCETSCSKDQFRCSNGQCIPAKWKCDGHEDCKYGEDEKSCEPASPTCSSREYICASDGCISASLKCNGEYDCADGSDEMDCVTECKEDQFRCKNKAHCIPIRWLCDGIHDCVDGSDEENCERGGNICRADEFLCNNSLCKLHFWVCDGEDDCGDNSDEAPDMCVKFLCPSTRPHRCRNNRICLQSEQMCNGIDECGDNSDEDHCGGKLTYKARPCKKDEFACSNKKCIPMDLQCDRLDDCGDGSDEQGCRIAPTEYTCEDNVNPCGDDAYCNQIKTSVFCRCKPGFQRNMKNRQCEDLNECLVFGTCSHQCINVEGSYKCVCDQNFQERNNTCIAEGSEDQVLYIANDTDILGFIYPFNYSGDHQQISHIEHNSRITGMDVYYQRDMIIWSTQFNPGGIFYKRIHGREKRQANSGLICPEFKRPRDIAVDWVAGNIYWTDHSRMHWFSYYTTHWTSLRYSINVGQLNGPNCTRLLTNMAGEPYAIAVNPKRGMMYWTVVGDHSHIEEAAMDGTLRRILVQKNLQRPTGLAVDYFSERIYWADFELSIIGSVLYDGSNSVVSVSSKQGLLHPHRIDIFEDYIYGAGPKNGVFRVQKFGHGSVEYLALNIDKTKGVLISHRYKQLDLPNPCLDLACEFLCLLNPSGATCVCPEGKYLINGTCNDDSLLDDSCKLTCENGGRCILNEKGDLRCHCWPSYSGERCEVNHCSNYCQNGGTCVPSVLGRPTCSCALGFTGPNCGKTVCEDFCQNGGTCIVTAGNQPYCHCQPEYTGDRCQYYVCHHYCVNSESCTIGDDGSVECVCPTRYEGPKCEVDKCVRCHGGHCIINKDSEDIFCNCTNGKIASSCQLCDGYCYNGGTCQLDPETNVPVCLCSTNWSGTQCERPAPKSSKSDHISTRSIAIIVPLVLLVTLITTLVIGLVLCKRKRRTKTIRRQPIINGGINVEIGNPSYNMYEVDHDHNDGGLLDPGFMIDPTKARYIGGGPSAFKLPHTAPPIYLNSDLKGPLTAGPTNYSNPVYAKLYMDGQNCRNSLGSVDERKELLPKKIEIGIRETVA,4599,"515,498",Chain (1); Disulfide bond (137); Domain (54); Glycosylation (46); Motif (2); Natural variant (6); Repeat (34); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 32..45;  /evidence=""ECO:0000250""; DISULFID 39..58;  /evidence=""ECO:0000250""; DISULFID 52..69;  /evidence=""ECO:0000250""; DISULFID 77..90;  /evidence=""ECO:0000250""; DISULFID 84..103;  /evidence=""ECO:0000250""; DISULFID 97..113;  /evidence=""ECO:0000250""; DISULFID 120..129;  /evidence=""ECO:0000250""; DISULFID 125..138;  /evidence=""ECO:0000250""; DISULFID 140..153;  /evidence=""ECO:0000250""; DISULFID 159..169;  /evidence=""ECO:0000250""; DISULFID 165..178;  /evidence=""ECO:0000250""; DISULFID 180..193;  /evidence=""ECO:0000250""; DISULFID 798..809;  /evidence=""ECO:0000250""; DISULFID 805..818;  /evidence=""ECO:0000250""; DISULFID 820..833;  /evidence=""ECO:0000250""; DISULFID 845..857;  /evidence=""ECO:0000250""; DISULFID 852..870;  /evidence=""ECO:0000250""; DISULFID 864..881;  /evidence=""ECO:0000250""; DISULFID 886..898;  /evidence=""ECO:0000250""; DISULFID 893..911;  /evidence=""ECO:0000250""; DISULFID 905..922;  /evidence=""ECO:0000250""; DISULFID 927..939;  /evidence=""ECO:0000250""; DISULFID 934..952;  /evidence=""ECO:0000250""; DISULFID 946..962;  /evidence=""ECO:0000250""; DISULFID 967..980;  /evidence=""ECO:0000250""; DISULFID 975..993;  /evidence=""ECO:0000250""; DISULFID 987..1002;  /evidence=""ECO:0000250""; DISULFID 1006..1018;  /evidence=""ECO:0000250""; DISULFID 1013..1031;  /evidence=""ECO:0000250""; DISULFID 1025..1042;  /evidence=""ECO:0000250""; DISULFID 1053..1066;  /evidence=""ECO:0000250""; DISULFID 1060..1079;  /evidence=""ECO:0000250""; DISULFID 1073..1088;  /evidence=""ECO:0000250""; DISULFID 1095..1109;  /evidence=""ECO:0000250""; DISULFID 1103..1122;  /evidence=""ECO:0000250""; DISULFID 1116..1131;  /evidence=""ECO:0000250""; DISULFID 1136..1150;  /evidence=""ECO:0000250""; DISULFID 1143..1163;  /evidence=""ECO:0000250""; DISULFID 1157..1173;  /evidence=""ECO:0000250""; DISULFID 1838..1849;  /evidence=""ECO:0000250""; DISULFID 1845..1859;  /evidence=""ECO:0000250""; DISULFID 1861..1874;  /evidence=""ECO:0000250""; DISULFID 2147..2158;  /evidence=""ECO:0000250""; DISULFID 2154..2168;  /evidence=""ECO:0000250""; DISULFID 2170..2182;  /evidence=""ECO:0000250""; DISULFID 2510..2523;  /evidence=""ECO:0000250""; DISULFID 2518..2536;  /evidence=""ECO:0000250""; DISULFID 2530..2547;  /evidence=""ECO:0000250""; DISULFID 2552..2564;  /evidence=""ECO:0000250""; DISULFID 2559..2577;  /evidence=""ECO:0000250""; DISULFID 2571..2586;  /evidence=""ECO:0000250""; DISULFID 2591..2603;  /evidence=""ECO:0000250""; DISULFID 2598..2616;  /evidence=""ECO:0000250""; DISULFID 2610..2625;  /evidence=""ECO:0000250""; DISULFID 2630..2652;  /evidence=""ECO:0000250""; DISULFID 2646..2665;  /evidence=""ECO:0000250""; DISULFID 2659..2674;  /evidence=""ECO:0000250""; DISULFID 2682..2694;  /evidence=""ECO:0000250""; DISULFID 2689..2707;  /evidence=""ECO:0000250""; DISULFID 2701..2716;  /evidence=""ECO:0000250""; DISULFID 2720..2732;  /evidence=""ECO:0000250""; DISULFID 2727..2745;  /evidence=""ECO:0000250""; DISULFID 2739..2756;  /evidence=""ECO:0000250""; DISULFID 2761..2774;  /evidence=""ECO:0000250""; DISULFID 2768..2787;  /evidence=""ECO:0000250""; DISULFID 2781..2799;  /evidence=""ECO:0000250""; DISULFID 2805..2817;  /evidence=""ECO:0000250""; DISULFID 2812..2830;  /evidence=""ECO:0000250""; DISULFID 2824..2840;  /evidence=""ECO:0000250""; DISULFID 2845..2857;  /evidence=""ECO:0000250""; DISULFID 2852..2871;  /evidence=""ECO:0000250""; DISULFID 2865..2884;  /evidence=""ECO:0000250""; DISULFID 2891..2903;  /evidence=""ECO:0000250""; DISULFID 2898..2916;  /evidence=""ECO:0000250""; DISULFID 2910..2925;  /evidence=""ECO:0000250""; DISULFID 2930..2942;  /evidence=""ECO:0000250""; DISULFID 2938..2951;  /evidence=""ECO:0000250""; DISULFID 2953..2966;  /evidence=""ECO:0000250""; DISULFID 2972..2982;  /evidence=""ECO:0000250""; DISULFID 2978..2991;  /evidence=""ECO:0000250""; DISULFID 2993..3007;  /evidence=""ECO:0000250""; DISULFID 3317..3329;  /evidence=""ECO:0000250""; DISULFID 3324..3342;  /evidence=""ECO:0000250""; DISULFID 3336..3352;  /evidence=""ECO:0000250""; DISULFID 3357..3369;  /evidence=""ECO:0000250""; DISULFID 3364..3382;  /evidence=""ECO:0000250""; DISULFID 3376..3391;  /evidence=""ECO:0000250""; DISULFID 3396..3409;  /evidence=""ECO:0000250""; DISULFID 3403..3422;  /evidence=""ECO:0000250""; DISULFID 3416..3431;  /evidence=""ECO:0000250""; DISULFID 3436..3449;  /evidence=""ECO:0000250""; DISULFID 3443..3462;  /evidence=""ECO:0000250""; DISULFID 3456..3471;  /evidence=""ECO:0000250""; DISULFID 3476..3488;  /evidence=""ECO:0000250""; DISULFID 3483..3501;  /evidence=""ECO:0000250""; DISULFID 3495..3510;  /evidence=""ECO:0000250""; DISULFID 3515..3527;  /evidence=""ECO:0000250""; DISULFID 3522..3540;  /evidence=""ECO:0000250""; DISULFID 3534..3549;  /evidence=""ECO:0000250""; DISULFID 3553..3565;  /evidence=""ECO:0000250""; DISULFID 3560..3578;  /evidence=""ECO:0000250""; DISULFID 3572..3587;  /evidence=""ECO:0000250""; DISULFID 3594..3606;  /evidence=""ECO:0000250""; DISULFID 3601..3619;  /evidence=""ECO:0000250""; DISULFID 3613..3628;  /evidence=""ECO:0000250""; DISULFID 3632..3645;  /evidence=""ECO:0000250""; DISULFID 3639..3658;  /evidence=""ECO:0000250""; DISULFID 3652..3667;  /evidence=""ECO:0000250""; DISULFID 3674..3686;  /evidence=""ECO:0000250""; DISULFID 3681..3699;  /evidence=""ECO:0000250""; DISULFID 3693..3710;  /evidence=""ECO:0000250""; DISULFID 3715..3729;  /evidence=""ECO:0000250""; DISULFID 3723..3742;  /evidence=""ECO:0000250""; DISULFID 3736..3751;  /evidence=""ECO:0000250""; DISULFID 3762..3774;  /evidence=""ECO:0000250""; DISULFID 3769..3787;  /evidence=""ECO:0000250""; DISULFID 3781..3796;  /evidence=""ECO:0000250""; DISULFID 3805..3818;  /evidence=""ECO:0000250""; DISULFID 3812..3827;  /evidence=""ECO:0000250""; DISULFID 3829..3842;  /evidence=""ECO:0000250""; DISULFID 3848..3858;  /evidence=""ECO:0000250""; DISULFID 3854..3867;  /evidence=""ECO:0000250""; DISULFID 3869..3880;  /evidence=""ECO:0000250""; DISULFID 4217..4227;  /evidence=""ECO:0000250""; DISULFID 4221..4237;  /evidence=""ECO:0000250""; DISULFID 4253..4263;  /evidence=""ECO:0000250""; DISULFID 4257..4273;  /evidence=""ECO:0000250""; DISULFID 4275..4284;  /evidence=""ECO:0000250""; DISULFID 4289..4299;  /evidence=""ECO:0000250""; DISULFID 4293..4309;  /evidence=""ECO:0000250""; DISULFID 4311..4320;  /evidence=""ECO:0000250""; DISULFID 4325..4335;  /evidence=""ECO:0000250""; DISULFID 4329..4345;  /evidence=""ECO:0000250""; DISULFID 4347..4356;  /evidence=""ECO:0000250""; DISULFID 4394..4404;  /evidence=""ECO:0000250""; DISULFID 4398..4415;  /evidence=""ECO:0000250""; DISULFID 4417..4426;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q12907,Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36),MAAEGWIWRWGWGRRCLGRPGLLGPGPGPTTPLFLLLLLGSVTADITDGNSEHLKREHSLIKPYQGVGSSSMPLWDFQGSTMLTSQYVRLTPDERSKEGSIWNHQPCFLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRLVPGPVFGSKDNFHGLAIFLDTYPNDETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLMVEHTPDEESIDWTKIEPSVNFLKSPKDNVDDPTGNFRSGPLTGWRVFLLLLCALLGIVVCAVVGAVVFQKRQERNKRFY,356,"40,229",Binding site (3); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Metal binding (4); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 202..239;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00658""","SIGNAL 1..44;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000255"""
P49257,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),MAGSRQRGLRARVRPLFCALLLSLGRFVRGDGVGGDPAVALPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSSDQIRVAPSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYAENQGLEGPVFGSADLWNGVGIFFDSFDNDGKKNNPAIVIIGNNGQIHYDHQNDGASQALASCQRDFRNKPYPVRAKITYYQNTLTVMINNGFTPDKNDYEFCAKVENMIIPAQGHFGISAATGGLADDHDVLSFLTFQLTEPGKEPPTPDKEISEKEKEKYQEEFEHFQQELDKKKEEFQKGHPDLQGQPAEEIFESVGDRELRQVFEGQNRIHLEIKQLNRQLDMILDEQRRYVSSLTEEISKRGAGMPGQHGQITQQELDTVVKTQHEILRQVNEMKNSMSETVRLVSGMQHPGSAGGVYETTQHFIDIKEHLHIVKRDIDNLVQRNMPSNEKPKCPELPPFPSCLSTVHFIIFVVVQTVLFIGYIMYRSQQEAAAKKFF,510,"57,549",Beta strand (21); Binding site (4); Chain (1); Disulfide bond (3); Domain (1); Helix (3); Metal binding (4); Modified residue (1); Motif (1); Natural variant (5); Region (2); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 190..230; DISULFID 466;  /note=""Interchain""; DISULFID 475;  /note=""Interchain""","SIGNAL 1..30;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:12665801, ECO:0000269|PubMed:7876089, ECO:0000269|PubMed:8223692"""
Q7Z7M0,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),MALGKVLAMALVLALAVLGSLSPGARAGDCKGQRQVLREAPGFVTDGAGNYSVNGNCEWLIEAPSPQHRILLDFLFLDTECTYDYLFVYDGDSPRGPLLASLSGSTRPPPIEASSGKMLLHLFSDANYNLLGFNASFRFSLCPGGCQSHGQCQPPGVCACEPGWGGPDCGLQECSAYCGSHGTCASPLGPCRCEPGFLGRACDLHLWENQGAGWWHNVSARDPAFSARIGAAGAFLSPPGLLAVFGGQDLNNALGDLVLYNFSANTWESWDLSPAPAARHSHVAVAWAGSLVLMGGELADGSLTNDVWAFSPLGRGHWELLAPPASSSSGPPGLAGHAAALVDDVWLYVSGGRTPHDLFSSGLFRFRLDSTSGGYWEQVIPAGGRPPAATGHSMVFHAPSRALLVHGGHRPSTARFSVRVNSTELFHVDRHVWTTLKGRDGLQGPRERAFHTASVLGNYMVVYGGNVHTHYQEEKCYEDGIFFYHLGCHQWVSGAELAPPGTPEGRAAPPSGRYSHVAAVLGGSVLLVAGGYSGRPRGDLMAYKVPPFVFQAPAPDYHLDYCSMYTDHSVCSRDPECSWCQGACQAAPPPGTPLGACPAASCLGLGRLLGDCQACLAFSSPTAPPRGPGTLGWCVHNESCLPRPEQARCRGEQISGTVGWWGPAPVFVTSLEACVTQSFLPGLHLLTFQQPPNTSQPDKVSIVRSTTITLTPSAETDVSLVYRGFIYPMLPGGPGGPGAEDVAVWTRAQRLHVLARMARGPDTENMEEVGRWVAHQEKETRRLQRPGSARLFPLPGRDHKYAVEIQGQLNGSAGPGHSELTLLWDRTGVPGGSEISFFFLEPYRSSSCTSYSSCLGCLADQGCGWCLTSATCHLRQGGAHCGDDGAGGSLLVLVPTLCPLCEEHRDCHACTQDPFCEWHQSTSRKGDAACSRRGRGRGALKSPEECPPLCSQRLTCEDCLANSSQCAWCQSTHTCFLFAAYLARYPHGGCRGWDDSVHSEPRCRSCDGFLTCHECLQSHECGWCGNEDNPTLGRCLQGDFSGPLGGGNCSLWVGEGLGLPVALPARWAYARCPDVDECRLGLARCHPRATCLNTPLSYECHCQRGYQGDGISHCNRTCLEDCGHGVCSGPPDFTCVCDLGWTSDLPPPTPAPGPPAPRCSRDCGCSFHSHCRKRGPGFCDECQDWTWGEHCERCRPGSFGNATGSRGCRPCQCNGHGDPRRGHCDNLSGLCFCQDHTEGAHCQLCSPGYYGDPRAGGSCFRECGGRALLTNVSSVALGSRRVGGLLPPGGGAARAGPGLSYCVWVVSATEELQPCAPGTLCPPLTLTFSPDSSTPCTLSYVLAFDGFPRFLDTGVVQSDRSLIAAFCGQRRDRPLTVQALSGLLVLHWEANGSSSWGFNASVGSARCGSGGPGSCPVPQECVPQDGAAGAGLCRCPQGWAGPHCRMALCPENCNAHTGAGTCNQSLGVCICAEGFGGPDCATKLDGGQLVWETLMDSRLSADTASRFLHRLGHTMVDGPDATLWMFGGLGLPQGLLGNLYRYSVSERRWTQMLAGAEDGGPGPSPRSFHAAAYVPAGRGAMYLLGGLTAGGVTRDFWVLNLTTLQWRQEKAPQTVELPAVAGHTLTARRGLSLLLVGGYSPENGFNQQLLEYQLATGTWVSGAQSGTPPTGLYGHSAVYHEATDSLYVFGGFRFHVELAAPSPELYSLHCPDRTWSLLAPSQGAKRDRMRNVRGSSRGLGQVPGEQPGSWGFREVRKKMALWAALAGTGGFLEEISPHLKEPRPRLFHASALLGDTMVVLGGRSDPDEFSSDVLLYQVNCNAWLLPDLTRSASVGPPMEESVAHAVAAVGSRLYISGGFGGVALGRLLALTLPPDPCRLLSSPEACNQSGACTWCHGACLSGDQAHRLGCGGSPCSPMPRSPEECRRLRTCSECLARHPRTLQPGDGEASTPRCKWCTNCPEGACIGRNGSCTSENDCRINQREVFWAGNCSEAACGAADCEQCTREGKCMWTRQFKRTGETRRILSVQPTYDWTCFSHSLLNVSPMPVESSPPLPCPTPCHLLPNCTSCLDSKGADGGWQHCVWSSSLQQCLSPSYLPLRCMAGGCGRLLRGPESCSLGCAQATQCALCLRRPHCGWCAWGGQDGGGRCMEGGLSGPRDGLTCGRPGASWAFLSCPPEDECANGHHDCNETQNCHDQPHGYECSCKTGYTMDNMTGLCRPVCAQGCVNGSCVEPDHCRCHFGFVGRNCSTECRCNRHSECAGVGARDHCLLCRNHTKGSHCEQCLPLFVGSAVGGGTCRPCHAFCRGNSHICISRKELQMSKGEPKKYSLDPEEIENWVTEGPSEDEAVCVNCQNNSYGEKCESCLQGYFLLDGKCTKCQCNGHADTCNEQDGTGCPCQNNTETGTCQGSSPSDRRDCYKYQCAKCRESFHGSPLGGQQCYRLISVEQECCLDPTSQTNCFHEPKRRALGPGRTVLFGVQPKFTNVDIRLTLDVTFGAVDLYVSTSYDTFVVRVAPDTGVHTVHIQPPPAPPPPPPPADGGPRGAGDPGGAGASSGPGAPAEPRVREVWPRGLITYVTVTEPSAVLVVRGVRDRLVITYPHEHHALKSSRFYLLLLGVGDPSGPGANGSADSQGLLFFRQDQAHIDLFVFFSVFFSCFFLFLSLCVLLWKAKQALDQRQEQRRHLQEMTKMASRPFAKVTVCFPPDPTAPASAWKPAGLPPPAFRRSEPFLAPLLLTGAGGPWGPMGGGCCPPAIPATTAGLRAGPITLEPTEDGMAGVATLLLQLPGGPHAPNGACLGSALVTLRHRLHEYCGGGGGAGGSGHGTGAGRKGLLSQDNLTSMSL,2845,"303,100",Alternative sequence (1); Chain (1); Compositional bias (2); Disulfide bond (32); Domain (18); Erroneous initiation (2); Glycosylation (6); Modified residue (1); Natural variant (3); Repeat (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 30..57;  /evidence=""ECO:0000250""; DISULFID 142..152;  /evidence=""ECO:0000250""; DISULFID 146..158;  /evidence=""ECO:0000250""; DISULFID 174..184;  /evidence=""ECO:0000250""; DISULFID 178..191;  /evidence=""ECO:0000250""; DISULFID 193..202;  /evidence=""ECO:0000250""; DISULFID 1078..1091;  /evidence=""ECO:0000250""; DISULFID 1085..1100;  /evidence=""ECO:0000250""; DISULFID 1102..1114;  /evidence=""ECO:0000250""; DISULFID 1163..1171;  /evidence=""ECO:0000250""; DISULFID 1165..1179;  /evidence=""ECO:0000250""; DISULFID 1182..1191;  /evidence=""ECO:0000250""; DISULFID 1194..1208;  /evidence=""ECO:0000250""; DISULFID 1211..1224;  /evidence=""ECO:0000250""; DISULFID 1213..1231;  /evidence=""ECO:0000250""; DISULFID 1233..1242;  /evidence=""ECO:0000250""; DISULFID 1245..1259;  /evidence=""ECO:0000250""; DISULFID 1263..1302;  /evidence=""ECO:0000250""; DISULFID 1336..1367;  /evidence=""ECO:0000250""; DISULFID 1407..1421;  /evidence=""ECO:0000250""; DISULFID 1415..1433;  /evidence=""ECO:0000250""; DISULFID 1435..1444;  /evidence=""ECO:0000250""; DISULFID 2182..2195;  /evidence=""ECO:0000250""; DISULFID 2189..2204;  /evidence=""ECO:0000250""; DISULFID 2253..2261;  /evidence=""ECO:0000250""; DISULFID 2255..2270;  /evidence=""ECO:0000250""; DISULFID 2273..2282;  /evidence=""ECO:0000250""; DISULFID 2285..2299;  /evidence=""ECO:0000250""; DISULFID 2380..2389;  /evidence=""ECO:0000250""; DISULFID 2382..2397;  /evidence=""ECO:0000250""; DISULFID 2399..2424;  /evidence=""ECO:0000250""; DISULFID 2427..2441;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
P16422,Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326),MAPPQVLAFGLLLAAATATFAAAQEECVCENYKLAVNCFVNNNRQCQCTSVGAQNTVICSKLAAKCLVMKAEMNGSKLGRRAKPEGALQNNDGLYDPDCDESGLFKAKQCNGTSMCWCVNTAGVRRTDKDTEITCSERVRTYWIIIELKHKAREKPYDSKSLRTALQKEITTRYQLDPKFITSILYENNVITIDLVQNSSQKTQNDVDIADVAYYFEKDVKGESLFHSKKMDLTVNGEQLDLDPGQTLIYYVDEKAPEFSMQGLKAGVIAVIVVVVIAVVAGIVVLVISRKKRMAKYEKAEIKEMGEMHRELNA,314,"34,932",Beta strand (12); Chain (1); Disulfide bond (6); Domain (1); Glycosylation (3); Helix (5); Mutagenesis (3); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 27..46;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""; DISULFID 29..59;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""; DISULFID 38..48;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""; DISULFID 66..99;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""; DISULFID 110..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""; DISULFID 118..135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00500, ECO:0000269|PubMed:11080501""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P78334,Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon),MLSKVLPVLLGILLILQSRVEGPQTESKNEASSRDVVYGPQPQPLENQLLSEETKSTETETGSRVGKLPEASRILNTILSNYDHKLRPGIGEKPTVVTVEISVNSLGPLSILDMEYTIDIIFSQTWYDERLCYNDTFESLVLNGNVVSQLWIPDTFFRNSKRTHEHEITMPNQMVRIYKDGKVLYTIRMTIDAGCSLHMLRFPMDSHSCPLSFSSFSYPENEMIYKWENFKLEINEKNSWKLFQFDFTGVSNKTEIITTPVGDFMVMTIFFNVSRRFGYVAFQNYVPSSVTTMLSWVSFWIKTESAPARTSLGITSVLTMTTLGTFSRKNFPRVSYITALDFYIAICFVFCFCALLEFAVLNFLIYNQTKAHASPKLRHPRINSRAHARTRARSRACARQHQEAFVCQIVTTEGSDGEERPSCSAQQPPSPGSPEGPRSLCSKLACCEWCKRFKKYFCMVPDCEGSTWQQGRLCIHVYRLDNYSRVVFPVTFFFFNVLYWLVCLNL,506,"57,972",Alternative sequence (2); Chain (1); Disulfide bond (1); Glycosylation (2); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 195..209;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P18507,Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2),MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYASNKTWVLTPKVPEGDVTVILNNLLEGYDNKLRPDIGVKPTLIHTDMYVNSIGPVNAINMEYTIDIFFAQTWYDRRLKFNSTIKVLRLNSNMVGKIWIPDTFFRNSKKADAHWITTPNRMLRIWNDGRVLYTLRLTIDAECQLQLHNFPMDEHSCPLEFSSYGYPREEIVYQWKRSSVEVGDTRSWRLYQFSFVGLRNTTEVVKTTSGDYVVMSVYFDLSRRMGYFTIQTYIPCTLIVVLSWVSFWINKDAVPARTSLGITTVLTMTTLSTIARKSLPKVSYVTAMDLFVSVCFIFVFSALVEYGTLHYFVSNRKPSKDKDKKKKNPAPTIDIRPRSATIQMNNATHLQERDEEYGYECLDGKDCASFFCCFEDCRTGAWRHGRIHIRIAKMDSYARIFFPTAFCLFNLVYWVSYLYL,467,"54,162",Alternative sequence (2); Beta strand (15); Chain (1); Disulfide bond (1); Glycosylation (3); Helix (9); Natural variant (13); Region (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (5),"DISULFID 190..204;  /evidence=""ECO:0000250""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
Q16099,"Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1)",MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPSSSPASSSIISNICGEKEVPHFKVAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILNFFNCTTACLICAKAECLLNLEKLLRQFLISKDTLSVRMLDDTRDPTPLLKEIRDDKTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTGPALSSALLFDAVYAVVTAVQELNRSQEIGVKPLSCGSAQIWQHGTSLMNYLRMVELEGLTGHIEFNSKGQRSNYALKILQFTRNGFRQIGQWHVAEGLSMDSHLYASNISDTLFNTTLVVTTILENPYLMLKGNHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEANGTWTGMVGELIARKADLAVAGLTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQTAIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLNSNYAFLLESTMNEYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGGKCPKEEDHRAKGLGMENIGGIFVVLICGLIVAIFMAMLEFLWTLRHSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPSPARSEESLEWEKTTNSSEPE,956,"107,246",Chain (1); Compositional bias (1); Glycosylation (9); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9UNN8,Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201),MLTTLLPILLLSGWAFCSQDASDGLQRLHMLQISYFRDPYHVWYQGNASLGGHLTHVLEGPDTNTTIIQLQPLQEPESWARTQSGLQSYLLQFHGLVRLVHQERTLAFPLTIRCFLGCELPPEGSRAHVFFEVAVNGSSFVSFRPERALWQADTQVTSGVVTFTLQQLNAYNRTRYELREFLEDTCVQYVQKHISAENTKGSQTSRSYTSLVLGVLVGSFIIAGVAVGIFLCTGGRRC,238,"26,671",Beta strand (10); Chain (1); Disulfide bond (1); Glycosylation (4); Helix (4); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 118..186;  /evidence=""ECO:0000269|PubMed:12034704""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q02643,Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR),MDRRMWGAHVFCVLSPLPTVLGHMHPECDFITQLREDESACLQAAEEMPNTTLGCPATWDGLLCWPTAGSGEWVTLPCPDFFSHFSSESGAVKRDCTITGWSEPFPPYPVACPVPLELLAEEESYFSTVKIIYTVGHSISIVALFVAITILVALRRLHCPRNYVHTQLFTTFILKAGAVFLKDAALFHSDDTDHCSFSTVLCKVSVAASHFATMTNFSWLLAEAVYLNCLLASTSPSSRRAFWWLVLAGWGLPVLFTGTWVSCKLAFEDIACWDLDDTSPYWWIIKGPIVLSVGVNFGLFLNIIRILVRKLEPAQGSLHTQSQYWRLSKSTLFLIPLFGIHYIIFNFLPDNAGLGIRLPLELGLGSFQGFIVAILYCFLNQEVRTEISRKWHGHDPELLPAWRTRAKWTTPSRSAAKVLTSMC,423,"47,402",Beta strand (3); Chain (1); Disulfide bond (3); Glycosylation (1); Helix (4); Natural variant (11); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 41..64;  /evidence=""ECO:0000269|Ref.9""; DISULFID 55..96;  /evidence=""ECO:0000269|Ref.9""; DISULFID 78..112;  /evidence=""ECO:0000269|Ref.9""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9HCN6,Platelet glycoprotein VI (GPVI) (Glycoprotein 6),MSPSPTALFCLGLCLGRVPAQSGPLPKPSLQALPSSLVPLEKPVTLRCQGPPGVDLYRLEKLSSSRYQDQAVLFIPAMKRSLAGRYRCSYQNGSLWSLPSDQLELVATGVFAKPSLSAQPGPAVSSGGDVTLQCQTRYGFDQFALYKEGDPAPYKNPERWYRASFPIITVTAAHSGTYRCYSFSSRDPYLWSAPSDPLELVVTGTSVTPSRLPTEPPSPVAEFSEATAELTVSFTNEVFTTETSRSITASPKESDSPAGPARQYYTKGNLVRICLGAVILIILAGFLAEDWHSRRKRLRHRGRAVQRPLPPLPPLPLTRKSNGGQDGGRQDVHSRGLCS,339,"36,866",Alternative sequence (2); Beta strand (16); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Helix (1); Mutagenesis (7); Natural variant (8); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 48..88;  /evidence=""ECO:0000269|PubMed:16861347""; DISULFID 134..180;  /evidence=""ECO:0000269|PubMed:16861347""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
O75311,Glycine receptor subunit alpha-3,MAHVRHFRTLVSGFYFWEAALLLSLVATKETDSARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRKNKTEAFALEKFYRFSDMDDEVRESRFSFTAYGMGPCLQAKDGMTPKGPNHPVQVMPKSPDEMRKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHQQQD,464,"53,800",Alternative sequence (1); Beta strand (16); Chain (1); Disulfide bond (2); Glycosylation (1); Helix (9); Metal binding (3); Modified residue (2); Region (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (4); Turn (6),"DISULFID 171..185;  /evidence=""ECO:0000244|PDB:5CFB, ECO:0000269|PubMed:26416729""; DISULFID 231..242;  /evidence=""ECO:0000244|PDB:5CFB, ECO:0000269|PubMed:26416729""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q92896,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),MAACGRVRRMFRLSAALHLLLLFAAGAEKLPGQGVHSQGQGPGANFVSFVGQAGGGGPAGQQLPQLPQSSQLQQQQQQQQQQQQPQPPQPPFPAGGPPARRGGAGAGGGWKLAEEESCREDVTRVCPKHTWSNNLAVLECLQDVREPENEISSDCNHLLWNYKLNLTTDPKFESVAREVCKSTITEIKECADEPVGKGYMVSCLVDHRGNITEYQCHQYITKMTAIIFSDYRLICGFMDDCKNDINILKCGSIRLGEKDAHSQGEVVSCLEKGLVKEAEEREPKIQVSELCKKAILRVAELSSDDFHLDRHLYFACRDDRERFCENTQAGEGRVYKCLFNHKFEESMSEKCREALTTRQKLIAQDYKVSYSLAKSCKSDLKKYRCNVENLPRSREARLSYLLMCLESAVHRGRQVSSECQGEMLDYRRMLMEDFSLSPEIILSCRGEIEHHCSGLHRKGRTLHCLMKVVRGEKGNLGMNCQQALQTLIQETDPGADYRIDRALNEACESVIQTACKHIRSGDPMILSCLMEHLYTEKMVEDCEHRLLELQYFISRDWKLDPVLYRKCQGDASRLCHTHGWNETSEFMPQGAVFSCLYRHAYRTEEQGRRLSRECRAEVQRILHQRAMDVKLDPALQDKCLIDLGKWCSEKTETGQELECLQDHLDDLVVECRDIVGNLTELESEDIQIEALLMRACEPIIQNFCHDVADNQIDSGDLMECLIQNKHQKDMNEKCAIGVTHFQLVQMKDFRFSYKFKMACKEDVLKLCPNIKKKVDVVICLSTTVRNDTLQEAKEHRVSLKCRRQLRVEELEMTEDIRLEPDLYEACKSDIKNFCSAVQYGNAQIIECLKENKKQLSTRCHQKVFKLQETEMMDPELDYTLMRVCKQMIKRFCPEADSKTMLQCLKQNKNSELMDPKCKQMITKRQITQNTDYRLNPMLRKACKADIPKFCHGILTKAKDDSELEGQVISCLKLRYADQRLSSDCEDQIRIIIQESALDYRLDPQLQLHCSDEISSLCAEEAAAQEQTGQVEECLKVNLLKIKTELCKKEVLNMLKESKADIFVDPVLHTACALDIKHHCAAITPGRGRQMSCLMEALEDKRVRLQPECKKRLNDRIEMWSYAAKVAPADGFSDLAMQVMTSPSKNYILSVISGSICILFLIGLMCGRITKRVTRELKDR,1179,"134,552",Alternative sequence (2); Chain (1); Compositional bias (2); Frameshift (1); Glycosylation (5); Modified residue (3); Repeat (16); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q14833,Metabotropic glutamate receptor 4 (mGluR4),MPGKRGLGWWWARLPLCLLLSLYGPWMPSSLGKPKGHPHMNSIRIDGDITLGGLFPVHGRGSEGKPCGELKKEKGIHRLEAMLFALDRINNDPDLLPNITLGARILDTCSRDTHALEQSLTFVQALIEKDGTEVRCGSGGPPIITKPERVVGVIGASGSSVSIMVANILRLFKIPQISYASTAPDLSDNSRYDFFSRVVPSDTYQAQAMVDIVRALKWNYVSTVASEGSYGESGVEAFIQKSREDGGVCIAQSVKIPREPKAGEFDKIIRRLLETSNARAVIIFANEDDIRRVLEAARRANQTGHFFWMGSDSWGSKIAPVLHLEEVAEGAVTILPKRMSVRGFDRYFSSRTLDNNRRNIWFAEFWEDNFHCKLSRHALKKGSHVKKCTNRERIGQDSAYEQEGKVQFVIDAVYAMGHALHAMHRDLCPGRVGLCPRMDPVDGTQLLKYIRNVNFSGIAGNPVTFNENGDAPGRYDIYQYQLRNDSAEYKVIGSWTDHLHLRIERMHWPGSGQQLPRSICSLPCQPGERKKTVKGMPCCWHCEPCTGYQYQVDRYTCKTCPYDMRPTENRTGCRPIPIIKLEWGSPWAVLPLFLAVVGIAATLFVVITFVRYNDTPIVKASGRELSYVLLAGIFLCYATTFLMIAEPDLGTCSLRRIFLGLGMSISYAALLTKTNRIYRIFEQGKRSVSAPRFISPASQLAITFSLISLQLLGICVWFVVDPSHSVVDFQDQRTLDPRFARGVLKCDISDLSLICLLGYSMLLMVTCTVYAIKTRGVPETFNEAKPIGFTMYTTCIVWLAFIPIFFGTSQSADKLYIQTTTLTVSVSLSASVSLGMLYMPKVYIILFHPEQNVPKRKRSLKAVVTAATMSNKFTQKGNFRPNGEAKSELCENLEAPALATKQTYVTYTNHAI,912,"101,868",Alternative sequence (6); Binding site (4); Chain (1); Disulfide bond (8); Glycosylation (5); Natural variant (2); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 67..109;  /evidence=""ECO:0000250""; DISULFID 249..538;  /evidence=""ECO:0000250""; DISULFID 372..388;  /evidence=""ECO:0000250""; DISULFID 428..435;  /evidence=""ECO:0000250""; DISULFID 520..539;  /evidence=""ECO:0000250""; DISULFID 524..542;  /evidence=""ECO:0000250""; DISULFID 545..557;  /evidence=""ECO:0000250""; DISULFID 560..573;  /evidence=""ECO:0000250""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9HB29,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2),MWSLLLCGLSIALPLSVTADGCKDIFMKNEILSASQPFAFNCTFPPITSGEVSVTWYKNSSKIPVSKIIQSRIHQDETWILFLPMEWGDSGVYQCVIKGRDSCHRIHVNLTVFEKHWCDTSIGGLPNLSDEYKQILHLGKDDSLTCHLHFPKSCVLGPIKWYKDCNEIKGERFTVLETRLLVSNVSAEDRGNYACQAILTHSGKQYEVLNGITVSITERAGYGGSVPKIIYPKNHSIEVQLGTTLIVDCNVTDTKDNTNLRCWRVNNTLVDDYYDESKRIREGVETHVSFREHNLYTVNITFLEVKMEDYGLPFMCHAGVSTAYIILQLPAPDFRAYLIGGLIALVAVAVSVVYIYNIFKIDIVLWYRSAFHSTETIVDGKLYDAYVLYPKPHKESQRHAVDALVLNILPEVLERQCGYKLFIFGRDEFPGQAVANVIDENVKLCRRLIVIVVPESLGFGLLKNLSEEQIAVYSALIQDGMKVILIELEKIEDYTVMPESIQYIKQKHGAIRWHGDFTEQSQCMKTKFWKTVRYHMPPRRCRPFPPVQLLQHTPCYRTAGPELGSRRKKCTLTTG,575,"65,405",Active site (1); Alternative sequence (3); Beta strand (16); Chain (1); Disulfide bond (3); Domain (4); Frameshift (1); Glycosylation (9); Helix (3); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 42..95;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 146..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 249..316;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P13598,Intercellular adhesion molecule 2 (ICAM-2) (CD antigen CD102),MSSFGYRTLTVALFTLICCPGSDEKVFEVHVRPKKLAVEPKGSLEVNCSTTCNQPEVGGLETSLDKILLDEQAQWKHYLVSNISHDTVLQCHFTCSGKQESMNSNVSVYQPPRQVILTLQPTLVAVGKSFTIECRVPTVEPLDSLTLFLFRGNETLHYETFGKAAPAPQEATATFNSTADREDGHRNFSCLAVLDLMSRGGNIFHKHSAPKMLEIYEPVSDSQMVIIVTVVSVLLSLFVTSVLLCFIFGQHLRQQRMGTYGVRAAWRRLPQAFRP,275,"30,654",Beta strand (15); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (6); Helix (3); Natural variant (3); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 48..91;  /evidence=""ECO:0000244|PDB:1ZXQ, ECO:0000269|PubMed:9153399""; DISULFID 52..95;  /evidence=""ECO:0000244|PDB:1ZXQ, ECO:0000269|PubMed:9153399""; DISULFID 134..190;  /evidence=""ECO:0000244|PDB:1ZXQ, ECO:0000269|PubMed:9153399""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:19892738"""
Q5HYA8,Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67),MATRGGAGVAMAVWSLLSARAVTAFLLLFLPRFLQAQTFSFPFQQPEKCDNNQYFDISALSCVPCGANQRQDARGTSCVCLPGFQMISNNGGPAIICKKCPENMKGVTEDGWNCISCPSDLTAEGKCHCPIGHILVERDINGTLLSQATCELCDGNENSFMVVNALGDRCVRCEPTFVNTSRSCACSEPNILTGGLCFSSTGNFPLRRISAARYGEVGMSLTSEWFAKYLQSSAAACWVYANLTSCQALGNMCVMNMNSYDFATFDACGLFQFIFENTAGLSTVHSISFWRQNLPWLFYGDQLGLAPQVLSSTSLPTNFSFKGENQNTKLKFVAASYDIRGNFLKWQTLEGGVLQLCPDTETRLNAAYSFGTTYQQNCEIPISKILIDFPTPIFYDVYLEYTDENQHQYILAVPVLNLNLQHNKIFVNQDSNSGKWLLTRRIFLVDAVSGRENDLGTQPRVIRVATQISLSVHLVPNTINGNIYPPLITIAYSDIDIKDANSQSVKVSFSVTYEMDHGEAHVQTDIALGVLGGLAVLASLLKTAGWKRRIGSPMIDLQTVVKFLVYYAGDLANVFFIITVGTGLYWLIFFKAQKSVSVLLPMPIQEERFVTYVGCAFALKALQFLHKLISQITIDVFFIDWERPKGKVLKAVEGEGGVRSATVPVSIWRTYFVANEWNEIQTVRKINSLFQVLTVLFFLEVVGFKNLALMDSSSSLSRNPPSYIAPYSCILRYAVSAALWLAIGIIQVVFFAVFYERFIEDKIRQFVDLCSMSNISVFLLSHKCFGYYIHGRSVHGHADTNMEEMNMNLKREAENLCSQRGLVPNTDGQTFEIAISNQMRQHYDRIHETLIRKNGPARLLSSSASTFEQSIKAYHMMNKFLGSFIDHVHKEMDYFIKDKLLLERILGMEFMEPMEKSIFYNDEGYSFSSVLYYGNEATLLIFDLLFFCVVDLACQNFILASFLTYLQQEIFRYIRNTVGQKNLASKTLVDQRFLI,995,"111,745",Alternative sequence (1); Chain (1); Erroneous initiation (2); Glycosylation (1); Natural variant (55); Sequence conflict (4); Signal peptide (1); Transmembrane (6),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
P24071,Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89),MDPKQTTLLCLVLCLGQRIQAQEGDFPMPFISAKSSPVIPLDGSVKIQCQAIREAYLTQLMIIKNSTYREIGRRLKFWNETDPEFVIDHMDANKAGRYQCQYRIGHYRFRYSDTLELVVTGLYGKPFLSADRGLVLMPGENISLTCSSAHIPFDRFSLAKEGELSLPQHQSGEHPANFSLGPVDLNVSGIYRCYGWYNRSPYLWSFPSNALELVVTDSIHQDYTTQNLIRMAVAGLVLVALLAILVENWHSHTALNKEASADVAEPSWSQQMCQPGLTFARTPSVCK,287,"32,265",Alternative sequence (8); Beta strand (21); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (5); Helix (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..100;  /evidence=""ECO:0000244|PDB:1OVZ, ECO:0000244|PDB:1OW0, ECO:0000244|PDB:1UCT, ECO:0000269|PubMed:12768205, ECO:0000269|PubMed:12783876""; DISULFID 146..193;  /evidence=""ECO:0000244|PDB:1OVZ, ECO:0000244|PDB:1OW0, ECO:0000244|PDB:1UCT, ECO:0000269|PubMed:12768205, ECO:0000269|PubMed:12783876""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9P2B2,Prostaglandin F2 receptor negative regulator (CD9 partner 1) (CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F) (EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315),MGRLASRPLLLALLSLALCRGRVVRVPTATLVRVVGTELVIPCNVSDYDGPSEQNFDWSFSSLGSSFVELASTWEVGFPAQLYQERLQRGEILLRRTANDAVELHIKNVQPSDQGHYKCSTPSTDATVQGNYEDTVQVKVLADSLHVGPSARPPPSLSLREGEPFELRCTAASASPLHTHLALLWEVHRGPARRSVLALTHEGRFHPGLGYEQRYHSGDVRLDTVGSDAYRLSVSRALSADQGSYRCIVSEWIAEQGNWQEIQEKAVEVATVVIQPSVLRAAVPKNVSVAEGKELDLTCNITTDRADDVRPEVTWSFSRMPDSTLPGSRVLARLDRDSLVHSSPHVALSHVDARSYHLLVRDVSKENSGYYYCHVSLWAPGHNRSWHKVAEAVSSPAGVGVTWLEPDYQVYLNASKVPGFADDPTELACRVVDTKSGEANVRFTVSWYYRMNRRSDNVVTSELLAVMDGDWTLKYGERSKQRAQDGDFIFSKEHTDTFNFRIQRTTEEDRGNYYCVVSAWTKQRNNSWVKSKDVFSKPVNIFWALEDSVLVVKARQPKPFFAAGNTFEMTCKVSSKNIKSPRYSVLIMAEKPVGDLSSPNETKYIISLDQDSVVKLENWTDASRVDGVVLEKVQEDEFRYRMYQTQVSDAGLYRCMVTAWSPVRGSLWREAATSLSNPIEIDFQTSGPIFNASVHSDTPSVIRGDLIKLFCIITVEGAALDPDDMAFDVSWFAVHSFGLDKAPVLLSSLDRKGIVTTSRRDWKSDLSLERVSVLEFLLQVHGSEDQDFGNYYCSVTPWVKSPTGSWQKEAEIHSKPVFITVKMDVLNAFKYPLLIGVGLSTVIGLLSCLIGYCSSHWCCKKEVQETRRERRRLMSMEMD,879,"98,556",Chain (1); Disulfide bond (6); Domain (6); Erroneous initiation (1); Erroneous termination (1); Glycosylation (9); Modified residue (1); Motif (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..119;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 169..247;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 299..373;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 429..515;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 571..655;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 711..793;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P42262,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)",MQKIMHISVLLSPVLWGLIFGVSSNSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTPHIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDGTHPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNIKFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLENKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEFEDGRETQSSESTNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKEKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKSRAEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI,883,"98,821",Alternative sequence (3); Beta strand (32); Binding site (3); Chain (1); Disulfide bond (2); Glycosylation (4); Helix (25); Intramembrane (2); Lipidation (2); Modified residue (6); Natural variant (2); Region (3); Sequence conflict (4); Signal peptide (1); Topological domain (5); Transmembrane (3); Turn (7),DISULFID 78..330; DISULFID 739..794,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
O75144,ICOS ligand (B7 homolog 2) (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1) (CD antigen CD275),MRLGSPGLLFLLFSSLRADTQEKEVRAMVGSDVELSCACPEGSRFDLNDVYVYWQTSESKTVVTYHIPQNSSLENVDSRYRNRALMSPAGMLRGDFSLRLFNVTPQDEQKFHCLVLSQSLGFQEVLSVEVTLHVAANFSVPVVSAPHSPSQDELTFTCTSINGYPRPNVYWINKTDNSLLDQALQNDTVFLNMRGLYDVVSVLRIARTPSVNIGCCIENVLLQQNLTVGSQTGNDIGERDKITENPVSTGEKNAATWSILAVLCLLVVVAVAIGWVCRDRCLQHSYAGAWAVSPETELTGHV,302,"33,349",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (5); Natural variant (1); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 158..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q14773,Intercellular adhesion molecule 4 (ICAM-4) (Landsteiner-Wiener blood group glycoprotein) (LW blood group protein) (CD antigen CD242),MGSLFPLSLLFFLAAAYPGVGSALGRRTKRAQSPKGSPLAPSGTSVPFWVRMSPEFVAVQPGKSVQLNCSNSCPQPQNSSLRTPLRQGKTLRGPGWVSYQLLDVRAWSSLAHCLVTCAGKTRWATSRITAYKPPHSVILEPPVLKGRKYTLRCHVTQVFPVGYLVVTLRHGSRVIYSESLERFTGLDLANVTLTYEFAAGPRDFWQPVICHARLNLDGLVVRNSSAPITLMLAWSPAPTALASGSIAALVGILLTVGAAYLCKCLAMKSQA,271,"29,265",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (2); Glycosylation (4); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 69..117;  /evidence=""ECO:0000250""; DISULFID 69..113;  /evidence=""ECO:0000250|UniProtKB:P32942, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 73..117;  /evidence=""ECO:0000250|UniProtKB:P32942""; DISULFID 153..210;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N6C5,Immunoglobulin superfamily member 1 (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120),MTLDRPGEGATMLKTFTVLLFCIRMSLGMTSIVMDPQPELWIESNYPQAPWENITLWCRSPSRISSKFLLLKDKTQMTWIRPSHKTFQVSFLIGALTESNAGLYRCCYWKETGWSKPSKVLELEAPGQLPKPIFWIQAETPALPGCNVNILCHGWLQDLVFMLFKEGYAEPVDYQVPTGTMAIFSIDNLTPEDEGVYICRTHIQMLPTLWSEPSNPLKLVVAGLYPKPTLTAHPGPIMAPGESLNLRCQGPIYGMTFALMRVEDLEKSFYHKKTIKNEANFFFQSLKIQDTGHYLCFYYDASYRGSLLSDVLKIWVTDTFPKTWLLARPSAVVQMGQNVSLRCRGPVDGVGLALYKKGEDKPLQFLDATSIDDNTSFFLNNVTYSDTGIYSCHYLLTWKTSIRMPSHNTVELMVVDKPPKPSLSAWPSTVFKLGKAITLQCRVSHPVLEFSLEWEERETFQKFSVNGDFIISNVDGKGTGTYSCSYRVETHPNIWSHRSEPLKLMGPAGYLTWNYVLNEAIRLSLIMQLVALLLVVLWIRWKCRRLRIREAWLLGTAQGVTMLFIVTALLCCGLCNGVLIEETEIVMPTPKPELWAETNFPLAPWKNLTLWCRSPSGSTKEFVLLKDGTGWIATRPASEQVRAAFPLGALTQSHTGSYHCHSWEEMAVSEPSEALELVGTDILPKPVISASPTIRGQELQLRCKGWLAGMGFALYKEGEQEPVQQLGAVGREAFFTIQRMEDKDEGNYSCRTHTEKRPFKWSEPSEPLELVIKEMYPKPFFKTWASPVVTPGARVTFNCSTPHQHMSFILYKDGSEIASSDRSWASPGASAAHFLIISVGIGDGGNYSCRYYDFSIWSEPSDPVELVVTEFYPKPTLLAQPGPVVFPGKSVILRCQGTFQGMRFALLQEGAHVPLQFRSVSGNSADFLLHTVGAEDSGNYSCIYYETTMSNRGSYLSMPLMIWVTDTFPKPWLFAEPSSVVPMGQNVTLWCRGPVHGVGYILHKEGEATSMQLWGSTSNDGAFPITNISGTSMGRYSCCYHPDWTSSIKIQPSNTLELLVTGLLPKPSLLAQPGPMVAPGENMTLQCQGELPDSTFVLLKEGAQEPLEQQRPSGYRADFWMPAVRGEDSGIYSCVYYLDSTPFAASNHSDSLEIWVTDKPPKPSLSAWPSTMFKLGKDITLQCRGPLPGVEFVLEHDGEEAPQQFSEDGDFVINNVEGKGIGNYSCSYRLQAYPDIWSEPSDPLELVGAAGPVAQECTVGNIVRSSLIVVVVVALGVVLAIEWKKWPRLRTRGSETDGRDQTIALEECNQEGEPGTPANSPSSTSQRISVELPVPI,1336,"148,936",Alternative sequence (4); Chain (1); Disulfide bond (9); Domain (12); Glycosylation (14); Natural variant (6); Sequence conflict (4); Signal peptide (1); Topological domain (3); Transmembrane (2),"DISULFID 58..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 248..296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 343..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 441..484;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 703..750;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 799..849;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 895..942;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1087..1134;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1183..1226;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q7L985,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C),MLHTAISCWQPFLGLAVVLIFMGSTIGCPARCECSAQNKSVSCHRRRLIAIPEGIPIETKILDLSKNRLKSVNPEEFISYPLLEEIDLSDNIIANVEPGAFNNLFNLRSLRLKGNRLKLVPLGVFTGLSNLTKLDISENKIVILLDYMFQDLHNLKSLEVGDNDLVYISHRAFSGLLSLEQLTLEKCNLTAVPTEALSHLRSLISLHLKHLNINNMPVYAFKRLFHLKHLEIDYWPLLDMMPANSLYGLNLTSLSVTNTNLSTVPFLAFKHLVYLTHLNLSYNPISTIEAGMFSDLIRLQELHIVGAQLRTIEPHSFQGLRFLRVLNVSQNLLETLEENVFSSPRALEVLSINNNPLACDCRLLWILQRQPTLQFGGQQPMCAGPDTIRERSFKDFHSTALSFYFTCKKPKIREKKLQHLLVDEGQTVQLECSADGDPQPVISWVTPRRRFITTKSNGRATVLGDGTLEIRFAQDQDSGMYVCIASNAAGNDTFTASLTVKGFASDRFLYANRTPMYMTDSNDTISNGTNANTFSLDLKTILVSTAMGCFTFLGVVLFCFLLLFVWSRGKGKHKNSIDLEYVPRKNNGAVVEGEVAGPRRFNMKMI,606,"68,066",Chain (1); Disulfide bond (1); Domain (3); Erroneous initiation (1); Glycosylation (5); Natural variant (1); Repeat (12); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 432..483;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9P2V4,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)",MRVALGMLWLLALAWPPQARGFCPSQCSCSLHIMGDGSKARTVVCNDPDMTLPPASIPPDTSRLRLERTAIRRVPGEAFRPLGRLEQLWLPYNALSELNALMLRGLRRLRELRLPGNRLAAFPWAALRDAPKLRLLDLQANRLSAVPAEAARFLENLTFLDLSSNQLMRLPQELIVSWAHLETGIFPPGHHPRRVLGLQDNPWACDCRLYDLVHLLDGWAPNLAFIETELRCASPRSLAGVAFSQLELRKCQGPELHPGVASIRSLLGGTALLRCGATGVPGPEMSWRRANGRPLNGTVHQEVSSDGTSWTLLGLPAVSHLDSGDYICQAKNFLGASETVISLIVTEPPTSTEHSGSPGALWARTGGGGEAAAYNNKLVARHVPQIPKPAVLATGPSVPSTKEELTLEHFQMDALGELSDGRAGPSEARMVRSVKVVGDTYHSVSLVWKAPQAKNTTAFSVLYAVFGQHSMRRVIVQPGKTRVTITGLLPKTKYVACVCVQGLVPRKEQCVIFSTNEVVDAENTQQLINVVVISVAIVIALPLTLLVCCSALQKRCRKCFNKDSTEATVTYVNLERLGYSEDGLEELSRHSVSEADRLLSARSSVDFQAFGVKGGRRINEYFC,623,"68,041",Chain (1); Disulfide bond (1); Domain (4); Glycosylation (3); Natural variant (4); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 275..328;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P22888,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R),MKQRFSALQLLKLLLLLQPPLPRALREALCPEPCNCVPDGALRCPGPTAGLTRLSLAYLPVKVIPSQAFRGLNEVIKIEISQIDSLERIEANAFDNLLNLSEILIQNTKNLRYIEPGAFINLPRLKYLSICNTGIRKFPDVTKVFSSESNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLTSLELKENVHLEKMHNGAFRGATGPKTLDISSTKLQALPSYGLESIQRLIATSSYSLKKLPSRETFVNLLEATLTYPSHCCAFRNLPTKEQNFSHSISENFSKQCESTVRKVNNKTLYSSMLAESELSGWDYEYGFCLPKTPRCAPEPDAFNPCEDIMGYDFLRVLIWLINILAIMGNMTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCSTAGFFTVFASELSVYTLTVITLERWHTITYAIHLDQKLRLRHAILIMLGGWLFSSLIAMLPLVGVSNYMKVSICFPMDVETTLSQVYILTILILNVVAFFIICACYIKIYFAVRNPELMATNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKVLLVLFYPINSCANPFLYAIFTKTFQRDFFLLLSKFGCCKRRAELYRRKDFSAYTSNCKNGFTGSNKPSQSTLKLSTLHCQGTALLDKTRYTEC,699,"78,643",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (6); Lipidation (2); Modified residue (1); Mutagenesis (4); Natural variant (33); Repeat (6); Sequence conflict (15); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 439..514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P98172,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)],MARPGQRWLGKWLVAMVVWALCRLATPLAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,346,"38,007",Chain (3); Disulfide bond (2); Domain (1); Glycosylation (1); Modified residue (2); Motif (2); Mutagenesis (2); Natural variant (22); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 64..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00884""; DISULFID 89..153;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00884""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:15340161"""
P08637,Low affinity immunoglobulin gamma Fc region receptor III-A (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a),MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLFGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK,254,"29,089",Beta strand (17); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (2); Glycosylation (5); Helix (3); Natural variant (6); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..89;  /evidence=""ECO:0000244|PDB:3AY4, ECO:0000244|PDB:3SGJ, ECO:0000244|PDB:3SGK, ECO:0000269|PubMed:21768335, ECO:0000269|PubMed:22023369""; DISULFID 128..172;  /evidence=""ECO:0000244|PDB:3AY4, ECO:0000244|PDB:3SGJ, ECO:0000244|PDB:3SGK, ECO:0000269|PubMed:21768335, ECO:0000269|PubMed:22023369""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q6UXV0,GDNF family receptor alpha-like,MIVFIFLAMGLSLENEYTSQTNNCTYLREQCLRDANGCKHAWRVMEDACNDSDPGDPCKMRNSSYCNLSIQYLVESNFQFKECLCTDDFYCTVNKLLGKKCINKSDNVKEDKFKWNLTTRSHHGFKGMWSCLEVAEACVGDVVCNAQLASYLKACSANGNPCDLKQCQAAIRFFYQNIPFNIAQMLAFCDCAQSDIPCQQSKEALHSKTCAVNMVPPPTCLSVIRSCQNDELCRRHYRTFQSKCWQRVTRKCHEDENCISTLSKQDLTCSGSDDCKAAYIDILGTVLQVQCTCRTITQSEESLCKIFQHMLHRKSCFNYPTLSNVKGMALYTRKHANKITLTGFHSPFNGEVIYAAMCMTVTCGILLLVMVKLRTSRISSKARDPSSIQIPGEL,394,"44,518",Beta strand (1); Chain (1); Disulfide bond (11); Glycosylation (6); Helix (14); Natural variant (3); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 131..189;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 138..144;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 155..167;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 162..210;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 191..198;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 220..291;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 227..233;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 244..275;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 252..258;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 269..316;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""; DISULFID 293..304;  /evidence=""ECO:0000244|PDB:5VZ4, ECO:0000269|PubMed:28953886""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q14956,Transmembrane glycoprotein NMB (Hematopoietic growth factor inducible neurokinin-1 type),MECLYYFLGFLLLAARLPLDAAKRFHDVLGNERPSAYMREHNQLNGWSSDENDWNEKLYPVWKRGDMRWKNSWKGGRVQAVLTSDSPALVGSNITFAVNLIFPRCQKEDANGNIVYEKNCRNEAGLSADPYVYNWTAWSEDSDGENGTGQSHHNVFPDGKPFPHHPGWRRWNFIYVFHTLGQYFQKLGRCSVRVSVNTANVTLGPQLMEVTVYRRHGRAYVPIAQVKDVYVVTDQIPVFVTMFQKNDRNSSDETFLKDLPIMFDVLIHDPSHFLNYSTINYKWSFGDNTGLFVSTNHTVNHTYVLNGTFSLNLTVKAAAPGPCPPPPPPPRPSKPTPSLATTLKSYDSNTPGPAGDNPLELSRIPDENCQINRYGHFQATITIVEGILEVNIIQMTDVLMPVPWPESSLIDFVVTCQGSIPTEVCTIISDPTCEITQNTVCSPVDVDEMCLLTVRRTFNGSGTYCVNLTLGDDTSLALTSTLISVPDRDPASPLRMANSALISVGCLAIFVTVISLLVYKKHKEYNPIENSPGNVVRSKGLSVFLNRAKAVFFPGNQEKDPLLKNQEFKGVS,572,"63,923",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Glycosylation (12); Modified residue (1); Motif (1); Natural variant (9); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q96PL5,Erythroid membrane-associated protein (hERMAP) (Radin blood group antigen) (Scianna blood group antigen),MEMASSAGSWLSGCLIPLVFLRLSVHVSGHAGDAGKFHVALLGGTAELLCPLSLWPGTVPKEVRWLRSPFPQRSQAVHIFRDGKDQDEDLMPEYKGRTVLVRDAQEGSVTLQILDVRLEDQGSYRCLIQVGNLSKEDTVILQVAAPSVGSLSPSAVALAVILPVLVLLIMVCLCLIWKQRRAKEKLLYEHVTEVDNLLSDHAKEKGKLHKAVKKLRSELKLKRAAANSGWRRARLHFVAVTLDPDTAHPKLILSEDQRCVRLGDRRQPVPDNPQRFDFVVSILGSEYFTTGCHYWEVYVGDKTKWILGVCSESVSRKGKVTASPANGHWLLRQSRGNEYEALTSPQTSFRLKEPPRCVGIFLDYEAGVISFYNVTNKSHIFTFTHNFSGPLRPFFEPCLHDGGKNTAPLVICSELHKSEESIVPRPEGKGHANGDVSLKVNSSLLPPKAPELKDIILSLPPDLGPALQELKAPSF,475,"52,605",Chain (1); Disulfide bond (1); Domain (2); Glycosylation (1); Modified residue (1); Natural variant (11); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q5SZK8,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),MHSAGTPGLSSRRTGNSTSFQPGPPPPPRLLLLLLLLLSLVSRVPAQPAAFGRALLSPGLAGAAGVPAEEAIVLANRGLRVPFGREVWLDPLHDLVLQVQPGDRCAVSVLDNDALAQRPGRLSPKRFPCDFGPGEVRYSHLGARSPSRDRVRLQLRYDAPGGAVVLPLVLEVEVVFTQLEVVTRNLPLVVEELLGTSNALDARSLEFAFQPETEECRVGILSGLGALPRYGELLHYPQVPGGAREGGAPETLLMDCKAFQELGVRYRHTAASRSPNRDWIPMVVELRSRGAPVGSPALKREHFQVLVRIRGGAENTAPKPSFVAMMMMEVDQFVLTALTPDMLAAEDAESPSDLLIFNLTSPFQPGQGYLVSTDDRSLPLSSFTQRDLRLLKIAYQPPSEDSDQERLFELELEVVDLEGAASDPFAFMVVVKPMNTMAPVVTRNTGLILYEGQSRPLTGPAGSGPQNLVISDEDDLEAVRLEVVAGLRHGHLVILGASSGSSAPKSFTVAELAAGQVVYQHDDRDGSLSDNLVLRMVDGGGRHQVQFLFPITLVPVDDQPPVLNANTGLTLAEGETVPILPLSLSATDMDSDDSLLLFVLESPFLTTGHLLLRQTHPPHEKQELLRGLWRKEGAFYERTVTEWQQQDITEGRLFYRHSGPHSPGPVTDQFTFRVQDNHDPPNQSGLQRFVIRIHPVDRLPPELGSGCPLRMVVQESQLTPLRKKWLRYTDLDTDDRELRYTVTQSPTDTDENHLPAPLGTLVLTDNPSVVVTHFTQAQINHHKIAYRPPGQELGVATRVAQFQFQVEDRAGNVAPGTFTLYLHPVDNQPPEILNTGFTIQEKGHHILSETELHVNDVDTDVAHISFTLTQAPKHGHMRVSGQILHVGGLFHLEDIKQGRVSYAHNGDKSLTDSCSLEVSDRHHVVPITLRVNVRPVDDEVPILSHPTGTLESYLDVLENGATEITANVIKGTNEETDDLMLTFLLEDPPLYGEILVNGIPAEQFTQRDILEGSVVYTHTSGEIGLLPKADSFNLSLSDMSQEWRIGGNTIQGVTIWVTILPVDSQAPEIFVGEQLIVMEGDKSVITSVHISAEDVDSLNDDILCTIVIQPTSGYVENISPAPGSEKSRAGIAISAFNLKDLRQGHINYVQSVHKGVEPVEDRFVFRCSDGINFSERQFFPIVIIPTNDEQPEMFMREFMVMEGMSLVIDTPILNAADADVPLDDLTFTITQFPTHGHIMNQLINGTVLVESFTLDQIIESSSIIYEHDDSETQEDSFVIKLTDGKHSVEKTVLIIVIPVDDETPRMTINNGLEIEIGDTKIINNKILMATDLDSEDKSLVYIIRYGPGHGLLQRRKPTGAFENITLGMNFTQDEVDRNLIQYVHLGQEGIRDLIKFDVTDGINPLIDRYFYVSIGSIDIVFPDVISKGVSLKEGGKVTLTTDLLSTSDLNSPDENLVFTITRAPMRGHLECTDQPGVSITSFTQLQLAGNKIYYIHTADDEVKMDSFEFQVTDGRNPVFRTFRISISDVDNKKPVVTIHKLVVSESENKLITPFELTVEDRDTPDKLLKFTITQVPIHGHLLFNNTRPVMVFTKQDLNENLISYKHDGTESSEDSFSFTVTDGTHTDFYVFPDTVFETRRPQVMKIQVLAVDNSVPQIAVNKGASTLRTLATGHLGFMITSKILKVEDRDSLHISLRFIVTEAPQHGYLLNLDKGNHSITQFTQADIDDMKICYVLREGANATSDMFYFAVEDGGGNKLTYQNFRLNWAWISFEKEYYLVNEDSKFLDVVLKRRGYLGETSFISIGTRDRTAEKDKDFKGKAQKQVQFNPGQTRATWRVRILSDGEHEQSETFQVVLSEPVLAALEFPTVATVEIVDPGDEPTVFIPQSKYSVEEDVGELFIPIRRSGDVSQELMVVCYTQQGTATGTVPTSVLSYSDYISRPEDHTSVVRFDKDEREKLCRIVIIDDSLYEEEETFHVLLSMPMGGRIGSEFPGAQVTIVPDKDDEPIFYFGDVEYSVDESAGYVEVQVWRTGTDLSKSSSVTVRSRKTDPPSADAGTDYVGISRNLDFAPGVNMQPVRVVILDDLGQPALEGIEKFELVLRMPMNAALGEPSKATVSINDSVSDLPKMQFKERIYTGSESDGQIVTMIHRTGDVQYRSSVRCYTRQGSAQVMMDFEERPNTDTSIITFLPGETEKPCILELMDDVLYEEVEELRLVLGTPQSNSPFGAAVGEQNETLIRIRDDADKTVIKFGETKFSVTEPKEPGESVVIRIPVIRQGDTSKVSIVRVHTKDGSATSGEDYHPVSEEIEFKEGETQHVVEIEVTFDGVREMREAFTVHLKPDENMIAEMQLTKAIVYIEEMSSMADVTFPSVPQIVSLLMYDDTSKAKESAEPMSGYPVICITACNPKYSDYDKTGSICASENINDTLTRYRWLISAPAGPDGVTSPMREVDFDTFFTSSKMVTLDSIYFQPGSRVQCAARAVNTNGDEGLELMSPIVTISREEGLCQPRVPGVVGAEPFSAKLRYTGPEDADYTNLIKLTVTMPHIDGMLPVISTRELSNFELTLSPDGTRVGNHKCSNLLDYTEVKTHYGFLTDATKNPEIIGETYPYQYSLSIRGSTTLRFYRNLNLEACLWEFVSYYDMSELLADCGGTIGTDGQVLNLVQSYVTLRVPLYVSYVFHSPVGVGGWQHFDLKSELRLTFVYDTAILWNDGIGSPPEAELQGSLYPTSMRIGDEGRLAVHFKTEAQFHGLFVLSHPASFTSSVIMSADHPGLTFSLRLIRSEPTYNQPVQQWSFVSDFAVRDYSGTYTVKLVPCTAPSHQEYRLPVTCNPREPVTFDLDIRFQQVSDPVAAEFSLNTQMYLLSKKSLWLSDGSMGFGQESDVAFAEGDIIYGRVMVDPVQNLGDSFYCSIEKVFLCTGADGYVPKYSPMNAEYGCLADSPSLLYRFKIVDKAQPETQATSFGNVLFNAKLAVDDPEAILLVNQPGSDGFKVDSTPLFQVALGREWYIHTIYTVRSKDNANRGIGKRSVEYHSLVSQGKPQSTTKSRKKREIRSTPSLAWEIGAENSRGTNIQHIALDRTKRQIPHGRAPPDGILPWELNSPSSAVSLVTVVGGTTVGLLTICLTVIAVLMCRGKESFRGKDAPKGSSSSEPMVPPQSHHNDSSEV,3169,"351,157",Alternative sequence (2); Chain (1); Domain (5); Erroneous initiation (1); Glycosylation (5); Natural variant (18); Repeat (12); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..46;  /evidence=""ECO:0000255"""
O75899,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPPPSSPPLSIMGLMPLTKEVAKGSIGRGVLPAVELAIEQIRNESLLRPYFLDLRLYDTECDNAKGLKAFYDAIKYGPNHLMVFGGVCPSVTSIIAESLQGWNLVQLSFAATTPVLADKKKYPYFFRTVPSDNAVNPAILKLLKHYQWKRVGTLTQDVQRFSEVRNDLTGVLYGEDIEISDTESFSNDPCTSVKKLKGNDVRIILGQFDQNMAAKVFCCAYEENMYGSKYQWIIPGWYEPSWWEQVHTEANSSRCLRKNLLAAMEGYIGVDFEPLSSKQIKTISGKTPQQYEREYNNKRSGVGPSKFHGYAYDGIWVIAKTLQRAMETLHASSRHQRIQDFNYTDHTLGRIILNAMNETNFFGVTGQVVFRNGERMGTIKFTQFQDSREVKVGEYNAVADTLEIINDTIRFQGSEPPKDKTIILEQLRKISLPLYSILSALTILGMIMASAFLFFNIKNRNQKLIKMSSPYMNNLIILGGMLSYASIFLFGLDGSFVSEKTFETLCTVRTWILTVGYTTAFGAMFAKTWRVHAIFKNVKMKKKIIKDQKLLVIVGGMLLIDLCILICWQAVDPLRRTVEKYSMEPDPAGRDISIRPLLEHCENTHMTIWLGIVYAYKGLLMLFGCFLAWETRNVSIPALNDSKYIGMSVYNVGIMCIIGAAVSFLTRDQPNVQFCIVALVIIFCSTITLCLVFVPKLITLRTNPDAATQNRRFQFTQNQKKEDSKTSTSVTSVNQASTSRLEGLQSENHRLRMKITELDKDLEEVTMQLQDTPEKTTYIKQNHYQELNDILNLGNFTESTDGGKAILKNHLDQNPQLQWNTTEPSRTCKDPIEDINSPEHIQRRLSLQLPILHHAYLPSIGGVDASCVSPCVSPTASPRHRHVPPSFRVMVSGL,941,"105,821",Beta strand (25); Chain (1); Coiled coil (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (5); Helix (28); Modified residue (9); Mutagenesis (1); Natural variant (8); Sequence conflict (4); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (11),DISULFID 108..135; DISULFID 237..266; DISULFID 265..302,"SIGNAL 1..41;  /evidence=""ECO:0000255"""
P14867,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1),MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLLDGYDNRLRPGLGERVTEVKTDIFVTSFGPVSDHDMEYTIDVFFRQSWKDERLKFKGPMTVLRLNNLMASKIWTPDTFFHNGKKSVAHNMTMPNKLLRITEDGTLLYTMRLTVRAECPMHLEDFPMDAHACPLKFGSYAYTRAEVVYEWTREPARSVVVAEDGSRLNQYDLLGQTVDSGIVQSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGYAWDGKSVVPEKPKKVKDPLIKKNNTYAPTATSYTPNLARGDPGLATIAKSATIEPKEVKPETKPPEPKKTFNSVSKIDRLSRIAFPLLFGIFNLVYWATYLNREPQLKAPTPHQ,456,"51,802",Beta strand (15); Binding site (1); Chain (1); Disulfide bond (1); Glycosylation (2); Helix (11); Mutagenesis (3); Natural variant (6); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (5),"DISULFID 166..180;  /evidence=""ECO:0000250""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
P47869,Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2),MKTKLNIYNMQFLLFVFLVWDPARLVLANIQEDEAKNNITIFTRILDRLLDGYDNRLRPGLGDSITEVFTNIYVTSFGPVSDTDMEYTIDVFFRQKWKDERLKFKGPMNILRLNNLMASKIWTPDTFFHNGKKSVAHNMTMPNKLLRIQDDGTLLYTMRLTVQAECPMHLEDFPMDAHSCPLKFGSYAYTTSEVTYIWTYNASDSVQVAPDGSRLNQYDLLGQSIGKETIKSSTGEYTVMTAHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGWAWDGKSVVNDKKKEKASVMIQNNAYAVAVANYAPNLSKDPVLSTISKSATTPEPNKKPENKPAEAKKTFNSVSKIDRMSRIVFPVLFGTFNLVYWATYLNREPVLGVSP,451,"51,326",Alternative sequence (2); Chain (1); Disulfide bond (1); Erroneous initiation (1); Glycosylation (2); Natural variant (7); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 166..180;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q13002,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)",MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQLEKRSFCSAMVEELRMSLKCQRRLKHKPQAPVIVKTEEVINMHTFNDRRLPGKETMA,908,"102,583",Alternative sequence (6); Beta strand (14); Binding site (2); Chain (1); Cross-link (1); Disulfide bond (1); Glycosylation (9); Helix (12); Modified residue (2); Natural variant (7); Region (2); Sequence conflict (6); Signal peptide (1); Topological domain (4); Transmembrane (3); Turn (2),"DISULFID 96..347;  /evidence=""ECO:0000250|UniProtKB:P42260""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P10321,"HLA class I histocompatibility antigen, C alpha chain (HLA-C) (HLA-Cw) (Human leukocyte antigen C)",MRVMAPRALLLLLSGGLALTETWACSHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQADRVSLRNLRGYYNQSEDGSHTLQRMSGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKLEAARAAEQLRAYLEGTCVEWLRRYLENGKETLQRAEPPKTHVTHHPLSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHMQHEGLQEPLTLSWEPSSQPTIPIMGIVAGLAVLVVLAVLGAVVTAMMCRRKSSGGKGGSCSQAACSNSAQGSDESLITCKA,366,"40,649",Alternative sequence (2); Beta strand (19); Binding site (5); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (8); Modified residue (2); Mutagenesis (1); Natural variant (75); Region (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 125..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10850706, ECO:0000269|PubMed:24990997""; DISULFID 227..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10850706, ECO:0000269|PubMed:24990997""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P17181,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1),MMVVLLGATTLVLVAVAPWVLSAAAGGKNLKSPQKVEVDIIDDNFILRWNRSDESVGNVTFSFDYQKTGMDNWIKLSGCQNITSTKCNFSSLKLNVYEEIKLRIRAEKENTSSWYEVDSFTPFRKAQIGPPEVHLEAEDKAIVIHISPGTKDSVMWALDGLSFTYSLVIWKNSSGVEERIENIYSRHKIYKLSPETTYCLKVKAALLTSWKIGVYSPVHCIKTTVENELPPPENIEVSVQNQNYVLKWDYTYANMTFQVQWLHAFLKRNPGNHLYKWKQIPDCENVKTTQCVFPQNVFQKGIYLLRVQASDGNNTSFWSEEIKFDTEIQAFLLPPVFNIRSLSDSFHIYIGAPKQSGNTPVIQDYPLIYEIIFWENTSNAERKIIEKKTDVTVPNLKPLTVYCVKARAHTMDEKLNKSSVFSDAVCEKTKPGNTSKIWLIVGICIALFALPFVIYAAKVFLRCINYVFFPSLKPSSSIDEYFSEQPLKNLLLSTSEEQIEKCFIIENISTIATVEETNQTDEDHKKYSSQTSQDSGNYSNEDESESKTSEELQQDFV,557,"63,525",Alternative sequence (5); Beta strand (20); Chain (1); Cross-link (3); Disulfide bond (4); Domain (4); Glycosylation (12); Helix (5); Lipidation (1); Modified residue (4); Mutagenesis (9); Natural variant (17); Region (1); Sequence caution (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 79..87;  /evidence=""ECO:0000244|PDB:3S98, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:21854986""; DISULFID 199..220;  /evidence=""ECO:0000244|PDB:3S98, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:21854986""; DISULFID 283..291;  /evidence=""ECO:0000244|PDB:3S98, ECO:0000244|PDB:3SE3, ECO:0000244|PDB:3SE4, ECO:0000269|PubMed:21854986""; DISULFID 403..426;  /evidence=""ECO:0000250|UniProtKB:P33896""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8IZU9,Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3],MKPFQLDLLFVCFFLFSQELGLQKRGCCLVLGYMAKDKFRRMNEGQVYSFSQQPQDQVVVSGQPVTLLCAIPEYDGFVLWIKDGLALGVGRDLSSYPQYLVVGNHLSGEHHLKILRAELQDDAVYECQAIQAAIRSRPARLTVLVPPDDPVILGGPVISLRAGDPLNLTCHADNAKPAASIIWLRKGEVINGATYSKTLLRDGKRESIVSTLFISPGDVENGQSIVCRATNKAIPGGKETSVTIDIQHPPLVNLSVEPQPVLEDNVVTFHCSAKANPAVTQYRWAKRGQIIKEASGEVYRTTVDYTYFSEPVSCEVTNALGSTNLSRTVDVYFGPRMTTEPQSLLVDLGSDAIFSCAWTGNPSLTIVWMKRGSGVVLSNEKTLTLKSVRQEDAGKYVCRAVVPRVGAGEREVTLTVNGPPIISSTQTQHALHGEKGQIKCFIRSTPPPDRIAWSWKENVLESGTSGRYTVETISTEEGVISTLTISNIVRADFQTIYNCTAWNSFGSDTEIIRLKEQGSEMKSGAGLEAESVPMAVIIGVAVGAGVAFLVLMATIVAFCCARSQRNLKGVVSAKNDIRVEIVHKEPASGREGEEHSTIKQLMMDRGEFQQDSVLKQLEVLKEEEKEFQNLKDPTNGYYSVNTFKEHHSTPTISLSSCQPDLRPAGKQRVPTGMSFTNIYSTLSGQGRLYDYGQRFVLGMGSSSIELCEREFQRGSLSDSSSFLDTQCDSSVSSSGKQDGYVQFDKASKASASSSHHSQSSSQNSDPSRPLQRRMQTHV,778,"85,255",Alternative sequence (2); Beta strand (8); Chain (2); Compositional bias (1); Disulfide bond (5); Domain (5); Erroneous initiation (2); Glycosylation (4); Helix (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 69..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 170..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 271..314;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 356..398;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 440..499;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
B6SEH8,Endogenous retrovirus group V member 1 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 1),MTEKFLFLYLSLLPMPLLSQAQWNENSLVSFSKIIASGNHLSNCWICHNFITRSSSYQYILVRNFSLNLTFGSGIPEGQHKSVPLQVSLANSAHQVPCLDLTPPFNQSSKTSFYFYNCSSLNQTCCPCPEGHCDRKNTSEEGFPSPTIHPMSFSPAGCHPNLTHWCPAKQMNDYRDKSPQNRCAAWEGKELITWRVLYLLPKAHTVPTWPKSTVPLGGPLSPACNQTIPAGWKSQLHKWFDSHIPRWACTPPGYVFLCGPQKNKLPFDGSPKITYSTPPVANLYTCINNIQHTGECAVGLLGPRGIGVTIYNTTQPRQKRALGLILAGMGAAIGMIAPWGGFTYHDVTLRNLSRQIDNIAKSTRDSISKLKASIDSLANVVMNNRLALDYLLAEQGGVCAVISKSCCIYVNNSGAIEEDIKKIYDEVTWLHNFGKGDSAGSIWEAVKSALPSLTWFVPLLGPAALNSLLSPLWPLSL,477,"52,557",Chain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P04626,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV,1255,"137,910",Active site (1); Alternative sequence (7); Beta strand (57); Binding site (1); Chain (1); Disulfide bond (25); Domain (1); Glycosylation (7); Helix (36); Modified residue (11); Motif (1); Mutagenesis (5); Natural variant (12); Nucleotide binding (1); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 26..53;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3H3B, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRL, ECO:0000244|PDB:4HRM""; DISULFID 162..192;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3H3B, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRL, ECO:0000244|PDB:4HRM""; DISULFID 195..204;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3H3B, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRL, ECO:0000244|PDB:4HRM""; DISULFID 199..212;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3H3B, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRL, ECO:0000244|PDB:4HRM""; DISULFID 220..227;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 224..235;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 236..244;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 240..252;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 255..264;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 268..295;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 299..311;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 315..331;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 334..338;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 342..367;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 475..504;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 511..520;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 515..528;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:2A91, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ""; DISULFID 531..540;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRN""; DISULFID 544..560;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRN""; DISULFID 563..576;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRN""; DISULFID 567..584;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:3WLW, ECO:0000244|PDB:3WSQ, ECO:0000244|PDB:4HRN""; DISULFID 587..596;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:1S78, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3MZW, ECO:0000244|PDB:3N85, ECO:0000244|PDB:4HRN""; DISULFID 600..623;  /evidence=""ECO:0000244|PDB:1N8Z, ECO:0000244|PDB:3BE1, ECO:0000244|PDB:3N85""; DISULFID 626..634;  /evidence=""ECO:0000244|PDB:3N85""; DISULFID 630..642;  /evidence=""ECO:0000244|PDB:3N85""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P21802,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332),MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT,821,"92,025",Active site (1); Alternative sequence (19); Beta strand (34); Binding site (2); Chain (1); Disulfide bond (3); Domain (4); Erroneous initiation (1); Glycosylation (8); Helix (19); Modified residue (7); Mutagenesis (5); Natural variant (74); Nucleotide binding (2); Region (1); Sequence caution (6); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 62..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 179..231;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16384934""; DISULFID 278..342;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:16384934""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q86UL3,Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7),MFLLLPFDSLIVNLLGISLTVLFTLLLVFIIVPAIFGVSFGIRKLYMKSLLKIFAWATLRMERGAKEKNHQLYKPYTNGIIAKDPTSLEEEIKEIRRSGSSKALDNTPEFELSDIFYFCRKGMETIMDDEVTKRFSAEELESWNLLSRTNYNFQYISLRLTVLWGLGVLIRYCFLLPLRIALAFTGISLLVVGTTVVGYLPNGRFKEFMSKHVHLMCYRICVRALTAIITYHDRENRPRNGGICVANHTSPIDVIILASDGYYAMVGQVHGGLMGVIQRAMVKACPHVWFERSEVKDRHLVAKRLTEHVQDKSKLPILIFPEGTCINNTSVMMFKKGSFEIGATVYPVAIKYDPQFGDAFWNSSKYGMVTYLLRMMTSWAIVCSVWYLPPMTREADEDAVQFANRVKSAIARQGGLVDLLWDGGLKREKVKDTFKEEQQKLYSKMIVGNHKDRSRS,456,"52,071",Chain (1); Glycosylation (4); Motif (1); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..37;  /evidence=""ECO:0000255"""
Q02846,"Retinal guanylyl cyclase 1 (RETGC-1) (EC 4.6.1.2) (CG-E) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase) (ROS-GC)",MTACARRAGGLPDPGLCGPAWWAPSLPRLPRALPRLPLLLLLLLLQPPALSAVFTVGVLGPWACDPIFSRARPDLAARLAAARLNRDPGLAGGPRFEVALLPEPCRTPGSLGAVSSALARVSGLVGPVNPAACRPAELLAEEAGIALVPWGCPWTQAEGTTAPAVTPAADALYALLRAFGWARVALVTAPQDLWVEAGRSLSTALRARGLPVASVTSMEPLDLSGAREALRKVRDGPRVTAVIMVMHSVLLGGEEQRYLLEAAEELGLTDGSLVFLPFDTIHYALSPGPEALAALANSSQLRRAHDAVLTLTRHCPSEGSVLDSLRRAQERRELPSDLNLQQVSPLFGTIYDAVFLLARGVAEARAAAGGRWVSGAAVARHIRDAQVPGFCGDLGGDEEPPFVLLDTDAAGDRLFATYMLDPARGSFLSAGTRMHFPRGGSAPGPDPSCWFDPNNICGGGLEPGLVFLGFLLVVGMGLAGAFLAHYVRHRLLHMQMVSGPNKIILTVDDITFLHPHGGTSRKVAQGSRSSLGARSMSDIRSGPSQHLDSPNIGVYEGDRVWLKKFPGDQHIAIRPATKTAFSKLQELRHENVALYLGLFLARGAEGPAALWEGNLAVVSEHCTRGSLQDLLAQREIKLDWMFKSSLLLDLIKGIRYLHHRGVAHGRLKSRNCIVDGRFVLKITDHGHGRLLEAQKVLPEPPRAEDQLWTAPELLRDPALERRGTLAGDVFSLAIIMQEVVCRSAPYAMLELTPEEVVQRVRSPPPLCRPLVSMDQAPVECILLMKQCWAEQPELRPSMDHTFDLFKNINKGRKTNIIDSMLRMLEQYSSNLEDLIRERTEELELEKQKTDRLLTQMLPPSVAEALKTGTPVEPEYFEQVTLYFSDIVGFTTISAMSEPIEVVDLLNDLYTLFDAIIGSHDVYKVETIGDAYMVASGLPQRNGQRHAAEIANMSLDILSAVGTFRMRHMPEVPVRIRIGLHSGPCVAGVVGLTMPRYCLFGDTVNTASRMESTGLPYRIHVNLSTVGILRALDSGYQVELRGRTELKGKGAEDTFWLVGRRGFNKPIPKPPDLQPGSSNHGISLQEIPPERRRKLEKARPGQFS,1103,"120,059",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Mutagenesis (4); Natural variant (47); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 449;  /note=""Interchain"";  /evidence=""ECO:0000305""; DISULFID 457;  /note=""Interchain"";  /evidence=""ECO:0000305""","SIGNAL 1..51;  /evidence=""ECO:0000250|UniProtKB:P55203"""
Q14CZ8,Hepatocyte cell adhesion molecule (Protein hepaCAM),MKRERGALSRASRALRLAPFVYLLLIQTDPLEGVNITSPVRLIHGTVGKSALLSVQYSSTSSDRPVVKWQLKRDKPVTVVQSIGTEVIGTLRPDYRDRIRLFENGSLLLSDLQLADEGTYEVEISITDDTFTGEKTINLTVDVPISRPQVLVASTTVLELSEAFTLNCSHENGTKPSYTWLKDGKPLLNDSRMLLSPDQKVLTITRVLMEDDDLYSCMVENPISQGRSLPVKITVYRRSSLYIILSTGGIFLLVTLVTVCACWKPSKRKQKKLEKQNSLEYMDQNDDRLKPEADTLPRSGEQERKNPMALYILKDKDSPETEENPAPEPRSATEPGPPGYSVSPAVPGRSPGLPIRSARRYPRSPARSPATGRTHSSPPRAPSSPGRSRSASRTLRTAGVHIIREQDEAGPVEISA,416,"46,026",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (4); Modified residue (3); Natural variant (13); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 168..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
P26012,Integrin beta-8,MCGSALAFFTAAFVCLQNDRRGPASFLWAAWVFSLVLGLGQGEDNRCASSNAASCARCLALGPECGWCVQEDFISGGSRSERCDIVSNLISKGCSVDSIEYPSVHVIIPTENEINTQVTPGEVSIQLRPGAEANFMLKVHPLKKYPVDLYYLVDVSASMHNNIEKLNSVGNDLSRKMAFFSRDFRLGFGSYVDKTVSPYISIHPERIHNQCSDYNLDCMPPHGYIHVLSLTENITEFEKAVHRQKISGNIDTPEGGFDAMLQAAVCESHIGWRKEAKRLLLVMTDQTSHLALDSKLAGIVVPNDGNCHLKNNVYVKSTTMEHPSLGQLSEKLIDNNINVIFAVQGKQFHWYKDLLPLLPGTIAGEIESKAANLNNLVVEAYQKLISEVKVQVENQVQGIYFNITAICPDGSRKPGMEGCRNVTSNDEVLFNVTVTMKKCDVTGGKNYAIIKPIGFNETAKIHIHRNCSCQCEDNRGPKGKCVDETFLDSKCFQCDENKCHFDEDQFSSESCKSHKDQPVCSGRGVCVCGKCSCHKIKLGKVYGKYCEKDDFSCPYHHGNLCAGHGECEAGRCQCFSGWEGDRCQCPSAAAQHCVNSKGQVCSGRGTCVCGRCECTDPRSIGRFCEHCPTCYTACKENWNCMQCLHPHNLSQAILDQCKTSCALMEQQHYVDQTSECFSSPSYLRIFFIIFIVTFLIGLLKVLIIRQVILQWNSNKIKSSSDYRVSASKKDKLILQSVCTRAVTYRREKPEEIKMDISKLNAHETFRCNF,769,"85,632",Alternative sequence (1); Beta strand (20); Chain (1); Disulfide bond (20); Domain (1); Glycosylation (7); Helix (13); Natural variant (1); Region (1); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 47..469;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 55..65;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 58..94;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 68..83;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 211..218;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 266..307;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 407..419;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 467..471;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 481..494;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 491..520;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 526..531;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 528..561;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 533..546;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 567..572;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 574..583;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 607..612;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 609..657;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 614..624;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 627..630;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""; DISULFID 634..643;  /evidence=""ECO:0000255|PIRSR:PIRSR002512-1""","SIGNAL 1..42;  /evidence=""ECO:0000255"""
P08514,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]",MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQFGFSLDFHKDSHGRVAIVVGAPRTLGPSQEETGGVFLCPWRAEGGQCPSLLFDLRDETRNVGSQTLQTFKARQGLGASVVSWSDVIVACAPWQHWNVLEKTEEAEKTPVGSCFLAQPESGRRAEYSPCRGNTLSRIYVENDFSWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFSSYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVAVGEFDGDLNTTEYVVGAPTWSWTLGAVEILDSYYQRLHRLRGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKLAEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGGPSGRGQVLVFLGQSEGLRSRPSQVLDSPFPTGSAFGFSLRGAVDIDDNGYPDLIVGAYGANQVAVYRAQPVVKASVQLLVQDSLNPAVKSCVLPQTKTPVSCFNIQMCVGATGHNIPQKLSLNAELQLDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADFRDKLSPIVLSLNVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDCGEDDVCVPQLQLTASVTGSPLLVGADNVLELQMDAANEGEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKKENETRVVLCELGNPMKKNAQIGIAMLVSVGNLEEAGESVSFQLQIRSKNSQNPNSKIVLLDVPVRAEAQVELRGNSFPASLVVAAEEGEREQNSLDSWGPKVEHTYELHNNGPGTVNGLHLSIHLPGQSQPSDLLYILDIQPQGGLQCFPQPPVNPLKVDWGLPIPSPSPIHPAHHKRDRRQIFLPEPEQPSRLQDPVLVSCDSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPLDQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRALEERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRPPLEEDDEEGE,1039,"113,377",Alternative sequence (2); Beta strand (77); Calcium binding (4); Chain (4); Disulfide bond (9); Glycosylation (7); Helix (11); Modified residue (1); Motif (1); Mutagenesis (1); Natural variant (40); Repeat (7); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 87..96;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 138..161;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 177..198;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 504..515;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 521..576;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 633..639;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 705..718;  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 857..911;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000269|PubMed:2775232""; DISULFID 916..921;  /evidence=""ECO:0000269|PubMed:2775232""","SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:1953640, ECO:0000269|PubMed:3534886, ECO:0000269|PubMed:8620874"""
Q9HBL6,Leucine-rich repeat and transmembrane domain-containing protein 1,MKGELLLFSSVIVLLQVVCSCPDKCYCQSSTNFVDCSQQGLAEIPSHLPPQTRTLHLQDNQIHHLPAFAFRSVPWLMTLNLSNNSLSNLAPGAFHGLQHLQVLNLTQNSLLSLESRLFHSLPQLRELDLSSNNISHLPTSLGETWENLTILAVQQNQLQQLDRALLESMPSVRLLLLKDNLWKCNCHLLGLKLWLEKFVYKGGLTDGIICESPDTWKGKDLLRIPHELYQPCPLPAPDPVSSQAQWPGSAHGVVLRPPENHNAGERELLECELKPKPRPANLRHAIATVIITGVVCGIVCLMMLAAAIYGCTYAAITAQYHGGPLAQTNDPGKVEEKERFDSSPA,345,"38,171",Alternative sequence (1); Chain (1); Domain (2); Glycosylation (2); Natural variant (2); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8N423,Leukocyte immunoglobulin-like receptor subfamily B member 2 (LIR-2) (Leukocyte immunoglobulin-like receptor 2) (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4) (ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10) (MIR-10) (CD antigen CD85d),MTPIVTVLICLGLSLGPRTHVQTGTIPKPTLWAEPDSVITQGSPVTLSCQGSLEAQEYRLYREKKSASWITRIRPELVKNGQFHIPSITWEHTGRYGCQYYSRARWSELSDPLVLVMTGAYPKPTLSAQPSPVVTSGGRVTLQCESQVAFGGFILCKEGEEEHPQCLNSQPHARGSSRAIFSVGPVSPNRRWSHRCYGYDLNSPYVWSSPSDLLELLVPGVSKKPSLSVQPGPVVAPGESLTLQCVSDVGYDRFVLYKEGERDLRQLPGRQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSECSAPSDPLDILITGQIRGTPFISVQPGPTVASGENVTLLCQSWRQFHTFLLTKAGAADAPLRLRSIHEYPKYQAEFPMSPVTSAHAGTYRCYGSLNSDPYLLSHPSEPLELVVSGPSMGSSPPPTGPISTPAGPEDQPLTPTGSDPQSGLGRHLGVVIGILVAVVLLLLLLLLLFLILRHRRQGKHWTSTQRKADFQHPAGAVGPEPTDRGLQWRSSPAADAQEENLYAAVKDTQPEDGVEMDTRAAASEAPQDVTYAQLHSLTLRRKATEPPPSQEREPPAEPSIYATLAIH,598,"65,039",Alternative sequence (4); Beta strand (35); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (3); Helix (4); Motif (3); Natural variant (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..98;  /evidence=""ECO:0000244|PDB:2GW5, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12390682""; DISULFID 144..196;  /evidence=""ECO:0000244|PDB:2GW5, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12390682""; DISULFID 156..166;  /evidence=""ECO:0000244|PDB:2GW5, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:12390682""; DISULFID 245..296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 345..396;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q15303,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)],MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIFLNYRKDGNFGLQELGLKNLTEILNGGVYVDQNKFLCYADTIHWQDIVRNPWPSNLTLVSTNGSSGCGRCHKSCTGRCWGPTENHCQTLTRTVCAEQCDGRCYGPYVSDCCHRECAGGCSGPKDTDCFACMNFNDSGACVTQCPQTFVYNPTTFQLEHNFNAKYTYGAFCVKKCPHNFVVDSSSCVRACPSSKMEVEENGIKMCKPCTDICPKACDGIGTGSLMSAQTVDSSNIDKFINCTKINGNLIFLVTGIHGDPYNAIEAIDPEKLNVFRTVREITGFLNIQSWPPNMTDFSVFSNLVTIGGRVLYSGLSLLILKQQGITSLQFQSLKEISAGNIYITDNSNLCYYHTINWTTLFSTINQRIVIRDNRKAENCTAEGMVCNHLCSSDGCWGPGPDQCLSCRRFSRGRICIESCNLYDGEFREFENGSICVECDPQCEKMEDGLLTCHGPGPDNCTKCSHFKDGPNCVEKCPDGLQGANSFIFKYADPDRECHPCHPNCTQGCNGPTSHDCIYYPWTGHSTLPQHARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRALRRFLETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFNIPPPIYTSRARIDSNRSEIGHSPPPAYTPMSGNQFVYRDGGFAAEQGVSVPYRAPTSTIPEAPVAQGATAEIFDDSCCNGTLRKPVAPHVQEDSSTQRYSADPTVFAPERSPRGELDEEGYMTPMRDKPKQEYLNPVEENPFVSRRKNGDLQALDNPEYHNASNGPPKAEDEYVNEPLYLNTFANTLGKAEYLKNNILSMPEKAKKAFDNPDYWNHSLPPRSTLQHPDYLQEYSTKYFYKQNGRIRPIVAENPEYLSEFSLKPGTVLPPPPYRHRNTVV,1308,"146,808",Active site (1); Alternative sequence (2); Beta strand (58); Binding site (1); Chain (2); Compositional bias (2); Disulfide bond (23); Domain (1); Glycosylation (11); Helix (32); Modified residue (10); Motif (5); Mutagenesis (26); Natural variant (4); Nucleotide binding (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 29..56;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 156..186;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 189..197;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 193..205;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 213..221;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 217..229;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 230..238;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 234..246;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 249..258;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 262..289;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 293..304;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 308..323;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 326..330;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 503..512;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 507..520;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 523..532;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 536..552;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 555..569;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 559..577;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 580..589;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 593..614;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 617..625;  /evidence=""ECO:0000269|PubMed:16203964""; DISULFID 621..633;  /evidence=""ECO:0000269|PubMed:16203964""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P49771,Fms-related tyrosine kinase 3 ligand (Flt3 ligand) (Flt3L) (SL cytokine),MTVLAPAWSPTTYLLLLLLLSSGLSGTQDCSFQHSPISSDFAVKIRELSDYLLQDYPVTVASNLQDEELCGGLWRLVLAQRWMERLKTVAGSKMQGLLERVNTEIHFVTKCAFQPPPSCLRFVQTNISRLLQETSEQLVALKPWITRQNFSRCLELQCQPDSSTLPPPWSPRPLEATAPTAPQPPLLLLLLLPVGLLLLAAAWCLHWQRTRRRTPRPGEQVPPVPSPQDLLLVEH,235,"26,416",Alternative sequence (3); Beta strand (2); Chain (1); Disulfide bond (3); Glycosylation (2); Helix (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),DISULFID 30..111; DISULFID 70..153; DISULFID 119..158,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q96D42,Hepatitis A virus cellular receptor 1 (HAVcr-1) (Kidney injury molecule 1) (KIM-1) (T-cell immunoglobulin and mucin domain-containing protein 1) (TIMD-1) (T-cell immunoglobulin mucin receptor 1) (TIM) (TIM-1) (T-cell membrane protein 1) (CD antigen CD365),MHPQVVILSLILHLADSVAGSVKVGGEAGPSVTLPCHYSGAVTSMCWNRGSCSLFTCQNGIVWTNGTHVTYRKDTRYKLLGDLSRRDVSLTIENTAVSDSGVYCCRVEHRGWFNDMKITVSLEIVPPKVTTTPIVTTVPTVTTVRTSTTVPTTTTVPMTTVPTTTVPTTMSIPTTTTVLTTMTVSTTTSVPTTTSIPTTTSVPVTTTVSTFVPPMPLPRQNHEPVATSPSSPQPAETHPTTLQGAIRREPTSSPLYSYTTDGNDTVTESSDGLWNNNQTQLFLEHSLLTANTTKGIYAGVCISVLVLLALLGVIIAKKYFFKKEVQQLSVSFSSLQIKALQNAVEKEVQAEDNIYIENSLYATD,364,"39,250",Beta strand (9); Chain (1); Compositional bias (1); Disulfide bond (3); Domain (1); Glycosylation (4); Helix (2); Natural variant (3); Region (1); Repeat (12); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 36..105;  /evidence=""ECO:0000244|PDB:5DZO, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:26487564""; DISULFID 46..57;  /evidence=""ECO:0000244|PDB:5DZO, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:26487564""; DISULFID 52..104;  /evidence=""ECO:0000244|PDB:5DZO, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:26487564""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8NI17,Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17),MMWTWALWMLPSLCKFSLAALPAKPENISCVYYYRKNLTCTWSPGKETSYTQYTVKRTYAFGEKHDNCTTNSSTSENRASCSFFLPRITIPDNYTIEVEAENGDGVIKSHMTYWRLENIAKTEPPKIFRVKPVLGIKRMIQIEWIKPELAPVSSDLKYTLRFRTVNSTSWMEVNFAKNRKDKNQTYNLTGLQPFTEYVIALRCAVKESKFWSDWSQEKMGMTEEEAPCGLELWRVLKPAEADGRRPVRLLWKKARGAPVLEKTLGYNIWYYPESNTNLTETMNTTNQQLELHLGGESFWVSMISYNSLGKSPVATLRIPAIQEKSFQCIEVMQACVAEDQLVVKWQSSALDVNTWMIEWFPDVDSEPTTLSWESVSQATNWTIQQDKLKPFWCYNISVYPMLHDKVGEPYSIQAYAKEGVPSEGPETKVENIGVKTVTITWKEIPKSERKGIICNYTIFYQAEGGKGFSKTVNSSILQYGLESLKRKTSYIVQVMASTSAGGTNGTSINFKTLSFSVFEIILITSLIGGGLLILIILTVAYGLKKPNKLTHLCWPTVPNPAESSIATWHGDDFKDKLNLKESDDSVNTEDRILKPCSTPSDKLVIDKLVVNFGNVLQEIFTDEARTGQENNLGGEKNGYVTCPFRPDCPLGKSFEELPVSPEIPPRKSQYLRSRMPEGTRPEAKEQLLFSGQSLVPDHLCEEGAPNPYLKNSVTAREFLVSEKLPEHTKGEV,732,"82,954",Alternative sequence (16); Chain (1); Domain (5); Erroneous initiation (2); Glycosylation (10); Mutagenesis (6); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
P05107,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)",MLGLRPPLLALVGLLSLGCVLSQECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDPTSLAETQEDHNGGQKQLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYSMLDDLRNVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPDKLRNPCPNKEKECQPPFAFRHVLKLTNNSNQFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHLEDNLYKRSNEFDYPSVGQLAHKLAENNIQPIFAVTSRMVKTYEKLTEIIPKSAVGELSEDSSNVVQLIKNAYNKLSSRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQVLPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGKNCECQTQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSDVPGKLIYGQYCECDTINCERYNGQVCGGPGRGLCFCGKCRCHPGFEGSACQCERTTEGCLNPRRVECSGRGRCRCNVCECHSGYQLPLCQECPGCPSPCGKYISCAECLKFEKGPFGKNCSAACPGLQLSNNPVKGRTCKERDSEGCWVAYTLEQQDGMDRYLIYVDESRECVAGPNIAAIVGGTVAGIVLIGILLLVIWKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES,769,"84,782",Beta strand (50); Chain (1); Disulfide bond (28); Domain (1); Erroneous initiation (1); Glycosylation (6); Helix (27); Metal binding (4); Modified residue (6); Motif (1); Mutagenesis (1); Natural variant (16); Region (1); Repeat (4); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 25..43;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 33..447;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 36..62;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 46..73;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 191..198;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 246..286;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 386..400;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 420..445;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 449..467;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 459..470;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 472..481;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 483..514;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 497..512;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 506..517;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 519..534;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 536..559;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 541..557;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 549..562;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 564..573;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 575..598;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 582..596;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 590..601;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 603..612;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 615..618;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 622..662;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 628..647;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 631..643;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 670..695;  /evidence=""ECO:0000269|PubMed:20033057""",SIGNAL 1..22
Q86YT9,Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1),MFCPLKLILLPVLLDYSLGLNDLNVSPPELTVHVGDSALMGCVFQSTEDKCIFKIDWTLSPGEHAKDEYVLYYYSNLSVPIGRFQNRVHLMGDILCNDGSLLLQDVQEADQGTYICEIRLKGESQVFKKAVVLHVLPEEPKELMVHVGGLIQMGCVFQSTEVKHVTKVEWIFSGRRAKEEIVFRYYHKLRMSVEYSQSWGHFQNRVNLVGDIFRNDGSIMLQGVRESDGGNYTCSIHLGNLVFKKTIVLHVSPEEPRTLVTPAALRPLVLGGNQLVIIVGIVCATILLLPVLILIVKKTCGNKSSVNSTVLVKNTKKTNPEIKEKPCHFERCEGEKHIYSPIIVREVIEEEEPSEKSEATYMTMHPVWPSLRSDRNNSLEKKSGGGMPKTQQAF,394,"44,339",Alternative sequence (4); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (2); Mutagenesis (1); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 155..234;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
P29322,Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK),MAPARGRLPPALWVVTAAAAAATCVSAARGEVNLLDTSTIHGDWGWLTYPAHGWDSINEVDESFQPIHTYQVCNVMSPNQNNWLRTSWVPRDGARRVYAEIKFTLRDCNSMPGVLGTCKETFNLYYLESDRDLGASTQESQFLKIDTIAADESFTGADLGVRRLKLNTEVRSVGPLSKRGFYLAFQDIGACLAILSLRIYYKKCPAMVRNLAAFSEAVTGADSSSLVEVRGQCVRHSEERDTPKMYCSAEGEWLVPIGKCVCSAGYEERRDACVACELGFYKSAPGDQLCARCPPHSHSAAPAAQACHCDLSYYRAALDPPSSACTRPPSAPVNLISSVNGTSVTLEWAPPLDPGGRSDITYNAVCRRCPWALSRCEACGSGTRFVPQQTSLVQASLLVANLLAHMNYSFWIEAVNGVSDLSPEPRRAAVVNITTNQAAPSQVVVIRQERAGQTSVSLLWQEPEQPNGIILEYEIKYYEKDKEMQSYSTLKAVTTRATVSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETGKPRPRYDTRTIVWICLTLITGLVVLLLLLICKKRHCGYSKAFQDSDEEKMHYQNGQAPPPVFLPLHHPPGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVSRCPPPAFVRSCFDLRGGSGGGGGLTVGDWLDSIRMGRYRDHFAAGGYSSLGMVLRMNAQDVRALGITLMGHQKKILGSIQTMRAQLTSTQGPRRHL,1005,"111,003",Active site (1); Alternative sequence (2); Beta strand (13); Binding site (1); Chain (1); Compositional bias (1); Domain (5); Erroneous initiation (1); Glycosylation (3); Helix (19); Modified residue (2); Motif (1); Natural variant (9); Nucleotide binding (1); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9NU53,Glycoprotein integral membrane protein 1,MEGAPPGSLALRLLLFVALPASGWLTTGAPEPPPLSGAPQDGIRINVTTLKDDGDISKQQVVLNITYESGQVYVNDLPVNSGVTRISCQTLIVKNENLENLEEKEYFGIVSVRILVHEWPMTSGSSLQLIVIQEEVVEIDGKQVQQKDVTEIDILVKNRGVLRHSNYTLPLEESMLYSISRDSDILFTLPNLSKKESVSSLQTTSQYLIRNVETTVDEDVLPGKLPETPLRAEPPSSYKVMCQWMEKFRKDLCRFWSNVFPVFFQFLNIMVVGITGAAVVITILKVFFPVSEYKGILQLDKVDVIPVTAINLYPDGPEKRAENLEDKTCI,330,"36,840",Chain (1); Glycosylation (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q6UXL0,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2),MQTFTMVLEEIWTSLFMWFFYALIPCLLTDEVAILPAPQNLSVLSTNMKHLLMWSPVIAPGETVYYSVEYQGEYESLYTSHIWIPSSWCSLTEGPECDVTDDITATVPYNLRVRATLGSQTSAWSILKHPFNRNSTILTRPGMEITKDGFHLVIELEDLGPQFEFLVAYWRREPGAEEHVKMVRSGGIPVHLETMEPGAAYCVKAQTFVKAIGRYSAFSQTECVEVQGEAIPLVLALFAFVGFMLILVVVPLFVWKMGRLLQYSCCPVVVLPDTLKITNSPQKLISCRREEVDACATAVMSPEELLRAWIS,311,"35,076",Alternative sequence (3); Beta strand (15); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (2); Helix (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 89..97;  /evidence=""ECO:0000269|PubMed:22802649""; DISULFID 202..223;  /evidence=""ECO:0000269|PubMed:22802649""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9UHF4,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7),MRAPGRPALRPLPLPPLLLLLLAAPWGRAVPCVSGGLPKPANITFLSINMKNVLQWTPPEGLQGVKVTYTVQYFIYGQKKWLNKSECRNINRTYCDLSAETSDYEHQYYAKVKAIWGTKCSKWAESGRFYPFLETQIGPPEVALTTDEKSISVVLTAPEKWKRNPEDLPVSMQQIYSNLKYNVSVLNTKSNRTWSQCVTNHTLVLTWLEPNTLYCVHVESFVPGPPRRAQPSEKQCARTLKDQSSEFKAKIIFWYVLPVSITVFLFSVMGYSIYRYIHVGKEKHPANLILIYGNEFDKRFFVPAEKIVINFITLNISDDSKISHQDMSLLGKSSDVSSLNDPQPSGNLRPPQEEEEVKHLGYASHLMEIFCDSEENTEGTSLTQQESLSRTIPPDKTVIEYEYDVRTTDICAGPEEQELSLQEEVSTQGTLLESQAALAVLGPQTLQYSYTPQLQDLDPLAQEHTDSEEGPEEEPSTTLVDWDPQTGRLCIPSLSSFDQDSEGCEPSEGDGLGEEGLLSRLYEEPAPDRPPGENETYLMQFMEEWGLYVQMEN,553,"62,485",Alternative sequence (3); Beta strand (13); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (6); Helix (3); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 87..95;  /evidence=""ECO:0000269|PubMed:22802649""; DISULFID 215..236;  /evidence=""ECO:0000269|PubMed:22802649""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8IYS2,Uncharacterized protein KIAA2013,MWLQQRLKGLPGLLSSSWARRLLCLLGLLLLLLWFGGSGARRAAGGLHLLPWSRGEPGAAEPSACLEAATRAWRGLRERGEVVPLGPGVPALVANGFLALDVAANRLWVTPGEREPAVAPDFVPFVQLRPLSALAEAGEAVLLLREGLLRRVRCLQLGSPGPGPVAAGPGPASVSGLAAGSGRDCVLLQEDFLAHRGRPHVYLQRIQLNNPTERVAALQTVGPTAGPAPKAFTSTLEKVGDHQFLLYSGRSPPTPTGLVHLVVVAAKKLVNRLQVAPKTQLDETVLWVVHVSGPINPQVLKSKAAKELKALQDLARKEMLELLDMPAAELLQDHQLLWAQLFSPGVEMKKITDTHTPSGLTVNLTLYYMLSCSPAPLLSPSLSHRERDQMESTLNYEDHCFSGHATMHAENLWPGRLSSVQQILQLSDLWRLTLQKRGCKGLVKVGAPGILQGMVLSFGGLQFTENHLQFQADPDVLHNSYALHGIRYKNDHINLAVLADAEGKPYLHVSVESRGQPVKIYACKAGCLDEPVELTSAPTGHTFSVMVTQPITPLLYISTDLTHLQDLRHTLHLKAILAHDEHMAQQDPGLPFLFWFSVASLITLFHLFLFKLIYNEYCGPGAKPLFRSKEDPSV,634,"69,157",Alternative sequence (1); Chain (1); Erroneous initiation (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..40;  /evidence=""ECO:0000255"""
Q8NHL6,Leukocyte immunoglobulin-like receptor subfamily B member 1 (LIR-1) (Leukocyte immunoglobulin-like receptor 1) (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2) (ILT-2) (Monocyte/macrophage immunoglobulin-like receptor 7) (MIR-7) (CD antigen CD85j),MTPILTVLICLGLSLGPRTHVQAGHLPKPTLWAEPGSVITQGSPVTLRCQGGQETQEYRLYREKKTALWITRIPQELVKKGQFPIPSITWEHAGRYRCYYGSDTAGRSESSDPLELVVTGAYIKPTLSAQPSPVVNSGGNVILQCDSQVAFDGFSLCKEGEDEHPQCLNSQPHARGSSRAIFSVGPVSPSRRWWYRCYAYDSNSPYEWSLPSDLLELLVLGVSKKPSLSVQPGPIVAPEETLTLQCGSDAGYNRFVLYKDGERDFLQLAGAQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSEWSAPSDPLDILIAGQFYDRVSLSVQPGPTVASGENVTLLCQSQGWMQTFLLTKEGAADDPWRLRSTYQSQKYQAEFPMGPVTSAHAGTYRCYGSQSSKPYLLTHPSDPLELVVSGPSGGPSSPTTGPTSTSGPEDQPLTPTGSDPQSGLGRHLGVVIGILVAVILLLLLLLLLFLILRHRRQGKHWTSTQRKADFQHPAGAVGPEPTDRGLQWRSSPAADAQEENLYAAVKHTQPEDGVEMDTRSPHDEDPQAVTYAEVKHSRPRREMASPPSPLSGEFLDTKDRQAEEDRQMDTEAAASEAPQDVTYAQLHSLTLRREATEPPPSQEGPSPAVPSIYATLAIH,650,"70,819",Alternative sequence (4); Beta strand (36); Chain (1); Disulfide bond (5); Domain (4); Glycosylation (3); Helix (6); Modified residue (3); Motif (4); Mutagenesis (4); Natural variant (8); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 49..98;  /evidence=""ECO:0000244|PDB:1G0X, ECO:0000269|PubMed:11114384""; DISULFID 145..197;  /evidence=""ECO:0000244|PDB:1G0X, ECO:0000269|PubMed:11114384""; DISULFID 157..167;  /evidence=""ECO:0000244|PDB:1G0X, ECO:0000269|PubMed:11114384""; DISULFID 246..297;  /evidence=""ECO:0000244|PDB:1G0X, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11114384""; DISULFID 346..397;  /evidence=""ECO:0000244|PDB:1G0X, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11114384""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q6PI73,Leukocyte immunoglobulin-like receptor subfamily A member 6 (Immunoglobulin-like transcript 8) (ILT-8) (Leukocyte Ig-like receptor),MTPALTALLCLGLSLGPRTRVQAGPFPKPTLWAEPGSVISWGSPVTIWCQGSLEAQEYQLDKEGSPEPLDRNNPLEPKNKARFSIPSMTQHHAGRYRCHYYSSAGWSEPSDPLELVMTGFYNKPTLSALPSPVVASGGNMTLRCGSQKGYHHFVLMKEGEHQLPRTLDSQQLHSGGFQALFPVGPVTPSHRWRFTCYYYYTNTPRVWSHPSDPLEILPSGVSRKPSLLTLQGPVLAPGQSLTLQCGSDVGYDRFVLYKEGERDFLQRPGQQPQAGLSQANFTLGPVSPSHGGQYRCYGAHNLSSEWSAPSDPLNILMAGQIYDTVSLSAQPGPTVASGENVTLLCQSRGYFDTFLLTKEGAAHPPLRLRSMYGAHKYQAEFPMSPVTSAHAGTYRCYGSYSSNPHLLSFPSEPLELMVSGHSGGSSLPPTGPPSTPASHAKDYTVENLIRMGMAGLVLVFLGILLFEAQHSQRNPQDAAGR,481,"52,399",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (2); Glycosylation (3); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""; DISULFID 144..196;  /evidence=""ECO:0000250|UniProtKB:Q8NHL6""; DISULFID 245..296;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 345..396;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9UKN1,Mucin-12 (MUC-12) (Mucin-11) (MUC-11),MLVIWILTLALRLCASVTTVTPEGSAVHKAISQQGTLWTGEVLEKQTVEQGKSTLRRQKNHFHRSAGELRCRNALKDEGASAGWSVMFAGESVVVLVHLWMTGARVKNLGLVEFASPGDDGDGRAEGFSLGLPLSEQARAAGAREKERQETVINHSTFSGFSQITGSTVNTSIGGNTTSASTPSSSDPFTTFSDYGVSVTFITGSTATKHFLDSSTNSGHSEESTVSHSGPGATGTTLFPSHSATSVFVGEPKTSPITSASMETTALPGSTTTAGLSEKSTTFYSSPRSPDRTLSPARTTSSGVSEKSTTSHSRPGPTHTIAFPDSTTMPGVSQESTASHSIPGSTDTTLSPGTTTPSSLGPESTTFHSSPGYTKTTRLPDNTTTSGLLEASTPVHSSTGSPHTTLSPSSSTTHEGEPTTFQSWPSSKDTSPAPSGTTSAFVKLSTTYHSSPSSTPTTHFSASSTTLGHSEESTPVHSSPVATATTPPPARSATSGHVEESTAYHRSPGSTQTMHFPESSTTSGHSEESATFHGSTTHTKSSTPSTTAALAHTSYHSSLGSTETTHFRDSSTISGRSEESKASHSSPDAMATTVLPAGSTPSVLVGDSTPSPISSGSMETTALPGSTTKPGLSEKSTTFYSSPRSPDTTHLPASMTSSGVSEESTTSHSRPGSTHTTAFPGSTTMPGLSQESTASHSSPGPTDTTLSPGSTTASSLGPEYTTFHSRPGSTETTLLPDNTTASGLLEASMPVHSSTRSPHTTLSPAGSTTRQGESTTFHSWPSSKDTRPAPPTTTSAFVEPSTTSHGSPSSIPTTHISARSTTSGLVEESTTYHSSPGSTQTMHFPESDTTSGRGEESTTSHSSTTHTISSAPSTTSALVEEPTSYHSSPGSTATTHFPDSSTTSGRSEESTASHSSQDATGTIVLPARSTTSVLLGESTTSPISSGSMETTALPGSTTTPGLSERSTTFHSSPRSPATTLSPASTTSSGVSEESTTSRSRPGSTHTTAFPDSTTTPGLSRHSTTSHSSPGSTDTTLLPASTTTSGPSQESTTSHSSSGSTDTALSPGSTTALSFGQESTTFHSNPGSTHTTLFPDSTTSSGIVEASTRVHSSTGSPRTTLSPASSTSPGLQGESTAFQTHPASTHTTPSPPSTATAPVEESTTYHRSPGSTPTTHFPASSTTSGHSEKSTIFHSSPDASGTTPSSAHSTTSGRGESTTSRISPGSTEITTLPGSTTTPGLSEASTTFYSSPRSPTTTLSPASMTSLGVGEESTTSRSQPGSTHSTVSPASTTTPGLSEESTTVYSSSRGSTETTVFPHSTTTSVHGEEPTTFHSRPASTHTTLFTEDSTTSGLTEESTAFPGSPASTQTGLPATLTTADLGEESTTFPSSSGSTGTKLSPARSTTSGLVGESTPSRLSPSSTETTTLPGSPTTPSLSEKSTTFYTSPRSPDATLSPATTTSSGVSEESSTSHSQPGSTHTTAFPDSTTTSDLSQEPTTSHSSQGSTEATLSPGSTTASSLGQQSTTFHSSPGDTETTLLPDDTITSGLVEASTPTHSSTGSLHTTLTPASSTSAGLQEESTTFQSWPSSSDTTPSPPGTTAAPVEVSTTYHSRPSSTPTTHFSASSTTLGRSEESTTVHSSPGATGTALFPTRSATSVLVGEPTTSPISSGSTETTALPGSTTTAGLSEKSTTFYSSPRSPDTTLSPASTTSSGVSEESTTSHSRPGSTHTTAFPGSTTMPGVSQESTASHSSPGSTDTTLSPGSTTASSLGPESTTFHSSPGSTETTLLPDNTTASGLLEASTPVHSSTGSPHTTLSPAGSTTRQGESTTFQSWPSSKDTMPAPPTTTSAFVELSTTSHGSPSSTPTTHFSASSTTLGRSEESTTVHSSPVATATTPSPARSTTSGLVEESTAYHSSPGSTQTMHFPESSTASGRSEESRTSHSSTTHTISSPPSTTSALVEEPTSYHSSPGSTATTHFPDSSTTSGRSEESTASHSSQDATGTIVLPARSTTSVLLGESTTSPISSGSMETTALPGSTTTPGLSEKSTTFHSSPRSPATTLSPASTTSSGVSEESTTSHSRPGSTHTTAFPDSTTTPGLSRHSTTSHSSPGSTDTTLLPASTTTSGPSQESTTSHSSPGSTDTALSPGSTTALSFGQESTTFHSSPGSTHTTLFPDSTTSSGIVEASTRVHSSTGSPRTTLSPASSTSPGLQGESTAFQTHPASTHTTPSPPSTATAPVEESTTYHRSPGSTPTTHFPASSTTSGHSEKSTIFHSSPDASGTTPSSAHSTTSGRGESTTSRISPGSTEITTLPGSTTTPGLSEASTTFYSSPRSPTTTLSPASMTSLGVGEESTTSRSQPGSTHSTVSPASTTTPGLSEESTTVYSSSPGSTETTVFPRTPTTSVRGEEPTTFHSRPASTHTTLFTEDSTTSGLTEESTAFPGSPASTQTGLPATLTTADLGEESTTFPSSSGSTGTTLSPARSTTSGLVGESTPSRLSPSSTETTTLPGSPTTPSLSEKSTTFYTSPRSPDATLSPATTTSSGVSEESSTSHSQPGSTHTTAFPDSTTTPGLSRHSTTSHSSPGSTDTTLLPASTTTSGPSQESTTSHSSPGSTDTALSPGSTTALSFGQESTTFHSSPGSTHTTLFPDSTTSSGIVEASTRVHSSTGSPRTTLSPASSTSPGLQGESTTFQTHPASTHTTPSPPSTATAPVEESTTYHRSPGSTPTTHFPASSTTSGHSEKSTIFHSSPDASGTTPSSAHSTTSGRGESTTSRISPGSTEITTLPGSTTTPGLSEASTTFYSSPRSPTTTLSPASMTSLGVGEESTTSRSQPGSTHSTVSPASTTTPGLSEESTTVYSSSPGSTETTVFPRSTTTSVRGEEPTTFHSRPASTHTTLFTEDSTTSGLTEESTAFPGSPASTQTGLPATLTTADLGEESTTFPSSSGSTGTTLSPARSTTSGLVGESTPSRLSPSSTETTTLPGSPTTPSLSEKSTTFYTSPRSPDATLSPATTTSSGVSEESSTSHSQPGSTHTTAFPDSTTTSGLSQEPTASHSSQGSTEATLSPGSTTASSLGQQSTTFHSSPGDTETTLLPDDTITSGLVEASTPTHSSTGSLHTTLTPASSTSAGLQEESTTFQSWPSSSDTTPSPPGTTAAPVEVSTTYHSRPSSTPTTHFSASSTTLGRSEESTTVHSSPGATGTALFPTRSATSVLVGEPTTSPISSGSTETTALPGSTTTAGLSEKSTTFYSSPRSPDTTLSPASTTSSGVSEESTTSHSRPGSTHTTAFPGSTTMPGVSQESTASHSSPGSTDTTLSPGSTTASSLGPESTTFHSGPGSTETTLLPDNTTASGLLEASTPVHSSTGSPHTTLSPAGSTTRQGESTTFQSWPNSKDTTPAPPTTTSAFVELSTTSHGSPSSTPTTHFSASSTTLGRSEESTTVHSSPVATATTPSPARSTTSGLVEESTTYHSSPGSTQTMHFPESDTTSGRGEESTTSHSSTTHTISSAPSTTSALVEEPTSYHSSPGSTATTHFPDSSTTSGRSEESTASHSSQDATGTIVLPARSTTSVLLGESTTSPISSGSMETTALPGSTTTPGLSEKSTTFHSSPRSPATTLSPASTTSSGVSEESTTSHSRPGSTHTTAFPDSTTTPGLSRHSTTSHSSPGSTDTTLLPASTTTSGSSQESTTSHSSSGSTDTALSPGSTTALSFGQESTTFHSSPGSTHTTLFPDSTTSSGIVEASTRVHSSTGSPRTTLSPASSTSPGLQGESTAFQTHPASTHTTPSPPSTATAPVEESTTYHRSPGSTPTTHFPASSTTSGHSEKSTIFHSSPDASGTTPSSAHSTTSGRGESTTSRISPGSTEITTLPGSTTTPGLSEASTTFYSSPRSPTTTLSPASMTSLGVGEESTTSRSQPGSTHSTVSPASTTTPGLSEESTTVYSSSPGSTETTVFPRSTTTSVRREEPTTFHSRPASTHTTLFTEDSTTSGLTEESTAFPGSPASTQTGLPATLTTADLGEESTTFPSSSGSTGTKLSPARSTTSGLVGESTPSRLSPSSTETTTLPGSPTTPSLSEKSTTFYTSPRSPDATLSPATTTSSGVSEESSTSHSQPGSTHTTAFPDSTTTSGLSQEPTTSHSSQGSTEATLSPGSTTASSLGQQSTTFHSSPGDTETTLLPDDTITSGLVEASTPTHSSTGSLHTTLTPASSTSTGLQEESTTFQSWPSSSDTTPSPPSTTAVPVEVSTTYHSRPSSTPTTHFSASSTTLGRSEESTTVHSSPGATGTALFPTRSATSVLVGEPTTSPISSGSTETTALPGSTTTAGLSEKSTTFYSSPRSPDTTLSPASTTSSGVSEESTTSHSRPGSMHTTAFPSSTTMPGVSQESTASHSSPGSTDTTLSPGSTTASSLGPESTTFHSSPGSTETTLLPDNTTASGLLEASTPVHSSTGSPHTTLSPAGSTTRQGESTTFQSWPNSKDTTPAPPTTTSAFVELSTTSHGSPSSTPTTHFSASSTTLGRSEESTTVHSSPVATATTPSPARSTTSGLVEESTTYHSSPGSTQTMHFPESNTTSGRGEESTTSHSSTTHTISSAPSTTSALVEEPTSYHSSPGSTATTHFPDSSTTSGRSEESTASHSSQDATGTIVLPARSTTSVLLGESTTSPISSGSMETTALPGSTTTPGLSEKSTTFHSSPSSTPTTHFSASSTTLGRSEESTTVHSSPVATATTPSPARSTTSGLVEESTAYHSSPGSTQTMHFPESSTASGRSEESRTSHSSTTHTISSPPSTTSALVEEPTSYHSSPGSIATTHFPESSTTSGRSEESTASHSSPDTNGITPLPAHFTTSGRIAESTTFYISPGSMETTLASTATTPGLSAKSTILYSSSRSPDQTLSPASMTSSSISGEPTSLYSQAESTHTTAFPASTTTSGLSQESTTFHSKPGSTETTLSPGSITTSSFAQEFTTPHSQPGSALSTVSPASTTVPGLSEESTTFYSSPGSTETTAFSHSNTMSIHSQQSTPFPDSPGFTHTVLPATLTTTDIGQESTAFHSSSDATGTTPLPARSTASDLVGEPTTFYISPSPTYTTLFPASSSTSGLTEESTTFHTSPSFTSTIVSTESLETLAPGLCQEGQIWNGKQCVCPQGYVGYQCLSPLESFPVETPEKLNATLGMTVKVTYRNFTEKMNDASSQEYQNFSTLFKNRMDVVLKGDNLPQYRGVNIRRLLNGSIVVKNDVILEADYTLEYEELFENLAEIVKAKIMNETRTTLLDPDSCRKAILCYSEEDTFVDSSVTPGFDFQEQCTQKAAEGYTQFYYVDVLDGKLACVNKCTKGTKSQMNCNLGTCQLQRSGPRCLCPNTNTHWYWGETCEFNIAKSLVYGIVGAVMAVLLLALIILIILFSLSQRKRHREQYDVPQEWRKEGTPGIFQKTAIWEDQNLRESRFGLENAYNNFRPTLETVDSGTELHIQRPEMVASTV,5478,"558,164",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (2); Glycosylation (14); Motif (1); Natural variant (1); Region (1); Repeat (28); Sequence conflict (12); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 5144..5153;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q14118,Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEAVPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGLPLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSAFMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIANKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRDPVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPPTTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRIRTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKLREQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQGDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWTNNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIPVVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRKGKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETTPLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP,895,"97,441",Beta strand (13); Chain (2); Compositional bias (2); Disulfide bond (2); Domain (1); Glycosylation (14); Helix (8); Modified residue (2); Motif (2); Mutagenesis (17); Natural variant (5); Region (6); Sequence conflict (4); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 182..264;  /evidence=""ECO:0000244|PDB:5LLK, ECO:0000269|PubMed:28781947""; DISULFID 669..713;  /evidence=""ECO:0000269|PubMed:17212656""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
P13765,"HLA class II histocompatibility antigen, DO beta chain (MHC class II antigen DOB)",MGSGWVPWVVALLVNLTRLDSSMTQGTDSPEDFVIQAKADCYFTNGTEKVQFVVRFIFNLEEYVRFDSDVGMFVALTKLGQPDAEQWNSRLDLLERSRQAVDGVCRHNYRLGAPFTVGRKVQPEVTVYPERTPLLHQHNLLHCSVTGFYPGDIKIKWFLNGQEERAGVMSTGPIRNGDWTFQTVVMLEMTPELGHVYTCLVDHSSLLSPVSVEWRAQSEYSWRKMLSGIAAFLLGLIFLLVGIVIQLRAQKGYVRTQMSGNEVSRAVLLPQSC,273,"30,822",Beta strand (12); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Helix (5); Natural variant (4); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 41..105;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..199;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..26
O60353,Frizzled-6 (Fz-6) (hFz6),MEMFTFLLTCIFLPLLRGHSLFTCEPITVPRCMKMAYNMTFFPNLMGHYDQSIAAVEMEHFLPLANLECSPNIETFLCKAFVPTCIEQIHVVPPCRKLCEKVYSDCKKLIDTFGIRWPEELECDRLQYCDETVPVTFDPHTEFLGPQKKTEQVQRDIGFWCPRHLKTSGGQGYKFLGIDQCAPPCPNMYFKSDELEFAKSFIGTVSIFCLCATLFTFLTFLIDVRRFRYPERPIIYYSVCYSIVSLMYFIGFLLGDSTACNKADEKLELGDTVVLGSQNKACTVLFMLLYFFTMAGTVWWVILTITWFLAAGRKWSCEAIEQKAVWFHAVAWGTPGFLTVMLLAMNKVEGDNISGVCFVGLYDLDASRYFVLLPLCLCVFVGLSLLLAGIISLNHVRQVIQHDGRNQEKLKKFMIRIGVFSGLYLVPLVTLLGCYVYEQVNRITWEITWVSDHCRQYHIPCPYQAKAKARPELALFMIKYLMTLIVGISAVFWVGSKKTCTEWAGFFKRNRKRDPISESRRVLQESCEFFLKHNSKVKHKKKHYKPSSHKLKVISKSMGTSTGATANHGTSAVAITSHDYLGQETLTEIQTSPETSMREVKADGASTPRLREQDCGEPASPAASISRLSGEQVDGKGQAGSVSESARSEGRISPKSDITDTGLAQSNNLQVPSSSEPSSLKGSTSLLVHPVSGVRKEQGGGCHSDT,706,"79,292",Alternative sequence (1); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Modified residue (1); Motif (1); Natural variant (11); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 24..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 32..78;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 69..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 95..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 99..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P48169,Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4),MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTRILDSLLDGYDNRLRPGFGGPVTEVKTDIYVTSFGPVSDVEMEYTMDVFFRQTWIDKRLKYDGPIEILRLNNMMVTKVWTPDTFFRNGKKSVSHNMTAPNKLFRIMRNGTILYTMRLTISAECPMRLVDFPMDGHACPLKFGSYAYPKSEMIYTWTKGPEKSVEVPKESSSLVQYDLIGQTVSSETIKSITGEYIVMTVYFHLRRKMGYFMIQTYIPCIMTVILSQVSFWINKESVPARTVFGITTVLTMTTLSISARHSLPKVSYATAMDWFIAVCFAFVFSALIEFAAVNYFTNIQMEKAKRKTSKPPQEVPAAPVQREKHPEAPLQNTNANLNMRKRTNALVHSESDVGNRTEVGNHSSKSSTVVQESSKGTPRSYLASSPNPFSRANAAETISAARALPSASPTSIRTGYMPRKASVGSASTRHVFGSRLQRIKTTVNTIGATGKLSATPPPSAPPPSGSGTSKIDKYARILFPVTFGAFNMVYWVVYLSKDTMEKSESLM,554,"61,623",Chain (1); Disulfide bond (1); Glycosylation (3); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 172..186;  /evidence=""ECO:0000250""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
O75054,Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3),MKCFFPVLSCLAVLGVVSAQRQVTVQEGPLYRTEGSHITIWCNVSGYQGPSEQNFQWSIYLPSSPEREVQIVSTMDSSFPYAIYTQRVRGGKIFIERVQGNSTLLHITDLQARDAGEYECHTPSTDKQYFGSYSAKMNLVVIPDSLQTTAMPQTLHRVEQDPLELTCEVASETIQHSHLSVAWLRQKVGEKPVEVISLSRDFMLHSSSEYAQRQSLGEVRLDKLGRTTFRLTIFHLQPSDQGEFYCEAAEWIQDPDGSWYAMTRKRSEGAVVNVQPTDKEFTVRLETEKRLHTVGEPVEFRCILEAQNVPDRYFAVSWAFNSSLIATMGPNAVPVLNSEFAHREARGQLKVAKESDSVFVLKIYHLRQEDSGKYNCRVTEREKTVTGEFIDKESKRPKNIPIIVLPLKSSISVEVASNASVILEGEDLRFSCSVRTAGRPQGRFSVIWQLVDRQNRRSNIMWLDRDGTVQPGSSYWERSSFGGVQMEQVQPNSFSLGIFNSRKEDEGQYECHVTEWVRAVDGEWQIVGERRASTPISITALEMGFAVTAISRTPGVTYSDSFDLQCIIKPHYPAWVPVSVTWRFQPVGTVEFHDLVTFTRDGGVQWGDRSSSFRTRTAIEKAESSNNVRLSISRASDTEAGKYQCVAELWRKNYNNTWTRLAERTSNLLEIRVLQPVTKLQVSKSKRTLTLVENKPIQLNCSVKSQTSQNSHFAVLWYVHKPSDADGKLILKTTHNSAFEYGTYAEEEGLRARLQFERHVSGGLFSLTVQRAEVSDSGSYYCHVEEWLLSPNYAWYKLAEEVSGRTEVTVKQPDSRLRLSQAQGNLSVLETRQVQLECVVLNRTSITSQLMVEWFVWKPNHPERETVARLSRDATFHYGEQAAKNNLKGRLHLESPSPGVYRLFIQNVAVQDSGTYSCHVEEWLPSPSGMWYKRAEDTAGQTALTVMRPDASLQVDTVVPNATVSEKAAFQLDCSIVSRSSQDSRFAVAWYSLRTKAGGKRSSPGLEEQEEEREEEEEEDDDDDDDPTERTALLSVGPDAVFGPEGSPWEGRLRFQRLSPVLYRLTVLQASPQDTGNYSCHVEEWLPSPQKEWYRLTEEESAPIGIRVLDTSPTLQSIICSNDALFYFVFFYPFPIFGILIITILLVRFKSRNSSKNSDGKNGVPLLWIKEPHLNYSPTCLEPPVLSIHPGAID,1194,"135,196",Alternative sequence (1); Chain (1); Disulfide bond (8); Domain (8); Erroneous initiation (1); Frameshift (1); Glycosylation (5); Motif (1); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 167..246;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 302..376;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 432..511;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 566..645;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 701..782;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 838..918;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 974..1080;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9H665,IGF-like family receptor 1 (Transmembrane protein 149) (U2 small nuclear RNA auxiliary factor 1-like 4),MGPGRCLLTALLLLALAPPPEASQYCGRLEYWNPDNKCCSSCLQRFGPPPCPDYEFRENCGLNDHGDFVTPPFRKCSSGQCNPDGAELCSPCGGGAVTPTPAAGGGRTPWRCRERPVPAKGHCPLTPGNPGAPSSQERSSPASSIAWRTPEPVPQQAWPNFLPLVVLVLLLTLAVIAILLFILLWHLCWPKEKADPYPYPGLVCGVPNTHTPSSSHLSSPGALETGDTWKEASLLPLLSRELSSLASQPLSRLLDELEVLEELIVLLDPEPGPGGGMAHGTTRHLAARYGLPAAWSTFAYSLRPSRSPLRALIEMVVAREPSASLGQLGTHLAQLGRADALRVLSKLGSSGVCWA,355,"37,895",Alternative sequence (1); Chain (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q6UXV1,Izumo sperm-egg fusion protein 2,MPLALTLLLLSGLGAPGGWGCLQCDPLVLEALGHLRSALIPSRFQLEQLQARAGAVLMGMEGPFFRDYALNVFVGKVETNQLDLVASFVKNQTQHLMGNSLKDEPLLEELVTLRANVIKEFKKVLISYELKACNPKLCRLLKEEVLDCLHCQRITPKCIHKKYCFVDRQPRVALQYQMDSKYPRNQALLGILISVSLAVFVFVVIVVSACTYRQNRKLLLQ,221,"24,856",Alternative sequence (1); Chain (1); Erroneous gene model prediction (2); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8NC54,Keratinocyte-associated transmembrane protein 2,MAAAVPKRMRGPAQAKLLPGSAIQALVGLARPLVLALLLVSAALSSVVSRTDSPSPTVLNSHISTPNVNALTHENQTKPSISQISTTLPPTTSTKKSGGASVVPHPSPTPLSQEEADNNEDPSIEEEDLLMLNSSPSTAKDTLDNGDYGEPDYDWTTGPRDDDESDDTLEENRGYMEIEQSVKSFKMPSSNIEEEDSHFFFHLIIFAFCIAVVYITYHNKRKIFLLVQSRKWRDGLCSKTVEYHRLDQNVNEAMPSLKITNDYIF,265,"29,235",Chain (1); Glycosylation (1); Modified residue (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..49;  /evidence=""ECO:0000255"""
P31644,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5),MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFTRILDGLLDGYDNRLRPGLGERITQVRTDIYVTSFGPVSDTEMEYTIDVFFRQSWKDERLRFKGPMQRLPLNNLLASKIWTPDTFFHNGKKSIAHNMTTPNKLLRLEDDGTLLYTMRLTISAECPMQLEDFPMDAHACPLKFGSYAYPNSEVVYVWTNGSTKSVVVAEDGSRLNQYHLMGQTVGTENISTSTGEYTIMTAHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGWAWDGKKALEAAKIKKKREVILNKSTNAFTTGKMSHPPNIPKEQTPAGTSNTTSVSVKPSEEKTSESKKTYNSISKIDKMSRIVFPVLFGTFNLVYWATYLNREPVIKGAASPK,462,"52,146",Chain (1); Cross-link (1); Disulfide bond (1); Glycosylation (4); Helix (5); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 173..187;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
O15303,Metabotropic glutamate receptor 6 (mGluR6),MARPRRAREPLLVALLPLAWLAQAGLARAAGSVRLAGGLTLGGLFPVHARGAAGRACGQLKKEQGVHRLEAMLYALDRVNADPELLPGVRLGARLLDTCSRDTYALEQALSFVQALIRGRGDGDEVGVRCPGGVPPLRPAPPERVVAVVGASASSVSIMVANVLRLFAIPQISYASTAPELSDSTRYDFFSRVVPPDSYQAQAMVDIVRALGWNYVSTLASEGNYGESGVEAFVQISREAGGVCIAQSIKIPREPKPGEFSKVIRRLMETPNARGIIIFANEDDIRRVLEAARQANLTGHFLWVGSDSWGAKTSPILSLEDVAVGAITILPKRASIDGFDQYFMTRSLENNRRNIWFAEFWEENFNCKLTSSGTQSDDSTRKCTGEERIGRDSTYEQEGKVQFVIDAVYAIAHALHSMHQALCPGHTGLCPAMEPTDGRMLLQYIRAVRFNGSAGTPVMFNENGDAPGRYDIFQYQATNGSASSGGYQAVGQWAETLRLDVEALQWSGDPHEVPSSLCSLPCGPGERKKMVKGVPCCWHCEACDGYRFQVDEFTCEACPGDMRPTPNHTGCRPTPVVRLSWSSPWAAPPLLLAVLGIVATTTVVATFVRYNNTPIVRASGRELSYVLLTGIFLIYAITFLMVAEPGAAVCAARRLFLGLGTTLSYSALLTKTNRIYRIFEQGKRSVTPPPFISPTSQLVITFSLTSLQVVGMIAWLGARPPHSVIDYEEQRTVDPEQARGVLKCDMSDLSLIGCLGYSLLLMVTCTVYAIKARGVPETFNEAKPIGFTMYTTCIIWLAFVPIFFGTAQSAEKIYIQTTTLTVSLSLSASVSLGMLYVPKTYVILFHPEQNVQKRKRSLKATSTVAAPPKGEDAEAHK,877,"95,468",Binding site (4); Chain (1); Disulfide bond (8); Glycosylation (4); Natural variant (13); Region (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 57..99;  /evidence=""ECO:0000250""; DISULFID 244..536;  /evidence=""ECO:0000250""; DISULFID 367..383;  /evidence=""ECO:0000250""; DISULFID 423..430;  /evidence=""ECO:0000250""; DISULFID 518..537;  /evidence=""ECO:0000250""; DISULFID 522..540;  /evidence=""ECO:0000250""; DISULFID 543..555;  /evidence=""ECO:0000250""; DISULFID 558..571;  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q96F46,Interleukin-17 receptor A (IL-17 receptor A) (IL-17RA) (CDw217) (CD antigen CD217),MGAARSPPSAVPGPLLGLLLLLLGVLAPGGASLRLLDHRALVCSQPGLNCTVKNSTCLDDSWIHPRNLTPSSPKDLQIQLHFAHTQQGDLFPVAHIEWTLQTDASILYLEGAELSVLQLNTNERLCVRFEFLSKLRHHHRRWRFTFSHFVVDPDQEYEVTVHHLPKPIPDGDPNHQSKNFLVPDCEHARMKVTTPCMSSGSLWDPNITVETLEAHQLRVSFTLWNESTHYQILLTSFPHMENHSCFEHMHHIPAPRPEEFHQRSNVTLTLRNLKGCCRHQVQIQPFFSSCLNDCLRHSATVSCPEMPDTPEPIPDYMPLWVYWFITGISILLVGSVILLIVCMTWRLAGPGSEKYSDDTKYTDGLPAADLIPPPLKPRKVWIIYSADHPLYVDVVLKFAQFLLTACGTEVALDLLEEQAISEAGVMTWVGRQKQEMVESNSKIIVLCSRGTRAKWQALLGRGAPVRLRCDHGKPVGDLFTAAMNMILPDFKRPACFGTYVVCYFSEVSCDGDVPDLFGAAPRYPLMDRFEEVYFRIQDLEMFQPGRMHRVGELSGDNYLRSPGGRQLRAALDRFRDWQVRCPDWFECENLYSADDQDAPSLDEEVFEEPLLPPGTGIVKRAPLVREPGSQACLAIDPLVGEEGGAAVAKLEPHLQPRGQPAPQPLHTLVLAAEEGALVAAVEPGPLADGAAVRLALAGEGEACPLLGSPGAGRNSVLFLPVDPEDSPLGSSTPMASPDLLPEDVREHLEGLMLSLFEQSLSCQAQGGCSRPAMVLTDPHTPYEEEQRQSVQSDQGYISRSSPQPPEGLTEMEEEEEEEQDPGKPALPLSPEDLESLRSLQRQLLFRQLQKNSGWDTMGSESEGPSA,866,"96,122",Alternative sequence (1); Beta strand (23); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (1); Glycosylation (7); Helix (18); Modified residue (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 43..50;  /evidence=""ECO:0000269|PubMed:19838198, ECO:0000269|PubMed:23695682""; DISULFID 57..126;  /evidence=""ECO:0000269|PubMed:19838198, ECO:0000269|PubMed:23695682""; DISULFID 185..196;  /evidence=""ECO:0000269|PubMed:19838198, ECO:0000269|PubMed:23695682""; DISULFID 245..276;  /evidence=""ECO:0000269|PubMed:19838198, ECO:0000269|PubMed:23695682""; DISULFID 277..303;  /evidence=""ECO:0000269|PubMed:23695682""; DISULFID 290..294;  /evidence=""ECO:0000269|PubMed:19838198, ECO:0000269|PubMed:23695682""","SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:15340161"""
P10721,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117),MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTDPGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLVDRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYHRLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSSSVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSANVTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWEDYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDRLVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDSSAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIVMILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNEYMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSVGSTASSSQPLLVHDDV,976,"109,865",Active site (1); Alternative sequence (3); Beta strand (61); Binding site (2); Chain (1); Disulfide bond (5); Domain (6); Glycosylation (10); Helix (23); Metal binding (3); Modified residue (15); Mutagenesis (8); Natural variant (37); Nucleotide binding (2); Region (1); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 58..97;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17662946""; DISULFID 136..186;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17662946""; DISULFID 151..183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17662946""; DISULFID 233..290;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17662946""; DISULFID 428..491;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:17662946""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q2I0M4,Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer),MRGPSWSRPRPLLLLLLLLSPWPVWAQVSATASPSGSLGAPDCPEVCTCVPGGLASCSALSLPAVPPGLSLRLRALLLDHNRVRALPPGAFAGAGALQRLDLRENGLHSVHVRAFWGLGALQLLDLSANQLEALAPGTFAPLRALRNLSLAGNRLARLEPAALGALPLLRSLSLQDNELAALAPGLLGRLPALDALHLRGNPWGCGCALRPLCAWLRRHPLPASEAETVLCVWPGRLTLSPLTAFSDAAFSHCAQPLALRDLAVVYTLGPASFLVSLASCLALGSGLTACRARRRRLRTAALRPPRPPDPNPDPDPHGCASPADPGSPAAAAQA,334,"34,857",Alternative sequence (2); Chain (1); Disulfide bond (4); Domain (2); Glycosylation (1); Repeat (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..49;  /evidence=""ECO:0000255""; DISULFID 47..57;  /evidence=""ECO:0000255""; DISULFID 205..231;  /evidence=""ECO:0000255""; DISULFID 207..253;  /evidence=""ECO:0000255""",SIGNAL 1..26
O75096,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),MRRQWGALLLGALLCAHGLASSPECACGRSHFTCAVSALGECTCIPAQWQCDGDNDCGDHSDEDGCILPTCSPLDFHCDNGKCIRRSWVCDGDNDCEDDSDEQDCPPRECEEDEFPCQNGYCIRSLWHCDGDNDCGDNSDEQCDMRKCSDKEFRCSDGSCIAEHWYCDGDTDCKDGSDEENCPSAVPAPPCNLEEFQCAYGRCILDIYHCDGDDDCGDWSDESDCSSHQPCRSGEFMCDSGLCINAGWRCDGDADCDDQSDERNCTTSMCTAEQFRCHSGRCVRLSWRCDGEDDCADNSDEENCENTGSPQCALDQFLCWNGRCIGQRKLCNGVNDCGDNSDESPQQNCRPRTGEENCNVNNGGCAQKCQMVRGAVQCTCHTGYRLTEDGHTCQDVNECAEEGYCSQGCTNSEGAFQCWCETGYELRPDRRSCKALGPEPVLLFANRIDIRQVLPHRSEYTLLLNNLENAIALDFHHRRELVFWSDVTLDRILRANLNGSNVEEVVSTGLESPGGLAVDWVHDKLYWTDSGTSRIEVANLDGAHRKVLLWQNLEKPRAIALHPMEGTIYWTDWGNTPRIEASSMDGSGRRIIADTHLFWPNGLTIDYAGRRMYWVDAKHHVIERANLDGSHRKAVISQGLPHPFAITVFEDSLYWTDWHTKSINSANKFTGKNQEIIRNKLHFPMDIHTLHPQRQPAGKNRCGDNNGGCTHLCLPSGQNYTCACPTGFRKISSHACAQSLDKFLLFARRMDIRRISFDTEDLSDDVIPLADVRSAVALDWDSRDDHVYWTDVSTDTISRAKWDGTGQEVVVDTSLESPAGLAIDWVTNKLYWTDAGTDRIEVANTDGSMRTVLIWENLDRPRDIVVEPMGGYMYWTDWGASPKIERAGMDASGRQVIISSNLTWPNGLAIDYGSQRLYWADAGMKTIEFAGLDGSKRKVLIGSQLPHPFGLTLYGERIYWTDWQTKSIQSADRLTGLDRETLQENLENLMDIHVFHRRRPPVSTPCAMENGGCSHLCLRSPNPSGFSCTCPTGINLLSDGKTCSPGMNSFLIFARRIDIRMVSLDIPYFADVVVPINITMKNTIAIGVDPQEGKVYWSDSTLHRISRANLDGSQHEDIITTGLQTTDGLAVDAIGRKVYWTDTGTNRIEVGNLDGSMRKVLVWQNLDSPRAIVLYHEMGFMYWTDWGENAKLERSGMDGSDRAVLINNNLGWPNGLTVDKASSQLLWADAHTERIEAADLNGANRHTLVSPVQHPYGLTLLDSYIYWTDWQTRSIHRADKGTGSNVILVRSNLPGLMDMQAVDRAQPLGFNKCGSRNGGCSHLCLPRPSGFSCACPTGIQLKGDGKTCDPSPETYLLFSSRGSIRRISLDTSDHTDVHVPVPELNNVISLDYDSVDGKVYYTDVFLDVIRRADLNGSNMETVIGRGLKTTDGLAVDWVARNLYWTDTGRNTIEASRLDGSCRKVLINNSLDEPRAIAVFPRKGYLFWTDWGHIAKIERANLDGSERKVLINTDLGWPNGLTLDYDTRRIYWVDAHLDRIESADLNGKLRQVLVSHVSHPFALTQQDRWIYWTDWQTKSIQRVDKYSGRNKETVLANVEGLMDIIVVSPQRQTGTNACGVNNGGCTHLCFARASDFVCACPDEPDSRPCSLVPGLVPPAPRATGMSEKSPVLPNTPPTTLYSSTTRTRTSLEEVEGRCSERDARLGLCARSNDAVPAAPGEGLHISYAIGGLLSILLILVVIAALMLYRHKKSKFTDPGMGNLTYSNPSYRTSTQEVKIEAIPKPAMYNQLCYKKEGGPDHNYTKEKIKIVEGICLLSGDDAEWDDLKQLRSSRGGLLRDHVCMKTDTVSIQASSGSLDDTETEQLLQEEQSECSSVHTAATPERRGSLPDTGWKHERKLSSESQV,1905,"212,045",Chain (1); Disulfide bond (33); Domain (11); Erroneous initiation (1); Glycosylation (7); Motif (1); Mutagenesis (4); Natural variant (17); Repeat (20); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 27..44;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 34..57;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 51..66;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 71..83;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 78..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 90..105;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 110..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 117..135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 129..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 148..160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 155..173;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 167..182;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 191..203;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 198..216;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 210..225;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 231..243;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 238..256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 250..265;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 270..282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 277..295;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 289..304;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 312..324;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 319..337;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 331..349;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 358..369;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 365..378;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 380..393;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 399..409;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 405..418;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 420..433;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 702..713;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 709..722;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 724..736;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q14114,Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2),MGLPEPGPLRLLALLLLLLLLLLLQLQHLAAAAADPLLGGQGPAKDCEKDQFQCRNERCIPSVWRCDEDDDCLDHSDEDDCPKKTCADSDFTCDNGHCIHERWKCDGEEECPDGSDESEATCTKQVCPAEKLSCGPTSHKCVPASWRCDGEKDCEGGADEAGCATLCAPHEFQCGNRSCLAAVFVCDGDDDCGDGSDERGCADPACGPREFRCGGDGGGACIPERWVCDRQFDCEDRSDEAAELCGRPGPGATSAPAACATASQFACRSGECVHLGWRCDGDRDCKDKSDEADCPLGTCRGDEFQCGDGTCVLAIKHCNQEQDCPDGSDEAGCLQGLNECLHNNGGCSHICTDLKIGFECTCPAGFQLLDQKTCGDIDECKDPDACSQICVNYKGYFKCECYPGYEMDLLTKNCKAAAGKSPSLIFTNRHEVRRIDLVKRNYSRLIPMLKNVVALDVEVATNRIYWCDLSYRKIYSAYMDKASDPKEQEVLIDEQLHSPEGLAVDWVHKHIYWTDSGNKTISVATVDGGRRRTLFSRNLSEPRAIAVDPLRGFMYWSDWGDQAKIEKSGLNGVDRQTLVSDNIEWPNGITLDLLSQRLYWVDSKLHQLSSIDFSGGNRKTLISSTDFLSHPFGIAVFEDKVFWTDLENEAIFSANRLNGLEISILAENLNNPHDIVIFHELKQPRAPDACELSVQPNGGCEYLCLPAPQISSHSPKYTCACPDTMWLGPDMKRCYRAPQSTSTTTLASTMTRTVPATTRAPGTTVHRSTYQNHSTETPSLTAAVPSSVSVPRAPSISPSTLSPATSNHSQHYANEDSKMGSTVTAAVIGIIVPIVVIALLCMSGYLIWRNWKRKNTKSMNFDNPVYRKTTEEEDEDELHIGRTAQIGHVYPAAISSFDRPLWAEPCLGETREPEDPAPALKELFVLPGEPRSQLHQLPKNPLSELPVVKSKRVALSLEDDGLP,963,"105,634",Alternative sequence (5); Beta strand (46); Chain (1); Disulfide bond (27); Domain (9); Frameshift (1); Glycosylation (6); Helix (10); Natural variant (9); Region (1); Repeat (5); Sequence conflict (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (13),"DISULFID 47..59;  /evidence=""ECO:0000250""; DISULFID 54..72;  /evidence=""ECO:0000250""; DISULFID 66..81;  /evidence=""ECO:0000250""; DISULFID 86..98;  /evidence=""ECO:0000250""; DISULFID 93..111;  /evidence=""ECO:0000250""; DISULFID 105..122;  /evidence=""ECO:0000250""; DISULFID 127..141;  /evidence=""ECO:0000250""; DISULFID 134..154;  /evidence=""ECO:0000250""; DISULFID 148..163;  /evidence=""ECO:0000250""; DISULFID 167..179;  /evidence=""ECO:0000250""; DISULFID 174..192;  /evidence=""ECO:0000250""; DISULFID 186..201;  /evidence=""ECO:0000250""; DISULFID 206..221;  /evidence=""ECO:0000250""; DISULFID 213..234;  /evidence=""ECO:0000250""; DISULFID 228..245;  /evidence=""ECO:0000250""; DISULFID 259..272;  /evidence=""ECO:0000250""; DISULFID 267..285;  /evidence=""ECO:0000250""; DISULFID 279..294;  /evidence=""ECO:0000250""; DISULFID 299..311;  /evidence=""ECO:0000250""; DISULFID 306..324;  /evidence=""ECO:0000250""; DISULFID 318..333;  /evidence=""ECO:0000250""; DISULFID 340..351;  /evidence=""ECO:0000250""; DISULFID 347..360;  /evidence=""ECO:0000250""; DISULFID 362..374;  /evidence=""ECO:0000250""; DISULFID 380..390;  /evidence=""ECO:0000250""; DISULFID 386..399;  /evidence=""ECO:0000250""; DISULFID 401..414;  /evidence=""ECO:0000250""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q9ULH4,Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1),METLLGGLLAFGMAFAVVDACPKYCVCQNLSESLGTLCPSKGLLFVPPDIDRRTVELRLGGNFIIHISRQDFANMTGLVDLTLSRNTISHIQPFSFLDLESLRSLHLDSNRLPSLGEDTLRGLVNLQHLIVNNNQLGGIADEAFEDFLLTLEDLDLSYNNLHGLPWDSVRRMVNLHQLSLDHNLLDHIAEGTFADLQKLARLDLTSNRLQKLPPDPIFARSQASALTATPFAPPLSFSFGGNPLHCNCELLWLRRLERDDDLETCGSPGGLKGRYFWHVREEEFVCEPPLITQHTHKLLVLEGQAATLKCKAIGDPSPLIHWVAPDDRLVGNSSRTAVYDNGTLDIFITTSQDSGAFTCIAANAAGEATAMVEVSIVQLPHLSNSTSRTAPPKSRLSDITGSSKTSRGGGGSGGGEPPKSPPERAVLVSEVTTTSALVKWSVSKSAPRVKMYQLQYNCSDDEVLIYRMIPASNKAFVVNNLVSGTGYDLCVLAMWDDTATTLTATNIVGCAQFFTKADYPQCQSMHSQILGGTMILVIGGIIVATLLVFIVILMVRYKVCNHEAPSKMAAAVSNVYSQTNGAQPPPPSSAPAGAPPQGPPKVVVRNELLDFTASLARASDSSSSSSLGSGEAAGLGRAPWRIPPSAPRPKPSLDRLMGAFASLDLKSQRKEELLDSRTPAGRGAGTSARGHHSDREPLLGPPAARARSLLPLPLEGKAKRSHSFDMGDFAAAAAGGVVPGGYSPPRKVSNIWTKRSLSVNGMLLPFEESDLVGARGTFGSSEWVMESTV,789,"84,731",Chain (1); Disulfide bond (1); Domain (4); Erroneous initiation (1); Glycosylation (4); Motif (1); Mutagenesis (1); Natural variant (1); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 310..359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q96Q04,Serine/threonine-protein kinase LMTK3 (EC 2.7.11.1) (Lemur tyrosine kinase 3),MPAPGALILLAAVSASGCLASPAHPDGFALGRAPLAPPYAVVLISCSGLLAFIFLLLTCLCCKRGDVGFKEFENPEGEDCSGEYTPPAEETSSSQSLPDVYILPLAEVSLPMPAPQPSHSDMTTPLGLSRQHLSYLQEIGSGWFGKVILGEIFSDYTPAQVVVKELRASAGPLEQRKFISEAQPYRSLQHPNVLQCLGLCVETLPFLLIMEFCQLGDLKRYLRAQRPPEGLSPELPPRDLRTLQRMGLEIARGLAHLHSHNYVHSDLALRNCLLTSDLTVRIGDYGLAHSNYKEDYYLTPERLWIPLRWAAPELLGELHGTFMVVDQSRESNIWSLGVTLWELFEFGAQPYRHLSDEEVLAFVVRQQHVKLARPRLKLPYADYWYDILQSCWRPPAQRPSASDLQLQLTYLLSERPPRPPPPPPPPRDGPFPWPWPPAHSAPRPGTLSSPFPLLDGFPGADPDDVLTVTESSRGLNLECLWEKARRGAGRGGGAPAWQPASAPPAPHANPSNPFYEALSTPSVLPVISARSPSVSSEYYIRLEEHGSPPEPLFPNDWDPLDPGVPAPQAPQAPSEVPQLVSETWASPLFPAPRPFPAQSSASGSFLLSGWDPEGRGAGETLAGDPAEVLGERGTAPWVEEEEEEEEGSSPGEDSSSLGGGPSRRGPLPCPLCSREGACSCLPLERGDAVAGWGGHPALGCPHPPEDDSSLRAERGSLADLPMAPPASAPPEFLDPLMGAAAPQYPGRGPPPAPPPPPPPPRAPADPAASPDPPSAVASPGSGLSSPGPKPGDSGYETETPFSPEGAFPGGGAAEEEGVPRPRAPPEPPDPGAPRPPPDPGPLPLPGPREKPTFVVQVSTEQLLMSLREDVTRNLLGEKGATARETGPRKAGRGPGNREKVPGLNRDPTVLGNGKQAPSLSLPVNGVTVLENGDQRAPGIEEKAAENGALGSPEREEKVLENGELTPPRREEKALENGELRSPEAGEKVLVNGGLTPPKSEDKVSENGGLRFPRNTERPPETGPWRAPGPWEKTPESWGPAPTIGEPAPETSLERAPAPSAVVSSRNGGETAPGPLGPAPKNGTLEPGTERRAPETGGAPRAPGAGRLDLGSGGRAPVGTGTAPGGGPGSGVDAKAGWVDNTRPQPPPPPLPPPPEAQPRRLEPAPPRARPEVAPEGEPGAPDSRAGGDTALSGDGDPPKPERKGPEMPRLFLDLGPPQGNSEQIKARLSRLSLALPPLTLTPFPGPGPRRPPWEGADAGAAGGEAGGAGAPGPAEEDGEDEDEDEEEDEEAAAPGAAAGPRGPGRARAAPVPVVVSSADADAARPLRGLLKSPRGADEPEDSELERKRKMVSFHGDVTVYLFDQETPTNELSVQAPPEGDTDPSTPPAPPTPPHPATPGDGFPSNDSGFGGSFEWAEDFPLLPPPGPPLCFSRFSVSPALETPGPPARAPDARPAGPVEN,1460,"153,661",Active site (1); Binding site (1); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (1); Frameshift (1); Glycosylation (2); Modified residue (5); Natural variant (2); Nucleotide binding (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
O14944,Proepiregulin [Cleaved into: Epiregulin (EPR)],MTAGRRMEMLCAGRVPALLLCLGFHLLQAVLSTTVIPSCIPGESSDNCTALVQTEDNPRVAQVSITKCSSDMNGYCLHGQCIYLVDMSQNYCRCEVGYTGVRCEHFFLTVHQPLSKEYVALTVILIILFLITVVGSTYYFCRWYRNRKSKEPKKEYERVTSGDPELPQV,169,"19,044",Beta strand (4); Chain (2); Compositional bias (1); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (1); Natural variant (2); Propeptide (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 68..81;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:14572630""; DISULFID 76..92;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:14572630""; DISULFID 94..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:14572630""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
P09958,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE),MELRPWLLWVVAATGTLVLLAADAQGQKVFTNTWAVRIPGGPAVANSVARKHGFLNLGQIFGDYYHFWHRGVTKRSLSPHRPRHSRLQREPQVQWLEQQVAKRRTKRDVYQEPTDPKFPQQWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDPDPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSLGLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREHDSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKCTESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKVSHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNHITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWDEDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAPEGLPVPPESSGCKTLTSSQACVVCEEGFSLHQKSCVQHCPPGFAPQVLDTHYSTENDVETIRASVCAPCHASCATCQGPALTDCLSCPSHASLDPVEQTCSRQSQSSRESPPQQQPPRLPPEVEAGQRLRAGLLPSHLPEVVAGLSCAFIVLVFVTVFLVLQLRSGFSFRGVKVYTMDRGLISYKGLPPEAWQEECPSDSEEDEGRGERTAFIKDQSAL,794,"86,678",Active site (3); Beta strand (23); Binding site (6); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (3); Helix (17); Metal binding (12); Modified residue (2); Motif (2); Mutagenesis (6); Natural variant (2); Propeptide (1); Region (4); Repeat (2); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (10),"DISULFID 211..360;  /evidence=""ECO:0000269|PubMed:24666235, ECO:0000269|PubMed:25974265""; DISULFID 303..333;  /evidence=""ECO:0000269|PubMed:24666235, ECO:0000269|PubMed:25974265""; DISULFID 450..474;  /evidence=""ECO:0000269|PubMed:24666235, ECO:0000269|PubMed:25974265""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9NPG1,Frizzled-3 (Fz-3) (hFz3),MAMTWIVFSLWPLTVFMGHIGGHSLFSCEPITLRMCQDLPYNTTFMPNLLNHYDQQTAALAMEPFHPMVNLDCSRDFRPFLCALYAPICMEYGRVTLPCRRLCQRAYSECSKLMEMFGVPWPEDMECSRFPDCDEPYPRLVDLNLAGEPTEGAPVAVQRDYGFWCPRELKIDPDLGYSFLHVRDCSPPCPNMYFRREELSFARYFIGLISIICLSATLFTFLTFLIDVTRFRYPERPIIFYAVCYMMVSLIFFIGFLLEDRVACNASIPAQYKASTVTQGSHNKACTMLFMILYFFTMAGSVWWVILTITWFLAAVPKWGSEAIEKKALLFHASAWGIPGTLTIILLAMNKIEGDNISGVCFVGLYDVDALRYFVLAPLCLYVVVGVSLLLAGIISLNRVRIEIPLEKENQDKLVKFMIRIGVFSILYLVPLLVVIGCYFYEQAYRGIWETTWIQERCREYHIPCPYQVTQMSRPDLILFLMKYLMALIVGIPSVFWVGSKKTCFEWASFFHGRRKKEIVNESRQVLQEPDFAQSLLRDPNTPIIRKSRGTSTQGTSTHASSTQLAMVDDQRSKAGSIHSKVSSYHGSLHRSRDGRYTPCSYRGMEERLPHGSMSRLTDHSRHSSSHRLNEQSRHSSIRDLSNNPMTHITHGTSMNRVIEEDGTSA,666,"76,263",Chain (1); Disulfide bond (5); Domain (1); Glycosylation (3); Motif (1); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 28..89;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 36..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 73..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 99..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""; DISULFID 103..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00090""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8WWB7,Glycosylated lysosomal membrane protein (Lysosomal protein NCU-G1),MRGSVECTWGWGHCAPSPLLLWTLLLFAAPFGLLGEKTRQVSLEVIPNWLGPLQNLLHIRAVGTNSTLHYVWSSLGPLAVVMVATNTPHSTLSVNWSLLLSPEPDGGLMVLPKDSIQFSSALVFTRLLEFDSTNVSDTAAKPLGRPYPPYSLADFSWNNITDSLDPATLSATFQGHPMNDPTRTFANGSLAFRVQAFSRSSRPAQPPRLLHTADTCQLEVALIGASPRGNRSLFGLEVATLGQGPDCPSMQEQHSIDDEYAPAVFQLDQLLWGSLPSGFAQWRPVAYSQKPGGRESALPCQASPLHPALAYSLPQSPIVRAFFGSQNNFCAFNLTFGASTGPGYWDQHYLSWSMLLGVGFPPVDGLSPLVLGIMAVALGAPGLMLLGGGLVLLLHHKKYSEYQSIN,406,"43,864",Alternative sequence (1); Chain (1); Erroneous initiation (1); Glycosylation (5); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q9Y6W8,Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278),MKSGLWYFFLFCLRIKVLTGEINGSANYEMFIFHNGGVQILCKYPDIVQQFKMQLLKGGQILCDLTKTKGSGNTVSIKSLKFCHSQLSNNSVSFFLYNLDHSHANYYFCNLSIFDPPPFKVTLTGGYLHIYESQLCCQLKFWLPIGCAAFVVVCILGCILICWLTKKKYSSSVHDPNGEYMFMRAVNTAKKSRLTDVTL,199,"22,625",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..109;  /evidence=""ECO:0000250""; DISULFID 63..83;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
P43628,Killer cell immunoglobulin-like receptor 2DL3 (CD158 antigen-like family member B2) (KIR-023GB) (Killer inhibitory receptor cl 2-3) (MHC class I NK cell receptor) (NKAT2a) (NKAT2b) (Natural killer-associated transcript 2) (NKAT-2) (p58 natural killer cell receptor clone CL-6) (p58 NK receptor CL-6) (p58.2 MHC class-I-specific NK receptor) (CD antigen CD158b2),MSLMVVSMVCVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHVLIGTSVVIILFILLLFFLLHRWCCNKKNAVVMDQEPAGNRTVNREDSDEQDPQEVTYAQLNHCVFTQRKITRPSQRPKTPPTDIIVYTELPNAEP,341,"37,886",Alternative sequence (1); Beta strand (14); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Natural variant (11); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 49..100;  /evidence=""ECO:0000250|UniProtKB:P43626""; DISULFID 149..198;  /evidence=""ECO:0000250|UniProtKB:P43626""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q14954,Killer cell immunoglobulin-like receptor 2DS1 (CD158 antigen-like family member H) (MHC class I NK cell receptor Eb6 ActI) (CD antigen CD158h),MSLTVVSMACVGFFLLQGAWPHEGVHRKPSLLAHPGRLVKSEETVILQCWSDVMFEHFLLHREGMFNDTLRLIGEHHDGVSKANFSISRMKQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVIIGLYEKPSLSAQPGPTVLAGENVTLSCSSRSSYDMYHLSREGEAHERRLPAGTKVNGTFQANFPLGPATHGGTYRCFGSFRDSPYEWSKSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHVLIGTSVVKIPFTILLFFLLHRWCSDKKNAAVMDQEPAGNRTVNSEDSDEQDHQEVSYA,304,"33,618",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (4); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000250|UniProtKB:P43626""; DISULFID 149..198;  /evidence=""ECO:0000250|UniProtKB:P43626""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q96PB8,Leucine-rich repeat-containing protein 3B (Leucine-rich repeat protein 15),MNLVDLWLTRSLSMCLLLQSFVLMILCFHSASMCPKGCLCSSSGGLNVTCSNANLKEIPRDLPPETVLLYLDSNQITSIPNEIFKDLHQLRVLNLSKNGIEFIDEHAFKGVAETLQTLDLSDNRIQSVHKNAFNNLKARARIANNPWHCDCTLQQVLRSMASNHETAHNVICKTSVLDEHAGRPFLNAANDADLCNLPKKTTDYAMLVTMFGWFTMVISYVVYYVRQNQEDARRHLEYLKSLPSRQKKADEPDDISTVV,259,"29,275",Beta strand (1); Chain (1); Domain (2); Glycosylation (2); Repeat (3); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q3SXY7,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3",MHLFACLCIVLSFLEGVGCLCPSQCTCDYHGRNDGSGSRLVLCNDMDMNELPTNLPVDTVKLRIEKTVIRRISAEAFYYLVELQYLWVTYNSVASIDPSSFYNLKQLHELRLDGNSLAAFPWASLLDMPLLRTLDLHNNKITSVPNEALRYLKNLAYLDLSSNRLTTLPPDFLESWTHLVSTPSGVLDLSPSRIILGLQDNPWFCDCHISKMIELSKVVDPAIVLLDPLMTCSEPERLTGILFQRAELEHCLKPSVMTSATKIMSALGSNVLLRCDATGFPTPQITWTRSDSSPVNYTVIQESPEEGVRWSIMSLTGISSKDAGDYKCKAKNLAGMSEAVVTVTVLGITTTPIPPDTSERTGDHPEWDVQPGSGRSTSVSSASSYLWSSSFSPTSSFSASTLSPPSTASFSLSPFSSSTVSSTTTLSTSISASTTMANKRSFQLHQGGKRNLKVAKNGSKLPPASTSKKEELALLDQTMLTETNAAIENLRVVSETKESVTLTWNMINTTHNSAVTVLYSKYGGKDLLLLNADSSKNQVTIDGLEPGGQYMACVCPKGVPPQKDQCITFSTERVEGDDSQWSLLLVVTSTACVVILPLICFLLYKVCKLQCKSEPFWEDDLAKETYIQFETLFPRSQSVGELWTRSHRDDSEKLLLCSRSSVESQVTFKSEGSRPEYYC,679,"74,754",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (3); Erroneous initiation (1); Glycosylation (1); Mutagenesis (1); Natural variant (8); Repeat (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 275..328;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P09848,Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)],MELSWHVVFIALLSFSCWGSDWESDRNFISTAGPLTNDLLHNLSGLLGDQSSNFVAGDKDMYVCHQPLPTFLPEYFSSLHASQITHYKVFLSWAQLLPAGSTQNPDEKTVQCYRRLLKALKTARLQPMVILHHQTLPASTLRRTEAFADLFADYATFAFHSFGDLVGIWFTFSDLEEVIKELPHQESRASQLQTLSDAHRKAYEIYHESYAFQGGKLSVVLRAEDIPELLLEPPISALAQDTVDFLSLDLSYECQNEASLRQKLSKLQTIEPKVKVFIFNLKLPDCPSTMKNPASLLFSLFEAINKDQVLTIGFDINEFLSCSSSSKKSMSCSLTGSLALQPDQQQDHETTDSSPASAYQRIWEAFANQSRAERDAFLQDTFPEGFLWGASTGAFNVEGGWAEGGRGVSIWDPRRPLNTTEGQATLEVASDSYHKVASDVALLCGLRAQVYKFSISWSRIFPMGHGSSPSLPGVAYYNKLIDRLQDAGIEPMATLFHWDLPQALQDHGGWQNESVVDAFLDYAAFCFSTFGDRVKLWVTFHEPWVMSYAGYGTGQHPPGISDPGVASFKVAHLVLKAHARTWHHYNSHHRPQQQGHVGIVLNSDWAEPLSPERPEDLRASERFLHFMLGWFAHPVFVDGDYPATLRTQIQQMNRQCSHPVAQLPEFTEAEKQLLKGSADFLGLSHYTSRLISNAPQNTCIPSYDTIGGFSQHVNHVWPQTSSSWIRVVPWGIRRLLQFVSLEYTRGKVPIYLAGNGMPIGESENLFDDSLRVDYFNQYINEVLKAIKEDSVDVRSYIARSLIDGFEGPSGYSQRFGLHHVNFSDSSKSRTPRKSAYFFTSIIEKNGFLTKGAKRLLPPNTVNLPSKVRAFTFPSEVPSKAKVVWEKFSSQPKFERDLFYHGTFRDDFLWGVSSSAYQIEGAWDADGKGPSIWDNFTHTPGSNVKDNATGDIACDSYHQLDADLNMLRALKVKAYRFSISWSRIFPTGRNSSINSHGVDYYNRLINGLVASNIFPMVTLFHWDLPQALQDIGGWENPALIDLFDSYADFCFQTFGDRVKFWMTFNEPMYLAWLGYGSGEFPPGVKDPGWAPYRIAHAVIKAHARVYHTYDEKYRQEQKGVISLSLSTHWAEPKSPGVPRDVEAADRMLQFSLGWFAHPIFRNGDYPDTMKWKVGNRSELQHLATSRLPSFTEEEKRFIRATADVFCLNTYYSRIVQHKTPRLNPPSYEDDQEMAEEEDPSWPSTAMNRAAPWGTRRLLNWIKEEYGDIPIYITENGVGLTNPNTEDTDRIFYHKTYINEALKAYRLDGIDLRGYVAWSLMDNFEWLNGYTVKFGLYHVDFNNTNRPRTARASARYYTEVITNNGMPLAREDEFLYGRFPEGFIWSAASAAYQIEGAWRADGKGLSIWDTFSHTPLRVENDAIGDVACDSYHKIAEDLVTLQNLGVSHYRFSISWSRILPDGTTRYINEAGLNYYVRLIDTLLAASIQPQVTIYHWDLPQTLQDVGGWENETIVQRFKEYADVLFQRLGDKVKFWITLNEPFVIAYQGYGYGTAAPGVSNRPGTAPYIVGHNLIKAHAEAWHLYNDVYRASQGGVISITISSDWAEPRDPSNQEDVEAARRYVQFMGGWFAHPIFKNGDYNEVMKTRIRDRSLAAGLNKSRLPEFTESEKRRINGTYDFFGFNHYTTVLAYNLNYATAISSFDADRGVASIADRSWPDSGSFWLKMTPFGFRRILNWLKEEYNDPPIYVTENGVSQREETDLNDTARIYYLRTYINEALKAVQDKVDLRGYTVWSAMDNFEWATGFSERFGLHFVNYSDPSLPRIPKASAKFYASVVRCNGFPDPATGPHACLHQPDAGPTISPVRQEEVQFLGLMLGTTEAQTALYVLFSLVLLGVCGLAFLSYKYCKRSKQGKTQRSQQELSPVSSF,1927,"218,587",Active site (4); Chain (1); Natural variant (7); Propeptide (1); Region (1); Repeat (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,SIGNAL 1..19
O60500,Nephrin (Renal glomerulus-specific cell adhesion receptor),MALGTTLRASLLLLGLLTEGLAQLAIPASVPRGFWALPENLTVVEGASVELRCGVSTPGSAVQWAKDGLLLGPDPRIPGFPRYRLEGDPARGEFHLHIEACDLSDDAEYECQVGRSEMGPELVSPRVILSILVPPKLLLLTPEAGTMVTWVAGQEYVVNCVSGDAKPAPDITILLSGQTISDISANVNEGSQQKLFTVEATARVTPRSSDNRQLLVCEASSPALEAPIKASFTVNVLFPPGPPVIEWPGLDEGHVRAGQSLELPCVARGGNPLATLQWLKNGQPVSTAWGTEHTQAVARSVLVMTVRPEDHGAQLSCEAHNSVSAGTQEHGITLQVTFPPSAIIILGSASQTENKNVTLSCVSKSSRPRVLLRWWLGWRQLLPMEETVMDGLHGGHISMSNLTFLARREDNGLTLTCEAFSEAFTKETFKKSLILNVKYPAQKLWIEGPPEGQKLRAGTRVRLVCLAIGGNPEPSLMWYKDSRTVTESRLPQESRRVHLGSVEKSGSTFSRELVLVTGPSDNQAKFTCKAGQLSASTQLAVQFPPTNVTILANASALRPGDALNLTCVSVSSNPPVNLSWDKEGERLEGVAAPPRRAPFKGSAAARSVLLQVSSRDHGQRVTCRAHSAELRETVSSFYRLNVLYRPEFLGEQVLVVTAVEQGEALLPVSVSANPAPEAFNWTFRGYRLSPAGGPRHRILSSGALHLWNVTRADDGLYQLHCQNSEGTAEARLRLDVHYAPTIRALQDPTEVNVGGSVDIVCTVDANPILPGMFNWERLGEDEEDQSLDDMEKISRGPTGRLRIHHAKLAQAGAYQCIVDNGVAPPARRLLRLVVRFAPQVEHPTPLTKVAAAGDSTSSATLHCRARGVPNIVFTWTKNGVPLDLQDPRYTEHTYHQGGVHSSLLTIANVSAAQDYALFTCTATNALGSDQTNIQLVSISRPDPPSGLKVVSLTPHSVGLEWKPGFDGGLPQRFCIRYEALGTPGFHYVDVVPPQATTFTLTGLQPSTRYRVWLLASNALGDSGLADKGTQLPITTPGLHQPSGEPEDQLPTEPPSGPSGLPLLPVLFALGGLLLLSNASCVGGVLWQRRLRRLAEGISEKTEAGSEEDRVRNEYEESQWTGERDTQSSTVSTTEAEPYYRSLRDFSPQLPPTQEEVSYSRGFTGEDEDMAFPGHLYDEVERTYPPSGAWGPLYDEVQMGPWDLHWPEDTYQDPRGIYDQVAGDLDTLEPDSLPFELRGHLV,1241,"134,742",Alternative sequence (1); Chain (1); Disulfide bond (8); Domain (9); Glycosylation (10); Modified residue (5); Natural variant (80); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 160..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 265..317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 361..417;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 465..528;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 567..623;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 761..816;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 863..920;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9Y5R2,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],MPRSRGGRAAPGPPPPPPPPGQAPRWSRWRVPGRLLLLLLPALCCLPGAARAAAAAAGAGNRAAVAVAVARADEAEAPFAGQNWLKSYGYLLPYDSRASALHSAKALQSAVSTMQQFYGIPVTGVLDQTTIEWMKKPRCGVPDHPHLSRRRRNKRYALTGQKWRQKHITYSIHNYTPKVGELDTRKAIRQAFDVWQKVTPLTFEEVPYHEIKSDRKEADIMIFFASGFHGDSSPFDGEGGFLAHAYFPGPGIGGDTHFDSDEPWTLGNANHDGNDLFLVAVHELGHALGLEHSSDPSAIMAPFYQYMETHNFKLPQDDLQGIQKIYGPPAEPLEPTRPLPTLPVRRIHSPSERKHERQPRPPRPPLGDRPSTPGTKPNICDGNFNTVALFRGEMFVFKDRWFWRLRNNRVQEGYPMQIEQFWKGLPARIDAAYERADGRFVFFKGDKYWVFKEVTVEPGYPHSLGELGSCLPREGIDTALRWEPVGKTYFFKGERYWRYSEERRATDPGYPKPITVWKGIPQAPQGAFISKEGYYTYFYKGRDYWKFDNQKLSVEPGYPRNILRDWMGCNQKEVERRKERRLPQDDVDIMVTINDVPGSVNAVAVVIPCILSLCILVLVYTIFQFKNKTGPQPVTYYKRPVQEWV,645,"73,231",Active site (1); Chain (2); Compositional bias (1); Disulfide bond (1); Metal binding (4); Motif (2); Natural variant (1); Propeptide (1); Repeat (4); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 380..569;  /evidence=""ECO:0000250""","SIGNAL 1..52;  /evidence=""ECO:0000255"""
P08581,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECILTEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVDTRPASFWETS,1390,"155,541",Active site (1); Alternative sequence (3); Beta strand (72); Binding site (1); Chain (1); Disulfide bond (12); Domain (5); Glycosylation (11); Helix (32); Modified residue (13); Mutagenesis (6); Natural variant (36); Nucleotide binding (1); Region (2); Sequence conflict (7); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1); Turn (8),"DISULFID 95..101; DISULFID 98..160; DISULFID 133..141;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 172..175;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 298..363;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 385..397;  /evidence=""ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 520..538;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 526..561;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 529..545;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 541..551;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 610..624;  /evidence=""ECO:0000244|PDB:2UZX, ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""; DISULFID 697..709;  /evidence=""ECO:0000244|PDB:2UZY, ECO:0000269|PubMed:17662939""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P48960,Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta],MGGRVFLAFCVWLTLPGAETQDSRGCARWCPQNSSCVNATACRCNPGFSSFSEIITTPTETCDDINECATPSKVSCGKFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQDVDECQQNPRLCKSYGTCVNTLGSYTCQCLPGFKFIPEDPKVCTDVNECTSGQNPCHSSTHCLNNVGSYQCRCRPGWQPIPGSPNGPNNTVCEDVDECSSGQHQCDSSTVCFNTVGSYSCRCRPGWKPRHGIPNNQKDTVCEDMTFSTWTPPPGVHSQTLSRFFDKVQDLGRDSKTSSAEVTIQNVIKLVDELMEAPGDVEALAPPVRHLIATQLLSNLEDIMRILAKSLPKGPFTYISPSNTELTLMIQERGDKNVTMGQSSARMKLNWAVAAGAEDPGPAVAGILSIQNMTTLLANASLNLHSKKQAELEEIYESSIRGVQLRRLSAVNSIFLSHNNTKELNSPILFAFSHLESSDGEAGRDPPAKDVMPGPRQELLCAFWKSDSDRGGHWATEGCQVLGSKNGSTTCQCSHLSSFAILMAHYDVEDWKLTLITRVGLALSLFCLLLCILTFLLVRPIQGSRTTIHLHLCICLFVGSTIFLAGIENEGGQVGLRCRLVAGLLHYCFLAAFCWMSLEGLELYFLVVRVFQGQGLSTRWLCLIGYGVPLLIVGVSAAIYSKGYGRPRYCWLDFEQGFLWSFLGPVTFIILCNAVIFVTTVWKLTQKFSEINPDMKKLKKARALTITAIAQLFLLGCTWVFGLFIFDDRSLVLTYVFTILNCLQGAFLYLLHCLLNKKVREEYRKWACLVAGGSKYSEFTSTTSGTGHNQTRALRASESGI,835,"91,869",Alternative sequence (2); Chain (3); Disulfide bond (15); Domain (6); Erroneous gene model prediction (2); Glycosylation (9); Modified residue (6); Natural variant (1); Sequence conflict (5); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 26..36;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 30..42;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 44..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 68..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 76..91;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 93..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 120..133;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 127..142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 144..158;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 164..177;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 171..186;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 188..207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 213..226;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 220..235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 237..256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
O43506,Disintegrin and metalloproteinase domain-containing protein 20 (ADAM 20) (EC 3.4.24.-),MAVGEPLVHIRVTLLLLWFGMFLSISGHSQARPSQYFTSPEVVIPLKVISRGRGAKAPGWLSYSLRFGGQRYIVHMRVNKLLFAAHLPVFTYTEQHALLQDQPFIQDDCYYHGYVEGVPESLVALSTCSGGFLGMLQINDLVYEIKPISVSATFEHLVYKIDSDDTQFPPMRCGLTEEKIAHQMELQLSYNFTLKQSSFVGWWTHQRFVELVVVVDNIRYLFSQSNATTVQHEVFNVVNIVDSFYHPLEVDVILTGIDIWTASNPLPTSGDLDNVLEDFSIWKNYNLNNRLQHDVAHLFIKDTQGMKLGVAYVKGICQNPFNTGVDVFEDNRLVVFAITLGHELGHNLGMQHDTQWCVCELQWCIMHAYRKVTTKFSNCSYAQYWDSTISSGLCIQPPPYPGNIFRLKYCGNLVVEEGEECDCGTIRQCAKDPCCLLNCTLHPGAACAFGICCKDCKFLPSGTLCRQQVGECDLPEWCNGTSHQCPDDVYVQDGISCNVNAFCYEKTCNNHDIQCKEIFGQDARSASQSCYQEINTQGNRFGHCGIVGTTYVKCWTPDIMCGRVQCENVGVIPNLIEHSTVQQFHLNDTTCWGTDYHLGMAIPDIGEVKDGTVCGPEKICIRKKCASMVHLSQACQPKTCNMRGICNNKQHCHCNHEWAPPYCKDKGYGGSADSGPPPKNNMEGLNVMGKLRYLSLLCLLPLVAFLLFCLHVLFKKRTKSKEDEEG,726,"81,603",Active site (1); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Erroneous initiation (3); Glycosylation (6); Metal binding (4); Motif (1); Natural variant (1); Propeptide (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 317..394;  /evidence=""ECO:0000250""; DISULFID 357..379;  /evidence=""ECO:0000250""; DISULFID 359..364;  /evidence=""ECO:0000250""; DISULFID 465..485;  /evidence=""ECO:0000250""; DISULFID 635..646;  /evidence=""ECO:0000250""; DISULFID 640..652;  /evidence=""ECO:0000250""; DISULFID 654..663;  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9HBW9,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",MKRLPLLVVFSTLLNCSYTQNCTKTPCLPNAKCEIRNGIEACYCNMGFSGNGVTICEDDNECGNLTQSCGENANCTNTEGSYYCMCVPGFRSSSNQDRFITNDGTVCIENVNANCHLDNVCIAANINKTLTKIRSIKEPVALLQEVYRNSVTDLSPTDIITYIEILAESSSLLGYKNNTISAKDTLSNSTLTEFVKTVNNFVQRDTFVVWDKLSVNHRRTHLTKLMHTVEQATLRISQSFQKTTEFDTNSTDIALKVFFFDSYNMKHIHPHMNMDGDYINIFPKRKAAYDSNGNVAVAFVYYKSIGPLLSSSDNFLLKPQNYDNSEEEERVISSVISVSMSSNPPTLYELEKITFTLSHRKVTDRYRSLCAFWNYSPDTMNGSWSSEGCELTYSNETHTSCRCNHLTHFAILMSSGPSIGIKDYNILTRITQLGIIISLICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAELVFLVGINTNTNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYNKGFLHKNFYIFGYLSPAVVVGFSAALGYRYYGTTKVCWLSTENNFIWSFIGPACLIILVNLLAFGVIIYKVFRHTAGLKPEVSCFENIRSCARGALALLFLLGTTWIFGVLHVVHASVVTAYLFTVSNAFQGMFIFLFLCVLSRKIQEEYYRLFKNVPCCFGCLR,690,"77,811",Chain (1); Compositional bias (1); Disulfide bond (6); Domain (3); Erroneous initiation (2); Glycosylation (9); Natural variant (3); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 22..33;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 27..42;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 44..56;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 62..75;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 69..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 86..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q15392,Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1),MEPAVSLAVCALLFLLWVRLKGLEFVLIHQRWVFVCLFLLPLSLIFDIYYYVRAWVVFKLSSAPRLHEQRVRDIQKQVREWKEQGSKTFMCTGRPGWLTVSLRVGKYKKTHKNIMINLMDILEVDTKKQIVRVEPLVTMGQVTALLTSIGWTLPVLPELDDLTVGGLIMGTGIESSSHKYGLFQHICTAYELVLADGSFVRCTPSENSDLFYAVPWSCGTLGFLVAAEIRIIPAKKYVKLRFEPVRGLEAICAKFTHESQRQENHFVEGLLYSLDEAVIMTGVMTDEAEPSKLNSIGNYYKPWFFKHVENYLKTNREGLEYIPLRHYYHRHTRSIFWELQDIIPFGNNPIFRYLFGWMVPPKISLLKLTQGETLRKLYEQHHVVQDMLVPMKCLQQALHTFQNDIHVYPIWLCPFILPSQPGLVHPKGNEAELYIDIGAYGEPRVKHFEARSCMRQLEKFVRSVHGFQMLYADCYMNREEFWEMFDGSLYHKLREKLGCQDAFPEVYDKICKAARH,516,"60,101",Alternative sequence (1); Chain (1); Domain (1); Erroneous initiation (1); Natural variant (6); Nucleotide binding (1); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q69384,Endogenous retrovirus group K member 6 Env polyprotein (EnvK2 protein) (Envelope polyprotein) (HERV-K(C7) envelope protein) (HERV-K(HML-2.HOM) envelope protein) (HERV-K108 envelope protein) (HERV-K_7p22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTYWAYVPFPPLIRAVTWMDNPTEVYVNDSVWVPGPIDDRCPAKPEEEGMMINISIGYHYPPICLGRAPGCLMPAVQNWLVEVPTVSPICRFTYHMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTIIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTPRPKIVSPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTIDLNSSLTVPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSVHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATAAVAGVALHSSVQSVNFVNDWQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNESEHHWDMVRRHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQLRRDSDHRERAMMTMAVLSKRKGGNVGKSKRDQIVTVSV,699,"79,218",Chain (3); Compositional bias (2); Erroneous initiation (2); Glycosylation (11); Region (1); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
Q14831,Metabotropic glutamate receptor 7 (mGluR7),MVQLRKLLRVLTLMKFPCCVLEVLLCALAAAARGQEMYAPHSIRIEGDVTLGGLFPVHAKGPSGVPCGDIKRENGIHRLEAMLYALDQINSDPNLLPNVTLGARILDTCSRDTYALEQSLTFVQALIQKDTSDVRCTNGEPPVFVKPEKVVGVIGASGSSVSIMVANILRLFQIPQISYASTAPELSDDRRYDFFSRVVPPDSFQAQAMVDIVKALGWNYVSTLASEGSYGEKGVESFTQISKEAGGLCIAQSVRIPQERKDRTIDFDRIIKQLLDTPNSRAVVIFANDEDIKQILAAAKRADQVGHFLWVGSDSWGSKINPLHQHEDIAEGAITIQPKRATVEGFDAYFTSRTLENNRRNVWFAEYWEENFNCKLTISGSKKEDTDRKCTGQERIGKDSNYEQEGKVQFVIDAVYAMAHALHHMNKDLCADYRGVCPEMEQAGGKKLLKYIRNVNFNGSAGTPVMFNKNGDAPGRYDIFQYQTTNTSNPGYRLIGQWTDELQLNIEDMQWGKGVREIPASVCTLPCKPGQRKKTQKGTPCCWTCEPCDGYQYQFDEMTCQHCPYDQRPNENRTGCQDIPIIKLEWHSPWAVIPVFLAMLGIIATIFVMATFIRYNDTPIVRASGRELSYVLLTGIFLCYIITFLMIAKPDVAVCSFRRVFLGLGMCISYAALLTKTNRIYRIFEQGKKSVTAPRLISPTSQLAITSSLISVQLLGVFIWFGVDPPNIIIDYDEHKTMNPEQARGVLKCDITDLQIICSLGYSILLMVTCTVYAIKTRGVPENFNEAKPIGFTMYTTCIVWLAFIPIFFGTAQSAEKLYIQTTTLTISMNLSASVALGMLYMPKVYIIIFHPELNVQKRKRSFKAVVTAATMSSRLSHKPSDRPNGEAKTELCENVDPNSPAAKKKYVSYNNLVI,915,"102,251",Alternative sequence (4); Beta strand (21); Binding site (4); Chain (1); Disulfide bond (8); Frameshift (1); Glycosylation (4); Helix (14); Modified residue (1); Natural variant (3); Region (1); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (5),"DISULFID 67..109;  /evidence=""ECO:0000250""; DISULFID 249..541;  /evidence=""ECO:0000250""; DISULFID 374..390;  /evidence=""ECO:0000250""; DISULFID 430..437;  /evidence=""ECO:0000250""; DISULFID 523..542;  /evidence=""ECO:0000250""; DISULFID 527..545;  /evidence=""ECO:0000250""; DISULFID 548..560;  /evidence=""ECO:0000250""; DISULFID 563..576;  /evidence=""ECO:0000250""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q95460,Major histocompatibility complex class I-related gene protein (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein),MGELMAFLLPLIIVLMVKHSDSRTHSLRYFRLGVSDPIHGVPEFISVGYVDSHPITTYDSVTRQKEPRAPWMAENLAPDHWERYTQLLRGWQQMFKVELKRLQRHYNHSGSHTYQRMIGCELLEDGSTTGFLQYAYDGQDFLIFNKDTLSWLAVDNVAHTIKQAWEANQHELLYQKNWLEEECIAWLKRFLEYGKDTLQRTEPPLVRVNRKETFPGVTALFCKAHGFYPPEIYMTWMKNGEEIVQEIDYGDILPSGDGTYQAWASIELDPQSSNLYSCHVEHCGVHMVLQVPQESETIPLVMKAVSGSIVLVIVLAGVGVLVWRRRPREQNGAIYLPTPDR,341,"39,366",Alternative sequence (5); Beta strand (20); Binding site (6); Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (1); Glycosylation (1); Helix (7); Mutagenesis (4); Natural variant (3); Region (5); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 120..183;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23051753, ECO:0000269|PubMed:24695216, ECO:0000269|PubMed:26795251""; DISULFID 222..278;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23051753, ECO:0000269|PubMed:24695216, ECO:0000269|PubMed:26795251""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:12794138"""
Q01113,Interleukin-9 receptor (IL-9 receptor) (IL-9R) (CD antigen CD129),MGLGRCIWEGWTLESEALRRDMGTWLLACICICTCVCLGVSVTGEGQGPRSRTFTCLTNNILRIDCHWSAPELGQGSSPWLLFTSNQAPGGTHKCILRGSECTVVLPPEAVLVPSDNFTITFHHCMSGREQVSLVDPEYLPRRHVKLDPPSDLQSNISSGHCILTWSISPALEPMTTLLSYELAFKKQEEAWEQAQHRDHIVGVTWLILEAFELDPGFIHEARLRVQMATLEDDVVEEERYTGQWSEWSQPVCFQAPQRQGPLIPPWGWPGNTLVAVSIFLLLTGPTYLLFKLSPRVKRIFYQNVPSPAMFFQPLYSVHNGNFQTWMGAHGAGVLLSQDCAGTPQGALEPCVQEATALLTCGPARPWKSVALEEEQEGPGTRLPGNLSSEDVLPAGCTEWRVQTLAYLPQEDWAPTSLTRPAPPDSEGSRSSSSSSSSNNNNYCALGCYGGWHLSALPGNTQSSGPIPALACGLSCDHQGLETQQGVAWVLAGHCQRPGLHEDLQGMLLPSVLSKARSWTF,521,"57,147",Alternative sequence (5); Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (1); Glycosylation (2); Motif (2); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..40;  /evidence=""ECO:0000255"""
P31785,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132),MLKPSLPFTSLLFLQLPLLGVGLNTTILTPNGNEDTTADFFLTTMPTDSLSVSTLPLPEVQCFVFNVEYMNCTWNSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGSNTSKENPFLFALEAVVISVGSMGLIISLLCVYFWLERTMPRIPTLKNLEDLVTEYHGNFSAWSGVSKGLAESLQPDYSERLCLVSEIPPKGGALGEGPGASPCNQHSPYWAPPCYTLKPET,369,"42,287",Alternative sequence (2); Beta strand (22); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (6); Helix (3); Modified residue (1); Motif (2); Natural variant (36); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 62..72; DISULFID 102..115; DISULFID 182..231,SIGNAL 1..22
Q6PHW0,Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1),MYFLTPILVAILCILVVWIFKNADRSMEKKKGEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTTPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTV,289,"33,360",Alternative sequence (9); Beta strand (8); Binding site (6); Chain (1); Erroneous initiation (1); Erroneous translation (1); Helix (10); Mutagenesis (5); Natural variant (5); Nucleotide binding (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q99706,Killer cell immunoglobulin-like receptor 2DL4 (CD158 antigen-like family member D) (G9P) (Killer cell inhibitory receptor 103AS) (KIR-103AS) (MHC class I NK cell receptor KIR103AS) (CD antigen CD158d),MSMSPTVIILACLGFFLDQSVWAHVGGQDKPFCSAWPSAVVPQGGHVTLRCHYRRGFNIFTLYKKDGVPVPELYNRIFWNSFLISPVTPAHAGTYRCRGFHPHSPTEWSAPSNPLVIMVTGLYEKPSLTARPGPTVRAGENVTLSCSSQSSFDIYHLSREGEAHELRLPAVPSINGTFQADFPLGPATHGETYRCFGSFHGSPYEWSDPSDPLPVSVTGNPSSSWPSPTEPSFKTGIARHLHAVIRYSVAIILFTILPFFLLHRWCSKKKDAAVMNQEPAGHRTVNREDSDEQDPQEVTYAQLDHCIFTQRKITGPSQRSKRPSTDTSVCIELPNAEPRALSPAHEHHSQALMGSSRETTALSQTQLASSNVPAAGI,377,"41,487",Alternative sequence (4); Beta strand (17); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (2); Helix (2); Mutagenesis (1); Natural variant (8); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 51..97;  /evidence=""ECO:0000250""; DISULFID 146..195;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q14952,Killer cell immunoglobulin-like receptor 2DS3 (MHC class I NK cell receptor) (Natural killer-associated transcript 7) (NKAT-7),MSLMVISMACVGFFWLQGAWPHEGFRRKPSLLAHPGRLVKSEETVILQCWSDVMFEHFLLHREGTFNDTLRLIGEHIDGVSKANFSIGRMRQDLAGTYRCYGSVPHSPYQFSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSWSSYDMYHLSTEGEAHERRFSAGPKVNGTFQADFPLGPATQGGTYRCFGSFHDSPYEWSKSSDPLLVSVTGNPSNSWPSPTEPSSKTGNPRHLHVLIGTSVVKLPFTILLFFLLHRWCSDKKNASVMDQGPAGNRTVNREDSDEQDHQEVSYA,304,"33,717",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000250|UniProtKB:P43626""; DISULFID 149..198;  /evidence=""ECO:0000250|UniProtKB:P43626""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
A6NM11,Leucine-rich repeat-containing protein 37A2,MSSAQCPALVCVMSRLRFWGPWPLLMWQLLWLLVKEAQPLEWVKDPLQLTSNPLGPPDSWSSHSSHFPRESPHAPTLPADPWDFDHLGPSASSEMPAPPQESTENLVPFLDTWDSAGEQPLEPEQFLASQQDLKDKLSPQERLPVSPKKLKKDPAQRWSLAEIIGITRQLSTPQSQKQTLQNEYSSTDTPYPGSLPPELRVKSDEPPGPSEQVGPSQFHLEPETQNPETLEDIQSSSLQQEAPAQLPQLLEEEPSSMQQEAPALPPESSMESLTLPNHEVSVQPPGEDQAYYHLPNITVKPADVEVTITSEPTNETESSQAQQETPIQFPEEVEPSATQQEAPIEPPVPPMEHELSISEQQQPVQPSESPREVESSPTQQETPGQPPEHHEVTVSPPGHHQTHHLASPSVSVKPPDVQLTIAAEPSAEVGTSLVHQEATTRLSGSGNDVEPPAIQHGGPPLLPESSEEAGPLAVQQETSFQSPEPINNENPSPTQQEAAAEHPQTAEEGESSLTHQEAPAQTPEFPNVVVAQPPEHSHLTQATVQPLDLGFTITPESKTEVELSPTMKETPTQPPKKVVPQLRVYQGVTNPTPGQDQAQHPVSPSVTVQLLDLGLTITPEPTTEVGHSTPPKRTIVSPKHPEVTLPHPDQVQTQHSHLTRATVQPLDLGFTITPKSMTEVEPSTALMTTAPPPGHPEVTLPPSDKGQAQHSHLTQATVQPLDLELTITTKPTTEVKPSPTTEETSTQPPDLGLAIIPEPTTETRHSTALEKTTAPRPDRVQTLHRSLTEVTGPPTELEPAQDSLVQSESYTQNKALTAPEEHKASTSTNICELCTCGDEMLSCIDLNPEQRLRQVPVPEPNTHNGTFTILNFQGNYISYIDGNVWKAYSWTEKLILRENNLTELHKDSFEGLLSLQYLDLSCNKIQSIERHTFEPLPFLKFINLSCNVITELSFGTFQAWHGMQFLHKLILNHNPLTTVEDPYLFKLPALKYLDMGTTLVPLTTLKNILMMTVELEKLILPSHMACCLCQFKNSIEAVCKTVKLHCNSACLTNTTHCPEEASVGNPEGAFMKVLQARKNYTSTELIVEPEEPSDSSGINLSGFGSEQLDTNDESDFISTLSYILPYFSAVNLDVKSLLLPFIKLPTTGNSLAKIQTVGQNRQRVKRVLMGPRSIQKRHFKEVGRQSIRREQGAQASVENAAEEKRLGSPAPREVEQPHTQQGPEKLAGNAVYTKPSFTQEHKAAVSVLKPFSKGAPSTSSPAKALPQVRDRWKDLTHAISILESAKARVTNTKTSKPIVHARKKYRFHKTRSHVTHRTPKVKKSPKVRKKSYLSRLMLANRLPFSAAKSLINSPSQGAFSSLGDLSPQENPFLEVSAPSEHFIENNNTKHTTARNAFEENDFMENTNMPEGTISENTNYNHPHEADSAGTAFNLGPTVKQTETKWEYNNVGTDLSPEPKSFNYPLLSSPGDQFEIQLTQQLQSLIPNNNVRRLIAHVIRTLKMDCSGAHVQVTCAKLISRTGHLMKLLSGQQEVKASKIEWDTDQWKIENYINESTEAQSEQKEKSLELKKEVPGYGYTDKLILALIVTGILTILIILFCLIVICCHRRSLQEDEEGFSRGIFRFLPWRGCSSRRESQDGLSSFGQPLWFKDMYKPLSATRINNHAWKLHKKSSNEDKILNRDPGDSEAPTEEEESEALP,1700,"188,393",Chain (1); Glycosylation (2); Natural variant (4); Repeat (10); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q6UXK5,Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1),MARMSFVIAACQLVLGLLMTSLTESSIQNSECPQLCVCEIRPWFTPQSTYREATTVDCNDLRLTRIPSNLSSDTQVLLLQSNNIAKTVDELQQLFNLTELDFSQNNFTNIKEVGLANLTQLTTLHLEENQITEMTDYCLQDLSNLQELYINHNQISTISAHAFAGLKNLLRLHLNSNKLKVIDSRWFDSTPNLEILMIGENPVIGILDMNFKPLANLRSLVLAGMYLTDIPGNALVGLDSLESLSFYDNKLVKVPQLALQKVPNLKFLDLNKNPIHKIQEGDFKNMLRLKELGINNMGELVSVDRYALDNLPELTKLEATNNPKLSYIHRLAFRSVPALESLMLNNNALNAIYQKTVESLPNLREISIHSNPLRCDCVIHWINSNKTNIRFMEPLSMFCAMPPEYKGHQVKEVLIQDSSEQCLPMISHDSFPNRLNVDIGTTVFLDCRAMAEPEPEIYWVTPIGNKITVETLSDKYKLSSEGTLEISNIQIEDSGRYTCVAQNVQGADTRVATIKVNGTLLDGTQVLKIYVKQTESHSILVSWKVNSNVMTSNLKWSSATMKIDNPHITYTARVPVDVHEYNLTHLQPSTDYEVCLTVSNIHQQTQKSCVNVTTKNAAFAVDISDQETSTALAAVMGSMFAVISLASIAVYFAKRFKRKNYHHSLKKYMQKTSSIPLNELYPPLINLWEGDSEKDKDGSADTKPTQVDTSRSYYMW,716,"80,716",Chain (1); Disulfide bond (1); Domain (4); Erroneous initiation (2); Glycosylation (4); Natural variant (2); Repeat (11); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 447..499;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9HBG7,T-lymphocyte surface antigen Ly-9 (Cell surface molecule Ly-9) (Lymphocyte antigen 9) (SLAM family member 3) (SLAMF3) (Signaling lymphocytic activation molecule 3) (CD antigen CD229),MVAPKSHTDDWAPGPFSSKPQRSQLQIFSSVLQTSLLFLLMGLRASGKDSAPTVVSGILGGSVTLPLNISVDTEIENVIWIGPKNALAFARPKENVTIMVKSYLGRLDITKWSYSLCISNLTLNDAGSYKAQINQRNFEVTTEEEFTLFVYEQLQEPQVTMKSVKVSENFSCNITLMCSVKGAEKSVLYSWTPREPHASESNGGSILTVSRTPCDPDLPYICTAQNPVSQRSSLPVHVGQFCTDPGASRGGTTGETVVGVLGEPVTLPLALPACRDTEKVVWLFNTSIISKEREEAATADPLIKSRDPYKNRVWVSSQDCSLKISQLKIEDAGPYHAYVCSEASSVTSMTHVTLLIYRRLRKPKITWSLRHSEDGICRISLTCSVEDGGNTVMYTWTPLQKEAVVSQGESHLNVSWRSSENHPNLTCTASNPVSRSSHQFLSENICSGPERNTKLWIGLFLMVCLLCVGIFSWCIWKRKGRCSVPAFCSSQAEAPADTPEPTAGHTLYSVLSQGYEKLDTPLRPARQQPTPTSDSSSDSNLTTEEDEDRPEVHKPISGRYEVFDQVTQEGAGHDPAPEGQADYDPVTPYVTEVESVVGENTMYAQVFNLQGKTPVSQKEESSATIYCSIRKPQVVPPPQQNDLEIPESPTYENFT,655,"72,139",Alternative sequence (4); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (8); Modified residue (1); Motif (2); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 172..242;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 178..222;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 377..446;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 383..427;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..47;  /evidence=""ECO:0000255"""
P29376,Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1),MGCWGQLLVWFGAAGAILCSSPGSQETFLRSSPLPLASPSPRDPKVSAPPSILEPASPLNSPGTEGSWLFSTCGASGRHGPTQTQCDGAYAGTSVVVTVGAAGQLRGVQLWRVPGPGQYLISAYGAAGGKGAKNHLSRAHGVFVSAIFSLGLGESLYILVGQQGEDACPGGSPESQLVCLGESRAVEEHAAMDGSEGVPGSRRWAGGGGGGGGATYVFRVRAGELEPLLVAAGGGGRAYLRPRDRGRTQASPEKLENRSEAPGSGGRGGAAGGGGGWTSRAPSPQAGRSLQEGAEGGQGCSEAWATLGWAAAGGFGGGGGACTAGGGGGGYRGGDASETDNLWADGEDGVSFIHPSSELFLQPLAVTENHGEVEIRRHLNCSHCPLRDCQWQAELQLAECLCPEGMELAVDNVTCMDLHKPPGPLVLMVAVVATSTLSLLMVCGVLILVKQKKWQGLQEMRLPSPELELSKLRTSAIRTAPNPYYCQVGLGPAQSWPLPPGVTEVSPANVTLLRALGHGAFGEVYEGLVIGLPGDSSPLQVAIKTLPELCSPQDELDFLMEALIISKFRHQNIVRCVGLSLRATPRLILLELMSGGDMKSFLRHSRPHLGQPSPLVMRDLLQLAQDIAQGCHYLEENHFIHRDIAARNCLLSCAGPSRVAKIGDFGMARDIYRASYYRRGDRALLPVKWMPPEAFLEGIFTSKTDSWSFGVLLWEIFSLGYMPYPGRTNQEVLDFVVGGGRMDPPRGCPGPVYRIMTQCWQHEPELRPSFASILERLQYCTQDPDVLNSLLPMELGPTPEEEGTSGLGNRSLECLRPPQPQELSPEKLKSWGGSPLGPWLSSGLKPLKSRGLQPQNLWNPTYRS,864,"91,681",Active site (1); Alternative sequence (6); Binding site (1); Chain (1); Domain (1); Glycosylation (3); Modified residue (1); Mutagenesis (4); Natural variant (8); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q96KG7,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),MVISLNSCLSFICLLLCHWIGTASPLNLEDPNVCSHWESYSVTVQESYPHPFDQIYYTSCTDILNWFKCTRHRVSYRTAYRHGEKTMYRRKSQCCPGFYESGEMCVPHCADKCVHGRCIAPNTCQCEPGWGGTNCSSACDGDHWGPHCTSRCQCKNGALCNPITGACHCAAGFRGWRCEDRCEQGTYGNDCHQRCQCQNGATCDHVTGECRCPPGYTGAFCEDLCPPGKHGPQCEQRCPCQNGGVCHHVTGECSCPSGWMGTVCGQPCPEGRFGKNCSQECQCHNGGTCDAATGQCHCSPGYTGERCQDECPVGTYGVLCAETCQCVNGGKCYHVSGACLCEAGFAGERCEARLCPEGLYGIKCDKRCPCHLENTHSCHPMSGECACKPGWSGLYCNETCSPGFYGEACQQICSCQNGADCDSVTGKCTCAPGFKGIDCSTPCPLGTYGINCSSRCGCKNDAVCSPVDGSCTCKAGWHGVDCSIRCPSGTWGFGCNLTCQCLNGGACNTLDGTCTCAPGWRGEKCELPCQDGTYGLNCAERCDCSHADGCHPTTGHCRCLPGWSGVHCDSVCAEGRWGPNCSLPCYCKNGASCSPDDGICECAPGFRGTTCQRICSPGFYGHRCSQTCPQCVHSSGPCHHITGLCDCLPGFTGALCNEVCPSGRFGKNCAGICTCTNNGTCNPIDRSCQCYPGWIGSDCSQPCPPAHWGPNCIHTCNCHNGAFCSAYDGECKCTPGWTGLYCTQRCPLGFYGKDCALICQCQNGADCDHISGQCTCRTGFMGRHCEQKCPSGTYGYGCRQICDCLNNSTCDHITGTCYCSPGWKGARCDQAGVIIVGNLNSLSRTSTALPADSYQIGAIAGIIILVLVVLFLLALFIIYRHKQKGKESSMPAVTYTPAMRVVNADYTISGTLPHSNGGNANSHYFTNPSYHTLTQCATSPHVNNRDRMTVTKSKNNQLFVNLKNVNPGKRGPVGDCTGTLPADWKHGGYLNELGAFGLDRSYMGKSLKDLGKNSEYNSSNCSLSSSENPYATIKDPPVLIPKSSECGYVEMKSPARRDSPYAEINNSTSANRNVYEVEPTVSVVQGVFSNNGRLSQDPYDLPKNSHIPCHYDLLPVRDSSSSPKQEDSGGSSSNSSSSSE,1140,"122,205",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (48); Domain (16); Erroneous initiation (1); Glycosylation (2); Modified residue (1); Mutagenesis (4); Natural variant (7); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..95;  /evidence=""ECO:0000255""; DISULFID 60..69;  /evidence=""ECO:0000255""; DISULFID 94..105;  /evidence=""ECO:0000255""; DISULFID 109..118;  /evidence=""ECO:0000250""; DISULFID 113..124;  /evidence=""ECO:0000250""; DISULFID 126..135;  /evidence=""ECO:0000250""; DISULFID 148..160;  /evidence=""ECO:0000250""; DISULFID 154..167;  /evidence=""ECO:0000250""; DISULFID 169..178;  /evidence=""ECO:0000250""; DISULFID 191..203;  /evidence=""ECO:0000250""; DISULFID 197..210;  /evidence=""ECO:0000250""; DISULFID 212..221;  /evidence=""ECO:0000250""; DISULFID 234..246;  /evidence=""ECO:0000250""; DISULFID 240..253;  /evidence=""ECO:0000250""; DISULFID 255..264;  /evidence=""ECO:0000250""; DISULFID 281..289;  /evidence=""ECO:0000250""; DISULFID 283..296;  /evidence=""ECO:0000250""; DISULFID 298..307;  /evidence=""ECO:0000250""; DISULFID 320..332;  /evidence=""ECO:0000250""; DISULFID 326..339;  /evidence=""ECO:0000250""; DISULFID 341..350;  /evidence=""ECO:0000250""; DISULFID 409..421;  /evidence=""ECO:0000250""; DISULFID 415..428;  /evidence=""ECO:0000250""; DISULFID 430..439;  /evidence=""ECO:0000250""; DISULFID 456..464;  /evidence=""ECO:0000250""; DISULFID 458..471;  /evidence=""ECO:0000250""; DISULFID 473..482;  /evidence=""ECO:0000250""; DISULFID 495..507;  /evidence=""ECO:0000250""; DISULFID 501..514;  /evidence=""ECO:0000250""; DISULFID 516..525;  /evidence=""ECO:0000250""; DISULFID 542..550;  /evidence=""ECO:0000250""; DISULFID 544..557;  /evidence=""ECO:0000250""; DISULFID 559..568;  /evidence=""ECO:0000250""; DISULFID 581..593;  /evidence=""ECO:0000250""; DISULFID 587..600;  /evidence=""ECO:0000250""; DISULFID 602..611;  /evidence=""ECO:0000250""; DISULFID 669..681;  /evidence=""ECO:0000250""; DISULFID 675..688;  /evidence=""ECO:0000250""; DISULFID 690..699;  /evidence=""ECO:0000250""; DISULFID 716..724;  /evidence=""ECO:0000250""; DISULFID 718..731;  /evidence=""ECO:0000250""; DISULFID 733..742;  /evidence=""ECO:0000250""; DISULFID 755..767;  /evidence=""ECO:0000250""; DISULFID 761..774;  /evidence=""ECO:0000250""; DISULFID 776..785;  /evidence=""ECO:0000250""; DISULFID 802..810;  /evidence=""ECO:0000250""; DISULFID 804..817;  /evidence=""ECO:0000250""; DISULFID 819..828;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P02724,Glycophorin-A (MN sialoglycoprotein) (PAS-2) (Sialoglycoprotein alpha) (CD antigen CD235a),MYGKIIFVLLLSEIVSISASSTTGVAMHTSTSSSVTKSYISSQTNDTHKRDTYAATPRAHEVSEISVRTVYPPEEETGERVQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRRLIKKSPSDVKPLPSPDTDVPLSSVEIENPETSDQ,150,"16,331",Alternative sequence (2); Beta strand (1); Chain (1); Erroneous initiation (1); Glycosylation (17); Helix (1); Modified residue (3); Mutagenesis (8); Natural variant (17); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:1059087"""
A8MVW5,HEPACAM family member 2 (Mitotic kinetics regulator),MGQDAFMEPFGDTLGVFQCKIYLLLFGACSGLKVTVPSHTVHGVRGQALYLPVHYGFHTPASDIQIIWLFERPHTMPKYLLGSVNKSVVPDLEYQHKFTMMPPNASLLINPLQFPDEGNYIVKVNIQGNGTLSASQKIQVTVDDPVTKPVVQIHPPSGAVEYVGNMTLTCHVEGGTRLAYQWLKNGRPVHTSSTYSFSPQNNTLHIAPVTKEDIGNYSCLVRNPVSEMESDIIMPIIYYGPYGLQVNSDKGLKVGEVFTVDLGEAILFDCSADSHPPNTYSWIRRTDNTTYIIKHGPRLEVASEKVAQKTMDYVCCAYNNITGRQDETHFTVIITSVGLEKLAQKGKSLSPLASITGISLFLIISMCLLFLWKKYQPYKVIKQKLEGRPETEYRKAQTFSGHEDALDDFGIYEFVAFPDVSGVSRIPSRSVPASDCVSGQDLHSTVYEVIQHIPAQQQDHPE,462,"51,407",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (4); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 170..219;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 270..315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P05362,Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54),MAPSSPRPALPALLVLLGALFPGPGNAQTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYELSNVQEDSQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLTVVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPYQLQTFVLPATPPQLVSPRVLEVDTQGTVVCSLDGLFPVSEAQVHLALGDQRLNPTVTYGNDSFSAKASVSVTAEDEGTQRLTCAVILGNQSQETLQTVTIYSFPAPNVILTKPEVSEGTEVTVKCEAHPRAKVTLNGVPAQPLGPRAQLLLKATPEDNGRSFSCSATLEVAGQLIHKNQTRELRVLYGPRLDERDCPGNWTWPENSQQTPMCQAWGNPLPELKCLKDGTFPLPIGESVTVTRDLEGTYLCRARSTQGEVTRKVTVNVLSPRYEIVIITVVAAAVIMGTAGLSTYLYNRQRKIKKYRLQQAQKGTPMKPNTQATPP,532,"57,825",Beta strand (41); Chain (1); Disulfide bond (7); Domain (5); Glycosylation (8); Helix (8); Modified residue (2); Motif (1); Natural variant (8); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 48..92;  /evidence=""ECO:0000244|PDB:1IAM, ECO:0000244|PDB:1IC1, ECO:0000244|PDB:1MQ8, ECO:0000269|PubMed:12526797, ECO:0000269|PubMed:9539702, ECO:0000269|PubMed:9539703""; DISULFID 52..96;  /evidence=""ECO:0000244|PDB:1IAM, ECO:0000244|PDB:1IC1, ECO:0000244|PDB:1MQ8, ECO:0000269|PubMed:12526797, ECO:0000269|PubMed:9539702, ECO:0000269|PubMed:9539703""; DISULFID 135..186;  /evidence=""ECO:0000244|PDB:1IAM, ECO:0000244|PDB:1IC1, ECO:0000244|PDB:1MQ8, ECO:0000269|PubMed:12526797, ECO:0000269|PubMed:9539702, ECO:0000269|PubMed:9539703""; DISULFID 237..290;  /evidence=""ECO:0000244|PDB:1P53, ECO:0000269|PubMed:15099525""; DISULFID 332..371;  /evidence=""ECO:0000244|PDB:1P53, ECO:0000269|PubMed:15099525""; DISULFID 403..419;  /evidence=""ECO:0000244|PDB:1P53, ECO:0000269|PubMed:15099525""; DISULFID 431..457;  /evidence=""ECO:0000244|PDB:1P53, ECO:0000269|PubMed:15099525""",SIGNAL 1..27
P32927,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131),MVLAQGLLSMALLALCWERSLAGAEETIPLQTLRCYNDYTSHITCRWADTQDAQRLVNVTLIRRVNEDLLEPVSCDLSDDMPWSACPHPRCVPRRCVIPCQSFVVTDVDYFSFQPDRPLGTRLTVTLTQHVQPPEPRDLQISTDQDHFLLTWSVALGSPQSHWLSPGDLEFEVVYKRLQDSWEDAAILLSNTSQATLGPEHLMPSSTYVARVRTRLAPGSRLSGRPSKWSPEVCWDSQPGDEAQPQNLECFFDGAAVLSCSWEVRKEVASSVSFGLFYKPSPDAGEEECSPVLREGLGSLHTRHHCQIPVPDPATHGQYIVSVQPRRAEKHIKSSVNIQMAPPSLNVTKDGDSYSLRWETMKMRYEHIDHTFEIQYRKDTATWKDSKTETLQNAHSMALPALEPSTRYWARVRVRTSRTGYNGIWSEWSEARSWDTESVLPMWVLALIVIFLTIAVLLALRFCGIYGYRLRRKWEEKIPNPSKSHLFQNGSAELWPPGSMSAFTSGSPPHQGPWGSRFPELEGVFPVGFGDSEVSPLTIEDPKHVCDPPSGPDTTPAASDLPTEQPPSPQPGPPAASHTPEKQASSFDFNGPYLGPPHSRSLPDILGQPEPPQEGGSQKSPPPGSLEYLCLPAGGQVQLVPLAQAMGPGQAVEVERRPSQGAAGSPSLESGGGPAPPALGPRVGGQDQKDSPVAIPMSSGDTEDPGVASGYVSSADLVFTPNSGASSVSLVPSLGLPSDQTPSLCPGLASGPPGAPGPVKSGFEGYVELPPIEGRSPRSPRNNPVPPEAKSPVLNPGERPADVSPTSPQPEGLLVLQQVGDYCFLPGLGPGPLSLRSKPSSPGPGPEIKNLDQAFQVKKPPGQAVPQVPVIQLFKALKQQDYLSLPPWEVNKPGEVC,897,"97,336",Alternative sequence (1); Beta strand (36); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (3); Helix (9); Modified residue (1); Motif (2); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),DISULFID 35..45; DISULFID 75..96; DISULFID 86..91; DISULFID 250..260; DISULFID 289..306,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q14627,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2),MAFVCLAIGCLYTFLISTTFGCTSSSDTEIKVNPPQDFEIVDPGYLGYLYLQWQPPLSLDHFKECTVEYELKYRNIGSETWKTIITKNLHYKDGFDLNKGIEAKIHTLLPWQCTNGSEVQSSWAETTYWISPQGIPETKVQDMDCVYYNWQYLLCSWKPGIGVLLDTNYNLFYWYEGLDHALQCVDYIKADGQNIGCRFPYLEASDYKDFYICVNGSSENKPIRSSYFTFQLQNIVKPLPPVYLTFTRESSCEIKLKWSIPLGPIPARCFDYEIEIREDDTTLVTATVENETYTLKTTNETRQLCFVVRSKVNIYCSDDGIWSEWSDKQCWEGEDLSKKTLLRFWLPFGFILILVIFVTGLLLRKPNTYPKMIPEFFCDT,380,"44,176",Beta strand (22); Chain (1); Disulfide bond (4); Domain (3); Glycosylation (4); Helix (2); Motif (1); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 65..113;  /evidence=""ECO:0000269|PubMed:20223216""; DISULFID 145..155;  /evidence=""ECO:0000269|PubMed:20223216""; DISULFID 184..197;  /evidence=""ECO:0000269|PubMed:20223216""; DISULFID 269..316;  /evidence=""ECO:0000269|PubMed:20223216""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q5SZI1,Low-density lipoprotein receptor class A domain-containing protein 2,MEACCLLQLPQRLLLLGAAALTATALETADLAELCGQTWQGDGLLLRSHAASRRFYFVAPDTDCGLWVQAAAPGDRIRFQFRFFLVYSLTPAPPALNTSSPAPADPCAPGSYLQFYEGPPGAPRPLGSPLCGLNIPVPVASSGPFLGLRLVTRGRQPRVDFVGEVTSFRLGPCGAYFRCQNGRCIPSSLVCDPWGMDNCGDGSDQGSWSPADCRGPSPVPSQTGSTDAHTSRSLTPSPALGSAGSLWIAAERSSPAGRDPTRQDAALEGSTE,272,"28,581",Chain (1); Disulfide bond (3); Domain (1); Glycosylation (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 173..184;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 179..199;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""; DISULFID 191..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00124""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q96NI6,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,MEKILFYLFLIGIAVKAQICPKRCVCQILSPNLATLCAKKGLLFVPPNIDRRTVELRLADNFVTNIKRKDFANMTSLVDLTLSRNTISFITPHAFADLRNLRALHLNSNRLTKITNDMFSGLSNLHHLILNNNQLTLISSTAFDDVFALEELDLSYNNLETIPWDAVEKMVSLHTLSLDHNMIDNIPKGTFSHLHKMTRLDVTSNKLQKLPPDPLFQRAQVLATSGIISPSTFALSFGGNPLHCNCELLWLRRLSREDDLETCASPPLLTGRYFWSIPEEEFLCEPPLITRHTHEMRVLEGQRATLRCKARGDPEPAIHWISPEGKLISNATRSLVYDNGTLDILITTVKDTGAFTCIASNPAGEATQIVDLHIIKLPHLLNSTNHIHEPDPGSSDISTSTKSGSNTSSSNGDTKLSQDKIVVAEATSSTALLKFNFQRNIPGIRMFQIQYNGTYDDTLVYRMIPPTSKTFLVNNLAAGTMYDLCVLAIYDDGITSLTATRVVGCIQFTTEQDYVRCHFMQSQFLGGTMIIIIGGIIVASVLVFIIILMIRYKVCNNNGQHKVTKVSNVYSQTNGAQIQGCSVTLPQSVSKQAVGHEENAQCCKATSDNVIQSSETCSSQDSSTTTSALPPSWTSSTSVSQKQKRKTGTKPSTEPQNEAVTNVESQNTNRNNSTALQLASRPPDSVTEGPTSKRAHIKPNALLTNVDQIVQETQRLELI,719,"79,445",Beta strand (13); Chain (1); Disulfide bond (1); Domain (4); Glycosylation (6); Helix (8); Repeat (7); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 308..357;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
O94898,Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2),MAPAPLGVPEEQLLGCRSRVLSRLLFIAQTALLLLPAAGAGLCPAPCSCRIPLLDCSRRKLPAPSWRALSGLLPPDTAILDFSHNRLSNWNISLESQTLQEVKMNYNELTEIPYFGEPTSNITLLSLVHNIIPEINAQALQFYPALESLDLSSNIISEIKTSSFPRMQLKYLNLSNNRITTLEAGCFDNLSSSLLVVKLNRNRMSMIPPKIFKLPHLQFLELKRNRIKIVEGLTFQGLDSLRSLKMQRNGISKLKDGAFFGLNNMEELELEHNNLTRVNKGWLYGLRMLQQLYVSQNAIERISPDAWEFCQRLSELDLSYNQLTRLDESAFVGLSLLERLNLGDNRVTHIADGVFRFLSNLQTLDLRNNEISWAIEDASEAFAGLTSLTKLILQGNQIKSITKKAFIGLESLEHLDLNNNAIMSIQENAFSQTHLKELILNTSSLLCDCHLKWLLQWLVDNNFQHSVNVSCAHPEWLAGQSILNVDLKDFVCDDFLKPQIRTHPETIIALRGMNVTLTCTAVSSSDSPMSTVWRKDSEILYDVDTENFVRYWQQAGEALEYTSILHLFNVNFTDEGKYQCIVTNHFGSNYSQKAKLTVNEMPSFLKTPMDLTIRTGAMARLECAAEGHPAPQISWQKDGGTDFPAARERRMHVMPEDDVFFIANVKIEDMGIYSCMAQNTAGGLSANASLTVLETPSFIRPLEDKTVTRGETAVLQCIAGGSPAPRLNWTKDDGPLLVTERHFFAAANQLLIIVDAGLEDAGKYTCIMSNTLGTERGHIYLNVISSPNCDSSQSSIGHEDDGWTTVGIVIIVVVCCVVGTSLIWVIVIYHMRRKNEDYSITNTEELNLPADIPSYLSSQGTLSEPQEGYSNSEAGSHQQLMPPANGYIHKGTDGGTGTRVICSDCYDNANIYSRTREYCPYTYIAEEDVLDQTLSSLMVQMPKETYLVHPPQDTTALESLIPSANREPSAFPTNHERISEKKLPSTQMSGETLQRPVWNINRELGLPHPPFSQQPVHESPQLHQNEGLAGREPDCSASSMSCHRLQDHAFDFSRTRNIQDGSEGT,1065,"118,965",Chain (1); Disulfide bond (3); Domain (5); Erroneous initiation (1); Glycosylation (12); Modified residue (1); Repeat (15); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 519..580;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 623..675;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 717..766;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..40;  /evidence=""ECO:0000255"""
Q9Y5Y7,Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) (Cell surface retention sequence-binding protein 1) (CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor),MARCFSLVLLLTSIWTTRLLVQGSLRAEELSIQVSCRIMGITLVSKKANQQLNFTEAKEACRLLGLSLAGKDQVETALKASFETCSYGWVGDGFVVISRISPNPKCGKNGVGVLIWKVPVSRQFAAYCYNSSDTWTNSCIPEIITTKDPIFNTQTATQTTEFIVSDSTYSVASPYSTIPAPTTTPPAPASTSIPRRKKLICVTEVFMETSTMSTETEPFVENKAAFKNEAAGFGGVPTALLVLALLFFGAAAGLGFCYVKRYVKAFPFTNKNQQKEMIETKVVKEEKANDSNPNEESKKTDKNPEESKSPSKTTVRCLEAEV,322,"35,213",Chain (1); Disulfide bond (2); Domain (1); Glycosylation (2); Natural variant (3); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 61..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00323""; DISULFID 85..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00323""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q8N387,Mucin-15 (MUC-15),MLALAKILLISTLFYSLLSGSHGKENQDINTTQNIAEVFKTMENKPISLESEANLNSDKENITTSNLKASHSPPLNLPNNSHGITDFSSNSSAEHSLGSLKPTSTISTSPPLIHSFVSKVPWNAPIADEDLLPISAHPNATPALSSENFTWSLVNDTVKTPDNSSITVSILSSEPTSPSVTPLIVEPSGWLTTNSDSFTGFTPYQEKTTLQPTLKFTNNSKLFPNTSDPQKENRNTGIVFGAILGAILGVSLLTLVGYLLCGKRKTDSFSHRRLYDDRNEPVLRLDNAPEPYDVSFGNSSYYNPTLNDSAMPESEENARDGIPMDDIPPLRTSV,334,"36,294",Alternative sequence (1); Chain (1); Erroneous termination (1); Glycosylation (9); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000250"""
Q9BYF1,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2],MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF,805,"92,463",Active site (2); Alternative sequence (1); Beta strand (19); Binding site (5); Chain (2); Disulfide bond (3); Glycosylation (7); Helix (38); Metal binding (3); Mutagenesis (65); Natural variant (4); Region (6); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (14),"DISULFID 133..141;  /evidence=""ECO:0000269|PubMed:14754895""; DISULFID 344..361;  /evidence=""ECO:0000269|PubMed:14754895""; DISULFID 530..542;  /evidence=""ECO:0000269|PubMed:14754895""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q86WK7,Amphoterin-induced protein 3 (AMIGO-3) (Alivin-3),MTWLVLLGTLLCMLRVGLGTPDSEGFPPRALHNCPYKCICAADLLSCTGLGLQDVPAELPAATADLDLSHNALQRLRPGWLAPLFQLRALHLDHNELDALGRGVFVNASGLRLLDLSSNTLRALGRHDLDGLGALEKLLLFNNRLVHLDEHAFHGLRALSHLYLGCNELASFSFDHLHGLSATHLLTLDLSSNRLGHISVPELAALPAFLKNGLYLHNNPLPCDCRLYHLLQRWHQRGLSAVRDFAREYVCLAFKVPASRVRFFQHSRVFENCSSAPALGLERPEEHLYALVGRSLRLYCNTSVPAMRIAWVSPQQELLRAPGSRDGSIAVLADGSLAIGNVQEQHAGLFVCLATGPRLHHNQTHEYNVSVHFPRPEPEAFNTGFTTLLGCAVGLVLVLLYLFAPPCRCCRRACRCRRWPQTPSPLQELSAQSSVLSTTPPDAPSRKASVHKHVVFLEPGRRGLNGRVQLAVAEEFDLYNPGGLQLKAGSESASSIGSEGPMTT,504,"55,250",Chain (1); Disulfide bond (5); Domain (3); Erroneous initiation (1); Glycosylation (5); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..40;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 38..47;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 223..251;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 225..273;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 300..352;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q96PZ7,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),MTAWRRFQSLLLLLGLLVLCARLLTAAKGQNCGGLVQGPNGTIESPGFPHGYPNYANCTWIIITGERNRIQLSFHTFALEEDFDILSVYDGQPQQGNLKVRLSGFQLPSSIVSTGSILTLWFTTDFAVSAQGFKALYEVLPSHTCGNPGEILKGVLHGTRFNIGDKIRYSCLPGYILEGHAILTCIVSPGNGASWDFPAPFCRAEGACGGTLRGTSSSISSPHFPSEYENNADCTWTILAEPGDTIALVFTDFQLEEGYDFLEISGTEAPSIWLTGMNLPSPVISSKNWLRLHFTSDSNHRRKGFNAQFQVKKAIELKSRGVKMLPSKDGSHKNSVLSQGGVALVSDMCPDPGIPENGRRAGSDFRVGANVQFSCEDNYVLQGSKSITCQRVTETLAAWSDHRPICRARTCGSNLRGPSGVITSPNYPVQYEDNAHCVWVITTTDPDKVIKLAFEEFELERGYDTLTVGDAGKVGDTRSVLYVLTGSSVPDLIVSMSNQMWLHLQSDDSIGSPGFKAVYQEIEKGGCGDPGIPAYGKRTGSSFLHGDTLTFECPAAFELVGERVITCQQNNQWSGNKPSCVFSCFFNFTASSGIILSPNYPEEYGNNMNCVWLIISEPGSRIHLIFNDFDVEPQFDFLAVKDDGISDITVLGTFSGNEVPSQLASSGHIVRLEFQSDHSTTGRGFNITYTTFGQNECHDPGIPINGRRFGDRFLLGSSVSFHCDDGFVKTQGSESITCILQDGNVVWSSTVPRCEAPCGGHLTASSGVILPPGWPGYYKDSLHCEWIIEAKPGHSIKITFDRFQTEVNYDTLEVRDGPASSSPLIGEYHGTQAPQFLISTGNFMYLLFTTDNSRSSIGFLIHYESVTLESDSCLDPGIPVNGHRHGGDFGIRSTVTFSCDPGYTLSDDEPLVCERNHQWNHALPSCDALCGGYIQGKSGTVLSPGFPDFYPNSLNCTWTIEVSHGKGVQMIFHTFHLESSHDYLLITEDGSFSEPVARLTGSVLPHTIKAGLFGNFTAQLRFISDFSISYEGFNITFSEYDLEPCDDPGVPAFSRRIGFHFGVGDSLTFSCFLGYRLEGATKLTCLGGGRRVWSAPLPRCVAECGASVKGNEGTLLSPNFPSNYDNNHECIYKIETEAGKGIHLRTRSFQLFEGDTLKVYDGKDSSSRPLGTFTKNELLGLILNSTSNHLWLEFNTNGSDTDQGFQLTYTSFDLVKCEDPGIPNYGYRIRDEGHFTDTVVLYSCNPGYAMHGSNTLTCLSGDRRVWDKPLPSCIAECGGQIHAATSGRILSPGYPAPYDNNLHCTWIIEADPGKTISLHFIVFDTEMAHDILKVWDGPVDSDILLKEWSGSALPEDIHSTFNSLTLQFDSDFFISKSGFSIQFSTSIAATCNDPGMPQNGTRYGDSREAGDTVTFQCDPGYQLQGQAKITCVQLNNRFFWQPDPPTCIAACGGNLTGPAGVILSPNYPQPYPPGKECDWRVKVNPDFVIALIFKSFNMEPSYDFLHIYEGEDSNSPLIGSYQGSQAPERIESSGNSLFLAFRSDASVGLSGFAIEFKEKPREACFDPGNIMNGTRVGTDFKLGSTITYQCDSGYKILDPSSITCVIGADGKPSWDQVLPSCNAPCGGQYTGSEGVVLSPNYPHNYTAGQICLYSITVPKEFVVFGQFAYFQTALNDLAELFDGTHAQARLLSSLSGSHSGETLPLATSNQILLRFSAKSGASARGFHFVYQAVPRTSDTQCSSVPEPRYGRRIGSEFSAGSIVRFECNPGYLLQGSTALHCQSVPNALAQWNDTIPSCVVPCSGNFTQRRGTILSPGYPEPYGNNLNCIWKIIVTEGSGIQIQVISFATEQNWDSLEIHDGGDVTAPRLGSFSGTTVPALLNSTSNQLYLHFQSDISVAAAGFHLEYKTVGLAACQEPALPSNSIKIGDRYMVNDVLSFQCEPGYTLQGRSHISCMPGTVRRWNYPSPLCIATCGGTLSTLGGVILSPGFPGSYPNNLDCTWRISLPIGYGAHIQFLNFSTEANHDFLEIQNGPYHTSPMIGQFSGTDLPAALLSTTHETLIHFYSDHSQNRQGFKLAYQAYELQNCPDPPPFQNGYMINSDYSVGQSVSFECYPGYILIGHPVLTCQHGINRNWNYPFPRCDAPCGYNVTSQNGTIYSPGFPDEYPILKDCIWLITVPPGHGVYINFTLLQTEAVNDYIAVWDGPDQNSPQLGVFSGNTALETAYSSTNQVLLKFHSDFSNGGFFVLNFHAFQLKKCQPPPAVPQAEMLTEDDDFEIGDFVKYQCHPGYTLVGTDILTCKLSSQLQFEGSLPTCEAQCPANEVRTGSSGVILSPGYPGNYFNSQTCSWSIKVEPNYNITIFVDTFQSEKQFDALEVFDGSSGQSPLLVVLSGNHTEQSNFTSRSNQLYLRWSTDHATSKKGFKIRYAAPYCSLTHPLKNGGILNRTAGAVGSKVHYFCKPGYRMVGHSNATCRRNPLGMYQWDSLTPLCQAVSCGIPESPGNGSFTGNEFTLDSKVVYECHEGFKLESSQQATAVCQEDGLWSNKGKPPTCKPVACPSIEAQLSEHVIWRLVSGSLNEYGAQVLLSCSPGYYLEGWRLLRCQANGTWNIGDERPSCRVISCGSLSFPPNGNKIGTLTVYGATAIFTCNTGYTLVGSHVRECLANGLWSGSETRCLAGHCGSPDPIVNGHISGDGFSYRDTVVYQCNPGFRLVGTSVRICLQDHKWSGQTPVCVPITCGHPGNPAHGFTNGSEFNLNDVVNFTCNTGYLLQGVSRAQCRSNGQWSSPLPTCRVVNCSDPGFVENAIRHGQQNFPESFEYGMSILYHCKKGFYLLGSSALTCMANGLWDRSLPKCLAISCGHPGVPANAVLTGELFTYGAVVHYSCRGSESLIGNDTRVCQEDSHWSGALPHCTGNNPGFCGDPGTPAHGSRLGDDFKTKSLLRFSCEMGHQLRGSPERTCLLNGSWSGLQPVCEAVSCGNPGTPTNGMIVSSDGILFSSSVIYACWEGYKTSGLMTRHCTANGTWTGTAPDCTIISCGDPGTLANGIQFGTDFTFNKTVSYQCNPGYVMEAVTSATIRCTKDGRWNPSKPVCKAVLCPQPPPVQNGTVEGSDFRWGSSISYSCMDGYQLSHSAILSCEGRGVWKGEIPQCLPVFCGDPGIPAEGRLSGKSFTYKSEVFFQCKSPFILVGSSRRVCQADGTWSGIQPTCIDPAHNTCPDPGTPHFGIQNSSRGYEVGSTVFFRCRKGYHIQGSTTRTCLANLTWSGIQTECIPHACRQPETPAHADVRAIDLPTFGYTLVYTCHPGFFLAGGSEHRTCKADMKWTGKSPVCKSKGVREVNETVTKTPVPSDVFFVNSLWKGYYEYLGKRQPATLTVDWFNATSSKVNATFSEASPVELKLTGIYKKEEAHLLLKAFQIKGQADIFVSKFENDNWGLDGYVSSGLERGGFTFQGDIHGKDFGKFKLERQDPLNPDQDSSSHYHGTSSGSVAAAILVPFFALILSGFAFYLYKHRTRPKVQYNGYAGHENSNGQASFENPMYDTNLKPTEAKAVRFDTTLNTVCTVV,3564,"388,736",Alternative sequence (6); Beta strand (4); Chain (1); Disulfide bond (70); Domain (42); Erroneous initiation (1); Glycosylation (40); Natural variant (6); Sequence conflict (16); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 32..58;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 145..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 171..202;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 208..234;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 349..389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 375..406;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 411..437;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 527..567;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 553..580;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 584..610;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 697..738;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 723..754;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 758..784;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 873..913;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 899..926;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 930..956;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1045..1085;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1071..1100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1104..1130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1217..1258;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1244..1273;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1277..1304;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1391..1431;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1417..1447;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1451..1477;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1564..1604;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1590..1621;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1625..1651;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1741..1781;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1767..1798;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1802..1828;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 1915..1955;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1941..1970;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 1974..2000;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 2087..2127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2113..2142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2146..2172;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 2258..2300;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2286..2315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2319..2347;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DISULFID 2432..2473;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2459..2490;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2495..2537;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2521..2552;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2557..2602;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2588..2617;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2622..2662;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2648..2675;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2680..2720;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2706..2733;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2738..2778;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2764..2791;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2796..2841;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2827..2854;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2859..2899;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2885..2912;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2920..2960;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2946..2973;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 2978..3019;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3005..3032;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3037..3079;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3063..3092;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3097..3137;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3123..3150;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3155..3195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3181..3208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3216..3257;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3243..3270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3275..3317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 3302..3330;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P20036,"HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1)",MRPEDRMFHIRAVILRALSLAFLLSLRGAGAIKADHVSTYAAFVQTHRPTGEFMFEFDEDEMFYVDLDKKETVWHLEEFGQAFSFEAQGGLANIAILNNNLNTLIQRSNHTQATNDPPEVTVFPKEPVELGQPNTLICHIDKFFPPVLNVTWLCNGELVTEGVAESLFLPRTDYSFHKFHYLTFVPSAEDFYDCRVEHWGLDQPLLKHWEAQEPIQMPETTETVLCALGLVLGLVGIIVGTVLIIKSLRSGHDPRAQGTL,260,"29,381",Beta strand (13); Chain (1); Disulfide bond (1); Domain (1); Erroneous gene model prediction (2); Glycosylation (2); Helix (2); Natural variant (23); Region (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 138..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..28
P04440,"HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)",MMVLQVSAAPRTVALTALLMVLLTSVVQGRATPENYLFQGRQECYAFNGTQRFLERYIYNREEFARFDSDVGEFRAVTELGRPAAEYWNSQKDILEEKRAVPDRMCRHNYELGGPMTLQRRVQPRVNVSPSKKGPLQHHNLLVCHVTDFYPGSIQVRWFLNGQEETAGVVSTNLIRNGDWTFQILVMLEMTPQQGDVYTCQVEHTSLDSPVTVEWKAQSDSARSKTLTGAGGFVLGLIICGVGIFMHRRSKKVQRGSA,258,"29,159",Beta strand (13); Chain (1); Disulfide bond (2); Domain (1); Frameshift (1); Glycosylation (1); Helix (6); Natural variant (56); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 44..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 144..200;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..29
P01909,"HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)",MILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGPSGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVLKHNLNSLIKRSNSTAATNEVPEVTVFSKSPVTLGQPNILICLVDNIFPPVVNITWLSNGHSVTEGVSETSFLSKSDHSFFKISYLTLLPSAEESYDCKVEHWGLDKPLLKHWEPEIPAPMSELTETVVCALGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL,254,"27,805",Beta strand (14); Chain (1); Disulfide bond (1); Domain (1); Erroneous gene model prediction (1); Glycosylation (2); Helix (2); Natural variant (64); Region (3); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 132..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912, ECO:0000269|PubMed:17629515""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:6576979"""
P01906,"HLA class II histocompatibility antigen, DQ alpha 2 chain (DX alpha chain) (HLA class II histocompatibility antigen, DQ(6) alpha chain) (HLA-DQA1) (MHC class II DQA2)",MILNKALLLGALALTAVMSPCGGEDIVADHVASYGVNFYQSHGPSGQYTHEFDGDEEFYVDLETKETVWQLPMFSKFISFDPQSALRNMAVGKHTLEFMMRQSNSTAATNEVPEVTVFSKFPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSETSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHWEPEIPAPMSELTETLVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGLL,255,"28,033",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Natural variant (2); Region (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 133..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..23
P01920,"HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)",MSWKKALRIPGGLRAATVTLMLAMLSTPVAEGRDSPEDFVYQFKAMCYFTNGTERVRYVTRYIYNREEYARFDSDVEVYRAVTPLGPPDAEYWNSQKEVLERTRAELDTVCRHNYQLELRTTLQRRVEPTVTISPSRTEALNHHNLLVCSVTDFYPAQIKVRWFRNDQEETTGVVSTPLIRNGDWTFQILVMLEMTPQHGDVYTCHVEHPSLQNPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIIHHRSQKGLLH,261,"29,991",Beta strand (14); Chain (1); Disulfide bond (2); Domain (1); Erroneous gene model prediction (2); Glycosylation (1); Helix (5); Natural variant (86); Region (3); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),DISULFID 47..111; DISULFID 149..205,"SIGNAL 1..32;  /evidence=""ECO:0000269|PubMed:6576979"""
P05538,"HLA class II histocompatibility antigen, DQ beta 2 chain (HLA class II histocompatibility antigen, DX beta chain) (MHC class II antigen DQB2)",MSWKMALQIPGGFWAAAVTVMLVMLSTPVAEARDFPKDFLVQFKGMCYFTNGTERVRGVARYIYNREEYGRFDSDVGEFQAVTELGRSIEDWNNYKDFLEQERAAVDKVCRHNYEAELRTTLQRQVEPTVTISPSRTEALNHHNLLVCSVTDFYPAQIKVRWFRNDQEETAGVVSTSLIRNGDWTFQILVMLEITPQRGDIYTCQVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIIRHRGQKGPRGPPPAGLLH,268,"30,387",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (1); Glycosylation (1); Natural variant (3); Region (2); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 47..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 148..204;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..32
Q902F9,Endogenous retrovirus group K member 113 Env polyprotein (EnvK5 protein) (Envelope polyprotein) (HERV-K113 envelope protein) (HERV-K_19p13.11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTYWAYVPFPPLIRAVTWMDNPIEIYVNDSVWVPGPTDDCCPAKPEEEGMMINISIGYRYPPICLGRAPGCLMPAVQNWLVEVPTVSPISRFTYHMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTLIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTARPKIISPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTIDLNSSLTVPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSVHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATAAVAGVALHSSVQSVNFVNDWQNNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNESEHHWDMVRCHLQGREDNLTLDISKLKEQIFEASKAHLNLVPGTEAIAGVADGLANLNTVTWVKTIGSTTIINLILILVCLFCLLLVYRCTQQLRRDSDHRERAMMTMVVLSKRKGGNVGKSKRDQIVTVSV,699,"79,195",Chain (3); Compositional bias (2); Glycosylation (12); Region (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
Q8IWK6,Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125),MEPPGRRRGRAQPPLLLPLSLLALLALLGGGGGGGAAALPAGCKHDGRPRGAGRAAGAAEGKVVCSSLELAQVLPPDTLPNRTVTLILSNNKISELKNGSFSGLSLLERLDLRNNLISSIDPGAFWGLSSLKRLDLTNNRIGCLNADIFRGLTNLVRLNLSGNLFSSLSQGTFDYLASLRSLEFQTEYLLCDCNILWMHRWVKEKNITVRDTRCVYPKSLQAQPVTGVKQELLTCDPPLELPSFYMTPSHRQVVFEGDSLPFQCMASYIDQDMQVLWYQDGRIVETDESQGIFVEKNMIHNCSLIASALTISNIQAGSTGNWGCHVQTKRGNNTRTVDIVVLESSAQYCPPERVVNNKGDFRWPRTLAGITAYLQCTRNTHGSGIYPGNPQDERKAWRRCDRGGFWADDDYSRCQYANDVTRVLYMFNQMPLNLTNAVATARQLLAYTVEAANFSDKMDVIFVAEMIEKFGRFTKEEKSKELGDVMVDIASNIMLADERVLWLAQREAKACSRIVQCLQRIATYRLAGGAHVYSTYSPNIALEAYVIKSTGFTGMTCTVFQKVAASDRTGLSDYGRRDPEGNLDKQLSFKCNVSNTFSSLALKNTIVEASIQLPPSLFSPKQKRELRPTDDSLYKLQLIAFRNGKLFPATGNSTNLADDGKRRTVVTPVILTKIDGVNVDTHHIPVNVTLRRIAHGADAVAARWDFDLLNGQGGWKSDGCHILYSDENITTIQCYSLSNYAVLMDLTGSELYTQAASLLHPVVYTTAIILLLCLLAVIVSYIYHHSLIRISLKSWHMLVNLCFHIFLTCVVFVGGITQTRNASICQAVGIILHYSTLATVLWVGVTARNIYKQVTKKAKRCQDPDEPPPPPRPMLRFYLIGGGIPIIVCGITAAANIKNYGSRPNAPYCWMAWEPSLGAFYGPASFITFVNCMYFLSIFIQLKRHPERKYELKEPTEEQQRLAANENGEINHQDSMSLSLISTSALENEHTFHSQLLGASLTLLLYVALWMFGALAVSLYYPLDLVFSFVFGATSLSFSAFFVVHHCVNREDVRLAWIMTCCPGRSSYSVQVNVQPPNSNGTNGEAPKCPNSSAESSCTNKSASSFKNSSQGCKLTNLQAAAAQCHANSLPLNSTPQLDNSLTEHSMDNDIKMHVAPLEVQFRTNVHSSRHHKNRSKGHRASRLTVLREYAYDVPTSVEGSVQNGLPKSRLGNNEGHSRSRRAYLAYRERQYNPPQQDSSDACSTLPKSSRNFEKPVSTTSKKDALRKPAVVELENQQKSYGLNLAIQNGPIKSNGQEGPLLGTDSTGNVRTGLWKHETTV,1321,"146,151",Alternative sequence (8); Chain (1); Disulfide bond (1); Domain (3); Glycosylation (13); Motif (1); Natural variant (2); Repeat (5); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 264..324;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9UHX3,Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312),MGGRVFLVFLAFCVWLTLPGAETQDSRGCARWCPQDSSCVNATACRCNPGFSSFSEIITTPMETCDDINECATLSKVSCGKFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQDVDECQQNPRLCKSYGTCVNTLGSYTCQCLPGFKLKPEDPKLCTDVNECTSGQNPCHSSTHCLNNVGSYQCRCRPGWQPIPGSPNGPNNTVCEDVDECSSGQHQCDSSTVCFNTVGSYSCRCRPGWKPRHGIPNNQKDTVCEDMTFSTWTPPPGVHSQTLSRFFDKVQDLGRDYKPGLANNTIQSILQALDELLEAPGDLETLPRLQQHCVASHLLDGLEDVLRGLSKNLSNGLLNFSYPAGTELSLEVQKQVDRSVTLRQNQAVMQLDWNQAQKSGDPGPSVVGLVSIPGMGKLLAEAPLVLEPEKQMLLHETHQGLLQDGSPILLSDVISAFLSNNDTQNLSSPVTFTFSHRSVIPRQKVLCVFWEHGQNGCGHWATTGCSTIGTRDTSTICRCTHLSSFAVLMAHYDVQEEDPVLTVITYMGLSVSLLCLLLAALTFLLCKAIQNTSTSLHLQLSLCLFLAHLLFLVAIDQTGHKVLCSIIAGTLHYLYLATLTWMLLEALYLFLTARNLTVVNYSSINRFMKKLMFPVGYGVPAVTVAISAASRPHLYGTPSRCWLQPEKGFIWGFLGPVCAIFSVNLVLFLVTLWILKNRLSSLNSEVSTLRNTRMLAFKATAQLFILGCTWCLGILQVGPAARVMAYLFTIINSLQGVFIFLVYCLLSQQVREQYGKWSKGIRKLKTESEMHTLSSSAKADTSKPSTVN,823,"90,472",Alternative sequence (5); Beta strand (14); Chain (1); Disulfide bond (15); Domain (6); Erroneous gene model prediction (1); Glycosylation (8); Helix (2); Mutagenesis (1); Natural variant (6); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 29..39;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 33..45;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 47..65;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 71..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 79..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 96..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 123..136;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 130..145;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:17449467""; DISULFID 147..161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 167..180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 174..189;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 191..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 216..229;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 223..238;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 240..259;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O14514,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],MRGQAAAPGPVWILAPLLLLLLLLGRRARAAAGADAGPGPEPCATLVQGKFFGYFSAAAVFPANASRCSWTLRNPDPRRYTLYMKVAKAPVPCSGPGRVRTYQFDSFLESTRTYLGVESFDEVLRLCDPSAPLAFLQASKQFLQMRRQQPPQHDGLRPRAGPPGPTDDFSVEYLVVGNRNPSRAACQMLCRWLDACLAGSRSSHPCGIMQTPCACLGGEAGGPAAGPLAPRGDVCLRDAVAGGPENCLTSLTQDRGGHGATGGWKLWSLWGECTRDCGGGLQTRTRTCLPAPGVEGGGCEGVLEEGRQCNREACGPAGRTSSRSQSLRSTDARRREELGDELQQFGFPAPQTGDPAAEEWSPWSVCSSTCGEGWQTRTRFCVSSSYSTQCSGPLREQRLCNNSAVCPVHGAWDEWSPWSLCSSTCGRGFRDRTRTCRPPQFGGNPCEGPEKQTKFCNIALCPGRAVDGNWNEWSSWSACSASCSQGRQQRTRECNGPSYGGAECQGHWVETRDCFLQQCPVDGKWQAWASWGSCSVTCGAGSQRRERVCSGPFFGGAACQGPQDEYRQCGTQRCPEPHEICDEDNFGAVIWKETPAGEVAAVRCPRNATGLILRRCELDEEGIAYWEPPTYIRCVSIDYRNIQMMTREHLAKAQRGLPGEGVSEVIQTLVEISQDGTSYSGDLLSTIDVLRNMTEIFRRAYYSPTPGDVQNFVQILSNLLAEENRDKWEEAQLAGPNAKELFRLVEDFVDVIGFRMKDLRDAYQVTDNLVLSIHKLPASGATDISFPMKGWRATGDWAKVPEDRVTVSKSVFSTGLTEADEASVFVVGTVLYRNLGSFLALQRNTTVLNSKVISVTVKPPPRSLRTPLEIEFAHMYNGTTNQTCILWDETDVPSSSAPPQLGPWSWRGCRTVPLDALRTRCLCDRLSTFAILAQLSADANMEKATLPSVTLIVGCGVSSLTLLMLVIIYVSVWRYIRSERSVILINFCLSIISSNALILIGQTQTRNKVVCTLVAAFLHFFFLSSFCWVLTEAWQSYMAVTGHLRNRLIRKRFLCLGWGLPALVVAISVGFTKAKGYSTMNYCWLSLEGGLLYAFVGPAAAVVLVNMVIGILVFNKLVSKDGITDKKLKERAGASLWSSCVVLPLLALTWMSAVLAVTDRRSALFQILFAVFDSLEGFVIVMVHCILRREVQDAVKCRVVDRQEEGNGDSGGSFQNGHAQLMTDFEKDVDLACRSVLNKDIAACRTATITGTLKRPSLPEEEKLKLAHAKGPPTNFNSLPANVSKLHLHGSPRYPGGPLPDFPNHSLTLKRDKAPKSSFVGDGDIFKKLDSELSRAQEKALDTSYVILPTATATLRPKPKEEPKYSIHIDQMPQTRLIHLSTAPEASLPARSPPSRQPPSGGPPEAPPAQPPPPPPPPPPPPQQPLPPPPNLEPAPPSLGDPGEPAAHPGPSTGPSTKNENVATLSVSSLERRKSRYAELDFEKIMHTRKRHQDMFQDLNRKLQHAAEKDKEVLGPDSKPEKQQTPNKRPWESLRKAHGTPTWVKKELEPLQPSPLELRSVEWERSGATIPLVGQDIIDLQTEV,1584,"173,501",Chain (3); Compositional bias (2); Disulfide bond (19); Domain (6); Glycosylation (7); Modified residue (2); Mutagenesis (4); Region (3); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 273..309;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 277..314;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 288..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 366..400;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 370..406;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 381..390;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 421..456;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 425..461;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 436..446;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 479..514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 483..519;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 494..504;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 534..569;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 538..574;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 549..559;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 581..616;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 604..634;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 884..921;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 909..923;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P19022,Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325),MCRIAGALRTLLPLLAALLQASVEASGEIALCKTGFPEDVYSAVLSKDVHEGQPLLNVKFSNCNGKRKVQYESSEPADFKVDEDGMVYAVRSFPLSSEHAKFLIYAQDKETQEKWQVAVKLSLKPTLTEESVKESAEVEEIVFPRQFSKHSGHLQRQKRDWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQLSVTKPLDREQIARFHLRAHAVDINGNQVENPIDIVINVIDMNDNRPEFLHQVWNGTVPEGSKPGTYVMTVTAIDADDPNALNGMLRYRIVSQAPSTPSPNMFTINNETGDIITVAAGLDREKVQQYTLIIQATDMEGNPTYGLSNTATAVITVTDVNDNPPEFTAMTFYGEVPENRVDIIVANLTVTDKDQPHTPAWNAVYRISGGDPTGRFAIQTDPNSNDGLVTVVKPIDFETNRMFVLTVAAENQVPLAKGIQHPPQSTATVSVTVIDVNENPYFAPNPKIIRQEEGLHAGTMLTTFTAQDPDRYMQQNIRYTKLSDPANWLKIDPVNGQITTIAVLDRESPNVKNNIYNATFLASDNGIPPMSGTGTLQIYLLDINDNAPQVLPQEAETCETPDPNSINITALDYDIDPNAGPFAFDLPLSPVTIKRNWTITRLNGDFAQLNLKIKFLEAGIYEVPIIITDSGNPPKSNISILRVKVCQCDSNGDCTDVDRIVGAGLGTGAIIAILLCIIILLILVLMFVVWMKRRDKERQAKQLLIDPEDDVRDNILKYDEEGGGEEDQDYDLSQLQQPDTVEPDAIKPVGIRRMDERPIHAEPQYPVRSAAPHPGDIGDFINEGLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGEQDYDYLNDWGPRFKKLADMYGGGDD,906,"99,809",Alternative sequence (1); Chain (1); Compositional bias (1); Domain (5); Glycosylation (7); Metal binding (15); Modified residue (2); Natural variant (6); Propeptide (1); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q86SJ2,Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA),MSLRVHTLPTLLGAVVRPGCRELLCLLMITVTVGPGASGVCPTACICATDIVSCTNKNLSKVPGNLFRLIKRLDLSYNRIGLLDSEWIPVSFAKLNTLILRHNNITSISTGSFSTTPNLKCLDLSSNKLKTVKNAVFQELKVLEVLLLYNNHISYLDPSAFGGLSQLQKLYLSGNFLTQFPMDLYVGRFKLAELMFLDVSYNRIPSMPMHHINLVPGKQLRGIYLHGNPFVCDCSLYSLLVFWYRRHFSSVMDFKNDYTCRLWSDSRHSRQVLLLQDSFMNCSDSIINGSFRALGFIHEAQVGERLMVHCDSKTGNANTDFIWVGPDNRLLEPDKEMENFYVFHNGSLVIESPRFEDAGVYSCIAMNKQRLLNETVDVTINVSNFTVSRSHAHEAFNTAFTTLAACVASIVLVLLYLYLTPCPCKCKTKRQKNMLHQSNAHSSILSPGPASDASADERKAGAGKRVVFLEPLKDTAAGQNGKVRLFPSEAVIAEGILKSTRGKSDSDSVNSVFSDTPFVAST,522,"57,934",Chain (1); Disulfide bond (5); Domain (3); Glycosylation (8); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..47;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 45..54;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 232..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 234..282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 310..363;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..39;  /evidence=""ECO:0000255"""
Q6UW56,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),MAPHDPGSLTTLVPWAAALLLALGVERALALPEICTQCPGSVQNLSKVAFYCKTTRELMLHARCCLNQKGTILGLDLQNCSLEDPGPNFHQAHTTVIIDLQANPLKGDLANTFRGFTQLQTLILPQHVNCPGGINAWNTITSYIDNQICQGQKNLCNNTGDPEMCPENGSCVPDGPGLLQCVCADGFHGYKCMRQGSFSLLMFFGILGATTLSVSILLWATQRRKAKTS,229,"24,747",Alternative sequence (2); Chain (1); Disulfide bond (3); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (4); Frameshift (2); Glycosylation (4); Natural variant (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 156..171;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 165..181;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 183..192;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..30;  /evidence=""ECO:0000269|PubMed:15340161"""
Q96A33,Coiled-coil domain-containing protein 47 (Calumin),MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLAILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRRLEEAALRREQKKLEKKQMKMKQIKVKAM,483,"55,874",Alternative sequence (1); Chain (1); Coiled coil (1); Frameshift (1); Glycosylation (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q3KPI0,Carcinoembryonic antigen-related cell adhesion molecule 21,MGPPSACPHRECIPWQGLLLTASLLTFWNAPTTAWLFIASAPFEVAEGENVHLSVVYLPENLYSYGWYKGKTVEPNQLIAAYVIDTHVRTPGPAYSGRETISPSGDLHFQNVTLEDTGYYTLQVTYRNSQIEQASHHLRVYESVAQPSIQASSTTVTEKGSVVLTCHTNNTGTSFQWIFNNQRLQVTKRMKLSWFNHMLTIDPIRQEDAGEYQCEVSNPVSSNRSDPLKLTVKSDDNTLGILIGVLVGSLLVAALVCFLLLRKTGRASDQSDFREQQPPASTPGHGPSDSSIS,293,"32,373",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (1); Erroneous gene model prediction (1); Glycosylation (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 166..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),MGLRSHHLSLGLLLLFLLPAECLGAEGRLALKLFRDLFANYTSALRPVADTDQTLNVTLEVTLSQIIDMDERNQVLTLYLWIRQEWTDAYLRWDPNAYGGLDAIRIPSSLVWRPDIVLYNKADAQPPGSASTNVVLRHDGAVRWDAPAITRSSCRVDVAAFPFDAQHCGLTFGSWTHGGHQLDVRPRGAAASLADFVENVEWRVLGMPARRRVLTYGCCSEPYPDVTFTLLLRRRAAAYVCNLLLPCVLISLLAPLAFHLPADSGEKVSLGVTVLLALTVFQLLLAESMPPAESVPLIGKYYMATMTMVTFSTALTILIMNLHYCGPSVRPVPAWARALLLGHLARGLCVRERGEPCGQSRPPELSPSPQSPEGGAGPPAGPCHEPRCLCRQEALLHHVATIANTFRSHRAAQRCHEDWKRLARVMDRFFLAIFFSMALVMSLLVLVQAL,450,"49,705",Chain (1); Disulfide bond (2); Glycosylation (2); Mutagenesis (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (4),"DISULFID 154..168;  /evidence=""ECO:0000250""; DISULFID 218..219;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q8WXG9,Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta],MSVFLGPGMPSASLLVNLLSALLILFVFGETEIRFTGQTEFVVNETSTTVIRLIIERIGEPANVTAIVSLYGEDAGDFFDTYAAAFIPAGETNRTVYIAVCDDDLPEPDETFIFHLTLQKPSANVKLGWPRTVTVTILSNDNAFGIISFNMLPSIAVSEPKGRNESMPLTLIREKGTYGMVMVTFEVEGGPNPPDEDLSPVKGNITFPPGRATVIYNLTVLDDEVPENDEIFLIQLKSVEGGAEINTSRNSIEIIIKKNDSPVRFLQSIYLVPEEDHILIIPVVRGKDNNGNLIGSDEYEVSISYAVTTGNSTAHAQQNLDFIDLQPNTTVVFPPFIHESHLKFQIVDDTIPEIAESFHIMLLKDTLQGDAVLISPSVVQVTIKPNDKPYGVLSFNSVLFERTVIIDEDRISRYEEITVVRNGGTHGNVSANWVLTRNSTDPSPVTADIRPSSGVLHFAQGQMLATIPLTVVDDDLPEEAEAYLLQILPHTIRGGAEVSEPAELLFYIQDSDDVYGLITFFPMENQKIESSPGERYLSLSFTRLGGTKGDVRLLYSVLYIPAGAVDPLQAKEGILNISRRNDLIFPEQKTQVTTKLPIRNDAFLQNGAHFLVQLETVELLNIIPLIPPISPRFGEICNISLLVTPAIANGEIGFLSNLPIILHEPEDFAAEVVYIPLHRDGTDGQATVYWSLKPSGFNSKAVTPDDIGPFNGSVLFLSGQSDTTINITIKGDDIPEMNETVTLSLDRVNVENQVLKSGYTSRDLIILENDDPGGVFEFSPASRGPYVIKEGESVELHIIRSRGSLVKQFLHYRVEPRDSNEFYGNTGVLEFKPGEREIVITLLARLDGIPELDEHYWVVLSSHGERESKLGSATIVNITILKNDDPHGIIEFVSDGLIVMINESKGDAIYSAVYDVVRNRGNFGDVSVSWVVSPDFTQDVFPVQGTVVFGDQEFSKNITIYSLPDEIPEEMEEFTVILLNGTGGAKVGNRTTATLRIRRNDDPIYFAEPRVVRVQEGETANFTVLRNGSVDVTCMVQYATKDGKATARERDFIPVEKGETLIFEVGSRQQSISIFVNEDGIPETDEPFYIILLNSTGDTVVYQYGVATVIIEANDDPNGIFSLEPIDKAVEEGKTNAFWILRHRGYFGSVSVSWQLFQNDSALQPGQEFYETSGTVNFMDGEEAKPIILHAFPDKIPEFNEFYFLKLVNISGGSPGPGGQLAETNLQVTVMVPFNDDPFGVFILDPECLEREVAEDVLSEDDMSYITNFTILRQQGVFGDVQLGWEILSSEFPAGLPPMIDFLLVGIFPTTVHLQQHMRRHHSGTDALYFTGLEGAFGTVNPKYHPSRNNTIANFTFSAWVMPNANTNGFIIAKDDGNGSIYYGVKIQTNESHVTLSLHYKTLGSNATYIAKTTVMKYLEESVWLHLLIILEDGIIEFYLDGNAMPRGIKSLKGEAITDGPGILRIGAGINGNDRFTGLMQDVRSYERKLTLEEIYELHAMPAKSDLHPISGYLEFRQGETNKSFIISARDDNDEEGEELFILKLVSVYGGARISEENTTARLTIQKSDNANGLFGFTGACIPEIAEEGSTISCVVERTRGALDYVHVFYTISQIETDGINYLVDDFANASGTITFLPWQRSEVLNIYVLDDDIPELNEYFRVTLVSAIPGDGKLGSTPTSGASIDPEKETTDITIKASDHPYGLLQFSTGLPPQPKDAMTLPASSVPHITVEEEDGEIRLLVIRAQGLLGRVTAEFRTVSLTAFSPEDYQNVAGTLEFQPGERYKYIFINITDNSIPELEKSFKVELLNLEGGVAELFRVDGSGSGDGDMEFFLPTIHKRASLGVASQILVTIAASDHAHGVFEFSPESLFVSGTEPEDGYSTVTLNVIRHHGTLSPVTLHWNIDSDPDGDLAFTSGNITFEIGQTSANITVEILPDEDPELDKAFSVSVLSVSSGSLGAHINATLTVLASDDPYGIFIFSEKNRPVKVEEATQNITLSIIRLKGLMGKVLVSYATLDDMEKPPYFPPNLARATQGRDYIPASGFALFGANQSEATIAISILDDDEPERSESVFIELLNSTLVAKVQSRSIPNSPRLGPKVETIAQLIIIANDDAFGTLQLSAPIVRVAENHVGPIINVTRTGGAFADVSVKFKAVPITAIAGEDYSIASSDVVLLEGETSKAVPIYVINDIYPELEESFLVQLMNETTGGARLGALTEAVIIIEASDDPYGLFGFQITKLIVEEPEFNSVKVNLPIIRNSGTLGNVTVQWVATINGQLATGDLRVVSGNVTFAPGETIQTLLLEVLADDVPEIEEVIQVQLTDASGGGTIGLDRIANIIIPANDDPYGTVAFAQMVYRVQEPLERSSCANITVRRSGGHFGRLLLFYSTSDIDVVALAMEEGQDLLSYYESPIQGVPDPLWRTWMNVSAVGEPLYTCATLCLKEQACSAFSFFSASEGPQCFWMTSWISPAVNNSDFWTYRKNMTRVASLFSGQAVAGSDYEPVTRQWAIMQEGDEFANLTVSILPDDFPEMDESFLISLLEVHLMNISASLKNQPTIGQPNISTVVIALNGDAFGVFVIYNISPNTSEDGLFVEVQEQPQTLVELMIHRTGGSLGQVAVEWRVVGGTATEGLDFIGAGEILTFAEGETKKTVILTILDDSEPEDDESIIVSLVYTEGGSRILPSSDTVRVNILANDNVAGIVSFQTASRSVIGHEGEILQFHVIRTFPGRGNVTVNWKIIGQNLELNFANFSGQLFFPEGSLNTTLFVHLLDDNIPEEKEVYQVILYDVRTQGVPPAGIALLDAQGYAAVLTVEASDEPHGVLNFALSSRFVLLQEANITIQLFINREFGSLGAINVTYTTVPGMLSLKNQTVGNLAEPEVDFVPIIGFLILEEGETAAAINITILEDDVPELEEYFLVNLTYVGLTMAASTSFPPRLDSEGLTAQVIIDANDGARGVIEWQQSRFEVNETHGSLTLVAQRSREPLGHVSLFVYAQNLEAQVGLDYIFTPMILHFADGERYKNVNIMILDDDIPEGDEKFQLILTNPSPGLELGKNTIALIIVLANDDGPGVLSFNNSEHFFLREPTALYVQESVAVLYIVREPAQGLFGTVTVQFIVTEVNSSNESKDLTPSKGYIVLEEGVRFKALQISAILDTEPEMDEYFVCTLFNPTGGARLGVHVQTLITVLQNQAPLGLFSISAVENRATSIDIEEANRTVYLNVSRTNGIDLAVSVQWETVSETAFGMRGMDVVFSVFQSFLDESASGWCFFTLENLIYGIMLRKSSVTVYRWQGIFIPVEDLNIENPKTCEAFNIGFSPYFVITHEERNEEKPSLNSVFTFTSGFKLFLVQTIIILESSQVRYFTSDSQDYLIIASQRDDSELTQVFRWNGGSFVLHQKLPVRGVLTVALFNKGGSVFLAISQANARLNSLLFRWSGSGFINFQEVPVSGTTEVEALSSANDIYLIFAENVFLGDQNSIDIFIWEMGQSSFRYFQSVDFAAVNRIHSFTPASGIAHILLIGQDMSALYCWNSERNQFSFVLEVPSAYDVASVTVKSLNSSKNLIALVGAHSHIYELAYISSHSDFIPSSGELIFEPGEREATIAVNILDDTVPEKEESFKVQLKNPKGGAEIGINDSVTITILSNDDAYGIVAFAQNSLYKQVEEMEQDSLVTLNVERLKGTYGRITIAWEADGSISDIFPTSGVILFTEGQVLSTITLTILADNIPELSEVVIVTLTRITTEGVEDSYKGATIDQDRSKSVITTLPNDSPFGLVGWRAASVFIRVAEPKENTTTLQLQIARDKGLLGDIAIHLRAQPNFLLHVDNQATENEDYVLQETIIIMKENIKEAHAEVSILPDDLPELEEGFIVTITEVNLVNSDFSTGQPSVRRPGMEIAEIMIEENDDPRGIFMFHVTRGAGEVITAYEVPPPLNVLQVPVVRLAGSFGAVNVYWKASPDSAGLEDFKPSHGILEFADKQVTAMIEITIIDDAEFELTETFNISLISVAGGGRLGDDVVVTVVIPQNDSPFGVFGFEEKTVMIDESLSSDDPDSYVTLTVVRSPGGKGTVRLEWTIDEKAKHNLSPLNGTLHFDETESQKTIVLHTLQDTVLEEDRRFTIQLISIDEVEISPVKGSASIIIRGDKRASGEVGIAPSSRHILIGEPSAKYNGTAIISLVRGPGILGEVTVFWRIFPPSVGEFAETSGKLTMRDEQSAVIVVIQALNDDIPEEKSFYEFQLTAVSEGGVLSESSSTANITVVASDSPYGRFAFSHEQLRVSEAQRVNITIIRSSGDFGHVRLWYKTMSGTAEAGLDFVPAAGELLFEAGEMRKSLHVEILDDDYPEGPEEFSLTITKVELQGRGYDFTIQENGLQIDQPPEIGNISIVRIIIMKNDNAEGIIEFDPKYTAFEVEEDVGLIMIPVVRLHGTYGYVTADFISQSSSASPGGVDYILHGSTVTFQHGQNLSFINISIIDDNESEFEEPIEILLTGATGGAVLGRHLVSRIIIAKSDSPFGVIRFLNQSKISIANPNSTMILSLVLERTGGLLGEIQVNWETVGPNSQEALLPQNRDIADPVSGLFYFGEGEGGVRTIILTIYPHEEIEVEETFIIKLHLVKGEAKLDSRAKDVTLTIQEFGDPNGVVQFAPETLSKKTYSEPLALEGPLLITFFVRRVKGTFGEIMVYWELSSEFDITEDFLSTSGFFTIADGESEASFDVHLLPDEVPEIEEDYVIQLVSVEGGAELDLEKSITWFSVYANDDPHGVFALYSDRQSILIGQNLIRSIQINITRLAGTFGDVAVGLRISSDHKEQPIVTENAERQLVVKDGATYKVDVVPIKNQVFLSLGSNFTLQLVTVMLVGGRFYGMPTILQEAKSAVLPVSEKAANSQVGFESTAFQLMNITAGTSHVMISRRGTYGALSVAWTTGYAPGLEIPEFIVVGNMTPTLGSLSFSHGEQRKGVFLWTFPSPGWPEAFVLHLSGVQSSAPGGAQLRSGFIVAEIEPMGVFQFSTSSRNIIVSEDTQMIRLHVQRLFGFHSDLIKVSYQTTAGSAKPLEDFEPVQNGELFFQKFQTEVDFEITIINDQLSEIEEFFYINLTSVEIRGLQKFDVNWSPRLNLDFSVAVITILDNDDLAGMDISFPETTVAVAVDTTLIPVETESTTYLSTSKTTTILQPTNVVAIVTEATGVSAIPEKLVTLHGTPAVSEKPDVATVTANVSIHGTFSLGPSIVYIEEEMKNGTFNTAEVLIRRTGGFTGNVSITVKTFGERCAQMEPNALPFRGIYGISNLTWAVEEEDFEEQTLTLIFLDGERERKVSVQILDDDEPEGQEFFYVFLTNPQGGAQIVEEKDDTGFAAFAMVIITGSDLHNGIIGFSEESQSGLELREGAVMRRLHLIVTRQPNRAFEDVKVFWRVTLNKTVVVLQKDGVNLVEELQSVSGTTTCTMGQTKCFISIELKPEKVPQVEVYFFVELYEATAGAAINNSARFAQIKILESDESQSLVYFSVGSRLAVAHKKATLISLQVARDSGTGLMMSVNFSTQELRSAETIGRTIISPAISGKDFVITEGTLVFEPGQRSTVLDVILTPETGSLNSFPKRFQIVLFDPKGGARIDKVYGTANITLVSDADSQAIWGLADQLHQPVNDDILNRVLHTISMKVATENTDEQLSAMMHLIEKITTEGKIQAFSVASRTLFYEILCSLINPKRKDTRGFSHFAEVTENFAFSLLTNVTCGSPGEKSKTILDSCPYLSILALHWYPQQINGHKFEGKEGDYIRIPERLLDVQDAEIMAGKSTCKLVQFTEYSSQQWFISGNNLPTLKNKVLSLSVKGQSSQLLTNDNEVLYRIYAAEPRIIPQTSLCLLWNQAAASWLSDSQFCKVVEETADYVECACSHMSVYAVYARTDNLSSYNEAFFTSGFICISGLCLAVLSHIFCARYSMFAAKLLTHMMAASLGTQILFLASAYASPQLAEESCSAMAAVTHYLYLCQFSWMLIQSVNFWYVLVMNDEHTERRYLLFFLLSWGLPAFVVILLIVILKGIYHQSMSQIYGLIHGDLCFIPNVYAALFTAALVPLTCLVVVFVVFIHAYQVKPQWKAYDDVFRGRTNAAEIPLILYLFALISVTWLWGGLHMAYRHFWMLVLFVIFNSLQGLYVFMVYFILHNQMCCPMKASYTVEMNGHPGPSTAFFTPGSGMPPAGGEISKSTQNLIGAMEEVPPDWERASFQQGSQASPDLKPSPQNGATFPSSGGYGQGSLIADEESQEFDDLIFALKTGAGLSVSDNESGQGSQEGGTLTDSQIVELRRIPIADTHL,6306,"693,069",Alternative sequence (6); Chain (3); Domain (36); Erroneous translation (1); Frameshift (1); Natural variant (29); Repeat (6); Sequence conflict (23); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q13145,BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA),MDRHSSYIFIWLQLELCAMAVLLTKGEIRCYCDAAHCVATGYMCKSELSACFSRLLDPQNSNSPLTHGCLDSLASTTDICQAKQARNHSGTTIPTLECCHEDMCNYRGLHDVLSPPRGEASGQGNRYQHDGSRNLITKVQELTSSKELWFRAAVIAVPIAGGLILVLLIMLALRMLRSENKRLQDQRQQMLSRLHYSFHGHHSKKGQVAKLDLECMVPVSGHENCCLTCDKMRQADLSNDKILSLVHWGMYSGHGKLEFV,260,"29,108",Chain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
P10966,T-cell surface glycoprotein CD8 beta chain (CD antigen CD8b),MRPRLWLLLAAQLTVLHGNSVLQQTPAYIKVQTNKMVMLSCEAKISLSNMRIYWLRQRQAPSSDSHHEFLALWDSAKGTIHGEEVEQEKIAVFRDASRFILNLTSVKPEDSGIYFCMIVGSPELTFGKGTQLSVVDFLPTTAQPTKKSTLKKRVCRLPRPETQKGPLCSPITLGLLVAGVLVLLVSLGVAIHLCCRRRRARLRFMKQFYK,210,"23,722",Alternative sequence (6); Chain (1); Disulfide bond (1); Domain (1); Erroneous gene model prediction (1); Glycosylation (1); Modified residue (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..21
P41180,Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1),MAFYSCCWVLLALTWHTSAYGPDQRAQKKGDIILGGLFPIHFGVAAKDQDLKSRPESVECIRYNFRGFRWLQAMIFAIEEINSSPALLPNLTLGYRIFDTCNTVSKALEATLSFVAQNKIDSLNLDEFCNCSEHIPSTIAVVGATGSGVSTAVANLLGLFYIPQVSYASSSRLLSNKNQFKSFLRTIPNDEHQATAMADIIEYFRWNWVGTIAADDDYGRPGIEKFREEAEERDICIDFSELISQYSDEEEIQHVVEVIQNSTAKVIVVFSSGPDLEPLIKEIVRRNITGKIWLASEAWASSSLIAMPQYFHVVGGTIGFALKAGQIPGFREFLKKVHPRKSVHNGFAKEFWEETFNCHLQEGAKGPLPVDTFLRGHEESGDRFSNSSTAFRPLCTGDENISSVETPYIDYTHLRISYNVYLAVYSIAHALQDIYTCLPGRGLFTNGSCADIKKVEAWQVLKHLRHLNFTNNMGEQVTFDECGDLVGNYSIINWHLSPEDGSIVFKEVGYYNVYAKKGERLFINEEKILWSGFSREVPFSNCSRDCLAGTRKGIIEGEPTCCFECVECPDGEYSDETDASACNKCPDDFWSNENHTSCIAKEIEFLSWTEPFGIALTLFAVLGIFLTAFVLGVFIKFRNTPIVKATNRELSYLLLFSLLCCFSSSLFFIGEPQDWTCRLRQPAFGISFVLCISCILVKTNRVLLVFEAKIPTSFHRKWWGLNLQFLLVFLCTFMQIVICVIWLYTAPPSSYRNQELEDEIIFITCHEGSLMALGFLIGYTCLLAAICFFFAFKSRKLPENFNEAKFITFSMLIFFIVWISFIPAYASTYGKFVSAVEVIAILAASFGLLACIFFNKIYIILFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRKRSSSLGGSTGSTPSSSISSKSNSEDPFPQPERQKQQQPLALTQQEQQQQPLTLPQQQRSQQQPRCKQKVIFGSGTVTFSLSFDEPQKNAMAHRNSTHQNSLEAQKSSDTLTRHEPLLPLQCGETDLDLTVQETGLQGPVGGDQRPEVEDPEELSPALVVSSSQSFVISGGGSTVTENVVNS,1078,"120,675",Alternative sequence (1); Beta strand (31); Binding site (4); Chain (1); Disulfide bond (10); Erroneous gene model prediction (1); Glycosylation (11); Helix (23); Metal binding (9); Modified residue (2); Mutagenesis (10); Natural variant (120); Region (6); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (6),"DISULFID 60..101;  /evidence=""ECO:0000244|PDB:5FBH, ECO:0000244|PDB:5FBK, ECO:0000244|PDB:5K5S, ECO:0000269|PubMed:27386547, ECO:0000269|PubMed:27434672""; DISULFID 129;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:27434672, ECO:0000305|PubMed:27386547""; DISULFID 131;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:27434672, ECO:0000305|PubMed:27386547""; DISULFID 236..561;  /evidence=""ECO:0000269|PubMed:27434672""; DISULFID 358..395;  /evidence=""ECO:0000244|PDB:5FBH, ECO:0000244|PDB:5FBK, ECO:0000244|PDB:5K5S, ECO:0000269|PubMed:27386547, ECO:0000269|PubMed:27434672""; DISULFID 437..449;  /evidence=""ECO:0000244|PDB:5FBH, ECO:0000244|PDB:5FBK, ECO:0000244|PDB:5K5S, ECO:0000269|PubMed:27386547, ECO:0000269|PubMed:27434672""; DISULFID 542..562;  /evidence=""ECO:0000269|PubMed:27434672""; DISULFID 546..565;  /evidence=""ECO:0000269|PubMed:27434672""; DISULFID 568..582;  /evidence=""ECO:0000269|PubMed:27434672""; DISULFID 585..598;  /evidence=""ECO:0000269|PubMed:27434672""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P30203,T-cell differentiation antigen CD6 (T12) (TP120) (CD antigen CD6) [Cleaved into: Soluble CD6],MWLFFGITGLLTAALSGHPSPAPPDQLNTSSAESELWEPGERLPVRLTNGSSSCSGTVEVRLEASWEPACGALWDSRAAEAVCRALGCGGAEAASQLAPPTPELPPPPAAGNTSVAANATLAGAPALLCSGAEWRLCEVVEHACRSDGRRARVTCAENRALRLVDGGGACAGRVEMLEHGEWGSVCDDTWDLEDAHVVCRQLGCGWAVQALPGLHFTPGRGPIHRDQVNCSGAEAYLWDCPGLPGQHYCGHKEDAGAVCSEHQSWRLTGGADRCEGQVEVHFRGVWNTVCDSEWYPSEAKVLCQSLGCGTAVERPKGLPHSLSGRMYYSCNGEELTLSNCSWRFNNSNLCSQSLAARVLCSASRSLHNLSTPEVPASVQTVTIESSVTVKIENKESRELMLLIPSIVLGILLLGSLIFIAFILLRIKGKYALPVMVNHQHLPTTIPAGSNSYQPVPITIPKEVFMLPIQVQAPPPEDSDSGSDSDYEHYDFSAQPPVALTTFYNSQRHRVTDEEVQQSRFQMPPLEEGLEELHASHIPTANPGHCITDPPSLGPQYHPRSNSESSTSSGEDYCNSPKSKLPPWNPQVFSSERSSFLEQPPNLELAGTQPAFSAGPPADDSSSTSSGEWYQNFQPPPQPPSEEQFGCPGSPSPQPDSTDNDDYDDISAA,668,"71,801",Alternative sequence (5); Beta strand (23); Chain (2); Disulfide bond (11); Domain (3); Glycosylation (8); Helix (5); Modified residue (1); Mutagenesis (12); Natural variant (6); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 54..88;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000269|PubMed:26146185""; DISULFID 70..144;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 83..155;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 129..137;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 170..204;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000269|PubMed:26146185""; DISULFID 186..249;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 199..259;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 230..240;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 290..350;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 303..360;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""; DISULFID 330..340;  /evidence=""ECO:0000244|PDB:5A2E, ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:26146185""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q8IZF6,Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112),MKEHIIYQKLYGLILMSSFIFLSDTLSLKGKKLDFFGRGDTYVSLIDTIPELSRFTACIDLVFMDDNSRYWMAFSYITNNALLGREDIDLGLAGDHQQLILYRLGKTFSIRHHLASFQWHTICLIWDGVKGKLELFLNKERILEVTDQPHNLTPHGTLFLGHFLKNESSEVKSMMRSFPGSLYYFQLWDHILENEEFMKCLDGNIVSWEEDVWLVNKIIPTVDRTLRCFVPENMTIQEKSTTVSQQIDMTTPSQITGVKPQNTAHSSTLLSQSIPIFATDYTTISYSNTTSPPLETMTAQKILKTLVDETATFAVDVLSTSSAISLPTQSISIDNTTNSMKKTKSPSSESTKTTKMVEAMATEIFQPPTPSNFLSTSRFTKNSVVSTTSAIKSQSAVTKTTSLFSTIESTSMSTTPCLKQKSTNTGALPISTAGQEFIESTAAGTVPWFTVEKTSPASTHVGTASSFPPEPVLISTAAPVDSVFPRNQTAFPLATTDMKIAFTVHSLTLPTRLIETTPAPRTAETELTSTNFQDVSLPRVEDAMSTSMSKETSSKTFSFLTSFSFTGTESVQTVIDAEATRTALTPEITLASTVAETMLSSTITGRVYTQNTPTADGHLLTLMSTRSASTSKAPESGPTSTTDEAAHLFSSNETIWTSRPDQALLASMNTTTILTFVPNENFTSAFHENTTYTEYLSATTNITPLKASPEGKGTTANDATTARYTTAVSKLTSPWFANFSIVSGTTSITNMPEFKLTTLLLKTIPMSTKPANELPLTPRETVVPSVDIISTLACIQPNFSTEESASETTQTEINGAIVFGGTTTPVPKSATTQRLNATVTRKEATSHYLMRKSTIAAVAEVSPFSTMLEVTDESAQRVTASVTVSSFPDIEKLSTPLDNKTATTEVRESWLLTKLVKTTPRSSYNEMTEMFNFNHTYVAHWTSETSEGISAGSPTSGSTHIFGEPLGASTTRISETSFSTTPTDRTATSLSDGILPPQPTAAHSSATPVPVTHMFSLPVNGSSVVAEETEVTMSEPSTLARAFSTSVLSDVSNLSSTTMTTALVPPLDQTASTTIVIVPTHGDLIRTTSEATVISVRKTSMAVPSLTETPFHSLRLSTPVTAKAETTLFSTSVDTVTPSTHTLVCSKPPPDNIPPASSTHVISTTSTPEATQPISQVEETSTYALSFPYTFSGGGVVASLATGTTETSVVDETTPSHISANKLTTSVNSHISSSATYRVHTPVSIQLVTSTSVLSSDKDQMTISLGKTPRTMEVTEMSPSKNSFISYSRGTPSLEMTDTGFPETTKISSHQTHSPSEIPLGTPSDGNLASSPTSGSTQITPTLTSSNTVGVHIPEMSTSLGKTALPSQALTITTFLCPEKESTSALPAYTPRTVEMIVNSTYVTHSVSYGQDTSFVDTTTSSSTRISNPMDINTTFSHLHSLRTQPEVTSVASFISESTQTFPESLSLSTAGLYNDGFTVLSDRITTAFSVPNVPTMLPRESSMATSTPIYQMSSLPVNVTAFTSKKVSDTPPIVITKSSKTMHPGCLKSPCTATSGPMSEMSSIPVNNSAFTPATVSSDTSTRVGLFSTLLSSVTPRTTMTMQTSTLDVTPVIYAGATSKNKMVSSAFTTEMIEAPSRITPTTFLSPTEPTLPFVKTVPTTIMAGIVTPFVGTTAFSPLSSKSTGAISSIPKTTFSPFLSATQQSSQADEATTLGILSGITNRSLSTVNSGTGVALTDTYSRITVPENMLSPTHADSLHTSFNIQVSPSLTSFKSASGPTKNVKTTTNCFSSNTRKMTSLLEKTSLTNYATSLNTPVSYPPWTPSSATLPSLTSFVYSPHSTEAEISTPKTSPPPTSQMVEFPVLGTRMTSSNTQPLLMTSWNIPTAEGSQFPISTTINVPTSNEMETETLHLVPGPLSTFTASQTGLVSKDVMAMSSIPMSGILPNHGLSENPSLSTSLRAITSTLADVKHTFEKMTTSVTPGTTLPSILSGATSGSVISKSPILTWLLSSLPSGSPPATVSNAPHVMTSSTVEVSKSTFLTSDMISAHPFTNLTTLPSATMSTILTRTIPTPTLGGITTGFPTSLPMSINVTDDIVYISTHPEASSRTTITANPRTVSHPSSFSRKTMSPSTTDHTLSVGAMPLPSSTITSSWNRIPTASSPSTLIIPKPTLDSLLNIMTTTSTVPGASFPLISTGVTYPFTATVSSPISSFFETTWLDSTPSFLSTEASTSPTATKSTVSFYNVEMSFSVFVEEPRIPITSVINEFTENSLNSIFQNSEFSLATLETQIKSRDISEEEMVMDRAILEQREGQEMATISYVPYSCVCQVIIKASSSLASSELMRKIKSKIHGNFTHGNFTQDQLTLLVNCEHVAVKKLEPGNCKADETASKYKGTYKWLLTNPTETAQTRCIKNEDGNATRFCSISINTGKSQWEKPKFKQCKLLQELPDKIVDLANITISDENAEDVAEHILNLINESPALGKEETKIIVSKISDISQCDEISMNLTHVMLQIINVVLEKQNNSASDLHEISNEILRIIERTGHKMEFSGQIANLTVAGLALAVLRGDHTFDGMAFSIHSYEEGTDPEIFLGNVPVGGILASIYLPKSLTERIPLSNLQTILFNFFGQTSLFKTKNVTKALTTYVVSASISDDMFIQNLADPVVITLQHIGGNQNYGQVHCAFWDFENNNGLGGWNSSGCKVKETNVNYTICQCDHLTHFGVLMDLSRSTVDSVNEQILALITYTGCGISSIFLGVAVVTYIAFHKLRKDYPAKILINLCTALLMLNLVFLINSWLSSFQKVGVCITAAVALHYFLLVSFTWMGLEAVHMYLALVKVFNIYIPNYILKFCLVGWGIPAIMVAITVSVKKDLYGTLSPTTPFCWIKDDSIFYISVVAYFCLIFLMNLSMFCTVLVQLNSVKSQIQKTRRKMILHDLKGTMSLTFLLGLTWGFAFFAWGPMRNFFLYLFAIFNTLQGFFIFVFHCVMKESVREQWQIHLCCGWLRLDNSSDGSSRCQIKVGYKQEGLKKIFEHKLLTPSLKSTATSSTFKSLGSAQGTPSEISFPNDDFDKDPYCSSP,3080,"333,368",Alternative sequence (7); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (8); Natural variant (5); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 58..123;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01172""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q13444,"Disintegrin and metalloproteinase domain-containing protein 15 (ADAM 15) (EC 3.4.24.-) (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15) (MDC-15) (Metargidin)",MRLALLWALGLLGAGSPLPSWPLPNIGGTEEQQAESEKAPREPLEPQVLQDDLPISLKKVLQTSLPEPLRIKLELDGDSHILELLQNRELVPGRPTLVWYQPDGTRVVSEGHTLENCCYQGRVRGYAGSWVSICTCSGLRGLVVLTPERSYTLEQGPGDLQGPPIISRIQDLHLPGHTCALSWRESVHTQKPPEHPLGQRHIRRRRDVVTETKTVELVIVADHSEAQKYRDFQHLLNRTLEVALLLDTFFRPLNVRVALVGLEAWTQRDLVEISPNPAVTLENFLHWRRAHLLPRLPHDSAQLVTGTSFSGPTVGMAIQNSICSPDFSGGVNMDHSTSILGVASSIAHELGHSLGLDHDLPGNSCPCPGPAPAKTCIMEASTDFLPGLNFSNCSRRALEKALLDGMGSCLFERLPSLPPMAAFCGNMFVEPGEQCDCGFLDDCVDPCCDSLTCQLRPGAQCASDGPCCQNCQLRPSGWQCRPTRGDCDLPEFCPGDSSQCPPDVSLGDGEPCAGGQAVCMHGRCASYAQQCQSLWGPGAQPAAPLCLQTANTRGNAFGSCGRNPSGSYVSCTPRDAICGQLQCQTGRTQPLLGSIRDLLWETIDVNGTELNCSWVHLDLGSDVAQPLLTLPGTACGPGLVCIDHRCQRVDLLGAQECRSKCHGHGVCDSNRHCYCEEGWAPPDCTTQLKATSSLTTGLLLSLLVLLVLVMLGASYWYRARLHQRLCQLKGPTCQYRAAQSGPSERPGPPQRALLARGTKQASALSFPAPPSRPLPPDPVSKRLQAELADRPNPPTRPLPADPVVRSPKSQGPAKPPPPRKPLPADPQGRCPSGDLPGPGAGIPPLVVPSRPAPPPPTVSSLYL,863,"92,959",Active site (1); Alternative sequence (14); Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (5); Metal binding (4); Modified residue (2); Motif (4); Mutagenesis (1); Natural variant (3); Propeptide (1); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 323..409;  /evidence=""ECO:0000250""; DISULFID 365..393;  /evidence=""ECO:0000250""; DISULFID 367..376;  /evidence=""ECO:0000250""; DISULFID 480..500;  /evidence=""ECO:0000250""; DISULFID 657..667;  /evidence=""ECO:0000250""; DISULFID 661..673;  /evidence=""ECO:0000250""; DISULFID 675..684;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P17342,Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C),MPSLLVLTFSPCVLLGWALLAGGTGGGGVGGGGGGAGIGGGRQEREALPPQKIEVLVLLPQDDSYLFSLTRVRPAIEYALRSVEGNGTGRRLLPPGTRFQVAYEDSDCGNRALFSLVDRVAAARGAKPDLILGPVCEYAAAPVARLASHWDLPMLSAGALAAGFQHKDSEYSHLTRVAPAYAKMGEMMLALFRHHHWSRAALVYSDDKLERNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEDIVRNIQASERVVIMCASSDTIRSIMLVAHRHGMTSGDYAFFNIELFNSSSYGDGSWKRGDKHDFEAKQAYSSLQTVTLLRTVKPEFEKFSMEVKSSVEKQGLNMEDYVNMFVEGFHDAILLYVLALHEVLRAGYSKKDGGKIIQQTWNRTFEGIAGQVSIDANGDRYGDFSVIAMTDVEAGTQEVIGDYFGKEGRFEMRPNVKYPWGPLKLRIDENRIVEHTNSSPCKSSGGLEESAVTGIVVGALLGAGLLMAFYFFRKKYRITIERRTQQEESNLGKHRELREDSIRSHFSVA,541,"59,808",Alternative sequence (3); Beta strand (19); Binding site (3); Chain (1); Disulfide bond (3); Glycosylation (3); Helix (15); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 108..136;  /evidence=""ECO:0000269|PubMed:11533490, ECO:0000269|PubMed:16870210, ECO:0000269|PubMed:7727388""; DISULFID 213..261;  /evidence=""ECO:0000269|PubMed:11533490, ECO:0000269|PubMed:16870210, ECO:0000269|PubMed:7727388""; DISULFID 473;  /note=""Interchain"";  /evidence=""ECO:0000269|PubMed:11533490, ECO:0000269|PubMed:16870210, ECO:0000269|PubMed:7727388""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P15812,"T-cell surface glycoprotein CD1e, membrane-associated (hCD1e) (R2G1) (CD antigen CD1e) [Cleaved into: T-cell surface glycoprotein CD1e, soluble (sCD1e)]",MLLLFLLFEGLCCPGENTAAPQALQSYHLAAEEQLSFRMLQTSSFANHSWAHSEGSGWLGDLQTHGWDTVLGTIRFLKPWSHGNFSKQELKNLQSLFQLYFHSFIQIVQASAGQFQLEYPFEIQILAGCRMNAPQIFLNMAYQGSDFLSFQGISWEPSPGAGIRAQNICKVLNRYLDIKEILQSLLGHTCPRFLAGLMEAGESELKRKVKPEAWLSCGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQRGTQRGDVLPNADETWYLRATLDVAAGEAAGLSCRVKHSSLGGHDLIIHWGGYSIFLILICLTVIVTLVILVVVDSRLKKQSSNKNILSPHTPSPVFLMGANTQDTKNSRHQFCLAQVSWIKNRVLKKWKTRLNQLW,388,"43,626",Alternative sequence (7); Beta strand (18); Chain (2); Disulfide bond (1); Domain (1); Erroneous gene model prediction (1); Glycosylation (2); Helix (5); Natural variant (6); Propeptide (1); Sequence conflict (2); Signal peptide (1); Transmembrane (1); Turn (6),"DISULFID 230..285;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9NPF0,CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6) (FDC-SM-8D6) (Transcobalamin receptor) (TCblR) (CD antigen CD320),MSGGWMAQVGAWRTGALGLALLLLLGLGLGLEAAASPLSTPTSAQAAGPSSGSCPPTKFQCRTSGLCVPLTWRCDRDLDCSDGSDEEECRIEPCTQKGQCPPPPGLPCPCTGVSDCSGGTDKKLRNCSRLACLAGELRCTLSDDCIPLTWRCDGHPDCPDSSDELGCGTNEILPEGDATTMGPPVTLESVTSLRNATTMGPPVTLESVPSVGNATSSSAGDQSGSPTAYGVIAAAAVLSASLVTATLLLLSWLRAQERLRPLGLLVAMKESLLLSEQKTSLP,282,"28,991",Alternative sequence (1); Beta strand (7); Chain (1); Compositional bias (3); Disulfide bond (6); Domain (2); Glycosylation (3); Helix (5); Metal binding (12); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 54..67;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000244|PDB:4ZRQ, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""; DISULFID 61..80;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000244|PDB:4ZRQ, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""; DISULFID 74..89;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""; DISULFID 132..145;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000244|PDB:4ZRQ, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""; DISULFID 139..158;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000244|PDB:4ZRQ, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""; DISULFID 152..167;  /evidence=""ECO:0000244|PDB:4ZRP, ECO:0000244|PDB:4ZRQ, ECO:0000255|PROSITE-ProRule:PRU00124, ECO:0000269|PubMed:27411955""","SIGNAL 1..35;  /evidence=""ECO:0000269|PubMed:15340161"""
P12821,"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]",MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQPVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLLLFLGIALLVATLGLSQRLFSIRHRSLHRHSHGPQFGSEVELRHS,1306,"149,715",Active site (2); Alternative sequence (6); Beta strand (19); Binding site (7); Chain (2); Disulfide bond (4); Erroneous initiation (1); Glycosylation (15); Helix (63); Metal binding (6); Modified residue (1); Mutagenesis (1); Natural variant (24); Propeptide (1); Region (2); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (13),"DISULFID 157..165;  /evidence=""ECO:0000269|PubMed:8755737""; DISULFID 757..763;  /evidence=""ECO:0000269|PubMed:8755737""; DISULFID 957..975;  /evidence=""ECO:0000269|PubMed:8755737""; DISULFID 1143..1155;  /evidence=""ECO:0000269|PubMed:8755737""","SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:2558109"""
P43681,Neuronal acetylcholine receptor subunit alpha-4,MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNKWSRPVANISDVVLVRFGLSIAQLIDVDEKNQMMTTNVWVKQEWHDYKLRWDPADYENVTSIRIPSELIWRPDIVLYNNADGDFAVTHLTKAHLFHDGRVQWTPPAIYKSSCSIDVTFFPFDQQNCTMKFGSWTYDKAKIDLVNMHSRVDQLDFWESGEWVIVDAVGTYNTRKYECCAEIYPDITYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSECGEKITLCISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPRTHTMPTWVRRVFLDIVPRLLLMKRPSVVKDNCRRLIESMHKMASAPRFWPEPEGEPPATSGTQSLHPPSPSFCVPLDVPAEPGPSCKSPSDQLPPQQPLEAEKASPHPSPGPCRPPHGTQAPGLAKARSLSVQHMSSPGEAVEGGVRCRSRSIQYCVPRDDAAPEADGQAAGALASRNTHSAELPPPDQPSPCKCTCKKEPSSVSPSATVKTRSTKAPPPHLPLSPALTRAVEGVQYIADHLKAEDTDFSVKEDWKYVAMVIDRIFLWMFIIVCLLGTVGLFLPPWLAGMI,627,"69,957",Alternative sequence (2); Beta strand (17); Chain (1); Disulfide bond (2); Glycosylation (3); Helix (11); Lipidation (1); Modified residue (3); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (7),"DISULFID 161..175;  /evidence=""ECO:0000250""; DISULFID 225..226;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P78325,Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a),MRGLGLWLLGAMMLPAIAPSRPWALMEQYEVVLPWRLPGPRVRRALPSHLGLHPERVSYVLGATGHNFTLHLRKNRDLLGSGYTETYTAANGSEVTEQPRGQDHCFYQGHVEGYPDSAASLSTCAGLRGFFQVGSDLHLIEPLDEGGEGGRHAVYQAEHLLQTAGTCGVSDDSLGSLLGPRTAAVFRPRPGDSLPSRETRYVELYVVVDNAEFQMLGSEAAVRHRVLEVVNHVDKLYQKLNFRVVLVGLEIWNSQDRFHVSPDPSVTLENLLTWQARQRTRRHLHDNVQLITGVDFTGTTVGFARVSAMCSHSSGAVNQDHSKNPVGVACTMAHEMGHNLGMDHDENVQGCRCQERFEAGRCIMAGSIGSSFPRMFSDCSQAYLESFLERPQSVCLANAPDLSHLVGGPVCGNLFVERGEQCDCGPPEDCRNRCCNSTTCQLAEGAQCAHGTCCQECKVKPAGELCRPKKDMCDLEEFCDGRHPECPEDAFQENGTPCSGGYCYNGACPTLAQQCQAFWGPGGQAAEESCFSYDILPGCKASRYRADMCGVLQCKGGQQPLGRAICIVDVCHALTTEDGTAYEPVPEGTRCGPEKVCWKGRCQDLHVYRSSNCSAQCHNHGVCNHKQECHCHAGWAPPHCAKLLTEVHAASGSLPVFVVVVLVLLAVVLVTLAGIIVYRKARSRILSRNVAPKTTMGRSNPLFHQAASRVPAKGGAPAPSRGPQELVPTTHPGQPARHPASSVALKRPPPAPPVTVSSPPFPVPVYTRQAPKQVIKPTFAPPVPPVKPGAGAANPGPAEGAVGPKVALKPPIQRKQGAGAPTAP,824,"88,771",Active site (1); Alternative sequence (6); Beta strand (5); Chain (1); Disulfide bond (12); Domain (3); Glycosylation (4); Helix (8); Metal binding (3); Natural variant (6); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 310..395;  /evidence=""ECO:0000250""; DISULFID 351..379;  /evidence=""ECO:0000250""; DISULFID 353..362;  /evidence=""ECO:0000250""; DISULFID 435..457;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 448..454;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 466..486;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 473..503;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 498..508;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 566..613;  /evidence=""ECO:0000250|UniProtKB:Q10741""; DISULFID 613..623;  /evidence=""ECO:0000250""; DISULFID 617..629;  /evidence=""ECO:0000250""; DISULFID 631..640;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q96PE1,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5),MGAGGRRMRGAPARLLLPLLPWLLLLLAPEARGAPGCPLSIRSCKCSGERPKGLSGGVPGPARRRVVCSGGDLPEPPEPGLLPNGTVTLLLSNNKITGLRNGSFLGLSLLEKLDLRNNIISTVQPGAFLGLGELKRLDLSNNRIGCLTSETFQGLPRLLRLNISGNIFSSLQPGVFDELPALKVVDLGTEFLTCDCHLRWLLPWAQNRSLQLSEHTLCAYPSALHAQALGSLQEAQLCCEGALELHTHHLIPSLRQVVFQGDRLPFQCSASYLGNDTRIRWYHNRAPVEGDEQAGILLAESLIHDCTFITSELTLSHIGVWASGEWECTVSMAQGNASKKVEIVVLETSASYCPAERVANNRGDFRWPRTLAGITAYQSCLQYPFTSVPLGGGAPGTRASRRCDRAGRWEPGDYSHCLYTNDITRVLYTFVLMPINASNALTLAHQLRVYTAEAASFSDMMDVVYVAQMIQKFLGYVDQIKELVEVMVDMASNLMLVDEHLLWLAQREDKACSRIVGALERIGGAALSPHAQHISVNARNVALEAYLIKPHSYVGLTCTAFQRREGGVPGTRPGSPGQNPPPEPEPPADQQLRFRCTTGRPNVSLSSFHIKNSVALASIQLPPSLFSSLPAALAPPVPPDCTLQLLVFRNGRLFHSHSNTSRPGAAGPGKRRGVATPVIFAGTSGCGVGNLTEPVAVSLRHWAEGAEPVAAWWSQEGPGEAGGWTSEGCQLRSSQPNVSALHCQHLGNVAVLMELSAFPREVGGAGAGLHPVVYPCTALLLLCLFATIITYILNHSSIRVSRKGWHMLLNLCFHIAMTSAVFAGGITLTNYQMVCQAVGITLHYSSLSTLLWMGVKARVLHKELTWRAPPPQEGDPALPTPSPMLRFYLIAGGIPLIICGITAAVNIHNYRDHSPYCWLVWRPSLGAFYIPVALILLITWIYFLCAGLRLRGPLAQNPKAGNSRASLEAGEELRGSTRLRGSGPLLSDSGSLLATGSARVGTPGPPEDGDSLYSPGVQLGALVTTHFLYLAMWACGALAVSQRWLPRVVCSCLYGVAASALGLFVFTHHCARRRDVRASWRACCPPASPAAPHAPPRALPAAAEDGSPVFGEGPPSLKSSPSGSSGHPLALGPCKLTNLQLAQSQVCEAGAAAGGEGEPEPAGTRGNLAHRHPNNVHHGRRAHKSRAKGHRAGEACGKNRLKALRGGAAGALELLSSESGSLHNSPTDSYLGSSRNSPGAGLQLEGEPMLTPSEGSDTSAAPLSEAGRAGQRRSASRDSLKGGGALEKESHRRSYPLNAASLNGAPKGGKYDDVTLMGAEVASGGCMKTGLWKSETTV,1338,"142,647",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (3); Erroneous initiation (4); Glycosylation (7); Modified residue (1); Motif (2); Mutagenesis (3); Natural variant (2); Repeat (4); Sequence conflict (3); Signal peptide (1); Site (2); Topological domain (8); Transmembrane (7),"DISULFID 268..328;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q8IZF3,Adhesion G protein-coupled receptor F4 (G-protein coupled receptor 115) (G-protein coupled receptor PGR18),MKMKSQATMICCLVFFLSTECSHYRSKIHLKAGDKLQSPEGKPKTGRIQEKCEGPCISSSNCSQPCAKDFHGEIGFTCNQKKWQKSAETCTSLSVEKLFKDSTGASRLSVAAPSIPLHILDFRAPETIESVAQGIRKNCPFDYACITDMVKSSETTSGNIAFIVELLKNISTDLSDNVTREKMKSYSEVANHILDTAAISNWAFIPNKNASSDLLQSVNLFARQLHIHNNSENIVNELFIQTKGFHINHNTSEKSLNFSMSMNNTTEDILGMVQIPRQELRKLWPNASQAISIAFPTLGAILREAHLQNVSLPRQVNGLVLSVVLPERLQEIILTFEKINKTRNARAQCVGWHSKKRRWDEKACQMMLDIRNEVKCRCNYTSVVMSFSILMSSKSMTDKVLDYITCIGLSVSILSLVLCLIIEATVWSRVVVTEISYMRHVCIVNIAVSLLTANVWFIIGSHFNIKAQDYNMCVAVTFFSHFFYLSLFFWMLFKALLIIYGILVIFRRMMKSRMMVIGFAIGYGCPLIIAVTTVAITEPEKGYMRPEACWLNWDNTKALLAFAIPAFVIVAVNLIVVLVVAVNTQRPSIGSSKSQDVVIIMRISKNVAILTPLLGLTWGFGIATLIEGTSLTFHIIFALLNAFQGFFILLFGTIMDHKIRDALRMRMSSLKGKSRAAENASLGPTNGSKLMNRQG,695,"77,719",Chain (1); Domain (1); Erroneous gene model prediction (2); Glycosylation (13); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P78536,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),MRQSLLFLTSVVPFVLAPRPPDDPGFGPHQRLEKLDSLLSDYDILSLSNIQQHSVRKRDLQTSTHVETLLTFSALKRHFKLYLTSSTERFSQNFKVVVVDGKNESEYTVKWQDFFTGHVVGEPDSRVLAHIRDDDVIIRINTDGAEYNIEPLWRFVNDTKDKRMLVYKSEDIKNVSRLQSPKVCGYLKVDNEELLPKGLVDREPPEELVHRVKRRADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTSWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSNCSKQSIYKTIESKAQECFQERSNKVCGNSRVDEGEECDPGIMYLNNDTCCNSDCTLKEGVQCSDRNSPCCKNCQFETAQKKCQEAINATCKGVSYCTGNSSECPPPGNAEDDTVCLDLGKCKDGKCIPFCEREQQLESCACNETDNSCKVCCRDLSGRCVPYVDAEQKNLFLRKGKPCTVGFCDMNGKCEKRVQDVIERFWDFIDQLSINTFGKFLADNIVGSVLVFSLIFWIPFSILVHCVDKKLDKQYESLSLFHPSNVEMLSSMDSASVRIIKPFPAPQTPGRLQPAPVIPSAPAAPKLDHQRMDTIQEDPSTDSHMDEDGFEKDPFPNSSTAAKSFEDLTDHPVTRSEKAASFKLQRQNRVDSKETEC,824,"93,021",Active site (1); Alternative sequence (1); Beta strand (19); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (2); Glycosylation (9); Helix (11); Metal binding (4); Modified residue (5); Motif (3); Natural variant (2); Propeptide (1); Region (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 225..333;  /evidence=""ECO:0000269|PubMed:9520379""; DISULFID 365..469;  /evidence=""ECO:0000269|PubMed:9520379""; DISULFID 423..453;  /evidence=""ECO:0000269|PubMed:9520379""; DISULFID 534..555;  /evidence=""ECO:0000250""; DISULFID 573..582;  /evidence=""ECO:0000250""; DISULFID 578..591;  /evidence=""ECO:0000250""; DISULFID 593..600;  /evidence=""ECO:0000250""","SIGNAL 1..17;  /evidence=""ECO:0000250|UniProtKB:Q9Z1K9"""
O75882,Attractin (DPPT-L) (Mahogany homolog),MVAAAAATEARLRRRTAATAALAGRSGGPHWDWDVTRAGRPGLGAGLRLPRLLSPPLRPRLLLLLLLLSPPLLLLLLPCEAEAAAAAAAVSGSAAAEAKECDRPCVNGGRCNPGTGQCVCPAGWVGEQCQHCGGRFRLTGSSGFVTDGPGNYKYKTKCTWLIEGQPNRIMRLRFNHFATECSWDHLYVYDGDSIYAPLVAAFSGLIVPERDGNETVPEVVATSGYALLHFFSDAAYNLTGFNITYSFDMCPNNCSGRGECKISNSSDTVECECSENWKGEACDIPHCTDNCGFPHRGICNSSDVRGCSCFSDWQGPGCSVPVPANQSFWTREEYSNLKLPRASHKAVVNGNIMWVVGGYMFNHSDYNMVLAYDLASREWLPLNRSVNNVVVRYGHSLALYKDKIYMYGGKIDSTGNVTNELRVFHIHNESWVLLTPKAKEQYAVVGHSAHIVTLKNGRVVMLVIFGHCPLYGYISNVQEYDLDKNTWSILHTQGALVQGGYGHSSVYDHRTRALYVHGGYKAFSANKYRLADDLYRYDVDTQMWTILKDSRFFRYLHTAVIVSGTMLVFGGNTHNDTSMSHGAKCFSSDFMAYDIACDRWSVLPRPDLHHDVNRFGHSAVLHNSTMYVFGGFNSLLLSDILVFTSEQCDAHRSEAACLAAGPGIRCVWNTGSSQCISWALATDEQEEKLKSECFSKRTLDHDRCDQHTDCYSCTANTNDCHWCNDHCVPRNHSCSEGQISIFRYENCPKDNPMYYCNKKTSCRSCALDQNCQWEPRNQECIALPENICGIGWHLVGNSCLKITTAKENYDNAKLFCRNHNALLASLTTQKKVEFVLKQLRIMQSSQSMSKLTLTPWVGLRKINVSYWCWEDMSPFTNSLLQWMPSEPSDAGFCGILSEPSTRGLKAATCINPLNGSVCERPANHSAKQCRTPCALRTACGDCTSGSSECMWCSNMKQCVDSNAYVASFPFGQCMEWYTMSTCPPENCSGYCTCSHCLEQPGCGWCTDPSNTGKGKCIEGSYKGPVKMPSQAPTGNFYPQPLLNSSMCLEDSRYNWSFIHCPACQCNGHSKCINQSICEKCENLTTGKHCETCISGFYGDPTNGGKCQPCKCNGHASLCNTNTGKCFCTTKGVKGDECQLCEVENRYQGNPLRGTCYYTLLIDYQFTFSLSQEDDRYYTAINFVATPDEQNRDLDMFINASKNFNLNITWAASFSAGTQAGEEMPVVSKTNIKEYKDSFSNEKFDFRNHPNITFFVYVSNFTWPIKIQIAFSQHSNFMDLVQFFVTFFSCFLSLLLVAAVVWKIKQSCWASRRREQLLREMQQMASRPFASVNVALETDEEPPDLIGGSIKTVPKPIALEPCFGNKAAVLSVFVRLPRGLGGIPPPGQSGLAVASALVDISQQMPIVYKEKSGAVRNRKQQPPAQPGTCI,1429,"158,537",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (13); Domain (9); Glycosylation (26); Natural variant (4); Propeptide (1); Repeat (6); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 101..111;  /evidence=""ECO:0000250""; DISULFID 105..118;  /evidence=""ECO:0000250""; DISULFID 120..129;  /evidence=""ECO:0000250""; DISULFID 250..260;  /evidence=""ECO:0000250""; DISULFID 254..271;  /evidence=""ECO:0000250""; DISULFID 273..282;  /evidence=""ECO:0000250""; DISULFID 816..918;  /evidence=""ECO:0000250""; DISULFID 1063..1071;  /evidence=""ECO:0000250""; DISULFID 1065..1077;  /evidence=""ECO:0000250""; DISULFID 1080..1089;  /evidence=""ECO:0000250""; DISULFID 1092..1106;  /evidence=""ECO:0000250""; DISULFID 1127..1137;  /evidence=""ECO:0000250""; DISULFID 1140..1155;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P55289,Cadherin-12 (Brain cadherin) (BR-cadherin) (Neural type cadherin 2) (N-cadherin 2),MLTRNCLSLLLWVLFDGGLLTPLQPQPQQTLATEPRENVIHLPGQRSHFQRVKRGWVWNQFFVLEEYVGSEPQYVGKLHSDLDKGEGTVKYTLSGDGAGTVFTIDETTGDIHAIRSLDREEKPFYTLRAQAVDIETRKPLEPESEFIIKVQDINDNEPKFLDGPYVATVPEMSPVGAYVLQVKATDADDPTYGNSARVVYSILQGQPYFSIDPKTGVIRTALPNMDREVKEQYQVLIQAKDMGGQLGGLAGTTIVNITLTDVNDNPPRFPKSIFHLKVPESSPIGSAIGRIRAVDPDFGQNAEIEYNIVPGDGGNLFDIVTDEDTQEGVIKLKKPLDFETKKAYTFKVEASNLHLDHRFHSAGPFKDTATVKISVLDVDEPPVFSKPLYTMEVYEDTPVGTIIGAVTAQDLDVGSSAVRYFIDWKSDGDSYFTIDGNEGTIATNELLDRESTAQYNFSIIASKVSNPLLTSKVNILINVLDVNEFPPEISVPYETAVCENAKPGQIIQIVSAADRDLSPAGQQFSFRLSPEAAIKPNFTVRDFRNNTAGIETRRNGYSRRQQELYFLPVVIEDSSYPVQSSTNTMTIRVCRCDSDGTILSCNVEAIFLPVGLSTGALIAILLCIVILLAIVVLYVALRRQKKKDTLMTSKEDIRDNVIHYDDEGGGEEDTQAFDIGALRNPKVIEENKIRRDIKPDSLCLPRQRPPMEDNTDIRDFIHQRLQENDVDPTAPPYDSLATYAYEGSGSVAESLSSIDSLTTEADQDYDYLTDWGPRFKVLADMFGEEESYNPDKVT,794,"88,332",Alternative sequence (1); Chain (1); Domain (5); Glycosylation (4); Modified residue (1); Natural variant (3); Propeptide (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9UJ99,Cadherin-22 (Pituitary and brain cadherin) (PB-cadherin),MRPRPEGRGLRAGVALSPALLLLLLLPPPPTLLGRLWAAGTPSPSAPGARQDGALGAGRVKRGWVWNQFFVVEEYTGTEPLYVGKIHSDSDEGDGAIKYTISGEGAGTIFLIDELTGDIHAMERLDREQKTFYTLRAQARDRATNRLLEPESEFIIKVQDINDSEPRFLHGPYIGSVAELSPTGTSVMQVMASDADDPTYGSSARLVYSVLDGEHHFTVDPKTGVIRTAVPDLDRESQERYEVVIQATDMAGQLGGLSGSTTVTIVVTDVNDNPPRFPQKMYQFSIQESAPIGTAVGRVKAEDSDVGENTDMTYHLKDESSSGGDVFKVTTDSDTQEAIIVVQKRLDFESQPVHTVILEALNKFVDPRFADLGTFRDQAIVRVAVTDVDEPPEFRPPSGLLEVQEDAQVGSLVGVVTARDPDAANRPVRYAIDRESDLDQIFDIDADTGAIVTGKGLDRETAGWHNITVLAMEADNHAQLSRASLRIRILDVNDNPPELATPYEAAVCEDAKPGQLIQTISVVDRDEPQGGHRFYFRLVPEAPSNPHFSLLDIQDNTAAVHTQHVGFNRQEQDVFFLPILVVDSGPPTLSSTGTLTIRICGCDSSGTIQSCNTTAFVMAASLSPGALIALLVCVLILVVLVLLILTLRRHHKSHLSSDEDEDMRDNVIKYNDEGGGEQDTEAYDMSALRSLYDFGELKGGDGGGSAGGGAGGGSGGGAGSPPQAHLPSERHSLPQGPPSPEPDFSVFRDFISRKVALADGDLSVPPYDAFQTYAFEGADSPAASLSSLHSGSSGSEQDFAYLSSWGPRFRPLAALYAGHRGDDEAQAS,828,"89,091",Chain (1); Domain (5); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
Q9BY67,Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1),MASVVLPSGSQCAAAAAAAAPPGLRLRLLLLLFSAAALIPTGDGQNLFTKDVTVIEGEVATISCQVNKSDDSVIQLLNPNRQTIYFRDFRPLKDSRFQLLNFSSSELKVSLTNVSISDEGRYFCQLYTDPPQESYTTITVLVPPRNLMIDIQKDTAVEGEEIEVNCTAMASKPATTIRWFKGNTELKGKSEVEEWSDMYTVTSQLMLKVHKEDDGVPVICQVEHPAVTGNLQTQRYLEVQYKPQVHIQMTYPLQGLTREGDALELTCEAIGKPQPVMVTWVRVDDEMPQHAVLSGPNLFINNLNKTDNGTYRCEASNIVGKAHSDYMLYVYDPPTTIPPPTTTTTTTTTTTTTILTIITDSRAGEEGSIRAVDHAVIGGVVAVVVFAMLCLLIILGRYFARHKGTYFTHEAKGADDAADADTAIINAEGGQNNSEEKKEYFI,442,"48,509",Alternative sequence (5); Beta strand (10); Chain (1); Disulfide bond (3); Domain (3); Frameshift (1); Glycosylation (6); Helix (1); Modified residue (2); Mutagenesis (2); Natural variant (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 64..124;  /evidence=""ECO:0000244|PDB:4H5S, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23871486""; DISULFID 166..220;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 267..313;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..44;  /evidence=""ECO:0000255"""
Q9ULX7,Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV),MLFSALLLEVIWILAADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDIQTDSVTFDPDLPALQPHGYDQPGTEPLDLHNNGHTVQLSLPSTLYLGGLPRKYVAAQLHLHWGQKGSPGGSEHQINSEATFAELHIVHYDSDSYDSLSEAAERPQGLAVLGILIEVGETKNIAYEHILSHLHEVRHKDQKTSVPPFNLRELLPKQLGQYFRYNGSLTTPPCYQSVLWTVFYRRSQISMEQLEKLQGTLFSTEEEPSKLLVQNYRALQPLNQRMVFASFIQAGSSYTTGEMLSLGVGILVGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA,337,"37,668",Active site (1); Beta strand (16); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Helix (9); Metal binding (3); Modified residue (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 40..221;  /evidence=""ECO:0000269|PubMed:24374484""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q16880,2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase),MKSYTPYFILLWSAVGIAKAAKIIIVPPIMFESHMYIFKTLASALHERGHHTVFLLSEGRDIAPSNHYSLQRYPGIFNSTTSDAFLQSKMRNIFSGRLTAIELFDILDHYTKNCDLMVGNHALIQGLKKEKFDLLLVDPNDMCGFVIAHLLGVKYAVFSTGLWYPAEVGAPAPLAYVPEFNSLLTDRMNLLQRMKNTGVYLISRLGVSFLVLPKYERIMQKYNLLPEKSMYDLVHGSSLWMLCTDVALEFPRPTLPNVVYVGGILTKPASPLPEDLQRWVNGANEHGFVLVSFGAGVKYLSEDIANKLAGALGRLPQKVIWRFSGPKPKNLGNNTKLIEWLPQNDLLGHSKIKAFLSHGGLNSIFETIYHGVPVVGIPLFGDHYDTMTRVQAKGMGILLEWKTVTEKELYEALVKVINNPSYRQRAQKLSEIHKDQPGHPVNRTIYWIDYIIRHNGAHHLRAAVHQISFCQYFLLDIAFVLLLGAALLYFLLSWVTKFIYRKIKSLWSRNKHSTVNGHYHNGILNGKYKRNGHIKHEKKVK,541,"61,438",Chain (1); Glycosylation (3); Natural variant (2); Sequence conflict (4); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q13740,CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166),MESKGASSCRLLFCLLISATVFRPGLGWYTVNSAYGDTIIIPCRLDVPQNLMFGKWKYEKPDGSPVFIAFRSSTKKSVQYDDVPEYKDRLNLSENYTLSISNARISDEKRFVCMLVTEDNVFEAPTIVKVFKQPSKPEIVSKALFLETEQLKKLGDCISEDSYPDGNITWYRNGKVLHPLEGAVVIIFKKEMDPVTQLYTMTSTLEYKTTKADIQMPFTCSVTYYGPSGQKTIHSEQAVFDIYYPTEQVTIQVLPPKNAIKEGDNITLKCLGNGNPPPEEFLFYLPGQPEGIRSSNTYTLTDVRRNATGDYKCSLIDKKSMIASTAITVHYLDLSLNPSGEVTRQIGDALPVSCTISASRNATVVWMKDNIRLRSSPSFSSLHYQDAGNYVCETALQEVEGLKKRESLTLIVEGKPQIKMTKKTDPSGLSKTIICHVEGFPKPAIQWTITGSGSVINQTEESPYINGRYYSKIIISPEENVTLTCTAENQLERTVNSLNVSAISIPEHDEADEISDENREKVNDQAKLIVGIVVGLLLAALVAGVVYWLYMKKSKTASKHVNKDLGNMEENKKLEENNHKTEA,583,"65,102",Alternative sequence (5); Beta strand (18); Chain (1); Disulfide bond (5); Domain (5); Glycosylation (9); Helix (3); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 43..113;  /evidence=""ECO:0000244|PDB:5A2F, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 157..220;  /evidence=""ECO:0000244|PDB:5A2F, ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 270..313;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 354..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 435..485;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q86VB7,Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],MSKLRMVLLEDSGSADFRRHFVNLSPFTITVVLLLSACFVTSSLGGTDKELRLVDGENKCSGRVEVKVQEEWGTVCNNGWSMEAVSVICNQLGCPTAIKAPGWANSSAGSGRIWMDHVSCRGNESALWDCKHDGWGKHSNCTHQQDAGVTCSDGSNLEMRLTRGGNMCSGRIEIKFQGRWGTVCDDNFNIDHASVICRQLECGSAVSFSGSSNFGEGSGPIWFDDLICNGNESALWNCKHQGWGKHNCDHAEDAGVICSKGADLSLRLVDGVTECSGRLEVRFQGEWGTICDDGWDSYDAAVACKQLGCPTAVTAIGRVNASKGFGHIWLDSVSCQGHEPAIWQCKHHEWGKHYCNHNEDAGVTCSDGSDLELRLRGGGSRCAGTVEVEIQRLLGKVCDRGWGLKEADVVCRQLGCGSALKTSYQVYSKIQATNTWLFLSSCNGNETSLWDCKNWQWGGLTCDHYEEAKITCSAHREPRLVGGDIPCSGRVEVKHGDTWGSICDSDFSLEAASVLCRELQCGTVVSILGGAHFGEGNGQIWAEEFQCEGHESHLSLCPVAPRPEGTCSHSRDVGVVCSRYTEIRLVNGKTPCEGRVELKTLGAWGSLCNSHWDIEDAHVLCQQLKCGVALSTPGGARFGKGNGQIWRHMFHCTGTEQHMGDCPVTALGASLCPSEQVASVICSGNQSQTLSSCNSSSLGPTRPTIPEESAVACIESGQLRLVNGGGRCAGRVEIYHEGSWGTICDDSWDLSDAHVVCRQLGCGEAINATGSAHFGEGTGPIWLDEMKCNGKESRIWQCHSHGWGQQNCRHKEDAGVICSEFMSLRLTSEASREACAGRLEVFYNGAWGTVGKSSMSETTVGVVCRQLGCADKGKINPASLDKAMSIPMWVDNVQCPKGPDTLWQCPSSPWEKRLASPSEETWITCDNKIRLQEGPTSCSGRVEIWHGGSWGTVCDDSWDLDDAQVVCQQLGCGPALKAFKEAEFGQGTGPIWLNEVKCKGNESSLWDCPARRWGHSECGHKEDAAVNCTDISVQKTPQKATTGRSSRQSSFIAVGILGVVLLAIFVALFFLTKKRRQRQRLAVSSRGENLVHQIQYREMNSCLNADDLDLMNSSENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGNL,1156,"125,451",Alternative sequence (3); Chain (2); Disulfide bond (26); Domain (9); Erroneous initiation (5); Glycosylation (4); Motif (1); Mutagenesis (3); Natural variant (1); Signal peptide (1); Site (4); Topological domain (2); Transmembrane (1),"DISULFID 76..141;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 89..151;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 120..130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 184..248;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 197..258;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 228..238;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 291..355;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 304..365;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 335..345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 398..462;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 411..472;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 442..452;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 503..567;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 516..577;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 547..557;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 608..672;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 621..682;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 652..662;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 744..808;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 757..818;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 788..798;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 864..925;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 895..905;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 954..1018;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 967..1028;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 998..1008;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""","SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q8TCZ2,CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99),MVAWRSAFLVCLAFSLATLVQRGSGDFDDFNLEDAVKETSSVKQPWDHTTTTTTNRPGTTRAPAKPPGSGLDLADALDDQDDGRRKPGIGGRERWNHVTTTTKRPVTTRAPANTLGNDFDLADALDDRNDRDDGRRKPIAGGGGFSDKDLEDIVGGGEYKPDKGKGDGRYGSNDDPGSGMVAEPGTIAGVASALAMALIGAVSSYISYQQKKFCFSIQQGLNADYVKGENLEAVVCEEPQVKYSTLHTQSAEPPPPPEPARI,262,"27,986",Alternative sequence (8); Chain (1); Compositional bias (4); Frameshift (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q7Z3S7,Voltage-dependent calcium channel subunit alpha-2/delta-4 (Voltage-gated calcium channel subunit alpha-2/delta-4) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-4; Voltage-dependent calcium channel subunit delta-4],MVCGCSALLPLPNPRPTMPATPNFLANPSSSSRWIPLQPMPVAWAFVQKTSALLWLLLLGTSLSPAWGQAKIPLETVKLWADTFGGDLYNTVTKYSGSLLLQKKYKDVESSLKIEEVDGLELVRKFSEDMENMLRRKVEAVQNLVEAAEEADLNHEFNESLVFDYYNSVLINERDEKGNFVELGAEFLLESNAHFSNLPVNTSISSVQLPTNVYNKDPDILNGVYMSEALNAVFVENFQRDPTLTWQYFGSATGFFRIYPGIKWTPDENGVITFDCRNRGWYIQAATSPKDIVILVDVSGSMKGLRMTIAKHTITTILDTLGENDFINIIAYNDYVHYIEPCFKGILVQADRDNREHFKLLVEELMVKGVGVVDQALREAFQILKQFQEAKQGSLCNQAIMLISDGAVEDYEPVFEKYNWPDCKVRVFTYLIGREVSFADRMKWIACNNKGYYTQISTLADTQENVMEYLHVLSRPMVINHDHDIIWTEAYMDSKLLSSQAQSLTLLTTVAMPVFSKKNETRSHGILLGVVGSDVALRELMKLAPRYKLGVHGYAFLNTNNGYILSHPDLRPLYREGKKLKPKPNYNSVDLSEVEWEDQAESLRTAMINRETGTLSMDVKVPMDKGKRVLFLTNDYFFTDISDTPFSLGVVLSRGHGEYILLGNTSVEEGLHDLLHPDLALAGDWIYCITDIDPDHRKLSQLEAMIRFLTRKDPDLECDEELVREVLFDAVVTAPMEAYWTALALNMSEESEHVVDMAFLGTRAGLLRSSLFVGSEKVSDRKFLTPEDEASVFTLDRFPLWYRQASEHPAGSFVFNLRWAEGPESAGEPMVVTASTAVAVTVDKRTAIAAAAGVQMKLEFLQRKFWAATRQCSTVDGPCTQSCEDSDLDCFVIDNNGFILISKRSRETGRFLGEVDGAVLTQLLSMGVFSQVTMYDYQAMCKPSSHHHSAAQPLVSPISAFLTATRWLLQELVLFLLEWSVWGSWYDRGAEAKSVFHHSHKHKKQDPLQPCDTEYPVFVYQPAIREANGIVECGPCQKVFVVQQIPNSNLLLLVTDPTCDCSIFPPVLQEATEVKYNASVKCDRMRSQKLRRRPDSCHAFHPEENAQDCGGASDTSASPPLLLLPVCAWGLLPQLLR,1137,"127,938",Alternative sequence (7); Chain (3); Disulfide bond (1); Domain (2); Erroneous initiation (1); Erroneous translation (1); Glycosylation (2); Metal binding (3); Motif (1); Natural variant (3); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 447..1097;  /note=""Interchain (between alpha-2-4 and delta-4 chains)"";  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P06127,T-cell surface glycoprotein CD5 (Lymphocyte antigen T1/Leu-1) (CD antigen CD5),MPMGSLQPLATLYLLGMLVASCLGRLSWYDPDFQARLTRSNSKCQGQLEVYLKDGWHMVCSQSWGRSSKQWEDPSQASKVCQRLNCGVPLSLGPFLVTYTPQSSIICYGQLGSFSNCSHSRNDMCHSLGLTCLEPQKTTPPTTRPPPTTTPEPTAPPRLQLVAQSGGQHCAGVVEFYSGSLGGTISYEAQDKTQDLENFLCNNLQCGSFLKHLPETEAGRAQDPGEPREHQPLPIQWKIQNSSCTSLEHCFRKIKPQKSGRVLALLCSGFQPKVQSRLVGGSSICEGTVEVRQGAQWAALCDSSSARSSLRWEEVCREQQCGSVNSYRVLDAGDPTSRGLFCPHQKLSQCHELWERNSYCKKVFVTCQDPNPAGLAAGTVASIILALVLLVVLLVVCGPLAYKKLVKKFRQKKQRQWIGPTGMNQNMSFHRNHTATVRSHAENPTASHVDNEYSQPPRNSHLSAYPALEGALHRSSMQPDNSSDSDYDLHGAQRL,495,"54,578",Beta strand (18); Chain (1); Disulfide bond (10); Domain (3); Glycosylation (2); Helix (4); Modified residue (5); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 44..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 60..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 81..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 107..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 201..267;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 244..250;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196""; DISULFID 285..321;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 301..360;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 316..367;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""; DISULFID 342..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000269|PubMed:18339402""",SIGNAL 1..24
A6H8M9,Cadherin-related family member 4 (Cadherin-like protein 29),MVLLRLLVFLFAPVVSDLCSLPCFINVSESQGPGTVLQFLSFNCSSYTPTPTLELLNVQPPTTFFNPPSLARWQGTYVGKLTLSSSAQLDALMVNHYKVQLKFTCGNHVMEGSLSVDVQRDLSHIQCAGQFASPAGEMIQVPETVTPGARLYTLLLPGLELHGAQMSIISAQDLPHFPGPFSINEQGWLQAPSQGLLGQAQKVFQLQISVSFGQRQSCQGMVIVKVLPVPSSQVSFLEQAQNITIPENLAPGSEVVQVQARGVDLRYEILSPVPSPLFSIGRADGVVRTTTPLELARTSGTAVSRLQVKAFEQGQLWASAKLNLTMNVQLVNLWPPRCLPALLVSQIPETAPVGTVLNTLTCEDPDSVGATLDYKLWFRSSSNPASLCLYDRVLEVNATLDCDTPGACFQHAASILVLDGGQPQMTTEVPVLVMVTPINEFSPACAPRTFRVQEDAAPHTLLGSVVGTDMDYPHDNIEYYTSGGPTTFAVDRLSGEVHLLGPLDYEQQRLYRLTVLVIDHGQDQNPNHHLSGSCTITIEVEDVNDHAPECEPPFQELTIYAPLGRSVEVTKMSCQIPQEPQRLIYSYSIVGGNSQNRFILQGAILVHSDLVLGPFWPEQPRTYELLICVADAGPSTPHLSTTATIIVHLVPRRASTVATSTHRTTVPSTMTPMLVTDTEAFWQPQPWFVVVLTATGALLLLALGWLLGRLLQGLAQLLQAPSKPAQALLLNSIQGTEGSIEGFLEAPKMEMSQAPSSVMSLHFDGRAQDSRTGRDYLFNTHTGARRWL,788,"85,827",Alternative sequence (2); Chain (1); Domain (4); Glycosylation (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),MNWSHSCISFCWIYFAASRLRAAETADGKYAQKLFNDLFEDYSNALRPVEDTDKVLNVTLQITLSQIKDMDERNQILTAYLWIRQIWHDAYLTWDRDQYDGLDSIRIPSDLVWRPDIVLYNKADDESSEPVNTNVVLRYDGLITWDAPAITKSSCVVDVTYFPFDNQQCNLTFGSWTYNGNQVDIFNALDSGDLSDFIEDVEWEVHGMPAVKNVISYGCCSEPYPDVTFTLLLKRRSSFYIVNLLIPCVLISFLAPLSFYLPAASGEKVSLGVTILLAMTVFQLMVAEIMPASENVPLIGKYYIATMALITASTALTIMVMNIHFCGAEARPVPHWARVVILKYMSRVLFVYDVGESCLSPHHSRERDHLTKVYSKLPESNLKAARNKDLSRKKDMNKRLKNDLGCQGKNPQEAESYCAQYKVLTRNIEYIAKCLKDHKATNSKGSEWKKVAKVIDRFFMWIFFIMVFVMTILIIARAD,479,"54,807",Beta strand (13); Chain (1); Disulfide bond (2); Glycosylation (2); Helix (3); Mutagenesis (1); Natural variant (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (4); Turn (4),"DISULFID 155..169;  /evidence=""ECO:0000269|PubMed:25282151""; DISULFID 219..220;  /evidence=""ECO:0000269|PubMed:25282151""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q04771,Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I),MVDGVMILPVLIMIALPSPSMEDEKPKVNPKLYMCVCEGLSCGNEDHCEGQQCFSSLSINDGFHVYQKGCFQVYEQGKMTCKTPPSPGQAVECCQGDWCNRNITAQLPTKGKSFPGTQNFHLEVGLIILSVVFAVCLLACLLGVALRKFKRRNQERLNPRDVEYGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKIDNSLDKLKTDC,509,"57,153",Active site (1); Beta strand (12); Binding site (1); Chain (1); Domain (2); Glycosylation (1); Helix (15); Modified residue (1); Natural variant (13); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..20;  /evidence=""ECO:0000250"""
O94910,Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2),MARLAAVLWNLCVTAVLVTSATQGLSRAGLPFGLMRRELACEGYPIELRCPGSDVIMVENANYGRTDDKICDADPFQMENVQCYLPDAFKIMSQRCNNRTQCVVVAGSDAFPDPCPGTYKYLEVQYDCVPYKVEQKVFVCPGTLQKVLEPTSTHESEHQSGAWCKDPLQAGDRIYVMPWIPYRTDTLTEYASWEDYVAARHTTTYRLPNRVDGTGFVVYDGAVFYNKERTRNIVKYDLRTRIKSGETVINTANYHDTSPYRWGGKTDIDLAVDENGLWVIYATEGNNGRLVVSQLNPYTLRFEGTWETGYDKRSASNAFMVCGVLYVLRSVYVDDDSEAAGNRVDYAFNTNANREEPVSLTFPNPYQFISSVDYNPRDNQLYVWNNYFVVRYSLEFGPPDPSAGPATSPPLSTTTTARPTPLTSTASPAATTPLRRAPLTTHPVGAINQLGPDLPPATAPVPSTRRPPAPNLHVSPELFCEPREVRRVQWPATQQGMLVERPCPKGTRGIASFQCLPALGLWNPRGPDLSNCTSPWVNQVAQKIKSGENAANIASELARHTRGSIYAGDVSSSVKLMEQLLDILDAQLQALRPIERESAGKNYNKMHKRERTCKDYIKAVVETVDNLLRPEALESWKDMNATEQVHTATMLLDVLEEGAFLLADNVREPARFLAAKENVVLEVTVLNTEGQVQELVFPQEEYPRKNSIQLSAKTIKQNSRNGVVKVVFILYNNLGLFLSTENATVKLAGEAGPGGPGGASLVVNSQVIAASINKESSRVFLMDPVIFTVAHLEDKNHFNANCSFWNYSERSMLGYWSTQGCRLVESNKTHTTCACSHLTNFAVLMAHREIYQGRINELLLSVITWVGIVISLVCLAICISTFCFLRGLQTDRNTIHKNLCINLFLAELLFLVGIDKTQYEIACPIFAGLLHYFFLAAFSWLCLEGVHLYLLLVEVFESEYSRTKYYYLGGYCFPALVVGIAAAIDYRSYGTEKACWLRVDNYFIWSFIGPVSFVIVVNLVFLMVTLHKMIRSSSVLKPDSSRLDNIKSWALGAIALLFLLGLTWAFGLLFINKESVVMAYLFTTFNAFQGVFIFVFHCALQKKVHKEYSKCLRHSYCCIRSPPGGTHGSLKTSAMRSNTRYYTGTQSRIRRMWNDTVRKQTESSFMAGDINSTPTLNRGTMGNHLLTNPVLQPRGGTSPYNTLIAESVGFNPSSPPVFNSPGSYREPKHPLGGREACGMDTLPLNGNFNNSYSLRSGDFPPGDGGPEPPRGRNLADAAAFEKMIISELVHNNLRGSSSAAKGPPPPEPPVPPVPGGGGEEEAGGPGGADRAEIELLYKALEEPLLLPRAQSVLYQSDLDESESCTAEDGATSRPLSSPPGRDSLYASGANLRDSPSYPDSSPEGPSEALPPPPPAPPGPPEIYYTSRPPALVARNPLQGYYQVRRPSHEGYLAAPGLEGPGPDGDGQMQLVTSL,1474,"162,717",Alternative sequence (1); Binding site (1); Chain (1); Compositional bias (4); Disulfide bond (9); Domain (3); Erroneous initiation (1); Glycosylation (7); Modified residue (3); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 41..71;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 50..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 83..115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 96..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 140..322;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 480..515;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 503..532;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 802..833;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""; DISULFID 821..835;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00446""","SIGNAL 1..24;  /evidence=""ECO:0000250"""
Q8TC27,Disintegrin and metalloproteinase domain-containing protein 32 (ADAM 32),MFRLWLLLAGLCGLLASRPGFQNSLLQIVIPEKIQTNTNDSSEIEYEQISYIIPIDEKLYTVHLKQRYFLADNFMIYLYNQGSMNTYSSDIQTQCYYQGNIEGYPDSMVTLSTCSGLRGILQFENVSYGIEPLESAVEFQHVLYKLKNEDNDIAIFIDRSLKEQPMDDNIFISEKSEPAVPDLFPLYLEMHIVVDKTLYDYWGSDSMIVTNKVIEIVGLANSMFTQFKVTIVLSSLELWSDENKISTVGEADELLQKFLEWKQSYLNLRPHDIAYLLIYMDYPRYLGAVFPGTMCITRYSAGVALYPKEITLEAFAVIVTQMLALSLGISYDDPKKCQCSESTCIMNPEVVQSNGVKTFSSCSLRSFQNFISNVGVKCLQNKPQMQKKSPKPVCGNGRLEGNEICDCGTEAQCGPASCCDFRTCVLKDGAKCYKGLCCKDCQILQSGVECRPKAHPECDIAENCNGTSPECGPDITLINGLSCKNNKFICYDGDCHDLDARCESVFGKGSRNAPFACYEEIQSQSDRFGNCGRDRNNKYVFCGWRNLICGRLVCTYPTRKPFHQENGDVIYAFVRDSVCITVDYKLPRTVPDPLAVKNGSQCDIGRVCVNRECVESRIIKASAHVCSQQCSGHGVCDSRNKCHCSPGYKPPNCQIRSKGFSIFPEEDMGSIMERASGKTENTWLLGFLIALPILIVTTAIVLARKQLKKWFAKEEEFPSSESKSEGSTQTYASQSSSEGSTQTYASQTRSESSSQADTSKSKSEDSAEAYTSRSKSQDSTQTQSSSN,787,"87,948",Chain (1); Compositional bias (1); Disulfide bond (7); Domain (3); Glycosylation (4); Modified residue (1); Natural variant (6); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 295..378;  /evidence=""ECO:0000250""; DISULFID 337..362;  /evidence=""ECO:0000250""; DISULFID 339..344;  /evidence=""ECO:0000250""; DISULFID 450..471;  /evidence=""ECO:0000250""; DISULFID 626..636;  /evidence=""ECO:0000250""; DISULFID 630..642;  /evidence=""ECO:0000250""; DISULFID 644..653;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000269|PubMed:15340161"""
Q96HA4,Uncharacterized protein C1orf159,MALRHLALLAGLLVGVASKSMENTVTRNSTAVINTQAEGTLSPPGLSSLPVVREWALTHTAQLPECCVDVVGVNASCPGASLCGPGCYRRWNADGSASCVRCGNGTLPAYNGSECRSFAGPGAPFPMNRSSGTPGRPHPGAPRVAASLFLGTFFISSGLILSVAGFFYLKRSSKLPRACYRRNKAPALQPGEAAAMIPPPQSSGNSSCRIPLWGFPSLGQSQGALWVCPQTGLPGSGSRPPLPGSPGDPPTRQGQGRIWLVPPALDLSWIWPAPPARPPLIPVTSMLFPVPETWGLQERRTHHDRADPQYLLLLEVQLHPRTDAAGLRQALLSSHRFSGAGSGGPKSQPVRKPRYVRRERPLDRATDPAAFPGEARISNV,380,"40,283",Alternative sequence (7); Chain (1); Compositional bias (1); Glycosylation (3); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9NPY3,Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR) (C1qR(p)) (C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93),MATSMGLLLLLLLLLTQPGAGTGADTEAVVCVGTACYTAHSGKLSAAEAQNHCNQNGGNLATVKSKEEAQHVQRVLAQLLRREAALTARMSKFWIGLQREKGKCLDPSLPLKGFSWVGGGEDTPYSNWHKELRNSCISKRCVSLLLDLSQPLLPSRLPKWSEGPCGSPGSPGSNIEGFVCKFSFKGMCRPLALGGPGQVTYTTPFQTTSSSLEAVPFASAANVACGEGDKDETQSHYFLCKEKAPDVFDWGSSGPLCVSPKYGCNFNNGGCHQDCFEGGDGSFLCGCRPGFRLLDDLVTCASRNPCSSSPCRGGATCVLGPHGKNYTCRCPQGYQLDSSQLDCVDVDECQDSPCAQECVNTPGGFRCECWVGYEPGGPGEGACQDVDECALGRSPCAQGCTNTDGSFHCSCEEGYVLAGEDGTQCQDVDECVGPGGPLCDSLCFNTQGSFHCGCLPGWVLAPNGVSCTMGPVSLGPPSGPPDEEDKGEKEGSTVPRAATASPTRGPEGTPKATPTTSRPSLSSDAPITSAPLKMLAPSGSPGVWREPSIHHATAASGPQEPAGGDSSVATQNNDGTDGQKLLLFYILGTVVAILLLLALALGLLVYRKRRAKREEKKEKKPQNAADSYSWVPERAESRAMENQYSPTPGTDC,652,"68,560",Chain (1); Disulfide bond (16); Domain (6); Glycosylation (1); Modified residue (2); Natural variant (3); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 141..165;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 264..275;  /evidence=""ECO:0000250""; DISULFID 271..285;  /evidence=""ECO:0000250""; DISULFID 287..300;  /evidence=""ECO:0000250""; DISULFID 306..317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 311..328;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 330..343;  /evidence=""ECO:0000250""; DISULFID 349..358;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 354..367;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 369..383;  /evidence=""ECO:0000250""; DISULFID 389..400;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 396..409;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 411..425;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 431..443;  /evidence=""ECO:0000250""; DISULFID 439..452;  /evidence=""ECO:0000250""; DISULFID 454..467;  /evidence=""ECO:0000250""",SIGNAL 1..21
P05067,Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN,770,"86,943",Alternative sequence (13); Beta strand (29); Chain (13); Compositional bias (2); Cross-link (1); Disulfide bond (9); Domain (3); Glycosylation (10); Helix (16); Metal binding (7); Modified residue (11); Motif (3); Mutagenesis (41); Natural variant (21); Peptide (2); Region (10); Sequence caution (1); Sequence conflict (8); Signal peptide (1); Site (14); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 38..62;  /evidence=""ECO:0000244|PDB:1MWP, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4JFN, ECO:0000244|PDB:4PQD, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 73..117;  /evidence=""ECO:0000244|PDB:1MWP, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4JFN, ECO:0000244|PDB:4PQD, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 98..105;  /evidence=""ECO:0000244|PDB:1MWP, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4PQD, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217""; DISULFID 133..187;  /evidence=""ECO:0000244|PDB:1OWT, ECO:0000244|PDB:2FJZ, ECO:0000244|PDB:2FK1, ECO:0000244|PDB:2FK2, ECO:0000244|PDB:2FK3, ECO:0000244|PDB:2FKL, ECO:0000244|PDB:2FMA, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217, ECO:0000269|PubMed:12611883, ECO:0000269|PubMed:17239395, ECO:0000269|PubMed:17909280""; DISULFID 144..174;  /evidence=""ECO:0000244|PDB:1OWT, ECO:0000244|PDB:2FJZ, ECO:0000244|PDB:2FK1, ECO:0000244|PDB:2FK2, ECO:0000244|PDB:2FK3, ECO:0000244|PDB:2FKL, ECO:0000244|PDB:2FMA, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217, ECO:0000269|PubMed:12611883, ECO:0000269|PubMed:17239395, ECO:0000269|PubMed:17909280""; DISULFID 158..186;  /evidence=""ECO:0000244|PDB:1OWT, ECO:0000244|PDB:2FJZ, ECO:0000244|PDB:2FK1, ECO:0000244|PDB:2FK2, ECO:0000244|PDB:2FK3, ECO:0000244|PDB:2FKL, ECO:0000244|PDB:2FMA, ECO:0000244|PDB:3KTM, ECO:0000244|PDB:4PWQ, ECO:0000255|PROSITE-ProRule:PRU01217, ECO:0000269|PubMed:12611883, ECO:0000269|PubMed:17239395, ECO:0000269|PubMed:17909280""; DISULFID 291..341;  /evidence=""ECO:0000244|PDB:1AAP, ECO:0000244|PDB:1BRC, ECO:0000244|PDB:1CA0, ECO:0000244|PDB:1TAW, ECO:0000244|PDB:1ZJD, ECO:0000244|PDB:3L33""; DISULFID 300..324;  /evidence=""ECO:0000244|PDB:1AAP, ECO:0000244|PDB:1BRC, ECO:0000244|PDB:1CA0, ECO:0000244|PDB:1TAW, ECO:0000244|PDB:1ZJD, ECO:0000244|PDB:3L33, ECO:0000244|PDB:5C67""; DISULFID 316..337;  /evidence=""ECO:0000244|PDB:1AAP, ECO:0000244|PDB:1BRC, ECO:0000244|PDB:1CA0, ECO:0000244|PDB:1TAW, ECO:0000244|PDB:1ZJD, ECO:0000244|PDB:3L33, ECO:0000244|PDB:5C67""","SIGNAL 1..17;  /evidence=""ECO:0000269|PubMed:12665801, ECO:0000269|PubMed:2900137, ECO:0000269|PubMed:3597385"""
Q9BY15,Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3),MQGPLLLPGLCFLLSLFGAVTQKTKTSCAKCPPNASCVNNTHCTCNHGYTSGSGQKLFTFPLETCNDINECTPPYSVYCGFNAVCYNVEGSFYCQCVPGYRLHSGNEQFSNSNENTCQDTTSSKTTEGRKELQKIVDKFESLLTNQTLWRTEGRQEISSTATTILRDVESKVLETALKDPEQKVLKIQNDSVAIETQAITDNCSEERKTFNLNVQMNSMDIRCSDIIQGDTQGPSAIAFISYSSLGNIINATFFEEMDKKDQVYLNSQVVSAAIGPKRNVSLSKSVTLTFQHVKMTPSTKKVFCVYWKSTGQGSQWSRDGCFLIHVNKSHTMCNCSHLSSFAVLMALTSQEEDPVLTVITYVGLSVSLLCLLLAALTFLLCKAIRNTSTSLHLQLSLCLFLAHLLFLVGIDRTEPKVLCSIIAGALHYLYLAAFTWMLLEGVHLFLTARNLTVVNYSSINRLMKWIMFPVGYGVPAVTVAISAASWPHLYGTADRCWLHLDQGFMWSFLGPVCAIFSANLVLFILVFWILKRKLSSLNSEVSTIQNTRMLAFKATAQLFILGCTWCLGLLQVGPAAQVMAYLFTIINSLQGFFIFLVYCLLSQQVQKQYQKWFREIVKSKSESETYTLSSKMGPDSKPSEGDVFPGQVKRKY,652,"72,621",Alternative sequence (2); Chain (1); Disulfide bond (6); Domain (3); Glycosylation (9); Natural variant (3); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),"DISULFID 28..37;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 31..43;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 45..65;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 71..85;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 79..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 96..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q8IZF2,Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116),MKSPRRTTLCLMFIVIYSSKAALNWNYESTIHPLSLHEHEPAGEEALRQKRAVATKSPTAEEYTVNIEISFENASFLDPIKAYLNSLSFPIHGNNTDQITDILSINVTTVCRPAGNEIWCSCETGYGWPRERCLHNLICQERDVFLPGHHCSCLKELPPNGPFCLLQEDVTLNMRVRLNVGFQEDLMNTSSALYRSYKTDLETAFRKGYGILPGFKGVTVTGFKSGSVVVTYEVKTTPPSLELIHKANEQVVQSLNQTYKMDYNSFQAVTINESNFFVTPEIIFEGDTVSLVCEKEVLSSNVSWRYEEQQLEIQNSSRFSIYTALFNNMTSVSKLTIHNITPGDAGEYVCKLILDIFEYECKKKIDVMPIQILANEEMKVMCDNNPVSLNCCSQGNVNWSKVEWKQEGKINIPGTPETDIDSSCSRYTLKADGTQCPSGSSGTTVIYTCEFISAYGARGSANIKVTFISVANLTITPDPISVSEGQNFSIKCISDVSNYDEVYWNTSAGIKIYQRFYTTRRYLDGAESVLTVKTSTREWNGTYHCIFRYKNSYSIATKDVIVHPLPLKLNIMVDPLEATVSCSGSHHIKCCIEEDGDYKVTFHTGSSSLPAAKEVNKKQVCYKHNFNASSVSWCSKTVDVCCHFTNAANNSVWSPSMKLNLVPGENITCQDPVIGVGEPGKVIQKLCRFSNVPSSPESPIGGTITYKCVGSQWEEKRNDCISAPINSLLQMAKALIKSPSQDEMLPTYLKDLSISIDKAEHEISSSPGSLGAIINILDLLSTVPTQVNSEMMTHVLSTVNVILGKPVLNTWKVLQQQWTNQSSQLLHSVERFSQALQSGDSPPLSFSQTNVQMSSMVIKSSHPETYQQRFVFPYFDLWGNVVIDKSYLENLQSDSSIVTMAFPTLQAILAQDIQENNFAESLVMTTTVSHNTTMPFRISMTFKNNSPSGGETKCVFWNFRLANNTGGWDSSGCYVEEGDGDNVTCICDHLTSFSILMSPDSPDPSSLLGILLDIISYVGVGFSILSLAACLVVEAVVWKSVTKNRTSYMRHTCIVNIAASLLVANTWFIVVAAIQDNRYILCKTACVAATFFIHFFYLSVFFWMLTLGLMLFYRLVFILHETSRSTQKAIAFCLGYGCPLAISVITLGATQPREVYTRKNVCWLNWEDTKALLAFAIPALIIVVVNITITIVVITKILRPSIGDKPCKQEKSSLFQISKSIGVLTPLLGLTWGFGLTTVFPGTNLVFHIIFAILNVFQGLFILLFGCLWDLKVQEALLNKFSLSRWSSQHSKSTSLGSSTPVFSMSSPISRRFNNLFGKTGTYNVSTPEATSSSLENSSSASSLLN,1346,"149,457",Alternative sequence (3); Chain (1); Disulfide bond (3); Domain (5); Erroneous initiation (1); Glycosylation (21); Modified residue (2); Natural variant (3); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Site (3); Topological domain (8); Transmembrane (7),"DISULFID 293..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 391..449;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 492..545;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9UKF5,Disintegrin and metalloproteinase domain-containing protein 29 (ADAM 29) (Cancer/testis antigen 73) (CT73),MKMLLLLHCLGVFLSCSGHIQDEHPQYHSPPDVVIPVRITGTTRGMTPPGWLSYILPFGGQKHIIHIKVKKLLFSKHLPVFTYTDQGAILEDQPFVQNNCYYHGYVEGDPESLVSLSTCFGGFQGILQINDFAYEIKPLAFSTTFEHLVYKMDSEEKQFSTMRSGFMQNEITCRMEFEEIDNSTQKQSSYVGWWIHFRIVEIVVVIDNYLYIRYERNDSKLLEDLYVIVNIVDSILDVIGVKVLLFGLEIWTNKNLIVVDDVRKSVHLYCKWKSENITPRMQHDTSHLFTTLGLRGLSGIGAFRGMCTPHRSCAIVTFMNKTLGTFSIAVAHHLGHNLGMNHDEDTCRCSQPRCIMHEGNPPITKFSNCSYGDFWEYTVERTKCLLETVHTKDIFNVKRCGNGVVEEGEECDCGPLKHCAKDPCCLSNCTLTDGSTCAFGLCCKDCKFLPSGKVCRKEVNECDLPEWCNGTSHKCPDDFYVEDGIPCKERGYCYEKSCHDRNEQCRRIFGAGANTASETCYKELNTLGDRVGHCGIKNATYIKCNISDVQCGRIQCENVTEIPNMSDHTTVHWARFNDIMCWSTDYHLGMKGPDIGEVKDGTECGIDHICIHRHCVHITILNSNCSPAFCNKRGICNNKHHCHCNYLWDPPNCLIKGYGGSVDSGPPPKRKKKKKFCYLCILLLIVLFILLCCLYRLCKKSKPIKKQQDVQTPSAKEEEKIQRRPHELPPQSQPWVMPSQSQPPVTPSQSHPQVMPSQSQPPVTPSQSQPRVMPSQSQPPVMPSQSHPQLTPSQSQPPVTPSQRQPQLMPSQSQPPVTPS,820,"92,759",Alternative sequence (3); Chain (1); Compositional bias (2); Disulfide bond (7); Domain (3); Glycosylation (9); Natural variant (17); Propeptide (1); Region (1); Repeat (9); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 307..384;  /evidence=""ECO:0000250""; DISULFID 347..369;  /evidence=""ECO:0000250""; DISULFID 349..354;  /evidence=""ECO:0000250""; DISULFID 455..475;  /evidence=""ECO:0000250""; DISULFID 625..636;  /evidence=""ECO:0000250""; DISULFID 630..642;  /evidence=""ECO:0000250""; DISULFID 644..653;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8NCL9,Protein APCDD1-like (Adenomatosis polyposis coli down-regulated 1 protein-like),MPAAMLPYACVLVLLGAHTAPAAGEAGGSCLRWEPHCQQPLPDRVPSTAILPPRLNGPWISTGCEVRPGPEFLTRAYTFYPSRLFRAHQFYYEDPFCGEPAHSLLVKGKVRLRRASWVTRGATEADYHLHKVGIVFHSRRALVDVTGRLNQTRAGRDCARRLPPARAWLPGALYELRSARAQGDCLEALGLTMHELSLVRVQRRLQPQPRASPRLVEELYLGDIHTDPAERRHYRPTGYQRPLQSALHHVQPCPACGLIARSDVHHPPVLPPPLALPLHLGGWWVSSGCEVRPAVLFLTRLFTFHGHSRSWEGYYHHFSDPACRQPTFTVYAAGRYTRGTPSTRVRGGTELVFEVTRAHVTPMDQVTTAMLNFSEPSSCGGAGAWSMGTERDVTATNGCLPLGIRLPHVEYELFKMEQDPLGQSLLFIGQRPTDGSSPDTPEKRPTSYQAPLVLCHGEAPDFSRPPQHRPSLQKHPSTGGLHIAPFPLLPLVLGLAFLHWL,501,"55,635",Chain (1); Glycosylation (1); Natural variant (4); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9H6X2,Anthrax toxin receptor 1 (Tumor endothelial marker 8),MATAERRALGIGFQWLSLATLVLICAGQGGRREDGGPACYGGFDLYFILDKSGSVLHHWNEIYYFVEQLAHKFISPQLRMSFIVFSTRGTTLMKLTEDREQIRQGLEELQKVLPGGDTYMHEGFERASEQIYYENRQGYRTASVIIALTDGELHEDLFFYSEREANRSRDLGAIVYCVGVKDFNETQLARIADSKDHVFPVNDGFQALQGIIHSILKKSCIEILAAEPSTICAGESFQVVVRGNGFRHARNVDRVLCSFKINDSVTLNEKPFSVEDTYLLCPAPILKEVGMKAALQVSMNDGLSFISSSVIITTTHCSDGSILAIALLILFLLLALALLWWFWPLCCTVIIKEVPPPPAEESEEEDDDGLPKKKWPTVDASYYGGRGVGGIKRMEVRWGEKGSTEEGAKLEKAKNARVKMPEQEYEFPEPRNLNNNMRRPSSPRKWYSPIKGKLDALWVLLRKGYDRVSVMRPQPGDTGRCINFTRVKNNQPAKYPLNNAYHTSSPPPAPIYTPPPPAPHCPPPPPSAPTPPIPSPPSTLPPPPQAPPPNRAPPPSRPPPRPSV,564,"62,789",Alternative sequence (9); Beta strand (6); Chain (1); Compositional bias (2); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (3); Helix (8); Metal binding (3); Modified residue (1); Natural variant (2); Region (1); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 39..220;  /evidence=""ECO:0000269|PubMed:20585457""","SIGNAL 1..32;  /evidence=""ECO:0000255"""
Q8IXH8,Cadherin-like protein 26 (Cadherin-like protein VR20),MAMRSGRHPSLLLLLVLLLWLLQVSIIDSVQQETDDLTKQTKEKIYQPLRRSKRRWVITTLELEEEDPGPFPKLIGELFNNMSYNMSLMYLISGPGVDEYPEIGLFSLEDHENGRIYVHRPVDREMTPSFTVYFDVVERSTGKIVDTSLIFNIRISDVNDHAPQFPEKEFNITVQENQSAGQPIFQMLAVDLDEENTPNSQVLYFLISQTPLLKESGFRVDRLSGEIRLSGCLDYETAPQFTLLIRARDCGEPSLSSTTTVHVDVQEGNNHRPAFTQENYKVQIPEGRASQGVLRLLVQDRDSPFTSAWRAKFNILHGNEEGHFDISTDPETNEGILNVIKPLDYETRPAQSLIIVVENEERLVFCERGKLQPPRKAAASATVSVQVTDANDPPAFHPQSFIVNKEEGARPGTLLGTFNAMDPDSQIRYELVHDPANWVSVDKNSGVVITVEPIDRESPHVNNSFYVIIIHAVDDGFPPQTATGTLMLFLSDINDNVPTLRPRSRYMEVCESAVHEPLHIEAEDPDLEPFSDPFTFELDNTWGNAEDTWKLGRNWGQSVELLTLRSLPRGNYLVPLFIGDKQGLSQKQTVHVRICPCASGLTCVELADAEVGLHVGALFPVCAAFVALAVALLFLLRCYFVLEPKRHGCSVSNDEGHQTLVMYNAESKGTSAQTWSDVEGQRPALLICTAAAGPTQGVKDLEEVPPSAASQSAQARCALGSWGYGKPFEPRSVKNIHSTPAYPDATMHRQLLAPVEGRMAETLNQKLHVANVLEDDPGYLPHVYSEEGECGGAPSLSSLASLEQELQPDLLDSLGSKATPFEEIYSESGVPS,832,"92,416",Alternative sequence (4); Chain (1); Domain (4); Glycosylation (5); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
P32248,C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197),MDLGKPMKSVLVVALLVIFQVCLCQDEVTDDYIGDNTTVDYTLFESLCSKKDVRNFKAWFLPIMYSIICFVGLLGNGLVVLTYIYFKRLKTMTDTYLLNLAVADILFLLTLPFWAYSAAKSWVFGVHFCKLIFAIYKMSFFSGMLLLLCISIDRYVAIVQAVSAHRHRARVLLISKLSCVGIWILATVLSIPELLYSDLQRSSSEQAMRCSLITEHVEAFITIQVAQMVIGFLVPLLAMSFCYLVIIRTLLQARNFERNKAIKVIIAVVVVFIVFQLPYNGVVLAQTVANFNITSSTCELSKQLNIAYDVTYSLACVRCCVNPFLYAFIGVKFRNDLFKLFKDLGCLSQEQLRQWSSCRHIRRSSMSVEAETTTTFSP,378,"42,874",Beta strand (2); Chain (1); Disulfide bond (1); Glycosylation (1); Helix (10); Natural variant (1); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 129..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9BZW8,Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244),MLGQVVTLILLLLLKVYQGKGCQGSADHVVSISGVPLQLQPNSIQTKVDSIAWKKLLPSQNGFHHILKWENGSLPSNTSNDRFSFIVKNLSLLIKAAQQQDSGLYCLEVTSISGKVQTATFQVFVFESLLPDKVEKPRLQGQGKILDRGRCQVALSCLVSRDGNVSYAWYRGSKLIQTAGNLTYLDEEVDINGTHTYTCNVSNPVSWESHTLNLTQDCQNAHQEFRFWPFLVIIVILSALFLGTLACFCVWRRKRKEKQSETSPKEFLTIYEDVKDLKTRRNHEQEQTFPGGGSTIYSMIQSQSSAPTSQEPAYTLYSLIQPSRKSGSRKRNHSPSFNSTIYEVIGKSQPKAQNPARLSRKELENFDVYS,370,"41,616",Alternative sequence (4); Chain (1); Disulfide bond (1); Domain (2); Glycosylation (8); Modified residue (4); Motif (4); Mutagenesis (2); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 157..199;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:10556801, ECO:0000269|PubMed:15340161"""
P06729,T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2),MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYKLFKNGTLKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQERVSKPKISWTCINTTLTCEVMNGTDPELNLYQDGKHLKLSQRVITHKWTTSLSAKFKCTAGNKVSKESSVEPVSCPEKGLDIYLIIGICGGGSLLMVFVALLVFYITKRKKQRSRRNDEELETRAHRVATEERGRKPHQIPASTPQNPATSQHPPPPPGHRSQAPSHRPPPPGHRVQHQPQKRPPAPSGTQVHQQKGPPLPRPRVQPKPPHGAAENSLSPSSN,351,"39,448",Beta strand (16); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (3); Helix (3); Mutagenesis (4); Natural variant (3); Region (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 139..203;  /evidence=""ECO:0000269|PubMed:7994575""; DISULFID 146..186;  /evidence=""ECO:0000269|PubMed:7994575""",SIGNAL 1..24
P40259,B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b),MARLALSPVPSHWMVALLLLLSAEPVPAARSEDRYRNPKGSACSRIWQSPRFIARKRGFTVKMHCYMNSASGNVSWLWKQEMDENPQQLKLEKGRMEESQNESLATLTIQGIRFEDNGIYFCQQKCNNTSEVYQGCGTELRVMGFSTLAQLKQRNTLKDGIIMIQTLLIILFIIVPIFLLLDKDDSKAGMEEDHTYEGLDIDQTATYEDIVTLRTGEVKWSVGEHPGQE,229,"26,048",Alternative sequence (2); Beta strand (9); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (4); Modified residue (2); Natural variant (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 43..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20696394""; DISULFID 65..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20696394""; DISULFID 136;  /note=""Interchain (with C-119 in alpha chain)"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:20696394""","SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:7514267"""
A5X5Y0,5-hydroxytryptamine receptor 3E (5-HT3-E) (5-HT3E) (Serotonin receptor 3E),MEGSWFHRKRFSFYLLLGFLLQGRGVTFTINCSGFGQHGADPTALNSVFNRKPFRPVTNISVPTQVNISFAMSAILDVNEQLHLLSSFLWLEMVWDNPFISWNPEECEGITKMSMAAKNLWLPDIFIIELMDVDKTPKGLTAYVSNEGRIRYKKPMKVDSICNLDIFYFPFDQQNCTLTFSSFLYTVDSMLLDMEKEVWEITDASRNILQTHGEWELLGLSKATAKLSRGGNLYDQIVFYVAIRRRPSLYVINLLVPSGFLVAIDALSFYLPVKSGNRVPFKITLLLGYNVFLLMMSDLLPTSGTPLIGVYFALCLSLMVGSLLETIFITHLLHVATTQPPPLPRWLHSLLLHCNSPGRCCPTAPQKENKGPGLTPTHLPGVKEPEVSAGQMPGPAEAELTGGSEWTRAQREHEAQKQHSVELWLQFSHAMDAMLFRLYLLFMASSIITVICLWNT,456,"51,438",Alternative sequence (3); Chain (1); Disulfide bond (1); Glycosylation (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 162..176;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P32297,Neuronal acetylcholine receptor subunit alpha-3,MGSGPLSLPLALSPPRLLLLLLLSLLPVARASEAEHRLFERLFEDYNEIIRPVANVSDPVIIHFEVSMSQLVKVDEVNQIMETNLWLKQIWNDYKLKWNPSDYGGAEFMRVPAQKIWKPDIVLYNNAVGDFQVDDKTKALLKYTGEVTWIPPAIFKSSCKIDVTYFPFDYQNCTMKFGSWSYDKAKIDLVLIGSSMNLKDYWESGEWAIIKAPGYKHDIKYNCCEEIYPDITYSLYIRRLPLFYTINLIIPCLLISFLTVLVFYLPSDCGEKVTLCISVLLSLTVFLLVITETIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHYRTPTTHTMPSWVKTVFLNLLPRVMFMTRPTSNEGNAQKPRPLYGAELSNLNCFSRAESKGCKEGYPCQDGMCGYCHHRRIKISNFSANLTRSSSSESVDAVLSLSALSPEIKEAIQSVKYIAENMKAQNEAKEIQDDWKYVAMVIDRIFLWVFTLVCILGTAGLFLQPLMAREDA,505,"57,480",Alternative sequence (2); Beta strand (15); Chain (1); Disulfide bond (2); Glycosylation (2); Helix (10); Modified residue (2); Natural variant (3); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (4); Turn (6),"DISULFID 159..173;  /evidence=""ECO:0000250""; DISULFID 223..224;  /note=""Associated with receptor activation"";  /evidence=""ECO:0000250""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
P36896,Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2),MAESAGASSFFPLVVLLLAGSGGSGPRGVQALLCACTSCLQANYTCETDGACMVSIFNLDGMEHHVRTCIPKVELVPAGKPFYCLSSEDLRNTHCCYTDYCNRIDLRVPSGHLKEPEHPSMWGPVELVGIIAGPVFLLFLIIIIVFLVINYHQRVYHNRQRLDMEDPSCEMCLSKDKTLQDLVYDLSTSGSGSGLPLFVQRTVARTIVLQEIIGKGRFGEVWRGRWRGGDVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTIEGMIKLALSAASGLAHLHMEIVGTQGKPGIAHRDLKSKNILVKKNGMCAIADLGLAVRHDAVTDTIDIAPNQRVGTKRYMAPEVLDETINMKHFDSFKCADIYALGLVYWEIARRCNSGGVHEEYQLPYYDLVPSDPSIEEMRKVVCDQKLRPNIPNWWQSYEALRVMGKMMRECWYANGAARLTALRIKKTLSQLSVQEDVKI,505,"56,807",Active site (1); Alternative sequence (4); Binding site (1); Chain (1); Domain (2); Glycosylation (1); Modified residue (1); Mutagenesis (6); Natural variant (3); Nucleotide binding (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q8IZF4,Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27),MDHCGALFLCLCLLTLQNATTETWEELLSYMENMQVSRGRSSVFSSRQLHQLEQMLLNTSFPGYNLTLQTPTIQSLAFKLSCDFSGLSLTSATLKRVPQAGGQHARGQHAMQFPAELTRDACKTRPRELRLICIYFSNTHFFKDENNSSLLNNYVLGAQLSHGHVNNLRDPVNISFWHNQSLEGYTLTCVFWKEGARKQPWGGWSPEGCRTEQPSHSQVLCRCNHLTYFAVLMQLSPALVPAELLAPLTYISLVGCSISIVASLITVLLHFHFRKQSDSLTRIHMNLHASVLLLNIAFLLSPAFAMSPVPGSACTALAAALHYALLSCLTWMAIEGFNLYLLLGRVYNIYIRRYVFKLGVLGWGAPALLVLLSLSVKSSVYGPCTIPVFDSWENGTGFQNMSICWVRSPVVHSVLVMGYGGLTSLFNLVVLAWALWTLRRLRERADAPSVRACHDTVTVLGLTVLLGTTWALAFFSFGVFLLPQLFLFTILNSLYGFFLFLWFCSQRCRSEAEAKAQIEAFSSSQTTQ,528,"59,000",Chain (1); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (1); Glycosylation (8); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
P58335,Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2),MVAERSPARSPGSWLFPGLWLLVLSGPGGLLRAQEQPSCRRAFDLYFVLDKSGSVANNWIEIYNFVQQLAERFVSPEMRLSFIVFSSQATIILPLTGDRGKISKGLEDLKRVSPVGETYIHEGLKLANEQIQKAGGLKTSSIIIALTDGKLDGLVPSYAEKEAKISRSLGASVYCVGVLDFEQAQLERIADSKEQVFPVKGGFQALKGIINSILAQSCTEILELQPSSVCVGEEFQIVLSGRGFMLGSRNGSVLCTYTVNETYTTSVKPVSVQLNSMLCPAPILNKAGETLDVSVSFNGGKSVISGSLIVTATECSNGIAAIIVILVLLLLLGIGLMWWFWPLCCKVVIKDPPPPPAPAPKEEEEEPLPTKKWPTVDASYYGGRGVGGIKRMEVRWGDKGSTEEGARLEKAKNAVVKIPEETEEPIRPRPPRPKPTHQPPQTKWYTPIKGRLDALWALLRRQYDRVSLMRPQEGDEVCIWECIEKELTA,489,"53,666",Alternative sequence (4); Beta strand (6); Chain (1); Compositional bias (2); Disulfide bond (1); Domain (1); Erroneous gene model prediction (1); Erroneous initiation (2); Glycosylation (2); Helix (9); Metal binding (3); Modified residue (1); Natural variant (8); Signal peptide (1); Topological domain (2); Transmembrane (1),DISULFID 39..218,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
A8K4G0,CMRF35-like molecule 7 (CLM-7) (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3) (IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5) (TREM-5) (CD antigen CD300b),MWLPPALLLLSLSGCFSIQGPESVRAPEQGSLTVQCHYKQGWETYIKWWCRGVRWDTCKILIETRGSEQGEKSDRVSIKDNQKDRTFTVTMEGLRRDDADVYWCGIERRGPDLGTQVKVIVDPEGAASTTASSPTNSNMAVFIGSHKRNHYMLLVFVKVPILLILVTAILWLKGSQRVPEEPGEQPIYMNFSEPLTKDMAT,201,"22,689",Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (3); Modified residue (1); Mutagenesis (2); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 36..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
Q13873,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),MTSSLQRPWRVPWLPWTILLVSTAAASQNQERLCAFKDPYQQDLGIGESRISHENGTILCSKGSTCYGLWEKSKGDINLVKQGCWSHIGDPQECHYEECVVTTTPPSIQNGTYRFCCCSTDLCNVNFTENFPPPDTTPLSPPHSFNRDETIIIALASVSVLAVLIVALCFGYRMLTGDRKQGLHSMNMMEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLCKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDCESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQCAEERMAELMMIWERNKSVSPTVNPMSTAMQNERNLSHNRRVPKIGPYPDYSSSSYIEDSIHHTDSIVKNISSEHSMSSTPLTIGEKNRNSINYERQQAQARIPSPETSVTSLSTNTTTTNTTGLTPSTGMTTISEMPYPDETNLHTTNVAQSIGPTPVCLQLTEEDLETNKLDPKEVDKNLKESSDENLMEHSLKQFSGPDPLSSTSSSLLYPLIKLAVEATGQQDFTQTANGQACLIPDVLPTQIYPLPKQQNLPKRPTSLPLNTKNSTKEPRLKFGSKHKSNLKQVETGVAKMNTINAAEPHVVTVTMNGVAGRNHSVNSHAATTQYANGTVLSGQTTNIVTHRAQEMLQNQFIGEDTRLNINSSPDEHEPLLRREQQAGHDEGVLDRLVDRRERPLEGGRTNSNNNNSNPCSEQDVLAQGVPSTAADPGPSKPRRAQRPNSLDLSATNVLDGSSIQIGESTQDGKSGSGEKIKKRVKTPYSLKRWRPSTWVISTESLDCEVNNNGSNRAVHSKSSTAVYLAEGGTATTMVSKDIGMNCL,1038,"115,201",Active site (1); Alternative sequence (2); Beta strand (14); Binding site (2); Chain (1); Compositional bias (3); Disulfide bond (5); Domain (1); Glycosylation (3); Helix (17); Modified residue (4); Natural variant (34); Nucleotide binding (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 34..66;  /evidence=""ECO:0000244|PDB:2HLQ, ECO:0000269|PubMed:17094948""; DISULFID 60..84;  /evidence=""ECO:0000244|PDB:2HLQ, ECO:0000269|PubMed:17094948""; DISULFID 94..117;  /evidence=""ECO:0000244|PDB:2HLQ, ECO:0000269|PubMed:17094948""; DISULFID 99..116;  /evidence=""ECO:0000244|PDB:2HLQ, ECO:0000269|PubMed:17094948""; DISULFID 118..123;  /evidence=""ECO:0000244|PDB:2HLQ, ECO:0000269|PubMed:17094948""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q5VU97,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),MARQPEEEETAVARARRPPLWLLCLVACWLLGAGAEADFSILDEAQVLASQMRRLAAEELGVVTMQRIFNSFVYTEKISNGESEVQQLAKKIREKFNRYLDVVNRNKQVVEASYTAHLTSPLTAIQDCCTIPPSMMEFDGNFNTNVSRTISCDRLSTTVNSRAFNPGRDLNSVLADNLKSNPGIKWQYFSSEEGIFTVFPAHKFRCKGSYEHRSRPIYVSTVRPQSKHIVVILDHGASVTDTQLQIAKDAAQVILSAIDEHDKISVLTVADTVRTCSLDQCYKTFLSPATSETKRKMSTFVSSVKSSDSPTQHAVGFQKAFQLIRSTNNNTKFQANTDMVIIYLSAGITSKDSSEEDKKATLQVINEENSFLNNSVMILTYALMNDGVTGLKELAFLRDLAEQNSGKYGVPDRMALPVIKGSMMVLNQLSNLETTVGRFYTNLPNRMIDEAVFSLPFSDEMGDGLIMTVSKPCYFGNLLLGIVGVDVNLAYILEDVTYYQDSLASYTFLIDDKGYTLMHPSLTRPYLLSEPPLHTDIIHYENIPKFELVRQNILSLPLGSQIIAVPVNSSLSWHINKLRETGKEAYNVSYAWKMVQDTSFILCIVVIQPEIPVKQLKNLNTVPSSKLLYHRLDLLGQPSACLHFKQLATLESPTIMLSAGSFSSPYEHLSQPETKRMVEHYTAYLSDNTRLIANPGLKFSVRNEVMATSHVTDEWMTQMEMSSLNTYIVRRYIATPNGVLRIYPGSLMDKAFDPTRRQWYLHAVANPGLISLTGPYLDVGGAGYVVTISHTIHSSSTQLSSGHTVAVMGIDFTLRYFYKVLMDLLPVCNQDGGNKIRCFIMEDRGYLVAHPTLIDPKGHAPVEQQHITHKEPLVANDILNHPNFVKKNLCNSFSDRTVQRFYKFNTSLAGDLTNLVHGSHCSKYRLARIPGTNAFVGIVNETCDSLAFCACSMVDRLCLNCHRMEQNECECPCECPLEVNECTGNLTNAENRNPSCEVHQEPVTYTAIDPGLQDALHQCVNSRCSQRLESGDCFGVLDCEWCMVDSDGKTHLDKPYCAPQKECFGGIVGAKSPYVDDMGAIGDEVITLNMIKSAPVGPVAGGIMGCIMVLVLAVYAYRHQIHRRSHQHMSPLAAQEMSVRMSNLENDRDERDDDSHEDRGIISNTRFIAAVIERHAHSPERRRRYWGRSGTESDHGYSTMSPQEDSENPPCNNDPLSAGVDVGNHDEDLDLDTPPQTAALLSHKFHHYRSHHPTLHHSHHLQAAVTVHTVDAEC,1274,"142,290",Alternative sequence (1); Chain (1); Compositional bias (2); Domain (3); Erroneous initiation (2); Glycosylation (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q13634,Cadherin-18 (Cadherin-14),MKITSTSCICPVLVCLCFVQRCYGTAHHSSIKVMRNQTKHIEGETEVHHRPKRGWVWNQFFVLEEHMGPDPQYVGKLHSNSDKGDGSVKYILTGEGAGTIFIIDDTTGDIHSTKSLDREQKTHYVLHAQAIDRRTNKPLEPESEFIIKVQDINDNAPKFTDGPYIVTVPEMSDMGTSVLQVTATDADDPTYGNSARVVYSILQGQPYFSVDPKTGVIRTALHNMDREAREHYSVVIQAKDMAGQVGGLSGSTTVNITLTDVNDNPPRFPQKHYQLYVPESAQVGSAVGKIKANDADTGSNADMTYSIINGDGMGIFSISTDKETREGILSLKKPLNYEKKKSYTLNIEGANTHLDFRFSHLGPFKDATMLKIIVGDVDEPPLFSMPSYLMEVYENAKIGTVVGTVLAQDPDSTNSLVRYFINYNVEDDRFFNIDANTGTIRTTKVLDREETPWYNITVTASEIDNPDLLSHVTVGIRVLDVNDNPPELAREYDIIVCENSKPGQVIHTISATDKDDFANGPRFNFFLDERLPVNPNFTLKDNEDNTASILTRRRRFSRTVQDVYYLPIMISDGGIPSLSSSSTLTIRVCACERDGRVRTCHAEAFLSSAGLSTGALIAILLCVLILLAIVVLFITLRRSKKEPLIISEEDVRENVVTYDDEGGGEEDTEAFDITALRNPSAAEELKYRRDIRPEVKLTPRHQTSSTLESIDVQEFIKQRLAEADLDPSVPPYDSLQTYAYEGQRSEAGSISSLDSATTQSDQDYHYLGDWGPEFKKLAELYGEIESERTT,790,"88,073",Alternative sequence (1); Chain (1); Domain (5); Glycosylation (4); Modified residue (1); Propeptide (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P55291,Cadherin-15 (Cadherin-14) (Muscle cadherin) (M-cadherin),MDAAFLLVLGLLAQSLCLSLGVPGWRRPTTLYPWRRAPALSRVRRAWVIPPISVSENHKRLPYPLVQIKSDKQQLGSVIYSIQGPGVDEEPRGVFSIDKFTGKVFLNAMLDREKTDRFRLRAFALDLGGSTLEDPTDLEIVVVDQNDNRPAFLQEAFTGRVLEGAVPGTYVTRAEATDADDPETDNAALRFSILQQGSPELFSIDELTGEIRTVQVGLDREVVAVYNLTLQVADMSGDGLTATASAIITLDDINDNAPEFTRDEFFMEAIEAVSGVDVGRLEVEDRDLPGSPNWVARFTILEGDPDGQFTIRTDPKTNEGVLSIVKALDYESCEHYELKVSVQNEAPLQAAALRAERGQAKVRVHVQDTNEPPVFQENPLRTSLAEGAPPGTLVATFSARDPDTEQLQRLSYSKDYDPEDWLQVDAATGRIQTQHVLSPASPFLKGGWYRAIVLAQDDASQPRTATGTLSIEILEVNDHAPVLAPPPPGSLCSEPHQGPGLLLGATDEDLPPHGAPFHFQLSPRLPELGRNWSLSQVNVSHARLRPRHQVPEGLHRLSLLLRDSGQPPQQREQPLNVTVCRCGKDGVCLPGAAALLAGGTGLSLGALVIVLASALLLLVLVLLVALRARFWKQSRGKGLLHGPQDDLRDNVLNYDEQGGGEEDQDAYDISQLRHPTALSLPLGPPPLRRDAPQGRLHPQPPRVLPTSPLDIADFINDGLEAADSDPSVPPYDTALIYDYEGDGSVAGTLSSILSSQGDEDQDYDYLRDWGPRFARLADMYGHPCGLEYGARWDHQAREGLSPGALLPRHRGRTA,814,"88,916",Chain (1); Domain (5); Glycosylation (4); Mutagenesis (2); Natural variant (4); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9HCU0,Endosialin (Tumor endothelial marker 1) (CD antigen CD248),MLLRLLLAWAAAGPTLGQDPWAAEPRAACGPSSCYALFPRRRTFLEAWRACRELGGDLATPRTPEEAQRVDSLVGAGPASRLLWIGLQRQARQCQLQRPLRGFTWTTGDQDTAFTNWAQPASGGPCPAQRCVALEASGEHRWLEGSCTLAVDGYLCQFGFEGACPALQDEAGQAGPAVYTTPFHLVSTEFEWLPFGSVAAVQCQAGRGASLLCVKQPEGGVGWSRAGPLCLGTGCSPDNGGCEHECVEEVDGHVSCRCTEGFRLAADGRSCEDPCAQAPCEQQCEPGGPQGYSCHCRLGFRPAEDDPHRCVDTDECQIAGVCQQMCVNYVGGFECYCSEGHELEADGISCSPAGAMGAQASQDLGDELLDDGEDEEDEDEAWKAFNGGWTEMPGILWMEPTQPPDFALAYRPSFPEDREPQIPYPEPTWPPPLSAPRVPYHSSVLSVTRPVVVSATHPTLPSAHQPPVIPATHPALSRDHQIPVIAANYPDLPSAYQPGILSVSHSAQPPAHQPPMISTKYPELFPAHQSPMFPDTRVAGTQTTTHLPGIPPNHAPLVTTLGAQLPPQAPDALVLRTQATQLPIIPTAQPSLTTTSRSPVSPAHQISVPAATQPAALPTLLPSQSPTNQTSPISPTHPHSKAPQIPREDGPSPKLALWLPSPAPTAAPTALGEAGLAEHSQRDDRWLLVALLVPTCVFLVVLLALGIVYCTRCGPHAPNKRITDCYRWVIHAGSKSPTEPMPPRGSLTGVQTCRTSV,757,"80,859",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (3); Glycosylation (27); Modified residue (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 131..147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 316..326;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 322..335;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 337..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P26842,CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27),MARPHPWWLCVLGTLVGLSATPAPKSCPERHYWAQGKLCCQMCEPGTFLVKDCDQHRKAAQCDPCIPGVSFSPDHHTRPHCESCRHCNSGLLVRNCTITANAECACRNGWQCRDKECTECDPLPNPSLTARSSQALSPHPQPTHLPYVSEMLEARTAGHMQTLADFRQLPARTLSTHWPPQRSLCSSDFIRILVIFSGMFLVFTLAGALFLHQRRKYRSNKGESPVEPAEPCHYSCPREEEGSTIPIQEDYRKPEPACSP,260,"29,137",Beta strand (10); Chain (1); Disulfide bond (8); Glycosylation (2); Modified residue (1); Natural variant (3); Repeat (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 27..39;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 40..53;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 43..62;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 65..81;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 84..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 87..104;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 106..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 112..120;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
P02748,Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b],MSACRSFAVAICILEISILTAQYTTSYDPELTESSGSASHIDCRMSPWSEWSQCDPCLRQMFRSRSIEVFGQFNGKRCTDAVGDRRQCVPTEPCEDAEDDCGNDFQCSTGRCIKMRLRCNGDNDCGDFSDEDDCESEPRPPCRDRVVEESELARTAGYGINILGMDPLSTPFDNEFYNGLCNRDRDGNTLTYYRRPWNVASLIYETKGEKNFRTEHYEEQIEAFKSIIQEKTSNFNAAISLKFTPTETNKAEQCCEETASSISLHGKGSFRFSYSKNETYQLFLSYSSKKEKMFLHVKGEIHLGRFVMRNRDVVLTTTFVDDIKALPTTYEKGEYFAFLETYGTHYSSSGSLGGLYELIYVLDKASMKRKGVELKDIKRCLGYHLDVSLAFSEISVGAEFNKDDCVKRGEGRAVNITSENLIDDVVSLIRGGTRKYAFELKEKLLRGTVIDVTDFVNWASSINDAPVLISQKLSPIYNLVPVKMKNAHLKKQNLERAIEDYINEFSVRKCHTCQNGGTVILMDGKCLCACPFKFEGIACEISKQKISEGLPALEFPNEK,559,"63,173",Chain (3); Disulfide bond (10); Domain (4); Glycosylation (4); Mutagenesis (2); Natural variant (7); Sequence conflict (3); Signal peptide (1); Site (1); Transmembrane (2),"DISULFID 43..78;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 54..88;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885""; DISULFID 57..94;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885""; DISULFID 101..112;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 107..125;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 119..134;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 142..181;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 510..526;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 513..528;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""; DISULFID 530..539;  /evidence=""ECO:0000244|PDB:6DLW, ECO:0000269|PubMed:30111885, ECO:0000269|PubMed:8603752""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:6095282"""
Q969P0,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),MGALRPTLLPPSLPLLLLLMLGMGCWAREVLVPEGPLYRVAGTAVSISCNVTGYEGPAQQNFEWFLYRPEAPDTALGIVSTKDTQFSYAVFKSRVVAGEVQVQRLQGDAVVLKIARLQAQDAGIYECHTPSTDTRYLGSYSGKVELRVLPDVLQVSAAPPGPRGRQAPTSPPRMTVHEGQELALGCLARTSTQKHTHLAVSFGRSVPEAPVGRSTLQEVVGIRSDLAVEAGAPYAERLAAGELRLGKEGTDRYRMVVGGAQAGDAGTYHCTAAEWIQDPDGSWAQIAEKRAVLAHVDVQTLSSQLAVTVGPGERRIGPGEPLELLCNVSGALPPAGRHAAYSVGWEMAPAGAPGPGRLVAQLDTEGVGSLGPGYEGRHIAMEKVASRTYRLRLEAARPGDAGTYRCLAKAYVRGSGTRLREAASARSRPLPVHVREEGVVLEAVAWLAGGTVYRGETASLLCNISVRGGPPGLRLAASWWVERPEDGELSSVPAQLVGGVGQDGVAELGVRPGGGPVSVELVGPRSHRLRLHSLGPEDEGVYHCAPSAWVQHADYSWYQAGSARSGPVTVYPYMHALDTLFVPLLVGTGVALVTGATVLGTITCCFMKRLRKR,613,"65,034",Alternative sequence (3); Chain (1); Disulfide bond (4); Domain (4); Glycosylation (3); Lipidation (2); Modified residue (1); Motif (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 186..270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 326..406;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 462..544;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000269|PubMed:19892738"""
P13612,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d),MAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESALLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTLSRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYWTGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVCAVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSGAVMNAMETNLVGSDKYAARFGESIVNLGDIDNDGFEDVAIGAPQEDDLQGAIYIYNGRADGISSTFSQRIEGLQISKSLSMFGQSISGQIDADNNGYVDVAVGAFRSDSAVLLRTRPVVIVDASLSHPESVNRTKFDCVENGWPSVCIDLTLCFSYKGKEVPGYIVLFYNMSLDVNRKAESPPRFYFSSNGTSDVITGSIQVSSREANCRTHQAFMRKDVRDILTPIQIEAAYHLGPHVISKRSTEEFPPLQPILQQKKEKDIMKKTINFARFCAHENCSADLQVSAKIGFLKPHENKTYLAVGSMKTLMLNVSLFNAGDDAYETTLHVKLPVGLYFIKILELEEKQINCEVTDNSGVVQLDCSIGYIYVDHLSRIDISFLLDVSSLSRAEEDLSITVHATCENEEEMDNLKHSRVTVAIPLKYEVKLTVHGFVNPTSFVYGSNDENEPETCMVEKMNLTFHVINTGNSMAPNVSVEIMVPNSFSPQTDKLFNILDVQTTTGECHFENYQRVCALEQQKSAMQTLKGIVRFLSKTDKRLLYCIKADPHCLNFLCNFGKMESGKEASVHIQLEGRPSILEMDETSALKFEIRATGFPEPNPRVIELNKDENVAHVLLEGLHHQRPKRYFTIVIISSSLLLGLIVLLLISYVMWKAGFFKRQYKSILQEENRRDSWSYINSKSNDD,1032,"114,900",Alternative sequence (2); Beta strand (41); Calcium binding (3); Chain (1); Disulfide bond (9); Frameshift (2); Glycosylation (11); Helix (6); Modified residue (1); Motif (2); Mutagenesis (7); Natural variant (3); Repeat (7); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 91..101;  /evidence=""ECO:0000250""; DISULFID 144..165;  /evidence=""ECO:0000250""; DISULFID 183..198;  /evidence=""ECO:0000250""; DISULFID 486..495;  /evidence=""ECO:0000250""; DISULFID 501..557;  /evidence=""ECO:0000250""; DISULFID 622..627;  /evidence=""ECO:0000250""; DISULFID 698..711;  /evidence=""ECO:0000250""; DISULFID 852..890;  /evidence=""ECO:0000250""; DISULFID 897..902;  /evidence=""ECO:0000250""","SIGNAL 1..33;  /evidence=""ECO:0000269|PubMed:3033641"""
Q86UE6,Leucine-rich repeat transmembrane neuronal protein 1,MDFLLLGLCLYWLLRRPSGVVLCLLGACFQMLPAAPSGCPQLCRCEGRLLYCEALNLTEAPHNLSGLLGLSLRYNSLSELRAGQFTGLMQLTWLYLDHNHICSVQGDAFQKLRRVKELTLSSNQITQLPNTTFRPMPNLRSVDLSYNKLQALAPDLFHGLRKLTTLHMRANAIQFVPVRIFQDCRSLKFLDIGYNQLKSLARNSFAGLFKLTELHLEHNDLVKVNFAHFPRLISLHSLCLRRNKVAIVVSSLDWVWNLEKMDLSGNEIEYMEPHVFETVPHLQSLQLDSNRLTYIEPRILNSWKSLTSITLAGNLWDCGRNVCALASWLNNFQGRYDGNLQCASPEYAQGEDVLDAVYAFHLCEDGAEPTSGHLLSAVTNRSDLGPPASSATTLADGGEGQHDGTFEPATVALPGGEHAENAVQIHKVVTGTMALIFSFLIVVLVLYVSWKCFPASLRQLRQCFVTQRRKQKQKQTMHQMAAMSAQEYYVDYKPNHIEGALVIINEYGSCTCHQQPARECEV,522,"58,641",Chain (1); Domain (2); Glycosylation (4); Natural variant (1); Repeat (10); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..34;  /evidence=""ECO:0000255"""
O75121,Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9),MDRLKSHLTVCFLPSVPFLILVSTLATAKSVTNSTLNGTNVVLGSVPVIIARTDHIIVKEGNSALINCSVYGIPDPQFKWYNSIGKLLKEEEDEKERGGGKWQMHDSGLLNITKVSFSDRGKYTCVASNIYGTVNNTVTLRVIFTSGDMGVYYMVVCLVAFTIVMVLNITRLCMMSSHLKKTEKAINEFFRTEGAEKLQKAFEIAKRIPIITSAKTLELAKVTQFKTMEFARYIEELARSVPLPPLIMNCRTIMEEIMEVVGLEEQGQNFVRHTPEGQEAADRDEVYTIPNSLKRSDSPAADSDASSLHEQPQQIAIKVSVHPQSKKEHADDQEGGQFEVKDVEETELSAEHSPETAEPSTDVTSTELTSEEPTPVEVPDKVLPPAYLEATEPAVTHDKNTCIIYESHV,409,"45,380",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (5); Modified residue (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 68..125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P20645,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),MFPFYSCWRTGLLLLLLAVAVRESWQTEEKTCDLVGEKGKESEKELALVKRLKPLFNKSFESTVGQGSDTYIYIFRVCREAGNHTSGAGLVQINKSNGKETVVGRLNETHIFNGSNWIMLIYKGGDEYDNHCGKEQRRAVVMISCNRHTLADNFNPVSEERGKVQDCFYLFEMDSSLACSPEISHLSVGSILLVTFASLVAVYVVGGFLYQRLVVGAKGMEQFPHLAFWQDLGNLVADGCDFVCRSKPRNVPAAYRGVGDDQLGEESEERDDHLLPM,277,"30,993",Chain (1); Disulfide bond (3); Domain (1); Glycosylation (5); Modified residue (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 32..78;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 132..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 145..179;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""",SIGNAL 1..26
O95297,Myelin protein zero-like protein 1 (Protein zero-related),MAASAGAGAVIAAPDSRRWLWSVLAAALGLLTAGVSALEVYTPKEIFVANGTQGKLTCKFKSTSTTGGLTSVSWSFQPEGADTTVSFFHYSQGQVYLGNYPPFKDRISWAGDLDKKDASINIENMQFIHNGTYICDVKNPPDIVVQPGHIRLYVVEKENLPVFPVWVVVGIVTAVVLGLTLLISMILAVLYRRKNSKRDYTGCSTSESLSPVKQAPRKSPSDTEGLVKSLPSGSHQGPVIYAQLDHSGGHHSDKINKSESVVYADIRKN,269,"29,082",Alternative sequence (4); Beta strand (13); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Helix (3); Modified residue (9); Motif (2); Mutagenesis (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 58..135;  /evidence=""ECO:0000244|PDB:6IGO, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:30392906""","SIGNAL 1..35;  /evidence=""ECO:0000255"""
P15941,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],MTPGTQSPFFLLLLLTVLTVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAVSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQDVTSVPVTRPALGSTTPPAHDVTSAPDNKPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDNRPALGSTAPPVHNVTSASGSASGSASTLVHNGTSARATTTPASKSTPFSIPSHHSDTPTTLASHSTKTDASSTHHSSVPPLTSSNHSTSPQLSTGVSFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPGSVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIALAVCQCRRKNYGQLDIFPARDTYHPMSEYPTYHTHGRYVPPSSTDRSPYEKVSAGNGGSSLSYTNPAVAATSANL,1255,"122,102",Alternative sequence (19); Beta strand (4); Chain (3); Domain (1); Erroneous initiation (2); Glycosylation (9); Helix (3); Lipidation (2); Modified residue (7); Motif (3); Mutagenesis (21); Natural variant (2); Region (4); Repeat (48); Sequence conflict (10); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:10373415, ECO:0000269|PubMed:11341784"""
Q86UK5,Limbin (Ellis-van Creveld syndrome protein 2) (EVC2),MDPSGSRGRPTWVLAGGLLAVALALGGRGCLGASSRPRWRPLGAQPPRDPQVAPRSGPGLRIPPGRSGAGPESSTQDLPCMIWPKVECCHFKTAVEAPLGMKLDKKMEVFIPLSTSAASSGPWAHSLFAFIPSWPKKNLFKRESPITHRLYGDISREVQGTSENGVIFQKCALVSGSSEAQTARIWLLVNNTKTTSSANLSELLLLDSIAGLTIWDSVGNRTSEGFQAFSKKFLQVGDAFAVSYAATLQAGDLGNGESLKLPAQLTFQSSSRNRTQLKVLFSITAEENVTVLPHHGLHAAGFFIAFLLSLVLTWAALFLMVRYQCLKGNMLTRHRVWQYESKLEPLPFTSADGVNEDLSLNDQMIDILSSEDPGSMLQALEELEIATLNRADADLEACRTQISKDIIALLLKNLTSSGHLSPQVERKMSAVFKKQFLLLENEIQEEYDRKMVALTAECDLETRKKMENQYQREMMAMEEAEELLKRAGERSAVECSNLLRTLHGLEQEHLRKSLALQQEEDFAKAHRQLAVFQRNELHSIFFTQIKSAIFKGELKPEAAKMLLQNYSKIQENVEELMDFFQASKRYHLSKRFGHREYLVQNLQSSETRVQGLLSTAAAQLTHLIQKHERAGYLDEDQMEMLLERAQTEVFSIKQKLDNDLKQEKKKLHQKLITKRRRELLQKHREQRREQASVGEAFRTVEDAGQYLHQKRSLMEEHGATLEELQERLDQAALDDLRTLTLSLFEKATDELRRLQNSAMTQELLKRGVPWLFLQQILEEHGKEMAARAEQLEGEERDRDQEGVQSVRQRLKDDAPEAVTEEQAELRRWEHLIFMKLCSSVFSLSEEELLRMRQEVHGCFAQMDRSLALPKIRARVLLQQFQTAWREAEFVKLDQAVAAPELQQQSKVRKSRSKSKSKGELLKKCIEDKIHLCEEQASEDLVEKVRGELLRERVQRMEAQEGGFAQSLVALQFQKASRVTETLSAYTALLSIQDLLLEELSASEMLTKSACTQILESHSRELQELERKLEDQLVQQEAAQQQQALASWQQWVADGPGILNEPGEVDSERQVSTVLHQALSKSQTLLEQHQQCLREEQQNSVVLEDLLENMEADTFATLCSQELRLASYLARMAMVPGATLRRLLSVVLPTASQPQLLALLDSATERHVDHAAESDGGAEQADVGRRRKHQSWWQALDGKLRGDLISRGLEKMLWARKRKQSILKKTCLPLRERMIFSGKGSWPHLSLEPIGELAPVPIVGAETIDLLNTGEKLFIFRNPKEPEISLHVPPRKKKNFLNAKKAMRALGMD,1308,"147,948",Alternative sequence (2); Chain (1); Coiled coil (3); Erroneous initiation (2); Glycosylation (1); Natural variant (6); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q96QE4,Leucine-rich repeat-containing protein 37B (C66 SLIT-like testicular protein),MSWLRFWGPWPLLTWQLLSLLVKEAQPLVWVKDPLQLTSNPLGPPEPWSSRSSHLPWESPHAPAPPAAPGDFDYLGPSASSQMSALPQEPTENLAPFLKELDSAGELPLGPEPFLAAHQDLNDKRTPEERLPEVVPLLNRDQNQALVQLPRLKWVQTTDLDRAAGHQADEILVPLDSKVSRPTKFVVSPKNLKKDLAERWSLPEIVGIPHQLSKPQRQKQTLPDDYLSMDTLYPGSLPPELRVNADEPPGPPEQVGLSQFHLEPKSQNPETLEDIQSSSLQEEAPAQLLQLPQEVEPSTQQEAPALPPESSMESLAQTPLNHEVTVQPPGEDQAHYNLPKFTVKPADVEVTMTSEPKNETESTQAQQEAPIQPPEEAEPSSTALRTTDPPPEHPEVTLPPSDKGQAQHSHLTEATVQPLDLELSITTEPTTEVKPSPTTEETSAQPPDPGLAITPEPTTEIGHSTALEKTRAPHPDQVQTLHRSLTEVTGPPTKLESSQDSLVQSETAPEEQKASTSTNICELCTCGDETLSCVGLSPKQRLRQVPVPEPDTYNGIFTTLNFQGNYISYLDGNVWKAYSWTEKLILSENYLTELPKDSFEGLLYLQYLDLSCNKIRYIERQTFESLPFLQYINLGCNLITKLSLGTFQAWHGMQFLHNLILNRNPLTTVEDPYLFELPALKYLDMGTTHITLTTLKNILTMTVELEKLILPSHMACCLCQFKNSIEAVCKTVKLHCNTACLTNSIHCPEEASVGNPEGAFMKMLQARKQHMSTQLTIESEAPSDSSGINLSGFGGDQLEIQLTEQLRSLIPNEDVRKFMSHVIRTLKMECSETHVQGSCAKLMLRTGLLMKLLSEQQEAKALNVEWDTDQQKTNYINENMEQNEQKEQKSSELMKEVPGDDYKNKLIFAISVTVILIILIIIFCLIEVNSHKRASEKYKDNPSISGA,947,"105,567",Alternative sequence (1); Chain (1); Coiled coil (1); Erroneous initiation (1); Glycosylation (2); Repeat (6); Sequence conflict (10); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9HCJ2,Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1),MLNKMTLHPQQIMIGPRFNRALFDPLLVVLLALQLLVVAGLVRAQTCPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKDMAPSNTACCARCNTPPNLKGRYIGELDQNYFTCYAPVIVEPPADLNVTEGMAAELKCRASTSLTSVSWITPNGTVMTHGAYKVRIAVLSDGTLNFTNVTVQDTGMYTCMVSNSVGNTTASATLNVTAATTTPFSYFSTVTVETMEPSQDEARTTDNNVGPTPVVDWETTNVTTSLTPQSTRSTEKTFTIPVTDINSGIPGIDEVMKTTKIIIGCFVAITLMAAVMLVIFYKMRKQHHRQNHHAPTRTVEIINVDDEITGDTPMESHLPMPAIEHEHLNHYNSYKSPFNHTTTVNTINSIHSSVHEPLLIRMNSKDNVQETQI,640,"71,950",Beta strand (22); Chain (1); Disulfide bond (1); Domain (3); Helix (2); Modified residue (1); Repeat (9); Signal peptide (1); Transmembrane (1); Turn (7),"DISULFID 375..426;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..44;  /evidence=""ECO:0000255"""
Q6PJG9,Leucine-rich repeat and fibronectin type-III domain-containing protein 4,MAPPLLLLLLASGAAACPLPCVCQNLSESLSTLCAHRGLLFVPPNVDRRTVELRLADNFIQALGPPDFRNMTGLVDLTLSRNAITRIGARAFGDLESLRSLHLDGNRLVELGTGSLRGPVNLQHLILSGNQLGRIAPGAFDDFLESLEDLDLSYNNLRQVPWAGIGAMPALHTLNLDHNLIDALPPGAFAQLGQLSRLDLTSNRLATLAPDPLFSRGRDAEASPAPLVLSFSGNPLHCNCELLWLRRLARPDDLETCASPPGLAGRYFWAVPEGEFSCEPPLIARHTQRLWVLEGQRATLRCRALGDPAPTMHWVGPDDRLVGNSSRARAFPNGTLEIGVTGAGDAGGYTCIATNPAGEATARVELRVLALPHGGNSSAEGGRPGPSDIAASARTAAEGEGTLESEPAVQVTEVTATSGLVSWGPGRPADPVWMFQIQYNSSEDETLIYRIVPASSHHFLLKHLVPGADYDLCLLALSPAAGPSDLTATRLLGCAHFSTLPASPLCHALQAHVLGGTLTVAVGGVLVAALLVFTVALLVRGRGAGNGRLPLKLSHVQSQTNGGPSPTPKAHPPRSPPPRPQRSCSLDLGDAGCYGYARRLGGAWARRSHSVHGGLLGAGCRGVGGSAERLEESVV,635,"66,860",Chain (1); Disulfide bond (1); Domain (4); Glycosylation (6); Modified residue (2); Motif (1); Mutagenesis (1); Natural variant (1); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 302..351;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
P16581,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),MIASQFLSALTLVLLIKESGAWSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKAVTCRAVRQPQNGSVRCSHSPAGEFTFKSSCNFTCEEGFMLQGPAQVECTTQGQWTQQIPVCEAFQCTALSNPERGYMNCLPSASGSFRYGSSCEFSCEQGFVLKGSKRLQCGPTGEWDNEKPTCEAVRCDAVHQPPKGLVRCAHSPIGEFTYKSSCAFSCEEGFELHGSTQLECTSQGQWTEEVPSCQVVKCSSLAVPGKINMSCSGEPVFGTVCKFACPEGWTLNGSAARTCGATGHWSGLLPTCEAPTESNIPLVAGLSAAGLSLLTLAPFLLWLRKCLRKAKKFVPASSCQSLESDGSYQKPSYIL,610,"66,655",Beta strand (25); Chain (1); Disulfide bond (19); Domain (8); Glycosylation (11); Helix (3); Metal binding (5); Mutagenesis (1); Natural variant (11); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 40..138;  /evidence=""ECO:0000244|PDB:1ESL, ECO:0000244|PDB:1G1T, ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:11081633, ECO:0000269|PubMed:26117840""; DISULFID 111..130;  /evidence=""ECO:0000244|PDB:1ESL, ECO:0000244|PDB:1G1T, ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:11081633, ECO:0000269|PubMed:26117840""; DISULFID 143..154;  /evidence=""ECO:0000244|PDB:1ESL, ECO:0000244|PDB:1G1T, ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:11081633, ECO:0000269|PubMed:26117840""; DISULFID 148..163;  /evidence=""ECO:0000244|PDB:1ESL, ECO:0000244|PDB:1G1T, ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:11081633, ECO:0000269|PubMed:26117840""; DISULFID 165..174;  /evidence=""ECO:0000244|PDB:1ESL, ECO:0000244|PDB:1G1T, ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:11081633, ECO:0000269|PubMed:26117840""; DISULFID 180..224;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 193..206;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 210..237;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 242..286;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 255..268;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 272..299;  /evidence=""ECO:0000244|PDB:4C16, ECO:0000244|PDB:4CSY, ECO:0000269|PubMed:26117840""; DISULFID 304..349;  /evidence=""ECO:0000250""; DISULFID 335..362;  /evidence=""ECO:0000250""; DISULFID 367..412;  /evidence=""ECO:0000250""; DISULFID 398..425;  /evidence=""ECO:0000250""; DISULFID 430..475;  /evidence=""ECO:0000250""; DISULFID 461..488;  /evidence=""ECO:0000250""; DISULFID 493..534;  /evidence=""ECO:0000250""; DISULFID 520..547;  /evidence=""ECO:0000250""",SIGNAL 1..21
Q9NTG1,Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog),MRPGPALLLLGVGLSLSVGRLPLPPVPRGAQAAVSGAPGGLLRGAPGLGVRGGRALLSLRPSAVRAGGAVLSGRGSLCFPHGGTGRRWYCLDLRVLLSAQRLPWPAAPALALVDLQLSARGGRLSLTWSVRLPRSPGRLAWAFRLRLLGPGAARPASPAARVSPRSAAPGPRPQQGFVARTECPTDGPARVMLQAVNSSSHRAVESSVSCQINACVIQRVRINTDQKGAPVRLSMQAEATINASVQLDCPAARAIAQYWQVFSVPAVGQAPDWTQPLDLPQLEIRNSPLFIHIPNNSLQWGVYVFNFTVSITTGNPKMPEVKDSDAVYVWIVRSSLQAVMLGDANITANFTEQLILDGSTSSDPDADSPLQGLQFFWYCTTDPRNYGGDRIILGSKEVCHPEQANLKWPWASGPVLTLLPETLKGDHVYFFRMVIRKDSRTAFSDKRVHVLQGPKAIAHITCIENCERNFIVSDRFSLFLNCTNCASRDFYKWSILSSSGGEMLFDWMGETVTGRNGAYLSIKAFAFRHFLEAEFSISLYLACWSGVTSVFRHSFIINHGPQIGECKINPAKGIALITKFVVQCSNFRDKHVPLTYKIIVSDLHSVGEISSVKENTLGTILYLGPQSTVPPSFLPVGMLASQYGLKIYAQVYDSLGAFSQVTLHATAQAPTDKNSSKTVLNQLLSFTVGPSSLLSTLIQKKDFLPAGYLLYIVASVLNNMKTELPLRDDRVNLRKHLIDQSFLLPVSTLVEIGQVVMTITKLTQKPSEFTWDAQKRATMRVWQANQALQEYQQKDKRFRSEQIEIVSTGILMSLSNILKMTSPHQVVKDPFYVIESLSDTILANKVPGNKTTSMRTPNFNMYVKKVEKWGINQLFRNEKHCRNCFYPTLNVSSVPGLSANGPISTMFCDFTNDLFPWLNDQENTSVEVSGFRMTGVADNGSVLEITPDVAEVYLVRKNLTFAAFNLTVGPNSEVDGSLKKTTGGFSFQVDSTVLREVLVHIVTEVMVLFTVLVYTGSQITPTALVATFLVPHDIPPFASQSALFDPACTVKKARVVCLPVSLLQLIAQHSHSPHCTVSIVLQAPRFVMKLNDKLVRISIFSVQCLDMYGIQSEWREGYCILGEKTSWYEVHCICKNVVRARRQLGTIGLTGIHLHTHYVMAKVIVIPNPVDLRLNIIKSLHQNPVTLFTVLFIILLYVGLAFWALYRDEMDQHLRGHVIVLPDNDPYDNLCYLVTIFTGSRWGSGTRANVFVQLRGTVSTSDVHCLSHPHFTTLYRGSINTFLLTTKSDLGDIHSIRVWHNNEGRSPSWYLSRIKVENLFSRHIWLFICQKWLSVDTTLDRTFHVTHPDERLTRKDFFFIDVSSNLRKNHMWFSIFASVVAKTFNRLQRLSCCLAMLLSSLLCNIMFFNLNRQEQTESRERKYMRSMMIGIESVLITIPVQLLITFLFTCSQRKPQADLKEVSPQKHPLMSEASEHWEEYLRKWHAYETAKVHPREVAKPASKGKPRLPKASPKATSKPKHRHRKAQIKTPETLGPNTNSNNNIEDDQDVHSEQHPSQKDLQQLKKKPRIVLPWWCVYVAWFLVFATSSISSFFIVFYGLTYGYDKSIEWLFASFCSFCQSVLLVQPSKIILLSGFRTNKPKYCKNLSWSTKYKYTEIRLDGMRMHPEEMQRIHDQIVRIRGTRMYQPLTEDEIRIFKRKKRIKRRALLFLSYILTHFIFLALLLILIVLLRHTDCFYYNQFIRDRFSMDLATVTKLEDIYRWLNSVLLPLLHNDLNPTFLPESSSKILGLPLMRQVRAKSSEKMCLPAEKFVQNSIRREIHCHPKYGIDPEDTKNYSGFWNEVDKQAIDESTNGFTYKPQGTQWLYYSYGLLHTYGSGGYALYFFPEQQRFNSTLRLKELQESNWLDEKTWAVVLELTTFNPDINLFCSISVIFEVSQLGVVNTSISLHSFSLADFDRKASAEIYLYVAILIFFLAYVVDEGCIIMQERASYVRSVYNLLNFALKCIFTVLIVLFLRKHFLATGIIRFYLSNPEDFIPFHAVSQVDHIMRIILGFLLFLTILKTLRYSRFFYDVRLAQRAIQAALPGICHMAFVVSVYFFVYMAFGYLVFGQHEWNYSNLIHSTQTVFSYCVSAFQNTEFSNNRILGVLFLSSFMLVMICVLINLFQAVILSAYEEMKQPVYEEPSDEVEAMTYLCRKLRTMFSFLTSQSKAKDEPEFFIDMLYGQPEKNSHRYLGLKTRNINGKKMVYLVV,2253,"255,449",Chain (1); Domain (2); Glycosylation (17); Natural variant (12); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P25116,Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor),MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT,425,"47,441",Beta strand (3); Chain (1); Compositional bias (1); Disulfide bond (1); Glycosylation (5); Helix (13); Modified residue (1); Natural variant (6); Propeptide (1); Sequence conflict (2); Signal peptide (1); Site (1); Topological domain (8); Transmembrane (7); Turn (2),"DISULFID 175..254;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:22659187"""
Q9Y5E4,Protocadherin beta-5 (PCDH-beta-5),METALAKTPQKRQVMFLAILLLLWEAGSEAVRYSIPEETESGYSVANLAKDLGLGVGELATRGARMHYKGNKELLQLDIKTGNLLLYEKLDREVMCGATEPCILHFQLLLENPVQFFQTDLQLTDINDHAPEFPEKEMLLKIPESTQPGTVFPLKIAQDFDIGSNTVQNYTISPNSHFHVATHNRGDGRKYPELVLDKALDREERPELSLTLTALDGGAPPRSGTTTIRIVVLDNNDNAPEFLQSFYEVQVPENSPLNSLVVVVSARDLDAGAYGSVAYALFQGDEVTQPFVIDEKTAEIRLKRALDFEATPYYNVEIVATDGGGLSGKCTVAIEVVDVNDNAPELTMSTLSSPTPENAPETVVAVFSVSDPDSGDNGRMICSIQNDLPFLLKPTLKNFYTLVTQRTLDRESQAEYNITITVTDMGTPRLKTEHNITVLVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQNPHLRLASLVSINADNGHLFALRSLDYEALQAFEFRVGATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFSMWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVSGTGTLSQSYHYEVCLTGDSGAGEFKFLKPIIPNLLPQGAGEEIGKTAAFRNSFGLN,795,"86,423",Chain (1); Domain (6); Glycosylation (4); Modified residue (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9UN75,Protocadherin alpha-12 (PCDH-alpha-12),MVIIGPRGPGSQRLLLSLLLLAAWEVGSGQLHYSVYEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKRHGDLLEVNLQNGILFVNSRIDREKLCGRSAECSIHLEVIVDRPLQVFHVDVEVKDINDNPPVFREREQKVPVSESAPLDSHFPLEGASDADIGVNSLLTYALSLNENFELKIKTKKDKSILPELVLRKLLDREQTPKLNLLLMVIDGGKPELTGSVQIQITVLDVNDNGPAFDKPSYKVVLSENVQNDTRVIQLNASDPDEGLNGEISYGIKMILPVSEKCMFSINPDTGEIRIYGELDFEENNAYEIQVNAIDKGIPSMAGHSMVLVEVLDVNDNVPEVMVTSLSLPVQEDAQVGTVIALISVSDRDSGANGQVICSLTPHVPFKLVSTYKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATARVSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSAWDADAQKNALVSYSLVERRVGEHALSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLATPAGSAGGAVSELVPRSVGAGHVVAKVRAVDADSGYNAWLSYELQPAAVGAHIPFHVGLYTGEISTTRILDEADAPRHRLLVLVKDHGEPALTSTATVLVSLVENGQAPKTSSRASVGAVDPEAALVDINVYLIIAICAVSSLLVLTLLLYTALRCSAPPTVSRCAPGKPTLVCSSAVGSWSYSQQRRQRVCSAESPPKTDLMAFSPSLQLSREDCLNPPSEPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,941,"101,652",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q8ND94,LRRN4 C-terminal-like protein,MLGSPCLLWLLAVTFLVPRAQPLAPQDFEEEEADETETAWPPLPAVPCDYDHCRHLQVPCKELQRVGPAACLCPGLSSPAQPPDPPRMGEVRIAAEEGRAVVHWCAPFSPVLHYWLLLWDGSEAAQKGPPLNATVRRAELKGLKPGGIYVVCVVAANEAGASRVPQAGGEGLEGADIPAFGPCSRLAVPPNPRTLVHAAVGVGTALALLSCAALVWHFCLRDRWGCPRRAAARAAGAL,238,"25,262",Chain (1); Compositional bias (1); Domain (1); Glycosylation (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
P55082,Microfibril-associated glycoprotein 3,MKLHCCLFTLVASIIVPAAFVLEDVDFDQMVSLEANRSSYNASFPSSFELSASSHSDDDVIIAKEGTSVSIECLLTASHYEDVHWHNSKGQQLDGRSRGGKWLVSDNFLNITNVAFDDRGLYTCFVTSPIRASYSVTLRVIFTSGDMSVYYMIVCLIAFTITLILNVTRLCMMSSHLRKTEKAINEFFRTEGAEKLQKAFEIAKRIPIITSAKTLELAKVTQFKTMEFARYIEELARSVPLPPLILNCRAFVEEMFEAVRVDDPDDLGERIKERPALNAQGGIYVINPEMGRSNSPGGDSDDGSLNEQGQEIAVQVSVHLQSETKSIDTESQGSSHFSPPDDIGSAESNCNYKDGAYENCQL,362,"40,165",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (1); Frameshift (1); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 73..124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q16653,Myelin-oligodendrocyte glycoprotein,MASLSRPSLPSCLCSFLLLLLLQVSSSYAGQFRVIGPRHPIRALVGDEVELPCRISPGKNATGMEVGWYRPPFSRVVHLYRNGKDQDGDQAPEYRGRTELLKDAIGEGKVTLRIRNVRFSDEGGFTCFFRDHSYQEEAAMELKVEDPFYWVSPGVLVLLAVLPVLLLQITVGLIFLCLQYRLRGKLRAEIENLHRTFDPHFLRVPCWKITLFVIVPVLGPLVALIICYNWLHRRLAGQFLEELRNPF,247,"28,193",Alternative sequence (11); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (3); Signal peptide (1); Topological domain (3); Transmembrane (2),"DISULFID 53..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9P2S2,Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha),MASGSRWRPTPPPLLLLLLLALAARADGLEFGGGPGQWARYARWAGAASSGELSFSLRTNATRALLLYLDDGGDCDFLELLLVDGRLRLRFTLSCAEPATLQLDTPVADDRWHMVLLTRDARRTALAVDGEARAAEVRSKRREMQVASDLFVGGIPPDVRLSALTLSTVKYEPPFRGLLANLKLGERPPALLGSQGLRGATADPLCAPARNPCANGGLCTVLAPGEVGCDCSHTGFGGKFCSEEEHPMEGPAHLTLNSEVGSLLFSEGGAGRGGAGDVHQPTKGKEEFVATFKGNEFFCYDLSHNPIQSSTDEITLAFRTLQRNGLMLHTGKSADYVNLSLKSGAVWLVINLGSGAFEALVEPVNGKFNDNAWHDVRVTRNLRQHAGIGHAMVNKLHYLVTISVDGILTTTGYTQEDYTMLGSDDFFYIGGSPNTADLPGSPVSNNFMGCLKDVVYKNNDFKLELSRLAKEGDPKMKLQGDLSFRCEDVAALDPVTFESPEAFVALPRWSAKRTGSISLDFRTTEPNGLLLFSQGRRAGGGAGSHSSAQRADYFAMELLDGHLYLLLDMGSGGIKLRASSRKVNDGEWCHVDFQRDGRKGSISVNSRSTPFLATGDSEILDLESELYLGGLPEGGRVDLPLPPEVWTAALRAGYVGCVRDLFIDGRSRDLRGLAEAQGAVGVAPFCSRETLKQCASAPCRNGGVCREGWNRFICDCIGTGFLGRVCEREATVLSYDGSMYMKIMLPNAMHTEAEDVSLRFMSQRAYGLMMATTSRESADTLRLELDGGQMKLTVNLDCLRVGCAPSKGPETLFAGHKLNDNEWHTVRVVRRGKSLQLSVDNVTVEGQMAGAHMRLEFHNIETGIMTERRFISVVPSNFIGHLSGLVFNGQPYMDQCKDGDITYCELNARFGLRAIVADPVTFKSRSSYLALATLQAYASMHLFFQFKTTAPDGLLLFNSGNGNDFIVIELVKGYIHYVFDLGNGPSLMKGNSDKPVNDNQWHNVVVSRDPGNVHTLKIDSRTVTQHSNGARNLDLKGELYIGGLSKNMFSNLPKLVASRDGFQGCLASVDLNGRLPDLIADALHRIGQVERGCDGPSTTCTEESCANQGVCLQQWDGFTCDCTMTSYGGPVCNDPGTTYIFGKGGALITYTWPPNDRPSTRMDRLAVGFSTHQRSAVLVRVDSASGLGDYLQLHIDQGTVGVIFNVGTDDITIDEPNAIVSDGKYHVVRFTRSGGNATLQVDSWPVNERYPAGNFDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQAAIKIGGRDQGRPFQGQVSGLYYNGLKVLALAAESDPNVRTEGHLRLVGEGPSVLLSAETTATTLLADMATTIMETTTTMATTTTRRGRSPTLRDSTTQNTDDLLVASAECPSDDEDLEECEPSTGGELILPIITEDSLDPPPVATRSPFVPPPPTFYPFLTGVGATQDTLPPPAARRPPSGGPCQAERDDSDCEEPIEASGFASGEVFDSSLPPTDDEDFYTTFPLVTDRTTLLSPRKPAPRPNLRTDGATGAPGVLFAPSAPAPNLPAGKMNHRDPLQPLLENPPLGPGAPTSFEPRRPPPLRPGVTSAPGFPHLPTANPTGPGERGPPGAVEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDQSRNYISNSAQSNGAVVKEKAPAAPKTPSKAKKNKDKEYYV,1712,"184,982",Alternative sequence (4); Chain (1); Compositional bias (4); Disulfide bond (12); Domain (9); Erroneous initiation (1); Glycosylation (4); Metal binding (3); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 206..219;  /evidence=""ECO:0000250""; DISULFID 213..229;  /evidence=""ECO:0000250""; DISULFID 231..241;  /evidence=""ECO:0000250""; DISULFID 450..486;  /evidence=""ECO:0000250""; DISULFID 657..686;  /evidence=""ECO:0000250""; DISULFID 694..705;  /evidence=""ECO:0000250""; DISULFID 699..714;  /evidence=""ECO:0000250""; DISULFID 716..726;  /evidence=""ECO:0000250""; DISULFID 1065..1093;  /evidence=""ECO:0000250""; DISULFID 1100..1111;  /evidence=""ECO:0000250""; DISULFID 1105..1120;  /evidence=""ECO:0000250""; DISULFID 1122..1132;  /evidence=""ECO:0000250""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
P58401,Neurexin-2-beta (Neurexin II-beta),MPPGGSGPGGCPRRPPALAGPLPPPPPPPPPPLLPLLPLLLLLLLGAAEGARVSSSLSTTHHVHHFHSKHGTVPIAINRMPFLTRGGHAGTTYIFGKGGALITYTWPPNDRPSTRMDRLAVGFSTHQRSAVLVRVDSASGLGDYLQLHIDQGTVGVIFNVGTDDITIDEPNAIVSDGKYHVVRFTRSGGNATLQVDSWPVNERYPAGNFDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQAAIKIGGRDQGRPFQGQVSGLYYNGLKVLALAAESDPNVRTEGHLRLVGEGPSVLLSAETTATTLLADMATTIMETTTTMATTTTRRGRSPTLRDSTTQNTDDLLVASAECPSDDEDLEECEPSTGGELILPIITEDSLDPPPVATRSPFVPPPPTFYPFLTGVGATQDTLPPPAARRPPSGGPCQAERDDSDCEEPIEASGFASGEVFDSSLPPTDDEDFYTTFPLVTDRTTLLSPRKPAPRPNLRTDGATGAPGVLFAPSAPAPNLPAGKMNHRDPLQPLLENPPLGPGAPTSFEPRRPPPLRPGVTSAPGFPHLPTANPTGPGERGPPGAVEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDQSRNYISNSAQSNGAVVKEKAPAAPKTPSKAKKNKDKEYYV,666,"70,927",Beta strand (1); Chain (1); Compositional bias (4); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..50;  /evidence=""ECO:0000250"""
P38484,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1),MRPTLLWSLLLLLGVFAAAAAAPPDPLSQLPAPQHPKIRLYNAEQVLSWEPVALSNSTRPVVYQVQFKYTDSKWFTADIMSIGVNCTQITATECDFTAASPSAGFPMDFNVTLRLRAELGALHSAWVTMPWFQHYRNVTVGPPENIEVTPGEGSLIIRFSSPFDIADTSTAFFCYYVHYWEKGGIQQVKGPFRSNSISLDNLKPSRVYCLQVQAQLLWNKSNIFRVGHLSNISCYETMADASTELQQVILISVGTFSLLSVLAGACFFLVLKYRGLIKYWFHTPPSIPLQIEEYLKDPTQPILEALDKDSSPKDDVWDSVSIISFPEKEQEDVLQTL,337,"37,806",Beta strand (15); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (6); Helix (2); Motif (1); Mutagenesis (10); Natural variant (10); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 86..94;  /evidence=""ECO:0000269|PubMed:27599734""; DISULFID 209..234;  /evidence=""ECO:0000269|PubMed:27599734""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P18627,Lymphocyte activation gene 3 protein (LAG-3) (CD antigen CD223) [Cleaved into: Secreted lymphocyte activation gene 3 protein (sLAG-3)],MWEAQFLGLLFLQPLWVAPVKPLQPGAEVPVVWAQEGAPAQLPCSPTIPLQDLSLLRRAGVTWQHQPDSGPPAAAPGHPLAPGPHPAAPSSWGPRPRRYTVLSVGPGGLRSGRLPLQPRVQLDERGRQRGDFSLWLRPARRADAGEYRAAVHLRDRALSCRLRLRLGQASMTASPPGSLRASDWVILNCSFSRPDRPASVHWFRNRGQGRVPVRESPHHHLAESFLFLPQVSPMDSGPWGCILTYRDGFNVSIMYNLTVLGLEPPTPLTVYAGAGSRVGLPCRLPAGVGTRSFLTAKWTPPGGGPDLLVTGDNGDFTLRLEDVSQAQAGTYTCHIHLQEQQLNATVTLAIITVTPKSFGSPGSLGKLLCEVTPVSGQERFVWSSLDTPSQRSFSGPWLEAQEAQLLSQPWQCQLYQGERLLGAAVYFTELSSPGAQRSGRAPGALPAGHLLLFLILGVLSLLLLVTGAFGFHLWRRQWRPRRFSALEQGIHPPQAQSKIEELEQEPEPEPEPEPEPEPEPEPEQL,525,"57,449",Alternative sequence (2); Chain (2); Disulfide bond (4); Domain (4); Glycosylation (4); Motif (1); Mutagenesis (16); Natural variant (1); Region (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 189..241;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 282..333;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 369..412;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9P2E8,E3 ubiquitin-protein ligase MARCHF4 (EC 2.3.2.27) (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV) (MARCH-IV) (RING finger protein 174) (RING-type E3 ubiquitin transferase MARCHF4),MLMPLCGLLWWWWCCCSGWYCYGLCAPAPQMLRHQGLLKCRCRMLFNDLKVFLLRRPPQAPLPMHGDPQPPGLAANNTLPALGAGGWAGWRGPREVVGREPPPVPPPPPLPPSSVEDDWGGPATEPPASLLSSASSDDFCKEKTEDRYSLGSSLDSGMRTPLCRICFQGPEQGELLSPCRCDGSVKCTHQPCLIKWISERGCWSCELCYYKYHVIAISTKNPLQWQAISLTVIEKVQVAAAILGSLFLIASISWLIWSTFSPSARWQRQDLLFQICYGMYGFMDVVCIGLIIHEGPSVYRIFKRWQAVNQQWKVLNYDKTKDLEDQKAGGRTNPRTSSSTQANIPSSEEETAGTPAPEQGPAQAAGHPSGPLSHHHCAYTILHILSHLRPHEQRSPPGSSRELVMRVTTV,410,"45,528",Chain (1); Compositional bias (1); Erroneous initiation (1); Signal peptide (1); Transmembrane (2); Zinc finger (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q02505,Mucin-3A (MUC-3A) (Intestinal mucin-3A),MQLLGLLGLLWMLKASPWATGTLSTATSISQVPFPRAEAASAVLSNSPHSRDLAGWPLGVPQLASPAPGHRENAPMTLTTSPHDTLISETLLNSPVSSNTSTTPTSKFAFKVETTPPTVLVYSATTECVYPTSFIITISHPTSICVTTTQVAFTSSYTSTPVTQKPVTTVTSTYSMTTTEKGTSAMTSSPSTTTARETPIVTVTPSSVSATDTTFHTTISSTTRTTERTPLPTGSIHTTTSPTPVFTTLKTAVTSTSPITSSITSTNTVTSMTTTASQPTATNTLSSPTRTILSSTPVLSTETITSGITNTTPLSTLVTTLPTTISRSTPTSETTYTTSPTSTVTDSTTKIAYSTSMTGTLSTETSLPPTSSSLPTTETATTPMTNLVTTTTEISSHSTPSFSSSTIYSTVSTSTTAISSLPPTSGTMVTSTTMTPSSLSTDIPFTTPTTITHHSVGSTGFLTTATDLTSTFTVSSSSAMSTSVIPSSPSIQNTETSSLVSMTSATTPNVRPTFVSTLSTPTSSLLTTFPATYSFSSSMSASSAGTTHTESISSPPASTSTLHTTAESTLAPTTTTSFTTSTTMEPPSTTAATTGTGQTTFTSSTATFPETTTPTPTTDMSTESLTTAMTSPPITSSVTSTNTVTSMTTTTSPPTTTNSFTSLTSMPLSSTPVPSTEVVTSGTINTIPPSILVTTLPTPNASSMTTSETTYPNSPTGPGTNSTTEITYPTTMTETSSTATSLPPTSPLVSTAKTAKTPTTNLVTTTTKTTSHSTTSFTSSTVYSTASTYTTAITSVPTTLGTMVTSTSMISSTVSTGIPTSQPTTITPSSVGISGSLPMMTDLTSVYTVSNMSARPTTVIPSSPTVQNTEISISVSMTSATTPSGGPTFTSTENTPTRSLLTSFPMTHSFSSSMSESSAGTTHTESISSPRGTTSTLHTTVESTPSPTTTTSFTTSTMMEPPSSTVSTTGRGQTTFPSSTATFPETTTLTPTTDISTVSLTTAMTSPPPVSSSITPTNTMTSMRTTTYWPTATNTLSPLTSSILSSTPVPSTEMITSHTTNTTPLSTLVTTLLTTITRSTPTSETTYPTSPTSIVSDSTTEITYSTSITGTLSTATTLPPTSSSLPTTETATMTPTTTLITTTPNTTSLSTPSFTSSTIYSTVSTSTTAISSASPTSGTMVTSTTMTPSSLSTDTPSTTPTTITYPSVGSTGFLTTATDLTSTFTVSSSSAMSTSVIPSSPSIQNTETSSLVSMTSATTPSLRPTITSTDSTLTSSLLTTFPSTYSFSSSMSASSAGTTHTETISSLPASTNTIHTTAESALAPTTTTSFTTSPTMEPPSTTVATTGTGQTTFPSSTATFLETTTLTPTTDFSTESLTTAMTSTPPITSSITPTDTMTSMRTTTSWPTATNTLSPLTSSILSSTPVPSTEVTTSHTTNTNPVSTLVTTLPITITRSTLTSETAYPSSPTSTVTESTTEITYPTTMTETSSTATSLPPTSSLVSTAETAKTPTTNLVTTTTKTTSHSTTSFTSSTIYSTASTPTTAITSVPTTLGTMVTSTSMIPSTVSTGIPTSQPTTITPSSVGISGSLPMMTDLTSVYTVSSMSARPTSVIPSSPTVQNTETSIFVSMMSATTPSGGPTFTSTENTPTRSLLTSFPVTHSFSSSMSASSVGTTHTQSISSPPAITSTLHTTAESTPSPTTTMSFTTFTKMETPSSTVATTGTGQTTFTSSTATSPKTTTLTPTSDISTGSFKTAVSSTPPITSSITSTYTVTSMTTTTPLGPTATNTLPSFTSSVSSSTPVPSTEAITSGTTNTTPLSTLVTTFSNSDTSSTPTSETTYPTSLTSALTDSTTRTTYSTNMTGTLSTVTSLRPTSSSLLTTVTATVPTTNLVTTTTKITSHSTPSFTSSIATTETPSHSTPRFTSSITTTETPSHSTPRFTSSITNTKTTSHSSPSFTSSITTTETTSHNTPSLTSSITTTKTTSHSTPSYTSLITTTTTTSHSTPSFTSSITTTETTSHNTPSLTSSITTTETTSHSTPSFTSSITTETTSHSTPSFTSLITITEITSHSTLSYTTSITTTETPSHSTLSFTSSITTTETTSHSTPSFTSSITTSEMPSHSTPSFTSSITTTENATHSTPNFTSSITTTETTSHSTPSFTSLITTTETTSHRWGTTETTSYSTPSFTSSNTITETTSHSTPSYITSITTTETPSSSTPSFSSSITTTETTSHSTPGFTSSITTTETTSHSTPSFTSSITTTETTSHDTPSFTSSITTSETPSHSTPSSTSLITTTKTTSHSTPSFTSSITTTETTSHSAHSFTSSITTTETTSHNTRSFTSSITTTETNSHSTTSFTSSITTTETTSHSTPSFSSSITTTETPLHSTPGLTSWVTTTKTTSHITPGLTSSITTTETTSHSTPGFTSSITTTETTSESTPSLSSSTIYSTVSTSTTAITSHFTTSETAVTPTPVTPSSLSTDIPTTSLRTLTPSSVGTSTSLTTTTDFPSIPTDISTLPTRTHIISSSPSIQSTETSSLVGTTSPTMSTVRMTLRITENTPISSFSTSIVVIPETPTQTPPVLTSATGTQTSPAPTTVTFGSTDSSTSTLHTLTPSTALSTIVSTSQVPIPSTHSSTLQTTPSTPSLQTSLTSTSEFTTESFTRGSTSTNAILTSFSTIIWSSTPTIIMSSSPSSASITPVFSTTIHSVPSSPYIFSTENVGSASITGFPSLSSSATTSTSSTSSSLTTALTEITPFSYISLPSTTPCPGTITITIVPASPTDPCVEMDPSTEATSPPTTPLTVFPFTTEMVTCPTSISIQTTLTTYMDTSSMMPESESSISPNASSSTGTGTVPTNTVFTSTRLPTSETWLSNSSVIPLPLPGVSTIPLTMKPSSSLPTILRTSSKSTHPSPPTTRTSETPVATTQTPTTLTSRRTTRITSQMTTQSTLTTTAGTCDNGGTWEQGQCACLPGFSGDRCQLQTRCQNGGQWDGLKCQCPSTFYGSSCEFAVEQVDLDVVETEVGMEVSVDQQFSPDLNDNTSQAYRDFNKTFWNQMQKIFADMQGFTFKGVEILSLRNGSIVVDYLVLLEMPFSPQLESEYEQVKTTLKEGLQNASQDVNSCQDSQTLCFKPDSIKVNNNSKTELTPAAICRRAAPTGYEEFYFPLVEATRLRCVTKCTSGVDNAIDCHQGQCVLETSGPTCRCYSTDTHWFSGPRCEVAVHWRALVGGLTAGAALLVLLLLALGVRAVRSGWWGGQRRGRSWDQDRKWFETWDEEVVGTFSNWGFEDDGTDKDTNFYVALENVDTTMKVHIKRPEMTSSSV,3323,"345,127",Alternative sequence (7); Chain (1); Compositional bias (2); Disulfide bond (2); Domain (2); Frameshift (1); Natural variant (3); Region (1); Repeat (32); Sequence caution (2); Sequence conflict (35); Signal peptide (1); Transmembrane (1),"DISULFID 2980..2986;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 2999..3008;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q92692,Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin cell adhesion molecule 2) (Poliovirus receptor-related protein 2) (CD antigen CD112),MARAAALLPSRSPPTPLLWPLLLLLLLETGAQDVRVQVLPEVRGQLGGTVELPCHLLPPVPGLYISLVTWQRPDAPANHQNVAAFHPKMGPSFPSPKPGSERLSFVSAKQSTGQDTEAELQDATLALHGLTVEDEGNYTCEFATFPKGSVRGMTWLRVIAKPKNQAEAQKVTFSQDPTTVALCISKEGRPPARISWLSSLDWEAKETQVSGTLAGTVTVTSRFTLVPSGRADGVTVTCKVEHESFEEPALIPVTLSVRYPPEVSISGYDDNWYLGRTDATLSCDVRSNPEPTGYDWSTTSGTFPTSAVAQGSQLVIHAVDSLFNTTFVCTVTNAVGMGRAEQVIFVRETPNTAGAGATGGIIGGIIAAIIATAVAATGILICRQQRKEQTLQGAEEDEDLEGPPSYKPPTPKAKLEAQEMPSQLFTLGASEHSPLKTPYFDAGASCTEQEMPRYHELPTLEERSGPLHPGATSLGSPIPVPPGPPAVEDVSLDLEDEEGEEEEEYLDKINPIYDALSYSSPSDSYQGKGFVMSRAMYV,538,"57,742",Alternative sequence (2); Beta strand (13); Chain (1); Disulfide bond (3); Domain (3); Glycosylation (2); Helix (3); Modified residue (4); Mutagenesis (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 54..140;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22927415""; DISULFID 183..238;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 283..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q15223,Nectin-1 (Herpes virus entry mediator C) (Herpesvirus entry mediator C) (HveC) (Herpesvirus Ig-like receptor) (HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111),MARMGLAGAAGRWWGLALGLTAFFLPGVHSQVVQVNDSMYGFIGTDVVLHCSFANPLPSVKITQVTWQKSTNGSKQNVAIYNPSMGVSVLAPYRERVEFLRPSFTDGTIRLSRLELEDEGVYICEFATFPTGNRESQLNLTVMAKPTNWIEGTQAVLRAKKGQDDKVLVATCTSANGKPPSVVSWETRLKGEAEYQEIRNPNGTVTVISRYRLVPSREAHQQSLACIVNYHMDRFKESLTLNVQYEPEVTIEGFDGNWYLQRMDVKLTCKADANPPATEYHWTTLNGSLPKGVEAQNRTLFFKGPINYSLAGTYICEATNPIGTRSGQVEVNITEFPYTPSPPEHGRRAGPVPTAIIGGVAGSILLVLIVVGGIVVALRRRRHTFKGDYSTKKHVYGNGYSKAGIPQHHPPMAQNLQYPDDSDDEKKAGPLGGSSYEEEEEEEEGGGGGERKVGGPHPKYDEDAKRPYFTVDEAEARQDGYGDRTLGYQYDPEQLDLAENMVSQNDGSFISKKEWYV,517,"57,158",Alternative sequence (4); Beta strand (25); Chain (1); Compositional bias (2); Disulfide bond (3); Domain (3); Erroneous initiation (1); Glycosylation (8); Helix (3); Modified residue (5); Mutagenesis (3); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 51..124;  /evidence=""ECO:0000269|PubMed:22146396, ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294""; DISULFID 172..226;  /evidence=""ECO:0000269|PubMed:22146396, ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294""; DISULFID 269..316;  /evidence=""ECO:0000269|PubMed:22146396, ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q13018,Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)],MLLSPSLLLLLLLGAPRGCAEGVAAALTPERLLEWQDKGIFVIQSESLKKCIQAGKSVLTLENCKQANKHMLWKWVSNHGLFNIGGSGCLGLNFSAPEQPLSLYECDSTLVSLRWRCNRKMITGPLQYSVQVAHDNTVVASRKYIHKWISYGSGGGDICEYLHKDLHTIKGNTHGMPCMFPFQYNHQWHHECTREGREDDLLWCATTSRYERDEKWGFCPDPTSAEVGCDTIWEKDLNSHICYQFNLLSSLSWSEAHSSCQMQGGTLLSITDETEENFIREHMSSKTVEVWMGLNQLDEHAGWQWSDGTPLNYLNWSPEVNFEPFVEDHCGTFSSFMPSAWRSRDCESTLPYICKKYLNHIDHEIVEKDAWKYYATHCEPGWNPYNRNCYKLQKEEKTWHEALRSCQADNSALIDITSLAEVEFLVTLLGDENASETWIGLSSNKIPVSFEWSNDSSVIFTNWHTLEPHIFPNRSQLCVSAEQSEGHWKVKNCEERLFYICKKAGHVLSDAESGCQEGWERHGGFCYKIDTVLRSFDQASSGYYCPPALVTITNRFEQAFITSLISSVVKMKDSYFWIALQDQNDTGEYTWKPVGQKPEPVQYTHWNTHQPRYSGGCVAMRGRHPLGRWEVKHCRHFKAMSLCKQPVENQEKAEYEERWPFHPCYLDWESEPGLASCFKVFHSEKVLMKRTWREAEAFCEEFGAHLASFAHIEEENFVNELLHSKFNWTEERQFWIGFNKRNPLNAGSWEWSDRTPVVSSFLDNTYFGEDARNCAVYKANKTLLPLHCGSKREWICKIPRDVKPKIPFWYQYDVPWLFYQDAEYLFHTFASEWLNFEFVCSWLHSDLLTIHSAHEQEFIHSKIKALSKYGASWWIGLQEERANDEFRWRDGTPVIYQNWDTGRERTVNNQSQRCGFISSITGLWGSEECSVSMPSICKRKKVWLIEKKKDTPKQHGTCPKGWLYFNYKCLLLNIPKDPSSWKNWTHAQHFCAEEGGTLVAIESEVEQAFITMNLFGQTTSVWIGLQNDDYETWLNGKPVVYSNWSPFDIINIPSHNTTEVQKHIPLCALLSSNPNFHFTGKWYFEDCGKEGYGFVCEKMQDTSGHGVNTSDMYPMPNTLEYGNRTYKIINANMTWYAAIKTCLMHKAQLVSITDQYHQSFLTVVLNRLGYAHWIGLFTTDNGLNFDWSDGTKSSFTFWKDEESSLLGDCVFADSNGRWHSTACESFLQGAICHVPPETRQSEHPELCSETSIPWIKFKSNCYSFSTVLDSMSFEAAHEFCKKEGSNLLTIKDEAENAFLLEELFAFGSSVQMVWLNAQFDGNNETIKWFDGTPTDQSNWGIRKPDTDYFKPHHCVALRIPEGLWQLSPCQEKKGFICKMEADIHTAEALPEKGPSHSIIPLAVVLTLIVIVAICTLSFCIYKHNGGFFRRLAGFRNPYYPATNFSTVYLEENILISDLEKSDQ,1463,"168,600",Alternative sequence (2); Beta strand (7); Chain (2); Disulfide bond (17); Domain (10); Glycosylation (3); Helix (3); Motif (1); Natural variant (8); Sequence conflict (13); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..64;  /evidence=""ECO:0000250""; DISULFID 89..106;  /evidence=""ECO:0000250""; DISULFID 178..204;  /evidence=""ECO:0000250""; DISULFID 192..219;  /evidence=""ECO:0000250""; DISULFID 260..354;  /evidence=""ECO:0000250""; DISULFID 330..346;  /evidence=""ECO:0000250""; DISULFID 406..501;  /evidence=""ECO:0000250""; DISULFID 478..493;  /evidence=""ECO:0000250""; DISULFID 617..634;  /evidence=""ECO:0000250""; DISULFID 699..796;  /evidence=""ECO:0000250""; DISULFID 774..788;  /evidence=""ECO:0000250""; DISULFID 840..937;  /evidence=""ECO:0000250""; DISULFID 914..929;  /evidence=""ECO:0000250""; DISULFID 1067..1087;  /evidence=""ECO:0000250""; DISULFID 1209..1223;  /evidence=""ECO:0000250""; DISULFID 1280..1377;  /evidence=""ECO:0000250""; DISULFID 1354..1369;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000250"""
P98161,Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein),MPPAAPARLALALGLGLWLGALAGGPGRGCGPCEPPCLCGPAPGAACRVNCSGRGLRTLGPALRIPADATALDVSHNLLRALDVGLLANLSALAELDISNNKISTLEEGIFANLFNLSEINLSGNPFECDCGLAWLPRWAEEQQVRVVQPEAATCAGPGSLAGQPLLGIPLLDSGCGEEYVACLPDNSSGTVAAVSFSAAHEGLLQPEACSAFCFSTGQGLAALSEQGWCLCGAAQPSSASFACLSLCSGPPPPPAPTCRGPTLLQHVFPASPGATLVGPHGPLASGQLAAFHIAAPLPVTATRWDFGDGSAEVDAAGPAASHRYVLPGRYHVTAVLALGAGSALLGTDVQVEAAPAALELVCPSSVQSDESLDLSIQNRGGSGLEAAYSIVALGEEPARAVHPLCPSDTEIFPGNGHCYRLVVEKAAWLQAQEQCQAWAGAALAMVDSPAVQRFLVSRVTRSLDVWIGFSTVQGVEVGPAPQGEAFSLESCQNWLPGEPHPATAEHCVRLGPTGWCNTDLCSAPHSYVCELQPGGPVQDAENLLVGAPSGDLQGPLTPLAQQDGLSAPHEPVEVMVFPGLRLSREAFLTTAEFGTQELRRPAQLRLQVYRLLSTAGTPENGSEPESRSPDNRTQLAPACMPGGRWCPGANICLPLDASCHPQACANGCTSGPGLPGAPYALWREFLFSVPAGPPAQYSVTLHGQDVLMLPGDLVGLQHDAGPGALLHCSPAPGHPGPRAPYLSANASSWLPHLPAQLEGTWACPACALRLLAATEQLTVLLGLRPNPGLRLPGRYEVRAEVGNGVSRHNLSCSFDVVSPVAGLRVIYPAPRDGRLYVPTNGSALVLQVDSGANATATARWPGGSVSARFENVCPALVATFVPGCPWETNDTLFSVVALPWLSEGEHVVDVVVENSASRANLSLRVTAEEPICGLRATPSPEARVLQGVLVRYSPVVEAGSDMVFRWTINDKQSLTFQNVVFNVIYQSAAVFKLSLTASNHVSNVTVNYNVTVERMNRMQGLQVSTVPAVLSPNATLALTAGVLVDSAVEVAFLWTFGDGEQALHQFQPPYNESFPVPDPSVAQVLVEHNVMHTYAAPGEYLLTVLASNAFENLTQQVPVSVRASLPSVAVGVSDGVLVAGRPVTFYPHPLPSPGGVLYTWDFGDGSPVLTQSQPAANHTYASRGTYHVRLEVNNTVSGAAAQADVRVFEELRGLSVDMSLAVEQGAPVVVSAAVQTGDNITWTFDMGDGTVLSGPEATVEHVYLRAQNCTVTVGAASPAGHLARSLHVLVFVLEVLRVEPAACIPTQPDARLTAYVTGNPAHYLFDWTFGDGSSNTTVRGCPTVTHNFTRSGTFPLALVLSSRVNRAHYFTSICVEPEVGNVTLQPERQFVQLGDEAWLVACAWPPFPYRYTWDFGTEEAAPTRARGPEVTFIYRDPGSYLVTVTASNNISAANDSALVEVQEPVLVTSIKVNGSLGLELQQPYLFSAVGRGRPASYLWDLGDGGWLEGPEVTHAYNSTGDFTVRVAGWNEVSRSEAWLNVTVKRRVRGLVVNASRTVVPLNGSVSFSTSLEAGSDVRYSWVLCDRCTPIPGGPTISYTFRSVGTFNIIVTAENEVGSAQDSIFVYVLQLIEGLQVVGGGRYFPTNHTVQLQAVVRDGTNVSYSWTAWRDRGPALAGSGKGFSLTVLEAGTYHVQLRATNMLGSAWADCTMDFVEPVGWLMVAASPNPAAVNTSVTLSAELAGGSGVVYTWSLEEGLSWETSEPFTTHSFPTPGLHLVTMTAGNPLGSANATVEVDVQVPVSGLSIRASEPGGSFVAAGSSVPFWGQLATGTNVSWCWAVPGGSSKRGPHVTMVFPDAGTFSIRLNASNAVSWVSATYNLTAEEPIVGLVLWASSKVVAPGQLVHFQILLAAGSAVTFRLQVGGANPEVLPGPRFSHSFPRVGDHVVSVRGKNHVSWAQAQVRIVVLEAVSGLQVPNCCEPGIATGTERNFTARVQRGSRVAYAWYFSLQKVQGDSLVILSGRDVTYTPVAAGLLEIQVRAFNALGSENRTLVLEVQDAVQYVALQSGPCFTNRSAQFEAATSPSPRRVAYHWDFGDGSPGQDTDEPRAEHSYLRPGDYRVQVNASNLVSFFVAQATVTVQVLACREPEVDVVLPLQVLMRRSQRNYLEAHVDLRDCVTYQTEYRWEVYRTASCQRPGRPARVALPGVDVSRPRLVLPRLALPVGHYCFVFVVSFGDTPLTQSIQANVTVAPERLVPIIEGGSYRVWSDTRDLVLDGSESYDPNLEDGDQTPLSFHWACVASTQREAGGCALNFGPRGSSTVTIPRERLAAGVEYTFSLTVWKAGRKEEATNQTVLIRSGRVPIVSLECVSCKAQAVYEVSRSSYVYLEGRCLNCSSGSKRGRWAARTFSNKTLVLDETTTSTGSAGMRLVLRRGVLRDGEGYTFTLTVLGRSGEEEGCASIRLSPNRPPLGGSCRLFPLGAVHALTTKVHFECTGWHDAEDAGAPLVYALLLRRCRQGHCEEFCVYKGSLSSYGAVLPPGFRPHFEVGLAVVVQDQLGAAVVALNRSLAITLPEPNGSATGLTVWLHGLTASVLPGLLRQADPQHVIEYSLALVTVLNEYERALDVAAEPKHERQHRAQIRKNITETLVSLRVHTVDDIQQIAAALAQCMGPSRELVCRSCLKQTLHKLEAMMLILQAETTAGTVTPTAIGDSILNITGDLIHLASSDVRAPQPSELGAESPSRMVASQAYNLTSALMRILMRSRVLNEEPLTLAGEEIVAQGKRSDPRSLLCYGGAPGPGCHFSIPEAFSGALANLSDVVQLIFLVDSNPFPFGYISNYTVSTKVASMAFQTQAGAQIPIERLASERAITVKVPNNSDWAARGHRSSANSANSVVVQPQASVGAVVTLDSSNPAAGLHLQLNYTLLDGHYLSEEPEPYLAVYLHSEPRPNEHNCSASRRIRPESLQGADHRPYTFFISPGSRDPAGSYHLNLSSHFRWSALQVSVGLYTSLCQYFSEEDMVWRTEGLLPLEETSPRQAVCLTRHLTAFGASLFVPPSHVRFVFPEPTADVNYIVMLTCAVCLVTYMVMAAILHKLDQLDASRGRAIPFCGQRGRFKYEILVKTGWGRGSGTTAHVGIMLYGVDSRSGHRHLDGDRAFHRNSLDIFRIATPHSLGSVWKIRVWHDNKGLSPAWFLQHVIVRDLQTARSAFFLVNDWLSVETEANGGLVEKEVLAASDAALLRFRRLLVAELQRGFFDKHIWLSIWDRPPRSRFTRIQRATCCVLLICLFLGANAVWYGAVGDSAYSTGHVSRLSPLSVDTVAVGLVSSVVVYPVYLAILFLFRMSRSKVAGSPSPTPAGQQVLDIDSCLDSSVLDSSFLTFSGLHAEQAFVGQMKSDLFLDDSKSLVCWPSGEGTLSWPDLLSDPSIVGSNLRQLARGQAGHGLGPEEDGFSLASPYSPAKSFSASDEDLIQQVLAEGVSSPAPTQDTHMETDLLSSLSSTPGEKTETLALQRLGELGPPSPGLNWEQPQAARLSRTGLVEGLRKRLLPAWCASLAHGLSLLLVAVAVAVSGWVGASFPPGVSVAWLLSSSASFLASFLGWEPLKVLLEALYFSLVAKRLHPDEDDTLVESPAVTPVSARVPRVRPPHGFALFLAKEEARKVKRLHGMLRSLLVYMLFLLVTLLASYGDASCHGHAYRLQSAIKQELHSRAFLAITRSEELWPWMAHVLLPYVHGNQSSPELGPPRLRQVRLQEALYPDPPGPRVHTCSAAGGFSTSDYDVGWESPHNGSGTWAYSAPDLLGAWSWGSCAVYDSGGYVQELGLSLEESRDRLRFLQLHNWLDNRSRAVFLELTRYSPAVGLHAAVTLRLEFPAAGRALAALSVRPFALRRLSAGLSLPLLTSVCLLLFAVHFAVAEARTWHREGRWRVLRLGAWARWLLVALTAATALVRLAQLGAADRQWTRFVRGRPRRFTSFDQVAQLSSAARGLAASLLFLLLVKAAQQLRFVRQWSVFGKTLCRALPELLGVTLGLVVLGVAYAQLAILLVSSCVDSLWSVAQALLVLCPGTGLSTLCPAESWHLSPLLCVGLWALRLWGALRLGAVILRWRYHALRGELYRPAWEPQDYEMVELFLRRLRLWMGLSKVKEFRHKVRFEGMEPLPSRSSRGSKVSPDVPPPSAGSDASHPSTSSSQLDGLSVSLGRLGTRCEPEPSRLQAVFEALLTQFDRLNQATEDVYQLEQQLHSLQGRRSSRAPAGSSRGPSPGLRPALPSRLARASRGVDLATGPSRTPLRAKNKVHPSST,4303,"462,529",Alternative sequence (2); Beta strand (7); Chain (1); Coiled coil (1); Disulfide bond (5); Domain (25); Glycosylation (60); Modified residue (1); Mutagenesis (2); Natural variant (186); Repeat (2); Sequence conflict (21); Signal peptide (1); Site (1); Topological domain (12); Transmembrane (11),"DISULFID 436..530;  /evidence=""ECO:0000250""; DISULFID 508..522;  /evidence=""ECO:0000250""; DISULFID 640..653;  /evidence=""ECO:0000250""; DISULFID 647..665;  /evidence=""ECO:0000250""; DISULFID 660..669;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9Y693,LHFPL tetraspan subfamily member 6 protein (Lipoma HMGIC fusion partner),MASSLTCTGVIWALLSFLCAATSCVGFFMPYWLWGSQLGKPVSFGTFRRCSYPVHDESRQMMVMVEECGRYASFQGIPSAEWRICTIVTGLGCGLLLLVALTALMGCCVSDLISRTVGRVAGGIQFLGGLLIGAGCALYPLGWDSEEVRQTCGYTSGQFDLGKCEIGWAYYCTGAGATAAMLLCTWLACFSGKKQKHYPY,200,"21,598",Chain (1); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
O60309,Leucine-rich repeat-containing protein 37A3,MTSAQCPALACVMSPLRFWGPWPLLMWQLLWLLVKEAQPLEWVKDPLQLTSNPLGPPEPWSSHSSHFPRESPHAPTLPADPWDFDHLGPSASSEMPAPPQESTENLVPFLDTWDSAGELPLEPEQFLASQQDLKDKLSPQERLPVSPKKLKKDPAQRWSLAEIIGIIHQLSTPQSQKQTLQNEYSSTDTPYPGSLPPELRVKSDEPPGPSEQVGPSQFHLEPETQNPETLEDIQSSSLQQEAPAQLPQLLEEEPSSMQQEAPALPPESSMESLTLPNHEVSVQPPGEDQAYYHLPNITVKPADVEVTITSEPTNETESSQAQQETPIQFPEEVEPSATQQEAPIEPPVPPMEHELSISEQQQPVQPSESSREVESSPTQQETPGQPPEHHEVTVSPPGHHQTHHLASPSVSVKPPDVQLTIAAEPSAEVGTSLVHQEATTRLSGSGNDVEPPAIQHGGPPLLPESSEEAGPLAVQQETSFQSPEPINNENPSPTQQEAAAEHPQTAEEGESSLTHQEAPAQTPEFPNVVVAQPPEHSHLTQATVQPLDLGFTITPESMTEVELSPTMKETPTQPPKKVVPQLRVYQGVTNPTPGQDQAQHPVSPSVTVQLLDLGLTITPEPTTEVGHSTPPKRTIVSPKHPEVTLPHPDQVQTQHSHLTRATVQPLDLGFTITPKSMTEVEPSTALMTTAPPPGHPEVTLPPSDKGQAQHSHLTQATVQPLDLELTITTKPTTEVKPSPTTEETSTQLPDLGLAIIPEPTTETGHSTALEKTTAPRPDRVQTLHRSLTEVTGPPTELEPAQDSLVQSESYTQNKALTAPEEHKASTSTNICELCTCGDEMLSCIDLNPEQRLRQVPVPEPNTHNGTFTILNFQGNYISYIDGNVWKAYSWTEKLILRENNLTELHKDSFEGLLSLQYLDLSCNKIQSIERHTFEPLPFLKFINLSCNVITELSFGTFQAWHGMQFLHKLILNHNPLTTVEDPYLFKLPALKYLDMGTTLVPLTTLKNILMMTVELEKLIVPSHMACCLCQFKNSIEAVCKTVKLHCNSACLTNTTHCPEEASVGNPEGAFMKVLQARKNYTSTELIIEPEEPSDSSGINLSGFGSEQLDTNDESDVTSTLSYILPYFSAVNLDVKSLLLPFIKLPTTGNSLAKIQTVGKNRQRLNRVLMGPRSIQKRHFKEVGRQSIRREQGAQASVENTAEEKRLGSPAPRELKQPHTQQGPEKLAGNAVYTKPSFTQEHKAAVSVLKPFSKGAPSTSSPAKALPQVRDRWKDLTHAISILESAKARVTNMKTSKPIVHSRKKYRFHKTRSRMTHRTPKVKKSPKVRKKSYLSRLMLSNRLPFSAAKSLINSPSQGAFSSLRDLSPQENPFLEVSAPSEHFIENNNTKDTTARNAFEENVFMENTNMPEGTISENTNYNHPPEADSAGTAFNLGPTVKQTETKWEYNNVGTDLSPEPKSFNYPLLSSPGDQFEIQLTQQLQSVIPNNNVRRLIAHVIRTLKMDCSGAHVQVTCAKLVSRTGHLMKLLSGQQEVKASKIEWDTDQWKTENYINESTEAQSEQKEKSLEFTKELPGYGYTKKLILALIVTGILTILIILLCLIEICCHRRSLQEDEEGFSRDSEAPTEEESEALP,1634,"180,621",Chain (1); Erroneous initiation (2); Glycosylation (2); Natural variant (2); Repeat (12); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q6UY18,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D),MDAATAPKQAWPPWPPLLFLLLLPGGSGGSCPAVCDCTSQPQAVLCGHRQLEAVPGGLPLDTELLDLSGNRLWGLQQGMLSRLSLLQELDLSYNQLSTLEPGAFHGLQSLLTLRLQGNRLRIMGPGVFSGLSALTLLDLRLNQIVLFLDGAFGELGSLQKLEVGDNHLVFVAPGAFAGLAKLSTLTLERCNLSTVPGLALARLPALVALRLRELDIGRLPAGALRGLGQLKELEIHLWPSLEALDPGSLVGLNLSSLAITRCNLSSVPFQALYHLSFLRVLDLSQNPISAIPARRLSPLVRLQELRLSGACLTSIAAHAFHGLTAFHLLDVADNALQTLEETAFPSPDKLVTLRLSGNPLTCDCRLLWLLRLRRHLDFGMSPPACAGPHHVQGKSLKEFSDILPPGHFTCKPALIRKSGPRWVIAEEGGHAVFSCSGDGDPAPTVSWMRPHGAWLGRAGRVRVLEDGTLEIRSVQLRDRGAYVCVVSNVAGNDSLRTWLEVIQVEPPNGTLSDPNITVPGIPGPFFLDSRGVAMVLAVGFLPFLTSVTLCFGLIALWSKGKGRVKHHMTFDFVAPRPSGDKNSGGNRVTAKLF,593,"63,774",Chain (1); Disulfide bond (1); Domain (3); Glycosylation (6); Repeat (11); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 435..484;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9BTN0,Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (Synaptic adhesion-like molecule 4),MAILPLLLCLLPLAPASSPPQSATPSPCPRRCRCQTQSLPLSVLCPGAGLLFVPPSLDRRAAELRLADNFIASVRRRDLANMTGLLHLSLSRNTIRHVAAGAFADLRALRALHLDGNRLTSLGEGQLRGLVNLRHLILSNNQLAALAAGALDDCAETLEDLDLSYNNLEQLPWEALGRLGNVNTLGLDHNLLASVPAGAFSRLHKLARLDMTSNRLTTIPPDPLFSRLPLLARPRGSPASALVLAFGGNPLHCNCELVWLRRLAREDDLEACASPPALGGRYFWAVGEEEFVCEPPVVTHRSPPLAVPAGRPAALRCRAVGDPEPRVRWVSPQGRLLGNSSRARAFPNGTLELLVTEPGDGGIFTCIAANAAGEATAAVELTVGPPPPPQLANSTSCDPPRDGDPDALTPPSAASASAKVADTGPPTDRGVQVTEHGATAALVQWPDQRPIPGIRMYQIQYNSSADDILVYRMIPAESRSFLLTDLASGRTYDLCVLAVYEDSATGLTATRPVGCARFSTEPALRPCGAPHAPFLGGTMIIALGGVIVASVLVFIFVLLMRYKVHGGQPPGKAKIPAPVSSVCSQTNGALGPTPTPAPPAPEPAALRAHTVVQLDCEPWGPGHEPVGP,628,"66,260",Chain (1); Disulfide bond (1); Domain (4); Glycosylation (5); Natural variant (1); Repeat (7); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 317..366;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
O43300,Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein),MGLHFKWPLGAPMLAAIYAMSMVLKMLPALGMACPPKCRCEKLLFYCDSQGFHSVPNATDKGSLGLSLRHNHITELERDQFASFSQLTWLHLDHNQISTVKEDAFQGLYKLKELILSSNKIFYLPNTTFTQLINLQNLDLSFNQLSSLHPELFYGLRKLQTLHLRSNSLRTIPVRLFWDCRSLEFLDLSTNRLRSLARNGFAGLIKLRELHLEHNQLTKINFAHFLRLSSLHTLFLQWNKISNLTCGMEWTWGTLEKLDLTGNEIKAIDLTVFETMPNLKILLMDNNKLNSLDSKILNSLRSLTTVGLSGNLWECSARICALASWLGSFQGRWEHSILCHSPDHTQGEDILDAVHGFQLCWNLSTTVTVMATTYRDPTTEYTKRISSSSYHVGDKEIPTTAGIAVTTEEHFPEPDNAIFTQRVITGTMALLFSFFFIIFIVFISRKCCPPTLRRIRQCSMVQNHRQLRSQTRLHMSNMSDQGPYNEYEPTHEGPFIIINGYGQCKCQQLPYKECEV,516,"59,076",Beta strand (15); Chain (1); Domain (2); Erroneous initiation (1); Glycosylation (4); Helix (5); Motif (1); Repeat (10); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (8),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q5SQ64,Lymphocyte antigen 6 complex locus protein G6f,MAVLFLLLFLCGTPQAADNMQAIYVALGEAVELPCPSPPTLHGDEHLSWFCSPAAGSFTTLVAQVQVGRPAPDPGKPGRESRLRLLGNYSLWLEGSKEEDAGRYWCAVLGQHHNYQNWRVYDVLVLKGSQLSARAADGSPCNVLLCSVVPSRRMDSVTWQEGKGPVRGRVQSFWGSEAALLLVCPGEGLSEPRSRRPRIIRCLMTHNKGVSFSLAASIDASPALCAPSTGWDMPWILMLLLTMGQGVVILALSIVLWRQRVRGAPGRDASIPQFKPEIQVYENIHLARLGPPAHKPR,297,"32,465",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (1); Erroneous gene model prediction (2); Glycosylation (1); Modified residue (1); Mutagenesis (1); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q9H1U4,Multiple epidermal growth factor-like domains protein 9 (Multiple EGF-like domains protein 9) (Epidermal growth factor-like protein 5) (EGF-like protein 5),MNGGAERAMRSLPSLGGLALLCCAAAAAAAAVASAASAGNVTGGGGAAGQVDASPGPGLRGEPSHPFPRATAPTAQAPRTGPPRATVHRPLAATSPAQSPETTPLWATAGPSSTTFQAPLGPSPTTPPAAERTSTTSQAPTRPAPTTLSTTTGPAPTTPVATTVPAPTTPRTPTPDLPSSSNSSVLPTPPATEAPSSPPPEYVCNCSVVGSLNVNRCNQTTGQCECRPGYQGLHCETCKEGFYLNYTSGLCQPCDCSPHGALSIPCNSSGKCQCKVGVIGSICDRCQDGYYGFSKNGCLPCQCNNRSASCDALTGACLNCQENSKGNHCEECKEGFYQSPDATKECLRCPCSAVTSTGSCSIKSSELEPECDQCKDGYIGPNCNKCENGYYNFDSICRKCQCHGHVDPVKTPKICKPESGECINCLHNTTGFWCENCLEGYVHDLEGNCIKKEVILPTPEGSTILVSNASLTTSVPTPVINSTFTPTTLQTIFSVSTSENSTSALADVSWTQFNIIILTVIIIVVVLLMGFVGAVYMYREYQNRKLNAPFWTIELKEDNISFSSYHDSIPNADVSGLLEDDGNEVAPNGQLTLTTPIHNYKA,602,"62,984",Chain (1); Compositional bias (2); Disulfide bond (20); Domain (5); Glycosylation (11); Sequence caution (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 204..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 206..224;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 226..235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 238..251;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 254..266;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 256..272;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 274..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 286..298;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 301..310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 303..317;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 320..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 332..346;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 349..360;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 351..371;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 374..383;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 386..397;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 400..415;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 402..422;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 425..434;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""; DISULFID 437..449;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00460""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
A6NHS7,MANSC domain-containing protein 4,MHVAEVAVNVILLLSMGWTSDSLCSPTIFYRDCWIRRFPGLLINLEESQKLGAQFLKYYSESTGQKCSRSCCLRKDVSCNLAVFYHSPIHDNINCLHVHCPTLESCILEPGTSAILYNITDGIDPDLLVFEQSPTYLNTRSSSNRWDRLRILKAMNLDKQTTTINGMLPSTEAPSSTTHQDLVVNTNSTSYSKELTTDFWARFTSLNESITTKINKVSPSTDFISNPDNKTISPFFEPIDTKLSHMPVPPGLNSSKQLLNKTKGYNSRNHTSANEDEVSVTSKTWLVSVALCTSVIFLGCCIVILASGCCGKQQGQYKPGQRKSGSLQIKNRNHMKENSS,340,"37,879",Chain (1); Domain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
P25189,Myelin protein P0 (Myelin peripheral protein) (MPP) (Myelin protein zero),MAPGAPSSSPSPILAVLLFSSLVLSPAQAIVVYTDREVHGAVGSRVTLHCSFWSSEWVSDDISFTWRYQPEGGRDAISIFHYAKGQPYIDEVGTFKERIQWVGDPRWKDGSIVIHNLDYSDNGTFTCDVKNPPDIVGKTSQVTLYVFEKVPTRYGVVLGAVIGGVLGVVLLLLLLFYVVRYCWLRRQAALQRRLSAMEKGKLHKPGKDASKRGRQTPVLYAMLDHSRSTKAVSEKKAKGLGESRKDKK,248,"27,555",Alternative sequence (1); Beta strand (9); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (5); Glycosylation (1); Helix (2); Modified residue (5); Natural variant (91); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 50..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21971831""",SIGNAL 1..29
Q12879,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)",MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV,1464,"165,283",Alternative sequence (1); Beta strand (18); Binding site (1); Chain (1); Disulfide bond (4); Glycosylation (7); Helix (13); Intramembrane (1); Metal binding (4); Modified residue (8); Motif (1); Mutagenesis (6); Natural variant (87); Region (4); Signal peptide (1); Site (1); Topological domain (5); Transmembrane (3); Turn (3),"DISULFID 87..320;  /evidence=""ECO:0000250|UniProtKB:Q00959""; DISULFID 429..455;  /evidence=""ECO:0000244|PDB:5H8F, ECO:0000244|PDB:5H8H, ECO:0000244|PDB:5H8N, ECO:0000244|PDB:5H8Q, ECO:0000244|PDB:5I2K, ECO:0000244|PDB:5I2N, ECO:0000244|PDB:5KCJ, ECO:0000244|PDB:5KDT, ECO:0000244|PDB:5TP9, ECO:0000244|PDB:5TPA, ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:26919761, ECO:0000269|PubMed:28105280""; DISULFID 436..456;  /evidence=""ECO:0000244|PDB:5H8F, ECO:0000244|PDB:5H8H, ECO:0000244|PDB:5H8N, ECO:0000244|PDB:5H8Q, ECO:0000244|PDB:5I2K, ECO:0000244|PDB:5I2N, ECO:0000244|PDB:5KCJ, ECO:0000244|PDB:5KDT, ECO:0000244|PDB:5TP9, ECO:0000244|PDB:5TPA, ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:26919761, ECO:0000269|PubMed:28105280""; DISULFID 745..800;  /evidence=""ECO:0000250|UniProtKB:Q00959""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q5JPE7,Nodal modulator 2 (pM5 protein 2),MLVGQGAGLLGPAVVTAAVVLLLSGVGPAHGSEDIVVGCGGFVKSDVEINYSLIEIKLYTKHGTLKYQTDCAPNNGYFMIPLYDKGDFILKIEPPLGWSFEPTTVELHVDGVSDICTKGGDINFVFTGFSVNGKVLSKGQPLGPAGVQVSLRNTGTEAKIQSTVTQPGGKFAFFKVLPGDYEILATHPTWALKEASTTVRVTNSNANAASPLIVAGYNVSGSVRSDGEPMKGVKFLLFSSLVTKEDVLGCNVSPVPGFQPQDESLVYLCYTVSREDGSFSFYSLPSGGYTVIPFYRGERITFDVAPSRLDFTVEHDSLKIEPVFHVMGFSVTGRVLNGPEGDGVPEAVVTLNNQIKVKTKADGSFRLENITTGTYTIHAQKEHLYFETVTIKIAPNTPQLADIVATGFSVCGRISIIRFPDTVKQMNKYKVVLSSQDKDKSLVTVETDAHGSFCFKAKPGTYKVQVMVPEAETRAGLTLKPQTFPLTVTDRPVMDVAFVQFLASVSGKVSCLDTCGDLLVTLQSLSRQGEKRSLQLSGKVNAMTFTFDNVLPGKYKISIMHEDWCWKNKSLEVEVLEDDVSAVEFRQTGYMLRCSLSHAITLEFYQDGNGRENVGIYNLSKGVNRFCLSKPGVYKVTPRSCHRFEQAFYTYDTSSPSILTLTAIRHHVLGTITTDKMMDVTVTIKSSIDSEPALVLGPLKSVQELRREQQLAEIEARRQEREKNGNEEGEERMTKPPVQEMVDELQGPFSYDFSYWARSGEKITVTPSSKELLFYPPSMEAVVSGESCPGKLIEIHGKAGLFLEGQIHPELEGVEIVISEKGASSPLITVFTDDKGAYSVGPLHSDLEYTVTSQKEGYVLTAVEGTIGDFKAYALAGVSFEIKAEDDQPLPGVLLSLSGGLFRSNLLTQDNGILTFSNLSPGQYYFKPMMKEFRFEPSSQMIEVQEGQNLKITITGYRTAYSCYGTVSSLNGEPEQGVAMEAVGQNDCSIYGEDTVTDEEGKFRLRGLLPGCVYHVQLKAEGNDHIERALPHHRVIEVGNNDIDDVNIIVFRQINQFDLSGNVITSSEYLPTLWVKLYKSENLDNPIQTVSLGQSLFFHFPPLLRDGENYVVLLDSTLPRSQYDYILPQVSFTAVGYHKHITLIFNPTRKLPEQDIAQGSYIALPLTLLVLLAGYNHDKLIPLLLQLTSRLQGVGALGQAASDNSGPEDAKRQAKKQKTRRTLRLQEEFQLMWCLVPWRGTLGIHLFSSLPFASEILLETTATCIHY,1267,"139,439",Alternative sequence (3); Chain (1); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q99466,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain],MQPPSLLLLLLLLLLLCVSVVRPRGLLCGSFPEPCANGGTCLSLSLGQGTCQCAPGFLGETCQFPDPCQNAQLCQNGGSCQALLPAPLGLPSSPSPLTPSFLCTCLPGFTGERCQAKLEDPCPPSFCSKRGRCHIQASGRPQCSCMPGWTGEQCQLRDFCSANPCVNGGVCLATYPQIQCHCPPGFEGHACERDVNECFQDPGPCPKGTSCHNTLGSFQCLCPVGQEGPRCELRAGPCPPRGCSNGGTCQLMPEKDSTFHLCLCPPGFIGPDCEVNPDNCVSHQCQNGGTCQDGLDTYTCLCPETWTGWDCSEDVDECETQGPPHCRNGGTCQNSAGSFHCVCVSGWGGTSCEENLDDCIAATCAPGSTCIDRVGSFSCLCPPGRTGLLCHLEDMCLSQPCHGDAQCSTNPLTGSTLCLCQPGYSGPTCHQDLDECLMAQQGPSPCEHGGSCLNTPGSFNCLCPPGYTGSRCEADHNECLSQPCHPGSTCLDLLATFHCLCPPGLEGQLCEVETNECASAPCLNHADCHDLLNGFQCICLPGFSGTRCEEDIDECRSSPCANGGQCQDQPGAFHCKCLPGFEGPRCQTEVDECLSDPCPVGASCLDLPGAFFCLCPSGFTGQLCEVPLCAPNLCQPKQICKDQKDKANCLCPDGSPGCAPPEDNCTCHHGHCQRSSCVCDVGWTGPECEAELGGCISAPCAHGGTCYPQPSGYNCTCPTGYTGPTCSEEMTACHSGPCLNGGSCNPSPGGYYCTCPPSHTGPQCQTSTDYCVSAPCFNGGTCVNRPGTFSCLCAMGFQGPRCEGKLRPSCADSPCRNRATCQDSPQGPRCLCPTGYTGGSCQTLMDLCAQKPCPRNSHCLQTGPSFHCLCLQGWTGPLCNLPLSSCQKAALSQGIDVSSLCHNGGLCVDSGPSYFCHCPPGFQGSLCQDHVNPCESRPCQNGATCMAQPSGYLCQCAPGYDGQNCSKELDACQSQPCHNHGTCTPKPGGFHCACPPGFVGLRCEGDVDECLDQPCHPTGTAACHSLANAFYCQCLPGHTGQWCEVEIDPCHSQPCFHGGTCEATAGSPLGFICHCPKGFEGPTCSHRAPSCGFHHCHHGGLCLPSPKPGFPPRCACLSGYGGPDCLTPPAPKGCGPPSPCLYNGSCSETTGLGGPGFRCSCPHSSPGPRCQKPGAKGCEGRSGDGACDAGCSGPGGNWDGGDCSLGVPDPWKGCPSHSRCWLLFRDGQCHPQCDSEECLFDGYDCETPPACTPAYDQYCHDHFHNGHCEKGCNTAECGWDGGDCRPEDGDPEWGPSLALLVVLSPPALDQQLFALARVLSLTLRVGLWVRKDRDGRDMVYPYPGARAEEKLGGTRDPTYQERAAPQTQPLGKETDSLSAGFVVVMGVDLSRCGPDHPASRCPWDPGLLLRFLAAMAAVGALEPLLPGPLLAVHPHAGTAPPANQLPWPVLCSPVAGVILLALGALLVLQLIRRRRREHGALWLPPGFTRRPRTQSAPHRRRPPLGEDSIGLKALKPKAEVDEDGVVMCSGPEEGEEVGQAEETGPPSTCQLWSLSGGCGALPQAAMLTPPQESEMEAPDLDTRGPDGVTPLMSAVCCGEVQSGTFQGAWLGCPEPWEPLLDGGACPQAHTVGTGETPLHLAARFSRPTAARRLLEAGANPNQPDRAGRTPLHAAVAADAREVCQLLLRSRQTAVDARTEDGTTPLMLAARLAVEDLVEELIAAQADVGARDKWGKTALHWAAAVNNARAARSLLQAGADKDAQDNREQTPLFLAAREGAVEVAQLLLGLGAARELRDQAGLAPADVAHQRNHWDLLTLLEGAGPPEARHKATPGREAGPFPRARTVSVSVPPHGGGALPRCRTLSAGAGPRGGGACLQARTWSVDLAARGGGAYSHCRSLSGVGAGGGPTPRGRRFSAGMRGPRPNPAIMRGRYGVAAGRGGRVSTDDWPCDWVALGACGSASNIPIPPPCLTPSPERGSPQLDCGPPALQEMPINQGGEGKK,2003,"209,622",Alternative sequence (2); Chain (3); Compositional bias (1); Disulfide bond (95); Domain (29); Frameshift (1); Glycosylation (4); Natural variant (13); Repeat (8); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 28..41;  /evidence=""ECO:0000250""; DISULFID 35..51;  /evidence=""ECO:0000250""; DISULFID 53..62;  /evidence=""ECO:0000250""; DISULFID 68..80;  /evidence=""ECO:0000250""; DISULFID 74..103;  /evidence=""ECO:0000250""; DISULFID 105..114;  /evidence=""ECO:0000250""; DISULFID 122..133;  /evidence=""ECO:0000250""; DISULFID 127..143;  /evidence=""ECO:0000250""; DISULFID 145..154;  /evidence=""ECO:0000250""; DISULFID 160..171;  /evidence=""ECO:0000250""; DISULFID 165..180;  /evidence=""ECO:0000250""; DISULFID 182..191;  /evidence=""ECO:0000250""; DISULFID 198..211;  /evidence=""ECO:0000250""; DISULFID 205..220;  /evidence=""ECO:0000250""; DISULFID 222..231;  /evidence=""ECO:0000250""; DISULFID 238..249;  /evidence=""ECO:0000250""; DISULFID 243..262;  /evidence=""ECO:0000250""; DISULFID 264..273;  /evidence=""ECO:0000250""; DISULFID 280..291;  /evidence=""ECO:0000250""; DISULFID 285..300;  /evidence=""ECO:0000250""; DISULFID 302..311;  /evidence=""ECO:0000250""; DISULFID 318..332;  /evidence=""ECO:0000250""; DISULFID 326..341;  /evidence=""ECO:0000250""; DISULFID 343..352;  /evidence=""ECO:0000250""; DISULFID 359..370;  /evidence=""ECO:0000250""; DISULFID 364..379;  /evidence=""ECO:0000250""; DISULFID 381..390;  /evidence=""ECO:0000250""; DISULFID 396..407;  /evidence=""ECO:0000250""; DISULFID 401..418;  /evidence=""ECO:0000250""; DISULFID 420..429;  /evidence=""ECO:0000250""; DISULFID 436..452;  /evidence=""ECO:0000250""; DISULFID 446..461;  /evidence=""ECO:0000250""; DISULFID 463..472;  /evidence=""ECO:0000250""; DISULFID 479..490;  /evidence=""ECO:0000250""; DISULFID 484..499;  /evidence=""ECO:0000250""; DISULFID 501..510;  /evidence=""ECO:0000250""; DISULFID 517..528;  /evidence=""ECO:0000250""; DISULFID 522..537;  /evidence=""ECO:0000250""; DISULFID 539..548;  /evidence=""ECO:0000250""; DISULFID 555..566;  /evidence=""ECO:0000250""; DISULFID 560..575;  /evidence=""ECO:0000250""; DISULFID 577..586;  /evidence=""ECO:0000250""; DISULFID 593..604;  /evidence=""ECO:0000250""; DISULFID 598..613;  /evidence=""ECO:0000250""; DISULFID 615..624;  /evidence=""ECO:0000250""; DISULFID 629..640;  /evidence=""ECO:0000250""; DISULFID 634..649;  /evidence=""ECO:0000250""; DISULFID 651..658;  /evidence=""ECO:0000250""; DISULFID 665..672;  /evidence=""ECO:0000250""; DISULFID 667..677;  /evidence=""ECO:0000250""; DISULFID 679..688;  /evidence=""ECO:0000250""; DISULFID 695..706;  /evidence=""ECO:0000250""; DISULFID 700..715;  /evidence=""ECO:0000250""; DISULFID 717..726;  /evidence=""ECO:0000250""; DISULFID 733..744;  /evidence=""ECO:0000250""; DISULFID 738..753;  /evidence=""ECO:0000250""; DISULFID 755..764;  /evidence=""ECO:0000250""; DISULFID 771..782;  /evidence=""ECO:0000250""; DISULFID 776..791;  /evidence=""ECO:0000250""; DISULFID 793..802;  /evidence=""ECO:0000250""; DISULFID 810..821;  /evidence=""ECO:0000250""; DISULFID 815..830;  /evidence=""ECO:0000250""; DISULFID 832..841;  /evidence=""ECO:0000250""; DISULFID 848..859;  /evidence=""ECO:0000250""; DISULFID 853..868;  /evidence=""ECO:0000250""; DISULFID 870..879;  /evidence=""ECO:0000250""; DISULFID 886..907;  /evidence=""ECO:0000250""; DISULFID 901..916;  /evidence=""ECO:0000250""; DISULFID 918..927;  /evidence=""ECO:0000250""; DISULFID 934..945;  /evidence=""ECO:0000250""; DISULFID 939..954;  /evidence=""ECO:0000250""; DISULFID 956..965;  /evidence=""ECO:0000250""; DISULFID 972..983;  /evidence=""ECO:0000250""; DISULFID 977..992;  /evidence=""ECO:0000250""; DISULFID 994..1003;  /evidence=""ECO:0000250""; DISULFID 1010..1023;  /evidence=""ECO:0000250""; DISULFID 1015..1032;  /evidence=""ECO:0000250""; DISULFID 1034..1043;  /evidence=""ECO:0000250""; DISULFID 1050..1061;  /evidence=""ECO:0000250""; DISULFID 1055..1073;  /evidence=""ECO:0000250""; DISULFID 1075..1084;  /evidence=""ECO:0000250""; DISULFID 1091..1102;  /evidence=""ECO:0000250""; DISULFID 1096..1114;  /evidence=""ECO:0000250""; DISULFID 1116..1125;  /evidence=""ECO:0000250""; DISULFID 1134..1146;  /evidence=""ECO:0000250""; DISULFID 1140..1159;  /evidence=""ECO:0000250""; DISULFID 1161..1170;  /evidence=""ECO:0000250""; DISULFID 1178..1191;  /evidence=""ECO:0000250""; DISULFID 1187..1203;  /evidence=""ECO:0000250""; DISULFID 1214..1238;  /evidence=""ECO:0000250""; DISULFID 1220..1233;  /evidence=""ECO:0000250""; DISULFID 1229..1245;  /evidence=""ECO:0000250""; DISULFID 1251..1277;  /evidence=""ECO:0000250""; DISULFID 1259..1272;  /evidence=""ECO:0000250""; DISULFID 1268..1284;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O60245,Protocadherin-7 (Brain-heart protocadherin) (BH-Pcdh),MLRMRTAGWARGWCLGCCLLLPLSLSLAAAKQLLRYRLAEEGPADVRIGNVASDLGIVTGSGEVTFSLESGSEYLKIDNLTGELSTSERRIDREKLPQCQMIFDENECFLDFEVSVIGPSQSWVDLFEGQVIVLDINDNTPTFPSPVLTLTVEENRPVGTLYLLPTATDRDFGRNGIERYELLQEPGGGGSGGESRRAGAADSAPYPGGGGNGASGGGSGGSKRRLDASEGGGGTNPGGRSSVFELQVADTPDGEKQPQLIVKGALDREQRDSYELTLRVRDGGDPPRSSQAILRVLITDVNDNSPRFEKSVYEADLAENSAPGTPILQLRAADLDVGVNGQIEYVFGAATESVRRLLRLDETSGWLSVLHRIDREEVNQLRFTVMARDRGQPPKTDKATVVLNIKDENDNVPSIEIRKIGRIPLKDGVANVAEDVLVDTPIALVQVSDRDQGENGVVTCTVVGDVPFQLKPASDTEGDQNKKKYFLHTSTPLDYEATREFNVVIVAVDSGSPSLSSNNSLIVKVGDTNDNPPMFGQSVVEVYFPENNIPGERVATVLATDADSGKNAEIAYSLDSSVMGIFAIDPDSGDILVNTVLDREQTDRYEFKVNAKDKGIPVLQGSTTVIVQVADKNDNDPKFMQDVFTFYVKENLQPNSPVGMVTVMDADKGRNAEMSLYIEENNNIFSIENDTGTIYSTMSFDREHQTTYTFRVKAVDGGDPPRSATATVSLFVMDENDNAPTVTLPKNISYTLLPPSSNVRTVVATVLATDSDDGINADLNYSIVGGNPFKLFEIDPTSGVVSLVGKLTQKHYGLHRLVVQVNDSGQPSQSTTTLVHVFVNESVSNATAIDSQIARSLHIPLTQDIAGDPSYEISKQRLSIVIGVVAGIMTVILIILIVVMARYCRSKNKNGYEAGKKDHEDFFTPQQHDKSKKPKKDKKNKKSKQPLYSSIVTVEASKPNGQRYDSVNEKLSDSPSMGRYRSVNGGPGSPDLARHYKSSSPLPTVQLHPQSPTAGKKHQAVQDLPPANTFVGAGDNISIGSDHCSEYSCQTNNKYSKQMRLHPYITVFG,1069,"116,071",Alternative sequence (1); Beta strand (7); Chain (1); Domain (7); Glycosylation (7); Helix (1); Modified residue (2); Sequence caution (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5F6,Protocadherin gamma-C5 (PCDH-gamma-C5),MGPKTLPQLAGKWQVLCMLSLCCWGWVSGQLRYSVVEESEPGTLVGNVAQDLGLKMTDLLSRRLQLGSEENGRYFSLSLMSGALAVNQKIDRESLCGASTSCLLPVQVVTEHPLELIRVEVEILDLNDNSPSFATPEREMRISESAASGARFPLDSAQDPDVGTNTVSFYTLSPNSHFSLNVKTLKDGKPFPELVLEQQLDREAQARHQLVLTAVDGGTPARSGTTLISVIVLDINDNAPTFQSSVLRVGIPENAPIGTLLLRLNATDPDEGTNGQLDYSFGDHTSEAVRNLFGLDPSSGAIHVLGPIDFEESRFYEIHARARDQGQPAMEGHCVIQVDVGDVNDNAPEVLLASLANPVLESTPVGTVVGLFNVRDRDSGRNGEVSLDISPDLPFQIKPSENHYSLLTSQPLDREATSHYIIELLASDAGSPSLHKHLTIRLNISDVNDNAPRFNQQLYTAYILENRPPGSLLCTVAASDPDTGDNARLTYSIVGNQVQGAPASSFVYVNPEDGRIFAQRTFDYELLQMLQIVVGVRDSGSPPLHANTSLHVFVLDENDNAPAVLHPRPDWEHSAPQRLPRSAPPGSLVTKVTAVDADAGHNAWLSYSLLPQSTAPGLFLVSTHTGEVRTARALLEDDSDTQQVVVLVRDNGDPSLSSTATVLLVLEDEDPEEMPKSSDFLIHPPERSDLTLYLIVALATVSLLSLVTFTFLSAKCLQGNADGDGGGGQCCRRQDSPSPDFYKQSSPNLQVSSDGTLKYMEVTLRPTDSQSHCYRTCFSPASDGSDFTFLRPLSVQQPTALALEPDAIRSRSNTLRERSQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,944,"101,921",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (3); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
P13591,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56),MLQTKDLIWTLFFLGTAVSLQVDIVPSQGEISVGESKFFLCQVAGDAKDKDISWFSPNGEKLTPNQQRISVVWNDDSSSTLTIYNANIDDAGIYKCVVTGEDGSESEATVNVKIFQKLMFKNAPTPQEFREGEDAVIVCDVVSSLPPTIIWKHKGRDVILKKDVRFIVLSNNYLQIRGIKKTDEGTYRCEGRILARGEINFKDIQVIVNVPPTIQARQNIVNATANLGQSVTLVCDAEGFPEPTMSWTKDGEQIEQEEDDEKYIFSDDSSQLTIKKVDKNDEAEYICIAENKAGEQDATIHLKVFAKPKITYVENQTAMELEEQVTLTCEASGDPIPSITWRTSTRNISSEEKASWTRPEKQETLDGHMVVRSHARVSSLTLKSIQYTDAGEYICTASNTIGQDSQSMYLEVQYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVQGEPSAPKLEGQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRALSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTSAQPTAIPANGSPTSGLSTGAIVGILIVIFVLLLVVVDITCYFLNKCGLFMCIAVNLCGKAGPGAKGKDMEEGKAAFSKDESKEPIVEVRTEEERTPNHDGGKHTEPNETTPLTEPEKGPVEAKPECQETETKPAPAEVKTVPNDATQTKENESKA,858,"94,574",Alternative sequence (8); Beta strand (33); Chain (1); Disulfide bond (5); Domain (7); Erroneous initiation (1); Glycosylation (6); Helix (3); Lipidation (2); Modified residue (2); Natural variant (4); Sequence conflict (8); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..96;  /evidence=""ECO:0000250|UniProtKB:P13595""; DISULFID 139..189;  /evidence=""ECO:0000250|UniProtKB:P13595""; DISULFID 235..287;  /evidence=""ECO:0000250|UniProtKB:P13590""; DISULFID 329..395;  /evidence=""ECO:0000305""; DISULFID 436..489;  /evidence=""ECO:0000305""","SIGNAL 1..19;  /evidence=""ECO:0000250"""
O15394,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2),MSLLLSFYLLGLLVSSGQALLQVTISLSKVELSVGESKFFTCTAIGEPESIDWYNPQGEKIISTQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQEATVVLEIYQKLTFREVVSPQEFKQGEDAEVVCRVSSSPAPAVSWLYHNEEVTTISDNRFAMLANNNLQILNINKSDEGIYRCEGRVEARGEIDFRDIIVIVNVPPAISMPQKSFNATAERGEEMTFSCRASGSPEPAISWFRNGKLIEENEKYILKGSNTELTVRNIINSDGGPYVCRATNKAGEDEKQAFLQVFVQPHIIQLKNETTYENGQVTLVCDAEGEPIPEITWKRAVDGFTFTEGDKSLDGRIEVKGQHGSSSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYLDIEYAPKFISNQTIYYSWEGNPINISCDVKSNPPASIHWRRDKLVLPAKNTTNLKTYSTGRKMILEIAPTSDNDFGRYNCTATNHIGTRFQEYILALADVPSSPYGVKIIELSQTTAKVSFNKPDSHGGVPIHHYQVDVKEVASEIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSKIEIFQTLPVREPSPPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDHIILEHLQWTMGYEVQITAANRLGYSEPTVYEFSMPPKPNIIKDTLFNGLGLGAVIGLGVAALLLILVVTDVSCFFIRQCGLLMCITRRMCGKKSGSSGKSKELEEGKAAYLKDGSKEPIVEMRTEDERVTNHEDGSPVNEPNETTPLTEPEKLPLKEEDGKEALNPETIEIKVSNDIIQSKEDDSKA,837,"93,046",Alternative sequence (3); Beta strand (64); Chain (1); Disulfide bond (5); Domain (7); Glycosylation (8); Helix (4); Modified residue (3); Natural variant (2); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (5),"DISULFID 42..93;  /evidence=""ECO:0000305""; DISULFID 136..186;  /evidence=""ECO:0000305""; DISULFID 232..281;  /evidence=""ECO:0000305""; DISULFID 322..380;  /evidence=""ECO:0000305""; DISULFID 422..475;  /evidence=""ECO:0000305""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
O60391,"Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B)",MEFVRALWLGLALALGPGSAGGHPQPCGVLARLGGSVRLGALLPRAPLARARARAALARAALAPRLPHNLSLELVVAAPPARDPASLTRGLCQALVPPGVAALLAFPEARPELLQLHFLAAATETPVLSLLRREARAPLGAPNPFHLQLHWASPLETLLDVLVAVLQAHAWEDVGLALCRTQDPGGLVALWTSRAGRPPQLVLDLSRRDTGDAGLRARLAPMAAPVGGEAPVPAAVLLGCDIARARRVLEAVPPGPHWLLGTPLPPKALPTAGLPPGLLALGEVARPPLEAAIHDIVQLVARALGSAAQVQPKRALLPAPVNCGDLQPAGPESPGRFLARFLANTSFQGRTGPVWVTGSSQVHMSRHFKVWSLRRDPRGAPAWATVGSWRDGQLDLEPGGASARPPPPQGAQVWPKLRVVTLLEHPFVFARDPDEDGQCPAGQLCLDPGTNDSATLDALFAALANGSAPRALRKCCYGYCIDLLERLAEDTPFDFELYLVGDGKYGALRDGRWTGLVGDLLAGRAHMAVTSFSINSARSQVVDFTSPFFSTSLGIMVRARDTASPIGAFMWPLHWSTWLGVFAALHLTALFLTVYEWRSPYGLTPRGRNRSTVFSYSSALNLCYAILFRRTVSSKTPKCPTGRLLMNLWAIFCLLVLSSYTANLAAVMVGDKTFEELSGIHDPKLHHPAQGFRFGTVWESSAEAYIKKSFPDMHAHMRRHSAPTTPRGVAMLTSDPPKLNAFIMDKSLLDYEVSIDADCKLLTVGKPFAIEGYGIGLPQNSPLTSNLSEFISRYKSSGFIDLLHDKWYKMVPCGKRVFAVTETLQMSIYHFAGLFVLLCLGLGSALLSSLGEHAFFRLALPRIRKGSRLQYWLHTSQKIHRALNTEPPEGSKEETAEAEPSGPEVEQQQQQQDQPTAPEGWKRARRAVDKERRVRFLLEPAVVVAPEADAEAEAAPREGPVWLCSYGRPPAARPTGAPQPGELQELERRIEVARERLRQALVRRGQLLAQLGDSARHRPRRLLQARAAPAEAPPHSGRPGSQE,1043,"112,992",Chain (1); Erroneous gene model prediction (1); Glycosylation (5); Natural variant (26); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8NFZ4,Neuroligin-2,MWLLALCLVGLAGAQRGGGGPGGGAPGGPGLGLGSLGEERFPVVNTAYGRVRGVRRELNNEILGPVVQFLGVPYATPPLGARRFQPPEAPASWPGVRNATTLPPACPQNLHGALPAIMLPVWFTDNLEAAATYVQNQSEDCLYLNLYVPTEDGPLTKKRDEATLNPPDTDIRDPGKKPVMLFLHGGSYMEGTGNMFDGSVLAAYGNVIVATLNYRLGVLGFLSTGDQAAKGNYGLLDQIQALRWLSENIAHFGGDPERITIFGSGAGASCVNLLILSHHSEGLFQKAIAQSGTAISSWSVNYQPLKYTRLLAAKVGCDREDSAEAVECLRRKPSRELVDQDVQPARYHIAFGPVVDGDVVPDDPEILMQQGEFLNYDMLIGVNQGEGLKFVEDSAESEDGVSASAFDFTVSNFVDNLYGYPEGKDVLRETIKFMYTDWADRDNGEMRRKTLLALFTDHQWVAPAVATAKLHADYQSPVYFYTFYHHCQAEGRPEWADAAHGDELPYVFGVPMVGATDLFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVVWSKFNSKEKQYLHIGLKPRVRDNYRANKVAFWLELVPHLHNLHTELFTTTTRLPPYATRWPPRPPAGAPGTRRPPPPATLPPEPEPEPGPRAYDRFPGDSRDYSTELSVTVAVGASLLFLNILAFAALYYKRDRRQELRCRRLSPPGGSGSGVPGGGPLLPAAGRELPPEEELVSLQLKRGGGVGADPAEALRPACPPDYTLALRRAPDDVPLLAPGALTLLPSGLGPPPPPPPPSLHPFGPFPPPPPTATSHNNTLPHPHSTTRV,835,"90,820",Beta strand (23); Chain (1); Disulfide bond (3); Glycosylation (3); Helix (22); Modified residue (2); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 106..141;  /evidence=""ECO:0000250""; DISULFID 317..328;  /evidence=""ECO:0000250""; DISULFID 487..521;  /evidence=""ECO:0000250""","SIGNAL 1..14;  /evidence=""ECO:0000255"""
Q8NET5,NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1),MENQPVRWRALPGLPRPPGLPAAPWLLLGVLLLPGTLRLAGGQSVTHTGLPIMASLANTAISFSCRITYPYTPQFKVFTVSYFHEDLQGQRSPKKPTNCHPGLGTENQSHTLDCQVTLVLPGASATGTYYCSVHWPHSTVRGSGTFILVRDAGYREPPQSPQKLLLFGFTGLLSVLSVVGTALLLWNKKRMRGPGKDPTRKCPDPRSASSPKQHPSESVYTALQRRETEVYACIENEDGSSPTAKQSPLSQERPHRFEDDGELNLVYENL,270,"29,686",Chain (1); Disulfide bond (1); Domain (2); Glycosylation (1); Modified residue (2); Mutagenesis (2); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 65..114;  /evidence=""ECO:0000250""","SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q5PT55,Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5),MIRKLFIVLLLLLVTIEEARMSSLSFLNIEKTEILFFTKTEETILVSSSYENKRPNSSHLFVKIEDPKILQMVNVAKKISSDATNFTINLVTDEEGETNVTIQLWDSEGRQERLIEEIKNVKVKVLKQKDSLLQAPMHIDRNILMLILPLILLNKCAFGCKIELQLFQTVWKRPLPVILGAVTQFFLMPFCGFLLSQIVALPEAQAFGVVMTCTCPGGGGGYLFALLLDGDFTLAILMTCTSTLLALIMMPVNSYIYSRILGLSGTFHIPVSKIVSTLLFILVPVSIGIVIKHRIPEKASFLERIIRPLSFILMFVGIYLTFTVGLVFLKTDNLEVILLGLLVPALGLLFGYSFAKVCTLPLPVCKTVAIESGMLNSFLALAVIQLSFPQSKANLASVAPFTVAMCSGCEMLLIILVYKAKKRCIFFLQDKRKRNFLI,438,"48,871",Chain (1); Glycosylation (3); Natural variant (1); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9Y5G4,Protocadherin gamma-A9 (PCDH-gamma-A9),MAAPTKCQLRGRLVLLCSLLGMLWEARASQIRYSVPEETEKGYIVGNISKDLALEPRELAERRVRIVSRGRTQLFSLNPRSGTLVTAGRIDREELCAQSPRCLVNFKVLVEDRVKLYGIEIEVTDINDSAPKFQAESLEVKINEIAVPGARYPLPEAIDPDVGVNSLQSYQLSPNHHFSLNVQTGDNGAINPELVLERALDREEATAHHLVLTASDGGEPRRSSTVRIHVTVLDTNDNAPVFAQRIYRVKVLENVPPGTWLLTATASDLDEGINGKVAYKFWKINEKQSLLFQLNENTGEISTAKSLDYEECSFYEMEIQAEDGGGLKGWTKVLISVEDVNDNRPEVTITSLFSPVREDAPQGTVILLFNAHDRDSGKNGQVVCSIQENLSFTLENSEEDYYRLLTAQILDREKASEYNITVTATDRGTPPLSTEIHITLQVTDINDNPPAFSQASYSVYLPENNARGTSIFSVIAYDPDSNENSRVIYSLAEDTIQGSPLSTYVSINSDTGVLYALCSFDYEQFRDLQMQVTASDSGSPPLSSNVSLRLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYRLFKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAIADSIPDILADLGSLQIPADLEASDLTLYLVVAVAVVSCVFLTFVITLLALRLRHWHSSHLLRATSDGLAGVPTSHFVGVDGVRAFLQTYSQEFSLTADSRKSHLIFPQPNYADTLISQQSCEKNEPLCVSVDSKFPIEDTPLVPQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"101,687",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (5); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9BZA8,Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22),MFRVGFLIISSSSSLSPLLLVSVVRVNTTNCHKCLLSGTYIFAVLLVCVVFHSGAQEKNYTIREEIPENVLIGNLLKDLNLSLIPNKSLTTTMQFKLVYKTGDVPLIRIEEDTGEIFTTGARIDREKLCAGIPRDEHCFYEVEVAILPDEIFRLVKIRFLIEDINDNAPLFPATVINISIPENSAINSKYTLPAAVDPDVGINGVQNYELIKSQNIFGLDVIETPEGDKMPQLIVQKELDREEKDTYVMKVKVEDGGFPQRSSTAILQVSVTDTNDNHPVFKETEIEVSIPENAPVGTSVTQLHATDADIGENAKIHFSFSNLVSNIARRLFHLNATTGLITIKEPLDREETPNHKLLVLASDGGLMPARAMVLVNVTDVNDNVPSIDIRYIVNPVNDTVVLSENIPLNTKIALITVTDKDADHNGRVTCFTDHEIPFRLRPVFSNQFLLENAAYLDYESTKEYAIKLLAADAGKPPLNQSAMLFIKVKDENDNAPVFTQSFVTVSIPENNSPGIQLMKVSATDADSGPNAEINYLLGPDAPPEFSLDRRTGMLTVVKKLDREKEDKYLFTILAKDNGVPPLTSNVTVFVSIIDQNDNSPVFTHNEYKFYVPENLPRHGTVGLITVTDPDYGDNSAVTLSILDENDDFTIDSQTGVIRPNISFDREKQESYTFYVKAEDGGRVSRSSSAKVTINVVDVNDNKPVFIVPPYNYSYELVLPSTNPGTVVFQVIAVDNDTGMNAEVRYSIVGGNTRDLFAIDQETGNITLMEKCDVTDLGLHRVLVKANDLGQPDSLFSVVIVNLFVNESVTNATLINELVRKSIEAPVTPNTEIADVSSPTSDYVKILVAAVAGTITVVVVIFITAVVRCRQAPHLKAAQKNMQNSEWATPNPENRQMIMMKKKKKKKKHSPKNLLLNVVTIEETKADDVDSDGNRVTLDLPIDLEEQTMGKYNWVTTPTTFKPDSPDLARHYKSASPQPAFQIQPETPLNLKHHIIQELPLDNTFVACDSISNCSSSSSDPYSVSDCGYPVTTFEVPVSVHTRPSQRRVTFHLPEGSQESSSDGGLGDHDAGSLTSTSHGLPLGYPQEEYFDRATPSNRTEGDGNSDPESTFIPGLKKEITVQPTVEEASDNCTQECLIYGHSDACWMPASLDHSSSSQAQASALCHSPPLSQASTQHHSPPVTQTIVLCHSPPVTQTIALCHSPPPIQVSALHHSPPLVQGTALHHSPPSAQASALCYSPPLAQAAAISHSSSLPQVIALHRSQAQSSVSLQQGWVQGANGLCSVDQGVQGSATSQFYTMSERLHPSDDSIKVIPLTTFAPRQQARPSRGDSPIMETHPL,1340,"146,775",Alternative sequence (5); Chain (1); Compositional bias (1); Domain (7); Glycosylation (6); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5I2,Protocadherin alpha-10 (PCDH-alpha-10),MVSRCSCLGVQCLLLSLLLLAAWEVGSGQLHYSVYEEARHGTFVGRIAQDLGLELAELVQRLFRVASKRHGDLLEVNLQNGILFVNSRIDREELCGRSVECSIHLEVIVDRPLQVFHVDVEVKDINDNPPRFSVTEQKLSIPESRLLDSRFPLEGASDADVGENALLTYKLSPNEYFVLDIINKKDKDKFPVLVLRKLLDREENPQLKLLLTATDGGKPEFTGSVSLLILVLDANDNAPIFDRPVYEVKMYENQVNQTLVIRLNASDSDEGINKEMMYSFSSLVPPTIRRKFWINERTGEIKVNDAIDFEDSNTYEIHVDVTDKGNPPMVGHCTVLVELLDENDNSPEVIVTSLSLPVKEDAQVGTVIALISVSDHDSGANGQVTCSLTPHVPFKLVSTYKNYYSLVLDSALDRERVSAYELVVTARDGGSPPLWATASVSVEVADVNDNAPAFAQSEYTVFVKENNPPGCHIFTVSAWDADAQENALVSYSLVERRLGERSLSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDGGVPPLGSNLTLQVFVLDENDNAPALLASPAGSAGGAVSELVLRSVVAGHVVAKVRAVDADSGYNAWLSYELQSAAVGARIPFRVGLYTGEISTTRALDETDSPRQRLLVLVKDHGEPSLTATATVLVSLVEGSQAPKASSRASVGVAPEVALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSAAPTEGACGPVKPTLVCSSAVGSWSYSQQRRQRVCSGEGLPKADLMAFSPSLPPCPMVDVDGEDQSIGGDHSRKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,948,"102,875",Alternative sequence (3); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (3); Region (1); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y5I0,Protocadherin alpha-13 (PCDH-alpha-13),MLSSWQGGPRPRQLLLWLLILAAWETGSGQLHYSVPEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKRHGDLLEVNLQNGILFVNSRIDREELCGRSAECSIHLEVIVDRPLQVFHVEVKVRDINDNPPIFPESKKRIIIAESRPPETRFPLDGASDADIGVNSALTYRLDPNDYFTLDAQNSLEQMSSLSLVLRKTLDREEIQEHSLLLTASDGGKPELTGTVQLLITILDVNDNAPEFYQSVYKVTVLENAFNGTLVIKLNATDPDDGTNGDIVYSFRRPVWPAVVYAFTINPNNGEIRTKGKLDFEEKKLYEISVEAVDKGNIPMAGHCTLLVEVLDVNDNAPEVTITSLSLPIREDTQPSAIIALISVSDRDSGSNGQVTCTLTPHVPFKLVSTYKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATASVSVGVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSAQDADAQENALVSYSLVERRVGERALSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDSGVPPLGSNVTLQVFVLDENDNAPALLTPGAGSAGGTVSELMPRSVGAGHVVAKVRAVDADSGYNAWLSYELQLAAVGARIPFRVGLYTGEISTTRPLDEVDAPHHRLLVLVKDHGEPALTATATVLLSLVESGQAPQASSRASAGAVGPEAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSAPPTEGACAPGKPTLVCSSAAGSWSYSQQRRPRVCSGEGPHKTDLMAFSPSLPPCLGSAEGTGQREEDSECLKEPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"102,483",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Region (1); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5F3,Protocadherin beta-1 (PCDH-beta-1),MAGTRRKSLQNRQVGSLLIFLCISVGDATTIRYSVAEEMESGSFVANVAKDLGLEVGKLAARGARLVSEGNKMHFRLHRKTGDLFVKEKLDRESLCGKADPCVLHFEVVLVEPLQSFRAEVRVFDINDNAPVFLNKEPLLKIPESTPLGSRFPLQSAQDLDVGLNGLQNYTLSANGYFHLHTRFCSHGPKYAELVLNKPLDREEQPEVNLTITAVDGGSPPKSGTAHIHVVVLDVNDHVPQFSRLVYRAQVSENSPNGSLVATVTAVDLDEGTNKAITYSLAQNPEAILKTFQIDPQNGEVRLRGPLDFEAIETYDIDIQATDGGGLSAHSKVLVEVVDVNDNPPEVMVSSVSSPLPEDSPPQTVVALFTIRDRDIRVGGKVTCFLREDLPFVIKPTFGNSYSLVTDRSLDREEVSGYNITIVAMDTGPPSLSAETMIEVLISDVNDNPPIFREDSYILTVRENNSPAVFIGKVHAEDLDLGENAQITYSLLPPKNGDLSVFAYISINSGNGKLYALRTMDYEAIQDFQFVVKATDGGFLSLSSQVTVRVVVLDDNDNRPMILYPLQNGTLPCNDLVPRSAEAGYLVTKVVAVDGDSGQNSWLSYHLLKATDLGLFSVQRQNGEIHTLRQISERDPMMQKLIILVQDHGQPALSTTVSLNILLVDGFSEPYLQFQDPTKHSRKVNPSTKYLVISLVILSFLFLLSVIVIFIIHVYQKIKYREKFTIQEHFYDDCNFSNNLVQGQGNGSLSRPCPYEMCSATGTGNSEFRFLKRFMPNFPFPHATGEIKMEAGSSLPPNSDRNKSQRLEGHDQVSDDYM,818,"90,491",Chain (1); Domain (6); Glycosylation (5); Natural variant (7); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9NZQ7,Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (hPD-L1) (B7 homolog 1) (B7-H1) (CD antigen CD274),MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET,290,"33,275",Alternative sequence (3); Beta strand (17); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (4); Helix (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 40..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18287011, ECO:0000269|PubMed:26602187""; DISULFID 155..209;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:18287011""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
P43632,Killer cell immunoglobulin-like receptor 2DS4 (CD158 antigen-like family member I) (MHC class I NK cell receptor) (Natural killer-associated transcript 8) (NKAT-8) (P58 natural killer cell receptor clones CL-39/CL-17) (p58 NK receptor CL-39/CL-17) (CD antigen CD158i),MSLMVIIMACVGFFLLQGAWPQEGVHRKPSFLALPGHLVKSEETVILQCWSDVMFEHFLLHREGKFNNTLHLIGEHHDGVSKANFSIGPMMPVLAGTYRCYGSVPHSPYQLSAPSDPLDMVIIGLYEKPSLSAQPGPTVQAGENVTLSCSSRSSYDMYHLSREGEAHERRLPAVRSINGTFQADFPLGPATHGGTYRCFGSFRDAPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSKTGNPRHLHVLIGTSVVKIPFTILLFFLLHRWCSDKKNAAVMDQEPAGNRTVNSEDSDEQDHQEVSYA,304,"33,583",Beta strand (16); Chain (1); Disulfide bond (2); Domain (2); Erroneous initiation (1); Glycosylation (5); Natural variant (10); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000269|PubMed:19858347""; DISULFID 149..198;  /evidence=""ECO:0000269|PubMed:19858347""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q4KMZ8,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),MGKCSGRCTLVAFCCLQLVAALERQIFDFLGYQWAPILANFLHIMAVILGIFGTVQYRSRYLILYAAWLVLWVGWNAFIICFYLEVGQLSQDRDFIMTFNTSLHRSWWMENGPGCLVTPVLNSRLALEDHHVISVTGCLLDYPYIEALSSALQIFLALFGFVFACYVSKVFLEEEDSFDFIGGFDSYGYQAPQKTSHLQLQPLYTSG,207,"23,552",Alternative sequence (2); Chain (1); Erroneous gene model prediction (1); Erroneous initiation (5); Glycosylation (1); Sequence conflict (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9NQS3,Nectin-3 (CDw113) (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3) (CD antigen CD113),MARTLRPSPLCPGGGKAQLSSASLLGAGLLLQPPTPPPLLLLLFPLLLFSRLCGALAGPIIVEPHVTAVWGKNVSLKCLIEVNETITQISWEKIHGKSSQTVAVHHPQYGFSVQGEYQGRVLFKNYSLNDATITLHNIGFSDSGKYICKAVTFPLGNAQSSTTVTVLVEPTVSLIKGPDSLIDGGNETVAAICIAATGKPVAHIDWEGDLGEMESTTTSFPNETATIISQYKLFPTRFARGRRITCVVKHPALEKDIRYSFILDIQYAPEVSVTGYDGNWFVGRKGVNLKCNADANPPPFKSVWSRLDGQWPDGLLASDNTLHFVHPLTFNYSGVYICKVTNSLGQRSDQKVIYISDPPTTTTLQPTIQWHPSTADIEDLATEPKKLPFPLSTLATIKDDTIATIIASVVGGALFIVLVSVLAGIFCYRRRRTFRGDYFAKNYIPPSDMQKESQIDVLQQDELDSYPDSVKKENKNPVNNLIRKDYLEEPEKTQWNNVENLNRFERPMDYYEDLKMGMKFVSDEHYDENEDDLVSHVDGSVISRREWYV,549,"61,002",Alternative sequence (4); Chain (1); Disulfide bond (3); Domain (3); Erroneous initiation (1); Erroneous termination (1); Glycosylation (6); Natural variant (1); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 78..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 193..246;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 291..338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..57;  /evidence=""ECO:0000255"""
Q9Y639,Neuroplastin (Stromal cell-derived receptor 1) (SDR-1),MSGSSLPSALALSLLLVSGSLLPGPGAAQNAGFVKSPMSETKLTGDAFELYCDVVGSPTPEIQWWYAEVNRAESFRQLWDGARKRRVTVNTAYGSNGVSVLRITRLTLEDSGTYECRASNDPKRNDLRQNPSITWIRAQATISVLQKPRIVTSEEVIIRDSPVLPVTLQCNLTSSSHTLTYSYWTKNGVELSATRKNASNMEYRINKPRAEDSGEYHCVYHFVSAPKANATIEVKAAPDITGHKRSENKNEGQDATMYCKSVGYPHPDWIWRKKENGMPMDIVNTSGRFFIINKENYTELNIVNLQITEDPGEYECNATNAIGSASVVTVLRVRSHLAPLWPFLGILAEIIILVVIIVVYEKRKRPDEVPDDDEPAGPMKTNSTNNHKDKNLRQRNTN,398,"44,387",Alternative sequence (3); Chain (1); Disulfide bond (3); Domain (3); Erroneous initiation (1); Glycosylation (6); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 52..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 170..218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 259..316;  /evidence=""ECO:0000269|PubMed:30190470""",SIGNAL 1..28
Q8NC67,Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2),MALERLCSVLKVLLITVLVVEGIAVAQKTQDGQNIGIKHIPATQCGIWVRTSNGGHFASPNYPDSYPPNKECIYILEAAPRQRIELTFDEHYYIEPSFECRFDHLEVRDGPFGFSPLIDRYCGVKSPPLIRSTGRFMWIKFSSDEELEGLGFRAKYSFIPDPDFTYLGGILNPIPDCQFELSGADGIVRSSQVEQEEKTKPGQAVDCIWTIKATPKAKIYLRFLDYQMEHSNECKRNFVAVYDGSSSIENLKAKFCSTVANDVMLKTGIGVIRMWADEGSRLSRFRMLFTSFVEPPCTSSTFFCHSNMCINNSLVCNGVQNCAYPWDENHCKEKKKAGVFEQITKTHGTIIGITSGIVLVLLIISILVQVKQPRKKVMACKTAFNKTGFQEVFDPPHYELFSLRDKEISADLADLSEELDNYQKMRRSSTASRCIHDHHCGSQASSVKQSRTNLSSMELPFRNDFAQPQPMKTFNSTFKKSSYTFKQGHECPEQALEDRVMEEIPCEIYVRGREDSAQASISIDF,525,"59,393",Alternative sequence (3); Chain (1); Disulfide bond (7); Domain (3); Glycosylation (1); Modified residue (1); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 45..72;  /evidence=""ECO:0000250""; DISULFID 100..122;  /evidence=""ECO:0000250""; DISULFID 177..207;  /evidence=""ECO:0000250""; DISULFID 234..256;  /evidence=""ECO:0000250""; DISULFID 297..309;  /evidence=""ECO:0000250""; DISULFID 304..322;  /evidence=""ECO:0000250""; DISULFID 316..331;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8IZU8,Dermatan-sulfate epimerase-like protein (EC 5.1.-.-),MALMFTGHLLFLALLMFAFSTFEESVSNYSEWAVFTDDIDQFKTQKVQDFRPNQKLKKSMLHPSLYFDAGEIQAMRQKSRASHLHLFRAIRSAVTVMLSNPTYYLPPPKHADFAAKWNEIYGNNLPPLALYCLLCPEDKVAFEFVLEYMDRMVGYKDWLVENAPGDEVPIGHSLTGFATAFDFLYNLLDNHRRQKYLEKIWVITEEMYEYSKVRSWGKQLLHNHQATNMIALLTGALVTGVDKGSKANIWKQAVVDVMEKTMFLLNHIVDGSLDEGVAYGSYTAKSVTQYVFLAQRHFNINNLDNNWLKMHFWFYYATLLPGFQRTVGIADSNYNWFYGPESQLVFLDKFILKNGAGNWLAQQIRKHRPKDGPMVPSTAQRWSTLHTEYIWYDPQLTPQPPADYGTAKIHTFPNWGVVTYGAGLPNTQTNTFVSFKSGKLGGRAVYDIVHFQPYSWIDGWRSFNPGHEHPDQNSFTFAPNGQVFVSEALYGPKLSHLNNVLVFAPSPSSQCNKPWEGQLGECAQWLKWTGEEVGDAAGEIITASQHGEMVFVSGEAVSAYSSAMRLKSVYRALLLLNSQTLLVVDHIERQEDSPINSVSAFFHNLDIDFKYIPYKFMNRYNGAMMDVWDAHYKMFWFDHHGNSPMASIQEAEQAAEFKKRWTQFVNVTFQMEPTITRIAYVFYGPYINVSSCRFIDSSNPGLQISLNVNNTEHVVSIVTDYHNLKTRFNYLGFGGFASVADQGQITRFGLGTQAIVKPVRHDRIIFPFGFKFNIAVGLILCISLVILTFQWRFYLSFRKLMRWILILVIALWFIELLDVWSTCSQPICAKWTRTEAEGSKKSLSSEGHHMDLPDVVITSLPGSGAEILKQLFFNSSDFLYIRVPTAYIDIPETELEIDSFVDACEWKVSDIRSGHFRLLRGWLQSLVQDTKLHLQNIHLHEPNRGKLAQYFAMNKDKKRKFKRRESLPEQRSQMKGAFDRDAEYIRALRRHLVYYPSARPVLSLSSGSWTLKLHFFQEVLGASMRALYIVRDPRAWIYSMLYNSKPSLYSLKNVPEHLAKLFKIEGGKGKCNLNSGYAFEYEPLRKELSKSKSNAVSLLSHLWLANTAAALRINTDLLPTSYQLVKFEDIVHFPQKTTERIFAFLGIPLSPASLNQILFATSTNLFYLPYEGEISPTNTNVWKQNLPRDEIKLIENICWTLMDRLGYPKFMD,1212,"139,238",Chain (1); Erroneous initiation (2); Glycosylation (5); Natural variant (4); Sequence conflict (1); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P39086,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)",MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKDLFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPSGNKDAKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGMMTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWRLGPRFMNLIKEARWDGLTGHITFNKTNGLRKDFDLDIISLKEEGTEKAAGEVSKHLYKVWKKIGIWNSNSGLNMTDSNKDKSSNITDSLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYVLLACLGVSCVLFVIARFTPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEDNKEASALGVENIGGIFIVLAAGLVLSVFVAIGEFIYKSRKNNDIEQAFCFFYGLQCKQTHPTNSTSGTTLSTDLECGKLIREERGIRKQSSVHTV,918,"103,981",Alternative sequence (2); Beta strand (14); Binding site (2); Chain (1); Glycosylation (9); Helix (12); Modified residue (2); Natural variant (6); Region (2); Sequence conflict (1); Signal peptide (1); Topological domain (4); Transmembrane (3); Turn (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
P41594,Metabotropic glutamate receptor 5 (mGluR5),MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLTSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNHRNPWFQEFWQHRFQCRLEGFPQENSKYNKTCNSSLTLKTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLESLMKTNFTGVSGDTILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKSNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVVFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLWKRRGSSGETLRYKDRRLAQHKSEIECFTPKGSMGNGGRATMSSSNGKSVTWAQNEKSSRGQHLWQRLSIHINKKENPNQTAVIKPFPKSTESRGLGAGAGAGGSAGGVGATGGAGCAGAGPGGPESPDAGPKALYDVAEAEEHFPAPARPRSPSPISTLSHRAGSASRTDDDVPSLHSEPVARSSSSQGSLMEQISSVVTRFTANISELNSMMLSTAAPSPGVGAPLCSSYLIPKEIQLPTTMTTFAEIQPLPAIEVTGGAQPAAGAQAAGDAARESPAAGPEAAAAKPDLEELVALTPPSPFRDSVDSGSTTPNSPVSESALCIPSSPKYDTLIIRDYTQSSSSL,1212,"132,469",Alternative sequence (2); Beta strand (23); Binding site (5); Chain (1); Disulfide bond (10); Glycosylation (6); Helix (27); Modified residue (5); Mutagenesis (4); Region (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (11),"DISULFID 57..99; DISULFID 241..530;  /evidence=""ECO:0000250""; DISULFID 276..278; DISULFID 365..381; DISULFID 419..426; DISULFID 511..531;  /evidence=""ECO:0000250""; DISULFID 515..534;  /evidence=""ECO:0000250""; DISULFID 537..549;  /evidence=""ECO:0000250""; DISULFID 552..565;  /evidence=""ECO:0000250""; DISULFID 644..733","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q8NAC3,Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14),MPVPWFLLSLALGRSPVVLSLERLVGPQDATHCSPVSLEPWGDEERLRVQFLAQQSLSLAPVTAATARTALSGLSGADGRREERGRGKSWVCLSLGGSGNTEPQKKGLSCRLWDSDILCLPGDIVPAPGPVLAPTHLQTELVLRCQKETDCDLCLRVAVHLAVHGHWEEPEDEEKFGGAADSGVEEPRNASLQAQVVLSFQAYPTARCVLLEVQVPAALVQFGQSVGSVVYDCFEAALGSEVRIWSYTQPRYEKELNHTQQLPDCRGLEVWNSIPSCWALPWLNVSADGDNVHLVLNVSEEQHFGLSLYWNQVQGPPKPRWHKNLTGPQIITLNHTDLVPCLCIQVWPLEPDSVRTNICPFREDPRAHQNLWQAARLQLLTLQSWLLDAPCSLPAEAALCWRAPGGDPCQPLVPPLSWENVTVDKVLEFPLLKGHPNLCVQVNSSEKLQLQECLWADSLGPLKDDVLLLETRGPQDNRSLCALEPSGCTSLPSKASTRAARLGEYLLQDLQSGQCLQLWDDDLGALWACPMDKYIHKRWALVWLACLLFAAALSLILLLKKDHAKGWLRLLKQDVRSGAAARGRAALLLYSADDSGFERLVGALASALCQLPLRVAVDLWSRRELSAQGPVAWFHAQRRQTLQEGGVVVLLFSPGAVALCSEWLQDGVSGPGAHGPHDAFRASLSCVLPDFLQGRAPGSYVGACFDRLLHPDAVPALFRTVPVFTLPSQLPDFLGALQQPRAPRSGRLQERAEQVSRALQPALDSYFHPPGTPAPGRGVGPGAGPGAGDGT,791,"86,240",Alternative sequence (6); Beta strand (32); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (9); Helix (8); Natural variant (1); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 265..277;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 341..391;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 343..359;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 400..409;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 439..453;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 481..488;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""; DISULFID 515..529;  /evidence=""ECO:0000244|PDB:6HG4, ECO:0000269|PubMed:32187518""","SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:15340161"""
P0C6S8,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 (Leucine-rich repeat neuronal protein 2) (Leucine-rich repeat neuronal protein 6B),MTCWLCVLSLPLLLLPAAPPPAGGCPARCECTVQTRAVACTRRRLTAVPDGIPAETRLLELSRNRIRCLNPGDLAALPALEELDLSENAIAHVEPGAFANLPRLRVLRLRGNQLKLIPPGVFTRLDNLTLLDLSENKLVILLDYTFQDLHSLRRLEVGDNDLVFVSRRAFAGLLALEELTLERCNLTALSGESLGHLRSLGALRLRHLAIASLEDQNFRRLPGLLHLEIDNWPLLEEVAAGSLRGLNLTSLSVTHTNITAVPAAALRHQAHLTCLNLSHNPISTVPRGSFRDLVRLRELHLAGALLAVVEPQAFLGLRQIRLLNLSNNLLSTLEESTFHSVNTLETLRVDGNPLACDCRLLWIVQRRKTLNFDGRLPACATPAEVRGDALRNLPDSVLFEYFVCRKPKIRERRLQRVTATAGEDVRFLCRAEGEPAPTVAWVTPQHRPVTATSAGRARVLPGGTLEIQDARPQDSGTYTCVASNAGGNDTYFATLTVRPEPAANRTPGEAHNETLAALRAPLDLTTILVSTAMGCITFLGVVLFCFVLLFVWSRGRGQHKNNFSVEYSFRKVDGPAAAAGQGGARKFNMKMI,592,"64,881",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (3); Glycosylation (8); Natural variant (1); Repeat (11); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 429..480;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q07954,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],MLTPPLLLLLPLLSALVAAAIDAPKTCSPKQFACRDQITCISKGWRCDGERDCPDGSDEAPEICPQSKAQRCQPNEHNCLGTELCVPMSRLCNGVQDCMDGSDEGPHCRELQGNCSRLGCQHHCVPTLDGPTCYCNSSFQLQADGKTCKDFDECSVYGTCSQLCTNTDGSFICGCVEGYLLQPDNRSCKAKNEPVDRPPVLLIANSQNILATYLSGAQVSTITPTSTRQTTAMDFSYANETVCWVHVGDSAAQTQLKCARMPGLKGFVDEHTINISLSLHHVEQMAIDWLTGNFYFVDDIDDRIFVCNRNGDTCVTLLDLELYNPKGIALDPAMGKVFFTDYGQIPKVERCDMDGQNRTKLVDSKIVFPHGITLDLVSRLVYWADAYLDYIEVVDYEGKGRQTIIQGILIEHLYGLTVFENYLYATNSDNANAQQKTSVIRVNRFNSTEYQVVTRVDKGGALHIYHQRRQPRVRSHACENDQYGKPGGCSDICLLANSHKARTCRCRSGFSLGSDGKSCKKPEHELFLVYGKGRPGIIRGMDMGAKVPDEHMIPIENLMNPRALDFHAETGFIYFADTTSYLIGRQKIDGTERETILKDGIHNVEGVAVDWMGDNLYWTDDGPKKTISVARLEKAAQTRKTLIEGKMTHPRAIVVDPLNGWMYWTDWEEDPKDSRRGRLERAWMDGSHRDIFVTSKTVLWPNGLSLDIPAGRLYWVDAFYDRIETILLNGTDRKIVYEGPELNHAFGLCHHGNYLFWTEYRSGSVYRLERGVGGAPPTVTLLRSERPPIFEIRMYDAQQQQVGTNKCRVNNGGCSSLCLATPGSRQCACAEDQVLDADGVTCLANPSYVPPPQCQPGEFACANSRCIQERWKCDGDNDCLDNSDEAPALCHQHTCPSDRFKCENNRCIPNRWLCDGDNDCGNSEDESNATCSARTCPPNQFSCASGRCIPISWTCDLDDDCGDRSDESASCAYPTCFPLTQFTCNNGRCININWRCDNDNDCGDNSDEAGCSHSCSSTQFKCNSGRCIPEHWTCDGDNDCGDYSDETHANCTNQATRPPGGCHTDEFQCRLDGLCIPLRWRCDGDTDCMDSSDEKSCEGVTHVCDPSVKFGCKDSARCISKAWVCDGDNDCEDNSDEENCESLACRPPSHPCANNTSVCLPPDKLCDGNDDCGDGSDEGELCDQCSLNNGGCSHNCSVAPGEGIVCSCPLGMELGPDNHTCQIQSYCAKHLKCSQKCDQNKFSVKCSCYEGWVLEPDGESCRSLDPFKPFIIFSNRHEIRRIDLHKGDYSVLVPGLRNTIALDFHLSQSALYWTDVVEDKIYRGKLLDNGALTSFEVVIQYGLATPEGLAVDWIAGNIYWVESNLDQIEVAKLDGTLRTTLLAGDIEHPRAIALDPRDGILFWTDWDASLPRIEAASMSGAGRRTVHRETGSGGWPNGLTVDYLEKRILWIDARSDAIYSARYDGSGHMEVLRGHEFLSHPFAVTLYGGEVYWTDWRTNTLAKANKWTGHNVTVVQRTNTQPFDLQVYHPSRQPMAPNPCEANGGQGPCSHLCLINYNRTVSCACPHLMKLHKDNTTCYEFKKFLLYARQMEIRGVDLDAPYYNYIISFTVPDIDNVTVLDYDAREQRVYWSDVRTQAIKRAFINGTGVETVVSADLPNAHGLAVDWVSRNLFWTSYDTNKKQINVARLDGSFKNAVVQGLEQPHGLVVHPLRGKLYWTDGDNISMANMDGSNRTLLFSGQKGPVGLAIDFPESKLYWISSGNHTINRCNLDGSGLEVIDAMRSQLGKATALAIMGDKLWWADQVSEKMGTCSKADGSGSVVLRNSTTLVMHMKVYDESIQLDHKGTNPCSVNNGDCSQLCLPTSETTRSCMCTAGYSLRSGQQACEGVGSFLLYSVHEGIRGIPLDPNDKSDALVPVSGTSLAVGIDFHAENDTIYWVDMGLSTISRAKRDQTWREDVVTNGIGRVEGIAVDWIAGNIYWTDQGFDVIEVARLNGSFRYVVISQGLDKPRAITVHPEKGYLFWTEWGQYPRIERSRLDGTERVVLVNVSISWPNGISVDYQDGKLYWCDARTDKIERIDLETGENREVVLSSNNMDMFSVSVFEDFIYWSDRTHANGSIKRGSKDNATDSVPLRTGIGVQLKDIKVFNRDRQKGTNVCAVANGGCQQLCLYRGRGQRACACAHGMLAEDGASCREYAGYLLYSERTILKSIHLSDERNLNAPVQPFEDPEHMKNVIALAFDYRAGTSPGTPNRIFFSDIHFGNIQQINDDGSRRITIVENVGSVEGLAYHRGWDTLYWTSYTTSTITRHTVDQTRPGAFERETVITMSGDDHPRAFVLDECQNLMFWTNWNEQHPSIMRAALSGANVLTLIEKDIRTPNGLAIDHRAEKLYFSDATLDKIERCEYDGSHRYVILKSEPVHPFGLAVYGEHIFWTDWVRRAVQRANKHVGSNMKLLRVDIPQQPMGIIAVANDTNSCELSPCRINNGGCQDLCLLTHQGHVNCSCRGGRILQDDLTCRAVNSSCRAQDEFECANGECINFSLTCDGVPHCKDKSDEKPSYCNSRRCKKTFRQCSNGRCVSNMLWCNGADDCGDGSDEIPCNKTACGVGEFRCRDGTCIGNSSRCNQFVDCEDASDEMNCSATDCSSYFRLGVKGVLFQPCERTSLCYAPSWVCDGANDCGDYSDERDCPGVKRPRCPLNYFACPSGRCIPMSWTCDKEDDCEHGEDETHCNKFCSEAQFECQNHRCISKQWLCDGSDDCGDGSDEAAHCEGKTCGPSSFSCPGTHVCVPERWLCDGDKDCADGADESIAAGCLYNSTCDDREFMCQNRQCIPKHFVCDHDRDCADGSDESPECEYPTCGPSEFRCANGRCLSSRQWECDGENDCHDQSDEAPKNPHCTSQEHKCNASSQFLCSSGRCVAEALLCNGQDDCGDSSDERGCHINECLSRKLSGCSQDCEDLKIGFKCRCRPGFRLKDDGRTCADVDECSTTFPCSQRCINTHGSYKCLCVEGYAPRGGDPHSCKAVTDEEPFLIFANRYYLRKLNLDGSNYTLLKQGLNNAVALDFDYREQMIYWTDVTTQGSMIRRMHLNGSNVQVLHRTGLSNPDGLAVDWVGGNLYWCDKGRDTIEVSKLNGAYRTVLVSSGLREPRALVVDVQNGYLYWTDWGDHSLIGRIGMDGSSRSVIVDTKITWPNGLTLDYVTERIYWADAREDYIEFASLDGSNRHVVLSQDIPHIFALTLFEDYVYWTDWETKSINRAHKTTGTNKTLLISTLHRPMDLHVFHALRQPDVPNHPCKVNNGGCSNLCLLSPGGGHKCACPTNFYLGSDGRTCVSNCTASQFVCKNDKCIPFWWKCDTEDDCGDHSDEPPDCPEFKCRPGQFQCSTGICTNPAFICDGDNDCQDNSDEANCDIHVCLPSQFKCTNTNRCIPGIFRCNGQDNCGDGEDERDCPEVTCAPNQFQCSITKRCIPRVWVCDRDNDCVDGSDEPANCTQMTCGVDEFRCKDSGRCIPARWKCDGEDDCGDGSDEPKEECDERTCEPYQFRCKNNRCVPGRWQCDYDNDCGDNSDEESCTPRPCSESEFSCANGRCIAGRWKCDGDHDCADGSDEKDCTPRCDMDQFQCKSGHCIPLRWRCDADADCMDGSDEEACGTGVRTCPLDEFQCNNTLCKPLAWKCDGEDDCGDNSDENPEECARFVCPPNRPFRCKNDRVCLWIGRQCDGTDNCGDGTDEEDCEPPTAHTTHCKDKKEFLCRNQRCLSSSLRCNMFDDCGDGSDEEDCSIDPKLTSCATNASICGDEARCVRTEKAAYCACRSGFHTVPGQPGCQDINECLRFGTCSQLCNNTKGGHLCSCARNFMKTHNTCKAEGSEYQVLYIADDNEIRSLFPGHPHSAYEQAFQGDESVRIDAMDVHVKAGRVYWTNWHTGTISYRSLPPAAPPTTSNRHRRQIDRGVTHLNISGLKMPRGIAIDWVAGNVYWTDSGRDVIEVAQMKGENRKTLISGMIDEPHAIVVDPLRGTMYWSDWGNHPKIETAAMDGTLRETLVQDNIQWPTGLAVDYHNERLYWADAKLSVIGSIRLNGTDPIVAADSKRGLSHPFSIDVFEDYIYGVTYINNRVFKIHKFGHSPLVNLTGGLSHASDVVLYHQHKQPEVTNPCDRKKCEWLCLLSPSGPVCTCPNGKRLDNGTCVPVPSPTPPPDAPRPGTCNLQCFNGGSCFLNARRQPKCRCQPRYTGDKCELDQCWEHCRNGGTCAASPSGMPTCRCPTGFTGPKCTQQVCAGYCANNSTCTVNQGNQPQCRCLPGFLGDRCQYRQCSGYCENFGTCQMAADGSRQCRCTAYFEGSRCEVNKCSRCLEGACVVNKQSGDVTCNCTDGRVAPSCLTCVGHCSNGGSCTMNSKMMPECQCPPHMTGPRCEEHVFSQQQPGHIASILIPLLLLLLLVLVAGVVFWYKRRVQGAKGFQHQRMTNGAMNVEIGNPTYKMYEGGEPDDVGGLLDADFALDPDKPTNFTNPVYATLYMGGHGSRHSLASTDEKRELLGRGPEDEIGDPLA,4544,"504,606",Alternative sequence (2); Beta strand (26); Chain (4); Disulfide bond (159); Domain (53); Glycosylation (52); Helix (7); Metal binding (18); Modified residue (6); Motif (2); Mutagenesis (9); Natural variant (10); Region (1); Repeat (34); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (11),"DISULFID 27..40;  /evidence=""ECO:0000250""; DISULFID 34..53;  /evidence=""ECO:0000250""; DISULFID 47..64;  /evidence=""ECO:0000250""; DISULFID 72..85;  /evidence=""ECO:0000250""; DISULFID 79..98;  /evidence=""ECO:0000250""; DISULFID 92..108;  /evidence=""ECO:0000250""; DISULFID 115..124;  /evidence=""ECO:0000250""; DISULFID 120..133;  /evidence=""ECO:0000250""; DISULFID 135..148;  /evidence=""ECO:0000250""; DISULFID 154..164;  /evidence=""ECO:0000250""; DISULFID 160..173;  /evidence=""ECO:0000250""; DISULFID 175..188;  /evidence=""ECO:0000250""; DISULFID 478..493;  /evidence=""ECO:0000250""; DISULFID 489..504;  /evidence=""ECO:0000250""; DISULFID 506..519;  /evidence=""ECO:0000250""; DISULFID 807..818;  /evidence=""ECO:0000250""; DISULFID 814..827;  /evidence=""ECO:0000250""; DISULFID 829..842;  /evidence=""ECO:0000250""; DISULFID 854..866; DISULFID 861..879; DISULFID 873..890; DISULFID 895..907;  /evidence=""ECO:0000250""; DISULFID 902..920;  /evidence=""ECO:0000250""; DISULFID 914..931;  /evidence=""ECO:0000250""; DISULFID 936..948; DISULFID 943..961; DISULFID 955..971; DISULFID 976..989; DISULFID 984..1002; DISULFID 996..1011; DISULFID 1015..1027; DISULFID 1022..1040; DISULFID 1034..1051; DISULFID 1062..1075; DISULFID 1069..1088; DISULFID 1082..1097; DISULFID 1104..1118;  /evidence=""ECO:0000250""; DISULFID 1112..1131;  /evidence=""ECO:0000250""; DISULFID 1125..1140;  /evidence=""ECO:0000250""; DISULFID 1145..1159;  /evidence=""ECO:0000250""; DISULFID 1152..1172;  /evidence=""ECO:0000250""; DISULFID 1166..1182;  /evidence=""ECO:0000250""; DISULFID 1185..1196;  /evidence=""ECO:0000250""; DISULFID 1192..1206;  /evidence=""ECO:0000250""; DISULFID 1208..1221;  /evidence=""ECO:0000250""; DISULFID 1227..1237;  /evidence=""ECO:0000250""; DISULFID 1233..1246;  /evidence=""ECO:0000250""; DISULFID 1248..1261;  /evidence=""ECO:0000250""; DISULFID 1540..1553;  /evidence=""ECO:0000250""; DISULFID 1549..1563;  /evidence=""ECO:0000250""; DISULFID 1565..1578;  /evidence=""ECO:0000250""; DISULFID 1850..1861;  /evidence=""ECO:0000250""; DISULFID 1857..1871;  /evidence=""ECO:0000250""; DISULFID 1873..1886;  /evidence=""ECO:0000250""; DISULFID 2159..2170;  /evidence=""ECO:0000250""; DISULFID 2166..2180;  /evidence=""ECO:0000250""; DISULFID 2182..2194;  /evidence=""ECO:0000250""; DISULFID 2482..2493;  /evidence=""ECO:0000250""; DISULFID 2489..2503;  /evidence=""ECO:0000250""; DISULFID 2505..2517;  /evidence=""ECO:0000250""; DISULFID 2524..2537;  /evidence=""ECO:0000250""; DISULFID 2532..2550;  /evidence=""ECO:0000250""; DISULFID 2544..2561;  /evidence=""ECO:0000250""; DISULFID 2566..2578;  /evidence=""ECO:0000250""; DISULFID 2573..2591;  /evidence=""ECO:0000250""; DISULFID 2585..2600;  /evidence=""ECO:0000250""; DISULFID 2605..2617;  /evidence=""ECO:0000250""; DISULFID 2612..2630;  /evidence=""ECO:0000250""; DISULFID 2624..2639;  /evidence=""ECO:0000250""; DISULFID 2644..2666;  /evidence=""ECO:0000250""; DISULFID 2660..2679;  /evidence=""ECO:0000250""; DISULFID 2673..2688;  /evidence=""ECO:0000250""; DISULFID 2696..2708;  /evidence=""ECO:0000250""; DISULFID 2703..2721;  /evidence=""ECO:0000250""; DISULFID 2715..2730;  /evidence=""ECO:0000250""; DISULFID 2734..2746;  /evidence=""ECO:0000250""; DISULFID 2741..2759;  /evidence=""ECO:0000250""; DISULFID 2753..2769;  /evidence=""ECO:0000250""; DISULFID 2774..2787;  /evidence=""ECO:0000250""; DISULFID 2781..2800;  /evidence=""ECO:0000250""; DISULFID 2794..2812;  /evidence=""ECO:0000250""; DISULFID 2818..2830;  /evidence=""ECO:0000250""; DISULFID 2825..2843;  /evidence=""ECO:0000250""; DISULFID 2837..2853;  /evidence=""ECO:0000250""; DISULFID 2858..2870;  /evidence=""ECO:0000250""; DISULFID 2865..2884;  /evidence=""ECO:0000250""; DISULFID 2878..2897;  /evidence=""ECO:0000250""; DISULFID 2904..2917;  /evidence=""ECO:0000250""; DISULFID 2912..2930;  /evidence=""ECO:0000250""; DISULFID 2924..2939;  /evidence=""ECO:0000250""; DISULFID 2944..2956;  /evidence=""ECO:0000250""; DISULFID 2952..2965;  /evidence=""ECO:0000250""; DISULFID 2967..2980;  /evidence=""ECO:0000250""; DISULFID 2986..2996;  /evidence=""ECO:0000250""; DISULFID 2992..3005;  /evidence=""ECO:0000250""; DISULFID 3007..3021;  /evidence=""ECO:0000250""; DISULFID 3294..3305;  /evidence=""ECO:0000250""; DISULFID 3301..3315;  /evidence=""ECO:0000250""; DISULFID 3317..3330;  /evidence=""ECO:0000250""; DISULFID 3334..3346;  /evidence=""ECO:0000250""; DISULFID 3341..3359;  /evidence=""ECO:0000250""; DISULFID 3353..3369;  /evidence=""ECO:0000250""; DISULFID 3374..3386;  /evidence=""ECO:0000250""; DISULFID 3381..3399;  /evidence=""ECO:0000250""; DISULFID 3393..3408;  /evidence=""ECO:0000250""; DISULFID 3413..3426;  /evidence=""ECO:0000250""; DISULFID 3420..3439;  /evidence=""ECO:0000250""; DISULFID 3433..3448;  /evidence=""ECO:0000250""; DISULFID 3453..3466;  /evidence=""ECO:0000250""; DISULFID 3460..3479;  /evidence=""ECO:0000250""; DISULFID 3473..3489;  /evidence=""ECO:0000250""; DISULFID 3494..3507;  /evidence=""ECO:0000250""; DISULFID 3501..3520;  /evidence=""ECO:0000250""; DISULFID 3514..3531;  /evidence=""ECO:0000250""; DISULFID 3536..3548;  /evidence=""ECO:0000250""; DISULFID 3543..3561;  /evidence=""ECO:0000250""; DISULFID 3555..3570;  /evidence=""ECO:0000250""; DISULFID 3575..3587;  /evidence=""ECO:0000250""; DISULFID 3582..3600;  /evidence=""ECO:0000250""; DISULFID 3594..3609;  /evidence=""ECO:0000250""; DISULFID 3613..3625;  /evidence=""ECO:0000250""; DISULFID 3620..3638;  /evidence=""ECO:0000250""; DISULFID 3632..3647;  /evidence=""ECO:0000250""; DISULFID 3654..3666;  /evidence=""ECO:0000250""; DISULFID 3661..3679;  /evidence=""ECO:0000250""; DISULFID 3673..3690;  /evidence=""ECO:0000250""; DISULFID 3695..3709;  /evidence=""ECO:0000250""; DISULFID 3703..3722;  /evidence=""ECO:0000250""; DISULFID 3716..3731;  /evidence=""ECO:0000250""; DISULFID 3741..3754;  /evidence=""ECO:0000250""; DISULFID 3749..3767;  /evidence=""ECO:0000250""; DISULFID 3761..3776;  /evidence=""ECO:0000250""; DISULFID 3785..3798;  /evidence=""ECO:0000250""; DISULFID 3792..3807;  /evidence=""ECO:0000250""; DISULFID 3809..3822;  /evidence=""ECO:0000250""; DISULFID 3828..3838;  /evidence=""ECO:0000250""; DISULFID 3834..3847;  /evidence=""ECO:0000250""; DISULFID 3849..3860;  /evidence=""ECO:0000250""; DISULFID 4151..4160;  /evidence=""ECO:0000250""; DISULFID 4156..4169;  /evidence=""ECO:0000250""; DISULFID 4171..4182;  /evidence=""ECO:0000250""; DISULFID 4200..4210;  /evidence=""ECO:0000250""; DISULFID 4204..4220;  /evidence=""ECO:0000250""; DISULFID 4222..4231;  /evidence=""ECO:0000250""; DISULFID 4236..4246;  /evidence=""ECO:0000250""; DISULFID 4240..4256;  /evidence=""ECO:0000250""; DISULFID 4258..4267;  /evidence=""ECO:0000250""; DISULFID 4272..4282;  /evidence=""ECO:0000250""; DISULFID 4276..4292;  /evidence=""ECO:0000250""; DISULFID 4294..4303;  /evidence=""ECO:0000250""; DISULFID 4308..4318;  /evidence=""ECO:0000250""; DISULFID 4312..4328;  /evidence=""ECO:0000250""; DISULFID 4330..4339;  /evidence=""ECO:0000250""; DISULFID 4344..4352;  /evidence=""ECO:0000250""; DISULFID 4347..4363;  /evidence=""ECO:0000250""; DISULFID 4365..4374;  /evidence=""ECO:0000250""; DISULFID 4377..4387;  /evidence=""ECO:0000250""; DISULFID 4381..4397;  /evidence=""ECO:0000250""; DISULFID 4399..4408;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q6UVY6,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X),MCCWPLLLLWGLLPGTAAGGSGRTYPHRTLLDSEGKYWLGWSQRGSQIAFRLQVRTAGYVGFGFSPTGAMASADIVVGGVAHGRPYLQDYFTNANRELKKDAQQDYHLEYAMENSTHTIIEFTRELHTCDINDKSITDSTVRVIWAYHHEDAGEAGPKYHDSNRGTKSLRLLNPEKTSVLSTALPYFDLVNQDVPIPNKDTTYWCQMFKIPVFQEKHHVIKVEPVIQRGHESLVHHILLYQCSNNFNDSVLESGHECYHPNMPDAFLTCETVIFAWAIGGEGFSYPPHVGLSLGTPLDPHYVLLEVHYDNPTYEEGLIDNSGLRLFYTMDIRKYDAGVIEAGLWVSLFHTIPPGMPEFQSEGHCTLECLEEALEAEKPSGIHVFAVLLHAHLAGRGIRLRHFRKGKEMKLLAYDDDFDFNFQEFQYLKEEQTILPGDNLITECRYNTKDRAEMTWGGLSTRSEMCLSYLLYYPRINLTRCASIPDIMEQLQFIGVKEIYRPVTTWPFIIKSPKQYKNLSFMDAMNKFKWTKKEGLSFNKLVLSLPVNVRCSKTDNAEWSIQGMTALPPDIERPYKAEPLVCGTSSSSSLHRDFSINLLVCLLLLSCTLSTKSL,613,"69,652",Active site (2); Alternative sequence (2); Chain (1); Disulfide bond (5); Domain (1); Erroneous initiation (1); Glycosylation (4); Metal binding (6); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 205..257;  /evidence=""ECO:0000250""; DISULFID 242..269;  /evidence=""ECO:0000250""; DISULFID 364..480;  /evidence=""ECO:0000250""; DISULFID 368..550;  /evidence=""ECO:0000250""; DISULFID 443..465;  /evidence=""ECO:0000250""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q969V3,Nicalin (Nicastrin-like protein),MLEEAGEVLENMLKASCLPLGFIVFLPAVLLLVAPPLPAADAAHEFTVYRMQQYDLQGQPYGTRNAVLNTEARTMAAEVLSRRCVLMRLLDFSYEQYQKALRQSAGAVVIILPRAMAAVPQDVVRQFMEIEPEMLAMETAVPVYFAVEDEALLSIYKQTQAASASQGSASAAEVLLRTATANGFQMVTSGVQSKAVSDWLIASVEGRLTGLGGEDLPTIVIVAHYDAFGVAPWLSLGADSNGSGVSVLLELARLFSRLYTYKRTHAAYNLLFFASGGGKFNYQGTKRWLEDNLDHTDSSLLQDNVAFVLCLDTVGRGSSLHLHVSKPPREGTLQHAFLRELETVAAHQFPEVRFSMVHKRINLAEDVLAWEHERFAIRRLPAFTLSHLESHRDGQRSSIMDVRSRVDSKTLTRNTRIIAEALTRVIYNLTEKGTPPDMPVFTEQMQIQQEQLDSVMDWLTNQPRAAQLVDKDSTFLSTLEHHLSRYLKDVKQHHVKADKRDPEFVFYDQLKQVMNAYRVKPAVFDLLLAVGIAAYLGMAYVAVQHFSLLYKTVQRLLVKAKTQ,563,"62,974",Alternative sequence (1); Chain (1); Erroneous initiation (3); Glycosylation (2); Natural variant (2); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..42;  /evidence=""ECO:0000255"""
P20702,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)",MTRTRAALLLFTALATSLGFNLDTEELTAFRVDSAGFGDSVVQYANSWVVVGAPQKITAANQTGGLYQCGYSTGACEPIGLQVPPEAVNMSLGLSLASTTSPSQLLACGPTVHHECGRNMYLTGLCFLLGPTQLTQRLPVSRQECPRQEQDIVFLIDGSGSISSRNFATMMNFVRAVISQFQRPSTQFSLMQFSNKFQTHFTFEEFRRSSNPLSLLASVHQLQGFTYTATAIQNVVHRLFHASYGARRDAAKILIVITDGKKEGDSLDYKDVIPMADAAGIIRYAIGVGLAFQNRNSWKELNDIASKPSQEHIFKVEDFDALKDIQNQLKEKIFAIEGTETTSSSSFELEMAQEGFSAVFTPDGPVLGAVGSFTWSGGAFLYPPNMSPTFINMSQENVDMRDSYLGYSTELALWKGVQSLVLGAPRYQHTGKAVIFTQVSRQWRMKAEVTGTQIGSYFGASLCSVDVDSDGSTDLVLIGAPHYYEQTRGGQVSVCPLPRGWRRWWCDAVLYGEQGHPWGRFGAALTVLGDVNGDKLTDVVIGAPGEEENRGAVYLFHGVLGPSISPSHSQRIAGSQLSSRLQYFGQALSGGQDLTQDGLVDLAVGARGQVLLLRTRPVLWVGVSMQFIPAEIPRSAFECREQVVSEQTLVQSNICLYIDKRSKNLLGSRDLQSSVTLDLALDPGRLSPRATFQETKNRSLSRVRVLGLKAHCENFNLLLPSCVEDSVTPITLRLNFTLVGKPLLAFRNLRPMLAADAQRYFTASLPFEKNCGADHICQDNLGISFSFPGLKSLLVGSNLELNAEVMVWNDGEDSYGTTITFSHPAGLSYRYVAEGQKQGQLRSLHLTCDSAPVGSQGTWSTSCRINHLIFRGGAQITFLATFDVSPKAVLGDRLLLTANVSSENNTPRTSKTTFQLELPVKYAVYTVVSSHEQFTKYLNFSESEEKESHVAMHRYQVNNLGQRDLPVSINFWVPVELNQEAVWMDVEVSHPQNPSLRCSSEKIAPPASDFLAHIQKNPVLDCSIAGCLRFRCDVPSFSVQEELDFTLKGNLSFGWVRQILQKKVSVVSVAEITFDTSVYSQLPGQEAFMRAQTTTVLEKYKVHNPTPLIVGSSIGGLLLLALITAVLYKVGFFKRQYKEMMEEANGQIAPENGTQTPSPPSEK,1163,"127,829",Beta strand (81); Calcium binding (3); Chain (1); Disulfide bond (10); Domain (1); Glycosylation (8); Helix (21); Metal binding (16); Motif (1); Natural variant (8); Repeat (7); Sequence conflict (15); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (18),"DISULFID 69..76;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 108..126;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 116..145;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 495..506;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 639..722;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 655..712;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 771..777;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 848..863;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 998..1022;  /evidence=""ECO:0000269|PubMed:20033057""; DISULFID 1027..1032;  /evidence=""ECO:0000269|PubMed:20033057""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:3549901"""
P11215,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b),MALRVLLLTALTLCHGFNLDTENAMTFQENARGFGQSVVQLQGSRVVVGAPQEIVAANQRGSLYQCDYSTGSCEPIRLQVPVEAVNMSLGLSLAATTSPPQLLACGPTVHQTCSENTYVKGLCFLFGSNLRQQPQKFPEALRGCPQEDSDIAFLIDGSGSIIPHDFRRMKEFVSTVMEQLKKSKTLFSLMQYSEEFRIHFTFKEFQNNPNPRSLVKPITQLLGRTHTATGIRKVVRELFNITNGARKNAFKILVVITDGEKFGDPLGYEDVIPEADREGVIRYVIGVGDAFRSEKSRQELNTIASKPPRDHVFQVNNFEALKTIQNQLREKIFAIEGTQTGSSSSFEHEMSQEGFSAAITSNGPLLSTVGSYDWAGGVFLYTSKEKSTFINMTRVDSDMNDAYLGYAAAIILRNRVQSLVLGAPRYQHIGLVAMFRQNTGMWESNANVKGTQIGAYFGASLCSVDVDSNGSTDLVLIGAPHYYEQTRGGQVSVCPLPRGRARWQCDAVLYGEQGQPWGRFGAALTVLGDVNGDKLTDVAIGAPGEEDNRGAVYLFHGTSGSGISPSHSQRIAGSKLSPRLQYFGQSLSGGQDLTMDGLVDLTVGAQGHVLLLRSQPVLRVKAIMEFNPREVARNVFECNDQVVKGKEAGEVRVCLHVQKSTRDRLREGQIQSVVTYDLALDSGRPHSRAVFNETKNSTRRQTQVLGLTQTCETLKLQLPNCIEDPVSPIVLRLNFSLVGTPLSAFGNLRPVLAEDAQRLFTALFPFEKNCGNDNICQDDLSITFSFMSLDCLVVGGPREFNVTVTVRNDGEDSYRTQVTFFFPLDLSYRKVSTLQNQRSQRSWRLACESASSTEVSGALKSTSCSINHPIFPENSEVTFNITFDVDSKASLGNKLLLKANVTSENNMPRTNKTEFQLELPVKYAVYMVVTSHGVSTKYLNFTASENTSRVMQHQYQVSNLGQRSLPISLVFLVPVRLNQTVIWDRPQVTFSENLSSTCHTKERLPSHSDFLAELRKAPVVNCSIAVCQRIQCDIPFFGIQEEFNATLKGNLSFDWYIKTSHNHLLIVSTAEILFNDSVFTLLPGQGAFVRSQTETKVEPFEVPNPLPLIVGSSVGGLLLLALITAALYKLGFFKRQYKDMMSEGGPPGAEPQ,1152,"127,179",Alternative sequence (1); Beta strand (6); Calcium binding (3); Chain (1); Disulfide bond (7); Domain (1); Glycosylation (19); Helix (14); Motif (1); Natural variant (4); Repeat (7); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 66..73;  /evidence=""ECO:0000250""; DISULFID 105..123;  /evidence=""ECO:0000250""; DISULFID 654..711;  /evidence=""ECO:0000250""; DISULFID 770..776;  /evidence=""ECO:0000250""; DISULFID 847..864;  /evidence=""ECO:0000250""; DISULFID 998..1022;  /evidence=""ECO:0000250""; DISULFID 1027..1032;  /evidence=""ECO:0000250""","SIGNAL 1..16;  /evidence=""ECO:0000269|PubMed:3539202"""
Q8N109,Killer cell immunoglobulin-like receptor 2DL5A (CD antigen CD158f1),MSLMVISMACVGFFLLQGAWTHEGGQDKPLLSAWPSAVVPRGGHVTLLCRSRLGFTIFSLYKEDGVPVPELYNKIFWKSILMGPVTPAHAGTYRCRGSHPRSPIEWSAPSNPLVIVVTGLFGKPSLSAQPGPTVRTGENVTLSCSSRSSFDMYHLSREGRAHEPRLPAVPSVNGTFQADFPLGPATHGGTYTCFGSLHDSPYEWSDPSDPLLVSVTGNSSSSSSSPTEPSSKTGIRRHLHILIGTSVAIILFIILFFFLLHCCCSNKKNAAVMDQEPAGDRTVNREDSDDQDPQEVTYAQLDHCVFTQTKITSPSQRPKTPPTDTTMYMELPNAKPRSLSPAHKHHSQALRGSSRETTALSQNRVASSHVPAAGI,375,"40,678",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..95;  /evidence=""ECO:0000250""; DISULFID 144..193;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P16150,Leukosialin (GPL115) (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43) [Cleaved into: CD43 cytoplasmic tail (CD43-ct) (CD43ct)],MATLLLLLGVLVVSPDALGSTTAVQTPTSGEPLVSTSEPLSSKMYTTSITSDPKADSTGDQTSALPPSTSINEGSPLWTSIGASTGSPLPEPTTYQEVSIKMSSVPQETPHATSHPAVPITANSLGSHTVTGGTITTNSPETSSRTSGAPVTTAASSLETSRGTSGPPLTMATVSLETSKGTSGPPVTMATDSLETSTGTTGPPVTMTTGSLEPSSGASGPQVSSVKLSTMMSPTTSTNASTVPFRNPDENSRGMLPVAVLVALLAVIVLVALLLLWRRRQKRRTGALVLSRGGKRNGVVDAWAGPAQVPEEGAVTVTVGGSGGDKGSGFPDGEGSSRRPTLTTFFGRRKSRQGSLAMEELKSGSGPSLKGEEEPLVASEDGAVDAPAPDEPEGGDGAAP,400,"40,322",Chain (2); Glycosylation (26); Modified residue (7); Natural variant (2); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:1731338"""
Q685J3,Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3),MPRPGTMALCLLTLVLSLLPPQAAAEQDLSVNRAVWDGGGCISQGDVLNRQCQQLSQHVRTGSAANTATGTTSTNVVEPRMYLSCSTNPEMTSIESSVTSDTPGVSSTRMTPTESRTTSESTSDSTTLFPSSTEDTSSPTTPEGTDVPMSTPSEESISSTMAFVSTAPLPSFEAYTSLTYKVDMSTPLTTSTQASSSPTTPESTTIPKSTNSEGSTPLTSMPASTMKVASSEAITLLTTPVEISTPVTISAQASSSPTTAEGPSLSNSAPSGGSTPLTRMPLSVMLVVSSEASTLSTTPAATNIPVITSTEASSSPTTAEGTSIPTSTYTEGSTPLTSTPASTMPVATSEMSTLSITPVDTSTLVTTSTEPSSLPTTAEATSMLTSTLSEGSTPLTNMPVSTILVASSEASTTSTIPVDSKTFVTTASEASSSPTTAEDTSIATSTPSEGSTPLTSMPVSTTPVASSEASNLSTTPVDSKTQVTTSTEASSSPPTAEVNSMPTSTPSEGSTPLTSMSVSTMPVASSEASTLSTTPVDTSTPVTTSSEASSSSTTPEGTSIPTSTPSEGSTPLTNMPVSTRLVVSSEASTTSTTPADSNTFVTTSSEASSSSTTAEGTSMPTSTYSERGTTITSMSVSTTLVASSEASTLSTTPVDSNTPVTTSTEATSSSTTAEGTSMPTSTYTEGSTPLTSMPVNTTLVASSEASTLSTTPVDTSTPVTTSTEASSSPTTADGASMPTSTPSEGSTPLTSMPVSKTLLTSSEASTLSTTPLDTSTHITTSTEASCSPTTTEGTSMPISTPSEGSPLLTSIPVSITPVTSPEASTLSTTPVDSNSPVTTSTEVSSSPTPAEGTSMPTSTYSEGRTPLTSMPVSTTLVATSAISTLSTTPVDTSTPVTNSTEARSSPTTSEGTSMPTSTPGEGSTPLTSMPDSTTPVVSSEARTLSATPVDTSTPVTTSTEATSSPTTAEGTSIPTSTPSEGTTPLTSTPVSHTLVANSEASTLSTTPVDSNTPLTTSTEASSPPPTAEGTSMPTSTPSEGSTPLTRMPVSTTMVASSETSTLSTTPADTSTPVTTYSQASSSSTTADGTSMPTSTYSEGSTPLTSVPVSTRLVVSSEASTLSTTPVDTSIPVTTSTEASSSPTTAEGTSIPTSPPSEGTTPLASMPVSTTLVVSSEANTLSTTPVDSKTQVATSTEASSPPPTAEVTSMPTSTPGERSTPLTSMPVRHTPVASSEASTLSTSPVDTSTPVTTSAETSSSPTTAEGTSLPTSTTSEGSTLLTSIPVSTTLVTSPEASTLLTTPVDTKGPVVTSNEVSSSPTPAEGTSMPTSTYSEGRTPLTSIPVNTTLVASSAISILSTTPVDNSTPVTTSTEACSSPTTSEGTSMPNSNPSEGTTPLTSIPVSTTPVVSSEASTLSATPVDTSTPGTTSAEATSSPTTAEGISIPTSTPSEGKTPLKSIPVSNTPVANSEASTLSTTPVDSNSPVVTSTAVSSSPTPAEGTSIAISTPSEGSTALTSIPVSTTTVASSEINSLSTTPAVTSTPVTTYSQASSSPTTADGTSMQTSTYSEGSTPLTSLPVSTMLVVSSEANTLSTTPIDSKTQVTASTEASSSTTAEGSSMTISTPSEGSPLLTSIPVSTTPVASPEASTLSTTPVDSNSPVITSTEVSSSPTPAEGTSMPTSTYTEGRTPLTSITVRTTPVASSAISTLSTTPVDNSTPVTTSTEARSSPTTSEGTSMPNSTPSEGTTPLTSIPVSTTPVLSSEASTLSATPIDTSTPVTTSTEATSSPTTAEGTSIPTSTLSEGMTPLTSTPVSHTLVANSEASTLSTTPVDSNSPVVTSTAVSSSPTPAEGTSIATSTPSEGSTALTSIPVSTTTVASSETNTLSTTPAVTSTPVTTYAQVSSSPTTADGSSMPTSTPREGRPPLTSIPVSTTTVASSEINTLSTTLADTRTPVTTYSQASSSPTTADGTSMPTPAYSEGSTPLTSMPLSTTLVVSSEASTLSTTPVDTSTPATTSTEGSSSPTTAGGTSIQTSTPSERTTPLAGMPVSTTLVVSSEGNTLSTTPVDSKTQVTNSTEASSSATAEGSSMTISAPSEGSPLLTSIPLSTTPVASPEASTLSTTPVDSNSPVITSTEVSSSPIPTEGTSMQTSTYSDRRTPLTSMPVSTTVVASSAISTLSTTPVDTSTPVTNSTEARSSPTTSEGTSMPTSTPSEGSTPFTSMPVSTMPVVTSEASTLSATPVDTSTPVTTSTEATSSPTTAEGTSIPTSTLSEGTTPLTSIPVSHTLVANSEVSTLSTTPVDSNTPFTTSTEASSPPPTAEGTSMPTSTSSEGNTPLTRMPVSTTMVASFETSTLSTTPADTSTPVTTYSQAGSSPTTADDTSMPTSTYSEGSTPLTSVPVSTMPVVSSEASTHSTTPVDTSTPVTTSTEASSSPTTAEGTSIPTSPPSEGTTPLASMPVSTTPVVSSEAGTLSTTPVDTSTPMTTSTEASSSPTTAEDIVVPISTASEGSTLLTSIPVSTTPVASPEASTLSTTPVDSNSPVVTSTEISSSATSAEGTSMPTSTYSEGSTPLRSMPVSTKPLASSEASTLSTTPVDTSIPVTTSTETSSSPTTAKDTSMPISTPSEVSTSLTSILVSTMPVASSEASTLSTTPVDTRTLVTTSTGTSSSPTTAEGSSMPTSTPGERSTPLTNILVSTTLLANSEASTLSTTPVDTSTPVTTSAEASSSPTTAEGTSMRISTPSDGSTPLTSILVSTLPVASSEASTVSTTAVDTSIPVTTSTEASSSPTTAEVTSMPTSTPSETSTPLTSMPVNHTPVASSEAGTLSTTPVDTSTPVTTSTKASSSPTTAEGIVVPISTASEGSTLLTSIPVSTTPVASSEASTLSTTPVDTSIPVTTSTEGSSSPTTAEGTSMPISTPSEVSTPLTSILVSTVPVAGSEASTLSTTPVDTRTPVTTSAEASSSPTTAEGTSMPISTPGERRTPLTSMSVSTMPVASSEASTLSRTPADTSTPVTTSTEASSSPTTAEGTGIPISTPSEGSTPLTSIPVSTTPVAIPEASTLSTTPVDSNSPVVTSTEVSSSPTPAEGTSMPISTYSEGSTPLTGVPVSTTPVTSSAISTLSTTPVDTSTPVTTSTEAHSSPTTSEGTSMPTSTPSEGSTPLTYMPVSTMLVVSSEDSTLSATPVDTSTPVTTSTEATSSTTAEGTSIPTSTPSEGMTPLTSVPVSNTPVASSEASILSTTPVDSNTPLTTSTEASSSPPTAEGTSMPTSTPSEGSTPLTSMPVSTTTVASSETSTLSTTPADTSTPVTTYSQASSSPPIADGTSMPTSTYSEGSTPLTNMSFSTTPVVSSEASTLSTTPVDTSTPVTTSTEASLSPTTAEGTSIPTSSPSEGTTPLASMPVSTTPVVSSEVNTLSTTPVDSNTLVTTSTEASSSPTIAEGTSLPTSTTSEGSTPLSIMPLSTTPVASSEASTLSTTPVDTSTPVTTSSPTNSSPTTAEVTSMPTSTAGEGSTPLTNMPVSTTPVASSEASTLSTTPVDSNTFVTSSSQASSSPATLQVTTMRMSTPSEGSSSLTTMLLSSTYVTSSEASTPSTPSVDRSTPVTTSTQSNSTPTPPEVITLPMSTPSEVSTPLTIMPVSTTSVTISEAGTASTLPVDTSTPVITSTQVSSSPVTPEGTTMPIWTPSEGSTPLTTMPVSTTRVTSSEGSTLSTPSVVTSTPVTTSTEAISSSATLDSTTMSVSMPMEISTLGTTILVSTTPVTRFPESSTPSIPSVYTSMSMTTASEGSSSPTTLEGTTTMPMSTTSERSTLLTTVLISPISVMSPSEASTLSTPPGDTSTPLLTSTKAGSFSIPAEVTTIRISITSERSTPLTTLLVSTTLPTSFPGASIASTPPLDTSTTFTPSTDTASTPTIPVATTISVSVITEGSTPGTTIFIPSTPVTSSTADVFPATTGAVSTPVITSTELNTPSTSSSSTTTSFSTTKEFTTPAMTTAAPLTYVTMSTAPSTPRTTSRGCTTSASTLSATSTPHTSTSVTTRPVTPSSESSRPSTITSHTIPPTFPPAHSSTPPTTSASSTTVNPEAVTTMTTRTKPSTRTTSFPTVTTTAVPTNTTIKSNPTSTPTVPRTTTCFGDGCQNTASRCKNGGTWDGLKCQCPNLYYGELCEEVVSSIDIGPPETISAQMELTVTVTSVKFTEELKNHSSQEFQEFKQTFTEQMNIVYSGIPEYVGVNITKLRLGSVVVEHDVLLRTKYTPEYKTVLDNATEVVKEKITKVTTQQIMINDICSDMMCFNTTGTQVQNITVTQYDPEEDCRKMAKEYGDYFVVEYRDQKPYCISPCEPGFSVSKNCNLGKCQMSLSGPQCLCVTTETHWYSGETCNQGTQKSLVYGLVGAGVVLMLIILVALLMLVFRSKREVKRQKYRLSQLYKWQEEDSGPAPGTFQNIGFDICQDDDSIHLESIYSNFQPSLRHIDPETKIRIQRPQVMTTSF,4493,"451,741",Alternative sequence (2); Chain (1); Compositional bias (2); Disulfide bond (3); Domain (2); Glycosylation (13); Natural variant (20); Region (1); Repeat (59); Sequence conflict (8); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 4135..4147;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4140..4158;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 4160..4169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
O60721,Sodium/potassium/calcium exchanger 1 (Na(+)/K(+)/Ca(2+)-exchange protein 1) (Retinal rod Na-Ca+K exchanger) (Solute carrier family 24 member 1),MGKLIRMGPQERWLLRTKRLHWSRLLFLLGMLIIGSTYQHLRRPRGLSSLWAAVSSHQPIKLASRDLSSEEMMMMSSSPSKPSSEMGGKMLVPQASVGSDEATLSMTVENIPSMPKRTAKMIPTTTKNNYSPTAAGTERRKEDTPTSSRTLTYYTSTSSRQIVKKYTPTPRGEMKSYSPTQVREKVKYTPSPRGRRVGTYVPSTFMTMETSHAITPRTTVKDSDITATYKILETNSLKRIMEETTPTTLKGMFDSTPTFLTHEVEANVLTSPRSVMEKNNLFPPRRVESNSSAHPWGLVGKSNPKTPQGTVLLHTPATSEGQVTISTMTGSSPAETKAFTAAWSLRNPSPRTSVSAIKTAPAIVWRLAKKPSTAPSTSTTPTVRAKLTMQVHHCVVVKPTPAMLTTPSPSLTTALLPEELSPSPSVLPPSLPDLHPKGEYPPDLFSVEERRQGWVVLHVFGMMYVFVALAIVCDEYFVPALGVITDKLQISEDVAGATFMAAGGSAPELFTSLIGVFISHSNVGIGTIVGSAVFNILFVIGTCSLFSREILNLTWWPLFRDVSFYILDLIMLILFFLDSLIAWWESLLLLLAYAFYVFTMKWNKHIEVWVKEQLSRRPVAKVMALEDLSKPGDGAIAVDELQDNKKLKLPSLLTRGSSSTSLHNSTIRSTIYQLMLHSLDPLREVRLAKEKEEESLNQGARAQPQAKAESKPEEEEPAKLPAVTVTPAPVPDIKGDQKENPGGQEDVAEAESTGEMPGEEGETAGEGETEEKSGGETQPEGEGETETQGKGEECEDENEAEGKGDNEGEDEGEIHAEDGEMKGNEGETESQELSAENHGEAKNDEKGVEDGGGSDGGDSEEEEEEEEEQEEEEEEEEQEEEEEEEEEEEEKGNEEPLSLDWPETRQKQAIYLFLLPIVFPLWLTVPDVRRQESRKFFVFTFLGSIMWIAMFSYLMVWWAHQVGETIGISEEIMGLTILAAGTSIPDLITSVIVARKGLGDMAVSSSVGSNIFDITVGLPVPWLLFSLINGLQPVPVSSNGLFCAIVLLFLMLLFVISSIASCKWRMNKILGFTMFLLYFVFLIISVMLEDRIISCPVSV,1099,"121,374",Alternative sequence (2); Chain (1); Compositional bias (1); Glycosylation (1); Modified residue (2); Natural variant (3); Repeat (2); Sequence conflict (1); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..?;  /note=""Not cleaved"""
P46531,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],MPPLLAPLLCLALLPALAARGPRCSQPGETCLNGGKCEAANGTEACVCGGAFVGPRCQDPNPCLSTPCKNAGTCHVVDRRGVADYACSCALGFSGPLCLTPLDNACLTNPCRNGGTCDLLTLTEYKCRCPPGWSGKSCQQADPCASNPCANGGQCLPFEASYICHCPPSFHGPTCRQDVNECGQKPGLCRHGGTCHNEVGSYRCVCRATHTGPNCERPYVPCSPSPCQNGGTCRPTGDVTHECACLPGFTGQNCEENIDDCPGNNCKNGGACVDGVNTYNCRCPPEWTGQYCTEDVDECQLMPNACQNGGTCHNTHGGYNCVCVNGWTGEDCSENIDDCASAACFHGATCHDRVASFYCECPHGRTGLLCHLNDACISNPCNEGSNCDTNPVNGKAICTCPSGYTGPACSQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQYDVDECASTPCKNGAKCLDGPNTYTCVCTEGYTGTHCEVDIDECDPDPCHYGSCKDGVATFTCLCRPGYTGHHCETNINECSSQPCRHGGTCQDRDNAYLCFCLKGTTGPNCEINLDDCASSPCDSGTCLDKIDGYECACEPGYTGSMCNINIDECAGNPCHNGGTCEDGINGFTCRCPEGYHDPTCLSEVNECNSNPCVHGACRDSLNGYKCDCDPGWSGTNCDINNNECESNPCVNGGTCKDMTSGYVCTCREGFSGPNCQTNINECASNPCLNQGTCIDDVAGYKCNCLLPYTGATCEVVLAPCAPSPCRNGGECRQSEDYESFSCVCPTGWQGQTCEVDINECVLSPCRHGASCQNTHGGYRCHCQAGYSGRNCETDIDDCRPNPCHNGGSCTDGINTAFCDCLPGFRGTFCEEDINECASDPCRNGANCTDCVDSYTCTCPAGFSGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCPPGFTGSYCQHDVNECDSQPCLHGGTCQDGCGSYRCTCPQGYTGPNCQNLVHWCDSSPCKNGGKCWQTHTQYRCECPSGWTGLYCDVPSVSCEVAAQRQGVDVARLCQHGGLCVDAGNTHHCRCQAGYTGSYCEDLVDECSPSPCQNGATCTDYLGGYSCKCVAGYHGVNCSEEIDECLSHPCQNGGTCLDLPNTYKCSCPRGTQGVHCEINVDDCNPPVDPVSRSPKCFNNGTCVDQVGGYSCTCPPGFVGERCEGDVNECLSNPCDARGTQNCVQRVNDFHCECRAGHTGRRCESVINGCKGKPCKNGGTCAVASNTARGFICKCPAGFEGATCENDARTCGSLRCLNGGTCISGPRSPTCLCLGPFTGPECQFPASSPCLGGNPCYNQGTCEPTSESPFYRCLCPAKFNGLLCHILDYSFGGGAGRDIPPPLIEEACELPECQEDAGNKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQRAEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYGREEELRKHPIKRAAEGWAAPDALLGQVKASLLPGGSEGGRRRRELDPMDVRGSIVYLEIDNRQCVQASSQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSETVEPPPPAQLHFMYVAAAAFVLLFFVGCGVLLSRKRRRQHGQLWFPEGFKVSEASKKKRREPLGEDSVGLKPLKNASDGALMDDNQNEWGDEDLETKKFRFEEPVVLPDLDDQTDHRQWTQQHLDAADLRMSAMAPTPPQGEVDADCMDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLHGAPLGGTPTLSPPLCSPNGYLGSLKPGVQGKKVRKPSSKGLACGSKEAKDLKARRKKSQDGKGCLLDSSGMLSPVDSLESPHGYLSDVASPPLLPSPFQQSPSVPLNHLPGMPDTHLGIGHLNVAAKPEMAALGGGGRLAFETGPPRLSHLPVASGTSTVLGSSSGGALNFTVGGSTSLNGQCEWLSRLQSGMVPNQYNPLRGSVAPGPLSTQAPSLQHGMVGPLHSSLAASALSQMMSYQGLPSTRLATQPHLVQTQQVQPQNLQMQQQNLQPANIQQQQSLQPPPPPPQPHLGVSSAASGHLGRSFLSGEPSQADVQPLGPSSLAVHTILPQESPALPTSLPSSLVPPVTAAQFLTPPSQHSYSSPVDNTPSHQLQVPEHPFLTPSPESPDQWSSSSPHSNVSDWSEGVSSPPTSMQSQIARIPEAFK,2555,"272,505",Beta strand (38); Chain (3); Compositional bias (9); Cross-link (1); Disulfide bond (115); Domain (36); Glycosylation (47); Helix (36); Metal binding (16); Modified residue (3); Mutagenesis (2); Natural variant (6); Region (5); Repeat (9); Sequence conflict (26); Signal peptide (1); Site (3); Topological domain (2); Transmembrane (1); Turn (9),"DISULFID 24..37;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 31..46;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 48..57;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 63..74;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 68..87;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 89..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 106..117;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 111..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 129..138;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 144..155;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 149..164;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 166..175;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 182..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 189..204;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 206..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 222..233;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 227..243;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 245..254;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 261..272;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 266..281;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 283..292;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 299..312;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 306..321;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 323..332;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 339..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 344..359;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 361..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 376..387;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 381..398;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 400..409;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 416..429;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 423..438;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 440..449;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 456..467;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 461..476;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 478..487;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 494..505;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 499..514;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 516..525;  /evidence=""ECO:0000250|UniProtKB:Q07008""; DISULFID 532..543;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 537..552;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 554..563;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 570..580;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 575..589;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 591..600;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 607..618;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 612..627;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 629..638;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 645..655;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 650..664;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 666..675;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 682..693;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 687..702;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 704..713;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 720..730;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 725..739;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 741..750;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 757..768;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 762..777;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 779..788;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 795..806;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 800..815;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 817..826;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 833..844;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 838..855;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 857..866;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 873..884;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 878..893;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 895..904;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 911..922;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 916..931;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 933..942;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 949..960;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 954..969;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 971..980;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 987..998;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 992..1007;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1009..1018;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1025..1036;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1030..1045;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1047..1056;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1063..1074;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1068..1083;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1085..1094;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1101..1122;  /evidence=""ECO:0000305""; DISULFID 1116..1131;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1133..1142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1149..1160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1154..1169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1171..1180;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1187..1198;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1192..1207;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1209..1218;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1238..1253;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1255..1264;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1271..1284;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1276..1293;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1295..1304;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1311..1322;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1316..1334;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1336..1345;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1352..1363;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1357..1372;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1374..1383;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1391..1403;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1397..1414;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1416..1425;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1449..1472;  /evidence=""ECO:0000269|PubMed:12795601""; DISULFID 1454..1467;  /evidence=""ECO:0000269|PubMed:12795601""; DISULFID 1463..1479;  /evidence=""ECO:0000269|PubMed:12795601""; DISULFID 1490..1514;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00525""; DISULFID 1496..1509;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00525""; DISULFID 1505..1521;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00525""; DISULFID 1536..1549;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00525""; DISULFID 1545..1561;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00525""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q15155,Nodal modulator 1 (pM5 protein),MLVGQGAGPLGPAVVTAAVVLLLSGVGPAHGSEDIVVGCGGFVKSDVEINYSLIEIKLYTKHGTLKYQTDCAPNNGYFMIPLYDKGDFILKIEPPLGWSFEPTTVELHVDGVSDICTKGGDINFVFTGFSVNGKVLSKGQPLGPAGVQVSLRNTGTEAKIQSTVTQPGGKFAFFKVLPGDYEILATHPTWALKEASTTVRVTNSNANAASPLIVAGYNVSGSVRSDGEPMKGVKFLLFSSLVTKEDVLGCNVSPVPGFQPQDESLVYLCYTVSREDGSFSFYSLPSGGYTVIPFYRGERITFDVAPSRLDFTVEHDSLKIEPVFHVMGFSVTGRVLNGPEGDGVPEAVVTLNNQIKVKTKADGSFRLENITTGTYTIHAQKEHLYFETVTIKIAPNTPQLADIIATGFSVCGQISIIRFPDTVKQMNKYKVVLSSQDKDKSLVTVETDAHGSFCFKAKPGTYKVQVMVPEAETRAGLTLKPQTFPLTVTNRPMMDVAFVQFLASVSGKVSCLDTCGDLLVTLQSLSRQGEKRSLQLSGKVNAMTFTFDNVLPGKYKISIMHEDWCWKNKSLEVEVLEDDMSAVEFRQTGYMLRCSLSHAITLEFYQDGNGRENVGIYNLSKGVNRFCLSKPGVYKVTPRSCHRFEQAFYTYDTSSPSILTLTAIRHHVLGTITTDKMMDVTVTIKSSIDSEPALVLGPLKSVQELRREQQLAEIEARRQEREKNGNEEGEERMTKPPVQEMVDELQGPFSYDFSYWARSGEKITVTPSSKELLFYPPSMEAVVSGESCPGKLIEIHGKAGLFLEGQIHPELEGVEIVISEKGASSPLITVFTDDKGAYSVGPLHSDLEYTVTSQKEGYVLTAVEGTIGDFKAYALAGVSFEIKAEDDQPLPGVLLSLSGGLFRSNLLTQDNGILTFSNLSPGQYYFKPMMKEFRFEPSSQMIEVQEGQNLKITITGYRTAYSCYGTVSSLNGEPEQGVAMEAVGQNDCSIYGEDTVTDEEGKFRLRGLLPGCVYHVQLKAEGNDHIERALPHHRVIEVGNNDIDDVNIIVFRQINQFDLSGNVITSSEYLPTLWVKLYKSENLDNPIQTVSLGQSLFFHFPPLLRDGENYVVLLDSTLPRSQYDYILPQVSFTAVGYHKHITLIFNPTRKLPEQDIAQGSYIALPLTLLVLLAGYNHDKLIPLLLQLTSRLQGVRALGQAASDNSGPEDAKRQAKKQKTRRT,1222,"134,324",Chain (1); Glycosylation (3); Modified residue (1); Natural variant (9); Sequence conflict (9); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9UHC9,NPC1-like intracellular cholesterol transporter 1 (Niemann-Pick C1-like protein 1),MAEAGLRGWLLWALLLRLAQSEPYTTIHQPGYCAFYDECGKNPELSGSLMTLSNVSCLSNTPARKITGDHLILLQKICPRLYTGPNTQACCSAKQLVSLEASLSITKALLTRCPACSDNFVNLHCHNTCSPNQSLFINVTRVAQLGAGQLPAVVAYEAFYQHSFAEQSYDSCSRVRVPAAATLAVGTMCGVYGSALCNAQRWLNFQGDTGNGLAPLDITFHLLEPGQAVGSGIQPLNEGVARCNESQGDDVATCSCQDCAASCPAIARPQALDSTFYLGQMPGSLVLIIILCSVFAVVTILLVGFRVAPARDKSKMVDPKKGTSLSDKLSFSTHTLLGQFFQGWGTWVASWPLTILVLSVIPVVALAAGLVFTELTTDPVELWSAPNSQARSEKAFHDQHFGPFFRTNQVILTAPNRSSYRYDSLLLGPKNFSGILDLDLLLELLELQERLRHLQVWSPEAQRNISLQDICYAPLNPDNTSLYDCCINSLLQYFQNNRTLLLLTANQTLMGQTSQVDWKDHFLYCANAPLTFKDGTALALSCMADYGAPVFPFLAIGGYKGKDYSEAEALIMTFSLNNYPAGDPRLAQAKLWEEAFLEEMRAFQRRMAGMFQVTFMAERSLEDEINRTTAEDLPIFATSYIVIFLYISLALGSYSSWSRVMVDSKATLGLGGVAVVLGAVMAAMGFFSYLGIRSSLVILQVVPFLVLSVGADNIFIFVLEYQRLPRRPGEPREVHIGRALGRVAPSMLLCSLSEAICFFLGALTPMPAVRTFALTSGLAVILDFLLQMSAFVALLSLDSKRQEASRLDVCCCVKPQELPPPGQGEGLLLGFFQKAYAPFLLHWITRGVVLLLFLALFGVSLYSMCHISVGLDQELALPKDSYLLDYFLFLNRYFEVGAPVYFVTTLGYNFSSEAGMNAICSSAGCNNFSFTQKIQYATEFPEQSYLAIPASSWVDDFIDWLTPSSCCRLYISGPNKDKFCPSTVNSLNCLKNCMSITMGSVRPSVEQFHKYLPWFLNDRPNIKCPKGGLAAYSTSVNLTSDGQVLDTVAILSPRLEYSGTISAHCNLYLLDSTSRFMAYHKPLKNSQDYTEALRAARELAANITADLRKVPGTDPAFEVFPYTITNVFYEQYLTILPEGLFMLSLCLVPTFAVSCLLLGLDLRSGLLNLLSIVMILVDTVGFMALWGISYNAVSLINLVSAVGMSVEFVSHITRSFAISTKPTWLERAKEATISMGSAVFAGVAMTNLPGILVLGLAKAQLIQIFFFRLNLLITLLGLLHGLVFLPVILSYVGPDVNPALALEQKRAEEAVAAVMVASCPNHPSRVSTADNIYVNHSFEGSIKGAGAISNFLPNNGRQF,1359,"148,728",Alternative sequence (4); Beta strand (10); Chain (1); Compositional bias (1); Disulfide bond (14); Domain (1); Glycosylation (11); Helix (10); Mutagenesis (3); Natural variant (14); Sequence conflict (2); Signal peptide (1); Topological domain (14); Transmembrane (13); Turn (4),"DISULFID 33..90;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 39..57;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 78..125;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 91..129;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 113..254;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 116..172;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 189..197;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 243..259;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 256..263;  /evidence=""ECO:0000269|PubMed:21525977""; DISULFID 471..485;  /evidence=""ECO:0000250|UniProtKB:O15118""; DISULFID 525..542;  /evidence=""ECO:0000250|UniProtKB:O15118""; DISULFID 920..925;  /evidence=""ECO:0000250|UniProtKB:O15118""; DISULFID 966..1024;  /evidence=""ECO:0000250|UniProtKB:O15118""; DISULFID 980..989;  /evidence=""ECO:0000250|UniProtKB:O15118""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
O94856,Neurofascin,MARQPPPPWVHAAFLLCLLSLGGAIEIPMDPSIQNELTQPPTITKQSAKDHIVDPRDNILIECEAKGNPAPSFHWTRNSRFFNIAKDPRVSMRRRSGTLVIDFRSGGRPEEYEGEYQCFARNKFGTALSNRIRLQVSKSPLWPKENLDPVVVQEGAPLTLQCNPPPGLPSPVIFWMSSSMEPITQDKRVSQGHNGDLYFSNVMLQDMQTDYSCNARFHFTHTIQQKNPFTLKVLTTRGVAERTPSFMYPQGTASSQMVLRGMDLLLECIASGVPTPDIAWYKKGGDLPSDKAKFENFNKALRITNVSEEDSGEYFCLASNKMGSIRHTISVRVKAAPYWLDEPKNLILAPGEDGRLVCRANGNPKPTVQWMVNGEPLQSAPPNPNREVAGDTIIFRDTQISSRAVYQCNTSNEHGYLLANAFVSVLDVPPRMLSPRNQLIRVILYNRTRLDCPFFGSPIPTLRWFKNGQGSNLDGGNYHVYENGSLEIKMIRKEDQGIYTCVATNILGKAENQVRLEVKDPTRIYRMPEDQVARRGTTVQLECRVKHDPSLKLTVSWLKDDEPLYIGNRMKKEDDSLTIFGVAERDQGSYTCVASTELDQDLAKAYLTVLADQATPTNRLAALPKGRPDRPRDLELTDLAERSVRLTWIPGDANNSPITDYVVQFEEDQFQPGVWHDHSKYPGSVNSAVLRLSPYVNYQFRVIAINEVGSSHPSLPSERYRTSGAPPESNPGDVKGEGTRKNNMEITWTPMNATSAFGPNLRYIVKWRRRETREAWNNVTVWGSRYVVGQTPVYVPYEIRVQAENDFGKGPEPESVIGYSGEDYPRAAPTEVKVRVMNSTAISLQWNRVYSDTVQGQLREYRAYYWRESSLLKNLWVSQKRQQASFPGDRLRGVVSRLFPYSNYKLEMVVVNGRGDGPRSETKEFTTPEGVPSAPRRFRVRQPNLETINLEWDHPEHPNGIMIGYTLKYVAFNGTKVGKQIVENFSPNQTKFTVQRTDPVSRYRFTLSARTQVGSGEAVTEESPAPPNEATPTAAPPTLPPTTVGATGAVSSTDATAIAATTEATTVPIIPTVAPTTIATTTTVATTTTTTAAATTTTESPPTTTSGTKIHESAPDEQSIWNVTVLPNSKWANITWKHNFGPGTDFVVEYIDSNHTKKTVPVKAQAQPIQLTDLYPGMTYTLRVYSRDNEGISSTVITFMTSTAYTNNQADIATQGWFIGLMCAIALLVLILLIVCFIKRSRGGKYPVREKKDVPLGPEDPKEEDGSFDYSDEDNKPLQGSQTSLDGTIKQQESDDSLVDYGEGGEGQFNEDGSFIGQYTVKKDKEETEGNESSEATSPVNAIYSLA,1347,"150,027",Alternative sequence (14); Beta strand (33); Chain (1); Compositional bias (1); Disulfide bond (6); Domain (11); Erroneous initiation (3); Glycosylation (8); Helix (6); Modified residue (9); Natural variant (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 63..118;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21047790""; DISULFID 162..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21047790""; DISULFID 268..316;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21047790""; DISULFID 358..408;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21047790""; DISULFID 452..501;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 543..592;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P08069,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],MKSGSGGGSPTSLWGLLFLSAALSLWPTSGEICGPGIDIRNDYQQLKRLENCTVIEGYLHILLISKAEDYRSYRFPKLTVITEYLLLFRVAGLESLGDLFPNLTVIRGWKLFYNYALVIFEMTNLKDIGLYNLRNITRGAIRIEKNADLCYLSTVDWSLILDAVSNNYIVGNKPPKECGDLCPGTMEEKPMCEKTTINNEYNYRCWTTNRCQKMCPSTCGKRACTENNECCHPECLGSCSAPDNDTACVACRHYYYAGVCVPACPPNTYRFEGWRCVDRDFCANILSAESSDSEGFVIHDGECMQECPSGFIRNGSQSMYCIPCEGPCPKVCEEEKKTKTIDSVTSAQMLQGCTIFKGNLLINIRRGNNIASELENFMGLIEVVTGYVKIRHSHALVSLSFLKNLRLILGEEQLEGNYSFYVLDNQNLQQLWDWDHRNLTIKAGKMYFAFNPKLCVSEIYRMEEVTGTKGRQSKGDINTRNNGERASCESDVLHFTSTTTSKNRIIITWHRYRPPDYRDLISFTVYYKEAPFKNVTEYDGQDACGSNSWNMVDVDLPPNKDVEPGILLHGLKPWTQYAVYVKAVTLTMVENDHIRGAKSEILYIRTNASVPSIPLDVLSASNSSSQLIVKWNPPSLPNGNLSYYIVRWQRQPQDGYLYRHNYCSKDKIPIRKYADGTIDIEEVTENPKTEVCGGEKGPCCACPKTEAEKQAEKEEAEYRKVFENFLHNSIFVPRPERKRRDVMQVANTTMSSRSRNTTAADTYNITDPEELETEYPFFESRVDNKERTVISNLRPFTLYRIDIHSCNHEAEKLGCSASNFVFARTMPAEGADDIPGPVTWEPRPENSIFLKWPEPENPNGLILMYEIKYGSQVEDQRECVSRQEYRKYGGAKLNRLNPGNYTARIQATSLSGNGSWTDPVFFYVQAKTGYENFIHLIIALPVAVLLIVGGLVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEELDLEPENMESVPLDPSASSSSLPLPDRHSGHKAENGPGPGVLVLRASFDERQPYAHMNGGRKNERALPLPQSSTC,1367,"154,793",Active site (1); Beta strand (73); Binding site (1); Chain (2); Cross-link (2); Disulfide bond (15); Domain (5); Erroneous initiation (1); Glycosylation (16); Helix (34); Modified residue (6); Motif (1); Mutagenesis (5); Natural variant (18); Nucleotide binding (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (15),"DISULFID 33..52;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 150..178;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 182..205;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 192..211;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 215..224;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 219..230;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 231..239;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 235..248;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 251..260;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 264..276;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 282..303;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 307..321;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 324..328;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 332..353;  /evidence=""ECO:0000269|PubMed:9690478""; DISULFID 455..488;  /evidence=""ECO:0000269|PubMed:9690478""","SIGNAL 1..30;  /evidence=""ECO:0000269|PubMed:2877871, ECO:0000269|PubMed:8257688"""
Q9BZV3,Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan),MIMFPLFGKISLGILIFVLIEGDFPSLTAQTYLSIEEIQEPKSAVSFLLPEESTDLSLATKKKQPLDRRETERQWLIRRRRSILFPNGVKICPDESVAEAVANHVKYFKVRVCQEAVWEAFRTFWDRLPGREEYHYWMNLCEDGVTSIFEMGTNFSESVEHRSLIMKKLTYAKETVSSSELSSPVPVGDTSTLGDTTLSVPHPEVDAYEGASESSLERPEESISNEIENVIEEATKPAGEQIAEFSIHLLGKQYREELQDSSSFHHQHLEEEFISEVENAFTGLPGYKEIRVLEFRSPKENDSGVDVYYAVTFNGEAISNTTWDLISLHSNKVENHGLVELDDKPTVVYTISNFRDYIAETLQQNFLLGNSSLNPDPDSLQLINVRGVLRHQTEDLVWNTQSSSLQATPSSILDNTFQAAWPSADESITSSIPPLDFSSGPPSATGRELWSESPLGDLVSTHKLAFPSKMGLSSSPEVLEVSSLTLHSVTPAVLQTGLPVASEERTSGSHLVEDGLANVEESEDFLSIDSLPSSSFTQPVPKETIPSMEDSDVSLTSSPYLTSSIPFGLDSLTSKVKDQLKVSPFLPDASMEKELIFDGGLGSGSGQKVDLITWPWSETSSEKSAEPLSKPWLEDDDSLLPAEIEDKKLVLVDKMDSTDQISKHSKYEHDDRSTHFPEEEPLSGPAVPIFADTAAESASLTLPKHISEVPGVDDYSVTKAPLILTSVAISASTDKSDQADAILREDMEQITESSNYEWFDSEVSMVKPDMQTLWTILPESERVWTRTSSLEKLSRDILASTPQSADRLWLSVTQSTKLPPTTISTLLEDEVIMGVQDISLELDRIGTDYYQPEQVQEQNGKVGSYVEMSTSVHSTEMVSVAWPTEGGDDLSYTQTSGALVVFFSLRVTNMMFSEDLFNKNSLEYKALEQRFLELLVPYLQSNLTGFQNLEILNFRNGSIVVNSRMKFANSVPPNVNNAVYMILEDFCTTAYNTMNLAIDKYSLDVESGDEANPCKFQACNEFSECLVNPWSGEAKCRCFPGYLSVEERPCQSLCDLQPDFCLNDGKCDIMPGHGAICRCRVGENWWYRGKHCEEFVSEPVIIGITIASVVGLLVIFSAIIYFFIRTLQAHHDRSERESPFSGSSRQPDSLSSIENAVKYNPVYESHRAGCEKYEGPYPQHPFYSSASGDVIGGLSREEIRQMYESSELSREEIQERMRVLELYANDPEFAAFVREQQVEEV,1241,"138,621",Chain (1); Disulfide bond (6); Domain (4); Glycosylation (10); Natural variant (21); Region (5); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 1014..1025;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1019..1036;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1038..1050;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1054..1067;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1061..1077;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 1079..1092;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P23229,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],MAAAGQLCLLYLSAGLLSRLGAAFNLDTREDNVIRKYGDPGSLFGFSLAMHWQLQPEDKRLLLVGAPRAEALPLQRANRTGGLYSCDITARGPCTRIEFDNDADPTSESKEDQWMGVTVQSQGPGGKVVTCAHRYEKRQHVNTKQESRDIFGRCYVLSQNLRIEDDMDGGDWSFCDGRLRGHEKFGSCQQGVAATFTKDFHYIVFGAPGTYNWKGIVRVEQKNNTFFDMNIFEDGPYEVGGETEHDESLVPVPANSYLGLLFLTSVSYTDPDQFVYKTRPPREQPDTFPDVMMNSYLGFSLDSGKGIVSKDEITFVSGAPRANHSGAVVLLKRDMKSAHLLPEHIFDGEGLASSFGYDVAVVDLNKDGWQDIVIGAPQYFDRDGEVGGAVYVYMNQQGRWNNVKPIRLNGTKDSMFGIAVKNIGDINQDGYPDIAVGAPYDDLGKVFIYHGSANGINTKPTQVLKGISPYFGYSIAGNMDLDRNSYPDVAVGSLSDSVTIFRSRPVINIQKTITVTPNRIDLRQKTACGAPSGICLQVKSCFEYTANPAGYNPSISIVGTLEAEKERRKSGLSSRVQFRNQGSEPKYTQELTLKRQKQKVCMEETLWLQDNIRDKLRPIPITASVEIQEPSSRRRVNSLPEVLPILNSDEPKTAHIDVHFLKEGCGDDNVCNSNLKLEYKFCTREGNQDKFSYLPIQKGVPELVLKDQKDIALEITVTNSPSNPRNPTKDGDDAHEAKLIATFPDTLTYSAYRELRAFPEKQLSCVANQNGSQADCELGNPFKRNSNVTFYLVLSTTEVTFDTPDLDINLKLETTSNQDNLAPITAKAKVVIELLLSVSGVAKPSQVYFGGTVVGEQAMKSEDEVGSLIEYEFRVINLGKPLTNLGTATLNIQWPKEISNGKWLLYLVKVESKGLEKVTCEPQKEINSLNLTESHNSRKKREITEKQIDDNRKFSLFAERKYQTLNCSVNVNCVNIRCPLRGLDSKASLILRSRLWNSTFLEEYSKLNYLDILMRAFIDVTAAAENIRLPNAGTQVRVTVFPSKTVAQYSGVPWWIILVAILAGILMLALLVFILWKCGFFKRSRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKKQWITKWNENESYS,1130,"126,606",Alternative sequence (5); Calcium binding (3); Chain (4); Disulfide bond (9); Erroneous initiation (1); Glycosylation (9); Lipidation (1); Modified residue (3); Motif (1); Region (1); Repeat (7); Sequence conflict (9); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 86..94;  /evidence=""ECO:0000250""; DISULFID 131..154;  /evidence=""ECO:0000250""; DISULFID 175..188;  /evidence=""ECO:0000250""; DISULFID 528..535;  /evidence=""ECO:0000250""; DISULFID 541..601;  /evidence=""ECO:0000250""; DISULFID 665..671;  /evidence=""ECO:0000250""; DISULFID 765..776;  /evidence=""ECO:0000250""; DISULFID 920..967;  /note=""Interchain (between heavy and light chains)"";  /evidence=""ECO:0000250""; DISULFID 973..978;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:1953640, ECO:0000269|PubMed:2542022, ECO:0000269|PubMed:2649503"""
Q6UX15,Layilin,MRPGTALQAVLLAVLLVGLRAATGRLLSASDLDLRGGQPVCRGGTQRPCYKVIYFHDTSRRLNFEEAKEACRRDGGQLVSIESEDEQKLIEKFIENLLPSDGDFWIGLRRREEKQSNSTACQDLYAWTDGSISQFRNWYVDEPSCGSEVCVVMYHQPSAPAGIGGPYMFQWNDDRCNMKNNFICKYSDEKPAVPSREAEGEETELTTPVLPEETQEEDAKKTFKESREAALNLAYILIPSIPLLLLLVVTTVVCWVWICRKRKREQPDPSTKKQHTIWPSPHQGNSPDLEVYNVIRKQSEADLAETRPDLKNISFRVCSGEATPDDMSCDYDNMAVNPSESGFVTLVSVESGFVTNDIYEFSPDQMGRSKESGWVENEIYGY,382,"43,108",Alternative sequence (3); Chain (1); Disulfide bond (2); Domain (1); Glycosylation (1); Modified residue (2); Natural variant (1); Region (4); Repeat (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 71..184;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""; DISULFID 150..176;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00040""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9HAT1,Protein ERGIC-53-like (ERGIC53-like protein) (Lectin mannose-binding 1-like) (LMAN1-like protein),MPAVSGPGPLFCLLLLLLDPHSPETGCPPLRRFEYKLSFKGPRLALPGAGIPFWSHHGDAILGLEEVRLTPSMRNRSGAVWSRASVPFSAWEVEVQMRVTGLGRRGAQGMAVWYTRGRGHVGSVLGGLASWDGIGIFFDSPAEDTQDSPAIRVLASDGHIPSEQPGDGASQGLGSCHWDFRNRPHPFRARITYWGQRLRMSLNSGLTPSDPGEFCVDVGPLLLVPGGFFGVSAATGTLADDHDVLSFLTFSLSEPSPEVPPQPFLEMQQLRLARQLEGLWARLGLGTREDVTPKSDSEAQGEGERLFDLEETLGRHRRILQALRGLSKQLAQAERQWKKQLGPPGQARPDGGWALDASCQIPSTPGRGGHLSMSLNKDSAKVGALLHGQWTLLQALQEMRDAAVRMAAEAQVSYLPVGIEHHFLELDHILGLLQEELRGPAKAAAKAPRPPGQPPRASSCLQPGIFLFYLLIQTVGFFGYVHFRQELNKSLQECLSTGSLPLGPAPHTPRALGILRRQPLPASMPA,526,"57,129",Alternative sequence (1); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 176..215;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00658""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P20916,Myelin-associated glycoprotein (Siglec-4a),MIFLTALPLFWIMISASRGGHWGAWMPSSISAFEGTCVSIPCRFDFPDELRPAVVHGVWYFNSPYPKNYPPVVFKSRTQVVHESFQGRSRLLGDLGLRNCTLLLSNVSPELGGKYYFRGDLGGYNQYTFSEHSVLDIVNTPNIVVPPEVVAGTEVEVSCMVPDNCPELRPELSWLGHEGLGEPAVLGRLREDEGTWVQVSLLHFVPTREANGHRLGCQASFPNTTLQFEGYASMDVKYPPVIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGTVLREAVAESLLLELEEVTPAEDGVYACLAENAYGQDNRTVGLSVMYAPWKPTVNGTMVAVEGETVSILCSTQSNPDPILTIFKEKQILSTVIYESELQLELPAVSPEDDGEYWCVAENQYGQRATAFNLSVEFAPVLLLESHCAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNESEREFVYSERSGLVLTSILTLRGQAQAPPRVICTARNLYGAKSLELPFQGAHRLMWAKIGPVGAVVAFAILIAIVCYITQTRRKKNVTESPSFSAGDNPPVLFSSDFRISGAPEKYESERRLGSERRLLGLRGEPPELDLSYSHSDLGKRPTKDSYTLTEELAEYAEIRVK,626,"69,069",Alternative sequence (2); Binding site (1); Chain (1); Disulfide bond (7); Domain (5); Glycosylation (8); Lipidation (1); Modified residue (3); Natural variant (4); Region (4); Sequence conflict (1); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 37..165;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 42..100;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 159..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 261..305;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 347..392;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 421..430;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 432..488;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""",SIGNAL 1..19
P11717,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),MGAAAGRSPHLGPAPARRPQRSLLLLQLLLLVAAPGSTQAQAAPFPELCSYTWEAVDTKNNVLYKINICGSVDIVQCGPSSAVCMHDLKTRTYHSVGDSVLRSATRSLLEFNTTVSCDQQGTNHRVQSSIAFLCGKTLGTPEFVTATECVHYFEWRTTAACKKDIFKANKEVPCYVFDEELRKHDLNPLIKLSGAYLVDDSDPDTSLFINVCRDIDTLRDPGSQLRACPPGTAACLVRGHQAFDVGQPRDGLKLVRKDRLVLSYVREEAGKLDFCDGHSPAVTITFVCPSERREGTIPKLTAKSNCRYEIEWITEYACHRDYLESKTCSLSGEQQDVSIDLTPLAQSGGSSYISDGKEYLFYLNVCGETEIQFCNKKQAAVCQVKKSDTSQVKAAGRYHNQTLRYSDGDLTLIYFGGDECSSGFQRMSVINFECNKTAGNDGKGTPVFTGEVDCTYFFTWDTEYACVKEKEDLLCGATDGKKRYDLSALVRHAEPEQNWEAVDGSQTETEKKHFFINICHRVLQEGKARGCPEDAAVCAVDKNGSKNLGKFISSPMKEKGNIQLSYSDGDDCGHGKKIKTNITLVCKPGDLESAPVLRTSGEGGCFYEFEWHTAAACVLSKTEGENCTVFDSQAGFSFDLSPLTKKNGAYKVETKKYDFYINVCGPVSVSPCQPDSGACQVAKSDEKTWNLGLSNAKLSYYDGMIQLNYRGGTPYNNERHTPRATLITFLCDRDAGVGFPEYQEEDNSTYNFRWYTSYACPEEPLECVVTDPSTLEQYDLSSLAKSEGGLGGNWYAMDNSGEHVTWRKYYINVCRPLNPVPGCNRYASACQMKYEKDQGSFTEVVSISNLGMAKTGPVVEDSGSLLLEYVNGSACTTSDGRQTTYTTRIHLVCSRGRLNSHPIFSLNWECVVSFLWNTEAACPIQTTTDTDQACSIRDPNSGFVFNLNPLNSSQGYNVSGIGKIFMFNVCGTMPVCGTILGKPASGCEAETQTEELKNWKPARPVGIEKSLQLSTEGFITLTYKGPLSAKGTADAFIVRFVCNDDVYSGPLKFLHQDIDSGQGIRNTYFEFETALACVPSPVDCQVTDLAGNEYDLTGLSTVRKPWTAVDTSVDGRKRTFYLSVCNPLPYIPGCQGSAVGSCLVSEGNSWNLGVVQMSPQAAANGSLSIMYVNGDKCGNQRFSTRITFECAQISGSPAFQLQDGCEYVFIWRTVEACPVVRVEGDNCEVKDPRHGNLYDLKPLGLNDTIVSAGEYTYYFRVCGKLSSDVCPTSDKSKVVSSCQEKREPQGFHKVAGLLTQKLTYENGLLKMNFTGGDTCHKVYQRSTAIFFYCDRGTQRPVFLKETSDCSYLFEWRTQYACPPFDLTECSFKDGAGNSFDLSSLSRYSDNWEAITGTGDPEHYLINVCKSLAPQAGTEPCPPEAAACLLGGSKPVNLGRVRDGPQWRDGIIVLKYVDGDLCPDGIRKKSTTIRFTCSESQVNSRPMFISAVEDCEYTFAWPTATACPMKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYSEKGLVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEARPTNRPMLISLDKQTCTLFFSWHTPLACEQATECSVRNGSSIVDLSPLIHRTGGYEAYDESEDDASDTNPDFYINICQPLNPMHGVPCPAGAAVCKVPIDGPPIDIGRVAGPPILNPIANEIYLNFESSTPCLADKHFNYTSLIAFHCKRGVSMGTPKLLRTSECDFVFEWETPVVCPDEVRMDGCTLTDEQLLYSFNLSSLSTSTFKVTRDSRTYSVGVCTFAVGPEQGGCKDGGVCLLSGTKGASFGRLQSMKLDYRHQDEAVVLSYVNGDRCPPETDDGVPCVFPFIFNGKSYEECIIESRAKLWCSTTADYDRDHEWGFCRHSNSYRTSSIIFKCDEDEDIGRPQVFSEVRGCDVTFEWKTKVVCPPKKLECKFVQKHKTYDLRLLSSLTGSWSLVHNGVSYYINLCQKIYKGPLGCSERASICRRTTTGDVQVLGLVHTQKLGVIGDKVVVTYSKGYPCGGNKTASSVIELTCTKTVGRPAFKRFDIDSCTYYFSWDSRAACAVKPQEVQMVNGTITNPINGKSFSLGDIYFKLFRASGDMRTNGDNYLYEIQLSSITSSRNPACSGANICQVKPNDQHFSRKVGTSDKTKYYLQDGDLDVVFASSSKCGKDKTKSVSSTIFFHCDPLVEDGIPEFSHETADCQYLFSWYTSAVCPLGVGFDSENPGDDGQMHKGLSERSQAVGAVLSLLLVALTCCLLALLLYKKERRETVISKLTTCCRRSSNVSYKYSKVNKEEETDENETEWLMEEIQLPPPRQGKEGQENGHITTKSVKALSSLHGDDQDSEDEVLTIPEVKVHSGRGAGAESSHPVRNAQSNALQEREDDRVGLVRGEKARKGKSSSAQQKTVSSTKLVSFHDDSDEDLLHI,2491,"274,375",Beta strand (115); Chain (1); Disulfide bond (59); Domain (15); Glycosylation (18); Helix (21); Modified residue (5); Natural variant (25); Sequence conflict (17); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (19),"DISULFID 49..69;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 77..84;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 117..149;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 134..161;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 174..212;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 228..235;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 275..306;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 288..318;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 328..366;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 374..382;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 420..454;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 434..466;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 475..519;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 531..538;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 572..605;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 586..617;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 627..664;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 672..679;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 731..760;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 767..814;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 823..830;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 875..910;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 893..922;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 934..970;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 976..987;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1042..1077;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1084..1125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1134..1142;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1177..1205;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1190..1217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1227..1262;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1270..1282;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1319..1349;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1333..1361;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1369..1408;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1420..1427;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1461..1494;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1476..1506;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 1516..1553;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1559..1566;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1598..1634;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1614..1646;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1652..1695;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1706..1713;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1750..1783;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1766..1795;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1804..1839;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1850..1856;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1893..1975;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1903..1927;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479, ECO:0000269|PubMed:18046459""; DISULFID 1917..1942;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479, ECO:0000269|PubMed:18046459""; DISULFID 1957..1987;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 1994..2029;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 2039..2046;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 2082..2113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 2096..2125;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262, ECO:0000269|PubMed:18046459""; DISULFID 2188..2194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 2232..2266;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""; DISULFID 2248..2278;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU01262""","SIGNAL 1..40;  /evidence=""ECO:0000269|PubMed:2957598"""
Q6UWV2,Myelin protein zero-like protein 3,MQQRGAAGSRGCALFPLLGVLFFQGVYIVFSLEIRADAHVRGYVGEKIKLKCTFKSTSDVTDKLTIDWTYRPPSSSHTVSIFHYQSFQYPTTAGTFRDRISWVGNVYKGDASISISNPTIKDNGTFSCAVKNPPDVHHNIPMTELTVTERGFGTMLSSVALLSILVFVPSAVVVALLLVRMGRKAAGLKKRSRSGYKKSSIEVSDDTDQEEEEACMARLCVRCAECLDSDYEETY,235,"25,989",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 52..128;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..31;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8N2Q7,Neuroligin-1,MALPRCTWPNYVWRAVMACLVHRGLGAPLTLCMLGCLLQAGHVLSQKLDDVDPLVATNFGKIRGIKKELNNEILGPVIQFLGVPYAAPPTGERRFQPPEPPSPWSDIRNATQFAPVCPQNIIDGRLPEVMLPVWFTNNLDVVSSYVQDQSEDCLYLNIYVPTEDVKRISKECARKPGKKICRKGGPLTKKQTDDLGDNDGAEDEDIRDSGGPKPVMVYIHGGSYMEGTGNLYDGSVLASYGNVIVITVNYRLGVLGFLSTGDQAAKGNYGLLDLIQALRWTSENIGFFGGDPLRITVFGSGAGGSCVNLLTLSHYSEGNRWSNSTKGLFQRAIAQSGTALSSWAVSFQPAKYARMLATKVGCNVSDTVELVECLQKKPYKELVDQDIQPARYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVENIVDSDDGISASDFDFAVSNFVDNLYGYPEGKDVLRETIKFMYTDWADRHNPETRRKTLLALFTDHQWVAPAVATADLHSNFGSPTYFYAFYHHCQTDQVPAWADAAHGDEVPYVLGIPMIGPTELFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWTRYSQKDQLYLHIGLKPRVKEHYRANKVNLWLELVPHLHNLNDISQYTSTTTKVPSTDITFRPTRKNSVPVTSAFPTAKQDDPKQQPSPFSVDQRDYSTELSVTIAVGASLLFLNILAFAALYYKKDKRRHDVHRRCSPQRTTTNDLTHAQEEEIMSLQMKHTDLDHECESIHPHEVVLRTACPPDYTLAMRRSPDDVPLMTPNTITMIPNTIPGIQPLHTFNTFTGGQNNTLPHPHPHPHSHSTTRV,863,"96,368",Alternative sequence (1); Beta strand (26); Chain (1); Disulfide bond (3); Erroneous initiation (2); Glycosylation (6); Helix (25); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 117..153;  /evidence=""ECO:0000250""; DISULFID 362..373;  /evidence=""ECO:0000250""; DISULFID 532..566;  /evidence=""ECO:0000250""","SIGNAL 1..45;  /evidence=""ECO:0000255"""
P61570,Endogenous retrovirus group K member 25 Env polyprotein (Envelope polyprotein) (HERV-K_11q22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],MNPSEMQRKAPPRRRRHRNRAPLTHKMNKMVTSEEQMKLPSTKKAEPPTWAQLKKLTQLATKYLENTKVTQTPESMLLAALMIVSMVVSLPMPAGAAAANYTYWAYVPFPPLIRAVTWMDNPIEVYVNDSVWVPGPIDDRCPAKPEEEGMMINISIGYRYPPICLGTAPGCLMPAVQNWLVEVPIVSPISRFTYHMVSGMSLRPRVNYLQDFSYQRSLKFRPKGKPCPKEIPKESKNTEVLVWEECVANSAVILQNNEFGTIIDWAPRGQFYHNCSGQTQSCPSAQVSPAVDSDLTESLDKHKHKKLQSFYPWEWGEKGISTPRPKIVSPVSGPEHPELWRLTVASHHIRIWSGNQTLETRDRKPFYTVDLNSSLTVPLQSCVKPPYMLVVGNIVIKPDSQTITCENCRLLTCIDSTFNWQHRILLVRAREGVWIPVSMDRPWEASPSIHILTEVLKGVLNRSKRFIFTLIAVIMGLIAVTATGAVAGVALHSSVQSVNFVNDWQKNSTRLWNSQSSIDQKLANQINDLRQTVIWMGDRLMSLEHRFQLQCDWNTSDFCITPQIYNESEHHWDMVRRHLQGREDNLTLDISKLKEQIFKASKAHLNLVPGTEAIAGVADGLANLNPVTWVKTIGSTTIINLILILVCLFCLLLVCRCTQQL,661,"74,892",Chain (3); Compositional bias (2); Glycosylation (11); Region (1); Signal peptide (1); Site (1); Transmembrane (1),,"SIGNAL 1..89;  /evidence=""ECO:0000255"""
Q13467,Frizzled-5 (Fz-5) (hFz5) (FzE5),MARPDPSAPPSLLLLLLAQLVGRAAAASKAPVCQEITVPMCRGIGYNLTHMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLRFFLCSMYTPICLPDYHKPLPPCRSVCERAKAGCSPLMRQYGFAWPERMSCDRLPVLGRDAEVLCMDYNRSEATTAPPRPFPAKPTLPGPPGAPASGGECPAGGPFVCKCREPFVPILKESHPLYNKVRTGQVPNCAVPCYQPSFSADERTFATFWIGLWSVLCFISTSTTVATFLIDMERFRYPERPIIFLSACYLCVSLGFLVRLVVGHASVACSREHNHIHYETTGPALCTIVFLLVYFFGMASSIWWVILSLTWFLAAGMKWGNEAIAGYAQYFHLAAWLIPSVKSITALALSSVDGDPVAGICYVGNQNLNSLRGFVLGPLVLYLLVGTLFLLAGFVSLFRIRSVIKQGGTKTDKLEKLMIRIGIFTLLYTVPASIVVACYLYEQHYRESWEAALTCACPGHDTGQPRAKPEYWVLMLKYFMCLVVGITSGVWIWSGKTVESWRRFTSRCCCRPRRGHKSGGAMAAGDYPEASAALTGRTGPPGPAATYHKQVSLSHV,585,"64,507",Beta strand (1); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (2); Helix (8); Motif (2); Natural variant (1); Sequence conflict (7); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 33..94;  /evidence=""ECO:0000244|PDB:5URY, ECO:0000244|PDB:5URZ, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:28377511""; DISULFID 41..87;  /evidence=""ECO:0000244|PDB:5URY, ECO:0000244|PDB:5URZ, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:28377511""; DISULFID 78..116;  /evidence=""ECO:0000244|PDB:5URY, ECO:0000244|PDB:5URZ, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:28377511""; DISULFID 105..147;  /evidence=""ECO:0000244|PDB:5URY, ECO:0000244|PDB:5URZ, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:28377511""; DISULFID 109..133;  /evidence=""ECO:0000244|PDB:5URY, ECO:0000244|PDB:5URZ, ECO:0000255|PROSITE-ProRule:PRU00090, ECO:0000269|PubMed:28377511""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9UBK5,Hematopoietic cell signal transducer (DNAX-activation protein 10) (Membrane protein DAP10) (Transmembrane adapter protein KAP10),MIHLGHILFLLLLPVAAAQTTPGERSSLPAFYPGTSGSCSGCGSLSLPLLAGLVAADAVASLLIVGAVFLCARPRRSPAQEDGKVYINMPGRG,93,"9,489",Alternative sequence (1); Chain (1); Modified residue (1); Mutagenesis (3); Region (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q08334,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b),MAWSLGSWLGGCLLVSALGMVPPPENVRMNSVNFKNILQWESPAFAKGNLTFTAQYLSYRIFQDKCMNTTLTECDFSSLSKYGDHTLRVRAEFADEHSDWVNITFCPVDDTIIGPPGMQVEVLADSLHMRFLAPKIENEYETWTMKNVYNSWTYNVQYWKNGTDEKFQITPQYDFEVLRNLEPWTTYCVQVRGFLPDRNKAGEWSEPVCEQTTHDETVPSWMVAVILMASVFMVCLALLGCFALLWCVYKKTKYAFSPRNSLPQHLKEFLGHPHHNTLLFFSFPLSDENDVFDKLSVIAEDSESGKQNPGDSCSLGTPPGQGPQS,325,"36,995",Beta strand (17); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (4); Helix (3); Natural variant (1); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 66..74;  /evidence=""ECO:0000269|PubMed:20462497""; DISULFID 188..209;  /evidence=""ECO:0000269|PubMed:20462497""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8NFR9,Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE),MGSSRLAALLLPLLLIVIDLSDSAGIGFRHLPHWNTRCPLASHTDDSFTGSSAYIPCRTWWALFSTKPWCVRVWHCSRCLCQHLLSGGSGLQRGLFHLLVQKSKKSSTFKFYRRHKMPAPAQRKLLPRRHLSEKSHHISIPSPDISHKGLRSKRTQPSDPETWESLPRLDSQRHGGPEFSFDLLPEARAIRVTISSGPEVSVRLCHQWALECEELSSPYDVQKIVSGGHTVELPYEFLLPCLCIEASYLQEDTVRRKKCPFQSWPEAYGSDFWKSVHFTDYSQHTQMVMALTLRCPLKLEAALCQRHDWHTLCKDLPNATARESDGWYVLEKVDLHPQLCFKFSFGNSSHVECPHQTGSLTSWNVSMDTQAQQLILHFSSRMHATFSAAWSLPGLGQDTLVPPVYTVSQARGSSPVSLDLIIPFLRPGCCVLVWRSDVQFAWKHLLCPDVSYRHLGLLILALLALLTLLGVVLALTCRRPQSGPGPARPVLLLHAADSEAQRRLVGALAELLRAALGGGRDVIVDLWEGRHVARVGPLPWLWAARTRVAREQGTVLLLWSGADLRPVSGPDPRAAPLLALLHAAPRPLLLLAYFSRLCAKGDIPPPLRALPRYRLLRDLPRLLRALDARPFAEATSWGRLGARQRRQSRLELCSRLEREAARLADLG,667,"74,810",Alternative sequence (7); Chain (1); Domain (1); Frameshift (1); Glycosylation (3); Natural variant (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P08648,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain],MGSRTPESPLHAVQLRWGPRRRPPLLPLLLLLLPPPPRVGGFNLDAEAPAVLSGPPGSFFGFSVEFYRPGTDGVSVLVGAPKANTSQPGVLQGGAVYLCPWGASPTQCTPIEFDSKGSRLLESSLSSSEGEEPVEYKSLQWFGATVRAHGSSILACAPLYSWRTEKEPLSDPVGTCYLSTDNFTRILEYAPCRSDFSWAAGQGYCQGGFSAEFTKTGRVVLGGPGSYFWQGQILSATQEQIAESYYPEYLINLVQGQLQTRQASSIYDDSYLGYSVAVGEFSGDDTEDFVAGVPKGNLTYGYVTILNGSDIRSLYNFSGEQMASYFGYAVAATDVNGDGLDDLLVGAPLLMDRTPDGRPQEVGRVYVYLQHPAGIEPTPTLTLTGHDEFGRFGSSLTPLGDLDQDGYNDVAIGAPFGGETQQGVVFVFPGGPGGLGSKPSQVLQPLWAASHTPDFFGSALRGGRDLDGNGYPDLIVGSFGVDKAVVYRGRPIVSASASLTIFPAMFNPEERSCSLEGNPVACINLSFCLNASGKHVADSIGFTVELQLDWQKQKGGVRRALFLASRQATLTQTLLIQNGAREDCREMKIYLRNESEFRDKLSPIHIALNFSLDPQAPVDSHGLRPALHYQSKSRIEDKAQILLDCGEDNICVPDLQLEVFGEQNHVYLGDKNALNLTFHAQNVGEGGAYEAELRVTAPPEAEYSGLVRHPGNFSSLSCDYFAVNQSRLLVCDLGNPMKAGASLWGGLRFTVPHLRDTKKTIQFDFQILSKNLNNSQSDVVSFRLSVEAQAQVTLNGVSKPEAVLFPVSDWHPRDQPQKEEDLGPAVHHVYELINQGPSSISQGVLELSCPQALEGQQLLYVTRVTGLNCTTNHPINPKGLELDPEGSLHHQQKREAPSRSSASSGPQILKCPEAECFRLRCELGPLHQQESQSLQLHFRVWAKTFLQREHQPFSLQCEAVYKALKMPYRILPRQLPQKERQVATAVQWTKAEGSYGVPLWIIILAILFGLLLLGLLIYILYKLGFFKRSLPYGTAMEKAQLKPPATSDA,1049,"114,536",Beta strand (52); Binding site (2); Calcium binding (4); Chain (3); Disulfide bond (9); Glycosylation (14); Helix (6); Metal binding (20); Modified residue (1); Motif (1); Natural variant (1); Region (1); Repeat (7); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),"DISULFID 99..108; DISULFID 156..176; DISULFID 192..205; DISULFID 513..522; DISULFID 528..584; DISULFID 645..651; DISULFID 718..731; DISULFID 869..921;  /note=""Interchain (between heavy and light chains)""; DISULFID 911..916","SIGNAL 1..41;  /evidence=""ECO:0000269|PubMed:3033641"""
Q14953,Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (MHC class I NK cell receptor) (Natural killer-associated transcript 9) (NKAT-9) (CD antigen CD158g),MSLMVISMACVAFFLLQGAWPHEGFRRKPSLLAHPGPLVKSEETVILQCWSDVMFEHFLLHREGTFNHTLRLIGEHIDGVSKGNFSIGRMTQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRLPAGPKVNRTFQADFPLDPATHGGTYRCFGSFRDSPYEWSKSSDPLLVSVTGNSSNSWPSPTEPSSETGNPRHLHVLIGTSVVKLPFTILLFFLLHRWCSNKKNASVMDQGPAGNRTVNREDSDEQDHQEVSYA,304,"33,698",Chain (1); Disulfide bond (2); Domain (2); Glycosylation (4); Mutagenesis (2); Natural variant (12); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..100;  /evidence=""ECO:0000250|UniProtKB:P43626""; DISULFID 149..198;  /evidence=""ECO:0000250|UniProtKB:P43626""","SIGNAL 1..21;  /evidence=""ECO:0000250"""
Q6UXM1,Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3),MSAPSLRARAAGLGLLLCAVLGRAGRSDSGGRGELGQPSGVAAERPCPTTCRCLGDLLDCSRKRLARLPEPLPSWVARLDLSHNRLSFIKASSMSHLQSLREVKLNNNELETIPNLGPVSANITLLSLAGNRIVEILPEHLKEFQSLETLDLSSNNISELQTAFPALQLKYLYLNSNRVTSMEPGYFDNLANTLLVLKLNRNRISAIPPKMFKLPQLQHLELNRNKIKNVDGLTFQGLGALKSLKMQRNGVTKLMDGAFWGLSNMEILQLDHNNLTEITKGWLYGLLMLQELHLSQNAINRISPDAWEFCQKLSELDLTFNHLSRLDDSSFLGLSLLNTLHIGNNRVSYIADCAFRGLSSLKTLDLKNNEISWTIEDMNGAFSGLDKLRRLILQGNRIRSITKKAFTGLDALEHLDLSDNAIMSLQGNAFSQMKKLQQLHLNTSSLLCDCQLKWLPQWVAENNFQSFVNASCAHPQLLKGRSIFAVSPDGFVCDDFPKPQITVQPETQSAIKGSNLSFICSAASSSDSPMTFAWKKDNELLHDAEMENYAHLRAQGGEVMEYTTILRLREVEFASEGKYQCVISNHFGSSYSVKAKLTVNMLPSFTKTPMDLTIRAGAMARLECAAVGHPAPQIAWQKDGGTDFPAARERRMHVMPEDDVFFIVDVKIEDIGVYSCTAQNSAGSISANATLTVLETPSFLRPLLDRTVTKGETAVLQCIAGGSPPPKLNWTKDDSPLVVTERHFFAAGNQLLIIVDSDVSDAGKYTCEMSNTLGTERGNVRLSVIPTPTCDSPQMTAPSLDDDGWATVGVVIIAVVCCVVGTSLVWVVIIYHTRRRNEDCSITNTDETNLPADIPSYLSSQGTLADRQDGYVSSESGSHHQFVTSSGAGFFLPQHDSSGTCHIDNSSEADVEAATDLFLCPFLGSTGPMYLKGNVYGSDPFETYHTGCSPDPRTVLMDHYEPSYIKKKECYPCSHPSEESCERSFSNISWPSHVRKLLNTSYSHNEGPGMKNLCLNKSSLDFSANPEPASVASSNSFMGTFGKALRRPHLDAYSSFGQPSDCQPRAFYLKAHSSPDLDSGSEEDGKERTDFQEENHICTFKQTLENYRTPNFQSYDLDT,1119,"123,434",Alternative sequence (1); Chain (1); Disulfide bond (3); Domain (5); Erroneous initiation (1); Glycosylation (12); Repeat (15); Signal peptide (1); Transmembrane (1),"DISULFID 520..581;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 624..676;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 718..767;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q8WUT4,Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4) (NLRR-4),MRQTLPLLLLTVLRPSWADPPQEKVPLFRVTQQGPWGSSGSNATDSPCEGLPAADATALTLANRNLERLPGCLPRTLRSLDASHNLLRALSTSELGHLEQLQVLTLRHNRIAALRWGPGGPAGLHTLDLSYNQLAALPPCTGPALSSLRALALAGNPLRALQPRAFACFPALQLLNLSCTALGRGAQGGIAEAAFAGEDGAPLVTLEVLDLSGTFLERVESGWIRDLPKLTSLYLRKMPRLTTLEGDIFKMTPNLQQLDCQDSPALASVATHIFQDTPHLQVLLFQNCNLSSFPPWTLDSSQVLSINLFGNPLTCSCDLSWLLTDAKRTVLSRAADTMCAPAAGSSGPFSASLSLSQLPGVCQSDQSTTLGASHPPCFNRSTYAQGTTVAPSAAPATRPAGDQQSVSKAPNVGSRTIAAWPHSDAREGTAPSTTNSVAGHSNSSVFPRAASTTRTQHRGEHAPELVLEPDISAASTPLASKLLGPFPTSWDRSISSPQPGQRTHATPQAPNPSLSEGEIPVLLLDDYSEEEEGRKEEVGTPHQDVPCDYHPCKHLQTPCAELQRRWRCRCPGLSGEDTIPDPPRLQGVTETTDTSALVHWCAPNSVVHGYQIRYSAEGWAGNQSVVGVIYATARQHPLYGLSPGTTYRVCVLAANRAGLSQPRSSGWRSPCAAFTTKPSFALLLSGLCAASGLLLASTVVLSACLCRRGQTLGLQRCDTHLVAYKNPAFDDYPLGLQTVS,740,"78,843",Chain (1); Compositional bias (1); Domain (1); Glycosylation (6); Natural variant (2); Repeat (10); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8NHJ6,Leukocyte immunoglobulin-like receptor subfamily B member 4 (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3) (ILT-3) (Leukocyte immunoglobulin-like receptor 5) (LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k),MIPTFTALLCLGLSLGPRTHMQAGPLPKPTLWAEPGSVISWGNSVTIWCQGTLEAREYRLDKEESPAPWDRQNPLEPKNKARFSIPSMTEDYAGRYRCYYRSPVGWSQPSDPLELVMTGAYSKPTLSALPSPLVTSGKSVTLLCQSRSPMDTFLLIKERAAHPLLHLRSEHGAQQHQAEFPMSPVTSVHGGTYRCFSSHGFSHYLLSHPSDPLELIVSGSLEDPRPSPTRSVSTAAGPEDQPLMPTGSVPHSGLRRHWEVLIGVLVVSILLLSLLLFLLLQHWRQGKHRTLAQRQADFQRPPGAAEPEPKDGGLQRRSSPAADVQGENFCAAVKNTQPEDGVEMDTRQSPHDEDPQAVTYAKVKHSRPRREMASPPSPLSGEFLDTKDRQAEEDRQMDTEAAASEAPQDVTYAQLHSFTLRQKATEPPPSQEGASPAEPSVYATLAIH,448,"49,356",Alternative sequence (2); Beta strand (15); Chain (1); Disulfide bond (2); Domain (2); Helix (4); Modified residue (1); Motif (3); Natural variant (9); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21454581""; DISULFID 144..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21454581""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P15529,Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46),MEPPGRRECPFPSWRFPGLLLAAMVLLLYSFSDACEEPPTFEAMELIGKPKPYYEIGERVDYKCKKGYFYIPPLATHTICDRNHTWLPVSDDACYRETCPYIRDPLNGQAVPANGTYEFGYQMHFICNEGYYLIGEEILYCELKGSVAIWSGKPPICEKVLCTPPPKIKNGKHTFSEVEVFEYLDAVTYSCDPAPGPDPFSLIGESTIYCGDNSVWSRAAPECKVVKCRFPVVENGKQISGFGKKFYYKATVMFECDKGFYLDGSDTIVCDSNSTWDPPVPKCLKVLPPSSTKPPALSHSVSTSSTTKSPASSASGPRPTYKPPVSNYPGYPKPEEGILDSLDVWVIAVIVIAIVVGVAVICVVPYRYLQRRKKKGTYLTDETHREVKFTSL,392,"43,747",Alternative sequence (11); Beta strand (27); Chain (1); Compositional bias (1); Disulfide bond (8); Domain (4); Glycosylation (21); Helix (2); Modified residue (7); Mutagenesis (3); Natural variant (13); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 35..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 64..94;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 99..141;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 127..157;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 162..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 191..223;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 228..270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""; DISULFID 256..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00302""","SIGNAL 1..34;  /evidence=""ECO:0000269|PubMed:1479546, ECO:0000269|PubMed:2298462, ECO:0000269|PubMed:3260937, ECO:0000269|PubMed:8371352"""
O14524,Nuclear envelope integral membrane protein 1,MAGGMKVAVSPAVGPGPWGSGVGGGGTVRLLLILSGCLVYGTAETDVNVVMLQESQVCEKRASQQFCYTNVLIPKWHDIWTRIQIRVNSSRLVRVTQVENEEKLKELEQFSIWNFFSSFLKEKLNDTYVNVGLYSTKTCLKVEIIEKDTKYSVIVIRRFDPKLFLVFLLGLMLFFCGDLLSRSQIFYYSTGMTVGIVASLLIIIFILSKFMPKKSPIYVILVGGWSFSLYLIQLVFKNLQEIWRCYWQYLLSYVLTVGFMSFAVCYKYGPLENERSINLLTWTLQLMGLCFMYSGIQIPHIALAIIIIALCTKNLEHPIQWLYITCRKVCKGAEKPVPPRLLTEEEYRIQGEVETRKALEELREFCNSPDCSAWKTVSRIQSPKRFADFVEGSSHLTPNEVSVHEQEYGLGSIIAQDEIYEEASSEEEDSYSRCPAITQNNFLT,444,"50,640",Alternative sequence (1); Chain (1); Erroneous initiation (2); Glycosylation (1); Modified residue (3); Natural variant (1); Region (3); Sequence conflict (1); Signal peptide (1); Transmembrane (5),,"SIGNAL 1..43;  /evidence=""ECO:0000255"""
A6NFY4,Nuclear envelope integral membrane protein 2,MGPRQGRWWLLLWLPPLATLPVRGEAAAAALSVRRCKALKEKDLIRTSESDCYCYNQNSQVEWKYIWSTMQVKITSPGLFRIVYIAERHNCQYPENILSFIKCVIHNFWIPKESNEITIIINPYRETVCFSVEPVKKIFNYMIHVNRNIMDFKLFLVFVAGVFLFFYARTLSQSPTFYYSSGTVLGVLMTLVFVLLLVKRFIPKYSTFWALMVGCWFASVYIVCQLMEDLKWLWYENRIYVLGYVLIVGFFSFVVCYKHGPLADDRSRSLLMWMLRLLSLVLVYAGVAVPQFAYAAIILLMSSWSLHYPLRACSYMRWKMEQWFTSKELVVKYLTEDEYREQADAETNSALEELRRACRKPDFPSWLVVSRLHTPSKFADFVLGGSHLSPEEISLHEEQYGLGGAFLEEQLFNPSTA,417,"48,664",Alternative sequence (3); Chain (1); Signal peptide (1); Transmembrane (5),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q9Y5G8,Protocadherin gamma-A5 (PCDH-gamma-A5),MASPPRGWGCGELLLPFMLLGTLCEPGSGQIRYSMPEELDKGSFVGNIAKDLGLEPQELAERGVRIVSRGRTQLFALNPRSGSLVTAGRIDREELCAQSPLCVVNFNILVENKMKIYGVEVEIIDINDNFPRFRDEELKVKVNENAAAGTRLVLPFARDADVGVNSLRSYQLSSNLHFSLDVVSGTDGQKYPELVLEQPLDREKETVHDLLLTALDGGDPVLSGTTHIRVTVLDANDNAPLFTPSEYSVSVPENIPVGTRLLMLTATDPDEGINGKLTYSFRNEEEKISETFQLDSNLGEISTLQSLDYEESRFYLMEVVAQDGGALVASAKVVVTVQDVNDNAPEVILTSLTSSISEDCLPGTVIALFSVHDGDSGENGEIACSIPRNLPFKLEKSVDNYYHLLTTRDLDREETSDYNITLTVMDHGTPPLSTESHIPLKVADVNDNPPNFPQASYSTSVTENNPRGVSIFSVTAHDPDSGDNARVTYSLAEDTFQGAPLSSYVSINSDTGVLYALRSFDYEQLRDLQLWVTASDSGNPPLSSNVSLSLFVLDQNDNTPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDKDSGQNAWLSYRLLKASEPGLFAVGLHTGEVRTARALLDRDALKQSLVVAVEDHGQPPLSATFTVTVAVADRIPDILADLGSIKTPIDPEDLDLTLYLVVAVAAVSCVFLAFVIVLLVLRLRRWHKSRLLQAEGSRLAGVPASHFVGVDGVRAFLQTYSHEVSLTADSRKSHLIFPQPNYADTLLSEESCEKSEPLLMSDKVDANKEERRVQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,931,"100,935",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9UN71,Protocadherin gamma-B4 (PCDH-gamma-B4) (Cadherin-20) (Fibroblast cadherin-2),MGSGAGELGRAERLPVLFLFLLSLFCPALCEQIRYRIPEEMPKGSVVGNLATDLGFSVQELPTRKLRVSSEKPYFTVSAESGELLVSSRLDREEICGKKPACALEFEAVAENPLNFYHVNVEIEDINDHTPKFTQNSFELQISESAQPGTRFILGSAHDADIGSNTLQNYQLSPSDHFSLINKEKSDGSKYPEMVLKTPLDREKQKSYHLTLTALDFGAPPLSSTAQIHVLVTDANDNAPVFSQDVYRVSLSENVYPGTTVLQVTATDQDEGVNAEITFSFSEASQITQFDLNSNTGEITVLNTLDFEEVKEYSIVLEARDGGGMIAQCTVEVEVIDENDNAPEVIFQSLPNLIMEDAELGTHIALLKVRDKDSRHNGEVTCKLEGDVPFKILTSSRNTYKLVTDAVLDREQNPEYNITVTATDRGKPPLSSSSSITLHIGDVNDNAPVFSQSSYIVHVAENNPPGASISQVRASDPDLGPNGQVSYCIMASDLEQRELSSYVSISAESGVVFAQRAFDHEQLRAFELTLQARDQGSPALSANVSLRVLVDDRNDNAPRVLYPALGPDGSALFDMVPHAAEPGYLVTKVVAVDADSGHNAWLSYHVLQASEPGLFSLGLRTGEVRTARALGDRDAVRQRLLVAVRDGGQPPLSATATLHLVFADSLQEVLPDITDRPDPSDLQAELQFYLVVALALISVLFLVAMILAIALRLRRSSSPASWSCFQPGLCVKSESVVPPNYSEGTLPYSYNLCVAHTGKTEFNFLKCSEQLSSGQDILCGDSSGALFPLCNSSELTSHQQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,923,"99,927",Alternative sequence (2); Chain (1); Domain (6); Glycosylation (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..30;  /evidence=""ECO:0000255"""
O60330,Protocadherin gamma-A12 (PCDH-gamma-A12) (Cadherin-21) (Fibroblast cadherin-3),MIPARLHRDYKGLVLLGILLGTLWETGCTQIRYSVPEELEKGSRVGDISRDLGLEPRELAERGVRIIPRGRTQLFALNPRSGSLVTAGRIDREELCMGAIKCQLNLDILMEDKVKIYGVEVEVRDINDNAPYFRESELEIKISENAATEMRFPLPHAWDPDIGKNSLQSYELSPNTHFSLIVQNGADGSKYPELVLKRALDREEKAAHHLVLTASDGGDPVRTGTARIRVMVLDANDNAPAFAQPEYRASVPENLALGTQLLVVNATDPDEGVNAEVRYSFRYVDDKAAQVFKLDCNSGTISTIGELDHEESGFYQMEVQAMDNAGYSARAKVLITVLDVNDNAPEVVLTSLASSVPENSPRGTLIALLNVNDQDSEENGQVICFIQGNLPFKLEKSYGNYYSLVTDIVLDREQVPSYNITVTATDRGTPPLSTETHISLNVADTNDNPPVFPQASYSAYIPENNPRGVSLVSVTAHDPDCEENAQITYSLAENTIQGASLSSYVSINSDTGVLYALSSFDYEQFRDLQVKVMARDNGHPPLSSNVSLSLFVLDQNDNAPEILYPALPTDGSTGVELAPRSAEPGYLVTKVVAVDRDSGQNAWLSYRLLKASEPGLFSVGLHTGEVRTARALLDRDALKQSLVVAVQDHGQPPLSATVTLTVAVADSIPQVLADLGSLESPANSETSDLTLYLVVAVAAVSCVFLAFVILLLALRLRRWHKSRLLQASGGGLTGAPASHFVGVDGVQAFLQTYSHEVSLTTDSRKSHLIFPQPNYADMLVSQESFEKSEPLLLSGDSVFSKDSHGLIEQAPPNTDWRFSQAQRPGTSGSQNGDDTGTWPNNQFDTEMLQAMILASASEAADGSSTLGGGAGTMGLSARYGPQFTLQHVPDYRQNVYIPGSNATLTNAAGKRDGKAPAGGNGNKKKSGKKEKK,932,"100,955",Alternative sequence (2); Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (3); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5E1,Protocadherin beta-9 (PCDH-beta-9) (Protocadherin-3H),MKTRGFSFPRQRQVLFLFLFWGVSLAGSGFGRYSVTEETEKGSFVVNLAKDLGLAEGELAARGTRVVSDDNKQYLLLDSHTGNLLTNEKLDREKLCGPKEPCMLYFQILMDDPFQIYRAELRVRDINDHSPVFRHKEMVLKISENTAEGTAFRLERAQDPDEGHNSIQNYTISSNSFFHIKISGSDEGMIYPELVLDKALDREEQEELSLTLTALDGGSPSRSGTSTIRIVVLDVNDNAPQFAQALYETQAPENSPVGSLIVKVSAGDADSGVNAEVSYSFFDASEDILTTFQINPFSGEIFLRELLDYELVNSYKINIQAMDGGGLSARCTVLIKVLDSNDNPPELIISSLSNSVAENSPGIVLAVFKIKDRDSGENGKTICYVQDNLPFFLKPSVDNFYILMTEGALDRESKAEYNITITVTDLGTPRLKTEHSITLQVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINADNGHLFALRSLDYEALQAFDFRVGASDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADLLTVYLVVALASVSSLFLLSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVSGTGTLFQSYQYEVCLTGGSETGEFKFLKPITPHLPPHRGGKEIEENSTLPNSFGFNY,797,"87,099",Chain (1); Domain (6); Glycosylation (3); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9Y5F1,Protocadherin beta-12 (PCDH-beta-12),MENGGAGTLQIRQVLLFFVLLGMSQAGSETGNFLVMEELQSGSFVGNLAKTLGLEVSELSSRGARVVSNDNKECLQLDTNTGDLLLREMLDREELCGSNEPCVLYFQVLMKNPTQFLQIELQVRDINDHSPVFLEKEMLLEIPENSPVGAVFLLESAKDLDVGINAVKSYTINPNSHFHVKIRVNPDNRKYPELVLDKALDYEERPELSFILTALDGGSPPRSGTALVRVVVVDINDNSPEFEQAFYEVKILENSILGSLVVTVSAWDLDSGTNSELSYTFSHASEDIRKTFEINQKSGDITLTAPLDFEAIESYSIIIQATDGGGLFGKSTVRIQVMDVNDNAPEITVSSITSPIPENTPETVVMVFRIRDRDSGDNGKMVCSIPEDIPFVLKSSVNNYYTLETERPLDRESRAEYNITITVTDLGTPRLKTEHNITVLVSDVNDNAPAFTQTSYALFVRENNSPALHIGSISATDRDSGTNAQVNYSLLPSQDPHLPLASLVSINADNGHLFALRSLDYEALQGFQFRVGATDHGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPWAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAAPVGRCSVPEGPFPGHLVDVSGTGTLSQSYHYEVCVTGGSRSNKFKFLKPIIPNFLPQSTGSEVEENPPFQNNLGF,795,"86,770",Alternative sequence (1); Chain (1); Domain (6); Glycosylation (4); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9Y5F0,Protocadherin beta-13 (PCDH-beta-13),MEASGKLICRQRQVLFSFLLLGLSLAGAAEPRSYSVVEETEGSSFVTNLAKDLGLEQREFSRRGVRVVSRGNKLHLQLNQETADLLLNEKLDREDLCGHTEPCVLRFQVLLESPFEFFQAELQVIDINDHSPVFLDKQMLVKVSESSPPGTTFPLKNAEDLDVGQNNIENYIISPNSYFRVLTRKRSDGRKYPELVLDKALDREEEAELRLTLTALDGGSPPRSGTAQVYIEVLDVNDNAPEFEQPFYRVQISEDSPVGFLVVKVSATDVDTGVNGEISYSLFQASEEIGKTFKINPLTGEIELKKQLDFEKLQSYEVNIEARDAGTFSGKCTVLIQVIDVNDHAPEVTMSAFTSPIPENAPETVVALFSVSDLDSGENGKISCSIQEDLPFLLKSAENFYTLLTERPLDRESRAEYNITITVTDLGTPMLITQLNMTVLIADVNDNAPAFTQTSYTLFVRENNSPALHIRSVSATDRDSGTNAQVTYSLLPPQDPHLPLTSLVSINADNGHLFALRSLDYEALQGFQFRVGASDHGSPALSSEALVRVVVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATELGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPTQAQADLLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCLVPEGPLPGHLVDMSGTRTLSQSYQYEVCLAGGSGTNEFKFLKPIIPNFPPQCPGKEIQGNSTFPNNFGFNIQ,798,"87,552",Chain (1); Domain (6); Glycosylation (3); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
P08887,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)],MLAVGCALLAALLAAPGAALAPRRCPAQEVARGVLTSLPGDSVTLTCPGVEPEDNATVHWVLRKPAAGSHPSRWAGMGRRLLLRSVQLHDSGNYSCYRAGRPAGTVHLLVDVPPEEPQLSCFRKSPLSNVVCEWGPRSTPSLTTKAVLLVRKFQNSPAEDFQEPCQYSQESQKFSCQLAVPEGDSSFYIVSMCVASSVGSKFSKTQTFQGCGILQPDPPANITVTAVARNPRWLSVTWQDPHSWNSSFYRLRFELRYRAERSKTFTTWMVKDLQHHCVIHDAWSGLRHVVQLRAQEEFGQGEWSEWSPEAMGTPWTESRSPPAENEVSTPMQALTTNKDDDNILFRDSANATSLPVQDSSSVPLPTFLVAGGSLAFGTLLCIAIVLRFKKTWKLRALKEGKTSMHPPYSLGQLVPERPRPTPVLVPLISPPVSPSSLGSDNTSSHNRPDARDPRSPYDISNTDYFFPR,468,"51,548",Alternative sequence (2); Beta strand (23); Chain (2); Disulfide bond (4); Domain (3); Glycosylation (6); Helix (2); Motif (1); Mutagenesis (35); Natural variant (2); Sequence conflict (1); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1); Turn (3),"DISULFID 25..193;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10066782""; DISULFID 47..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10066782""; DISULFID 121..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10066782""; DISULFID 165..176;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:10066782""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:2529343"""
P32942,Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50),MATMVPSVLWPRACWTLLVCCLLTPGVQGQEFLLRVEPQNPVLSAGGSLFVNCSTDCPSSEKIALETSLSKELVASGMGWAAFNLSNVTGNSRILCSVYCNGSQITGSSNITVYRLPERVELAPLPPWQPVGQNFTLRCQVEDGSPRTSLTVVLLRWEEELSRQPAVEEPAEVTATVLASRDDHGAPFSCRTELDMQPQGLGLFVNTSAPRQLRTFVLPVTPPRLVAPRFLEVETSWPVDCTLDGLFPASEAQVYLALGDQMLNATVMNHGDTLTATATATARADQEGAREIVCNVTLGGERREARENLTVFSFLGPIVNLSEPTAHEGSTVTVSCMAGARVQVTLDGVPAAAPGQPAQLQLNATESDDGRSFFCSATLEVDGEFLHRNSSVQLRVLYGPKIDRATCPQHLKWKDKTRHVLQCQARGNPYPELRCLKEGSSREVPVGIPFFVNVTHNGTYQCQASSSRGKYTLVVVMDIEAGSSHFVPVFVAVLLTLGVVTIVLALMYVFREHQRSGSYHVREESTYLPLTSMQPTEAMGEEPSRAE,547,"59,541",Beta strand (7); Chain (1); Disulfide bond (6); Domain (5); Glycosylation (15); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 53..96;  /evidence=""ECO:0000244|PDB:1T0P, ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:15728350""; DISULFID 57..100;  /evidence=""ECO:0000244|PDB:1T0P, ECO:0000269|PubMed:15728350""; DISULFID 139..190;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 241..294;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 336..375;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 423..462;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
P26951,Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123),MVLLWLTLLLIALPCLLQTKEDPNPPITNLRMKAKAQQLTWDLNRNVTDIECVKDADYSMPAVNNSYCQFGAISLCEVTNYTVRVANPPFSTWILFPENSGKPWAGAENLTCWIHDVDFLSCSWAVGPGAPADVQYDLYLNVANRRQQYECLHYKTDAQGTRIGCRFDDISRLSSGSQSSHILVRGRSAAFGIPCTDKFVVFSQIEILTPPNMTAKCNKTHSFMHWKMRSHFNRKFRYELQIQKRMQPVITEQVRDRTSFQLLNPGTYTVQIRARERVYEFLSAWSTPQRFECDQEEGANTRAWRTSLLIALGTLLALVCVFVICRRYLVMQRLFPRIPHMKDPIGDSFQNDKLVVWEAGKAGLEECLVTEVQVVQKT,378,"43,330",Alternative sequence (1); Beta strand (25); Chain (1); Erroneous gene model prediction (1); Glycosylation (6); Helix (2); Motif (2); Natural variant (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (7),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q3MIP1,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2",MSVHYTLNLRVFWPLVTGLCTALVCLYHVLRGSGGARAEPADGVDGGFPLLKVAVLLLLSYVLLRCRHAVRQRFLPGSPRLEGHAAFSSRHFREPGLSILLESYYEHEVRLSPHVLGHSKAHVSRIVGELVRAGRARGSPGLIPGGALALAFRGDFIQVGSAYEQHKIRRPDSFDVLVPLRLPPLVALEPRSLGEEPALAPAFRGCFLCALKAPPSPSGASGGHWLRDCKPFADAFCVDVRGRRHLSATLVLRWFQSHLQRSLATVRYSLEGRCRVTLTPGGLEQPPTLHILPCRTDYGCCRLSMAVRLIPAVHLGDGVFLVAPPPPPLPSAPLLELPEGLRAEALWGVNTARQEQKLLSWLQERAAPGACYLKCLQLLKALRDLGARGLDSAAATQWGRILSSYVLKTVLLAVLLRKGAPGQGWDEEHLGRCLEELVQFLRDCLLRRHTLFHCVLGPGGAAAEVGPLPKALREAAPVDLLAAFDGHARELAAARLLSTWQRLPQLLRAYGGPRYLARCPPPRSQRTQGFLEGEP,535,"58,446",Chain (1); Compositional bias (1); Modified residue (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q9NZ53,Podocalyxin-like protein 2 (Endoglycan),MGRLLRAARLPPLLSPLLLLLVGGAFLGACVAGSDEPGPEGLTSTSLLDLLLPTGLEPLDSEEPSETMGLGAGLGAPGSGFPSEENEESRILQPPQYFWEEEEELNDSSLDLGPTADYVFPDLTEKAGSIEDTSQAQELPNLPSPLPKMNLVEPPWHMPPREEEEEEEEEEEREKEEVEKQEEEEEEELLPVNGSQEEAKPQVRDFSLTSSSQTPGATKSRHEDSGDQASSGVEVESSMGPSLLLPSVTPTTVTPGDQDSTSQEAEATVLPAAGLGVEFEAPQEASEEATAGAAGLSGQHEEVPALPSFPQTTAPSGAEHPDEDPLGSRTSASSPLAPGDMELTPSSATLGQEDLNQQLLEGQAAEAQSRIPWDSTQVICKDWSNLAGKNYIILNMTENIDCEVFRQHRGPQLLALVEEVLPRHGSGHHGAWHISLSKPSEKEQHLLMTLVGEQGVVPTQDVLSMLGDIRRSLEEIGIQNYSTTSSCQARASQVRSDYGTLFVVLVVIGAICIIIIALGLLYNCWQRRLPKLKHVSHGEELRFVENGCHDNPTLDVASDSQSEMQEKHPSLNGGGALNGPGSWGALMGGKRDPEDSDVFEEDTHL,605,"65,076",Alternative sequence (1); Chain (1); Compositional bias (1); Glycosylation (3); Modified residue (4); Mutagenesis (3); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
C9JH25,Proline-rich transmembrane protein 4,MARHGCLGLGLFCCVLFAATVGPQPTPSIPGAPATTLTPVPQSEASMLSLNLGLNFKFHLRGPAAVWGSPVTETQPLSLGPGQEPGEEVASGLRTDPLWELLVGSSGNSLTEWGSTEGGSKPRASSLLPESTSRRSGPSDGPTAPYQPRRSTVTWDTALMVTALPSSAPRPHQSELELKFDMALRAGAAPTLGHRTLPLLPSLRASLAEIAGRLGPFGFFGTTLSPLRNFSGLSPPGETTSTSSASGVSGSLGFLGTTLSLPPYSLERKLSSPSPLDPAASLSFASIATTSLDPTVPISGPDDLSPPASLGNPSGQPECGPGSCSVGELPEREGQPPEAPRPLFFLTLEADWAEARARWGLAWEAHVYGVGALFGLVALLALLALALLPWRCPPGAPCLALLDLLLLSAGTTRAFPLFYDAYGHRDRLPALAWLLLQDLPLPCLAAGLGLACLLLARPRPPRCPTGLAALLLLGLGLAAAAALGSAAHRPLRPLRLASRGLHAFLAAFLSGLLLALSCWGGRRRRAGAPLGGSGFKGATPLPQGRSPFAPRESWRRAARTAPVAGTFGLLSGALQGYEVLHALGYGGQSGLEGPWPWWAFQLGLRLGEVGVALPLALLGLYPALCSPRVPPRCWAKLFRLSPGHAAPLLPGGWVTGPPDKEPLGSAIARGDAELLQLCALAGPGPDLLLQGGGCRGFEGAAANPAPSPASSPCSDYTVDFRPPSPINLRRSIEEALCSEALLAPGLFQGPAFEDALPGLGLYRTASLGTGGRASERSGEASGPAAPPELPSPGAWPAGSSVSSGSFCGLSRDSSSMLLCSSPDRPPRCPLVCVLSPPRPSGSSPSLPASGSYQALSPPSRDSPEPASELQAEEALLQEQFLDACRQIDELSVGSDTIDL,899,"92,712",Alternative sequence (3); Chain (1); Compositional bias (3); Modified residue (1); Signal peptide (1); Transmembrane (5),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q86WI1,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1),MGHLWLLGIWGLCGLLLCAADPSTDGSQIIPKVTEIIPKYGSINGATRLTIRGEGFSQANQFNYGVDNAELGNSVQLISSFQSITCDVEKDASHSTQITCYTRAMPEDSYTVRVSVDGVPVTENNTCKGHINSWECTFNAKSFRTPTIRSITPLSGTPGTLITIQGRIFTDVYGSNIALSSNGKNVRILRVYIGGMPCELLIPQSDNLYGLKLDHPNGDMGSMVCKTTGTFIGHHNVSFILDNDYGRSFPQKMAYFVSSLNKIAMFQTYAEVTMIFPSQGSIRGGTTLTISGRFFDQTDFPVRVLVGGEPCDILNVTENSICCKTPPKPHILKTVYPGGRGLKLEVWNNSRPIRLEEILEYNEKTPGYMGASWVDSASYIWLMEQDTFVARFSGFLVAPDSDVYRFYIKGDDRYAIYFSQTGLPEDKVRIAYHSANANSYFSSPTQRSDDIHLQKGKEYYIEILLQEYRLSAFVDVGLYQYRNVYTEQQTGDAVNEEQVIKSQSTILQEVQVITLENWETTNAINEVQKIKVTSPCVEANSCSLYQYRLIYNMEKTVFLPADASEFILQSALNDLWSIKPDTVQVIRTQNPQSYVYMVTFISTRGDFDLLGYEVVEGNNVTLDITEQTKGKPNLETFTLNWDGIASKPLTLWSSEAEFQGAVEEMVSTKCPPQIANFEEGFVVKYFRDYETDFNLEHINRGQKTAETDAYCGRYSLKNPAVLFDSADVKPNRRPYGDILLFPYNQLCLAYKGFLANYIGLKFQYQDNSKITRSTDTQFTYNFAYGNNWTYTCIDLLDLVRTKYTGTNVSLQRISLHKASESQSFYVDVVYIGHTSTISTLDEMPKRRLPALANKGIFLEHFQVNQTKTNGPTMTNQYSVTMTSYNCSYNIPMMAVSFGQIITHETENEFVYRGNNWPGESKIHIQRIQAASPPLSGSFDIQAYGHILKGLPAAVSAADLQFALQSLEGMGRISVTREGTCAGYAWNIKWRSTCGKQNLLQINDSNIIGEKANMTVTRIKEGGLFRQHVLGDLLRTPSQQPQVEVYVNGIPAKCSGDCGFTWDSNITPLVLAISPSQGSYEEGTILTIVGSGFSPSSAVTVSVGPVGCSLLSVDEKELKCQILNGSAGHAPVAVSMADVGLAQNVGGEEFYFVYQSQISHIWPDSGSIAGGTLLTLSGFGFNENSKVLVGNETCNVIEGDLNRITCRTPKKTEGTVDISVTTNGFQATARDAFSYNCLQTPIITDFSPKVRTILGEVNLTIKGYNFGNELTQNMAVYVGGKTCQILHWNFTDIRCLLPKLSPGKHDIYVEVRNWGFASTRDKLNSSIQYVLEVTSMFPQRGSLFGGTEITIRGFGFSTIPAENTVLLGSIPCNVTSSSENVIKCILHSTGNIFRITNNGKDSVHGLGYAWSPPVLNVSVGDTVAWHWQTHPFLRGIGYRIFSVSSPGSVIYDGKGFTSGRQKSTSGSFSYQFTSPGIHYYSSGYVDEAHSIFLQGVINVLPAETRHIPLHLFVGRSEATYAYGGPENLHLGSSVAGCLATEPLCSLNNTRVKNSKRLLFEVSSCFSPSISNITPSTGTVNELITIIGHGFSNLPWANKVTIGSYPCVVEESSEDSITCHIDPQNSMDVGIRETVTLTVYNLGTAINTLSNEFDRRFVLLPNIDLVLPNAGSTTGMTSVTIKGSGFAVSSAGVKVLMGHFPCKVLSVNYTAIECETSPAAQQLVDVDLLIHGVPAQCQGNCTFSYLESITPYITGVFPNSVIGSVKVLIEGEGLGTVLEDIAVFIGNQQFRAIEVNENNITALVTPLPVGHHSVSVVVGSKGLALGNLTVSSPPVASLSPTSGSIGGGTTLVITGNGFYPGNTTVTIGDEPCQIISINPNEVYCRTPAGTTGMVDVKIFVNTIAYPPLLFTYALEDTPFLRGIIPSRGPPGTEIEITGSNFGFEILEISVMINNIQCNVTMANDSVVQCIVGDHAGGTFPVMMHHKTKGSAMSTVVFEYPLNIQNINPSQGSFGGGQTMTVTGTGFNPQNSIILVCGSECAIDRLRSDYTTLLCEIPSNNGTGAEQACEVSVVNGKDLSQSMTPFTYAVSLTPLITAVSPKRGSTAGGTRLTVVGSGFSENMEDVHITIAEAKCDVEYSNKTHIICMTDAHTLSGWAPVCVHIRGVGMAKLDNADFLYVDAWSSNFSWGGKSPPEEGSLVVITKGQTILLDQSTPILKMLLIQGGTLIFDEADIELQAENILITDGGVLQIGTETSPFQHKAVITLHGHLRSPELPVYGAKTLAVREGILDLHGVPVPVTWTRLAHTAKAGERILILQEAVTWKPGDNIVIASTGHRHSQGENEKMTIASVSADGINITLSNPLNYTHLGITVTLPDGTLFEARAEVGILTRNILIRGSDNVEWNNKIPACPDGFDTGEFATQTCLQGKFGEEIGSDQFGGCVMFHAPVPGANMVTGRIEYVEVFHAGQAFRLGRYPIHWHLLGDLQFKSYVRGCAIHQAYNRAVTIHNTHHLLVERNIIYDIKGGAFFIEDGIEHGNILQYNLAVFVQQSTSLLNDDVTPAAFWVTNPNNTIRHNAVAGGTHFGFWYRMNNHPDGPSYDRNICQKRVPLGEFFNNTVHSQGWFGMWIFEEYFPMQTGSCTSTVPAPAIFNSLTTWNCQKGAEWVNGGALQFHNFVMVNNYEAGIETKRILAPYVGGWGETNGAVIKNAKIVGHLDELGMGSAFCTAKGLVLPFSEGLTVSSVHFMNFDRPNCVALGVTSISGVCNDRCGGWSAKFVDVQYSHTPNKAGFRWEHEMVMIDVDGSLTGHKGHTVIPHSSLLDPSHCTQEAEWSIGFPGSVCDASVSFHRLAFNQPSPVSLLEKDVVLSDSFGTSIIPFQKKRLTHMSGWMALIPNANHINWYFKGVDHITNISYTSTFYGFKEEDYVIISHNFTQNPDMFNIIDMRNGSSNPLNWNTSKNGDWHLEANTSTLYYLVSGRNDLHQSQLISGNLDPDVKDVVINFQAYCCILQDCFPVHPPSRKPIPKKRPATYNLWSNDSFWQSSRENNYTVPHPGANVIIPEGTWIVADIDMPSMERLIIWGVLELEDKYNVGAAESSYREVVLNATYISLQGGRLIGGWEDNPFKGDLKIVLRGNHTTQDWALPEGPNQGAKVLGVFGELDLHGIPHSIYKTKLSETAFAGSKVLSLMDAVDWQEGEEIVITTTSYDFHQTETRSIVKILHDHKILILNDSLSYTHFAEKYHVPGTGESYTLAADVGILSRNIKIVGEDYPGWSEDSFGARVLVGSFTENMMTFKGNARISNVEFYHSGQEGFRDSTDPRYAVTFLNLGQIQEHGSSYIRGCAFHHGFSPAIGVFGTDGLDIDDNIIHFTVGEGIRIWGNANRVRGNLIALSVWPGTYQNRKDLSSTLWHAAIEINRGTNTVLQNNVVAGFGRAGYRIDGEPCPGQFNPVEKWFDNEAHGGLYGIYMNQDGLPGCSLIQGFTIWTCWDYGIYFQTTESVHIYNVTLVDNGMAIFPMIYMPAAISHKISSKNVQIKSSLIVGSSPGFNCSDVLTNDDPNIELTAAHRSPRSPSGGRSGICWPTFASAHNMAPRKPHAGIMSYNAISGLLDISGSTFVGFKNVCSGETNVIFITNPLNEDLQHPIHVKNIKLVDTTEQSKIFIHRPDISKVNPSDCVDMVCDAKRKSFLRDIDGSFLGNAGSVIPQAEYEWDGNSQVGIGDYRIPKAMLTFLNGSRIPVTEKAPHKGIIRDSTCKYLPEWQSYQCFGMEYAMMVIESLDPDTETRRLSPVAIMGNGYVDLINGPQDHGWCAGYTCQRRLSLFHSIVALNKSYEVYFTGTSPQNLRLMLLNVDHNKAVLVGIFFSTLQRLDVYVNNLLVCPKTTIWNAQQKHCELNNHLYKDQFLPNLDSTVLGENYFDGTYQMLYLLVKGTIPVEIHTATVIFVSFQLSVATEDDFYTSHNLVKNLALFLKIPSDKIRISKIRGKSLRRKRSMGFIIEIEIGDPPIQFISNGTTGQMQLSELQEIAGSLGQAVILGNISSILGFNISSMSITNPLPSPSDSGWIKVTAQPVERSAFPVHHVAFVSSLLVITQPVAAQPGQPFPQQPSVKATDSDGNCVSVGITALTLRAILKDSNNNQVNGLSGNTTIPFSSCWANYTDLTPLRTGKNYKIEFILDNVVGVESRTFSLLAESVSSSGSSSSSNSKASTVGTYAQIMTVVISCLVGRMWLLEIFMAAVSTLNITLRSY,4243,"465,734",Chain (1); Compositional bias (1); Domain (17); Glycosylation (6); Natural variant (15); Repeat (9); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
O75473,Leucine-rich repeat-containing G-protein coupled receptor 5 (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38),MDTSRLGVLLSLPVLLQLATGGSSPRSGVLLRGCPTHCHCEPDGRMLLRVDCSDLGLSELPSNLSVFTSYLDLSMNNISQLLPNPLPSLRFLEELRLAGNALTYIPKGAFTGLYSLKVLMLQNNQLRHVPTEALQNLRSLQSLRLDANHISYVPPSCFSGLHSLRHLWLDDNALTEIPVQAFRSLSALQAMTLALNKIHHIPDYAFGNLSSLVVLHLHNNRIHSLGKKCFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSNNIRSIPEKAFVGNPSLITIHFYDNPIQFVGRSAFQHLPELRTLTLNGASQITEFPDLTGTANLESLTLTGAQISSLPQTVCNQLPNLQVLDLSYNLLEDLPSFSVCQKLQKIDLRHNEIYEIKVDTFQQLLSLRSLNLAWNKIAIIHPNAFSTLPSLIKLDLSSNLLSSFPITGLHGLTHLKLTGNHALQSLISSENFPELKVIEMPYAYQCCAFGVCENAYKISNQWNKGDNSSMDDLHKKDAGMFQAQDERDLEDFLLDFEEDLKALHSVQCSPSPGPFKPCEHLLDGWLIRIGVWTIAVLALTCNALVTSTVFRSPLYISPIKLLIGVIAAVNMLTGVSSAVLAGVDAFTFGSFARHGAWWENGVGCHVIGFLSIFASESSVFLLTLAALERGFSVKYSAKFETKAPFSSLKVIILLCALLALTMAAVPLLGGSKYGASPLCLPLPFGEPSTMGYMVALILLNSLCFLMMTIAYTKLYCNLDKGDLENIWDCSMVKHIALLLFTNCILNCPVAFLSFSSLINLTFISPEVIKFILLVVVPLPACLNPLLYILFNPHFKEDLVSLRKQTYVWTRSKHPSLMSINSDDVEKQSCDSTQALVTFTSSSITYDLPPSSVPSPAYPVTESCHLSSVAFVPCL,907,"99,998",Alternative sequence (2); Beta strand (22); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (5); Helix (6); Mutagenesis (5); Natural variant (2); Repeat (16); Sequence conflict (2); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (11),"DISULFID 34..40; DISULFID 38..52; DISULFID 348..373; DISULFID 479..541; DISULFID 637..712;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00521""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
E2RYF6,Mucin-22 (Panbronchiolitis-related mucin-like protein 1),MRRGNISPAFWFLWLLLFGLLGPSSENTTAFTKGSDTTTASITGSETTMASTMASTSALTTGSKITTDSTTGSETTSASTMASTAAFTTGSETNTASTTDSGTTIASTRTFTTGSDTTTGSTAGSETIVASTTVSGTTTTFTIASTTVPETTMASSTTSTAGSEKTMASSIISETTMASTTGSETATVSTTGSETTTTSTASSEATKVSTTGSETTTASTAGSETTTTSTSMAGSEATTTSTADSKVITASSMSSETTVAPAAGSNTTTASTTGSETTTILIKASETTTASTAGSETTTPSPTGSQTTIVSISGSEITTTSTAGSENTTVSSAGSGTTTASMAGSETTVSTAGSETTTVSITGTETTMVSAMGSETTTNSTTSSETTVTSTAGSETTTVSTVGSETTTAYTADSETTAASTTGSEMTTVFTAGSETITPSTAGSETTTVSTAGSETTTVSTTGSETTTASTAHSETTAASTMGSETTKVSTAGSETTVSTAGSETTAASTEDSETNTAFTEDSKTTTASTTGFETTAASTTGSEPTMASTMGSETTMASTIGPETTKVSTASSEVTTVFAAGSETIRASTVGSETTTVSTTGSETTTASIMGSETSTDSTTGSETTTASTEGSETTTASTEGSEATTVSTTGSETTTVSITDSETTTTCTEGSEMTAVSTTVFETTTASTEGSEITIASTSDSETTTASTEGSETTTVTTAGSETKTAYTTGSETTTASNTGLETTTVFTIGSDTTTASTEGSETTAVSATGSEMTTVSTEGSENTTVSTTGSETTTVSTTGLETTTTSTEGSEMTTVSTTGAETTTDSTEGSGTTAASTAGSETTTVSTADSENTTASTADSETTSASTTGSETTTASTTSSETTTASTEGSETTTVSTTDSETTMVSTTGSERTITSTEGSETTTVSATGSETTVSTEGSGTTTVSITGSETTKVSTTGSETTTTSTEGSEITTASITGSETTTASTEGSETTTASTEGSETTSASTTGSETTTASTTSSETTMASIMGSETTMASTIGSETTKVSTASSKMTTVFTENSETTIASTTASETTTVSTAGSETIPASTAGSETTTTTSTEGSETTTASTEGSETTTASTESSETTTATTIGSETTTASTEGSETTTTSTEGSETTTASTEGSEITTVSTTGSETTTASTEGSETTTASTEGSELTTVSTTGSETITVSAEGSETTTVTTMGSETTTASTAGSETTTVSTAGSETTTASIEGSETTTVSSTGSETTTVSTTGTETTITSTEGSETTTVTTAGSETTAVYTTGSETTTTSTEGSETTTVSTTGSETTTASTADLETTTVSTSGSGTTTASTAGSETTTVYITGSKTTTASTEGSEATTVSTTSSETTTASTTGSEMTTVFTTVSETTTVSTIGSEATTSSAAGSEATTTSTEGSETTTASTAGSETTTASTAGSETTTASTSGSETNTACTTGSETSTPSSAGSETNTAFIIGSESTIASTASLEPTATSLTGSETTTVSITASGATAASTTVSSTTFVLTKATDVSIQPITNTPMSGTRTTGTRLTASSSVTMAPGMDFTASAASHTVPGIVLNTSGLGTSTMGASSTTSAHGVRTTTGSTREPTSSTFQETGPVSMGTNTVSMSHTPTNVIKPSGYLQPWAIILISLAAVVAAVGLSVGLSFCLRNLFFPLRYCGIYYPHGHSHSLGLDLNLGLGSGTFHSLGNALVHGGELEMGHGGTHGFGYGVGHGLSHIHGDGYGVNHGGHYGHGGGH,1773,"173,478",Chain (1); Compositional bias (1); Natural variant (1); Region (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q05586,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLGLTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYSWNHIILLVSDDHEGRAAQKRLETLLEERESKAEKVLQFDPGTKNVTALLMEAKELEARVIILSASEDDAATVYRAAAMLNMTGSGYVWLVGEREISGNALRYAPDGILGLQLINGKNESAHISDAVGVVAQAVHELLEKENITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRKLVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTLSDGTCKEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVADGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTILVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDALTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRPEERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQAVRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSHENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRHKDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDTSTGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES,938,"105,373",Alternative sequence (7); Beta strand (16); Binding site (3); Chain (1); Disulfide bond (4); Glycosylation (12); Helix (13); Intramembrane (1); Modified residue (4); Mutagenesis (1); Natural variant (24); Region (2); Sequence conflict (2); Signal peptide (1); Topological domain (5); Transmembrane (3); Turn (1),"DISULFID 79..308;  /evidence=""ECO:0000250|UniProtKB:P35439""; DISULFID 420..454;  /evidence=""ECO:0000244|PDB:5H8F, ECO:0000244|PDB:5H8H, ECO:0000244|PDB:5H8N, ECO:0000244|PDB:5H8Q, ECO:0000244|PDB:5I2K, ECO:0000244|PDB:5I2N, ECO:0000244|PDB:5KCJ, ECO:0000244|PDB:5KDT, ECO:0000244|PDB:5TP9, ECO:0000244|PDB:5TPA, ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:26919761, ECO:0000269|PubMed:28105280""; DISULFID 436..455;  /evidence=""ECO:0000244|PDB:5H8F, ECO:0000244|PDB:5H8H, ECO:0000244|PDB:5H8N, ECO:0000244|PDB:5H8Q, ECO:0000244|PDB:5I2K, ECO:0000244|PDB:5I2N, ECO:0000244|PDB:5KCJ, ECO:0000244|PDB:5KDT, ECO:0000244|PDB:5TP9, ECO:0000244|PDB:5TPA, ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:26919761, ECO:0000269|PubMed:28105280""; DISULFID 744..798;  /evidence=""ECO:0000244|PDB:5H8F, ECO:0000244|PDB:5I2K, ECO:0000244|PDB:5TPA, ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:26919761, ECO:0000269|PubMed:28105280""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q8TDF5,Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1),MIHGRSVLHIVASLIILHLSGATKKGTEKQTTSETQKSVQCGTWTKHAEGGIFTSPNYPSKYPPDRECIYIIEAAPRQCIELYFDEKYSIEPSWECKFDHIEVRDGPFGFSPIIGRFCGQQNPPVIKSSGRFLWIKFFADGELESMGFSARYNFTPDPDFKDLGALKPLPACEFEMGGSEGIVESIQIMKEGKATASEAVDCKWYIRAPPRSKIYLRFLDYEMQNSNECKRNFVAVYDGSSSVEDLKAKFCSTVANDVMLRTGLGVIRMWADEGSRNSRFQMLFTSFQEPPCEGNTFFCHSNMCINNTLVCNGLQNCVYPWDENHCKEKRKTSLLDQLTNTSGTVIGVTSCIVIILIIISVIVQIKQPRKKYVQRKSDFDQTVFQEVFEPPHYELCTLRGTGATADFADVADDFENYHKLRRSSSKCIHDHHCGSQLSSTKGSRSNLSTRDASILTEMPTQPGKPLIPPMNRRNILVMKHSYSQDAADACDIDEIEEVPTTSHRLSRHDKAVQRFCLIGSLSKHESEYNTTRV,533,"60,191",Alternative sequence (3); Chain (1); Disulfide bond (7); Domain (3); Glycosylation (2); Modified residue (1); Motif (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..68;  /evidence=""ECO:0000250""; DISULFID 96..118;  /evidence=""ECO:0000250""; DISULFID 172..202;  /evidence=""ECO:0000250""; DISULFID 229..251;  /evidence=""ECO:0000250""; DISULFID 292..304;  /evidence=""ECO:0000250""; DISULFID 299..317;  /evidence=""ECO:0000250""; DISULFID 311..326;  /evidence=""ECO:0000250""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
P57087,Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322),MARRSRHRLLLLLLRYLVVALGYHKAYGFSAPKDQQVVTAVEYQEAILACKTPKKTVSSRLEWKKLGRSVSFVYYQQTLQGDFKNRAEMIDFNIRIKNVTRSDAGKYRCEVSAPSEQGQNLEEDTVTLEVLVAPAVPSCEVPSSALSGTVVELRCQDKEGNPAPEYTWFKDGIRLLENPRLGSQSTNSSYTMNTKTGTLQFNTVSKLDTGEYSCEARNSVGYRRCPGKRMQVDDLNISGIIAAVVVVALVISVCGLGVCYAQRKGYFSKETSFQKSNSSSKATTMSENDFKHTKSFII,298,"33,207",Alternative sequence (2); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (3); Mutagenesis (1); Natural variant (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 50..109;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 155..214;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000269|PubMed:10779521, ECO:0000269|PubMed:15340161"""
Q9BUR5,MICOS complex subunit MIC26 (Apolipoprotein O) (MICOS complex subunit MIC23) (Protein FAM121B),MFKVIQRSVGPASLSLLTFKVYAAPKKDSPPKNSVKVDELSLYSVPEGQSKYVEEARSQLEESISQLRHYCEPYTTWCQETYSQTKPKMQSLVQWGLDSYDYLQNAPPGFFPRLGVIGFAGLIGLLLARGSKIKKLVYPPGFMGLAASLYYPQQAIVFAQVSGERLYDWGLRGYIVIEDLWKENFQKPGNVKNSPGTK,198,"22,285",Alternative sequence (1); Chain (1); Glycosylation (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q3MIW9,Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1),MAQPVHSLCSAFGLQCCLLFLLASWGAGATTFQEYQKTGELSTSDHIFPLTPGLVYSIPFDHIVLHSGQRPPELPKSTEIHEQKRHCNTTRHSKPTDKPTGNSKTIDHKSSTDNHEAPPTSEENSSNQGKDPMIRNQRSVDPADSTTTHKESAGKKHITPAPKSKINCRKSTTGKSTVTRKSDKTGRPLEKSMSTLDKTSTSSHKTTTSFHNSGNSQTKQKSTSFPEKITAASKTTYKTTGTPEESEKTEDSRTTVASDKLLTKTTKNIQETISANELTQSLAEPTEHGGRTANENNTPSPAEPTENRERTANENKKTICTKGKNTPVPEKPTENLGNTTLTTETIKAPVKSTENPEKTAAVTKTIKPSVKVTGDKSLTTTSSHLNKTEVTHQVPTGSFTLITSRTKLSSITSEATGNESHPYLNKDGSQKGIHAGQMGENDSFPAWAIVIVVLVAVILLLVFLGLIFLVSYMMRTRRTLTQNTQYNDAEDEGGPNSYPVYLMEQQNLGMGQIPSPR,517,"56,347",Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (3); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9BQ51,Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273),MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQKVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVKASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVLRLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATVIALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI,273,"30,957",Alternative sequence (3); Beta strand (7); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (5); Helix (2); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 42..102;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 143..192;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..19;  /evidence=""ECO:0000269|PubMed:15340161"""
Q71RS6,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),MQTKGGQTWARRALLLGILWATAHLPLSGTSLPQRLPRATGNSTQCVISPSSEFPEGFFTRQERRDGGIIIYFLIIVYMFMAISIVCDEYFLPSLEIISESLGLSQDVAGTTFMAAGSSAPELVTAFLGVFITKGDIGISTILGSAIYNLLGICAACGLLSNTVSTLSCWPLFRDCAAYTISAAAVLGIIYDNQVYWYEGALLLLIYGLYVLVLCFDIKINQYIIKKCSPCCACLAKAMERSEQQPLMGWEDEGQPFIRRQSRTDSGIFYEDSGYSQLSISLHGLSQVSEDPPSVFNMPEADLKRIFWVLSLPIITLLFLTTPDCRKKFWKNYFVITFFMSAIWISAFTYILVWMVTITGETLEIPDTVMGLTLLAAGTSIPDTIASVLVARKGKGDMAMSNIVGSNVFDMLCLGIPWFIKTAFINGSAPAEVNSRGLTYITISLNISIIFLFLAVHFNGWKLDRKLGIVCLLSYLGLATLSVLYELGIIGNNKIRGCGG,500,"54,888",Alternative sequence (1); Chain (1); Natural variant (1); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q92859,Neogenin (Immunoglobulin superfamily DCC subclass member 2),MAAERGARRLLSTPSFWLYCLLLLGRRAPGAAAARSGSAPQSPGASIRTFTPFYFLVEPVDTLSVRGSSVILNCSAYSEPSPKIEWKKDGTFLNLVSDDRRQLLPDGSLFISNVVHSKHNKPDEGYYQCVATVESLGTIISRTAKLIVAGLPRFTSQPEPSSVYAGNNAILNCEVNADLVPFVRWEQNRQPLLLDDRVIKLPSGMLVISNATEGDGGLYRCVVESGGPPKYSDEVELKVLPDPEVISDLVFLKQPSPLVRVIGQDVVLPCVASGLPTPTIKWMKNEEALDTESSERLVLLAGGSLEISDVTEDDAGTYFCIADNGNETIEAQAELTVQAQPEFLKQPTNIYAHESMDIVFECEVTGKPTPTVKWVKNGDMVIPSDYFKIVKEHNLQVLGLVKSDEGFYQCIAENDVGNAQAGAQLIILEHAPATTGPLPSAPRDVVASLVSTRFIKLTWRTPASDPHGDNLTYSVFYTKEGIARERVENTSHPGEMQVTIQNLMPATVYIFRVMAQNKHGSGESSAPLRVETQPEVQLPGPAPNLRAYAASPTSITVTWETPVSGNGEIQNYKLYYMEKGTDKEQDVDVSSHSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRTLSDVPSAAPQNLSLEVRNSKSIMIHWQPPAPATQNGQITGYKIRYRKASRKSDVTETLVSGTQLSQLIEGLDRGTEYNFRVAALTINGTGPATDWLSAETFESDLDETRVPEVPSSLHVRPLVTSIVVSWTPPENQNIVVRGYAIGYGIGSPHAQTIKVDYKQRYYTIENLDPSSHYVITLKAFNNVGEGIPLYESAVTRPHTDTSEVDLFVINAPYTPVPDPTPMMPPVGVQASILSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFELVPTSPPKDVTVVSKEGKPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEPVVGNRLTHQIQELTLDTPYYFKIQARNSKGMGPMSEAVQFRTPKADSSDKMPNDQASGSGGKGSRLPDLGSDYKPPMSGSNSPHGSPTSPLDSNMLLVIIVSVGVITIVVVVIIAVFCTRRTTSHQKKKRAACKSVNGSHKYKGNSKDVKPPDLWIHHERLELKPIDKSPDPNPIMTDTPIPRNSQDITPVDNSMDSNIHQRRNSYRGHESEDSMSTLAGRRGMRPKMMMPFDSQPPQPVISAHPIHSLDNPHHHFHSSSLASPARSHLYHPGSPWPIGTSMSLSDRANSTESVRNTPSTDTMPASSSQTCCTDHQDPEGATSSSYLASSQEEDSGQSLPTAHVRPSHPLKSFAVPAIPPPGPPTYDPALPSTPLLSQQALNHHIHSVKTASIGTLGRSRPPMPVVVPSAPEVQETTRMLEDSESSYEPDELTKEMAHLEGLMKDLNAITTA,1461,"160,017",Alternative sequence (3); Beta strand (46); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (10); Glycosylation (8); Helix (2); Modified residue (8); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 74..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 173..221;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 270..320;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 362..410;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..33;  /evidence=""ECO:0000255"""
Q9Y5E5,Protocadherin beta-4 (PCDH-beta-4),MKKLGRIHPNRQVLAFILMVFLSQVRLEPIRYSVLEETESGSFVAHLAKDLGLGIGELASRSARVLSDDDKQRLQLDRQTGDLLLREKLDREELCGPIEPCVLHFQVFLEMPVQFFQGELLIQDINDHSPIFPEREVLLKILENSQPGTLFPLLIAEDLDVGSNGLQKYTISPNSHFHILTRNHSEGKKYPDLVQDKPLDREEQPEFSLTLVALDGGSPPRSGTVMVRILIMDINDNAPEFVHTPYGVQVLENSPLDSPIVRVLARDIDAGNFGSVSYGLFQASDEIKQTFSINEVTGEILLKKKLDFEKIKSYHVEIEATDGGGLSGKGTVVIEVVDVNDNPPELIISSLTSSIPENAPETVVSIFRIRDRDSGENGKMICSIPDNLPFILKPTLKNFYTLVTERPLDRETSAEYNITIAVTDLGTPRLKTQQNITVQVSDVNDNAPAFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINADNGHLFALRSLDYEALQAFEFRVGASDRGSPALSSEALVRVLVLDTNDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLHVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSVPEGPFPGHLVDVSGTGTLSQSYQYEVCLTGDSGTGEFKFLKPIFPNLLVQDTGREVKENPKFRNSLVFS,795,"87,270",Chain (1); Domain (6); Glycosylation (4); Natural variant (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q8NBR0,Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1),MAPPPPSPQLLLLAALARLLGPSEVMAGPAEEAGAHCPESLWPLPPQVSPRVTYTRVSPGQAEDVTFLYHPCAHPWLKLQLALLAYACMANPSLTPDFSLTQDRPLVLTAWGLALEMAWVEPAWAAHWLMRRRRRKQRKKKAWIYCESLSGPAPSEPTPGRGRLCRRGCVQALALAFALRSWRPPGTEVTSQGPRQPSSSGAKRRRLRAALGPQPTRSALRFPSASPGSLKAKQSMAGIPGRESNAPSVPTVSLLPGAPGGNASSRTEAQVPNGQGSPGGCVCSSQASPAPRAAAPPRAARGPTPRTEEAAWAAMALTFLLVLLTLATLCTRLHRNFRRGESIYWGPTADSQDTVAAVLKRRLLQPSRRVKRSRRRPLLPPTPDSGPEGESSE,393,"42,238",Chain (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q14165,Malectin,MLGAWAVEGTAVALLRLLLLLLPPAIRGPGLGVAGVAGAAGAGLPESVIWAVNAGGEAHVDVHGIHFRKDPLEGRVGRASDYGMKLPILRSNPEDQILYQTERYNEETFGYEVPIKEEGDYVLVLKFAEVYFAQSQQKVFDVRLNGHVVVKDLDIFDRVGHSTAHDEIIPMSIRKGKLSVQGEVSTFTGKLYIEFVKGYYDNPKVCALYIMAGTVDDVPKLQPHPGLEKKEEEEEEEEYDEGSNLKKQTNKNRVQSGPRTPNPYASDNSSLMFPILVAFGVFIPTLFCLCRL,292,"32,234",Binding site (5); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (1); Helix (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9UBG0,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),MGPGRPAPAPWPRHLLRCVLLLGCLHLGRPGAPGDAALPEPNVFLIFSHGLQGCLEAQGGQVRVTPACNTSLPAQRWKWVSRNRLFNLGTMQCLGTGWPGTNTTASLGMYECDREALNLRWHCRTLGDQLSLLLGARTSNISKPGTLERGDQTRSGQWRIYGSEEDLCALPYHEVYTIQGNSHGKPCTIPFKYDNQWFHGCTSTGREDGHLWCATTQDYGKDERWGFCPIKSNDCETFWDKDQLTDSCYQFNFQSTLSWREAWASCEQQGADLLSITEIHEQTYINGLLTGYSSTLWIGLNDLDTSGGWQWSDNSPLKYLNWESDQPDNPSEENCGVIRTESSGGWQNRDCSIALPYVCKKKPNATAEPTPPDRWANVKVECEPSWQPFQGHCYRLQAEKRSWQESKKACLRGGGDLVSIHSMAELEFITKQIKQEVEELWIGLNDLKLQMNFEWSDGSLVSFTHWHPFEPNNFRDSLEDCVTIWGPEGRWNDSPCNQSLPSICKKAGQLSQGAAEEDHGCRKGWTWHSPSCYWLGEDQVTYSEARRLCTDHGSQLVTITNRFEQAFVSSLIYNWEGEYFWTALQDLNSTGSFFWLSGDEVMYTHWNRDQPGYSRGGCVALATGSAMGLWEVKNCTSFRARYICRQSLGTPVTPELPGPDPTPSLTGSCPQGWASDTKLRYCYKVFSSERLQDKKSWVQAQGACQELGAQLLSLASYEEEHFVANMLNKIFGESEPEIHEQHWFWIGLNRRDPRGGQSWRWSDGVGFSYHNFDRSRHDDDDIRGCAVLDLASLQWVAMQCDTQLDWICKIPRGTDVREPDDSPQGRREWLRFQEAEYKFFEHHSTWAQAQRICTWFQAELTSVHSQAELDFLSHNLQKFSRAQEQHWWIGLHTSESDGRFRWTDGSIINFISWAPGKPRPVGKDKKCVYMTASREDWGDQRCLTALPYICKRSNVTKETQPPDLPTTALGGCPSDWIQFLNKCFQVQGQEPQSRVKWSEAQFSCEQQEAQLVTITNPLEQAFITASLPNVTFDLWIGLHASQRDFQWVEQEPLMYANWAPGEPSGPSPAPSGNKPTSCAVVLHSPSAHFTGRWDDRSCTEETHGFICQKGTDPSLSPSPAALPPAPGTELSYLNGTFRLLQKPLRWHDALLLCESRNASLAYVPDPYTQAFLTQAARGLRTPLWIGLAGEEGSRRYSWVSEEPLNYVGWQDGEPQQPGGCTYVDVDGAWRTTSCDTKLQGAVCGVSSGPPPPRRISYHGSCPQGLADSAWIPFREHCYSFHMELLLGHKEARQRCQRAGGAVLSILDEMENVFVWEHLQSYEGQSRGAWLGMNFNPKGGTLVWQDNTAVNYSNWGPPGLGPSMLSHNSCYWIQSNSGLWRPGACTNITMGVVCKLPRAEQSSFSPSALPENPAALVVVLMAVLLLLALLTAALILYRRRQSIERGAFEGARYSRSSSSPTEATEKNILVSDMEMNEQQE,1479,"166,674",Beta strand (30); Chain (1); Cross-link (1); Disulfide bond (16); Domain (10); Erroneous initiation (1); Glycosylation (7); Helix (8); Mutagenesis (4); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (14),"DISULFID 54..68;  /evidence=""ECO:0000250""; DISULFID 93..112;  /evidence=""ECO:0000250""; DISULFID 187..213;  /evidence=""ECO:0000250""; DISULFID 201..228;  /evidence=""ECO:0000250""; DISULFID 266..359;  /evidence=""ECO:0000250""; DISULFID 335..351;  /evidence=""ECO:0000250""; DISULFID 410..504;  /evidence=""ECO:0000250""; DISULFID 481..496;  /evidence=""ECO:0000250""; DISULFID 618..635;  /evidence=""ECO:0000250""; DISULFID 704..808;  /evidence=""ECO:0000250""; DISULFID 785..800;  /evidence=""ECO:0000250""; DISULFID 853..950;  /evidence=""ECO:0000250""; DISULFID 927..942;  /evidence=""ECO:0000250""; DISULFID 1078..1098;  /evidence=""ECO:0000250""; DISULFID 1220..1234;  /evidence=""ECO:0000250""; DISULFID 1369..1384;  /evidence=""ECO:0000250""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q9UK23,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),MATSTGRWLLLRLALFGFLWEASGGLDSGASRDDDLLLPYPRARARLPRDCTRVRAGNREHESWPPPPATPGAGGLAVRTFVSHFRDRAVAGHLTRAVEPLRTFSVLEPGGPGGCAARRRATVEETARAADCRVAQNGGFFRMNSGECLGNVVSDERRVSSSGGLQNAQFGIRRDGTLVTGYLSEEEVLDTENPFVQLLSGVVWLIRNGSIYINESQATECDETQETGSFSKFVNVISARTAIGHDRKGQLVLFHADGQTEQRGINLWEMAEFLLKQDVVNAINLDGGGSATFVLNGTLASYPSDHCQDNMWRCPRQVSTVVCVHEPRCQPPDCHGHGTCVDGHCQCTGHFWRGPGCDELDCGPSNCSQHGLCTETGCRCDAGWTGSNCSEECPLGWHGPGCQRPCKCEHHCPCDPKTGNCSVSRVKQCLQPPEATLRAGELSFFTRTAWLALTLALAFLLLISTAANLSLLLSRAERNRRLHGDYAYHPLQEMNGEPLAAEKEQPGGAHNPFKD,515,"56,073",Alternative sequence (3); Chain (1); Disulfide bond (5); Domain (1); Glycosylation (6); Motif (2); Mutagenesis (19); Natural variant (3); Propeptide (1); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 115..148;  /evidence=""ECO:0000305|PubMed:23572527""; DISULFID 132..323;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:23572527""; DISULFID 307..314;  /evidence=""ECO:0000305|PubMed:23572527""; DISULFID 362..373;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 380..389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:12058031"""
O15118,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNF,1278,"142,167",Alternative sequence (3); Beta strand (35); Binding site (2); Chain (1); Compositional bias (1); Disulfide bond (15); Domain (1); Glycosylation (19); Helix (55); Motif (1); Mutagenesis (38); Natural variant (167); Region (2); Signal peptide (1); Site (1); Topological domain (14); Transmembrane (13); Turn (14),"DISULFID 25..74;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 31..42;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 63..109;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 75..113;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 97..238;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 100..160;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 177..184;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 227..243;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5JNX, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017""; DISULFID 240..247;  /evidence=""ECO:0000244|PDB:3GKH, ECO:0000244|PDB:3GKI, ECO:0000244|PDB:3GKJ, ECO:0000269|PubMed:19563754""; DISULFID 468..479;  /evidence=""ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5F18, ECO:0000244|PDB:5F1B, ECO:0000244|PDB:5HNS, ECO:0000244|PDB:5JNX, ECO:0000244|PDB:5KWY, ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:26771495, ECO:0000269|PubMed:26846330, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:28784760""; DISULFID 516..533;  /evidence=""ECO:0000244|PDB:3JD8, ECO:0000244|PDB:5F18, ECO:0000244|PDB:5F1B, ECO:0000244|PDB:5HNS, ECO:0000244|PDB:5JNX, ECO:0000244|PDB:5KWY, ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:26771495, ECO:0000269|PubMed:26846330, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:28784760""; DISULFID 909..914;  /evidence=""ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:28784760""; DISULFID 956..1011;  /evidence=""ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:28784760""; DISULFID 957..979;  /evidence=""ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:28784760""; DISULFID 967..976;  /evidence=""ECO:0000244|PDB:5U73, ECO:0000244|PDB:5U74, ECO:0000269|PubMed:28784760""","SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q9ULC0,Endomucin (Endomucin-2) (Gastric cancer antigen Ga34) (Mucin-14) (MUC-14),MELLQVTILFLLPSICSSNSTGVLEAANNSLVVTTTKPSITTPNTESLQKNVVTPTTGTTPKGTITNELLKMSLMSTATFLTSKDEGLKATTTDVRKNDSIISNVTVTSVTLPNAVSTLQSSKPKTETQSSIKTTEIPGSVLQPDASPSKTGTLTSIPVTIPENTSQSQVIGTEGGKNASTSATSRSYSSIILPVVIALIVITLSVFVLVGLYRMCWKADPGTPENGNDQPQSDKESVKLLTVKTISHESGEHSAQGKTKN,261,"27,452",Alternative sequence (2); Chain (1); Compositional bias (1); Glycosylation (6); Modified residue (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9UPR5,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),MAPLALVGVTLLLAAPPCSGAATPTPSLPPPPANDSDTSTGGCQGSYRCQPGVLLPVWEPDDPSLGDKAARAVVYFVAMVYMFLGVSIIADRFMAAIEVITSKEKEITITKANGETSVGTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFQAGELGPGTIVGSAAFNMFVVIAVCIYVIPAGESRKIKHLRVFFVTASWSIFAYVWLYLILAVFSPGVVQVWEALLTLVFFPVCVVFAWMADKRLLFYKYVYKRYRTDPRSGIIIGAEGDPPKSIELDGTFVGAEAPGELGGLGPGPAEARELDASRREVIQILKDLKQKHPDKDLEQLVGIANYYALLHQQKSRAFYRIQATRLMTGAGNVLRRHAADASRRAAPAEGAGEDEDDGASRIFFEPSLYHCLENCGSVLLSVTCQGGEGNSTFYVDYRTEDGSAKAGSDYEYSEGTLVFKPGETQKELRIGIIDDDIFEEDEHFFVRLLNLRVGDAQGMFEPDGGGRPKGRLVAPLLATVTILDDDHAGIFSFQDRLLHVSECMGTVDVRVVRSSGARGTVRLPYRTVDGTARGGGVHYEDACGELEFGDDETMKTLQVKIVDDEEYEKKDNFFIELGQPQWLKRGISALLLNQGDGDRKLTAEEEEARRIAEMGKPVLGENCRLEVIIEESYDFKNTVDKLIKKTNLALVIGTHSWREQFLEAITVSAGDEEEEEDGSREERLPSCFDYVMHFLTVFWKVLFACVPPTEYCHGWACFGVSILVIGLLTALIGDLASHFGCTVGLKDSVNAVVFVALGTSIPDTFASKVAALQDQCADASIGNVTGSNAVNVFLGLGVAWSVAAVYWAVQGRPFEVRTGTLAFSVTLFTVFAFVGIAVLLYRRRPHIGGELGGPRGPKLATTALFLGLWLLYILFASLEAYCHIRGF,921,"100,368",Chain (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Glycosylation (2); Metal binding (26); Modified residue (1); Natural variant (2); Region (1); Repeat (2); Signal peptide (1); Topological domain (12); Transmembrane (11),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P32418,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVILPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNGETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMFIIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFFFFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHVENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKSRAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLENCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGIIDDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIFTFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQNDEIVKTISVKVIDDEEYEKNKTFFLEIGEPRLVEMSEKKALLLNELGGFTITGKYLFGQPVFRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESYEFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHFLTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVFVALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQFKVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIFFSSLEAYCHIKGF,973,"108,547",Alternative sequence (4); Chain (1); Compositional bias (3); Domain (2); Erroneous initiation (1); Glycosylation (2); Metal binding (27); Modified residue (2); Natural variant (1); Region (1); Repeat (2); Signal peptide (1); Topological domain (11); Transmembrane (10),,"SIGNAL 1..35;  /evidence=""ECO:0000255"""
Q8NFZ3,"Neuroligin-4, Y-linked (Neuroligin Y)",MLRPQGLLWLPLLFTSVCVMLNSNVLLWITALAIKFTLIDSQAQYPVVNTNYGKIQGLRTPLPSEILGPVEQYLGVPYASPPTGERRFQPPESPSSWTGIRNATQFSAVCPQHLDERFLLHDMLPIWFTTSLDTLMTYVQDQNEDCLYLNIYVPMEDDIHEQNSKKPVMVYIHGGSYMEGTGNMIDGSILASYGNVIVITINYRLGILGFLSTGDQAAKGNYGLLDQIQALRWIEENVGAFGGDPKRVTIFGSGAGASCVSLLTLSHYSEGLFQKAIIQSGTALSSWAVNYQPAKYTRILADKVGCNMLDTTDMVECLKNKNYKELIQQTITPATYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVDGIVDNEDGVTPNDFDFSVSNFVDNLYGYPEGKDTLRETIKFMYTDWADKENPETRRKTLVALFTDHQWVAPAVATADLHAQYGSPTYFYAFYHHCQSEMKPSWADSAHGDEVPYVFGIPMIGPTELFSCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWSKYNPKDQLYLHIGLKPRVRDHYRATKVAFWLELVPHLHNLNEIFQYVSTTTKVPPPDMTSFPYGTRRSPAKIWPTTKRPAITPANNPKHSKDPHKTGPEDTTVLIETKRDYSTELSVTIAVGASLLFLNILAFAALYYKKDKRRHETHRHPSPQRNTTNDITHIQNEEIMSLQMKQLEHDHECESLQAHDTLRLTCPPDYTLTLRRSPDDIPFMTPNTITMIPNTLMGMQPLHTFKTFSGGQNSTNLPHGHSTTRV,816,"92,021",Alternative sequence (5); Chain (1); Disulfide bond (3); Erroneous initiation (1); Glycosylation (2); Modified residue (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 110..146;  /evidence=""ECO:0000250""; DISULFID 306..317;  /evidence=""ECO:0000250""; DISULFID 476..510;  /evidence=""ECO:0000250""","SIGNAL 1..43;  /evidence=""ECO:0000255"""
O95206,Protocadherin-8 (Arcadlin),MSPVRRWGSPCLFPLQLFSLCWVLSVAQSKTVRYSTFEEDAPGTVIGTLAEDLHMKVSGDTSFRLMKQFNSSLLRVREGDGQLTVGDAGLDRERLCGQAPQCVLAFDVVSFSQEQFRLVHVEVEVRDVNDHAPRFPRAQIPVEVSEGAAVGTRIPLEVPVDEDVGANGLQTVRLAEPHSPFRVELQTRADGAQCADLVLLQELDRESQAAYSLELVAQDGGRPPRSATAALSVRVLDANDHSPAFPQGAVAEVELAEDAPVGSLLLDLDAADPDEGPNGDVVFAFGARTPPEARRLFRLDPRSGRLTLAGPVDYERQDTYELDVRAQDRGPGPRAATCKVIVRIRDVNDNAPDIAITPLAAPGAPATSPFAAAAAAAALGGADASSPAGAGTPEAGATSLVPEGAARESLVALVSTSDRDSGANGQVRCALYGHEHFRLQPAYAGSYLVVTAASLDRERIAEYNLTLVAEDRGAPPLRTVRPYTVRVGDENDNAPLFTRPVYEVSVRENNPPGAYLATVAARDRDLGRNGQVTYRLLEAEVGRAGGAVSTYVSVDPATGAIYALRSFDYETLRQLDVRIQASDGGSPQLSSSALVQVRVLDQNDHAPVLVHPAPANGSLEVAVPGRTAKDTVVARVQARDADEGANGELAFELQQQEPREAFAIGRRTGEILLTGDLSQEPPGRVFRALLVISDGGRPPLTTTATVSFVVTAGGGRGPAAPASAGSPERSRPPGSRLGVSGSVLQWDTPLIVIIVLAGSCTLLLAAIIAIATTCNRRKKEVRKGGALREERPGAAGGGASAPGSPEEAARGAGPRPNMFDVLTFPGTGKAPFGSPAADAPPPAVAAAEVPGSEGGSATGESACHFEGQQRLRGAHAEPYGASPGFGKEPAPPVAVWKGHSFNTISGREAEKFSGKDSGKGDSDFNDSDSDISGDALKKDLINHMQSGLWACTAECKILGHSDRCWSPSCSGPNAHPSPHPPAQMSTFCKSTSLPRDPLRRDNYYQAQLPKTVGLQSVYEKVLHRDYDRTVTLLSPPRPGRLPDLQEIGVPLYQSPPGRYLSPKKGANENV,1070,"113,019",Alternative sequence (1); Beta strand (18); Chain (1); Domain (6); Glycosylation (3); Helix (3); Modified residue (1); Natural variant (5); Sequence caution (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5F2,Protocadherin beta-11 (PCDH-beta-11),MENQGTRTQQIRQVLLLFVLLGMSQAGSETWSFSVAEEMQSGSFVGNLAKDLGLKVRELSSRGARVVSNDKKQRLQLDINTGDLLLSETLDREELCGSIEPCVLHLQVLMQNPTQFLQIELQVRDINDHSPIFSEKQMLLEIPENSPVGAVFLLESAKDLDVGINAVKSYTISPNSHFHIKMRVIPDNRKYPELVLDKALDYEELPELSFILSALDGGSPPRSGTALVRVVVVDINDNSPEFEQAFYEVKIRENSILGSLILIVSAWDLDSGTNGEICYTFSHASEDIRKTFEINQKSGEITLRAPLDFETIESYSIIIQATDGGGLFGKSTVIIHVIDVNDNAPEITVSSITSPIPENTPETVVMVFSIQDIDSGDNGRIVCSIPEDLPFVLKSSVENYYTLETERPLDRESTAEYNITITVTDLGIPRLKTEHNTTVLVSDVNDNAPTFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVNYSLLPPQDLHLPLASLVSINTDNGHLFALRSLDYEALQAFDFRVGATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKHRLVVLVKDNGEPPRSATATLQVLLVDGFSQPYLPLPEAAPAQAQADSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGSCSVPKGPFPGHLVDVSGTGTLSQSYQYEVCLTGGSETNEFKFLKPVIPNIQAKGLGKNSEENSTFRNSFGFNF,797,"87,088",Alternative sequence (1); Chain (1); Domain (6); Glycosylation (4); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q9UN74,Protocadherin alpha-4 (PCDH-alpha-4),MEFSWGSGQESRRLLLLLLLLAAWEAGNGQLHYSVSEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKGRGGLLEVNLQNGILFVNSRIDREELCRRSAECSIHLEVIVDRPLQVFHVDVEVRDINDNPPVFPATQKNLSIAESRPLDSRFPLEGASDADIGENALLTYRLSPNEYFSLEKPPDDELVKGLGLILRKSLDREEAPEIFLVLTATDGGKPELTGTVQLLITVLDANDNAPAFDRTIYKVRLLENVPNGTLVIKLNASDLDEGLNGDIVYSFSNDISPNVKSKFHIDPITGQIIVKGYIDFEESKSYEIIVEGIDKGQLPLSGHCRVIVEVEDNNDNVPDLEFKSLSLPIREDAPLGTVIALISVSDKDMGVNGLVTCSLTSHVPFKLVSTFKNYYSLVLDSALDRESVSAYELVVTARDGGSPSLWATASVSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSAWDADAQENALVSYSLVERRVGERALSSYVSVHAESGKVYALQPLDHEELELLQFQVTARDAGVPPLGSNVTLQVFVLDENDNAPALLAPRAGGTGGAVSELVPWSVGVGHVVAKVRAVDADSGYNAWLSYELQPGTGGARIPFRVGLYTGEISTTRALDETDAPRHRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRALVGAVGPDAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSALPTEGACAPGKPTLVCSSAVGSWSYSQQRRPRVCSGEGPPKTDLMAFSPSLPDSRDREDQLQTTEESFAKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,947,"102,293",Alternative sequence (2); Chain (1); Compositional bias (1); Disulfide bond (1); Domain (6); Glycosylation (4); Natural variant (2); Region (2); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 96..102;  /evidence=""ECO:0000250|UniProtKB:O88689""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y5H5,Protocadherin alpha-9 (PCDH-alpha-9),MLYSSRGDPEGQPLLLSLLILAMWVVGSGQLHYSVPEEAEHGTFVGRIAQDLGLELAELVPRLFQLDSKGRGDLLEVNLQNGILFVNSRIDREELCGRSAECSIHLEVIVDRPLQVFHVDVEVKDINDNPPVFPATQKNLFIAESRPLDSRFPLEGASDADIGENALLTYRLSPNEYFFLDVPTSNQQVKPLGLVLRKLLDREETPELHLLLTATDGGKPELTGTVQLLITVLDNNDNAPVFDRTLYTVKLPENVSIGTLVIHPNASDLDEGLNGDIIYSFSSDVSPDIKSKFHMDPLSGAITVIGHMDFEESRAHKIPVEAVDKGFPPLAGHCTLLVEVVDVNDNAPQLTIKTLSVPVKEDAQLGTVIALISVIDLDADANGQVTCSLTPHVPFKLVSTYKNYYSLVLDRALDRESVSAYELVVTARDGGSPSLWATARVSVEVADVNDNAPAFAQSEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRLGERSLSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLTPRMRGTDGAVSEMVLRSVGAGVVVGKVRAVDADSGYNAWLSYELQPETASASIPFRVGLYTGEISTTRALDETDAPRQRLLVLVKDHGEPALTATATVLVSLVESGQAPKSSSRASVGATGPEVTLVDVNVYLIIAICAVSSLLVLTLLLYTVLRCSAMPTEGECAPGKPTLVCSSAVGSWSYSQQRRQRVCSGEGKQKTDLMAFSPGLSPCAGSTERTGEPSASSDSTGKPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,950,"102,402",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Erroneous initiation (1); Glycosylation (3); Natural variant (8); Region (1); Repeat (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9HBW1,Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2),MKLLWQVTVHHHTWNAILLPFVYLTAQVWILCAAIAAAASAGPQNCPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWWLREYIPTNSTCCGRCHAPMHMRGRYLVEVDQASFQCSAPFIMDAPRDLNISEGRMAELKCRTPPMSSVKWLLPNGTVLSHASRHPRISVLNDGTLNFSHVLLSDTGVYTCMVTNVAGNSNASAYLNVSTAELNTSNYSFFTTVTVETTEISPEDTTRKYKPVPTTSTGYQPAYTTSTTVLIQTTRVPKQVAVPATDTTDKMQTSLDEVMKTTKIIIGCFVAVTLLAAAMLIVFYKLRKRHQQRSTVTAARTVEIIQVDEDIPAATSAAATAAPSGVSGEGAVVLPTIHDHINYNTYKPAHGAHWTENSLGNSLHPTVTTISEPYIIQTHTKDKVQETQI,653,"72,717",Beta strand (25); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (3); Glycosylation (9); Helix (3); Natural variant (1); Repeat (9); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (10),"DISULFID 46..52;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21946559""; DISULFID 50..61;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21946559""; DISULFID 304..329;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21946559""; DISULFID 306..350;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21946559""; DISULFID 374..424;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:21946559""","SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q9H3R2,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),MKAIIHLTLLALLSVNTATNQGNSADAVTTTETATSGPTVAAADTTETNFPETASTTANTPSFPTATSPAPPIISTHSSSTIPTPAPPIISTHSSSTIPIPTAADSESTTNVNSLATSDIITASSPNDGLITMVPSETQSNNEMSPTTEDNQSSGPPTGTALLETSTLNSTGPSNPCQDDPCADNSLCVKLHNTSFCLCLEGYYYNSSTCKKGKVFPGKISVTVSETFDPEEKHSMAYQDLHSEITSLFKDVFGTSVYGQTVILTVSTSLSPRSEMRADDKFVNVTIVTILAETTSDNEKTVTEKINKAIRSSSSNFLNYDLTLRCDYYGCNQTADDCLNGLACDCKSDLQRPNPQSPFCVASSLKCPDACNAQHKQCLIKKSGGAPECACVPGYQEDANGNCQKCAFGYSGLDCKDKFQLILTIVGTIAGIVILSMIIALIVTARSNNKTKHIEEENLIDEDFQNLKLRSTGFTNLGAEGSVFPKVRITASRDSQMQNPYSRHSSMPRPDY,512,"54,604",Chain (1); Compositional bias (1); Disulfide bond (9); Domain (4); Erroneous initiation (1); Glycosylation (6); Natural variant (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 177..188;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 182..197;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 199..210;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 326..338;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 331..344;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 346..360;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 367..378;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 371..389;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 391..403;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9Y5I1,Protocadherin alpha-11 (PCDH-alpha-11),MFGFQRRGLGTPRLQLWLLLLEFWEVGSGQLHYSVSEEAKHGTFVGRIAQDLGLELAELVQRLFRVASKTHGDLLEVNLQNGILFVNSRIDREELCGQSAECSIHLEVIVDRPLQVFHVNVEVKDINDNPPVFSLREQKLLIAESKQSDSRFPLEGASDADIEENALLTYRLSKNEYFSLDSPTNGKQIKRLSLILKKSLDREKTPELNLLLTATDGGKPELTGTVRLLVQVLDVNDNDPEFDKSEYKVSLMENAAKETLVLKLNATDRDEGVNGEVTYSLMSIKPNGRHLFTLDQNNGEVRVNGTLDYEENKFYKIEVQATDKGTPPMAGHCTVWVEILDTNDNSPEVAVTSLSLPVREDAQPSTVIALISVSDRDSGVNGQVTCSLTPHVPFKLVSTFKNYYSLVLDSALDRENVWAYELVVTARDGGSPSLWATARVSVEVADVNDNAPAFAQPEYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRLGDRALSSYVSVHAESGKVYALQPLDHEELELLQFQVSARDAGVPPLSSNVTLQVFVLDENDNAPALLATQAGSAGGAVNKLVPRSVGAGHVVAKVRAVDADSGYNAWLSYELQPAAGGSRIPFRVGLYTGEISTTRALDEADSPRHRLLVLVKDHGEPALTATATVLVSLVESGQAPKASSRTLAGAASPEAALVDVNVYLIIAICVVSSLLVLTLLLYTALWWSATPTEGACAPGKPTLVCSRAVGSWSYSQQRRQRVCSEEGPPKTDLMAFSPSLPLGLNKEEEGERQEPGSNHPGQPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,949,"103,298",Alternative sequence (2); Chain (1); Compositional bias (1); Domain (6); Glycosylation (3); Natural variant (2); Region (1); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9ULL4,Plexin-B3,MCHAAQETPLLHHFMAPVMARWPPFGLCLLLLLLSPPPLPLTGAHRFSAPNTTLNHLALAPGRGTLYVGAVNRLFQLSPELQLEAVAVTGPVIDSPDCVPFRDPAECPQAQLTDNANQLLLVSSRAQELVACGQVRQGVCETRRLGDVAEVLYQAEDPGDGQFVAANTPGVATVGLVVPLPGRDLLLVARGLAGKLSAGVPPLAIRQLAGSQPFSSEGLGRLVVGDFSDYNNSYVGAFADARSAYFVFRRRGARAQAEYRSYVARVCLGDTNLYSYVEVPLACQGQGLIQAAFLAPGTLLGVFAAGPRGTQAALCAFPMVELGASMEQARRLCYTAGGRGPSGAEEATVEYGVTSRCVTLPLDSPESYPCGDEHTPSPIAGRQPLEVQPLLKLGQPVSAVAALQADGHMIAFLGDTQGQLYKVFLHGSQGQVYHSQQVGPPGSAISPDLLLDSSGSHLYVLTAHQVDRIPVAACPQFPDCASCLQAQDPLCGWCVLQGRCTRKGQCGRAGQLNQWLWSYEEDSHCLHIQSLLPGHHPRQEQGQVTLSVPRLPILDADEYFHCAFGDYDSLAHVEGPHVACVTPPQDQVPLNPPGTDHVTVPLALMFEDVTVAATNFSFYDCSAVQALEAAAPCRACVGSIWRCHWCPQSSHCVYGEHCPEGERTIYSAQEVDIQVRGPGACPQVEGLAGPHLVPVGWESHLALRVRNLQHFRGLPASFHCWLELPGELRGLPATLEETAGDSGLIHCQAHQFYPSMSQRELPVPIYVTQGEAQRLDNTHALYVILYDCAMGHPDCSHCQAANRSLGCLWCADGQPACRYGPLCPPGAVELLCPAPSIDAVEPLTGPPEGGLALTILGSNLGRAFADVQYAVSVASRPCNPEPSLYRTSARIVCVTSPAPNGTTGPVRVAIKSQPPGISSQHFTYQDPVLLSLSPRWGPQAGGTQLTIRGQHLQTGGNTSAFVGGQPCPILEPVCPEAIVCRTRPQAAPGEAAVLVVFGHAQRTLLASPFRYTANPQLVAAEPSASFRGGGRLIRVRGTGLDVVQRPLLSVWLEADAEVQASRAQPQDPQPRRSCGAPAADPQACIQLGGGLLQCSTVCSVNSSSLLLCRSPAVPDRAHPQRVFFTLDNVQVDFASASGGQGFLYQPNPRLAPLSREGPARPYRLKPGHVLDVEGEGLNLGISKEEVRVHIGRGECLVKTLTRTHLYCEPPAHAPQPANGSGLPQFVVQMGNVQLALGPVQYEAEPPLSAFPVEAQAGVGMGAAVLIAAVLLLTLMYRHKSKQALRDYQKVLVQLESLETGVGDQCRKEFTDLMTEMTDLSSDLEGSGIPFLDYRTYAERAFFPGHGGCPLQPKPEGPGEDGHCATVRQGLTQLSNLLNSKLFLLTLIHTLEEQPSFSQRDRCHVASLLSLALHGKLEYLTDIMRTLLGDLAAHYVHRNPKLMLRRTETMVEKLLTNWLSICLYAFLREVAGEPLYMLFRAIQYQVDKGPVDAVTGKAKRTLNDSRLLREDVEFQPLTLMVLVGPGAGGAAGSSEMQRVPARVLDTDTITQVKEKVLDQVYKGTPFSQRPSVHALDLEWRSGLAGHLTLSDEDLTSVTQNHWKRLNTLQHYKVPDGATVGLVPQLHRGSTISQSLAQRCPLGENIPTLEDGEEGGVCLWHLVKATEEPEGAKVRCSSLREREPARAKAIPEIYLTRLLSMKGTLQKFVDDTFQAILSVNRPIPIAVKYLFDLLDELAEKHGIEDPGTLHIWKTNSLLLRFWVNALKNPQLIFDVRVSDNVDAILAVIAQTFIDSCTTSEHKVGRDSPVNKLLYAREIPRYKQMVERYYADIRQSSPASYQEMNSALAELSGNYTSAPHCLEALQELYNHIHRYYDQIISALEEDPVGQKLQLACRLQQVAALVENKVTDL,1909,"206,847",Alternative sequence (1); Chain (1); Disulfide bond (10); Domain (8); Erroneous initiation (1); Glycosylation (8); Natural variant (6); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 98..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 132..140;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 267..370;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 283..315;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 333..357;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 474..491;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 480..525;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 483..500;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 494..506;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""; DISULFID 562..580;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00352""","SIGNAL 1..44;  /evidence=""ECO:0000255"""
Q7Z443,Polycystic kidney disease protein 1-like 3 (PC1-like 3 protein) (Polycystin-1L3),MFFKGGSWLWLYIRTSIILGSELNSPAPHGQNNCYQLNRFQCSFEEAQHYCHVQRGFLAHIWNKEVQDLIRDYLEEGKKWWIGQNVMPLKKHQDNKYPADVAANGPPKPLSCTYLSRNFIRISSKGDKCLLKYYFICQTGDFLDGDAHYERNGNNSHLYQRHKKTKRGVAIARDKMPPGPGHLPTTCHYPLPAHLSKTLCHPISQFPSVLSSITSQVTSAASEPSSQPLPVITQLTMPVSVTHAGQSLAETTSSPKEEGHPNTFTSYLQVSLQKASGQVIDEIAGNFSRAVHGLQALNKLQEACEFLQKLTALTPRFSKPAQVNLINSLIYLSEELLRIPFQNNNSLGFKVPPTVCPFHSLNNVTKAGEGSWLESKRHTEPVEDILEMSLVEFGNIGEAFLEQNQSPESSVTLTSANATLLLSRQNISTLPLSSYTLGHPAPVRLGFPSALALKELLNKHPGVNVQITGLAFNPFKDLDNRNIVGSIGSVLLSANRKLLQVHDLMEDIEIMLWRNVSLETHPTSLNMSTHQLTITVNVTSLEKSLIVSIDPDSPLLMTLYLGFQYQPNCTHFHLNITLPKDKVWQKDEEYTWVLNPEHLQHGIGTYYITAVLSERQEGAQQTPSLVSVITAVTQCYYWEIHNQTWSSAGCQVGPQSTILRTQCLCNHLTFFASDFFVVPRTVNVEDTIKLFLRVTNNPVGVSLLASLLGFYVITVVWARKKDQADMQKVKVTVLADNDPSAQFHYLIQVYTGYRRSAATTAKVVITLYGSEGRSEPHHLCDPQKTVFERGGLDVFLLTTWTSLGNLHSLRLWHDNSGVSPSWYVSQVIVCDMAVKRKWHFLCNCWLAVDLGDCELDRVFIPVSKRELFSFRHLFSSMIVEKFTQDYLWLSIATRHPWNQFTRVQRLSCCMTLLLCNMVINVMFWKINSTTAKRDEQMRPFAVAWSELLVSIHTAVILFPINLVIGRLFPLIEPQETLPLFPPIQASCLSDASVEPLSATMVVEELKETVRFLLRRNTYLLSKCEQPPWSSWDITKLVKLLSSLVSSHLEGQGCHQQGERHWARVVPENHHHFCCYLHRVLQRLKSHLGTLGLTQGHQSCDFLDAASQLQKLQELLETHILPTEQEPSREVTSFAILSSEEGKKPISNGLSKWLTSVCWLLLGFTSLASAFFTALYSLELSKDQATSWMISIILSVLQNIFISQPVKVVFFTFLYSLMMSRMPRLNKENEQQTKRILALLAKCSSSVPGSRDKNNPVYVAPAINSPTKHPERTLKKKKLFKLTGDILVQILFLTLLMTAIYSAKNSNRFYLHQAIWKTFSHQFSEIKLLQDFYPWANHILLPSLYGDYRGKNAVLEPSHCKCGVQLIFQIPRTKTYEKVDEGQLAFCDNGHTCGRPKSLFPGLHLRRFSYICSPRPMVLIPTDELHERLTSKNENGFSYIMRGAFFTSLRLESFTSLQMSKKGCVWSIISQVIYYLLVCYYAFIQGCQLKQQKWRFFTGKRNILDTSIILISFILLGLDMKSISLHKKNMARYRDDQDRFISFYEAVKVNSAATHLVGFPVLLATVQLWNLLRHSPRLRVISRTLSRAWDEVVGFLLIILILLTGYAIAFNLLFGCSISDYRTFFSSAVTVVGLLMGISHQEEVFALDPVLGTFLILTSVILMVLVVINLFVSAILMAFGKERKSLKKEAALIDTLLQKLSNLLGISWPQKTSSEQAATTAVGSDTEVLDELP,1732,"195,894",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (3); Glycosylation (5); Natural variant (10); Region (1); Signal peptide (1); Topological domain (13); Transmembrane (12),"DISULFID 51..137;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00152""; DISULFID 112..129;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00152""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P37173,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFSTCDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPKCIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAISVIIIFYCYRVNRQQKLSSTWETGKTRKLMEFSEHCAIILEDDRSDISSTCANNINHNTELLPIELDTLVGKGRFAEVYKAKLKQNTSEQFETVAVKIFPYEEYASWKTEKDIFSDINLKHENILQFLTAEERKTELGKQYWLITAFHAKGNLQEYLTRHVISWEDLRKLGSSLARGIAHLHSDHTPCGRPKMPIVHRDLKSSNILVKNDLTCCLCDFGLSLRLDPTLSVDDLANSGQVGTARYMAPEVLESRMNLENVESFKQTDVYSMALVLWEMTSRCNAVGEVKDYEPPFGSKVREHPCVESMKDNVLRDRGRPEIPSFWLNHQGIQMVCETLTECWDHDPEARLTAQCVAERFSELEHLDRLSGRSCSEEKIPEDGSLNTTK,567,"64,568",Active site (1); Alternative sequence (1); Beta strand (23); Binding site (1); Chain (1); Disulfide bond (6); Domain (1); Glycosylation (3); Helix (16); Modified residue (3); Mutagenesis (1); Natural variant (38); Nucleotide binding (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (4),"DISULFID 51..84;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 54..71;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 61..67;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 77..101;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 121..136;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""; DISULFID 138..143;  /evidence=""ECO:0000269|PubMed:11850637, ECO:0000269|PubMed:12121646, ECO:0000269|PubMed:12939140, ECO:0000269|PubMed:18243111, ECO:0000269|PubMed:20207738""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15340161"""
Q5T2D2,Trem-like transcript 2 protein (TLT-2) (Triggering receptor expressed on myeloid cells-like protein 2),MAPAFLLLLLLWPQGCVSGPSADSVYTKVRLLEGETLSVQCSYKGYKNRVEGKVWCKIRKKKCEPGFARVWVKGPRYLLQDDAQAKVVNITMVALKLQDSGRYWCMRNTSGILYPLMGFQLDVSPAPQTERNIPFTHLDNILKSGTVTTGQAPTSGPDAPFTTGVMVFTPGLITLPRLLASTRPASKTGYSFTATSTTSQGPRRTMGSQTVTASPSNARDSSAGPESISTKSGDLSTRSPTTGLCLTSRSLLNRLPSMPSIRHQDVYSTVLGVVLTLLVLMLIMVYGFWKKRHMASYSMCSDPSTRDPPGRPEPYVEVYLI,321,"35,127",Chain (1); Disulfide bond (2); Domain (1); Erroneous initiation (3); Glycosylation (1); Natural variant (4); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 41..105;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 56..63;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q9BX59,Tapasin-related protein (TAPASIN-R) (TAP-binding protein-like) (TAP-binding protein-related protein) (TAPBP-R) (Tapasin-like),MGTQEGWCLLLCLALSGAAETKPHPAEGQWRAVDVVLDCFLAKDGAHRGALASSEDRARASLVLKQVPVLDDGSLEDFTDFQGGTLAQDDPPIIFEASVDLVQIPQAEALLHADCSGKEVTCEISRYFLQMTETTVKTAAWFMANMQVSGGGPSISLVMKTPRVTKNEALWHPTLNLPLSPQGTVRTAVEFQVMTQTQSLSFLLGSSASLDCGFSMAPGLDLISVEWRLQHKGRGQLVYSWTAGQGQAVRKGATLEPAQLGMARDASLTLPGLTIQDEGTYICQITTSLYRAQQIIQLNIQASPKVRLSLANEALLPTLICDIAGYYPLDVVVTWTREELGGSPAQVSGASFSSLRQSVAGTYSISSSLTAEPGSAGATYTCQVTHISLEEPLGASTQVVPPERRTALGVIFASSLFLLALMFLGLQRRQAPTGLGLLQAERWETTSCADTQSSHLHEDRTARVSQPS,468,"50,183",Alternative sequence (8); Beta strand (21); Chain (1); Disulfide bond (2); Domain (2); Helix (1); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 212..283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 321..382;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:15340161"""
Q969Z4,Tumor necrosis factor receptor superfamily member 19L (Receptor expressed in lymphoid tissues),MKPSLLCRPLSCFLMLLPWPLATLTSTTLWQCPPGEEPDLDPGQGTLCRPCPPGTFSAAWGSSPCQPHARCSLWRRLEAQVGMATRDTLCGDCWPGWFGPWGVPRVPCQPCSWAPLGTHGCDEWGRRARRGVEVAAGASSGGETRQPGNGTRAGGPEETAAQYAVIAIVPVFCLMGLLGILVCNLLKRKGYHCTAHKEVGPGPGGGGSGINPAYRTEDANEDTIGVLVRLITEKKENAAALEELLKEYHSKQLVQTSHRPVSKLPPAPPNVPHICPHRHHLHTVQGLASLSGPCCSRCSQKKWPEVLLSPEAVAATTPVPSLLPNPTRVPKAGAKAGRQGEITILSVGRFRVARIPEQRTSSMVSEVKTITEAGPSWGDLPDSPQPGLPPEQQALLGSGGSRTKWLKPPAENKAEENRYVVRLSESNLVI,430,"46,092",Chain (1); Disulfide bond (2); Frameshift (1); Glycosylation (1); Modified residue (1); Motif (1); Mutagenesis (1); Natural variant (2); Repeat (1); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 51..65;  /evidence=""ECO:0000250""; DISULFID 71..90;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000269|PubMed:11313261, ECO:0000269|PubMed:15340161"""
O75795,UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT),MSLKWMSVFLLMQLSCYFSSGSCGKVLVWPTEYSHWINMKTILEELVQRGHEVIVLTSSASILVNASKSSAIKLEVYPTSLTKNDLEDFFMKMFDRWTYSISKNTFWSYFSQLQELCWEYSDYNIKLCEDAVLNKKLMRKLQESKFDVLLADAVNPCGELLAELLNIPFLYSLRFSVGYTVEKNGGGFLFPPSYVPVVMSELSDQMIFMERIKNMIYMLYFDFWFQAYDLKKWDQFYSEVLGRPTTLFETMGKAEMWLIRTYWDFEFPRPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSSGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRTMSSRDLLNALKSVINDPIYKENIMKLSRIHHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHNLTWIQYHSLDVIAFLLACVATMIFMITKCCLFCFRKLAKTGKKKKRD,530,"61,095",Chain (1); Glycosylation (3); Modified residue (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P35504,UDP-glucuronosyltransferase 1A5 (UGT1A5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-5) (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E),MATGLQVPLPQLATGLLLLLSVQPWAESGKVLVVPTDGSHWLSMREALRDLHARGHQVVVLTLEVNMYIKEENFFTLTTYAISWTQDEFDRLLLGHTQSFFETEHLLMKFSRRMAIMNNMSLIIHRSCVELLHNEALIRHLHATSFDVVLTDPFHLCAAVLAKYLSIPAVFFLRNIPCDLDFKGTQCPNPSSYIPRLLTTNSDHMTFLQRVKNMLYPLALSYLCHAVSAPYASLASELFQREVSVVDLVSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANGKPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,534,"60,071",Alternative sequence (1); Chain (1); Glycosylation (3); Natural variant (9); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q495A1,T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3),MRWCLLLIWAQGLRQAPLASGMMTGTIETTGNISAEKGGSIILQCHLSSTTAQVTQVNWEQQDQLLAICNADLGWHISPSFKDRVAPGPGLGLTLQSLTVNDTGEYFCIYHTYPDGTYTGRIFLEVLESSVAEHGARFQIPLLGAMAATLVVICTAVIVVVALTRKKKALRIHSVEGDLRRKSAGQEEWSPSAPSPPGSCVQAEAAPAGLCGEQRGEDCAELHDYFNVLSYRSLGNCSFFTETG,244,"26,319",Alternative sequence (2); Beta strand (11); Chain (1); Disulfide bond (1); Domain (1); Erroneous initiation (1); Glycosylation (2); Helix (2); Motif (1); Mutagenesis (2); Natural variant (1); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 45..108;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:22421438""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q5JRA6,Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3),MAAAPGLLVWLLVLRLPWRVPGQLDPSTGRRFSEHKLCADDECSMLMYRGEALEDFTGPDCRFVNFKKGDPVYVYYKLARGWPEVWAGSVGRTFGYFPKDLIQVVHEYTKEELQVPTDETDFVCFDGGRDDFHNYNVEELLGFLELYNSAATDSEKAVEKTLQDMEKNPELSKEREPEPEPVEANSEESDSVFSENTEDLQEQFTTQKHHSHANSQANHAQGEQASFESFEEMLQDKLKVPESENNKTSNSSQVSNEQDKIDAYKLLKKEMTLDLKTKFGSTADALVSDDETTRLVTSLEDDFDEELDTEYYAVGKEDEENQEDFDELPLLTFTDGEDMKTPAKSGVEKYPTDKEQNSNEEDKVQLTVPPGIKNDDKNILTTWGDTIFSIVTGGEETRDTMDLESSSSEEEKEDDDDALVPDSKQGKPQSATDYSDPDNVDDGLFIVDIPKTNNDKEVNAEHHIKGKGRGVQESKRGLVQDKTELEDENQEGMTVHSSVHSNNLNSMPAAEKGKDTLKSAYDDTENDLKGAAIHISKGMLHEEKPGEQILEGGSESESAQKAAGNQMNDRKIQQESLGSAPLMGDDHPNASRDSVEGDALVNGAKLHTLSVEHQREELKEELVLKTQNQPRFSSPDEIDLPRELEDEVPILGRNLPWQQERDVAATASKQMSEKIRLSEGEAKEDSLDEEFFHHKAMQGTEVGQTDQTDSTGGPAFLSKVEEDDYPSEELLEDENAINAKRSKEKNPGNQGRQFDVNLQVPDRAVLGTIHPDPEIEESKQETSMILDSEKTSETAAKGVNTGGREPNTMVEKERPLADKKAQRPFERSDFSDSIKIQTPELGEVFQNKDSDYLKNDNPEEHLKTSGLAGEPEGELSKEDHENTEKYMGTESQGSAAAEPEDDSFHWTPHTSVEPGHSDKREDLLIISSFFKEQQSLQRFQKYFNVHELEALLQEMSSKLKSAQQESLPYNMEKVLDKVFRASESQILSIAEKMLDTRVAENRDLGMNENNIFEEAAVLDDIQDLIYFVRYKHSTAEETATLVMAPPLEEGLGGAMEEMQPLHEDNFSREKTAELNVQVPEEPTHLDQRVIGDTHASEVSQKPNTEKDLDPGPVTTEDTPMDAIDANKQPETAAEEPASVTPLENAILLIYSFMFYLTKSLVATLPDDVQPGPDFYGLPWKPVFITAFLGIASFAIFLWRTVLVVKDRVYQVTEQQISEKLKTIMKENTELVQKLSNYEQKIKESKKHVQETRKQNMILSDEAIKYKDKIKTLEKNQEILDDTAKNLRVMLESEREQNVKNQDLISENKKSIEKLKDVISMNASEFSEVQIALNEAKLSEEKVKSECHRVQEENARLKKKKEQLQQEIEDWSKLHAELSEQIKSFEKSQKDLEVALTHKDDNINALTNCITQLNLLECESESEGQNKGGNDSDELANGEVGGDRNEKMKNQIKQMMDVSRTQTAISVVEEDLKLLQLKLRASVSTKCNLEDQVKKLEDDRNSLQAAKAGLEDECKTLRQKVEILNELYQQKEMALQKKLSQEEYERQEREHRLSAADEKAVSAAEEVKTYKRRIEEMEDELQKTERSFKNQIATHEKKAHENWLKARAAERAIAEEKREAANLRHKLLELTQKMAMLQEEPVIVKPMPGKPNTQNPPRRGPLSQNGSFGPSPVSGGECSPPLTVEPPVRPLSATLNRRDMPRSEFGSVDGPLPHPRWSAEASGKPSPSDPGSGTATMMNSSSRGSSPTRVLDEGKVNMAPKGPPPFPGVPLMSTPMGGPVPPPIRYGPPPQLCGPFGPRPLPPPFGPGMRPPLGLREFAPGVPPGRRDLPLHPRGFLPGHAPFRPLGSLGPREYFIPGTRLPPPTHGPQEYPPPPAVRDLLPSGSRDEPPPASQSTSQDCSQALKQSP,1907,"213,702",Alternative sequence (5); Chain (1); Coiled coil (3); Compositional bias (1); Domain (1); Erroneous initiation (2); Glycosylation (2); Intramembrane (1); Modified residue (15); Natural variant (5); Region (3); Sequence conflict (4); Signal peptide (1); Topological domain (3); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q8N0Z9,V-set and immunoglobulin domain-containing protein 10,MAAGGSAPEPRVLVCLGALLAGWVAVGLEAVVIGEVHENVTLHCGNISGLRGQVTWYRNNSEPVFLLSSNSSLRPAEPRFSLVDATSLHIESLSLGDEGIYTCQEILNVTQWFQVWLQVASGPYQIEVHIVATGTLPNGTLYAARGSQVDFSCNSSSRPPPVVEWWFQALNSSSESFGHNLTVNFFSLLLISPNLQGNYTCLALNQLSKRHRKVTTELLVYYPPPSAPQCWAQMASGSFMLQLTCRWDGGYPDPDFLWIEEPGGVIVGKSKLGVEMLSESQLSDGKKFKCVTSHIVGPESGASCMVQIRGPSLLSEPMKTCFTGGNVTLTCQVSGAYPPAKILWLRNLTQPEVIIQPSSRHLITQDGQNSTLTIHNCSQDLDEGYYICRADSPVGVREMEIWLSVKEPLNIGGIVGTIVSLLLLGLAIISGLLLHYSPVFCWKVGNTSRGQNMDDVMVLVDSEEEEEEEEEEEEDAAVGEQEGAREREELPKEIPKQDHIHRVTALVNGNIEQMGNGFQDLQDDSSEEQSDIVQEEDRPV,540,"59,217",Alternative sequence (1); Chain (1); Compositional bias (2); Disulfide bond (4); Domain (4); Glycosylation (9); Natural variant (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 153..201;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 245..290;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 331..388;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P60852,Zona pellucida sperm-binding protein 1 (Zona pellucida glycoprotein 1) (Zp-1) [Cleaved into: Processed zona pellucida sperm-binding protein 1],MAGGSATTWGYPVALLLLVATLGLGRWLQPDPGLPGLRHSYDCGIKGMQLLVFPRPGQTLRFKVVDEFGNRFDVNNCSICYHWVTSRPQEPAVFSADYRGCHVLEKDGRFHLRVFMEAVLPNGRVDVAQDATLICPKPDPSRTLDSQLAPPAMFSVSTPQTLSFLPTSGHTSQGSGHAFPSPLDPGHSSVHPTPALPSPGPGPTLATLAQPHWGTLEHWDVNKRDYIGTHLSQEQCQVASGHLPCIVRRTSKEACQQAGCCYDNTREVPCYYGNTATVQCFRDGYFVLVVSQEMALTHRITLANIHLAYAPTSCSPTQHTEAFVVFYFPLTHCGTTMQVAGDQLIYENWLVSGIHIQKGPQGSITRDSTFQLHVRCVFNASDFLPIQASIFPPPSPAPMTQPGPLRLELRIAKDETFSSYYGEDDYPIVRLLREPVHVEVRLLQRTDPNLVLLLHQCWGAPSANPFQQPQWPILSDGCPFKGDSYRTQMVALDGATPFQSHYQRFTVATFALLDSGSQRALRGLVYLFCSTSACHTSGLETCSTACSTGTTRQRRSSGHRNDTARPQDIVSSPGPVGFEDSYGQEPTLGPTDSNGNSSLRPLLWAVLLLPAVALVLGFGVFVGLSQTWAQKLWESNRQ,638,"70,049",Chain (2); Disulfide bond (4); Domain (2); Glycosylation (4); Natural variant (1); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 236..261;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00779""; DISULFID 245..260;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00779""; DISULFID 255..270;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00779""; DISULFID 457..478;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00779""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
Q7L0X0,TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644),MEAARALRLLLVVCGCLALPPLAEPVCPERCDCQHPQHLLCTNRGLRVVPKTSSLPSPHDVLTYSLGGNFITNITAFDFHRLGQLRRLDLQYNQIRSLHPKTFEKLSRLEELYLGNNLLQALAPGTLAPLRKLRILYANGNEISRLSRGSFEGLESLVKLRLDGNALGALPDAVFAPLGNLLYLHLESNRIRFLGKNAFAQLGKLRFLNLSANELQPSLRHAATFAPLRSLSSLILSANNLQHLGPRIFQHLPRLGLLSLRGNQLTHLAPEAFWGLEALRELRLEGNRLSQLPTALLEPLHSLEALDLSGNELSALHPATFGHLGRLRELSLRNNALSALSGDIFAASPALYRLDLDGNGWTCDCRLRGLKRWMGDWHSQGRLLTVFVQCRHPPALRGKYLDYLDDQQLQNGSCADPSPSASLTADRRRQPLPTAAGEEMTPPAGLAEELPPQPQLQQQGRFLAGVAWDGAARELVGNRSALRLSRRGPGLQQPSPSVAAAAGPAPQSLDLHKKPQRGRPTRADPALAEPTPTASPGSAPSPAGDPWQRATKHRLGTEHQERAAQSDGGAGLPPLVSDPCDFNKFILCNLTVEAVGADSASVRWAVREHRSPRPLGGARFRLLFDRFGQQPKFHRFVYLPESSDSATLRELRGDTPYLVCVEGVLGGRVCPVAPRDHCAGLVTLPEAGSRGGVDYQLLTLALLTVNALLVLLALAAWASRWLRRKLRARRKGGAPVHVRHMYSTRRPLRSMGTGVSADFSGFQSHRPRTTVCALSEADLIEFPCDRFMDSAGGGAGGSLRREDRLLQRFAD,811,"88,723",Chain (1); Domain (2); Erroneous gene model prediction (1); Erroneous initiation (1); Glycosylation (3); Modified residue (1); Natural variant (4); Repeat (12); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
P0DSE2,M1-specific T cell receptor beta chain (TR beta chain TRBV19*01J2S7*01C*02),MSNQVLCCVVLCLLGANTVDGGITQSPKYLFRKEGQNVTLSCEQNLNHDAMYWYRQDPGQGLRLIYYSQIVNDFQKGDIAEGYSVSREKKESFPLTVTSAQKNPTAFYLCASSIRSSYEQYFGPGTRLTVTEDLKNVFPPKVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVSTDPQPLKEQPALNDSRYCLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRADCGFTSESYQQGVLSATILYEILLGKATLYAVLVSALVLMAMVKRKDSRG,310,"34,792",Binding site (1); Chain (1); Disulfide bond (3); Domain (2); Glycosylation (2); Mutagenesis (4); Natural variant (1); Region (7); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 42..110;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:27036003""; DISULFID 162..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:27036003""; DISULFID 262;  /note=""Interchain (with C-224 in TRAC)"";  /evidence=""ECO:0000250|UniProtKB:P01850""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q15904,V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1),MMAAMATARVRMGPRCAQALWRMPWLPVFLSLAAAAAAAAAEQQVPLVLWSSDRDLWAPAADTHEGHITSDLQLSTYLDPALELGPRNVLLFLQDKLSIEDFTAYGGVFGNKQDSAFSNLENALDLAPSSLVLPAVDWYAVSTLTTYLQEKLGASPLHVDLATLRELKLNASLPALLLIRLPYTASSGLMAPREVLTGNDEVIGQVLSTLKSEDVPYTAALTAVRPSRVARDVAVVAGGLGRQLLQKQPVSPVIHPPVSYNDTAPRILFWAQNFSVAYKDQWEDLTPLTFGVQELNLTGSFWNDSFARLSLTYERLFGTTVTFKFILANRLYPVSARHWFTMERLEVHSNGSVAYFNASQVTGPSIYSFHCEYVSSLSKKGSLLVARTQPSPWQMMLQDFQIQAFNVMGEQFSYASDCASFFSPGIWMGLLTSLFMLFIFTYGLHMILSLKTMDRFDDHKGPTISLTQIV,470,"52,026",Chain (1); Erroneous initiation (2); Glycosylation (7); Modified residue (1); Mutagenesis (1); Natural variant (4); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..41;  /evidence=""ECO:0000255"""
Q6ZP80,Transmembrane protein 182,MRLNIAIFFGALFGALGVLLFLVAFGSDYWLLATEVGRCSGEKNIENVTFHHEGFFWRCWFNGIVEENDSNIWKFWYTNQPPSKNCTHAYLSPYPFMRGEHNSTSYDSAVIYRGFWAVLMLLGVVAVVIASFLIICAAPFASHFLYKAGGGSYIAAGILFSLVVMLYVIWVQAVADMESYRNMKMKDCLDFTPSVLYGWSFFLAPAGIFFSLLAGLLFLVVGWHIQIHH,229,"25,879",Alternative sequence (2); Chain (1); Erroneous initiation (2); Glycosylation (2); Natural variant (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
Q8NDY8,Transmembrane protein 52,MARGPLAARGLRLLLPLLPLLPLLPLPQVALGFADGSCDPSDQCPPQARWSSLWHVGLILLAVLLLLLCGVTAGCVRFCCLRKQAQAQPHLPPARQPCDVAVIPMDSDSPVHSTVTSYSSVQYPLGMRLPLPFGELDLDSMAPPAYSLYTPEPPPSYDEAVKMAKPREEGPALSQKPSPLLGASGLETTPVPQESGPNTQLPPCSPGAP,209,"22,122",Alternative sequence (1); Chain (1); Natural variant (2); Sequence conflict (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..32;  /evidence=""ECO:0000255"""
P36941,Tumor necrosis factor receptor superfamily member 3 (Lymphotoxin-beta receptor) (Tumor necrosis factor C receptor) (Tumor necrosis factor receptor 2-related protein) (Tumor necrosis factor receptor type III) (TNF-RIII) (TNFR-III),MLLPWATSAPGLAWGPLVLGLFGLLAASQPQAVPPYASENQTCRDQEKEYYEPQHRICCSRCPPGTYVSAKCSRIRDTVCATCAENSYNEHWNYLTICQLCRPCDPVMGLEEIAPCTSKRKTQCRCQPGMFCAAWALECTHCELLSDCPPGTEAELKDEVGKGNNHCVPCKAGHFQNTSSPSARCQPHTRCENQGLVEAAPGTAQSDTTCKNPLEPLPPEMSGTMLMLAVLLPLAFFLLLATVFSCIWKSHPSLCRKLGSLLKRRPQGEGPNPVAGSWEPPKAHPYFPDLVQPLLPISGDVSPVSTGLPAAPVLEAGVPQQQSPLDLTREPQLEPGEQSQVAHGTNGIHVTGGSMTITGNIYIYNGPVLGGPPGPGDLPATPEPPYPIPEEGDPGPPGLSTPHQEDGKAWHLAETEHCGATPSNRGPRNQFITHD,435,"46,709",Alternative sequence (1); Chain (1); Disulfide bond (10); Glycosylation (2); Modified residue (1); Natural variant (1); Repeat (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 43..58;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 59..72;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 62..80;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 83..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 101..116;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 104..124;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 126..132;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 139..148;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 142..167;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 170..185;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
P06133,UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (UGT2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1),MSMKWTSALLLIQLSCYFSSGSCGKVLVWPTEFSHWMNIKTILDELVQRGHEVTVLASSASISFDPNSPSTLKFEVYPVSLTKTEFEDIIKQLVKRWAELPKDTFWSYFSQVQEIMWTFNDILRKFCKDIVSNKKLMKKLQESRFDVVLADAVFPFGELLAELLKIPFVYSLRFSPGYAIEKHSGGLLFPPSYVPVVMSELSDQMTFIERVKNMIYVLYFEFWFQIFDMKKWDQFYSEVLGRPTTLSETMAKADIWLIRNYWDFQFPHPLLPNVEFVGGLHCKPAKPLPKEMEEFVQSSGENGVVVFSLGSMVSNTSEERANVIASALAKIPQKVLWRFDGNKPDTLGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGVPLFADQPDNIAHMKAKGAAVSLDFHTMSSTDLLNALKTVINDPLYKENAMKLSRIHHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHDLTWFQYHSLDVTGFLLACVATVIFIITKCLFCVWKFVRTGKKGKRD,528,"60,513",Alternative sequence (4); Chain (1); Glycosylation (1); Natural variant (8); Sequence conflict (5); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000250"""
Q86XT9,Insulin-like growth factor-binding protein 3 receptor (IGFBP-3R) (Transmembrane protein 219),MGNCQAGHNLHLCLAHHPPLVCATLILLLLGLSGLGLGSFLLTHRTGLRSPDIPQDWVSFLRSFGQLTLCPRNGTVTGKWRGSHVVGLLTTLNFGDGPDRNKTRTFQATVLGSQMGLKGSSAGQLVLITARVTTERTAGTCLYFSAVPGILPSSQPPISCSEEGAGNATLSPRMGEECVSVWSHEGLVLTKLLTSEELALCGSRLLVLGSFLLLFCGLLCCVTAMCFHPRRESHWSRTRL,240,"25,724",Chain (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..38;  /evidence=""ECO:0000255"""
Q03167,Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III),MTSHYVIAIFALMSSCLATAGPEPGALCELSPVSASHPVQALMESFTVLSGCASRGTTGLPQEVHVLNLRTAGQGPGQLQREVTLHLNPISSVHIHHKSVVFLLNSPHPLVWHLKTERLATGVSRLFLVSEGSVVQFSSANFSLTAETEERNFPHGNEHLLNWARKEYGAVTSFTELKIARNIYIKVGEDQVFPPKCNIGKNFLSLNYLAEYLQPKAAEGCVMSSQPQNEEVHIIELITPNSNPYSAFQVDITIDIRPSQEDLEVVKNLILILKCKKSVNWVIKSFDVKGSLKIIAPNSIGFGKESERSMTMTKSIRDDIPSTQGNLVKWALDNGYSPITSYTMAPVANRFHLRLENNAEEMGDEEVHTIPPELRILLDPGALPALQNPPIRGGEGQNGGLPFPFPDISRRVWNEEGEDGLPRPKDPVIPSIQLFPGLREPEEVQGSVDIALSVKCDNEKMIVAVEKDSFQASGYSGMDVTLLDPTCKAKMNGTHFVLESPLNGCGTRPRWSALDGVVYYNSIVIQVPALGDSSGWPDGYEDLESGDNGFPGDMDEGDASLFTRPEIVVFNCSLQQVRNPSSFQEQPHGNITFNMELYNTDLFLVPSQGVFSVPENGHVYVEVSVTKAEQELGFAIQTCFISPYSNPDRMSHYTIIENICPKDESVKFYSPKRVHFPIPQADMDKKRFSFVFKPVFNTSLLFLQCELTLCTKMEKHPQKLPKCVPPDEACTSLDASIIWAMMQNKKTFTKPLAVIHHEAESKEKGPSMKEPNPISPPIFHGLDTLTVMGIAFAAFVIGALLTGALWYIYSHTGETAGRQQVPTSPPASENSSAAHSIGSTQSTPCSSSSTA,851,"93,499",Alternative sequence (1); Chain (1); Disulfide bond (3); Domain (1); Frameshift (1); Glycosylation (7); Natural variant (7); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 639..705;  /evidence=""ECO:0000250""; DISULFID 660..730;  /evidence=""ECO:0000250""; DISULFID 710..723;  /evidence=""ECO:0000250""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q6NUS6,Tectonic-3,MRTPQLALLQVFFLVFPDGVRPQPSSSPSGAVPTSLELQRGTDGGTLQSPSEATATRPAVPGLPTVVPTLVTPSAPGNRTVDLFPVLPICVCDLTPGACDINCCCDRDCYLLHPRTVFSFCLPGSVRSSSWVCVDNSVIFRSNSPFPSRVFMDSNGIRQFCVHVNNSNLNYFQKLQKVNATNFQALAAEFGGESFTSTFQTQSPPSFYRAGDPILTYFPKWSVISLLRQPAGVGAGGLCAESNPAGFLESKSTTCTRFFKNLASSCTLDSALNAASYYNFTVLKVPRSMTDPQNMEFQVPVILTSQANAPLLAGNTCQNVVSQVTYEIETNGTFGIQKVSVSLGQTNLTVEPGASLQQHFILRFRAFQQSTAASLTSPRSGNPGYIVGKPLLALTDDISYSMTLLQSQGNGSCSVKRHEVQFGVNAISGCKLRLKKADCSHLQQEIYQTLHGRPRPEYVAIFGNADPAQKGGWTRILNRHCSISAINCTSCCLIPVSLEIQVLWAYVGLLSNPQAHVSGVRFLYQCQSIQDSQQVTEVSLTTLVNFVDITQKPQPPRGQPKMDWKWPFDFFPFKVAFSRGVFSQKCSVSPILILCLLLLGVLNLETM,607,"66,157",Alternative sequence (8); Chain (1); Compositional bias (1); Erroneous initiation (3); Frameshift (1); Glycosylation (3); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q6UXU6,Transmembrane protein 92,MSQAWVPGLAPTLLFSLLAGPQKIAAKCGLILACPKGFKCCGDSCCQENELFPGPVRIFVIIFLVILSVFCICGLAKCFCRNCREPEPDSPVDCRGPLELPSIIPPERVRVSLSAPPPPYSEVILKPSLGPTPTEPPPPYSFRPEEYTGDQRGIDNPAF,159,"17,229",Chain (1); Compositional bias (1); Natural variant (3); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P19438,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]",MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVDRDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECVSCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR,455,"50,495",Alternative sequence (5); Beta strand (15); Chain (2); Disulfide bond (12); Domain (1); Glycosylation (3); Helix (9); Natural variant (15); Region (1); Repeat (4); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),DISULFID 44..58; DISULFID 59..72; DISULFID 62..81; DISULFID 84..99; DISULFID 102..117; DISULFID 105..125; DISULFID 127..143; DISULFID 146..158; DISULFID 149..166; DISULFID 168..179; DISULFID 182..195; DISULFID 185..191,"SIGNAL 1..29;  /evidence=""ECO:0000269|PubMed:2158862"""
Q8TE23,Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2),MGPRAKTISSLFFLLWVLAEPAENSDFYLPGDYLLGGLFSLHANMKGIVHLNFLQVPMCKEYEVKVIGYNLMQAMRFAVEEINNDSSLLPGVLLGYEIVDVCYISNNVQPVLYFLAHEDNLLPIQEDYSNYISRVVAVIGPDNSESVMTVANFLSLFLLPQITYSAISDELRDKVRFPALLRTTPSADHHIEAMVQLMLHFRWNWIIVLVSSDTYGRDNGQLLGERVARRDICIAFQETLPTLQPNQNMTSEERQRLVTIVDKLQQSTARVVVVFSPDLTLYHFFNEVLRQNFTGAVWIASESWAIDPVLHNLTELRHLGTFLGITIQSVPIPGFSEFREWGPQAGPPPLSRTSQSYTCNQECDNCLNATLSFNTILRLSGERVVYSVYSAVYAVAHALHSLLGCDKSTCTKRVVYPWQLLEEIWKVNFTLLDHQIFFDPQGDVALHLEIVQWQWDRSQNPFQSVASYYPLQRQLKNIQDISWHTINNTIPMSMCSKRCQSGQKKKPVGIHVCCFECIDCLPGTFLNHTEDEYECQACPNNEWSYQSETSCFKRQLVFLEWHEAPTIAVALLAALGFLSTLAILVIFWRHFQTPIVRSAGGPMCFLMLTLLLVAYMVVPVYVGPPKVSTCLCRQALFPLCFTICISCIAVRSFQIVCAFKMASRFPRAYSYWVRYQGPYVSMAFITVLKMVIVVIGMLATGLSPTTRTDPDDPKITIVSCNPNYRNSLLFNTSLDLLLSVVGFSFAYMGKELPTNYNEAKFITLSMTFYFTSSVSLCTFMSAYSGVLVTIVDLLVTVLNLLAISLGYFGPKCYMILFYPERNTPAYFNSMIQGYTMRRD,839,"95,183",Chain (1); Glycosylation (8); Natural variant (7); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
P22310,UDP-glucuronosyltransferase 1A4 (UGT1A4) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 2) (hUG-BR2) (UDP-glucuronosyltransferase 1-4) (UDPGT 1-4) (UGT1*4) (UGT1-04) (UGT1.4) (UDP-glucuronosyltransferase 1-D) (UGT-1D) (UGT1D),MARGLQVPLPRLATGLLLLLSVQPWAESGKVLVVPTDGSPWLSMREALRELHARGHQAVVLTPEVNMHIKEEKFFTLTAYAVPWTQKEFDRVTLGYTQGFFETEHLLKRYSRSMAIMNNVSLALHRCCVELLHNEALIRHLNATSFDVVLTDPVNLCGAVLAKYLSIPAVFFWRYIPCDLDFKGTQCPNPSSYIPKLLTTNSDHMTFLQRVKNMLYPLALSYICHTFSAPYASLASELFQREVSVVDLVSYASVWLFRGDFVMDYPRPIMPNMVFIGGINCANGKPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,534,"60,025",Alternative sequence (1); Chain (1); Glycosylation (4); Natural variant (5); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
P21754,Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3) (Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3],MELSYRLFICLLLWGSTELCYPQPLWLLQGGASHPETSVQPVLVECQEATLMVMVSKDLFGTGKLIRAADLTLGPEACEPLVSMDTEDVVRFEVGLHECGNSMQVTDDALVYSTFLLHDPRPVGNLSIVRTNRAEIPIECRYPRQGNVSSQAILPTWLPFRTTVFSEEKLTFSLRLMEENWNAEKRSPTFHLGDAAHLQAEIHTGSHVPLRLFVDHCVATPTPDQNASPYHTIVDFHGCLVDGLTDASSAFKVPRPGPDTLQFTVDVFHFANDSRNMIYITCHLKVTLAEQDPDELNKACSFSKPSNSWFPVEGSADICQCCNKGDCGTPSHSRRQPHVMSQWSRSASRNRRHVTEEADVTVGPLIFLDRRGDHEVEQWALPSDTSVVLLGVGLAVVVSLTLTAVILVLTRRCRTASHPVSASE,424,"47,018",Alternative sequence (3); Chain (2); Disulfide bond (4); Domain (1); Glycosylation (6); Modified residue (1); Natural variant (4); Propeptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 46..140;  /evidence=""ECO:0000269|PubMed:15379548""; DISULFID 78..99;  /evidence=""ECO:0000269|PubMed:15379548""; DISULFID 217..282;  /evidence=""ECO:0000269|PubMed:15379548""; DISULFID 239..300;  /evidence=""ECO:0000269|PubMed:15379548""","SIGNAL 1..22;  /evidence=""ECO:0000269|PubMed:15379548"""
P32241,Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1),MRPPSPLPARWLCVLAGALAWALGPAGGQAARLQEECDYVQMIEVQHKQCLEEAQLENETIGCSKMWDNLTCWPATPRGQVVVLACPLIFKLFSSIQGRNVSRSCTDEGWTHLEPGPYPIACGLDDKAASLDEQQTMFYGSVKTGYTIGYGLSLATLLVATAILSLFRKLHCTRNYIHMHLFISFILRAAAVFIKDLALFDSGESDQCSEGSVGCKAAMVFFQYCVMANFFWLLVEGLYLYTLLAVSFFSERKYFWGYILIGWGVPSTFTMVWTIARIHFEDYGCWDTINSSLWWIIKGPILTSILVNFILFICIIRILLQKLRPPDIRKSDSSPYSRLARSTLLLIPLFGVHYIMFAFFPDNFKPEVKMVFELVVGSFQGFVVAILYCFLNGEVQAELRRKWRRWHLQGVLGWNPKYRHPSGGSNGATCSTQVSMLTRVSPGARRSSSFQAEVSLV,457,"51,547",Alternative sequence (5); Chain (1); Disulfide bond (4); Glycosylation (4); Natural variant (2); Sequence conflict (5); Signal peptide (1); Topological domain (8); Transmembrane (7),"DISULFID 50..72;  /evidence=""ECO:0000250""; DISULFID 63..105;  /evidence=""ECO:0000250""; DISULFID 86..122;  /evidence=""ECO:0000250""; DISULFID 215..285;  /evidence=""ECO:0000269|PubMed:9928020""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q8IW00,V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv],MRLLALAAAALLARAPAPEVCAALNVTVSPGPVVDYLEGENATLLCHVSQKRRKDSLLAVRWFFAHSFDSQEALMVKMTKLRVVQYYGNFSRSAKRRRLRLLEEQRGALYRLSVLTLQPSDQGHYVCRVQEISRHRNKWTAWSNGSSATEMRVISLKASEESSFEKTKETWAFFEDLYVYAVLVCCVGILSILLFMLVIVWQSVFNKRKSRVRHYLVKCPQNSSGETVTSVTSLAPLQPKKGKRQKEKPDIPPAVPAKAPIAPTFHKPKLLKPQRKVTLPKIAEENLTYAELELIKPHRAAKGAPTSTVYAQILFEENKL,320,"36,146",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (4); Natural variant (3); Peptide (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 46..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
O00206,Toll-like receptor 4 (EC 3.2.2.6) (hToll) (CD antigen CD284),MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNITCQMNKTIIGVSVLSVLVVSVVAVLVYKFYFHLMLLAGCIKYGRGENIYDAFVIYSSQDEDWVRNELVKNLEEGVPPFQLCLHYRDFIPGVAIAANIIHEGFHKSRKVIVVVSQHFIQSRWCIFEYEIAQTWQFLSSRAGIIFIVLQKVEKTLLRQQVELYRLLSRNTYLEWEDSVLGRHIFWRRLRKALLDGKSWNPEGTVGTGCNWQEATSI,839,"95,680",Active site (1); Alternative sequence (2); Beta strand (36); Chain (1); Disulfide bond (5); Domain (2); Glycosylation (10); Helix (18); Mutagenesis (9); Natural variant (18); Repeat (18); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (12),"DISULFID 29..40;  /evidence=""ECO:0000269|PubMed:17803912, ECO:0000269|PubMed:19252480""; DISULFID 281..306;  /evidence=""ECO:0000269|PubMed:19252480""; DISULFID 390..391;  /evidence=""ECO:0000269|PubMed:19252480""; DISULFID 583..609;  /evidence=""ECO:0000269|PubMed:19252480""; DISULFID 585..627;  /evidence=""ECO:0000269|PubMed:19252480""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BZD6,Transmembrane gamma-carboxyglutamic acid protein 4 (Proline-rich gamma-carboxyglutamic acid protein 4) (Proline-rich Gla protein 4),MFTLLVLLSQLPTVTLGFPHCARGPKASKHAGEEVFTSKEEANFFIHRRLLYNRFDLELFTPGNLERECNEELCNYEEAREIFVDEDKTIAFWQEYSAKGPTTKSDGNREKIDVMGLLTGLIAAGVFLVIFGLLGYYLCITKCNRLQHPCSSAVYERGRHTPSIIFRRPEEAALSPLPPSVEDAGLPSYEQAVALTRKHSVSPPPPYPGHTKGFRVFKKSMSLPSH,226,"25,403",Chain (1); Compositional bias (1); Disulfide bond (1); Domain (1); Modified residue (2); Motif (2); Mutagenesis (2); Natural variant (3); Propeptide (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 69..74;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00463""","SIGNAL 1..17;  /evidence=""ECO:0000255"""
P0DPE3,Transmembrane and death domain protein 1,MAARTLASALVLTLWVWALAPAGAVDAMGPHAAVRLAELLTPEECGHFRSLLEAPEPDVEAELSRLSEDRLARPEPLNTTSGSPSRRRRREAAEDPAGRVAGPGEVSDGCREALAAWLAPQAASLSWDRLARALRRSGRPDVARELGKNLHQQATLQLRKFGQRFLPRPGAAARVPFAPAPRPRRAAVPAPDWDALQLIVERLPQPLYERSPMGWAGPLALGLLTGFVGALGTGALVVLLTLWITGGDGDRASPGSPGPLATVQGWWETKLLLPKERRAPPGAWAADGPDSPSPHSALALSCKMGAQSWGSGALDGL,317,"33,577",Chain (1); Domain (1); Glycosylation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q5DID0,Uromodulin-like 1 (Olfactorin),MLRTSGLALLALVSAVGPSQASGFTEKGLSLLGYQLCSHRVTHTVQKVEAVQTSYTSYVSCGGWIPWRRCPKMVYRTQYLVVEVPESRNVTDCCEGYEQLGLYCVLPLNQSGQFTSRPGACPAEGPEPSTSPCSLDIDCPGLEKCCPWSGGRYCMAPAPQAPERDPVGSWYNVTILVKMDFKELQQVDPRLLNHMRLLHSLVTSALQPMASTVHHLHSAPGNASTTVSRLLLGLPRPLPVADVSTLLGDIAKRVYEVISVQVQDVNECFYEELNACSGRELCANLEGSYWCVCHQEAPATSPRKLNLEWEDCPPVSDYVVLNVTSDSFQVSWRLNSTQNHTFHVRVYRGMELLRSARTQSQALAVAGLEAGVLYRVKTSYQGCGADVSTTLTIKTNAQVFEVTIKIVNHNLTEKLLNRSSVEYQDFSRQLLHEVESSFPPVVSDLYRSGKLRMQIVSLQAGSVVVRLKLTVQDPGFPMGISTLAPILQPLLASTVFQIDRQGTRVQDWDECVDSAEHDCSPAAWCINLEGSYTCQCRTTRDATPSRAGRACEGDLVSPMGGGLSAATGVTVPGLGTGTAALGLENFTLSPSPGYPQGTPAAGQAWTPEPSPRRGGSNVVGYDRNNTGKGVEQELQGNSIMEPPSWPSPTEDPTGHFLWHATRSTRETLLNPTWLRNEDSGPSGSVDLPLTSTLTALKTPACVPVSIGRIMVSNVTSTGFHLAWEADLAMDSTFQLTLTSMWSPAVVLETWNTSVTLSGLEPGVLHLVEIMAKACGKEGARAHLKVRTAARKLIGKVRIKNVRYSESFRNASSQEYRDFLELFFRMVRGSLPATMCQHMDAGGVRMEVVSVTNGSIVVEFHLLIIADVDVQEVSAAFLTAFQTVPLLEVIRGDTFIQDYDECERKEDDCVPGTSCRNTLGSFTCSCEGGAPDFPVEYSERPCEGDSPGNETWATSPERPLTTAGTKAAFVQGTSPTPQGLPQRLNLTGAVRVLCEIEKVVVAIQKRFLQQESIPESSLYLSHPSCNVSHSNGTHVLLEAGWSECGTLMQSNMTNTVVRTTLRNDLSQEGIIHHLKILSPIYCAFQNDLLTSSGFTLEWGVYTIIEDLHGAGNFVTEMQLFIGDSPIPQNYSVSASDDVRIEVGLYRQKSNLKVVLTECWATPSSNARDPITFSFINNSCPVPNTYTNVIENGNSNKAQFKLRIFSFINDSIVYLHCKLRVCMESPGATCKINCNNFRLLQNSETSATHQMSWGPLIRSEGEPPHAEAGLGAGYVVLIVVAIFVLVAGTATLLIVRYQRMNGRYNFKIQSNNFSYQVFYE,1318,"144,294",Alternative sequence (2); Chain (1); Disulfide bond (9); Domain (10); Erroneous initiation (1); Glycosylation (10); Natural variant (16); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 37..94;  /evidence=""ECO:0000255""; DISULFID 61..70;  /evidence=""ECO:0000255""; DISULFID 93..104;  /evidence=""ECO:0000255""; DISULFID 511..525;  /evidence=""ECO:0000250""; DISULFID 519..534;  /evidence=""ECO:0000250""; DISULFID 536..551;  /evidence=""ECO:0000250""; DISULFID 901..914;  /evidence=""ECO:0000250""; DISULFID 908..923;  /evidence=""ECO:0000250""; DISULFID 1157..1215;  /evidence=""ECO:0000250""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
P35590,Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1),MVWRVPPFLLPILFLASHVGAAVDLTLLANLRLTDPQRFFLTCVSGEAGAGRGSDAWGPPLLLEKDDRIVRTPPGPPLRLARNGSHQVTLRGFSKPSDLVGVFSCVGGAGARRTRVIYVHNSPGAHLLPDKVTHTVNKGDTAVLSARVHKEKQTDVIWKSNGSYFYTLDWHEAQDGRFLLQLPNVQPPSSGIYSATYLEASPLGSAFFRLIVRGCGAGRWGPGCTKECPGCLHGGVCHDHDGECVCPPGFTGTRCEQACREGRFGQSCQEQCPGISGCRGLTFCLPDPYGCSCGSGWRGSQCQEACAPGHFGADCRLQCQCQNGGTCDRFSGCVCPSGWHGVHCEKSDRIPQILNMASELEFNLETMPRINCAAAGNPFPVRGSIELRKPDGTVLLSTKAIVEPEKTTAEFEVPRLVLADSGFWECRVSTSGGQDSRRFKVNVKVPPVPLAAPRLLTKQSRQLVVSPLVSFSGDGPISTVRLHYRPQDSTMDWSTIVVDPSENVTLMNLRPKTGYSVRVQLSRPGEGGEGAWGPPTLMTTDCPEPLLQPWLEGWHVEGTDRLRVSWSLPLVPGPLVGDGFLLRLWDGTRGQERRENVSSPQARTALLTGLTPGTHYQLDVQLYHCTLLGPASPPAHVLLPPSGPPAPRHLHAQALSDSEIQLTWKHPEALPGPISKYVVEVQVAGGAGDPLWIDVDRPEETSTIIRGLNASTRYLFRMRASIQGLGDWSNTVEESTLGNGLQAEGPVQESRAAEEGLDQQLILAVVGSVSATCLTILAALLTLVCIRRSCLHRRRTFTYQSGSGEETILQFSSGTLTLTRRPKLQPEPLSYPVLEWEDITFEDLIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEYASENDHRDFAGELEVLCKLGHHPNIINLLGACKNRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAREHGTASTLSSRQLLRFASDAANGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEQPRNCDDEVYELMRQCWRDRPYERPPFAQIALQLGRMLEARKAYVNMSLFENFTYAGIDATAEEA,1138,"125,090",Active site (1); Alternative sequence (4); Beta strand (6); Binding site (1); Chain (1); Disulfide bond (6); Domain (9); Glycosylation (5); Modified residue (1); Natural variant (3); Nucleotide binding (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 228..237;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 231..244;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 246..255;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 315..327;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 321..333;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DISULFID 335..344;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","SIGNAL 1..21;  /evidence=""ECO:0000269|PubMed:15340161"""
Q96K49,Transmembrane protein 87B,MVAACRSVAGLLPRRRRCFPARAPLLRVALCLLCWTPAAVRAVPELGLWLETVNDKSGPLIFRKTMFNSTDIKLSVKSFHCSGPVKFTIVWHLKYHTCHNEHSNLEELFQKHKLSVDEDFCHYLKNDNCWTTKNENLDCNSDSQVFPSLNNKELINIRNVSNQERSMDVVARTQKDGFHIFIVSIKTENTDASWNLNVSLSMIGPHGYISASDWPLMIFYMVMCIVYILYGILWLTWSACYWKDILRIQFWIAAVIFLGMLEKAVFYSEYQNISNTGLSTQGLLIFAELISAIKRTLARLLVIIVSLGYGIVKPRLGTVMHRVIGLGLLYLIFAAVEGVMRVIGGSNHLAVVLDDIILAVIDSIFVWFIFISLAQTMKTLRLRKNTVKFSLYRHFKNTLIFAVLASIVFMGWTTKTFRIAKCQSDWMERWVDDAFWSFLFSLILIVIMFLWRPSANNQRYAFMPLIDDSDDEIEEFMVTSENLTEGIKLRASKSVSNGTAKPATSENFDEDLKWVEENIPSSFTDVALPVLVDSDEEIMTRSEMAEKMFSSEKIM,555,"63,536",Alternative sequence (1); Chain (1); Glycosylation (3); Modified residue (4); Natural variant (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..42;  /evidence=""ECO:0000255"""
P0DSE1,M1-specific T cell receptor alpha chain (TR alpha chain TRAV27*01J42*01C*01),MVLKFSVSILWIQLAWVSTQLLEQSPQFLSIQEGENLTVYCNSSSVFSSLQWYRQEPGEGPVLLVTVVTGGEVKKLKRLTFQFGDARKDSSLHITAAQPGDTGLYLCAGGGSQGNLIFGKGTKLSVKPIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESSCDVKLVEKSFETDTNLNFQNLSVIGFRILLLKVAGFNLLMTLRLWSS,268,"29,608",Chain (1); Disulfide bond (3); Domain (2); Glycosylation (6); Mutagenesis (3); Natural variant (1); Region (7); Sequence caution (1); Sequence conflict (1); Signal peptide (1); Topological domain (1); Transmembrane (1),"DISULFID 41..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:27036003""; DISULFID 150..200;  /evidence=""ECO:0000250|UniProtKB:P01848""; DISULFID 222;  /note=""Interchain (with C-262 in TRBC2)"";  /evidence=""ECO:0000250|UniProtKB:P01848""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q9UPX0,Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B),MIWYVATFIASVIGTRGLAAEGAHGLREEPEFVTARAGESVVLRCDVIHPVTGQPPPYVVEWFKFGVPIPIFIKFGYYPPHVDPEYAGRASLHDKASLRLEQVRSEDQGWYECKVLMLDQQYDTFHNGSWVHLTINAPPTFTETPPQYIEAKEGGSITMTCTAFGNPKPIVTWLKEGTLLGASGKYQVSDGSLTVTSVSREDRGAYTCRAYSIQGEAVHTTHLLVQGPPFIVSPPENITVNISQDALLTCRAEAYPGNLTYTWYWQDENVYFQNDLKLRVRILIDGTLIIFRVKPEDSGKYTCVPSNSLGRSPSASAYLTVQYPARVLNMPPVIYVPVGIHGYIRCPVDAEPPATVVKWNKDGRPLQVEKNLGWTLMEDGSIRIEEATEEALGTYTCVPYNTLGTMGQSAPARLVLKDPPYFTVLPGWEYRQEAGRELLIPCAAAGDPFPVITWRKVGKPSRSKHSALPSGSLQFRALSKEDHGEWECVATNVVTSITASTHLTVIGTSPHAPGSVRVQVSMTTANVSWEPGYDGGYEQTFSVWMKRAQFGPHDWLSLPVPPGPSWLLVDTLEPETAYQFSVLAQNKLGTSAFSEVVTVNTLAFPITTPEPLVLVTPPRCLIANRTQQGVLLSWLPPANHSFPIDRYIMEFRVAERWELLDDGIPGTEGEFFAKDLSQDTWYEFRVLAVMQDLISEPSNIAGVSSTDIFPQPDLTEDGLARPVLAGIVATICFLAAAILFSTLAACFVNKQRKRKLKRKKDPPLSITHCRKSLESPLSSGKVSPESIRTLRAPSESSDDQGQPAAKRMLSPTREKELSLYKKTKRAISSKKYSVAKAEAEAEATTPIELISRGPDGRFVMDPAEMEPSLKSRRIEGFPFAEETDMYPEFRQSDEENEDPLVPTSVAALKSQLTPLSSSQESYLPPPAYSPRFQPRGLEGPGGLEGRLQATGQARPPAPRPFHHGQYYGYLSSSSPGEVEPPPFYVPEVGSPLSSVMSSPPLPTEGPFGHPTIPEENGENASNSTLPLTQTPTGGRSPEPWGRPEFPFGGLETPAMMFPHQLPPCDVPESLQPKAGLPRGLPPTSLQVPAAYPGILSLEAPKGWAGKSPGRGPVPAPPAAKWQDRPMQPLVSQGQLRHTSQGMGIPVLPYPEPAEPGAHGGPSTFGLDTRWYEPQPRPRPSPRQARRAEPSLHQVVLQPSRLSPLTQSPLSSRTGSPELAARARPRPGLLQQAEMSEITLQPPAAVSFSRKSTPSTGSPSQSSRSGSPSYRPAMGFTTLATGYPSPPPGPAPAGPGDSLDVFGQTPSPRRTGEELLRPETPPPTLPTSGKLQRDRPAPATSPPERALSKL,1349,"147,089",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (5); Domain (7); Glycosylation (3); Modified residue (6); Natural variant (2); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 45..113;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 161..208;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 250..303;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 346..397;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 442..488;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q05996,Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2],MACRQRGGSWSPSGWFNAGWSTYRSISLFFALVTSGNSIDVSQLVNPAFPGTVTCDEREITVEFPSSPGTKKWHASVVDPLGLDMPNCTYILDPEKLTLRATYDNCTRRVHGGHQMTIRVMNNSAALRHGAVMYQFFCPAMQVEETQGLSASTICQKDFMSFSLPRVFSGLADDSKGTKVQMGWSIEVGDGARAKTLTLPEAMKEGFSLLIDNHRMTFHVPFNATGVTHYVQGNSHLYMVSLKLTFISPGQKVIFSSQAICAPDPVTCNATHMTLTIPEFPGKLKSVSFENQNIDVSQLHDNGIDLEATNGMKLHFSKTLLKTKLSEKCLLHQFYLASLKLTFLLRPETVSMVIYPECLCESPVSIVTGELCTQDGFMDVEVYSYQTQPALDLGTLRVGNSSCQPVFEAQSQGLVRFHIPLNGCGTRYKFEDDKVVYENEIHALWTDFPPSKISRDSEFRMTVKCSYSRNDMLLNINVESLTPPVASVKLGPFTLILQSYPDNSYQQPYGENEYPLVRFLRQPIYMEVRVLNRDDPNIKLVLDDCWATSTMDPDSFPQWNVVVDGCAYDLDNYQTTFHPVGSSVTHPDHYQRFDMKAFAFVSEAHVLSSLVYFHCSALICNRLSPDSPLCSVTCPVSSRHRRATGATEAEKMTVSLPGPILLLSDDSSFRGVGSSDLKASGSSGEKSRSETGEEVGSRGAMDTKGHKTAGDVGSKAVAAVAAFAGVVATLGFIYYLYEKRTVSNH,745,"82,357",Alternative sequence (1); Chain (2); Disulfide bond (7); Domain (1); Glycosylation (3); Natural variant (1); Propeptide (1); Region (1); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),"DISULFID 55..138;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 88..106;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 372..465;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 403..424;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 545..615;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 566..634;  /evidence=""ECO:0000250|UniProtKB:P20239""; DISULFID 620..630;  /evidence=""ECO:0000250|UniProtKB:P20239""",SIGNAL 1..38
Q9UPZ6,"Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]",MGLQARRWASGSRGAAGPRRGVLQLLPLPLPLPLLLLLLLRPGAGRAAAQGEAEAPTLYLWKTGPWGRCMGDECGPGGIQTRAVWCAHVEGWTTLHTNCKQAERPNNQQNCFKVCDWHKELYDWRLGPWNQCQPVISKSLEKPLECIKGEEGIQVREIACIQKDKDIPAEDIICEYFEPKPLLEQACLIPCQQDCIVSEFSAWSECSKTCGSGLQHRTRHVVAPPQFGGSGCPNLTEFQVCQSSPCEAEELRYSLHVGPWSTCSMPHSRQVRQARRRGKNKEREKDRSKGVKDPEARELIKKKRNRNRQNRQENKYWDIQIGYQTREVMCINKTGKAADLSFCQQEKLPMTFQSCVITKECQVSEWSEWSPCSKTCHDMVSPAGTRVRTRTIRQFPIGSEKECPEFEEKEPCLSQGDGVVPCATYGWRTTEWTECRVDPLLSQQDKRRGNQTALCGGGIQTREVYCVQANENLLSQLSTHKNKEASKPMDLKLCTGPIPNTTQLCHIPCPTECEVSPWSAWGPCTYENCNDQQGKKGFKLRKRRITNEPTGGSGVTGNCPHLLEAIPCEEPACYDWKAVRLGNCEPDNGKECGPGTQVQEVVCINSDGEEVDRQLCRDAIFPIPVACDAPCPKDCVLSTWSTWSSCSHTCSGKTTEGKQIRARSILAYAGEEGGIRCPNSSALQEVRSCNEHPCTVYHWQTGPWGQCIEDTSVSSFNTTTTWNGEASCSVGMQTRKVICVRVNVGQVGPKKCPESLRPETVRPCLLPCKKDCIVTPYSDWTSCPSSCKEGDSSIRKQSRHRVIIQLPANGGRDCTDPLYEEKACEAPQACQSYRWKTHKWRRCQLVPWSVQQDSPGAQEGCGPGRQARAITCRKQDGGQAGIHECLQYAGPVPALTQACQIPCQDDCQLTSWSKFSSCNGDCGAVRTRKRTLVGKSKKKEKCKNSHLYPLIETQYCPCDKYNAQPVGNWSDCILPEGKVEVLLGMKVQGDIKECGQGYRYQAMACYDQNGRLVETSRCNSHGYIEEACIIPCPSDCKLSEWSNWSRCSKSCGSGVKVRSKWLREKPYNGGRPCPKLDHVNQAQVYEVVPCHSDCNQYLWVTEPWSICKVTFVNMRENCGEGVQTRKVRCMQNTADGPSEHVEDYLCDPEEMPLGSRVCKLPCPEDCVISEWGPWTQCVLPCNQSSFRQRSADPIRQPADEGRSCPNAVEKEPCNLNKNCYHYDYNVTDWSTCQLSEKAVCGNGIKTRMLDCVRSDGKSVDLKYCEALGLEKNWQMNTSCMVECPVNCQLSDWSPWSECSQTCGLTGKMIRRRTVTQPFQGDGRPCPSLMDQSKPCPVKPCYRWQYGQWSPCQVQEAQCGEGTRTRNISCVVSDGSADDFSKVVDEEFCADIELIIDGNKNMVLEESCSQPCPGDCYLKDWSSWSLCQLTCVNGEDLGFGGIQVRSRPVIIQELENQHLCPEQMLETKSCYDGQCYEYKWMASAWKGSSRTVWCQRSDGINVTGGCLVMSQPDADRSCNPPCSQPHSYCSETKTCHCEEGYTEVMSSNSTLEQCTLIPVVVLPTMEDKRGDVKTSRAVHPTQPSSNPAGRGRTWFLQPFGPDGRLKTWVYGVAAGAFVLLIFIVSMIYLACKKPKKPQRRQNNRLKPLTLAYDGDADM,1657,"185,363",Chain (2); Coiled coil (1); Disulfide bond (31); Domain (19); Glycosylation (14); Natural variant (5); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 435..505;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 455..509;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 466..494;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 635..677;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 646..650;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 689..694;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 707..764;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 728..768;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 739..752;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 772..814;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 783..787;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 824..830;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 972..1028;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 994..1032;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1005..1018;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1036..1073;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1047..1051;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1090..1094;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1213..1219;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1232..1279;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1240..1283;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1251..1264;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1287..1325;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1298..1302;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1335..1340;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1351..1407;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1358..1411;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1369..1388;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1415..1459;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1426..1430;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 1469..1474;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""","SIGNAL 1..47;  /evidence=""ECO:0000255"""
Q86VR7,V-set and immunoglobulin domain-containing protein 10-like (VSIG10-like protein),MDNPQALPLFLLLASLVGILTLRASSGLQQTNFSSAFSSDSKSSSQGLGVEVPSIKPPSWKVPDQFLDSKASAGISDSSWFPEALSSNMSGSFWSNVSAEGQDLSPVSPFSETPGSEVFPDISDPQVPAKDPKPSFTVKTPASNISTQVSHTKLSVEAPDSKFSPDDMDLKLSAQSPESKFSAETHSAASFPQQVGGPLAVLVGTTIRLPLVPIPNPGPPTSLVVWRRGSKVLAAGGLGPGAPLISLDPAHRDHLRFDQARGVLELASAQLDDAGVYTAEVIRAGVSQQTHEFTVGVYEPLPQLSVQPKAPETEEGAAELRLRCLGWGPGRGELSWSRDGRALEAAESEGAETPRMRSEGDQLLIVRPVRSDHARYTCRVRSPFGHREAAADVSVFYGPDPPTITVSSDRDAAPARFVTAGSNVTLRCAAASRPPADITWSLADPAEAAVPAGSRLLLPAVGPGHAGTYACLAANPRTGRRRRSLLNLTVADLPPGAPQCSVEGGPGDRSLRFRCSWPGGAPAASLQFQGLPEGIRAGPVSSVLLAAVPAHPRLSGVPITCLARHLVATRTCTVTPEAPREVLLHPLVAETRLGEAEVALEASGCPPPSRASWAREGRPLAPGGGSRLRLSQDGRKLHIGNFSLDWDLGNYSVLCSGALGAGGDQITLIGPSISSWRLQRARDAAVLTWDVERGALISSFEIQAWPDGPALGRTSTYRDWVSLLILGPQERSAVVPLPPRNPGTWTFRILPILGGQPGTPSQSRVYRAGPTLSHGAIAGIVLGSLLGLALLAVLLLLCICCLCRFRGKTPEKKKHPSTLVPVVTPSEKKMHSVTPVEISWPLDLKVPLEDHSSTRAYQAQTPVQLSL,867,"91,625",Alternative sequence (1); Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Glycosylation (8); Natural variant (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 324..378;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 428..471;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..27;  /evidence=""ECO:0000255"""
Q9Y5H7,Protocadherin alpha-5 (PCDH-alpha-5),MVYSRRGSLGSRLLLLWLLLAYWKAGSGQLHYSIPEEAKHGTFVGRIAQDLGLELAELVPRLFRVASKGRGDLLEVNLQNGILFVNSRIDREELCRRRAECSIHLEVIVDRPLQVFHVEVAVKDINDNPPRFSRQEQRLFILESRMPDSRFPLEGASDLDIGANAQLRYRLNPNEYFDLDVKTNEEETNFLELVLRKSLDREETQEHRLLVIATDGGKPELTGTVQLLINVLDANDNAPEFDKSIYNVRLLENAPSGTLVIKLNASDADEGINKEIVYFFSNLVLDDVKSKFIINSNTGEIKVNGELDYEDYNSYEINIDAMDKSTFPLSGHCKVVVKLLDVNDNTPEMAITTLFLPVKEDAPLSTVIALISVSDRDSGANGQVTCSLMPHVPFKLVSTFKNYYSLVLDSALDRESVSVYELVVTARDGGSPSLWATASVSVEVADVNDNAPAFAQPQYTVFVKENNPPGCHIFTVSARDADAQENALVSYSLVERRVGERPLSSYVSVHAESGKVYALQPLDHEEVELLQFQVSARDAGVPPLGSNVTLQVFVLDENDNAPALLVPRVGGTGGAVSELVPRSVGAGHVVAKVRAVDPDSGYNAWLSYELQPAPGSARIPFRVGLYTGEISTTRSLDETEAPRHRLLVLVKDHGEPPLTATATVLVSLVESGQAPKASSRASAGAVGPEAALVDVNVYLIIAICAVSSLLVLTLLLYTALRCSAQPTEAVCTRGKPTLLCSSAVGSWSYSQQRRQRVCSGEAPPKTDLMAFSPSLPQGPTSTDNPRQPNPDWRYSASLRAGMHSSVHLEEAGILRAGPGGPDQQWPTVSSATPEPEAGEVSPPVGAGVNSNSWTFKYGPGNPKQSGPGELPDKFIIPGSPAIISIRQEPTNSQIDKSDFITFGKKEETKKKKKKKKGNKTQEKKEKGNSTTDNSDQ,936,"102,048",Alternative sequence (4); Chain (1); Compositional bias (1); Domain (6); Glycosylation (2); Natural variant (1); Region (1); Repeat (5); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q96JQ0,Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1),MQKELGIVPSCPGMKSPRPHLLLPLLLLLLLLLGAGVPGAWGQAGSLDLQIDEEQPAGTLIGDISAGLPAGTAAPLMYFISAQEGSGVGTDLAIDEHSGVVRTARVLDREQRDRYRFTAVTPDGATVEVTVRVADINDHAPAFPQARAALQVPEHTAFGTRYPLEPARDADAGRLGTQGYALSGDGAGETFRLETRPGPDGTPVPELVVTGELDRENRSHYMLQLEAYDGGSPPRRAQALLDVTLLDINDHAPAFNQSRYHAVVSESLAPGSPVLQVFASDADAGVNGAVTYEINRRQSEGDGPFSIDAHTGLLQLERPLDFEQRRVHELVVQARDGGAHPELGSAFVTVHVRDANDNQPSMTVIFLSADGSPQVSEAAPPGQLVARISVSDPDDGDFAHVNVSLEGGEGHFALSTQDSVIYLVCVARRLDREERDAYNLRVTATDSGSPPLRAEAAFVLHVTDVNDNAPAFDRQLYRPEPLPEVALPGSFVVRVTARDPDQGTNGQVTYSLAPGAHTHWFSIDPTSGIITTAASLDYELEPQPQLIVVATDGGLPPLASSATVSVALQDVNDNEPQFQRTFYNASLPEGTQPGTCFLQVTATDADSGPFGLLSYSLGAGLGSSGSPPFRIDAHSGDVCTTRTLDRDQGPSSFDFTVTAVDGGGLKSMVYVKVFLSDENDNPPQFYPREYAASISAQSPPGTAVLRLRAHDPDQGSHGRLSYHILAGNSPPLFTLDEQSGLLTVAWPLARRANSVVQLEIGAEDGGGLQAEPSARVDISIVPGTPTPPIFEQLQYVFSVPEDVAPGTSVGIVQAHNPPGRLAPVTLSLSGGDPRGLFSLDAVSGLLQTLRPLDRELLGPVLELEVRAGSGVPPAFAVARVRVLLDDVNDNSPAFPAPEDTVLLPPNTAPGTPIYTLRALDPDSGVNSRVTFTLLAGGGGAFTVDPTTGHVRLMRPLGPSGGPAHELELEARDGGSPPRTSHFRLRVVVQDVGTRGLAPRFNSPTYRVDLPSGTTAGTQVLQVQAQAPDGGPITYHLAAEGASSPFGLEPQSGWLWVRAALDREAQELYILKVMAVSGSKAELGQQTGTATVRVSILNQNEHSPRLSEDPTFLAVAENQPPGTSVGRVFATDRDSGPNGRLTYSLQQLSEDSKAFRIHPQTGEVTTLQTLDREQQSSYQLLVQVQDGGSPPRSTTGTVHVAVLDLNDNSPTFLQASGAAGGGLPIQVPDRVPPGTLVTTLQAKDPDEGENGTILYTLTGPGSELFSLHPHSGELLTAAPLIRAERPHYVLTLSAHDQGSPPRSASLQLLVQVLPSARLAEPPPDLAERDPAAPVPVVLTVTAAEGLRPGSLLGSVAAPEPAGVGALTYTLVGGADPEGTFALDAASGRLYLARPLDFEAGPPWRALTVRAEGPGGAGARLLRVQVQVQDENEHAPAFARDPLALALPENPEPGAALYTFRASDADGPGPNSDVRYRLLRQEPPVPALRLDARTGALSAPRGLDRETTPALLLLVEATDRPANASRRRAARVSARVFVTDENDNAPVFASPSRVRLPEDQPPGPAALHVVARDPDLGEAARVSYRLASGGDGHFRLHSSTGALSVVRPLDREQRAEHVLTVVASDHGSPPRSATQVLTVSVADVNDEAPTFQQQEYSVLLRENNPPGTSLLTLRATDPDVGANGQVTYGGVSSESFSLDPDTGVLTTLRALDREEQEEINLTVYAQDRGSPPQLTHVTVRVAVEDENDHAPTFGSAHLSLEVPEGQDPQTLTMLRASDPDVGANGQLQYRILDGDPSGAFVLDLASGEFGTMRPLDREVEPAFQLRIEARDGGQPALSATLLLTVTVLDANDHAPAFPVPAYSVEVPEDVPAGTLLLQLQAHDPDAGANGHVTYYLGAGTAGAFLLEPSSGELRTAAALDREQCPSYTFSVSAVDGAAAGPLSTTVSVTITVRDVNDHAPTFPTSPLRLRLPRPGPSFSTPTLALATLRAEDRDAGANASILYRLAGTPPPGTTVDSYTGEIRVARSPVALGPRDRVLFIVATDLGRPARSATGVIIVGLQGEAERGPRFPRASSEATIRENAPPGTPIVSPRAVHAGGTNGPITYSILSGNEKGTFSIQPSTGAITVRSAEGLDFEVSPRLRLVLQAESGGAFAFTVLTLTLQDANDNAPRFLRPHYVAFLPESRPLEGPLLQVEADDLDQGSGGQISYSLAASQPARGLFHVDPTTGTITTTAILDREIWAETRLVLMATDRGSPALVGSATLTVMVIDTNDNRPTIPQPWELRVSEDALLGSEIAQVTGNDVDSGPVLWYVLSPSGPQDPFSVGRYGGRVSLTGPLDFEQCDRYQLQLLAHDGPHEGRANLTVLVEDVNDNAPAFSQSLYQVMLLEHTPPGSAILSVSATDRDSGANGHISYHLASPADGFSVDPNNGTLFTIVGTVALGHDGSGAVDVVLEARDHGAPGRAARATVHVQLQDQNDHAPSFTLSHYRVAVTEDLPPGSTLLTLEATDADGSRSHAAVDYSIISGNWGRVFQLEPRLAEAGESAGPGPRALGCLVLLEPLDFESLTQYNLTVAAADRGQPPQSSVVPVTVTVLDVNDNPPVFTRASYRVTVPEDTPVGAELLHVEASDADPGPHGLVRFTVSSGDPSGLFELDESSGTLRLAHALDCETQARHQLVVQAADPAGAHFALAPVTIEVQDVNDHGPAFPLNLLSTSVAENQPPGTLVTTLHAIDGDAGAFGRLRYSLLEAGPGPEGREAFALNSSTGELRARVPFDYEHTESFRLLVGAADAGNLSASVTVSVLVTGEDEYDPVFLAPAFHFQVPEGARRGHSLGHVQATDEDGGADGLVLYSLATSSPYFGINQTTGALYLRVDSRAPGSGTATSGGGGRTRREAPRELRLEVIARGPLPGSRSATVPVTVDITHTALGLAPDLNLLLVGAVAASLGVVVVLALAALVLGLVRARSRKAEAAPGPMSQAAPLASDSLQKLGREPPSPPPSEHLYHQTLPSYGGPGAGGPYPRGGSLDPSHSSGRGSAEAAEDDEIRMINEFPRVASVASSLAARGPDSGIQQDADGLSDTSCEPPAPDTWYKGRKAGLLLPGAGATLYREEGPPATATAFLGGCGLSPAPTGDYGFPADGKPCVAGALTAIVAGEEELRGSYNWDYLLSWCPQFQPLASVFTEIARLKDEARPCPPAPRIDPPPLITAVAHPGAKSVPPKPANTAAARAIFPPASHRSPISHEGSLSSAAMSPSFSPSLSPLAARSPVVSPFGVAQGPSASALSAESGLEPPDDTELHI,3298,"346,181",Chain (1); Domain (27); Erroneous initiation (1); Glycosylation (14); Modified residue (1); Natural variant (9); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..42;  /evidence=""ECO:0000255"""
Q9NRJ7,Protocadherin beta-16 (PCDH-beta-16) (Protocadherin-3X),MEIGWMHNRRQRQVLVFFVLLSLSGAGAELGSYSVVEETERGSFVANLGKDLGLGLTEMSTRKARIISQGNKQHLQLKAQTGDLLINEKLDREELCGPTEPCILHFQVLMENPLEIFQAELRVIDINDHSPMFTEKEMILKIPENSPLGTEFPLNHALDLDVGSNNVQNYKISPSSHFRVLIHEFRDGRKYPELVLDKELDREEEPQLRLTLTALDGGSPPRSGTAQVRIEVVDINDNAPEFEQPIYKVQIPENSPLGSLVATVSARDLDGGANGKISYTLFQPSEDISKTLEVNPMTGEVRLRKQVDFEMVTSYEVRIKATDGGGLSGKCTLLLQVVDVNDNPPQVTMSALTSPIPENSPEIVVAVFSVSDPDSGNNGKTISSIQEDLPFLLKPSVKNFYTLVTERALDREARAEYNITLTVTDMGTPRLKTEHNITVQISDVNDNAPTFTQTSYTLFVRENNSPALHIGSVSATDRDSGTNAQVTYSLLPPQDPHLPLASLVSINADNGHLFALRSLDYEALREFEFRVSATDRGSPALSSEALVRVLVLDANDNSPFVLYPLQNGSAPCTELVPRAAEPGYLVTKVVAVDGDSGQNAWLSYQLLKATEPGLFGVWAHNGEVRTARLLSERDAAKQRLVVLVKDNGEPPRSATATLHVLLVDGFSQPFLPLPEAAPGQTQANSLTVYLVVALASVSSLFLFSVLLFVAVRLCRRSRAASVGRCSMPEGPFPGRLVDVSGTGTLSQSYQYEVCLTGGSETSEFKFLKPIIPNFSP,776,"84,983",Chain (1); Domain (6); Erroneous initiation (1); Glycosylation (3); Natural variant (5); Sequence conflict (12); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q7RTX0,Taste receptor type 1 member 3 (Sweet taste receptor T1R3),MLGPAVLGLSLWALLHPGTGAPLCLSQQLRMKGDYVLGGLFPLGEAEEAGLRSRTRPSSPVCTRFSSNGLLWALAMKMAVEEINNKSDLLPGLRLGYDLFDTCSEPVVAMKPSLMFLAKAGSRDIAAYCNYTQYQPRVLAVIGPHSSELAMVTGKFFSFFLMPQVSYGASMELLSARETFPSFFRTVPSDRVQLTAAAELLQEFGWNWVAALGSDDEYGRQGLSIFSALAAARGICIAHEGLVPLPRADDSRLGKVQDVLHQVNQSSVQVVLLFASVHAAHALFNYSISSRLSPKVWVASEAWLTSDLVMGLPGMAQMGTVLGFLQRGAQLHEFPQYVKTHLALATDPAFCSALGEREQGLEEDVVGQRCPQCDCITLQNVSAGLNHHQTFSVYAAVYSVAQALHNTLQCNASGCPAQDPVKPWQLLENMYNLTFHVGGLPLRFDSSGNVDMEYDLKLWVWQGSVPRLHDVGRFNGSLRTERLKIRWHTSDNQKPVSRCSRQCQEGQVRRVKGFHSCCYDCVDCEAGSYRQNPDDIACTFCGQDEWSPERSTRCFRRRSRFLAWGEPAVLLLLLLLSLALGLVLAALGLFVHHRDSPLVQASGGPLACFGLVCLGLVCLSVLLFPGQPSPARCLAQQPLSHLPLTGCLSTLFLQAAEIFVESELPLSWADRLSGCLRGPWAWLVVLLAMLVEVALCTWYLVAFPPEVVTDWHMLPTEALVHCRTRSWVSFGLAHATNATLAFLCFLGTFLVRSQPGCYNRARGLTFAMLAYFITWVSFVPLLANVQVVLRPAVQMGALLLCVLGILAAFHLPRCYLLMRQPGLNTPEFFLGGGPGDAQGQNDGNTGNQGKHE,852,"93,386",Chain (1); Glycosylation (8); Mutagenesis (6); Natural variant (1); Region (1); Sequence conflict (1); Signal peptide (1); Topological domain (8); Transmembrane (7),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
P19224,UDP-glucuronosyltransferase 1-6 (UDPGT 1-6) (UGT1*6) (UGT1-06) (UGT1.6) (EC 2.4.1.17) (Phenol-metabolizing UDP-glucuronosyltransferase) (UDP-glucuronosyltransferase 1-F) (UGT-1F) (UGT1F) (UDP-glucuronosyltransferase 1A6),MACLLRSFQRISAGVFFLALWGMVVGDKLLVVPQDGSHWLSMKDIVEVLSDRGHEIVVVVPEVNLLLKESKYYTRKIYPVPYDQEELKNRYQSFGNNHFAERSFLTAPQTEYRNNMIVIGLYFINCQSLLQDRDTLNFFKESKFDALFTDPALPCGVILAEYLGLPSVYLFRGFPCSLEHTFSRSPDPVSYIPRCYTKFSDHMTFSQRVANFLVNLLEPYLFYCLFSKYEELASAVLKRDVDIITLYQKVSVWLLRYDFVLEYPRPVMPNMVFIGGINCKKRKDLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,532,"60,751",Alternative sequence (2); Chain (1); Erroneous termination (1); Frameshift (1); Glycosylation (2); Natural variant (5); Sequence caution (1); Sequence conflict (8); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
P35916,Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4),MQRGAALCLRLWLCLGLLDGLVSGYSMTPPTLNITEESHVIDTGDSLSISCRGQHPLEWAWPGAQEAPATGDKDSEDTGVVRDCEGTDARPYCKVLLLHEVHANDTGSYVCYYKYIKARIEGTTAASSYVFVRDFEQPFINKPDTLLVNRKDAMWVPCLVSIPGLNVTLRSQSSVLWPDGQEVVWDDRRGMLVSTPLLHDALYLQCETTWGDQDFLSNPFLVHITGNELYDIQLLPRKSLELLVGEKLVLNCTVWAEFNSGVTFDWDYPGKQAERGKWVPERRSQQTHTELSSILTIHNVSQHDLGSYVCKANNGIQRFRESTEVIVHENPFISVEWLKGPILEATAGDELVKLPVKLAAYPPPEFQWYKDGKALSGRHSPHALVLKEVTEASTGTYTLALWNSAAGLRRNISLELVVNVPPQIHEKEASSPSIYSRHSRQALTCTAYGVPLPLSIQWHWRPWTPCKMFAQRSLRRRQQQDLMPQCRDWRAVTTQDAVNPIESLDTWTEFVEGKNKTVSKLVIQNANVSAMYKCVVSNKVGQDERLIYFYVTTIPDGFTIESKPSEELLEGQPVLLSCQADSYKYEHLRWYRLNLSTLHDAHGNPLLLDCKNVHLFATPLAASLEEVAPGARHATLSLSIPRVAPEHEGHYVCEVQDRRSHDKHCHKKYLSVQALEAPRLTQNLTDLLVNVSDSLEMQCLVAGAHAPSIVWYKDERLLEEKSGVDLADSNQKLSIQRVREEDAGRYLCSVCNAKGCVNSSASVAVEGSEDKGSMEIVILVGTGVIAVFFWVLLLLIFCNMRRPAHADIKTGYLSIIMDPGEVPLEEQCEYLSYDASQWEFPRERLHLGRVLGYGAFGKVVEASAFGIHKGSSCDTVAVKMLKEGATASEHRALMSELKILIHIGNHLNVVNLLGACTKPQGPLMVIVEFCKYGNLSNFLRAKRDAFSPCAEKSPEQRGRFRAMVELARLDRRRPGSSDRVLFARFSKTEGGARRASPDQEAEDLWLSPLTMEDLVCYSFQVARGMEFLASRKCIHRDLAARNILLSESDVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLRDGTRMRAPELATPAIRRIMLNCWSGDPKARPAFSELVEILGDLLQGRGLQEEEEVCMAPRSSQSSEEGSFSQVSTMALHIAQADAEDSPPSLQRHSLAARYYNWVSFPGCLARGAETRGSSRMKTFEEFPMTPTTYKGSVDNQTDSGMVLASEEFEQIESRHRQESGFSCKGPGQNVAVTRAHPDSQGRRRRPERGARGGQVFYNSEYGELSEPSEEDHCSPSARVTFFTDNSY,1363,"152,757",Active site (1); Alternative sequence (3); Beta strand (13); Binding site (1); Chain (1); Disulfide bond (7); Domain (8); Erroneous initiation (1); Glycosylation (12); Helix (2); Modified residue (11); Mutagenesis (12); Natural variant (35); Nucleotide binding (1); Sequence conflict (14); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 51..111;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23878260""; DISULFID 158..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23878260""; DISULFID 252..310;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 445..534;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:23878260""; DISULFID 466..486;  /evidence=""ECO:0000269|PubMed:23878260""; DISULFID 578..653;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 699..751;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000269|PubMed:15340161"""
Q8WZ71,Transmembrane protein 158 (40 kDa BINP-binding protein) (p40BBP) (Ras-induced senescence protein 1),MLPLLAALLAAACPLPPVRGGAADAPGLLGVPSNASVNASSADEPIAPRLLASAAPGPPERPGPEEAAAAAAPCNISVQRQMLSSLLVRWGRPRGFQCDLLLFSTNAHGRAFFAAAFHRVGPPLLIEHLGLAAGGAQQDLRLCVGCGWVRGRRTGRLRPAAAPSAAAATAGAPTALPAYPAAEPPGPLWLQGEPLHFCCLDFSLEELQGEPGWRLNRKPIESTLVACFMTLVIVVWSVAALIWPVPIIAGFLPNGMEQRRTTASTTAATPAAVPAGTTAAAAAAAAAAAAAAVTSGVATK,300,"30,404",Alternative sequence (1); Chain (1); Compositional bias (3); Glycosylation (1); Sequence conflict (2); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q99805,Transmembrane 9 superfamily member 2 (p76),MSARLPVLSPPRWPRLLLLSLLLLGAVPGPRRSGAFYLPGLAPVNFCDEEKKSDECKAEIELFVNRLDSVESVLPYEYTAFDFCQASEGKRPSENLGQVLFGERIEPSPYKFTFNKKETCKLVCTKTYHTEKAEDKQKLEFLKKSMLLNYQHHWIVDNMPVTWCYDVEDGQRFCNPGFPIGCYITDKGHAKDACVISSDFHERDTFYIFNHVDIKIYYHVVETGSMGARLVAAKLEPKSFKHTHIDKPDCSGPPMDISNKASGEIKIAYTYSVSFEEDDKIRWASRWDYILESMPHTHIQWFSIMNSLVIVLFLSGMVAMIMLRTLHKDIARYNQMDSTEDAQEEFGWKLVHGDIFRPPRKGMLLSVFLGSGTQILIMTFVTLFFACLGFLSPANRGALMTCAVVLWVLLGTPAGYVAARFYKSFGGEKWKTNVLLTSFLCPGIVFADFFIMNLILWGEGSSAAIPFGTLVAILALWFCISVPLTFIGAYFGFKKNAIEHPVRTNQIPRQIPEQSFYTKPLPGIIMGGILPFGCIFIQLFFILNSIWSHQMYYMFGFLFLVFIILVITCSEATILLCYFHLCAEDYHWQWRSFLTSGFTAVYFLIYAVHYFFSKLQITGTASTILYFGYTMIMVLIFFLFTGTIGFFACFWFVTKIYSVVKVD,663,"75,776",Chain (1); Signal peptide (1); Topological domain (10); Transmembrane (9),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
P25942,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40),MVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECLPCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCVLHRSCSPGFGVKQIATGVSDTICEPCPVGFFSNVSSAFEKCHPWTSCETKDLVVQQAGTNKTDVVCGPQDRLRALVVIPIIFGILFAILLVLVFIKKVAKKPTNKAPHPKQEPQEINFPDDLPGSNTAAPVQETLHGCQPVTQEDGKESRISVQERQ,277,"30,619",Alternative sequence (2); Beta strand (19); Chain (1); Disulfide bond (8); Glycosylation (2); Helix (1); Natural variant (7); Repeat (4); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),DISULFID 26..37; DISULFID 38..51; DISULFID 41..59; DISULFID 62..77; DISULFID 83..103; DISULFID 105..119; DISULFID 111..116; DISULFID 125..143,"SIGNAL 1..20;  /evidence=""ECO:0000269|PubMed:11676606, ECO:0000269|PubMed:15340161, ECO:0000269|PubMed:2463309"""
P25445,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV,335,"37,732",Alternative sequence (11); Beta strand (6); Chain (1); Disulfide bond (8); Domain (1); Glycosylation (3); Helix (8); Lipidation (1); Modified residue (3); Mutagenesis (7); Natural variant (36); Region (2); Repeat (3); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 59..73;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 63..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 85..101;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 104..119;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 107..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 129..143;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 146..157;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 149..165;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P01135,Protransforming growth factor alpha [Cleaved into: Transforming growth factor alpha (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1)],MVPSAGQLALFALGIVLAACQALENSTSPLSADPPVAAAVVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLAVVAASQKKQAITALVVVSIVALAVLIITCVLIHCCQVRKHCEWCRALICRHEKPSALLKGRTACCHSETVV,160,"17,006",Alternative sequence (3); Beta strand (5); Chain (2); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (1); Lipidation (2); Natural variant (1); Propeptide (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 47..60;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:1632509""; DISULFID 55..71;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:1632509""; DISULFID 73..82;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076, ECO:0000269|PubMed:1632509""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
Q9H3N1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),MAPSGSLAVPLAVLVLLLWGAPWTHGRRSNVRVITDENWRELLEGDWMIEFYAPWCPACQNLQPEWESFAEWGEDLEVNIAKVDVTEQPGLSGRFIITALPTIYHCKDGEFRRYQGPRTKKDFINFISDKEWKSIEPVSSWFGPGSVLMSSMSALFQLSMWIRTCHNYFIEDLGLPVWGSYTVFALATLFSGLLLGLCMIFVADCLCPSKRRRPQPYPYPSKKLLSESAQPLKKVEEEQEADEEDVSEEEAESKEGTNKDFPQNAIRQRSLGPSLATDKS,280,"31,791",Beta strand (5); Chain (1); Disulfide bond (1); Domain (1); Helix (6); Modified residue (5); Mutagenesis (2); Sequence conflict (3); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 56..59;  /note=""Redox-active"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00691, ECO:0000269|PubMed:11152479""","SIGNAL 1..26;  /evidence=""ECO:0000255"""
P0DPA2,V-set and immunoglobulin domain-containing protein 8,MRVGGAFHLLLVCLSPALLSAVRINGDGQEVLYLAEGDNVRLGCPYVLDPEDYGPNGLDIEWMQVNSDPAHHRENVFLSYQDKRINHGSLPHLQQRVRFAASDPSQYDASINLMNLQVSDTATYECRVKKTTMATRKVIVTVQARPAVPMCWTEGHMTYGNDVVLKCYASGGSQPLSYKWAKISGHHYPYRAGSYTSQHSYHSELSYQESFHSSINQGLNNGDLVLKDISRADDGLYQCTVANNVGYSVCVVEVKVSDSRRIGVIIGIVLGSLLALGCLAVGIWGLVCCCCGGSGAGGARGAFGYGNGGGVGGGACGDLASEIREDAVAPGCKASGRGSRVTHLLGYPTQNVSRSLRRKYAPPPCGGPEDVALAPCTAAAACEAGPSPVYVKVKSAEPADCAEGPVQCKNGLLV,414,"43,891",Chain (1); Compositional bias (1); Disulfide bond (2); Domain (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 44..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 167..239;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q96IQ7,V-set and immunoglobulin domain-containing protein 2 (Cortical thymocyte-like protein) (CT-like protein),MAELPGPFLCGALLGFLCLSGLAVEVKVPTEPLSTPLGKTAELTCTYSTSVGDSFALEWSFVQPGKPISESHPILYFTNGHLYPTGSKSKRVSLLQNPPTVGVATLKLTDVHPSDTGTYLCQVNNPPDFYTNGLGLINLTVLVPPSNPLCSQSGQTSVGGSTALRCSSSEGAPKPVYNWVRLGTFPTPSPGSMVQDEVSGQLILTNLSLTSSGTYRCVATNQMGSASCELTLSVTEPSQGRVAGALIGVLLGVLLLSVAAFCLVRFQKERGKKPKETYGGSDLREDAIAPGISEHTCMRADSSKGFLERPSSASTVTTTKSKLPMVV,327,"34,348",Alternative sequence (1); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (2); Sequence conflict (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 45..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 166..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..23;  /evidence=""ECO:0000269|PubMed:15340161"""
Q401N2,Zinc-activated ligand-gated ion channel (Ligand-gated ion channel zinc-activated 1) (Ligand-gated ion-channel receptor L2),MMALWSLLHLTFLGFSITLLLVHGQGFQGTAAIWPSLFNVNLSKKVQESIQIPNNGSAPLLVDVRVFVSNVFNVDILRYTMSSMLLLRLSWLDTRLAWNTSAHPRHAITLPWESLWTPRLTILEALWVDWRDQSPQARVDQDGHVKLNLALATETNCNFELLHFPRDHSNCSLSFYALSNTAMELEFQAHVVNEIVSVKREYVVYDLKTQVPPQQLVPCFQVTLRLKNTALKSIIALLVPAEALLLADVCGGLLPLRAIERIGYKVTLLLSYLVLHSSLVQALPSSSSCNPLLIYYFTILLLLLFLSTIETVLLAGLLARGNLGAKSGPSPAPRGEQREHGNPGPHPAEEPSRGVKGSQRSWPETADRIFFLVYVVGVLCTQFVFAGIWMWAACKSDAAPGEAAPHGRRPRL,412,"45,816",Alternative sequence (4); Chain (1); Compositional bias (1); Disulfide bond (1); Erroneous initiation (3); Glycosylation (4); Natural variant (1); Signal peptide (1); Topological domain (5); Transmembrane (4),"DISULFID 157..171;  /evidence=""ECO:0000250""","SIGNAL 1..25;  /evidence=""ECO:0000255"""
P41587,Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2),MRTLLPPALLTCWLLAPVNSIHPECRFHLEIQEEETKCAELLRSQTEKHKACSGVWDNITCWRPANVGETVTVPCPKVFSNFYSKAGNISKNCTSDGWSETFPDFVDACGYSDPEDESKITFYILVKAIYTLGYSVSLMSLATGSIILCLFRKLHCTRNYIHLNLFLSFILRAISVLVKDDVLYSSSGTLHCPDQPSSWVGCKLSLVFLQYCIMANFFWLLVEGLYLHTLLVAMLPPRRCFLAYLLIGWGLPTVCIGAWTAARLYLEDTGCWDTNDHSVPWWVIRIPILISIIVNFVLFISIIRILLQKLTSPDVGGNDQSQYKRLAKSTLLLIPLFGVHYMVFAVFPISISSKYQILFELCLGSFQGLVVAVLYCFLNSEVQCELKRKWRSRCPTPSASRDYRVCGSSFSRNGSEGALQFHRGSRAQSFLQTETSVI,438,"49,479",Alternative sequence (2); Beta strand (5); Chain (1); Disulfide bond (4); Glycosylation (3); Helix (3); Natural variant (2); Sequence conflict (3); Signal peptide (1); Topological domain (8); Transmembrane (7); Turn (1),"DISULFID 38..61;  /evidence=""ECO:0000269|Ref.12""; DISULFID 52..93;  /evidence=""ECO:0000269|Ref.12""; DISULFID 75..109;  /evidence=""ECO:0000269|Ref.12""; DISULFID 202..271;  /evidence=""ECO:0000250""","SIGNAL 1..23;  /evidence=""ECO:0000255"""
P55808,Glycoprotein Xg (Protein PBDX),MESWWGLPCLAFLCFLMHARGQRDFDLADALDDPEPTKKPNSDIYPKPKPPYYPQPENPDSGGNIYPRPKPRPQPQPGNSGNSGGYFNDVDRDDGRYPPRPRPRPPAGGGGGGYSSYGNSDNTHGGDHHSTYGNPEGNMVAKIVSPIVSVVVVTLLGAAASYFKLNNRRNCFRTHEPENV,180,"19,723",Alternative sequence (2); Chain (1); Natural variant (1); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q6UX27,V-set and transmembrane domain-containing protein 1 (Signal inhibitory receptor on leukocytes-1) (SIRL-1),MTAEFLSLLCLGLCLGYEDEKKNEKPPKPSLHAWPSSVVEAESNVTLKCQAHSQNVTFVLRKVNDSGYKQEQSSAENEAEFPFTDLKPKDAGRYFCAYKTTASHEWSESSEHLQLVVTDKHDELEAPSMKTDTRTIFVAIFSCISILLLFLSVFIIYRCSQHSSSSEESTKRTSHSKLPEQEAAEADLSNMERVSLSTADPQGVTYAELSTSALSEAASDTTQEPPGSHEYAALKV,236,"26,109",Alternative sequence (3); Chain (1); Disulfide bond (1); Domain (1); Glycosylation (2); Motif (2); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 49..96;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..16;  /evidence=""ECO:0000269|PubMed:15340161"""
O15533,Tapasin (TPN) (TPSN) (NGS-17) (TAP-associated protein) (TAP-binding protein),MKSLSLLLAVALGLATAVSAGPAVIECWFVEDASGKGLAKRPGALLLRQGPGEPPPRPDLDPELYLSVHDPAGALQAAFRRYPRGAPAPHCEMSRFVPLPASAKWASGLTPAQNCPRALDGAWLMVSISSPVLSLSSLLRPQPEPQQEPVLITMATVVLTVLTHTPAPRVRLGQDALLDLSFAYMPPTSEAASSLAPGPPPFGLEWRRQHLGKGHLLLAATPGLNGQMPAAQEGAVAFAAWDDDEPWGPWTGNGTFWLPRVQPFQEGTYLATIHLPYLQGQVTLELAVYKPPKVSLMPATLARAAPGEAPPELLCLVSHFYPSGGLEVEWELRGGPGGRSQKAEGQRWLSALRHHSDGSVSLSGHLQPPPVTTEQHGARYACRIHHPSLPASGRSAEVTLEVAGLSGPSLEDSVGLFLSAFLLLGLFKALGWAAVYLSTCKDSKKKAE,448,"47,626",Alternative sequence (3); Beta strand (25); Chain (1); Disulfide bond (3); Domain (1); Glycosylation (1); Helix (5); Mutagenesis (3); Natural variant (1); Sequence caution (1); Sequence conflict (3); Signal peptide (1); Site (2); Topological domain (2); Transmembrane (1),"DISULFID 27..91;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:19119025""; DISULFID 115;  /note=""Interchain (with C-57 in PDIA3)"";  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:19119025""; DISULFID 315..382;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114, ECO:0000269|PubMed:19119025""","SIGNAL 1..20;  /evidence=""ECO:0000244|PubMed:25944712"""
Q13641,Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1),MPGGCSRGPAAGDGRLRLARLALVLLGWVSSSSPTSSASSFSSSAPFLASAVSAQPPLPDQCPALCECSEAARTVKCVNRNLTEVPTDLPAYVRNLFLTGNQLAVLPAGAFARRPPLAELAALNLSGSRLDEVRAGAFEHLPSLRQLDLSHNPLADLSPFAFSGSNASVSAPSPLVELILNHIVPPEDERQNRSFEGMVVAALLAGRALQGLRRLELASNHFLYLPRDVLAQLPSLRHLDLSNNSLVSLTYVSFRNLTHLESLHLEDNALKVLHNGTLAELQGLPHIRVFLDNNPWVCDCHMADMVTWLKETEVVQGKDRLTCAYPEKMRNRVLLELNSADLDCDPILPPSLQTSYVFLGIVLALIGAIFLLVLYLNRKGIKKWMHNIRDACRDHMEGYHYRYEINADPRLTNLSSNSDV,420,"46,032",Beta strand (16); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (2); Glycosylation (3); Helix (11); Modified residue (1); Mutagenesis (5); Repeat (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 62..68;  /evidence=""ECO:0000269|PubMed:24582434""; DISULFID 66..77;  /evidence=""ECO:0000269|PubMed:24582434""; DISULFID 298..323;  /evidence=""ECO:0000269|PubMed:24582434""; DISULFID 300..344;  /evidence=""ECO:0000269|PubMed:24582434""","SIGNAL 1..31;  /evidence=""ECO:0000255"""
Q9P0T7,Proton-transporting V-type ATPase complex assembly regulator TMEM9 (v-ATPase assembly regulator TMEM9) (Dermal papilla-derived protein 4) (Transmembrane protein 9) (Protein TMEM9),MKLLSLVAVVGCLLVPPAEANKSSEDIRCKCICPPYRNISGHIYNQNVSQKDCNCLHVVEPMPVPGHDVEAYCLLCECRYEERSTTTIKVIIVIYLSVVGALLLYMAFLMLVDPLIRKPDAYTEQLHNEEENEDARSMAAAAASLGGPRANTVLERVEGAQQRWKLQVQEQRKTVFDRHKMLS,183,"20,574",Chain (1); Glycosylation (3); Modified residue (2); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q6P7N7,Transmembrane protein 81,MKVLATSFVLGSLGLAFYLPLVVTTPKTLAIPEKLQEAVGKVIINATTCTVTCGLGYKEETVCEVGPDGVRRKCQTRRLECLTNWICGMLHFTILIGKEFELSCLSSDILEFGQEAFRFTWRLARGVISTDDEVFKPFQANSHFVKFKYAQEYDSGTYRCDVQLVKNLRLVKRLYFGLRVLPPNLVNLNFHQSLTEDQKLIDEGLEVNLDSYSKPHHPKWKKKVASALGIGIAIGVVGGVLVRIVLCALRGGLQQ,255,"28,468",Chain (1); Disulfide bond (1); Domain (1); Glycosylation (1); Natural variant (2); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 104..160;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..30;  /evidence=""ECO:0000255"""
Q6UWJ1,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),MKVLGRSFFWVLFPVLPWAVQAVEHEEVAQRVIKLHRGRGVAAMQSRQWVRDSCRKLSGLLRQKNAVLNKLKTAIGAVEKDVGLSDEEKLFQVHTFEIFQKELNESENSVFQAVYGLQRALQGDYKDVVNMKESSRQRLEALREAAIKEETEYMELLAAEKHQVEALKNMQHQNQSLSMLDEILEDVRKAADRLEEEIEEHAFDDNKSVKGVNFEAVLRVEEEEANSKQNITKREVEDDLGLSMLIDSQNNQYILTKPRDSTIPRADHHFIKDIVTIGMLSLPCGWLCTAIGLPTMFGYIICGVLLGPSGLNSIKSIVQVETLGEFGVFFTLFLVGLEFSPEKLRKVWKISLQGPCYMTLLMIAFGLLWGHLLRIKPTQSVFISTCLSLSSTPLVSRFLMGSARGDKEGDIDYSTVLLGMLVTQDVQLGLFMAVMPTLIQAGASASSSIVVEVLRILVLIGQILFSLAAVFLLCLVIKKYLIGPYYRKLHMESKGNKEILILGISAFIFLMLTVTELLDVSMELGCFLAGALVSSQGPVVTEEIATSIEPIRDFLAIVFFASIGLHVFPTFVAYELTVLVFLTLSVVVMKFLLAALVLSLILPRSSQYIKWIVSAGLAQVSEFSFVLGSRARRAGVISREVYLLILSVTTLSLLLAPVLWRAAITRCVPRPERRSSL,677,"75,598",Alternative sequence (4); Chain (1); Coiled coil (1); Compositional bias (1); Erroneous initiation (1); Frameshift (1); Glycosylation (2); Natural variant (3); Sequence conflict (4); Signal peptide (1); Transmembrane (10),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
Q96AW1,"Vesicular, overexpressed in cancer, prosurvival protein 1 (EGFR-coamplified and overexpressed protein) (ECop) (Glioblastoma-amplified secreted protein) (Putative NF-kappa-B-activating protein 055N)",MRRQPAKVAALLLGLLLECTEAKKHCWYFEGLYPTYYICRSYEDCCGSRCCVRALSIQRLWYFWFLLMMGVLFCCGAGFFIRRRMYPPPLIEEPAFNVSYTRQPPNPGPGAQQPGPPYYTDPGGPGMNPVGNSMAMAFQVPPNSPQGSVACPPPPAYCNTPPPPYEQVVKAK,172,"19,224",Alternative sequence (3); Chain (1); Compositional bias (1); Erroneous translation (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
A8MXK1,V-set and transmembrane domain-containing protein 5,MRPLPSGRRKTRGISLGLFALCLAAARCLQSQGVSLYIPQATINATVKEDILLSVEYSCHGVPTIEWTYSSNWGTQKIVEWKPGTQANISQSHKDRVCTFDNGSIQLFSVGVRDSGYYVITVTERLGSSQFGTIVLHVSEILYEDLHFVAVILAFLAAVAAVLISLMWVCNKCAYKFQRKRRHKLKESTTEEIELEDVEC,200,"22,377",Chain (1); Domain (1); Glycosylation (1); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9Y6Q6,Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265),MAPRARRRRPLFALLLLCALLARLQVALQIAPPCTSEKHYEHLGRCCNKCEPGKYMSSKCTTTSDSVCLPCGPDEYLDSWNEEDKCLLHKVCDTGKALVAVVAGNSTTPRRCACTAGYHWSQDCECCRRNTECAPGLGAQHPLQLNKDTVCKPCLAGYFSDAFSSTDKCRPWTNCTFLGKRVEHHGTEKSDAVCSSSLPARKPPNEPHVYLPGLIILLLFASVALVAAIIFGVCYRKKGKALTANLWHWINEACGRLSGDKESSGDSCVSTHTANFGQQGACEGVLLLTLEEKTFPEDMCYPDQGGVCQGTCVGGGPYAQGEDARMLSLVSKTEIEEDSFRQMPTEDEYMDRPSQPTDQLLFLTEPGSKSTPPFSEPLEVGENDSLSQCFTGTQSTVGSESCNCTEPLCRTDWTPMSSENYLQKEVDSGHCPHWAASPSPNWADVCTGCRNPPGEDCEPLVGSPKRGPLPQCAYGMGLPPEEEASRTEARDQPEDGADGRLPSSARAGAGSGSSPGGQSPASGNVTGNSNSTFISSGQVMNFKGDIIVVYVSQTSQEGAAAAAEPMGRPVQEETLARRDSFAGNGPRFPDPCGGPEGLREPEKASRPVQEQGGAKA,616,"66,034",Alternative sequence (6); Beta strand (1); Chain (1); Disulfide bond (10); Erroneous initiation (1); Glycosylation (2); Metal binding (3); Modified residue (1); Natural variant (9); Repeat (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 34..46;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 47..60;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 50..68;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 71..86;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 92..112;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 114..127;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 124..126;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 133..151;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 154..169;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 175..194;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q93038,Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death) (LARD) (Protein WSL) (Protein WSL-1),MEQRPRGCAAVAAALLLVLLGARAQGGTRSPRCDCAGDFHKKIGLFCCRGCPAGHYLKAPCTEPCGNSTCLVCPQDTFLAWENHHNSECARCQACDEQASQVALENCSAVADTRCGCKPGWFVECQVSQCVSSSPFYCQPCLDCGALHRHTRLLCSRRDTDCGTCLPGFYEHGDGCVSCPTSTLGSCPERCAAVCGWRQMFWVQVLLAGLVVPLLLGATLTYTYRHCWPHKPLVTADEAGMEALTPPPATHLSPLDSAHTLLAPPDSSEKICTVQLVGNSWTPGYPETQEALCPQVTWSWDQLPSRALGPAAAPTLSPESPAGSPAMMLQPGPQLYDVMDAVPARRWKEFVRTLGLREAEIEAVEVEIGRFRDQQYEMLKRWRQQQPAGLGAVYAALERMGLDGCVEDLRSRLQRGP,417,"45,385",Alternative sequence (14); Chain (1); Disulfide bond (12); Domain (1); Glycosylation (2); Helix (6); Mutagenesis (3); Natural variant (5); Repeat (4); Sequence conflict (7); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 35..47;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 48..61;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 51..70;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 73..89;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 92..107;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 95..115;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 117..130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 138..155;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 141..162;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 165..176;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 179..191;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 187..195;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P40126,L-dopachrome tautomerase (DCT) (DT) (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2),MSPLWWGFLLSCLGCKILPGAQGQFPRVCMTVDSLVNKECCPRLGAESANVCGSQQGRGQCTEVRADTRPWSGPYILRNQDDRELWPRKFFHRTCKCTGNFAGYNCGDCKFGWTGPNCERKKPPVIRQNIHSLSPQEREQFLGALDLAKKRVHPDYVITTQHWLGLLGPNGTQPQFANCSVYDFFVWLHYYSVRDTLLGPGRPYRAIDFSHQGPAFVTWHRYHLLCLERDLQRLIGNESFALPYWNFATGRNECDVCTDQLFGAARPDDPTLISRNSRFSSWETVCDSLDDYNHLVTLCNGTYEGLLRRNQMGRNSMKLPTLKDIRDCLSLQKFDNPPFFQNSTFSFRNALEGFDKADGTLDSQVMSLHNLVHSFLNGTNALPHSAANDPIFVVLHSFTDAIFDEWMKRFNPPADAWPQELAPIGHNRMYNMVPFFPPVTNEELFLTSDQLGYSYAIDLPVSVEETPGWPTTLLVVMGTLVALVGLFVLLAFLQYRRLRKGYTPLMETHLSSKRYTEEA,519,"59,145",Alternative sequence (1); Chain (1); Glycosylation (6); Metal binding (6); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P22309,UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1),MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVLAPDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDSAMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLEFEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQREVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH,533,"59,591",Alternative sequence (1); Chain (1); Erroneous gene model prediction (2); Glycosylation (3); Mutagenesis (4); Natural variant (48); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..25;  /evidence=""ECO:0000255"""
P54855,UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3),MSLKWTSVFLLIQLSCYFSSGSCGKVLVWPTEYSHWINMKTILEELVQRGHEVTVLTSSASTLVNASKSSAIKLEVYPTSLTKNYLEDSLLKILDRWIYGVSKNTFWSYFSQLQELCWEYYDYSNKLCKDAVLNKKLMMKLQESKFDVILADALNPCGELLAELFNIPFLYSLRFSVGYTFEKNGGGFLFPPSYVPVVMSELSDQMIFMERIKNMIHMLYFDFWFQIYDLKKWDQFYSEVLGRPTTLFETMGKAEMWLIRTYWDFEFPRPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSSGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRTMSSRDLLNALKSVINDPVYKENVMKLSRIHHDQPMKPLDRAVFWIEFVMRHKGAKHLRVAAHNLTWIQYHSLDVIAFLLACVATVIFIITKFCLFCFRKLAKKGKKKKRD,530,"61,036",Beta strand (6); Chain (1); Glycosylation (3); Helix (9); Modified residue (1); Natural variant (2); Sequence conflict (12); Signal peptide (1); Transmembrane (1); Turn (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
P0DTE4,UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17),MLNNLLLFSLQISLIGTTLGGNVLIWPMEGSHWLNVKIIIDELIKKEHNVTVLVASGALFITPTSNPSLTFEIYRVPFGKERIEGVIKDFVLTWLENRPSPSTIWRFYQEMAKVIKDFHMVSQEICDGVLKNQQLMAKLKKSKFEVLVSDPVFPCGDIVALKLGIPFMYSLRFSPASTVEKHCGKVPYPPSYVPAVLSELTDQMSFTDRIRNFISYHLQDYMFETLWKSWDSYYSKALGRPTTLCETMGKAEIWLIRTYWDFEFPRPYLPNFEFVGGLHCKPAKPLPKEMEEFIQSSGKNGVVVFSLGSMVKNLTEEKANLIASALAQIPQKVLWRYKGKKPATLGNNTQLFDWIPQNDLLGHPKTKAFITHGGTNGIYEAIYHGVPMVGVPMFADQPDNIAHMKAKGAAVEVNLNTMTSVDLLSALRTVINEPSYKENAMRLSRIHHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHDLTWFQYHSLDVIGFLLVCVTTAIFLVIQCCLFSCQKFGKIGKKKKRE,527,"59,926",Alternative sequence (3); Chain (1); Glycosylation (3); Natural variant (3); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..20;  /evidence=""ECO:0000255"""
Q9UK28,Transmembrane protein 59-like (Brain-specific membrane-anchored protein),MAAVALMPPPLLLLLLLASPPAASAPSARDPFAPQLGDTQNCQLRCRDRDLGPQPSQAGLEGASESPYDRAVLISACERGCRLFSICRFVARSSKPNATQTECEAACVEAYVKEAEQQACSHGCWSQPAEPEPEQKRKVLEAPSGALSLLDLFSTLCNDLVNSAQGFVSSTWTYYLQTDNGKVVVFQTQPIVESLGFQGGRLQRVEVTWRGSHPEALEVHVDPVGPLDKVRKAKIRVKTSSKAKVESEEPQDNDFLSCMSRRSGLPRWILACCLFLSVLVMLWLSCSTLVTAPGQHLKFQPLTLEQHKGFMMEPDWPLYPPPSHACEDSLPPYKLKLDLTKL,342,"37,619",Chain (1); Glycosylation (1); Motif (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..24;  /evidence=""ECO:0000255"""
Q8N816,Transmembrane protein 99,MVGILPLCCSGCVPSLCCSSYVPSVAPTAAHSVRVPHSAGHCGQRVLACSLPQVFLKPWIFVEHFSSWLSLELFSFLRYLGTLLCACGHRLREGLLLPCLLGVGSWLLFNNWTGGSWFSLHLQQVSLSQGSHVAAFLPEAIGPGVPVPVSGESTSAQQSHAGWQLSAEADACPSVLYSEVLEWNKNINTYTSFHDFCLILGIFLFCFVLAVIGLPYIKPGLSLSVALLWQSLILLSSLVQQDSQVHTWGCLFSTFTST,258,"27,975",Alternative sequence (1); Chain (1); Natural variant (3); Signal peptide (1); Transmembrane (3),,"SIGNAL 1..19;  /evidence=""ECO:0000255"""
Q3KNT9,Sperm-egg fusion protein TMEM95 (Transmembrane protein 95),MWRLALGGVFLAAAQACVFCRLPAHDLSGRLARLCSQMEARQKECGASPDFSAFALDEVSMNKVTEKTHRVLRVMEIKEAVSSLPSYWSWLRKTKLPEYTREALCPPACRGSTTLYNCSTCKGTEVSCWPRKRCFPGSQDLWEAKILLLSIFGAFLLLGVLSLLVESHHLQAKSGL,176,"19,597",Alternative sequence (2); Chain (1); Erroneous initiation (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..16;  /evidence=""ECO:0000255"""
Q7Z7H5,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),MAGVGAGPLRAMGRQALLLLALCATGAQGLYFHIGETEKRCFIEEIPDETMVIGNYRTQMWDKQKEVFLPSTPGLGMHVEVKDPDGKVVLSRQYGSEGRFTFTSHTPGDHQICLHSNSTRMALFAGGKLRVHLDIQVGEHANNYPEIAAKDKLTELQLRARQLLDQVEQIQKEQDYQRYREERFRLTSESTNQRVLWWSIAQTVILILTGIWQMRHLKSFFEAKKLV,227,"25,943",Alternative sequence (3); Chain (1); Coiled coil (1); Domain (1); Erroneous initiation (2); Glycosylation (1); Motif (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9Y3A6,Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28),MGDKIWLPFPVLLLAALPPVLLPGAAGFTPSLDSDFTFTLPAGQKECFYQPMPLKASLEIEYQVLDGAGLDIDFHLASPEGKTLVFEQRKSDGVHTVETEVGDYMFCFDNTFSTISEKVIFFELILDNMGEQAQEQEDWKKYITGTDILDMKLEDILESINSIKSRLSKSGHIQTLLRAFEARDRNIQESNFDRVNFWSMVNLVVMVVVSAIQVYMLKSLFEDKRKSRT,229,"26,005",Alternative sequence (1); Chain (1); Domain (1); Natural variant (1); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..27;  /evidence=""ECO:0000244|PubMed:25944712, ECO:0000255"""
O43914,TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein),MGGLEPCSRLLLLPLLLAVSGLRPVQAQAQSDCSCSTVSPGVLAGIVMGDLVLTVLIALAVYFLGRLVPRGRGAAEAATRKQRITETESPYQELQGQRSDVYSDLNTQRPYYK,113,"12,179",Alternative sequence (2); Chain (1); Disulfide bond (1); Domain (1); Helix (1); Metal binding (1); Modified residue (2); Mutagenesis (7); Natural variant (9); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 35;  /note=""Interchain"";  /evidence=""ECO:0000244|PDB:2L34, ECO:0000244|PDB:2L35, ECO:0000244|PDB:4WOL, ECO:0000269|PubMed:20890284, ECO:0000269|PubMed:25981043""","SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q6NUS8,UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17),MVGQRVLLLVAFLLSGVLLSEAAKILTISTLGGSHYLLLDRVSQILQEHGHNVTMLHQSGKFLIPDIKEEEKSYQVIRWFSPEDHQKRIKKHFDSYIETALDGRKESEALVKLMEIFGTQCSYLLSRKDIMDSLKNENYDLVFVEAFDFCSFLIAEKLVKPFVAILPTTFGSLDFGLPSPLSYVPVFPSLLTDHMDFWGRVKNFLMFFSFSRSQWDMQSTFDNTIKEHFPEGSRPVLSHLLLKAELWFVNSDFAFDFARPLLPNTVYIGGLMEKPIKPVPQDLDNFIANFGDAGFVLVAFGSMLNTHQSQEVLKKMHNAFAHLPQGVIWTCQSSHWPRDVHLATNVKIVDWLPQSDLLAHPSIRLFVTHGGQNSVMEAIRHGVPMVGLPVNGDQHGNMVRVVAKNYGVSIRLNQVTADTLTLTMKQVIEDKRYKSAVVAASVILHSQPLSPAQRLVGWIDHILQTGGATHLKPYAFQQPWHEQYLIDVFVFLLGLTLGTMWLCGKLLGVVARWLRGARKVKKT,523,"59,151",Alternative sequence (3); Chain (1); Glycosylation (1); Natural variant (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..22;  /evidence=""ECO:0000255"""
A0A1B0GUA7,Testis-expressed protein 51,MLPLLIICLLPAIEGKNCLRCWPELSALIDYDLQILWVTPGPPTELSQNRDHLEEETAKFFTQVHQAIKTLRDDKTVLLEEIYTHKNLFTERLNKISDGLKEKDIQSTLKVTSCADCRTHFLSCNDPTFCPARNRRTSLWAVSLSSALLLAIAGDVSFTGKGRRRQ,166,"18,842",Chain (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..15;  /evidence=""ECO:0000255"""
Q9UIK5,Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains),MVLWESPRQCSSWTLCEGFCWLLLLPVMLLIVARPVKLAAFPTSLSDCQTPTGWNCSGYDDRENDLFLCDTNTCKFDGECLRIGDTVTCVCQFKCNNDYVPVCGSNGESYQNECYLRQAACKQQSEILVVSEGSCATDAGSGSGDGVHEGSGETSQKETSTCDICQFGAECDEDAEDVWCVCNIDCSQTNFNPLCASDGKSYDNACQIKEASCQKQEKIEVMSLGRCQDNTTTTTKSEDGHYARTDYAENANKLEESAREHHIPCPEHYNGFCMHGKCEHSINMQEPSCRCDAGYTGQHCEKKDYSVLYVVPGPVRFQYVLIAAVIGTIQIAVICVVVLCITRKCPRSNRIHRQKQNTGHYSSDNTTRASTRLI,374,"41,428",Alternative sequence (4); Chain (1); Disulfide bond (9); Domain (3); Glycosylation (3); Region (1); Sequence caution (1); Sequence conflict (4); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 91..121;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 95..114;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 103..135;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 182..213;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 186..206;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 195..227;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00798""; DISULFID 265..278;  /evidence=""ECO:0000250""; DISULFID 273..289;  /evidence=""ECO:0000250""; DISULFID 291..300;  /evidence=""ECO:0000250""","SIGNAL 1..40;  /evidence=""ECO:0000269|PubMed:15340161"""
Q9BRN9,TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2) (BBP-like protein 2),MAGGVLPLRGLRALCRVLLFLSQFCILSGGEQSQALAQSIKDPGPTRTFTVVPRAAESTEIPPYVMKCPSNGLCSRLPADCIDCTTNFSCTYGKPVTFDCAVKPSVTCVDQDFKSQKNFIINMTCRFCWQLPETDYECTNSTSCMTVSCPRQRYPANCTVRDHVHCLGNRTFPKMLYCNWTGGYKWSTALALSITLGGFGADRFYLGQWREGLGKLFSFGGLGIWTLIDVLLIGVGYVGPADGSLYI,247,"27,118",Alternative sequence (1); Chain (1); Glycosylation (1); Sequence conflict (6); Signal peptide (1); Transmembrane (2),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
P07202,Thyroid peroxidase (TPO) (EC 1.11.1.8),MRALAVLSVTLVMACTEAFFPFISRGKELLWGKPEESRVSSVLEESKRLVDTAMYATMQRNLKKRGILSPAQLLSFSKLPEPTSGVIARAAEIMETSIQAMKRKVNLKTQQSQHPTDALSEDLLSIIANMSGCLPYMLPPKCPNTCLANKYRPITGACNNRDHPRWGASNTALARWLPPVYEDGFSQPRGWNPGFLYNGFPLPPVREVTRHVIQVSNEVVTDDDRYSDLLMAWGQYIDHDIAFTPQSTSKAAFGGGADCQMTCENQNPCFPIQLPEEARPAAGTACLPFYRSSAACGTGDQGALFGNLSTANPRQQMNGLTSFLDASTVYGSSPALERQLRNWTSAEGLLRVHARLRDSGRAYLPFVPPRAPAACAPEPGIPGETRGPCFLAGDGRASEVPSLTALHTLWLREHNRLAAALKALNAHWSADAVYQEARKVVGALHQIITLRDYIPRILGPEAFQQYVGPYEGYDSTANPTVSNVFSTAAFRFGHATIHPLVRRLDASFQEHPDLPGLWLHQAFFSPWTLLRGGGLDPLIRGLLARPAKLQVQDQLMNEELTERLFVLSNSSTLDLASINLQRGRDHGLPGYNEWREFCGLPRLETPADLSTAIASRSVADKILDLYKHPDNIDVWLGGLAENFLPRARTGPLFACLIGKQMKALRDGDWFWWENSHVFTDAQRRELEKHSLSRVICDNTGLTRVPMDAFQVGKFPEDFESCDSITGMNLEAWRETFPQDDKCGFPESVENGDFVHCEESGRRVLVYSCRHGYELQGREQLTCTQEGWDFQPPLCKDVNECADGAHPPCHASARCRNTKGGFQCLCADPYELGDDGRTCVDSGRLPRVTWISMSLAALLIGGFAGLTSTVICRWTRTGTKSTLPISETGGGTPELRCGKHQAVGTSPQRAAAQDSEQESAGMEGRDTHRLPRAL,933,"102,963",Active site (1); Alternative sequence (5); Binding site (2); Chain (1); Disulfide bond (8); Domain (2); Glycosylation (4); Metal binding (6); Natural variant (36); Sequence conflict (14); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 142..158;  /evidence=""ECO:0000250""; DISULFID 259..269;  /evidence=""ECO:0000250""; DISULFID 263..286;  /evidence=""ECO:0000250""; DISULFID 598..655;  /evidence=""ECO:0000250""; DISULFID 696..721;  /evidence=""ECO:0000250""; DISULFID 800..814;  /evidence=""ECO:0000250""; DISULFID 808..823;  /evidence=""ECO:0000250""; DISULFID 825..838;  /evidence=""ECO:0000250""","SIGNAL 1..18;  /evidence=""ECO:0000255"""
Q16827,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),MGHLPTGIHGARRLLPLLWLFVLFKNATAFHVTVQDDNNIVVSLEASDVISPASVYVVKITGESKNYFFEFEEFNSTLPPPVIFKASYHGLYYIITLVVVNGNVVTKPSRSITVLTKPLPVTSVSIYDYKPSPETGVLFEIHYPEKYNVFTRVNISYWEGKDFRTMLYKDFFKGKTVFNHWLPGMCYSNITFQLVSEATFNKSTLVEYSGVSHEPKQHRTAPYPPQNISVRIVNLNKNNWEEQSGNFPEESFMRSQDTIGKEKLFHFTEETPEIPSGNISSGWPDFNSSDYETTSQPYWWDSASAAPESEDEFVSVLPMEYENNSTLSETEKSTSGSFSFFPVQMILTWLPPKPPTAFDGFHIHIEREENFTEYLMVDEEAHEFVAELKEPGKYKLSVTTFSSSGSCETRKSQSAKSLSFYISPSGEWIEELTEKPQHVSVHVLSSTTALMSWTSSQENYNSTIVSVVSLTCQKQKESQRLEKQYCTQVNSSKPIIENLVPGAQYQVVIYLRKGPLIGPPSDPVTFAIVPTGIKDLMLYPLGPTAVVLSWTRPYLGVFRKYVVEMFYFNPATMTSEWTTYYEIAATVSLTASVRIANLLPAWYYNFRVTMVTWGDPELSCCDSSTISFITAPVAPEITSVEYFNSLLYISWTYGDDTTDLSHSRMLHWMVVAEGKKKIKKSVTRNVMTAILSLPPGDIYNLSVTACTERGSNTSMLRLVKLEPAPPKSLFAVNKTQTSVTLLWVEEGVADFFEVFCQQVGSSQKTKLQEPVAVSSHVVTISSLLPATAYNCSVTSFSHDSPSVPTFIAVSTMVTEMNPNVVVISVLAILSTLLIGLLLVTLIILRKKHLQMARECGAGTFVNFASLERDGKLPYNWRRSIFAFLTLLPSCLWTDYLLAFYINPWSKNGLKKRKLTNPVQLDDFDAYIKDMAKDSDYKFSLQFEELKLIGLDIPHFAADLPLNRCKNRYTNILPYDFSRVRLVSMNEEEGADYINANYIPGYNSPQEYIATQGPLPETRNDFWKMVLQQKSQIIVMLTQCNEKRRVKCDHYWPFTEEPIAYGDITVEMISEEEQDDWACRHFRINYADEMQDVMHFNYTAWPDHGVPTANAAESILQFVHMVRQQATKSKGPMIIHCSAGVGRTGTFIALDRLLQHIRDHEFVDILGLVSEMRSYRMSMVQTEEQYIFIHQCVQLMWMKKKQQFCISDVIYENVSKS,1216,"138,344",Active site (1); Alternative sequence (4); Beta strand (13); Binding site (2); Chain (1); Domain (9); Glycosylation (15); Helix (10); Modified residue (2); Region (1); Sequence conflict (18); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (3),,"SIGNAL 1..29;  /evidence=""ECO:0000255"""
Q9BVC6,Transmembrane protein 109 (Mitsugumin-23) (Mg23),MAASSISSPWGKHVFKAILMVLVALILLHSALAQSRRDFAPPGQQKREAPVDVLTQIGRSVRGTLDAWIGPETMHLVSESSSQVLWAISSAISVAFFALSGIAAQLLNALGLAGDYLAQGLKLSPGQVQTFLLWGAGALVVYWLLSLLLGLVLALLGRILWGLKLVIFLAGFVALMRSVPDPSTRALLLLALLILYALLSRLTGSRASGAQLEAKVRGLERQVEELRWRQRRAAKGARSVEEE,243,"26,210",Chain (1); Signal peptide (1); Topological domain (4); Transmembrane (3),,"SIGNAL 1..33;  /evidence=""ECO:0000255"""
P07204,Thrombomodulin (TM) (Fetomodulin) (CD antigen CD141),MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGGVGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEVKADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAPGAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQHRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHEPHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDCDSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKEVVLQHVRTERTPQRL,575,"60,329",Beta strand (14); Chain (1); Disulfide bond (19); Domain (7); Glycosylation (7); Helix (3); Modified residue (1); Natural variant (11); Region (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (2),"DISULFID 137..158;  /evidence=""ECO:0000250""; DISULFID 245..256;  /evidence=""ECO:0000250""; DISULFID 252..265;  /evidence=""ECO:0000250""; DISULFID 267..280;  /evidence=""ECO:0000250""; DISULFID 288..296;  /evidence=""ECO:0000250""; DISULFID 292..308;  /evidence=""ECO:0000250""; DISULFID 310..323;  /evidence=""ECO:0000250""; DISULFID 329..340;  /evidence=""ECO:0000250""; DISULFID 336..349;  /evidence=""ECO:0000250""; DISULFID 351..362;  /evidence=""ECO:0000250""; DISULFID 369..378;  /evidence=""ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:1ZAQ, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 374..388;  /evidence=""ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:1ZAQ, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 390..404;  /evidence=""ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:1TMR, ECO:0000244|PDB:1ZAQ, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 408..413;  /evidence=""ECO:0000244|PDB:1ADX, ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:2ADX, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 417..425;  /evidence=""ECO:0000244|PDB:1ADX, ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:2ADX, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 427..439;  /evidence=""ECO:0000244|PDB:1ADX, ECO:0000244|PDB:1DQB, ECO:0000244|PDB:1DX5, ECO:0000244|PDB:1EGT, ECO:0000244|PDB:1FGD, ECO:0000244|PDB:2ADX, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 445..455;  /evidence=""ECO:0000244|PDB:1DX5, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 451..464;  /evidence=""ECO:0000244|PDB:1DX5, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""; DISULFID 466..480;  /evidence=""ECO:0000244|PDB:1DX5, ECO:0000244|PDB:3GIS, ECO:0000244|PDB:5TO3""","SIGNAL 1..18;  /evidence=""ECO:0000269|PubMed:2820710"""
P28908,Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30),MRVLLAALGLLFLGALRAFPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQRPTDCRKQCEPDYYLDEADRCTACVTCSRDDLVEKTPCAWNSSRVCECRPGMFCSTSAVNSCARCFFHSVCPAGMIVKFPGTAQKNTVCEPASPGVSPACASPENCKEPSSGTIPQAKPTPVSPATSSASTMPVRGGTRLAQEAASKLTRAPDSPSSVGRPSSDPGLSPTQPCPEGSGDCRKQCEPDYYLDEAGRCTACVSCSRDDLVEKTPCAWNSSRTCECRPGMICATSATNSCARCVPYPICAAETVTKPQDMAEKDTTFEAPPLGTQPDCNPTPENGEAPASTSPTQSLLVDSQASKTLPIPTSAPVALSSTGKPVLDAGPVLFWVILVLVVVVGSSAFLLCHRRACRKRIRQKLHLCYPVQTSQPKLELVDSRPRRSSTQLRSGASVTEPVAEERGLMSQPLMETCHSVGAAYLESLPLQDASPAGGPSSPRDLPEPRVSTEHTNNKIEKIYIMKADTVIVGTVKAELPEGRGLAGPAEPELEEELEADHTPHYPEQETEPPLGSCSDVMLSVEEEGKEDPLPTAASGK,595,"63,747",Alternative sequence (3); Chain (1); Compositional bias (1); Disulfide bond (14); Glycosylation (4); Modified residue (2); Natural variant (6); Repeat (6); Signal peptide (1); Topological domain (2); Transmembrane (1),"DISULFID 29..44;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 45..58;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 48..65;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 69..81;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 84..98;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 87..106;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 108..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 131..149;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 233..240;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 244..256;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 259..273;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 262..281;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 283..297;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""; DISULFID 289..300;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00206""",SIGNAL 1..18
Q7Z7D3,V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x),MASLGQILFWSIISIIIILAGAIALIIGFGISGRHSITVTTVASAGNIGEDGILSCTFEPDIKLSDIVIQWLKEGVLGLVHEFKEGKDELSEQDEMFRGRTAVFADQVIVGNASLRLKNVQLTDAGTYKCYIITSKGKGNANLEYKTGAFSMPEVNVDYNASSETLRCEAPRWFPQPTVVWASQVDQGANFSEVSNTSFELNSENVTMKVVSVLYNVTINNTYSCMIENDIAKATGDIKVTESEIKRRSHLQLLNSKASLCVSSFFAISWALLPLSPYLMLK,282,"30,878",Alternative sequence (4); Beta strand (9); Chain (1); Disulfide bond (2); Domain (2); Glycosylation (1); Helix (4); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (1),"DISULFID 56..130;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 168..225;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..24;  /evidence=""ECO:0000255"""
P35968,Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309),MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV,1356,"151,527",Active site (1); Alternative sequence (4); Beta strand (55); Binding site (1); Chain (1); Disulfide bond (7); Domain (8); Glycosylation (18); Helix (23); Modified residue (15); Mutagenesis (11); Natural variant (16); Nucleotide binding (1); Sequence conflict (9); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1); Turn (10),"DISULFID 53..103;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 150..200; DISULFID 246..307; DISULFID 445..530;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 571..642;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 688..737;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 1024..1045;  /note=""Redox-active""","SIGNAL 1..19;  /evidence=""ECO:0000255"""
P0DP72,V-set and immunoglobulin domain-containing protein 10-like 2,MVGQRAQHSPVSLLLLIHLCLLHLRASGQPHPTPEAPVEEVVSVQGVRGGSVELACGSGPAPLLVLWSFTPLGSLVPRPVAVTDGAMSKVEAIASALGVVSLRNSSLVLGELHEGARGHFLCQVLHVAGGQLHAAYSHLTLAVLVPVSKPQVRLSNPSPVEGASVVATCAVREGTEPVTFAWQHRAPRGLGEALVGVTEPLFQLDPVNRTHLGWYMCSASNSVNRLSSDGAFLDVIYGPDKPVITMEPLGLTEEGFWASEREEVTLSCLAASNPPSHYVWLRDHTQVHTGPTYVIARAGRVHTGLYTCLARNSYLDTRTQTTVQLTIYYPPEGQPSCAVHPSPEAVTLLCAWPGGLPPAQLQWEGPQGPGPTAPSNVTWSHAAAQLPSGSVFTCTGQHPALAPPALCTVMLWEPLGRPTCWSTATMGDQFIMLSCEWPGGEPPATLGWLDEQQQPLGGSSSSMAVHLLQAQEDLAGREFTCRGTHLLRTPDPHCHLQLEAPQLDVAEPRVSVLEGGEAWLECSLRGGTPPAQLLWLGPQQQKVDPGTSGFMLHPEGAQLRLGIYDADPAHHRGTYQCVARNAVGNSSQSVLLEVLRYPAPPNVTISRLTYGRHRREVQLQWAILGPGNLTGFLVQRKASALGPGAGAWETAASDIEPESRGRRLGGLDPGVLYAFRILALNHHTAGHPSEVKIPADPPFSAYPAVLGAAGTGMVVATVASLLVFQYAARHPETFPRLETPTTTPGLDPAQETTDSPVNVTITVTATP,767,"81,629",Chain (1); Disulfide bond (5); Domain (6); Glycosylation (3); Signal peptide (1); Transmembrane (1),"DISULFID 56..122;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 169..217;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 268..308;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 435..481;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""; DISULFID 522..577;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00114""","SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q9NYK1,Toll-like receptor 7,MVFPMWTLKRQILILFNIILISKLLGARWFPKTLPCDVTLDVPKNHVIVDCTDKHLTEIPGGIPTNTTNLTLTINHIPDISPASFHRLDHLVEIDFRCNCVPIPLGSKNNMCIKRLQIKPRSFSGLTYLKSLYLDGNQLLEIPQGLPPSLQLLSLEANNIFSIRKENLTELANIEILYLGQNCYYRNPCYVSYSIEKDAFLNLTKLKVLSLKDNNVTAVPTVLPSTLTELYLYNNMIAKIQEDDFNNLNQLQILDLSGNCPRCYNAPFPCAPCKNNSPLQIPVNAFDALTELKVLRLHSNSLQHVPPRWFKNINKLQELDLSQNFLAKEIGDAKFLHFLPSLIQLDLSFNFELQVYRASMNLSQAFSSLKSLKILRIRGYVFKELKSFNLSPLHNLQNLEVLDLGTNFIKIANLSMFKQFKRLKVIDLSVNKISPSGDSSEVGFCSNARTSVESYEPQVLEQLHYFRYDKYARSCRFKNKEASFMSVNESCYKYGQTLDLSKNSIFFVKSSDFQHLSFLKCLNLSGNLISQTLNGSEFQPLAELRYLDFSNNRLDLLHSTAFEELHKLEVLDISSNSHYFQSEGITHMLNFTKNLKVLQKLMMNDNDISSSTSRTMESESLRTLEFRGNHLDVLWREGDNRYLQLFKNLLKLEELDISKNSLSFLPSGVFDGMPPNLKNLSLAKNGLKSFSWKKLQCLKNLETLDLSHNQLTTVPERLSNCSRSLKNLILKNNQIRSLTKYFLQDAFQLRYLDLSSNKIQMIQKTSFPENVLNNLKMLLLHHNRFLCTCDAVWFVWWVNHTEVTIPYLATDVTCVGPGAHKGQSVISLDLYTCELDLTNLILFSLSISVSLFLMVMMTASHLYFWDVWYIYHFCKAKIKGYQRLISPDCCYDAFIVYDTKDPAVTEWVLAELVAKLEDPREKHFNLCLEERDWLPGQPVLENLSQSIQLSKKTVFVMTDKYAKTENFKIAFYLSHQRLMDEKVDVIILIFLEKPFQKSKFLQLRKRLCGSSVLEWPTNPQAHPYFWQCLKNALATDNHVAYSQVFKETV,1049,"120,922",Chain (1); Domain (1); Glycosylation (14); Natural variant (2); Repeat (27); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..26;  /evidence=""ECO:0000255"""
A0A1B0GTY4,Testis-expressed protein 50,MSNQRLPLIFSLLFICFFGESFCICDGTVWTKVGWEILPEEVHYWKVKGSPSHCLPYLLDKLCCDFANMDIFQGCLYLIYNLLQAVFFVLFVLSVHYLWKKWKKHQKKLKKQASLEKPGNDLESPLINNIDQTLHRVATTASVIYKIWEHRSHHPSSKKIKHCKLKKKSKEEGARRY,177,"20,847",Chain (1); Signal peptide (1); Transmembrane (1),,"SIGNAL 1..23;  /evidence=""ECO:0000255"""
O43493,Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2),MRFVVALVLLNVAAAGAVPLLATESVKQEEAGVRPSAGNVSTHPSLSQRPGGSTKSHPEPQTPKDSPSKSSAEAQTPEDTPNKSGAEAKTQKDSSNKSGAEAKTQKGSTSKSGSEAQTTKDSTSKSHPELQTPKDSTGKSGAEAQTPEDSPNRSGAEAKTQKDSPSKSGSEAQTTKDVPNKSGADGQTPKDGSSKSGAEDQTPKDVPNKSGAEKQTPKDGSNKSGAEEQGPIDGPSKSGAEEQTSKDSPNKVVPEQPSRKDHSKPISNPSDNKELPKADTNQLADKGKLSPHAFKTESGEETDLISPPQEEVKSSEPTEDVEPKEAEDDDTGPEEGSPPKEEKEKMSGSASSENREGTLSDSTGSEKDDLYPNGSGNGSAESSHFFAYLVTAAILVAVLYIAHHNKRKIIAFVLEGKRSKVTRRPKASDYQRLDQKS,437,"45,880",Alternative sequence (6); Chain (1); Glycosylation (9); Modified residue (5); Motif (3); Mutagenesis (1); Natural variant (8); Region (1); Repeat (14); Sequence conflict (14); Signal peptide (1); Topological domain (2); Transmembrane (1),,"SIGNAL 1..21;  /evidence=""ECO:0000255"""
Q9HD45,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),MRPLPGALGVAAAAALWLLLLLLPRTRADEHEHTYQDKEEVVLWMNTVGPYHNRQETYKYFSLPFCVGSKKSISHYHETLGEALQGVELEFSGLDIKFKDDVMPATYCEIDLDKEKRDAFVYAIKNHYWYQMYIDDLPIWGIVGEADENGEDYYLWTYKKLEIGFNGNRIVDVNLTSEGKVKLVPNTKIQMSYSVKWKKSDVKFEDRFDKYLDPSFFQHRIHWFSIFNSFMMVIFLVGLVSMILMRTLRKDYARYSKEEEMDDMDRDLGDEYGWKQVHGDVFRPSSHPLIFSSLIGSGCQIFAVSLIVIIVAMIEDLYTERGSMLSTAIFVYAATSPVNGYFGGSLYARQGGRRWIKQMFIGAFLIPAMVCGTAFFINFIAIYYHASRAIPFGTMVAVCCICFFVILPLNLVGTILGRNLSGQPNFPCRVNAVPRPIPEKKWFMEPAVIVCLGGILPFGSIFIEMYFIFTSFWAYKIYYVYGFMMLVLVILCIVTVCVTIVCTYFLLNAEDYRWQWTSFLSAASTAIYVYMYSFYYYFFKTKMYGLFQTSFYFGYMAVFSTALGIMCGAIGYMGTSAFVRKIYTNVKID,589,"67,888",Chain (1); Erroneous initiation (1); Frameshift (2); Glycosylation (2); Sequence conflict (6); Signal peptide (1); Transmembrane (9),,"SIGNAL 1..28;  /evidence=""ECO:0000255"""
Q8WWF5,E3 ubiquitin-protein ligase ZNRF4 (EC 2.3.2.27) (Nixin) (RING finger protein 204) (RING-type E3 ubiquitin transferase ZNRF4) (Zinc/RING finger protein 4),MPLCRPEHLMPRASRVPVAASLPLSHAVIPTQLPSRPGHRPPGRPRRCPKASCLPPPVGPSSTQTAKRVTMGWPRPGRALVAVKALLVLSLLQVPAQAVVRAVLEDNSSSVDFADLPALFGVPLAPEGIRGYLMEVKPANACHPIEAPRLGNRSLGAIVLIRRYDCTFDLKVLNAQRAGFEAAIVHNVHSDDLVSMTHVYEDLRGQIAIPSVFVSEAASQDLRVILGCNKSAHALLLPDDPPCHDLGCHPVLTVSWVLGCTLALVVSAFFVLNHLWLWAQACCSHRRPVKTSTCQKAQVRTFTWHNDLCAICLDEYEEGDQLKILPCSHTYHCKCIDPWFSQAPRRSCPVCKQSVAATEDSFDSTTYSFRDEDPSLPGHRPPIWAIQVQLRSRRLELLGRASPHCHCSTTSLEAEYTTVSSAPPEAPGQ,429,"46,958",Chain (1); Domain (1); Erroneous initiation (1); Glycosylation (3); Mutagenesis (4); Natural variant (8); Sequence conflict (1); Signal peptide (1); Topological domain (2); Transmembrane (1); Zinc finger (1),,"SIGNAL 1..27;  /evidence=""ECO:0000255"""
O95185,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),MRKGLRATAARCGLGLGYLLQMLVLPALALLSASGTGSAAQDDDFFHELPETFPSDPPEPLPHFLIEPEEAYIVKNKPVNLYCKASPATQIYFKCNSEWVHQKDHIVDERVDETSGLIVREVSIEISRQQVEELFGPEDYWCQCVAWSSAGTTKSRKAYVRIAYLRKTFEQEPLGKEVSLEQEVLLQCRPPEGIPVAEVEWLKNEDIIDPVEDRNFYITIDHNLIIKQARLSDTANYTCVAKNIVAKRKSTTATVIVYVNGGWSTWTEWSVCNSRCGRGYQKRTRTCTNPAPLNGGAFCEGQSVQKIACTTLCPVDGRWTPWSKWSTCGTECTHWRRRECTAPAPKNGGKDCDGLVLQSKNCTDGLCMQTAPDSDDVALYVGIVIAVIVCLAISVVVALFVYRKNHRDFESDIIDSSALNGGFQPVNIKAARQDLLAVPPDLTSAAAMYRGPVYALHDVSDKIPMTNSPILDPLPNLKIKVYNTSGAVTPQDDLSEFTSKLSPQMTQSLLENEALSLKNQSLARQTDPSCTAFGSFNSLGGHLIVPNSGVSLLIPAGAIPQGRVYEMYVTVHRKETMRPPMDDSQTLLTPVVSCGPPGALLTRPVVLTMHHCADPNTEDWKILLKNQAAQGQWEDVVVVGEENFTTPCYIQLDAEACHILTENLSTYALVGHSTTKAAAKRLKLAIFGPLCCSSLEYSIRVYCLDDTQDALKEILHLERQMGGQLLEEPKALHFKGSTHNLRLSIHDIAHSLWKSKLLAKYQEIPFYHVWSGSQRNLHCTFTLERFSLNTVELVCKLCVRQVEGEGQIFQLNCTVSEEPTGIDLPLLDPANTITTVTGPSAFSIPLPIRQKLCSSLDAPQTRGHDWRMLAHKLNLDRYLNYFATKSSPTGVILDLWEAQNFPDGNLSMLAAVLEEMGRHETVVSLAAEGQY,931,"103,146",Alternative sequence (2); Chain (1); Disulfide bond (9); Domain (6); Glycosylation (2); Modified residue (2); Natural variant (4); Region (2); Sequence conflict (3); Signal peptide (1); Site (1); Topological domain (2); Transmembrane (1),"DISULFID 83..144;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 95..142;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 188..239;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 272..309;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 276..313;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 287..299;  /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DISULFID 328..362;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 332..367;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""; DISULFID 340..352;  /evidence=""ECO:0000250|UniProtKB:Q6ZN44""","SIGNAL 1..40;  /evidence=""ECO:0000255"""
P05556,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGECIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDIENPRGSKDIKKNKNVTNRSKGTAEKLKPEDITQIQPQQLVLRLRSGEPQTFTLKFKRAEDYPIDLYYLMDLSYSMKDDLENVKSLGTDLMNEMRRITSDFRIGFGSFVEKTVMPYISTTPAKLRNPCTSEQNCTSPFSYKNVLSLTNKGEVFNELVGKQRISGNLDSPEGGFDAIMQVAVCGSLIGWRNVTRLLVFSTDAGFHFAGDGKLGGIVLPNDGQCHLENNMYTMSHYYDYPSIAHLVQKLSENNIQTIFAVTEEFQPVYKELKNLIPKSAVGTLSANSSNVIQLIIDAYNSLSSEVILENGKLSEGVTISYKSYCKNGVNGTGENGRKCSNISIGDEVQFEISITSNKCPKKDSDSFKIRPLGFTEEVEVILQYICECECQSEGIPESPKCHEGNGTFECGACRCNEGRVGRHCECSTDEVNSEDMDAYCRKENSSEICSNNGECVCGQCVCRKRDNTNEIYSGKFCECDNFNCDRSNGLICGGNGVCKCRVCECNPNYTGSACDCSLDTSTCEASNGQICNGRGICECGVCKCTDPKFQGQTCEMCQTCLGVCAEHKECVQCRAFNKGEKKDTCTQECSYFNITKVESRDKLPQPVQPDPVSHCKEKDVDDCWFYFTYSVNGNNEVMVHVVENPECPTGPDIIPIVAGVVAGIVLIGLALLLIWKLLMIIHDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK,798,"88,415",Alternative sequence (4); Beta strand (21); Chain (1); Cross-link (1); Disulfide bond (28); Domain (1); Erroneous initiation (1); Glycosylation (12); Helix (21); Metal binding (11); Modified residue (5); Mutagenesis (14); Region (5); Repeat (4); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (6),"DISULFID 27..45;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 35..464;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 38..64;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 48..75;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 207..213;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 261..301;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 401..415;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 435..462;  /evidence=""ECO:0000269|PubMed:22451694""; DISULFID 466..691;  /evidence=""ECO:0000305|PubMed:22451694""; DISULFID 477..489;  /evidence=""ECO:0000250""; DISULFID 486..525;  /evidence=""ECO:0000250""; DISULFID 491..500;  /evidence=""ECO:0000250""; DISULFID 502..516;  /evidence=""ECO:0000250""; DISULFID 531..536;  /evidence=""ECO:0000250""; DISULFID 533..568;  /evidence=""ECO:0000250""; DISULFID 538..553;  /evidence=""ECO:0000250""; DISULFID 555..560;  /evidence=""ECO:0000250""; DISULFID 574..579;  /evidence=""ECO:0000250""; DISULFID 576..607;  /evidence=""ECO:0000250""; DISULFID 581..590;  /evidence=""ECO:0000250""; DISULFID 592..599;  /evidence=""ECO:0000250""; DISULFID 613..618;  /evidence=""ECO:0000250""; DISULFID 615..661;  /evidence=""ECO:0000250""; DISULFID 620..630;  /evidence=""ECO:0000250""; DISULFID 633..636;  /evidence=""ECO:0000250""; DISULFID 640..649;  /evidence=""ECO:0000250""; DISULFID 646..723;  /evidence=""ECO:0000250""; DISULFID 665..699;  /evidence=""ECO:0000250""",SIGNAL 1..20
P08575,Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45),MTMYLWLKLLAFGFAFLDTEVFVTGQSPTPSPTGLTTAKMPSVPLSSDPLPTHTTAFSPASTFERENDFSETTTSLSPDNTSTQVSPDSLDNASAFNTTGVSSVQTPHLPTHADSQTPSAGTDTQTFSGSAANAKLNPTPGSNAISDVPGERSTASTFPTDPVSPLTTTLSLAHHSSAALPARTSNTTITANTSDAYLNASETTTLSPSGSAVISTTTIATTPSKPTCDEKYANITVDYLYNKETKLFTAKLNVNENVECGNNTCTNNEVHNLTECKNASVSISHNSCTAPDKTLILDVPPGVEKFQLHDCTQVEKADTTICLKWKNIETFTCDTQNITYRFQCGNMIFDNKEIKLENLEPEHEYKCDSEILYNNHKFTNASKIIKTDFGSPGEPQIIFCRSEAAHQGVITWNPPQRSFHNFTLCYIKETEKDCLNLDKNLIKYDLQNLKPYTKYVLSLHAYIIAKVQRNGSAAMCHFTTKSAPPSQVWNMTVSMTSDNSMHVKCRPPRDRNGPHERYHLEVEAGNTLVRNESHKNCDFRVKDLQYSTDYTFKAYFHNGDYPGEPFILHHSTSYNSKALIAFLAFLIIVTSIALLVVLYKIYDLHKKRSCNLDEQQELVERDDEKQLMNVEPIHADILLETYKRKIADEGRLFLAEFQSIPRVFSKFPIKEARKPFNQNKNRYVDILPYDYNRVELSEINGDAGSNYINASYIDGFKEPRKYIAAQGPRDETVDDFWRMIWEQKATVIVMVTRCEEGNRNKCAEYWPSMEEGTRAFGDVVVKINQHKRCPDYIIQKLNIVNKKEKATGREVTHIQFTSWPDHGVPEDPHLLLKLRRRVNAFSNFFSGPIVVHCSAGVGRTGTYIGIDAMLEGLEAENKVDVYGYVVKLRRQRCLMVQVEAQYILIHQALVEYNQFGETEVNLSELHPYLHNMKKRDPPSEPSPLEAEFQRLPSYRSWRTQHIGNQEENKSKNRNSNVIPYDYNRVPLKHELEMSKESEHDSDESSDDDSDSEEPSKYINASFIMSYWKPEVMIAAQGPLKETIGDFWQMIFQRKVKVIVMLTELKHGDQEICAQYWGEGKQTYGDIEVDLKDTDKSSTYTLRVFELRHSKRKDSRTVYQYQYTNWSVEQLPAEPKELISMIQVVKQKLPQKNSSEGNKHHKSTPLLIHCRDGSQQTGIFCALLNLLESAETEEVVDIFQVVKALRKARPGMVSTFEQYQFLYDVIASTYPAQNGQVKKNNHQEDKIEFDNEVDKVKQDANCVNPLGAPEKLPEAKEQAEGSEPTSGTEGPEHSVNGPASPALNQGS,1306,"147,486",Active site (2); Alternative sequence (6); Beta strand (53); Binding site (2); Chain (1); Domain (4); Erroneous initiation (3); Glycosylation (17); Helix (23); Modified residue (9); Mutagenesis (1); Natural variant (8); Region (1); Sequence conflict (2); Signal peptide (1); Topological domain (2); Transmembrane (1); Turn (12),,SIGNAL 1..25
